PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pan, J; Qian, Y; Zhou, XD; Lu, H; Ramacciotti, E; Zhang, LJ				Pan, Jing; Qian, Yi; Zhou, Xiaodong; Lu, Hong; Ramacciotti, Eduardo; Zhang, Lijuan			Chemically Oversulfated Glycosaminoglycans Are Potent Modulators of Contact System Activation and Different Cell Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; ADVERSE CLINICAL EVENTS; CHONDROITIN SULFATE-E; CONTAMINATED HEPARIN; FACTOR-XII; MITOGENIC ACTIVITY; PLASMA KALLIKREIN; CRYSTAL-STRUCTURE; DERMATAN SULFATE; HIGH-AFFINITY	Contaminated heparin was associated with adverse reactions by activating the contact system. Chemically oversulfated/modified glycosaminoglycans (GAGs) consisting of heparan sulfate, dermatan sulfate, and chondroitin sulfate have been identified as heparin contaminants. Current studies demonstrated that each component of oversulfated GAGs was comparable with oversulfated chondroitin sulfate in activating the contact system. By testing a series of unrelated negatively charged compounds, we found that the contact system recognized negative charges rather than specific chemical structures. We further tested how oversulfated GAGs and contaminated heparins affect different cell signaling pathways. Our data showed that chemically oversulfated GAGs and contaminated heparin had higher activity than the parent compounds and authentic heparin, indicative of sulfation-dominant and GAG sequence-dependent activities in BaF cell-based models of fibroblast growth factor/fibroblast growth factor receptor, glial cell line-derived neurotrophic factor/c-Ret, and hepatocyte growth factor/c-Met signaling. In summary, these data indicate that contaminated heparins intended for blood anticoagulation not only activated the contact system but also modified different GAG-dependent cell signaling pathways.	[Pan, Jing; Qian, Yi; Zhou, Xiaodong; Lu, Hong; Zhang, Lijuan] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Ramacciotti, Eduardo] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA; [Ramacciotti, Eduardo] Univ Michigan, Ctr Cardiovasc, Vasc Surg Sect, Jobst Vasc Surg Res Lab, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Loyola University Chicago; University of Michigan System; University of Michigan	Zhang, LJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	ljzhang@wustl.edu	Zhou, Xiaodong/B-4017-2011	Ramacciotti, Eduardo/0000-0002-5735-1333	National Institutes of Health [R01GM069968]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM069968 (to L.Z.).	Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bischof D, 2006, BLOOD, V107, P3235, DOI 10.1182/blood-2005-01-0256; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Clark A, 2008, MOL IMMUNOL, V45, P3125, DOI 10.1016/j.molimm.2008.03.008; Colman R, 2006, HEMOSTASIS THROMBOSI, P107; Conrad H. E., 1998, HEPARIN BINDING PROT; Davies JA, 2003, GROWTH FACTORS, V21, P109, DOI 10.1080/08977190310001621005; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Fareed J, 2008, SEMIN THROMB HEMOST, V34, P58, DOI 10.1055/s-2008-1066025; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; GAO GX, 1995, EMBO J, V14, P2183, DOI 10.1002/j.1460-2075.1995.tb07212.x; Gilstad CW, 2003, CURR OPIN HEMATOL, V10, P419, DOI 10.1097/00062752-200311000-00004; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Guerrini M, 2009, P NATL ACAD SCI USA, V106, P16956, DOI 10.1073/pnas.0906861106; HOJIMA Y, 1984, BLOOD, V63, P1453; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; JENNY NS, 2006, HEMOSTASIS THROMBOSI, P193; Keire DA, 2010, J PHARMACEUT BIOMED, V51, P921, DOI 10.1016/j.jpba.2009.10.017; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Krufka A, 1996, BIOCHEMISTRY-US, V35, P11131, DOI 10.1021/bi960125+; Lyon M, 2004, J BIOL CHEM, V279, P43560, DOI 10.1074/jbc.M408510200; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; McDowell LM, 2006, J BIOL CHEM, V281, P6924, DOI 10.1074/jbc.M512932200; MCKEE J, 2010, J CLIN PHARM; Meth MJ, 2006, DRUG SAFETY, V29, P133, DOI 10.2165/00002018-200629020-00003; Mullins ES, 2009, BLOOD, V113, P696, DOI 10.1182/blood-2008-07-169003; NAGASAWA K, 1986, CARBOHYD RES, V158, P183, DOI 10.1016/0008-6215(86)84016-2; NAGGI A, 1987, BIOCHEM PHARMACOL, V36, P1895, DOI 10.1016/0006-2952(87)90485-0; Onodera H, 1999, NEPHROL DIAL TRANSPL, V14, P1604, DOI 10.1093/ndt/14.6.1604; PAN J, 2010, GLYCOBIOL INSIGHTS, V2, P1; Pan J, 2010, NAT BIOTECHNOL, V28, P203, DOI 10.1038/nbt0310-203; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Qian Y, 2010, CLIN APPL THROMB-HEM, V16, P251, DOI 10.1177/1076029610362072; Qian Y, 2010, CLIN APPL THROMB-HEM, V16, P261, DOI 10.1177/1076029610362073; Rolny C, 2002, J BIOL CHEM, V277, P19315, DOI 10.1074/jbc.M111805200; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Saito A, 2007, BBA-GEN SUBJECTS, V1770, P241, DOI 10.1016/j.bbagen.2006.10.015; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Schwall RH, 1996, J CELL BIOL, V133, P709, DOI 10.1083/jcb.133.3.709; SHIMADA T, 1985, THROMB RES, V38, P21, DOI 10.1016/0049-3848(85)90004-0; SHIMADA T, 1985, J BIOCHEM-TOKYO, V97, P429, DOI 10.1093/oxfordjournals.jbchem.a135077; SHIMOMURA T, 1993, J BIOL CHEM, V268, P22927; Thompson RW, 1990, GROWTH FACTORS, V3, P221, DOI 10.3109/08977199009043906; Toida T, 1999, INT J BIOL MACROMOL, V26, P233, DOI 10.1016/S0141-8130(99)00088-4; UCHIYAMA H, 1991, J BIOL CHEM, V266, P6756; VANDERGRAAF F, 1983, J CLIN INVEST, V71, P149, DOI 10.1172/JCI110743; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; ZIONCHECK TF, 1995, J BIOL CHEM, V270, P16871, DOI 10.1074/jbc.270.28.16871	56	50	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					22964	22973		10.1074/jbc.M109.063735	http://dx.doi.org/10.1074/jbc.M109.063735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20418371	hybrid, Green Published			2022-12-27	WOS:000279999900031
J	Gupta, K; Diamond, T; Hwang, Y; Bushman, F; Van Duyne, GD				Gupta, Kushol; Diamond, Tracy; Hwang, Young; Bushman, Frederic; Van Duyne, Gregory D.			Structural Properties of HIV Integrase.Lens Epithelium-derived Growth Factor Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; RETROVIRAL DNA INTEGRATION; BINDING DOMAIN; CRYSTAL-STRUCTURE; TERMINAL DOMAINS; IN-VITRO; LEDGF/P75; PROTEINS; IDENTIFICATION; SCATTERING	Integrase (IN) is the catalytic component of the preintegration complex, a large nucleoprotein assembly critical for the integration of the retroviral genome into a host chromosome. Although partial crystal structures of human immunodeficiency virus IN alone and its complex with the integrase binding domain of the host factor PSIP1/lens epithelium-derived growth factor (LEDGF)/p75 are available, many questions remain regarding the properties and structures of LEDGF-bound IN oligomers. Using analytical ultracentrifugation, multiangle light scattering, and small angle x-ray scattering, we have established the oligomeric state, stoichiometry, and molecular shapes of IN center dot LEDGF complexes in solution. Analyses of intact IN tetramers bound to two different LEDGF truncations allow for placement of the integrase binding domain by difference analysis. Modeling of the small angle x-ray scattering envelopes using existing structural data suggests domain arrangements in the IN oligomers that support and extend existing biochemical data for IN center dot LEDGF complexes and lend new insights into the quaternary structure of LEDGF-bound IN tetramers. These IN oligomers may be involved in stages of the viral life cycle other than integration, including assembly, budding, and early replication.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19105 USA; Howard Hughes Med Inst, Philadelphia, PA 19105 USA; [Diamond, Tracy; Hwang, Young; Bushman, Frederic] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Van Duyne, GD (corresponding author), Univ Penn, Howard Hughes Med Inst, Sch Med, Dept Biochem & Biophys, 809C Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	vanduyne@mail.med.upenn.edu	Gupta, Kushol/GOE-5620-2022	Gupta, Kushol/0000-0002-7006-2667; Bushman, Frederic/0000-0003-4740-4056	National Institutes of Health [AI52845, AI082020, RR-01646]; University of Pennsylvania Center for AIDS Research; Penn Genome Frontiers Institute; Pennsylvania Department of Health; Swarthmore College; amfAR Mathilde Krim Fellowship in Basic Biomedical Research [106994-43-RFNT]; National Science Foundation [DMR 0225180]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052845, R01AI082020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research; Penn Genome Frontiers Institute; Pennsylvania Department of Health; Swarthmore College; amfAR Mathilde Krim Fellowship in Basic Biomedical Research; National Science Foundation(National Science Foundation (NSF)); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI52845 and AI082020. This work was also supported by the University of Pennsylvania Center for AIDS Research, the Penn Genome Frontiers Institute, and a grant from the Pennsylvania Department of Health.; Supported by a Swarthmore College Postdoctoral Teaching Fellowship and the amfAR Mathilde Krim Fellowship in Basic Biomedical Research 106994-43-RFNT.; We are grateful to Marc Ruff for supplying the model coordinates derived from the cryo-EM studies by his group; Richard Gillilan (Cornell University High Energy Synchrotron Source), Hiro Tsuruta (Stanford Synchrotron Radiation Light Source), and Lin Yang (National Synchrotron Light Source) for their technical expertise and support; and G. V. and F. B. laboratory members for helpful discussions. Cornell University High Energy Synchrotron Source is supported by National Science Foundation Grant DMR 0225180, and the MacCHESS facility is supported by National Institutes of Health Grant RR-01646. Financial support for the National Synchrotron Light Source comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from the National Center for Research Resources, National Institutes of Health. The Stanford Synchrotron Radiation Light Source is a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Baranova S, 2007, NUCLEIC ACIDS RES, V35, P975, DOI 10.1093/nar/gkl1111; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Berthoux L, 2007, VIROLOGY, V364, P227, DOI 10.1016/j.virol.2007.02.029; Birmanns S, 2007, J STRUCT BIOL, V157, P271, DOI 10.1016/j.jsb.2006.08.008; Bosserman MA, 2007, BIOCHEMISTRY-US, V46, P11231, DOI 10.1021/bi700197a; Briones MS, 2010, J VIROL, V84, P5181, DOI 10.1128/JVI.02382-09; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; CARTEAU S, 1993, ARCH BIOCHEM BIOPHYS, V300, P756, DOI 10.1006/abbi.1993.1105; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ciuffi A, 2006, HUM GENE THER, V17, P960, DOI 10.1089/hum.2006.17.960; Craigie R, 2002, MOBILE DNA, P613; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano W.L, PYMOL MOL GRAPHICS S; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Deprez E, 2001, P NATL ACAD SCI USA, V98, P10090, DOI 10.1073/pnas.181024498; Diamond TL, 2005, J VIROL, V79, P15376, DOI 10.1128/JVI.79.24.15376-15387.2005; Dolan J, 2009, J MOL BIOL, V385, P568, DOI 10.1016/j.jmb.2008.10.083; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Havlir DV, 2008, NEW ENGL J MED, V359, P416, DOI 10.1056/NEJMe0804289; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Nishitsuji H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007825; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Van Duyne GD, 2008, RSC BIOMOL SCI, P303, DOI 10.1039/9781847558268-00303; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Vogt V.M., 1997, RETROVIRUSES, P263; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wang LD, 2005, BIOCHEM BIOPH RES CO, V337, P313, DOI 10.1016/j.bbrc.2005.08.274; WOERNER AM, 1993, NUCLEIC ACIDS RES, V21, P3507, DOI 10.1093/nar/21.15.3507; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000	75	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20303	20315		10.1074/jbc.M110.114413	http://dx.doi.org/10.1074/jbc.M110.114413			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406807	Green Published, hybrid			2022-12-27	WOS:000279012000065
J	El-Kadi, AM; Bros-Facer, V; Deng, WH; Philpott, A; Stoddart, E; Banks, G; Jackson, GS; Fisher, EMC; Duchen, MR; Greensmith, L; Moore, AL; Hafezparast, M				El-Kadi, Ali Morsi; Bros-Facer, Virginie; Deng, Wenhan; Philpott, Amelia; Stoddart, Eleanor; Banks, Gareth; Jackson, Graham S.; Fisher, Elizabeth M. C.; Duchen, Michael R.; Greensmith, Linda; Moore, Anthony L.; Hafezparast, Majid			The Legs at odd angles (Loa) Mutation in Cytoplasmic Dynein Ameliorates Mitochondrial Function in SOD1(G93A) Mouse Model for Motor Neuron Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FAST AXONAL-TRANSPORT; LINKED SOD1 MUTANTS; SUPEROXIDE-DISMUTASE; DEGENERATION; DYSFUNCTION; SURVIVAL; DEFECTS; CELLS; ONSET	Amyotrophic lateral sclerosis (ALS) is a debilitating and fatal late-onset neurodegenerative disease. Familial cases of ALS (FALS) constitute similar to 10% of all ALS cases, and mutant superoxide dismutase 1 (SOD1) is found in 15-20% of FALS. SOD1 mutations confer a toxic gain of unknown function to the protein that specifically targets the motor neurons in the cortex and the spinal cord. We have previously shown that the autosomal dominant Legs at odd angles (Loa) mutation in cytoplasmic dynein heavy chain (Dync1h1) delays disease onset and extends the life span of transgenic mice harboring human mutant SOD1(G93A). In this study we provide evidence that despite the lack of direct interactions between mutant SOD1 and either mutant or wild-type cytoplasmic dynein, the Loa mutation confers significant reductions in the amount of mutant SOD1 protein in the mitochondrial matrix. Moreover, we show that the Loa mutation ameliorates defects in mitochondrial respiration and membrane potential observed in SOD1(G93A) motor neuron mitochondria. These data suggest that the Loa mutation reduces the vulnerability of mitochondria to the toxic effects of mutant SOD1, leading to improved mitochondrial function in SOD1(G93A) motor neurons.	[El-Kadi, Ali Morsi; Deng, Wenhan; Philpott, Amelia; Stoddart, Eleanor; Moore, Anthony L.; Hafezparast, Majid] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Bros-Facer, Virginie; Greensmith, Linda] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Banks, Gareth; Jackson, Graham S.; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Duchen, Michael R.] UCL Div Biosci, London WC1B 6BT, England	University of Sussex; University of London; University College London; University of London; University College London; University of London; University College London	Hafezparast, M (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	m.hafezparast@sussex.ac.uk	Hafezparast, Majid/N-8292-2019; duchen, michael/A-2116-2009; Fisher, Elizabeth MC/C-2168-2008; Hafezparast, Majid/H-6728-2018	Hafezparast, Majid/0000-0002-5262-7150; duchen, michael/0000-0003-2548-4294; Fisher, Elizabeth MC/0000-0003-2850-9936; Jackson, Graham/0000-0002-3125-2011; Banks, Gareth/0000-0002-8647-667X	Medical Research Council; Biotechnology and Biological Sciences Research Council; Amyotrophic Lateral Sclerosis Association and Robert Packard Center for ALS Research at Johns Hopkins; Brain Research Trust; Wellcome Trust; University of Sussex; BBSRC [BB/D012309/1] Funding Source: UKRI; MRC [MC_U123170362, G0500288, G0500865, G0601943] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D012309/1] Funding Source: researchfish; Medical Research Council [G0500865, G0601943, MC_U123170362, G0500288, G0601943B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Amyotrophic Lateral Sclerosis Association and Robert Packard Center for ALS Research at Johns Hopkins; Brain Research Trust; Wellcome Trust(Wellcome Trust); University of Sussex; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (to M. H., A. M. E.-K., and E. S.), the Biotechnology and Biological Sciences Research Council (to M. H., W. D., and A. L. M.), the Amyotrophic Lateral Sclerosis Association and Robert Packard Center for ALS Research at Johns Hopkins (to M. H., L. G., E. M. C. F., and V. B.-F.), the Brain Research Trust (to L. G.), The Wellcome Trust (to G. B. and E. M. C. F.), and the University of Sussex (to A. P.).	Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Bilsland LG, 2008, J NEUROCHEM, V107, P1271, DOI 10.1111/j.1471-4159.2008.05699.x; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BREUER AC, 1987, NEUROLOGY, V37, P738, DOI 10.1212/WNL.37.5.738; Brill LB, 2000, METHODS, V22, P307, DOI 10.1006/meth.2000.1083; Brown RH, 1995, CURR OPIN NEUROBIOL, V5, P841, DOI 10.1016/0959-4388(95)80114-6; Browne SE, 1998, J NEUROCHEM, V71, P281; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hafezparast M, 2002, LANCET NEUROL, V1, P215, DOI 10.1016/S1474-4422(02)00100-X; Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Jablonka S, 2004, J NEUROBIOL, V58, P272, DOI 10.1002/neu.10313; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1998, CELL MOTIL CYTOSKEL, V41, P154, DOI 10.1002/(SICI)1097-0169(1998)41:2<154::AID-CM6>3.0.CO;2-E; Rao MV, 2003, NEUROCHEM RES, V28, P1041, DOI 10.1023/A:1023259207015; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw PJ, 1999, BMJ-BRIT MED J, V318, P1118, DOI 10.1136/bmj.318.7191.1118; Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; Strom AL, 2008, J BIOL CHEM, V283, P22795, DOI 10.1074/jbc.M800276200; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wang J, 2007, J BIOL CHEM, V282, P345, DOI 10.1074/jbc.M604503200; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200	60	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18627	18639		10.1074/jbc.M110.129320	http://dx.doi.org/10.1074/jbc.M110.129320			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20382740	Green Published, hybrid			2022-12-27	WOS:000278453900056
J	Feng, QY; Baird, D; Yoo, S; Antonyak, M; Cerione, RA				Feng, Qiyu; Baird, Dan; Yoo, Sungsoo; Antonyak, Marc; Cerione, Richard A.			Phosphorylation of the Cool-1/beta-Pix Protein Serves as a Regulatory Signal for the Migration and Invasive Activity of Src-transformed Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; P85 BETA-PIX; P21-ACTIVATED KINASE; RHO-GTPASES; MENTAL-RETARDATION; GIT1 FUNCTIONS; ACTIN; FAMILY; ACTIVATION; MECHANISMS	Previously we showed that Cool-1 (Cloned out of library-1)/beta-Pix (Pak-interactive exchange factor) is phosphorylated at a specific tyrosine residue (Tyr-442) in a Src-dependent manner and serves as a dual function guanine nucleotide exchange factor (GEF)/signaling-effector for Cdc42 that is essential for transformation by Src. Here, we show that knocking-down Cool-1 or overexpressing a Cool-1 mutant that contains substitutions within its Dbl homology domain and is defective for GEF activity, inhibits Src-promoted cell migration. Similarly, the expression of a Cool-1 mutant containing a tyrosine to phenylalanine substitution at position 442, making it incapable of being phosphorylated in response to serum, epidermal growth factor (EGF), or Src, also causes a significant inhibition of the migration and invasive activity of cells expressing oncogenic Src. We further demonstrate that the phosphorylation of Cool-1 at Tyr-442 weakens its ability to bind to one of its primary interaction-partners, Cat-1 (Cool-associated tyrosine phosphosubstrate-1)/Git-1 (G protein-coupled receptor kinase-interactor-1), thus making Cat more accessible for binding to paxillin. This enables cells to alternate between states where they contain large numbers of focal complexes (i.e. conditions favoring Cool-1-Cat interactions) versus reduced numbers of focal complexes (conditions favoring Cat-paxillin interactions). Overall, these findings show that the phosphorylation-dephosphorylation cycle of Cool-1 at Tyr-442 can serve as a key regulatory signal for focal complex assembly-disassembly, and consequently, for the migration and invasive activity of Src-transformed cells.	[Feng, Qiyu; Baird, Dan; Yoo, Sungsoo; Antonyak, Marc; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			National Institutes of Health [GM047458, GM61762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R01GM061762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM047458 and GM61762.	Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Castellano F, 2001, EMBO J, V20, P5603, DOI 10.1093/emboj/20.20.5603; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 2005, EXP CELL RES, V307, P315, DOI 10.1016/j.yexcr.2005.03.028; Lee Juliet, 1993, Trends in Cell Biology, V3, P366, DOI 10.1016/0962-8924(93)90084-E; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; Manabe R, 2002, J CELL SCI, V115, P1497; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Matafora V, 2001, J CELL SCI, V114, P4509; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sheetz Michael P., 1994, Seminars in Cell Biology, V5, P149, DOI 10.1006/scel.1994.1019; Shin EY, 2004, J BIOL CHEM, V279, P1994, DOI 10.1074/jbc.M307330200; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; Totaro A, 2007, MOL BIOL CELL, V18, P5124, DOI 10.1091/mbc.E07-06-0550; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; VAN AL, 1997, GENE DEV, V11, P2295; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996	51	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18806	18816		10.1074/jbc.M109.098079	http://dx.doi.org/10.1074/jbc.M109.098079			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20375009	Green Published, hybrid			2022-12-27	WOS:000278453900071
J	Tanco, S; Zhang, X; Morano, C; Aviles, FX; Lorenzo, J; Fricker, LD				Tanco, Sebastian; Zhang, Xin; Morano, Cain; Xavier Aviles, Francesc; Lorenzo, Julia; Fricker, Lloyd D.			Characterization of the Substrate Specificity of Human Carboxypeptidase A4 and Implications for a Role in Extracellular Peptide Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-BRAIN; CANCER; INHIBITION; NEUROTENSIN; ACID; METALLOCARBOXYPEPTIDASES; ACTIVATION; MECHANISM; PATHWAY; MATRIX	CPA4 (carboxypeptidase A4) is a member of the metallocarboxypeptidase family. CPA4 was originally found in a screen of mRNAs up-regulated by sodium butyrate-induced differentiation of cancer cells. Further studies suggested a relation between CPA4 and prostate cancer aggressiveness. In the present study, we determined that CPA4 is secreted from cells as a soluble proenzyme (pro-CPA4) that can be activated by endoproteases, such as trypsin. Three complementary approaches were used to study the substrate specificity of CPA4; kinetic analysis was performed using a new series of chromogenic substrates and some biologically relevant peptides, the cleavage of synthetic peptides was tested individually, and the cleavage of a mixture of > 100 mouse brain peptides was examined using a quantitative peptidomics mass spectrometry-based approach. CPA4 was able to cleave hydrophobic C-terminal residues with a preference for Phe, Leu, Ile, Met, Tyr, and Val. However, not all peptides with C-terminal hydrophobic residues were cleaved, indicating the importance of additional residues within the peptide. Aliphatic, aromatic, and basic residues in the P1 position have a positive influence on the cleavage specificity. In contrast, acidic residues, Pro, and Gly have a negative influence in the P1 position. Some of the peptides identified as CPA4 substrates (such as neurotensin, granins, and opioid peptides) have been previously shown to function in cell proliferation and differentiation, potentially explaining the link between CPA4 and cancer aggressiveness. Taken together, these studies suggest that CPA4 functions in neuropeptide processing and regulation in the extracellular environment.	[Tanco, Sebastian; Xavier Aviles, Francesc; Lorenzo, Julia] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Barcelona, Spain; [Tanco, Sebastian; Xavier Aviles, Francesc; Lorenzo, Julia] Univ Autonoma Barcelona, Dept Bioquim, Bellaterra 08193, Barcelona, Spain; [Zhang, Xin; Morano, Cain; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Autonomous University of Barcelona; Autonomous University of Barcelona; Yeshiva University; Albert Einstein College of Medicine	Lorenzo, J (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Barcelona, Spain.	julia.lorenzo@uab.es; lloyd.fricker@einstein.yu.edu	Lorenzo, Julia/E-9015-2011; Aviles, Francesc Xavier/F-3482-2019; Tanco, Sebastian Martin/R-2528-2016; Avilés, Francesc Xavier/A-2664-2015	Lorenzo, Julia/0000-0001-5659-6008; Aviles, Francesc Xavier/0000-0002-1399-6789; Tanco, Sebastian Martin/0000-0003-2130-4401; Avilés, Francesc Xavier/0000-0002-1399-6789	National Institutes of Health [DK-51271, DA-04494]; European Commission [FP7-Health-2009-241919-LIVIMODE]; Spanish Ministry of Science and Technology [BIO2007-68046-C02]; Xarxa de Referencia en Biotecnologia (Generalitat de Catalunya); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xarxa de Referencia en Biotecnologia (Generalitat de Catalunya)(Generalitat de Catalunya); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grants DK-51271 and DA-04494 (to L. D. F.). This work was also supported by European Commission Grant FP7-Health-2009-241919-LIVIMODE (to F. X. A.), by Spanish Ministry of Science and Technology Grant BIO2007-68046-C02 (to F. X. A.), and by Xarxa de Referencia en Biotecnologia (Generalitat de Catalunya).	Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Bayes A, 2007, BIOCHEMISTRY-US, V46, P6921, DOI 10.1021/bi700480b; Bentley L, 2003, J MED GENET, V40, P249, DOI 10.1136/jmg.40.4.249; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BLUMBERG S, 1975, BIOCHEMISTRY-US, V14, P2410, DOI 10.1021/bi00682a022; BYERS LD, 1973, BIOCHEMISTRY-US, V12, P2070, DOI 10.1021/bi00735a008; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; Davila-Garcia M I, 1990, Adv Exp Med Biol, V265, P75; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Escobar ML, 1997, BRAIN RES, V751, P330, DOI 10.1016/S0006-8993(96)01373-X; FELBER JP, 1962, BIOCHEMISTRY-US, V1, P231, DOI 10.1021/bi00908a006; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Garcia-Castellanos R, 2005, CELL MOL LIFE SCI, V62, P1996, DOI 10.1007/s00018-005-5174-4; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; Grishin AM, 2008, PROTEIN ENG DES SEL, V21, P545, DOI 10.1093/protein/gzn031; Hamstra DA, 1999, HUM GENE THER, V10, P235, DOI 10.1089/10430349950019020; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Huang HJ, 1999, CANCER RES, V59, P2981; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kayashima T, 2003, HUM GENET, V112, P220, DOI 10.1007/s00439-002-0891-3; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leung LLK, 2008, MOL IMMUNOL, V45, P4080, DOI 10.1016/j.molimm.2008.07.010; Lundequist A, 2004, J BIOL CHEM, V279, P32339, DOI 10.1074/jbc.M405576200; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Mosca A, 2005, J Endocrinol Invest, V28, P141; Myers RM, 2009, ACS CHEM BIOL, V4, P503, DOI 10.1021/cb900038e; Nagakawa O, 2001, INT J UROL, V8, P65, DOI 10.1046/j.1442-2042.2001.00250.x; Novikova EG, 2000, J BIOL CHEM, V275, P4865, DOI 10.1074/jbc.275.7.4865; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Pallares I, 2008, ACTA CRYSTALLOGR D, V64, P784, DOI 10.1107/S0907444908013474; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; PETERSON LM, 1982, ANAL BIOCHEM, V125, P420, DOI 10.1016/0003-2697(82)90024-0; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Reverter D, 1997, FEBS LETT, V420, P7, DOI 10.1016/S0014-5793(97)01476-2; Reverter D, 1998, J BIOL CHEM, V273, P32927, DOI 10.1074/jbc.273.49.32927; Ross PL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-69; RYAN CA, 1974, J BIOL CHEM, V249, P5495; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Vias M, 2007, PROSTATE, V67, P190, DOI 10.1002/pros.20518; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; WHITE D, 2004, Patent No. 2004007001; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; ZHANG FM, 1991, J BIOL CHEM, V266, P24606; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	50	48	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18385	18396		10.1074/jbc.M109.060350	http://dx.doi.org/10.1074/jbc.M109.060350			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385563	hybrid, Green Published			2022-12-27	WOS:000278453900032
J	Bugge, A; Siersbaek, M; Madsen, MS; Gondor, A; Rougier, C; Mandrup, S				Bugge, Anne; Siersbaek, Majken; Madsen, Maria S.; Gondor, Anita; Rougier, Carole; Mandrup, Susanne			A Novel Intronic Peroxisome Proliferator-activated Receptor gamma Enhancer in the Uncoupling Protein (UCP) 3 Gene as a Regulator of Both UCP2 and-3 Expression in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN-ADIPOSE-TISSUE; FATTY-ACID OXIDATION; UP-REGULATION; SKELETAL-MUSCLE; THYROID-HORMONE; MESSENGER-RNA; AGONISTS; BINDING; THIAZOLIDINEDIONES; TRANSACTIVATION	Uncoupling Proteins (UCPs) are integral ion channels residing in the inner mitochondrial membrane. UCP2 is ubiquitously expressed, while UCP3 is found primarily in muscles and adipose tissue. Although the exact molecular mechanism of action is controversial, it is generally agreed that both homologues function to facilitate mitochondrial fatty acid oxidation. UCP2 and -3 expression is activated by the peroxisome proliferator-activated receptors (PPARs), but so far no PPAR response element has been reported in the vicinity of the Ucp2 and Ucp3 genes. Using genome-wide profiling of PPAR gamma occupancy in 3T3-L1 adipocytes we demonstrate that PPAR gamma associates with three chromosomal regions in the vicinity of the Ucp3 locus and weakly with a site in intron 1 of the Ucp2 gene. These sites are isolated from the nearest neighboring sites by >900 kb. The most prominent PPAR gamma binding site in the Ucp2 and Ucp3 loci is located in intron 1 of the Ucp3 gene and is the only site that facilitates PPAR gamma transactivation of a heterologous promoter. This site furthermore transactivates the endogenous Ucp3 promoter, and using chromatin conformation capture we show that it loops out to specifically interact with the Ucp2 promoter and intron 1. Our data indicate that PPAR gamma transactivation of both UCP2 and -3 is mediated through this novel enhancer in Ucp3 intron 1.	[Bugge, Anne; Siersbaek, Majken; Madsen, Maria S.; Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Gondor, Anita] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Rougier, Carole] Uppsala Univ, Dept Genet & Dev, SE-75105 Uppsala, Sweden	University of Southern Denmark; Karolinska Institutet; Uppsala University	Mandrup, S (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.	s.mandrup@bmb.sdu.dkmailto	Mandrup, Susanne/B-6693-2008	Bugge, Anne/0000-0001-5885-4541; Gondor, Anita/0000-0002-1523-4411; Siersbaek, Majken/0000-0003-1030-182X; Mandrup, Susanne/0000-0002-0961-5787	Danish Natural Science Research Foundation; Novo Nordisk Foundation; NordForsk; Novo Scholarship program	Danish Natural Science Research Foundation(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NordForsk; Novo Scholarship program	This work has been supported in part by grants from the Danish Natural Science Research Foundation, the Novo Nordisk Foundation, and grants from NordForsk given to the Nordic Center of Excellence MitoHealth.; Supported by the Novo Scholarship program.	Acin A, 1999, BIOCHEM BIOPH RES CO, V258, P278, DOI 10.1006/bbrc.1999.0530; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Aubert J, 1997, BIOCHEM BIOPH RES CO, V238, P606, DOI 10.1006/bbrc.1997.7348; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Bugge A, 2009, MOL ENDOCRINOL, V23, P794, DOI 10.1210/me.2008-0236; Camirand A, 1998, ENDOCRINOLOGY, V139, P428, DOI 10.1210/en.139.1.428; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chevillotte E, 2001, J BIOL CHEM, V276, P10853, DOI 10.1074/jbc.M008010200; Emilsson V, 2000, METABOLISM, V49, P1610, DOI 10.1053/meta.2000.18692; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fromme T, 2009, PHYSIOL GENOMICS, V38, P54, DOI 10.1152/physiolgenomics.00249.2007; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; Girousse A, 2009, DIABETOLOGIA, V52, P1638, DOI 10.1007/s00125-009-1385-9; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Helledie T, 2000, J LIPID RES, V41, P1740; Helledie T, 2002, J BIOL CHEM, V277, P26821, DOI 10.1074/jbc.M111295200; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Jucker BM, 2000, J BIOL CHEM, V275, P39279, DOI 10.1074/jbc.M007760200; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Matsuda J, 1998, DIABETES, V47, P1809, DOI 10.2337/diabetes.47.11.1809; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nielsen R, 2006, MOL CELL BIOL, V26, P5698, DOI 10.1128/MCB.02266-05; Orlicky DJ, 2001, J LIPID RES, V42, P910; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Rieusset J, 1999, BIOCHEM BIOPH RES CO, V265, P265, DOI 10.1006/bbrc.1999.1657; Schrauwen P, 2003, FASEB J, V17, P2272, DOI 10.1096/fj.03-0515fje; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Son C, 2001, ENDOCRINOLOGY, V142, P4189, DOI 10.1210/en.142.10.4189; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tu N, 2000, LIFE SCI, V67, P2267, DOI 10.1016/S0024-3205(00)00802-X; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Weigle DS, 1998, DIABETES, V47, P298, DOI 10.2337/diabetes.47.2.298; Yoshitomi H, 1999, BIOCHEM J, V340, P397, DOI 10.1042/0264-6021:3400397; Young ME, 2001, FASEB J, V15, P833, DOI 10.1096/fj.00-0351com	44	46	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17310	17317		10.1074/jbc.M110.120584	http://dx.doi.org/10.1074/jbc.M110.120584			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20360005	Green Published, hybrid			2022-12-27	WOS:000278133400008
J	Giesecke, A; Stewart, M				Giesecke, Astrid; Stewart, Murray			Novel Binding of the Mitotic Regulator TPX2 (Target Protein for Xenopus Kinesin-like Protein 2) to Importin-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; STRUCTURAL BASIS; KARYOPHERIN-ALPHA; CRYSTALLOGRAPHIC ANALYSIS; SPINDLE; RAN; RECOGNITION; MECHANISM; COMPLEX; REQUIREMENTS	Several aspects of mitotic spindle assembly are orchestrated by the Ran GTPase through its modulation of the interaction between spindle assembly factors and importin-alpha. One such factor is TPX2 that promotes microtubule assembly in the vicinity of chromosomes. TPX2 is inhibited when bound to importin-alpha, which occurs when the latter is bound to importin-beta. The importin-alpha:beta interaction is disrupted by the high RanGTP concentration near the chromosomes, releasing TPX2. In more distal regions, where Ran is predominantly GDP-bound, TPX2 remains bound to importin-alpha and so is inhibited. Here we use a combination of structural and biochemical methods to define the basis for TPX2 binding to importin-alpha. A 2.2 angstrom resolution crystal structure shows that the primary nuclear localization signal ((KRKH287)-K-284) of TPX2, which has been shown to be crucial for inhibition, binds to the minor NLS-binding site on importin-alpha. This atypical interaction pattern was confirmed using complementary binding studies that employed importin-alpha variants in which binding to either the major or minor NLS-binding site was impaired, together with competition assays using the SV40 monopartite NLS that binds primarily to the major site. The different way in which TPX2 binds to importin-alpha could account for much of the selectivity necessary during mitosis because this would reduce the competition for binding to importin-alpha from other NLS-containing proteins.	[Giesecke, Astrid; Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk			Wellcome Trust; MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a Wellcome Trust Programme grant (to M. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Bibby RA, 2009, J BIOL CHEM, V284, P33177, DOI 10.1074/jbc.M109.032722; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; COLLEDGE WH, 1986, MOL CELL BIOL, V6, P4136, DOI 10.1128/MCB.6.11.4136; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Groen AC, 2009, MOL BIOL CELL, V20, P2766, DOI 10.1091/mbc.E09-01-0043; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7	42	65	65	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17628	17635		10.1074/jbc.M110.102343	http://dx.doi.org/10.1074/jbc.M110.102343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20335181	hybrid, Green Published			2022-12-27	WOS:000278133400041
J	Lee, M; Tazzari, V; Giustarini, D; Rossi, R; Sparatore, A; Del Soldato, P; McGeer, E; McGeer, PL				Lee, Moonhee; Tazzari, Valerio; Giustarini, Daniela; Rossi, Ranieri; Sparatore, Anna; Del Soldato, Piero; McGeer, Edith; McGeer, Patrick L.			Effects of Hydrogen Sulfide-releasing L-DOPA Derivatives on Glial Activation POTENTIAL FOR TREATING PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MONOAMINE-OXIDASE-B; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; LEVODOPA; ASTROCYTES; CELLS; INFLAMMATION; NSAIDS; INHIBITION	The main lesion in Parkinson disease (PD) is loss of substantia nigra dopaminergic neurons. Levodopa (L-DOPA) is the most widely used therapy, but it does not arrest disease progression. Some possible contributing factors to the continuing neuronal loss are oxidative stress, including oxidation of L-DOPA, and neurotoxins generated by locally activated microglia and astrocytes. A possible method of reducing these factors is to produce L-DOPA hybrid compounds that have antioxidant and anti-inflammatory properties. Here we demonstrate the properties of four such L-DOPA hybrids based on coupling L-DOPA to four different hydrogen sulfide-donating compounds. The donors themselves were shown to be capable of conversion by isolated mitochondria to H2S or equivalent SH- ions. This capability was confirmed by in vivo results, showing a large increase in intracerebral dopamine and glutathione after iv administration in rats. When human microglia, astrocytes, and SH-SY5Y neuroblastoma cells were treated with these donating agents, they all accumulated H2S intracellularly as did their derivatives coupled to L-DOPA. The donating agents and the L-DOPA hybrids reduced the release of tumor necrosis factor-alpha, interleukin-6, and nitric oxide from stimulated microglia, astrocytes as well as the THP-1 and U373 cell lines. They also demonstrated a neuroprotective effect by reducing the toxicity of supernatants from these stimulated cells to SH-SY5Y cells. L-DOPA itself was without effect in any of these assays. The H2S-releasing L-DOPA hybrid molecules also inhibited MAO B activity. They may be useful for the treatment of PD because of their significant anti-inflammatory, antioxidant, and neuroprotective properties.	[Lee, Moonhee; McGeer, Edith; McGeer, Patrick L.] Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1Z3, Canada; [Tazzari, Valerio; Sparatore, Anna] Univ Milan, Dipartimento Sci Farmaceut Pietro Pratesi, I-20133 Milan, Italy; [Giustarini, Daniela; Rossi, Ranieri] Univ Siena, Dept Evolutionary Biol, Lab Pharmacol & Toxicol, I-53100 Siena, Italy; [Del Soldato, Piero] CTG Pharma, I-20131 Milan, Italy	University of British Columbia; University of Milan; University of Siena	McGeer, PL (corresponding author), Univ British Columbia, Kinsmen Lab Neurol Res, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	mcgeerpl@interchange.ubc.ca	Rossi, Ranieri/C-8743-2011; Sparatore, Anna/J-8634-2015; Giustarini, Daniela/AAV-6629-2021	Rossi, Ranieri/0000-0002-0187-4530; Sparatore, Anna/0000-0003-2135-2649; Giustarini, Daniela/0000-0003-4929-5316	Pacific Alzheimer Research Foundation	Pacific Alzheimer Research Foundation	This research was supported by the Pacific Alzheimer Research Foundation.	Adelaere B., 1989, SULFUR LETT, V10, P31; Asanuma M, 2008, CURR PHARM DESIGN, V14, P1428, DOI 10.2174/138161208784480153; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Damier P, 1996, NEUROLOGY, V46, P1262, DOI 10.1212/WNL.46.5.1262; DARTIGUES B, 1980, EUR J MED CHEM, V15, P405; Drukarch B, 2006, J NEURAL TRANSM, V113, P593, DOI 10.1007/s00702-005-0350-0; Esposito E, 2007, EXP NEUROL, V205, P295, DOI 10.1016/j.expneurol.2007.02.008; Eto K, 2002, J NEUROSCI, V22, P3386; FAHN S, 1991, AM J CLIN NUTR, V53, pS380, DOI 10.1093/ajcn/53.1.380S; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Giustarini D, 2009, FEBS J, V276, P4946, DOI 10.1111/j.1742-4658.2009.07197.x; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; HU LF, 2010, AGING CELL IN PRESS; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Kamoun P, 2004, AMINO ACIDS, V26, P243, DOI 10.1007/s00726-004-0072-x; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Klegeris A, 1999, NEUROPHARMACOLOGY, V38, P1017, DOI 10.1016/S0028-3908(99)00014-3; Klegeris A, 2000, EXP NEUROL, V166, P458, DOI 10.1006/exnr.2000.7517; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Kostrzewa RM, 2002, AMINO ACIDS, V23, P57, DOI 10.1007/s00726-001-0110-x; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; LEE M, 2010, FASEB J IN PRESS; Lee M, 2010, GLIA, V58, P103, DOI 10.1002/glia.20905; Lee M, 2009, NEUROBIOL AGING, V30, P1523, DOI 10.1016/j.neurobiolaging.2009.06.001; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Lowicka E, 2007, PHARMACOL REP, V59, P4; LOZACH N, 1950, B SOC CHIM FR, P1243; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Muzzi C, 2008, BIOMED PHARMACOTHER, V62, P253, DOI 10.1016/j.biopha.2007.10.018; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Nagatsu T, 2006, J NEURAL TRANSM-SUPP, P53; Postuma RB, 2004, NEUROLOGY, V63, P886, DOI 10.1212/01.WNL.0000137886.74175.5A; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Wahner AD, 2007, NEUROLOGY, V69, P1836, DOI 10.1212/01.wnl.0000279519.99344.ad; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zoccolella S, 2009, MOVEMENT DISORD, V24, P1028, DOI 10.1002/mds.22511	47	84	97	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17318	17328		10.1074/jbc.M110.115261	http://dx.doi.org/10.1074/jbc.M110.115261			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368333	Green Published, hybrid			2022-12-27	WOS:000278133400009
J	Rajagopal, V; Gurjar, M; Levin, MK; Patel, SS				Rajagopal, Vaishnavi; Gurjar, Madhura; Levin, Mikhail K.; Patel, Smita S.			The Protease Domain Increases the Translocation Stepping Efficiency of the Hepatitis C Virus NS3-4A Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ATP-DEPENDENT TRANSLOCATION; ESCHERICHIA-COLI; RNA HELICASE; NONSTRUCTURAL PROTEIN-3; DISPLACE STREPTAVIDIN; PHOSPHATE RELEASE; FLUORESCENT-PROBE; KINETIC-ANALYSIS; STEADY-STATE	Hepatitis C virus (HCV) NS3 protein has two enzymatic activities of helicase and protease that are essential for viral replication. The helicase separates the strands of DNA and RNA duplexes using the energy from ATP hydrolysis. To understand how ATP hydrolysis is coupled to helicase movement, we measured the single turnover helicase translocation-dissociation kinetics and the pre-steady-state Pi release kinetics on single-stranded RNA and DNA substrates of different lengths. The parameters of stepping were determined from global fitting of the two types of kinetic measurements into a computational model that describes translocation as a sequence of coupled hydrolysis-stepping reactions. Our results show that the HCV helicase moves with a faster rate on single stranded RNA than on DNA. The HCV helicase steps on the RNA or DNA one nucleotide at a time, and due to imperfect coupling, not every ATP hydrolysis event produces a successful step. Comparison of the helicase domain (NS3h) with the protease-helicase (NS3-4A) shows that the most significant contribution of the protease domain is to improve the translocation stepping efficiency of the helicase. Whereas for NS3h, only 20% of the hydrolysis events result in translocation, the coupling for NS3-4A is near-perfect 93%. The presence of the protease domain also significantly reduces the stepping rate, but it doubles the processivity. These effects of the protease domain on the helicase can be explained by an improved allosteric cross-talk between the ATP- and nucleic acid-binding sites achieved by the overall stabilization of the helicase domain structure.	[Levin, Mikhail K.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Levin, MK (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA.	svarneticist@gmail.com; patelss@umdnj.edu	Rajagopal, Vaishnavi/E-5272-2012		National Institutes of Health [GM55310]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55310.	Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Beran RKF, 2009, J VIROL, V83, P3268, DOI 10.1128/JVI.01849-08; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Donmez I, 2008, EMBO J, V27, P1718, DOI 10.1038/emboj.2008.100; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Evans Jared D, 2006, Hepatology, V43, P615, DOI 10.1002/hep.21096; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Fischer CJ, 2004, J MOL BIOL, V344, P1265, DOI 10.1016/j.jmb.2004.10.004; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Garai A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061910; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Gwack Y, 1997, EUR J BIOCHEM, V250, P47, DOI 10.1111/j.1432-1033.1997.00047.x; HAHM B, 1995, J VIROL, V69, P2534, DOI 10.1128/JVI.69.4.2534-2539.1995; Howe AYM, 1999, PROTEIN SCI, V8, P1332, DOI 10.1110/ps.8.6.1332; Johnson CL, 2007, J BIOL CHEM, V282, P10792, DOI 10.1074/jbc.M610361200; Khu YL, 2004, BIOCHEM J, V384, P401, DOI 10.1042/BJ20040858; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Levin Mikhail K., 2009, V500, P335, DOI 10.1007/978-1-59745-525-1_12; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; LEVIN MK, 2002, MOL MOTORS; Liu DJ, 2001, J MOL BIOL, V314, P543, DOI 10.1006/jmbi.2001.5146; Locatelli GA, 2002, BIOCHEMISTRY-US, V41, P10332, DOI 10.1021/bi026082g; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Masaike T, 2002, J BIOL CHEM, V277, P21643, DOI 10.1074/jbc.M110297200; MATLOCK DL, BIOCHEMISTRY, V49, P2097; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Morris PD, 2002, BIOCHEMISTRY-US, V41, P2372, DOI 10.1021/bi012058b; Murayama A, 2007, J VIROL, V81, P8030, DOI 10.1128/JVI.02088-06; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Porter DJT, 1998, J BIOL CHEM, V273, P14247, DOI 10.1074/jbc.273.23.14247; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; RANEY KD, 1995, J BIOL CHEM, V270, P22236, DOI 10.1074/jbc.270.38.22236; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Sillanpaa M, 2008, J GEN VIROL, V89, P432, DOI 10.1099/vir.0.83316-0; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Wardell AD, 1999, J GEN VIROL, V80, P701, DOI 10.1099/0022-1317-80-3-701; Webb MR, 2007, MOL BIOSYST, V3, P249, DOI 10.1039/b614154d; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; YOUNG MC, 1994, J MOL BIOL, V235, P1436, DOI 10.1006/jmbi.1994.1099; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100	73	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17821	17832		10.1074/jbc.M110.114785	http://dx.doi.org/10.1074/jbc.M110.114785			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363755	Green Published, hybrid			2022-12-27	WOS:000278133400060
J	Sano, K; Miyamoto, Y; Kawasaki, N; Hashii, N; Itoh, S; Murase, M; Date, K; Yokoyama, M; Sato, C; Kitajima, K; Ogawa, H				Sano, Kotone; Miyamoto, Yasunori; Kawasaki, Nana; Hashii, Noritaka; Itoh, Satsuki; Murase, Misaki; Date, Kimie; Yokoyama, Miki; Sato, Chihiro; Kitajima, Ken; Ogawa, Haruko			Survival Signals of Hepatic Stellate Cells in Liver Regeneration Are Regulated by Glycosylation Changes in Rat Vitronectin, Especially Decreased Sialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; LIGAND-BINDING ACTIVITIES; EXTRACELLULAR-MATRIX; COLLAGEN-BINDING; PARTIAL-HEPATECTOMY; PLASMA VITRONECTIN; MASS-SPECTROMETRY; IDENTIFICATION; GLYCOPROTEINS; ACID	The extracellular matrix (ECM) molecules play important roles in many biological and pathological processes. During tissue remodeling, the ECM molecules that are glycosylated are different from those of normal tissue owing to changes in the expression of many proteins that are responsible for glycan synthesis. Vitronectin (VN) is a major ECM molecule that recognizes integrin on hepatic stellate cells (HSCs). The present study attempted to elucidate how changes in VN glycans modulate the survival of HSCs, which play a critical role in liver regeneration. Plasma VN was purified from partially hepatectomized (PH) and sham-operated (SH) rats at 24 h after operation and non-operated (NO) rats. Adhesion of rat HSCs (rHSCs), together with phosphorylation of focal adhesion kinase, in PH-VN was decreased to one-half of that in NO-or SH-VN. Spreading of rHSCs on desialylated NO-VN was decreased to one-half of that of control VN, indicating the importance of sialylation of VN for activation of HSCs. Liquid chromatography/multiple-stage mass spectrometry analysis of Glu-C glycopeptides of each VN determined the site-specific glycosylation. In addition to the major biantennary complex-type N-glycans, hybrid-type N-glycans were site-specifically present at Asn(167). Highly sialylated O-glycans were found to be present in the Thr(110)-Thr(124) region. In PH-VN, the disialyl O-glycans and complex-type N-glycans were decreased while core-fucosylated N-glycans were increased. In addition, immunodetection after two-dimensional PAGE indicated the presence of hyper- and hyposialylated molecules in each VN and showed that hypersialylation was markedly attenuated in PH-VN. This study proposes that the alteration of VN glycosylation modulates the substrate adhesion to rat HSCs, which is responsible for matrix restructuring.	[Ogawa, Haruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Sano, Kotone; Miyamoto, Yasunori; Murase, Misaki; Date, Kimie; Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Tokyo 1128610, Japan; [Kawasaki, Nana; Hashii, Noritaka; Itoh, Satsuki] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan; [Yokoyama, Miki] Tokyo Med & Dent Univ, Grad Sch, Dept Hard Tissue Engn, Tokyo 1138510, Japan; [Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648610, Japan	Ochanomizu University; Ochanomizu University; National Institute of Health Sciences - Japan; Tokyo Medical & Dental University (TMDU); Nagoya University	Ogawa, H (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	ogawa.haruko@ocha.ac.jp	SATO, Chihiro/B-7396-2014; Naganawa, Shinji/I-1572-2012; Asanuma, Kimie/AAW-2543-2020; Miyamoto, Yasunori/M-4825-2019	Naganawa, Shinji/0000-0002-0214-613X; Asanuma, Kimie/0000-0003-4311-0544; Miyamoto, Yasunori/0000-0001-9192-4281	Japan Society for the Promotion of Science [12995]; Hayashi Memorial Foundation for Female Natural Scientists; Ministry of Education, Culture, Sports, Science, and Technology [15040209, 17046004]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science Grant 12995 (to K. S.), a fellowship of the Hayashi Memorial Foundation for Female Natural Scientists (to K. S.), and Grants-in-aid for Scientific Research on Priority Areas 15040209 and 17046004 (to H. O.) from the Ministry of Education, Culture, Sports, Science, and Technology.	Asanuma K, 2001, INT CONGR SER, V1223, P97, DOI 10.1016/S0531-5131(01)00417-4; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; DeClerck YA, 2004, AM J PATHOL, V164, P1131, DOI 10.1016/S0002-9440(10)63200-2; FINNE J, 1977, BIOCHEM BIOPH RES CO, V74, P405, DOI 10.1016/0006-291X(77)90318-7; Harazono A, 2005, GLYCOBIOLOGY, V15, P447, DOI 10.1093/glycob/cwi033; Higgins GM, 1931, ARCH PATHOL, V12, P186; Itoh S, 2005, J CHROMATOGR A, V1094, P105, DOI 10.1016/j.chroma.2005.07.100; JEZEQUELCUER M, 1992, LIVER, V12, P140; KATO S, 1985, BIOCHEM J, V229, P521, DOI 10.1042/bj2290521; Kim TH, 1997, HEPATOLOGY, V26, P896, DOI 10.1002/hep.510260415; KITAGAKIOGAWA H, 1990, BIOCHIM BIOPHYS ACTA, V1033, P49, DOI 10.1016/0304-4165(90)90193-Z; McKeownLongo PJ, 1996, TRENDS GLYCOSCI GLYC, V8, P327, DOI 10.4052/tigg.8.327; ODATAMAI S, 1985, J BIOL CHEM, V260, P57; OGAWA H, 1995, EUR J BIOCHEM, V230, P994, DOI 10.1111/j.1432-1033.1995.tb20647.x; OKAMOTO Y, 1977, BIOCHIM BIOPHYS ACTA, V498, P272, DOI 10.1016/0304-4165(77)90265-3; OKAMOTO Y, 1978, BIOCHIM BIOPHYS ACTA, V542, P21, DOI 10.1016/0304-4165(78)90228-3; Peake PW, 1996, CLIN EXP IMMUNOL, V106, P416, DOI 10.1046/j.1365-2249.1996.d01-833.x; PODACK ER, 1977, J IMMUNOL, V119, P2024; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Pretzlaff RK, 2000, CELL ADHES COMMUN, V7, P491, DOI 10.3109/15419060009040306; Sano K, 2008, CARBOHYD RES, V343, P2329, DOI 10.1016/j.carres.2008.03.027; Sano K, 2007, GLYCOBIOLOGY, V17, P784, DOI 10.1093/glycob/cwm031; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SEIFFERT D, 1991, P NATL ACAD SCI USA, V88, P9402, DOI 10.1073/pnas.88.21.9402; Seiffert D, 1997, HISTOL HISTOPATHOL, V12, P787; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; Uchibori-Iwaki H, 2000, GLYCOBIOLOGY, V10, P865, DOI 10.1093/glycob/10.9.865; Ueda H, 1999, FEBS LETT, V448, P75, DOI 10.1016/S0014-5793(99)00334-8; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068; Yasukawa Z, 2007, J BIOCHEM, V141, P429, DOI 10.1093/jb/mvm047; Yasukawa Z, 2006, GLYCOBIOLOGY, V16, P651, DOI 10.1093/glycob/cwj112; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Yoneda A, 1996, J BIOCHEM, V120, P954; Yoneda A, 1998, BIOCHEMISTRY-US, V37, P6351, DOI 10.1021/bi972247n; YONEDA A, 1993, EUR J BIOCHEM, V218, P797, DOI 10.1111/j.1432-1033.1993.tb18434.x; Yuan J, 2005, J CHROMATOGR A, V1067, P145, DOI 10.1016/j.chroma.2004.11.070; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200	39	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17301	17309		10.1074/jbc.M109.077016	http://dx.doi.org/10.1074/jbc.M109.077016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20335177	hybrid, Green Published			2022-12-27	WOS:000278133400007
J	Tang, YF; Urs, S; Boucher, J; Bernaiche, T; Venkatesh, D; Spicer, DB; Vary, CPH; Liaw, L				Tang, Yuefeng; Urs, Sumithra; Boucher, Joshua; Bernaiche, Tyler; Venkatesh, Deepak; Spicer, Douglas B.; Vary, Calvin P. H.; Liaw, Lucy			Notch and Transforming Growth Factor-beta (TGF beta) Signaling Pathways Cooperatively Regulate Vascular Smooth Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RBP-J-KAPPA; INTRACELLULAR DOMAIN; DEPENDENT PATHWAY; ACTIN EXPRESSION; ALPHA-ACTIN; CROSS-TALK; IN-VITRO; INHIBITION; MYOCARDIN; APOPTOSIS	Notch and transforming growth factor-beta (TGF beta) play pivotal roles during vascular development and the pathogenesis of vascular disease. The interaction of these two pathways is not fully understood. The present study utilized primary human smooth muscle cells (SMC) to examine molecular cross-talk between TGF beta 1 and Notch signaling on contractile gene expression. Activation of Notch signaling using Notch intracellular domain or Jagged1 ligand induced smooth muscle alpha-actin (SM actin), smooth muscle myosin heavy chain, and calponin1, and the expression of Notch downstream effectors hairy-related transcription factors. Similarly, TGF beta 1 treatment of human aortic smooth muscle cells induced SM actin, calponin1, and smooth muscle protein 22-alpha (SM22 alpha) in a dose-and time-dependent manner. Hairy-related transcription factor proteins, which antagonize Notch activity, also suppressed the TGF beta 1-induced increase in SMC markers, suggesting a general mechanism of inhibition. We found that Notch and TGF beta 1 cooperatively activate SMC marker transcripts and protein through parallel signaling axes. Although the intracellular domain of Notch4 interacted with phosphoSmad2/3 in SMC, this interaction was not observed with Notch1 or Notch2. However, we found that CBF1 co-immunoprecipitated with phosphoSmad2/3, suggesting a mechanism to link canonical Notch signaling to phosphoSmad activity. Indeed, the combination of Notch activation and TGF beta 1 treatment led to synergistic activation of a TGF beta-responsive promoter. This increase corresponded to increased levels of phosphoSmad2/3 interaction at Smad consensus binding sites within the SM actin, calponin1, and SM22 alpha promoters. Thus, Notch and TGF beta coordinately induce a molecular and functional contractile phenotype by co-regulation of Smad activity at SMC promoters.	[Tang, Yuefeng; Urs, Sumithra; Boucher, Joshua; Bernaiche, Tyler; Venkatesh, Deepak; Spicer, Douglas B.; Vary, Calvin P. H.; Liaw, Lucy] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	Maine Medical Center	Liaw, L (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	liawl@mmc.org	Tang, Yuefeng/J-9770-2012		National Institutes of Health, National Center for Research Resources [R01 HL070865, P20RR15555]; Founders Affiliate of the American Heart Association; Graduate School of Biomedical Sciences at University of Maine, Orono, ME; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555, P20RR018789] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083151, R01HL070865] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Founders Affiliate of the American Heart Association(American Heart Association); Graduate School of Biomedical Sciences at University of Maine, Orono, ME; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL070865 (to L. L.) and P20RR15555 from the National Center for Research Resources (to R. E. Friesel and L. L.).; Supported by a predoctoral fellowship from the Founders Affiliate of the American Heart Association.; Supported by a fellowship from the Graduate School of Biomedical Sciences at University of Maine, Orono, ME.	Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; Herrmann J, 2007, BBA-MOL BASIS DIS, V1772, P1250, DOI 10.1016/j.bbadis.2007.10.006; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hung SC, 2006, CELL TISSUE RES, V324, P457, DOI 10.1007/s00441-006-0156-x; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; King IN, 2006, BIOCHEM BIOPH RES CO, V345, P446, DOI 10.1016/j.bbrc.2006.04.097; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; LeClair RJ, 2007, CIRC RES, V100, P826, DOI 10.1161/01.RES.0000260806.99307.72; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Ono Y, 2007, J CELL PHYSIOL, V210, P358, DOI 10.1002/jcp.20838; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozbun LL, 2005, BBA-GENE STRUCT EXPR, V1728, P163, DOI 10.1016/j.bbaexp.2005.02.010; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Rao P, 2003, MOL CELL BIOL, V23, P6694, DOI 10.1128/MCB.23.18.6694-6701.2003; Schwappacher R, 2009, EMBO J, V28, P1537, DOI 10.1038/emboj.2009.103; Singh R, 2009, CIRC RES, V105, P442, DOI 10.1161/CIRCRESAHA.109.196063; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	41	109	114	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17556	17563		10.1074/jbc.M109.076414	http://dx.doi.org/10.1074/jbc.M109.076414			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368328	Green Published, hybrid			2022-12-27	WOS:000278133400034
J	Haferkamp, S; Haase, W; Pascal, AA; van Amerongen, H; Kirchhoff, H				Haferkamp, Silvia; Haase, Winfried; Pascal, Andrew A.; van Amerongen, Herbert; Kirchhoff, Helmut			Efficient Light Harvesting by Photosystem II Requires an Optimized Protein Packing Density in Grana Thylakoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-TRANSFER; PHOTOSYNTHETIC MEMBRANES; EXCITATION-ENERGY; HIGHER-PLANTS; CHARGE SEPARATION; COMPLEXES; ORGANIZATION; CHLOROPLAST; MODEL; IDENTIFICATION	A recently developed technique for dilution of the naturally high protein packing density in isolated grana membranes was applied to study the dependence of the light harvesting efficiency of photosystem (PS) II on macromolecular crowding. Slight dilution of the protein packing from 80% area fraction to the value found in intact grana thylakoids (70%) leads to an improved functionality of PSII (increased antenna size, enhanced connectivity between reaction centers). Further dilution induces a functional disconnection of light-harvesting complex (LHC) II from PSII. It is concluded that efficient light harvesting by PSII requires an optimal protein packing density in grana membranes that is close to 70%. We hypothesize that the decreased efficiency in overcrowded isolated grana thylakoids is caused by excited state quenching in LHCII, which has previously been correlated with neoxanthin distortion. Resonance Raman spectroscopy confirms this increase in neoxanthin distortion in overcrowded grana as compared with intact thylakoids. Furthermore, analysis of the changes in the antenna size in highly diluted membranes indicates a lipid-induced dissociation of up to two trimeric LHCII from PSII, leaving one trimer connected. This observation supports a hierarchy of LHCII-binding sites on PSII.	[Kirchhoff, Helmut] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Haase, Winfried] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Pascal, Andrew A.] CEA, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; [van Amerongen, Herbert] Wageningen Univ, Biophys Lab, NL-6700 ET Wageningen, Netherlands	Washington State University; Max Planck Society; CEA; UDICE-French Research Universities; Universite Paris Saclay; Wageningen University & Research	Kirchhoff, H (corresponding author), Washington State Univ, Inst Biol Chem, POB 646340, Pullman, WA 99164 USA.	kirchhh@wsu.edu	pascal, andrew a/B-6186-2014; Kirchhoff, Helmut/AAN-6695-2020; van Amerongen, Herbert/J-9483-2016	pascal, andrew a/0000-0002-1844-6065; Kirchhoff, Helmut/0000-0001-5874-3681; van Amerongen, Herbert/0000-0002-9783-2895				Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; ANDERSON JM, 1986, ANNU REV PLANT PHYS, V37, P93, DOI 10.1146/annurev.arplant.37.1.93; Andreeva A, 2003, J PHOTOCH PHOTOBIO B, V70, P153, DOI 10.1016/S1011-1344(03)00075-7; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; *BLANK, 2002, MOL MECH PHOT; Broess K, 2006, BIOPHYS J, V91, P3776, DOI 10.1529/biophysj.106.085068; Bumba L, 2003, PHOTOSYNTH RES, V77, P1, DOI 10.1023/A:1024927631196; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Duchene S, 2000, LIPIDS, V35, P739, DOI 10.1007/s11745-000-0580-4; Eijckelhoff C, 1997, PHOTOSYNTH RES, V52, P69, DOI 10.1023/A:1005834006985; FORSTER T, 1949, Z NATURFORSCH A, V4, P321; Garab G, 2000, TRENDS PLANT SCI, V5, P489, DOI 10.1016/S1360-1385(00)01767-2; Haferkamp S, 2008, PHOTOSYNTH RES, V95, P129, DOI 10.1007/s11120-007-9253-2; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; Kirchhoff H, 2004, BIOCHEMISTRY-US, V43, P14508, DOI 10.1021/bi048473w; Kirchhoff H, 2004, BIOCHEMISTRY-US, V43, P9204, DOI 10.1021/bi0494626; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kirchhoff H, 2007, BIOCHEMISTRY-US, V46, P11169, DOI 10.1021/bi700748y; Kirchhoff H, 2007, BBA-BIOENERGETICS, V1767, P1180, DOI 10.1016/j.bbabio.2007.05.009; LAVERGNE J, 1995, BIOPHYS J, V68, P2474, DOI 10.1016/S0006-3495(95)80429-7; MELIS A, 1976, PHOTOCHEM PHOTOBIOL, V23, P343, DOI 10.1111/j.1751-1097.1976.tb07259.x; Miloslavina Y, 2006, BIOCHEMISTRY-US, V45, P2436, DOI 10.1021/bi052248c; Nield J, 2006, BBA-BIOENERGETICS, V1757, P353, DOI 10.1016/j.bbabio.2006.03.019; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; SIEGEL CO, 1981, J CELL BIOL, V91, P113, DOI 10.1083/jcb.91.1.113; STAEHELIN LA, 1996, OXYGENIC PHOTOSYNTHE, P11; Sturgis JN, 1997, J PHYS CHEM B, V101, P7227, DOI 10.1021/jp963363n; Takahashi T, 2009, J BIOL CHEM, V284, P15598, DOI 10.1074/jbc.M109.000372; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Oort B, 2007, FEBS LETT, V581, P3528, DOI 10.1016/j.febslet.2007.06.070; WEBB MS, 1989, BIOCHIM BIOPHYS ACTA, V984, P41, DOI 10.1016/0005-2736(89)90340-4; WILLIAMS WP, 1998, LIPIDS PHOTOSYNTHES, P145	43	81	82	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17020	17028		10.1074/jbc.M109.077750	http://dx.doi.org/10.1074/jbc.M109.077750			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360011	Green Published, hybrid			2022-12-27	WOS:000277982600065
J	Imai, K; Togami, H; Okamoto, T				Imai, Kenichi; Togami, Hiroaki; Okamoto, Takashi			Involvement of Histone H3 Lysine 9 (H3K9) Methyltransferase G9a in the Maintenance of HIV-1 Latency and Its Reactivation by BIX01294	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; T-CELL CLONE; DNA METHYLATION; TRANSCRIPTIONAL ACTIVATION; EARLY EMBRYOGENESIS; CHROMATIN-STRUCTURE; GENE-EXPRESSION; COMPLEX; TYPE-1	Elucidating the mechanism of human immunodeficiency virus, type 1 (HIV-1) provirus transcriptional silencing in latently infected cells is crucial for understanding the pathophysiological process of HIV-1 infection. It is well established that hypoacetylation of histone proteins by histone deacetylases is involved in the maintenance of HIV-1 latency by repressing viral transcription. Although histone methylation is involved in the organization of chromatin domains and plays a central epigenetic role in gene expression, the role of histone methylation in the maintenance of HIV-1 latency has not been clarified. Here we present evidence that histone H3 Lys9 (H3K9) methyltransferase G9a is responsible for transcriptional repression of HIV-1 by promoting repressive dimethylation at H3K9 and for the maintenance of viral latency. We observed that G9a significantly inhibited basal, as well as, the induced HIV-1 gene expression by tumor necrosis factor-alpha or Tat. Mutant G9a, however, lacking the SET domain responsible for the catalytic activity of histone methyltransferase, did not show such an effect. When G9a expression was knocked down by small interfering RNA, HIV-1 replication was augmented from cells transiently transfected with a full-length HIV-1 clone. Moreover, a specific inhibitor of G9a, BIX01294, could reactivate expression of HIV-1 from latently infected cells such as ACH-2 and OM10.1. Furthermore, chromatin immunoprecipitation assays revealed the presence of G9a and H3K9 dimethylation on nucleosome histones in the vicinity of the HIV-1 long terminal repeat promoter. These results suggest that G9a is responsible for the transcriptional quiescence of latent HIV-1 provirus and provide a molecular basis for understanding the mechanism by which HIV-1 latency is maintained.	[Imai, Kenichi; Togami, Hiroaki; Okamoto, Takashi] Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University	Okamoto, T (corresponding author), Nagoya City Univ, Dept Mol & Cellular Biol, Grad Sch Med Sci, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	tokamoto@med.nagoya-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Human Sciences Foundation; Takeda Science Foundation	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Human Sciences Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Human Sciences Foundation, and the Takeda Science Foundation.	Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; BUTERA ST, 1991, J VIROL, V65, P4645, DOI 10.1128/JVI.65.9.4645-4653.1991; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; Dieudonne M, 2009, EMBO J, V28, P2231, DOI 10.1038/emboj.2009.141; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; FOLKS TM, 1988, J IMMUNOL, V140, P1117; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Imai K, 2005, J BIOL CHEM, V280, P26701, DOI 10.1074/jbc.M503313200; Imai K, 2009, FEBS J, V276, P7124, DOI 10.1111/j.1742-4658.2009.07424.x; Imai K, 2009, J IMMUNOL, V182, P3688, DOI 10.4049/jimmunol.0802906; Ishida T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-69; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; Victoriano AFB, 2006, ANTIMICROB AGENTS CH, V50, P547, DOI 10.1128/AAC.50.2.547-555.2006; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Xin ZH, 2003, J BIOL CHEM, V278, P14996, DOI 10.1074/jbc.M211753200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	61	182	192	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16538	16545		10.1074/jbc.M110.103531	http://dx.doi.org/10.1074/jbc.M110.103531			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20335163	Green Published, hybrid			2022-12-27	WOS:000277982600016
J	Terada, K; Oike, Y				Terada, Kazutoyo; Oike, Yuichi			Multiple Molecules of Hsc70 and a Dimer of DjA1 Independently Bind to an Unfolded Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SIGMA(32); NEWLY SYNTHESIZED PROTEINS; HEAT-SHOCK PROTEINS; CRYSTAL-STRUCTURE; PEPTIDE-BINDING; SUBSTRATE-SPECIFICITY; HSP70 CHAPERONES; DNAK CHAPERONE; REACTION CYCLE; HSP40	Protein folding is a prominent chaperone function of the Hsp70 system. Refolding of an unfolded protein is efficiently mediated by the Hsc70 system with either type 1 DnaJ protein, DjA1 or DjA2, and a nucleotide exchange factor. A surface plasmon resonance technique was applied to investigate substrate recognition by the Hsc70 system and demonstrated that multiple Hsc70 proteins and a dimer of DjA1 initially bind independently to an unfolded protein. The association rate of the Hsc70 was faster than that of DjA1 under folding-compatible conditions. The Hsc70 binding involved a conformational change, whereas the DjA1 binding was bivalent and substoichiometric. Consistently, we found that the bound C-14-labeled Hsc70 to the unfolded protein became more resistant to tryptic digestion. The gel filtration and cross-linking experiments revealed the predominant presence of the DjA1 dimer. Furthermore, the Hsc70 and DjA1 bound to distinct sets of peptide array sequences. All of these findings argue against the generality of the widely proposed hypothesis that the DnaJ-bound substrate is targeted and transferred to Hsp70. Instead, these results suggest the importance of the bivalent binding of DjA1 dimer that limits unfavorable transitions of substrate conformations in protein folding.	[Terada, Kazutoyo; Oike, Yuichi] Kumamoto Univ, Dept Mol Genet, Grad Sch Med Sci, Kumamoto 8608556, Japan	Kumamoto University	Terada, K (corresponding author), Kumamoto Univ, Dept Mol Genet, Grad Sch Med Sci, Honjo 1-1-1, Kumamoto 8608556, Japan.	terada@gpo.kumamoto-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [19058010, 20590287]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants 19058010 and 20590287 from the Ministry of Education, Science, Sports and Culture of Japan (to K. T.).	Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; GRAGEROV A, 1994, J MOL BIOL, V241, P133, DOI 10.1006/jmbi.1994.1482; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hendrickson WA, 2008, STRUCTURE, V16, P1153, DOI 10.1016/j.str.2008.07.002; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jiang RF, 1997, J BIOL CHEM, V272, P6141, DOI 10.1074/jbc.272.10.6141; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Nagata H, 1998, BIOCHEMISTRY-US, V37, P6924, DOI 10.1021/bi980164g; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Uchiyama Y, 2006, J BIOCHEM, V140, P805, DOI 10.1093/jb/mvj212; WEBER K, 1969, J BIOL CHEM, V244, P4406; WICKNER SH, 1990, P NATL ACAD SCI USA, V87, P2690, DOI 10.1073/pnas.87.7.2690; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009	42	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16789	16797		10.1074/jbc.M110.101501	http://dx.doi.org/10.1074/jbc.M110.101501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363747	Green Published, hybrid			2022-12-27	WOS:000277982600042
J	Lodeiro, MF; Uchida, AU; Arnold, JJ; Reynolds, SL; Moustafa, IM; Cameron, CE				Lodeiro, Maria F.; Uchida, Akira U.; Arnold, Jamie J.; Reynolds, Shelley L.; Moustafa, Ibrahim M.; Cameron, Craig E.			Identification of Multiple Rate-limiting Steps during the Human Mitochondrial Transcription Cycle in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; OPEN COMPLEX-FORMATION; DNA COPY NUMBER; RIBOSOMAL-RNA; YEAST MITOCHONDRIAL; EVOLUTIONARY MEDICINE; PROMOTER RECOGNITION; MAMMALIAN-CELLS; SCHNEIDER CELLS; FACTOR-A	We have reconstituted human mitochondrial transcription in vitro on DNA oligonucleotide templates representing the light strand and heavy strand-1 promoters using protein components (RNA polymerase and transcription factors A and B2) isolated from Escherichia coli. We show that 1 eq of each transcription factor and polymerase relative to the promoter is required to assemble a functional initiation complex. The light strand promoter is at least 2-fold more efficient than the heavy strand-1 promoter, but this difference cannot be explained solely by the differences in the interaction of the transcription machinery with the different promoters. In both cases, the rate-limiting step for production of the first phosphodiester bond is open complex formation. Open complex formation requires both transcription factors; however, steps immediately thereafter only require transcription factor B2. The concentration of nucleotide required for production of the first dinucleotide product is substantially higher than that required for subsequent cycles of nucleotide addition. In vitro, promoter-specific differences in post-initiation control of transcription exist, as well as a second rate-limiting step that controls conversion of the transcription initiation complex into a transcription elongation complex. Rate-limiting steps of the biochemical pathways are often those that are targeted for regulation. Like the more complex multisubunit transcription systems, multiple steps may exist for control of transcription in human mitochondria. The tools and mechanistic framework presented here will facilitate not only the discovery of mechanisms regulating human mitochondrial transcription but also interrogation of the structure, function, and mechanism of the complexes that are regulated during human mitochondrial transcription.	[Lodeiro, Maria F.; Uchida, Akira U.; Arnold, Jamie J.; Reynolds, Shelley L.; Moustafa, Ibrahim M.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, 201 Althouse Lab, University Pk, PA 16802 USA.	cec9@psu.edu			Paul Berg Endowment of the Eberly College of Science, Pennsylvania State University	Paul Berg Endowment of the Eberly College of Science, Pennsylvania State University	This work was supported in part by the Paul Berg Endowment of the Eberly College of Science, Pennsylvania State University.	Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Arnold JJ, 1999, BIOTECHNIQUES, V27, P450, DOI 10.2144/99273bm11; Arnold JJ, 1999, J BIOL CHEM, V274, P2706, DOI 10.1074/jbc.274.5.2706; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Bandwar RP, 2002, BIOCHEMISTRY-US, V41, P3586, DOI 10.1021/bi0158472; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; CHANG DD, 1987, BIOCHIM BIOPHYS ACTA, V909, P85, DOI 10.1016/0167-4781(87)90029-7; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; Davis CA, 2005, P NATL ACAD SCI USA, V102, P285, DOI 10.1073/pnas.0405779102; DIAZ GA, 1993, J MOL BIOL, V229, P805, DOI 10.1006/jmbi.1993.1086; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; FISHER RP, 1989, GENE DEV, V3, P2202, DOI 10.1101/gad.3.12b.2202; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; GAINES G, 1987, J BIOL CHEM, V262, P1907; Gangelhoff TA, 2009, NUCLEIC ACIDS RES, V37, P3153, DOI 10.1093/nar/gkp157; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Gong P, 2006, J BIOL CHEM, V281, P23533, DOI 10.1074/jbc.M604023200; Holstege FCP, 1997, METHODS, V12, P203, DOI 10.1006/meth.1997.0472; Hsu LLM, 2003, BIOCHEMISTRY-US, V42, P3777, DOI 10.1021/bi026954e; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kuzmine I, 2003, J BIOL CHEM, V278, P2819, DOI 10.1074/jbc.M208405200; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; MARTIN CT, 1987, BIOCHEMISTRY-US, V26, P2690, DOI 10.1021/bi00384a006; MARTIN CT, 1989, BIOCHEMISTRY-US, V28, P2760, DOI 10.1021/bi00433a002; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; Nudler E, 2009, ANNU REV BIOCHEM, V78, P335, DOI 10.1146/annurev.biochem.76.052705.164655; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; Place C, 1999, BIOCHEMISTRY-US, V38, P4948, DOI 10.1021/bi982689e; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Schon Eric A, 2007, Novartis Found Symp, V287, P214; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; TINTUT Y, 1995, J BIOL CHEM, V270, P24392, DOI 10.1074/jbc.270.41.24392; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Villemain J, 1997, J MOL BIOL, V273, P958, DOI 10.1006/jmbi.1997.1358; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200	77	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16387	16402		10.1074/jbc.M109.092676	http://dx.doi.org/10.1074/jbc.M109.092676			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20351113	Green Published, hybrid			2022-12-27	WOS:000277715900075
J	Vercruysse, T; Pardon, E; Vanstreels, E; Steyaert, J; Daelemans, D				Vercruysse, Thomas; Pardon, Els; Vanstreels, Els; Steyaert, Jan; Daelemans, Dirk			An Intrabody Based on a Llama Single-domain Antibody Targeting the N-terminal alpha-Helical Multimerization Domain of HIV-1 Rev Prevents Viral Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 REPLICATION; PFIZER MONKEY VIRUS; NUCLEAR EXPORT; FUNCTIONAL-ANALYSIS; STRUCTURAL MODEL; TRANS-ACTIVATOR; PROTEIN; BINDING; RNA; INHIBITION	The human immunodeficiency virus, type 1 (HIV-1)-encoded Rev protein is essential for the expression of late viral mRNAs. Rev forms a large organized multimeric protein-protein complex on the Rev response element of these viral mRNA species and transports them from the nucleus to the cytoplasm, exploiting the CRM1-mediated cellular machinery. Here we report the selection of a nanobody, derived from a llama heavy-chain only antibody, that efficiently blocks the assembly of Rev multimers. The nanobody inhibits HIV-1 replication in cells and specifically suppresses the Rev-dependent expression of partially spliced and unspliced HIV-1 RNA. In HIV-susceptible cells, this nanobody thus has potential as an effective anti-HIV agent using genetic immunization strategies. Its binding site was mapped to Rev residues Lys-20 and Tyr-23 located in the N-terminal alpha-helical multimerization domain. In the presence of this nanobody, we observed an accumulation of dimeric Rev species, supporting a head-to-head/tail-to-tail molecular model for Rev assembly. The results indicate that the oligomeric assembly of Rev follows an ordered stepwise process and identify a new epitope within Rev that could guide strategies for the development of novel HIV inhibitors.	[Vercruysse, Thomas; Vanstreels, Els; Daelemans, Dirk] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel VIB, Struct Biol Brussels Lab, B-1050 Brussels, Belgium; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel VIB, Dept Mol & Cell Interact, B-1050 Brussels, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Daelemans, D (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.	dirk.daelemans@rega.kuleuven.be	Vanstreels, Els/I-2366-2018; steyaert, jan/GQP-7811-2022; Vercruysse, Thomas/AAK-8879-2020; Steyaert, Jan/H-4662-2011; Daelemans, Dirk/P-7923-2017	Vanstreels, Els/0000-0002-7814-8035; Steyaert, Jan/0000-0002-3825-874X; Daelemans, Dirk/0000-0001-7092-1153; Vercruysse, Thomas/0000-0002-8649-777X; Pardon, Els/0000-0002-2466-0172	Fonds voor Weteschappelijk Onderzoek-Vlaanderen [1.5.104.07, 1.5.165.10]; Belgian Government [I.A.P. P6/19]; K.U. Leuven Impulsfinanciering	Fonds voor Weteschappelijk Onderzoek-Vlaanderen; Belgian Government; K.U. Leuven Impulsfinanciering	This work was supported by "Fonds voor Weteschappelijk Onderzoek-Vlaanderen" Grants 1.5.104.07 and 1.5.165.10, the Belgian Government under the framework of the Interuniversity Attraction Poles (I.A.P. P6/19), the "Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie," and the "K.U. Leuven Impulsfinanciering."	AUER M, 1994, BIOCHEMISTRY-US, V33, P2988, DOI 10.1021/bi00176a031; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; BEVEC D, 1992, P NATL ACAD SCI USA, V89, P9870, DOI 10.1073/pnas.89.20.9870; Blanco FJ, 2001, J MOL BIOL, V313, P845, DOI 10.1006/jmbi.2001.5067; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; COCHRANE AW, 1990, J VIROL, V64, P881, DOI 10.1128/JVI.64.2.881-885.1990; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; Daelemans D, 2004, J BIOL CHEM, V279, P50167, DOI 10.1074/jbc.M407713200; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; Daugherty MD, 2008, MOL CELL, V31, P824, DOI 10.1016/j.molcel.2008.07.016; DAYTON ET, 1989, SCIENCE, V246, P1625, DOI 10.1126/science.2688093; DUAN LX, 1994, P NATL ACAD SCI USA, V91, P5075, DOI 10.1073/pnas.91.11.5075; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Fischer PM, 2004, TRENDS PHARMACOL SCI, V25, P343, DOI 10.1016/j.tips.2004.04.011; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FISHER AG, 1985, NATURE, V316, P262, DOI 10.1038/316262a0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; Jain C, 2001, MOL CELL, V7, P603, DOI 10.1016/S1097-2765(01)00207-6; KALLAND KH, 1994, MOL CELL BIOL, V14, P7436, DOI 10.1128/MCB.14.11.7436; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Kubota S, 1998, ONCOGENE, V16, P1851, DOI 10.1038/sj.onc.1201738; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; MADORE SJ, 1994, VIROLOGY, V202, P186, DOI 10.1006/viro.1994.1334; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; POMERANTZ RJ, 1992, J VIROL, V66, P1809, DOI 10.1128/JVI.66.3.1809-1813.1992; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; Smith CA, 2000, MOL CELL, V6, P1067, DOI 10.1016/S1097-2765(00)00105-2; SONIGO P, 1986, CELL, V45, P375, DOI 10.1016/0092-8674(86)90323-5; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; Thomas SL, 1998, J VIROL, V72, P2935, DOI 10.1128/JVI.72.4.2935-2944.1998; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; Van Neck T, 2008, BIOORGAN MED CHEM, V16, P9487, DOI 10.1016/j.bmc.2008.09.051; Watts NR, 1998, J STRUCT BIOL, V121, P41, DOI 10.1006/jsbi.1998.3964; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994	56	54	60	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21768	21780		10.1074/jbc.M110.112490	http://dx.doi.org/10.1074/jbc.M110.112490			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20406803	Green Published, hybrid			2022-12-27	WOS:000279516100062
J	Fayyad-Kazan, H; Rouas, R; Merimi, M; El Zein, N; Lewalle, P; Jebbawi, F; Mourtada, M; Badran, H; Ezzeddine, M; Salaun, B; Romero, P; Burny, A; Martiat, P; Badran, B				Fayyad-Kazan, Hussein; Rouas, Redouane; Merimi, Makram; El Zein, Nabil; Lewalle, Philippe; Jebbawi, Fadi; Mourtada, Mohamad; Badran, Hussein; Ezzeddine, Mohamad; Salaun, Bruno; Romero, Pedro; Burny, Arsene; Martiat, Philippe; Badran, Bassam			Valproate Treatment of Human Cord Blood CD4-positive Effector T Cells Confers on Them the Molecular Profile (MicroRNA Signature and FOXP3 Expression) of Natural Regulatory CD4-positive Cells through Inhibition of Histone Deacetylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; CHROMATIN-STRUCTURE; TRICHOSTATIN-A; IN-VIVO; ACID; DIFFERENTIATION; INDUCTION; APOPTOSIS; TARGET; GROWTH	Regulatory T cells (Tregs) play a key role in immune system homeostasis and tolerance to antigens, thereby preventing autoimmunity, and may be partly responsible for the lack of an appropriate immune response against tumor cells. Although not sufficient, a high expression of forkhead box P3 (FOXP3) is necessary for their suppressive function. Recent reports have shown that histones deacetylase inhibitors increased FOXP3 expression in T cells. We therefore decided to investigate in non-Tregs CD4-positive cells, the mechanisms by which an aspecific opening of the chromatin could lead to an increased FOXP3 expression. We focused on binding of potentially activating transcription factors to the promoter region of FOXP3 and on modifications in the five miRs constituting the Tregs signature. Valproate treatment induced binding of Ets-1 and Ets-2 to the FOXP3 promoter and acted positively on its expression, by increasing the acetylation of histone H4 lysines. Valproate treatment also induced the acquisition of the miRs Tregs signature. To elucidate whether the changes in the miRs expression could be due to the increased FOXP3 expression, we transduced these non-Tregs with a FOXP3 lentiviral expression vector, and found no changes in miRs expression. Therefore, the modification in their miRs expression profile is not due to an increased expression of FOXP3 but directly results from histones deacetylase inhibition. Rather, the increased FOXP3 expression results from the additive effects of Ets factors binding and the change in expression level of miR-21 and miR-31. We conclude that valproate treatment of human non-Tregs confers on them a molecular profile similar to that of their regulatory counterpart.	[Martiat, Philippe] Univ Libre Bruxelles, Dept Expt Hematol, Inst Jules Bordet, Lab Expt Hematol, B-1000 Brussels, Belgium; [Mourtada, Mohamad; Ezzeddine, Mohamad; Badran, Bassam] Lebanese Univ, Fac Sci, Dept Biochem, Immunol Lab, Hadath Beirut 657314, Lebanon; [Salaun, Bruno; Romero, Pedro] Ludwig Inst Canc Res, Div Clin Oncoimmunol, Lausanne Branch, CH-1005 Lausanne, Switzerland	Institut Jules Bordet; Universite Libre de Bruxelles; Lebanese University; Ludwig Institute for Cancer Research	Martiat, P (corresponding author), Univ Libre Bruxelles, Dept Expt Hematol, Inst Jules Bordet, Lab Expt Hematol, 121 Blvd Waterloo, B-1000 Brussels, Belgium.	pmartiat@ulb.ac.be	Romero, Pedro/S-6015-2017; Jebbawi, Fadi/AAD-6063-2020	Romero, Pedro/0000-0002-9688-2882; Fayyad-Kazan, Hussein/0000-0002-3465-4630; el zein, nabil/0000-0002-8596-5359	Belgian Fonds National de la Recherche Scientifique (Televie); MEDIC Foundation; International Brachet Stiftung; les Amis de l'Institut Bordet; Van Buuren and Hoguet Foundations; Lebanese University; Lambeau-Marteaux Foundation.	Belgian Fonds National de la Recherche Scientifique (Televie)(Fonds de la Recherche Scientifique - FNRS); MEDIC Foundation; International Brachet Stiftung; les Amis de l'Institut Bordet; Van Buuren and Hoguet Foundations; Lebanese University; Lambeau-Marteaux Foundation.	This work was supported in part by grants from the Belgian Fonds National de la Recherche Scientifique (Televie), the MEDIC Foundation, The International Brachet Stiftung, les Amis de l'Institut Bordet, the Van Buuren and Hoguet Foundations, the Lebanese University, and the Lambeau-Marteaux Foundation.	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Achachi A, 2005, P NATL ACAD SCI USA, V102, P10309, DOI 10.1073/pnas.0504248102; Acharya MR, 2005, MOL PHARMACOL, V68, P917, DOI 10.1124/mol.105.014167; Arinze IJ, 2003, J BIOL CHEM, V278, P17785, DOI 10.1074/jbc.M209430200; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Chatila TA, 2005, J ALLERGY CLIN IMMUN, V116, P949, DOI 10.1016/j.jaci.2005.08.047; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cinatl J, 1997, ANTI-CANCER DRUG, V8, P958, DOI 10.1097/00001813-199711000-00007; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Colter DC, 2005, MATRIX BIOL, V24, P185, DOI 10.1016/j.matbio.2005.04.001; Costello JF, 2003, FRONT BIOSCI, V8, pS175, DOI 10.2741/1027; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Drucker L, 2006, CARCINOGENESIS, V27, P197, DOI 10.1093/carcin/bgi209; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Herold C, 2002, J HEPATOL, V36, P233, DOI 10.1016/S0168-8278(01)00257-4; Holmen N, 2007, NEUROGASTROENT MOTIL, V19, P119, DOI 10.1111/j.1365-2982.2006.00878.x; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Kim YB, 1999, ANN NY ACAD SCI, V886, P200, DOI 10.1111/j.1749-6632.1999.tb09416.x; Lucas JL, 2009, CELL IMMUNOL, V257, P97, DOI 10.1016/j.cellimm.2009.03.004; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Munster PN, 2001, CANCER RES, V61, P8492; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen LT, 2007, ARTHRITIS RHEUM-US, V56, P509, DOI 10.1002/art.22272; Olsen CM, 2004, MOL CELL ENDOCRINOL, V213, P173, DOI 10.1016/j.mce.2003.10.032; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Qiu L, 1999, BRIT J CANCER, V80, P1252, DOI 10.1038/sj.bjc.6690493; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sakajiri S, 2005, EXP HEMATOL, V33, P53, DOI 10.1016/j.exphem.2004.09.008; Sands SA, 2000, NEUROPSYCHOPHARMACOL, V22, P27, DOI 10.1016/S0893-133X(99)00072-X; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Suzuki T, 2000, INT J CANCER, V88, P992, DOI 10.1002/1097-0215(20001215)88:6<992::AID-IJC24>3.0.CO;2-9; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Verhagen J, 2006, J ALLERGY CLIN IMMUN, V117, P176, DOI 10.1016/j.jaci.2005.10.040; Yamashita Y, 2003, INT J CANCER, V103, P572, DOI 10.1002/ijc.10699; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	56	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20481	20491		10.1074/jbc.M110.119628	http://dx.doi.org/10.1074/jbc.M110.119628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427269	hybrid, Green Published			2022-12-27	WOS:000279228600008
J	Krautwald, S; Ziegler, E; Rolver, L; Linkermann, A; Keyser, KA; Steen, P; Wollert, KC; Korf-Klingebiel, M; Kunzendorf, U				Krautwald, Stefan; Ziegler, Ekkehard; Roelver, Lars; Linkermann, Andreas; Keyser, Kirsten A.; Steen, Philip; Wollert, Kai C.; Korf-Klingebiel, Mortimer; Kunzendorf, Ulrich			Effective Blockage of Both the Extrinsic and Intrinsic Pathways of Apoptosis in Mice by TAT-crmA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ISCHEMIA; CASPASE INHIBITOR; IN-VIVO; DEATH; FAS; HEART; PROTEIN; TRANSDUCTION; REPERFUSION; ACTIVATION	Evidence accumulates that in clinically relevant cell death, both the intrinsic and extrinsic apoptotic pathway synergistically contribute to organ failure. In search for an inhibitor of apoptosis that provides effective blockage of these pathways, we analyzed viral proteins that evolved to protect the infected host cells. In particular, the cowpox virus protein crmA has been demonstrated to be capable of blocking key caspases of both pro-apoptotic pathways. To deliver crmA into eukaryotic cells, we fused the TAT protein transduction domain of HIV to the N terminus of crmA. In vitro, the TAT-crmA fusion protein was efficiently translocated into target cells and inhibited apoptosis mediated through caspase-8, caspase-9, and caspase-3 after stimulation with alpha-Fas, etoposide, doxorubicin, or staurosporine. The extrinsic apoptotic pathway was investigated following alpha-Fas stimulation. In vivo 90% of TAT-crmA-treated animals survived an otherwise lethal dose of alpha-Fas and showed protection from Fas-induced organ failure. To examine the intrinsic apoptotic pathway, we investigated the survival of mice treated with an otherwise lethal dose of doxorubicin. Whereas all control mice died within 31 days, 40% of mice that concomitantly received intraperitoneal injections of TAT-crmA survived. To test the ability to comprehensively block both the intrinsic and extrinsic apoptotic pathway in a clinically relevant setting, we employed a murine cardiac ischemia-reperfusion model. TAT-crmA reduced infarction size by 40% and preserved left ventricular function. In summary, these results provide a proof of principle for the inhibition of apoptosis with TAT-crmA, which might provide a new treatment option for ischemia-reperfusion injuries.	[Kunzendorf, Ulrich] Univ Kiel, Div Nephrol & Hypertens, D-24105 Kiel, Germany; [Wollert, Kai C.; Korf-Klingebiel, Mortimer] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany	University of Kiel; Hannover Medical School	Kunzendorf, U (corresponding author), Univ Kiel, Div Nephrol & Hypertens, Schittenhelmstr 12, D-24105 Kiel, Germany.	kunzendorf@nephro.uni-kiel.de	Kunzendorf, Ulrich/A-8257-2010; Linkermann, Andreas/AAB-8308-2020; Krautwald, Stefan/J-9984-2016; Linkermann, Andreas/H-3551-2012	Linkermann, Andreas/0000-0001-6287-9725; Krautwald, Stefan/0000-0001-7768-2132; Linkermann, Andreas/0000-0001-6287-9725				Bhuiyan MS, 2008, CARDIOVASC THER, V26, P10, DOI 10.1111/j.1527-3466.2008.00039.x; BRAUNWALD E, 1989, CIRCULATION, V79, P441, DOI 10.1161/01.CIR.79.2.441; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Gomez L, 2005, AM J PHYSIOL-HEART C, V289, pH2153, DOI 10.1152/ajpheart.00165.2005; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kilic E, 2007, BRAIN RES, V1185, P293, DOI 10.1016/j.brainres.2007.09.031; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krautwald S, 2004, J BIOL CHEM, V279, P44005, DOI 10.1074/jbc.M401327200; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li YW, 2004, CIRC RES, V95, P627, DOI 10.1161/01.RES.0000141528.54850.bd; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Meldrum DR, 1998, AM J PHYSIOL-REG I, V274, pR577, DOI 10.1152/ajpregu.1998.274.3.R577; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Nogae S, 1998, J AM SOC NEPHROL, V9, P620; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Sung JH, 2007, NEUROSCIENCE, V149, P804, DOI 10.1016/j.neuroscience.2007.07.030; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Toro A, 2006, J CLIN INVEST, V116, P2717, DOI 10.1172/JCI25052; Wiessner C, 2000, CELL MOL BIOL, V46, P53	31	27	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19997	20005		10.1074/jbc.M110.122127	http://dx.doi.org/10.1074/jbc.M110.122127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427266	Green Published, hybrid			2022-12-27	WOS:000279012000033
J	Voorhees, JL; Brooks, CL				Voorhees, Jeffery L.; Brooks, Charles L.			Obligate Ordered Binding of Human Lactogenic Cytokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROWTH-HORMONE; HUMAN PLACENTAL-LACTOGEN; HUMAN PROLACTIN; RECEPTOR-BINDING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; DISULFIDE BONDS; NB2 CELLS; PROTEIN; SITES	Class 1 cytokines bind two receptors to create an active heterotrimeric complex. It has been argued that ligand binding to their receptors is an ordered process, but a structural mechanism describing this process has not been determined. We have previously described an obligate ordered binding mechanism for the human prolactin/prolactin receptor heterotrimeric complex. In this work we expand this conceptual understanding of ordered binding to include three human lactogenic hormones: prolactin, growth hormone, and placental lactogen. We independently blocked either of the two receptor binding sites of each hormone and used surface plasmon resonance to measure human prolactin receptor binding kinetics and stoichiometries to the remaining binding surface. When site 1 of any of the three hormones was blocked, site 2 could not bind the receptor. But blocking site 2 did not affect receptor binding at site 1, indicating a requirement for receptor binding to site 1 before site 2 binding. In addition we noted variable responses to the presence of zinc in hormone-receptor interaction. Finally, we performed Forster resonance energy transfer (FRET) analyses where receptor binding at subsaturating stoichiometries induced changes in FRET signaling, indicative of binding-induced changes in hormone conformation, whereas at receptor: hormone ratios in excess of 2:1 no additional changes in FRET signaling were observed. These results strongly support a conformationally mediated obligate-ordered receptor binding for each of the three lactogenic hormones.	[Voorhees, Jeffery L.; Brooks, Charles L.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Voorhees, Jeffery L.] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Brooks, Charles L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Brooks, Charles L.] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Brooks, CL (corresponding author), Ohio State Univ, Ohio State Biochem Program, 1925 Coffey Rd, Columbus, OH 43210 USA.	brooks.8@osu.edu			National Institutes of Health [R01-DK72275]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK72275.	Bernat B, 2003, P NATL ACAD SCI USA, V100, P952, DOI 10.1073/pnas.0235023100; BEWLEY TA, 1969, INT J PROT RES, V1, P117; Chen WY, 1999, CLIN CANCER RES, V5, P3583; CUNNINGHAM BC, 1990, SCIENCE, V250, P1709, DOI 10.1126/science.2270485; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DATTANI MT, 1995, J BIOL CHEM, V270, P9222, DOI 10.1074/jbc.270.16.9222; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DONEEN BA, 1979, BIOCHEMISTRY-US, V18, P4851, DOI 10.1021/bi00589a013; Duda KM, 2003, PROTEIN ENG, V16, P531, DOI 10.1093/protein/gzg067; Duda KM, 2003, J BIOL CHEM, V278, P22734, DOI 10.1074/jbc.M212550200; Duda KM, 1999, FEBS LETT, V449, P120, DOI 10.1016/S0014-5793(99)00416-0; FORSYTH IA, 1986, J DAIRY SCI, V69, P886, DOI 10.3168/jds.S0022-0302(86)80479-9; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GOFFIN V, 1994, J BIOL CHEM, V269, P32598; HOOPER KP, 1993, J BIOL CHEM, V268, P22347; Huising MO, 2006, J ENDOCRINOL, V189, P1, DOI 10.1677/joe.1.06591; Jomain JB, 2007, J BIOL CHEM, V282, P33118, DOI 10.1074/jbc.M704364200; Keeler C, 2003, J MOL BIOL, V328, P1105, DOI 10.1016/S0022-2836(03)00367-X; Kinet S, 1999, J BIOL CHEM, V274, P26033, DOI 10.1074/jbc.274.37.26033; Kossiakoff AA, 2004, ADV PROTEIN CHEM, V68, P147; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LOWMAN HB, 1991, J BIOL CHEM, V266, P10982; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Permyakov EA, 1997, FEBS LETT, V405, P273, DOI 10.1016/S0014-5793(97)00203-2; Peterson FC, 1999, PROTEIN EXPRES PURIF, V15, P16, DOI 10.1006/prep.1998.0984; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Schiffer C, 2002, J MOL BIOL, V316, P277, DOI 10.1006/jmbi.2001.5348; Sivaprasad U, 2004, BIOCHEMISTRY-US, V43, P13755, DOI 10.1021/bi049333p; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Svensson LA, 2008, J BIOL CHEM, V283, P19085, DOI 10.1074/jbc.M801202200; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; UIVAPRASAD U, 2003, THESIS OHIO STATE U; Walsh STR, 2006, J MOL BIOL, V358, P773, DOI 10.1016/j.jmb.2006.02.038; Walsh STR, 2004, P NATL ACAD SCI USA, V101, P17078, DOI 10.1073/pnas.0403336101; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	39	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20022	20030		10.1074/jbc.M109.084988	http://dx.doi.org/10.1074/jbc.M109.084988			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427283	Green Published, hybrid			2022-12-27	WOS:000279012000036
J	Cornea, RL; Nitu, FR; Samso, M; Thomas, DD; Fruen, BR				Cornea, Razvan L.; Nitu, Florentin R.; Samso, Montserrat; Thomas, David D.; Fruen, Bradley R.			Mapping the Ryanodine Receptor FK506-binding Protein Subunit Using Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; POLYMORPHIC VENTRICULAR-TACHYCARDIA; FK-506 BINDING-PROTEIN; SKELETAL-MUSCLE; FKBP12.6 BINDING; CALMODULIN; VISUALIZATION; LOCATIONS; INSIGHTS; REGION	The 12-kDa FK506-binding proteins (FKBP12 and FKBP12.6) are regulatory subunits of ryanodine receptor (RyR) Ca2+ release channels. To investigate the structural basis of FKBP interactions with the RyR1 and RyR2 isoforms, we used site-directed fluorescent labeling of FKBP12.6, ligand binding measurements, and fluorescence resonance energy transfer (FRET). Single-cysteine substitutions were introduced at five positions distributed over the surface of FKBP12.6. Fluorescent labeling at position 14, 32, 49, or 85 did not affect high affinity binding to the RyR1. By comparison, fluorescent labeling at position 41 reduced the affinity of FKBP12.6 binding by 10-fold. Each of the five fluorescent FKBPs retained the ability to inhibit [3H]ryanodine binding to the RyR1, although the maximal extent of inhibition was reduced by half when the label was attached at position 32. The orientation of FKBP12.6 bound to the RyR1 and RyR2 was examined by measuring FRET from the different labeling positions on FKBP12.6 to an acceptor attached within the RyR calmodulin subunit. FRET was dependent on the position of fluorophore attachment on FKBP12.6; however, for any given position, the distance separating donors and acceptors bound to RyR1 versus RyR2 did not differ significantly. Our results show that FKBP12.6 binds to RyR1 and RyR2 in the same orientation and suggest new insights into the discrete structural domains responsible for channel binding and inhibition. FRET mapping of RyR-bound FKBP12.6 is consistent with the predictions of a previous cryoelectron microscopy study and strongly supports the proposed structural model	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Samso, Montserrat] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital	Fruen, BR (corresponding author), 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	fruen001@umn.edu	Thomas, David D/B-4257-2012	Nitu, Florentin/0000-0001-9768-6333; Samso, Montserrat/0000-0002-2788-3283; Thomas, David D./0000-0002-8822-2040; Cornea, Razvan/0000-0001-5739-0992	National Institutes of Health [R01HL076433, R01GM27906, R01HL092097]; BWH Biomedical Research Institute Fund to Sustain Research Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092097, R01HL076433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BWH Biomedical Research Institute Fund to Sustain Research Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL076433 (to B.R.F.) and R01GM27906 (to D.D.T.).This work was also supported by a subcontract (to R.L.C.) from National Institutes of Health Grant R01HL092097 (to D.M.Bers, University of California, Davis, CA) and the BWH Biomedical Research Institute Fund to Sustain Research Excellence (to M.S.).	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; Bers Donald M, 2006, Biochem J, V396, pe1; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; CRYAN J, 1991, BIOCHEM BIOPH RES CO, V180, P846, DOI 10.1016/S0006-291X(05)81142-8; Deivanayagam CCS, 2000, ACTA CRYSTALLOGR D, V56, P266, DOI 10.1107/S0907444999016571; Fruen BR, 2005, BIOCHEMISTRY-US, V44, P278, DOI 10.1021/bi048246u; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; GUO T, 2010, CIRC RES IN PRESS; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; HAUGLAND R, 2005, HDB GUIDE FLUORESCEN, P23; HOLZMAN TF, 1991, J BIOL CHEM, V266, P2474; Huang FN, 2006, P NATL ACAD SCI USA, V103, P3456, DOI 10.1073/pnas.0511282103; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; Lehnart SE, 2004, CIRCULATION, V109, P3208, DOI 10.1161/01.CIR.0000132472.98675.EC; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; MAYRLEITNER M, 1994, CELL CALCIUM, V15, P99, DOI 10.1016/0143-4160(94)90048-5; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; PARK ST, 1992, J BIOL CHEM, V267, P3316; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi Y, 1998, J BIOL CHEM, V273, P34813, DOI 10.1074/jbc.273.52.34813; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Seidler T, 2007, CIRC RES, V101, P1020, DOI 10.1161/CIRCRESAHA.107.154609; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wagenknecht T, 2002, FRONT BIOSCI, V7, pD1464, DOI 10.2741/wagen; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xiao JM, 2007, J BIOL CHEM, V282, P34828, DOI 10.1074/jbc.M707423200; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315; Zissimofolilos S, 2009, BIOCHEM J, V419, P273, DOI 10.1042/BJ20082324; Zissimopoulos S, 2007, J BIOL CHEM, V282, P6976, DOI 10.1074/jbc.M607590200	39	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19219	19226		10.1074/jbc.M109.066944	http://dx.doi.org/10.1074/jbc.M109.066944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404344	Green Published, hybrid			2022-12-27	WOS:000278727800031
J	Tapia, VE; Nicolaescu, E; McDonald, CB; Musi, V; Oka, T; Inayoshi, Y; Satteson, AC; Mazack, V; Humbert, J; Gaffney, CJ; Beullens, M; Schwartz, CE; Landgraf, C; Volkmer, R; Pastore, A; Farooq, A; Bollen, M; Sudol, M				Tapia, Victor E.; Nicolaescu, Emilia; McDonald, Caleb B.; Musi, Valeria; Oka, Tsutomu; Inayoshi, Yujin; Satteson, Adam C.; Mazack, Virginia; Humbert, Jasper; Gaffney, Christian J.; Beullens, Monique; Schwartz, Charles E.; Landgraf, Christiane; Volkmer, Rudolf; Pastore, Annalisa; Farooq, Amjad; Bollen, Mathieu; Sudol, Marius			Y65C Missense Mutation in the WW Domain of the Golabi-Ito-Hall Syndrome Protein PQBP1 Affects Its Binding Activity and Deregulates Pre-mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE TRACT-BINDING; LINKED MENTAL-RETARDATION; CARBOXYL-TERMINAL DOMAIN; YES-ASSOCIATED PROTEIN; RENPENNING SYNDROME; POLYMERASE-II; GENE PQBP1; TRANSCRIPTION; MECHANISM; LIGAND	The PQBP1 (polyglutamine tract-binding protein 1) gene encodes a nuclear protein that regulates pre-mRNA splicing and transcription. Mutations in the PQBP1 gene were reported in several X chromosome-linked mental retardation disorders including Golabi-Ito-Hall syndrome. The missense mutation that causes this syndrome is unique among other PQBP1 mutations reported to date because it maps within a functional domain of PQBP1, known as the WW domain. The mutation substitutes tyrosine 65 with cysteine and is located within the conserved core of aromatic amino acids of the domain. We show here that the binding property of the Y65C-mutated WW domain and the full-length mutant protein toward its cognate proline-rich ligands was diminished. Furthermore, in Golabi-Ito-Hall-derived lymphoblasts we showed that the complex between PQBP1-Y65C and WBP11 (WW domain-binding protein 11) splicing factor was compromised. In these cells a substantial decrease in pre-mRNA splicing efficiency was detected. Our study points to the critical role of the WW domain in the function of the PQBP1 protein and provides an insight into the molecular mechanism that underlies the X chromosome-linked mental retardation entities classified globally as Renpenning syndrome.	[Tapia, Victor E.; Landgraf, Christiane; Volkmer, Rudolf] Charite, Inst Med Immunol, D-10115 Berlin, Germany; [Nicolaescu, Emilia; Beullens, Monique; Bollen, Mathieu] Univ Louvain, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [McDonald, Caleb B.; Farooq, Amjad] Univ Miami, Dept Biochem & Mol Biol, Leonard Miller Sch Med, Miami, FL 33136 USA; [McDonald, Caleb B.; Farooq, Amjad] Univ Miami, Leonard Miller Sch Med, UMSylvester Braman Family Breast Canc Inst, Miami, FL 33136 USA; [Musi, Valeria; Pastore, Annalisa] Natl Inst Med Res, Dept Mol Struct, London NW7 1AA, England; [Oka, Tsutomu; Inayoshi, Yujin; Satteson, Adam C.; Mazack, Virginia; Humbert, Jasper; Gaffney, Christian J.; Sudol, Marius] Weis Ctr Res, Lab Signal Transduct & Prote Profiling, Danville, PA 17822 USA; [Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Sudol, Marius] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Miami; University of Miami; MRC National Institute for Medical Research; Greenwood Genetic Center; Icahn School of Medicine at Mount Sinai	Sudol, M (corresponding author), Weis Ctr Res, Geisinger Clin, Lab 202, 100 N Acad Ave, Danville, PA 17822 USA.	msudol1@geisinger.edu	Farooq, Amjad/B-5084-2012	Volkmer, Rudolf/0000-0003-4710-1143	National Institutes of Health [T32-CA119929, R01-GM083897, HD26202]; NICHD; Deutsche Forschungsgemeinschaft [SFB 449]; UMSylvester Braman Family Breast Cancer Institute; Medical Research Council [U117584256]; Concerted Research Action and the Fund for Scientific Research-Flanders [G.0670.09N, KAN1.5.101.07]; Geisinger Clinic; Medical Research Council [MC_U117533887, MC_U117584256] Funding Source: researchfish; MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA119929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UMSylvester Braman Family Breast Cancer Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Concerted Research Action and the Fund for Scientific Research-Flanders(FWO); Geisinger Clinic; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32-CA119929 (to C. B. M.), R01-GM083897 (to A. F.), and HD26202, NICHD (to C. E. S.). This work was also supported by Deutsche Forschungsgemeinschaft Grant SFB 449 (to V. T.), by the UMSylvester Braman Family Breast Cancer Institute (to A. F.), by Medical Research Council Grant U117584256 (to A. P.), by Concerted Research Action and the Fund for Scientific Research-Flanders Grants G.0670.09N and KAN1.5.101.07 (to M. B.), and by the Geisinger Clinic (to M. S.).	Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chang A, 2000, J BIOL CHEM, V275, P20562, DOI 10.1074/jbc.M002479200; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cossee M, 2006, EUR J HUM GENET, V14, P418, DOI 10.1038/sj.ejhg.5201593; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Enokido Y, 2002, BIOCHEM BIOPH RES CO, V294, P268, DOI 10.1016/S0006-291X(02)00477-1; Fairbrother W, 2008, BIOESSAYS, V30, P1, DOI 10.1002/bies.20696; Fernandez-Escamilla AM, 2006, PROTEIN SCI, V15, P2278, DOI 10.1110/ps.062186506; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gavva NR, 1997, J BIOL CHEM, V272, P24105, DOI 10.1074/jbc.272.39.24105; Gibson TJ, 2009, TRENDS BIOCHEM SCI, V34, P471, DOI 10.1016/j.tibs.2009.06.007; Gregersen N, 2000, J INHERIT METAB DIS, V23, P441, DOI 10.1023/A:1005663728291; Guo F, 2007, MOL BIOTECHNOL, V36, P38, DOI 10.1007/s12033-007-0018-0; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Ito H, 2009, HUM MOL GENET, V18, P4239, DOI 10.1093/hmg/ddp378; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; Jiang Y, 2008, INT J BIOCHEM CELL B, V40, P776, DOI 10.1016/j.biocel.2007.10.022; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Kato Y, 2004, J BIOL CHEM, V279, P31833, DOI 10.1074/jbc.M404719200; Kleefstra T, 2004, CLIN GENET, V66, P318, DOI 10.1111/j.1399-0004.2004.00308.x; Koepf EK, 1999, BIOCHEMISTRY-US, V38, P14338, DOI 10.1021/bi991105l; Komuro A, 1999, NUCLEIC ACIDS RES, V27, P1957, DOI 10.1093/nar/27.9.1957; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Lappalainen K, 2008, PROTEINS, V72, P779, DOI 10.1002/prot.21970; Lenski C, 2004, AM J HUM GENET, V74, P777, DOI 10.1086/383205; Llorian M, 2005, J BIOL CHEM, V280, P38862, DOI 10.1074/jbc.M509185200; Llorian M, 2004, BIOCHEM J, V378, P229, DOI 10.1042/BJ20030950; Lubs H, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037556; Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martinez-Garay I, 2007, EUR J HUM GENET, V15, P29, DOI 10.1038/sj.ejhg.5201717; Musante L, 2010, HUM MUTAT, V31, P90, DOI 10.1002/humu.21146; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Nicolaescu E, 2008, EUR J CELL BIOL, V87, P817, DOI 10.1016/j.ejcb.2008.05.001; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Okazawa H, 2001, BRAIN RES BULL, V56, P273, DOI 10.1016/S0361-9230(01)00579-2; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Okuda T, 2003, HUM MOL GENET, V12, P711, DOI 10.1093/hmg/ddg084; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Stevenson RE, 2005, AM J MED GENET A, V134A, P415, DOI 10.1002/ajmg.a.30664; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; SUDOL M, 2005, WW DOMAIN MODULAR PR, P59; Tsuji S, 1999, Adv Neurol, V79, P399; Volkmer R, 2009, CHEMBIOCHEM, V10, P1431, DOI 10.1002/cbic.200900078; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6; Yoshimura N, 2006, FEBS LETT, V580, P2335, DOI 10.1016/j.febslet.2006.03.056; Yu JH, 2009, DEV DYNAM, V238, P2471, DOI 10.1002/dvdy.22063; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3	61	45	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19391	19401		10.1074/jbc.M109.084525	http://dx.doi.org/10.1074/jbc.M109.084525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410308	hybrid, Green Published			2022-12-27	WOS:000278727800050
J	Eliades, A; Papadantonakis, N; Ravid, K				Eliades, Alexia; Papadantonakis, Nikolaos; Ravid, Katya			New Roles for Cyclin E in Megakaryocytic Polyploidization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMITOTIC CELL-CYCLE; DNA-REPLICATION; MOLECULAR-MECHANISMS; PLATELET PRODUCTION; TRANSGENIC MICE; RE-REPLICATION; G1 CYCLIN; S PHASE; C-MYC; EXPRESSION	Megakaryocytes are platelet precursor cells that undergo endomitosis. During this process, repeated rounds of DNA synthesis are characterized by lack of late anaphase and cytokinesis. Physiologically, the majority of the polyploid megakaryocytes in the bone marrow are cell cycle arrested. As previously reported, cyclin E is essential for megakaryocyte polyploidy; however, it has remained unclear whether up-regulated cyclin E is an inducer of polyploidy in vivo. We found that cyclin E is up-regulated upon stimulation of primary megakaryocytes by thrombopoietin. Transgenic mice in which elevated cyclin E expression is targeted to megakaryocytes display an increased ploidy profile. Examination of S phase markers, specifically proliferating cell nuclear antigen, cyclin A, and 5-bromo-2-deoxyuridine reveals that cyclin E promotes progression to S phase and cell cycling. Interestingly, analysis of Cdc6 and Mcm2 indicates that cyclin E mediates its effect by promoting the expression of components of the pre-replication complex. Furthermore, we show that up-regulated cyclin E results in the up-regulation of cyclin B1 levels, suggesting an additional mechanism of cyclin E-mediated ploidy increase. These findings define a key role for cyclin E in promoting megakaryocyte entry into S phase and hence, increase in the number of cell cycling cells and in augmenting polyploidization.	[Ravid, Katya] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Whitaker Cardiovasc Inst,CVI,Dept Med, Boston, MA 02118 USA; [Eliades, Alexia; Papadantonakis, Nikolaos; Ravid, Katya] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Whitaker Cardiovasc Inst,Dept Biochem, Boston, MA 02118 USA; [Papadantonakis, Nikolaos] Univ Crete, Sch Med, Grad Program Mol Basis Human Dis, Iraklion 71003, Greece	Boston University; Boston University; University of Crete	Ravid, K (corresponding author), Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Whitaker Cardiovasc Inst,CVI,Dept Med, W-601,700 Albany St, Boston, MA 02118 USA.	kravid@bu.edu		Ravid, Katya/0000-0002-9918-3024; Eliades, Alexia/0000-0001-8459-7163	National Institutes of Health NHLBI [HL80442]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080442] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Grant HL80442 (to K. R.).	Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Arata Y, 2000, J BIOL CHEM, V275, P6337, DOI 10.1074/jbc.275.9.6337; Balduini CL, 2004, SEMIN THROMB HEMOST, V30, P513, DOI 10.1055/s-2004-835672; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Carow CE, 2001, J CELL PHYSIOL, V188, P291, DOI 10.1002/jcp.1120; Datta NS, 1998, CELL GROWTH DIFFER, V9, P639; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Early A, 2004, PHILOS T R SOC B, V359, P31, DOI 10.1098/rstb.2003.1362; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; Garcia P, 1996, ONCOGENE, V13, P695; Garcia P, 2000, ONCOGENE, V19, P1820, DOI 10.1038/sj.onc.1203494; Geddis AE, 2004, BLOOD, V104, P1017, DOI 10.1182/blood-2004-02-0419; Geddis AE, 2006, CELL CYCLE, V5, P538, DOI 10.4161/cc.5.5.2537; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Gudas JM, 1999, MOL CELL BIOL, V19, P612; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Italiano JE, 2007, J THROMB HAEMOST, V5, P18, DOI 10.1111/j.1538-7836.2007.02487.x; Iwabe K, 1998, BRIT J HAEMATOL, V102, P812, DOI 10.1046/j.1365-2141.1998.00819.x; Kaushansky K, 1999, BIOESSAYS, V21, P353, DOI 10.1002/(SICI)1521-1878(199904)21:4<353::AID-BIES12>3.0.CO;2-P; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; Keck JM, 2007, J CELL BIOL, V178, P371, DOI 10.1083/jcb.200703202; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; McCrann DJ, 2008, BLOOD, V111, P4092, DOI 10.1182/blood-2007-11-122150; McCrann DJ, 2009, BLOOD, V114, P1243, DOI 10.1182/blood-2008-12-195883; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Muntean AG, 2007, BLOOD, V109, P5199, DOI 10.1182/blood-2006-11-059378; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; Nguyen HG, 2005, BLOOD, V106, P1559, DOI 10.1182/blood-2005-02-0638; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Papadantonakis N, 2008, CELL CYCLE, V7, P2352, DOI 10.4161/cc.6325; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; PAULUS JM, 1970, BLOOD-J HEMATOL, V35, P298, DOI 10.1182/blood.V35.3.298.298; RAVID K, 1991, P NATL ACAD SCI USA, V88, P1521, DOI 10.1073/pnas.88.4.1521; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; Roy L, 2001, BLOOD, V97, P2238, DOI 10.1182/blood.V97.8.2238; Sun S, 2001, HAEMATOLOGICA, V86, P17; Thompson A, 1996, J BIOL CHEM, V271, P22976, DOI 10.1074/jbc.271.38.22976; Tomer A, 2004, BLOOD, V104, P2722, DOI 10.1182/blood-2004-02-0769; Tsuruga H, 1997, BIOCHEM BIOPH RES CO, V236, P118, DOI 10.1006/bbrc.1997.6865; Vitrat N, 1998, BLOOD, V91, P3711; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; WANG ZY, 1995, BLOOD, V86, P3783, DOI 10.1182/blood.V86.10.3783.bloodjournal86103783; Wen Q, 2009, BLOOD, V114, P153, DOI 10.1182/blood-2008-11-190801; Zariwala M, 1998, ONCOGENE, V17, P2787, DOI 10.1038/sj.onc.1202505; Zhang Y, 2004, BLOOD, V103, P3717, DOI 10.1182/blood-2003-09-3365; Zhang Y, 1998, J BIOL CHEM, V273, P1387, DOI 10.1074/jbc.273.3.1387; Zhang Y, 1996, J BIOL CHEM, V271, P4266; Zimmet JM, 1997, MOL CELL BIOL, V17, P7248, DOI 10.1128/MCB.17.12.7248	57	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18909	18917		10.1074/jbc.M110.102145	http://dx.doi.org/10.1074/jbc.M110.102145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392692	hybrid, Green Published			2022-12-27	WOS:000278453900081
J	He, C; Nora, GP; Schneider, EL; Kerr, ID; Hansell, E; Hirata, K; Gonzalez, D; Sajid, M; Boyd, SE; Hruz, P; Cobo, ER; Le, C; Liu, WT; Eckmann, L; Dorrestein, PC; Houpt, ER; Brinen, LS; Craik, CS; Roush, WR; McKerrow, J; Reed, SL				He, Chen; Nora, George P.; Schneider, Eric L.; Kerr, Iain D.; Hansell, Elizabeth; Hirata, Ken; Gonzalez, David; Sajid, Mohammed; Boyd, Sarah E.; Hruz, Petr; Cobo, Eduardo R.; Le, Christine; Liu, Wei-ting; Eckmann, Lars; Dorrestein, Pieter C.; Houpt, Eric R.; Brinen, Linda S.; Craik, Charles S.; Roush, William R.; McKerrow, James; Reed, Sharon L.			A Novel Entamoeba histolytica Cysteine Proteinase, EhCP4, Is Key for Invasive Amebiasis and a Therapeutic Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOZOAN PARASITE; TRANSCRIPTION FACTOR; GAL/GALNAC LECTIN; GENE-EXPRESSION; PROTEASES; CELLS; IDENTIFICATION; INHIBITION; PURIFICATION; COMPARTMENTS	Entamoeba histolytica cysteine proteinases (EhCPs) play a key role in disrupting the colonic epithelial barrier and the innate host immune response during invasion of E. histolytica, the protozoan cause of human amebiasis. EhCPs are encoded by 50 genes, of which ehcp4 (ehcp-a4) is the most up-regulated during invasion and colonization in a mouse cecal model of amebiasis. Up-regulation of ehcp4 in vivo correlated with our finding that co-culture of E. histolytica trophozoites with mucin-producing T84 cells increased ehcp4 expression up to 6-fold. We have expressed recombinant EhCP4, which was autocatalytically activated at acidic pH but had highest proteolytic activity at neutral pH. In contrast to the other amebic cysteine proteinases characterized so far, which have a preference for arginine in the P2 position, EhCP4 displayed a unique preference for valine and isoleucine at P2. This preference was confirmed by homology modeling, which revealed a shallow, hydrophobic S2 pocket. Endogenous EhCP4 localized to cytoplasmic vesicles, the nuclear region, and perinuclear endoplasmic reticulum (ER). Following co-culture with colonic cells, EhCP4 appeared in acidic vesicles and was released extracellularly. A specific vinyl sulfone inhibitor, WRR605, synthesized based on the substrate specificity of EhCP4, inhibited the recombinant enzyme in vitro and significantly reduced parasite burden and inflammation in the mouse cecal model. The unique expression pattern, localization, and biochemical properties of EhCP4 could be exploited as a potential target for drug design.	[Reed, Sharon L.] Univ Calif San Diego, Med Ctr, Div Infect Dis, Dept Pathol, San Diego, CA 92103 USA; [He, Chen; Hirata, Ken; Cobo, Eduardo R.; Reed, Sharon L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Nora, George P.; Roush, William R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Schneider, Eric L.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Kerr, Iain D.; Brinen, Linda S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Hansell, Elizabeth; Sajid, Mohammed; McKerrow, James] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94158 USA; [Gonzalez, David; Liu, Wei-ting; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Sajid, Mohammed] Leiden Univ, Med Ctr, NL-233 ZA Leiden, Netherlands; [Boyd, Sarah E.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia; [Boyd, Sarah E.] La Trobe Univ, Biosci Res Ctr, Bundoora, Vic 3086, Australia; [Hruz, Petr; Le, Christine; Eckmann, Lars] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Houpt, Eric R.] Univ Virginia, Dept Internal Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; La Trobe University; La Trobe University; University of California System; University of California San Diego; University of Virginia	Reed, SL (corresponding author), Univ Calif San Diego, Med Ctr, Div Infect Dis, Dept Pathol, 200 W Arbor Dr, San Diego, CA 92103 USA.	slreed@ucsd.edu	Cobo, Eduardo R/AAF-2656-2021; Dorrestein, Pieter/D-5012-2012; Hruz, Petr/F-1406-2011; Boyd, Sarah E/I-9047-2012; Dorrestein, Pieter/ABF-2930-2020	Cobo, Eduardo R/0000-0001-5450-7673; Hruz, Petr/0000-0003-2767-0445; Boyd, Sarah/0000-0002-7264-8602	National Institutes of Health [1-UO1-AI077822, R01 CA128765]; University of California, San Diego; University of California, San Francisco; NATIONAL CANCER INSTITUTE [R01CA128765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); University of California, San Francisco(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1-UO1-AI077822 (to S.L.R., J.M., and W.R.R.) and R01 CA128765 (to E.L.S. and C.S.C.).; We are grateful for the technical support and the initial cecum-passed E. histolytica trophozoites from S. Stroup and Dr. X. T. Guo (University of Virginia). We thank the mouse surgery supporting team, G. Hwang, Y. Anderson, J. Scholtz, and H. Yoo (University of California, San Diego). We thank Dr. J. Engel (University of California, San Francisco) and J. Steinauer and Dr. L. Ellies (University of California, San Diego) for technical advice and support of microscopy; Dr. M. Diccianni (University of California, San Diego) for fluorescence scan; Dr. M. Ramos and Dr. S. Melendez-Lopez (Universidad Autonoma de Baja California, Mexico) for general advice; and Dr. S. J. Bark (University of California, San Diego) for identification of the purified recombinant EhCP4 antigen for antibody production. In addition, we thank Dr. C. Davis for critical review of the manuscript.	Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; Beck DL, 2005, EUKARYOT CELL, V4, P722, DOI 10.1128/EC.4.4.722-732.2005; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; BEYNON R, 2001, PROTEOLYTIC ENZYMES, P144; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Brinen LS, 2000, ARCH MED RES, V31, pS63, DOI 10.1016/S0188-4409(00)00154-5; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Bruchhaus I, 1996, MOL MICROBIOL, V22, P255, DOI 10.1046/j.1365-2958.1996.00111.x; Camenisch G, 1999, FASEB J, V13, P81, DOI 10.1096/fasebj.13.1.81; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; DeLano W.L, PYMOL MOL GRAPHICS S; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Gilchrist CA, 1998, INFECT IMMUN, V66, P2383, DOI 10.1128/IAI.66.5.2383-2386.1998; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; Gottke MU, 1998, J EUKARYOT MICROBIOL, V45, p17S, DOI 10.1111/j.1550-7408.1998.tb04519.x; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Hellberg A, 2002, PROTEIN EXPRES PURIF, V24, P131, DOI 10.1006/prep.2001.1548; Houpt ER, 2002, J IMMUNOL, V169, P4496, DOI 10.4049/jimmunol.169.8.4496; Jacobs T, 1998, MOL MICROBIOL, V27, P269, DOI 10.1046/j.1365-2958.1998.00662.x; KEENE WE, 1986, J EXP MED, V163, P536, DOI 10.1084/jem.163.3.536; KELSALL BL, 1993, J INFECT DIS, V168, P1319, DOI 10.1093/infdis/168.5.1319; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Lauwaet T, 2003, J BIOL CHEM, V278, P22650, DOI 10.1074/jbc.M300142200; LihBrody L, 1996, DIGEST DIS SCI, V41, P2078, DOI 10.1007/BF02093613; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; Maubach G, 2008, MOL BIOL CELL, V19, P4238, DOI 10.1091/mbc.E08-03-0291; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Melendez-Lopez SG, 2007, EUKARYOT CELL, V6, P1130, DOI 10.1128/EC.00094-07; Mitra BN, 2007, CELL MICROBIOL, V9, P2112, DOI 10.1111/j.1462-5822.2007.00941.x; Mitra BN, 2006, EXP PARASITOL, V114, P57, DOI 10.1016/j.exppara.2006.02.009; Moncada D, 2003, INFECT IMMUN, V71, P838, DOI 10.1128/IAI.71.2.838-844.2003; Okada M, 2006, MOL BIOCHEM PARASIT, V145, P171, DOI 10.1016/j.molbiopara.2005.10.001; Pizzorno MC, 2001, BBA-MOL BASIS DIS, V1536, P31, DOI 10.1016/S0925-4439(01)00032-1; Que XC, 2003, INFECT IMMUN, V71, P1274, DOI 10.1128/IAI.71.3.1274-1280.2003; Que XC, 2002, MOL BIOCHEM PARASIT, V119, P23, DOI 10.1016/S0166-6851(01)00387-5; Quintas-Granados LI, 2009, PROTEIN EXPRES PURIF, V63, P26, DOI 10.1016/j.pep.2008.09.006; REED SL, 1989, J IMMUNOL, V143, P189; REED SL, 1995, J IMMUNOL, V155, P266; Roush WR, 2001, BIOORG MED CHEM LETT, V11, P2759, DOI 10.1016/S0960-894X(01)00566-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato D, 2006, FEBS LETT, V580, P5306, DOI 10.1016/j.febslet.2006.08.081; Screen M, 2008, DEVELOPMENT, V135, P3311, DOI 10.1242/dev.025627; Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Teixeira JE, 2008, EUKARYOT CELL, V7, P1222, DOI 10.1128/EC.00007-08; Tillack M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-170; Tran VQ, 1998, J INFECT DIS, V177, P508, DOI 10.1086/517388; Zhang Z, 2000, MOL MICROBIOL, V37, P542, DOI 10.1046/j.1365-2958.2000.02037.x	55	52	52	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18516	18527		10.1074/jbc.M109.086181	http://dx.doi.org/10.1074/jbc.M109.086181			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378535	Green Published, hybrid			2022-12-27	WOS:000278453900045
J	Illuzzi, G; Bernacchioni, C; Aureli, M; Prioni, S; Frera, G; Donati, C; Valsecchi, M; Chigorno, V; Bruni, P; Sonnino, S; Prinetti, A				Illuzzi, Giuditta; Bernacchioni, Caterina; Aureli, Massimo; Prioni, Simona; Frera, Gianluca; Donati, Chiara; Valsecchi, Manuela; Chigorno, Vanna; Bruni, Paola; Sonnino, Sandro; Prinetti, Alessandro			Sphingosine Kinase Mediates Resistance to the Synthetic Retinoid N-(4-Hydroxyphenyl)retinamide in Human Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; GLUCOSYLCERAMIDE SYNTHASE; SPHINGOLIPID METABOLISM; SPHINGOSINE-1-PHOSPHATE RECEPTOR; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; P-GLYCOPROTEIN; EXPRESSION; CERAMIDE; FENRETINIDE	A2780 human ovarian carcinoma cells respond to treatment with the synthetic retinoid N-(4-hydroxyphenyl) retinamide (HPR) with the production of dihydroceramide and with a concomitant reduction of cell proliferation and induction of apoptosis. The derived HPR-resistant clonal cell line, A2780/HPR, is less responsive to HPR in terms of dihydroceramide generation. In this report, we show that the production of sphingosine 1-phosphate (S1P) is significantly higher in A2780/HPR versus A2780 cells due to an increased sphingosine kinase (SK) activity and SK-1 mRNA and protein levels. Treatment of A2780 and A2780/HPR cells with a potent and highly selective pharmacological SK inhibitor effectively reduced S1P production and resulted in a marked reduction of cell proliferation. Moreover, A2780/HPR cells treated with a SK inhibitor were sensitized to the cytotoxic effect of HPR, due to an increased dihydroceramide production. On the other hand, the ectopic expression of SK-1 in A2780 cells was sufficient to induce HPR resistance in these cells. Challenge of A2780 and A2780/HPR cells with agonists and antagonists of S1P receptors had no effects on their sensitivity to the drug, suggesting that the role of SK in HPR resistance in these cells is not mediated by the S1P receptors. These data clearly demonstrate a role for SK in determining resistance to HPR in ovarian carcinoma cells, due to its effect in the regulation of intracellular ceramide/S1P ratio, which is critical in the control of cell death and proliferation.	[Illuzzi, Giuditta; Aureli, Massimo; Prioni, Simona; Frera, Gianluca; Valsecchi, Manuela; Chigorno, Vanna; Sonnino, Sandro; Prinetti, Alessandro] Univ Milan, Dipartimento Chim Biochim Biotecnol & Med, Ctr Excellence Neurodegenerat Dis, I-20090 Milan, Italy; [Bernacchioni, Caterina; Donati, Chiara; Bruni, Paola] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy	University of Milan; University of Florence	Prinetti, A (corresponding author), Univ Milan, Dipartimento Chim Biochim Biotecnol & Med, Ctr Excellence Neurodegenerat Dis, Via Fratelli Cervi 93, I-20090 Milan, Italy.	alessandro.prinetti@unimi.it	Sonnino, Sandro/R-4154-2017; Prinetti, Alessandro/R-4206-2017; Bruni, Paola/A-1151-2008; Frera, Gianluca/N-2904-2017; Aureli, Massimo/G-3876-2014; donati, chiara/AAN-2682-2021	Sonnino, Sandro/0000-0001-8180-5908; Prinetti, Alessandro/0000-0003-0252-2593; Aureli, Massimo/0000-0003-1916-2440; donati, chiara/0000-0003-2224-4199; Bernacchioni, Caterina/0000-0002-1023-0067; Bruni, Paola/0000-0002-1151-3413	Mizutani Foundation for Glycoscience [070002]; Associazione Italiana per la Ricerca sul Cancro [2007]	Mizutani Foundation for Glycoscience; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Mizutani Foundation for Glycoscience Grant 070002 (to A. P.) and Associazione Italiana per la Ricerca sul Cancro Grant 2007 (to S. S.).	Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Appierto V, 2001, BRIT J CANCER, V84, P1528, DOI 10.1054/bjoc.2001.1826; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Bonanni B, 2007, EXPERT REV ANTICANC, V7, P423, DOI 10.1586/14737140.7.4.423; Cornish-Bowden A, 1998, CARBOHYD RES, V312, P167; Donati C, 2007, FEBS LETT, V581, P4384, DOI 10.1016/j.febslet.2007.08.007; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; Gouaze V, 2004, MOL CANCER THER, V3, P633; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Guillermet-Guibert J, 2009, MOL CANCER THER, V8, P809, DOI 10.1158/1535-7163.MCT-08-1096; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Liu YY, 2004, J LIPID RES, V45, P933, DOI 10.1194/jlr.M300486-JLR200; Liu YY, 1999, J BIOL CHEM, V274, P1140, DOI 10.1074/jbc.274.2.1140; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Merrill AH, 2009, J LIPID RES, V50, pS97, DOI 10.1194/jlr.R800073-JLR200; Murate T, 2001, J HISTOCHEM CYTOCHEM, V49, P845, DOI 10.1177/002215540104900705; Nemoto S, 2009, J BIOL CHEM, V284, P10422, DOI 10.1074/jbc.M900735200; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Prinetti A, 2003, J BIOL CHEM, V278, P5574, DOI 10.1074/jbc.M207269200; Riboni L, 2000, METHOD ENZYMOL, V311, P656; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Spiegl-Kreinecker S, 2002, J NEURO-ONCOL, V57, P27, DOI 10.1023/A:1015735815111; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; VALSECCHI M, 2010, J LIPID RES IN PRESS; Valsecchi M, 2007, J LIPID RES, V48, P417, DOI 10.1194/jlr.M600344-JLR200; Wamhoff BR, 2008, ARTERIOSCL THROM VAS, V28, P1454, DOI 10.1161/ATVBAHA.107.159392; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2003, UROLOGY, V61, P1047, DOI 10.1016/S0090-4295(02)02511-6; Wang HT, 2001, CANCER RES, V61, P5102; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	40	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18594	18602		10.1074/jbc.M109.072801	http://dx.doi.org/10.1074/jbc.M109.072801			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404323	hybrid, Green Published			2022-12-27	WOS:000278453900053
J	Choi, YS; Wu, K; Jeong, K; Lee, D; Jeon, YH; Choi, BS; Pan, ZQ; Ryu, KS; Cheong, C				Choi, Yun-Seok; Wu, Kenneth; Jeong, Kwiwan; Lee, Daeyoup; Jeon, Young Ho; Choi, Byong-Seok; Pan, Zhen-Qiang; Ryu, Kyoung-Seok; Cheong, Chaejoon			The Human Cdc34 Carboxyl Terminus Contains a Non-covalent Ubiquitin Binding Activity That Contributes to SCF-dependent Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME; POLYUBIQUITIN CHAINS; LIGASE; CULLIN; NEDD8; COMPLEX; UBC3; TAIL; DEGRADATION; ACTIVATION	Cdc34 is an E2 ubiquitin-conjugating enzyme that functions in conjunction with SCF (Skp1.Cullin1.F-box) E3 ubiquitin ligase to catalyze covalent attachment of polyubiquitin chains to a target protein. Here we identified direct interactions between the human Cdc34 C terminus and ubiquitin using NMR chemical shift perturbation assays. The ubiquitin binding activity was mapped to two separate Cdc34 C-terminal motifs (UBS1 and UBS2) that comprise residues 206-215 and 216-225, respectively. UBS1 and UBS2 bind to ubiquitin in the proximity of ubiquitin Lys(48) and C-terminal tail, both of which are key sites for conjugation. When bound to ubiquitin in one orientation, the Cdc34 UBS1 aromatic residues (Phe(206), Tyr(207), Tyr(210), and Tyr(211)) are probably positioned in the vicinity of ubiquitin C-terminal residue Val(70). Replacement of UBS1 aromatic residues by glycine or of ubiquitin Val70 by alanine decreased UBS1-ubiquitin affinity interactions. UBS1 appeared to support the function of Cdc34 in vivo because human Cdc34(1-215) but not Cdc34(1-200) was able to complement the growth defect by yeast Cdc34 mutant strain. Finally, reconstituted I kappa B alpha ubiquitination analysis revealed a role for each adjacent pair of UBS1 aromatic residues (Phe(206)/Tyr(207), Tyr(210)/Tyr(211)) in conjugation, with Tyr(210) exhibiting the most pronounced catalytic function. Intriguingly, Cdc34 Tyr(210) was required for the transfer of the donor ubiquitin to a receptor lysine on either I kappa B alpha ora ubiquitin in a manner that depended on the neddylated RING subcomplex of the SCF. Taken together, our results identified a new ubiquitin binding activity within the human Cdc34 C terminus that contributes to SCF-dependent ubiquitination.	[Wu, Kenneth; Pan, Zhen-Qiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Choi, Yun-Seok; Jeon, Young Ho; Ryu, Kyoung-Seok; Cheong, Chaejoon] Korea Basic Sci Inst, Div Magnet Resonance, Ochang Eup 363883, Chungcheongbuk, South Korea; [Choi, Yun-Seok; Jeon, Young Ho; Ryu, Kyoung-Seok; Cheong, Chaejoon] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 350333, South Korea; [Jeong, Kwiwan; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Choi, Byong-Seok] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Icahn School of Medicine at Mount Sinai; Korea Basic Science Institute (KBSI); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Pan, ZQ (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu; ksryu@kbsi.re.kr; cheong@kbsi.re.kr	Cheong, Chaejoon/GWC-3135-2022; Choi, Byong-Seok/C-1937-2011; Jeon, Young Ho/F-4483-2011; Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823	National Institutes of Health [GM61051, CA095634]; Korea Basic Science Institute [T3022E, T29221]; NCI, National Institutes of Health [T32 CA078207]; NATIONAL CANCER INSTITUTE [R01CA095634, T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Basic Science Institute; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61051 and CA095634 (to Z.-Q.P.). This work was also supported by the NMR Research Programs of the Korea Basic Science Institute (Grants T3022E (to K.-S.R.) and T29221 (to Y.H.J.)).; Supported by NCI, National Institutes of Health, Postdoctoral Training Grant T32 CA078207.	Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Choi YS, 2009, FEBS LETT, V583, P3323, DOI 10.1016/j.febslet.2009.09.034; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; PICKART CM, 1992, J BIOL CHEM, V267, P14418; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; PRENDERGAST JA, 1995, J BIOL CHEM, V270, P9347, DOI 10.1074/jbc.270.16.9347; PTAK C, 1994, J BIOL CHEM, V269, P26539; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105	32	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17754	17762		10.1074/jbc.M109.090621	http://dx.doi.org/10.1074/jbc.M109.090621			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353940	Green Published, hybrid			2022-12-27	WOS:000278133400053
J	Inforzato, A; Baldock, C; Jowitt, TA; Holmes, DF; Lindstedt, R; Marcellini, M; Rivieccio, V; Briggs, DC; Kadler, KE; Verdoliva, A; Bottazzi, B; Mantovani, A; Salvatori, G; Day, AJ				Inforzato, Antonio; Baldock, Clair; Jowitt, Thomas A.; Holmes, David F.; Lindstedt, Ragnar; Marcellini, Marcella; Rivieccio, Vincenzo; Briggs, David C.; Kadler, Karl E.; Verdoliva, Antonio; Bottazzi, Barbara; Mantovani, Alberto; Salvatori, Giovanni; Day, Anthony J.			The Angiogenic Inhibitor Long Pentraxin PTX3 Forms an Asymmetric Octamer with Two Binding Sites for FGF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; FIBROBLAST-GROWTH-FACTOR; INNATE IMMUNITY; BIOLOGICAL MACROMOLECULES; NITRITE REDUCTASE; GENOMIC STRUCTURE; COILED COILS; RECOGNITION; SCATTERING; INFLAMMATION	The inflammation-associated long pentraxin PTX3 plays key roles in innate immunity, female fertility, and vascular biology (e.g. it inhibits FGF2 (fibroblast growth factor 2)-mediated angiogenesis). PTX3 is composed of multiple protomers, each composed of distinct N- and C-terminal domains; however, it is not known how these are organized or contribute to its functional properties. Here, biophysical analyses reveal that PTX3 is composed of eight identical protomers, associated through disulfide bonds, forming an elongated and asymmetric, molecule with two differently sized domains interconnected by a stalk. The N-terminal region of the protomer provides the main structural determinant underlying this quaternary organization, supporting formation of a disulfide-linked tetramer and a dimer of dimers (a non-covalent tetramer), giving rise to the asymmetry of the molecule. Furthermore, the PTX3 octamer is shown to contain two FGF2 binding sites, where it is the tetramers that act as the functional units in ligand recognition. Thus, these studies provide a unifying model of the PTX3 oligomer, explaining both its quaternary organization and how this is required for its anti-angiogenic function.	[Inforzato, Antonio; Baldock, Clair; Jowitt, Thomas A.; Holmes, David F.; Briggs, David C.; Kadler, Karl E.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Lindstedt, Ragnar; Marcellini, Marcella; Salvatori, Giovanni] Sigma Tau Ind Farmaceut Riunite SpA, I-00040 Pomezia, Italy; [Rivieccio, Vincenzo; Verdoliva, Antonio] Tecnogen SpA, I-81030 Loc La Fagianeria, Piana Monte Ver, Italy; [Bottazzi, Barbara; Mantovani, Alberto] Ist Clin Humanitas, I-20089 Rozzano, Italy; [Mantovani, Alberto] Univ Milan, Dipartimento Med Traslaz, I-20089 Rozzano, Italy	University of Manchester; IRCCS Humanitas Research Hospital; University of Milan	Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Oxford Rd, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk	Inforzato, Antonio/K-6954-2012; Inforzato, Antonio/ABG-4513-2020; Briggs, David/F-1199-2010; Mantovani, Alberto/HCI-7449-2022; KADLER, KARL/ABI-2403-2020; Day, Anthony/O-1658-2015; bottazzi, barbara/ABH-9274-2020	Inforzato, Antonio/0000-0001-8110-0027; Mantovani, Alberto/0000-0001-5578-236X; KADLER, KARL/0000-0003-4977-4683; Day, Anthony/0000-0002-1415-3134; bottazzi, barbara/0000-0002-1930-9257; Jowitt, Thomas/0000-0002-4045-0933; Baldock, Clair/0000-0003-3497-1959; Briggs, David/0000-0002-9793-7339	Sigma-Tau; Tecnogen; Arthritis Research UK [16539]; Medical Research Council [G0701180]; European Research Council; Fondazione Italiana per la Ricerca sul Cancro; Fondazione "Humanitas" per la Ricerca; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; MRC [G0701180] Funding Source: UKRI	Sigma-Tau; Tecnogen; Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione "Humanitas" per la Ricerca; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Sigma-Tau, Tecnogen, Arthritis Research UK Grant 16539, Medical Research Council Grant G0701180, and European Research Council Project HIIS.; Recipient of Fondazione Italiana per la Ricerca sul Cancro and Fondazione "Humanitas" per la Ricerca fellowships.	Aquilina JA, 2003, BIOCHEM J, V375, P323, DOI 10.1042/BJ20030541; Bamford VA, 2002, BIOCHEMISTRY-US, V41, P2921, DOI 10.1021/bi015765d; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2006, J LEUKOCYTE BIOL, V79, P909, DOI 10.1189/jlb.1005557; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Camozzi M, 2005, ARTERIOSCL THROM VAS, V25, P1837, DOI 10.1161/01.ATV.0000177807.54959.7d; Camozzi M, 2006, J BIOL CHEM, V281, P22605, DOI 10.1074/jbc.M601023200; Cotena A, 2007, J IMMUNOL, V179, P6311, DOI 10.4049/jimmunol.179.9.6311; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Einsle O, 2000, J BIOL CHEM, V275, P39608, DOI 10.1074/jbc.M006188200; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Goodman Adam R., 1996, Cytokine and Growth Factor Reviews, V7, P191, DOI 10.1016/1359-6101(96)00019-6; HSU YC, 1995, GENOMICS, V28, P220, DOI 10.1006/geno.1995.1134; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2006, BIOCHEMISTRY-US, V45, P11540, DOI 10.1021/bi0607453; Introna M, 1996, BLOOD, V87, P1862; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Kishore U, 2001, Results Probl Cell Differ, V33, P225; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; LEALI D, 2010, J CELL MOL IN PRESS; LEE GW, 1993, J IMMUNOL, V150, P1804; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Mantovani A, 2006, VASC PHARMACOL, V45, P326, DOI 10.1016/j.vph.2006.08.011; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Omeis IA, 1996, GENOMICS, V36, P543, DOI 10.1006/geno.1996.0503; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Presta M, 2007, J CELL MOL MED, V11, P723, DOI 10.1111/j.1582-4934.2007.00061.x; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Rivieccio V, 2007, PROTEIN EXPRES PURIF, V51, P49, DOI 10.1016/j.pep.2006.07.009; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Ruprecht J, 2001, PROG BIOPHYS MOL BIO, V75, P121, DOI 10.1016/S0079-6107(01)00004-9; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shrive AK, 1999, J MOL BIOL, V290, P997, DOI 10.1006/jmbi.1999.2956; SQUIRES CH, 1988, J BIOL CHEM, V263, P16297; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Yadav MK, 2006, BIOCHEMISTRY-US, V45, P4463, DOI 10.1021/bi060092q	53	88	90	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17681	17692		10.1074/jbc.M109.085639	http://dx.doi.org/10.1074/jbc.M109.085639			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363749	Green Published, hybrid			2022-12-27	WOS:000278133400046
J	Natarajan, M; August, A; Henderson, AJ				Natarajan, Malini; August, Avery; Henderson, Andrew J.			Combinatorial Signals from CD28 Differentially Regulate Human Immunodeficiency Virus Transcription in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LONG-TERMINAL REPEAT; KINASE-C-THETA; HIV-1 GENE-EXPRESSION; P-TEFB; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNOLOGICAL SYNAPSE; HISTONE ACETYLATION; CYTOPLASMIC TAIL; 7SK SNRNA	Activation through the T-cell receptor and the costimulatory receptor CD28 supports efficient HIV transcription as well as reactivation of latent provirus. To characterize critical signals associated with CD28 that regulate HIV-1 transcription, we generated a library of chimeric CD28 receptors that harbored different combinations of key tyrosine residues in the cytoplasmic tail, Tyr-173, Tyr-188, Tyr-191, and Tyr-200. We found that Tyr-191 and Tyr-200 induce HIV-1 transcription via the activation of NF-kappa B and its recruitment to the HIV-long terminal repeat. Tyr-188 modifies positive and negative signals associated with CD28. Importantly, signaling through Tyr-188, Tyr-191, and Tyr-200 is required to overcome the inhibition posed by Tyr-173. CD28 also regulates P-TEFb activity, which is necessary for HIV-1 transcription processivity, by limiting the release of P-TEFb from the HEXIM1-7SK inhibitory complex in response to T-cell receptor signaling. Our studies reveal that CD28 regulates HIV-1 provirus transcription through a complex interplay of positive and negative signals that may be manipulated to control HIV-1 transcription and replication.	Penn State Univ, Intercoll Grad Degree Program Immunol & Infect Di, University Pk, PA 16802 USA; [August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Natarajan, Malini; Henderson, Andrew J.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis,Ctr HIV AIDS Care & Res, Boston, MA 02118 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Boston University	Henderson, AJ (corresponding author), Boston Univ, Sch Med, Dept Med, Evans Biomed Res Ctr 648, 650 Albany St, Boston, MA 02118 USA.	andrew.henderson@bmc.org		Henderson, Andrew/0000-0002-9299-5302	National Institutes of Health, NIAID [AI062467]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI062467, R01AI062467] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI062467 (to A. J. H.) from NIAID.	ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; AUGUST A, 1994, INT IMMUNOL, V6, P769, DOI 10.1093/intimm/6.5.769; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; Bagasra O, 2006, EXPERT OPIN BIOL TH, V6, P1135, DOI 10.1517/14712598.6.11.1135; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bieniasz PD, 1999, P NATL ACAD SCI USA, V96, P7791, DOI 10.1073/pnas.96.14.7791; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brooks DG, 2003, P NATL ACAD SCI USA, V100, P12955, DOI 10.1073/pnas.2233345100; Burke B, 2007, J VIROL, V81, P7424, DOI 10.1128/JVI.02838-06; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Cook JA, 2003, J BIOL CHEM, V278, P35812, DOI 10.1074/jbc.M302878200; Cook JA, 2002, J IMMUNOL, V169, P254, DOI 10.4049/jimmunol.169.1.254; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dienz O, 2003, J IMMUNOL, V170, P365, DOI 10.4049/jimmunol.170.1.365; Dodson LF, 2009, MOL CELL BIOL, V29, P3710, DOI 10.1128/MCB.01869-08; Duverger A, 2009, J VIROL, V83, P3078, DOI 10.1128/JVI.02058-08; Gogishvili T, 2008, EUR J IMMUNOL, V38, P2528, DOI 10.1002/eji.200838223; GRUTERS RA, 1991, EUR J IMMUNOL, V21, P167, DOI 10.1002/eji.1830210125; Gummuluru S, 1999, J VIROL, V73, P5422, DOI 10.1128/JVI.73.7.5422-5430.1999; Hehner SP, 2000, J BIOL CHEM, V275, P18160, DOI 10.1074/jbc.275.24.18160; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; King PD, 1997, J IMMUNOL, V158, P580; Lee ES, 2002, VIROLOGY, V299, P20, DOI 10.1006/viro.2002.1500; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Marinari B, 2002, EUR J IMMUNOL, V32, P447, DOI 10.1002/1521-4141(200202)32:2<447::AID-IMMU447>3.0.CO;2-5; Nolz JC, 2007, J IMMUNOL, V179, P1104, DOI 10.4049/jimmunol.179.2.1104; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pumfery A, 2003, CURR HIV RES, V1, P343, DOI 10.2174/1570162033485186; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Sadowski I, 2008, CURR HIV RES, V6, P286, DOI 10.2174/157016208785132563; Sadra A, 2004, P NATL ACAD SCI USA, V101, P11422, DOI 10.1073/pnas.0403792101; Sanchez-Lockhart M, 2008, J IMMUNOL, V181, P7639, DOI 10.4049/jimmunol.181.11.7639; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Slavik JM, 1999, IMMUNOL RES, V19, P1, DOI 10.1007/BF02786473; Strasner AB, 2008, J IMMUNOL, V181, P3706, DOI 10.4049/jimmunol.181.5.3706; Teng JMC, 1996, TISSUE ANTIGENS, V48, P255, DOI 10.1111/j.1399-0039.1996.tb02643.x; TOOHEY MG, 1989, GENE DEV, V3, P265, DOI 10.1101/gad.3.3.265; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang SD, 2004, MICROBES INFECT, V6, P759, DOI 10.1016/j.micinf.2004.03.007; Ward SG, 1996, BIOCHEM J, V318, P361, DOI 10.1042/bj3180361; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Xu Z, 2002, CELL GROWTH DIFFER, V13, P285; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Zhang J, 2000, J BIOL CHEM, V275, P34314, DOI 10.1074/jbc.M006804200; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200	62	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17338	17347		10.1074/jbc.M109.085324	http://dx.doi.org/10.1074/jbc.M109.085324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368329	hybrid, Green Published			2022-12-27	WOS:000278133400011
J	Kim, HJ; Yamaguchi, S; Li, Q; So, I; Muallem, S				Kim, Hyun Jin; Yamaguchi, Soichiro; Li, Qin; So, Insuk; Muallem, Shmuel			Properties of the TRPML3 Channel Pore and Its Stable Expansion by the Varitint-Waddler-causing Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X RECEPTOR CHANNELS; CONSTITUTIVE ACTIVITY; IONIC SELECTIVITY; CELL DEGENERATION; ORGANIC CATIONS; MOUSE; DEAFNESS; CA2+; TRAFFICKING; PERMEATION	TRPML3 is a H+-regulated Ca2+ channel that shuttles between intracellular compartments and the plasma membrane. The A419P mutation causes the varitint-waddler phenotype as a result of gain-of-function (GOF). The mechanism by which A419P leads to GOF is not known. Here, we show that the TRPML3 pore is dynamic when conducting Ca2+ to change its conductance and permeability, which appears to be mediated by trapping Ca2+ within the pore. The pore properties can be restored by strong depolarization or by conducting Na+ through the pore. The A419P mutation results in expanded channel pore with altered permeability that limits modulation of the pore by Ca2+. This effect is specific for the A419P mutation and is not reproduced by other GOF mutations, including A419G, H283A, and proline mutations in the fifth transmembrane domain. These findings describe a novel mode of a transient receptor potential channel behavior and suggest that pore expansion by the A419P mutation may contribute to the varitint-waddler phenotype.	[So, Insuk] Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul 110799, South Korea; Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Seoul National University (SNU); University of Texas System; University of Texas Southwestern Medical Center Dallas		shmuel.muallem@utsouthwestern.edu	So, Insuk/J-2762-2012; Yamaguchi, Soichiro/Q-8563-2019		National Institutes of Health [DE12309, DK38938]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DE12309 and DK38938 and the Ruth S. Harrell Professorship in Medical Research.	Atiba-Davies M, 2007, BBA-MOL BASIS DIS, V1772, P1028, DOI 10.1016/j.bbadis.2007.01.007; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Cuajungco MP, 2008, PFLUG ARCH EUR J PHY, V457, P463, DOI 10.1007/s00424-008-0523-4; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Karashima Y, 2010, BIOPHYS J, V98, P773, DOI 10.1016/j.bpj.2009.11.007; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Lev S, 2010, J BIOL CHEM, V285, P2771, DOI 10.1074/jbc.M109.046508; Liu DM, 2001, J PHYSIOL-LONDON, V534, P423, DOI 10.1111/j.1469-7793.2001.00423.x; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; SABOVCIK R, 1995, J GEN PHYSIOL, V106, P149, DOI 10.1085/jgp.106.2.149; Samways DSK, 2008, J BIOL CHEM, V283, P31274, DOI 10.1074/jbc.C800131200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104	25	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16513	16520		10.1074/jbc.M109.078204	http://dx.doi.org/10.1074/jbc.M109.078204			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20378547	hybrid, Green Published			2022-12-27	WOS:000277982600013
J	Okuhira, K; Fitzgerald, ML; Tamehiro, N; Ohoka, N; Suzuki, K; Sawada, J; Naito, M; Nishimaki-Mogami, T				Okuhira, Keiichiro; Fitzgerald, Michael L.; Tamehiro, Norimasa; Ohoka, Nobumichi; Suzuki, Kazuhiro; Sawada, Jun-ichi; Naito, Mikihiko; Nishimaki-Mogami, Tomoko			Binding of PDZ-RhoGEF to ATP-binding Cassette Transporter A1 (ABCA1) Induces Cholesterol Efflux through RhoA Activation and Prevention of Transporter Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HIGH-DENSITY-LIPOPROTEIN; LEUKEMIA-ASSOCIATED RHO; HETEROTRIMERIC G-PROTEINS; TANGIER-DISEASE; APOA-I; CELLULAR CHOLESTEROL; ABCA1-DEFICIENT MACROPHAGES; P115 RHOGEF; RECEPTOR	ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux to apolipoprotein A1 (apoA-I) initiates the biogenesis of high density lipoprotein. Here we show that the Rho guanine nucleotide exchange factors PDZ-RhoGEF and LARG bind to the C terminus of ABCA1 by a PDZ-PDZ interaction and prevent ABCA1 protein degradation by activating RhoA. ABCA1 is a protein with a short half-life, and apoA-I stabilizes ABCA1 protein; however, depletion of PDZ-RhoGEF/LARG by RNA interference suppressed the apoA-I stabilization of ABCA1 protein in human primary fibroblasts. Exogenous PDZ-RhoGEF expression activated RhoA and increased ABCA1 protein levels and cholesterol efflux activity. Likewise, forced expression of a constitutively active RhoA mutant significantly increased ABCA1 protein levels, whereas a dominant negative RhoA mutant decreased them. The constitutively active RhoA retarded ABCA1 degradation, thus accounting for its ability to increase ABCA1 protein. Moreover, stimulation with apoA-I transiently activated RhoA, and the pharmacological inhibition of RhoA or the dominant negative RhoA blocked the ability of apoA-I to stabilize ABCA1. Finally, depletion of RhoA or RhoGEFs/RhoA reduces the cholesterol efflux when transcriptional regulation via PPAR gamma is eliminated. Taken together, our results have identified a novel physical and functional interaction between ABCA1 and PDZ-RhoGEF/LARG, which activates RhoA, resulting in ABCA1 stabilization and cholesterol efflux activity.	[Okuhira, Keiichiro; Ohoka, Nobumichi; Suzuki, Kazuhiro; Sawada, Jun-ichi; Naito, Mikihiko; Nishimaki-Mogami, Tomoko] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588511, Japan; [Fitzgerald, Michael L.; Tamehiro, Norimasa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit, Boston, MA 02114 USA; [Fitzgerald, Michael L.; Tamehiro, Norimasa] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	National Institute of Health Sciences - Japan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Okuhira, K (corresponding author), Natl Inst Hlth Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588511, Japan.	okuhira@nihs.go.jp			National Institutes of Health [HL-074136]; Japan Society for the Promotion of Science; Japan Health Sciences Foundation; Takeda Science Foundation; American Heart Association [09GRNT2260352]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074136] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22790102] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Health Sciences Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health Grant HL-074136 (to M. L. F.). This work was also supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, by a research fund from Japan Health Sciences Foundation, by a Takeda Science Foundation grant (to K. O.), and by American Heart Association Grant 09GRNT2260352 (to M. L. F.).	Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Bared SM, 2004, MOL BIOL CELL, V15, P5399, DOI 10.1091/mbc.E04-03-0182; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Buechler C, 2002, J BIOL CHEM, V277, P41307, DOI 10.1074/jbc.C200436200; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hirotani M, 2002, BIOCHEM BIOPH RES CO, V297, P32, DOI 10.1016/S0006-291X(02)02122-8; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nofer JR, 2006, J LIPID RES, V47, P794, DOI 10.1194/jlr.M500502-JLR200; Nofer JR, 2003, J BIOL CHEM, V278, P53055, DOI 10.1074/jbc.M305673200; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Togashi H, 2000, J BIOL CHEM, V275, P29570, DOI 10.1074/jbc.M003726200; Walter M, 2004, J BIOL CHEM, V279, P20866, DOI 10.1074/jbc.M401714200; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	55	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16369	16377		10.1074/jbc.M109.061424	http://dx.doi.org/10.1074/jbc.M109.061424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348106	Green Published, hybrid			2022-12-27	WOS:000277715900073
J	Powell, E; Wang, YD; Shapiro, DJ; Xu, W				Powell, Emily; Wang, Yidan; Shapiro, David J.; Xu, Wei			Differential Requirements of Hsp90 and DNA for the Formation of Estrogen Receptor Homodimers and Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; RESPONSE ELEMENTS; STEROID-RECEPTORS; ALPHA; LIGAND; BETA; HORMONE; TARGET; DIMERIZATION; INHIBITOR	The two estrogen receptor (ER) subforms, ER alpha and ER beta, are capable of forming DNA-binding homodimers and heterodimers. Although binding to DNA is thought to stabilize ER dimers, how ER alpha/alpha, ER beta/beta, and ER alpha/beta dimerization is regulated by DNA and the chaperone protein Hsp90 is poorly understood. Using our highly optimized bioluminescence resonance energy transfer assays in conjunction with assays for transcriptional activation of ERs, we determined that DNA binding appears to play a minor role in the stabilization of ER dimers, especially in the case of ER beta/beta homodimers. These findings suggest that ER dimers form before they associate with chromatin and that DNA binding plays a minor role in stabilizing ER dimers. Additionally, although Hsp90 is essential for the proper dimerization of ER beta/beta and ER alpha/beta, it is not required for the proper dimerization of ER alpha/alpha. Despite this, Hsp90 is critical for the estrogen-dependent transcriptional activity of the ER beta/beta homodimer. Thus, Hsp90 is implicated as an important regulator of distinct aspects of ER alpha and ER beta action.	[Powell, Emily; Wang, Yidan; Xu, Wei] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Shapiro, David J.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign	Xu, W (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Rm 421A,1400 Univ Ave, Madison, WI 53706 USA.	wxu@oncology.wisc.edu	wang, yidan/G-4566-2013		National Institutes of Health [RO1 CA125387, RO3 MH089442, RO1 DK071909, T32 CA009135]; NATIONAL CANCER INSTITUTE [T32CA009135, R01CA125387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH089442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA125387 and RO3 MH089442 (to W. X.), RO1 DK071909 (to D.J.S.), and T32 CA009135 (to E. P.).	Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Bagatell R, 2001, CLIN CANCER RES, V7, P2076; Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; Beliakoff J, 2003, CLIN CANCER RES, V9, P4961; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Drysdale MJ, 2006, CURR OPIN DRUG DISC, V9, P483; Egorin MJ, 2002, CANCER CHEMOTH PHARM, V49, P7, DOI 10.1007/s00280-001-0380-8; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Gougelet A, 2005, J STEROID BIOCHEM, V94, P71, DOI 10.1016/j.jsbmb.2005.01.018; GREEN S, 1989, CANCER RES, V49, pS2282; GREEN S, 1988, EMBO J, V7, P3037, DOI 10.1002/j.1460-2075.1988.tb03168.x; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hergenrother PJ, 2006, CURR OPIN CHEM BIOL, V10, P213, DOI 10.1016/j.cbpa.2006.04.005; HIRST MA, 1992, P NATL ACAD SCI USA, V89, P5527, DOI 10.1073/pnas.89.12.5527; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Koterba Kristen L, 2006, Nucl Recept Signal, V4, pe021; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Kuntz MA, 1997, J BIOL CHEM, V272, P27949, DOI 10.1074/jbc.272.44.27949; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Michelini E, 2004, ANAL CHEM, V76, P7069, DOI 10.1021/ac048914h; MURDOCH FE, 1995, BIOCHEMISTRY-US, V34, P9144, DOI 10.1021/bi00028a025; Pace P, 1997, J BIOL CHEM, V272, P25832, DOI 10.1074/jbc.272.41.25832; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Putt KS, 2004, ANAL BIOCHEM, V333, P256, DOI 10.1016/j.ab.2004.04.032; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Saji S, 2005, CANCER CHEMOTH PHARM, V56, pS21, DOI 10.1007/s0028-005-0107-3; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Sun J, 1999, ENDOCRINOLOGY, V140, P800, DOI 10.1210/en.140.2.800; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; WHITE R, 1991, J STEROID BIOCHEM, V40, P333, DOI 10.1016/0960-0760(91)90199-F; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	42	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16125	16134		10.1074/jbc.M110.104356	http://dx.doi.org/10.1074/jbc.M110.104356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20353944	Green Published, hybrid			2022-12-27	WOS:000277715900050
J	Venereau, E; Diveu, C; Grimaud, L; Ravon, E; Froger, J; Preisser, L; Danger, Y; Maillasson, M; Garrigue-Antar, L; Jacques, Y; Chevalier, S; Gascan, H				Venereau, Emilie; Diveu, Caroline; Grimaud, Linda; Ravon, Elisa; Froger, Josy; Preisser, Laurence; Danger, Yannic; Maillasson, Mike; Garrigue-Antar, Laure; Jacques, Yannick; Chevalier, Sylvie; Gascan, Hugues			Definition and Characterization of an Inhibitor for Interleukin-31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-6 SIGNAL TRANSDUCER; ONCOSTATIN-M RECEPTOR; CYTOKINE RECEPTOR; ATOPIC-DERMATITIS; NC/NGA MICE; T-CELLS; SCRATCHING BEHAVIOR; SKIN INFLAMMATION; SHARED RECEPTOR; LIF RECEPTOR	Interleukin-31 (IL-31) is a recently described T cell-derived cytokine, mainly produced by T helper type 2 cells and related to the IL-6 cytokine family according to its structure and receptor. IL-31 is the ligand for a heterodimeric receptor composed of a gp130-like receptor (GPL) associated with the oncostatin M receptor (OSMR). A link between IL-31 and atopic dermatitis was shown by studying the phenotype of IL-31 transgenic mice and IL-31 gene haplotypes in patients suffering from dermatitis. In this study, we generated a potent IL-31 antagonist formed by external portions of OSMR and GPL fused with a linker. This fusion protein, OSMR-L-GPL, consisting of 720 amino acids, counteracted the binding of IL-31 to its membrane receptor complex and the subsequent signaling events involving the STATs and MAPK pathways. Neutralizing effects were found in IL-31-sensitive cell lines, including brain-derived cells and primary cultures of keratinocytes.	[Danger, Yannic; Chevalier, Sylvie] INSERM, Unite Mixte 564, F-49033 Angers 09, France; [Froger, Josy; Danger, Yannic] PADAM IBiSA, F-49033 Angers, France; [Preisser, Laurence; Chevalier, Sylvie] Univ Angers, Serv Commun Cytometrie & Analyse Nucleotid, F-49033 Angers, France; [Maillasson, Mike; Garrigue-Antar, Laure; Jacques, Yannick] INSERM, Unite Mixte 892, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gascan, H (corresponding author), INSERM, U564, 4 Rue Larrey, F-49933 Angers 09, France.	hugues.gascan@univ-angers.fr	preisser, laurence/K-7583-2015; Venereau, Emilie/AAN-4856-2020; maillasson, mike/K-9627-2015; Jacques, Yannick/K-9294-2015	Garrigue-Antar, Laure/0000-0001-6331-8882; Venereau, Emilie/0000-0002-6590-7434; Danger, Yannic/0000-0002-5611-5048	Association pour la Recherche contre le Cancer [5176]; Region Pays de la Loire	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Region Pays de la Loire(Region Pays de la Loire)	This work was supported by Grant 5176 from the Association pour la Recherche contre le Cancer and by the Ciblage Moleculaire et Applications Therapeutiques (CIMATH) Program of the Region Pays de la Loire.	Ancey C, 2003, J BIOL CHEM, V278, P16968, DOI 10.1074/jbc.C300081200; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Diveu C, 2003, J BIOL CHEM, V278, P49850, DOI 10.1074/jbc.M307286200; Diveu C, 2004, EUR CYTOKINE NETW, V15, P291; Diveu C, 2006, J BIOL CHEM, V281, P36673, DOI 10.1074/jbc.M607005200; Dreuw A, 2004, J BIOL CHEM, V279, P36112, DOI 10.1074/jbc.M401122200; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Ghilardi N, 2002, J BIOL CHEM, V277, P16831, DOI 10.1074/jbc.M201140200; Grant SL, 1999, MOL MED TODAY, V5, P406, DOI 10.1016/S1357-4310(99)01540-3; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Heise R, 2009, J INVEST DERMATOL, V129, P240, DOI 10.1038/jid.2008.183; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HONDA M, 1992, J IMMUNOL, V148, P2175; Le Saux S, 2010, J BIOL CHEM, V285, P3470, DOI 10.1074/jbc.M109.049189; Lelievre E, 2001, J BIOL CHEM, V276, P22476, DOI 10.1074/jbc.M101681200; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; LIU JW, 1992, J BIOL CHEM, V267, P16763; Metz S, 2008, J BIOL CHEM, V283, P5985, DOI 10.1074/jbc.M706610200; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Murakami M, 2004, GROWTH FACTORS, V22, P75, DOI 10.1080/08977190410001715181; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Olivier C, 2000, J BIOL CHEM, V275, P5648, DOI 10.1074/jbc.275.8.5648; Plun-Favreau H, 2003, J BIOL CHEM, V278, P27169, DOI 10.1074/jbc.M303168200; Renne C, 1998, J BIOL CHEM, V273, P27213, DOI 10.1074/jbc.273.42.27213; Schulz F, 2007, J ALLERGY CLIN IMMUN, V120, P1097, DOI 10.1016/j.jaci.2007.07.065; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; SPORENO E, 1994, J BIOL CHEM, V269, P10991; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Takaoka A, 2005, EUR J PHARMACOL, V516, P180, DOI 10.1016/j.ejphar.2005.04.040; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; THOMA B, 1994, J BIOL CHEM, V269, P6215; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiesinger MY, 2009, CHEM BIOL, V16, P783, DOI 10.1016/j.chembiol.2009.06.010; Yamaoka K, 2009, INT ARCH ALLERGY IMM, V149, P73, DOI 10.1159/000211376; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	44	20	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14955	14963		10.1074/jbc.M109.049163	http://dx.doi.org/10.1074/jbc.M109.049163			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20335179	Green Published, hybrid			2022-12-27	WOS:000277399000016
J	Yuan, TC; Wang, YP; Zhao, ZZJ; Gu, HH				Yuan, Taichang; Wang, Yongping; Zhao, Zhizhuang J.; Gu, Haihua			Protein-tyrosine Phosphatase PTPN9 Negatively Regulates ErbB2 and Epidermal Growth Factor Receptor Signaling in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UP-REGULATION; ACTIVATION; 1B; SHP-1; SRC; PHOSPHORYLATION; IDENTIFICATION; TRANSFORMATION; EXPRESSION; PTP-MEG2	ErbB family of the receptor protein-tyrosine kinase plays an important role in the progression of human cancers including breast cancer. Finding protein-tyrosine phosphatase (PTPs) that can specifically regulate the function of ErbB should help design novel therapies for treatment. By performing a small interfering RNA screen against 43 human PTPs, we find that knockdown of protein-tyrosine phosphatase PTPN9 significantly increases ErbB2 tyrosyl phosphorylation in the SKBR3 breast cancer cell line. In addition, knockdown of PTPN9 expression also enhances tyrosyl phosphorylation of the ErbB1/epidermal growth factor receptor (EGFR) in the MDA-MB-231 breast cancer cell line. Conversely, increasing expression of PTPN9 wild type (WT) inhibits tyrosyl phosphorylation of ErbB2 and EGFR. To test whether ErbB2 and EGFR are substrates of PTPN9, PTPN9 WT, and a substrate trapping mutant (PTPN9 DA) are overexpressed in SKBR3 and MDA-MB-231 cells. Compared with vector control, expression of PTPN9 WT significantly inhibits whereas expression of PTPN9 DA dramatically enhances tyrosyl phosphorylation of ErbB2 and EGFR, respectively. In contrast, expression of PTPN9 WT or DA mutant does not affect tyrosyl phosphorylation of ErbB3 and Shc. Importantly, coimmunoprecipitation and glutathione S-transferase fusion protein pulldown experiments show that tyrosol-phosphorylated ErbB2 or EGFR is preferentially associated with PTPN9 DA compared with PTPN9 WT, indicating that ErbB2 and EGFR are substrates of PTPN9. Furthermore, PTPN9 WT expression specifically impairs EGF-induced STAT3 and STAT5 activation, and inhibits the cell growth in soft agar. Last, PTPN9 WT expression also reduces invasion and MMP2 expression of MDA-MB-231 cells. Our data suggest PTPN9 as a negative regulator of breast cancer cells by targeting ErbB2 and EGFR and inhibiting STAT activation.	[Yuan, Taichang; Wang, Yongping; Gu, Haihua] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Aurora, CO 80045 USA; [Zhao, Zhizhuang J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oklahoma System; University of Oklahoma Health Sciences Center	Gu, HH (corresponding author), Mail Stop 8104,POB 6511, Aurora, CO 80045 USA.	haihua.gu@ucdenver.edu	Gu, Haihua/G-6364-2011		National Institutes of Health [HL076309, HL079441]; Department of Pathology, University of Colorado Denver; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076309, R01HL079441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, University of Colorado Denver; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL076309 and HL079441 ( to Z.J.Z) and the start-up fund from the Department of Pathology, University of Colorado Denver ( to H. G).	Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Baum O, 2007, INT J ONCOL, V30, P325; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Campos SM, 2008, CANCER INVEST, V26, P757, DOI 10.1080/07357900801971040; Cho CY, 2006, CELL METAB, V3, P367, DOI 10.1016/j.cmet.2006.03.006; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hayes DF, 2002, SEMIN ONCOL, V29, P231, DOI 10.1053/sonc.2002.32899; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Sartor CI, 1997, CANCER RES, V57, P978; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang YC, 2005, J EXP MED, V202, P1587, DOI 10.1084/jem.20051108; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xu MJ, 2003, BLOOD, V102, P4354, DOI 10.1182/blood-2003-04-1308; Yip SS, 2000, INT J CANCER, V88, P363, DOI 10.1002/1097-0215(20001101)88:3<363::AID-IJC7>3.0.CO;2-4; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	31	63	67	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14861	14870		10.1074/jbc.M109.099879	http://dx.doi.org/10.1074/jbc.M109.099879			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20335174	hybrid, Green Published			2022-12-27	WOS:000277399000007
J	Bate, C; Tayebi, M; Williams, A				Bate, Clive; Tayebi, Mourad; Williams, Alun			Glycosylphosphatidylinositol Anchor Analogues Sequester Cholesterol and Reduce Prion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; PHOSPHOLIPASE A(2); INTRACELLULAR TRAFFICKING; NEUROBLASTOMA-CELLS; SIGNAL-TRANSDUCTION; DEPENDENT RETENTION; SCRAPIE; PROTEIN; DISEASE; PRP	A hallmark of prion diseases is the conversion of the host-encoded prion protein (PrPC where C is cellular) into an alternatively folded, disease-related isoform (PrPSc, where Sc is scrapie), the accumulation of which is associated with synapse degeneration and ultimately neuronal death. The formation of PrPSc is dependent upon the presence of PrPC in specific, cholesterol-sensitive membrane microdomains, commonly called lipid rafts. PrPC is targeted to these lipid rafts because it is attached to membranes via a glycosylphosphatidylinositol anchor. Here, we show that treatment of prion-infected neuronal cell lines (ScN2a, ScGT1, or SMB cells) with synthetic glycosylphosphatidylinositol analogues, glucosamine-phosphatidylinositol (glucosamine-PI) or glucosamine 2-O-methyl inositol octadecyl phosphate, reduced the PrPSc content of these cells in a dose-dependent manner. In addition, ScGT1 cells treated with glucosamine-PI did not transmit infection following intracerebral injection to mice. Treatment with glucosamine-PI increased the cholesterol content of ScGT1 cell membranes and reduced activation of cytoplasmic phospholipase A(2) (PLA(2)), consistent with the hypothesis that the composition of cell membranes affects key PLA(2)-dependent signaling pathways involved in PrPSc formation. The effect of glucosamine-PI on PrPSc formation was also reversed by the addition of platelet-activating factor. Glucosamine-PI caused the displacement of PrPC from lipid rafts and reduced expression of PrPC at the cell surface, putative sites for PrPSc formation. We propose that treatment with glucosamine-PI modifies local micro-environments that control PrPC expression and activation of PLA(2) and subsequently inhibits PrPSc formation.	[Bate, Clive; Tayebi, Mourad; Williams, Alun] Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, N Mymms AL9 7TA, Herts, England.	c.bate@rvc.ac.uk	TAYEBI, MOURAD/F-7404-2010	TAYEBI, MOURAD/0000-0001-8664-6918	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission FP6-NeuroPrion-Network of Excellence.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bate C, 2004, J GEN VIROL, V85, P3797, DOI 10.1099/vir.0.80366-0; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-8; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; BERGELSON LD, 1985, FEBS LETT, V190, P305, DOI 10.1016/0014-5793(85)81306-5; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; FELISTE R, 1989, ATHEROSCLEROSIS, V78, P151, DOI 10.1016/0021-9150(89)90219-0; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Frick W, 1998, BIOCHEMISTRY-US, V37, P13421, DOI 10.1021/bi9806201; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; GOCZE PM, 1992, ENDOCRINOLOGY, V131, P2972, DOI 10.1210/en.131.6.2972; Hagiwara K, 2007, BIOL PHARM BULL, V30, P835, DOI 10.1248/bpb.30.835; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kempster S, 2007, NEUROREPORT, V18, P479, DOI 10.1097/WNR.0b013e328058678d; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Legler DF, 2004, FASEB J, V18, P73, DOI 10.1096/fj.03-1338fje; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; MAJOR S, 2004, NAT REV MOL CELL BIO, V5, P110; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Mok SWF, 2006, BIOCHEM BIOPH RES CO, V348, P697, DOI 10.1016/j.bbrc.2006.07.123; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Schroeder F, 2001, EXP BIOL MED, V226, P873, DOI 10.1177/153537020122601002; SHUKLA SD, 1992, FASEB J, V6, P2296, DOI 10.1096/fasebj.6.6.1312046; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Vijaykumar M, 2001, J BIOL CHEM, V276, P6909, DOI 10.1074/jbc.C100007200; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457	56	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22017	22026		10.1074/jbc.M110.108548	http://dx.doi.org/10.1074/jbc.M110.108548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20427265	Green Published, hybrid			2022-12-27	WOS:000279702200014
J	Kang, HJ; Bin Hong, Y; Kim, HJ; Bae, I				Kang, Hyo Jin; Bin Hong, Young; Kim, Hee Jeong; Bae, Insoo			CR6-interacting Factor 1 (CRIF1) Regulates NF-E2-related Factor 2 (NRF2) Protein Stability by Proteasome-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT-RESPONSE ELEMENT; GADD45 FAMILY PROTEINS; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; GENE-EXPRESSION; HEME OXYGENASE-1; CELL-CYCLE; INDUCTION; KEAP1; ACTIVATION	Free radicals generated by oxidative stress cause damage that can contribute to numerous chronic diseases. Mammalian cells respond to this damage by increased transcription of cytoprotective phase II genes, which are regulated by NRF2. Previously, it has been shown that NRF2 protein levels increase after oxidative stress because its negative regulator, KEAP1, loses its ability to bind NRF2 and cause its proteasome-mediated degradation during oxidative stress. Here, we show that CRIF1, a protein previously known as cell cycle regulator and transcription cofactor, is also able to negatively regulate NRF2 protein stability. However, in contrast to KEAP1, which regulates NRF2 stability only under normal reducing conditions, CRIF1 regulates NRF2 stability and its target gene expression under both reducing and oxidative stress conditions. Thus, CRIF1-NRF2 interactions and their consequences are redox-independent. In addition, we found that CRIF1, unlike KEAP1 (which only interacts with N-terminal region of NRF2), physically interacts with both Nand C-terminal regions of NRF2 and promotes NRF2 ubiquitination and subsequent proteasome-mediated NRF2 protein degradation.	[Kang, Hyo Jin; Bin Hong, Young; Kim, Hee Jeong; Bae, Insoo] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Bae, Insoo] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Radiat Med, Washington, DC 20057 USA; [Bae, Insoo] Dankook Univ, WCU, Res Ctr Nanobiomed Sci, Anseo Dong 330714, Cheonan, South Korea	Georgetown University; Georgetown University; Dankook University	Bae, I (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	ib42@georgetown.edu			United States Department of Defense [DAMD17-02-1-0525]; American Cancer Society [IRG 97-152-13]; Susan G. Komen for the Cure [BCTR119906]; Ministry of Education, Science and Technology [R31-10069]	United States Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Supported by the United States Department of Defense Breast Cancer Program Idea Award DAMD17-02-1-0525, American Cancer Society Grant IRG 97-152-13, Susan G. Komen for the Cure Grant BCTR119906, and by Grant R31-10069 (WCU Program) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. To whom correspondence should be addressed: Dept. of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Rd., NW, Washington, D. C. 20057. Tel.: 202-687-5267; E-mail: ib42@georgetown.edu.	ALAM J, 1994, J BIOL CHEM, V269, P25049; Rubiolo JA, 2008, EUR J PHARMACOL, V591, P66, DOI 10.1016/j.ejphar.2008.06.067; Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dhakshinamoorthy S, 2002, ONCOGENE, V21, P5301, DOI 10.1038/sj.onc.1205642; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kang ES, 2007, FREE RADICAL BIO MED, V43, P535, DOI 10.1016/j.freeradbiomed.2007.05.006; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; Kang HJ, 2006, J BIOL CHEM, V281, P14654, DOI 10.1074/jbc.M601613200; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kovacic P, 2001, CURR MED CHEM, V8, P773, DOI 10.2174/0929867013373084; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Kwon MC, 2009, J BIOL CHEM, V284, P33634, DOI 10.1074/jbc.M109.059840; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nakamura Y, 2003, BIOCHEMISTRY-US, V42, P4300, DOI 10.1021/bi0340090; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Park KC, 2005, MOL ENDOCRINOL, V19, P12, DOI 10.1210/me.2004-0107; Patel R, 2008, FREE RADICAL BIO MED, V44, P1897, DOI 10.1016/j.freeradbiomed.2008.02.006; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Suh JH, 2008, MOL ENDOCRINOL, V22, P33, DOI 10.1210/me.2007-0194; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	39	56	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21258	21268		10.1074/jbc.M109.084590	http://dx.doi.org/10.1074/jbc.M109.084590			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20427290	Green Published, hybrid			2022-12-27	WOS:000279516100011
J	Charbonneau, NL; Jordan, CD; Keene, DR; Lee-Arteaga, S; Dietz, HC; Rifkin, DB; Ramirez, F; Sakai, LY				Charbonneau, Noe L.; Jordan, C. Diana; Keene, Douglas R.; Lee-Arteaga, Sui; Dietz, Harry C.; Rifkin, Daniel B.; Ramirez, Francesco; Sakai, Lynn Y.			Microfibril Structure Masks Fibrillin-2 in Postnatal Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR MICROFIBRILS; MARFAN-SYNDROME; EXPRESSION; ORGANIZATION; COMPONENT; DOMAIN; IDENTIFICATION; PROTEINS; BONE	Fibrillin microfibrils are polymeric structures present in connective tissues. The importance of fibrillin microfibrils to connective tissue function has been demonstrated by the multiple genetic disorders caused by mutations in fibrillins and in microfibril-associated molecules. However, knowledge of microfibril structure is limited, largely due to their insolubility. Most previous studies have focused on how fibrillin-1 is organized within microfibril polymers. In this study, an immunochemical approach was used to circumvent the insolubility of microfibrils to determine the role of fibrillin-2 in postnatal microfibril structure. Results obtained from studies of wild type and fibrillin-1 null tissues, using monoclonal and polyclonal antibodies with defined epitopes, demonstrated that N-terminal fibrillin-2 epitopes are masked in postnatal microfibrils and can be revealed by enzymatic digestion or by genetic ablation of Fbn1. From these studies, we conclude that fetal fibrillin polymers form an inner core within postnatal microfibrils and that microfibril structure evolves as growth and development proceed into the postnatal period. Furthermore, documentation of a novel cryptic site present in EGF4 in fibrillin-1 underscores the molecular complexity and tissue-specific differences in microfibril structure.	[Charbonneau, Noe L.; Keene, Douglas R.; Sakai, Lynn Y.] Shriners Hosp Children, Portland, OR 97239 USA; [Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Jordan, C. Diana] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [Lee-Arteaga, Sui; Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Dietz, Harry C.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Rifkin, Daniel B.] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; New York University; NYU Langone Medical Center	Sakai, LY (corresponding author), Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org			National Institutes of Health [P01 AR049698, AR042044]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042044, P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AR049698 ( to F. R., D. B. R., H. C. D., and L. Y. S.) and AR042044 ( to F. R.). This work was also supported by Shriners Hospitals for Children ( to D. R. K. and to L. Y. S.).	Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Boregowda R, 2008, MATRIX BIOL, V27, P661, DOI 10.1016/j.matbio.2008.09.579; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023; GALLAGHER BC, 1993, DEV DYNAM, V196, P70, DOI 10.1002/aja.1001960109; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Jensen SA, 2009, STRUCTURE, V17, P759, DOI 10.1016/j.str.2009.03.014; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P441, DOI 10.1177/39.4.2005373; KIELTY CM, 1995, J CELL SCI, V108, P1317; KIELTY CM, 1994, J CELL BIOL, V124, P997, DOI 10.1083/jcb.124.6.997; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; LOW FN, 1962, ANAT REC, V142, P131, DOI 10.1002/ar.1091420205; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Werneck CC, 2004, J BIOL CHEM, V279, P23045, DOI 10.1074/jbc.M402656200; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	28	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20242	20251		10.1074/jbc.M109.087031	http://dx.doi.org/10.1074/jbc.M109.087031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404337	hybrid, Green Published			2022-12-27	WOS:000279012000059
J	Liu, HY; Enyeart, JA; Enyeart, JJ				Liu, Haiyan; Enyeart, Judith A.; Enyeart, John J.			ACTH Induces Ca(v)3.2 Current and mRNA by cAMP-dependent and cAMP-independent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL-CORTICAL CELLS; NONINACTIVATING K+ CURRENT; STEROID HYDROXYLASE GENES; ADRENOCORTICOTROPIC HORMONE; CYCLIC-AMP; TRANSCRIPTIONAL REGULATION; NONHYDROLYTIC BINDING; CORTISOL PRODUCTION; FASCICULATA CELLS; ZONA-FASCICULATA	Bovine adrenal zona fasciculata (AZF) cells express Ca(v)3.2 T-type Ca2+ channels that function pivotally in adrenocorticotropic hormone (ACTH)-stimulated cortisol secretion. The regulation of Ca(v)3.2 expression in AZF cells by ACTH, cAMP analogs, and their metabolites was studied using Northern blot and patch clamp recording. Exposing AZF cells to ACTH for 3-6 days markedly enhanced the expression of Ca(v)3.2 current. The increase in Ca(v)3.2 current was preceded by an increase in corresponding CACNA1H mRNA. O-Nitrophenyl, sulfenyl-adrenocorticotropin, which produces a minimal increase in cAMP, also enhanced Ca(v)3.2 current. cAMP analogs, including 8-bromoadenosine cAMP (600 mu M) and 6-benzoyladenosine cAMP (300 mu M) induced CACNA1H mRNA, but not Ca(v)3.2 current. In contrast, 8-(4-chlorophenylthio) (8CPT)-cAMP (10-50 mu M) enhanced CACNA1H mRNA and Ca(v)3.2 current, whereas nonhydrolyzable Sp-8CPT-cAMP failed to increase either Ca(v)3.2 current or mRNA. Metabolites of 8CPT-cAMP, including 8CPT-adenosine and 8CPT-adenine, increased Ca(v)3.2 current and mRNA with a potency and effectiveness similar to the parent compound. The Epac activator 8CPT-2'-O-methyl-cAMP and its metabolites 8CPT-2'-OMe-5'-AMP and 8CPT-2'O-methyl-adenosine increased CACNA1H mRNA and Ca(v)3.2 current; Sp-8CPT-2'-O-methyl-cAMP increased neither Ca(v)3.2 current nor mRNA. These results reveal an interesting dichotomy between ACTH and cAMP with regard to regulation of CACNA1H mRNA and Ca2+ current. Specifically, ACTH induces expression of CACNA1H mRNA and Ca(v)3.2 current in AZF cells by mechanisms that depend at most only partly on cAMP. In contrast, cAMP enhances expression of CACNA1H mRNA but not the corresponding Ca2+ current. Surprisingly, chlorophenylthio-cAMP analogs stimulate the expression of Ca(v)3.2 current indirectly through metabolites. ACTH and the metabolites may induce Ca(v)3.2 expression by the same, unidentified mechanism.	[Liu, Haiyan; Enyeart, Judith A.; Enyeart, John J.] Ohio State Univ, Coll Med & Publ Hlth, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Enyeart, JJ (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Neurosci, 5196 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	enyeart.1@osu.edu			National Institutes of Health [R01-DK47875]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK47875 (to J.J.E.).	BARBARA JG, 1995, J PHYSIOL-LONDON, V488, P609, DOI 10.1113/jphysiol.1995.sp020994; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Enyeart JA, 2000, J BIOL CHEM, V275, P34640, DOI 10.1074/jbc.M004214200; Enyeart JA, 2003, MOL PHARMACOL, V64, P132, DOI 10.1124/mol.64.1.132; Enyeart JJ, 1997, J GEN PHYSIOL, V110, P679, DOI 10.1085/jgp.110.6.679; Enyeart JJ, 2002, J BIOL CHEM, V277, P49186, DOI 10.1074/jbc.M207233200; ENYEART JJ, 1993, MOL ENDOCRINOL, V7, P1031, DOI 10.1210/me.7.8.1031; Enyeart JJ, 1996, J GEN PHYSIOL, V108, P251, DOI 10.1085/jgp.108.4.251; Enyeart JJ, 1998, ENDOCR RES, V24, P325, DOI 10.3109/07435809809032612; Enyeart JA, 2010, MOL PHARMACOL, V77, P469, DOI 10.1124/mol.109.061861; Enyeart JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006088; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; GRAHAMES.DG, 1967, J BIOL CHEM, V242, P5535; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYNES RC, 1957, J BIOL CHEM, V225, P115; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Ivins JK, 2004, J NEUROSCI, V24, P1212, DOI 10.1523/JNEUROSCI.4689-03.2004; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Liu HY, 2008, J GEN PHYSIOL, V132, P279, DOI 10.1085/jgp.200810003; MLINAR B, 1993, J BIOL CHEM, V268, P8640; MLINAR B, 1993, J GEN PHYSIOL, V102, P217, DOI 10.1085/jgp.102.2.217; MOYLE WR, 1973, J BIOL CHEM, V248, P2409; Novara M, 2004, J PHYSIOL-LONDON, V558, P433, DOI 10.1113/jphysiol.2004.061184; Omura M, 2007, ENDOCR J, V54, P585, DOI 10.1507/endocrj.K07-015; Parker KL, 1995, VITAM HORM, V51, P339, DOI 10.1016/S0083-6729(08)61044-4; PENHOAT A, 1989, P NATL ACAD SCI USA, V86, P4978, DOI 10.1073/pnas.86.13.4978; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; PRICE NC, 1999, FUNDAMENTALS ENZYMOL, P450; QUINTON PM, 1992, NATURE, V360, P79, DOI 10.1038/360079a0; RAIKHINSTEIN M, 1994, BBA-MOL CELL RES, V1220, P329, DOI 10.1016/0167-4889(94)90157-0; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; RICHARDSON MC, 1973, BIOCHEM J, V136, P993, DOI 10.1042/bj1360993; SALA GB, 1979, J BIOL CHEM, V254, P3861; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Su H, 2002, J NEUROSCI, V22, P3645; WATERMAN MR, 1994, J BIOL CHEM, V269, P27783; WATERMAN MR, 1989, RECENT PROG HORM RES, V45, P533; Yamazaki T, 1998, ENDOCRINOLOGY, V139, P4765, DOI 10.1210/en.139.12.4765; Zazopoulos E, 1997, NATURE, V390, P311, DOI 10.1038/36899	53	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20040	20050		10.1074/jbc.M110.104190	http://dx.doi.org/10.1074/jbc.M110.104190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424171	Green Published, hybrid			2022-12-27	WOS:000279012000038
J	Rowling, PJE; Cook, R; Itzhaki, LS				Rowling, Pamela J. E.; Cook, Rebecca; Itzhaki, Laura S.			Toward Classification of BRCA1 Missense Variants Using a Biophysical Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER SUSCEPTIBILITY; PHOSPHOPEPTIDE BINDING; FUNCTIONAL-ANALYSIS; PROTEIN-STRUCTURE; STRUCTURAL BASIS; MUTATIONS; STABILITY; SEQUENCE; DOMAINS; DISEASE	Carriers of germ line mutations in breast cancer susceptibility gene BRCA1 have an increased risk of developing breast and ovarian cancers; missense mutations have, however, been difficult to assess for disease association. Here we have used a biophysical approach to classify these variants. We established an assay for measuring the thermodynamic stability of the BRCA1 BRCT domains and investigated the effects of 36 missense mutations. The mutations show a range of effects. Some do not change the stability, whereas others destabilize the protein by as much as 6 kcal mol(-1); one-third of the mutants could not be expressed in soluble form in Escherichia coli, and we conclude that these destabilize the protein by an even greater amount. We tested several computer algorithms for their ability to predict the mutant effects and found that by grouping them into two classes (destabilizing by less than or more than 2.2 kcal mol(-1)), the algorithms could predict the stability changes. Importantly, with the exception of the few mutants located in the binding site, none showed a significant reduction in affinity for phosphorylated substrate. These results indicate that despite very large losses in stability, the integrity of the structure is not compromised by the mutations. Thus, the majority of mutations cause loss of function by reducing the proportion of BRCA1 molecules that are in the folded state and increasing the proportion of molecules that are unfolded. Consequently, small molecule stabilization of the structure could be a generally applicable preventative therapeutic strategy for rescuing many BRCA1 mutations.	[Rowling, Pamela J. E.; Cook, Rebecca; Itzhaki, Laura S.] MRC, Canc Cell Unit, Hutchison MRC Res Ctr, Cambridge CB2 0XZ, England		Itzhaki, LS (corresponding author), MRC, Canc Cell Unit, Hutchison MRC Res Ctr, Hills Rd, Cambridge CB2 0XZ, England.	lsi@hutchison-mrc.cam.ac.uk		Cook, Rebecca/0000-0003-3359-9745	Medical Research Council [MC_U105370180] Funding Source: Medline; MRC [MC_U105370180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Coyne RS, 2004, CANCER BIOL THER, V3, P453, DOI 10.4161/cbt.3.5.809; Dalby PA, 1998, J MOL BIOL, V276, P625, DOI 10.1006/jmbi.1997.1546; Deffenbaugh AM, 2002, GENET TEST, V6, P119, DOI 10.1089/10906570260199375; EASTON DF, 1995, AM J HUM GENET, V56, P265; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Gaiser OJ, 2004, BIOCHEMISTRY-US, V43, P15983, DOI 10.1021/bi049550q; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glover JNM, 2006, FAM CANCER, V5, P89, DOI 10.1007/s10689-005-2579-z; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hayes F, 2000, CANCER RES, V60, P2411; Karchin R, 2007, PLOS COMPUT BIOL, V3, P268, DOI 10.1371/journal.pcbi.0030026; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Rodriguez MC, 2008, FRONT BIOSCI-LANDMRK, V13, P5905, DOI 10.2741/3125; Starita LM, 2006, CANCER BIOL THER, V5, P137, DOI 10.4161/cbt.5.2.2479; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Varma AK, 2005, BIOCHEMISTRY-US, V44, P10941, DOI 10.1021/bi0509651; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Williams RS, 2003, J BIOL CHEM, V278, P53007, DOI 10.1074/jbc.M310182200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Worth Catherine L, 2007, J Bioinform Comput Biol, V5, P1297, DOI 10.1142/S0219720007003120; Wu WW, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-1; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhou HY, 2002, PROTEINS, V49, P483, DOI 10.1002/prot.10241	37	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20080	20087		10.1074/jbc.M109.088922	http://dx.doi.org/10.1074/jbc.M109.088922			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20378548	Green Published, hybrid			2022-12-27	WOS:000279012000042
J	Blomster, HA; Imanishi, SY; Siimes, J; Kastu, J; Morrice, NA; Eriksson, JE; Sistonen, L				Blomster, Henri A.; Imanishi, Susumu Y.; Siimes, Jenny; Kastu, Juha; Morrice, Nick A.; Eriksson, John E.; Sistonen, Lea			In Vivo Identification of Sumoylation Sites by a Signature Tag and Cysteine-targeted Affinity Purification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GO EXTRACTION TIPS; MASS-SPECTROMETRY; TRANSCRIPTIONAL ACTIVITY; PHOSPHORYLATED PEPTIDES; SUMO MODIFICATION; HEAT-SHOCK; PROTEOMICS; UBIQUITIN; ENRICHMENT; STRATEGY	Small ubiquitin-like modifier ( SUMO) is conjugated to its substrates via an enzymatic cascade consisting of three enzymes, E1, E2, and E3. The active site of the E2 enzyme, Ubc9, recognizes the substrate through binding to a consensus tetrapeptide Psi KXE. However, recent proteomics studies suggested that a considerable part of sumoylation occurs on non-consensus sites. Current unbiased sumoylation site identification techniques typically require high stoichiometry in vitro sumoylation, mass spectrometry, and complex data analysis. To facilitate in vivo analysis, we have designed a mass spectrometric method based on an engineered human SUMO-1 construct that creates a signature tag on SUMO substrates. This construct enables affinity purification by covalent binding to cysteine residues in LysC/trypsin-cleaved peptides and site identification by diglycyl lysine tagging of sumoylation sites. As a proof of concept, site-specific and substrate-unbiased in vivo sumoylation analysis of HeLa cells was performed. We identified 14 sumoylation sites, including well known sites, such as Lys(524) of RanGAP1, and novel non-consensus sites. Only 3 of the 14 sites matched consensus sites, supporting the emerging view that non-consensus sumoylation is a common event in live cells. Six of the non-consensus sites had a nearby SUMO interaction motif (SIM), which emphasizes the role of SIM in non-consensus sumoylation. Nevertheless, the lack of near by SIM residues among the remaining non-consensus sites indicates that there are also other specificity determinants of non-consensus sumoylation. The method we have developed proved to be a useful tool for sumoylation studies and will facilitate identification of novel SUMO substrates containing both consensus and non-consensus sites.	[Eriksson, John E.; Sistonen, Lea] Abo Akad Univ, Dept Biosci, FI-20520 Turku, Finland; [Blomster, Henri A.; Imanishi, Susumu Y.; Siimes, Jenny; Kastu, Juha; Eriksson, John E.; Sistonen, Lea] Abo Akad Univ, Turku Ctr Biotechnol, FI-20521 Turku, Finland; [Blomster, Henri A.; Imanishi, Susumu Y.; Siimes, Jenny; Kastu, Juha; Eriksson, John E.; Sistonen, Lea] Univ Turku, FI-20521 Turku, Finland; [Morrice, Nick A.] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	Abo Akademi University; Abo Akademi University; University of Turku; University of Turku; University of Dundee	Eriksson, JE (corresponding author), Abo Akad Univ, Dept Biosci, Tykistokatu 6, FIN-20520 Turku, Finland.	john.eriksson@abo.fi; lea.sistonen@btk.fi	Imanishi, Susumu/B-8697-2014	Imanishi, Susumu/0000-0002-3641-4390; Sistonen, Lea/0000-0003-1341-2867; Joutsen, Jenny/0000-0002-7868-556X	Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Organizations; Abo Akademi University; Turku Graduate School of Biomedical Sciences; Magnus Ehrnrooth Foundation; Stiftelsens for Abo Akademi forskningsinstitut	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Abo Akademi University; Turku Graduate School of Biomedical Sciences; Magnus Ehrnrooth Foundation; Stiftelsens for Abo Akademi forskningsinstitut	This work was supported by grants from the Academy of Finland (to J.E.E., L. S., and S.Y.I.), the Sigrid Juselius Foundation, the Finnish Cancer Organizations and the Abo Akademi University (to J.E.E. and L. S.), the Turku Graduate School of Biomedical Sciences, the Magnus Ehrnrooth Foundation, and the Stiftelsens for Abo Akademi forskningsinstitut (to H. A. B.).	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Boja ES, 2001, ANAL CHEM, V73, P3576, DOI 10.1021/ac0103423; Cooper HJ, 2005, ANAL CHEM, V77, P6310, DOI 10.1021/ac058019d; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Imanishi SY, 2007, MOL CELL PROTEOMICS, V6, P1380, DOI 10.1074/mcp.M600480-MCP200; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939; Jeram SM, 2009, PROTEOMICS, V9, P922, DOI 10.1002/pmic.200800666; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Liu T, 2004, ANAL CHEM, V76, P5345, DOI 10.1021/ac049485q; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Messner S, 2009, FASEB J, V23, P3978, DOI 10.1096/fj.09-137695; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Thingholm TE, 2008, MOL CELL PROTEOMICS, V7, P661, DOI 10.1074/mcp.M700362-MCP200; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	27	58	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19324	19329		10.1074/jbc.M110.106955	http://dx.doi.org/10.1074/jbc.M110.106955			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20388717	Green Published, hybrid			2022-12-27	WOS:000278727800042
J	Wathen, B; Jia, ZC				Wathen, Brent; Jia, Zongchao			Protein beta-Sheet Nucleation Is Driven by Local Modular Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN INTERACTIONS; HAIRPIN FORMATION; SECONDARY STRUCTURE; CONFORMATIONAL-ANALYSIS; PAIR CORRELATIONS; RESIDUE PAIRS; ANTIPARALLEL; STABILITY; MECHANISM; PEPTIDES	Despite its central role in the protein folding process, the specific mechanism(s) behind beta-sheet formation has yet to be determined. For example, whether the nucleation of beta-sheets, often containing strands separated in sequence by many residues, is local or not remains hotly debated. Here, we investigate the initial nucleation step of beta-sheet formation by performing an analysis of the smallest beta-sheets in a non-redundant dataset on the grounds that the smallest sheets, having undergone little growth after nucleation, will be enriched for nucleating characteristics. We find that the residue propensities are similar for small and large beta-sheets as are their interstrand pairing preferences, suggesting that nucleation is not primarily driven by specific residues or interacting pairs. Instead, an examination of the structural environments of the two-stranded sheets shows that virtually all of them are contained in single, compact structural modules, or when multiple modules are present, one or both of the chain termini are involved. We, therefore, find that beta-nucleation is a local phenomenon resulting either from sequential or topological proximity. We propose that beta-nucleation is a result of two opposite factors; that is, the relative rigidity of an associated folding module that holds two stretches of coil close together in topology coupled with sufficient chain flexibility that enables the stretches of coil to bring their backbones in close proximity. Our findings lend support to the hydrophobic zipper model of protein folding (Dill, K. A., Fiebig, K. M., and Chan, H. S. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 1942-1946). Implications for protein folding are discussed.	[Wathen, Brent; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Jia, ZC (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	jia@queensu.ca			Canadian Institutes of Health Research; Natural Science and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research.; Recipient of Natural Science and Engineering Research Council of Canada graduate studentship.	Blanco F, 1998, CURR OPIN STRUC BIOL, V8, P107, DOI 10.1016/S0959-440X(98)80017-1; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; COLLOCH N, 1991, J MOL BIOL, V221, P603, DOI 10.1016/0022-2836(91)80075-6; Colombo G, 2003, PROTEIN SCI, V12, P538, DOI 10.1110/ps.0227203; Cootes AP, 1998, PROTEINS, V32, P175, DOI 10.1002/(SICI)1097-0134(19980801)32:2<175::AID-PROT4>3.0.CO;2-K; Deechongkit S, 2006, CURR OPIN STRUC BIOL, V16, P94, DOI 10.1016/j.sbi.2006.01.014; DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942; Dinner AR, 1999, P NATL ACAD SCI USA, V96, P9068, DOI 10.1073/pnas.96.16.9068; Dyer RB, 2004, BIOCHEMISTRY-US, V43, P11560, DOI 10.1021/bi049177m; Espinosa JF, 2002, PROTEIN SCI, V11, P1492, DOI 10.1110/ps.4140102; Fooks HM, 2006, J MOL BIOL, V356, P32, DOI 10.1016/j.jmb.2005.11.008; Ho BK, 2002, J MOL BIOL, V317, P291, DOI 10.1006/jmbi.2001.5385; Hughes RM, 2006, CURR OPIN STRUC BIOL, V16, P514, DOI 10.1016/j.sbi.2006.06.008; Hutchinson EG, 1998, PROTEIN SCI, V7, P2287, DOI 10.1002/pro.5560071106; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuo NNW, 2005, J AM CHEM SOC, V127, P16945, DOI 10.1021/ja0543191; Lacroix E, 1999, CURR OPIN STRUC BIOL, V9, P487, DOI 10.1016/S0959-440X(99)80069-4; LIFSON S, 1979, NATURE, V282, P109, DOI 10.1038/282109a0; Mandel-Gutfreund Y, 2001, J MOL BIOL, V305, P1145, DOI 10.1006/jmbi.2000.4364; Munoz V, 1998, P NATL ACAD SCI USA, V95, P5872, DOI 10.1073/pnas.95.11.5872; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Noguchi T, 2001, NUCLEIC ACIDS RES, V29, P219, DOI 10.1093/nar/29.1.219; Pal D, 2000, ACTA CRYSTALLOGR D, V56, P589, DOI 10.1107/S090744490000367X; PAULING L, 1951, P NATL ACAD SCI USA, V37, P729, DOI 10.1073/pnas.37.11.729; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; Pickford AR, 2004, CHEM REV, V104, P3557, DOI 10.1021/cr0304018; RamirezAlvarado M, 1997, PROTEIN SCI, V6, P162; Santiveri CM, 2004, J PEPT SCI, V10, P546, DOI 10.1002/psc.564; Santiveri CM, 2004, PROTEIN SCI, V13, P1134, DOI 10.1110/ps.03520704; Sung SS, 1999, BIOPHYS J, V76, P164, DOI 10.1016/S0006-3495(99)77186-9; Syud FA, 2001, J AM CHEM SOC, V123, P8667, DOI 10.1021/ja0109803; Viguera AR, 1996, J MOL BIOL, V255, P507, DOI 10.1006/jmbi.1996.0042; Wathen B, 2009, INT J MOL SCI, V10, P1567, DOI 10.3390/ijms10041567; WOUTERS MA, 1995, PROTEINS, V22, P119, DOI 10.1002/prot.340220205; Zhang C, 2000, J MOL BIOL, V299, P1075, DOI 10.1006/jmbi.2000.3678; Zhu HY, 1999, PROTEIN SCI, V8, P326	40	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18376	18384		10.1074/jbc.M110.120824	http://dx.doi.org/10.1074/jbc.M110.120824			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20382979	Green Published, hybrid			2022-12-27	WOS:000278453900031
J	Jensen, PJ; Gunter, LB; Carayannopoulos, MO				Jensen, Penny J.; Gunter, Laura B.; Carayannopoulos, Mary O.			Akt2 Modulates Glucose Availability and Downstream Apoptotic Pathways during Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL HYPOGLYCEMIA; CELL-DEATH; GROWTH; GLUT1; INSULIN; INHIBITION; ZEBRAFISH; SURVIVAL; BAX; PHOSPHORYLATION	Glucose is the primary energy substrate for eukaryotic cells and the predominant substrate for the brain. Studies suggest that glucose serves an additional role in the regulation of cellular functions, including viability. Zebrafish is a tractable system for defining the cellular and molecular mechanisms perturbed by impaired glucose transport and metabolism. Previously, we demonstrated a critical role for the facilitative glucose transporter, Glut1, in the regulation of embryonic brain development. In this study, we aim to identify mediators in this Glut1-sensitive process by investigating the role of the antiapoptotic kinase, Akt2. Results show that abrogating expression of akt2 causes a phenotype strikingly similar to that observed when glut1 expression is inhibited. akt2-deficient embryos exhibit increased neuronal apoptosis, impaired glucose uptake, and death by 72 h postfertilization. Similar to what was observed in the glut1 morphants, inhibiting the expression of the proapoptotic protein, bad, in the context of impaired akt2 expression results in the inhibition of apoptosis and rescue of the morphant embryos. Intriguingly, overexpression of glut1 in the akt2 morphants was also able to rescue these embryos. Quantitative reverse transcription-PCR analysis revealed decreased glut1 transcript expression in akt2 morphant embryos. Taken together, these data suggest that Akt2 modulates glucose availability by regulating Glut1 expression at the transcript level. These data support a role for akt2 in an integrative pathway directly linking glucose, Glut1 expression, and activation of apoptosis and demonstrate the dependence of akt2 on glucose availability for the maintenance of cellular viability, particularly in the central nervous system.	[Jensen, Penny J.; Gunter, Laura B.; Carayannopoulos, Mary O.] Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL)	Carayannopoulos, MO (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, 125 Paterson St,MEB 212, New Brunswick, NJ 08901 USA.	carayamo@umdnj.edu			National Institutes of Health (NIH) [NS057105, HD01459]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Neuroscience Blueprint Core Grant NS057105 (to Washington University and the Bakewell Family Foundation) and NIH Grant HD01459 (to M. O. C.).	Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Boluyt N, 2006, PEDIATRICS, V117, P2231, DOI 10.1542/peds.2005-1919; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Lonlay Pascale, 2004, Semin Neonatol, V9, P49, DOI 10.1016/j.siny.2003.08.002; Dekelbab Bassem H, 2006, Adv Pediatr, V53, P5, DOI 10.1016/j.yapd.2006.04.004; DEL PL, 1997, SCIENCE, V278, P687; DEVIVO DC, 2002, J CHILD NEUROL S3, V17; Duvanel CB, 1999, J PEDIATR-US, V134, P492, DOI 10.1016/S0022-3476(99)70209-X; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; HEYWORTH CM, 1992, BLOOD, V80, P2230; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Jensen PJ, 2006, J BIOL CHEM, V281, P13382, DOI 10.1074/jbc.M601881200; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; KAN O, 1994, J EXP MED, V180, P917, DOI 10.1084/jem.180.3.917; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; MENON RK, 1988, SEMIN PERINATOL, V12, P157; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; MOLEY K, 1999, DIABETES PREIMPLANTA; Moley KH, 1998, AM J PHYSIOL-ENDOC M, V275, pE38, DOI 10.1152/ajpendo.1998.275.1.E38; Moley KH, 1998, NAT MED, V4, P1421, DOI 10.1038/4013; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Rozance PJ, 2006, BIOL NEONATE, V90, P74, DOI 10.1159/000091948; Rozen S, 2000, Methods Mol Biol, V132, P365; Russo VC, 2004, BRAIN RES, V1009, P40, DOI 10.1016/j.brainres.2004.02.042; Sperling MA, 2004, PEDIATR CLIN N AM, V51, P703, DOI 10.1016/j.pcl.2004.01.014; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; Wang D, 2005, ANN NEUROL, V57, P111, DOI 10.1002/ana.20331; Wang D, 2003, J BIOL CHEM, V278, P49015, DOI 10.1074/jbc.M308765200; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Wirrell E, 2005, CAN J NEUROL SCI, V32, P409, DOI 10.1017/S0317167100004388; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Yager JY, 2002, CLIN PERINATOL, V29, P651, DOI 10.1016/S0095-5108(02)00054-4; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5	52	23	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17673	17680		10.1074/jbc.M109.079343	http://dx.doi.org/10.1074/jbc.M109.079343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356836	hybrid, Green Published			2022-12-27	WOS:000278133400045
J	Sohl, CD; Guengerich, FP				Sohl, Christal D.; Guengerich, F. Peter			Kinetic Analysis of the Three-step Steroid Aromatase Reaction of Human Cytochrome P450 19A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PLACENTAL AROMATASE; ESTROGEN SYNTHETASE AROMATASE; ESCHERICHIA-COLI; SPECTRAL CHARACTERIZATION; SUCCESSIVE REACTIONS; LIGAND-BINDING; BREAST-CANCER; PURIFICATION; EXPRESSION; MICROSOMES	Cytochrome P450 19A1 (P450 19A1), the aromatase, catalyzes the conversion of androgens to estrogens through a sequential three-step reaction, generating 19-hydroxy and 19-aldehyde intermediates en route to the product estrogen. A procedure for the heterologous expression and purification of P450 19A1 in Escherichia coli was developed (k(cat) of 0.06 s(-1) for the conversion of androstenedione to estrone). Binding of the substrate and intermediates show low micromolar dissociation constants and are at least two-step processes. Rates of reduction of the iron were fast in the presence of substrate, either intermediate, or product. P450 19A1 is a distributive rather than a processive enzyme, with the sequential reaction allowing free dissociation of the intermediates as revealed by pulse-chase experiments. Conversion of androstenedione to estrone (under single turnover conditions) generated a progress curve showing changes in the concentrations of the substrate, intermediates, and product. A minimal kinetic model containing the individual rate constants for the steps in P450 19A1 catalysis was developed to globally fit the time course of the overall reaction, the dissociation constants, the two-step ligand binding, the distributive character, the iron-reduction rates, and the steady-state conversion of the 19-hydroxy androstenedione and 19-aldehyde androstenedione intermediates to estrone.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R37 CA090426, P30 ES000267, T32 ES007028]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426, P30 ES000267, and T32 ES007028 (to F. P. G.).	AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; Altundag K, 2006, ONCOLOGIST, V11, P553, DOI 10.1634/theoncologist.11-6-553; AMARNEH B, 1995, MOL CELL ENDOCRINOL, V109, pR1, DOI 10.1016/0303-7207(95)03524-B; BEDNARSKI PJ, 1989, J STEROID BIOCHEM, V32, P309, DOI 10.1016/0022-4731(89)90269-0; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; BRASELTON WE, 1974, EUR J BIOCHEM, V48, P35, DOI 10.1111/j.1432-1033.1974.tb03740.x; Chowdhury G, 2010, J BIOL CHEM, V285, P8031, DOI 10.1074/jbc.M109.088039; COLE PA, 1991, J AM CHEM SOC, V113, P8130, DOI 10.1021/ja00021a044; DEMONTELLANO PRO, 2005, CYTOCHROME P450S STR; FALK JE, 1964, PORPHYRINS METALLOPO, P213; FERSHT A, 1999, STRUCTURE MECH PROTE, P158; FISHMAN J, 1967, BIOCHEMISTRY-US, V6, P1683, DOI 10.1021/bi00858a016; FISHMAN J, 1981, J BIOL CHEM, V256, P4466; Gartner CA, 2001, PROTEIN EXPRES PURIF, V22, P443, DOI 10.1006/prep.2001.1464; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; GUO ZY, 1994, ARCH BIOCHEM BIOPHYS, V312, P436, DOI 10.1006/abbi.1994.1330; Hackett JC, 2005, J AM CHEM SOC, V127, P5224, DOI 10.1021/ja044716w; HAGERMAN DD, 1987, J BIOL CHEM, V262, P2398; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HARADA N, 1988, J BIOCHEM-TOKYO, V103, P106, DOI 10.1093/oxfordjournals.jbchem.a122213; HOLLANDER N, 1962, ENDOCRINOLOGY, V71, P723, DOI 10.1210/endo-71-5-723; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hosea NA, 1998, ARCH BIOCHEM BIOPHYS, V353, P365, DOI 10.1006/abbi.1998.0659; Imai T, 1998, BIOCHEMISTRY-US, V37, P8097, DOI 10.1021/bi9802768; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Johnson KA, 1998, CURR OPIN BIOTECH, V9, P87, DOI 10.1016/S0958-1669(98)80089-X; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Kagawa N, 2004, STEROIDS, V69, P235, DOI 10.1016/j.steroids.2004.01.002; KELLIS JT, 1984, SCIENCE, V225, P1032, DOI 10.1126/science.6474163; KELLIS JT, 1987, J BIOL CHEM, V262, P4413; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Nakayama K, 2001, J BIOL CHEM, V276, P31459, DOI 10.1074/jbc.M103943200; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; OSAWA Y, 1993, J STEROID BIOCHEM, V44, P469, DOI 10.1016/0960-0760(93)90252-R; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; RICHARDSON TH, 1995, ARCH BIOCHEM BIOPHYS, V323, P87, DOI 10.1006/abbi.1995.0013; RYAN KJ, 1959, J BIOL CHEM, V234, P268; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; SHIMIZU Y, 1993, J STEROID BIOCHEM, V44, P651, DOI 10.1016/0960-0760(93)90274-Z; SIGLE RO, 1994, BIOCHEM BIOPH RES CO, V201, P694, DOI 10.1006/bbrc.1994.1756; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Sohl CD, 2008, J BIOL CHEM, V283, P7293, DOI 10.1074/jbc.M709783200; TAN L, 1986, EUR J BIOCHEM, V156, P243, DOI 10.1111/j.1432-1033.1986.tb09574.x; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; Tomaszewski M, 2009, ATHEROSCLEROSIS, V203, P257, DOI 10.1016/j.atherosclerosis.2008.06.002; VICKERY L E, 1987, Steroids, V50, P29, DOI 10.1016/0039-128X(83)90059-4; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; YOSHIDA N, 1991, BIOCHEMISTRY-US, V30, P3003, DOI 10.1021/bi00226a004; Yun CH, 2000, BIOCHEMISTRY-US, V39, P11319, DOI 10.1021/bi000869u; Zhang FM, 2002, BIOCHEM PHARMACOL, V64, P1317, DOI 10.1016/S0006-2952(02)01361-8; ZHOU D, 1992, J BIOL CHEM, V267, P762	58	64	68	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17734	17743		10.1074/jbc.M110.123711	http://dx.doi.org/10.1074/jbc.M110.123711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385561	Green Published, hybrid			2022-12-27	WOS:000278133400051
J	Garcia-Diaz, M; Murray, MS; Kunkel, TA; Chou, KM				Garcia-Diaz, Miguel; Murray, Michael S.; Kunkel, Thomas A.; Chou, Kai-ming			Interaction between DNA Polymerase lambda and Anticancer Nucleoside Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR; GEMCITABINE; CELLS; FIBROBLASTS; METABOLISM; MECHANISM; SOFTWARE; EXTRACTS; CANCER	The anticancer activity of cytarabine (AraC) and gemcitabine (dFdC) is thought to result from chain termination after incorporation into DNA. To investigate their incorporation into DNA at atomic level resolution, we present crystal structures of human DNA polymerase lambda (Pol lambda) bound to gapped DNA and containing either AraC or dFdC paired opposite template dG. These structures reveal that AraC and dFdC can bind within the nascent base pair binding pocket of Pol lambda. Although the conformation of the ribose of AraCTP is similar to that of normal dCTP, the conformation of dFdCTP is significantly different. Consistent with these structures, Pol lambda efficiently incorporates AraCTP but not dFdCTP. The data are consistent with the possibility that Pol lambda could modulate the cytotoxic effect of AraC.	[Chou, Kai-ming] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; NIEHS, Struct Biol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; NIEHS, Mol Genet Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chou, KM (corresponding author), Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,MS 552, Indianapolis, IN 46202 USA.	chouk@iupui.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788	National Institutes of Health (NIH) [RO1 CA112446]; NIH, NIEHS [Z01 ES065070]; NATIONAL CANCER INSTITUTE [R01CA112446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065070, ZIAES065070] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant RO1 CA112446 (to K.-m.C.) and by NIH, NIEHS, Division of Intramural Research Project Z01 ES065070 (to T.A.K.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BALZARINI J, 1994, PHARM WORLD SCI, V16, P113, DOI 10.1007/BF01880662; Bebenek K, 2008, EMBO REP, V9, P459, DOI 10.1038/embor.2008.33; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkes RL, 1995, ANN ONCOL, V6, P57, DOI 10.1093/annonc/6.suppl_3.S57; Capp JP, 2006, NUCLEIC ACIDS RES, V34, P2998, DOI 10.1093/nar/gkl380; Cisneros GA, 2008, DNA REPAIR, V7, P1824, DOI 10.1016/j.dnarep.2008.07.007; Crespan E, 2005, NUCLEIC ACIDS RES, V33, P4117, DOI 10.1093/nar/gki723; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Diaz M, 2005, DNA REPAIR, V4, P1358, DOI 10.1016/j.dnarep.2005.09.001; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Garcia-Diaz M, 2007, DNA REPAIR, V6, P1333, DOI 10.1016/j.dnarep.2007.03.005; Garcia-Diaz M, 2009, NAT STRUCT MOL BIOL, V16, P967, DOI 10.1038/nsmb.1654; HIDDEMANN W, 1991, ANN HEMATOL, V62, P119, DOI 10.1007/BF01702925; HUANG P, 1991, CANCER RES, V51, P6110; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; King R S, 1996, Cancer Pract, V4, P353; Konerding D, 2002, BIOCHEMISTRY-US, V41, P839, DOI 10.1021/bi015678l; KUFE DW, 1982, MED PEDIATR ONCOL, P49; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; MIKITA T, 1988, BIOCHEMISTRY-US, V27, P4698, DOI 10.1021/bi00413a018; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Ohba T, 2009, MUTAT RES-GEN TOX EN, V677, P66, DOI 10.1016/j.mrgentox.2009.05.008; Picher AJ, 2006, NUCLEIC ACIDS RES, V34, P3259, DOI 10.1093/nar/gkl377; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; Possinger K, 1995, ANTI-CANCER DRUG, V6, P55, DOI 10.1097/00001813-199512006-00009; Shevelev I, 2003, NUCLEIC ACIDS RES, V31, P6916, DOI 10.1093/nar/gkg896; SOMMADOSSI JP, 1993, CLIN INFECT DIS, V16, pS7, DOI 10.1093/clinids/16.Supplement_1.S7; TANAKA M, 1980, ACTA HAEMATOL JAPON, V43, P996; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vermeulen C, 2007, RADIAT RES, V168, P683, DOI 10.1667/RR1057R.1	37	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16874	16879		10.1074/jbc.M109.094391	http://dx.doi.org/10.1074/jbc.M109.094391			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20348107	hybrid, Green Published			2022-12-27	WOS:000277982600051
J	Haug-Schifferdecker, E; Arican, D; Bruckner, R; Heide, L				Haug-Schifferdecker, Elisa; Arican, Deniz; Brueckner, Reinhard; Heide, Lutz			A New Group of Aromatic Prenyltransferases in Fungi, Catalyzing a 2,7-Dihydroxynaphthalene 3-Dimethylallyl-transferase Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPULVINONE DIMETHYLALLYLTRANSFERASE; FOLD RECOGNITION; BIOSYNTHESIS; SYNTHASE; PRENYLATION; SEQUENCE; IDENTIFICATION; PURIFICATION; GENTHREADER; DERIVATIVES	Five fungal genomes from the Ascomycota (sac fungi) were found to contain a gene with sequence similarity to a recently discovered small group of bacterial prenyltransferases that catalyze the C-prenylation of aromatic substrates in secondary metabolism. The genes from Aspergillus terreus NIH2624, Botryotinia fuckeliana B05.10 and Sclerotinia sclerotiorum 1980 were expressed in Escherichia coli, and the resulting His(8)-tagged proteins were purified and investigated biochemically. Their substrate specificity was found to be different from that of any other prenyltransferase investigated previously. Using 2,7-dihydroxynaphthalene (2,7-DHN) and dimethylallyl diphosphate as substrates, they catalyzed a regiospecific Friedel-Crafts alkylation of 2,7-DHN at position 3. Using the enzyme of A. terreus, the Km values for 2,7-DHN and dimethylallyl diphosphate were determined as 324 +/- 25 mu M and 325 +/- 35 mu M, respectively, and k(cat) as 0.026 +/- 0.001 s(-1). A significantly lower level of prenylation activity was found using dihydrophenazine-1-carboxylic acid as aromatic substrate, and only traces of products were detected with aspulvinone E, flaviolin, or 4-hydroxybenzoic acid. No product was formed with L-tryptophan, L-tyrosine, or 4-hydroxyphenylpyruvate. The genes for these fungal prenyltransferases are not located within recognizable secondary metabolic gene clusters. Their physiological function is yet unknown.	[Haug-Schifferdecker, Elisa; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Arican, Deniz; Brueckner, Reinhard] Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Freiburg	Heide, L (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	heide@uni-tuebingen.de		Heide, Lutz/0000-0001-7809-7453	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bernier D, 2007, SYNTHESIS-STUTTGART, P2249, DOI 10.1055/s-2007-983803; Botta B, 2005, TRENDS PHARMACOL SCI, V26, P606, DOI 10.1016/j.tips.2005.09.012; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gross F, 2006, ARCH MICROBIOL, V185, P28, DOI 10.1007/s00203-005-0059-3; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Koehl P, 2005, NAT CHEM BIOL, V1, P71, DOI 10.1038/nchembio0705-71; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Macone A, 2009, BIOORGAN MED CHEM, V17, P6003, DOI 10.1016/j.bmc.2009.06.061; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; SAGAMI I, 1985, METHOD ENZYMOL, V110, P320; Saleh O, 2009, PHYTOCHEMISTRY, V70, P1728, DOI 10.1016/j.phytochem.2009.05.009; Saleh O, 2009, J BIOL CHEM, V284, P14439, DOI 10.1074/jbc.M901312200; Sambrook J., 2001, MOL CLONING LAB MANU; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steffan N, 2009, CURR MED CHEM, V16, P218, DOI 10.2174/092986709787002772; Steffensky M, 1998, FEMS MICROBIOL LETT, V161, P69, DOI 10.1111/j.1574-6968.1998.tb12930.x; TAKAHASHI I, 1978, BIOCHEMISTRY-US, V17, P2696, DOI 10.1021/bi00606a037; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Williams RM, 2000, TOP CURR CHEM, V209, P97; WOODSIDE AB, 1988, ORG SYNTH, V66, P211	34	21	28	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16487	16494		10.1074/jbc.M110.113720	http://dx.doi.org/10.1074/jbc.M110.113720			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351110	hybrid, Green Published			2022-12-27	WOS:000277982600010
J	Yin, Y; Yang, SQ; Yu, L; Yu, CA				Yin, Ying; Yang, Shaoqing; Yu, Linda; Yu, Chang-An			Reaction Mechanism of Superoxide Generation during Ubiquinol Oxidation by the Cytochrome bc(1) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; Q-CYCLE; HEART-MITOCHONDRIA; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; QUINOL OXIDATION; Q(O) SITE; RHODOBACTER-SPHAEROIDES; BOUND UBISEMIQUINONE; C REDUCTASE	In addition to its main functions of electron transfer and proton translocation, the cytochrome bc(1) complex (bc(1)) also catalyzes superoxide anion (O-2(center dot-)) generation upon oxidation of ubiquinol in the presence of molecular oxygen. The reaction mechanism of superoxide generation by bc(1) remains elusive. The maximum O(2)radical anion. generation activity is observed when the complex is inhibited by antimycin A or inactivated by heat treatment or proteinase K digestion. The fact that the cytochrome bc(1) complex with less structural integrity has higher O-2(center dot-)-generating activity encouraged us to speculate that O-2(center dot-) is generated inside the complex, perhaps in the hydrophobic environment of the Q(P) pocket through bifurcated oxidation of ubiquinol by transferring its two electrons to a high potential electron acceptor, iron-sulfur cluster, and a low potential heme b(L) or molecular oxygen. If this speculation is correct, then one should see more O-2(center dot-) generation upon oxidation of ubiquinol by a high potential oxidant, such as cytochrome c or ferricyanide, in the presence of phospholipid vesicles or detergent micelles than in the hydrophilic conditions, and this is indeed the case. The protein subunits, at least those surrounding the Q(P) pocket, may play a role either in preventing the release of O-2(center dot-) from its production site to aqueous environments or in preventing O-2(center dot-) from getting access to the hydrophobic Q(P) pocket and might not directly participate in superoxide production.	[Yin, Ying; Yang, Shaoqing; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yu, CA (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	cayuq@okstate.edu	yang, shaoqing/C-9761-2012		National Institutes of Health [GM30721]; Oklahoma State University [1819, 2372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030721, R37GM030721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM30721 (to C.-A.Y.). This work was also supported by Oklahoma Agricultural Experiment Station Projects 1819 and 2372 from the Oklahoma State University.	AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4; Berry EA, 2003, FEBS LETT, V555, P13, DOI 10.1016/S0014-5793(03)01099-8; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; DEVRIES S, 1981, J BIOL CHEM, V256, P1996; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2; Gong X, 2005, J BIOL CHEM, V280, P9251, DOI 10.1074/jbc.M409994200; Helenius A, 1979, Methods Enzymol, V56, P734; Hong SJ, 1999, J BIOL CHEM, V274, P33931, DOI 10.1074/jbc.274.48.33931; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; LOSCHEN G, 1973, FEBS LETT, V33, P84, DOI 10.1016/0014-5793(73)80165-6; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; NAKANO M, 1990, METHOD ENZYMOL, V186, P585; NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; Trumpower BL, 2002, BBA-BIOENERGETICS, V1555, P166, DOI 10.1016/S0005-2728(02)00273-6; Tso SC, 2006, BBA-BIOENERGETICS, V1757, P1561, DOI 10.1016/j.bbabio.2006.06.010; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Yang SQ, 2008, J BIOL CHEM, V283, P28767, DOI 10.1074/jbc.M803013200; YU C, 1980, BIOCHIM BIOPHYS ACTA, V591, P409, DOI 10.1016/0005-2728(80)90172-3; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; Yu LD, 2009, METHOD ENZYMOL, V456, P459, DOI 10.1016/S0076-6879(08)04425-X; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	42	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17038	17045		10.1074/jbc.M110.104364	http://dx.doi.org/10.1074/jbc.M110.104364			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371599	Green Published, hybrid			2022-12-27	WOS:000277982600067
J	Clarke, CA; Scheurwater, EM; Clarke, AJ				Clarke, Chelsea A.; Scheurwater, Edie M.; Clarke, Anthony J.			The Vertebrate Lysozyme Inhibitor Ivy Functions to Inhibit the Activity of Lytic Transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; O-ACETYLPEPTIDOGLYCAN ESTERASE; ESCHERICHIA-COLI K-12; PSEUDOMONAS-AERUGINOSA; PEPTIDOGLYCAN; IDENTIFICATION; ACETYLATION; AUTOLYSINS; RESISTANCE; FAMILY	The proteinaceous inhibitor of vertebrate lysozymes (Ivy) is produced by a collection of Gram-negative bacteria as a stress response to damage to their essential cell wall component peptidoglycan. A paralog of Ivy, Ivyp2 is produced exclusively by a number of pseudomonads, including Pseudomonas aeruginosa, but this protein does not inhibit the lysozymes, and its function was unknown. In this study, we demonstrate that the production of Ivy (homologs of both Ivyp1 and Ivyp2) correlates with bacteria that do not O-acetylate their peptidoglycan, a modification that controls the activity of the lytic transglycosylases. Furthermore, we show that both Ivy proteins are potent inhibitors of the lytic transglycoslyases, enzymes involved in the biosynthesis and maintenance of peptidoglycan. These data suggest that the true physiological function of the Ivy proteins is to control the autolytic activity of lytic transglycosylases within the periplasm of Gram-negative bacteria that do not produce O-acetylated peptidoglycan and that the inhibition of exogenous lysozyme by Ivy is simply a fortuitous coincidence.	[Clarke, Chelsea A.; Scheurwater, Edie M.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	aclarke@uoguelph.ca			Canadian Institutes for Health Research [MOP 49623, MOP 81223]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Operating Grants MOP 49623 and MOP 81223 from the Canadian Institutes for Health Research (to A.J.C.).	Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; Deckers D, 2004, CELL MOL LIFE SCI, V61, P1229, DOI 10.1007/s00018-004-4066-3; Deckers D, 2008, APPL ENVIRON MICROB, V74, P4434, DOI 10.1128/AEM.00589-08; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; HASH JH, 1967, J BACTERIOL, V93, P1201, DOI 10.1128/JB.93.3.1201-1202.1967; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Kyomuhendo P, 2008, J MOL MODEL, V14, P777, DOI 10.1007/s00894-008-0317-9; LAEMMLI UK, 1970, NATURE, V227, P685; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; PAYIE KG, 1995, J BACTERIOL, V177, P4303, DOI 10.1128/jb.177.15.4303-4310.1995; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; ROGERS HJ, 1971, J BACTERIOL, V108, P1235, DOI 10.1128/JB.108.3.1235-1243.1971; ROGERS HJ, 1967, NATURE, V213, P31, DOI 10.1038/213031a0; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2008, J BIOL CHEM, V283, P8363, DOI 10.1074/jbc.M710135200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMASZ A, 1974, ANN NY ACAD SCI, V235, P439, DOI 10.1111/j.1749-6632.1974.tb43282.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s	31	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14843	14847		10.1074/jbc.C110.120931	http://dx.doi.org/10.1074/jbc.C110.120931			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20351104	Green Published, hybrid			2022-12-27	WOS:000277399000001
J	McLean, S; Bowman, LAH; Sanguinetti, G; Read, RC; Poole, RK				McLean, Samantha; Bowman, Lesley A. H.; Sanguinetti, Guido; Read, Robert C.; Poole, Robert K.			Peroxynitrite Toxicity in Escherichia coli K12 Elicits Expression of Oxidative Stress Responses and Protein Nitration and Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; TYROSINE NITRATION; S-NITROSYLATION; MYCOBACTERIUM-TUBERCULOSIS; METHIONINE BIOSYNTHESIS; HYDROGEN-PEROXIDE; CARBON-DIOXIDE; YTFE PROTEIN; COLI; SUPEROXIDE	Peroxynitrite is formed in macrophages by the diffusion-limited reaction of superoxide and nitric oxide. This highly reactive species is thought to contribute to bacterial killing by interaction with diverse targets and nitration of protein tyrosines. This work presents for the first time a comprehensive analysis of transcriptional responses to peroxynitrite under tightly controlled chemostat growth conditions. Up-regulation of the cysteine biosynthesis pathway and an increase in S-nitrosothiol levels suggest S-nitrosylation to be a consequence of peroxynitrite exposure. Genes involved in the assembly/repair of iron-sulfur clusters also show enhanced transcription. Unexpectedly, arginine biosynthesis gene transcription levels were also elevated after treatment with peroxynitrite. Analysis of the negative regulator for these genes, ArgR, showed that post-translational nitration of tyrosine residues within this protein is responsible for its degradation in vitro. Further up-regulation was seen in oxidative stress response genes, including katG and ahpCF. However, genes known to be up-regulated by nitric oxide and nitrosating agents (e.g. hmp and norVW) were unaffected. Probabilistic modeling of the transcriptomic data identified five altered transcription factors in response to peroxynitrite exposure, including OxyR and ArgR. Hydrogen peroxide can be present as a contaminant in commercially available peroxynitrite preparations. Transcriptomic analysis of cells treated with hydrogen peroxide alone also revealed up-regulation of oxidative stress response genes but not of many other genes that are up-regulated by peroxynitrite. Thus, the cellular responses to peroxynitrite and hydrogen peroxide are distinct.	[McLean, Samantha; Bowman, Lesley A. H.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sanguinetti, Guido] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Read, Robert C.] Univ Sheffield, Sch Med, Royal Hallamshire Hosp, Acad Unit Infect & Immun, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	McLean, S (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	S.McLean@Sheffield.ac.uk		Bowman, Lesley/0000-0001-6838-7174; Read, Robert/0000-0002-4297-6728	Biotechnology and Biological Sciences Research Council (United Kingdom); Biotechnology and Biological Sciences Research Council [BB/E015883/1] Funding Source: researchfish; BBSRC [BB/E015883/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (United Kingdom).	Alvarez MN, 2004, ARCH BIOCHEM BIOPHYS, V432, P222, DOI 10.1016/j.abb.2004.09.015; Ascenzi P, 2006, BIOCHEM BIOPH RES CO, V351, P528, DOI 10.1016/j.bbrc.2006.10.060; Bartesaghi S, 2007, AMINO ACIDS, V32, P501, DOI 10.1007/s00726-006-0425-8; Bartesaghi S, 2006, BIOCHEMISTRY-US, V45, P6813, DOI 10.1021/bi060363x; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beltran B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNELLI L, 1995, ARCH BIOCHEM BIOPHYS, V316, P327, DOI 10.1006/abbi.1995.1044; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Curry-McCoy TV, 2009, BBA-GEN SUBJECTS, V1790, P778, DOI 10.1016/j.bbagen.2009.04.008; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; FLORIS R, 1993, EUR J BIOCHEM, V215, P767, DOI 10.1111/j.1432-1033.1993.tb18091.x; Gebicka L, 2009, J INORG BIOCHEM, V103, P1375, DOI 10.1016/j.jinorgbio.2009.07.011; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hurst JK, 1997, CHEM RES TOXICOL, V10, P802, DOI 10.1021/tx970008v; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Ischiropoulos H, 2009, ARCH BIOCHEM BIOPHYS, V484, P117, DOI 10.1016/j.abb.2008.10.034; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Kohr MJ, 2009, NITRIC OXIDE-BIOL CH, V20, P217, DOI 10.1016/j.niox.2009.01.003; Laver JR, 2008, METHOD ENZYMOL, V436, P113, DOI 10.1016/S0076-6879(08)36007-8; Lee JB, 1998, J AM CHEM SOC, V120, P6053, DOI 10.1021/ja9801036; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; McLean S, 2010, FEBS LETT, V584, P1628, DOI 10.1016/j.febslet.2010.03.029; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Radi R., 2000, BIOL CHEM PEROXYNITR, P57; Saha A, 1998, FREE RADICAL BIO MED, V24, P653, DOI 10.1016/S0891-5849(97)00365-1; Sahoo R, 2009, BIOCHEM BIOPH RES CO, V385, P507, DOI 10.1016/j.bbrc.2009.05.062; SALGO MG, 1995, ARCH BIOCHEM BIOPHYS, V322, P500, DOI 10.1006/abbi.1995.1493; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Szwajkajzer D, 2001, J MOL BIOL, V312, P949, DOI 10.1006/jmbi.2001.4941; Todorovic S, 2008, J BIOL INORG CHEM, V13, P765, DOI 10.1007/s00775-008-0362-y; Trujillo M, 2008, ANTIOXID REDOX SIGN, V10, P1607, DOI 10.1089/ars.2008.2060; Wengenack NL, 1999, BIOCHEM BIOPH RES CO, V256, P485, DOI 10.1006/bbrc.1999.0358; Zhang HW, 1997, ARCH BIOCHEM BIOPHYS, V339, P183, DOI 10.1006/abbi.1996.9863; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; ZHU L, 1992, ARCH BIOCHEM BIOPHYS, V298, P452, DOI 10.1016/0003-9861(92)90434-X	45	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20724	20731		10.1074/jbc.M109.085506	http://dx.doi.org/10.1074/jbc.M109.085506			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427277	hybrid, Green Published			2022-12-27	WOS:000279228600036
J	Hartman, IZ; Liu, PS; Zehmer, JK; Luby-Phelps, K; Jo, Y; Anderson, RGW; Debose-Boyd, RA				Hartman, Isamu Z.; Liu, Pingsheng; Zehmer, John K.; Luby-Phelps, Katherine; Jo, Youngah; Anderson, Richard G. W.; Debose-Boyd, Russell A.			Sterol-induced Dislocation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase from Endoplasmic Reticulum Membranes into the Cytosol through a Subcellular Compartment Resembling Lipid Droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; DIFFERENTIATION-RELATED PROTEIN; PROTEASOMAL DEGRADATION; UBIQUITIN LIGASE; APOLIPOPROTEIN-B; MESSENGER-RNA; BINDING; ER; INSIG-1; CELLS	Sterol-induced binding to Insigs in the endoplasmic reticulum ( ER) allows for ubiquitination of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme in cholesterol synthesis. This ubiquitination marks reductase for recognition by the ATPase VCP/p97, which mediates extraction and delivery of reductase from ER membranes to cytosolic 26 S proteasomes for degradation. Here, we report that reductase becomes dislocated from ER membranes into the cytosol of sterol-treated cells. This dislocation exhibits an absolute requirement for the actions of Insigs and VCP/p97. Reductase also appears in a buoyant fraction of sterol-treated cells that co-purifies with lipid droplets, cytosolic organelles traditionally regarded as storage depots for neutral lipids such as triglycerides and cholesteryl esters. Genetic, biochemical, and localization studies suggest a model in which reductase is dislodged into the cytosol from an ER subdomain closely associated with lipid droplets.	[Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Hartman, Isamu Z.; Jo, Youngah; Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Liu, Pingsheng; Zehmer, John K.; Luby-Phelps, Katherine; Anderson, Richard G. W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Debose-Boyd, RA (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	russell.debose-boyd@utsouthwestern.edu	Liu, Pingsheng/B-7124-2012	Luby-Phelps, Katherine/0000-0002-8378-1409	National Institutes of Health [HL20948]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL20948. This work was also supported by the Perot Family Foundation.	Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1980, J LIPID RES, V21, P505; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Lee JN, 2006, P NATL ACAD SCI USA, V103, P4958, DOI 10.1073/pnas.0600422103; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Leichner GS, 2009, MOL BIOL CELL, V20, P3330, DOI 10.1091/mbc.E08-09-0953; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; LISCUM L, 1983, P NATL ACAD SCI-BIOL, V80, P7165, DOI 10.1073/pnas.80.23.7165; LISCUM L, 1985, J BIOL CHEM, V260, P522; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; NOVIKOFF AB, 1980, J CELL BIOL, V87, P180, DOI 10.1083/jcb.87.1.180; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013	52	67	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19288	19298		10.1074/jbc.M110.134213	http://dx.doi.org/10.1074/jbc.M110.134213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406816	hybrid, Green Published			2022-12-27	WOS:000278727800038
J	Lou, Y; Shanklin, J				Lou, Ying; Shanklin, John			Evidence That the Yeast Desaturase Ole1p Exists as a Dimer in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER-PROTEIN-DESATURASE; FATTY-ACID DESATURASE; STEAROYL-COA DESATURASE; ACYL-LIPID DESATURASE; HISTIDINE-RESIDUES; MEMBRANE TOPOLOGY; CRYSTAL-STRUCTURE; ENZYME; SITE; PURIFICATION	Desaturase enzymes are composed of two classes, the structurally well characterized soluble class found predominantly in the plastids of higher plants and the more widely distributed but poorly structurally defined integral membrane class. Despite their distinct evolutionary origins, the two classes both require an iron cofactor and molecular oxygen for activity and are inhibited by azide and cyanide, suggesting strong mechanistic similarities. The fact that the soluble desaturase is active as a homodimer prompted us test the hypothesis that an archetypal integral membrane desaturase from Saccharomyces cerevisiae, the Delta(9)-acyl-Co-A desaturase Ole1p, also exhibits a dimeric organization. Ole1p was chosen because it is one of the best characterized integral membrane desaturase and because it retains activity when fused with epitope tags. FLAG-Ole1p was detected by Western blotting of immunoprecipitates in which anti-Myc antibodies were used for capture from yeast extracts co-expressing Ole1p-Myc and Ole1p-FLAG. Interaction was confirmed by two independent bimolecular complementation assays (i.e. the split ubiquitin system and the split luciferase system). Co-expression of active and inactive Ole1p subunits resulted in an similar to 75% suppression of the accumulation of palmitoleic acid, demonstrating that the physiologically active form of Ole1p in vivo is the dimer in which both protomers must be functional.	[Lou, Ying; Shanklin, John] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Shanklin, J (corresponding author), Brookhaven Natl Lab, Dept Biol, Bldg 463,50 Bell Ave, Upton, NY 11973 USA.	shanklin@bnl.gov		Shanklin, John/0000-0002-6774-8043	Office of Basic Energy Sciences of the United States Department of Energy; Bayer Corp	Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Bayer Corp	This work was supported by the Office of Basic Energy Sciences of the United States Department of Energy and by the Bayer Corp.	AVELANGEMACHEREL MH, 1995, FEBS LETT, V361, P111, DOI 10.1016/0014-5793(95)00163-4; Behrouzian B, 2002, CURR OPIN CHEM BIOL, V6, P577, DOI 10.1016/S1367-5931(02)00365-4; BLOCH K, 1969, ACCOUNTS CHEM RES, V2, P193, DOI 10.1021/ar50019a001; Broadwater JA, 1998, BIOCHEMISTRY-US, V37, P14664, DOI 10.1021/bi981839i; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; Chapman KD, 2001, J AM OIL CHEM SOC, V78, P941, DOI 10.1007/s11746-001-0368-y; Chapman KD, 2008, CROP SCI, V48, P1470, DOI 10.2135/cropsci2007.11.0618; Davydov R, 2005, BIOCHEMISTRY-US, V44, P1309, DOI 10.1021/bi048599t; Diaz AR, 2002, J BIOL CHEM, V277, P48099, DOI 10.1074/jbc.M208960200; Fox BG, 2004, ACCOUNTS CHEM RES, V37, P421, DOI 10.1021/ar030186h; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Guy JE, 2007, J BIOL CHEM, V282, P19863, DOI 10.1074/jbc.M702520200; Haas JA, 2002, BIOCHEMISTRY-US, V41, P14472, DOI 10.1021/bi020340s; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; LINDQVIST Y, 2001, DELTA 9 STEAROYL ACY, P725; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Moche M, 2003, J BIOL CHEM, V278, P25072, DOI 10.1074/jbc.M301662200; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; SCHMIDT H, 1994, PLANT MOL BIOL, V26, P631, DOI 10.1007/BF00013749; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 1997, P NATL ACAD SCI USA, V94, P2981, DOI 10.1073/pnas.94.7.2981; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STUKEY JE, 1990, J BIOL CHEM, V265, P20144	32	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19384	19390		10.1074/jbc.M110.125377	http://dx.doi.org/10.1074/jbc.M110.125377			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406812	Green Published, hybrid			2022-12-27	WOS:000278727800049
J	Pierard, V; Guiguen, A; Colin, L; Wijmeersch, G; Vanhulle, C; Van Driessche, B; Dekoninck, A; Blazkova, J; Cardona, C; Merimi, M; Vierendeel, V; Calomme, C; Nguyen, TLA; Nuttinck, M; Twizere, JC; Kettmann, R; Portetelle, D; Burny, A; Hirsch, I; Rohr, O; Van Lint, C				Pierard, Valerie; Guiguen, Allan; Colin, Laurence; Wijmeersch, Gaelle; Vanhulle, Caroline; Van Driessche, Benoit; Dekoninck, Ann; Blazkova, Jana; Cardona, Christelle; Merimi, Makram; Vierendeel, Valerie; Calomme, Claire; Nguyen, Thi Lien-Anh; Nuttinck, Michele; Twizere, Jean-Claude; Kettmann, Richard; Portetelle, Daniel; Burny, Arsene; Hirsch, Ivan; Rohr, Olivier; Van Lint, Carine			DNA Cytosine Methylation in the Bovine Leukemia Virus Promoter Is Associated with Latency in a Lymphoma-derived B-cell Line POTENTIAL INVOLVEMENT OF DIRECT INHIBITION OF cAMP-RESPONSIVE ELEMENT (CRE)-BINDING PROTEIN/CRE MODULATOR/ACTIVATION TRANSCRIPTION FACTOR BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; VIRAL GENE-EXPRESSION; PERIPHERAL-BLOOD LYMPHOCYTES; IN-VIVO; HTLV-1 TAX; BINDING PROTEIN; TRANSCRIPTIONAL ACTIVATION; PERSISTENT LYMPHOCYTOSIS; CPG METHYLATION; PROVIRAL DNA	Bovine leukemia virus (BLV) proviral latency represents a viral strategy to escape the host immune system and allow tumor development. Besides the previously demonstrated role of histone deacetylation in the epigenetic repression of BLV expression, we showed here that BLV promoter activity was induced by several DNA methylation inhibitors (such as 5-aza-2'-deoxycytidine) and that overexpressed DNMT1 and DNMT3A, but not DNMT3B, down-regulated BLV promoter activity. Importantly, cytosine hypermethylation in the 5'-long terminal repeat (LTR) U3 and R regions was associated with true latency in the lymphoma-derived B-cell line L267 but not with defective latency in YR2 cells. Moreover, the virus-encoded transactivator Tax(BLV) decreased DNA methyltransferase expression levels, which could explain the lower level of cytosine methylation observed in the L267(LTaxSN) 5'-LTR compared with the L267 5'-LTR. Interestingly, DNA methylation inhibitors and Tax(BLV) synergistically activated BLV promoter transcriptional activity in a cAMP-responsive element (CRE)-dependent manner. Mechanistically, methylation at the -154 or -129 CpG position (relative to the transcription start site) impaired in vitro binding of CRE-binding protein (CREB) transcription factors to their respective CRE sites. Methylation at -129 CpG alone was sufficient to decrease BLV promoter-driven reporter gene expression by 2-fold. We demonstrated in vivo the recruitment of CREB/CRE modulator (CREM) and to a lesser extent activating transcription factor-1 (ATF-1) to the hypomethylated CRE region of the YR2 5'-LTR, whereas we detected no CREB/CREM/ATF recruitment to the hypermethylated corresponding region in the L267 cells. Altogether, these findings suggest that site-specific DNA methylation of the BLV promoter represses viral transcription by directly inhibiting transcription factor binding, thereby contributing to true proviral latency.	[Rohr, Olivier] Univ Strasbourg, Inst Univ Technol Louis Pasteur Schiltigheim, F-67300 Schiltigheim, France; [Pierard, Valerie; Guiguen, Allan; Colin, Laurence; Wijmeersch, Gaelle; Vanhulle, Caroline; Van Driessche, Benoit; Dekoninck, Ann; Cardona, Christelle; Vierendeel, Valerie; Calomme, Claire; Nguyen, Thi Lien-Anh; Van Lint, Carine] Univ Libre Bruxelles, IBMM, Mol Virol Lab, B-6041 Gosselies, Belgium; [Blazkova, Jana; Hirsch, Ivan] Univ Mediterranee, Inst J Paoli I Calmettes, INSERM, Inst Cancerol Marseille,UMR 599, F-13009 Marseille, France; [Merimi, Makram] Univ Libre Bruxelles, Inst Jules Bordet, Lab Expt Hematol, B-1000 Brussels, Belgium; [Nuttinck, Michele; Twizere, Jean-Claude; Kettmann, Richard; Portetelle, Daniel; Burny, Arsene] Fac Univ Sci Agron Gembloux, Dept Biol Mol, B-5030 Gembloux, Belgium	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut Jules Bordet; Universite Libre de Bruxelles; University of Liege	Rohr, O (corresponding author), Univ Strasbourg, Inst Univ Technol Louis Pasteur Schiltigheim, 1 Allee Athenes, F-67300 Schiltigheim, France.	olivier.rohr@iutlpa.u-strasbg.fr; cvlint@ulb.ac.be	Hirsch, Ivan/J-7726-2015; Twizere, Jean-Claude/AAG-3706-2019	Hirsch, Ivan/0000-0003-1701-1438; TWIZERE, Jean-Claude/0000-0002-8683-705X; Colin, Laurence/0000-0002-8544-7746; ROHR, Olivier/0000-0001-8992-2025	Belgian Fund for Scientific Research (FRS-FNRS, Belgium); Televie Program; "Action de Recherche Concertee du Ministere de la Communaute Francaise" (Universite Libre de Bruxelles) [04/09-309]; Internationale Brachet Stiftung; CGRI-INSERM Cooperation; Region Wallonne-Commission Europeenne FEDER (Fonds Europeen de Developpment Regionale); "Fortis Banque Assurance," ANRS, Sidaction; French Ministry of Research; Theyskens-Mineur Foundation; "Centre National des Oeuvres Universitaires et Scolaires" and by Sidaction (France)	Belgian Fund for Scientific Research (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Televie Program; "Action de Recherche Concertee du Ministere de la Communaute Francaise" (Universite Libre de Bruxelles); Internationale Brachet Stiftung; CGRI-INSERM Cooperation; Region Wallonne-Commission Europeenne FEDER (Fonds Europeen de Developpment Regionale); "Fortis Banque Assurance," ANRS, Sidaction; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Theyskens-Mineur Foundation; "Centre National des Oeuvres Universitaires et Scolaires" and by Sidaction (France)	This work was supported by grants from the Belgian Fund for Scientific Research (FRS-FNRS, Belgium), the Televie Program, the "Action de Recherche Concertee du Ministere de la Communaute Francaise" (Universite Libre de Bruxelles, ARC Program 04/09-309), the Internationale Brachet Stiftung, the CGRI-INSERM Cooperation, the Region Wallonne-Commission Europeenne FEDER (Fonds Europeen de Developpment Regionale), the "Fortis Banque Assurance," ANRS, Sidaction, the French Ministry of Research, and the Theyskens-Mineur Foundation.; Doctoral fellows of the FNRS-Televie Program.; Supported by the "Centre National des Oeuvres Universitaires et Scolaires" and by Sidaction (France). Present address: Inst. of Molecular Genetics, Academy of Sciences of the Czech Republic, 16637 Prague, Czech Republic.	Achachi A, 2005, P NATL ACAD SCI USA, V102, P10309, DOI 10.1073/pnas.0504248102; Adam E, 1996, J VIROL, V70, P1990, DOI 10.1128/JVI.70.3.1990-1999.1996; ADAM E, 1994, J VIROL, V68, P5845, DOI 10.1128/JVI.68.9.5845-5853.1994; Bhende PM, 2005, J VIROL, V79, P7338, DOI 10.1128/JVI.79.12.7338-7348.2005; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; BLOOM JC, 1979, BLOOD, V53, P899; BLOOM JC, 1980, CANCER RES, V40, P2240; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner C, 2006, CURR TOP MICROBIOL, V301, P45; BURNY A, 1987, CANCER SURV, V6, P139; Burny A., 1980, Viral oncology, P231; BURNY A, 1994, BOVINE LEUKEMIA VIRU, P213; Calomme C, 2004, J VIROL, V78, P13848, DOI 10.1128/JVI.78.24.13848-13864.2004; Calomme C, 2002, J BIOL CHEM, V277, P8775, DOI 10.1074/jbc.M107441200; Dekoninck A, 2003, ONCOGENE, V22, P2882, DOI 10.1038/sj.onc.1206392; DERSE D, 1987, J VIROL, V61, P2462, DOI 10.1128/JVI.61.8.2462-2471.1987; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; Ego T, 2005, ONCOGENE, V24, P1914, DOI 10.1038/sj.onc.1208394; Ego T, 2002, ONCOGENE, V21, P7241, DOI 10.1038/sj.onc.1205701; FERRER JF, 1979, J AM VET MED ASSOC, V175, P1281; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; GUPTA P, 1982, SCIENCE, V215, P405, DOI 10.1126/science.6276975; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; JENSEN WA, 1992, J VIROL, V66, P4427, DOI 10.1128/JVI.66.7.4427-4433.1992; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Kamoi K, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-5; KASHMIRI SVS, 1985, BIOCHEM BIOPH RES CO, V129, P126, DOI 10.1016/0006-291X(85)91412-3; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kerkhofs P, 1996, J VIROL, V70, P2170, DOI 10.1128/JVI.70.4.2170-2177.1996; KETTMANN R, 1980, P NATL ACAD SCI-BIOL, V77, P2577, DOI 10.1073/pnas.77.5.2577; KETTMANN R, 1982, P NATL ACAD SCI-BIOL, V79, P2465, DOI 10.1073/pnas.79.8.2465; KETTMANN R, 1985, J VIROL, V54, P899, DOI 10.1128/JVI.54.3.899-901.1985; Kiermer V, 1998, J VIROL, V72, P5526, DOI 10.1128/JVI.72.7.5526-5534.1998; Koiwa T, 2002, J VIROL, V76, P9389, DOI 10.1128/JVI.76.18.9389-9397.2002; LAGARIAS DM, 1989, J VIROL, V63, P2099, DOI 10.1128/JVI.63.5.2099-2107.1989; Latham T, 2008, CELL TISSUE RES, V331, P31, DOI 10.1007/s00441-007-0537-9; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; Merezak C, 2002, J VIROL, V76, P5034, DOI 10.1128/JVI.76.10.5034-5042.2002; Merimi M, 2007, J VIROL, V81, P5929, DOI 10.1128/JVI.02606-06; Merimi M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-51; Nguyen TLA, 2007, J BIOL CHEM, V282, P20854, DOI 10.1074/jbc.M703060200; Nguyen TLA, 2004, J BIOL CHEM, V279, P35025, DOI 10.1074/jbc.M404081200; Niermann GL, 1997, VIROLOGY, V239, P249, DOI 10.1006/viro.1997.8868; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; PORTETELLE D, 1989, J VIROL METHODS, V23, P211, DOI 10.1016/0166-0934(89)90135-3; SAGGIORO D, 1990, CANCER RES, V50, P4968; StanfieldOakley SA, 1996, J MOL BIOL, V256, P503, DOI 10.1006/jmbi.1996.0104; Tajima S, 2003, J VIROL, V77, P4423, DOI 10.1128/JVI.77.7.4423-4430.2003; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Taniguchi Y, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-64; UNK I, 1994, NUCLEIC ACIDS RES, V22, P4872; Van den Broeke A, 1999, J VIROL, V73, P1054, DOI 10.1128/JVI.73.2.1054-1065.1999; Van Den Broeke Anne, 1997, P2127; van der Vlag J, 2000, J BIOL CHEM, V275, P697, DOI 10.1074/jbc.275.1.697; VANDENBROEKE A, 1988, P NATL ACAD SCI USA, V85, P9263, DOI 10.1073/pnas.85.23.9263; VANLINT C, 1994, J VIROL, V68, P2632, DOI 10.1128/JVI.68.4.2632-2648.1994; Villanueva R, 2006, ONCOL REP, V16, P581; WILLEMS L, 1992, J VIROL, V66, P766, DOI 10.1128/JVI.66.2.766-772.1992; Willems L, 1987, Haematol Blood Transfus, V31, P482; WILLEMS L, 1993, J VIROL, V67, P4078, DOI 10.1128/JVI.67.7.4078-4085.1993; Willems L, 2000, AIDS RES HUM RETROV, V16, P1787, DOI 10.1089/08892220050193326; WILLEMS L, 1999, CURRENT TOP VIROL, V1, P139; Xiao JQ, 1998, J VIROL, V72, P5994, DOI 10.1128/JVI.72.7.5994-6003.1998	72	22	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19434	19449		10.1074/jbc.M110.107607	http://dx.doi.org/10.1074/jbc.M110.107607			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20413592	Green Published, hybrid			2022-12-27	WOS:000278727800054
J	Rudolph, B; Gebendorfer, KM; Buchner, J; Winter, J				Rudolph, Birgit; Gebendorfer, Katharina M.; Buchner, Johannes; Winter, Jeannette			Evolution of Escherichia coli for Growth at High Temperatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; MOLECULAR CHAPERONES; ENDOSYMBIOTIC BACTERIA; DELETERIOUS MUTATIONS; ELEVATED-TEMPERATURES; STATIONARY-PHASE; PROTEIN; STRESS; GROEL; AGGREGATION	Evolution depends on the acquisition of genomic mutations that increase cellular fitness. Here, we evolved Escherichia coli MG1655 cells to grow at extreme temperatures. We obtained a maximum growth temperature of 48.5 degrees C, which was not increased further upon continuous cultivation at this temperature for >600 generations. Despite a permanently induced heat shock response in thermoresistant cells, only exquisitely high GroEL/GroES levels are essential for growth at 48.5 degrees C. They depend on the presence of lysyl-tRNA-synthetase, LysU, because deletion of lysU rendered thermoresistant cells thermosensitive. Our data suggest that GroEL/GroES are especially required for the folding of mutated proteins generated during evolution. GroEL/GroES therefore appear as mediators of evolution of extremely heat-resistant E. coli cells.	[Rudolph, Birgit; Gebendorfer, Katharina M.; Buchner, Johannes; Winter, Jeannette] Tech Univ Munich, Dept Chem, CiPSM, D-85747 Garching, Germany	Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, Dept Chem, CiPSM, Lichtenbergstr 4, D-85747 Garching, Germany.	jeannette.winter@ch.tum.de	Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737	Elitenetzwerk Bayern; Fonds der chemischen Industrie and Sonderforschungsbereich [594]; Deutsche Forschungsgemeinschaft	Elitenetzwerk Bayern; Fonds der chemischen Industrie and Sonderforschungsbereich; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Elitenetzwerk Bayern (to K. M. G.), the Fonds der chemischen Industrie and Sonderforschungsbereich 594 (to J.B.), and the Emmy-Noether program of the Deutsche Forschungsgemeinschaft (to J.W.).	BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Beissinger M, 1999, J MOL BIOL, V289, P1075, DOI 10.1006/jmbi.1999.2780; BREVET A, 1989, P NATL ACAD SCI USA, V86, P8275, DOI 10.1073/pnas.86.21.8275; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cullum AJ, 2001, EVOLUTION, V55, P2194; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Grallert H, 1999, J BIOL CHEM, V274, P20171, DOI 10.1074/jbc.274.29.20171; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; JOHNSTONE DB, 1991, EMBO J, V10, P3897, DOI 10.1002/j.1460-2075.1991.tb04959.x; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LANGE R, 1991, J BACTERIOL, V173, P4474, DOI 10.1128/JB.173.14.4474-4481.1991; LEE PC, 1983, P NATL ACAD SCI-BIOL, V80, P7496, DOI 10.1073/pnas.80.24.7496; LILIE H, 1995, P NATL ACAD SCI USA, V92, P8100, DOI 10.1073/pnas.92.18.8100; Loewe L, 2003, SCIENCE, V302, P1558, DOI 10.1126/science.1087911; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Matic I, 2004, RES MICROBIOL, V155, P337, DOI 10.1016/j.resmic.2004.01.010; McKenzie GJ, 2001, CURR OPIN MICROBIOL, V4, P586, DOI 10.1016/S1369-5274(00)00255-1; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Mordukhova EA, 2008, APPL ENVIRON MICROB, V74, P7660, DOI 10.1128/AEM.00654-08; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; PARSELL DA, 1989, GENE DEV, V3, P1226, DOI 10.1101/gad.3.8.1226; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; RON EZ, 1971, J BACTERIOL, V107, P391, DOI 10.1128/JB.107.2.391-396.1971; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schafer H, 2001, ELECTROPHORESIS, V22, P2955, DOI 10.1002/1522-2683(200108)22:14<2955::AID-ELPS2955>3.0.CO;2-U; Tanner JA, 2006, BIOCHEMISTRY-US, V45, P3095, DOI 10.1021/bi052529k; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; VANBOGELEN RA, 1987, GENE DEV, V1, P525, DOI 10.1101/gad.1.6.525; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027	43	92	95	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19029	19034		10.1074/jbc.M110.103374	http://dx.doi.org/10.1074/jbc.M110.103374			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406805	Green Published, hybrid			2022-12-27	WOS:000278727800011
J	Antony, R; Lukiw, WJ; Bazan, NG				Antony, Rajee; Lukiw, Walter J.; Bazan, Nicolas G.			Neuroprotectin D1 Induces Dephosphorylation of Bcl-x(L) in a PP2A-dependent Manner during Oxidative Stress and Promotes Retinal Pigment Epithelial Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; BCL-X-L; DOCOSAHEXAENOIC ACID; MACULAR DEGENERATION; PROAPOPTOTIC FUNCTION; PHOSPHORYLATION SITE; CARDIAC MYOCYTES; FAMILY PROTEINS; LEUKEMIA-CELLS; APOPTOSIS	Retinal pigment epithelial (RPE) cell integrity is critical for the survival of photoreceptor cells. Bcl-x(L) is a major anti-apoptotic Bcl-2 protein required for RPE cell survival, and phosphorylation of Bcl-x(L) at residue Ser-62 renders this protein pro-apoptotic. In this study, we identify serine/threonine protein phosphatase 2A (PP2A) as a key regulator of Bcl-x(L) phosphorylation at residue Ser-62 in ARPE-19 cells, a spontaneously arising RPE cell line in which Bcl-x(L) is highly expressed. We found that either PP2A inhibitor okadaic acid or depletion of catalytic subunit alpha of PP2A (PP2A/C alpha) by small interfering RNA enhanced Bcl-x(L) phosphorylation when activated with hydrogen peroxide and tumor necrosis factor alpha-induced oxidative stress. Disruption of PP2A/C alpha exacerbated oxidative stress-induced apoptosis. PP2A/C alpha colocalized and interacted with S62Bcl-x(L) in cells stressed with H2O2/tumor necrosis factor alpha. By contrast, the omega-3 fatty acid docosahexaenoic acid derivative, neuroprotectin D1 (NPD1), a potent activator of survival signaling, down-regulated oxidative stress-induced phosphorylation of Bcl-x(L) by increasing protein phosphatase activity. NPD1 also attenuated the oxidative stress-induced apoptosis by knockdown of PP2A/C alpha and increased the association of PP2A/C alpha with S62Bcl-x(L) as well as total Bcl-x(L). NPD1 also enhanced the heterodimerization of Bcl-x(L) with its counterpart, pro-apoptotic protein Bax. Thus, NPD1 modulates the activation of this Bcl-2 family protein by dephosphorylating in a PP2A-dependent manner, suggesting a coordinated, NPD1-mediated regulation of cell survival in response to oxidative stress.	[Antony, Rajee; Lukiw, Walter J.; Bazan, Nicolas G.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bazan, NG (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, 2020 Gravier St,Ste D, New Orleans, LA 70112 USA.	nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institutes of Health through the NEI [R01 EY005121]; United States Public Health Service; NATIONAL EYE INSTITUTE [R01EY005121] Funding Source: NIH RePORTER	National Institutes of Health through the NEI; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY005121 through the NEI, United States Public Health Service.	Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Basu A, 2008, INT J ONCOL, V33, P657, DOI 10.3892/ijo_00000051; Bazan NG, 2007, INVEST OPHTH VIS SCI, V48, P4866, DOI 10.1167/iovs.07-0918; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Benito A, 1997, LEUKEMIA, V11, P940, DOI 10.1038/sj.leu.2400699; Bok D, 2007, ARCH OPHTHALMOL-CHIC, V125, P160, DOI 10.1001/archopht.125.2.160; Boon-Unge K, 2007, CHEM BIOL, V14, P1386, DOI 10.1016/j.chembiol.2007.11.004; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Cittelly DM, 2007, J NEUROSCI RES, V85, P1894, DOI 10.1002/jnr.21313; Cook SA, 1999, CIRC RES, V85, P940; Covacci V, 2001, CHEM RES TOXICOL, V14, P1492, DOI 10.1021/tx010021m; Deng XM, 2009, BLOOD, V113, P422, DOI 10.1182/blood-2008-06-165134; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Er E, 2007, J BIOL CHEM, V282, P24938, DOI 10.1074/jbc.M703823200; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kovacech B, 2007, FEBS LETT, V581, P617, DOI 10.1016/j.febslet.2007.01.015; LAW B, 1995, J BIOL CHEM, V270, P12808, DOI 10.1074/jbc.270.21.12808; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Lotery A, 2007, HUM GENET, V122, P219, DOI 10.1007/s00439-007-0406-3; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marcheselli VL, 2010, PROSTAG LEUKOTR ESS, V82, P27, DOI 10.1016/j.plefa.2009.10.010; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13152, DOI 10.1073/pnas.0705949104; Parsons Ramon, 1998, Current Opinion in Oncology, V10, P88, DOI 10.1097/00001622-199801000-00014; Reed JC, 1996, ADV EXP MED BIOL, V406, P99; Rothstein EC, 2002, AM J PHYSIOL-HEART C, V283, pH598, DOI 10.1152/ajpheart.00198.2002; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Schmierer K, 2007, J MAGN RESON IMAGING, V26, P41, DOI 10.1002/jmri.20984; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Sheets KG, 2010, MOL VIS, V16, P320; Simizu S, 2004, CANCER SCI, V95, P266, DOI 10.1111/j.1349-7006.2004.tb02214.x; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tamura Y, 2004, FEBS LETT, V569, P249, DOI 10.1016/j.febslet.2004.06.003; Thuduppathy GR, 2006, J MOL BIOL, V359, P1045, DOI 10.1016/j.jmb.2006.03.052; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Valks DM, 2003, J BIOL CHEM, V278, P25542, DOI 10.1074/jbc.M303760200; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhou H, 2005, EXP CELL RES, V309, P316, DOI 10.1016/j.yexcr.2005.06.014	56	55	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18301	18308		10.1074/jbc.M109.095232	http://dx.doi.org/10.1074/jbc.M109.095232			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20363734	hybrid, Green Published			2022-12-27	WOS:000278453900023
J	Blue, R; Li, JH; Steinberger, J; Murcia, M; Filizola, M; Coller, BS				Blue, Robert; Li, Jihong; Steinberger, Jonathan; Murcia, Marta; Filizola, Marta; Coller, Barry S.			Effects of Limiting Extension at the alpha IIb Genu on Ligand Binding to Integrin alpha IIb beta 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MONOCLONAL-ANTIBODY; I-LIKE DOMAIN; GLYCOPROTEIN-IIB; CRYSTAL-STRUCTURE; IMMOBILIZED FIBRINOGEN; CONFORMATIONAL-CHANGES; EXTRACELLULAR SEGMENT; CYTOPLASMIC DOMAIN; PLATELET-ADHESION; IIIA COMPLEX	Structural data of integrin alpha IIb beta 3 have been interpreted as supporting a model in which: 1) the receptor exists primarily in a "bent," low affinity conformation on unactivated platelets and 2) activation induces an extended, high affinity conformation prior to, or following, ligand binding. Previous studies found that "clasping" the alpha IIb head domain to the beta 3 tail decreased fibrinogen binding. To study the role of alpha IIb extension about the genu, we introduced a disulfide "clamp" between the alpha IIb thigh and calf-1 domains. Clamped alpha IIb beta 3 had markedly reduced ability to bind the large soluble ligands fibrinogen and PAC-1 when activated with monoclonal antibody (mAb) PT25-2 but not when activated by Mn2+ or by coexpressing the clamped alpha IIb with a beta 3 subunit containing the activating mutation N339S. The clamp had little effect on the binding of the snake venom kistrin (M-r 7,500) or alpha IIb beta 3-mediated adhesion to immobilized fibrinogen, but it did diminish the enhanced binding of mAbAP5 in the presence of kistrin. Collectively, our studies support a role for alpha IIb extension about the genu in the binding of ligands of 340,000 and 900,000 M-r with mAb-induced activation but indicate that it is not an absolute requirement. Our data are consistent with alpha IIb extension resulting in increased access to the ligand-binding site and/or facilitating the conformational change(s) in beta 3 that affect the intrinsic affinity of the binding pocket for ligand.	[Blue, Robert; Li, Jihong; Steinberger, Jonathan; Coller, Barry S.] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA; [Murcia, Marta; Filizola, Marta] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10065 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Coller, BS (corresponding author), 1230 York Ave,Box 309, New York, NY 10065 USA.	collerb@rockefeller.edu		Blue, Robert/0000-0002-0872-0358; Filizola, Marta/0000-0002-4382-8276	National Institutes of Health [19278]; National Center for Research Resources at the National Institutes of Health [UL1-RR024143]; Stony Brook University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Stony Brook University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 19278. This work was also supported by Clinical and Translational Science Award UL1-RR024143 from the National Center for Research Resources at the National Institutes of Health and by funds from Stony Brook University.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; BEER JH, 1992, BLOOD, V79, P117; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; COLLER BS, 1986, J CELL BIOL, V103, P451, DOI 10.1083/jcb.103.2.451; COLLER BS, 1980, BLOOD, V55, P169; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DENNIS MS, 1990, P NATL ACAD SCI USA, V87, P2471, DOI 10.1073/pnas.87.7.2471; DU XP, 1993, J BIOL CHEM, V268, P23087; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; KOUNS WC, 1990, J BIOL CHEM, V265, P20594; Law DA, 1999, BLOOD, V93, P2645, DOI 10.1182/blood.V93.8.2645.408k13_2645_2652; LINDON JN, 1986, BLOOD, V68, P355; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Mitchell WB, 2007, BLOOD, V109, P3725, DOI 10.1182/blood-2006-11-058420; Moskowitz KA, 1998, THROMB HAEMOSTASIS, V79, P824, DOI 10.1055/s-0037-1615072; PARISE LV, 1987, J BIOL CHEM, V262, P12597; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Rocco M, 2008, STRUCTURE, V16, P954, DOI 10.1016/j.str.2008.02.019; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; SAVAGE B, 1991, J BIOL CHEM, V266, P11227; SHADLE PJ, 1984, J CELL BIOL, V99, P2056, DOI 10.1083/jcb.99.6.2056; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHATTIL SJ, 1987, BLOOD, V70, P307; Shi ML, 2005, J BIOL CHEM, V280, P30586, DOI 10.1074/jbc.M502525200; STANFORD MF, 1983, ANN NY ACAD SCI, V416, P504, DOI 10.1111/j.1749-6632.1983.tb35208.x; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200; ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318; ZUCKER MB, 1984, THROMB HAEMOSTASIS, V51, P119	47	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17604	17613		10.1074/jbc.M110.107763	http://dx.doi.org/10.1074/jbc.M110.107763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363746	Green Published, hybrid			2022-12-27	WOS:000278133400039
J	Hall, JE; da Silva, AA; do Carmo, JM; Dubinion, J; Hamza, S; Munusamy, S; Smith, G; Stec, DE				Hall, John E.; da Silva, Alexandre A.; do Carmo, Jussara M.; Dubinion, John; Hamza, Shereen; Munusamy, Shankar; Smith, Grant; Stec, David E.			Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BLOOD-PRESSURE; ARTERIAL-PRESSURE; MICE; ACTIVATION; EPIDEMICS; WEIGHT; KIDNEY	Excess weight gain contributes to increased blood pressure in most patients with essential hypertension. Although the mechanisms of obesity hypertension are not fully understood, increased renal sodium reabsorption and impaired pressure natriuresis play key roles. Several mechanisms contribute to altered kidney function and hypertension in obesity, including activation of the sympathetic nervous system, which appears to be mediated in part by increased levels of the adipocyte-derived hormone leptin, stimulation of pro-opiomelanocortin neurons, and subsequent activation of central nervous system melanocortin 4 receptors.	[Hall, John E.; da Silva, Alexandre A.; do Carmo, Jussara M.; Dubinion, John; Hamza, Shereen; Munusamy, Shankar; Smith, Grant; Stec, David E.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Hall, JE (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA.	jehall@physiology.umsmed.edu	Munusamy, Shankar/D-6474-2014; Silva, Alexandre A/K-8054-2014; da Silva, Alexandre/A-6947-2009	Munusamy, Shankar/0000-0002-2023-7705; Silva, Alexandre A/0000-0003-4504-0607; da Silva, Alexandre/0000-0002-3233-7674; Hall, John/0000-0001-9867-5855	National Institutes of Health, NHLBI [P01 HL51971]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL51971 from NHLBI. This work was also supported by the American Heart Association.	Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Anderson SE, 2009, ARCH PEDIAT ADOL MED, V163, P344, DOI 10.1001/archpediatrics.2009.18; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bouret SG, 2008, ENDOCRINOLOGY, V149, P875, DOI 10.1210/en.2007-1698; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Corander MP, 2009, CIRCULATION, V120, P2260, DOI 10.1161/CIRCULATIONAHA.109.854612; da Silva AA, 2004, HYPERTENSION, V43, P1312, DOI 10.1161/01.HYP.0000128421.23499.b9; da Silva AA, 2008, HYPERTENSION, V51, P884, DOI 10.1161/HYPERTENSIONAHA.107.100636; da Silva AA, 2009, CURR HYPERTENS REP, V11, P206, DOI 10.1007/s11906-009-0036-3; Davy KP, 2004, AM J PHYSIOL-REG I, V286, pR803, DOI 10.1152/ajpregu.00707.2003; do Carmo JM, 2009, HYPERTENSION, V54, pE102; Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; GARRISON RJ, 1987, PREV MED, V16, P235, DOI 10.1016/0091-7435(87)90087-9; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Hall JE, 2004, ADV RENAL REPLACE TH, V11, P41, DOI 10.1053/j.arrt.2003.10.007; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hall JE, 2007, COMPREHENSIVE HYPERT, P447; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Kowalski TJ, 2001, DIABETES, V50, P425, DOI 10.2337/diabetes.50.2.425; Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A; Mark AL, 2002, J HYPERTENS, V20, P1245, DOI 10.1097/00004872-200207000-00001; Mark AL, 1999, J HYPERTENS, V17, P1949, DOI 10.1097/00004872-199917121-00026; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; Tallam LS, 2006, HYPERTENSION, V48, P58, DOI 10.1161/01.HYP.0000227966.36744.d9; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Wofford MR, 2004, CURR PHARM DESIGN, V10, P3621, DOI 10.2174/1381612043382855; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	38	344	368	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17271	17276		10.1074/jbc.R110.113175	http://dx.doi.org/10.1074/jbc.R110.113175			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20348094	hybrid, Green Published			2022-12-27	WOS:000278133400001
J	Rajagopal, S; Ji, YX; Xu, K; Li, YHA; Wicks, K; Liu, JW; Wong, KW; Herman, IM; Isberg, RR; Buchsbaum, RJ				Rajagopal, Soumitra; Ji, Yuxin; Xu, Kun; Li, Yuhuan; Wicks, Kathleen; Liu, Jiewei; Wong, Ka-Wing; Herman, Ira M.; Isberg, Ralph R.; Buchsbaum, Rachel J.			Scaffold Proteins IRSp53 and Spinophilin Regulate Localized Rac Activation by T-lymphocyte Invasion and Metastasis Protein 1 (TIAM1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; COMPLEX-FORMATION; PLASMA-MEMBRANE; ACTIN ISOFORMS; LIVING CELLS; KINASE; RHO; GTP; MIGRATION; BINDING	The Rac exchange factor Tiam1 is involved in diverse cell functions and signaling pathways through multiple protein interactions, raising the question of how signaling and functional specificity are achieved. We have shown that Tiam1 interactions with different scaffold proteins activate different Rac-dependent pathways by recruiting specific Rac effector proteins, and reasoned that there must be regulatory mechanisms governing each interaction. Fibroblasts express at least two Tiam1-interacting proteins, insulin receptor substrate protein 53 kDa (IRSp53) and spinophilin. We used fluorescent resonance energy transfer (FRET) to measure localized Rac activation associated with IRSp53 and spinophilin complexes in individual fibroblasts to test this hypothesis. Pervanadate or platelet-derived growth factor induced localized Rac activation dependent on Tiam1 and IRSp53. Forskolin or epinephrine induced localized Rac activation dependent on Tiam1 and spinophilin. In spinophilin-deficient cells, Tiam1 co-localized with IRSp53 in response to pervanadate or platelet-derived growth factor. In IRSp53-deficient cells, Tiam1 co-localized with spinophilin in response to forskolin or epinephrine. Total cellular levels of activated Rac were affected only in cells with exogenous Tiam1, and were primarily increased in the membrane fraction. Downstream effects of Rac activation were also stimulus and scaffold-specific. Cell ruffling, spreading, and cell adhesion were dependent on IRSp53, but not spinophilin. Epinephrine decreased IRSp53-dependent adhesion and increased cell migration in a Rac and spinophilin-dependent fashion. These results support the idea that Tiam1 interactions with different scaf-fold proteins couple distinct upstream signals to localized Rac activation and specific downstream pathways, and suggest that manipulating Tiam1-scaffold interactions can modulate Rac-dependent cellular behaviors.	[Rajagopal, Soumitra; Ji, Yuxin; Xu, Kun; Liu, Jiewei] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Buchsbaum, Rachel J.] Tufts Univ, Dept Med, Sch Med, Boston, MA 02111 USA; [Wong, Ka-Wing; Isberg, Ralph R.] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Herman, Ira M.] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Cellular & Mol Physiol, Boston, MA 02111 USA; [Li, Yuhuan] Providence Portland Med Ctr, Portland, OR 97213 USA; [Wicks, Kathleen] Boston Univ, Sch Med, Boston, MA 02118 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; Providence Portland Medical Center; Boston University	Buchsbaum, RJ (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 75 Kneeland St,12th Floor, Boston, MA 02111 USA.	rachel.buchsbaum@tufts.edu			National Institutes of Health [CA95559]; NCI; NIAID [R37AI023538]; NEI [EY15125, EY19533]; Howard Hughes Medical Institute; Tufts Medical Center GRASP Digestive Disease Center [P30DK34928]; Center for Neuroscience Research Core facility [P30NS047243]; NATIONAL CANCER INSTITUTE [R01CA095559] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015125, K08EY019533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Tufts Medical Center GRASP Digestive Disease Center; Center for Neuroscience Research Core facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA95559 (to R. J. B.) from the NCI, R37AI023538 (to R. R. I.) from the NIAID, and EY15125 and EY19533 (to I. M. H.) from the NEI, grants from the Howard Hughes Medical Institute (to K. W. and R. R. I.), Tufts Medical Center GRASP Digestive Disease Center Grant P30DK34928 (to R. J. B.), and Center for Neuroscience Research Core facility Grant P30NS047243.	Allen PG, 1996, BIOCHEMISTRY-US, V35, P14062, DOI 10.1021/bi961326g; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bourguignon LYW, 2000, J CELL BIOL, V150, P177, DOI 10.1083/jcb.150.1.177; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Buchsbaum R, 1996, MOL CELL BIOL, V16, P4888; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DENOFRIO D, 1989, J CELL BIOL, V109, P191, DOI 10.1083/jcb.109.1.191; Downes CP, 2005, BIOCHEM SOC T, V33, P1303, DOI 10.1042/BST0331303; Fleming IN, 2004, BIOCHEM J, V382, P857, DOI 10.1042/BJ20040916; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Mertens AEE, 2006, TRENDS CELL BIOL, V16, P308, DOI 10.1016/j.tcb.2006.04.001; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Ten Klooster JP, 2006, BIOCHEM J, V397, P39, DOI 10.1042/BJ20051957; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Wong KW, 2008, J BIOL CHEM, V283, P35954, DOI 10.1074/jbc.M804717200; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	43	22	24	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18060	18071		10.1074/jbc.M109.051490	http://dx.doi.org/10.1074/jbc.M109.051490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20360004	hybrid, Green Published			2022-12-27	WOS:000278133400081
J	Lombardi, A; Busiello, RA; Napolitano, L; Cioffi, F; Moreno, M; de Lange, P; Silvestri, E; Lanni, A; Goglia, F				Lombardi, Assunta; Busiello, Rosa Anna; Napolitano, Laura; Cioffi, Federica; Moreno, Maria; de Lange, Pieter; Silvestri, Elena; Lanni, Antonia; Goglia, Fernando			UCP3 Translocates Lipid Hydroperoxide and Mediates Lipid Hydroperoxide-dependent Mitochondrial Uncoupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; PROTON CONDUCTANCE; FATTY-ACIDS; PROTEIN-3; SUPEROXIDE; METABOLISM; ACTIVATION; TRANSITION; MECHANISM; MATRIX	Although the literature contains many studies on the function of UCP3, its role is still being debated. It has been hypothesized that UCP3 may mediate lipid hydroperoxide (LOOH) translocation across the mitochondrial inner membrane (MIM), thus protecting the mitochondrial matrix from this very aggressive molecule. However, no experiments on mitochondria have provided evidence in support of this hypothesis. Here, using mitochondria isolated from UCP3-null mice and their wild-type littermates, we demonstrate the following. (i) In the absence of free fatty acids, proton conductance did not differ between wild-type and UCP3-null mitochondria. Addition of arachidonic acid (AA) to such mitochondria induced an increase in proton conductance, with wild-type mitochondria showing greater enhancement. In wild-type mitochondria, the uncoupling effect of AA was significantly reduced both when the release of O-2(+) in the matrix was inhibited and when the formation of LOOH was inhibited. In UCP3-null mitochondria, however, the uncoupling effect of AA was independent of the above mechanisms. (ii) In the presence of AA, wild-type mitochondria released significantly more LOOH compared with UCP3-null mitochondria. This difference was abolished both when UCP3 was inhibited by GDP and under a condition in which there was reduced LOOH formation on the matrix side of the MIM. These data demonstrate that UCP3 is involved both in mediating the translocation of LOOH across the MIM and in LOOH-dependent mitochondrial uncoupling.	Univ Naples Federico II, Dipartimento Sci Biol, I-80134 Naples, Italy; [Cioffi, Federica; de Lange, Pieter; Lanni, Antonia] Univ Naples 2, Dipartimento Sci Vita, I-81100 Caserta, Italy; [Moreno, Maria; Silvestri, Elena; Goglia, Fernando] Univ Sannio, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; University of Sannio		assunta.lombardi@unina.it; goglia@unisannio.it	cioffi, federica/AAB-8161-2019; de Lange, Pieter/GXA-3052-2022	cioffi, federica/0000-0002-1530-8556; MORENO, Maria/0000-0002-6218-5501; GOGLIA, Fernando/0000-0003-0468-9645; Silvestri, Elena/0000-0002-0592-9033	Ministero dell'Istruzione, dell'Universitae della Ricerca [COFIN-MIUR 2008]	Ministero dell'Istruzione, dell'Universitae della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione, dell'Universitae della Ricerca COFIN-MIUR 2008.	Beck V, 2007, FASEB J, V21, P1137, DOI 10.1096/fj.06-7489com; Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Brand MD, 2002, BIOCHEM J, V368, P597, DOI 10.1042/BJ20021077; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Cioffi F, 2009, BIOFACTORS, V35, P417, DOI 10.1002/biof.54; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Jaburek M, 2004, J BIOL CHEM, V279, P53097, DOI 10.1074/jbc.M405339200; Khailova LS, 2006, BBA-BIOENERGETICS, V1757, P1324, DOI 10.1016/j.bbabio.2006.04.024; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lanni A, 1999, FEBS LETT, V444, P250, DOI 10.1016/S0014-5793(99)00061-7; Lombardi A, 2008, BBA-BIOENERGETICS, V1777, P826, DOI 10.1016/j.bbabio.2008.04.019; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Pamplona R, 2000, J GERONTOL A-BIOL, V55, pB286, DOI 10.1093/gerona/55.6.B286; Parker N, 2008, BIOSCIENCE REP, V28, P83, DOI 10.1042/BSR20080002; Parker N, 2008, BIOCHEM J, V412, P131, DOI 10.1042/BJ20080006; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Schrauwen P, 2004, P NUTR SOC, V63, P287, DOI 10.1079/PNS2003336; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Talbot DA, 2005, BBA-BIOENERGETICS, V1709, P150, DOI 10.1016/j.bbabio.2005.07.001; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199	34	44	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16599	16605		10.1074/jbc.M110.102699	http://dx.doi.org/10.1074/jbc.M110.102699			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363757	Green Published, hybrid			2022-12-27	WOS:000277982600023
J	Buhler, D; Rossmann, R; Landolt, S; Balsiger, S; Fischer, HM; Hennecke, H				Buehler, Doris; Rossmann, Reinhild; Landolt, Sarah; Balsiger, Sylvia; Fischer, Hans-Martin; Hennecke, Hauke			Disparate Pathways for the Biogenesis of Cytochrome Oxidases in Bradyrhizobium japonicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-LIKE PROTEIN; THIOL-DISULFIDE OXIDOREDUCTASE; NITROUS-OXIDE REDUCTASE; B SITE FORMATION; C-OXIDASE; CRYSTAL-STRUCTURE; PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; RNA-POLYMERASE; ACTIVE-SITE	This work addresses the biogenesis of heme-copper terminal oxidases in Bradyrhizobium japonicum, the nitrogen-fixing root nodule symbiont of soybean. B. japonicum has four quinol oxidases and four cytochrome oxidases. The latter include the aa(3)- and cbb(3)-type oxidases. Although both have a Cu-B center in subunit I, the subunit II proteins differ in having either a Cu-A center (in aa(3)) or a covalently bound heme c (in cbb(3)). Two biogenesis factors were genetically studied here, the periplasmically exposed CoxG and ScoI proteins, which are the respective homologs of the mitochondrial copper-trafficking chaperones Cox11 and Sco1 for the formation of the Cu-B center in subunit I and the Cu-A center in subunit II of cytochrome aa(3). We could demonstrate copper binding to ScoI in vitro, a process for which the thiols of cysteine residues 74 and 78 in the ScoI polypeptide were shown to be essential. Knock-out mutations in the B. japonicum coxG and scoI genes led to loss of cytochrome aa(3) assembly and activity in the cytoplasmic membrane, whereas the cbb(3)-type cytochrome oxidase apparently remained unaffected. This suggests that subunit I of the cbb(3)-type oxidase obtains its copper cofactor via a different pathway than cytochrome aa(3). In contrast to the coxG mutation, the scoI mutation caused a decreased symbiotic nitrogen fixation activity. We hypothesize that a periplasmic B. japonicum protein other than any of the identified Cu-A proteins depends on ScoI and is required for an effective symbiosis.	[Buehler, Doris; Rossmann, Reinhild; Landolt, Sarah; Balsiger, Sylvia; Fischer, Hans-Martin; Hennecke, Hauke] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland	ETH Zurich	Hennecke, H (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	hennecke@micro.biol.ethz.ch			ETH Zurich; Swiss National Foundation for Scientific Research	ETH Zurich(ETH Zurich); Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by grants from ETH Zurich and the Swiss National Foundation for Scientific Research.	Abajian C, 2006, J BIOL INORG CHEM, V11, P459, DOI 10.1007/s00775-006-0096-7; Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; ALEXEYEV MF, 1995, BIOTECHNIQUES, V18, P52; Arslan E, 2000, FEBS LETT, V470, P7, DOI 10.1016/S0014-5793(00)01277-1; ARSLAN E, 2001, THESIS FEDERAL I TEC; Badrick AC, 2007, FEBS LETT, V581, P4663, DOI 10.1016/j.febslet.2007.08.058; Balatri E, 2003, STRUCTURE, V11, P1431, DOI 10.1016/j.str.2003.10.004; Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Banci L, 2007, STRUCTURE, V15, P1132, DOI 10.1016/j.str.2007.07.011; Banting GS, 2006, EUKARYOT CELL, V5, P568, DOI 10.1128/EC.5.3.568-578.2006; BOTT M, 1992, ARCH MICROBIOL, V158, P335, DOI 10.1007/BF00245362; BOTT M, 1990, MOL MICROBIOL, V4, P2147, DOI 10.1111/j.1365-2958.1990.tb00576.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bundschuh FA, 2008, BBA-BIOENERGETICS, V1777, P1336, DOI 10.1016/j.bbabio.2008.05.448; Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; CAO J, 1992, J BIOL CHEM, V267, P24273; Capitani G, 2001, J MOL BIOL, V311, P1037, DOI 10.1006/jmbi.2001.4913; Carr HS, 2005, J BIOL CHEM, V280, P22664, DOI 10.1074/jbc.M414077200; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; Cawthorn TR, 2009, BIOCHEMISTRY-US, V48, P4448, DOI 10.1021/bi802288m; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; DEMEREC M, 1968, J GEN MICROBIOL, V50, P1; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; FISCHER HM, 1993, EMBO J, V12, P2901, DOI 10.1002/j.1460-2075.1993.tb05952.x; Frangipani E, 2009, FEMS MICROBIOL LETT, V298, P234, DOI 10.1111/j.1574-6968.2009.01726.x; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; GERHUS E, 1990, J BACTERIOL, V172, P2392, DOI 10.1128/jb.172.5.2392-2400.1990; GOTTFERT M, 1990, P NATL ACAD SCI USA, V87, P2680, DOI 10.1073/pnas.87.7.2680; Gottfert M, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P99; GOTTFERT M, 1990, MOL PLANT MICROBE IN, V3, P308, DOI 10.1094/MPMI-3-308; Greiner P, 2008, BBA-BIOENERGETICS, V1777, P904, DOI 10.1016/j.bbabio.2008.04.003; HAHN M, 1984, MOL GEN GENET, V193, P46, DOI 10.1007/BF00327412; Haltia T, 2003, BIOCHEM J, V369, P77, DOI 10.1042/BJ20020782; Hauser F, 2006, MOL GENET GENOMICS, V275, P55, DOI 10.1007/s00438-005-0059-7; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; Hemp J, 2005, BIOCHEMISTRY-US, V44, P10766, DOI 10.1021/bi050464f; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Horng YC, 2005, J BIOL CHEM, V280, P34113, DOI 10.1074/jbc.M506801200; Imriskova-Sosova I, 2005, BIOCHEMISTRY-US, V44, P16949, DOI 10.1021/bi051343i; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Kaneko T, 2002, DNA RES, V9, P225, DOI 10.1093/dnares/9.6.225; Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002; Khalimonchuk O, 2005, CURR GENET, V47, P223, DOI 10.1007/s00294-005-0569-1; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; LOFERER H, 1993, EMBO J, V12, P3373, DOI 10.1002/j.1460-2075.1993.tb06011.x; LOFERER H, 1994, EUR J BIOCHEM, V223, P339, DOI 10.1111/j.1432-1033.1994.tb18999.x; Lu ZH, 2002, ADV PROTEIN CHEM, V60, P93; Mesa S, 2004, PHYSIOL PLANTARUM, V120, P205, DOI 10.1111/j.0031-9317.2004.0211.x; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; Nittis T, 2001, J BIOL CHEM, V276, P42520, DOI 10.1074/jbc.M107077200; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Preisig O, 1996, ARCH MICROBIOL, V165, P297, DOI 10.1007/s002030050330; PREISIG O, 1993, P NATL ACAD SCI USA, V90, P3309, DOI 10.1073/pnas.90.8.3309; Rauhamaki V, 2009, J BIOL CHEM, V284, P11301, DOI 10.1074/jbc.M808839200; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; Rossmann R, 1997, FEBS LETT, V406, P249, DOI 10.1016/S0014-5793(97)00270-6; Saenkham P, 2009, FEMS MICROBIOL LETT, V293, P122, DOI 10.1111/j.1574-6968.2009.01516.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Surpin MA, 1996, GENE, V183, P201, DOI 10.1016/S0378-1119(96)00559-8; Surpin MA, 1999, APPL ENVIRON MICROB, V65, P339; Swem DL, 2005, J BACTERIOL, V187, P8081, DOI 10.1128/JB.187.23.8081-8087.2005; Thony-Meyer L, 2002, BIOCHEM SOC T, V30, P633; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VANDEROOST J, 1991, J BIOENERG BIOMEMBR, V23, P257, DOI 10.1007/BF00762221; Velasco L, 2004, ANTON LEEUW INT J G, V85, P229, DOI 10.1023/B:ANTO.0000020156.42470.db; Williams JC, 2005, J BIOL CHEM, V280, P15202, DOI 10.1074/jbc.M410705200; Ye QL, 2005, BIOCHEMISTRY-US, V44, P2934, DOI 10.1021/bi0480537; Zufferey R, 1997, FEBS LETT, V412, P75, DOI 10.1016/S0014-5793(97)00746-1; Zufferey R, 1996, J BIOL CHEM, V271, P9114, DOI 10.1074/jbc.271.15.9114; Zumft WG, 2005, J MOL MICROB BIOTECH, V10, P154, DOI 10.1159/000091562	86	32	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15704	15713		10.1074/jbc.M109.085217	http://dx.doi.org/10.1074/jbc.M109.085217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335176	hybrid, Green Published			2022-12-27	WOS:000277715900005
J	Pfaff, SJ; Fletterick, RJ				Pfaff, Samuel J.; Fletterick, Robert J.			Hormone Binding and Co-regulator Binding to the Glucocorticoid Receptor are Allosterically Coupled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; RETINOID-X-RECEPTOR; HEAT-SHOCK-PROTEIN; NUCLEAR RECEPTOR; ANDROGEN RECEPTOR; LIVING CELLS; TRANSCRIPTIONAL COACTIVATOR; ESTROGEN-RECEPTORS; STEROID-RECEPTORS; COFACTOR BINDING	The glucocorticoid receptor initiates the cellular response to glucocorticoid steroid hormones in vertebrates. Co-regulator proteins dock to the receptor in response to hormone binding and potentiate the transcriptional activity of the receptor by modifying DNA and recruiting essential transcription factors like RNA polymerase II. Hormones and co-regulators bind at distinct sites in the ligand binding domain yet function cooperatively to mediate transcriptional control. This study reveals and quantifies energetic coupling between two binding sites using purified components. Using a library of peptides taken from co-regulator proteins, we determine the pattern of co-regulator binding to the glucocorticoid receptor ligand binding domain. We show that peptides from co-regulators differ in their effects on hormone binding and kinetics. Peptides from DAX1 and SRC1 bind with similar affinity, but DAX1 binding is coupled to hormone binding, and SRC1 is not. Mechanistic details of co-regulator binding and coupling to the hormone binding pocket are uncovered by analysis of properties endowed by mutation of a key residue in the allosteric network connecting the sites.	[Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Pfaff, Samuel J.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fletterick, RJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	robert.fletterick@ucsf.edu						BAUMANN H, 1993, BIOCHEMISTRY-US, V32, P13463, DOI 10.1021/bi00212a011; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Biddie SC, 2009, STRESS, V12, P193, DOI 10.1080/10253890802506409; Biggadike K, 2008, J MED CHEM, V51, P3349, DOI 10.1021/jm800279t; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Borgius LJ, 2002, J BIOL CHEM, V277, P49761, DOI 10.1074/jbc.M205641200; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Bramlett KS, 2001, MOL ENDOCRINOL, V15, P909, DOI 10.1210/me.15.6.909; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; Chrousos GP, 2007, STRESS, V10, P213, DOI 10.1080/10253890701292119; Chrousos GP, 2004, J CLIN ENDOCR METAB, V89, P563, DOI 10.1210/jc.2003-032026; DALMAN FC, 1990, J BIOL CHEM, V265, P3615; DALMAN FC, 1991, BIOCHEMISTRY-US, V30, P5605, DOI 10.1021/bi00236a038; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Frego L, 2006, PROTEIN SCI, V15, P722, DOI 10.1110/ps.051781406; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Gee AC, 1999, MOL ENDOCRINOL, V13, P1912, DOI 10.1210/me.13.11.1912; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; HUTCHISON KA, 1994, J BIOL CHEM, V269, P27894; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; KATZENELLENBOGEN BS, 1980, ANNU REV PHYSIOL, V42, P17, DOI 10.1146/annurev.ph.42.030180.000313; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; Kroe RR, 2007, BIOPHYS CHEM, V128, P156, DOI 10.1016/j.bpc.2007.03.013; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Lin SQ, 2002, ANAL BIOCHEM, V300, P15, DOI 10.1006/abio.2001.5437; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Madauss KP, 2008, BIOORG MED CHEM LETT, V18, P6097, DOI 10.1016/j.bmcl.2008.10.021; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Moore JMR, 2005, MOL CELL PROTEOMICS, V4, P475, DOI 10.1074/mcp.R500001-MCP200; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Santin EP, 2009, J MED CHEM, V52, P3150, DOI 10.1021/jm900096q; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Pratt WB, 1998, TRENDS ENDOCRIN MET, V9, P244, DOI 10.1016/S1043-2760(98)00059-9; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; SCHLATTER LK, 1992, MOL ENDOCRINOL, V6, P132, DOI 10.1210/me.6.1.132; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Simmons CA, 2008, PROTEIN EXPRES PURIF, V62, P29, DOI 10.1016/j.pep.2008.07.008; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Suino-Powell K, 2008, MOL CELL BIOL, V28, P1915, DOI 10.1128/MCB.01541-07; Tanaka M, 2003, ENDOCRINOLOGY, V144, P4070, DOI 10.1210/en.2003-0282; Teichert A, 2009, BIOCHEMISTRY-US, V48, P1454, DOI 10.1021/bi801874n; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Warnmark A, 2000, J BIOL CHEM, V275, P15014, DOI 10.1074/jbc.M001007200; Wu J, 2004, MOL ENDOCRINOL, V18, P53, DOI 10.1210/me.2002-0373; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Zhou J, 2008, MOL ENDOCRINOL, V22, P1521, DOI 10.1210/me.2007-0273; Zhu YJ, 1996, GENE EXPRESSION, V6, P185	83	22	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15256	15267		10.1074/jbc.M110.108118	http://dx.doi.org/10.1074/jbc.M110.108118			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20335180	hybrid, Green Published			2022-12-27	WOS:000277399000046
J	Narala, VR; Adapala, RK; Suresh, MV; Brock, TG; Peters-Golden, M; Reddy, RC				Narala, Venkata R.; Adapala, Ravi K.; Suresh, Madathilparambil V.; Brock, Thomas G.; Peters-Golden, Marc; Reddy, Raju C.			Leukotriene B-4 Is a Physiologically Relevant Endogenous Peroxisome Proliferator-activated Receptor-alpha Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; PPAR-ALPHA; LIGAND; INFLAMMATION; METABOLISM; IDENTIFICATION; BIOSYNTHESIS; EICOSANOIDS	Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription factors that play central roles in metabolism and inflammation. Although a variety of compounds have been shown to activate PPARs, identification of physiologically relevant ligands has proven difficult. In silico studies of lipid derivatives reported here identify specific 5-lipoxygenase products as candidate physiologically relevant PPAR-alpha activators. Subsequent studies show both in vitro and in a murine model of inflammation that 5-lipoxygenase stimulation induces PPAR-alpha signaling and that this results specifically from production of the inflammatory mediator and chemoattractant leukotriene B-4 (LTB4). Activation of PPAR-alpha is a direct effect of intracellularly generated LTB4 binding to the nuclear receptor and not of secreted LTB4 acting via its cell-surface receptors. Activation of PPAR-alpha reduces secretion of LTB4 by stimulating degradation of this fatty acid derivative. We also show that the LTB4 precursors leukotriene A(4) (LTA(4)) and 5-hydroperoxyeicosatetrenoic acid (5-HPETE) activate PPAR-alpha but have no significant endogenous effect independent of conversion to LTB4. We conclude that LTB4 is a physiologically relevant PPAR-alpha activator in cells of the immune system. This, together with previous findings, demonstrates that different types of lipids serve as endogenous PPAR-alpha ligands, with the relevant ligand varying between functionally different cell types. Our results also support the suggestion that regulation of inflammation may involve balancing proinflammatory effects of LTB4, exerted through cell-surface receptors, and anti-inflammatory effects exerted through PPAR-alpha activation.	[Narala, Venkata R.; Adapala, Ravi K.; Suresh, Madathilparambil V.; Brock, Thomas G.; Peters-Golden, Marc; Reddy, Raju C.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Reddy, RC (corresponding author), 109 Zina Pitcher Pl,4062 BSRB, Ann Arbor, MI 48109 USA.	rajuc@umich.edu	Narala, Venkata Ramireddy/W-5197-2018; Reddy, Raju C/GLR-5338-2022; Adapala, Ravi kumar/AAD-1282-2020; madathilparambil, suresh/L-6791-2019	Reddy, Raju C/0000-0001-7079-1520; Adapala, Ravi kumar/0000-0002-4082-5301; Narala, Venkata/0000-0001-6672-4165	National Institutes of Health [HL093196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL093196.	Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; CLAESSON HE, 1981, BIOCHEM BIOPH RES CO, V99, P1230, DOI 10.1016/0006-291X(81)90751-8; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Fiedler J, 2001, J PHARMACOL EXP THER, V299, P691; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Kalsotra A, 2007, ARCH BIOCHEM BIOPHYS, V461, P104, DOI 10.1016/j.abb.2007.02.027; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; LEIER I, 1992, EUR J BIOCHEM, V209, P281, DOI 10.1111/j.1432-1033.1992.tb17287.x; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Ng VY, 2007, DRUG METAB DISPOS, V35, P1126, DOI 10.1124/dmd.106.013839; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Woerly G, 2003, J EXP MED, V198, P411, DOI 10.1084/jem.20021384; WONG A, 1991, BIOCHEMISTRY-US, V30, P9346, DOI 10.1021/bi00102a030; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	24	91	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22067	22074		10.1074/jbc.M109.085118	http://dx.doi.org/10.1074/jbc.M109.085118			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20400503	Green Published, hybrid			2022-12-27	WOS:000279702200019
J	Wang, XNH; Zhang, LP; Mitch, WE; LeDoux, JM; Hu, JP; Du, J				Wang, Xiaonan H.; Zhang, Liping; Mitch, William E.; LeDoux, Joseph M.; Hu, Junping; Du, Jie			Caspase-3 Cleaves Specific 19 S Proteasome Subunits in Skeletal Muscle Stimulating Proteasome Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; PROTEOLYTIC PATHWAY; PROTEIN-DEGRADATION; UBIQUITIN LIGASES; SUBSTRATE ENTRY; 20S PROTEASOME; 26S PROTEASOME; ATROPHY; ACTIVATION; EXPRESSION	With muscle wasting, caspase-3 activation and the ubiquitin-proteasome system act synergistically to increase the degradation of muscle proteins. Whether proteasome activity is also elevated in response to catabolic conditions is unknown. We find that caspase-3 increases proteasome activity in myotubes but not in myoblasts. This difference is related to the cleavage of specific 19 S proteasome subunits. In mouse muscle or myotubes, caspase-3 cleaves Rpt2 and Rpt6 increasing proteasome activity. In myoblasts, caspase-3 cleaves Rpt5 to decrease proteasome activity. To confirm the caspase-3 dependence, caspase-3 cleavage sites in Rpt2, Rpt6, or Rpt5 were mutated. This prevented the cleavage of these subunits by caspase-3 as well as the changes in proteasome activity. During differentiation of myoblasts to myotubes, there is an obligatory, transient increase in caspase-3 activity, accompanied by a corresponding increase in proteasome activity and cleavage of Rpt2 and Rpt6. Therefore, differentiation changes the proteasome type from sensitivity of Rpt5 to caspase-3 in myoblasts to sensitivity of Rpt2 and Rpt6 in myotubes. This novel mechanism identifies a feed-forward amplification that augments muscle proteolysis in catabolic conditions. Indeed, we found that in mice with a muscle wasting condition, chronic kidney disease, there was cleavage of subunits Rpt2 and Rpt6 and stimulation of proteasome activity.	[Wang, Xiaonan H.; Hu, Junping] Emory Univ, Div Renal, Atlanta, GA 30322 USA; [Zhang, Liping; Mitch, William E.; Du, Jie] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA; [LeDoux, Joseph M.] Georgia Tech & Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA	Emory University; Baylor College of Medicine; University System of Georgia; Georgia Institute of Technology	Wang, XNH (corresponding author), 1639 Pierce Dr,WMB 338, Atlanta, GA 30322 USA.	xwang03@emory.edu; jiedu@yahoo.com	Hu, Junping/J-2019-2014; Hu, Junping/F-3404-2013		National Institutes of Health [NIH R37 DK37175, P50 DK64233, R01HL70762]; University Research Committee of Emory University; Satellite Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064233, R37DK037175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Research Committee of Emory University; Satellite Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Grants NIH R37 DK37175 and P50 DK64233 (to W. E. M.) and R01HL70762 (to J.D.). This work was also supported by the University Research Committee of Emory University and a Norman S. Coplon extramural research grant from Satellite Health (to X. H. W. and L.Z.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bailey JL, 2006, J AM SOC NEPHROL, V17, P1388, DOI 10.1681/ASN.2004100842; Bailey JL, 1996, J CLIN INVEST, V97, P1447, DOI 10.1172/JCI118566; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; HU J, 2010, J AM SOC NE IN PRESS; Isozaki Y, 1996, P NATL ACAD SCI USA, V93, P1967, DOI 10.1073/pnas.93.5.1967; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; Minetti CASA, 1998, J BIOL CHEM, V273, P25329, DOI 10.1074/jbc.273.39.25329; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Tiao G, 1997, J CLIN INVEST, V99, P163, DOI 10.1172/JCI119143; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang XH, 2007, GENE THER, V14, P711, DOI 10.1038/sj.gt.3302927; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; Williams A, 1999, SURGERY, V126, P744, DOI 10.1067/msy.2099.99888; YANG Y, 1992, P NATL ACAD SCI USA, V89, P4928, DOI 10.1073/pnas.89.11.4928; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	46	57	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21249	21257		10.1074/jbc.M109.041707	http://dx.doi.org/10.1074/jbc.M109.041707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20424172	hybrid, Green Published			2022-12-27	WOS:000279516100010
J	Bai, JP; Surguchev, A; Ogando, Y; Song, L; Bian, SM; Santos-Sacchi, J; Navaratnam, D				Bai, Jun-Ping; Surguchev, Alexei; Ogando, Yudelca; Song, Lei; Bian, Shumin; Santos-Sacchi, Joseph; Navaratnam, Dhasakumar			Prestin Surface Expression and Activity Are Augmented by Interaction with MAP1S, a Microtubule-associated Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; TRANSCRIPTION FACTOR SIGMA(F); MOTILITY-RELATED CHARGE; TRANSPORTER DTDST GENE; SULFATE TRANSPORTER; STAS DOMAIN; VOLTAGE-DEPENDENCE; MOTOR PROTEIN; GUINEA-PIG; MEMBRANE	Prestin is a member of the SLC26 family of anion transporters that is responsible for outer hair cell (OHC) electromotility. Measures of voltage-evoked charge density (Q(sp)) of prestin indicated that the protein is highly expressed in OHCs, with single cells expressing up to 10 million molecules within the lateral membrane. In contrast, charge density measures in transfected cells indicated that they express, at best, only a fifth as many proteins on their surface. We sought to determine whether associations with other OHC-specific proteins could account for this difference. Using a yeast two-hybrid technique, we found microtubule-associated protein 1S (MAP1S) bound to prestin. The interaction was limited to the STAS domain of prestin and the region connecting the heavy and light chain of MAP1S. Using reciprocal immunoprecipitation and Forster resonance energy transfer, we confirmed these interactions. Furthermore, co-expression of prestin with MAP1S resulted in a 2.7-fold increase in Q(sp) in single cells that was paralleled by a 2.8-fold increase in protein surface expression, indicating that the interactions are physiological. Quantitative PCR data showed gradients in the expression of prestin and MAP1S across the tonotopic axis that may partially contribute to a previously observed 6-fold increase in Q(sp) in high frequency hair cells. These data highlight the importance of protein partner effects on prestin.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph; Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Surguchev, Alexei; Song, Lei; Bian, Shumin; Santos-Sacchi, Joseph; Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Navaratnam, D (corresponding author), LCI 703,310 Cedar St, New Haven, CT 06510 USA.	Dhasakumar.Navaratnam@Yale.Edu			National Institutes of Health, NIDCD [DC 007894, DC 000273, DC 0081130]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008130, R01DC000273, R01DC007894] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC 007894, DC 000273, and DC 0081130 from NIDCD.	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Ashmore J. F., 1989, MECH HEARING, P107; Bai JP, 2006, NEUROSCI LETT, V404, P270, DOI 10.1016/j.neulet.2006.05.062; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Blot Vincent, 2008, V457, P347, DOI 10.1007/978-1-59745-261-8-26; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Clarkson J, 2003, BIOCHEM J, V372, P113, DOI 10.1042/BJ20021748; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; Dorwart MR, 2008, J BIOL CHEM, V283, P8711, DOI 10.1074/jbc.M704328200; Eriksson M, 2007, BIOCHEM BIOPH RES CO, V361, P127, DOI 10.1016/j.bbrc.2007.06.179; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Gale JE, 1997, PFLUG ARCH EUR J PHY, V434, P267, DOI 10.1007/s004240050395; HUANG GJ, 1993, BIOPHYS J, V65, P2228, DOI 10.1016/S0006-3495(93)81248-7; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; Iwasa KH, 2001, BIOPHYS J, V81, P2495, DOI 10.1016/S0006-3495(01)75895-X; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Karniski LP, 2004, HUM MOL GENET, V13, P2165, DOI 10.1093/hmg/ddh242; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Kovacs H, 1998, P NATL ACAD SCI USA, V95, P5067, DOI 10.1073/pnas.95.9.5067; Kroos L, 1999, MOL MICROBIOL, V31, P1285, DOI 10.1046/j.1365-2958.1999.01214.x; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P4191, DOI 10.1158/0008-5472.CAN-04-3865; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Navaratnam Dhasakumar S., 2009, V493, P257, DOI 10.1007/978-1-59745-523-7_15; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Orban-Nemeth Z, 2005, J BIOL CHEM, V280, P2257, DOI 10.1074/jbc.M408984200; Pattnaik B, 2000, J NEUROSCI, V20, P6789, DOI 10.1523/JNEUROSCI.20-18-06789.2000; Pocklington A. J., 2006, Briefings in Functional Genomics & Proteomics, V5, P66, DOI 10.1093/bfgp/ell013; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Rouached H, 2005, J BIOL CHEM, V280, P15976, DOI 10.1074/jbc.M501635200; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; Santos-Sacchi J, 2004, BIOPHYS J, V87, P714, DOI 10.1529/biophysj.103.033993; SANTOS-SACCHI J, 1993, BIOPHYS J, V65, P2217, DOI 10.1016/S0006-3495(93)81247-5; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Santos-Sacchi J, 1998, NEUROSCI LETT, V256, P155, DOI 10.1016/S0304-3940(98)00788-5; Scherer MP, 2005, BIOPHYS J, V88, pL27, DOI 10.1529/biophysj.105.059782; Seavers PR, 2001, STRUCTURE, V9, P605, DOI 10.1016/S0969-2126(01)00623-2; Shibagaki N, 2004, J BIOL CHEM, V279, P30791, DOI 10.1074/jbc.M403248200; Shibagaki N, 2006, J BIOL CHEM, V281, P22964, DOI 10.1074/jbc.M603462200; Song MS, 2005, J BIOL CHEM, V280, P3920, DOI 10.1074/jbc.M409115200; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Wong EYM, 2004, BIOL REPROD, V70, P775, DOI 10.1095/biolreprod.103.018531; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2002, AUDIOL NEURO-OTOL, V7, P9, DOI 10.1159/000046855; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	55	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20834	20843		10.1074/jbc.M110.117853	http://dx.doi.org/10.1074/jbc.M110.117853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20418376	Green Published, hybrid			2022-12-27	WOS:000279228600047
J	Subramaniam, S; Mealer, RG; Sixt, KM; Barrow, RK; Usiello, A; Snyder, SH				Subramaniam, Srinivasa; Mealer, Robert G.; Sixt, Katherine M.; Barrow, Roxanne K.; Usiello, Alessandro; Snyder, Solomon H.			Rhes, a Physiologic Regulator of Sumoylation, Enhances Cross-sumoylation between the Basic Sumoylation Enzymes E1 and Ubc9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; GTP-BINDING PROTEIN; HUNTINGTONS-DISEASE; SUMO MODIFICATION; AUTOUBIQUITINATION; SYSTEM; GENES; MICE	We recently reported that the small G-protein Rhes has the properties of a SUMO-E3 ligase and mediates mutant huntingtin (mHtt) cytotoxicity. We now demonstrate that Rhes is a physiologic regulator of sumoylation, which is markedly reduced in the corpus striatum of Rhes-deleted mice. Sumoylation involves activation and transfer of small ubiquitin-like modifier (SUMO) from the thioester of E1 to the thioester of Ubc9 (E2) and final transfer to lysines on target proteins, which is enhanced by E3s. We show that E1 transfers SUMO from its thioester directly to lysine residues on Ubc9, forming isopeptide linkages. Conversely, sumoylation on E1 requires transfer of SUMO from the thioester of Ubc9. Thus, the process regarded as "autosumoylation" reflects intermolecular transfer between E1 and Ubc9, which we designate "cross-sumoylation." Rhes binds directly to both E1 and Ubc9, enhancing cross-sumoylation as well as thioester transfer from E1 to Ubc9.	[Subramaniam, Srinivasa; Mealer, Robert G.; Sixt, Katherine M.; Barrow, Roxanne K.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Subramaniam, Srinivasa; Mealer, Robert G.; Sixt, Katherine M.; Barrow, Roxanne K.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Usiello, Alessandro] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Usiello, Alessandro] Univ Del Molise, Dept Hlth Sci, I-86100 Campobasso, Italy	Johns Hopkins University; Johns Hopkins University; CEINGE Biotecnologie Avanzate; University of Molise	Snyder, SH (corresponding author), Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Dept Pharmacol & Mol Sci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	usiello, alessandro/B-2368-2012	Usiello, Alessandro/0000-0001-9203-853X	National Institutes of Health through the United States Public Health Service [MH18501];  [DA00074]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	National Institutes of Health through the United States Public Health Service; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant MH18501 (to S.H.S.) through the United States Public Health Service. This work was also supported a Research Scientist Award DA00074 (to S.H.S.).	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; ARNOLD JE, 1990, BIOCHEM J, V267, P751, DOI 10.1042/bj2670751; Baek SH, 2006, CELL CYCLE, V5, P1492, DOI 10.4161/cc.5.14.3008; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GUSELLA JF, 1995, CURR OPIN NEUROBIOL, V5, P656, DOI 10.1016/0959-4388(95)80072-7; Harrison LM, 2006, NEUROSCIENCE, V137, P483, DOI 10.1016/j.neuroscience.2005.08.017; Hayashi T, 2002, EXP CELL RES, V280, P212, DOI 10.1006/excr.2002.5634; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; PTAK C, 1994, J BIOL CHEM, V269, P26539; Quintero GC, 2008, NEUROREPORT, V19, P1563, DOI 10.1097/WNR.0b013e3283118434; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Spano D, 2004, MOL CELL BIOL, V24, P5788, DOI 10.1128/MCB.24.13.5788-5796.2004; St Croix B, 2000, SCIENCE, V289, P1197; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Thapliyal A, 2008, AM J PHYSIOL-CELL PH, V295, pC1417, DOI 10.1152/ajpcell.00341.2008; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; Vargiu P, 2004, ONCOGENE, V23, P559, DOI 10.1038/sj.onc.1207161; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	32	58	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20428	20432		10.1074/jbc.C110.127191	http://dx.doi.org/10.1074/jbc.C110.127191			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20424159	hybrid, Green Published			2022-12-27	WOS:000279228600002
J	Falandry, C; Fourel, G; Galy, V; Ristriani, T; Horard, B; Bensimon, E; Salles, G; Gilson, E; Magdinier, F				Falandry, Claire; Fourel, Genevieve; Galy, Vincent; Ristriani, Tutik; Horard, Beatrice; Bensimon, Elsa; Salles, Gilles; Gilson, Eric; Magdinier, Frederique			CLLD8/KMT1F Is a Lysine Methyltransferase That Is Important for Chromosome Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 METHYLATION; PERICENTRIC HETEROCHROMATIN; CHROMATIN; PROTEIN; GENE; TRANSCRIPTION; SETDB1; CELLS; HP1; TRIMETHYLATION	Proteins bearing a SET domain have been shown to methylate lysine residues in histones and contribute to chromatin architecture. Methylation of histone H3 at lysine 9 (H3K9) has emerged as an important player in the formation of heterochromatin, chromatin condensation, and transcriptional repression. Here, we have characterized a previously undescribed member of the histone H3K9 methyltransferase family named CLLD8 (or SETDB2 or KMT1F). This protein contributes to the trimethylation of both interspersed repetitive elements and centromere-associated repeats and participates in the recruitment of heterochromatin protein 1 to centromeres. Consistently, depletion in CLLD8/KMT1F coincides with a loss of CENP proteins and delayed mitosis, suggesting that this protein participates in chromosome condensation and segregation. Altogether, our results provide evidence that CLLD8/KMT1F is recruited to heterochromatin regions and contributes in vivo to the deposition of trimethyl marks in concert with SUV39H1/KMT1A.	[Salles, Gilles; Gilson, Eric] Univ Lyon 1, Ecole Normale Super Lyon, Fac Med Lyon Sud, CNRS,UMR 5239,IFR 128,Lab Biol Mol Cellule, F-69600 Oullins, France; [Falandry, Claire; Horard, Beatrice; Bensimon, Elsa; Salles, Gilles; Magdinier, Frederique] Univ Lyon, F-69622 Lyon, France; [Falandry, Claire; Fourel, Genevieve; Ristriani, Tutik; Gilson, Eric] Univ Lyon 1, Ecole Normale Super Lyon, Lab Biol Mol Cellule, CNRS,UMR 5239,IFR128, F-69364 Lyon 07, France; [Falandry, Claire] Hosp Civils Lyon, Ctr Hosp Lyon Sud, F-69495 Pierre Benite, France; [Galy, Vincent] Univ Paris 06, CNRS, UMR 7622, Dev Biol Lab, F-75252 Paris 05, France; [Gilson, Eric] Ctr Hosp Univ Nice, Dept Med Genet, Archet Hosp 2, F-06107 Nice, France; [Gilson, Eric] Univ Nice Sophia Antipolis, Fac Med, Lab Biol & Pathol Genomes, INSERM,U988,CNRS 6267, F-06107 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Gilson, E (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Fac Med Lyon Sud, CNRS,UMR 5239,IFR 128,Lab Biol Mol Cellule, F-69600 Oullins, France.	Eric.Gilson@ens-lyon.fr; Frederique.Magdinier@univmed.fr	FALANDRY, Claire/H-6055-2012; Salles, Gilles/Z-2336-2019; Magdinier, Frederique/I-4735-2016; Falandry, Claire/AAI-5736-2021	FALANDRY, Claire/0000-0001-7267-4723; Salles, Gilles/0000-0002-9541-8666; Magdinier, Frederique/0000-0002-0159-9559; Falandry, Claire/0000-0001-7267-4723	La Ligue Nationale contre le Cancer (Comite de la Drome and Comite du Rhone); l'Association pour la Recherche sur le Cancer (Programme National et Programme Alliance des Recherches sur le Cancer); Canceropole Rhone-Alpes; European Economic Community; French Minister of Research; La Fondation pour la Recherche Medicale; La Ligue Contre le Cancer	La Ligue Nationale contre le Cancer (Comite de la Drome and Comite du Rhone); l'Association pour la Recherche sur le Cancer (Programme National et Programme Alliance des Recherches sur le Cancer); Canceropole Rhone-Alpes; European Economic Community; French Minister of Research; La Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); La Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from La Ligue Nationale contre le Cancer (Comite de la Drome and Comite du Rhone, to G.F.; and Equipe Labelisee, to E. G.), l'Association pour la Recherche sur le Cancer (Programme National et Programme Alliance des Recherches sur le Cancer), Canceropole Rhone-Alpes, "RISCRAD, an FP6 program from European Economic Community (to E. G.), and an Action Concertee Incitative grant from the French Minister of Research (to G. F.).; Recipient of a fellowship from La Fondation pour la Recherche Medicale.; Recipient of a fellowship from La Ligue Contre le Cancer.	Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Ekwall K, 1996, J CELL SCI, V109, P2637; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Harte PJ, 1999, CYTOGENET CELL GENET, V84, P83, DOI 10.1159/000015220; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Kourmouli N, 2005, BIOCHEM BIOPH RES CO, V337, P901, DOI 10.1016/j.bbrc.2005.09.132; Lee J, 2008, HUM MOL GENET, V17, P1774, DOI 10.1093/hmg/ddn067; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Mabuchi H, 2001, CANCER RES, V61, P2870; Magdinier F, 2004, J BIOL CHEM, V279, P25381, DOI 10.1074/jbc.M403121200; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; SMALL JV, 1981, J CELL BIOL, V91, P695, DOI 10.1083/jcb.91.3.695; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; Waring PM, 1997, CURR TOP MICROBIOL, V220, P1; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998	34	58	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20234	20241		10.1074/jbc.M109.052399	http://dx.doi.org/10.1074/jbc.M109.052399			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404330	Green Published, hybrid			2022-12-27	WOS:000279012000058
J	Li, DQ; Ohshiro, K; Khan, MN; Kumar, R				Li, Da-Qiang; Ohshiro, Kazufumi; Khan, Mudassar N.; Kumar, Rakesh			Requirement of MTA1 in ATR-mediated DNA Damage Checkpoint Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; DOUBLE-STRAND BREAKS; HISTONE H2AX; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; FISSION YEAST; TRANSCRIPTIONAL REPRESSION; REPLICATION CHECKPOINT; GENOMIC INSTABILITY; UV-RADIATION	MTA1 (metastasis-associated protein 1), an integral component of the nucleosome remodeling and deacetylase complex, has recently been implicated in the ionizing radiation-induced DNA damage response. However, whether MTA1 also participates in the UV-induced DNA damage checkpoint pathway remains unknown. In response to UV radiation, ATR (ataxia teleangiectasia- and Rad3-related) is the major kinase activated that orchestrates cell cycle progression with DNA repair machinery by phosphorylating and activating a number of downstream substrates, such as Chk1 (checkpoint kinase 1) and H2AX (histone 2A variant X). Here, we report that UV radiation stabilizes MTA1 in an ATR-dependent manner and increases MTA1 binding to ATR. On the other hand, depletion of MTA1 compromises the ATR-mediated Chk1 activation following UV treatment, accompanied by a marked down-regulation of Chk1 and its interacting partner Claspin, an adaptor protein that is required for the phosphorylation and activation of Chk1 by ATR. Furthermore, MTA1 deficiency decreases the induction of phosphorylated H2AX (referred to as gamma-H2AX) and gamma-H2AX focus formation after UV treatment. Consequently, depletion of MTA1 results in a defect in the G(2)-M checkpoint and increases cellular sensitivity to UV-induced DNA damage. Thus, MTA1 is required for the activation of the ATR-Claspin-Chk1 and ATR-H2AX pathways following UV treatment, and the noted abrogation of the DNA damage checkpoint in the MTA1-depleted cells may be, at least in part, a consequence of dysregulation of the expression of these two pathways. These findings suggest that, in addition to its role in the repair of double strand breaks caused by ionizing radiation, MTA1 also participates in the UV-induced ATR-mediated DNA damage checkpoint pathway.	[Li, Da-Qiang; Ohshiro, Kazufumi; Khan, Mudassar N.; Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Kumar, Rakesh] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	George Washington University; University of Texas System; UTMD Anderson Cancer Center	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 (to R.K.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018; Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Burd CJ, 2008, J BIOL CHEM, V283, P34976, DOI 10.1074/jbc.M805383200; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Chini C, 2006, ONCOGENE, V25, P4165, DOI 10.1038/sj.onc.1209447; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Freire R, 2006, CELL CYCLE, V5, P2831, DOI 10.4161/cc.5.24.3559; Fujita N, 2004, MOL ENDOCRINOL, V18, P2937, DOI 10.1210/me.2004-0258; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; HERRLICH P, 1994, ADV ENZYME REGUL, V34, P381, DOI 10.1016/0065-2571(94)90024-8; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; LI DQ, 2010, CELL CYCLE IN PRESS, V9; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; PARKER RC, 1977, P NATL ACAD SCI USA, V74, P851, DOI 10.1073/pnas.74.3.851; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schmidt DR, 1999, BIOCHEMISTRY-US, V38, P14711, DOI 10.1021/bi991614n; SCHROTER H, 1985, EMBO J, V4, P3867, DOI 10.1002/j.1460-2075.1985.tb04159.x; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Takai H, 2000, GENE DEV, V14, P1439; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Wang X, 2003, J BIOL CHEM, V278, P30869, DOI 10.1074/jbc.M301876200; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	78	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19802	19812		10.1074/jbc.M109.085258	http://dx.doi.org/10.1074/jbc.M109.085258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427275	hybrid, Green Published			2022-12-27	WOS:000279012000013
J	Prakash, H; Albrecht, M; Becker, D; Kuhlmann, T; Rudel, T				Prakash, Hridayesh; Albrecht, Marco; Becker, Daniel; Kuhlmann, Tanja; Rudel, Thomas			Deficiency of XIAP Leads to Sensitization for Chlamydophila pneumoniae Pulmonary Infection and Dysregulation of Innate Immune Response in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; NEGATIVE BACTERIAL-INFECTION; CHLAMYDIA-PNEUMONIAE; APOPTOSIS RESISTANCE; DROSOPHILA INHIBITOR; CYTOKINE PRODUCTION; NITRIC-OXIDE; CELLS; PROTEIN	Obligate intracellular Chlamydophila pneumoniae induce apoptosis resistance in host cells to escape eradication by immune effector cells. Apoptosis resistance depends on the increased expression and stabilization of cellular inhibitor of apoptosis proteins (cIAPs) and X-linked inhibitor of apoptosis protein (XIAP). Here we investigated the role of XIAP in experimental pulmonary infection of mice with C. pneumoniae. XIAP knock out (KO) mice were sensitized for C. pneumoniae infection compared with wild type mice. XIAP was involved in lipopolysaccharide (LPS)-induced production of nitric oxide (NO) and endotoxin shock. Hyper-secretion of tumor necrosis factor-alpha and lower NO in LPS-treated KO mouse macrophages revealed its regulatory role in inflammatory responses. Unexpectedly, activating stimuli like LPS, tumor necrosis factor-alpha, or interferon-gamma very efficiently induced apoptotic cell death in KO macrophages but not in wild type macrophages. Cell survival transcription factor nuclear factor kappa B (NF-kappa B) p65 levels were reduced in lungs and pulmonary macrophages of infected KO mice. Furthermore, a reduced CD8 T cell population and their increased sensitivity for concanavalin A and chlamydial HSP60 stimulation revealed a defect in CD8 T cells in XIAP KO mice. These data demonstrated a role of XIAP for the integrity of both innate and cellular immune responses during C. pneumoniae infection.	[Albrecht, Marco; Rudel, Thomas] Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany; [Prakash, Hridayesh; Becker, Daniel; Rudel, Thomas] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Kuhlmann, Tanja] Univ Hosp Muenster, Inst Neuropathol, D-48149 Munster, Germany	University of Wurzburg; Max Planck Society; University of Munster	Rudel, T (corresponding author), Univ Wurzburg, Dept Microbiol, Bioctr, Hubland, D-97074 Wurzburg, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Hridayesh, Prakash/W-9478-2019	Hridayesh, Prakash/0000-0001-5269-2481	Sixth Research Framework Program [LSHB-CT-2004-005276]	Sixth Research Framework Program	This work was supported by Sixth Research Framework Program Grant LSHB-CT-2004-005276 ( to T. R.).	Arno G, 2005, BRIT J BIOMED SCI, V62, P155, DOI 10.1080/09674845.2005.11732703; Bauler LD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000142; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; EDELSON PJ, 1976, J EXP MED, V144, P1581, DOI 10.1084/jem.144.6.1581; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Gesellchen V, 2005, EMBO REP, V6, P979, DOI 10.1038/sj.embor.7400530; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; HAHN DL, 2002, FRONT BIOSCI, V7, P66; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Heinemann M, 1996, INFECT IMMUN, V64, P4872, DOI 10.1128/IAI.64.11.4872-4875.1996; HOLTMANN H, 1990, INFECT IMMUN, V58, P3168, DOI 10.1128/IAI.58.10.3168-3172.1990; Huh JR, 2007, J BIOL CHEM, V282, P2056, DOI 10.1074/jbc.M608051200; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Kragsbjerg P, 1998, RESPIRATION, V65, P299, DOI 10.1159/000029280; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; LY IA, 1974, J IMMUNOL METHODS, V5, P239, DOI 10.1016/0022-1759(74)90108-2; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Netea MG, 2002, EUR J IMMUNOL, V32, P1188, DOI 10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.3.CO;2-1; Paland N, 2008, J BIOL CHEM, V283, P6438, DOI 10.1074/jbc.M708422200; Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x; Prakash H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006519; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Sharma M, 2009, FEMS IMMUNOL MED MIC, V55, P154, DOI 10.1111/j.1574-695X.2008.00515.x; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Tvinnereim A, 2007, J IMMUNOL, V179, P3947, DOI 10.4049/jimmunol.179.6.3947; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Winsauer G, 2008, CELL SIGNAL, V20, P2107, DOI 10.1016/j.cellsig.2008.08.004; Zhao Haizhen, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P630	46	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20291	20302		10.1074/jbc.M109.096297	http://dx.doi.org/10.1074/jbc.M109.096297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427267	Green Published, hybrid			2022-12-27	WOS:000279012000064
J	Sayed, D; He, MZ; Hong, C; Gao, SM; Rane, S; Yang, Z; Abdellatif, M				Sayed, Danish; He, Minzhen; Hong, Chull; Gao, Shumin; Rane, Shweta; Yang, Zhi; Abdellatif, Maha			MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN HYPERSENSITIVITY; CARDIAC-HYPERTROPHY; HEART-FAILURE; EXPRESSION SIGNATURE; TENSIN HOMOLOG; BREAST-CANCER; FEEDBACK LOOP; UP-REGULATION; PTEN; GENE	MicroRNA-21 (miR-21) is highly up-regulated during hypertrophic and cancerous cell growth. In contrast, we found that it declines in cardiac myocytes upon exposure to hypoxia. Thus, the objective was to explore its role during hypoxia. We show that miR-21 not only regulates phosphatase and tensin homologue deleted on chromosome 10 (PTEN), but also targets Fas ligand (FasL). During prolonged hypoxia, down-regulation of miR-21 proved necessary and sufficient for enhancing expression of both proteins. We demonstrate here for the first time that miR-21 is positively regulated via an AKT-dependent pathway, which is depressed during prolonged hypoxia. Accordingly, hypoxia-induced down-regulation of miR-21 and up-regulation of FasL and PTEN were reversed by activated AKT and reproduced by a dominant negative mutant, wortmannin, or PTEN. Moreover, the antiapoptotic function of AKT partly required miR-21, which was sufficient for inhibition of caspase-8 activity and mitochondrial damage. In consensus, overexpression of miR-21 in a transgenic mouse heart resulted in suppression of ischemia-induced up-regulation of PTEN and FasL expression, an increase in phospho-AKT, a smaller infarct size, and ameliorated heart failure. Thus, we have identified a unique aspect of the function of AKT by which it inhibits apoptosis through miR-21-dependent suppression of FasL.	[Sayed, Danish; He, Minzhen; Hong, Chull; Gao, Shumin; Rane, Shweta; Yang, Zhi; Abdellatif, Maha] Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Abdellatif, M (corresponding author), Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA.	abdellma@umdnj.edu	Sayed, Danish/B-9047-2012; Yang, Zhi/B-8629-2012		National Institutes of Health [2R01 HL057970, R01 HL081381]; Dept. of Cell Biology and Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057970, R01HL081381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Cell Biology and Molecular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01 HL057970 and R01 HL081381 ( to M. A.).; We thank Dr. Stephen F. Vatner, Chairman of the Dept. of Cell Biology and Molecular Medicine for his support.	ABDELLATIF M, 1994, J BIOL CHEM, V269, P15423; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Chen HH, 2009, BRIT J ORAL MAX SURG, V47, P14, DOI 10.1016/j.bjoms.2008.06.008; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fukazawa T, 1999, ONCOGENE, V18, P2189, DOI 10.1038/sj.onc.1202561; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Graham FL, 1991, METHOD MOL BIOL, P109; Hlobilkova Alice, 2003, Biomedical Papers (Olomouc), V147, P19; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jiang L, 2003, EUR HEART J, V24, P742, DOI 10.1016/S0195-668X(02)00655-3; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Lee P, 2003, AM J PHYSIOL-HEART C, V284, pH456, DOI 10.1152/ajpheart.00777.2002; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Li YW, 2004, CIRC RES, V95, P627, DOI 10.1161/01.RES.0000141528.54850.bd; Li YX, 2006, AM J PHYSIOL-HEART C, V290, pH2116, DOI 10.1152/ajpheart.00551.2005; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Rane S, 2010, CELL SIGNAL, V22, P1054, DOI 10.1016/j.cellsig.2010.02.008; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Ruan HM, 2009, J MOL CELL CARDIOL, V46, P193, DOI 10.1016/j.yjmcc.2008.10.021; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Setsuta K, 2004, CIRC J, V68, P747, DOI 10.1253/circj.68.747; Shilkrut M, 2003, J MOL CELL CARDIOL, V35, P1229, DOI 10.1016/S0022-2828(03)00232-3; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wong JT, 2007, DIABETOLOGIA, V50, P395, DOI 10.1007/s00125-006-0531-x; Woodard J, 2008, CLIN CANCER RES, V14, P4640, DOI 10.1158/1078-0432.CCR-07-5232; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yin C, 2009, CIRC RES, V104, P572, DOI 10.1161/CIRCRESAHA.108.193250; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	47	265	285	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20281	20290		10.1074/jbc.M110.109207	http://dx.doi.org/10.1074/jbc.M110.109207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404348	Green Published, hybrid			2022-12-27	WOS:000279012000063
J	Biesiadecki, BJ; Tachampa, K; Yuan, C; Jin, JP; de Tombe, PP; Solaro, RJ				Biesiadecki, Brandon J.; Tachampa, Kittipong; Yuan, Chao; Jin, Jian-Ping; de Tombe, Pieter P.; Solaro, R. John			Removal of the Cardiac Troponin I N-terminal Extension Improves Cardiac Function in Aged Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC HEART-FAILURE; BINDING-PROTEIN-C; RAT HEARTS; PHOSPHORYLATION; KINASE; MUSCLE; DYSFUNCTION; KINETICS; MUTATION; MUTANT	The cardiac troponin I (cTnI) isoform contains a unique N-terminal extension that functions to modulate activation of cardiac myofilaments. During cardiac remodeling restricted proteolysis of cTnI removes this cardiac specific N-terminal modulatory extension to alter myofilament regulation. We have demonstrated expression of the N-terminal-deleted cTnI (cTnI-ND) in the heart decreased the development of the cardiomyopathy like phenotype in a beta-adrenergic-deficient transgenic mouse model. To investigate the potential beneficial effects of cTnI-ND on the development of naturally occurring cardiac dysfunction, we measured the hemodynamic and biochemical effects of cTnI-ND transgenic expression in the aged heart. Echocardiographic measurements demonstrate cTnI-ND transgenic mice exhibit increased systolic and diastolic functions at 16 months of age compared with age-matched controls. This improvement likely results from decreased Ca2+ sensitivity and increased cross-bridge kinetics as observed in skinned papillary bundles from young transgenic mice prior to the effects of aging. Hearts of cTnI-ND transgenic mice further exhibited decreased beta myosin heavy chain expression compared to age matched non-transgenic mice as well as altered cTnI phosphorylation. Finally, we demonstrated cTnI-ND expressed in the heart is not phosphorylated indicating the cTnI N-terminal is necessary for the higher level phosphorylation of cTnI. Taken together, our data suggest the regulated proteolysis of cTnI during cardiac stress to remove the unique cardiac N-terminal extension functions to improve cardiac contractility at the myofilament level and improve overall cardiac function.	[Tachampa, Kittipong; Yuan, Chao; de Tombe, Pieter P.; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Tachampa, Kittipong; Yuan, Chao; de Tombe, Pieter P.; Solaro, R. John] Univ Illinois, Coll Med, Cardiovasc Res Ctr, Chicago, IL 60612 USA; Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Jin, Jian-Ping] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Wayne State University	Biesiadecki, BJ (corresponding author), 404 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	biesiadecki.1@osu.edu	Jin, Jian-Ping/AAD-1149-2020; Tachampa, Kittipong/AAK-3634-2020	Jin, JP/0000-0001-9932-1063; Tachampa, Kittipong/0000-0002-2011-3542	National Institutes of Health [HL091056, HL078773, HL75494, HL62426, HL22231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL091056, R00HL091056, P01HL062426, R01HL078773, R01HL022231, R37HL022231, R01HL075494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL091056, HL078773, HL75494, HL62426 Project 4, HL22231, and HL62426 Project 1.	Abbott MB, 2001, BIOCHEMISTRY-US, V40, P5992, DOI 10.1021/bi0100642; Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Biesiadecki BJ, 2004, J BIOL CHEM, V279, P13825, DOI 10.1074/jbc.M314225200; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Hunlich M, 2005, J MOL CELL CARDIOL, V38, P119, DOI 10.1016/j.yjmcc.2004.10.005; Javadpour MM, 2003, J CLIN INVEST, V112, P768, DOI 10.1172/JC1200315967; JIN JP, 1990, HYBRIDOMA, V9, P597, DOI 10.1089/hyb.1990.9.597; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; PACKER M, 1995, EUR HEART J, V16, P4, DOI 10.1093/eurheartj/16.suppl_F.4; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Reddy AK, 2007, J GERONTOL A-BIOL, V62, P1319, DOI 10.1093/gerona/62.12.1319; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2008, FASEB J, V22, P1246, DOI 10.1096/fj.07-9458com; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Scruggs SB, 2006, J MOL CELL CARDIOL, V40, P465, DOI 10.1016/j.yjmcc.2005.12.009; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; STRANG KT, 1994, CIRC RES, V74, P542, DOI 10.1161/01.RES.74.3.542; Tachampa K, 2008, J BIOL CHEM, V283, P15114, DOI 10.1074/jbc.M801636200; Tachampa K, 2009, BIOPHYS J, V96, p502A, DOI 10.1016/j.bpj.2008.12.2589; VanEyk JE, 1997, J BIOL CHEM, V272, P10529; Ward DG, 2002, J BIOL CHEM, V277, P41795, DOI 10.1074/jbc.M206744200; WATTANAPERMPOOL J, 1995, J MOL CELL CARDIOL, V27, P1383, DOI 10.1006/jmcc.1995.0131; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894	41	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19688	19698		10.1074/jbc.M109.086892	http://dx.doi.org/10.1074/jbc.M109.086892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410305	Green Published, hybrid			2022-12-27	WOS:000278727800077
J	Lau, C; Dolle, C; Gossmann, TI; Agledal, L; Niere, M; Ziegler, M				Lau, Corinna; Dolle, Christian; Gossmann, Toni I.; Agledal, Line; Niere, Marc; Ziegler, Mathias			Isoform-specific Targeting and Interaction Domains in Human Nicotinamide Mononucleotide Adenylyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; MULTIPLE SEQUENCE ALIGNMENT; NMN/NAMN ADENYLYLTRANSFERASE; ADENINE-DINUCLEOTIDE; AXONAL DEGENERATION; NAD BIOSYNTHESIS; ADP-RIBOSYLATION; MATRIX PROTEINS; GOLGI PROTEINS; NUCLEAR ENZYME	Several important signaling pathways require NAD as substrate, thereby leading to significant consumption of the molecule. Because NAD is also an essential redox carrier, its continuous resynthesis is vital. In higher eukaryotes, maintenance of compartmentalized NAD pools is critical, but so far rather little is known about the regulation and subcellular distribution of NAD biosynthetic enzymes. The key step in NAD biosynthesis is the formation of the dinucleotide by nicotinamide/nicotinic acid mononucleotide adenylyltransferases (NMNATs). The three human isoforms were localized to the nucleus, the Golgi complex, and mitochondria. Here, we show that their genes contain unique exons that encode isoform-specific domains to mediate subcellular targeting and post-translational modifications. These domains are dispensable for catalytic activity, consistent with their absence from NMNATs of lower organisms. We further demonstrate that the Golgi-associated NMNAT is palmitoylated at two adjacent cysteine residues of its isoform-specific domain and thereby anchored at the cytoplasmic surface, a potential mechanism to regulate the cytosolic NAD pool. Insertion of unique domains thus provides a yet unrecognized enzyme targeting mode, which has also been adapted to modulate subcellular NAD supply.	[Lau, Corinna; Dolle, Christian; Agledal, Line; Niere, Marc; Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5008 Bergen, Norway; [Gossmann, Toni I.] Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England	University of Bergen; University of Sussex	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway.	mathias.ziegler@mbi.uib.no	Gossmann, Toni/H-6579-2013	Gossmann, Toni/0000-0001-6609-4116; Ziegler, Mathias/0000-0001-6961-2396; Lau, Corinna/0000-0003-1750-8065	National Research Council of Norway; University of Bergen	National Research Council of Norway(Research Council of Norway); University of Bergen	This work was supported by the National Research Council of Norway and the University of Bergen.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Couture JF, 2004, J MOL BIOL, V339, P89, DOI 10.1016/j.jmb.2004.03.035; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; DeLano W.L, PYMOL MOL GRAPHICS S; Denu JM, 2005, TRENDS BIOCHEM SCI, V30, P479, DOI 10.1016/j.tibs.2005.07.004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 2004, CURR MED CHEM, V11, P873, DOI 10.2174/0929867043455666; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang J, 2009, CELL ADHES MIGR, V3, P77, DOI 10.4161/cam.3.1.7483; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Yang W, 1998, MOL BIOL CELL, V9, P191, DOI 10.1091/mbc.9.1.191; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhai RG, 2009, CELL MOL LIFE SCI, V66, P2805, DOI 10.1007/s00018-009-0047-x; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	65	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18868	18876		10.1074/jbc.M110.107631	http://dx.doi.org/10.1074/jbc.M110.107631			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388704	Green Published, hybrid			2022-12-27	WOS:000278453900077
J	Shi, QA; Banks, EA; Yu, XS; Gu, SM; Lauer, J; Fields, GB; Jiang, JX				Shi, Qian; Banks, Eric A.; Yu, X. Sean; Gu, Sumin; Lauer, Janelle; Fields, Gregg B.; Jiang, Jean X.			Amino Acid Residue Val(362) Plays a Critical Role in Maintaining the Structure of C Terminus of Connexin 50 and in Lens Epithelial-fiber Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; GAP-JUNCTION COMMUNICATION; INTERCELLULAR COMMUNICATION; BINDING DOMAIN; SWISS-MODEL; CHICK LENS; MICE; EYE; CATARACTOGENESIS; MICROPHTHALMIA	We have previously shown that connexin (Cx) 50, unlike the other two lens connexins, Cx43 and Cx46, promotes chicken lens epithelial-fiber differentiation in a channel-independent manner. Here, we show that deletion of the PEST motif at the C terminus (CT) domain of Cx50 attenuates the stimulatory effect of Cx50 on lens fiber differentiation. Valine 362, a residue located within the PEST domain, is functionally involved. The structure of the Cx50 CT predicted by molecular modeling revealed four alpha-helices and Val(362) was found to be located in the middle of the 3rd helix. Replacement of Val(362) with amino acid residues that disrupt the alpha-helical structure predicted by molecular modeling, such as arginine, glutamate, or phenylalanine, attenuated the stimulatory effects of Cx50 on lens differentiation, whereas replacement with threonine, isoleucine, leucine, or proline, which maintain the structure preserved the function of Cx50. Circular dichroism (CD) studies supported the structural predictions and showed that the substitution with Glu, but not Thr or Pro, disrupted the alpha-helix, which appears to be the structural feature important for lens epithelial-fiber differentiation. Together, our results suggest that Val(362) is important for maintaining the helical structure and is crucial for the role of Cx50 in promoting lens epithelial-fiber differentiation.	[Shi, Qian; Banks, Eric A.; Yu, X. Sean; Gu, Sumin; Lauer, Janelle; Fields, Gregg B.; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Shi, Qian/C-5962-2013	Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY12085]; Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R29EY012085, R01EY012085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY12085 and Welch Foundation Grant AQ-1507.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banks EA, 2007, J CELL SCI, V120, P3602, DOI 10.1242/jcs.000935; BRUZZONE R, 2001, METHOD MOL BIOL, V154, P159; COX M, 1993, BIOCHEMISTRY-US, V32, P6032, DOI 10.1021/bi00074a014; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Dunia I, 2006, EUR J CELL BIOL, V85, P729, DOI 10.1016/j.ejcb.2006.03.006; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Fort AG, 2009, BIOPOLYMERS, V92, P173, DOI 10.1002/bip.21166; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Gu SM, 2003, INVEST OPHTH VIS SCI, V44, P2103, DOI 10.1167/iovs.02-1045; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Hirst-Jensen BJ, 2007, J BIOL CHEM, V282, P5801, DOI 10.1074/jbc.M605233200; Jiang JX, 1998, INVEST OPHTH VIS SCI, V39, P537; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Nielsen PA, 2003, MOL BIOL CELL, V14, P2470, DOI 10.1091/mbc.E02-10-0637; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rong P, 2002, DEVELOPMENT, V129, P167; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sorgen PL, 2004, BIOPHYS J, V87, P574, DOI 10.1529/biophysj.103.039230; Tholozan FMD, 2007, INT J BIOCHEM CELL B, V39, P1754, DOI 10.1016/j.biocel.2007.06.021; Wallace P, 1998, GENE, V211, P19, DOI 10.1016/S0378-1119(98)00117-6; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yin XY, 2000, J BIOL CHEM, V275, P6850, DOI 10.1074/jbc.275.10.6850; Yin XY, 2001, J BIOL CHEM, V276, P34567, DOI 10.1074/jbc.M106073200; Zhang YW, 2003, J BIOL CHEM, V278, P44852, DOI 10.1074/jbc.M305072200; Zhang YW, 2003, CANCER RES, V63, P1623; Zhou L, 2002, MOL VIS, V8, P143; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	39	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18415	18422		10.1074/jbc.M110.107052	http://dx.doi.org/10.1074/jbc.M110.107052			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395299	Green Published, hybrid			2022-12-27	WOS:000278453900035
J	Brown, SAN; Ghosh, A; Winkles, JA				Brown, Sharron A. N.; Ghosh, Arundhati; Winkles, Jeffrey A.			Full-length, Membrane-anchored TWEAK Can Function as a Juxtacrine Signaling Molecule and Activate the NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HYPOHIDROTIC ECTODERMAL DYSPLASIA; HUMAN FAS LIGAND; FACTOR-ALPHA; PROPROTEIN CONVERTASES; TNF SUPERFAMILY; FACTOR FAMILY; WEAK INDUCER; RECEPTOR ACTIVATOR; CEREBRAL-ISCHEMIA	Tumor necrosis factor (TNF) family members are initially synthesized as type II transmembrane proteins, but some of these proteins are substrates for proteolytic enzymes that generate soluble cytokines with biological activity. TWEAK (TNF-like weak inducer of apoptosis), a member of the TNF family, is a multifunctional cytokine that acts via binding to a cell surface receptor named Fn14 (fibroblast growth factor-inducible 14). Studies conducted to date indicate that TWEAK-producing cells can co-express both membrane-anchored and soluble TWEAK isoforms, but there is little information on TWEAK proteolytic processing. Also, it is presently unclear whether membrane-anchored TWEAK, like soluble TWEAK, is biologically active. Here we show that full-length human TWEAK is processed intracellularly by the serine protease furin and identify TWEAK amino acid residues 90-93 as the predominant furin recognition site. In addition, we report that full-length, membrane-anchored TWEAK can bind the Fn14 receptor on neighboring cells and activate the NF-kappa B signaling pathway. Thus, TWEAKcan act in a juxtacrine manner to initiate cellular responses, and this property may be important for TWEAK function during physiological wound repair and disease pathogenesis.	Univ Maryland, Sch Med, Dept Surg, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Winkles, JA (corresponding author), 800 W Baltimore St,Rm 320, Baltimore, MD 21201 USA.	jwinkles@som.umaryland.edu			National Institutes of Health [NS55126, CA130967]; Susan G. Komen for the Cure [KG081095]; NATIONAL CANCER INSTITUTE [P30CA134274, R01CA130967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS55126 and CA130967. This work was also supported by Susan G. Komen for the Cure Grant KG081095 (to J. A. W.).	Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Contin C, 2003, J BIOL CHEM, V278, P32801, DOI 10.1074/jbc.M209993200; CROWE PD, 1995, J EXP MED, V181, P1205, DOI 10.1084/jem.181.3.1205; DECOSTER E, 1995, J BIOL CHEM, V270, P18473, DOI 10.1074/jbc.270.31.18473; Desplat-Jego S, 2009, J LEUKOCYTE BIOL, V85, P132, DOI 10.1189/jlb.0608347; Diwan A, 2004, CIRCULATION, V109, P262, DOI 10.1161/01.CIR.0000109642.27985.FA; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Elomaa O, 2001, HUM MOL GENET, V10, P953, DOI 10.1093/hmg/10.9.953; Felli N, 2005, J IMMUNOL, V175, P1464, DOI 10.4049/jimmunol.175.3.1464; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Glenney GW, 2007, J IMMUNOL, V178, P7955, DOI 10.4049/jimmunol.178.12.7955; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Kamata K, 2006, J IMMUNOL, V177, P6433, DOI 10.4049/jimmunol.177.9.6433; Kawakita T, 2005, INT J ONCOL, V26, P87; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kolfschoten GA, 2003, BIOCHEM PHARMACOL, V66, P1427, DOI 10.1016/S0006-2952(03)00493-3; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; MARIANI SM, 1995, EUR J IMMUNOL, V25, P2303, DOI 10.1002/eji.1830250828; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mueller C, 1999, J BIOL CHEM, V274, P38112, DOI 10.1074/jbc.274.53.38112; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nakayama M, 2003, BIOCHEM BIOPH RES CO, V306, P819, DOI 10.1016/S0006-291X(03)01051-9; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Pradet-Balade B, 2002, EMBO J, V21, P5711, DOI 10.1093/emboj/cdf565; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; RobacheGallea S, 1997, EUR J IMMUNOL, V27, P1275, DOI 10.1002/eji.1830270532; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Scapini P, 2003, J EXP MED, V197, P297, DOI 10.1084/jem.20021343; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Shui Y, 2008, VET IMMUNOL IMMUNOP, V126, P396, DOI 10.1016/j.vetimm.2008.08.005; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vaisanen T, 2006, J BIOL CHEM, V281, P33352, DOI 10.1074/jbc.M605896200; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yepes M, 2005, AM J PATHOL, V166, P511, DOI 10.1016/S0002-9440(10)62273-0; Zhang XH, 2007, J CEREBR BLOOD F MET, V27, P534, DOI 10.1038/sj.jcbfm.9600368; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	77	58	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17432	17441		10.1074/jbc.M110.131979	http://dx.doi.org/10.1074/jbc.M110.131979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385556	hybrid, Green Published			2022-12-27	WOS:000278133400021
J	Chia, DJ; Varco-Merth, B; Rotwein, P				Chia, Dennis J.; Varco-Merth, Ben; Rotwein, Peter			Dispersed Chromosomal Stat5b-binding Elements Mediate Growth Hormone-activated Insulin-like Growth Factor-I Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-I; BINDING-SITES; SIGNAL TRANSDUCER; HUMAN GENOME; CHROMATIN IMMUNOPRECIPITATION; TYROSINE PHOSPHORYLATION; TARGET GENES; IDENTIFICATION; EXPRESSION; STAT5B	The growth hormone (GH)-insulin-like growth factor-I (IGF-I) axis regulates somatic growth during childhood and orchestrates tissue repair throughout the life span. Recently described inactivating mutations in Stat5b in humans with impaired growth have focused attention on this transcription factor as a key agent linking GH-stimulated signals to IGF-I gene expression, and several putative Stat5b sites have been identified in the IGF-I gene. Here, we define and characterize potential GH- and Stat5b-activated chromosomal enhancers that can regulate IGF-I gene transcription. Of 89 recognizable Stat5 sequences in 200 kb centering on the rat IGF-I gene, 22 resided within conserved regions and/or were identical among different species. Only 15 of these sites, organized into 7 distinct domains, were found to bind Stat5b by quantitative chromatin immunoprecipitation assays in liver chromatin of rats, but only after acute GH treatment. These sites could bind Stat5b in vitro, and individual domains could mediate GH- and Stat5b-stimulated IGF-I promoter activity in cultured cells. Further analyses revealed that four Stat5b domains possessed chromatin signatures of enhancers, including binding of co-activators p300 and Med1, and RNA polymerase II. These modifications preceded GH-stimulated recruitment of Stat5b, as did lysine 4 monomethylation of histone H3, which was enriched in 6/7 Stat5b-binding elements. In contrast, histone acetylation was induced by GH but was limited to Stat5b binding domains found within the IGF-I transcription unit. We conclude that GH stimulates recruitment of Stat5b to multiple dispersed regions within the igf1 locus, including several with properties consistent with long range transcriptional enhancers that collectively regulate GH-activated IGF-I gene transcription.	[Varco-Merth, Ben; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Chia, Dennis J.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd,Mail Code L224, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [K08 DK077897, K12 HD057588, T32 DK007674-16, R01 DK069703]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD057588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK077897, R01DK069703, T32DK007680, T32DK007674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 DK077897 and K12 HD057588 (to D. J. C.), T32 DK007674-16 (to B. V.-M.), and R01 DK069703 (to P. R.).	ADAMO ML, 1991, MOL ENDOCRINOL, V5, P1677, DOI 10.1210/mend-5-11-1677; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chia DJ, 2010, MOL ENDOCRINOL, V24, P779, DOI 10.1210/me.2009-0430; Chia DJ, 2006, J BIOL CHEM, V281, P3190, DOI 10.1074/jbc.M510204200; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Eleswarapu S, 2008, ENDOCRINOLOGY, V149, P2230, DOI 10.1210/en.2007-1344; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Good SR, 2009, J IMMUNOL, V183, P3839, DOI 10.4049/jimmunol.0901411; Gronowski AM, 1996, ENDOCRINOLOGY, V137, P55, DOI 10.1210/en.137.1.55; HALL LJ, 1992, DNA CELL BIOL, V11, P301, DOI 10.1089/dna.1992.11.301; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; HOYT EC, 1988, MOL ENDOCRINOL, V2, P1077, DOI 10.1210/mend-2-11-1077; Hwa V, 2005, J CLIN ENDOCR METAB, V90, P4260, DOI 10.1210/jc.2005-0515; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaneshiro K, 2007, GENOMICS, V89, P178, DOI 10.1016/j.ygeno.2006.09.001; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Laz EV, 2009, MOL ENDOCRINOL, V23, P1242, DOI 10.1210/me.2008-0449; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LeRoith Derek, 2008, Pediatr Endocrinol Rev, V5 Suppl 2, P739; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; Nelson EA, 2006, J BIOL CHEM, V281, P26216, DOI 10.1074/jbc.M605001200; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenfeld RG, 2009, HORM RES, V71, P36, DOI 10.1159/000192434; Rotwein P, 2010, PEDIATR NEPHROL, V25, P651, DOI 10.1007/s00467-009-1258-y; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang Y, 2005, J BIOL CHEM, V280, P10955, DOI 10.1074/jbc.M412808200; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933; Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200; Woelfle J, 2005, PEDIATR NEPHROL, V20, P295, DOI 10.1007/s00467-004-1602-1; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; WOOD TJJ, 1995, J BIOL CHEM, V270, P9448, DOI 10.1074/jbc.270.16.9448; Ye P, 1997, ENDOCRINOLOGY, V138, P5466, DOI 10.1210/en.138.12.5466; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	56	47	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17636	17647		10.1074/jbc.M110.117697	http://dx.doi.org/10.1074/jbc.M110.117697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378540	Green Published, hybrid			2022-12-27	WOS:000278133400042
J	Lowey, S; Trybus, KM				Lowey, Susan; Trybus, Kathleen M.			Common Structural Motifs for the Regulation of Divergent Class II Myosins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SMOOTH-MUSCLE MYOSIN; LIGHT-CHAIN PHOSPHORYLATION; HEAVY-MEROMYOSIN; SCALLOP MYOSIN; 3-DIMENSIONAL STRUCTURE; IMAGE-RECONSTRUCTION; ANGSTROM RESOLUTION; 10S CONFORMATION; THICK FILAMENTS; CARDIAC-MUSCLE	This minireview focuses on structural studies that have provided insights into our current understanding of thick filament regulation in muscle. We describe how different domains in the myosin molecule interact to produce an inactive "off" state; included are head-head and head-rod interactions, the role of the regulatory light chain, and the significance of the alpha-helical coiled-coil rod in regulation. Several of these interactions have now been visualized in a wide variety of native myosin filaments, testifying to the generality of these structural motifs across the phylogenetic tree.	[Lowey, Susan; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont	Lowey, S (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	susan.lowey@uvm.edu; kathleen.trybus@uvm.edu			National Institutes of Health [AR53975, HL38113]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038113, R01HL038113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR53975 (to S. L.) and HL38113 (to K. M. T.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Al-Khayat HA, 2008, J STRUCT BIOL, V163, P117, DOI 10.1016/j.jsb.2008.03.011; Al-Khayat HA, 2009, J STRUCT BIOL, V166, P183, DOI 10.1016/j.jsb.2009.02.006; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; CREMO CR, 1995, J BIOL CHEM, V270, P2171, DOI 10.1074/jbc.270.5.2171; CROSS RA, 1988, J MOL BIOL, V203, P173, DOI 10.1016/0022-2836(88)90100-3; CROSS RA, 1986, EMBO J, V5, P2637, DOI 10.1002/j.1460-2075.1986.tb04545.x; CROWTHER RA, 1985, J MOL BIOL, V184, P429, DOI 10.1016/0022-2836(85)90292-X; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Espinoza-Fonseca LM, 2007, BIOPHYS J, V93, P2083, DOI 10.1529/biophysj.106.095802; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; IKEBE M, 1994, J BIOL CHEM, V269, P28173; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Jung HS, 2008, P NATL ACAD SCI USA, V105, P6022, DOI 10.1073/pnas.0707846105; Lauzon AM, 2001, BIOPHYS J, V80, P1900, DOI 10.1016/S0006-3495(01)76159-0; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Liu J, 2003, J MOL BIOL, V329, P963, DOI 10.1016/S0022-2836(03)00516-3; LOWEY S, 1995, BIOPHYS J, V68, pS120; Nelson WD, 2005, P NATL ACAD SCI USA, V102, P4000, DOI 10.1073/pnas.0401664102; Olney JJ, 1996, J BIOL CHEM, V271, P20375, DOI 10.1074/jbc.271.34.20375; ONISHI H, 1982, J BIOCHEM-TOKYO, V92, P871, DOI 10.1093/oxfordjournals.jbchem.a134001; PASTRALANDIS SC, 1986, J BIOL CHEM, V261, P4811; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Seow CY, 2005, AM J PHYSIOL-CELL PH, V289, pC1363, DOI 10.1152/ajpcell.00329.2005; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Tama F, 2005, J MOL BIOL, V345, P837, DOI 10.1016/j.jmb.2004.10.084; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; TRYBUS KM, 1984, J BIOL CHEM, V259, P8564; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Wahlstrom JL, 2003, J BIOL CHEM, V278, P5123, DOI 10.1074/jbc.M206963200; Wendt T, 1999, J CELL BIOL, V147, P1385, DOI 10.1083/jcb.147.7.1385; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0; Zhao FQ, 2009, J MOL BIOL, V385, P423, DOI 10.1016/j.jmb.2008.10.038; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	44	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16403	16407		10.1074/jbc.R109.025551	http://dx.doi.org/10.1074/jbc.R109.025551			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20339003	Green Published, hybrid			2022-12-27	WOS:000277982600001
J	Gartmann, M; Blau, M; Armache, JP; Mielke, T; Topf, M; Beckmann, R				Gartmann, Marco; Blau, Michael; Armache, Jean-Paul; Mielke, Thorsten; Topf, Maya; Beckmann, Roland			Mechanism of eIF6-mediated Inhibition of Ribosomal Subunit Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE HOMOLOG; EUKARYOTIC INITIATION FACTOR-6; ELECTRON-MICROSCOPY; 80S RIBOSOME; PROTEIN; TRANSLATION; YEAST; VISUALIZATION; TRANSLOCATION; REFINEMENT	During the process of ribosomal assembly, the essential eukaryotic translation initiation factor 6 (eIF6) is known to act as a ribosomal anti-association factor. However, a molecular understanding of the anti-association activity of eIF6 is still missing. Here we present the cryo-electron microscopy reconstruction of a complex of the large ribosomal subunit with eukaryotic eIF6 from Saccharomyces cerevisiae. The structure reveals that the eIF6 binding site involves mainly rpL23 (L14p in Escherichia coli). Based on our structural data, we propose that the mechanism of the anti-association activity of eIF6 is based on steric hindrance of intersubunit bridge formation around the dynamic bridge B6.	[Gartmann, Marco; Armache, Jean-Paul; Beckmann, Roland] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany; [Gartmann, Marco; Armache, Jean-Paul; Beckmann, Roland] Univ Munich, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Mielke, Thorsten] Charite, Inst Med Phys & Biophys, D-10098 Berlin, Germany; [Blau, Michael] Humboldt Univ, Inst Biochem Charite, D-10117 Berlin, Germany; [Topf, Maya] Univ London Birkbeck Coll, Inst Struct & Mol Biol, Sch Crystallog, London WC1E 7HX, England	University of Munich; University of Munich; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; Birkbeck University London	Beckmann, R (corresponding author), Univ Munich, Dept Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	beckmann@lmb.uni-muenchen.de	Armache, Jean-Paul/U-3113-2019	Armache, Jean-Paul/0000-0001-9195-2282; Topf, Maya/0000-0002-8185-1215	Deutsche Forschungsgemeinschaft (DFG) [SFB594, SFB646, SFB740]; Center for Integrated Protein Science Munich; European Union; Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (Anwenderzentrum); MRC [G0600084] Funding Source: UKRI; Medical Research Council [G0600084] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; European Union(European Commission); Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (Anwenderzentrum); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (Grants SFB594 and SFB646) and the Center for Integrated Protein Science Munich (to R. B.), by a grant from the Deutsche Forschungsgemeinschaft SFB740 (to T. M.), and by grants from the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (Anwenderzentrum).	Basu U, 2003, MOL CELL BIOL, V23, P6187, DOI 10.1128/MCB.23.17.6187-6199.2003; Benelli D, 2009, NUCLEIC ACIDS RES, V37, P256, DOI 10.1093/nar/gkn959; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Graindorge JS, 2005, J MOL BIOL, V352, P355, DOI 10.1016/j.jmb.2005.07.037; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Miluzio A, 2009, EMBO REP, V10, P459, DOI 10.1038/embor.2009.70; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Si K, 1999, MOL CELL BIOL, V19, P1416; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Topf M, 2006, J MOL BIOL, V357, P1655, DOI 10.1016/j.jmb.2006.01.062; Topf M, 2005, J STRUCT BIOL, V149, P191, DOI 10.1016/j.jsb.2004.11.004; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712	26	84	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14848	14851		10.1074/jbc.C109.096057	http://dx.doi.org/10.1074/jbc.C109.096057			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20356839	Green Published, hybrid			2022-12-27	WOS:000277399000002
J	Ingermann, AR; Yang, YF; Han, JF; Mikami, A; Garza, AE; Mohanraj, L; Fan, LB; Idowu, M; Ware, JL; Kim, HS; Lee, DY; Oh, Y				Ingermann, Angela R.; Yang, Yong-Feng; Han, Jinfeng; Mikami, Aki; Garza, Amanda E.; Mohanraj, Lathika; Fan, Lingbo; Idowu, Michael; Ware, Joy L.; Kim, Ho-Seong; Lee, Dae-Yeol; Oh, Youngman			Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEIN-3; FACTOR (IGF)-INDEPENDENT ACTION; LUNG EPITHELIAL-CELLS; GROWTH-INHIBITION; INDUCED APOPTOSIS; IGFBP-3 BINDING; LEUCINE-ZIPPER; INDUCTION; ACTIVATION; EXPRESSION	Insulin-like growth factor-binding protein-3 (IGFBP-3), a major regulator of endocrine actions of IGFs, is a p53-regulated potent apoptotic factor and is significantly suppressed in a variety of cancers. Recent epidemiologic studies suggest that IGFBP-3 contributes to cancer risk protection in a variety of cancers, and a polymorphic variation of IGFBP-3 influences cancer risk, although other studies vary in their conclusions. Some antiproliferative actions of IGFBP-3 have been reported to be independent of IGFs, but the precise biochemical/molecular mechanisms of IGF-independent, antiproliferative actions of IGFBP-3 are largely unknown. Here we report a new cell death receptor, IGFBP-3R, that is a singlespan membrane protein and binds specifically to IGFBP-3 but not other IGFBP species. Expression analysis of IGFBP-3 and IGFBP-3R indicates that the IGFBP-3/IGFBP-3R axis is impaired in breast and prostate cancer. We also provide evidence for anti-tumor effect of IGFBP-3R in vivo using prostate and breast cancer xenografts in athymic nude mice. Further in vitro studies demonstrate that IGFBP-3R mediates IGFBP-3-induced caspase-8-dependent apoptosis in various cancer cells. Knockdown of IGFBP-3R attenuated IGFBP-3-induced caspase activities and apoptosis, whereas overexpression of IGFBP-3R enhanced IGFBP-3 biological effects. IGFBP-3R physically interacts and activates caspase-8, and knockdown of caspase-8 expression or activity inhibited IGFBP-3/IGFBP- 3R-induced apoptosis. Here, we propose that IGFBP-3R represents a novel cell death receptor and is essential for the IGFBP-3- induced apoptosis and tumor suppression. Thus, the IGFBP-3/IGFBP-3R axis may provide therapeutic and prognostic value for the treatment of cancer.	[Ingermann, Angela R.; Yang, Yong-Feng; Kim, Ho-Seong; Oh, Youngman] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Kim, Ho-Seong] Yonsei Univ, Dept Pediat, Yongdong Severance Hosp, Seoul 135720, South Korea; [Lee, Dae-Yeol] Chonbuk Natl Univ Hosp, Dept Pediat, Jeonju 560182, Jeonbuk, South Korea; [Han, Jinfeng; Mikami, Aki; Garza, Amanda E.; Mohanraj, Lathika; Fan, Lingbo; Idowu, Michael; Ware, Joy L.; Oh, Youngman] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23298 USA	Oregon Health & Science University; Yonsei University; Jeonbuk National University; Jeonbuk National University Hospital; Virginia Commonwealth University	Oh, Y (corresponding author), 1101 E Marshall St,POB 980662, Richmond, VA 23298 USA.	yoh@mcvh-vcu.edu		Kim, Ho-Seong/0000-0003-1135-099X; Mohanraj, Lathika/0000-0002-5504-1518	NINDS, National Institutes of Health [5P30NS047463]; United States Department of Defense [DAMD17-97-17204, DAMD17-02-1-0533, PC040971, PC061151]; Korea Science and Engineering Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); United States Department of Defense(United States Department of Defense); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant Center Core Grant 5P30NS047463 (NINDS). This work was also supported by United States Department of Defense Grants DAMD17-97-17204, DAMD17-02-1-0533, PC040971, and PC061151 (to Y.O.) and by the Korea Science and Engineering Foundation Grant (to D.-Y.L.).	Bhattacharyya N, 2006, J BIOL CHEM, V281, P24588, DOI 10.1074/jbc.M509463200; Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chen XY, 2006, GROWTH HORM IGF RES, V16, P41, DOI 10.1016/j.ghir.2005.09.003; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; Fu P, 2007, J BIOL CHEM, V282, P22298, DOI 10.1074/jbc.M703066200; Grimberg A, 2005, J CLIN ENDOCR METAB, V90, P3568, DOI 10.1210/jc.2004-1213; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Kiepe D, 2008, ENDOCRINOLOGY, V149, P4901, DOI 10.1210/en.2007-1395; Kim HS, 2004, CANCER RES, V64, P2229, DOI 10.1158/0008-5472.CAN-03-1675; Leal SM, 1999, J BIOL CHEM, V274, P6711, DOI 10.1074/jbc.274.10.6711; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Mishra S, 2004, MOL CELL BIOCHEM, V267, P83, DOI 10.1023/B:MCBI.0000049368.40558.0a; Mishra S, 2004, CANCER RES, V64, P2516, DOI 10.1158/0008-5472.CAN-03-2877; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; OH Y, 1993, J BIOL CHEM, V268, P26045; OH YM, 1993, J BIOL CHEM, V268, P14964; Oufattole M, 2006, ENDOCRINOLOGY, V147, P2138, DOI 10.1210/en.2005-1269; Perks CM, 1999, J MOL ENDOCRINOL, V22, P141, DOI 10.1677/jme.0.0220141; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Schedlich LJ, 2004, BIOCHEM BIOPH RES CO, V314, P83, DOI 10.1016/j.bbrc.2003.12.049; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Takaoka M, 2004, CANCER RES, V64, P7711, DOI 10.1158/0008-5472.CAN-04-0715; Walker G.E., 2004, INSULIN LIKE GROWTH, P1; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Williams AC, 2007, CELL DEATH DIFFER, V14, P137, DOI 10.1038/sj.cdd.4401919; Wu HB, 2000, J CELL BIOCHEM, V77, P288, DOI 10.1002/(SICI)1097-4644(20000501)77:2<288::AID-JCB11>3.0.CO;2-J; Yamanaka Y, 1999, ENDOCRINOLOGY, V140, P1319, DOI 10.1210/en.140.3.1319; Zappala G, 2008, ENDOCRINOLOGY, V149, P1802, DOI 10.1210/en.2007-1315; Zhao HB, 2005, MOL ENDOCRINOL, V19, P771, DOI 10.1210/me.2004-0161; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	43	89	97	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30233	30246		10.1074/jbc.M110.122226	http://dx.doi.org/10.1074/jbc.M110.122226			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20353938	Green Published, hybrid			2022-12-27	WOS:000281984300060
J	Rosental, N; Kanner, BI				Rosental, Noa; Kanner, Baruch I.			A Conserved Methionine Residue Controls the Substrate Selectivity of a Neuronal Glutamate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; RAT-BRAIN; NEUROTRANSMITTER TRANSPORTERS; INDIVIDUAL SUBUNITS; ANION CONDUCTANCE; MEMBRANE-VESICLES; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; REENTRANT LOOP; GLT-1	Glutamate transporters located in the brain maintain low synaptic concentrations of the neurotransmitter by coupling its flux to that of sodium and other cations. In the binding pocket of the archeal homologue Glt(Ph), a conserved methionine residue has been implicated in the binding of the benzyl moiety of the non-transportable substrate analogue threo-beta-benzyloxyaspartate. To determine whether the corresponding methionine residue of the neuronal glutamate transporter EAAC1, Met-367, fulfills a similar role, M367L, M367C, and M367S mutants were expressed in HeLa cells and Xenopus laevis oocytes to monitor radioactive transport and transport currents, respectively. The apparent affinity of the Met-367 mutants for D-aspartate and L-glutamate, but not for L-aspartate, was 10-20-fold reduced as compared with wild type. Unlike wild type, the magnitude of I-max was different for each of the three substrates. D-Glutamate, which is also a transportable substrate of EAAC1, did not elicit any detectable response with M367C and M367S but acted as a nontransportable substrate analogue in M367L. In the mutants, substrates inhibited the anion conductance as opposed to the stimulation observed with wild type. Remarkably, the apparent affinity of the blocker D, L-threo-beta-benzyloxyaspartate in the mutants was similar to that of wild type EAAC1. Our results are consistent with the idea that the side chain of Met-367 fulfills a steric role in the positioning of the substrate in the binding pocket in a step subsequent to its initial binding.	[Rosental, Noa; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			National Institutes of Health [NS16708]; United States-Israel Binational Science Foundation [2007051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS16708. This work was also supported by United States-Israel Binational Science Foundation Grant 2007051.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	47	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21241	21248		10.1074/jbc.M109.087163	http://dx.doi.org/10.1074/jbc.M109.087163			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20424168	Green Published, hybrid			2022-12-27	WOS:000279516100009
J	Lefurgy, ST; Rodriguez, SB; Park, CS; Cahill, S; Silverman, RB; Leyh, TS				Lefurgy, Scott T.; Rodriguez, Sofia B.; Park, Chan Sun; Cahill, Sean; Silverman, Richard B.; Leyh, Thomas S.			Probing Ligand-binding Pockets of the Mevalonate Pathway Enzymes from Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; ISOPRENOID BIOSYNTHESIS; INHIBITION; DECARBOXYLASE; MECHANISM; KINASE; EVOLUTION; CARRIAGE; COMPLEX	Diphosphomevalonate (Mev.pp) is the founding member of a new class of potential antibiotics targeting the Streptococcus pneumoniae mevalonate (Mev) pathway. We have synthesized a series of Mev.pp analogues designed to simultaneously block two steps in this pathway, through allosteric inhibition of mevalonate kinase (MK) and, for five of the analogues, by mechanism-based inactivation of diphosphomevalonate decarboxylase (DPM-DC). The analogue series expands the C-3-methyl group of Mev.pp with hydrocarbons of varying size, shape, and chemical and physical properties. Previously, we established the feasibility of a prodrug strategy in which unphosphorylated Mev analogues could be enzymatically converted to the active Mev.pp forms by the endogenous MK and phosphomevalonate kinase. We now report the kinetic parameters for the turnover of non-, mono-, and diphosphorylated analogues as substrates and inhibitors of the three mevalonate pathway enzymes. The inhibition of MK by Mev.pp analogues revealed that the allosteric site is selective for compact, electron-rich C-3-subsitutents. The lack of reactivity of analogues with DPM-DC provided evidence, counter to the existing model, for a decarboxylation transition state that is concerted rather than dissociative. The Mev pathway is composed of three structurally and functionally conserved enzymes that catalyze consecutive steps in a metabolic pathway. The current work reveals that these enzymes exhibit significant differences in specificity toward R-group substitution at C-3 and that these patterns are explained well by changes in the volume of the C-3 R-group-binding pockets of the enzymes.	Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Cahill, Sean] Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Park, Chan Sun; Silverman, Richard B.] Northwestern Univ, Dept Chem, Dept Biochem Mol Biol & Cell Biol, Ctr Mol Innovat & Drug Discovery, Evanston, IL 60208 USA; [Park, Chan Sun; Silverman, Richard B.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Northwestern University; Northwestern University	Leyh, TS (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	thomas.leyh@einstein.yu.edu			National Institutes of Health [AI 068989]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 068989.	Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P16461, DOI 10.1021/bi048075t; Andreassi JL, 2007, PROTEIN SCI, V16, P983, DOI 10.1110/ps.072755707; Andreassi JL, 2009, BIOCHEMISTRY-US, V48, P6461, DOI 10.1021/bi900537u; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Byres E, 2007, J MOL BIOL, V371, P540, DOI 10.1016/j.jmb.2007.05.094; Camoretti-Mercado B, 2009, TRANSL RES, V154, P165, DOI 10.1016/j.trsl.2009.06.008; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; CORNFORTH RH, 1960, NATURE, V185, P923, DOI 10.1038/185923a0; DAVIS AM, 1999, ANGEW CHEM INT EDIT, V122, P736; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; DeLano W.L, PYMOL MOL GRAPHICS S; DHEPAGANON S, 1994, BIOCHEMISTRY-US, V33, P13355, DOI 10.1021/bi00249a023; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUNTHER H, 1997, NMR SPECTROSCOPY BAS; HART H, 1959, J AM CHEM SOC, V81, P320, DOI 10.1021/ja01511a016; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Kawaguchi S, 1997, J BIOCHEM-TOKYO, V122, P55; Kudoh T, 2010, BIOORGAN MED CHEM, V18, P1124, DOI 10.1016/j.bmc.2009.12.050; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; LIEBMAN JF, 1976, CHEM REV, V76, P311, DOI 10.1021/cr60301a002; LONDON JW, 1977, ANAL CHEM, V49, P1716, DOI 10.1021/ac50020a021; Lyn RK, 2009, VIROLOGY, V394, P130, DOI 10.1016/j.virol.2009.08.022; Mandel J, 1964, STAT ANAL EXPT DATA, P131; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; Obaro S, 2002, J MED MICROBIOL, V51, P98, DOI 10.1099/0022-1317-51-2-98; Pilloff D, 2003, J BIOL CHEM, V278, P4510, DOI 10.1074/jbc.M210551200; Qiu YG, 2006, BBA-GEN SUBJECTS, V1760, P1080, DOI 10.1016/j.bbagen.2006.03.009; REARDON JE, 1987, BIOCHEMISTRY-US, V26, P4717, DOI 10.1021/bi00389a018; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SUCKLING CJ, 1988, ANGEW CHEM INT EDIT, V27, P537, DOI 10.1002/anie.198805371; TCHEN TT, 1958, J BIOL CHEM, V233, P1100; Van Bambeke F, 2007, DRUGS, V67, P2355, DOI 10.2165/00003495-200767160-00005; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Wolfenden R, 1999, BIOORGAN MED CHEM, V7, P647, DOI 10.1016/S0968-0896(98)00247-8; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Zeki AA, 2009, AM J RESP CRIT CARE, V180, P731, DOI 10.1164/rccm.200901-0018OC	40	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20654	20663		10.1074/jbc.M109.098350	http://dx.doi.org/10.1074/jbc.M109.098350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20404339	hybrid, Green Published			2022-12-27	WOS:000279228600029
J	Zhu, XF; van Pee, KH; Naismith, JH				Zhu, Xiaofeng; van Pee, Karl-Heinz; Naismith, James H.			The Ternary Complex of PrnB (the Second Enzyme in the Pyrrolnitrin Biosynthesis Pathway), Tryptophan, and Cyanide Yields New Mechanistic Insights into the Indolamine Dioxygenase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-FLUORESCENS; DEPENDENT HALOGENASES; HEME; 2,3-DIOXYGENASE; CHLORINATION; INTERMEDIATE; CHEMISTRY; GENES; O-2	Pyrrolnitrin (3-chloro-4-(2'-nitro-3'-chlorophenyl)pyrrole) is a broad-spectrum antifungal compound isolated from Pseudomonas pyrrocinia. Four enzymes (PrnA, PrnB, PrnC, and PrnD) are required for pyrrolnitrin biosynthesis from tryptophan. PrnB rearranges the indole ring of 7-Cl-L-tryptophan and eliminates the carboxylate group. PrnB shows robust activity in vivo, but in vitro activity for PrnB under defined conditions remains undetected. The structure of PrnB establishes that the enzyme belongs to the heme b-dependent indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) family. We report the cyanide complex of PrnB and two ternary complexes with both L-tryptophan or 7-Cl-L-tryptophan and cyanide. The latter two complexes are essentially identical and mimic the likely catalytic ternary complex that occurs during turnover. In the cyanide ternary complexes, a loop previously disordered becomes ordered, contributing to the binding of substrates. The conformations of the bound tryptophan substrates are changed from that seen previously in the binary complexes. In L-tryptophan ternary complex, the indole ring now adopts the same orientation as seen in the PrnB binary complexes with other tryptophan substrates. The amide and carboxylate group of the substrate are orientated in a new conformation. Tyr(321) and Ser(332) play a key role in binding these groups. The structures suggest that catalysis requires an L-configured substrate. Isothermal titration calorimetry data suggest D-tryptophan does not bind after cyanide (or oxygen) coordinates with the distal (or sixth) site of heme. This is the first ternary complex with a tryptophan substrate of a member of the tryptophan dioxygenase superfamily and has mechanistic implications.	[Zhu, Xiaofeng; Naismith, James H.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [van Pee, Karl-Heinz] Tech Univ Dresden, D-01062 Dresden, Germany	University of St Andrews; Technische Universitat Dresden	Naismith, JH (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	naismith@st-and.ac.uk	Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061	Biotechnology and Biological Sciences Research Council UK; Biotechnology and Biological Sciences Research Council [BB/C000080/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council UK.	ARIMA K, 1964, AGR BIOL CHEM TOKYO, V28, P575, DOI 10.1080/00021369.1964.10858275; Bolognesi M, 1999, BIOPHYS J, V77, P1093, DOI 10.1016/S0006-3495(99)76959-6; CHANG CJ, 1981, J ANTIBIOT, V34, P555, DOI 10.7164/antibiotics.34.555; Chauhan N, 2009, J AM CHEM SOC, V131, P4186, DOI 10.1021/ja808326g; Chung LW, 2008, J AM CHEM SOC, V130, P12299, DOI 10.1021/ja803107w; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davydov RM, 2010, J AM CHEM SOC, V132, P5494, DOI 10.1021/ja100518z; De Laurentis W, 2007, BIOCHEMISTRY-US, V46, P12393, DOI 10.1021/bi7012189; De Laurentis W, 2006, ACTA CRYSTALLOGR F, V62, P1134, DOI 10.1107/S1744309106041649; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flecks S, 2008, ANGEW CHEM INT EDIT, V47, P9533, DOI 10.1002/anie.200802466; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Hammer PE, 1999, FEMS MICROBIOL LETT, V180, P39, DOI 10.1111/j.1574-6968.1999.tb08775.x; Hohaus K, 1997, ANGEW CHEM INT EDIT, V36, P2012, DOI 10.1002/anie.199720121; Kirner S, 1998, J BACTERIOL, V180, P1939, DOI 10.1128/JB.180.7.1939-1943.1998; Lee JK, 2006, J BACTERIOL, V188, P6179, DOI 10.1128/JB.00259-06; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Littlejohn TK, 2000, PROTEIN EXPRES PURIF, V19, P22, DOI 10.1006/prep.2000.1214; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Sugishima M, 2003, BIOCHEMISTRY-US, V42, P9898, DOI 10.1021/bi027268i; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; van Pee KH, 2000, NAT PROD REP, V17, P157, DOI 10.1039/a902138h; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhu XF, 2009, J MOL BIOL, V391, P74, DOI 10.1016/j.jmb.2009.06.008	30	25	28	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21126	21133		10.1074/jbc.M110.120485	http://dx.doi.org/10.1074/jbc.M110.120485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421301	Green Published, hybrid			2022-12-27	WOS:000279228600075
J	Loukin, S; Su, ZW; Zhou, XL; Kung, C				Loukin, Stephen; Su, Zhenwei; Zhou, Xinliang; Kung, Ching			Forward Genetic Analysis Reveals Multiple Gating Mechanisms of TRPV4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; OF-FUNCTION MUTATIONS; YEAST K+ CHANNEL; CATION CHANNEL; MOLECULAR DETERMINANTS; VR-OAC; HELIX; ARCHITECTURE; VOLTAGE; DOMAIN	TRPV4 is a polymodal cation channel gain-of-function (GOF) allele which causes skeletal dysplasia in humans. To better understand its gating, we screened for additional GOF alleles based on their ability to block yeast proliferation. Repeatedly, only a limited number of such growth-blocking mutations were isolated. Expressed in oocytes, wild-type channels can be strongly activated by either hypotonicity or exposure to the potent agonist 4 alpha PDD, although the GOF channels behaved as if they were fully prestimulated as well as lacking a previously uncharacterized voltage-dependent inactivation. Five of six mutations occurred at or near the inner ends of the predicted core helices, giving further direct evidence that this region indeed forms the main intracellular gate in TRP channels. Surprisingly, both wild-type channels as well as these GOF channels maintain strong steady-state outward rectification that is not due to a Ca2+ block, as has been proposed elsewhere. We conclude that TRPV4 contains an additional voltage-dependent gating mechanism in series with the main intracellular gate.	[Loukin, Stephen; Su, Zhenwei; Zhou, Xinliang; Kung, Ching] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kung, Ching] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loukin, S (corresponding author), 1525 Linden Dr, Madison, WI 53706 USA.	shloukin@wisc.edu	Su, Zhenwei/C-3185-2018	Su, Zhenwei/0000-0002-5591-418X	National Institutes of Health [GM047856]; Vilas Trust of the University of Wisconsin, Madison	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vilas Trust of the University of Wisconsin, Madison	This work was supported, in whole or in part, by National Institutes of Health Grant GM047856 and the Vilas Trust of the University of Wisconsin, Madison.	Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; GOLDIN AL, 1992, METHODS ENZYMOLOGY; Guler AD, 2002, J NEUROSCI, V22, P6408; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Liedtke W, 2008, ANN NY ACAD SCI, V1144, P42, DOI 10.1196/annals.1418.012; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Loukin SH, 1999, BIOPHYS J, V77, P3060, DOI 10.1016/S0006-3495(99)77137-7; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Loukin SH, 2009, FEBS LETT, V583, P754, DOI 10.1016/j.febslet.2009.01.027; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Sherman F, 1991, GUIDE YEAST GENETICS; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Zhou XL, 2007, P NATL ACAD SCI USA, V104, P15555, DOI 10.1073/pnas.0704039104	39	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19884	19890		10.1074/jbc.M110.113936	http://dx.doi.org/10.1074/jbc.M110.113936			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424166	Green Published, hybrid			2022-12-27	WOS:000279012000021
J	Mazauric, MH; Dirick, L; Purushothaman, SK; Bjork, GR; Lapeyre, B				Mazauric, Marie-Helene; Dirick, Leon; Purushothaman, Suresh K.; Bjoerk, Glenn R.; Lapeyre, Bruno			Trm112p Is a 15-kDa Zinc Finger Protein Essential for the Activity of Two tRNA and One Protein Methyltransferases in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION FACTOR IIIA; RELEASE FACTOR ERF1; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNAS; RSC; TRANSLATION; EXPRESSION; GENES; TERMINATION	The degenerate base at position 34 of the tRNA anticodon is the target of numerous modification enzymes. In Saccharomyces cerevisiae, five tRNAs exhibit a complex modification of uridine 34 (mcm(5)U(34) and mcm(5)s(2)U(34)), the formation of which requires at least 25 different proteins. The addition of the last methyl group is catalyzed by the methyltransferase Trm9p. Trm9p interacts with Trm112p, a 15-kDa protein with a zinc finger domain. Trm112p is essential for the activity of Trm11p, another tRNA methyltransferase, and for Mtq2p, an enzyme that methylates the translation termination factor eRF1/Sup45. Here, we report that Trm112p is required in vivo for the formation of mcm(5)U(34) and mcm(5)s(2)U(34). When produced in Escherichia coli, Trm112p forms a complex with Trm9p, which renders the latter soluble. This recombinant complex catalyzes the formation of mcm(5)U(34) on tRNA in vitro but not mcm(5)s(2)U(34). An mtq2-0 trm9-0 strain exhibits a synthetic growth defect, thus revealing the existence of an unexpected link between tRNA anticodon modification and termination of translation. Trm112p is associated with other partners involved in ribosome biogenesis and chromatin remodeling, suggesting that it has additional roles in the cell.	[Lapeyre, Bruno] Univ Montpellier 1 & 2, CRBM, CNRS, F-34293 Montpellier, France; [Dirick, Leon] Univ Montpellier 1 & 2, Inst Genet Mol, F-34293 Montpellier, France; [Bjoerk, Glenn R.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Umea University	Lapeyre, B (corresponding author), Univ Montpellier 1 & 2, CRBM, CNRS, 1919 Route Mende, F-34293 Montpellier, France.	bruno.lapeyre@crbm.cnrs.fr	Björk, Glenn/AAE-8219-2022		CNRS; Association pour la Recherche sur le Cancer [ARC3793]; Swedish Science Research Council [BU-2930]; Carl Tryggers Foundation	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Swedish Science Research Council; Carl Tryggers Foundation	This work was supported by the CNRS and Grant ARC3793 from the Association pour la Recherche sur le Cancer (to B. L.) and by grants from Swedish Science Research Council Project BU-2930 and the Carl Tryggers Foundation (to G. R. B.).	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Alexandrov A, 2002, RNA, V8, P1253, DOI 10.1017/S1355838202024019; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; BUTLER AR, 1994, MOL CELL BIOL, V14, P6306, DOI 10.1128/MCB.14.9.6306; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Cao YX, 1997, MOL CELL BIOL, V17, P3323, DOI 10.1128/MCB.17.6.3323; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Colley A, 2000, MOL CELL BIOL, V20, P7238, DOI 10.1128/MCB.20.19.7238-7246.2000; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; FELICI F, 1989, MOL CELL BIOL, V9, P3260, DOI 10.1128/MCB.9.8.3260; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; GEHRKE CW, 1990, CHROMATOGRAPHY MOD A, pA3; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GROSJEAN H, 2005, MODIFICATION EDITING, P1; Guthrie C., 1991, METHODS ENZYMOLOGY G, V194; Hasegawa Y, 2008, RNA, V14, P2333, DOI 10.1261/rna.1016508; Heurgue-Hamard V, 2005, J BIOL CHEM, V280, P2439, DOI 10.1074/jbc.M407252200; Heurgue-Hamard V, 2006, J BIOL CHEM, V281, P36140, DOI 10.1074/jbc.M608571200; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; Hu ZB, 2010, PLANT J, V61, P600, DOI 10.1111/j.1365-313X.2009.04085.x; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Huang JA, 2004, CELL CYCLE, V3, P973; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MONIER R, 1960, BIOCHIM BIOPHYS ACTA, V43, P1, DOI 10.1016/0006-3002(60)90399-1; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; OKADA K, 2009, NUCL ACIDS S SER, V53, P303, DOI DOI 10.1093/NASS/NRP152; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Polevoda B, 2006, J BIOL CHEM, V281, P2562, DOI 10.1074/jbc.M507651200; Purushothaman SK, 2005, MOL CELL BIOL, V25, P4359, DOI 10.1128/MCB.25.11.4359-4370.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Searles MA, 2000, J MOL BIOL, V301, P47, DOI 10.1006/jmbi.2000.3946; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Studte P, 2008, MOL MICROBIOL, V69, P1266, DOI 10.1111/j.1365-2958.2008.06358.x; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Urbonavicius J, 2002, J BACTERIOL, V184, P5348, DOI 10.1128/JB.184.19.5348-5357.2002; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhouravleva GA, 2006, MOL BIOL+, V40, P724	55	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18505	18515		10.1074/jbc.M110.113100	http://dx.doi.org/10.1074/jbc.M110.113100			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400505	hybrid, Green Published			2022-12-27	WOS:000278453900044
J	Soto, AG; Trejo, J				Soto, Antonio G.; Trejo, JoAnn			N-Linked Glycosylation of Protease-activated Receptor-1 Second Extracellular Loop A CRITICAL DETERMINANT FOR LIGAND-INDUCED RECEPTOR ACTIVATION AND INTERNALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELL INVASION; THROMBIN RECEPTOR; COUPLED RECEPTORS; ENDOPLASMIC-RETICULUM; PHOSPHOLIPASE-C; DOWN-REGULATION; BINDING; OLIGOSACCHARIDES; EXPRESSION; CLEAVAGE	Protease-activated receptor-1 (PAR1) contains five N-linked glycosylation consensus sites as follows: three residing in the N terminus and two localized on the surface of the second extracellular loop (ECL2). To study the effect of N-linked glycosylation in the regulation of PAR1 signaling and trafficking, we generated mutants in which the critical asparagines of the consensus sites were mutated. Here, we report that both the PAR1 N terminus and ECL2 serve as sites for N-linked glycosylation but have different functions in the regulation of receptor signaling and trafficking. N-Linked glycosylation of the PAR1 N terminus is important for transport to the cell surface, whereas the PAR1 mutant lacking glycosylation at ECL2 (NA ECL2) trafficked to the cell surface like the wild-type receptor. However, activated PAR1 NA ECL2 mutant internalization was impaired compared with wild-type receptor, whereas constitutive internalization of unactivated receptor remained intact. Remarkably, thrombin-activated PAR1 NA ECL2 mutant displayed an enhanced maximal signaling response compared with wild-type receptor. The increased PAR1 NA ECL2 mutant signaling was not due to defects in the ability of thrombin to cleave the receptor or signal termination mechanisms. Rather, the PAR1 NA ECL2 mutant displayed a greater efficacy in thrombin-stimulated G protein signaling. Thus, N-linked glycosylation of the PAR1 extracellular surface likely influences ligand docking interactions and the stability of the active receptor conformation. Together, these studies strongly suggest that N-linked glycosylation of PAR1 at the N terminus versus the surface of ECL2 serves distinct functions critical for proper regulation of receptor trafficking and the fidelity of thrombin signaling.	[Soto, Antonio G.; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Soto, Antonio G.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3044A, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [HL073328]; American Heart Association; National Institutes of Health, NIGMS [T32]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073328 (to J. T.). This work was also supported by an American Heart Association established investigator award (to J. T.).; Supported by National Institutes of Health Training Grant T32 from NIGMS (pharmacological sciences training grant).	Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; BAFFY G, 1994, J BIOL CHEM, V269, P8483; BENKA ML, 1995, FEBS LETT, V363, P49, DOI 10.1016/0014-5793(95)00278-H; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; BRASS LF, 1994, J BIOL CHEM, V269, P2943; Compton SJ, 2003, DRUG DEVELOP RES, V59, P350, DOI 10.1002/ddr.10303; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Datta A, 2003, PROTEIN SCI, V12, P2482, DOI 10.1110/ps.03254303; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; HOE MH, 1992, J BIOL CHEM, V267, P4916; ISHII K, 1993, J BIOL CHEM, V268, P9780; Jacques SL, 2000, J BIOL CHEM, V275, P40671, DOI 10.1074/jbc.M004544200; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; LIU XB, 1993, J BIOL CHEM, V268, P1513; Luga V, 2009, BIOCHEM J, V421, P119, DOI 10.1042/BJ20081131; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Mize GJ, 2008, PROTEIN EXPRES PURIF, V57, P280, DOI 10.1016/j.pep.2007.09.018; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TORDAI A, 1995, BIOCHEM BIOPH RES CO, V206, P857, DOI 10.1006/bbrc.1995.1122; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P8367, DOI 10.1074/jbc.270.14.8367; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154	50	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18781	18793		10.1074/jbc.M110.111088	http://dx.doi.org/10.1074/jbc.M110.111088			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20368337	hybrid, Green Published			2022-12-27	WOS:000278453900069
J	Ghosh, S; Hamdan, SM; Richardson, CC				Ghosh, Sharmistha; Hamdan, Samir M.; Richardson, Charles C.			Two Modes of Interaction of the Single-stranded DNA-binding Protein of Bacteriophage T7 with the DNA Polymerase-Thioredoxin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 2.5 PROTEIN; ESCHERICHIA-COLI THIOREDOXIN; HELICASE-PRIMASE; CONFERS PROCESSIVITY; CRYSTAL-STRUCTURE; REPLICATION FORK; DOMAIN; TERMINUS; RESIDUES; MOLECULE	The DNA polymerase encoded by bacteriophage T7 has low processivity. Escherichia coli thioredoxin binds to a segment of 76 residues in the thumb subdomain of the polymerase and increases the processivity. The binding of thioredoxin leads to the formation of two basic loops, loops A and B, located within the thioredoxin-binding domain (TBD). Both loops interact with the acidic C terminus of the T7 helicase. A relatively weak electrostatic mode involves the C-terminal tail of the helicase and the TBD, whereas a high affinity interaction that does not involve the C-terminal tail occurs when the polymerase is in a polymerization mode. T7 gene 2.5 single-stranded DNA-binding protein (gp2.5) also has an acidic C-terminal tail. gp2.5 also has two modes of interaction with the polymerase, but both involve the C-terminal tail of gp2.5. An electrostatic interaction requires the basic residues in loops A and B, and gp2.5 binds to both loops with similar affinity as measured by surface plasmon resonance. When the polymerase is in a polymerization mode, the C terminus of gene 2.5 protein interacts with the polymerase in regions outside the TBD. gp2.5 increases the processivity of the polymerase-helicase complex during leading strand synthesis. When loop B of the TBD is altered, abortive DNA products are observed during leading strand synthesis. Loop B appears to play an important role in communication with the helicase and gp2.5, whereas loop A plays a stabilizing role in these interactions.	[Ghosh, Sharmistha; Hamdan, Samir M.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu		Hamdan, Samir/0000-0001-5192-1852	National Institutes of Health [GM 54937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM054937, R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54937.	Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; Ghosh S, 2008, J BIOL CHEM, V283, P32077, DOI 10.1074/jbc.M805062200; Ghosh S, 2009, J BIOL CHEM, V284, P30339, DOI 10.1074/jbc.M109.024059; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; KIM YT, 1994, J BIOL CHEM, V269, P5270; KIM YT, 1992, J BIOL CHEM, V267, P15032; KIM YT, 1992, J BIOL CHEM, V267, P15022; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200; Marintcheva B, 2008, P NATL ACAD SCI USA, V105, P1855, DOI 10.1073/pnas.0711919105; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; Marintcheva B, 2009, MOL MICROBIOL, V72, P869, DOI 10.1111/j.1365-2958.2009.06682.x; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; TABOR S, 1987, J BIOL CHEM, V262, P16212; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yang XM, 1996, J BIOL CHEM, V271, P24207, DOI 10.1074/jbc.271.39.24207	25	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18103	18112		10.1074/jbc.M110.107656	http://dx.doi.org/10.1074/jbc.M110.107656			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375019	Green Published, hybrid			2022-12-27	WOS:000278133400085
J	Severin, IC; Gaudry, JP; Johnson, Z; Kungl, A; Jansma, A; Gesslbauer, B; Mulloy, B; Power, C; Proudfoot, AEI; Handel, T				Severin, India C.; Gaudry, Jean-Philippe; Johnson, Zoe; Kungl, Andreas; Jansma, Ariane; Gesslbauer, Bernd; Mulloy, Barbara; Power, Christine; Proudfoot, Amanda E. I.; Handel, Tracy			Characterization of the Chemokine CXCL11-Heparin Interaction Suggests Two Different Affinities for Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; HUMAN-PLATELET FACTOR-4; HEPARIN-BINDING SITES; I-TAC; RECEPTOR-BINDING; CC-CHEMOKINE; MCP-1 RECEPTOR; CXC CHEMOKINE; T-CELLS; IDENTIFICATION	Chemokines orchestrate the migration of leukocytes in the context of homeostasis and inflammation. In addition to interactions of chemokines with receptors on migrating cells, these processes require interactions of chemokines with glycosaminoglycans (GAGs) for cell surface localization. Most chemokines are basic proteins with Arg/Lys/His residue clusters functioning as recognition epitopes for GAGs. In this study we characterized the GAG-binding epitopes of the chemokine I-TAC/CXCL11. Four separate clusters of basic residues were mutated to alanine and tested for their ability to bind to GAGs in vitro and to activate the receptor, CXCR3. Mutation of a set of basic residues in the C-terminal helix (the 50s cluster, (57)KSKQAR(62)) along with Lys(17), significantly impaired heparin binding in vitro, identifying these residues as components of the dominant epitope. However, this GAG mutant retained nearly wild type receptor binding affinity, and its ability to induce cell migration in vitro was only mildly perturbed. Nevertheless, the mutant was unable to induce cell migration in vivo, establishing a requirement of CXCL11 for GAG binding for in vivo function. These studies also led to some interesting findings. First, CXCL11 exhibits conformational heterogeneity, as evidenced by the doubling of peaks in its HSQC spectra. Second, it exhibits more than one affinity state for both heparin and CXCR3, which may be related to its structural plasticity. Finally, although the binding affinities of chemokines for GAGs are typically weaker than interactions with receptors, the high affinity GAG binding state of CXCL11 is comparable with typical receptor binding affinities, suggesting some unique properties of this chemokine.	[Severin, India C.; Gaudry, Jean-Philippe; Johnson, Zoe; Power, Christine; Proudfoot, Amanda E. I.] Merck Serono Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Kungl, Andreas; Gesslbauer, Bernd] ProtAffin Biotechnol AG, A-8020 Graz, Austria; [Mulloy, Barbara] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Jansma, Ariane; Handel, Tracy] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Merck KGaA; EMD Serono Inc.; National Institute for Biological Standards & Control; University of California System; University of California San Diego	Proudfoot, AEI (corresponding author), Merck Serono Geneva Res Ctr, 9 Chemin Mines, CH-1202 Geneva, Switzerland.	amanda.proudfoot@merckserono.net	Severin, India/J-1558-2017; Gesslbauer, Bernd/U-4033-2018; Sawant, Kirti V/H-3778-2013	Gesslbauer, Bernd/0000-0003-4910-8322; Kungl, Andreas/0000-0003-3362-797X; Johnson, Zoe/0000-0002-4120-2579	National Institutes of Health [RO1-AI37113]; Lymphoma Research Foundation; United States Department of Defense [USAMRAA W81XWH0710446]; European Union [LSHB-CT-2005-518167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; United States Department of Defense(United States Department of Defense); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-AI37113 (T. M. H.). This work was also supported by the Lymphoma Research Foundation, United States Department of Defense Grant USAMRAA W81XWH0710446, and European Union FP6 INNOCHEM Award LSHB-CT-2005-518167 (to A. E. I. P.).	Ali S, 2005, J IMMUNOL, V175, P1257, DOI 10.4049/jimmunol.175.2.1257; Ali S, 2007, MOL IMMUNOL, V44, P1477, DOI 10.1016/j.molimm.2006.08.011; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Booth V, 2004, PROTEIN SCI, V13, P2022, DOI 10.1110/ps.04791404; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Campanella GSV, 2003, J BIOL CHEM, V278, P17066, DOI 10.1074/jbc.M212077200; CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Crown SE, 2006, J BIOL CHEM, V281, P25438, DOI 10.1074/jbc.M601518200; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Dehner A, 2005, CHEMBIOCHEM, V6, P1550, DOI 10.1002/cbic.200500093; Falsone SF, 2007, PROTEOMICS, V7, P2375, DOI 10.1002/pmic.200600996; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; Hamel DJ, 2009, METHOD ENZYMOL, V461, P71, DOI 10.1016/S0076-6879(09)05404-4; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hartley O, 2005, CURR PROTEIN PEPT SC, V6, P207, DOI 10.2174/1389203054065400; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hoogewerf AJ, 2000, METH MOL B, V138, P173; Jabeen T, 2008, ACTA CRYSTALLOGR D, V64, P611, DOI 10.1107/S0907444908007026; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Koopmann W, 1997, J BIOL CHEM, V272, P10103; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Langenkamp A, 2003, EUR J IMMUNOL, V33, P474, DOI 10.1002/immu.200310023; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Loetscher P, 2001, J LEUKOCYTE BIOL, V69, P881; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; MAYO KH, 1989, BIOCHEMISTRY-US, V28, P9469, DOI 10.1021/bi00450a034; Mulloy B, 2008, MOL SIMULAT, V34, P481, DOI 10.1080/08927020701784754; O'Boyle G, 2009, FASEB J, V23, P3906, DOI 10.1096/fj.09-134643; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Peterson FC, 2004, J BIOL CHEM, V279, P12598, DOI 10.1074/jbc.M311633200; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Sauty A, 1999, J IMMUNOL, V162, P3549; Shahrara S, 2008, J IMMUNOL, V180, P3447, DOI 10.4049/jimmunol.180.5.3447; Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5; Swaminathan GJ, 2003, STRUCTURE, V11, P521, DOI 10.1016/S0969-2126(03)00070-4; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Wijtmans M, 2008, CHEMMEDCHEM, V3, P861, DOI 10.1002/cmdc.200700365; ZHANG XH, 1994, BIOCHEMISTRY-US, V33, P8361, DOI 10.1021/bi00193a025	61	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17713	17724		10.1074/jbc.M109.082552	http://dx.doi.org/10.1074/jbc.M109.082552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363748	hybrid, Green Published			2022-12-27	WOS:000278133400049
J	Collaco, A; Jakab, R; Hegan, P; Mooseker, M; Ameen, N				Collaco, Anne; Jakab, Robert; Hegan, Peter; Mooseker, Mark; Ameen, Nadia			alpha-AP-2 Directs Myosin VI-dependent Endocytosis of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels in the Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER; CELLULAR FUNCTIONS; EPITHELIAL-CELLS; CFTR; LOCALIZATION; DISABLED-2; PROTEIN; DAB2; AP-2; TRAFFICKING	The actin motor myosin VI regulates endocytosis of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestine, but the endocytic adaptor linking CFTR to myosin VI is unknown. Dab2 (Disabled 2) is the binding partner for myosin VI, clathrin, and alpha-AP-2 and directs endocytosis of low density lipoprotein receptor family members by recognizing a phosphotyrosine-binding domain. However, CFTR does not possess a phosphotyrosine-binding domain. We examined whether alpha-AP-2 and/or Dab2 were binding partners for CFTR and the role of myosin VI in localizing endocytic adaptors in the intestine. CFTR co-localized with alpha-AP-2, Dab2, and myosin VI and was identified in a complex with all three endocytic proteins in the intestine. Apical CFTR was increased in the intestines of Dab-2KOmice, suggesting its involvement in regulating surface CFTR. Glutathione S-transferase pulldown assays revealed binding of CFTR to alpha-AP-2 (but not Dab2) in the intestine, whereas Dab-2 interacted with alpha-AP-2. siRNA silencing of alpha-AP-2 in cells significantly reduced CFTR endocytosis, further supporting alpha-AP-2 as the direct binding partner for CFTR. alpha-AP-2 and Dab2 localized to the terminal web regions of enterocytes, but Dab2 accumulated in this location in Snell's Waltzer myosin VI(sv/sv) intestine. Ultrastructural examination revealed that the accumulation of Dab2 correlated with prominent involution and the loss of normal positioning of the inter-microvillar membranes that resulted in expansion of the terminal web region in myosin VI(sv/sv) enterocytes. The findings support alpha-AP-2 in directing myosin VI-dependent endocytosis of CFTR and a requirement for myosin VI in membrane invagination and coated pit formation in enterocytes.	[Ameen, Nadia] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Hegan, Peter; Mooseker, Mark] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Collaco, Anne; Jakab, Robert; Ameen, Nadia] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Collaco, Anne; Jakab, Robert; Ameen, Nadia] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ameen, N (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,FMP 408, New Haven, CT 06520 USA.	nadia.ameen@yale.edu			National Institutes of Health [R01 DK 077065, DK 25387, GM 073823]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK025387, R01DK025387, R01DK077065, R37DK025387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK 077065 (to N.A.) and DK 25387 and GM 073823 (to M. M.).	Ameen N, 2000, HISTOCHEM CELL BIOL, V114, P69; Ameen NA, 2000, HISTOCHEM CELL BIOL, V114, P219; Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; BAXTER PS, 1988, ARCH DIS CHILD, V63, P1496, DOI 10.1136/adc.63.12.1496; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Gotoh N, 2010, CYTOSKELETON, V67, P178, DOI 10.1002/cm.20435; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hu W, 2001, BIOCHEM J, V354, P561, DOI 10.1042/0264-6021:3540561; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Nagai J, 2005, AM J PHYSIOL-RENAL, V289, pF569, DOI 10.1152/ajprenal.00292.2004; Naren AP, 2000, J CLIN INVEST, V105, P377, DOI 10.1172/JCI8631; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1992, J CELL SCI, V102, P581; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; TAYLOR CJ, 1990, ARCH DIS CHILD, V65, P175, DOI 10.1136/adc.65.2.175; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TRIER JLM, 1994, PHYSL GASTROINTESTIN; Weixel Kelly, 2002, Methods Mol Med, V70, P323; Weixel KM, 2001, PFLUG ARCH EUR J PHY, V443, pS70; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200	36	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17177	17187		10.1074/jbc.M110.127613	http://dx.doi.org/10.1074/jbc.M110.127613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351096	Green Published, hybrid			2022-12-27	WOS:000277982600080
J	Singh, NK; Van Quyen, D; Kundumani-Sridharan, V; Brooks, PC; Rao, GN				Singh, Nikhlesh K.; Van Quyen, Dong; Kundumani-Sridharan, Venkatesh; Brooks, Peter C.; Rao, Gadiparthi N.			AP-1 (Fra-1/c-Jun)-mediated Induction of Expression of Matrix Metalloproteinase-2 Is Required for 15(S)-Hydroxyeicosatetraenoic Acid-induced Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; RHO-GTPASES; MUSCLE; ACTIVATION; 15-HETE; GROWTH; HYPOXIA; KINASE; MMP-2; 12/15-LIPOXYGENASE	To understand the involvement of matrix metalloproteinases (MMPs) in 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE)-induced angiogenesis, we have studied the role of MMP-2. 15(S)-HETE induced MMP-2 expression and activity in a time-dependent manner in human dermal microvascular endothelial cells (HDMVECs). Inhibition of MMP-2 activity or depletion of its levels attenuated 15(S)-HETE-induced HDMVEC migration, tube formation, and Matrigel plug angiogenesis. 15(S)-HETE also induced Fra-1 and c-Jun expression in a Rac1-MEK1-JNK1-dependent manner. In addition, 15(S)-HETE-induced MMP-2 expression and activity were mediated by Rac1-MEK1-JNK1 dependent activation of AP-1 (Fra-1/c-Jun). Cloning and site-directed mutagenesis of MMP-2 promoter revealed that AP-1 site proximal to the transcriptional start site is required for 15(S)-HETE-induced MMP-2 expression, and Fra-1 and c-Jun are the essential components of AP-1 that bind to MMP-2 promoter in response to 15(S)-HETE. Hind limb ischemia led to an increase in MEK1 and JNK1 activation and Fra-1, c-Jun, and MMP-2 expression resulting in enhanced neovascularization and recovery of blood perfusion in wild-type mice as compared with 12/15-Lox(-/-) mice. Together, these results provide the first direct evidence for a role of 12/15-Lox-12/15(S)-HETE axis in the regulation of ischemia-induced angiogenesis.	[Singh, Nikhlesh K.; Van Quyen, Dong; Kundumani-Sridharan, Venkatesh; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Brooks, Peter C.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	University of Tennessee System; University of Tennessee Health Science Center; Maine Medical Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Singh, Nikhlesh/AAA-4253-2020	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023; Quyen, Dong Van/0000-0003-1002-7517	NHLBI [HL074860]; NATIONAL CANCER INSTITUTE [R01CA091645] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074860] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL074860 from NHLBI.	Alexander SM, 1997, DEV DYNAM, V209, P261, DOI 10.1002/(SICI)1097-0177(199707)209:3<261::AID-AJA2>3.0.CO;2-G; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Cheranov SY, 2009, BLOOD, V113, P6023, DOI 10.1182/blood-2008-10-183210; Coker ML, 1999, AM J PHYSIOL-HEART C, V277, pH777, DOI 10.1152/ajpheart.1999.277.2.H777; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Droppelmann CA, 2009, J BIOL CHEM, V284, P13551, DOI 10.1074/jbc.M807352200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fatar M, 2005, CEREBROVASC DIS, V20, P141, DOI 10.1159/000087197; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Freedman SB, 2001, J MOL CELL CARDIOL, V33, P379, DOI 10.1006/jmcc.2000.1329; Gagne PJ, 2005, AM J PATHOL, V167, P1349, DOI 10.1016/S0002-9440(10)61222-9; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gonzalez AL, 2004, HUM PATHOL, V35, P840, DOI 10.1016/j.humpath.2004.04.001; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Gu JL, 2001, CIRCULATION, V103, P1446, DOI 10.1161/01.CIR.103.10.1446; HANEMAAIJER R, 1993, BIOCHEM J, V296, P803, DOI 10.1042/bj2960803; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Kelavkar UP, 2004, NEOPLASIA, V6, P821, DOI 10.1593/neo.04286; Khurana R, 2004, CIRCULATION, V110, P2436, DOI 10.1161/01.CIR.0000145138.25577.F1; Koutouzis M, 2007, ATHEROSCLEROSIS, V192, P457, DOI 10.1016/j.atherosclerosis.2007.01.035; Kundumani-Sridharan V, 2010, BLOOD, V115, P2105, DOI 10.1182/blood-2009-09-241802; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Levi E, 1996, P NATL ACAD SCI USA, V93, P7069, DOI 10.1073/pnas.93.14.7069; Li YM, 2009, APOPTOSIS, V14, P42, DOI 10.1007/s10495-008-0286-6; Linask KK, 2005, MICROSC MICROANAL, V11, P200, DOI 10.1017/S1431927605050440; Linask KK, 2005, DEV DYNAM, V233, P739, DOI 10.1002/dvdy.20377; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Mohammed FF, 2003, ANN RHEUM DIS, V62, P43; Poeckel D, 2009, J BIOL CHEM, V284, P21077, DOI 10.1074/jbc.M109.000901; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Preston IR, 2006, AM J PHYSIOL-LUNG C, V290, pL367, DOI 10.1152/ajplung.00114.2005; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V157, P457, DOI 10.1016/S0006-291X(88)80271-7; SIMON TC, 1989, ATHEROSCLEROSIS, V75, P31, DOI 10.1016/0021-9150(89)90204-9; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Viita H, 2008, CIRC RES, V102, P177, DOI 10.1161/CIRCRESAHA.107.155556; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zahradka P, 2004, AM J PHYSIOL-HEART C, V287, pH2861, DOI 10.1152/ajpheart.00230.2004; Zhang BL, 2005, CANCER RES, V65, P7283, DOI 10.1158/0008-5472.CAN-05-0633; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhao TQ, 2009, J LIPID RES, V50, P521, DOI 10.1194/jlr.M800388-JLR200; Zhu DL, 2003, CIRC RES, V92, P992, DOI 10.1161/01.RES.0000070881.65194.8F; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	65	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16830	16843		10.1074/jbc.M110.106187	http://dx.doi.org/10.1074/jbc.M110.106187			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353950	hybrid, Green Published			2022-12-27	WOS:000277982600047
J	Bee, C; Moshnikova, A; Mellor, CD; Molloy, JE; Koryakina, Y; Stieglitz, B; Khokhlatchev, A; Herrmann, C				Bee, Christine; Moshnikova, Anna; Mellor, Christopher D.; Molloy, Justin E.; Koryakina, Yulia; Stieglitz, Benjamin; Khokhlatchev, Andrei; Herrmann, Christian			Growth and Tumor Suppressor NORE1A Is a Regulatory Node between Ras Signaling and Microtubule Nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A; EFFECTOR; RASSF1A; CELLS; IDENTIFICATION; STABILITY; PROTEINS; PATHWAY; FAMILY; SWITCH	NORE1A is a Ras-binding protein that belongs to a group of tumor suppressors known as the Ras association domain family. Their growth- and tumor-suppressive function is assumed to be dependent on association with the microtubule cytoskeleton. However, a detailed understanding of this interplay is still missing. Here, we show that NORE1A directly interacts with tubulin and is capable of nucleating microtubules. Strikingly, the ability to stimulate nucleation is regulated in a dual specific way either via phosphorylation of NORE1A within the Ras-binding domain by Aurora A kinase or via binding to activated Ras. We also demonstrate that NORE1A mediates a negative effect of activated Ras on microtubule nucleation. On the basis of our results, we propose a novel regulatory network composed of the tumor suppressor NORE1A, the mitotic kinase Aurora A, the small GTPase Ras, and the microtubule cytoskeleton.	[Mellor, Christopher D.; Molloy, Justin E.; Stieglitz, Benjamin] Natl Inst Med Res, MRC, London NW7 1AA, England; [Bee, Christine; Herrmann, Christian] Ruhr Univ Bochum, Dept Chem, D-44780 Bochum, Germany; [Moshnikova, Anna; Khokhlatchev, Andrei] Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA; [Koryakina, Yulia] Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA	MRC National Institute for Medical Research; Ruhr University Bochum; University of Virginia; University of Virginia	Stieglitz, B (corresponding author), Natl Inst Med Res, MRC, Ridgeway,Mill Hill, London NW7 1AA, England.	bstiegl@nimr.mrc.ac.uk; ak9k@cms.mail.virginia.edu	Stieglitz, Benjamin/AAY-4140-2020	Stieglitz, Benjamin/0000-0003-3634-6997; Molloy, Justin/0000-0002-8307-2450	German National Academic Foundation; Ruhr University Research School; Deutsche Forschungsgemeinschaft [SFB 642]; Elsa U. Pardee Foundation; CONCERN Foundation; MRC [MC_U117570592] Funding Source: UKRI; Medical Research Council [MC_U117570592] Funding Source: researchfish	German National Academic Foundation; Ruhr University Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elsa U. Pardee Foundation; CONCERN Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the German National Academic Foundation, the Ruhr University Research School, the Deutsche Forschungsgemeinschaft (SFB 642), the Elsa U. Pardee Foundation, and the CONCERN Foundation.	Dallol A, 2009, CURR BIOL, V19, P1227, DOI 10.1016/j.cub.2009.05.064; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eckfeld K, 2004, CANCER RES, V64, P8688, DOI 10.1158/0008-5472.CAN-04-2065; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Liu L, 2008, ONCOGENE, V27, P6175, DOI 10.1038/onc.2008.220; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Moshnikova A, 2006, J BIOL CHEM, V281, P8143, DOI 10.1074/jbc.M511837200; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Song SJ, 2009, CANCER RES, V69, P2314, DOI 10.1158/0008-5472.CAN-08-3984; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Waterman-Storer C M, 2001, Curr Protoc Cell Biol, VChapter 13, DOI 10.1002/0471143030.cb1301s00; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	26	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16258	16266		10.1074/jbc.M109.081562	http://dx.doi.org/10.1074/jbc.M109.081562			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20339001	Green Published, hybrid			2022-12-27	WOS:000277715900062
J	Rangwala, SM; Wang, XM; Calvo, JA; Lindsley, L; Zhang, YY; Deyneko, G; Beaulieu, V; Gao, JP; Turner, G; Markovits, J				Rangwala, Shamina M.; Wang, Xiaomei; Calvo, Jennifer A.; Lindsley, Loren; Zhang, Yunyu; Deyneko, Galina; Beaulieu, Valerie; Gao, Jiaping; Turner, Gordon; Markovits, Judit			Estrogen-related Receptor gamma Is a Key Regulator of Muscle Mitochondrial Activity and Oxidative Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKELETAL-MUSCLE; HYPOXIA-INDUCIBLE FACTOR-2; ERR-ALPHA; TRANSCRIPTIONAL ACTIVATION; PGC-1-ALPHA; EXERCISE; EXPRESSION; GENE; COACTIVATOR-1-ALPHA; PATHWAY	Estrogen-related receptor gamma (ERR gamma) regulates the perinatal switch to oxidative metabolism in the myocardium. We wanted to understand the significance of induction of ERR gamma expression in skeletal muscle by exercise. Muscle-specific VP16ERR gamma transgenic mice demonstrated an increase in exercise capacity, mitochondrial enzyme activity, and enlarged mitochondria despite lower muscle weights. Furthermore, peak oxidative capacity was higher in the transgenics as compared with control littermates. In contrast, mice lacking one copy of ERR gamma exhibited decreased exercise capacity and muscle mitochondrial function. Interestingly, we observed that increased ERR gamma in muscle generates a gene expression profile that closely overlays that of red oxidative fiber-type muscle. We further demonstrated that a small molecule agonist of ERR beta/gamma can increase mitochondrial function in mouse myotubes. Our data indicate that ERR gamma plays an important role in causing a shift toward slow twitch muscle type and, concomitantly, a greater capacity for endurance exercise. Thus, the activation of this nuclear receptor provides a potential node for therapeutic intervention for diseases such as obesity, which is associated with reduced oxidative metabolism and a lower type I fiber content in skeletal muscle.	[Rangwala, Shamina M.; Wang, Xiaomei; Calvo, Jennifer A.; Lindsley, Loren; Zhang, Yunyu; Deyneko, Galina; Beaulieu, Valerie; Gao, Jiaping; Turner, Gordon] Novartis Inst BioMed Res, Cardiovasc & Metab Dis Area, Cambridge, MA 02139 USA	Novartis	Rangwala, SM (corresponding author), 100 Technol Sq, Cambridge, MA 02139 USA.	shamina.rangwala@novartis.com		Turner, Gordon/0000-0001-9156-7499				*AFF, 2008, PLIER TECHN; Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alaynick WA, 2010, MOL ENDOCRINOL, V24, P299, DOI 10.1210/me.2009-0114; Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Goodpaster BH, 2003, DIABETES, V52, P2191, DOI 10.2337/diabetes.52.9.2191; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KIERNAN JA, 2004, HISTOLOGICAL HISTOCH, P319; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lavery GG, 2008, J BIOL CHEM, V283, P8453, DOI 10.1074/jbc.M710067200; Lundby C, 2006, EUR J APPL PHYSIOL, V96, P363, DOI 10.1007/s00421-005-0085-5; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Naranjo-Suarez S, 2003, J BIOL CHEM, V278, P31895, DOI 10.1074/jbc.M304079200; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Wang SCM, 2010, MOL CELL ENDOCRINOL, V315, P146, DOI 10.1016/j.mce.2009.07.012; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Zuercher WJ, 2005, J MED CHEM, V48, P3107, DOI 10.1021/jm050161j	49	122	126	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22619	22629		10.1074/jbc.M110.125401	http://dx.doi.org/10.1074/jbc.M110.125401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20418374	hybrid, Green Published			2022-12-27	WOS:000279702200072
J	Nistal-Villan, E; Gack, MU; Martinez-Delgado, G; Maharaj, NP; Inn, KS; Yang, HY; Wang, R; Aggarwal, AK; Jung, JU; Garcia-Sastre, A				Nistal-Villan, Estanislao; Gack, Michaela U.; Martinez-Delgado, Gustavo; Maharaj, Natalya P.; Inn, Kyung-Soo; Yang, Heyi; Wang, Rong; Aggarwal, Aneel K.; Jung, Jae U.; Garcia-Sastre, Adolfo			Negative Role of RIG-I Serine 8 Phosphorylation in the Regulation of Interferon-beta Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; E3 UBIQUITIN LIGASE; DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; INFLUENZA-A; TRANSCRIPTION FACTORS; ADAPTER PROTEIN; NS1 PROTEIN; INDUCTION; RECOGNITION	RIG-I (retinoic acid-inducible gene I) and TRIM25 (tripartite motif protein 25) have emerged as key regulatory factors to induce interferon (IFN)-mediated innate immune responses to limit viral replication. Upon recognition of viral RNA, TRIM25 E3 ligase binds the first caspase recruitment domain (CARD) of RIG-I and subsequently induces lysine 172 ubiquitination of the second CARD of RIG-I, which is essential for the interaction with downstream MAVS/IPS-1/CARDIF/VISA and, thereby, IFN-beta mRNA production. Although ubiquitination has emerged as a major factor involved in RIG-I activation, the potential contribution of other post-translational modifications, such as phosphorylation, to the regulation of RIG-I activity has not been addressed. Here, we report the identification of serine 8 phosphorylation at the first CARD of RIG-I as a negative regulatory mechanism of RIG-I-mediated IFN-beta production. Immunoblot analysis with a phosphospecific antibody showed that RIG-I serine 8 phosphorylation steady-state levels were decreased upon stimulation of cells with IFN-beta or virus infection. Substitution of serine 8 in the CARD RIG-I functional domain with phosphomimetic aspartate or glutamate results in decreased TRIM25 binding, RIG-I ubiquitination, MAVS binding, and downstream signaling. Finally, sequence comparison reveals that only primate species carry serine 8, whereas other animal species carry an asparagine, indicating that serine 8 phosphorylation may represent a primate-specific regulation of RIG-I activation. Collectively, these data suggest that the phosphorylation of RIG-I serine 8 operates as a negative switch of RIG-I activation by suppressing TRIM25 interaction, further underscoring the importance of RIG-I and TRIM25 connection in type I IFN signal transduction.	[Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Yang, Heyi; Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Gack, Michaela U.; Maharaj, Natalya P.; Jung, Jae U.] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; [Gack, Michaela U.; Maharaj, Natalya P.; Jung, Jae U.] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Tumor Virol, Southborough, MA 01772 USA; [Inn, Kyung-Soo; Jung, Jae U.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard University; University of Southern California	Garcia-Sastre, A (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	adolfo.garcia-sastre@mssm.edu	Inn, Kyung-Soo/AAJ-4118-2020; Martinez-Delgado, Gustavo/X-7033-2019; Nistal-Villán, Estanislao/AAM-8029-2020; Nistal-Villan, Estanislao/GWM-7994-2022; Wang, Rong/A-8721-2009	Martinez-Delgado, Gustavo/0000-0003-4655-3770; Nistal-Villán, Estanislao/0000-0003-2458-8833; Garcia-Sastre, Adolfo/0000-0002-6551-1827	National Institutes of Health (NIH) [RR00168, CA082057, U19AI083025, AI083355, AI041706, R01AI46954]; NIH, NIAID [HHSN266200700010C]; Fletcher Jones Foundation; Hastings Foundation; NATIONAL CANCER INSTITUTE [R01CA082057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046954, R01AI083355, R01AI041706, R01AI087846, U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fletcher Jones Foundation; Hastings Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants RR00168 (to M. U. G.); CA082057, U19AI083025, and AI083355 (to J. U. J. and M. U. G.); AI041706 (to A. K. A.); and U19AI083025 and R01AI46954 and NIH, NIAID, Contract HHSN266200700010C (to A. G.-S.). This work was also supported by grants from the Fletcher Jones Foundation and Hastings Foundation (to J. U. J. and M. U. G.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; DeLano W.L, PYMOL MOL GRAPHICS S; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Levy DE, 2002, J EXP MED, V195, pF15, DOI 10.1084/jem.20020075; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Steen Hanno, 2002, Sci STKE, V2002, ppl16, DOI 10.1126/stke.2002.154.pl16; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	42	84	90	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20252	20261		10.1074/jbc.M109.089912	http://dx.doi.org/10.1074/jbc.M109.089912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406818	Green Published, hybrid			2022-12-27	WOS:000279012000060
J	van Duijn, TJ; Anthony, EC; Hensbergen, PJ; Deelder, AM; Hordijk, PL				van Duijn, Trynette J.; Anthony, Eloise C.; Hensbergen, Paul J.; Deelder, Andre M.; Hordijk, Peter L.			Rac1 Recruits the Adapter Protein CMS/CD2AP to Cell-Cell Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PODOCYTE SLIT-DIAPHRAGM; RHO GTPASES; NEPHROTIC SYNDROME; IN-VITRO; CD2AP; MIGRATION; NEPHRIN; RAP1; CMS; IDENTIFICATION	Rac1 is a member of the Rho family of small GTPases, which regulate cell adhesion and migration through their control of the actin cytoskeleton. Rho-GTPases are structurally very similar, with the exception of a hypervariable domain in the C terminus. Using peptide-based pulldown assays in combination with mass spectrometry, we previously showed that the hypervariable domain in Rac1 mediates specific protein-protein interactions. Most recently, we found that the Rac1 C terminus associates to the ubiquitously expressed adapter protein CMS/CD2AP. CD2AP is critical for the formation and maintenance of a specialized cell-cell contact between kidney podocyte foot processes, the slit diaphragm. Here, CD2AP links the cell adhesion protein nephrin to the actin cytoskeleton. In addition, CMS/CD2AP binds actin-regulating proteins, such as CAPZ and cortactin, and has been implicated in the internalization of growth factor receptors. We found that CD2AP specifically interacts with the C-terminal domain of Rac1 but not with that of other Rho family members. Efficient interaction between Rac1 and CD2AP requires both the proline-rich domain and the polybasic region in the Rac1 C terminus, and at least two of the three N-terminal SH3 domains of CD2AP. CD2AP co-localizes with Rac1 to membrane ruffles, and small interfering RNA-based experiments showed that CD2AP links Rac1 to CAPZ and cortactin. Finally, expression of constitutive active Rac1 recruits CD2AP to cell-cell contacts in epithelial cells, where we found CD2AP to participate in the control of the epithelial barrier function. These data identify CD2AP as a novel Rac1-associated adapter protein that participates in the regulation of epithelial cell-cell contact.	Univ Amsterdam, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Hensbergen, Paul J.; Deelder, Andre M.] Leiden Univ, Med Ctr, Biomol Mass Spectrometry Unit, Dept Parasitol, NL-2333 ZA Leiden, Netherlands	University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hordijk, PL (corresponding author), Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	p.hordijk@sanquin.nl		Hensbergen, Paul/0000-0002-3193-5445; Hordijk, Peter/0000-0002-3348-078X				Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Attias O, 2010, NEPHRON EXP NEPHROL, V114, pE93, DOI 10.1159/000262317; Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Gigante M, 2009, NEPHROL DIAL TRANSPL, V24, P1858, DOI 10.1093/ndt/gfn712; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; Ho A, 2001, CANCER RES, V61, P474; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Johnson RI, 2008, J CELL BIOL, V180, P1191, DOI 10.1083/jcb.200706108; Kanters E, 2008, J BIOL CHEM, V283, P31830, DOI 10.1074/jbc.M804888200; Kawachi H, 2006, NEPHROLOGY, V11, P274, DOI 10.1111/j.1440-1797.2006.00583.x; Khoshnoodi J, 2001, EXP NEPHROL, V9, P355; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Li C, 2000, AM J PHYSIOL-RENAL, V279, pF785, DOI 10.1152/ajprenal.2000.279.4.F785; Lorenowicz MJ, 2008, EUR J CELL BIOL, V87, P779, DOI 10.1016/j.ejcb.2008.05.004; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Mustonen H, 2005, BIOCHEM BIOPH RES CO, V332, P426, DOI 10.1016/j.bbrc.2005.04.140; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Pop M, 2004, J BIOL CHEM, V279, P35840, DOI 10.1074/jbc.M404346200; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; ten Klooster JP, 2007, BIOL CELL, V99, P1, DOI 10.1042/BC20060071; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Voermans C, 2001, BLOOD, V97, P799, DOI 10.1182/blood.V97.3.799; Welsch T, 2001, AM J PHYSIOL-RENAL, V281, pF769, DOI 10.1152/ajprenal.2001.281.4.F769; Wolf G, 2003, LANCET, V362, P1746, DOI 10.1016/S0140-6736(03)14856-8; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; Yuan HP, 2002, AM J PHYSIOL-RENAL, V282, pF585, DOI 10.1152/ajprenal.00290.2001	50	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20137	20146		10.1074/jbc.M109.099481	http://dx.doi.org/10.1074/jbc.M109.099481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404345	Green Published, hybrid			2022-12-27	WOS:000279012000048
J	Wice, BM; Wang, SY; Crimmins, DL; Diggs-Andrews, KA; Althage, MC; Ford, EL; Tran, H; Ohlendorf, M; Griest, TA; Wang, QL; Fisher, SJ; Ladenson, JH; Polonsky, KS				Wice, Burton M.; Wang, Songyan; Crimmins, Dan L.; Diggs-Andrews, Kelly A.; Althage, Matthew C.; Ford, Eric L.; Tran, Hung; Ohlendorf, Matthew; Griest, Terry A.; Wang, Qiuling; Fisher, Simon J.; Ladenson, Jack H.; Polonsky, Kenneth S.			Xenin-25 Potentiates Glucose-dependent Insulinotropic Polypeptide Action via a Novel Cholinergic Relay Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; MUSCARINIC ACETYLCHOLINE-RECEPTOR; ACTIVATED PROTEIN-KINASE; TYPE-2 DIABETES-MELLITUS; RAT PANCREATIC-ISLETS; BETA-CELL LINE; ENTEROINSULAR AXIS; INCRETIN HORMONES; IN-VITRO	The intestinal peptides GLP-1 and GIP potentiate glucose-mediated insulin release. Agents that increase GLP-1 action are effective therapies in type 2 diabetes mellitus (T2DM). However, GIP action is blunted in T2DM, and GIP-based therapies have not been developed. Thus, it is important to increase our understanding of the mechanisms of GIP action. We developed mice lacking GIP-producing K cells. Like humans with T2DM, "GIP/DT" animals exhibited a normal insulin secretory response to exogenous GLP-1 but a blunted response to GIP. Pharmacologic doses of xenin-25, another peptide produced by K cells, restored the GIP-mediated insulin secretory response and reduced hyperglycemia in GIP/DT mice. Xenin-25 alone had no effect. Studies with islets, insulin-producing cell lines, and perfused pancreata indicated xenin-25 does not enhance GIP-mediated insulin release by acting directly on the beta-cell. The in vivo effects of xenin-25 to potentiate insulin release were inhibited by atropine sulfate and atropine methyl bromide but not by hexamethonium. Consistent with this, carbachol potentiated GIP-mediated insulin release from in situ perfused pancreata of GIP/DT mice. In vivo, xenin-25 did not activate c-fos expression in the hind brain or paraventricular nucleus of the hypothalamus indicating that central nervous system activation is not required. These data suggest that xenin-25 potentiates GIP-mediated insulin release by activating non-ganglionic cholinergic neurons that innervate the islets, presumably part of an enteric-neuronal-pancreatic pathway. Xenin-25, or molecules that increase acetylcholine receptor signaling in beta-cells, may represent a novel approach to overcome GIP resistance and therefore treat humans with T2DM.	[Wice, Burton M.; Wang, Songyan; Diggs-Andrews, Kelly A.; Althage, Matthew C.; Ford, Eric L.; Tran, Hung; Wang, Qiuling; Fisher, Simon J.; Polonsky, Kenneth S.] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Crimmins, Dan L.; Ohlendorf, Matthew; Griest, Terry A.; Ladenson, Jack H.] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Wice, BM (corresponding author), Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	bwice@dom.wustl.edu			National Institutes of Health [DK31842, RC1DK086163]; American Diabetes Association; Washington University Clinical Nutrition Research Center [P30 DK056341]; Washington University Digestive Diseases Research Core Center Morphology and Transgenic Mouse Cores [5P30 DK052574]; Washington University Diabetes Research and Training Center Radioimmunoassay, Transgenic and Mouse Phenotyping Cores [P60 DK020579]; Washington University Clinical and Translational Science Award [UL1 RR024992]; Blum Kovler Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, P60DK020579, R01DK088126, R37DK031842, R01DK031842, RC1DK086163, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Washington University Clinical Nutrition Research Center; Washington University Digestive Diseases Research Core Center Morphology and Transgenic Mouse Cores; Washington University Diabetes Research and Training Center Radioimmunoassay, Transgenic and Mouse Phenotyping Cores; Washington University Clinical and Translational Science Award; Blum Kovler Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK31842 (to K.S.P.) and RC1DK086163 (to B.M.W. and K.S.P.). This work was also supported by funds from a Career Development Award from the American Diabetes Association (to B.M.W.), by a pilot and feasibility grant from the Washington University Clinical Nutrition Research Center (Grant P30 DK056341 to B.M.W.), by the Washington University Digestive Diseases Research Core Center Morphology and Transgenic Mouse Cores (Grant 5P30 DK052574), by the Washington University Diabetes Research and Training Center Radioimmunoassay, Transgenic and Mouse Phenotyping Cores (Grant P60 DK020579), by a Washington University Clinical and Translational Science Award (UL1 RR024992), and by the Blum Kovler Foundation. Washington University is pursuing a patent related to the use of xenin-25 to treat T2DM. In the future, this could lead to personal financial benefit to B.M.W., K.S.P., and the University.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; Ahren B, 2004, INT TXB DIABETES MEL, P153; Alexiou C, 1998, BRAIN RES, V800, P294, DOI 10.1016/S0006-8993(98)00535-6; Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Anlauf M, 2000, J HISTOCHEM CYTOCHEM, V48, P1617, DOI 10.1177/002215540004801205; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; BIESOLD D, 1989, NEUROSCI LETT, V98, P39, DOI 10.1016/0304-3940(89)90370-4; Brand SJ, 1995, TXB GASTROENTEROLOGY, P25; BREZENOFF HE, 1988, LIFE SCI, V42, P905, DOI 10.1016/0024-3205(88)90389-X; BROWN JH, 2006, GOODMAN GILMANS PHAR, P1; Campbell RK, 2007, ANN PHARMACOTHER, V41, P51, DOI 10.1345/aph.1H459; Christophe J, 1998, ANN NY ACAD SCI, V865, P323, DOI 10.1111/j.1749-6632.1998.tb11192.x; Cline MA, 2007, BEHAV BRAIN RES, V179, P28, DOI 10.1016/j.bbr.2007.01.008; Cohen A, 2007, CURR MED RES OPIN, V23, P905, DOI 10.1185/030079907X182068; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; ELAHI D, 1994, REGUL PEPTIDES, V51, P63, DOI 10.1016/0167-0115(94)90136-8; FEHMANN HC, 1995, ENDOCR REV, V16, P390, DOI 10.1210/er.16.3.390; Feurle GE, 1998, PEPTIDES, V19, P609, DOI 10.1016/S0196-9781(97)00378-1; Feurle GE, 2003, REGUL PEPTIDES, V111, P153, DOI 10.1016/S0167-0115(02)00281-1; Feurle GE, 1996, J PHARMACOL EXP THER, V278, P654; Feurle GE, 1997, J PEPT RES, V49, P324; Feurle GE, 2001, NEUROGASTROENT MOTIL, V13, P237, DOI 10.1046/j.1365-2982.2001.00263.x; Filipsson K, 2000, AM J PHYSIOL-REG I, V279, pR424, DOI 10.1152/ajpregu.2000.279.2.R424; Freeman R, 2005, LANCET, V365, P1259, DOI 10.1016/S0140-6736(05)74815-7; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gautam D, 2007, DIABETES OBES METAB, V9, P158, DOI 10.1111/j.1463-1326.2007.00781.x; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; HAMSCHER G, 1995, PEPTIDES, V16, P791, DOI 10.1016/0196-9781(95)00053-M; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Iismaa TP, 2000, DIABETES, V49, P392, DOI 10.2337/diabetes.49.3.392; Ilcol YO, 2008, NEUROSCI LETT, V431, P71, DOI 10.1016/j.neulet.2007.11.024; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JOHNSTON CF, 1988, HISTOCHEMISTRY, V90, P161, DOI 10.1007/BF00500981; Kamiyama Y, 2007, NEUROGASTROENT MOTIL, V19, P233, DOI 10.1111/j.1365-2982.2006.00881.x; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Kirchgessner A L, 1991, Z Gastroenterol Verh, V26, P230; KIRCHGESSNER AL, 1992, DEV DYNAM, V194, P142, DOI 10.1002/aja.1001940207; KIRCHGESSNER AL, 1990, J NEUROSCI, V10, P1626; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Leckstrom A, 2009, DIABETES, V58, P87, DOI 10.2337/db08-0260; Leiter EH, 2004, DIABETES, V53, pS4, DOI 10.2337/diabetes.53.2007.S4; Li L, 2005, AM J PHYSIOL-ENDOC M, V288, pE208, DOI 10.1152/ajpendo.00346.2004; MALICK JB, 1975, J PHARM SCI, V64, P1066, DOI 10.1002/jps.2600640650; McKennon SA, 2007, DIABETES EDUCATOR, V33, P55, DOI 10.1177/0145721706297451; Meier JJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE621, DOI 10.1152/ajpendo.00499.2003; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Montrose-Rafizadeh C, 1999, ENDOCRINOLOGY, V140, P1132, DOI 10.1210/en.140.3.1132; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Nustede R, 1999, REGUL PEPTIDES, V81, P61, DOI 10.1016/S0167-0115(99)00019-1; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, pE931, DOI 10.1152/ajpendo.00270.2002; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Reifsnyder PC, 2002, DIABETES, V51, P825, DOI 10.2337/diabetes.51.3.825; Renuka TR, 2006, NEUROCHEM RES, V31, P313, DOI 10.1007/s11064-005-9022-6; Silvestre JS, 2005, METHOD FIND EXP CLIN, V27, P289, DOI 10.1358/mf.2005.27.5.908643; Silvestre RA, 2003, REGUL PEPTIDES, V115, P25, DOI 10.1016/S0167-0115(03)00147-2; Sreenan S, 1996, AM J PHYSIOL-ENDOC M, V271, pE742, DOI 10.1152/ajpendo.1996.271.4.E742; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Tornoe K, 1997, AM J PHYSIOL-GASTR L, V273, pG436, DOI 10.1152/ajpgi.1997.273.2.G436; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; WALSH JH, 1994, PHYSL GASTROINTESTIN, V1, P1; Wice BM, 2001, DIABETOLOGIA, V44, P453, DOI 10.1007/s001250051643; Winawer MR, 2007, MAMM GENOME, V18, P23, DOI 10.1007/s00335-006-0087-6; Winzell MS, 2007, PEPTIDES, V28, P1805, DOI 10.1016/j.peptides.2007.04.024; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yuan J, 2008, J CELL BIOCHEM, V103, P648, DOI 10.1002/jcb.21439; Zawalich WS, 2004, BIOCHEM BIOPH RES CO, V315, P872, DOI 10.1016/j.bbrc.2004.01.139	80	57	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19842	19853		10.1074/jbc.M110.129304	http://dx.doi.org/10.1074/jbc.M110.129304			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421298	Green Published, hybrid			2022-12-27	WOS:000279012000017
J	Atkinson, A; Khalimonchuk, O; Smith, P; Sabic, H; Eide, D; Winge, DR				Atkinson, Aaron; Khalimonchuk, Oleh; Smith, Pamela; Sabic, Hana; Eide, David; Winge, Dennis R.			Mzm1 Influences a Labile Pool of Mitochondrial Zinc Important for Respiratory Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; SACCHAROMYCES-CEREVISIAE; SYNAPTIC VESICLES; C-OXIDASE; YEAST; TRANSPORTERS; TRAFFICKING; SYNTHASE; BINDING; STORAGE	Zinc is essential for function of mitochondria as a cofactor for several matrix zinc metalloproteins. We demonstrate that a labile cationic zinc component of low molecular mass exists in the yeast mitochondrial matrix. This zinc pool is homeostatically regulated in response to the cellular zinc status. This pool of zinc is functionally important because matrix targeting of a cytosolic zinc-binding protein reduces the level of labile zinc and interferes with mitochondrial respiratory function. We identified a series of proteins that modulate the matrix zinc pool, one of which is a novel conserved mitochondrial protein designated Mzm1. Mutant mzm1 Delta cells have reduced total and labile mitochondrial zinc, and these cells are hypersensitive to perturbations of the labile pool. In addition, mzm1 Delta cells have a destabilized cytochrome c reductase (Complex III) without any effects on Complexes IV or V. Thus, we have established that a link exists between Complex III integrity and the labile mitochondrial zinc pool.	[Atkinson, Aaron; Khalimonchuk, Oleh; Smith, Pamela; Sabic, Hana; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Atkinson, Aaron; Khalimonchuk, Oleh; Smith, Pamela; Sabic, Hana; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Eide, David] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Khalimonchuk, Oleh/AAM-1194-2021	Khalimonchuk, Oleh/0000-0002-3972-8678	Center for Excellence in Molecular Hematology (CEMH); FPLC [DK P30 072437]; National Institutes of Health [GM083292, GM56285, T32 DK007115]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072437, T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285, R01GM083292] Funding Source: NIH RePORTER	Center for Excellence in Molecular Hematology (CEMH); FPLC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Amanda Bird for her gift of the Adh1 expression construct and Dr. Jared Rutter for participation in the CEMH yeast consortium efforts. We acknowledge the support of the Center for Excellence in Molecular Hematology (CEMH) core facility for FPLC chromatography and pilot project funding (DK P30 072437).; This work was supported, in whole or in part, by National Institutes of Health Grants GM083292 (to D. R. W.) and GM56285 (to D. E.).; Supported by National Institutes of Health Training Grant T32 DK007115.	Atkinson A, 2009, CHEM REV, V109, P4708, DOI 10.1021/cr900006y; Berry EA, 2000, BBA-BIOENERGETICS, V1459, P440, DOI 10.1016/S0005-2728(00)00182-1; BRAUN HP, 1992, EMBO J, V11, P3219, DOI 10.1002/j.1460-2075.1992.tb05399.x; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Coyne HJ, 2007, J BIOL CHEM, V282, P8926, DOI 10.1074/jbc.M610303200; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Haase H, 2002, BIOCHEM BIOPH RES CO, V296, P923, DOI 10.1016/S0006-291X(02)02017-X; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Leskovac V, 2002, FEMS YEAST RES, V2, P481, DOI 10.1016/S1567-1356(02)00157-5; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Sekiya-Kawasaki M, 2002, GENETICS, V162, P663; Sensi SL, 2003, CELL CALCIUM, V34, P281, DOI 10.1016/S0143-4160(03)00122-2; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Thompson RB, 2002, J NEUROSCI METH, V118, P63, DOI 10.1016/S0165-0270(02)00144-9; Wang QY, 2010, J BIOL CHEM, V285, P10408, DOI 10.1074/jbc.M109.085787; WHITE C, 1987, J GEN MICROBIOL, V133, P727; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	32	48	49	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19450	19459		10.1074/jbc.M110.109793	http://dx.doi.org/10.1074/jbc.M110.109793			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404342	hybrid, Green Published			2022-12-27	WOS:000278727800055
J	Georgopoulou, E; Mermelekas, G; Karena, E; Frillingos, S				Georgopoulou, Ekaterini; Mermelekas, George; Karena, Ekaterini; Frillingos, Stathis			Purine Substrate Recognition by the Nucleobase-Ascorbate Transporter Signature Motif in the YgfO Xanthine Permease ASN-325 BINDS AND ALA-323 SENSES SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; LACTOSE PERMEASE; FUNCTIONAL-CHARACTERIZATION; NAT/NCS2 FAMILY; BACTERIAL; HELIX; SPECIFICITY; SELECTIVITY	The nucleobase-ascorbate transporter (NAT) signature motif is a conserved 11-amino acid sequence of the ubiquitous NAT/NCS2 family, essential for function and selectivity of both a bacterial (YgfO) and a fungal (UapA) purine-transporting homolog. We examined the role of NAT motif in more detail, using Cys-scanning and site-directed alkylation analysis of the YgfO xanthine permease of Escherichia coli. Analysis of single-Cys mutants in the sequence 315-339 for sensitivity to inactivation by 2-sulfonatoethyl methanethiosulfonate (MTSES-) and N-ethylmaleimide (NEM) showed a similar pattern: highly sensitive mutants clustering at the motif sequence (323-329) and a short alpha-helical face downstream (332, 333, 336). In the presence of substrate, N325C is protected from alkylation with either MTSES-or NEM, whereas sensitivity of A323C to inactivation by NEM is enhanced, shifting IC50 from 34 to 14 mu M. Alkylation or sensitivity of the other mutants is unaffected by substrate; the lack of an effect on Q324C is attributed to gross inability of this mutant for high affinity binding. Site-directed mutants G333R and S336N at the alpha-helical face downstream the motif display specific changes in ligand recognition relative to wild type; G333R allows binding of 7-methyl and 8-methylxanthine, whereas S336N disrupts affinity for 6-thioxanthine. Finally, all assayable motif-mutants are highly accessible to MTSES-from the periplasmic side. The data suggest that the NAT motif region lines the solvent- and substrate-accessible inner cavity, Asn-325 is at the binding site, Ala-323 responds to binding with a specific conformational shift, and Gly-333 and Ser-336 form part of the purine permeation pathway.	[Georgopoulou, Ekaterini; Mermelekas, George; Karena, Ekaterini; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021		European Union [03ED204]	European Union(European Commission)	This work was supported by the 03ED204 research project, implemented within the framework of the "Reinforcement Programme of Human Research Manpower" (PENED) and co-financed by National and Community Funds (25% from the Greek Ministry of Development, General Secretariat for Research and Technology, and 75% from the European Union European Social Fund).	Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P6408, DOI 10.1021/bi970233b; Frillingos S, 1997, PROTEIN SCI, V6, P438; FRILLINGOS S, 1994, BIOCHEMISTRY-US, V33, P8074, DOI 10.1021/bi00192a012; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Goudela S, 2005, MOL MEMBR BIOL, V22, P263, DOI 10.1080/09687860500093016; Goudela S, 2008, FUNGAL GENET BIOL, V45, P459, DOI 10.1016/j.fgb.2007.08.001; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; KONINGS WN, 1971, J BIOL CHEM, V246, P5857; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Nie Y, 2009, BIOCHEMISTRY-US, V48, P738, DOI 10.1021/bi801976r; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Stroud Robert M., 2009, Journal of Structural and Functional Genomics, V10, P193, DOI 10.1007/s10969-008-9058-3; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Tavoulari S, 2008, J MOL BIOL, V376, P681, DOI 10.1016/j.jmb.2007.12.015; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Velho AM, 2009, EXP CELL RES, V315, P2312, DOI 10.1016/j.yexcr.2009.04.007; Vlanti A, 2006, J MOL BIOL, V357, P808, DOI 10.1016/j.jmb.2005.12.070; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961	28	19	19	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19422	19433		10.1074/jbc.M110.120543	http://dx.doi.org/10.1074/jbc.M110.120543			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406814	Green Published, hybrid			2022-12-27	WOS:000278727800053
J	Gunasekaran, K; Pentony, M; Shen, M; Garrett, L; Forte, C; Woodward, A; Bin Ng, S; Born, T; Retter, M; Manchulenko, K; Sweet, H; Foltz, IN; Wittekind, M; Yan, W				Gunasekaran, Kannan; Pentony, Martin; Shen, Min; Garrett, Logan; Forte, Carla; Woodward, Anne; Bin Ng, Soo; Born, Teresa; Retter, Marc; Manchulenko, Kathy; Sweet, Heather; Foltz, Ian N.; Wittekind, Michael; Yan, Wei			Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; COILED-COIL; CONSTANT DOMAINS; IN-VIVO; DESIGN; FRAGMENT; IDENTIFICATION; THERAPEUTICS; ASSOCIATION; INTERFACE	Naturally occurring IgG antibodies are bivalent and monospecific. Bispecific antibodies having binding specificities for two different antigens can be produced using recombinant technologies and are projected to have broad clinical applications. However, co-expression of multiple light and heavy chains often leads to contaminants and pose purification challenges. In this work, we have modified the CH3 domain interface of the antibody Fc region with selected mutations so that the engineered Fc proteins preferentially form heterodimers. These novel mutations create altered charge polarity across the Fc dimer interface such that coexpression of electrostatically matched Fc chains support favorable attractive interactions thereby promoting desired Fc heterodimer formation, whereas unfavorable repulsive charge interactions suppress unwanted Fc homodimer formation. This new Fc heterodimer format was used to produce bispecific single chain antibody fusions and monovalent IgGs with minimal homodimer contaminants. The strategy proposed here demonstrates the feasibility of robust production of novel Fc-based heterodimeric molecules and hence broadens the scope of bispecific molecules for therapeutic applications.	[Gunasekaran, Kannan; Pentony, Martin; Shen, Min; Garrett, Logan; Forte, Carla; Woodward, Anne; Wittekind, Michael; Yan, Wei] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA; [Bin Ng, Soo; Born, Teresa] Amgen Inc, Dept Inflammat, Seattle, WA 98119 USA; [Retter, Marc] Amgen Inc, Dept Pharmacokinet & Drug Metab, Seattle, WA 98119 USA; [Manchulenko, Kathy; Sweet, Heather; Foltz, Ian N.] Amgen British Columbia, Burnaby, BC V5A 1V7, Canada	Amgen; Amgen; Amgen	Gunasekaran, K (corresponding author), Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA.	kannan@amgen.com; mwitteki@amgen.com; ywei@amgen.com		Sweet, Heather/0000-0001-7478-0474				Arndt KM, 2002, STRUCTURE, V10, P1235, DOI 10.1016/S0969-2126(02)00838-9; Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; Arndt KM, 2001, J MOL BIOL, V312, P221, DOI 10.1006/jmbi.2001.4915; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; BERNSTEIN FC, 1977, J MOL BIOL, V112, P542; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; ELLERSON JR, 1976, J IMMUNOL, V116, P510; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fredericks ZL, 2004, PROTEIN ENG DES SEL, V17, P95, DOI 10.1093/protein/gzh012; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; KUNG PC, 1979, SCIENCE, V206, P347, DOI 10.1126/science.314668; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Marvin JS, 2003, BIOCHEMISTRY-US, V42, P7077, DOI 10.1021/bi026947q; MATTHEWS BW, 1995, ADV PROTEIN CHEM, V46, P249, DOI 10.1016/S0065-3233(08)60337-X; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; MILLER S, 1990, J MOL BIOL, V216, P965, DOI 10.1016/S0022-2836(99)80014-X; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Worn A, 1999, BIOCHEMISTRY-US, V38, P8739, DOI 10.1021/bi9902079; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430	33	187	393	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19637	19646		10.1074/jbc.M110.117382	http://dx.doi.org/10.1074/jbc.M110.117382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20400508	hybrid, Green Published			2022-12-27	WOS:000278727800073
J	Gupte, RS; Rawat, DK; Chettimada, S; Cioffi, DL; Wolin, MS; Gerthoffer, WT; McMurtry, IF; Gupte, SA				Gupte, Rakhee S.; Rawat, Dhawjbahadur K.; Chettimada, Sukrutha; Cioffi, Donna L.; Wolin, Michael S.; Gerthoffer, William T.; McMurtry, Ivan F.; Gupte, Sachin A.			Activation of Glucose-6-phosphate Dehydrogenase Promotes Acute Hypoxic Pulmonary Artery Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; SUPEROXIDE GENERATION; MYOSIN PHOSPHATASE; CORONARY-ARTERY; BOVINE CORONARY; RHO-KINASE; HYPERTENSION; VASOCONSTRICTION; CELLS; PATHWAY	Hypoxic pulmonary vasoconstriction (HPV) is a physiological response to a decrease in airway O-2 tension, but the underlying mechanism is incompletely understood. We studied the contribution of glucose-6-phosphate dehydrogenase (Glc-6-PD), an important regulator of NADPH redox and production of reactive oxygen species, to the development of HPV. We found that hypoxia (95% N-2, 5% CO2) increased contraction of bovine pulmonary artery (PA) precontracted with KCl or serotonin. Depletion of extracellular glucose reducedNADPH, NADH, and HPV, substantiating the idea that glucose metabolism and Glc-6-PD play roles in the response of PA to hypoxia. Our data also show that inhibition of glycolysis and mitochondrial respiration (indicated by an increase in NAD(+) and decrease in the ATP-toADP ratio) by hypoxia, or by inhibitors of pyruvate dehydrogenase or electron transport chain complexes I or III, increased generation of reactive oxygen species, which in turn activated Glc6-PD. Inhibition of Glc-6-PD decreased Ca2+ sensitivity to the myofilaments and diminished Ca2+ -independent and -dependent myosin light chain phosphorylation otherwise increased by hypoxia. Silencing Glc-6-PD expression in PA using a targeted small interfering RNA abolished HPV and decreased extracellular Ca2+-dependent PA contraction increased by hypoxia. Similarly, Glc-6-PD expression and activity were significantly reduced in lungs from Glc-6-PDmut(-/-) mice, and there was a corresponding reduction in HPV. Finally, regression analysis relating Glc-6-PD activity and the NADPH-to-NADP(+) ratio to the HPV response clearly indicated a positive linear relationship between Glc-6-PD activity and HPV. Based on these findings, we propose that Glc-6-PD and NADPH redox are crucially involved in the mechanism of HPV and, in turn, may play a key role in increasing pulmonary arterial pressure, which is involved in the development of pulmonary hypertension.	[Gupte, Rakhee S.; Rawat, Dhawjbahadur K.; Chettimada, Sukrutha; Cioffi, Donna L.; Gerthoffer, William T.; Gupte, Sachin A.] Univ S Alabama, Dept Biochem & Mol Biol, Coll Med, Mobile, AL 36688 USA; [McMurtry, Ivan F.] Univ S Alabama, Dept Pharmacol, Coll Med, Mobile, AL 36688 USA; [Wolin, Michael S.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	University of South Alabama; University of South Alabama; New York Medical College	Gupte, SA (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, Coll Med, MSB Rm 2312,307 N Univ Blvd, Mobile, AL 36688 USA.	sagupte@usouthal.edu		Chettimada, Sukrutha/0000-0002-2224-9988; Gerthoffer, William/0000-0001-5154-4962	National Institutes of Health [HL085352, HL31069, HL43023, HL66331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031069, R01HL077726, R01HL085352, P01HL043023, R01HL066331, R21HL097220, R01HL132574, R23HL031069, R37HL031069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085352, HL31069, HL43023, and HL66331.	Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; BARRON JT, 1986, ATHEROSCLEROSIS, V59, P57, DOI 10.1016/0021-9150(86)90033-X; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bonnet S, 2003, P NATL ACAD SCI USA, V100, P9488, DOI 10.1073/pnas.1633724100; Eddahibi S, 2002, EUR RESPIR J, V20, P1559, DOI 10.1183/09031936.02.00081302; EGGLESTON LV, 1974, BIOCHEM J, V138, P425, DOI 10.1042/bj1380425; Esteve JM, 2007, CELL BIOCHEM BIOPHYS, V47, P33, DOI 10.1385/CBB:47:1:33; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Fagan KA, 2004, AM J PHYSIOL-LUNG C, V287, pL656, DOI 10.1152/ajplung.00090.2003; Gao Q, 2008, AM J PHYSIOL-HEART C, V295, pH978, DOI 10.1152/ajpheart.00316.2008; Gupte SA, 2006, PULM PHARMACOL THER, V19, P303, DOI 10.1016/j.pupt.2005.08.002; Gupte SA, 2005, AM J PHYSIOL-HEART C, V288, pH13, DOI 10.1152/ajpheart.00629.2004; Gupte SA, 2003, AM J PHYSIOL-HEART C, V285, pH2316, DOI 10.1152/ajpheart.00229.2003; Gupte SA, 2002, J PHARMACOL EXP THER, V301, P299, DOI 10.1124/jpet.301.1.299; Gupte SA, 2008, ANTIOXID REDOX SIGN, V10, P1137, DOI 10.1089/ars.2007.1995; Homma N, 2008, AM J PHYSIOL-LUNG C, V295, pL71, DOI 10.1152/ajplung.90251.2008; KAUFFMAN FC, 1969, J BIOL CHEM, V244, P3647; LAMANNA JC, 1980, CIRC RES, V46, P755, DOI 10.1161/01.RES.46.6.755; Leach RM, 2002, RESP PHYSIOL NEUROBI, V132, P55, DOI 10.1016/S1569-9048(02)00049-6; Leach RM, 2001, J PHYSIOL-LONDON, V536, P211, DOI 10.1111/j.1469-7793.2001.00211.x; LEE S, 1994, PFLUG ARCH EUR J PHY, V427, P378, DOI 10.1007/BF00374548; LYNCH RM, 1983, SCIENCE, V222, P1344, DOI 10.1126/science.6658455; MARTIN GR, 1994, PHARMACOL THERAPEUT, V62, P283, DOI 10.1016/0163-7258(94)90048-5; McMurtry I F, 1982, Adv Shock Res, V8, P21; Mohazzab-H KM, 1999, AM J PHYSIOL-HEART C, V276, pH235; Oka M, 2008, BRIT J PHARMACOL, V155, P444, DOI 10.1038/bjp.2008.239; Oka M, 2007, CARDIOVASC RES, V74, P377, DOI 10.1016/j.cardiores.2007.01.021; OZAKI H, 1991, J PHYSIOL-LONDON, V440, P207, DOI 10.1113/jphysiol.1991.sp018704; Palacios-Callender M, 2007, P NATL ACAD SCI USA, V104, P18508, DOI 10.1073/pnas.0709440104; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Park MK, 1997, PFLUG ARCH EUR J PHY, V434, P764, DOI 10.1007/s004240050463; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; Perez JF, 2005, J GEN PHYSIOL, V125, P555, DOI 10.1085/jgp.200409217; Peri R, 2001, J BIOL CHEM, V276, P738, DOI 10.1074/jbc.M008445200; POST JM, 1992, AM J PHYSIOL, V262, P882; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; SATO K, 1994, J PHYSIOL-LONDON, V481, P677, DOI 10.1113/jphysiol.1994.sp020473; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Sommer N, 2008, EUR RESPIR J, V32, P1639, DOI 10.1183/09031936.00013908; STANBROOK HS, 1983, J APPL PHYSIOL, V55, P1467, DOI 10.1152/jappl.1983.55.5.1467; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Tipparaju SM, 2008, BIOCHEMISTRY-US, V47, P8840, DOI 10.1021/bi800301b; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Ward JPT, 2009, CURR OPIN PHARMACOL, V9, P287, DOI 10.1016/j.coph.2009.02.006; Ward JPT, 2004, CELL CALCIUM, V36, P209, DOI 10.1016/j.ceca.2004.02.017; Wardle RL, 2006, J PHYSIOL-LONDON, V572, P259, DOI 10.1113/jphysiol.2005.104083; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Waypa GB, 2006, CIRC RES, V99, P970, DOI 10.1161/01.RES.0000247068.75808.3f; WIENER CM, 1991, J APPL PHYSIOL, V70, P439, DOI 10.1152/jappl.1991.70.1.439; Zhao Y, 1996, EXP LUNG RES, V22, P51, DOI 10.3109/01902149609074017; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013	51	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19561	19571		10.1074/jbc.M109.092916	http://dx.doi.org/10.1074/jbc.M109.092916			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20363753	Green Published, hybrid			2022-12-27	WOS:000278727800066
J	Katz, A; Lifshitz, Y; Bab-Dinitz, E; Kapri-Pardes, E; Goldshleger, R; Tal, DM; Karlish, SJD				Katz, Adriana; Lifshitz, Yael; Bab-Dinitz, Elizabeta; Kapri-Pardes, Einat; Goldshleger, Rivka; Tal, Daniel M.; Karlish, Steven J. D.			Selectivity of Digitalis Glycosides for Isoforms of Human Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; NA+-K+-ATPASE; CARDIAC-GLYCOSIDES; PICHIA-PASTORIS; CARDIOTONIC STEROIDS; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; BINDING-SITE; OUABAIN; SUGAR	There are four isoforms of the alpha subunit (alpha 1-4) and three isoforms of the beta subunit (beta 1-3) of Na,K-ATPase, with distinct tissue-specific distribution and physiological functions. alpha 2 is thought to play a key role in cardiac and smooth muscle contraction and be an important target of cardiac glycosides. An alpha 2-selective cardiac glycoside could provide important insights into physiological and pharmacological properties of alpha 2. The isoform selectivity of a large number of cardiac glycosides has been assessed utilizing alpha 1 beta 1, alpha 2 beta 1, and alpha 3 beta 1 isoforms of human Na, K-ATPase expressed in Pichia pastoris and the purified detergent-soluble isoform proteins. Binding affinities of the digitalis glycosides, digoxin, beta-methyl digoxin, and digitoxin show moderate but highly significant selectivity (up to 4-fold) for alpha 2/beta 3 over alpha 1 (K-D alpha 1 > alpha 2 = alpha 3). By contrast, ouabain shows moderate selectivity (approximate to 2.5-fold) for alpha 1 over alpha 2 (K-D alpha 1 <= alpha 3 < alpha 2). Binding affinities for the three isoforms of digoxigenin, digitoxigenin, and all other aglycones tested are indistinguishable (K-D alpha 1 = alpha 3 = alpha 2), showing that the sugar determines isoform selectivity. Selectivity patterns for inhibition of Na, K-ATPase activity of the purified isoform proteins are consistent with binding selectivities, modified somewhat by different affinities of K+ ions for antagonizing cardiac glycoside binding on the three isoforms. The mechanistic insight on the role of the sugars is strongly supported by a recent structure of Na, K-ATPase with bound ouabain, which implies that aglycones of cardiac glycosides cannot discriminate between isoforms. In conclusion, several digitalis glycosides, but not ouabain, are moderately alpha 2-selective. This supports a major role of alpha 2 in cardiac contraction and cardiotonic effects of digitalis glycosides.	[Katz, Adriana; Lifshitz, Yael; Bab-Dinitz, Elizabeta; Kapri-Pardes, Einat; Goldshleger, Rivka; Tal, Daniel M.; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	steven.karlish@weizmann.ac.il						Ahmed A, 2006, EUR HEART J, V27, P178, DOI 10.1093/eurheartj/ehi687; AHMED K, 1983, J BIOL CHEM, V258, P8092; Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Blaustein MP, 2006, AM J PHYSIOL-REG I, V290, pR514, DOI 10.1152/ajpregu.00819.2005; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; DESPA S, 2010, BIOPHYS J, V98; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Dostanic-Larson I, 2006, AM J PHYSIOL-REG I, V290, pR524, DOI 10.1152/ajpregu.00838.2005; Dvela Moran, 2007, Pathophysiology, V14, P159, DOI 10.1016/j.pathophys.2007.09.011; FORBUSH B, 1983, CURR TOP MEMBR TRANS, V19, P167; FROM AHL, 1990, MOL CELL BIOCHEM, V94, P157, DOI 10.1007/BF00214122; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; HASHIMOTO T, 1986, J MED CHEM, V29, P997, DOI 10.1021/jm00156a017; Hauck C, 2009, EUR J PHARMACOL, V622, P7, DOI 10.1016/j.ejphar.2009.08.039; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; MANUNTA P, 1994, J HYPERTENS, V12, P549; Manunta P, 2001, HYPERTENSION, V37, P472, DOI 10.1161/01.HYP.37.2.472; Mijatovic T, 2008, EXPERT OPIN THER TAR, V12, P1403, DOI [10.1517/14728222.12.11.1403, 10.1517/14728222.12.11.1403 ]; Muller-Ehmsen J, 2001, AM J PHYSIOL-CELL PH, V281, pC1355, DOI 10.1152/ajpcell.2001.281.4.C1355; Muller-Ehmsen J, 2001, CELL MOL BIOL, V47, P373; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Pedersen PA, 1996, BIOCHEMISTRY-US, V35, P16085, DOI 10.1021/bi961614c; Perry G, 1997, NEW ENGL J MED, V336, P525; RATHORE H, 1986, J MED CHEM, V29, P1945, DOI 10.1021/jm00160a025; SATOH D, 1970, Chemical and Pharmaceutical Bulletin (Tokyo), V18, P94; SCHON R, 1995, N-S ARCH PHARMACOL, V351, P282; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; SCHONFELD W, 1985, N-S ARCH PHARMACOL, V329, P414, DOI 10.1007/BF00496377; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; Wang JN, 2001, AM J PHYSIOL-CELL PH, V281, pC1336, DOI 10.1152/ajpcell.2001.281.4.C1336; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; YODA A, 1973, MOL PHARMACOL, V9, P51; Zhang J, 2005, J PHYSIOL-LONDON, V569, P243, DOI 10.1113/jphysiol.2005.091801	46	115	124	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19582	19592		10.1074/jbc.M110.119248	http://dx.doi.org/10.1074/jbc.M110.119248			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20388710	Green Published, hybrid			2022-12-27	WOS:000278727800068
J	Nygaard, R; Valentin-Hansen, L; Mokrosinski, J; Frimurer, TM; Schwartz, TW				Nygaard, Rie; Valentin-Hansen, Louise; Mokrosinski, Jacek; Frimurer, Thomas M.; Schwartz, Thue W.			Conserved Water-mediated Hydrogen Bond Network between TM-I, -II, -VI, and -VII in 7TM Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; PROTONATION STATES; METARHODOPSIN-II; RHODOPSIN FAMILY; BOVINE RHODOPSIN; LIGAND-BINDING; SWITCH; GPCR	Five highly conserved polar residues connected by a number of structural water molecules together with two rotamer microswitches, TrpVI:13 and TyrVII:20, constitute an extended hydrogen bond network between the intracellular segments of TM-I, -II, -VI, and -VII of 7TM receptors. Molecular dynamics simulations showed that, although the fewer water molecules in rhodopsin were relatively movable, the hydrogen bond network of the beta 2-adrenergic receptor was fully loaded with water molecules that were surprisingly immobilized between the two rotamer switches, both apparently being in their closed conformation. Manipulations of the rotamer state of TyrVII:20 and TrpVI:13 demonstrated that these residues served as gates for the water molecules at the intracellular and extracellular ends of the hydrogen bond network, respectively. TrpVI:13 at the bottom of the main ligand-binding pocket was shown to apparently function as a catching trap for water molecules. Mutational analysis of the beta 2-adrenergic receptor demonstrated that the highly conserved polar residues of the hydrogen bond network were all important for receptor signaling but served different functions, some dampening constitutive activity (AsnI:18, AspII:10, and AsnVII:13), whereas others (AsnVII:12 and AsnVII:16) located one helical turn apart and sharing a water molecule were shown to be essential for agonist-induced signaling. It is concluded that the conserved water hydrogen bond network of 7TM receptors constitutes an extended allosteric interface between the transmembrane segments being of crucial importance for receptor signaling and that part of the function of the rotamer micro-switches, TyrVII:20 and TrpVI:13, is to gate or trap the water molecules.	[Nygaard, Rie; Valentin-Hansen, Louise; Mokrosinski, Jacek; Schwartz, Thue W.] Univ Copenhagen, Mol Pharmacol Lab, Inst Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn, Prot Res Ctr, DK-2200 Copenhagen, Denmark; [Nygaard, Rie; Frimurer, Thomas M.] 7TM Pharma, DK-2970 Horsholm, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Schwartz, TW (corresponding author), Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	tws@sund.ku.dk	Nygaard, Rie/B-7351-2013; Mokrosinski, Jacek/J-9506-2012; Mokrosinski, Jacek/M-1963-2019	Mokrosinski, Jacek/0000-0003-1710-1679; Mokrosinski, Jacek/0000-0001-5008-0457; Schwartz, Thue W./0000-0002-0261-6904; Frimruer, Thomas/0000-0002-9682-8245	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; European Union [223057-GIPIO]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); European Union(European Commission)	The work was supported by grants from The Danish Medical Research Council, The Novo Nordisk Foundation, The Lundbeck Foundation, and European Union's Seventh Framework Programme (Grant Agreement 223057-GIPIO).	Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Crozier PS, 2007, PROTEINS, V66, P559, DOI 10.1002/prot.21175; Crozier PS, 2003, J MOL BIOL, V333, P493, DOI 10.1016/j.jmb.2003.08.045; Donnelly D, 1999, BIOCHEM J, V339, P55, DOI 10.1042/0264-6021:3390055; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2001, J BIOL CHEM, V276, P19793, DOI 10.1074/jbc.M100621200; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Huber T, 2004, BIOPHYS J, V86, P2078, DOI 10.1016/S0006-3495(04)74268-X; Huber T, 2008, BIOCHEMISTRY-US, V47, P11013, DOI 10.1021/bi800891r; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Khelashvili G, 2009, PROTEINS, V76, P403, DOI 10.1002/prot.22355; Kholmurodov Kh T, 2007, Neurosci Behav Physiol, V37, P161, DOI 10.1007/s11055-007-0164-7; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Lau PW, 2007, J MOL BIOL, V372, P906, DOI 10.1016/j.jmb.2007.06.047; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Maragakis P, 2008, J PHYS CHEM B, V112, P6155, DOI 10.1021/jp077018h; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schertler GFX, 2008, NATURE, V453, P292, DOI 10.1038/453292a; Schlegel B, 2005, J MOL MODEL, V12, P49, DOI 10.1007/s00894-005-0004-z; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Spooner PJR, 2004, J MOL BIOL, V343, P719, DOI 10.1016/j.jmb.2004.08.049; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Vanni S, 2009, BIOCHEMISTRY-US, V48, P4789, DOI 10.1021/bi900299f; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; ZHOU W, 1994, MOL PHARMACOL, V45, P165	56	41	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19625	19636		10.1074/jbc.M110.106021	http://dx.doi.org/10.1074/jbc.M110.106021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20395291	Green Published, hybrid			2022-12-27	WOS:000278727800072
J	Cavigiolio, G; Geier, EG; Shao, BH; Heinecke, JW; Oda, MN				Cavigiolio, Giorgio; Geier, Ethan G.; Shao, Baohai; Heinecke, Jay W.; Oda, Michael N.			Exchange of Apolipoprotein A-I between Lipid-associated and Lipid-free States A POTENTIAL TARGET FOR OXIDATIVE GENERATION OF DYSFUNCTIONAL HIGH DENSITY LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABCA1-DEPENDENT CHOLESTEROL EFFLUX; FLUORESCENCE ENERGY-TRANSFER; ESTER TRANSFER PROTEIN; N-TERMINAL DOMAIN; PRE-BETA-HDL; APOA-I; METHIONINE OXIDATION; MOLECULAR REGULATION; SCAVENGER RECEPTOR; MYELOPEROXIDASE	An important event in cholesterol metabolism is the efflux of cellular cholesterol by apolipoprotein A-I (apoA-I), the major protein of high density lipoproteins (HDL). Lipid-free apoA-I is the preferred substrate for ATP-binding cassette A1, which promotes cholesterol efflux from macrophage foam cells in the arterial wall. However, the vast majority of apoA-I in plasma is associated with HDL, and the mechanisms for the generation of lipid-free apoA-I remain poorly understood. In the current study, we used fluorescently labeled apoA-I that exhibits a distinct fluorescence emission spectrum when in different states of lipid association to establish the kinetics of apoA-I transition between the lipid-associated and lipid-free states. This approach characterized the spontaneous and rapid exchange of apoA-I between the lipid-associated and lipid-free states. In contrast, the kinetics of apoA-I exchange were significantly reduced when apoA-I on HDL was cross-linked with a bi-functional reagent or oxidized by myeloperoxidase. Our observations support the hypothesis that oxidative damage to apoA-I by myeloperoxidase limits the ability of apoA-I to be liberated in a lipid-free form from HDL. This impairment of apoA-I exchange reaction may be a trait of dysfunctional HDL contributing to reduced ATP-binding cassette A1-mediated cholesterol efflux and atherosclerosis.	[Cavigiolio, Giorgio; Geier, Ethan G.; Oda, Michael N.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Shao, Baohai; Heinecke, Jay W.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of Washington; University of Washington Seattle	Oda, MN (corresponding author), 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	moda@chori.org		Cavigiolio, Giorgio/0000-0002-1622-0628; Shao, Baohai/0000-0001-8832-2845	National Institutes of Health [HL077268, HL086708, HL030086]; Tobacco-related Disease Research Program of California [16FT-0163, 16FT-0054, 18KT-0021]; National Institutes of Health, NHLBI [K99/R00, K99HL091055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL091055, R01HL086798, P01HL030086, R00HL091055, R01HL077268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program of California(University of California System); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077268, HL086708, and HL030086. This work was also supported by Tobacco-related Disease Research Program of California Grant 16FT-0163.; Supported by Postdoctoral Fellowship 16FT-0054 and New Investigator Award 18KT-0021 from the Tobacco-related Disease Research Program of California.; Supported by K99/R00 Award K99HL091055 from the National Institutes of Health, NHLBI.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Artola RL, 1997, BIOCHEM BIOPH RES CO, V239, P570, DOI 10.1006/bbrc.1997.7496; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Bernhard D, 2005, FASEB J, V19, P1096, DOI 10.1096/fj.04-3192com; BIELICKI JK, 1995, J LIPID RES, V36, P322; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Brouillette CG, 2005, BIOCHEMISTRY-US, V44, P16413, DOI 10.1021/bi051018v; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; CLAY MA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P52, DOI 10.1016/0005-2760(92)90125-F; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; DALLINGATHIE GM, 1986, J LIPID RES, V27, P1035; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DEPAUW M, 1995, BIOCHEMISTRY-US, V34, P10953, DOI 10.1021/bi00034a030; Duong PT, 2008, J LIPID RES, V49, P1006, DOI 10.1194/jlr.M700506-JLR200; Fisher CA, 1999, J LIPID RES, V40, P93; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Forster T., 1965, MODERN QUANTUM CHEM; Forte TM, 1996, J LIPID RES, V37, P1076; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Gillard BK, 2007, BIOCHEMISTRY-US, V46, P12968, DOI 10.1021/bi701525w; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Gursky O, 2005, CURR OPIN LIPIDOL, V16, P287, DOI 10.1097/01.mol.0000169348.61191.ac; Heinecke JW, 2003, AM J CARDIOL, V91, p12A; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kawashiri MA, 2002, ATHEROSCLEROSIS, V165, P15, DOI 10.1016/S0021-9150(02)00103-X; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, P367; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P3520, DOI 10.1074/jbc.272.6.3520; LIANG HQ, 1995, BBA-LIPID LIPID MET, V1257, P31, DOI 10.1016/0005-2760(95)00055-H; Liang HQ, 1996, J LIPID RES, V37, P1962; Lillo MP, 1997, BIOCHEMISTRY-US, V36, P11273, DOI 10.1021/bi970789z; Lund-Katz S, 2010, J LIPID RES, V51, P606, DOI 10.1194/jlr.M002055; Lusa S, 1996, BIOCHEM J, V313, P275, DOI 10.1042/bj3130275; Maiorano JN, 2004, BIOCHEMISTRY-US, V43, P11717, DOI 10.1021/bi0496642; Malle E, 2006, ARCH BIOCHEM BIOPHYS, V445, P245, DOI 10.1016/j.abb.2005.08.008; MALMENDIER CL, 1983, CLIN CHIM ACTA, V131, P201, DOI 10.1016/0009-8981(83)90089-X; Marcel YL, 2008, CURR OPIN LIPIDOL, V19, P455, DOI 10.1097/MOL.0b013e32830f4a1d; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MASSEY JB, 1981, BIOCHEM BIOPH RES CO, V99, P466, DOI 10.1016/0006-291X(81)91768-X; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Miyazaki M, 2009, BIOCHEMISTRY-US, V48, P7756, DOI 10.1021/bi900785x; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Navab Mohamad, 2007, Curr Atheroscler Rep, V9, P244, DOI 10.1007/s11883-007-0026-3; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Oda MN, 2001, BIOCHEMISTRY-US, V40, P1710, DOI 10.1021/bi001922h; Okuhira K, 2004, J LIPID RES, V45, P645, DOI 10.1194/jlr.M300257-JLR200; PASZTY C, 1994, J CLIN INVEST, V94, P899, DOI 10.1172/JCI117412; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Pennathur Subramaniam, 2007, Curr Diab Rep, V7, P257, DOI 10.1007/s11892-007-0041-3; Petersen M, 2005, CLIN CHEM, V51, P1457, DOI 10.1373/clinchem.2004.046748; Phu MJ, 2005, J NEUROSCI RES, V80, P877, DOI 10.1002/jnr.20503; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Pownall HJ, 2007, BIOCHEMISTRY-US, V46, P7449, DOI 10.1021/bi700496w; Pownall HJ, 2005, BIOCHEMISTRY-US, V44, P9714, DOI 10.1021/bi050729q; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; REIJNGOUD DJ, 1982, BIOCHEMISTRY-US, V21, P2969, DOI 10.1021/bi00541a026; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; RYAN RO, 1992, BIOCHEMISTRY-US, V31, P4509, DOI 10.1021/bi00133a018; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Rye KA, 1997, J BIOL CHEM, V272, P3953, DOI 10.1074/jbc.272.7.3953; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Schobel U, 1999, BIOCONJUGATE CHEM, V10, P1107, DOI 10.1021/bc990073b; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Yamamoto T, 2006, J LIPID RES, V47, P1091, DOI 10.1194/jlr.D600001-JLR200; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	94	72	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18847	18857		10.1074/jbc.M109.098434	http://dx.doi.org/10.1074/jbc.M109.098434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385548	Green Published, hybrid			2022-12-27	WOS:000278453900075
J	Matsuyama, R; Takada, I; Yokoyama, A; Fujiyma-Nakamura, S; Tsuji, N; Kitagawa, H; Fujiki, R; Kim, M; Kouzu-Fujita, M; Yano, T; Kato, S				Matsuyama, Reiko; Takada, Ichiro; Yokoyama, Atsushi; Fujiyma-Nakamura, Sally; Tsuji, Naoya; Kitagawa, Hirochika; Fujiki, Ryoji; Kim, Misun; Kouzu-Fujita, Madoka; Yano, Tetsu; Kato, Shigeaki			Double PHD Fingers Protein DPF2 Recognizes Acetylated Histones and Suppresses the Function of Estrogen-related Receptor alpha through Histone Deacetylase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; NUCLEAR RECEPTOR; ERR-ALPHA; ADAPTIVE THERMOGENESIS; CRYSTAL-STRUCTURE; GENE; COACTIVATOR; LIGAND; GAMMA; EXPRESSION	Estrogen-related receptor alpha (ERR alpha) is a member of the nuclear receptor superfamily and regulates many physiological functions, including mitochondrial biogenesis and lipid metabolism. ERR alpha enhances the transactivation function without endogenous ligand by associating with coactivators such as peroxisome proliferator-activated receptor gamma coactivator 1 alpha and beta (PGC-1 alpha and -beta) and members of the steroid receptor coactivator family. However, the molecular mechanism by which the transactivation function of ERR alpha is converted from a repressive state to an active state is poorly understood. Here we used biochemical purification techniques to identify ERR alpha-associated proteins in HeLa cells stably expressing ERR alpha. Interestingly, we found that double PHD fingers protein DPF2/BAF45d suppressed PGC-1 alpha-dependent transactivation of ERR alpha by recognizing acetylated histone H3 and associating with HDAC1. DPF2 directly bound to ERR alpha and suppressed the transactivation function of nuclear receptors such as androgen receptor. DPF2 was recruited to ERR target gene promoters in myoblast cells, and knockdown of DPF2 derepressed the level of mRNA expressed by target genes of ERR alpha. These results show that DPF2 acts as a nuclear receptor-selective co-repressor for ERR alpha by associating with both acetylated histone H3 and HDAC1.	[Matsuyama, Reiko; Takada, Ichiro; Yokoyama, Atsushi; Fujiyma-Nakamura, Sally; Tsuji, Naoya; Kitagawa, Hirochika; Fujiki, Ryoji; Kim, Misun; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Matsuyama, Reiko; Kouzu-Fujita, Madoka; Yano, Tetsu] Univ Tokyo, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan; [Yokoyama, Atsushi; Fujiyma-Nakamura, Sally; Kato, Shigeaki] Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp	Yokoyama, Atsushi/W-3519-2019	Yokoyama, Atsushi/0000-0003-2842-4334	Nakatomi Foundation; Cell Science Research Foundation; Ministry of Education, Science, Sports, and Culture of Japan	Nakatomi Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for Basic Research on Priority Areas (Dynamics of Extracellular Environments), The Nakatomi Foundation, The Cell Science Research Foundation (to I. T.), and a grant-in-aid for Basic Research Activities for Innovative Biosciences (BRAIN) and Priority Areas from the Ministry of Education, Science, Sports, and Culture of Japan (to S. K.).	Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018; BUCHMAN VL, 1992, NUCLEIC ACIDS RES, V20, P5579, DOI 10.1093/nar/20.21.5579; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; GABIG TG, 1994, J BIOL CHEM, V269, P29515; Huang EY, 2000, GENE DEV, V14, P45; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Kallen J, 2007, J BIOL CHEM, V282, P23231, DOI 10.1074/jbc.M703337200; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kishimoto M, 2006, ENDOCR J, V53, P157, DOI 10.1507/endocrj.53.157; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Matsui D, 2002, NUCLEIC ACIDS RES, V30, P1387, DOI 10.1093/nar/30.6.1387; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Mertsalov I. B., 2000, Genetika, V36, P314; Ninkina NN, 2001, MAMM GENOME, V12, P862, DOI 10.1007/s00335-001-3039-1; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Yamamoto A, 2000, J CELL BIOL, V150, P873, DOI 10.1083/jcb.150.4.873; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07	37	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18166	18176		10.1074/jbc.M109.077024	http://dx.doi.org/10.1074/jbc.M109.077024			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400511	Green Published, hybrid			2022-12-27	WOS:000278453900007
J	Miedlich, SU; Zalutskaya, A; Zhu, ED; Demay, MB				Miedlich, Susanne U.; Zalutskaya, Alena; Zhu, Eric D.; Demay, Marie B.			Phosphate-induced Apoptosis of Hypertrophic Chondrocytes Is Associated with a Decrease in Mitochondrial Membrane Potential and Is Dependent upon Erk1/2 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; SIGNALING PATHWAY; RICKETS; MATURATION; MICE; MINERALIZATION; EXPRESSION	Growth plate abnormalities, associated with impaired hypertrophic chondrocyte apoptosis, are observed in humans and animals with abnormalities of vitamin D action and renal phosphate reabsorption. Low circulating phosphate levels impair hypertrophic chondrocyte apoptosis, whereas treatment of these cells with phosphate activates the mitochondrial apoptotic pathway. Because phosphate-mediated apoptosis of chondrocytes is differentiation-dependent, studies were performed to identify factors that contribute to hypertrophic chondrocyte apoptosis. An increase in the percentage of cells with low mitochondrial membrane potential, evaluated by JC-1 fluorescence, was observed during hypertrophic differentiation of primary murine chondrocytes in culture. This percentage was further increased by treatment of hypertrophic, but not proliferative, chondrocytes with phosphate. Phosphate-mediated apoptosis was observed as early as 30 min post-treatment and was dependent upon Erk1/2 phosphorylation. Inhibition of Erk1/2 phosphorylation in vivo confirmed an important role for this signaling pathway in regulating hypertrophic chondrocyte apoptosis in growing mice. Murine embryonic metatarsals cultured under phosphate-restricted conditions demonstrated a 2.5-fold increase in parathyroid hormone-related protein mRNA expression accompanied by a marked attenuation in phospho-Erk immunoreactivity in hypertrophic chondrocytes. Thus, these investigations point to an important role for phosphate in regulating mitochondrial membrane potential in hypertrophic chondrocytes and growth plate maturation by the parathyroid hormone-related protein signaling pathway.	[Miedlich, Susanne U.; Zalutskaya, Alena; Zhu, Eric D.; Demay, Marie B.] Harvard Univ, Endocrine Unit, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Demay, MB (corresponding author), Harvard Univ, Endocrine Unit, Sch Med, Massachusetts Gen Hosp, 50 Blossom St,Thier 11, Boston, MA 02114 USA.	demay@helix.mgh.harvard.edu			National Institutes of Health [R01 DK46974, P50 AR054086, T32 DK007028]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046974, T32DK007028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK46974, P50 AR054086, and T32 DK007028.	Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Chang WH, 2002, ENDOCRINOLOGY, V143, P1467, DOI 10.1210/en.143.4.1467; Donohue MM, 2002, ENDOCRINOLOGY, V143, P3691, DOI 10.1210/en.2002-220454; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Li YP, 2004, AM J PHYSIOL-REG I, V287, pR328, DOI 10.1152/ajpregu.00042.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Okoumassoun LE, 2007, J CELL PHYSIOL, V212, P591, DOI 10.1002/jcp.21055; Oshima Y, 2008, J BIOL CHEM, V283, P26499, DOI 10.1074/jbc.M800933200; PETTIFOR MP, 1997, VITAMIN D DEFICIENCY; Provot S, 2008, MOL CELL BIOL, V28, P344, DOI 10.1128/MCB.00617-07; Pucci R, 2007, J CELL PHYSIOL, V210, P609, DOI 10.1002/jcp.20857; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Teixeira CC, 2003, J BONE MINER RES, V18, P662, DOI 10.1359/jbmr.2003.18.4.662; Teixeira CC, 2001, AM J PHYSIOL-CELL PH, V281, pC833, DOI 10.1152/ajpcell.2001.281.3.C833; Ueda K, 2007, BONE, V41, P13, DOI 10.1016/j.bone.2007.02.028; Zalutskaya AA, 2009, J CELL BIOCHEM, V108, P668, DOI 10.1002/jcb.22302	22	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18270	18275		10.1074/jbc.M109.098616	http://dx.doi.org/10.1074/jbc.M109.098616			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404333	Green Published, hybrid			2022-12-27	WOS:000278453900019
J	Serra-Perez, A; Planas, AM; Nunez-O'Mara, A; Berra, E; Garcia-Villoria, J; Ribes, A; Santalucia, T				Serra-Perez, Anna; Planas, Anna M.; Nunez-O'Mara, Analia; Berra, Edurne; Garcia-Villoria, Judit; Ribes, Antonia; Santalucia, Tomas			Extended Ischemia Prevents HIF1 alpha Degradation at Reoxygenation by Impairing Prolyl-hydroxylation ROLE OF KREBS CYCLE METABOLITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; LINDAU TUMOR-SUPPRESSOR; MAMMALIAN TARGET; CELL-METABOLISM; GLUCOSE DEPRIVATION; CEREBRAL-ISCHEMIA; MOUSE MODEL; HIF-ALPHA; HIF-1-ALPHA; OXYGEN	Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that activates the cellular response to hypoxia. The HIF1 alpha subunit is constantly synthesized and degraded under normoxia, but degradation is rapidly inhibited when oxygen levels drop. Oxygen-dependent hydroxylation by prolyl-4-hydroxylases (PHD) mediates HIF1 alpha proteasome degradation. Brain ischemia limits the availability not only of oxygen but also of glucose. We hypothesized that this circumstance could have a modulating effect on HIF. We assessed the separate involvement of oxygen and glucose in HIF1 alpha regulation in differentiated neuroblastoma cells subjected to ischemia. We report higher transcriptional activity and HIF1 alpha expression under oxygen deprivation in the presence of glucose (OD), than in its absence (oxygen and glucose deprivation, OGD). Unexpectedly, HIF1 alpha was not degraded at reoxygenation after an episode of OGD. This was not due to impairment of proteasome function, but was associated with lower HIF1 alpha hydroxylation. Krebs cycle metabolites fumarate and succinate are known inhibitors of PHD, while zeta-ketoglutarate is a co-substrate of the reaction. Lack of HIF1 alpha degradation in the presence of oxygen was accompanied by a very low alpha-ketoglutarate/fumarate ratio. Furthermore, treatment with a fumarate analogue prevented HIF1 alpha degradation under normoxia. In all, our data suggest that postischemic metabolic alterations in Krebs cycle metabolites impair HIF1 alpha degradation in the presence of oxygen by decreasing its hydroxylation, and highlight the involvement of metabolic pathways in HIF1 alpha regulation besides the well known effects of oxygen.	[Serra-Perez, Anna; Planas, Anna M.; Santalucia, Tomas] IIBB CSIC IDIBAPS, Dept Brain Ischemia & Neurodegenerat, E-08036 Barcelona, Spain; [Nunez-O'Mara, Analia; Berra, Edurne] Cooperat Res Ctr Biosci, Cell Biol & Stem Cells Unit, Derio 48160, Spain; [Garcia-Villoria, Judit; Ribes, Antonia] IDIBAPS, Dept Biochem & Mol Genet, Barcelona 08028, Spain; [Garcia-Villoria, Judit; Ribes, Antonia] IDIBAPS, CIBERER, Barcelona 08028, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Santalucia, T (corresponding author), IIBB CSIC IDIBAPS, Dept Brain Ischemia & Neurodegenerat, Rossello 161,6th Floor, E-08036 Barcelona, Spain.	tomas.santalucia@iibb.csic.es	Berra, Edurne/F-9692-2011; cancer, biogune/H-7276-2012; Garcia, Judit/AAN-1753-2021; Planas, Anna M/J-5991-2014; Santalucia, Tomas/I-7411-2012; Santalucia, Tomas/B-6140-2012	Berra, Edurne/0000-0002-3820-5744; Planas, Anna M/0000-0002-6147-1880; Santalucia, Tomas/0000-0003-4604-9195; Santalucia, Tomas/0000-0003-4604-9195; Ribes Rubio, Antonia/0000-0002-2249-246X	MICINN [SAF2005-05793-C02-02, SAF2008-04515-C02-02]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was funded by projects from MICINN (Projects SAF2005-05793-C02-02 and SAF2008-04515-C02-02).	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Banasiak KJ, 1998, BRAIN RES, V797, P295, DOI 10.1016/S0006-8993(98)00286-8; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Boulahbel H, 2009, BIOCHEM SOC T, V37, P291, DOI 10.1042/BST0370291; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Guo SH, 2009, J NEUROCHEM, V108, P1309, DOI 10.1111/j.1471-4159.2009.05877.x; Halterman MW, 1999, J NEUROSCI, V19, P6818, DOI 10.1523/JNEUROSCI.19-16-06818.1999; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Lee MN, 2009, MOL CELL BIOL, V29, P3991, DOI 10.1128/MCB.00165-09; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Mole DR, 2001, IUBMB LIFE, V52, P43; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; RIBES A, 1992, J INHERIT METAB DIS, V15, P367, DOI 10.1007/BF02435978; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Serra-Perez A, 2008, J NEUROCHEM, V106, P1237, DOI 10.1111/j.1471-4159.2008.05467.x; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; TANAKA K, 1980, CLIN CHEM, V26, P1847; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Vordermark D, 2005, CANCER LETT, V230, P122, DOI 10.1016/j.canlet.2004.12.040; YAGER JY, 1991, AM J PHYSIOL, V261, pH1102, DOI 10.1152/ajpheart.1991.261.4.H1102; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhou Jing, 2008, Kobe J Med Sci, V53, P283	40	35	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18217	18224		10.1074/jbc.M110.101048	http://dx.doi.org/10.1074/jbc.M110.101048			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20368331	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000278453900013
J	Staples, GO; Shi, XF; Zaia, J				Staples, Gregory O.; Shi, Xiaofeng; Zaia, Joseph			Extended N-Sulfated Domains Reside at the Nonreducing End of Heparan Sulfate Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; HEPARIN/HEPARAN SULFATE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; CELL-SURFACE; FACTOR FGF; K5 LYASE; RECEPTOR; BINDING; SPECIFICITY	Heparan sulfate (HS) serves as a cell-surface co-receptor for growth factors, morphogens, and chemokines. These HS and protein binding events depend on the fine structure and distribution of domains along an HS chain. A given domain can vary in terms of uronic acid epimer, N- and O-sulfate, and N-acetate content. The most highly sulfated regions of HS chains, N-sulfated (NS) domains, play prominent roles in HS and protein binding. We have analyzed HS oligosaccharides from various mammalian sources and provide evidence that NS domains residing at the nonreducing end (NRE) are, on average, longer than those residing in the internal regions of the chain. Additionally, they are more highly sulfated than their internal counterparts. These features are independent of the sulfation pattern of the bulk HS chains. From disaccharide analysis, it is clear that NS domains do not always occupy HS NREs. However, when they do, they tend to terminate in a subset of N-sulfated disaccharides. Our observations are consistent with a significant role of NRE NS domains in HS-growth factor interactions.	[Staples, Gregory O.; Shi, Xiaofeng; Zaia, Joseph] Boston Univ, Sch Med, Dept Biochem, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA	Boston University	Zaia, J (corresponding author), 670 Albany St,Rm 509, Boston, MA 02118 USA.	jzaia@bu.edu	Shi, Xiaofeng/B-8700-2011; Zaia, Joseph/U-7850-2019	Zaia, Joseph/0000-0001-9497-8701	National Institutes of Health [P41RR10888]; Agilent Technologies Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agilent Technologies Foundation(Principality of Asturias); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P41RR10888. This work was also supported by the Agilent Technologies Foundation through a Research Project Gift.	Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Hitchcock AM, 2006, BIOCHEMISTRY-US, V45, P2350, DOI 10.1021/bi052100t; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; LYON M, 1994, J BIOL CHEM, V269, P11216; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MIDURA RJ, 1995, J BIOL CHEM, V270, P8009, DOI 10.1074/jbc.270.14.8009; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Oesterholm C, 2009, J BIOL CHEM, V284, P34935, DOI 10.1074/jbc.M109.005264; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; STAPLES G, 2009, P 57 ASMS C MASS SPE; STAPLES GO, 2010, ANAL CHEM IN PRESS; Staples GO, 2009, PROTEOMICS, V9, P686, DOI 10.1002/pmic.200701008; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wu ZLL, 2005, J BIOL CHEM, V280, P33749, DOI 10.1074/jbc.M505677200; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Xu XL, 2007, J BIOL CHEM, V282, P2363, DOI 10.1074/jbc.M604218200; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200	47	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18336	18343		10.1074/jbc.M110.101592	http://dx.doi.org/10.1074/jbc.M110.101592			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20363743	Green Published, hybrid			2022-12-27	WOS:000278453900027
J	Vilardo, E; Barbato, C; Ciotti, M; Cogoni, C; Ruberti, F				Vilardo, Elisa; Barbato, Christian; Ciotti, MariaTeresa; Cogoni, Carlo; Ruberti, Francesca			MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; ALZHEIMERS-DISEASE; SECRETASE ACTIVITY; PROSTAGLANDIN E-2; CELL-LINES; BRAIN; IDENTIFICATION; INTERLEUKIN-1; GENE; REGION	The amyloid precursor protein (APP) and its proteolytic product amyloid beta (A beta) are associated with both familial and sporadic forms of Alzheimer disease (AD). Aberrant expression and function of microRNAs has been observed in AD. Here, we show that in rat hippocampal neurons cultured in vitro, the down-regulation of Argonaute-2, a key component of the RNA-induced silencing complex, produced an increase in APP levels. Using site-directed mutagenesis, a microRNA responsive element (RE) for miR-101 was identified in the 3'-untranslated region (UTR) of APP. The inhibition of endogenous miR-101 increased APP levels, whereas lentiviral-mediated miR-101 overexpression significantly reduced APP and A beta load in hippocampal neurons. In addition, miR-101 contributed to the regulation of APP in response to the proinflammatory cytokine interleukin-1 beta (IL-1 beta). Thus, miR-101 is a negative regulator of APP expression and affects the accumulation of A beta, suggesting a possible role for miR-101 in neuropathological conditions.	[Vilardo, Elisa; Barbato, Christian; Ciotti, MariaTeresa; Ruberti, Francesca] CNR, INMM, I-00143 Rome, Italy; [Barbato, Christian; Cogoni, Carlo] Fdn EBRI Rita Levi Montalcini, EBRI, I-00143 Rome, Italy; [Cogoni, Carlo] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, I-00161 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	Ruberti, F (corresponding author), CNR, INMM, Via Fosso Fiorano 64-65, I-00143 Rome, Italy.	francesca.ruberti@inmm.cnr.it	Vilardo, Elisa/F-3656-2010; Barbato, Christian/B-8080-2015	Vilardo, Elisa/0000-0003-2733-6009; Barbato, Christian/0000-0003-1737-9064; Ruberti, Francesca/0000-0001-5880-9564	National Research Council (CNR) [DG.RSTL.059.012]; Compagnia di San Paolo-Programma Neuroscienze; REGIONE LAZIO	National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Compagnia di San Paolo-Programma Neuroscienze(Compagnia di San Paolo); REGIONE LAZIO(Regione Lazio)	This work was supported by National Research Council (CNR) Grant DG.RSTL.059.012 (to F. R.) and partially supported by Compagnia di San Paolo-Programma Neuroscienze (to C. B.) and REGIONE LAZIO grant (to C. C.).	Amara FM, 1999, MOL BRAIN RES, V71, P42, DOI 10.1016/S0169-328X(99)00158-8; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/871313; Barbato C, 2010, J NEUROCHEM, V113, P591, DOI 10.1111/j.1471-4159.2009.06560.x; Barbato C, 2008, MAMM GENOME, V19, P541, DOI 10.1007/s00335-008-9129-6; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Broytman O, 2009, NEUROBIOL AGING, V30, P1962, DOI 10.1016/j.neurobiolaging.2008.02.011; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; DEL BR, 1995, NEUROSCI LETT, V188, P70; Dewji NN, 1996, MOL BRAIN RES, V35, P325, DOI 10.1016/0169-328X(95)00214-D; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Ge YW, 2004, J NEUROCHEM, V90, P1432, DOI 10.1111/j.1471-4159.2004.02608.x; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GONZALEZGONZALE.E, 2008, BIOCH BIOPHYS ACTA G, V1179, P306; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Hong X, 2009, P NATL ACAD SCI USA, V106, P15085, DOI 10.1073/pnas.0908149106; Hoshino T, 2007, J BIOL CHEM, V282, P32676, DOI 10.1074/jbc.M703087200; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee RKK, 1999, J NEUROSCI, V19, P940; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; PODLISNY MB, 1987, SCIENCE, V238, P669, DOI 10.1126/science.2960019; Rogers JT, 1999, J BIOL CHEM, V274, P6421, DOI 10.1074/jbc.274.10.6421; Romano A, 2003, BEHAV BRAIN RES, V147, P73, DOI 10.1016/S0166-4328(03)00118-9; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Theuns J, 2000, HUM MOL GENET, V9, P2383, DOI 10.1093/hmg/9.16.2383; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Viviani B, 2003, J NEUROSCI, V23, P8692; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Westmark PR, 2006, NEUROBIOL AGING, V27, P787, DOI 10.1016/j.neurobiolaging.2006.03.003; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24007	49	157	174	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18344	18351		10.1074/jbc.M110.112664	http://dx.doi.org/10.1074/jbc.M110.112664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395292	Green Published, hybrid			2022-12-27	WOS:000278453900028
J	Haq, SR; Jurgens, MC; Chi, CN; Koh, CS; Elfstrom, L; Selmer, M; Gianni, S; Jemth, P				Haq, S. Raza; Jurgens, Maike C.; Chi, Celestine N.; Koh, Cha-San; Elfstrom, Lisa; Selmer, Maria; Gianni, Stefano; Jemth, Per			The Plastic Energy Landscape of Protein Folding A TRIANGULAR FOLDING MECHANISM WITH AN EQUILIBRIUM INTERMEDIATE FOR A SMALL PROTEIN DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ON-PATHWAY INTERMEDIATE; PDZ DOMAIN; TRANSITION-STATES; KINETIC-ANALYSIS; 3-STATE MODEL; IM7; REFINEMENT	Protein domains usually fold without or with only transiently populated intermediates, possibly to avoid misfolding, which could result in amyloidogenic disease. Whether observed intermediates are productive and obligatory species on the folding reaction pathway or dispensable by-products is a matter of debate. Here, we solved the crystal structure of a small protein domain, SAP97 PDZ2 I342W C378A, and determined its folding pathway. The presence of a folding intermediate was demonstrated both by single and double-mixing kinetic experiments using urea-induced (un) folding as well as ligand-induced folding. This protein domain was found to fold via a triangular scheme, where the folding intermediate could be either on-or off-pathway, depending on the experimental conditions. Furthermore, we found that the intermediate was present at equilibrium, which is rarely seen in folding reactions of small protein domains. The folding mechanism observed here illustrates the roughness and plasticity of the protein folding energy landscape, where several routes may be employed to reach the native state. The results also reconcile the folding mechanisms of topological variants within the PDZ domain family.	[Jurgens, Maike C.; Koh, Cha-San; Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; [Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Gianni, Stefano] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Gianni, Stefano] Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy	Uppsala University; Uppsala University; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Selmer, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden.	Maria.Selmer@icm.uu.se; Stefano.Gianni@uniroma1.it; Per.Jemth@imbim.uu.se	gianni, stefano/C-8536-2009	Gianni, Stefano/0000-0003-1653-1925	Swedish Research Council; Edla Johansson's Foundation; Carl Trygger's Foundation; Jeansson's Foundation; Clas Groschinskys Minnesfond; Swedish Foundation for Strategic Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Edla Johansson's Foundation; Carl Trygger's Foundation; Jeansson's Foundation; Clas Groschinskys Minnesfond; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Research Council (to P. J. and M. S.), O. E. and Edla Johansson's Foundation, Carl Trygger's Foundation, Jeansson's Foundation, Clas Groschinskys Minnesfond (to P. J.), and the Swedish Foundation for Strategic Research (to M. S.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68; Chi CN, 2007, FEBS LETT, V581, P1109, DOI 10.1016/j.febslet.2007.02.011; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P14121, DOI 10.1073/pnas.260502597; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2005, PROTEIN ENG DES SEL, V18, P389, DOI 10.1093/protein/gzi047; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gianni S, 2003, J MOL BIOL, V330, P1145, DOI 10.1016/S0022-2836(03)00689-2; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Ivarsson Y, 2008, PROTEIN ENG DES SEL, V21, P155, DOI 10.1093/protein/gzm077; Ivarsson Y, 2007, J BIOL CHEM, V282, P8568, DOI 10.1074/jbc.M611026200; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; KIELHABER T, 1995, P NATL ACAD SCI USA, V92, P9029; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Liu Y, 2007, BIOCHEMISTRY-US, V46, P10864, DOI 10.1021/bi700879k; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Sauder JM, 1996, BIOCHEMISTRY-US, V35, P16852, DOI 10.1021/bi961976k; Spence GR, 2004, J MOL BIOL, V341, P215, DOI 10.1016/j.jmb.2004.05.049; Travaglini-Allocatelli C, 2004, TRENDS BIOCHEM SCI, V29, P535, DOI 10.1016/j.tibs.2004.08.004; Travaglini-Allocatelli C, 2003, J BIOL CHEM, V278, P41136, DOI 10.1074/jbc.M303990200; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030; Zhang Y, 2007, J VIROL, V81, P3618, DOI 10.1128/JVI.02044-06	47	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18051	18059		10.1074/jbc.M110.110833	http://dx.doi.org/10.1074/jbc.M110.110833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356847	Green Published, hybrid			2022-12-27	WOS:000278133400080
J	Ohtsu, I; Wiriyathanawudhiwong, N; Morigasaki, S; Nakatani, T; Kadokura, H; Takagi, H				Ohtsu, Iwao; Wiriyathanawudhiwong, Natthawut; Morigasaki, Susumu; Nakatani, Takeshi; Kadokura, Hiroshi; Takagi, Hiroshi			The L-Cysteine/L-Cystine Shuttle System Provides Reducing Equivalents to the Periplasm in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-BOND-FORMATION; HYDROGEN-PEROXIDE; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; PROTEIN; TRANSPORTER; GLUTATHIONE; GENE; EXPRESSION; K-12	Intracellular thiols like L-cysteine and glutathione play a critical role in the regulation of cellular processes. Escherichia coli has multiple L-cysteine transporters, which export L-cysteine from the cytoplasm into the periplasm. However, the role of L-cysteine in the periplasm remains unknown. Here we show that an L-cysteine transporter, YdeD, is required for the tolerance of E. coli cells to hydrogen peroxide. We also present evidence that L-cystine, a product from the oxidation of L-cysteine by hydrogen peroxide, is imported back into the cytoplasm in a manner dependent on FliY, the periplasmic L-cystine-binding protein. Remarkably, this protein, which is involved in the recycling of the oxidized L-cysteine, is also found to be important for the hydrogen peroxide resistance of this organism. Furthermore, our analysis of the transcription of relevant genes revealed that the transcription of genes encoding FliY and YdeD is highly induced by hydrogen peroxide rather than by L-cysteine. These findings led us to propose that the inducible L-cysteine/L-cystine shuttle system plays an important role in oxidative stress tolerance through providing a reducing equivalent to the periplasm in E. coli.	[Ohtsu, Iwao; Wiriyathanawudhiwong, Natthawut; Morigasaki, Susumu; Nakatani, Takeshi; Kadokura, Hiroshi; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Nara Institute of Science & Technology	Ohtsu, I (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	iohtsu@bs.naist.jp	Morigasaki, Susumu/Q-6981-2017; Kadokura, Hiroshi/AAE-1645-2019	Morigasaki, Susumu/0000-0002-6938-5119; Takagi, Hiroshi/0000-0002-1786-3174; Kadokura, Hiroshi/0000-0001-7308-7141; Ohtsu, Iwao/0000-0002-3553-0306	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Ajinomoto Co., Inc.; JSPS [21580092]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ajinomoto Co., Inc.; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by KAKENHI (Grant-in-Aid for Young Scientists on priority areas (B) and funding from the NAIST Global COE Program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to I. O.). This work was also supported in part by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Applied Genomics" from MEXT of Japan and by a grant from Ajinomoto Co., Inc. (to I. O. and H. T.). This work was further supported in part by an international research fellowship from the Global COE Program in NAIST from MEXT of Japan and a Grant-in-Aid for Scientific Research (C) (21580092) from JSPS (to H. K.).	Baba Tomoya, 2008, V416, P171, DOI 10.1007/978-1-59745-321-9_11; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BUTLER JD, 1993, LIFE SCI, V52, P1209, DOI 10.1016/0024-3205(93)90103-A; Dassler T, 2000, MOL MICROBIOL, V36, P1101, DOI 10.1046/j.1365-2958.2000.01924.x; DENK D, 1987, J GEN MICROBIOL, V133, P515; Eser M, 2009, P NATL ACAD SCI USA, V106, P1572, DOI 10.1073/pnas.0812596106; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; GREENBERG JT, 1986, J BACTERIOL, V168, P1026, DOI 10.1128/jb.168.2.1026-1029.1986; HARRIS CL, 1981, J BACTERIOL, V145, P1031, DOI 10.1128/JB.145.2.1031-1035.1981; HOHMANN S, 2003, YEAST STRESS RESPONS, P242; Hung J, 2003, FEMS MICROBIOL LETT, V227, P93, DOI 10.1016/S0378-1097(03)00653-0; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kaino T, 2008, APPL MICROBIOL BIOT, V79, P273, DOI 10.1007/s00253-008-1431-4; Kaur J, 2007, GENETICS, V176, P877, DOI 10.1534/genetics.107.070342; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; LEHMANN A, 1993, EUR J NEUROSCI, V5, P1398, DOI 10.1111/j.1460-9568.1993.tb00926.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Olm E, 2009, P NATL ACAD SCI USA, V106, P11400, DOI 10.1073/pnas.0902204106; Ozkan Y, 2002, INT J CARDIOL, V82, P269, DOI 10.1016/S0167-5273(02)00010-4; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sambrook J., 1989, MOLECULAR CLONING LA, V2 nd; SORENSEN MA, 1991, J BACTERIOL, V173, P5244, DOI 10.1128/jb.173.16.5244-5246.1991; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; Tao K, 2008, FEMS MICROBIOL LETT, V289, P41, DOI 10.1111/j.1574-6968.2008.01372.x; WINTERHALTER C, 1997, MICROORGANISMS PROCE; Wiriyathanawudhiwong N, 2009, APPL MICROBIOL BIOT, V81, P903, DOI 10.1007/s00253-008-1686-9	37	81	85	4	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17479	17487		10.1074/jbc.M109.081356	http://dx.doi.org/10.1074/jbc.M109.081356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351115	Green Published, hybrid			2022-12-27	WOS:000278133400026
J	Schott, A; Ravaud, S; Keller, S; Radzimanowski, J; Viotti, C; Hillmer, S; Sinning, I; Strahl, S				Schott, Andrea; Ravaud, Stephanie; Keller, Sabrina; Radzimanowski, Jens; Viotti, Corrado; Hillmer, Stefan; Sinning, Irmgard; Strahl, Sabine			Arabidopsis Stromal-derived Factor2 (SDF2) Is a Crucial Target of the Unfolded Protein Response in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREVACUOLAR COMPARTMENT; QUALITY-CONTROL; STRESS; GENE; SEQUENCE; INSIGHTS; PATTERN; COMPLEX; YEAST	Stresses increasing the load of unfolded proteins that enter the endoplasmic reticulum (ER) trigger a protective response termed the unfolded protein response (UPR). Stromal cell-derived factor2 (SDF2)-type proteins are highly conserved throughout the plant and animal kingdoms. In this study we have characterized AtSDF2 as crucial component of the UPR in Arabidopsis thaliana. Using a combination of biochemical and cell biological methods, we demonstrate that SDF2 is induced in response to ER stress conditions causing the accumulation of unfolded proteins. Transgenic reporter plants confirmed induction of SDF2 during ER stress. Under normal growth conditions SDF2 is highly expressed in fast growing, differentiating cells and meristematic tissues. The increased production of SDF2 due to ER stress and in tissues that require enhanced protein biosynthesis and secretion, and its association with the ER membrane qualifies SDF2 as a downstream target of the UPR. Determination of the SDF2 three-dimensional crystal structure at 1.95 angstrom resolution revealed the typical beta-trefoil fold with potential carbohydrate binding sites. Hence, SDF2 might be involved in the quality control of glycoproteins. Arabidopsis sdf2 mutants display strong defects and morphological phenotypes during seedling development specifically under ER stress conditions, thus establishing that SDF2-type proteins play a key role in the UPR.	[Ravaud, Stephanie; Radzimanowski, Jens; Sinning, Irmgard] Heidelberg Univ, Heidelberg Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Schott, Andrea; Keller, Sabrina; Strahl, Sabine] Heidelberg Univ, Dept Cell Chem, Inst Plant Sci, D-69120 Heidelberg, Germany; [Viotti, Corrado; Hillmer, Stefan] Heidelberg Univ, Dept Cell Biol, Inst Plant Sci, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Sinning, I (corresponding author), Heidelberg Univ, Heidelberg Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de; sstrahl@HIP.uni-heidelberg.de	Hillmer, Stefan/E-1910-2014; Ravaud, Stephanie/I-4059-2015	Ravaud, Stephanie/0000-0001-5867-0785; Hillmer, Stefan/0000-0002-2739-5044; Viotti, Corrado/0000-0002-0135-7533	Deutsche Forschungs Gemeinschaft [SFB638]	Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungs Gemeinschaft (SFB638).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bies C, 2004, BIOL CHEM, V385, P389, DOI 10.1515/BC.2004.043; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Bubeck J, 2008, TRAFFIC, V9, P1629, DOI 10.1111/j.1600-0854.2008.00803.x; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Christensen A, 2008, PLANT CELL PHYSIOL, V49, P912, DOI 10.1093/pcp/pcn065; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; daSilva LLP, 2005, PLANT CELL, V17, P132, DOI 10.1105/tpc.104.026351; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuda S, 2001, BIOCHEM BIOPH RES CO, V280, P407, DOI 10.1006/bbrc.2000.4111; Gosavi S, 2008, P NATL ACAD SCI USA, V105, P10384, DOI 10.1073/pnas.0801343105; Hamada T, 1996, GENE, V176, P211, DOI 10.1016/0378-1119(96)00251-X; Holm L, 1996, METHOD ENZYMOL, V266, P653; Inoue K, 2003, MICROBIOL-SGM, V149, P3361, DOI 10.1099/mic.0.26586-0; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; MCLACHLAN AD, 1979, J MOL BIOL, V133, P557, DOI 10.1016/0022-2836(79)90408-X; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; PRYME IF, 1986, MOL CELL BIOCHEM, V71, P3; Radzimanowski J, 2010, ACTA CRYSTALLOGR F, V66, P12, DOI 10.1107/S1744309109042018; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Transue TR, 1997, NAT STRUCT BIOL, V4, P779, DOI 10.1038/nsb1097-779; Urade R, 2007, FEBS J, V274, P1152, DOI 10.1111/j.1742-4658.2007.05664.x; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Weigel D., 2002, ARABIDOPSIS LAB MANU; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yamamoto M, 2008, PLANT CELL PHYSIOL, V49, P1547, DOI 10.1093/pcp/pcn119	46	38	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18113	18121		10.1074/jbc.M110.117176	http://dx.doi.org/10.1074/jbc.M110.117176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378538	Green Published, hybrid			2022-12-27	WOS:000278133400086
J	Zhang, Z; Zhu, WJ; Lapolla, SM; Miao, YW; Shao, YL; Falcone, M; Boreham, D; McFarlane, N; Ding, JZ; Johnson, AE; Zhang, XJC; Andrews, DW; Lin, JL				Zhang, Zhi; Zhu, Weijia; Lapolla, Suzanne M.; Miao, Yiwei; Shao, Yuanlong; Falcone, Mina; Boreham, Doug; McFarlane, Nicole; Ding, Jingzhen; Johnson, Arthur E.; Zhang, Xuejun C.; Andrews, David W.; Lin, Jialing			Bax Forms an Oligomer via Separate, Yet Interdependent, Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MITOCHONDRIAL APOPTOSIS; MEMBRANE PERMEABILIZATION; CONFORMATIONAL-CHANGE; BH3-ONLY PROTEINS; PEPTIDE COMPLEX; ACTIVATED BAX; BCL-2 FAMILY; BH3 DOMAIN; CELL-DEATH	Interactions of Bcl-2 family proteins regulate permeability of the mitochondrial outer membrane and apoptosis. In particular, Bax forms an oligomer that permeabilizes the membrane. To map the interface of the Bax oligomer we used Triton X-100 as a membrane surrogate and performed site-specific photocross-linking. Bax-specific adducts were formed through photo-reactive probes at multiple sites that can be grouped into two surfaces. The first surface overlaps with the BH1-3 groove formed by Bcl-2 Homology motif 1, 2, and 3; the second surface is a rear pocket located on the opposite side of the protein from the BH1-3 groove. Further cross-linking experiments using Bax BH3 peptides and mutants demonstrated that the two surfaces interact with their counterparts in neighboring proteins to form two separated interfaces and that interaction at the BH1-3 groove primes the rear pocket for further interaction. Therefore, Bax oligomerization proceeds through a series of interactions that occur at separate, yet allosterically, coupled interfaces.	[Zhang, Zhi; Lapolla, Suzanne M.; Ding, Jingzhen; Lin, Jialing] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Zhu, Weijia; Falcone, Mina; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Boreham, Doug; McFarlane, Nicole] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8N 3Z5, Canada; [Johnson, Arthur E.] Texas A&M Univ Syst, Hlth Sci Ctr, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Miao, Yiwei; Shao, Yuanlong; Johnson, Arthur E.] Texas A&M Univ Syst, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ Syst, Hlth Sci Ctr, Dept Chem, College Stn, TX 77843 USA; [Zhang, Xuejun C.] Oklahoma Med Res Fdn, Crystallog Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; McMaster University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Oklahoma Medical Research Foundation	Lin, JL (corresponding author), 940 Stanton L Young Blvd,Biomed Sci Bldg 935,POB, Oklahoma City, OK 73126 USA.	jialing-lin@ouhsc.edu	Johnson, Arthur E/G-3457-2012; ding, Jingzhen/B-5427-2015	Andrews, David/0000-0002-9266-7157	National Institutes of Health [GM062964]; Canadian Institutes of Health Research [FRN 12517]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494, R01GM062964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062964 (to J. L.). This work was also supported by Canadian Institutes of Health Research Grant FRN 12517 (to D. W. A. and Brian Leber).	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; BHAIRI SM, 2001, DETERGENTS GUIDE PRO, P37; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Cartron PF, 2005, J BIOL CHEM, V280, P10587, DOI 10.1074/jbc.M409714200; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; HJELMELAND LM, 1990, METHOD ENZYMOL, V182, P277; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Ivashyna O, 2009, J BIOL CHEM, V284, P23935, DOI 10.1074/jbc.M109.023853; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lin JL, 2001, J BIOL CHEM, V276, P41733, DOI 10.1074/jbc.M103475200; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Makin GWJ, 2001, EMBO J, V20, P6306, DOI 10.1093/emboj/20.22.6306; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; OLTVAI ZN, 1993, CELL, V74, P619; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Peyerl FW, 2007, CELL DEATH DIFFER, V14, P447, DOI 10.1038/sj.cdd.4402025; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200	54	65	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17614	17627		10.1074/jbc.M110.113456	http://dx.doi.org/10.1074/jbc.M110.113456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20382739	Green Published, hybrid			2022-12-27	WOS:000278133400040
J	van Mourik, A; Steeghs, L; van Laar, J; Meiring, HD; Hamstra, HJ; van Putten, JPM; Wosten, MMSM				van Mourik, Andries; Steeghs, Liana; van Laar, Jacoline; Meiring, Hugo D.; Hamstra, Hendrik-Jan; van Putten, Jos P. M.; Wosten, Marc M. S. M.			Altered Linkage of Hydroxyacyl Chains in Lipid A of Campylobacter jejuni Reduces TLR4 Activation and Antimicrobial Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; ESCHERICHIA-COLI; LIPOPOLYSACCHARIDE; SALMONELLA; ENDOTOXIN; HEMA; 4-AMINO-4-DEOXY-L-ARABINOSE; TOLL-LIKE-RECEPTOR-4; LIPOOLIGOSACCHARIDES; TYPHIMURIUM	Modification of the lipid A moiety of bacterial lipopolysaccharide influences cell wall properties, endotoxic activity, and bacterial resistance to antimicrobial peptides. Known modifications are variation in the number or length of acyl chains and/or attached phosphoryl groups. Here we identified two genes (gnnA and gnnB) in the major foodborne pathogen Campylobacter jejuni that enable the synthesis of a GlcN3N precursor UDP 2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose (UDP-GlcNAc3N) in the lipid A backbone. Mass spectrometry of purified lipooligosaccharide verified that the gene products facilitate the formation of a 2,3-diamino-2,3-dideoxy-D-glucose (GlcN3N) disaccharide lipid A backbone when compared with the beta-1'-6-linked D-glucosamine (GlcN) disaccharide observed in Escherichia coli lipid A. Functional assays showed that inactivation of the gnnA or gnnB gene enhanced the TLR4-MD2-mediated NF-kappa B activation. The mutants also displayed increased susceptibility to killing by the antimicrobial peptides polymyxin B, colistin and the chicken cathelicidin-1. The gnnA and gnnB genes are organized in one operon with hemH, encoding a ferrochelatase catalyzing the last step in heme biosynthesis. These results indicate that lipid A modification resulting in amide-linked acyl chains in the lipid A is an effective mechanism to evade activation of the innate host defense and killing by antimicrobial peptides.	[van Mourik, Andries; Steeghs, Liana; van Laar, Jacoline; van Putten, Jos P. M.; Wosten, Marc M. S. M.] Univ Utrecht, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Meiring, Hugo D.; Hamstra, Hendrik-Jan] NVI, NL-3720 AL Bilthoven, Netherlands	Utrecht University	Wosten, MMSM (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Yalelaan 1, NL-3584 CL Utrecht, Netherlands.	M.Wosten@uu.nl		van Putten, Jos/0000-0002-4126-8172; Wosten, Marc/0000-0002-7464-7232	NWO-VIDI [917.66.330]; ZonMW [9120-6150]	NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development)	This work was supported by NWO-VIDI Grant 917.66.330 (to M. M. S. M. W.) and ZonMW Grant 9120-6150 (to J. P. M. v. P.).	Baysse C, 2001, FEMS MICROBIOL LETT, V205, P57, DOI 10.1016/S0378-1097(01)00441-4; Bhunia A, 2009, BIOPOLYMERS, V92, P9, DOI 10.1002/bip.21104; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Elgrably-Weiss M, 2002, J BACTERIOL, V184, P3774, DOI 10.1128/JB.184.14.3774-3784.2002; Geurtsen J, 2007, J BIOL CHEM, V282, P37875, DOI 10.1074/jbc.M706391200; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; LABIGNEROUSSEL A, 1987, J BACTERIOL, V169, P5320, DOI 10.1128/jb.169.11.5320-5323.1987; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Marsden GL, 2009, J BACTERIOL, V191, P2392, DOI 10.1128/JB.01397-08; McNicholas PM, 1997, FEMS MICROBIOL LETT, V146, P143, DOI 10.1016/S0378-1097(96)00467-3; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MORAN AP, 1991, EUR J BIOCHEM, V198, P459, DOI 10.1111/j.1432-1033.1991.tb16036.x; Moran AP, 1997, J INFECT DIS, V176, pS115, DOI 10.1086/513781; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; Steeghs L, 2008, INFECT IMMUN, V76, P3801, DOI 10.1128/IAI.00005-08; Sweet CR, 2004, J BIOL CHEM, V279, P25400, DOI 10.1074/jbc.M400596200; Sweet CR, 2004, J BIOL CHEM, V279, P25411, DOI 10.1074/jbc.M400597200; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; van Aubel RAMH, 2007, MOL IMMUNOL, V44, P3702, DOI 10.1016/j.molimm.2007.04.001; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; WILM MS, 1994, INT J MASS SPECTROM, V136, P167, DOI 10.1016/0168-1176(94)04024-9; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	45	40	40	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15828	15836		10.1074/jbc.M110.102061	http://dx.doi.org/10.1074/jbc.M110.102061			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20351099	hybrid, Green Published			2022-12-27	WOS:000277715900020
J	Vukcevic, M; Zorzato, F; Spagnoli, G; Treves, S				Vukcevic, Mirko; Zorzato, Francesco; Spagnoli, Giulio; Treves, Susan			Frequent Calcium Oscillations Lead to NFAT Activation in Human Immature Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 RYANODINE RECEPTORS; MESENCHYMAL STEM-CELLS; KAPPA-B; CYTOKINE PRODUCTION; CA-2+ OSCILLATIONS; IMMUNE-RESPONSES; GENE-EXPRESSION; T-CELLS; ATP; MACROPHAGES	Spontaneous Ca2+ oscillations have been observed in a number of excitable and non-excitable cells, but in most cases their biological role remains elusive. In the present study we demonstrate that spontaneous Ca2+ oscillations occur in immature human monocyte-derived dendritic cells but not in dendritic cells stimulated to undergo maturation with lipopolysaccharide or other toll like-receptor agonists. We investigated the mechanism and role of spontaneous Ca2+ oscillations in immature dendritic cells and found that they are mediated by the inositol 1,4,5-trisphosphate receptor as they were blocked by pretreatment of cells with the inositol 1,4,5-trisphosphate receptor antagonist Xestospongin C and 2-aminoethoxydiphenylborate. A component of the Ca2+ signal is also due to influx from the extracellular environment and may be involved in maintaining the level of the intracellular Ca2+ stores. As to their biological role, our results indicate that they are intimately linked to the "immature" phenotype and are associated with the translocation of the transcription factor NFAT into the nucleus. In fact, once the Ca2+ oscillations are blocked with 2-aminoethoxydiphenylborate or by treating the cells with lipopolysaccharide, NFAT remains cytoplasmic. The results presented in this report provide novel insights into the physiology of monocyte-derived dendritic cells and into the mechanisms involved in maintaining the cells in the immature stage.	[Vukcevic, Mirko; Zorzato, Francesco; Treves, Susan] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland; [Vukcevic, Mirko; Zorzato, Francesco; Treves, Susan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Spagnoli, Giulio] Univ Basel Hosp, Inst Surg Res, CH-4031 Basel, Switzerland; [Zorzato, Francesco; Treves, Susan] Univ Ferrara, Dept Expt & Diagnost Med, Gen Pathol Sect, I-44100 Ferrara, Italy	University of Basel; University of Basel; University of Basel; University of Ferrara	Treves, S (corresponding author), Univ Basel Hosp, Dept Anesthesia, Hebelstr 20, CH-4031 Basel, Switzerland.	susan.treves@unibas.ch		Treves, Susan/0000-0002-0007-9631	Swiss National Science Foundation [SNF 3200B0-114597, SNF 3200B0-104060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051532, R01GM051532] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Swiss National Science Foundation Grants SNF 3200B0-114597 and 3200B0-104060.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bagley KC, 2004, CLIN DIAGN LAB IMMUN, V11, P77, DOI 10.1128/CDLI.11.1.77-82.2004; Balaji J, 2008, J NEUROSCI, V28, P6742, DOI 10.1523/JNEUROSCI.1082-08.2008; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bracci L, 2008, J IMMUNOTHER, V31, P466, DOI 10.1097/CJI.0b013e318174a52a; Bracci L, 2007, J CELL SCI, V120, P2232, DOI 10.1242/jcs.007203; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goth SR, 2006, ENVIRON HEALTH PERSP, V114, P1083, DOI 10.1289/ehp.8881; Harks EGA, 2003, FASEB J, V17, P941, DOI 10.1096/fj.02-0786fje; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hengge UR, 2004, DERMATOL SURG, V30, P1101, DOI 10.1111/j.1524-4725.2004.30335.x; Hsu SF, 2001, J IMMUNOL, V166, P6126, DOI 10.4049/jimmunol.166.10.6126; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Kawano S, 2006, CELL CALCIUM, V39, P313, DOI 10.1016/j.ceca.2005.11.008; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Koski GK, 1999, J IMMUNOL, V163, P82; KRUSKAL BA, 1987, J CELL BIOL, V105, P2685, DOI 10.1083/jcb.105.6.2685; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lee JI, 1999, TRANSPLANTATION, V68, P1255, DOI 10.1097/00007890-199911150-00007; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mahnke K, 2002, IMMUNOL CELL BIOL, V80, P477, DOI 10.1046/j.1440-1711.2002.01115.x; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Myers JT, 2002, J LEUKOCYTE BIOL, V72, P677; O'Connell PJ, 2002, FEBS LETT, V512, P67, DOI 10.1016/S0014-5793(01)03321-X; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; Ronde P, 2000, BBA-MOL CELL RES, V1498, P273, DOI 10.1016/S0167-4889(00)00102-6; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sauer H, 1998, EXP CELL RES, V238, P13, DOI 10.1006/excr.1997.3809; Schnurr M, 2003, BLOOD, V102, P613, DOI 10.1182/blood-2002-12-3745; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Uemura Y, 2007, BIOCHEM BIOPH RES CO, V362, P510, DOI 10.1016/j.bbrc.2007.08.024; Urosevic M, 2004, AM J CLIN DERMATOL, V5, P453, DOI 10.2165/00128071-200405060-00010; Vukcevic M, 2008, J BIOL CHEM, V283, P34913, DOI 10.1074/jbc.M804472200; Wang TF, 2006, ACTA PHARMACOL SIN, V27, P861, DOI 10.1111/j.1745-7254.2006.00397.x; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118	52	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16003	16011		10.1074/jbc.M109.066704	http://dx.doi.org/10.1074/jbc.M109.066704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348098	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000277715900038
J	Han, J; Goldstein, LA; Hou, W; Gastman, BR; Rabinowich, H				Han, Jie; Goldstein, Leslie A.; Hou, Wen; Gastman, Brian R.; Rabinowich, Hannah			Regulation of Mitochondrial Apoptotic Events by p53-mediated Disruption of Complexes between Antiapoptotic Bcl-2 Members and Bim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-INDEPENDENT DEATH; BH3-ONLY PROTEINS PUMA; TUMOR-SUPPRESSOR P53; DNA-BINDING DOMAIN; HUMAN CANCER-CELLS; IN-VIVO; GRANZYME-B; MEMBRANE PERMEABILIZATION; BH3 DOMAINS; BAX	Multiple mechanisms have been proposed for the mitochondrial function of p53 that are either dependent on or independent of its transcriptional activity. However, none of these mechanisms involves Bim functioning downstream of p53 mitochondrial translocation. Utilizing a p53 nuclear localization signal mutant, whose nuclear import is completely abrogated, we demonstrate that its apoptotic activity at the outer mitochondrial membrane, which involves conformational changes in Bax and Bak, is mediated by Bim. We further demonstrate an inverse correlation between the binding levels of p53 and Bim to Mcl-1. Thus, enhanced binding of p53 to Mcl-1 involves the disruption of existing complexes between Mcl-1 and Bim. We propose that mitochondrial p53 functions as a Bim derepressor by releasing Bim from sequestrating complexes with Mcl-1, Bcl-2, and Bcl-XL, and allowing its engagement in Bak/Bax activation.	[Rabinowich, Hannah] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Han, Jie; Goldstein, Leslie A.; Hou, Wen; Rabinowich, Hannah] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Gastman, Brian R.] Univ Maryland, Sch Med, Dept Otolaryngol, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore	Rabinowich, H (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavil Rm G17C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	rabinow@pitt.edu			National Institutes of Health [RO1 CA109285, RO1 CA111786]; NATIONAL CANCER INSTITUTE [T32CA060397, R01CA111786, R01CA109285, R01CA132796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA109285 and RO1 CA111786 (to H. R.).	Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Erster S, 2005, BIOCHEM BIOPH RES CO, V331, P843, DOI 10.1016/j.bbrc.2005.03.187; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; HALL PA, 1993, ONCOGENE, V8, P203; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Petros AM, 2004, FEBS LETT, V559, P171, DOI 10.1016/s0014-5793(04)00059-6; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhu YN, 2006, J EXP MED, V203, P1147, DOI 10.1084/jem.20051736; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	52	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22473	22483		10.1074/jbc.M109.081042	http://dx.doi.org/10.1074/jbc.M109.081042			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20404322	hybrid, Green Published			2022-12-27	WOS:000279702200059
J	Dong, CM; Yang, LL; Zhang, XP; Gu, H; Lam, ML; Claycomb, WC; Xia, HH; Wu, GY				Dong, Chunmin; Yang, Lingling; Zhang, Xiaoping; Gu, Hua; Lam, May L.; Claycomb, William C.; Xia, Houhui; Wu, Guangyu			Rab8 Interacts with Distinct Motifs in alpha(2B)- and beta(2)-Adrenergic Receptors and Differentially Modulates Their Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; DI-LEUCINE MOTIF; PLASMA-MEMBRANE; ANGIOTENSIN-II; ENDOPLASMIC-RETICULUM; ALPHA(2)-ADRENERGIC RECEPTORS; CARDIAC MYOCYTES; ANTEROGRADE TRAFFICKING; SEROTONIN RECEPTORS	The molecular mechanism underlying the post-Golgi transport of G protein-coupled receptors (GPCRs) remains poorly understood. Here we determine the role of Rab8 GTPase, which modulates vesicular protein transport between the trans-Golgi network (TGN) and the plasma membrane, in the cell surface targeting of alpha(2B)- and beta(2)-adrenergic receptors (AR). Transient expression of GDP- and GTP-bound Rab8 mutants and short hairpin RNA-mediated knockdown of Rab8 more potently inhibited the cell surface expression of alpha(2B)-AR than beta(2)-AR. The GDP-bound Rab8(T22N) mutant attenuated ERK1/2 activation by alpha(2B)-AR, but not beta(2)-AR, and arrested alpha(2B)-AR in the TGN compartment. Co-immunoprecipitation revealed that both alpha(2B)-AR and beta(2)-AR physically interacted with Rab8 and glutathione S-transferase fusion protein pulldown assays demonstrated that Rab8 interacted with the C termini of both receptors. Interestingly, mutation of the highly conserved membrane-proximal C terminus dileucine motif selectively blocked beta(2)-AR interaction with Rab8, whereas mutation of residues Val(431)-Phe(432)-Asn(433)-Gln(434), Pro(447)-Trp(448), Gln(450)-Thr(451), and Trp(453) in the C terminus impaired alpha(2B)-AR interaction with Rab8. Furthermore, transport inhibition by Rab8(T22N) of a chimeric beta(2)-AR carrying the alpha(2B)-AR C terminus was similar to alpha(2B)-AR. These data provide strong evidence indicating that Rab8 GTPase interacts with distinct motifs in the C termini of alpha(2B)-AR and beta(2)-AR and differentially modulates their traffic from the TGN to the cell surface.	[Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Gu, Hua; Xia, Houhui] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; [Lam, May L.; Claycomb, William C.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wu, GY (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	gwu@lsuhsc.edu			National Institutes of Health [R01GM076167, R01NS060879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM076167 ( to G. W.) and R01NS060879 ( to H. X.).	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; HUBER LA, 1993, J CELL BIOL, V123, P47, DOI 10.1083/jcb.123.1.47; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Murph MM, 2003, J CELL SCI, V116, P1969, DOI 10.1242/jcs.00397; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; SCHEININ M, 1994, MOL BRAIN RES, V21, P133, DOI 10.1016/0169-328X(94)90386-7; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; VAN ISC, 2002, DEV CELL, V2, P219; Venkatesan S, 2002, J BIOL CHEM, V277, P2287, DOI 10.1074/jbc.M108321200; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Xia HH, 2002, J BIOL CHEM, V277, P47765, DOI 10.1074/jbc.M207122200; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	55	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20369	20380		10.1074/jbc.M109.081521	http://dx.doi.org/10.1074/jbc.M109.081521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424170	Green Published, hybrid			2022-12-27	WOS:000279012000070
J	Kenchappa, RS; Tep, C; Korade, Z; Urra, S; Bronfman, FC; Yoon, SO; Carter, BD				Kenchappa, Rajappa S.; Tep, Chhavy; Korade, Zeljka; Urra, Soledad; Bronfman, Francisca C.; Yoon, Sung Ok; Carter, Bruce D.			p75 Neurotrophin Receptor-mediated Apoptosis in Sympathetic Neurons Involves a Biphasic Activation of JNK and Up-regulation of Tumor Necrosis Factor-alpha-converting Enzyme/ADAM17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; C-JUN; IN-VIVO; INTRAMEMBRANE PROTEOLYSIS; NUCLEAR TRANSLOCATION; INTRACELLULAR DOMAIN; HIPPOCAMPAL-NEURONS; INTERACTING FACTOR	During the development of the sympathetic nervous system, the p75 neurotrophin receptor (p75NTR) has a dual function: promoting survival together with TrkA in response to NGF, but inducing cell death upon binding pro or mature brain-derived neurotrophic factor (BDNF). Apoptotic signaling through p75NTR requires activation of the stress kinase, JNK. However, the receptor also undergoes regulated proteolysis, first by a metalloprotease, and then by gamma-secretase, in response to pro-apoptotic ligands and this is necessary for receptor mediated neuronal death (Kenchappa, R. S., Zampieri, N., Chao, M. V., Barker, P. A., Teng, H. K., Hempstead, B. L., and Carter, B. D. (2006) Neuron 50, 219-232). Hence, the relationship between JNK activation and receptor proteolysis remains to be defined. Here, we report that JNK3 activation is necessary for p75NTR cleavage; however, following release of the intracellular domain, there is a secondary activation of JNK3 that is cleavage dependent. Receptor proteolysis and apoptosis were prevented in sympathetic neurons from jnk3(-/-) mice, while activation of JNK by ectopic expression of MEKK1 induced p75NTR cleavage and cell death. Proteolysis of the receptor was not detected until 6 h after BDNF treatment, suggesting that JNK3 promotes cleavage through a transcriptional mechanism. In support of this hypothesis, BDNF up-regulated tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM17 mRNA and protein in wildtype, but not jnk3(-/-) sympathetic neurons. Down-regulation of TACE by RNA interference blocked BDNF-induced p75NTR cleavage and apoptosis, indicating that this metalloprotease is responsible for the initial processing of the receptor. Together, these results demonstrate that p75NTR-mediated activation of JNK3 is required for up-regulation of TACE, which promotes receptor proteolysis, leading to prolonged activation of JNK3 and subsequent apoptosis in sympathetic neurons.	[Kenchappa, Rajappa S.; Korade, Zeljka; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Kenchappa, Rajappa S.; Korade, Zeljka; Carter, Bruce D.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Tep, Chhavy; Yoon, Sung Ok] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Tep, Chhavy; Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Urra, Soledad; Bronfman, Francisca C.] Pontificia Univ Catolica Chile, Fac Biol Sci, Ctr Aging & Regenerat,Neurobiol Unit, Nucleus Millenium Regenerat Biol,Dept Physiol, Santiago 8320000, Chile	Vanderbilt University; Vanderbilt University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pontificia Universidad Catolica de Chile	Kenchappa, RS (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 625 Light Hall, Nashville, TN 37232 USA.	rajappa.kenchappa@vanderbilt.edu	Korade, Zeljka/AIE-2127-2022	Urra, Soledad/0000-0003-4432-6582; Korade, Zeljka/0000-0002-8690-4507	National Institutes of Health [NS038220, NS039472]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1085273]; Conicyt [PFB12/2007]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220, R01NS039472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS038220 (to B. D. C. and R. S. K.) and NS039472 (to S. O. Y.). This work was also supported by the Fondo Nacional de Desarrollo Cientifico y Tecnologico (1085273) and Conicyt PFB12/2007 (to F. C. B.).	Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BARNJI SX, 1998, J CELL BIOL, V140, P911; Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; Bertrand MJM, 2008, CELL DEATH DIFFER, V15, P1921, DOI 10.1038/cdd.2008.127; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; DISTEFANO PS, 1993, J NEUROSCI, V13, P2405, DOI 10.1523/JNEUROSCI.13-06-02405.1993; DISTEFANO PS, 1990, BRAIN RES, V534, P340, DOI 10.1016/0006-8993(90)90154-4; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Epa WR, 2004, J NEUROCHEM, V89, P344, DOI 10.1111/j.1471-4159.2004.02344.x; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gentry JJ, 2004, J BIOL CHEM, V279, P16646, DOI 10.1074/jbc.M309209200; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Habecker BA, 2008, AUTON NEUROSCI-BASIC, V140, P40, DOI 10.1016/j.autneu.2008.03.002; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Heidinger M, 2006, BIOL CHEM, V387, P69, DOI 10.1515/BC.2006.010; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Jahed A, 2005, AUTON NEUROSCI-BASIC, V118, P32, DOI 10.1016/j.autneu.2004.12.004; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jin HO, 2006, J CELL PHYSIOL, V206, P477, DOI 10.1002/jcp.20488; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kohn J, 1999, J NEUROSCI, V19, P5393; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; LEVIMONTALCINI R, 1960, ANN NY ACAD SCI, V85, P324; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; SHELTON DL, 1984, P NATL ACAD SCI-BIOL, V81, P7951, DOI 10.1073/pnas.81.24.7951; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Sodhi CP, 2008, BRAIN RES, V1198, P204, DOI 10.1016/j.brainres.2008.01.031; Srinivasan B, 2007, MOL CELL NEUROSCI, V36, P449, DOI 10.1016/j.mcn.2007.08.005; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Worley JR, 2003, J BIOL CHEM, V278, P51340, DOI 10.1074/jbc.M310865200; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	60	97	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20358	20368		10.1074/jbc.M109.082834	http://dx.doi.org/10.1074/jbc.M109.082834			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421303	hybrid, Green Published			2022-12-27	WOS:000279012000069
J	Goswami, AV; Chittoor, B; D'Silva, P				Goswami, Arvind Vittal; Chittoor, Balasubramanyam; D'Silva, Patrick			Understanding the Functional Interplay between Mammalian Mitochondrial Hsp70 Chaperone Machine Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT MOTOR; SACCHAROMYCES-CEREVISIAE; ATPASE ACTIVITY; CO-CHAPERONE; DNAK; HOMOLOG; IDENTIFICATION; MECHANISM; SYSTEM; PURIFICATION	Mitochondria biogenesis requires the import of several precursor proteins that are synthesized in the cytosol. The mitochondrial heat shock protein 70 (mtHsp70) machinery components are highly conserved among eukaryotes, including humans. However, the functional properties of human mtHsp70 machinery components have not been characterized among all eukaryotic families. To study the functional interactions, we have reconstituted the components of the mtHsp70 chaperone machine (Hsp70/J-protein/GrpE/Hep) and systematically analyzed in vitro conditions for biochemical functions. We observed that the sequence-specific interaction of human mtHsp70 toward mitochondrial client proteins differs significantly from its yeast counterpart Ssc1. Interestingly, the helical lid of human mtHsp70 was found dispensable to the binding of P5 peptide as compared with the other Hsp70s. We observed that the two human mitochondrial matrix J-protein splice variants differentially regulate the mtHsp70 chaperone cycle. Strikingly, our results demonstrated that human Hsp70 escort protein (Hep) possesses a unique ability to stimulate the ATPase activity of mtHsp70 as well as to prevent the aggregation of unfolded client proteins similar to J-proteins. We observed that Hep binds with the C terminus of mtHsp70 in a full-length context and this interaction is distinctly different from unfolded client-specific or J-protein binding. In addition, we found that the interaction of Hep at theCterminus of mtHsp70 is regulated by the helical lid region. However, the interaction of Hep at the ATPase domain of the human mtHsp70 is mutually exclusive with J-proteins, thus promoting a similar conformational change that leads to ATPase stimulation. Additionally, we highlight the biochemical defects of the mtHsp70 mutant (G489E) associated with a myelodysplastic syndrome.	[Goswami, Arvind Vittal; Chittoor, Balasubramanyam; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	D'Silva, P (corresponding author), CV Raman Ave, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	D'Silva, Patrick/L-6653-2019		Wellcome Trust [WT081643MA]; Council of Scientific and Industrial Research Fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); Council of Scientific and Industrial Research Fellowship(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Wellcome Trust International Senior Research Fellowship in Biomedical Science WT081643MA (to P. D.) and a Council of Scientific and Industrial Research Fellowship (to A. V. G.).	Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; Blamowska M, 2010, J BIOL CHEM, V285, P4423, DOI 10.1074/jbc.M109.061697; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Choglay AA, 2001, GENE, V267, P125, DOI 10.1016/S0378-1119(01)00396-1; Chou CC, 2003, J BIOL CHEM, V278, P30311, DOI 10.1074/jbc.M304563200; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; Kaul SC, 2000, DNA RES, V7, P229, DOI 10.1093/dnares/7.3.229; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Leverenz JB, 2007, BRAIN PATHOL, V17, P139, DOI 10.1111/j.1750-3639.2007.00048.x; Lopez-Buesa P, 1998, P NATL ACAD SCI USA, V95, P15253, DOI 10.1073/pnas.95.26.15253; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; NEUPERT W, 1990, CELL, V63, P447, DOI 10.1016/0092-8674(90)90437-J; Ohno M, 2004, FEBS LETT, V576, P381, DOI 10.1016/j.febslet.2004.09.044; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rajan VBV, 2009, FUNCT INTEGR GENOMIC, V9, P433, DOI 10.1007/s10142-009-0132-0; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200	45	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19472	19482		10.1074/jbc.M110.105957	http://dx.doi.org/10.1074/jbc.M110.105957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392697	hybrid, Green Published			2022-12-27	WOS:000278727800057
J	Liu, L; Luo, GZ; Yang, W; Zhao, XY; Zheng, QY; Lv, Z; Li, W; Wu, HJ; Wang, L; Wang, XJ; Zhou, Q				Liu, Lei; Luo, Guan-Zheng; Yang, Wei; Zhao, Xiaoyang; Zheng, Qinyuan; Lv, Zhuo; Li, Wei; Wu, Hua-Jun; Wang, Liu; Wang, Xiu-Jie; Zhou, Qi			Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE; FIBROBLASTS; MICE	Low reprogramming efficiency and reduced pluripotency have been the two major obstacles in induced pluripotent stem (iPS) cell research. An effective and quick method to assess the pluripotency levels of iPS cells at early stages would significantly increase the successrate of iPS cell generation and promote its applications. We have identified a conserved imprinted region of the mouse genome, the Dlk1-Dio3 region, which was activated in fully pluripotent mouse stem cells but repressed in partially pluripotent cells. The degree of activation of this region was positively correlated with the pluripotency levels of stem cells. A mammalian conserved cluster of microRNAs encoded by this region exhibited significant expression differences between full and partial pluripotent stem cells. Several microRNAs from this cluster potentially target components of the polycomb repressive complex 2 (PRC2) and may form a feedback regulatory loop resulting in the expression of all genes and non-coding RNAs encoded by this region in full pluripotent stem cells. No other genomic regions were found to exhibit such clear expression changes between cell lines with different pluripotency levels; therefore, the Dlk1-Dio3 region may serve as a marker to identify fully pluripotent iPS or embryonic stem cells from partial pluripotent cells. These findings also provide a step forward toward understanding the operating mechanisms during reprogramming to produce iPS cells and can potentially promote the application of iPS cells in regenerative medicine and cancer therapy.	[Wang, Liu; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Luo, Guan-Zheng; Yang, Wei; Wu, Hua-Jun; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Luo, Guan-Zheng; Yang, Wei; Zhao, Xiaoyang; Zheng, Qinyuan; Lv, Zhuo; Li, Wei; Wu, Hua-Jun] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XJ (corresponding author), 1 Beichen W Rd, Beijing 100101, Peoples R China.	xjwang@genetics.ac.cn; qzhou@ioz.ac.cn	Wang, Xiu-Jie/L-1312-2019; Lu, Zhuo/D-4517-2014	ZHAO, Xiao-Yang/0000-0003-2544-8293	National High Technology Research and Development Program of China [2006AA02A101]; Ministry of Science and Technology of China [2006CB701501, 2007CB946901]; National Natural Science Foundation of China [90919060, 30725014]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was in part supported by the National High Technology Research and Development Program of China Grant 2006AA02A101 (to Q.Z.), the Ministry of Science and Technology of China Grants 2006CB701501 (to Q.Z.) and 2007CB946901 to (X.-J.W.), and the National Natural Science Foundation of China Grants 90919060 (to Q.Z.) and 30725014 (to X.-J.W.).	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Loh YH, 2008, CELL CYCLE, V7, P885, DOI 10.4161/cc.7.7.5636; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	23	206	228	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19483	19490		10.1074/jbc.M110.131995	http://dx.doi.org/10.1074/jbc.M110.131995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382743	Green Published, hybrid			2022-12-27	WOS:000278727800058
J	Watanabe, TM; Tokuo, H; Gonda, K; Higuchi, H; Ikebe, M				Watanabe, Tomonobu M.; Tokuo, Hiroshi; Gonda, Kohsuke; Higuchi, Hideo; Ikebe, Mitsuo			Myosin-X Induces Filopodia by Multiple Elongation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE FLOW; MOLECULAR MOTOR; ACTIN; PROTEINS; LAMELLIPODIA; KERATOCYTES; DOWNSTREAM; EXTENSION; DOMAIN; CELLS	Filopodia are actin-rich finger-like cytoplasmic projections extending from the leading edge of cells. Unconventional myosin- X is involved in the protrusion of filopodia. However, the underlying mechanism of myosin-X-induced filopodia formation is obscure. Here, we studied the movements of myosin-X during filopodia protrusion using a total internal reflection microscope to clarify the mechanism of myosin-X-induced filopodia formation. Myosin-X was recruited to the discrete site at the leading edge where it assembles with exponential kinetics before the filopodia extension. The myosin-X-induced filopodia showed repeated extension-retraction cycles with each extension of 2.4 mu m, which was critical to produce long filopodia. Myosin-X, lacking the FERM domain, could move to the tip as does the wild type. However, it was transported toward the cell body during filopodia retraction, did not undergo multiple extension-retraction cycles, and failed to produce long filopodia. During the filopodia protrusion, the single molecules of full-length myosin-X moved within filopodia. The majority of the fluorescence spots showed two-step photobleaching, suggesting that the moving myosin-X is a dimer. Deletion of the FERM domain did not change the movement at the single molecule level with the same velocity of similar to 600 nm/s as wild-type, suggesting that the myosin-X in filopodia moves without interaction with the attached membrane via the FERM domain. Based upon these results, we have proposed a model of myosin-X-induced filopodia protrusion.	[Watanabe, Tomonobu M.; Tokuo, Hiroshi; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; [Watanabe, Tomonobu M.] Osaka Univ, Immunol Frontier Res Ctr, World Premier Int Res Ctr Initiat, Suita, Osaka 5650871, Japan; [Watanabe, Tomonobu M.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Gonda, Kohsuke] Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Higuchi, Hideo] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyou Ku, Tokyo 1138654, Japan	University of Massachusetts System; University of Massachusetts Worcester; Osaka University; Japan Science & Technology Agency (JST); Tohoku University; University of Tokyo	Ikebe, M (corresponding author), Univ Massachusetts, Sch Med, Dept Physiol, 55 Lake Ave N, Worcester, MA 01655 USA.	Mitsuo.Ikebe@umassmed.edu	Watanabe, Tomonobu/J-4812-2013	Watanabe, Tomonobu/0000-0002-2420-4230; Tokuo, Hiroshi/0000-0002-7614-7805	NHLBI NIH HHS [R01 HL073050] Funding Source: Medline; NIAMS NIH HHS [AR048898, R01 AR048898, R01 AR048526, AR048526] Funding Source: Medline; NIDCD NIH HHS [R01 DC006103, DC006103] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048898, R01AR048526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006103] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bennett RD, 2007, J BIOL CHEM, V282, P3205, DOI 10.1074/jbc.M607174200; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Homma K, 2005, J BIOL CHEM, V280, P29381, DOI 10.1074/jbc.M504779200; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kovacs M, 2005, J BIOL CHEM, V280, P15071, DOI 10.1074/jbc.M500616200; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Sako Y, 2003, NAT CELL BIOL, pSS1, DOI 10.1038/nrm1193; SHEETZ MP, 1992, CELL MOTIL CYTOSKEL, V22, P160, DOI 10.1002/cm.970220303; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; WARD WW, 1980, PHOTOCHEM PHOTOBIOL, V31, P611, DOI 10.1111/j.1751-1097.1980.tb03755.x; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136	33	59	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19605	19614		10.1074/jbc.M109.093864	http://dx.doi.org/10.1074/jbc.M109.093864			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392702	hybrid, Green Published			2022-12-27	WOS:000278727800070
J	Vasudevan, SR; Lewis, AM; Chan, JW; Machin, CL; Sinha, D; Galione, A; Churchill, GC				Vasudevan, Sridhar R.; Lewis, Alexander M.; Chan, Jennifer W.; Machin, Claire L.; Sinha, Debroshi; Galione, Antony; Churchill, Grant C.			The Calcium-mobilizing Messenger Nicotinic Acid Adenine Dinucleotide Phosphate Participates in Sperm Activation by Mediating the Acrosome Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; SEA-URCHIN EGGS; LYSOSOME-RELATED ORGANELLES; PHOSPHOLIPASE-C-DELTA; INDUCED CA2+ RELEASE; STARFISH OOCYTES; INOSITOL TRISPHOSPHATE; MOLECULAR CHARACTERIZATION; BETA-CELLS; PH CHANGES	Before a sperm can fertilize an egg it must undergo a final activation step induced by the egg termed the acrosome reaction. During the acrosome reaction a lysosome-related organelle, the acrosome, fuses with the plasma membrane to release hydrolytic enzymes and expose an egg-binding protein. Because NAADP (nicotinic acid adenine dinucleotide phosphate) releases Ca2+ from acidic lysosome-related organelles in other cell types, we investigated a possible role for NAADP in mediating the acrosome reaction. We report that NAADP binds with high affinity to permeabilized sea urchin sperm. Moreover, we used Mn2+ quenching of luminal fura-2 and Ca-45(2+) to directly demonstrate NAADP regulation of a cation channel on the acrosome. Additionally, we show that NAADP synthesis occurs through base exchange and is driven by an increase in Ca2+. We propose a new model for acrosome reaction signaling in which Ca2+ influx initiated by egg jelly stimulates NAADP synthesis and that this NAADP acts on its receptor/channel on the acrosome to release Ca2+ to drive acrosomal exocytosis.	[Vasudevan, Sridhar R.; Lewis, Alexander M.; Chan, Jennifer W.; Machin, Claire L.; Sinha, Debroshi; Galione, Antony; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	grant.churchill@pharm.ox.ac.uk	Vasudevan, Sridhar/B-1841-2015; Galione, Antony/E-5884-2011	Vasudevan, Sridhar/0000-0003-0516-2984; Galione, Antony/0000-0002-4132-7646	Wellcome Trust [075203/Z/04/Z]; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; BBSRC [BB/G008523/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Wellcome Trust Grant 075203/Z/04/Z.	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; Bacher I, 2004, BIOCHEM J, V381, P147, DOI 10.1042/BJ20031977; Beltran C, 2007, SIGNAL TRANSDUCTION, V7, P103; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Billington RA, 2002, J PHYSIOL-LONDON, V544, P107, DOI 10.1113/jphysiol.2002.030098; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2004, BIOCHEM J, V380, P449, DOI 10.1042/BJ20031754; CHURAMANI D, 2006, THESIS U COLL LONDON; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Coward K, 2004, BIOCHEM BIOPH RES CO, V313, P894, DOI 10.1016/j.bbrc.2003.12.029; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Darszon A, 2006, CELL CALCIUM, V40, P241, DOI 10.1016/j.ceca.2006.04.028; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Docampo R, 1999, PARASITOL TODAY, V15, P443, DOI 10.1016/S0169-4758(99)01531-8; DOMINO SE, 1988, J BIOL CHEM, V263, P690; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Genazzani AA, 1997, BRIT J PHARMACOL, V121, P1489, DOI 10.1038/sj.bjp.0701295; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Gonzalez-Martinez MT, 2001, DEV BIOL, V236, P220, DOI 10.1006/dbio.2001.0323; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gunaratne HJ, 2006, BIOCHEM BIOPH RES CO, V339, P443, DOI 10.1016/j.bbrc.2005.11.033; HAJNOCZKY G, 1994, NATURE, V370, P474, DOI 10.1038/370474a0; HALLAM TJ, 1985, FEBS LETT, V186, P175, DOI 10.1016/0014-5793(85)80703-1; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hirohashi N, 2003, BIOCHEM BIOPH RES CO, V304, P285, DOI 10.1016/S0006-291X(03)00587-4; HORSTMAN DA, 1988, J BIOL CHEM, V263, P15297; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; LEE HC, 2000, SCI STKE, pPE1; Lewis AM, 2007, ANAL BIOCHEM, V371, P26, DOI 10.1016/j.ab.2007.08.030; Love ML, 2004, STRUCTURE, V12, P477, DOI 10.1016/j.str.2004.02.006; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Moccia F, 2006, BIOCHEM BIOPH RES CO, V348, P329, DOI 10.1016/j.bbrc.2006.05.157; Moccia F, 2004, CELL CALCIUM, V36, P515, DOI 10.1016/j.ceca.2004.05.004; Moccia F, 2006, DEV BIOL, V294, P24, DOI 10.1016/j.ydbio.2006.02.011; MORGAN AJ, 2006, METHODS CALCIUM SIGN, P265; Morgan AJ, 2007, J BIOL CHEM, V282, P37730, DOI 10.1074/jbc.M704630200; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; Santella L, 2000, J BIOL CHEM, V275, P8301, DOI 10.1074/jbc.275.12.8301; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; SCHACKMANN RW, 1978, DEV BIOL, V65, P483, DOI 10.1016/0012-1606(78)90043-X; Sethi JK, 1996, BIOCHEM J, V319, P613, DOI 10.1042/bj3190613; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Vacquier VD, 1997, DEV BIOL, V192, P125, DOI 10.1006/dbio.1997.8729; VACQUIER VD, 1977, P NATL ACAD SCI USA, V74, P2456, DOI 10.1073/pnas.74.6.2456; Vasudevan SR, 2008, BIOCHEM J, V411, P63, DOI 10.1042/BJ20071616; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zapata O, 1997, ZYGOTE, V5, P355, DOI 10.1017/S0967199400003932	66	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18262	18269		10.1074/jbc.M109.087858	http://dx.doi.org/10.1074/jbc.M109.087858			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400502	Green Published, hybrid			2022-12-27	WOS:000278453900018
J	Baur, R; Kaur, KH; Sigel, E				Baur, Roland; Kaur, Kuldeep H.; Sigel, Erwin			Diversity of Structure and Function of alpha(1)alpha(6)beta(3)delta GABA(A) Receptors COMPARISON WITH alpha(1)beta(3)delta AND alpha(6)beta(3)delta RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTOR; CEREBELLAR GRANULE CELLS; DELTA-SUBUNIT; A RECEPTORS; RAT-BRAIN; QUANTITATIVE IMPORTANCE; ALPHA(6) SUBUNITS; ETHANOL; SENSITIVITY; CHANNELS	delta subunit-containing gamma-aminobutyric acid, type A (GABA(A))-receptors are expressed extrasynaptically and mediate tonic inhibition. In cerebellar granule cells, they often form receptors together with alpha(1) and/ or alpha(6) subunits. We were interested in determining the architecture of receptors containing both subunits. We predefined the subunit arrangement of several different GABAA receptor pentamers by concatenation. These receptors composed of alpha(1), alpha(6), beta(3), and delta subunits were expressed in Xenopus oocytes. Currents elicited in response to GABA were determined in the presence and absence of 3 alpha,21-dihydroxy-5 alpha-pregnan-20-one (THDOC) or ethanol, or currents were elicited by 4,5,6,7-tetrahydroisoxazolo[5,4-c]-pyridin-3-ol (THIP). Several subunit configurations formed active channels. We therefore conclude that delta can assume multiple positions in a receptor pentamer made up of alpha(1), alpha(6), beta(3), and delta subunits. The different receptors differ in their functional properties. Functional expression of one receptor type was only evident in the combined presence of the neurosteroid THDOC with the channel agonist GABA. Most, but not all, receptors active with GABA/THDOC responded to THIP. None of the receptors was modulated by ethanol concentrations up to 30 mM. Several observations point to a preferred position of delta subunits between two alpha subunits in alpha(1)alpha(6)beta(3)delta receptors. This property is shared by alpha(1)beta(3)delta and alpha(6)beta(3)delta receptors, but there are differences in the additionally expressed isoforms.	[Baur, Roland; Kaur, Kuldeep H.; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland	University of Bern	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	erwin.sigel@mci.unibe.ch	Sigel, Erwin/F-7736-2015		Swiss National Science Foundation [3100A0-105272/2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 3100A0-105272/2.	Araujo F, 1998, EUR J PHARMACOL, V347, P347, DOI 10.1016/S0014-2999(98)00122-8; Barnard EA, 1998, PHARMACOL REV, V50, P291; Baumann SW, 2003, J NEUROSCI, V23, P11158; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Borghese CM, 2006, J PHARMACOL EXP THER, V316, P1360, DOI 10.1124/jpet.105.092452; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Jechlinger M, 1998, J NEUROSCI, V18, P2449; Jones A, 1997, J NEUROSCI, V17, P1350; KAUR KH, 2009, BIOL CHEM, V284, P7889; Khan ZU, 1996, J NEUROCHEM, V66, P685; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, J NEUROSCI, V16, P103; Poltl A, 2003, J NEUROCHEM, V87, P1444, DOI 10.1046/j.1471-4159.2003.02135.x; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Saxena NC, 1996, MOL PHARMACOL, V49, P567; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; Sigel E, 2000, J NEUROCHEM, V74, P2590, DOI 10.1046/j.1471-4159.2000.0742590.x; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Sigel E, 2009, BIOCHEM SOC T, V37, P1338, DOI 10.1042/BST0371338; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Zheleznova N, 2008, BRIT J PHARMACOL, V153, P1062, DOI 10.1038/sj.bjp.0707665	40	26	26	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17398	17405		10.1074/jbc.M110.108670	http://dx.doi.org/10.1074/jbc.M110.108670			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20382738	Green Published, hybrid			2022-12-27	WOS:000278133400017
J	Bolos, M; Fernandez, S; Torres-Aleman, I				Bolos, Marta; Fernandez, Silvia; Torres-Aleman, Ignacio			Oral Administration of a GSK3 Inhibitor Increases Brain Insulin-like Growth Factor I Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR BINDING-PROTEINS; ALZHEIMERS-DISEASE; CHOROID-PLEXUS; CEREBROSPINAL-FLUID; MESSENGER-RNA; RAT-BRAIN; SERUM; MEGALIN; EXPRESSION; RECEPTORS	Reduced brain input of serum insulin-like growth factor I (IGF-I), a potent neurotrophic peptide, may be associated with neurodegenerative processes. Thus, analysis of the mechanisms involved in passage of blood-borne IGF-I into the brain may shed light onto pathological mechanisms in neurodegeneration and provide new drug targets. A site of entrance of serum IGF-I into the brain is the choroid plexus. The transport mechanism for IGF-I in this specialized epithelium involves the IGF-I receptor and the membrane multicargo transporter megalin/LRP2. We have now analyzed this process in greater detail and found that the IGF-I receptor interacts with the transmembrane region of megalin, whereas the perimembrane domain of megalin is required for IGF-I internalization. Furthermore, a GSK3 site within the Src homology 3 domain of the C-terminal region of megalin is a key regulator of IGF-I transport. Thus, inhibition of GSK3 markedly increased internalization of IGF-I, whereas mutation of this GSK3 site abrogated this increase. Notably, oral administration of a GSK3 inhibitor to adult wild-type mice or to amyloid precursor protein/presenilin 1 mice modeling Alzheimer amyloidosis significantly increased brain IGF-I content. These results indicate that pharmacological modulation of IGF-I transport by megalin may be used to increase brain availability of serum IGF-I. Interestingly, GSK3 inhibitors such as those under development to treat Alzheimer disease may show therapeutic efficacy in part by increasing brain IGF-I levels, an effect already reported for other neuroprotective compounds.	[Torres-Aleman, Ignacio] CSIC, Inst Cajal, E-28002 Madrid, Spain; Ciberned, Madrid 28002, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED	Torres-Aleman, I (corresponding author), CSIC, Inst Cajal, Avda Dr Arce 37, E-28002 Madrid, Spain.	torres@cajal.csic.es	Fernandez, Silvia/Z-4848-2019; Bolos Jurado, Marta/J-7620-2014; Torres-Aleman, Ignacio/A-1613-2008	Bolos Jurado, Marta/0000-0003-2652-8607; Torres-Aleman, Ignacio/0000-0001-8107-7947	Comunidad Autonoma de Madrid (Neurodegs consortium); Ciberned	Comunidad Autonoma de Madrid (Neurodegs consortium)(Comunidad de Madrid); Ciberned(Instituto de Salud Carlos III)	This work was supported by Comunidad Autonoma de Madrid (Neurodegs consortium) and Ciberned.	Armstrong CS, 2000, J NEUROSCI RES, V59, P649, DOI 10.1002/(SICI)1097-4547(20000301)59:5<649::AID-JNR8>3.0.CO;2-W; Barth JL, 2001, TRENDS CARDIOVAS MED, V11, P26, DOI 10.1016/S1050-1738(01)00080-9; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Carro E, 2006, NEUROBIOL AGING, V27, P1250, DOI 10.1016/j.neurobiolaging.2005.06.015; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Carro E, 2000, J NEUROSCI, V20, P2926; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Carro Eva, 2006, Keio Journal of Medicine, V55, P59, DOI 10.2302/kjm.55.59; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Chun JT, 1999, EXP NEUROL, V157, P194, DOI 10.1006/exnr.1999.7052; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; DAVIDSON DA, 1990, J HISTOCHEM CYTOCHEM, V38, P1289, DOI 10.1177/38.9.2167329; Davila D, 2007, FRONT BIOSCI-LANDMRK, V12, P3194, DOI 10.2741/2306; Eliakim A, 1997, AM J PHYSIOL-REG I, V273, pR1557, DOI 10.1152/ajpregu.1997.273.4.R1557; GEARY ES, 1989, HORM METAB RES, V21, P1, DOI 10.1055/s-2007-1009135; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Larsson M, 2003, BIOCHEM J, V373, P381, DOI 10.1042/BJ20021958; Martinez A, 2008, J ALZHEIMERS DIS, V15, P181; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Mustafa A, 1999, DEMENT GERIATR COGN, V10, P446, DOI 10.1159/000017188; Obermayr RP, 2005, EXP GERONTOL, V40, P157, DOI 10.1016/j.exger.2004.11.001; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Salehi Z, 2008, BIOFACTORS, V33, P99, DOI 10.1002/biof.5520330202; Sharma S, 2008, NEUROBIOL DIS, V32, P426, DOI 10.1016/j.nbd.2008.08.002; THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Vardy ERLC, 2007, J ALZHEIMERS DIS, V12, P285; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x	34	29	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17693	17700		10.1074/jbc.M109.096594	http://dx.doi.org/10.1074/jbc.M109.096594			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351102	Green Published, hybrid			2022-12-27	WOS:000278133400047
J	Daniel, JL; Dangelmaier, CA; Mada, S; Buitrago, L; Jin, JG; Langdon, WY; Tsygankov, AY; Kunapuli, SP; Sanjay, A				Daniel, James L.; Dangelmaier, Carol A.; Mada, Sripal; Buitrago, Lorena; Jin, Jianguo; Langdon, Wallace Y.; Tsygankov, Alexander Y.; Kunapuli, Satya P.; Sanjay, Archana			Cbl-b Is a Novel Physiologic Regulator of Glycoprotein VI-dependent Platelet Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CELL ANTIGEN RECEPTOR; MEDIATED NEGATIVE REGULATION; HOMOLOGY 3 DOMAIN; FORMATION IN-VIVO; C-CBL; TYROSINE KINASE; T-CELLS; PHOSPHOLIPASE C-GAMMA-2; PHOSPHORYLATION SITES	Cbl-b, a member of the Cbl family of E3 ubiquitin ligases, plays an important role in the activation of lymphocytes. However, its function in platelets remains unknown. We show that Cbl-b is expressed in human platelets along with c-Cbl, but in contrast to c-Cbl, it is not tyrosine-phosphorylated upon glycoprotein VI (GPVI) stimulation. Cbl-b, unlike c-Cbl, is not required for Syk ubiquitylation downstream of GPVI activation. Phospholipase C gamma 2 (PLC gamma 2) and Bruton's tyrosine kinase (BTK) are constituently associated with Cbl-b. Cbl-b-deficient (Cbl-b(-/-)) platelets display an inhibition in the concentration-response curve for GPVI-specific agonist-induced aggregation, secretion, and Ca2+ mobilization. A parallel inhibition is found for activation of PLC gamma 2 and BTK. However, Syk activation is not affected by the absence of Cbl-b, indicating that Cbl-b acts downstream of Syk but upstream of BTK and PLC gamma 2. When Cbl-b(-/-) mice were tested in the ferric chloride thrombosis model, occlusion time was increased and clot stability was reduced compared with wild type controls. These data indicate that Cbl-b plays a positive modulatory role in GPVI-dependent platelet signaling, which translates to an important regulatory role in hemostasis and thrombosis in vivo.	[Daniel, James L.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Sanjay, Archana] Temple Univ, Dept Anat, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.; Kunapuli, Satya P.] Temple Univ, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Buitrago, Lorena] Temple Univ, Dept Physiol, Philadelphia, PA 19140 USA; [Daniel, James L.; Dangelmaier, Carol A.; Mada, Sripal; Jin, Jianguo; Tsygankov, Alexander Y.; Kunapuli, Satya P.; Sanjay, Archana] Temple Univ, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Langdon, Wallace Y.] Univ Western Australia, Sch Surg & Pathol, Crawley, WA 6009, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Western Australia	Daniel, JL (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, 3420 N Broad St, Philadelphia, PA 19140 USA.	james.daniel@temple.edu	Tsygankov, Alexander Y/K-6205-2017		American Heart Association; National Institutes of Health [HL60683, HL80444, HL81322, DE004724, CA 78499]; NATIONAL CANCER INSTITUTE [R01CA078499] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081322, R01HL080444, R01HL060683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE004724, R37DE004724] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by a grant from the Southeastern Pennsylvania Affiliate of the American Heart Association and National Institutes of Health Grants HL60683, HL80444, HL81322, DE004724, and CA 78499.	Andoniou CE, 1996, ONCOGENE, V12, P1981; Auger JM, 2003, J THROMB HAEMOST, V1, P2419, DOI 10.1046/j.1538-7836.2003.00464.x; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BLAKE TJ, 1991, ONCOGENE, V6, P653; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Dogne JM, 2005, THROMB RES, V116, P431, DOI 10.1016/j.thromres.2005.02.006; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Elly C, 1999, ONCOGENE, V18, P1147, DOI 10.1038/sj.onc.1202411; Falati S, 2006, BLOOD, V107, P535, DOI 10.1182/blood-2005-04-1512; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Graham LJ, 1998, BIOCHEM BIOPH RES CO, V249, P537, DOI 10.1006/bbrc.1998.9177; Grossmann AH, 2004, FEBS LETT, V577, P555, DOI 10.1016/j.febslet.2004.10.054; Hechler B, 2010, J THROMB HAEMOST, V8, P173, DOI 10.1111/j.1538-7836.2009.03666.x; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Judd BA, 2002, J EXP MED, V195, P705, DOI 10.1084/jem.20011583; Kahner BN, 2007, BLOOD, V110, P2449, DOI 10.1182/blood-2006-11-056069; Kauffenstein G, 2001, FEBS LETT, V505, P281, DOI 10.1016/S0014-5793(01)02824-1; KEANE MM, 1995, ONCOGENE, V10, P2367; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nakajima A, 2009, J BONE MINER RES, V24, P1162, DOI [10.1359/JBMR.090205, 10.1359/jbmr.090205]; Oda A, 1996, BLOOD, V88, P1330, DOI 10.1182/blood.V88.4.1330.bloodjournal8841330; Oksvold MP, 2008, MOL IMMUNOL, V45, P925, DOI 10.1016/j.molimm.2007.08.002; Ozdener F, 2002, MOL PHARMACOL, V62, P672, DOI 10.1124/mol.62.3.672; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Patel HV, 1997, PROTEINS, V29, P545, DOI 10.1002/(SICI)1097-0134(199712)29:4<545::AID-PROT13>3.0.CO;2-M; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Quinter PG, 2007, J THROMB HAEMOST, V5, P362, DOI 10.1111/j.1538-7836.2007.02309.x; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Rellahan BL, 2003, EXP CELL RES, V289, P184, DOI 10.1016/S0014-4827(03)00260-X; Robertson JO, 2009, THROMB RES, V123, P644, DOI 10.1016/j.thromres.2008.07.003; Rumbaut RE, 2005, MICROCIRCULATION, V12, P259, DOI 10.1080/10739680590925664; Stalker TJ, 2009, J THROMB HAEMOST, V7, P1886, DOI 10.1111/j.1538-7836.2009.03606.x; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 1999, J IMMUNOL, V162, P7133; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Yasuda T, 2002, J EXP MED, V196, P51, DOI 10.1084/jem.20020068; Zhang ZH, 1999, CURR BIOL, V9, P203, DOI 10.1016/S0960-9822(99)80090-6	56	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17282	17291		10.1074/jbc.M109.080200	http://dx.doi.org/10.1074/jbc.M109.080200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20400514	Green Published, hybrid			2022-12-27	WOS:000278133400005
J	Fitzkee, NC; Masse, JE; Shen, Y; Davies, DR; Bax, A				Fitzkee, Nicholas C.; Masse, James E.; Shen, Yang; Davies, David R.; Bax, Ad			Solution Conformation and Dynamics of the HIV-1 Integrase Core Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLEAR-MAGNETIC-RESONANCE; REFINED SOLUTION STRUCTURE; MODEL-FREE APPROACH; DNA-BINDING DOMAIN; PARAMAGNETIC RELAXATION ENHANCEMENT; PROTEIN SECONDARY STRUCTURE; RIBONUCLEASE-H DOMAIN; TERMINAL HHCC DOMAIN; NMR CHEMICAL-SHIFTS	The human immunodeficiency virus type 1 (HIV-1) integrase (IN) is a critical enzyme involved in infection. It catalyzes two reactions to integrate the viral cDNA into the host genome, 3' processing and strand transfer, but the dynamic behavior of the active site during catalysis of these two processes remains poorly characterized. NMR spectroscopy can reveal important structural details about enzyme mechanisms, but to date the IN catalytic core domain has proven resistant to such an analysis. Here, we present the first NMR studies of a soluble variant of the catalytic core domain. The NMR chemical shifts are found to corroborate structures observed in crystals, and confirm prior studies suggesting that the alpha 4 helix extends toward the active site. We also observe a dramatic improvement in NMR spectra with increasing MgCl2 concentration. This improvement suggests a structural transition not only near the active site residues but also throughout the entire molecule as IN binds Mg2+. In particular, the stability of the core domain is linked to the conformation of its C-terminal helix, which has implications for relative domain orientation in the full-length enzyme. N-15 relaxation experiments further show that, although conformationally flexible, the catalytic loop of IN is not fully disordered in the absence of DNA. Indeed, automated chemical shift-based modeling of the active site loop reveals several stable clusters that show striking similarity to a recent crystal structure of prototype foamy virus IN bound to DNA.	NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Davies, David R.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bax, A (corresponding author), 5 Mem Dr, Bethesda, MD 20892 USA.	bax@nih.gov	Shen, Yang/C-3064-2008; Shen, Yang/ABH-8248-2022; Shen, Yang/AAH-2403-2022	Shen, Yang/0000-0003-1408-8034; 	NIDDK; Office of the Director, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075024, ZIADK034002, ZIADK029048] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of the Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDDK and the Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH.	Andrake MD, 1996, J BIOL CHEM, V271, P19633, DOI 10.1074/jbc.271.33.19633; Asante-Appiah E, 1998, J BIOL CHEM, V273, P35078, DOI 10.1074/jbc.273.52.35078; AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Baldanti F, 2010, J MED VIROL, V82, P116, DOI 10.1002/jmv.21651; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; Bujacz G, 1996, FEBS LETT, V398, P175, DOI 10.1016/S0014-5793(96)01236-7; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; BUSHMAN FD, 1990, SCIENCE, V249, P1555, DOI 10.1126/science.2171144; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chill JH, 2006, J BIOMOL NMR, V36, P123, DOI 10.1007/s10858-006-9071-4; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; Daniel R, 2004, J VIROL, V78, P8573, DOI 10.1128/JVI.78.16.8573-8581.2004; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eaton WA, 1998, ACCOUNTS CHEM RES, V31, P745, DOI 10.1021/ar9700825; Eijkelenboom APAM, 1997, CURR BIOL, V7, P739, DOI 10.1016/S0960-9822(06)00332-0; Eijkelenboom APAM, 2000, J BIOMOL NMR, V18, P119, DOI 10.1023/A:1008342312269; Eijkelenboom APAM, 1999, PROTEINS, V36, P556, DOI 10.1002/(SICI)1097-0134(19990901)36:4<556::AID-PROT18>3.0.CO;2-6; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; ENGELMAN A, 1995, J VIROL, V69, P5908, DOI 10.1128/JVI.69.9.5908-5911.1995; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Esposito D, 1999, ADV VIRUS RES, V52, P319, DOI 10.1016/S0065-3527(08)60304-8; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; GEEN H, 1991, J MAGN RESON, V93, P93, DOI 10.1016/0022-2364(91)90034-Q; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Goldgur Y, 1999, P NATL ACAD SCI USA, V96, P13040, DOI 10.1073/pnas.96.23.13040; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Greenwald J, 1999, BIOCHEMISTRY-US, V38, P8892, DOI 10.1021/bi9907173; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; IKURA M, 1990, FEBS LETT, V266, P155, DOI 10.1016/0014-5793(90)81528-V; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jones JA, 1996, J MAGN RESON SER B, V113, P25, DOI 10.1006/jmrb.1996.0151; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoh E, 2003, PROTEIN SCI, V12, P1376, DOI 10.1110/ps.0300703; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; KATZMAN M, 1989, J VIROL, V63, P5319, DOI 10.1128/JVI.63.12.5319-5327.1989; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R. L. J., 2004, THESIS EIDGENOSSISCH, P1; Kontaxis G, 2005, METHOD ENZYMOL, V394, P42, DOI 10.1016/S0076-6879(05)94003-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; LAFEMINA RL, 1992, J VIROL, V66, P7414, DOI 10.1128/JVI.66.12.7414-7419.1992; Lee MC, 2005, BIOPHYS J, V88, P3133, DOI 10.1529/biophysj.104.058446; Lins RD, 1999, BIOPHYS J, V76, P2999, DOI 10.1016/S0006-3495(99)77453-9; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Newman JL, 2004, PROTEIN SCI, V13, P2101, DOI 10.1110/ps.04614804; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; POWERS R, 1992, BIOCHEMISTRY-US, V31, P9150, DOI 10.1021/bi00153a006; R Core Team, 2020, R LANG ENV STAT COMP; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Semenova EA, 2008, ADV PHARMACOL, V56, P199, DOI 10.1016/S1054-3589(07)56007-2; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SHERMAN PA, 1990, P NATL ACAD SCI USA, V87, P5119, DOI 10.1073/pnas.87.13.5119; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tong KI, 2008, J BIOMOL NMR, V42, P59, DOI 10.1007/s10858-008-9264-0; TORCHIA DA, 1989, BIOCHEMISTRY-US, V28, P5509, DOI 10.1021/bi00439a028; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; WAGNER G, 1990, PROG NUCL MAG RES SP, V22, P101, DOI 10.1016/0079-6565(90)80003-Z; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wang Y, 2009, BIOCHEMISTRY-US, V48, P4548, DOI 10.1021/bi9002887; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yi JZ, 1999, BIOCHEMISTRY-US, V38, P8458, DOI 10.1021/bi982870n; Ying JF, 2007, J BIOMOL NMR, V37, P195, DOI 10.1007/s10858-006-9120-z; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000	107	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18072	18084		10.1074/jbc.M110.113407	http://dx.doi.org/10.1074/jbc.M110.113407			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20363759	Green Published, hybrid			2022-12-27	WOS:000278133400082
J	Ojha, AK; Trivelli, X; Guerardel, Y; Kremer, L; Hatfull, GF				Ojha, Anil K.; Trivelli, Xavier; Guerardel, Yann; Kremer, Laurent; Hatfull, Graham F.			Enzymatic Hydrolysis of Trehalose Dimycolate Releases Free Mycolic Acids during Mycobacterial Growth in Biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL BIOFILMS; CORD FACTOR; TUBERCULOSIS; COMPLEX; ANTIGEN; IDENTIFICATION; BIOSYNTHESIS; RESISTANCE; MORPHOLOGY; CHAPERONE	Mycobacterial species, like other microbes, spontaneously form multicellular drug-tolerant biofilms when grown in vitro in detergent-free liquid media. The structure of Mycobacterium tuberculosis biofilms is formed through genetically programmed pathways and is built upon a large abundance of novel extracellular free mycolic acids (FM), although the mechanism of FM synthesis remained unclear. Here we show that the FM in Mycobacterium smegmatis biofilms is produced through the enzymatic release from constitutively present mycolyl derivatives. One of the precursors for FM is newly synthesized trehalose dimycolate (TDM), which is cleaved by a novel TDM-specific serine esterase, Msmeg_1529. Disruption of Msmeg_1529 leads to undetectable hydrolytic activity, reduced levels of FM in the mutant, and retarded biofilm growth. Furthermore, enzymatic hydrolysis of TDM remains conserved in M. tuberculosis, suggesting the presence of a TDM-specific esterase in this pathogen. Overall, this study provides the first evidence for an enzymatic release of free mycolic acids from cell envelope mycolates during mycobacterial growth.	Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hatfull, Graham F.] Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15261 USA; [Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Kremer, Laurent] Univ Montpellier I, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Trivelli, Xavier; Guerardel, Yann] Univ Lille 1, CNRS, UGSF UMR 8576, F-59650 Villeneuve Dascq, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Ojha, AK (corresponding author), 130 DeSoto St, Pittsburgh, PA 15261 USA.	ano7@pitt.edu	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Trivelli, Xavier/0000-0001-6775-9650; Guerardel, Yann/0000-0003-4967-9512	National Institutes of Health [AI079288, AI064494]; American Lung Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064494, R21AI079288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI079288 (to A. K. O.) and AI064494 (to G. F. H.). This work was also supported by an award from the American Lung Association (to A. K. O.).	Allison DG, 2003, BIOFOULING, V19, P139, DOI 10.1038/nrmicro2415; Anderson GG, 2004, TRENDS MICROBIOL, V12, P424, DOI 10.1016/j.tim.2004.07.005; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.188.2.633-641.2006; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; COSTERTON JW, 1981, CRC CR REV MICROBIOL, V8, P303, DOI 10.3109/10408418109085082; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Kremer L, 2002, LETT APPL MICROBIOL, V34, P233, DOI 10.1046/j.1472-765x.2002.01091.x; LAM J, 1980, INFECT IMMUN, V28, P546; Lewis JA, 2000, MOL MICROBIOL, V35, P350, DOI 10.1046/j.1365-2958.2000.01695.x; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; McNeill K, 2003, FEMS MICROBIOL LETT, V221, P25, DOI 10.1016/S0378-1097(03)00164-2; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; NOLL H, 1956, BIOCHIM BIOPHYS ACTA, V20, P299, DOI 10.1016/0006-3002(56)90289-X; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha A, 2007, MOL MICROBIOL, V66, P468, DOI 10.1111/j.1365-2958.2007.05935.x; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; SCHU M, 2010, FASEB J IN PRESS; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Teng R, 2003, FEMS MICROBIOL LETT, V227, P171, DOI 10.1016/S0378-1097(03)00584-6; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; *WHO, 2009, WHO REP 2009 GLOB TU	54	88	91	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17380	17389		10.1074/jbc.M110.112813	http://dx.doi.org/10.1074/jbc.M110.112813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375425	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000278133400015
J	Ladner, CL; Chen, M; Smith, DP; Platt, GW; Radford, SE; Langen, R				Ladner, Carol L.; Chen, Min; Smith, David P.; Platt, Geoffrey W.; Radford, Sheena E.; Langen, Ralf			Stacked Sets of Parallel, In-register beta-Strands of beta(2)-Microglobulin in Amyloid Fibrils Revealed by Site-directed Spin Labeling and Chemical Labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; HUMAN PRION PROTEIN; DISULFIDE BOND; LIMITED PROTEOLYSIS; ALPHA-SYNUCLEIN; HIGH-PRESSURE; H/D-EXCHANGE; SIDE-CHAINS; BETA-2-MICROGLOBULIN; VITRO	beta(2)-microglobulin (beta 2m) is a 99-residue protein with an immunoglobulin fold that forms beta-sheet-rich amyloid fibrils in dialysis-related amyloidosis. Here the environment and accessibility of side chains within amyloid fibrils formed in vitro from beta(2)m with a long straight morphology are probed by site-directed spin labeling and accessibility to modification with N-ethyl maleimide using 19 site-specific cysteine variants. Continuous wave electron paramagnetic resonance spectroscopy of these fibrils reveals a core predominantly organized in a parallel, in-register arrangement, by contrast with other beta(2)m aggregates. A continuous array of parallel, in-register beta-strands involving most of the polypeptide sequence is inconsistent with the cryo-electron microscopy structure, which reveals an architecture based on subunit repeats. To reconcile these data, the number of spins in close proximity required to give rise to spin exchange was determined. Systematic studies of a model protein system indicated that juxtaposition of four spin labels is sufficient to generate exchange narrowing. Combined with information about side-chain mobility and accessibility, we propose that the amyloid fibrils of beta(2)m consist of about six beta(2)m monomers organized in stacks with a parallel, in-register array. The results suggest an organization more complex than the accordion-like beta-sandwich structure commonly proposed for amyloid fibrils.	[Ladner, Carol L.; Smith, David P.; Platt, Geoffrey W.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Chen, Min; Langen, Ralf] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	University of Leeds; University of Southern California	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk; langen@usc.edu	Platt, Geoffrey/D-2416-2013	Ladner-Keay, Carol/0000-0003-0273-713X; Radford, Sheena/0000-0002-3079-8039; Smith, David/0000-0001-5177-8574; Platt, Geoffrey/0000-0003-1754-0110	National Institutes of Health [AG027936]; Wellcome Trust [080859/B/06/Z, GR075675MA, WT069851MA]; Hillblom Foundation; NATIONAL INSTITUTE ON AGING [R01AG027936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG027936. This work was also supported by Wellcome Trust Grants 080859/B/06/Z, GR075675MA, and WT069851MA and the Hillblom Foundation.	Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Fabian H, 2008, BIOCHEMISTRY-US, V47, P6895, DOI 10.1021/bi800279y; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hasegawa K, 2003, BIOCHEM BIOPH RES CO, V304, P101, DOI 10.1016/S0006-291X(03)00543-6; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Isas JM, 2002, BIOCHEMISTRY-US, V41, P1464, DOI 10.1021/bi011856z; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Jones S, 2003, J MOL BIOL, V325, P249, DOI 10.1016/S0022-2836(02)01227-5; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kardos J, 2005, BBA-PROTEINS PROTEOM, V1753, P108, DOI 10.1016/j.bbapap.2005.08.013; Kihara M, 2006, J BIOL CHEM, V281, P31061, DOI 10.1074/jbc.M605358200; Koteiche HA, 1998, BIOCHEMISTRY-US, V37, P12681, DOI 10.1021/bi9814078; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Lietzow MA, 2004, BIOCHEMISTRY-US, V43, P3137, DOI 10.1021/bi0360962; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Monti M, 2005, BBA-PROTEINS PROTEOM, V1753, P44, DOI 10.1016/j.bbapap.2005.09.004; Myers SL, 2006, RAPID COMMUN MASS SP, V20, P1628, DOI 10.1002/rcm.2482; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Platt GW, 2009, FEBS LETT, V583, P2623, DOI 10.1016/j.febslet.2009.05.005; Platt GW, 2009, ANGEW CHEM INT EDIT, V48, P5705, DOI 10.1002/anie.200901343; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Qoronfleh MW, 2007, PROTEIN EXPRES PURIF, V55, P209, DOI 10.1016/j.pep.2007.05.014; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399; van der Wel PCA, 2007, J AM CHEM SOC, V129, P5117, DOI 10.1021/ja068633m; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067	54	48	48	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17137	17147		10.1074/jbc.M110.117234	http://dx.doi.org/10.1074/jbc.M110.117234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20335170	Green Published, hybrid			2022-12-27	WOS:000277982600076
J	Nguyen, DT; Gopfert, JC; Ikezawa, N; MacNevin, G; Kathiresan, M; Conrad, J; Spring, O; Ro, DK				Nguyen, Don Trinh; Goepfert, Jens Christian; Ikezawa, Nobuhiro; MacNevin, Gillian; Kathiresan, Meena; Conrad, Juergen; Spring, Otmar; Ro, Dae-Kyun			Biochemical Conservation and Evolution of Germacrene A Oxidase in Asteraceae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPITATE GLANDULAR TRICHOMES; ANTIMALARIAL-DRUG PRECURSOR; KAPPA-B KINASE; SESQUITERPENE LACTONE; FUNCTIONAL-CHARACTERIZATION; BARNADESIOIDEAE ASTERACEAE; HETEROLOGOUS EXPRESSION; EUDESMANE DERIVATIVES; ARTEMISINIC ACID; CANCER CELLS	Sesquiterpene lactones are characteristic natural products in Asteraceae, which constitutes similar to 8% of all plant species. Despite their physiological and pharmaceutical importance, the biochemistry and evolution of sesquiterpene lactones remain unexplored. Here we show that germacrene A oxidase (GAO), evolutionarily conserved in all major subfamilies of Asteraceae, catalyzes three consecutive oxidations of germacrene A to yield germacrene A acid. Furthermore, it is also capable of oxidizing non-natural substrate amorphadiene. Co-expression of lettuce GAO with germacrene synthase in engineered yeast synthesized aberrant products, costic acids and ilicic acid, in an acidic condition. However, cultivation in a neutral condition allowed the de novo synthesis of a single novel compound that was identified as germacrene A acid by gas and liquid chromatography and NMR analyses. To trace the evolutionary lineage of GAO in Asteraceae, homologous genes were further isolated from the representative species of three major subfamilies of Asteraceae (sunflower, chicory, and costus from Asteroideae, Cichorioideae, and Carduoideae, respectively) and also from the phylogenetically basal species, Barnadesia spinosa, from Barnadesioideae. The recombinant GAOs from these genes clearly showed germacrene A oxidase activities, suggesting that GAO activity is widely conserved in Asteraceae including the basal lineage. All GAOs could catalyze the three-step oxidation of non-natural substrate amorphadiene to artemisinic acid, whereas amorphadiene oxidase diverged from GAO displayed negligible activity for germacrene A oxidation. The observed amorphadiene oxidase activity in GAOs suggests that the catalytic plasticity is embedded in ancestral GAO enzymes that may contribute to the chemical and catalytic diversity in nature.	[Ro, Dae-Kyun] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Goepfert, Jens Christian; Spring, Otmar] Univ Hohenheim, Inst Bot, D-70599 Stuttgart, Germany	University of Calgary; University Hohenheim	Ro, DK (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	daekyun.ro@ucalgary.ca	Ro, Dae-Kyun/G-9289-2012	Ro, Dae-Kyun/0000-0003-1288-5347; Nguyen, Trinh-Don/0000-0002-2759-5791	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair; Canada Foundation for Innovation; German Research Foundation (Deutsche Forschungsgemeinschaft)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant, the Canada Research Chair program, and the Canada Foundation for Innovation (to D.-K.R.) and also by a German Research Foundation (Deutsche Forschungsgemeinschaft) grant (to O.S. and J.C.G.).	Abou-Douh AM, 2008, CHEM PHARM BULL, V56, P1535, DOI 10.1248/cpb.56.1535; ASAKAWA Y, 1981, PHYTOCHEMISTRY, V20, P257, DOI 10.1016/0031-9422(81)85102-3; Bennett MH, 2002, PHYTOCHEMISTRY, V60, P255, DOI 10.1016/S0031-9422(02)00103-6; Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; BOHM BA, 1995, SYST BOT, V20, P22, DOI 10.2307/2419629; Bouwmeester HJ, 2002, PLANT PHYSIOL, V129, P134, DOI 10.1104/pp.001024; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Christensen SB, 1999, BIOORGAN MED CHEM, V7, P1273; CRONQUIST A, 1977, BRITTONIA, V29, P137, DOI 10.2307/2805847; de Kraker JW, 2002, PLANT PHYSIOL, V129, P257, DOI 10.1104/pp.010957; de Kraker JW, 2001, PHYTOCHEMISTRY, V58, P481, DOI 10.1016/S0031-9422(01)00291-6; de Kraker JW, 2001, PLANT PHYSIOL, V125, P1930, DOI 10.1104/pp.125.4.1930; Faraldos JA, 2007, TETRAHEDRON, V63, P7733, DOI 10.1016/j.tet.2007.04.037; FISCHER NH, 1990, RECENT ADV PHYTOCHEM, V24, P161; FURUYA Y, 1994, CANCER RES, V54, P6167; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gopfert JC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-86; Gopfert JC, 2005, PLANT BIOLOGY, V7, P148, DOI 10.1055/s-2005-837575; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hernandez V, 2001, PLANTA MED, V67, P726, DOI 10.1055/s-2001-18342; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; KNOCHE H, 1969, SCIENCE, V166, P239, DOI 10.1126/science.166.3902.239; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Leon LG, 2009, BIOORGAN MED CHEM, V17, P6251, DOI 10.1016/j.bmc.2009.07.053; Mendiondo ME, 1997, BIOCHEM SYST ECOL, V25, P673, DOI 10.1016/S0305-1978(97)00060-4; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Ober D, 1999, P NATL ACAD SCI USA, V96, P14777, DOI 10.1073/pnas.96.26.14777; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; PICMAN AK, 1986, BIOCHEM SYST ECOL, V14, P255, DOI 10.1016/0305-1978(86)90101-8; Pittayakhajonwut P, 2009, PLANTA MED, V75, P1431, DOI 10.1055/s-0029-1185698; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Robinson A, 2008, BIOORG MED CHEM LETT, V18, P4015, DOI 10.1016/j.bmcl.2008.06.008; Sessa RA, 2000, J BIOL CHEM, V275, P26877; SPRING O, 1991, MODERN PHYTOCHEMICAL, V25, P319; Takahashi S, 2007, J BIOL CHEM, V282, P31744, DOI 10.1074/jbc.M703378200; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; VIDARI G, 1976, PHYTOCHEMISTRY, V15, P1953, DOI 10.1016/S0031-9422(00)88853-6; Wesolowska A, 2006, J ETHNOPHARMACOL, V107, P254, DOI 10.1016/j.jep.2006.03.003; Zheng QX, 2003, J NAT PROD, V66, P1078, DOI 10.1021/np0205856; Zidorn C, 2008, PHYTOCHEMISTRY, V69, P2270, DOI 10.1016/j.phytochem.2008.06.013; [No title captured]	46	100	112	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16588	16598		10.1074/jbc.M110.111757	http://dx.doi.org/10.1074/jbc.M110.111757			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351109	Green Published, hybrid			2022-12-27	WOS:000277982600022
J	Bernal-Bayard, J; Cardenal-Munoz, E; Ramos-Morales, F				Bernal-Bayard, Joaquin; Cardenal-Munoz, Elena; Ramos-Morales, Francisco			The Salmonella Type III Secretion Effector, Salmonella Leucine-rich Repeat Protein (SIrP), Targets the Human Chaperone ERdj3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASES; ENDOPLASMIC-RETICULUM; DENDRITIC CELLS; ANTIGEN PRESENTATION; PEPTIDE SUBSTRATE; SIGNAL SEQUENCES; DNAJ HOMOLOG; TYPHIMURIUM; HSP40; FAMILY	Effectors of the type III secretion systems (T3SS) are key elements in the interaction between many Gram-negative pathogens and their hosts. SlrP is an effector that is translocated into the eukaryotic host cell through the two virulence-associated T3SS of Salmonella enterica. We found previously that this effector is an E3 ubiquitin ligase for mammalian thioredoxin. Here, we identified ERdj3, an endoplasmic reticulum lumenal chaperone of the Hsp40/DnaJ family, as a new target for SlrP. Experiments with truncated forms of ERdj3 showed that domain II was essential for the interaction with SlrP. Confocal microscopy and subcellular fractionation demonstrated that, in transfected HeLa cells, SlrP was partially located in the endoplasmic reticulum. The presence of SlrP interfered with the binding of ERdj3 to a denatured substrate. Taken together, these data suggest that the role of SlrP in the interaction between Salmonella and the host cell is exerted through the modulation of the function of two independent targets: thioredoxin in the cytosol, and ERdj3 in the endoplasmic reticulum.	[Bernal-Bayard, Joaquin; Cardenal-Munoz, Elena; Ramos-Morales, Francisco] Univ Seville, Fac Biol, Dept Genet, E-41080 Seville, Spain	University of Sevilla	Ramos-Morales, F (corresponding author), Univ Seville, Fac Biol, Dept Genet, Avda Reina Mercedes 6, E-41012 Seville, Spain.	framos@us.es	Bayard, Joaquin Bernal/E-9836-2016; Ramos-Morales, Francisco/C-5734-2008; Cardenal-Munoz, Elena/J-5819-2019	Bayard, Joaquin Bernal/0000-0003-1199-3629; Ramos-Morales, Francisco/0000-0002-1151-4547; Cardenal-Munoz, Elena/0000-0003-4757-9323	Spanish Ministry of Science and Innovation [SAF2007-60738]; European Regional Development Fund; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain [P08-CVI-03487]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain(Junta de Andalucia)	This work was supported by Grants SAF2007-60738 from the Spanish Ministry of Science and Innovation and the European Regional Development Fund and P08-CVI-03487 from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain.	Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bies C, 1999, BIOL CHEM, V380, P1175, DOI 10.1515/BC.1999.149; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; HARPER JW, 1993, CELL, V75, P805; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marcus NY, 2007, ARCH BIOCHEM BIOPHYS, V468, P147, DOI 10.1016/j.abb.2007.10.001; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Nakanishi K, 2004, CELL STRESS CHAPERON, V9, P253, DOI 10.1379/CSC-52.1; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Sherman F., 1986, METHODS YEAST GENETI; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Tobar JA, 2006, INFECT IMMUN, V74, P6438, DOI 10.1128/IAI.00063-06; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	41	53	57	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16360	16368		10.1074/jbc.M110.100669	http://dx.doi.org/10.1074/jbc.M110.100669			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335166	Green Published, hybrid			2022-12-27	WOS:000277715900072
J	Komurov, K; Padron, D; Cheng, TL; Roth, M; Rosenblatt, KP; White, MA				Komurov, Kakajan; Padron, David; Cheng, Tzuling; Roth, Michael; Rosenblatt, Kevin P.; White, Michael A.			Comprehensive Mapping of the Human Kinome to Epidermal Growth Factor Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST; SOMATIC MUTATIONS; DOWN-REGULATION; CANCER; KINASE; PATHWAYS; ELEMENTS; DATABASE; NETWORK; TARGET	Disregulation of epidermal growth factor receptor (EGFR) signaling directly promotes bypass of proliferation and survival restraints in a high frequency of epithelia-derived cancer. As such, much effort is currently focused on decoding the molecular architecture supporting EGFR activation and function. Here, we have leveraged high throughput reverse phase protein lysate arrays, with a sensitive fluorescent nanocrystal-based phosphoprotein detection assay, together with large scale siRNA-mediated loss of function to execute a quantitative interrogation of all elements of the human kinome supporting EGF-dependent signaling. This screening platform has captured multiple novel contributions of diverse protein kinases to modulation of EGFR signal generation, signal amplitude, and signal duration. As examples, the prometastatic SNF1/AMPK-related kinase hormonally upregulated Neu kinase was found to support EGFR activation in response to ligand binding, whereas the enigmatic kinase MGC16169 selectively supports coupling of active EGFR to ERK1/2 regulation. Of note, the receptor tyrosine kinase MERTK and the pyrimidine kinase UCK1 were both found to be required for surface accumulation of EGFR and subsequent pathway activation in multiple cancer cell backgrounds and may represent new targets for therapeutic intervention.	Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Padron, David; Roth, Michael] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rosenblatt, Kevin P.] Brown Fdn Inst Mol Med, Ctr Clin & Translat Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75220 USA.	michael.white@utsouthwestern.edu		Roth, Michael/0000-0002-9056-332X	Welch Foundation [I-1414]; National Cancer Institute [CA71443]; NATIONAL CANCER INSTITUTE [R01CA071443] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Welch Foundation (I-1414) and the National Cancer Institute (CA71443).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bi J, 2009, INT J CANCER, V124, P1587, DOI 10.1002/ijc.24164; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Geho D, 2005, BIOCONJUGATE CHEM, V16, P559, DOI 10.1021/bc0497113; Geho David H, 2007, Methods Mol Biol, V374, P229; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Guan M, 2009, INT J CANCER, V124, P88, DOI 10.1002/ijc.23890; Herbst RS, 2004, NAT REV CANCER, V4, P956, DOI 10.1038/nrc1506; Hiraga T, 2009, J BONE MINER METAB, V27, P149, DOI 10.1007/s00774-009-0039-9; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lovasz L, 1993, BOLYAI MATH STUD, V1, P9; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tagliabue E, 2010, EXPERT OPIN BIOL TH, V10, P711, DOI 10.1517/14712591003689972; Tuveson DA, 2003, CANCER CELL, V4, P95, DOI 10.1016/S1535-6108(03)00189-2; Wang JD, 2005, ONCOGENE, V24, P5637, DOI 10.1038/sj.onc.1208720; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; WU XP, 1995, J CLIN INVEST, V95, P1897, DOI 10.1172/JCI117871	39	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21134	21142		10.1074/jbc.M110.137828	http://dx.doi.org/10.1074/jbc.M110.137828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421302	hybrid, Green Published			2022-12-27	WOS:000279228600076
J	Larsen, KS; Ostergaard, H; Olsen, OH; Bjelke, JR; Ruf, W; Petersen, LC				Larsen, Katrine S.; Ostergaard, Henrik; Olsen, Ole H.; Bjelke, Jais R.; Ruf, Wolfram; Petersen, Lars C.			Engineering of Substrate Selectivity for Tissue Factor.Factor VIIa Complex Signaling through Protease-activated Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR CYTOPLASMIC DOMAIN; BLOOD-COAGULATION FACTOR; INHIBITOR SPECIFICITIES; FACTOR-X; SURFACE RESIDUES; MDA-MB-231 CELLS; THROMBIN; BINDING; PAR1; PROTEASE-ACTIVATED-RECEPTOR-2	The complex of factor VIIa (FVIIa) with tissue factor (TF) triggers coagulation by recognizing its macromolecular substrate factors IX (FIX) and X (FX) predominantly through extended exosite interactions. In addition, TF mediates unique cell-signaling properties in cancer, angiogenesis, and inflammation that involve proteolytic cleavage of protease-activated receptor 2 (PAR2). PAR2 is cleaved by FVIIa in the binary TF.FVIIa complex and by FXa in the ternary TF.FVIIa.FXa complex, but physiological roles of these signaling complexes are incompletely understood. In a screen of FVIIa protease domain mutants, three variants (Q40A, Q143N, and T151S) activated macromolecular coagulation substrates and supported signaling of the ternary TF.FVIIa.Xa complex normally but were severely impaired in binary TF.FVIIa.PAR2 signaling. The residues identified were located in the model-predicted S2' pocket of FVIIa, and complementary PAR2 P2' Leu-38 replacements demonstrated that the P2' side chain was indeed crucial for PAR2 cleavage by TF.FVIIa. In addition, PAR2 was activated more efficiently by FVIIa T99Y, consistent with further contributions from the S2 subsite. The P2 residue preference of FVIIa and FXa predicted additional PAR2 mutants that were efficiently activated by TF.FVIIa but resistant to cleavage by the alternative PAR2 activator FXa. Thus, contrary to the paradigm of exosite-assisted cleavage of PAR1 by thrombin, the cofactor-associated protease FVIIa recognizes PAR2 predominantly by catalytic cleft interactions. Furthermore, the delineated molecular details of this substrate interaction enabled protein engineering of protease-selective PAR2 receptors that will aid further studies to dissect the roles of TF signaling complexes in vivo.	[Petersen, Lars C.] Novo Nordisk AS, Dept Vitro Haemostasis Biol, DK-2760 Malov, Denmark; [Bjelke, Jais R.] Novo Nordisk AS, Dept Prot Purificat, DK-2760 Malov, Denmark; [Larsen, Katrine S.; Ostergaard, Henrik; Olsen, Ole H.] Novo Nordisk AS, Dept Haemostasis Biochem, DK-2760 Malov, Denmark; [Larsen, Katrine S.; Ostergaard, Henrik; Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Novo Nordisk; Novo Nordisk; Novo Nordisk; Scripps Research Institute	Petersen, LC (corresponding author), Novo Nordisk AS, Dept Vitro Haemostasis Biol, Novo Nordisk Pk, DK-2760 Malov, Denmark.	lcp@novonordisk.com			National Institutes of Health [P01-HL31950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL31950 (to W.R.).	Ahamed J, 2004, J BIOL CHEM, V279, P23038, DOI 10.1074/jbc.M401376200; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Albrektsen T, 2007, J THROMB HAEMOST, V5, P1588, DOI 10.1111/j.1538-7836.2007.02603.x; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Baugh RJ, 2000, J BIOL CHEM, V275, P28826, DOI 10.1074/jbc.M005266200; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; Bjelke JR, 2008, J BIOL CHEM, V283, P25863, DOI 10.1074/jbc.M800841200; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Chang YJ, 1999, BIOCHEMISTRY-US, V38, P10940, DOI 10.1021/bi990055h; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; Dickinson CD, 1996, CIRCULATION, V94, P1272; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; ISHII K, 1993, J BIOL CHEM, V268, P9780; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; Larsen KS, 2007, BIOCHEM J, V405, P429, DOI 10.1042/BJ20061901; LIU LW, 1991, J BIOL CHEM, V266, P16977; Myles T, 2001, EUR J BIOCHEM, V268, P70, DOI 10.1046/j.1432-1327.2001.01844.x; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P8701, DOI 10.1021/bi00027a020; Norledge BV, 2003, PROTEINS, V53, P640, DOI 10.1002/prot.10445; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Schaffner F, 2008, SEMIN THROMB HEMOST, V34, P147, DOI 10.1055/s-2008-1079254; Shobe J, 1999, J BIOL CHEM, V274, P24171, DOI 10.1074/jbc.274.34.24171; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Uusitalo-Jarvinen H, 2007, ARTERIOSCL THROM VAS, V27, P1456, DOI 10.1161/ATVBAHA.107.142539; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Zhang E, 1999, J MOL BIOL, V285, P2089, DOI 10.1006/jmbi.1998.2452; Zhong DG, 2002, J BIOL CHEM, V277, P3622, DOI 10.1074/jbc.M111202200	43	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19959	19966		10.1074/jbc.M110.101030	http://dx.doi.org/10.1074/jbc.M110.101030			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20388709	Green Published, hybrid			2022-12-27	WOS:000279012000029
J	Luo, JL; Li, WM; Zhao, YM; Fu, HJ; Ma, DL; Tang, J; Li, CY; Peoples, RW; Li, FS; Wang, QW; Huang, PB; Xia, J; Pang, YP; Han, YF				Luo, Jialie; Li, Wenming; Zhao, Yuming; Fu, Hongjun; Ma, Dik-Lung; Tang, Jing; Li, Chaoying; Peoples, Robert W.; Li, Fushun; Wang, Qinwen; Huang, Pingbo; Xia, Jun; Pang, Yuanping; Han, Yifan			Pathologically Activated Neuroprotection via Uncompetitive Blockade of N-Methyl-D-aspartate Receptors with Fast Off-rate by Novel Multifunctional Dimer Bis(propyl)-cognitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-CHANNEL BLOCKER; SYNAPTIC-TRANSMISSION; IN-VITRO; MEMANTINE; GLUTAMATE; ANTAGONISTS; KINETICS; MODEL; NEURODEGENERATION; EXCITOTOXICITY	Uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists with fast off-rate (UFO) may represent promising drug candidates for various neurodegenerative disorders. In this study, we report that bis(propyl)-cognitin, a novel dimeric acetylcholinesterase inhibitor and gamma-aminobutyric acid subtype A receptor antagonist, is such an antagonist of NMDA receptors. In cultured rat hippocampal neurons, we demonstrated that bis(propyl)-cognitin voltage-dependently, selectively, and moderately inhibited NMDA-activated currents. The inhibitory effects of bis(propyl)-cognitin increased with the rise in NMDA and glycine concentrations. Kinetics analysis showed that the inhibition was of fast onset and offset with an off-rate time constant of 1.9 s. Molecular docking simulations showed moderate hydrophobic interaction between bis(propyl)-cognitin and the MK-801 binding region in the ion channel pore of the NMDA receptor. Bis(propyl)-cognitin was further found to compete with [H-3]MK-801 with aK(i) value of 0.27 mu M, and the mutation of NR1(N616R) significantly reduced its inhibitory potency. Under glutamate-mediated pathological conditions, bis(propyl)-cognitin, in contrast to bis(heptyl)-cognitin, prevented excitotoxicity with increasing effectiveness against escalating levels of glutamate and much more effectively protected against middle cerebral artery occlusion-induced brain damage than did memantine. More interestingly, under NMD Areceptor-mediated physiological conditions, bis(propyl)-cognitin enhanced longterm potentiation in hippocampal slices, whereas MK-801 reduced and memantine did not alter this process. These results suggest that bis(propyl)-cognitin is a UFO antagonist of NMDA receptors with moderate affinity, which may provide a pathologically activated therapy for various neurodegenerative disorders associated with NMD Areceptor dysregulation.	[Luo, Jialie; Li, Wenming; Fu, Hongjun; Han, Yifan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Inst Modern Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Luo, Jialie; Zhao, Yuming; Xia, Jun; Han, Yifan] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Ma, Dik-Lung] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Tang, Jing; Pang, Yuanping] Mayo Fdn Med Educ & Res, Rochester, MN 55905 USA; [Li, Chaoying] Jianghan Univ, Wuhan Inst Neurosci & Drug Res, Wuhan 430056, Peoples R China; [Peoples, Robert W.] Marquette Univ, Dept Biomed Sci, Milwaukee, WI 53201 USA; [Li, Fushun; Wang, Qinwen] Ningbo Univ, Dept Physiol, Sch Med, Ningbo 315211, Zhejiang, Peoples R China	Hong Kong Polytechnic University; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of Hong Kong; Mayo Clinic; Jianghan University; Marquette University; Ningbo University	Han, YF (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Inst Modern Chinese Med, Hong Kong, Hong Kong, Peoples R China.	bcyfhan@polyu.edu.hk	Huang, Pingbo/I-1127-2019; Fu, Hongjun/ABB-3558-2021; FU, HONGJUN/H-4498-2011; Xia, Jun/C-7234-2009	Huang, Pingbo/0000-0002-4560-8760; FU, HONGJUN/0000-0001-5346-7075; Pang, Yuan-Ping/0000-0003-0838-2560; Ma, Dik-Lung/0000-0002-9515-340X; Han, Yifan/0000-0002-5833-069X; Xia, Jun/0000-0001-9308-2188	Research Grants Council of Hong Kong [PolyU6608/07M, 5609/09M, N_PolyU618/07, AoE/B15/01-II]; Hong Kong Polytechnic University [G-YX96, G-U439]; National Nature Science Foundation of China [30770684]; National Nature Science Foundation of Zhejiang [Y207193]; Ministry of Science and Technology of China [2008CB517411]; Shenzhen Shuangbai Scheme	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Polytechnic University(Hong Kong Polytechnic University); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of Zhejiang; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shenzhen Shuangbai Scheme	This work was supported by grants from the Research Grants Council of Hong Kong (PolyU6608/07M, 5609/09M; N_PolyU618/07; AoE/B15/01-II), Hong Kong Polytechnic University (G-YX96, G-U439), the National Nature Science Foundation of China (30770684), Zhejiang (Y207193), the Ministry of Science and Technology of China (2008CB517411), and the Shenzhen Shuangbai Scheme 2008.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Carlier PR, 1999, BIOORGAN MED CHEM, V7, P351, DOI 10.1016/S0968-0896(98)00213-2; Cavalli A, 2008, J MED CHEM, V51, P347, DOI 10.1021/jm7009364; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909; Cheng XP, 2006, NEUROSCI RES, V55, P142, DOI 10.1016/j.neures.2006.02.011; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Frankiewicz T, 1996, BRIT J PHARMACOL, V117, P689, DOI 10.1111/j.1476-5381.1996.tb15245.x; Gilling KE, 2007, NEUROPHARMACOLOGY, V53, P415, DOI 10.1016/j.neuropharm.2007.05.022; Giorgetti M, 2000, EUR J NEUROSCI, V12, P1941, DOI 10.1046/j.1460-9568.2000.00079.x; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Hare W, 2001, SURV OPHTHALMOL, V45, pS284, DOI 10.1016/S0039-6257(01)00200-4; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Kashiwagi K, 2002, MOL PHARMACOL, V61, P533, DOI 10.1124/mol.61.3.533; Klimaviciusa L, 2008, NEUROTOXICOLOGY, V29, P101, DOI 10.1016/j.neuro.2007.09.006; Krasel C, 2004, BIOCHEM SOC T, V32, P1029, DOI 10.1042/BST0321029; Li CY, 2007, NEUROPHARMACOLOGY, V52, P436, DOI 10.1016/j.neuropharm.2006.07.039; Li WM, 2007, CURR ALZHEIMER RES, V4, P386, DOI 10.2174/156720507781788918; Li WM, 2005, J BIOL CHEM, V280, P18179, DOI 10.1074/jbc.M411085200; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2004, J ALZHEIMERS DIS, V6, pS61; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Matsuyama S, 2008, NEUROREPORT, V19, P1809, DOI 10.1097/WNR.0b013e328319ab94; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; PARSONS CG, 1995, NEUROPHARMACOLOGY, V34, P1239, DOI 10.1016/0028-3908(95)00092-K; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Petrovic M, 2005, Prague Med Rep, V106, P113; Planells-Cases R, 2002, J PHARMACOL EXP THER, V302, P163, DOI 10.1124/jpet.302.1.163; Rogawski MA, 2000, AMINO ACIDS, V19, P133, DOI 10.1007/s007260070042; Stieg PE, 1999, EUR J PHARMACOL, V375, P115, DOI 10.1016/S0014-2999(99)00214-9; Tai KK, 2001, P NATL ACAD SCI USA, V98, P3519, DOI 10.1073/pnas.061449498; Takadera T, 1999, J NEUROCHEM, V73, P548, DOI 10.1046/j.1471-4159.1999.0730548.x; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Youdim MBH, 2005, TRENDS PHARMACOL SCI, V26, P27, DOI 10.1016/j.tips.2004.11.007; Zhang Y, 2006, J PHARMACOL EXP THER, V317, P973, DOI 10.1124/jpet.105.098517; Zhao XL, 2006, NEUROPHARMACOLOGY, V51, P1181, DOI 10.1016/j.neuropharm.2006.08.007	44	32	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19947	19958		10.1074/jbc.M110.111286	http://dx.doi.org/10.1074/jbc.M110.111286			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404346	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000279012000028
J	Albert, M; Jehle, AK; Mueller, K; Eisele, C; Lipschis, M; Felix, G				Albert, Markus; Jehle, Anna K.; Mueller, Katharina; Eisele, Claudia; Lipschis, Martin; Felix, Georg			Arabidopsis thaliana Pattern Recognition Receptors for Bacterial Elongation Factor Tu and Flagellin Can Be Combined to Form Functional Chimeric Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; EXTRACELLULAR DOMAIN; MOLECULAR-PATTERNS; ELICITOR FLAGELLIN; TOMATO CELLS; KINASE; PERCEPTION; DISTINCT; FLS2; SPECIFICITY	The receptor kinase EFR of Arabidopsis thaliana detects the microbe-associated molecular pattern elf18, a peptide that represents the N terminus of bacterial elongation factor Tu. Here, we tested subdomains of EFR for their importance in receptor function. Transient expression of tagged versions of EFR and EFR lacking its cytoplasmic domain in leaves of Nicotiana benthamiana resulted in functional binding sites for elf18. No binding of ligand was found with the ectodomain lacking the transmembrane domain or with EFR lacking the first 5 of its 21 leucine-rich repeats (LRRs). EFR is structurally related to the receptor kinase flagellin-sensing 2 (FLS2) that detects bacterial flagellin. Chimeric receptors with subdomains of FLS2 substituting for corresponding parts of EFR were tested for functionality in ligand binding and receptor activation assays. Substituting the transmembrane domain and the cytoplasmic domain resulted in a fully functional receptor for elf18. Replacing also the outer juxtamembrane domain with that of FLS2 led to a receptor with full affinity for elf18 but with a lower efficiency in response activation. Extending the substitution to encompass also the last two of the LRRs abolished binding and receptor activation. Substitution of the N terminus by the first six LRRs from FLS2 reduced binding affinity and strongly affected receptor activation. In summary, chimeric receptors allow mapping of subdomains relevant for ligand binding and receptor activation. The results also show that modular assembly of chimeras from different receptors can be used to form functional receptors.	[Albert, Markus; Jehle, Anna K.; Mueller, Katharina; Eisele, Claudia; Lipschis, Martin; Felix, Georg] Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Felix, G (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, Morgenstelle 5, D-72076 Tubingen, Germany.	georg.felix@uni-tuebingen.de		Albert, Markus/0000-0003-4729-2453; Witte, Anna Kristina/0000-0001-6471-0763	Deutsche Forschungsgemeinschaft [SFB 446, SFB 766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft as part of initiatives SFB 446, SFB 766, and ERA-PG RLKRLP.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BAUREITHEL K, 1994, J BIOL CHEM, V269, P17931; Belkhadir Y, 2006, SCIENCE, V314, P1410, DOI 10.1126/science.1134040; Boggs NA, 2009, GENETICS, V182, P1313, DOI 10.1534/genetics.109.102442; Boggs NA, 2009, CURR BIOL, V19, P786, DOI 10.1016/j.cub.2009.03.037; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Butenko MA, 2009, TRENDS PLANT SCI, V14, P255, DOI 10.1016/j.tplants.2009.02.002; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Van der Hoorn RAL, 2001, P NATL ACAD SCI USA, V98, P10493, DOI 10.1073/pnas.181241798; Van der Hoorn RAL, 2001, PLANT CELL, V13, P273, DOI 10.1105/tpc.13.2.273; Wulff BBH, 2009, MOL PLANT MICROBE IN, V22, P1191, DOI 10.1094/MPMI-22-10-1191; Wulff BBH, 2001, PLANT CELL, V13, P255, DOI 10.1105/tpc.13.2.255; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	41	62	70	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19035	19042		10.1074/jbc.M110.124800	http://dx.doi.org/10.1074/jbc.M110.124800			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410299	Green Published, hybrid			2022-12-27	WOS:000278727800012
J	Matsumoto, Y; Matsumoto, K; Irie, F; Fukushi, J; Stallcup, WB; Yamaguchi, Y				Matsumoto, Yoshihiro; Matsumoto, Kazu; Irie, Fumitoshi; Fukushi, Jun-ichi; Stallcup, William B.; Yamaguchi, Yu			Conditional Ablation of the Heparan Sulfate-synthesizing Enzyme Ext1 Leads to Dysregulation of Bone Morphogenic Protein Signaling and Severe Skeletal Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNOVIAL JOINT FORMATION; LIMB BUD; GENE-EXPRESSION; SONIC HEDGEHOG; CELL-SURFACE; CHICK LIMB; DIFFERENTIATION; CHONDROCYTES; GROWTH; RANGE	Increasing evidence indicates that heparan sulfate (HS) is an integral component of many morphogen signaling pathways. However, its mechanisms of action appear to be diverse, depending on the type of morphogen and the developmental contexts. To define the function of HS in skeletal development, we conditionally ablated Ext1, which encodes an essential glycosyltransferase for HS synthesis, in limb bud mesenchyme using the Prx1-Cre transgene. These conditional Ext1 mutant mice display severe limb skeletal defects, including shortened and malformed limb bones, oligodactyly, and fusion of joints. In developing limb buds of mutant mice, chondrogenic differentiation of mesenchymal condensations is delayed and impaired, whereas the area of differentiation is diffusely expanded. Correspondingly, the distribution of both bone morphogenic protein (BMP) signaling domains and BMP2 immunoreactivity in the mutant limb mesenchyme is broadened and diffuse. In micromass cultures, chondrogenic differentiation of mutant chondrocytes is delayed, and the responsiveness to exogenous BMPs is attenuated. Moreover, the segregation of the pSmad1/5/8-expressing chondrocytes and fibronectin-expressing perichondrium-like cells surrounding chondrocyte nodules is disrupted in mutant micromass cultures. Together, our results show that HS is essential for patterning of limb skeletal elements and that BMP signaling is one of the major targets for the regulatory role of HS in this developmental context.	[Matsumoto, Yoshihiro; Matsumoto, Kazu; Irie, Fumitoshi; Yamaguchi, Yu] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Fukushi, Jun-ichi; Stallcup, William B.] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Yamaguchi, Y (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yyamaguchi@burnham.org			National Institutes of Health [R01 AR055670, R01 CA95238, P01 HD25938]; MHE Coalition; MHE Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MHE Coalition; MHE Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR055670 (to Y.Y.), R01 CA95238 (to W.B.S.), and P01 HD25938 (to Y.Y.and W.B.S.).This work was also supported by the MHE Coalition and the MHE Research Foundation.	Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; BURKE AC, 1995, DEVELOPMENT, V121, P333; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; Deirmengian GK, 2008, J BONE JOINT SURG AM, V90A, P366, DOI 10.2106/JBJS.G.00774; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Fisher MC, 2006, MATRIX BIOL, V25, P27, DOI 10.1016/j.matbio.2005.07.008; Fukushi J, 2003, DEV DYNAM, V228, P143, DOI 10.1002/dvdy.10359; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LEFEBVRE V, 1995, J CELL BIOL, V128, P239, DOI 10.1083/jcb.128.1.239; Li CL, 2005, DEVELOPMENT, V132, P4755, DOI 10.1242/dev.02065; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Macias D, 1997, DEVELOPMENT, V124, P1109; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; vanderHoeven F, 1996, MECH DEVELOP, V54, P9, DOI 10.1016/0925-4773(95)00455-6; Verheyden JM, 2005, DEVELOPMENT, V132, P4235, DOI 10.1242/dev.02001; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053	46	51	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19227	19234		10.1074/jbc.M110.105338	http://dx.doi.org/10.1074/jbc.M110.105338			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404326	Green Published, hybrid			2022-12-27	WOS:000278727800032
J	Wu, L; Nam, YJ; Kung, G; Crow, MT; Kitsis, RN				Wu, Lily; Nam, Young-Jae; Kung, Gloria; Crow, Michael T.; Kitsis, Richard N.			Induction of the Apoptosis Inhibitor ARC by Ras in Human Cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; CASPASE RECRUITMENT DOMAIN; ETS TRANSCRIPTION FACTORS; CELL-DEATH; PROTEIN ARC; ACTIVATION; PATHWAY; KINASE; GROWTH; GENE	Inhibition of apoptosis is critical for carcinogenesis. ARC (apoptosis repressor with caspase recruitment domain) is an endogenous inhibitor of apoptosis that antagonizes both intrinsic and extrinsic apoptosis pathways. Although normally expressed in striated myocytes and neurons, ARC is markedly induced in a variety of primary human epithelial cancers and renders cancer cells resistant to killing. The mechanisms that mediate the induction of ARC in cancer are unknown. Herein we demonstrate that increases in ARC abundance are stimulated by Ras through effects on transcription and protein stability. Overexpression of activated N-Ras or H-Ras in normal cells is sufficient to increase ARC mRNA and protein levels. Similarly, transgenic expression of activated H-Ras induces ARC in both the normal mammary epithelium and resulting tumors of intact mice. Conversely, knockdown of endogenous N-Ras in breast and colon cancer cells significantly reduces ARC mRNA and protein levels. The promoter of the Nol3 locus, encoding ARC, is activated by N-Ras and H-Ras in a MEK/ERK-dependent manner. Ras also stabilizes ARC protein by suppressing its polyubiquitination and subsequent proteasomal degradation. In addition to the effects of Ras on ARC abundance, ARC mediates Ras-induced cell survival and cell cycle progression. Thus, Ras induces ARC in epithelial cancers, and ARC plays a role in the oncogenic actions of Ras.	[Wu, Lily; Nam, Young-Jae; Kung, Gloria; Kitsis, Richard N.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Wu, Lily; Nam, Young-Jae; Kung, Gloria; Kitsis, Richard N.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10461 USA; [Kitsis, Richard N.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Crow, Michael T.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	Kitsis, RN (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	richard.kitsis@einstein.yu.edu			National Institutes of Health [HL60665, HL61550, HL80607, CA013330]; Wilf Family; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060665, R01HL061550, R01HL080607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wilf Family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants HL60665, HL61550, and HL80607 (to R.N.K.) and institutional National Institutes of Health P30 Cancer Center Grant CA013330. This work was also supported by the Wilf Family.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chen LH, 2008, CANCER RES, V68, P834, DOI 10.1158/0008-5472.CAN-07-5056; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Cosenza MA, 2002, NEUROPATH APPL NEURO, V28, P480, DOI 10.1046/j.1365-2990.2002.00420.x; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gartel AL, 2000, ONCOGENE, V19, P961, DOI 10.1038/sj.onc.1203411; Geertman R, 1996, BBA-GENE STRUCT EXPR, V1306, P147, DOI 10.1016/0167-4781(96)00036-X; GIARETTI W, 1994, METHOD CELL BIOL, V41, P389; GRAHAM KA, 1985, CANCER RES, V45, P2201; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARRINGTON EA, 1994, CURR OPIN GENET DEV, V4, P120, DOI 10.1016/0959-437X(94)90100-7; IGLEHART JD, 1990, CANCER RES, V50, P6701; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; LACROIX H, 1989, ONCOGENE, V4, P145; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mercier I, 2005, CELL DEATH DIFFER, V12, P682, DOI 10.1038/sj.cdd.4401631; Mercier I, 2008, CELL CYCLE, V7, P1640, DOI 10.4161/cc.7.11.5979; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nam YJ, 2007, J BIOL CHEM, V282, P5522, DOI 10.1074/jbc.M609186200; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; PEAR W, 1997, METHODS MOL MED GENE; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Sotgia F, 2006, AM J PATHOL, V168, P292, DOI 10.2353/ajpath.2006.050429; Stoss O, 1999, J BIOL CHEM, V274, P10951, DOI 10.1074/jbc.274.16.10951; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Turner DP, 2007, J CELL BIOCHEM, V102, P549, DOI 10.1002/jcb.21494; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Zhang L, 1999, NUCLEIC ACIDS RES, V27, P2947, DOI 10.1093/nar/27.14.2947	48	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19235	19245		10.1074/jbc.M110.114892	http://dx.doi.org/10.1074/jbc.M110.114892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392691	Green Published, hybrid			2022-12-27	WOS:000278727800033
J	Foti, R; Zucchelli, S; Biagioli, M; Roncaglia, P; Vilotti, S; Calligaris, R; Krmac, H; Girardini, JE; Del Sal, G; Gustincich, S				Foti, Rossana; Zucchelli, Silvia; Biagioli, Marta; Roncaglia, Paola; Vilotti, Sandra; Calligaris, Raffaella; Krmac, Helena; Girardini, Javier Enrique; Del Sal, Giannino; Gustincich, Stefano			Parkinson Disease-associated DJ-1 Is Required for the Expression of the Glial Cell Line-derived Neurotrophic Factor Receptor RET in Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; GENE-EXPRESSION; MOTOR DEFICITS; IN-VITRO; HYPOXIA; PROTEIN; INACTIVATION; APOPTOSIS; MUTANTS	Mutations in PARK7/DJ-1 are associated with autosomal recessive, early onset Parkinson disease (PD). DJ-1 is an atypical peroxiredoxin-like peroxidase that may act as a redox-dependent chaperone and a regulator of transcription. Here we show that DJ-1 plays an essential role in the expression of rearranged during transfection (RET), a receptor for the glial cell line-derived neurotrophic factor, a neuroprotective molecule for dopaminergic neurons, the main target of degeneration in PD. The inducible loss of DJ-1 triggers the establishment of hypoxia and the production of reactive oxygen species that stabilize the hypoxia-inducible factor-1 alpha (HIF-1a). HIF-1a expression is required for RET down-regulation. This study establishes for the first time a molecular link between the lack of functional DJ-1 and the glial cell line-derived neurotrophic factor signaling pathway that may explain the adult-onset loss of dopaminergic neurons. Furthermore, it suggests that hypoxia may play an important role in PD.	[Foti, Rossana; Zucchelli, Silvia; Biagioli, Marta; Roncaglia, Paola; Vilotti, Sandra; Calligaris, Raffaella; Krmac, Helena; Gustincich, Stefano] SISSA, Sector Neurobiol, Int Sch Adv Studies, I-34149 Trieste, Italy; [Zucchelli, Silvia; Gustincich, Stefano] Italian Inst Technol, SISSA Unit, Basovizza, Italy; [Zucchelli, Silvia; Biagioli, Marta; Calligaris, Raffaella; Krmac, Helena; Gustincich, Stefano] Giovanni Armenise Harvard Fdn Lab, Basovizza, Italy; [Girardini, Javier Enrique; Del Sal, Giannino] Lab Nazl CIB, I-34149 Trieste, Italy; [Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; University of Trieste	Gustincich, S (corresponding author), SISSA, Sector Neurobiol, Int Sch Adv Studies, AREA Sci Pk,SS 14,Km 163-5 Basovizza, I-34149 Trieste, Italy.	gustinci@sissa.it		Foti, Rossana/0000-0003-1095-9453; DEL SAL, GIANNINO/0000-0003-2185-6003; Roncaglia, Paola/0000-0002-2825-0621; Biagioli, Marta/0000-0001-8295-8025; Gustincich, Stefano/0000-0002-2749-2514; Zucchelli, Silvia/0000-0003-4556-2990	Telethon [GGP06268]; Giovanni Armenise-Harvard Foundation; Italian Institute of Technology	Telethon(Fondazione Telethon); Giovanni Armenise-Harvard Foundation; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT)	This work was supported by Telethon Grant GGP06268, The Giovanni Armenise-Harvard Foundation, and the Italian Institute of Technology.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; BURKE RE, 1992, NEUROSCIENCE, V50, P559, DOI 10.1016/0306-4522(92)90447-A; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Decker Michael J, 2002, Sleep Breath, V6, P205, DOI 10.1007/s11325-002-0205-y; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Gonzalez-Polo RA, 2009, J NEUROCHEM, V109, P889, DOI 10.1111/j.1471-4159.2009.06020.x; Guo SH, 2009, J NEUROCHEM, V108, P1309, DOI 10.1111/j.1471-4159.2009.05877.x; Gutsaeva DR, 2006, NEUROSCIENCE, V137, P493, DOI 10.1016/j.neuroscience.2005.07.061; Herrera FE, 2007, J BIOL CHEM, V282, P24905, DOI 10.1074/jbc.M701013200; Hirata Y, 2007, J NEUROCHEM, V102, P1606, DOI 10.1111/j.1471-4159.2007.04695.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Lavara-Culebras E, 2007, GENE, V400, P158, DOI 10.1016/j.gene.2007.06.013; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Nosrat CA, 1997, EXP BRAIN RES, V115, P410, DOI 10.1007/PL00005711; OO TF, 1995, NEUROSCIENCE, V69, P893, DOI 10.1016/0306-4522(95)00282-N; Piruat JI, 2005, J BIOL CHEM, V280, P42676, DOI 10.1074/jbc.M507044200; Pisani A, 2006, NEUROBIOL DIS, V23, P54, DOI 10.1016/j.nbd.2006.02.001; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	49	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18565	18574		10.1074/jbc.M109.088294	http://dx.doi.org/10.1074/jbc.M109.088294			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395301	Green Published, hybrid			2022-12-27	WOS:000278453900050
J	Kim, G; Cole, NB; Lim, JC; Zhao, H; Levine, RL				Kim, Geumsoo; Cole, Nelson B.; Lim, Jung Chae; Zhao, Hang; Levine, Rodney L.			Dual Sites of Protein Initiation Control the Localization and Myristoylation of Methionine Sulfoxide Reductase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; N-MYRISTOYLATION; OXIDATIVE DAMAGE; GENE ENCODES; SUBCELLULAR-LOCALIZATION; CYTOSOLIC ISOFORMS; MESSENGER-RNAS; A MSRA; MITOCHONDRIAL	Methionine sulfoxide reductase A is an essential enzyme in the antioxidant system, which scavenges reactive oxygen species through cyclic oxidation and reduction of methionine and methionine sulfoxide. In mammals, one gene encodes two forms of the reductase, one targeted to the cytosol and the other to mitochondria. The cytosolic form displays faster mobility than the mitochondrial form, suggesting a lower molecular weight for the former. The apparent size difference and targeting to two cellular compartments had been proposed to result from differential splicing of mRNA. We now show that differential targeting is effected by use of two initiation sites, one of which includes a mitochondrial targeting sequence, whereas the other does not. We also demonstrate that the mass of the cytosolic form is not less than that of the mitochondrial form; the faster mobility of cytosolic form is due to its myristoylation. Lipidation of methionine sulfoxide reductase A occurs in the mouse, in transfected tissue culture cells, and even in a cell-free protein synthesis system. The physiologic role of myristoylation of MsrA remains to be elucidated.	[Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Cole, Nelson B.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Levine, RL (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 50,Rm 2351, Bethesda, MD 20892 USA.	rlevine@nih.gov	Levine, Rodney L/D-9885-2011; Zhao, Hang/A-2558-2012		National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole by the National Institutes of Health, NHLBI, Intramural Research Program.	BELTZER JP, 1988, J BIOL CHEM, V263, P368; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabreiro F, 2007, BIOCHIMIE, V89, P1388, DOI 10.1016/j.biochi.2007.05.005; Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Chabregas SM, 2003, J CELL SCI, V116, P285, DOI 10.1242/jcs.00228; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Cole NB, 2010, EXP GERONTOL, V45, P596, DOI 10.1016/j.exger.2010.01.016; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295, DOI 10.1128/MCB.8.10.4295; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Gangal M, 1999, P NATL ACAD SCI USA, V96, P12394, DOI 10.1073/pnas.96.22.12394; GODDARD C, 1988, BIOCHEM J, V253, P839, DOI 10.1042/bj2530839; Hansel A, 2002, FASEB J, V16, P911, DOI 10.1096/fj.01-0737fje; Kim G, 2000, ARCH BIOCHEM BIOPHYS, V377, P334, DOI 10.1006/abbi.2000.1793; Kim HY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-11; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; Stadtman ER, 2006, REDOX PROTEOMICS PRO, P123; Taggart C, 2000, J BIOL CHEM, V275, P27258; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; Ueda M, 1998, BBA-GENE STRUCT EXPR, V1397, P213, DOI 10.1016/S0167-4781(98)00009-8; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Willer M, 1999, CURR BIOL, V9, P1085, DOI 10.1016/S0960-9822(99)80477-1; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	49	41	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18085	18094		10.1074/jbc.M110.119701	http://dx.doi.org/10.1074/jbc.M110.119701			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368336	hybrid, Green Published			2022-12-27	WOS:000278133400083
J	Tate, JJ; Georis, I; Dubois, E; Cooper, TG				Tate, Jennifer J.; Georis, Isabelle; Dubois, Evelyne; Cooper, Terrance G.			Distinct Phosphatase Requirements and GATA Factor Responses to Nitrogen Catabolite Repression and Rapamycin Treatment in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE GENE-EXPRESSION; TOR SIGNALING PATHWAY; METHIONINE SULFOXIMINE TREATMENT; DNA-BINDING DOMAIN; NUCLEAR-LOCALIZATION; GLN3 PHOSPHORYLATION; INTRACELLULAR-LOCALIZATION; TRANSCRIPTION FACTORS; CARBON STARVATION; 2A PHOSPHATASES	In yeast, rapamycin (Rap)-inhibited TorC1, and the phosphatases it regulates (Sit4 and PP2A) are components of a conserved pathway regulating the response of eukaryotic cells to nutrient availability. TorC1 and intracellular nitrogen levels regulate the localization of Gln3 and Gat1, the activators of nitrogen catabolite repression (NCR)-sensitive genes whose products are required to utilize poor nitrogen sources. In nitrogen excess, Gln3 and Gat1 are cytoplasmic, and NCR-sensitive transcription is repressed. During nitrogen limitation or Rap treatment, Gln3 and Gat1 are nuclear, and transcription is derepressed. We previously demonstrated that the Sit4 and Pph21/22-Tpd3-Cdc55/Rts1 requirements for nuclear Gln3 localization differ. We now show that Sit4 and Pph21/22-Tpd3-Cdc55/Rts1 requirements for NCR-sensitive and Rap-induced nuclear Gat1 localization markedly differ from those of Gln3. Our data suggest that Gln3 and Gat1 localizations are controlled by two different regulatory pathways. Gln3 localization predominantly responds to intracellular nitrogen levels, as reflected by its stronger NCR-sensitivity, weaker response to Rap treatment, and strong response to methionine sulfoximine (Msx, a glutamine synthetase inhibitor). In contrast, Gat1 localization predominantly responds to TorC1 regulation as reflected by its weaker NCR sensitivity, stronger response to Rap, and immunity to the effects of Msx. Nuclear Gln3 localization in proline-grown (nitrogen limited) cells exhibits no requirement for Pph21/22-Tpd3/Cdc55, whereas nuclear Gat1 localization under these conditions is absolutely dependent on Pph21/22- Tpd3/Cdc55. Furthermore, the extent to which Pph21/22-Tpd3-Cdc55 is required for the TorC1 pathway (Rap) to induce nuclear Gat1 localization is regulated in parallel with Pph21/22-Tpd3-Cdc55-dependent Gln3 dephosphorylation and NCRsensitive transcription, being highest in limiting nitrogen and lowest when nitrogen is in excess.	[Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; [Georis, Isabelle; Dubois, Evelyne] Univ Libre Bruxelles, Microbiol Lab, Inst Rech Microbiol JM Wiame, B-1070 Brussels, Belgium	University of Tennessee System; University of Tennessee Health Science Center; Universite Libre de Bruxelles	Cooper, TG (corresponding author), Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642]; Commission Communautaire Francaise; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commission Communautaire Francaise; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642 (to T. G. C. and J .J. T.). This work was also supported by Commission Communautaire Francaise (to E. D. and I. G.).	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carr-Schmid A, 1999, J BIOL CHEM, V274, P30297, DOI 10.1074/jbc.274.42.30297; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; Chen JCY, 2006, CURR GENET, V49, P281, DOI 10.1007/s00294-005-0055-9; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 1996, J BACTERIOL, V178, P3470, DOI 10.1128/jb.178.12.3470-3479.1996; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Georis I, 2009, GENETICS, V182, P927, DOI 10.1534/genetics.109.105031; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Georis I, 2009, MOL CELL BIOL, V29, P3803, DOI 10.1128/MCB.00399-09; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MAREK ET, 1987, J BACTERIOL, V169, P2440, DOI 10.1128/jb.169.6.2440-2448.1987; MINEHART PL, 1991, MOL CELL BIOL, V11, P6216, DOI 10.1128/MCB.11.12.6216; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Presser A, 2008, P NATL ACAD SCI USA, V105, P950, DOI 10.1073/pnas.0707293105; Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Starich MR, 1998, J MOL BIOL, V277, P605, DOI 10.1006/jmbi.1998.1625; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Tate JJ, 2008, FEMS YEAST RES, V8, P1223, DOI 10.1111/j.1567-1364.2008.00441.x; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463; 2009, NAT CELL BIOL, V11, P667	58	45	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17880	17895		10.1074/jbc.M109.085712	http://dx.doi.org/10.1074/jbc.M109.085712			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378536	Green Published, hybrid			2022-12-27	WOS:000278133400065
J	Min, BS; Collins, K				Min, Bosun; Collins, Kathleen			Multiple Mechanisms for Elongation Processivity within the Reconstituted Tetrahymena Telomerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE; IN-VITRO; G-QUADRUPLEXES; DNA; RNA; EXTENSION; TEMPLATE; RPA; MAINTENANCE; PROTEINS	To maintain telomeres, telomerase evolved a unique biochemical activity: the use of a single-stranded RNA template for the synthesis of single-stranded DNA repeats. High repeat addition processivity (RAP) of the Tetrahymena telomerase holoenzyme requires association of the catalytic core with the telomere adaptor subcomplex (TASC) and an RPA1-related subunit (p82 or Teb1). Here, we used DNA binding and holoenzyme reconstitution assays to investigate the mechanism by which Teb1 and TASC confer high RAP. We show that TASC association with the recombinant telomerase catalytic core increases enzyme activity. Subsequent association of the Teb1 C-terminal domain with TASC confers the capacity for high RAP even though the Teb1 C-terminal domain does not provide a high-affinity DNA interaction site. Efficient RAP also requires suppression of nascent product folding mediated by the central Teb1 DNA-binding domains (DBDs). These sequence-specific high-affinity DBDs of Teb1 can be functionally substituted by the analogous DBDsof Tetrahymena Rpa1 to suppress nascent product folding but only if the Rpa1 high-affinity DBDs are physically tethered into holoenzyme context though the Teb1 C-terminal domain. Overall, our findings reveal multiple mechanisms and multiple surfaces of protein-DNA and protein-protein interaction that give rise to elongation processivity in the synthesis of a single-stranded nucleic acid product.	[Min, Bosun; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu			National Institutes of Health [GM54198]; University of California Berkeley Cancer Research Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Berkeley Cancer Research Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health GM54198. This work was also supported by a University of California Berkeley Cancer Research Laboratory training grant.	Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Cohen S, 2004, BBA-GENE STRUCT EXPR, V1679, P129, DOI 10.1016/j.bbaexp.2004.06.002; Collins Kathleen, 2009, V13, P285, DOI 10.1007/978-3-540-70840-7_14; Fan JH, 2009, BIOCHEMISTRY-US, V48, P1099, DOI 10.1021/bi801538h; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Forstemann K, 2005, EMBO REP, V6, P361, DOI 10.1038/sj.embor.7400374; Greene EC, 1998, GENE DEV, V12, P2921, DOI 10.1101/gad.12.18.2921; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; Hardy CD, 2001, J BIOL CHEM, V276, P4863, DOI 10.1074/jbc.M005158200; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Jarstfer MB, 2002, BIOCHEMISTRY-US, V41, P151, DOI 10.1021/bi011649z; Karamysheva Z, 2003, CELL, V113, P565, DOI 10.1016/S0092-8674(03)00363-5; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Lue NF, 2004, BIOESSAYS, V26, P955, DOI 10.1002/bies.20093; Maine IP, 1999, BIOCHEMISTRY-US, V38, P15325, DOI 10.1021/bi991596+; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Oganesian L, 2009, J CELL SCI, V122, P4013, DOI 10.1242/jcs.050567; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Prathapam R, 2005, NAT STRUCT MOL BIOL, V12, P252, DOI 10.1038/nsmb900; Qiao F, 2008, NAT STRUCT MOL BIOL, V15, P634, DOI 10.1038/nsmb.1420; Romi E, 2007, P NATL ACAD SCI USA, V104, P8791, DOI 10.1073/pnas.0703157104; Rubtsova MP, 2009, BIOCHEMISTRY-MOSCOW+, V74, P92, DOI 10.1134/S0006297909010143; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Sekaran VG, 2010, BBA-PROTEINS PROTEOM, V1804, P1190, DOI 10.1016/j.bbapap.2009.07.019; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wellinger RJ, 2009, MOL CELL, V36, P168, DOI 10.1016/j.molcel.2009.10.001; Witkin KL, 2007, MOL CELL BIOL, V27, P2074, DOI 10.1128/MCB.02105-06; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Xie MY, 2010, NUCLEIC ACIDS RES, V38, P1982, DOI 10.1093/nar/gkp1198; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	36	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16434	16443		10.1074/jbc.M110.119172	http://dx.doi.org/10.1074/jbc.M110.119172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363756	Green Published, hybrid			2022-12-27	WOS:000277982600005
J	Peralta, ER; Martin, BC; Edinger, AL				Peralta, Eigen R.; Martin, Brent C.; Edinger, Aimee L.			Differential Effects of TBC1D15 and Mammalian Vps39 on Rab7 Activation State, Lysosomal Morphology, and Growth Factor Dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST VACUOLE FUSION; SMALL GTPASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE PREFERENCE; LATE ENDOSOME; PROTEIN RILP; AUTOPHAGY; DOCKING; COMPLEX; TRANSPORT	The small GTPase Rab7 promotes fusion events between late endosomes and lysosomes. Rab7 activity is regulated by extrinsic signals, most likely via effects on its guanine nucleotide exchange factor (GEF) or GTPase-activating protein (GAP). Based on their homology to the yeast proteins that regulate the Ypt7 GTP binding state, TBC1D15, and mammalian Vps39 (mVps39) have been suggested to function as the Rab7 GAP and GEF, respectively. We developed an effector pull-down assay to test this model. TBC1D15 functioned as a Rab7 GAP in cells, reducing Rab7 binding to its effector protein RILP, fragmenting the lysosome, and conferring resistance to growth factor with-drawal-induced cell death. In a cellular context, TBC1D15 GAP activity was selective for Rab7. TBC1D15 overexpression did not inhibit transferrin internalization or recycling, Rab7-independent processes that require Rab4, Rab5, and Rab11 activation. TBC1D15 was thus renamed Rab7-GAP. Contrary to expectations for a Rab7 GEF, mVps39 induced lysosomal clustering without increasing Rab7 GTP binding. Moreover, a dominant-negative mVps39 mutant fragmented the lysosome and promoted growth factor independence without decreasing Rab7-GTP levels. These findings suggest that a protein other than mVps39 serves as the Rab7 GEF. In summary, although only TBC1D15/Rab7-GAP altered Rab7-GTP levels, both Rab7-GAP and mVps39 regulate lysosomal morphology and play a role in maintaining growth factor dependence.	[Peralta, Eigen R.; Martin, Brent C.; Edinger, Aimee L.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Edinger, AL (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, 2128 Nat Sci 1, Irvine, CA 92697 USA.	aedinger@uci.edu			NCI, National Institutes of Health [K08 CA100526]; Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE [K08CA100526] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Public Health Service Grant K08 CA100526 from the NCI, National Institutes of Health and by a Medical Research Award from the Gabrielle's Angel Foundation (to A. L. E.).	Bertram EM, 2002, INT IMMUNOL, V14, P309, DOI 10.1093/intimm/14.3.309; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Colombo MI, 2007, IUBMB LIFE, V59, P238, DOI 10.1080/15216540701230503; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Dabbeekeh JTS, 2007, ONCOGENE, V26, P2804, DOI 10.1038/sj.onc.1210081; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Ishibashi K, 2009, GENES CELLS, V14, P41, DOI 10.1111/j.1365-2443.2008.01251.x; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Karnauskas R, 2003, ONCOGENE, V22, P688, DOI 10.1038/sj.onc.1206159; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; Marsman M, 2004, MOL BIOL CELL, V15, P2954, DOI 10.1091/mbc.E03-08-0614; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Meggouh F, 2006, NEUROLOGY, V67, P1476, DOI 10.1212/01.wnl.0000240068.21499.f5; Meijerink JPP, 2005, INT J CANCER, V114, P917, DOI 10.1002/ijc.20822; Nakamura N, 1997, J BIOL CHEM, V272, P11344; NUNEZ G, 1990, J IMMUNOL, V144, P3602; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pfeffer S, 2005, NAT CELL BIOL, V7, P856, DOI 10.1038/ncb0905-856; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Price A, 2000, J CELL BIOL, V148, P1223, DOI 10.1083/jcb.148.6.1223; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rosales KR, 2009, MOL BIOL CELL, V20, P2831, DOI 10.1091/mbc.E08-09-0911; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SCHIMMOLLER F, 1993, J CELL SCI, V106, P823; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Sklan EH, 2007, J BIOL CHEM, V282, P36354, DOI 10.1074/jbc.M705221200; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Vollmer P, 1999, EUR J BIOCHEM, V260, P284, DOI 10.1046/j.1432-1327.1999.00192.x; WADA Y, 1992, J BIOL CHEM, V267, P18665; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XM, 2005, BIOCHEM BIOPH RES CO, V335, P154, DOI 10.1016/j.bbrc.2005.07.070	77	80	85	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16814	16821		10.1074/jbc.M110.111633	http://dx.doi.org/10.1074/jbc.M110.111633			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363736	Green Published, hybrid			2022-12-27	WOS:000277982600045
J	Steiger, D; Fetchko, M; Vardanyan, A; Atanesyan, L; Steiner, K; Turski, ML; Thiele, DJ; Georgiev, O; Schaffner, W				Steiger, Dominik; Fetchko, Michael; Vardanyan, Alla; Atanesyan, Lilit; Steiner, Kurt; Turski, Michelle L.; Thiele, Dennis J.; Georgiev, Oleg; Schaffner, Walter			The Drosophila Copper Transporter Ctr1C Functions in Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR MTF-1; HOMOLOGOUS RECOMBINATION; CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; SEX-CHROMOSOMES; X-CHROMOSOME; MELANOGASTER; HOMEOSTASIS; EVOLUTION; PROTEIN	Living organisms have evolved intricate systems to harvest trace elements from the environment, to control their intracellular levels, and to ensure adequate delivery to the various organs and cellular compartments. Copper is one of these trace elements. It is at the same time essential for life but also highly toxic, not least because it facilitates the generation of reactive oxygen species. In mammals, copper uptake in the intestine and copper delivery into other organs are mediated by the copper importer Ctr1. Drosophila has three Ctr1 homologs: Ctr1A, Ctr1B, and Ctr1C. Earlier work has shown that Ctr1A is an essential gene that is ubiquitously expressed throughout development, whereas Ctr1B is responsible for efficient copper uptake in the intestine. Here, we characterize the function of Ctr1C and show that it functions as a copper importer in the male germline, specifically in maturing spermatocytes and mature sperm. We further demonstrate that loss of Ctr1C in a Ctr1B mutant background results in progressive loss of male fertility that can be rescued by copper supplementation to the food. These findings hint at a link between copper and male fertility, which might also explain the high Ctr1 expression in mature mammalian spermatozoa. In both mammals and Drosophila, the X chromosome is known to be inactivated in the male germline. In accordance with such a scenario, we provide evidence that in Drosophila, the autosomal Ctr1C gene originated as a retrogene copy of the X-linked Ctr1A, thus maintaining copper delivery during male spermatogenesis.	[Georgiev, Oleg; Schaffner, Walter] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Turski, Michelle L.; Thiele, Dennis J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of Zurich; Duke University	Schaffner, W (corresponding author), Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.	walter.schaffner@imls.uzh.ch	Steiger, Dominik/F-1092-2010	Steiger, Dominik/0000-0003-2191-8091	Kanton Zurich; Swiss National Science Foundation; National Institutes of Health [GM062555]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062555] Funding Source: NIH RePORTER	Kanton Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Kanton Zurich and the Swiss National Science Foundation (to W. S.), and by National Institutes of Health Grant GM062555 (to D. J. T.).	Bachtrog D, 2009, PLOS BIOL, V7, P712, DOI 10.1371/journal.pbio.1000082; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; DANCIS A, 1994, J BIOL CHEM, V269, P25660; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; HIDIROGLOU M, 1984, J DAIRY SCI, V67, P1147, DOI 10.3168/jds.S0022-0302(84)81416-2; Hua HQ, 2010, J BIOL INORG CHEM, V15, P107, DOI 10.1007/s00775-009-0599-0; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Knopfel M, 2005, BIOCHEM BIOPH RES CO, V330, P645, DOI 10.1016/j.bbrc.2005.03.023; Kuo YM, 2006, J NUTR, V136, P21, DOI 10.1093/jn/136.1.21; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; LUCCHESI JC, 1978, SCIENCE, V202, P711, DOI 10.1126/science.715437; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; Ruiz-Pesini E, 1998, CLIN CHEM, V44, P1616; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; SHOUP JR, 1967, J CELL BIOL, V32, P663, DOI 10.1083/jcb.32.3.663; Southon A, 2008, J EXP BIOL, V211, P709, DOI 10.1242/jeb.014159; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	41	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17089	17097		10.1074/jbc.M109.090282	http://dx.doi.org/10.1074/jbc.M109.090282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351114	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000277982600072
J	Humphrey, RK; Newcomb, CJ; Yu, SMA; Hao, E; Yu, D; Krajewski, S; Du, KY; Jhala, US				Humphrey, Rohan K.; Newcomb, Christina J.; Yu, Shu-Mei A.; Hao, Ergeng; Yu, Doris; Krajewski, Stan; Du, Keyong; Jhala, Ulupi S.			Mixed Lineage Kinase-3 Stabilizes and Functionally Cooperates with TRIBBLES-3 to Compromise Mitochondrial Integrity in Cytokine-induced Death of Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-INDEPENDENT SURVIVAL; MEMBRANE PERMEABILIZATION; NEURONAL APOPTOSIS; SCAFFOLD PROTEINS; BCL-2 FAMILY; IN-VIVO; B-RAF; AKT; BAX	Mixed lineage kinases (MLKs) have been implicated in cytokine signaling as well as in cell death pathways. Our studies show that MLK3 is activated in leukocyte-infiltrated islets of non-obese diabetic mice and that MLK3 activation compromises mitochondrial integrity and induces apoptosis of beta cells. Using an ex vivo model of islet-splenocyte co-culture, we show that MLK3 mediates its effects via the pseudokinase TRB3, a mammalian homolog of Drosophila Tribbles. TRB3 expression strongly coincided with conformational change and mitochondrial translocation of BAX. Mechanistically, MLK3 directly interacted with and stabilized TRB3, resulting in inhibition of Akt, a strong suppressor of BAX translocation and mitochondrial membrane permeabilization. Accordingly, attenuation of MLK3 or TRB3 expression each prevented cytokine-induced BAX conformational change and attenuated the progression to apoptosis. We conclude that MLKs compromise mitochondrial integrity and suppress cellular survival mechanisms via TRB3-dependent inhibition of Akt.	[Humphrey, Rohan K.; Newcomb, Christina J.; Yu, Shu-Mei A.; Hao, Ergeng; Yu, Doris; Jhala, Ulupi S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92037 USA; [Krajewski, Stan] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Tufts Medical Center	Jhala, US (corresponding author), Pediat Diabet Res Ctr UCSD, 3525 John Hopkins Ct, San Diego, CA 92121 USA.	ujhala@ucsd.edu			National Institutes of Health [R01DK080147]; University of California San Diego-UCLA Diabetes Endocrinology Research Center; Juvenile Diabetes Research Foundation; Hillblom Foundation network; Thomas R. Lee ADA career development award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego-UCLA Diabetes Endocrinology Research Center; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Hillblom Foundation network; Thomas R. Lee ADA career development award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080147. This work was also supported by a University of California San Diego-UCLA Diabetes Endocrinology Research Center Pilot and feasibility grant, a Juvenile Diabetes Research Foundation grant, and a Hillblom Foundation network grant (to U.S.J.).; Recipient of the Thomas R. Lee ADA career development award.	Bodner A, 2002, J NEUROCHEM, V82, P1424, DOI 10.1046/j.1471-4159.2002.01088.x; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Chadee DN, 2004, CELL CYCLE, V3, P1227, DOI 10.4161/cc.3.10.1187; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Dansen TB, 2006, J BIOL CHEM, V281, P10890, DOI 10.1074/jbc.M513655200; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; Krajewska M, 2002, NEOPLASIA, V4, P129, DOI 10.1038/sj.neo.7900222; Krajewska M, 2004, EXP NEUROL, V189, P261, DOI 10.1016/j.expneurol.2004.05.020; Krajewska M, 2002, CELL DEATH DIFFER, V9, P145, DOI 10.1038/sj/cdd/4400934; Krajewski S, 1997, J IMMUNOL, V159, P5841; Krajewski S, 1997, CLIN CANCER RES, V3, P199; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lemasters JJ, 2002, ANTIOXID REDOX SIGN, V4, P769, DOI 10.1089/152308602760598918; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; Miyamoto S, 2009, J BIOENERG BIOMEMBR, V41, P169, DOI 10.1007/s10863-009-9205-y; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Murakata C, 2002, BIOORG MED CHEM LETT, V12, P147, DOI 10.1016/S0960-894X(01)00690-4; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan J, 2005, NEUROSCIENCE, V131, P147, DOI 10.1016/j.neuroscience.2004.09.031; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Roy SK, 2005, J BIOL CHEM, V280, P24462, DOI 10.1074/jbc.M413661200; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Sharma S, 1997, MOL CELL BIOL, V17, P2598, DOI 10.1128/MCB.17.5.2598; Sheridan C, 2008, TRENDS CELL BIOL, V18, P353, DOI 10.1016/j.tcb.2008.06.002; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Szabadkai G, 2009, APOPTOSIS, V14, P1405, DOI 10.1007/s10495-009-0363-5; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Venieratos PD, 2010, CELL SIGNAL, V22, P791, DOI 10.1016/j.cellsig.2010.01.003; Wang LH, 2004, ANNU REV PHARMACOL, V44, P451, DOI 10.1146/annurev.pharmtox.44.101802.121840; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	57	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22426	22436		10.1074/jbc.M110.123786	http://dx.doi.org/10.1074/jbc.M110.123786			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20421299	hybrid, Green Published			2022-12-27	WOS:000279702200055
J	LowKam, C; Liotard, B; Sygusch, J				LowKam, Clotilde; Liotard, Brigitte; Sygusch, Jurgen			Structure of a Class I Tagatose-1,6-bisphosphate Aldolase INVESTIGATION INTO AN APPARENT LOSS OF STEREOSPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROXYACETONE PHOSPHATE; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; MUSCLE ALDOLASE; RABBIT MUSCLE; TAGATOSE; LIVER; STEREOSELECTIVITY; CARBOXYPEPTIDASE; CRYSTALLOGRAPHY; CRYSTALLIZATION	Tagatose-1,6-bisphosphate aldolase from Streptococcus pyogenes is a class I aldolase that exhibits a remarkable lack of chiral discrimination with respect to the configuration of hydroxyl groups at both C3 and C4 positions. The enzyme catalyzes the reversible cleavage of four diastereoisomers (fructose 1,6-bisphosphate (FBP), psicose 1,6-bisphosphate, sorbose 1,6-bisphosphate, and tagatose 1,6-bisphosphate) to dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde 3-phosphate with high catalytic efficiency. To investigate its enzymatic mechanism, high resolution crystal structures were determined of both native enzyme and native enzyme in complex with dihydroxyacetone-P. The electron density map revealed a (alpha/beta)(8) fold in each dimeric subunit. Flash-cooled crystals of native enzyme soaked with dihydroxyacetone phosphate trapped a covalent intermediate with carbanionic character at Lys(205), different from the enamine mesomer bound in stereospecific class I FBP aldolase. Structural analysis indicates extensive active site conservation with respect to class I FBP aldolases, including conserved conformational responses to DHAP binding and conserved stereospecific proton transfer at the DHAP C3 carbon mediated by a proximal water molecule. Exchange reactions with tritiated water and tritium-labeled DHAP at C3 hydrogen were carried out in both solution and crystalline state to assess stereochemical control at C3. The kinetic studies show labeling at both pro-R and pro-S C3 positions of DHAP yet detritiation only at the C3 pro-S-labeled position. Detritiation of the C3 pro-R label was not detected and is consistent with preferential cis-trans isomerism about the C2-C3 bond in the carbanion as the mechanism responsible for C3 epimerization in tagatose-1,6-bisphosphate aldolase.	[LowKam, Clotilde; Liotard, Brigitte; Sygusch, Jurgen] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), CP 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	Jurgen.Sygusch@UMontreal.ca		Sygusch, Jurgen/0000-0002-6629-2128	Natural Science and Engineering Research Council (Canada); Canadian Institutes for Health Research; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Natural Science and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the Natural Science and Engineering Research Council (Canada) and Canadian Institutes for Health Research (to J.S.).; Work was carried out in part at beamlines X12B, X25, and X29 of the National Synchrotron Light Source (supported principally by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and the National Center for Research Resources of the National Institutes of Health). Assistance by beamline personnel, Drs. L. Flaks, D. K. Schneider, A. Soares, A. Heroux, and H. Robinson, is gratefully acknowledged. The help of Laurent Cappadoccia in data collection was particularly appreciated. Critical reading of the manuscript by Dr. Casimir Blonski was also appreciated. Tagatose 1,6-bisphosphate was a generous gift of Dr. W. Fessner.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BISSETT DL, 1980, J BIOL CHEM, V255, P8750; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHIU TH, 1969, BIOCHEMISTRY-US, V8, P98, DOI 10.1021/bi00829a015; CHIU TH, 1965, BIOCHEM BIOPH RES CO, V19, P511, DOI 10.1016/0006-291X(65)90155-5; Chudzik DM, 2000, J MOL BIOL, V300, P697, DOI 10.1006/jmbi.2000.3910; CORINA DL, 1976, BIOCHEM J, V157, P573, DOI 10.1042/bj1570573; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalby AR, 2001, ACTA CRYSTALLOGR D, V57, P1526, DOI 10.1107/S0907444901012719; DeLano W.L, PYMOL MOL GRAPHICS S; DIAMOND R, 1992, PROTEIN SCI, V1, P1279, DOI 10.1002/pro.5560011006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espelt L, 2005, CHEM-EUR J, V11, P1392, DOI 10.1002/chem.200400648; Fessner WD, 1998, CURR OPIN CHEM BIOL, V2, P85, DOI 10.1016/S1367-5931(98)80040-9; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V7, P250, DOI 10.1016/0006-291X(62)90184-5; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARRIS CE, 1969, BIOCHEMISTRY-US, V8, P2442, DOI 10.1021/bi00834a029; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; JENCKS WP, 1987, CATALYSIS CHEM ENZYM, P120; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOBASHI K, 1966, ARCH BIOCHEM BIOPHYS, V117, P437, DOI 10.1016/0003-9861(66)90433-4; KOBES RD, 1969, J BIOL CHEM, V244, P1919; KOBES RD, 1969, BIOCHEMISTRY-US, V8, P585, DOI 10.1021/bi00830a018; Lee JH, 2006, BIOCHEM BIOPH RES CO, V347, P616, DOI 10.1016/j.bbrc.2006.06.139; Liotard B, 2004, ACTA CRYSTALLOGR D, V60, P528, DOI 10.1107/S0907444903028427; Lorentzen E, 2004, BIOCHEM SOC T, V32, P259, DOI 10.1042/BST0320259; Loughman JA, 2007, MOL MICROBIOL, V64, P269, DOI 10.1111/j.1365-2958.2007.05663.x; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; MELOCHE HP, 1973, J BIOL CHEM, V248, P6333; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RACKER E, 1947, J BIOL CHEM, V167, P843; Rose I.A., 1969, COMPR BIOCHEM, V17, P93; ROSE IA, 1958, J AM CHEM SOC, V80, P5835, DOI 10.1021/ja01554a063; ROSE IA, 1958, J BIOL CHEM, V231, P315; RUTTER WJ, 1961, J BIOL CHEM, V236, P3193; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SPOLTER PD, 1965, J BIOL CHEM, V240, P1327; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; St-Jean M, 2007, J BIOL CHEM, V282, P31028, DOI 10.1074/jbc.M704968200; Suri JT, 2006, J ORG CHEM, V71, P3822, DOI 10.1021/jo0602017; SYGUSCH J, 1987, P NATL ACAD SCI USA, V84, P7846, DOI 10.1073/pnas.84.22.7846; Takayama S, 1997, ANNU REV MICROBIOL, V51, P285, DOI 10.1146/annurev.micro.51.1.285; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Williams GJ, 2003, P NATL ACAD SCI USA, V100, P3143, DOI 10.1073/pnas.0635924100; WONG CH, 1994, ENZYMES SYNTHETIC OR, P195; Zgiby SM, 2000, EUR J BIOCHEM, V267, P1858, DOI 10.1046/j.1432-1327.2000.01191.x	51	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21143	21152		10.1074/jbc.M109.080358	http://dx.doi.org/10.1074/jbc.M109.080358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427286	Green Published, hybrid			2022-12-27	WOS:000279228600077
J	Roell, MK; Issafras, H; Bauer, RJ; Michelson, KS; Mendoza, N; Vanegas, SI; Gross, LM; Larsen, PD; Bedinger, DH; Bohmann, DJ; Nonet, GH; Liu, NC; Lee, SR; Handa, M; Kantak, SS; Horwitz, AH; Hunter, JJ; Owyang, AM; Mirza, AM; Corbin, JA; White, ML				Roell, Marina K.; Issafras, Hassan; Bauer, Robert J.; Michelson, Kristen S.; Mendoza, Nerissa; Vanegas, Sandra I.; Gross, Lisa M.; Larsen, Paul D.; Bedinger, Daniel H.; Bohmann, David J.; Nonet, Genevieve H.; Liu, Naichi; Lee, Steve R.; Handa, Masahisa; Kantak, Seema S.; Horwitz, Arnold H.; Hunter, John J.; Owyang, Alexander M.; Mirza, Amer M.; Corbin, John A.; White, Mark L.			Kinetic Approach to Pathway Attenuation Using XOMA 052, a Regulatory Therapeutic Antibody That Modulates Interleukin-1 beta Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; IL-1 RECEPTOR; II INTERLEUKIN-1; IIIL-1 RECEPTOR; DECOY RECEPTOR; GENE-TRANSFER; HOST-DEFENSE; ANTAGONIST; IL-1-BETA; RESPONSIVENESS	Many therapeutic antibodies act as antagonists to competitively block cellular signaling pathways. We describe here an approach for the therapeutic use of monoclonal antibodies based on context-dependent attenuation to reduce pathologically high activity while allowing homeostatic signaling in biologically important pathways. Such attenuation is achieved by modulating the kinetics of a ligand binding to its various receptors and regulatory proteins rather than by complete blockade of signaling pathways. The anti-interleukin-1 beta (IL-1 beta) antibody XOMA 052 is a potent inhibitor of IL-1 beta activity that reduces the affinity of IL-1 beta for its signaling receptor and co-receptor but not for its decoy and soluble inhibitory receptors. This mechanism shifts the effective dose response of the cytokine so that the potency of IL-1 beta bound by XOMA 052 is 20-100-fold lower than that of IL-1 beta in the absence of antibody in a variety of in vitro cell-based assays. We propose that by decreasing potency of IL-1 beta while allowing binding to its clearance and inhibitory receptors, XOMA 052 treatment will attenuate IL-1 beta activity in concert with endogenous regulatory mechanisms. Furthermore, the ability to bind the decoy receptor may reduce the potential for accumulation of antibody target complexes. Regulatory antibodies like XOMA 052, which selectively modulate signaling pathways, may represent a new mechanistic class of therapeutic antibodies.	[Roell, Marina K.; Issafras, Hassan; Bauer, Robert J.; Michelson, Kristen S.; Mendoza, Nerissa; Vanegas, Sandra I.; Gross, Lisa M.; Larsen, Paul D.; Bedinger, Daniel H.; Bohmann, David J.; Nonet, Genevieve H.; Liu, Naichi; Lee, Steve R.; Handa, Masahisa; Kantak, Seema S.; Horwitz, Arnold H.; Hunter, John J.; Owyang, Alexander M.; Mirza, Amer M.; Corbin, John A.; White, Mark L.] XOMA US LLC, Preclin Res Dept, Berkeley, CA 94710 USA		Roell, MK (corresponding author), 2910 7th St, Berkeley, CA 94710 USA.	roell@xoma.com		Hunter, John/0000-0001-8262-4404; Bedinger, Daniel/0000-0001-5009-9369				Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; BOSSU P, 1995, AM J PATHOL, V147, P1852; Bourke E, 2003, J IMMUNOL, V170, P5999, DOI 10.4049/jimmunol.170.12.5999; BURGER D, 1995, J CLIN INVEST, V96, P38, DOI 10.1172/JCI118045; CLIN TRIALS, 2004, Patent No. 20040063913; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Dinarello CA, 2005, ARTHRITIS RHEUM-US, V52, P1960, DOI 10.1002/art.21107; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Donath MY, 2008, DIABETOLOGIA, V51, pS7; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2008, NAT CLIN PRACT ENDOC, V4, P240, DOI 10.1038/ncpendmet0783; Donath MY, 2009, DIABETES, V58, pA30; Ehses Jan A., 2009, Archives of Physiology and Biochemistry, V115, P240, DOI 10.1080/13813450903025879; Einstein R, 1996, CYTOKINE, V8, P206, DOI 10.1006/cyto.1996.0029; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; Graves DT, 2000, INFECT IMMUN, V68, P4746, DOI 10.1128/IAI.68.8.4746-4751.2000; GREEN L, 2008, Patent No. 7566772; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hofmeister R, 1997, J BIOL CHEM, V272, P27730, DOI 10.1074/jbc.272.44.27730; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Lang D, 1998, J IMMUNOL, V161, P6871; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Liu XY, 2008, IMMUNOL REV, V222, P9, DOI 10.1111/j.1600-065X.2008.00601.x; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Masat L, 2009, IL-1&beta; binding antibodies and fragments thereof, Patent No. [7531166, US7531166]; OWYANG A, 2009, DIABETES, V58, P310; OWYANG AM, 2010, ENDOCRINOLO IN PRESS; Re F, 1996, J EXP MED, V183, P1841, DOI 10.1084/jem.183.4.1841; Rol GP, 1997, EUR CYTOKINE NETW, V8, P265; Schreuder H, 1997, NATURE, V386, P194, DOI 10.1038/386194a0; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; SPINAS GA, 1988, ACTA ENDOCRINOL-COP, V119, P307, DOI 10.1530/acta.0.1190307; SPINAS GA, 1986, ACTA ENDOCRINOL-COP, V113, P551, DOI 10.1530/acta.0.1130551; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Trikha M, 2002, CURR OPIN BIOTECH, V13, P609, DOI 10.1016/S0958-1669(02)00348-8; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Waterhouse CCM, 2001, EXP CELL RES, V269, P109, DOI 10.1006/excr.2001.5303	42	33	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20607	20614		10.1074/jbc.M110.115790	http://dx.doi.org/10.1074/jbc.M110.115790			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20410301	hybrid, Green Published			2022-12-27	WOS:000279228600024
J	Tsai, YL; Chiang, YR; Narberhaus, F; Baron, C; Lai, EM				Tsai, Yun-Long; Chiang, Yin-Ru; Narberhaus, Franz; Baron, Christian; Lai, Erh-Min			The Small Heat-shock Protein HspL Is a VirB8 Chaperone Promoting Type IV Secretion-mediated DNA Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CRYSTALLIN; AGROBACTERIUM-TUMEFACIENS; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; MEMBRANE-PROTEIN; T-PILUS; MUTATION; SYSTEM; MECHANISM; IDENTIFICATION	Agrobacterium tumefaciens is a plant pathogen that utilizes a type IV secretion system (T4SS) to transfer DNA and effector proteins into host cells. In this study we discovered that an alpha-crystallin type small heat-shock protein (alpha-Hsp), HspL, is a molecular chaperone for VirB8, a T4SS assembly factor. HspL is a typical alpha-Hsp capable of protecting the heat-labile model substrate citrate synthase from thermal aggregation. It forms oligomers in a concentration-dependent manner in vitro. Biochemical fractionation revealed that HspL is mainly localized in the inner membrane and formed large complexes with certain VirB protein subassemblies. Protein-protein interaction studies indicated that HspL interacts with VirB8, a bitopic integral inner membrane protein that is essential for T4SS assembly. Most importantly, HspL is able to prevent the aggregation of VirB8 fused with glutathione S-transferase in vitro, suggesting that it plays a role as VirB8 chaperone. The chaperone activity of two HspL variants with amino acid substitutions (F98A and G118A) for both citrate synthase and glutathione S-transferase-VirB8 was reduced and correlated with HspL functions in T4SS-mediated DNA transfer and virulence. This study directly links in vitro and in vivo functions of an alpha-Hsp and reveals a novel alpha-Hsp function in T4SS stability and bacterial virulence.	[Tsai, Yun-Long; Chiang, Yin-Ru; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Narberhaus, Franz] Ruhr Univ Bochum, Lehrstuhl Biol Mikroorganismen, D-44780 Bochum, Germany; [Baron, Christian] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Academia Sinica - Taiwan; Ruhr University Bochum; Universite de Montreal	Lai, EM (corresponding author), 128,Sec 2,Acad Rd, Taipei 11529, Taiwan.	emlai@gate.sinica.edu.tw	Chiang, Yin-Ru/L-7727-2019; Lai, Erh-Min/ABG-9558-2020	Lai, Erh-Min/0000-0003-3630-8683; Chiang, Yin-Ru/0000-0001-6899-3166; Narberhaus, Franz/0000-0002-8552-5310	Taiwan National Science Council [NSC 95-2320-B-001-009, 0970029248P]; NSC; German Academic Exchange Service (DAAD) and Taiwan National Science Council [0970029248P]; Canadian Institutes of Health Research [MOP-84239]; Canada Foundation for Innovation; Fonds de la Recherche en Sante du Quebec	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); German Academic Exchange Service (DAAD) and Taiwan National Science Council(Deutscher Akademischer Austausch Dienst (DAAD)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Taiwan National Science Council (NSC) Grant NSC 95-2320-B-001-009 (to E.-M.L.), an NSC postdoctoral fellowship (to Y.-L.T.), and a joint grant from the German Academic Exchange Service (DAAD) and Taiwan National Science Council PPP Grant 0970029248P (to F.N. and E.-M.L.). This work was also supported by Canadian Institutes of Health Research Grant MOP-84239, the Canada Foundation for Innovation, and the Fonds de la Recherche en Sante du Quebec.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Andley UP, 2008, BIOCHEMISTRY-US, V47, P9697, DOI 10.1021/bi800594t; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Balsiger S, 2004, J BACTERIOL, V186, P6824, DOI 10.1128/JB.186.20.6824-6829.2004; Baron C, 2001, J BACTERIOL, V183, P6852, DOI 10.1128/JB.183.23.6852-6861.2001; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; BEIJERSBERGEN A, 1992, SCIENCE, V256, P1324, DOI 10.1126/science.256.5061.1324; Biswas A, 2006, BIOCHEMISTRY-US, V45, P4569, DOI 10.1021/bi052574s; BUCHANANWOLLASTON V, 1987, NATURE, V328, P172, DOI 10.1038/328172a0; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; CHANG BY, 1994, J BACTERIOL, V176, P3102, DOI 10.1128/jb.176.11.3102-3110.1994; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; DELLAGOSTIN OA, 1995, MICROBIOL-UK, V141, P1785, DOI 10.1099/13500872-141-8-1785; DEMAAGD RA, 1986, J BACTERIOL, V167, P1083, DOI 10.1128/jb.167.3.1083-1085.1986; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Giese KC, 2004, J BIOL CHEM, V279, P32674, DOI 10.1074/jbc.M404455200; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Horvath I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; KADO CI, 1970, PHYTOPATHOLOGY, V60, P969, DOI 10.1094/Phyto-60-969; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2006, PROTEOMICS, V6, P4130, DOI 10.1002/pmic.200600254; Laskowska E, 2004, MICROBIOL-SGM, V150, P247, DOI 10.1099/mic.0.26470-0; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Lentze N, 2003, J MOL BIOL, V328, P927, DOI 10.1016/S0022-2836(03)00356-5; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Munchbach M, 1999, J BACTERIOL, V181, P83; Munchbach M, 1999, EUR J BIOCHEM, V264, P39, DOI 10.1046/j.1432-1327.1999.00567.x; Nakamoto H, 2000, FEBS LETT, V483, P169, DOI 10.1016/S0014-5793(00)02097-4; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Paschos A, 2006, P NATL ACAD SCI USA, V103, P7252, DOI 10.1073/pnas.0600862103; Rashkova S, 1997, J BACTERIOL, V179, P583, DOI 10.1128/jb.179.3.583-591.1997; Rosen R, 2002, J BACTERIOL, V184, P1772, DOI 10.1128/JB.184.6.1772-1778.2002; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIRASU K, 1993, FEMS MICROBIOL LETT, V111, P287, DOI 10.1111/j.1574-6968.1993.tb06400.x; Stewart GR, 2005, MOL MICROBIOL, V55, P1127, DOI 10.1111/j.1365-2958.2004.04450.x; Stewart JN, 2006, MICROBIOL-SGM, V152, P233, DOI 10.1099/mic.0.28275-0; Tsai YL, 2009, MICROBIOL-SGM, V155, P3270, DOI 10.1099/mic.0.030676-0; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299; Wilkinson KA, 2005, J IMMUNOL, V174, P4237, DOI 10.4049/jimmunol.174.7.4237; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200	57	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19757	19766		10.1074/jbc.M110.110296	http://dx.doi.org/10.1074/jbc.M110.110296			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427270	Green Published, hybrid			2022-12-27	WOS:000279012000008
J	Dunne, A; Carpenter, S; Brikos, C; Gray, P; Strelow, A; Wesche, H; Morrice, N; O'Neill, LAJ				Dunne, Aisling; Carpenter, Susan; Brikos, Constantinos; Gray, Pearl; Strelow, Astrid; Wesche, Holger; Morrice, Nick; O'Neill, Luke A. J.			IRAK1 and IRAK4 Promote Phosphorylation, Ubiquitination, and Degradation of MyD88 Adaptor-like (Mal)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; SIGNAL-TRANSDUCTION; KINASE; ACTIVATION; BETA; EXPRESSION; REGULATOR; MOLECULE; CELLS	Signal transduction by Toll-like receptor 2 (TLR2) and TLR4 requires the adaptors MyD88 and Mal (MyD88 adaptor-like) and serine/threonine kinases, interleukin-1 receptor-associated kinases IRAK1 and IRAK4. We have found that both IRAK1 and IRAK4 can directly phosphorylate Mal. In addition, co-expression of Mal with either IRAK resulted in depletion of Mal from cell lysates. This is likely to be due to Mal phosphorylation by the IRAKs because kinase-inactive forms of either IRAK had no effect. Furthermore, lipopolysaccharide stimulation resulted in ubiquitination and degradation of Mal, which was inhibited using an IRAK1/4 inhibitor or by knocking down expression of IRAK1 and IRAK4. MyD88 is not a substrate for either IRAK and did not undergo degradation. We there fore conclude that Mal is a substrate for IRAK1 and IRAK4 with phosphorylation promoting ubiquitination and degradation of Mal. This process may serve to negatively regulate signaling by TLR2 and TLR4.	[Dunne, Aisling; Carpenter, Susan; Brikos, Constantinos; Gray, Pearl; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Wesche, Holger] Amgen San Francisco, San Francisco, CA 94080 USA; [Strelow, Astrid] CFD Therapeut, San Francisco, CA 94080 USA; [Morrice, Nick] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	Trinity College Dublin; Amgen; University of Dundee	Dunne, A (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	aidunne@tcd.ie		dunne, aisling/0000-0002-2342-9518; O'Neill, Luke/0000-0002-4333-2748	Science Foundation of Ireland; Health Research Board	Science Foundation of Ireland(Science Foundation Ireland); Health Research Board	This work was supported by grants from the Science Foundation of Ireland and the Health Research Board.	Bhattacharyya S, 2007, AM J PHYSIOL-GASTR L, V293, pG429, DOI 10.1152/ajpgi.00149.2007; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Huang YS, 2004, J BIOL CHEM, V279, P51697, DOI 10.1074/jbc.M410369200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Kubo-Murai M, 2008, J BIOCHEM, V143, P295, DOI 10.1093/jb/mvm234; Liu G, 2008, FASEB J, V22, P2285, DOI 10.1096/fj.07-101816; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Meylan E, 2008, NAT IMMUNOL, V9, P581, DOI 10.1038/ni0608-581; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Song KW, 2009, MOL IMMUNOL, V46, P1458, DOI 10.1016/j.molimm.2008.12.012; Strelow A, 2003, FEBS LETT, V547, P157, DOI 10.1016/S0014-5793(03)00697-5; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	23	39	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18276	18282		10.1074/jbc.M109.098137	http://dx.doi.org/10.1074/jbc.M109.098137			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400509	Green Published, hybrid			2022-12-27	WOS:000278453900020
J	Eiseler, T; Hausser, A; De Kimpe, L; Van Lint, J; Pfizenmaier, K				Eiseler, Tim; Hausser, Angelika; De Kimpe, Line; Van Lint, Johan; Pfizenmaier, Klaus			Protein Kinase D Controls Actin Polymerization and Cell Motility through Phosphorylation of Cortactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COFILIN-PHOSPHATASE SLINGSHOT; ARP2/3 COMPLEX; CARCINOMA-CELLS; F-ACTIN; LEADING-EDGE; N-WASP; C-MU; SITES; MIGRATION; LAMELLIPODIA	We here identify protein kinase D (PKD) as an upstream regulator of the F-actin-binding protein cortactin and the Arp actin polymerization machinery. PKD phosphorylates cortactin in vitro and in vivo at serine 298 thereby generating a 14-3-3 binding motif. In vitro, a phosphorylation-deficient cortactin-S298A protein accelerated VCA-Arp-cortactin-mediated synergistic actin polymerization and showed reduced F-actin binding, indicative of enhanced turnover of nucleation complexes. In vivo, cortactin co-localized with the nucleation promoting factor WAVE2, essential for lamellipodia extension, in the actin polymerization zone in Heregulin-treated MCF-7 cells. Using a 3-dye FRET-based approach we further demonstrate that WAVE2-Arp and cortactin prominently interact at these structures. Accordingly, cortactin-S298A significantly enhanced lamellipodia extension and directed cell migration. Our data thus unravel a previously unrecognized mechanism by which PKD controls cancer cell motility.	[Eiseler, Tim; Hausser, Angelika; Pfizenmaier, Klaus] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; [De Kimpe, Line; Van Lint, Johan] Katholieke Univ Leuven, Fac Med, Dept Mol Cell Biol, B-3000 Louvain, Belgium	University of Stuttgart; KU Leuven	Pfizenmaier, K (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.	klaus.pfizenmaier@izi.uni-stuttgart.de	Van Lint, Johan/P-9073-2019; Hausser, Angelika/AAC-4531-2021	Van Lint, Johan/0000-0002-0275-571X	Baden-Wurttemberg State Ministry for Science and Arts for the Center Systems Biology Stuttgart [A1]; BMBF; Heidelberger Akademie der Wissenschaften (WIN-Kolleg); FWO-Vlaanderen (Research Foundation-Flanders) [G.0612.07]; FWO-Vlaanderen; Interuniversity Attraction Poles Programme [IAP 6/18]	Baden-Wurttemberg State Ministry for Science and Arts for the Center Systems Biology Stuttgart; BMBF(Federal Ministry of Education & Research (BMBF)); Heidelberger Akademie der Wissenschaften (WIN-Kolleg); FWO-Vlaanderen (Research Foundation-Flanders)(FWO); FWO-Vlaanderen(FWO); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office)	This work was supported by grants from the Baden-Wurttemberg State Ministry for Science and Arts for the Center Systems Biology Stuttgart (project A1) (to K. P. and A. H.), the BMBF Systec-Program (to K. P.), and the Heidelberger Akademie der Wissenschaften (WIN-Kolleg) (to A. H.). This work was also supported by Grant G.0612.07 from FWO-Vlaanderen (Research Foundation-Flanders) (to J.V.L.), an Aspirtant Fellowship of the FWO-Vlaanderen (to L. D. K.), and Grant IAP 6/18 from the Interuniversity Attraction Poles Programme, initiated by the Belgian State Science Policy Office.	Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; De Kimpe L, 2009, CELL SIGNAL, V21, P253, DOI 10.1016/j.cellsig.2008.10.015; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Eiseler T, 2007, FEBS LETT, V581, P4279, DOI 10.1016/j.febslet.2007.07.079; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Storz P, 2009, CELL CYCLE, V8, P1975; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2005, NOVART FDN SYMP, V269, P30; Takenawa T, 2005, NOVART FDN SYMP, V269, P10; Takenawa Tadaomi, 2005, Novartis Found Symp, V269, P3; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090	39	81	81	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18672	18683		10.1074/jbc.M109.093880	http://dx.doi.org/10.1074/jbc.M109.093880			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20363754	Green Published, hybrid			2022-12-27	WOS:000278453900060
J	Faoro, L; Singleton, PA; Cervantes, GM; Lennon, FE; Choong, NW; Kanteti, R; Ferguson, BD; Husain, AN; Tretiakova, MS; Ramnath, N; Vokes, EE; Salgia, R				Faoro, Leonardo; Singleton, Patrick A.; Cervantes, Gustavo M.; Lennon, Frances E.; Choong, Nicholas W.; Kanteti, Rajani; Ferguson, Benjamin D.; Husain, Aliya N.; Tretiakova, Maria S.; Ramnath, Nithya; Vokes, Everett E.; Salgia, Ravi			EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; PROTEIN EXPRESSION; COLORECTAL-CANCER; OVARIAN-CANCER; GROWTH; OVEREXPRESSION; SUPPRESSES; P130(CAS); THERAPY; GENE	Non-small cell lung cancer (NSCLC) has a poor prognosis and improved therapies are needed. Expression of EphA2 is increased in NSCLC metastases. In this study, we investigated EphA2 mutations in NSCLC and examined molecular pathways involved in NSCLC. Tumor and cell line DNA was sequenced. One EphA2 mutation was modeled by expression in BEAS2B cells, and functional and biochemical studies were conducted. A G391R mutation was detected in H2170 and 2/28 squamous cell carcinoma patient samples. EphA2 G391R caused constitutive activation of EphA2 with increased phosphorylation of Src, cortactin, and p130Cas. Wild-type (WT) and G391R cells had 20 and 40% increased invasiveness; this was attenuated with knockdown of Src, cortactin, or p130Cas. WT and G391R cells demonstrated a 70% increase in focal adhesion area. Mammalian target of rapamycin (mTOR) phosphorylation was increased in G391R cells with increased survival (55%) compared with WT (30%) and had increased sensitivity to rapamycin. A recurrent EphA2 mutation is present in lung squamous cell carcinoma and increases tumor invasion and survival through activation of focal adhesions and actin cytoskeletal regulatory proteins as well as mTOR. Further study of EphA2 as a therapeutic target is warranted.	[Faoro, Leonardo; Cervantes, Gustavo M.; Choong, Nicholas W.; Kanteti, Rajani; Ferguson, Benjamin D.; Vokes, Everett E.; Salgia, Ravi] Univ Chicago, Sect Hematol & Oncol, Chicago, IL 60637 USA; [Singleton, Patrick A.; Lennon, Frances E.] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; [Husain, Aliya N.; Tretiakova, Maria S.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Ferguson, Benjamin D.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Ramnath, Nithya] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Michigan System; University of Michigan	Salgia, R (corresponding author), Univ Chicago, Med Ctr, Hematol Oncol Sect, 5841 S Maryland Ave,MC2115, Chicago, IL 60637 USA.	rsalgia@medicine.bsd.uchicago.edu	Tretiakova, Maria/U-3320-2019; Vokes, Everett/Q-2146-2019; Ferguson, Benjamin/O-3214-2013	Ferguson, Benjamin/0000-0001-8358-3368	V-Foundation (Guy Geleerd Memorial Foundation); Kate McMullen Foundation; Respiratory Health Association of Chicago; ASCO Translational Award;  [5P01HL058064-140009];  [5R01CA100750-07];  [3R01CA100750-06S1];  [5R01CA125541-04];  [5R01CA129501-02];  [5R21CA140003-02]; NATIONAL CANCER INSTITUTE [R21CA140003, R01CA100750, R01CA125541, R01CA129501] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064] Funding Source: NIH RePORTER	V-Foundation (Guy Geleerd Memorial Foundation); Kate McMullen Foundation; Respiratory Health Association of Chicago; ASCO Translational Award; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the following research grants and awards: 5P01HL058064-140009, 5R01CA100750-07, 3R01CA100750-06S1, 5R01CA125541-04, 5R01CA129501-02, 5R21CA140003-02, V-Foundation (Guy Geleerd Memorial Foundation), Kate McMullen Foundation, Respiratory Health Association of Chicago (to R.S.), and ASCO Translational Award (to E.E.V.).	Astier A, 1997, J BIOL CHEM, V272, P228; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brannan JM, 2009, CLIN CANCER RES, V15, P4423, DOI 10.1158/1078-0432.CCR-09-0473; Carayol N, 2008, J BIOL CHEM, V283, P8601, DOI 10.1074/jbc.M707934200; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Faoroa L, 2008, ANTI-CANCER DRUG, V19, P841, DOI 10.1097/CAD.0b013e32830ce506; Hammond SA, 2007, CANCER RES, V67, P3927, DOI 10.1158/0008-5472.CAN-06-2760; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kataoka H, 2004, CANCER SCI, V95, P136, DOI 10.1111/j.1349-7006.2004.tb03194.x; Kinch MS, 2003, CLIN CANCER RES, V9, P613; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; Landen CN, 2006, CANCER BIOL THER, V5, P1708, DOI 10.4161/cbt.5.12.3468; Larsen AB, 2007, MOL CANCER RES, V5, P283, DOI 10.1158/1541-7786.MCR-06-0321; Leung ELH, 2009, MOL CANCER RES, V7, P923, DOI 10.1158/1541-7786.MCR-09-0003; Lin YG, 2007, CANCER, V109, P332, DOI 10.1002/cncr.22415; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Mudali SV, 2006, CLIN EXP METASTAS, V23, P357, DOI 10.1007/s10585-006-9045-7; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Nasreen N, 2006, CANCER-AM CANCER SOC, V107, P2425, DOI 10.1002/cncr.22254; NESBITT JC, 1995, ANN THORAC SURG, V60, P466, DOI 10.1016/0003-4975(95)00169-L; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Saito T, 2004, ONCOL REP, V11, P605; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Thaker PH, 2004, CLIN CANCER RES, V10, P5145, DOI 10.1158/1078-0432.CCR-03-0589; van Rens MTM, 2000, CHEST, V117, P374, DOI 10.1378/chest.117.2.374; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Zelinski DP, 2001, CANCER RES, V61, P2301; Zeng GY, 2003, AM J PATHOL, V163, P2271, DOI 10.1016/S0002-9440(10)63584-5	41	85	90	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18575	18585		10.1074/jbc.M109.075085	http://dx.doi.org/10.1074/jbc.M109.075085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20360610	Green Published, hybrid			2022-12-27	WOS:000278453900051
J	Litonin, D; Sologub, M; Shi, YH; Savkina, M; Anikin, M; Falkenberg, M; Gustafsson, CM; Temiakov, D				Litonin, Dmitry; Sologub, Marina; Shi, Yonghong; Savkina, Maria; Anikin, Michael; Falkenberg, Maria; Gustafsson, Claes M.; Temiakov, Dmitry			Human Mitochondrial Transcription Revisited ONLY TFAM AND TFB2M ARE REQUIRED FOR TRANSCRIPTION OF THE MITOCHONDRIAL GENES IN VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTDNA COPY NUMBER; RNA-POLYMERASE; RIBOSOMAL-RNA; FACTOR-A; MULTIPLE FUNCTIONS; INITIATION SITES; MAMMALIAN-CELLS; GENE-EXPRESSION; DISTINCT ROLES; IN-VIVO	Human mitochondrial transcription is driven by a single subunit RNA polymerase and a set of basal transcription factors. The development of a recombinant in vitro transcription system has allowed for a detailed molecular characterization of the individual components and their contribution to transcription initiation. We found that TFAM and TFB2M act synergistically and increase transcription efficiency 100-200-fold as compared with RNA polymerase alone. Both the light-strand promoter (LSP) and the HSP1 promoters displayed maximal levels of in vitro transcription when TFAM was present in an amount equimolar to the DNA template. Importantly, we did not detect any significant transcription activity in the presence of the TFB2M paralog, TFB1M, or when templates containing the putative HSP2 promoter were used. These data confirm previous observations that TFB1M does not function as a bona fide transcription factor and raise questions as to whether HSP2 serves as a functional promoter in vivo. In addition, we did not detect transcription stimulation by the ribosomal protein MRPL12. Thus, only two essential initiation factors, TFAM and TFB2M, and two promoters, LSP and HSP1, are required to drive transcription of the mitochondrial genome.	[Shi, Yonghong; Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Dept Med Biochem & Cell Biol, SE-40530 Gothenburg, Sweden; [Litonin, Dmitry; Sologub, Marina; Savkina, Maria; Anikin, Michael; Temiakov, Dmitry] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	University of Gothenburg; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gustafsson, CM (corresponding author), Univ Gothenburg, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.	claes.gustafsson@medkem.gu.se; d.temiakov@umdnj.edu	Savkina, Maria/C-9075-2018; shi, yonghong/E-8254-2017	Savkina, Maria/0000-0002-8527-2157; shi, yonghong/0000-0002-5265-7982; Gustafsson, Claes/0000-0003-3531-8468	National Institutes of Health [GM38147]; University of Medicine and Dentistry of New Jersey (UMDNJ) Research Foundation; Swedish Research Council; Swedish Cancer Society; Goran Gustafsson Foundation; Foundation for Strategic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Medicine and Dentistry of New Jersey (UMDNJ) Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Goran Gustafsson Foundation; Foundation for Strategic Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38147 (to Dr. William McAllister). This work was also supported in part by a University of Medicine and Dentistry of New Jersey (UMDNJ) Research Foundation grant (to D. T.) and by grants from the Swedish Research Council, the Swedish Cancer Society, the Goran Gustafsson Foundation, and the Foundation for Strategic Research (to C. M. G. and M. F.).	ANTOSHECHKIN I, 1995, MOL CELL BIOL, V15, P7032; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; CHRISTIANSON TW, 1986, P NATL ACAD SCI USA, V83, P6277, DOI 10.1073/pnas.83.17.6277; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FISHER RP, 1987, CELL, V50, P247, DOI 10.1016/0092-8674(87)90220-0; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; HIXSON JE, 1985, P NATL ACAD SCI USA, V82, P2660, DOI 10.1073/pnas.82.9.2660; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Maniura-Weber K, 2006, NUCLEIC ACIDS RES, V34, P6404, DOI 10.1093/nar/gkl727; Markov DA, 2009, YEAST, V26, P423, DOI 10.1002/yea.1672; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Sato H, 2004, PROTOPLASMA, V223, P175, DOI 10.1007/s00709-004-0040-z; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; YOZA BK, 1984, J BIOL CHEM, V259, P3909	33	138	146	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18129	18133		10.1074/jbc.C110.128918	http://dx.doi.org/10.1074/jbc.C110.128918			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20410300	Green Published, hybrid			2022-12-27	WOS:000278453900002
J	Bicknell, AA; Tourtellotte, J; Niwa, M				Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho			Late Phase of the Endoplasmic Reticulum Stress Response Pathway Is Regulated by Hog1 MAP Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-WALL STRESS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; TYROSINE PHOSPHATASES; TRANSMEMBRANE PROTEIN; MONITORING AUTOPHAGY; SIGNALING PATHWAYS; YEAST; GENE	When unfolded proteins accumulate in the endoplasmic reticulum (ER) causing ER stress, the unfolded protein response (UPR) responds rapidly to induce a transcriptional program that functions to alleviate the stress. However, under extreme conditions, when UPR activation is not sufficient to alleviate ER stress, the stress may persist long term. Very little is known about how the cell responds to persistent ER stress that is not resolved by the immediate activation of the UPR. We show that Hog1 MAP kinase becomes phosphorylated during the late stage of ER stress and helps the ER regain homeostasis. Although Hog1 is well known to function in osmotic stress and cell wall integrity pathways, we show that the activation mechanism for Hog1 during ER stress is distinct from both of these pathways. During late stage ER stress, upon phosphorylation, Hog1 translocates into the nucleus and regulates gene expression. Subsequently, Hog1 returns to the cytoplasm, where its phosphorylation levels remain high. From its cytoplasmic location, Hog1 contributes to the activation of autophagy by enhancing the stability of Atg8, a critical autophagy protein. Thus, Hog1 coordinates a multifaceted response to persistent ER stress.	[Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Niwa, M (corresponding author), 9500 Gilman Dr,MC0377, La Jolla, CA 92093 USA.	niwa@ucsd.edu			American Cancer Society [ACS RSG-05-01 GMC]; Searle [03-G107]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087415] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Searle; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society (Grant ACS RSG-05-01 GMC) and Searle (Grant 03-G107) (to M. N.).; Supported in part by a National Science Foundation predoctoral fellowship.	Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Arroyo J, 2009, CLIN MICROBIOL INFEC, V15, P44, DOI 10.1111/j.1469-0691.2008.02676.x; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky Daniel J., 2007, V390, P363; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marquez JA, 1998, EMBO J, V17, P2543, DOI 10.1093/emboj/17.9.2543; Mattison CP, 2000, GENE DEV, V14, P1229; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; MORI K, 1993, CELL, V74, P743; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; PRAEKELT UM, 1990, MOL GEN GENET, V223, P97, DOI 10.1007/BF00315801; Prick T, 2006, BIOCHEM J, V394, P153, DOI 10.1042/BJ20051243; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 1999, MOL CELL BIOL, V19, P5474; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sales K, 2000, BBA-BIOMEMBRANES, V1463, P267, DOI 10.1016/S0005-2736(99)00215-1; Schmid D, 2006, J MOL MED-JMM, V84, P194, DOI 10.1007/s00109-005-0014-4; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; VARELA JCS, 1995, MOL CELL BIOL, V15, P6232; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	73	46	47	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17545	17555		10.1074/jbc.M109.084681	http://dx.doi.org/10.1074/jbc.M109.084681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20382742	Green Published, hybrid			2022-12-27	WOS:000278133400033
J	Deshane, J; Kim, J; Bolisetty, S; Hock, TD; Hill-Kapturczak, N; Agarwal, A				Deshane, Jessy; Kim, Junghyun; Bolisetty, Subhashini; Hock, Thomas D.; Hill-Kapturczak, Nathalie; Agarwal, Anupam			Sp1 Regulates Chromatin Looping between an Intronic Enhancer and Distal Promoter of the Human Heme Oxygenase-1 Gene in Renal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; CARBON-MONOXIDE; 1ST INTRON; IN-VIVO; EXPRESSION; INDUCTION; RECEPTOR; ELEMENTS; REGION; MCP-1	HO-1(heme oxygenase-1) is an inducible microsomal enzyme that catalyzes the degradation of pro-oxidant heme. The goal of this study was to characterize a minimal enhancer region within the human HO-1 gene and delineate its role in modulating HO-1 expression by participation with its promoter elements in renal epithelial cells. Deletion analysis and site-directed mutagenesis identified a 220-bp minimal enhancer in intron 1 of the HO-1 gene, which regulates hemin-mediated HO-1 gene expression. Small interfering RNA, decoy oligonucleotides, site-directed mutagenesis, and chromatin immunoprecipitation assays confirmed the functional interaction of Sp1 with a consensus binding sequence within the 220-bp region. Mutations of regulatory elements within the -4.5 kb promoter region (a cyclic AMP response and a downstream NF-E2/AP-1 element, both located at -4.0 kb, and/or an E-box sequence located at -44 bp) resulted in the loss of enhancer activity. A chromosome conformation capture assay performed in human renal epithelial (HK-2) cells demonstrated hemin-inducible chromatin looping between the intronic enhancer and the -4.0 kb promoter region in a time-dependent manner. Restriction digestion with ApaLI (which cleaves the 220-bp enhancer) led to a loss of stimulus-dependent chromatin looping. Sp1 small interfering RNA and mithramycin A, a Sp1 binding site inhibitor, resulted in loss of the loop formation between the intronic enhancer and the distal HO-1 promoter by the chromosome conformation capture assay. These results provide novel insight into the complex molecular interactions that underlie human HO-1 regulation in renal epithelial cells.	[Deshane, Jessy; Kim, Junghyun; Bolisetty, Subhashini; Hock, Thomas D.; Hill-Kapturczak, Nathalie; Agarwal, Anupam] Univ Alabama Birmingham, Dept Med, Nephrol Res & Training Ctr, Birmingham, AL 35294 USA; [Deshane, Jessy; Kim, Junghyun; Bolisetty, Subhashini; Hock, Thomas D.; Hill-Kapturczak, Nathalie; Agarwal, Anupam] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Deshane, Jessy; Hock, Thomas D.; Agarwal, Anupam] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Kim, Junghyun] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Agarwal, A (corresponding author), THT 647 Univ Alabama Birmingham, Div Nephrol, 1900 Univ Blvd, Birmingham, AL 35294 USA.	agarwal@uab.edu	Bolisetty, Subhashini/F-6496-2011		National Institutes of Health [DK059600, DK075332, DK079337, DK071875]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337, R01DK075532, R01DK071875, R01DK059600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK059600, DK075332, DK079337, and DK071875 (to A.A.).	ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeradbiomed.2005.03.010; Adoue V, 2008, J MOL BIOL, V384, P1048, DOI 10.1016/j.jmb.2008.10.019; AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; ALAM J, 1989, J BIOL CHEM, V264, P17637; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Babu DA, 2008, J BIOL CHEM, V283, P8164, DOI 10.1074/jbc.M800336200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Chavanas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003408; Choi YS, 2007, NUCLEIC ACIDS RES, V35, P5511, DOI 10.1093/nar/gkm547; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Flodby P, 2007, BIOCHEM BIOPH RES CO, V356, P26, DOI 10.1016/j.bbrc.2007.02.076; Guo H, 2008, J BIOL CHEM, V283, P25209, DOI 10.1074/jbc.M804062200; Hill-Kapturczak N, 2003, AM J PHYSIOL-RENAL, V285, pF515, DOI 10.1152/ajprenal.00137.2003; Hock TD, 2004, BIOCHEM J, V383, P209, DOI 10.1042/BJ20040794; Hock TD, 2007, J BIOL CHEM, V282, P6875, DOI 10.1074/jbc.M608456200; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Inguaggiato P, 2001, KIDNEY INT, V60, P2181, DOI 10.1046/j.1523-1755.2001.00046.x; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Liu XD, 2007, J IMMUNOL, V179, P2999, DOI 10.4049/jimmunol.179.5.2999; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Miele Adriana, 2008, V464, P105; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nath KA, 2000, AM J PATHOL, V156, P1527, DOI 10.1016/S0002-9440(10)65024-9; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nawrocki AR, 2002, J BIOL CHEM, V277, P14647, DOI 10.1074/jbc.M111549200; O'Reilly D, 2007, GENOMICS, V90, P407, DOI 10.1016/j.ygeno.2007.04.010; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Pittock ST, 2005, KIDNEY INT, V68, P611, DOI 10.1111/j.1523-1755.2005.00439.x; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Rogers RJ, 2000, BIOCHEM J, V347, P233, DOI 10.1042/0264-6021:3470233; Ryter SW, 2006, CURR OPIN PHARMACOL, V6, P257, DOI 10.1016/j.coph.2006.03.002; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Sridhar P, 1999, MOL CELL BIOL, V19, P4219; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Traylor A, 2007, AM J PHYSIOL-RENAL, V293, pF885, DOI 10.1152/ajprenal.00519.2006; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang X, 1998, ENDOCRINOLOGY, V139, P1054, DOI 10.1210/en.139.3.1054; YOSHIDA T, 1988, EUR J BIOCHEM, V171, P457, DOI 10.1111/j.1432-1033.1988.tb13811.x; ZHANG K, 1987, GENE, V57, P27, DOI 10.1016/0378-1119(87)90173-9	51	47	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16476	16486		10.1074/jbc.M109.058586	http://dx.doi.org/10.1074/jbc.M109.058586			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351094	Green Published, hybrid			2022-12-27	WOS:000277982600009
J	Shaya, D; Zhao, WJ; Garron, ML; Xiao, ZP; Cui, QZ; Zhang, ZQ; Sulea, T; Linhardt, RJ; Cygler, M				Shaya, David; Zhao, Wenjing; Garron, Marie-Line; Xiao, Zhongping; Cui, Qizhi; Zhang, Zhenqing; Sulea, Traian; Linhardt, Robert J.; Cygler, Miroslaw			Catalytic Mechanism of Heparinase II Investigated by Site-directed Mutagenesis and the Crystal Structure with Its Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN AC LYASE; FLAVOBACTERIUM-HEPARINUM; HEPARAN-SULFATE; COMPLEX; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; PURIFICATION; DEGRADATION; PRODUCT; ENZYMES	Heparinase II (HepII) is an 85-kDa dimeric enzyme that depolymerizes both heparin and heparan sulfate glycosaminoglycans through a beta-elimination mechanism. Recently, we determined the crystal structure of HepII from Pedobacter heparinus (previously known as Flavobacterium heparinum) in complex with a heparin disaccharide product, and identified the location of its active site. Here we present the structure of HepII complexed with a heparan sulfate disaccharide product, proving that the same binding/active site is responsible for the degradation of both uronic acid epimers containing substrates. The key enzymatic step involves removal of a proton from the C5 carbon (a chiral center) of the uronic acid, posing a topological challenge to abstract the proton from either side of the ring in a single active site. We have identified three potential active site residues equidistant from C5 and located on both sides of the uronate product and determined their role in catalysis using a set of defined tetrasaccharide substrates. HepII H202A/Y257A mutant lost activity for both substrates and we determined its crystal structure complexed with a heparan sulfate-derived tetrasaccharide. Based on kinetic characterization of various mutants and the structure of the enzyme-substrate complex we propose residues participating in catalysis and their specific roles.	[Cui, Qizhi; Sulea, Traian; Cygler, Miroslaw] NRC, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Shaya, David; Garron, Marie-Line; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Zhao, Wenjing; Xiao, Zhongping; Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Zhao, Wenjing; Xiao, Zhongping; Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol Chem, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Zhao, Wenjing; Xiao, Zhongping; Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Zhao, Wenjing; Xiao, Zhongping; Zhang, Zhenqing; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol & Chem Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	National Research Council Canada; McGill University; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Cygler, M (corresponding author), NRC, Biotechnol Res Inst, 6100 Royalmt Ave, Montreal, PQ H4P 2R2, Canada.	mirek@bri.nrc.ca		Garron, Marie-Line/0000-0001-5846-1246	National Institutes of Health [HL62244, GM38060]; Canadian Institutes for Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62244 and GM38060 (to R.J.L.) and the Canadian Institutes for Health Research (to M.C.). This is NRCC publication number 50698.	[Anonymous], 2008, AMBER 10; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chi LL, 2005, CURR ANAL CHEM, V1, P223, DOI 10.2174/157341105774573929; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Menozzi FD, 2002, MOL MICROBIOL, V43, P1379, DOI 10.1046/j.1365-2958.2002.02841.x; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; MOFFAT CF, 1991, EUR J BIOCHEM, V202, P531, DOI 10.1111/j.1432-1033.1991.tb16405.x; MOFFAT CF, 1991, EUR J BIOCHEM, V197, P449, DOI 10.1111/j.1432-1033.1991.tb15931.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NADER HB, 1990, J BIOL CHEM, V265, P16807; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; Rhomberg AJ, 1998, P NATL ACAD SCI USA, V95, P12232, DOI 10.1073/pnas.95.21.12232; Shaya D, 2004, ACTA CRYSTALLOGR D, V60, P1644, DOI 10.1107/S0907444904016695; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Su HS, 2001, MICROBIOL-UK, V147, P581, DOI 10.1099/00221287-147-3-581; Su HS, 1996, APPL ENVIRON MICROB, V62, P2723, DOI 10.1128/AEM.62.8.2723-2734.1996; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wolff JJ, 2007, J AM SOC MASS SPECTR, V18, P234, DOI 10.1016/j.jasms.2006.09.020; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Zhang ZQ, 2008, J AM SOC MASS SPECTR, V19, P82, DOI 10.1016/j.jasms.2007.10.012	37	38	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20051	20061		10.1074/jbc.M110.101071	http://dx.doi.org/10.1074/jbc.M110.101071			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20404324	Green Published, hybrid			2022-12-27	WOS:000279012000039
J	Bang, S; Yoo, S; Yang, TJ; Cho, H; Hwang, SW				Bang, Sangsu; Yoo, Sungjae; Yang, Tae-Jin; Cho, Hawon; Hwang, Sun Wook			Farnesyl Pyrophosphate Is a Novel Pain-producing Molecule via Specific Activation of TRPV3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY NEURONS; 2-AMINOETHOXYDIPHENYL BORATE; ENDOGENOUS LIGANDS; ION CHANNELS; RECEPTOR; HEAT; KERATINOCYTES; SKIN; BISPHOSPHONATES; IDENTIFICATION	Temperature-sensitive transient receptor potential ion channels (thermoTRPs) expressed in epidermal keratinocytes and sensory afferents play an important role as peripheral pain detectors for our body. Many natural and synthetic compounds have been found to act on the thermoTRPs leading to altered nociception, but little is known about endogenous painful molecules activating TRPV3. Here, we show that farnesyl pyrophosphate (FPP), an intermediate metabolite in the mevalonate pathway, specifically activates TRPV3 among six thermoTRPs using Ca2+ imaging and electrophysiology with cultured keratinocytes and TRPV3-overexpressing cells. Agonistic potencies of related compounds in the FPP metabolism were ignorable. Voltage-dependence of TRPV3 was shifted by FPP, which appears to be the activation mechanism. An intraplantar injection of FPP acutely elicits nociceptive behaviors in inflamed animals, indicating that FPP is a novel endogenous pain-producing substance via TRPV3 activation. Co-culture experiments demonstrated that this FPP-evoked signal in the keratinocytes is transmitted to sensory neurons. In addition, FPP reduced TRPV3 heat threshold resulting in heightened behavioral sensitivity to noxious heat. Taken together, our data suggest that FPP is the firstly identified endogenous TRPV3 activator that causes nociception. Our results may provide useful chemical information to elucidate TRPV3 physiology and novel pain-related metabolisms.	Korea Univ, Grad Sch Med, Seoul 136705, South Korea; [Cho, Hawon] Seoul Natl Univ, Sensory Res Ctr, Coll Pharm, CRI, Seoul 151742, South Korea	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Hwang, SW (corresponding author), Korea Univ, Ansan Hosp, 3513,Gojan 1 Dong, Ansan 425707, Gyeonggi Do, South Korea.	sunhwang@korea.ac.kr	bang, sangsu/U-4313-2017; Bang, Sangsu/AAN-7238-2020	bang, sangsu/0000-0002-9092-0075; Hwang, Sun Wook/0000-0001-8460-7480	Korea Research Foundation, the Republic of Korea [KRF-2008-331-E00457, 2009-0076543]	Korea Research Foundation, the Republic of Korea(National Research Foundation of Korea)	This work was supported by Korea Research Foundation Grants (Codes KRF-2008- 331-E00457 and 2009-0076543), the Republic of Korea.	Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bang S, 2007, EUR J NEUROSCI, V26, P2516, DOI 10.1111/j.1460-9568.2007.05882.x; Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Henneman L, 2008, ANAL BIOCHEM, V383, P18, DOI 10.1016/j.ab.2008.08.023; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Kim KY, 2008, BIOCHEM BIOPH RES CO, V370, P295, DOI 10.1016/j.bbrc.2008.03.077; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Liliom K, 2006, BBA-MOL CELL BIOL L, V1761, P1506, DOI 10.1016/j.bbalip.2006.09.012; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Moussaieff A, 2008, FASEB J, V22, P3024, DOI 10.1096/fj.07-101865; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; Saisho Y, 1997, ANAL BIOCHEM, V252, P89, DOI 10.1006/abio.1997.2314; Sharma A, 2006, CURR OPIN ANESTHESIO, V19, P566, DOI 10.1097/01.aco.0000245286.30282.ab; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Stotz SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002082; Sutherland S P, 2000, Prog Brain Res, V129, P21; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; von Moos R, 2008, SUPPORT CARE CANCER, V16, P1105, DOI 10.1007/s00520-008-0487-0; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yoo S, 2009, MOL CELLS, V27, P417, DOI 10.1007/s10059-009-0059-2; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245	37	94	96	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19362	19371		10.1074/jbc.M109.087742	http://dx.doi.org/10.1074/jbc.M109.087742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20395302	Green Published, hybrid			2022-12-27	WOS:000278727800047
J	Li, C; Pazgier, M; Li, J; Li, CQ; Liu, M; Zou, GZ; Li, ZY; Chen, JD; Tarasov, SG; Lu, WY; Lu, WY				Li, Chong; Pazgier, Marzena; Li, Jing; Li, Changqing; Liu, Min; Zou, Guozhang; Li, Zhenyu; Chen, Jiandong; Tarasov, Sergey G.; Lu, Wei-Yue; Lu, Wuyuan			Limitations of Peptide Retro-inverso Isomerization in Molecular Mimicry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; HIV-1 CAPSID PROTEIN; IMAGE PHAGE DISPLAY; SH3 DOMAINS; P53 PATHWAY; TRANSACTIVATION DOMAIN; DIMERIZATION DOMAIN; CHEMICAL LIGATION; STRUCTURAL BASIS; DRUG DISCOVERY	A retro-inverso peptide is made up of D-amino acids in a reversed sequence and, when extended, assumes a side chain topology similar to that of its parent molecule but with inverted amide peptide bonds. Despite their limited success as antigenic mimicry, retro-inverso isomers generally fail to emulate the protein-binding activities of their parent peptides of an alpha-helical nature. In studying the interaction between the tumor suppressor protein p53 and its negative regulator MDM2, Sakurai et al. (Sakurai, K., Chung, H. S., and Kahne, D. (2004) J. Am. Chem. Soc. 126, 16288-16289) made a surprising finding that the retro-inverso isomer of p53(15-29) retained the same binding activity as the wild type peptide as determined by inhibition enzyme-linked immunosorbent assay. The authors attributed the unusual outcome to the ability of the D-peptide to adopt a right-handed helical conformation upon MDM2 binding. Using a battery of biochemical and biophysical tools, we found that retro-inverso isomerization diminished p53 (15-29) binding to MDM2 or MDMX by 3.2-3.3 kcal/mol. Similar results were replicated with the C-terminal domain of HIV-1 capsid protein (3.0 kcal/mol) and the Src homology 3 domain of Abl tyrosine kinase (3.4 kcal/mol). CD and NMR spectroscopic as well as x-ray crystallographic studies showed that D-peptide ligands ofMDM2invariably adopted left-handed helical conformations in both free and bound states. Our findings reinforce that the retro-inverso strategy works poorly in molecular mimicry of biologically active helical peptides, due to inherent differences at the secondary and tertiary structure levels between an L-peptide and its retro-inverso isomer despite their similar side chain topologies at the primary structure level.	[Li, Chong; Pazgier, Marzena; Li, Jing; Li, Changqing; Liu, Min; Zou, Guozhang; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Li, Chong; Pazgier, Marzena; Li, Jing; Li, Changqing; Liu, Min; Zou, Guozhang; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Li, Chong; Lu, Wei-Yue] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Li, Zhenyu; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; [Tarasov, Sergey G.] NCI Frederick, Struct Biophys Lab, NIH, Frederick, MD 21702 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Fudan University; H Lee Moffitt Cancer Center & Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Lu, WY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.	wlu@ihv.umaryland.edu	Lu, Weiyue/E-7938-2010; Lu, Wuyuan/B-2268-2010; Lu, Wuyuan/J-8452-2017; Pazgier, Marzena/B-7295-2012; Li, Chong/H-2515-2011	Lu, Wuyuan/0000-0003-1318-9968; Liu, Min/0000-0002-5059-3743; LIU, MIN/0000-0003-2420-2769	NATIONAL CANCER INSTITUTE [ZICBC010965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R01AI072732, R21AI087423] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI072732, R01 AI061482, R21 AI087423, AI061482, AI072732] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; GOODMAN M, 1979, ACCOUNTS CHEM RES, V12, P1, DOI 10.1021/ar50133a001; GUICHARD G, 1994, P NATL ACAD SCI USA, V91, P9765, DOI 10.1073/pnas.91.21.9765; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Keller R., 2004, COMPUTER AIDED RESON, V1; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lai ZH, 2000, ARCH BIOCHEM BIOPHYS, V381, P278, DOI 10.1006/abbi.2000.1998; LANE DP, 1992, NATURE, V358, P16; LI C, 2010, ANGEW CHEM IN PRESS; Li C, 2008, J AM CHEM SOC, V130, P13546, DOI 10.1021/ja8042036; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Li CH, 2009, INORG CHEM, V48, P2010, DOI 10.1021/ic801846h; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mayer BJ, 2001, J CELL SCI, V114, P1253; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair DT, 2003, J IMMUNOL, V170, P1362, DOI 10.4049/jimmunol.170.3.1362; Nanda V, 2006, J AM CHEM SOC, V128, P809, DOI 10.1021/ja054452t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pal-Bhowmick I, 2007, BIOCHEM BIOPH RES CO, V364, P608, DOI 10.1016/j.bbrc.2007.10.056; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; Rai J, 2007, CHEM BIOL DRUG DES, V70, P552, DOI 10.1111/j.1747-0285.2007.00595.x; RICHARDS FM, 1963, ANNU REV BIOCHEM, V32, P269, DOI 10.1146/annurev.bi.32.070163.001413; Sakurai K, 2004, J AM CHEM SOC, V126, P16288, DOI 10.1021/ja044883w; Santamaria F, 2003, J MOL RECOGNIT, V16, P131, DOI 10.1002/jmr.620; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Sia SK, 2001, BIOCHEMISTRY-US, V40, P8981, DOI 10.1021/bi010725v; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; Van Regenmortel MHV, 1998, CURR OPIN BIOTECH, V9, P377, DOI 10.1016/S0958-1669(98)80011-6; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Welch BD, 2007, P NATL ACAD SCI USA, V104, P16828, DOI 10.1073/pnas.0708109104; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	73	57	62	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19572	19581		10.1074/jbc.M110.116814	http://dx.doi.org/10.1074/jbc.M110.116814			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382735	hybrid, Green Published			2022-12-27	WOS:000278727800067
J	Kolachala, VL; Wang, LX; Obertone, TS; Prasad, M; Yan, YT; Dalmasso, G; Gewirtz, AT; Merlin, D; Sitaraman, SV				Kolachala, Vasantha L.; Wang, Lixin; Obertone, Tracy S.; Prasad, Meena; Yan, Yutao; Dalmasso, Guillaume; Gewirtz, Andrew T.; Merlin, Didier; Sitaraman, Shanthi V.			Adenosine 2B Receptor Expression Is Post-transcriptionally Regulated by MicroRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL LINE; INTESTINAL EPITHELIA; APICAL MEMBRANE; A2B RECEPTOR; SECRETION; RNAS; INHIBITION	We have reported that epithelial adenosine 2B receptor (A(2B)AR) mRNA and protein are up-regulated in colitis, which we demonstrated to be regulated by tumor necrosis factor alpha (TNF-alpha). Here, we examined the mechanism that governs A(2B)AR expression during colitis. A 1.4-kb sequence of the A(2B)AR promoter was cloned into the pFRL7 luciferase vector. Anti-microRNA (miRNA) was custom-synthesized based on specific miRNA binding sites. The binding of miRNA to the 3'-untranslated region (UTR) of A(2B)AR mRNA was examined by cloning this 3'-UTR downstream of the luciferase gene in pMIR-REPORT. In T84 cells, TNF-alpha induced a 35-fold increase in A(2B)AR mRNA but did not increase promoter activity in luciferase assays. By nuclear run-on assay, no increase in A(2B)AR mRNA following TNF-alpha treatment was observed. Four putative miRNA target sites (miR27a, miR27b, miR128a, miR128b) in the 3'-UTR of the A(2B)AR mRNA were identified in T84 cells and mouse colon. Pretreatment of cells with TNF-alpha reduced the levels of miR27b and miR128a by 60%. Over expression of premiR27b and pre-miR128a reduced A(2B)AR levels by >60%. Blockade of miR27b increased A(2B)AR mRNA levels by 6-fold in vitro. miR27b levels declined significantly in colitis-affected tissue in mice in the presence of increased A(2B)AR mRNA. Collectively, these data demonstrate that TNF-alpha -induced A(2B)AR expression in colonic epithelial cells is post-transcriptionally regulated by miR27b and miR128a and show that miR27b influences A2BAR expression in murine colitis.	[Kolachala, Vasantha L.; Wang, Lixin; Obertone, Tracy S.; Prasad, Meena; Yan, Yutao; Dalmasso, Guillaume; Merlin, Didier; Sitaraman, Shanthi V.] Emory Univ, Div Digest Dis, Sch Med, Atlanta, GA 30322 USA; [Gewirtz, Andrew T.] Emory Univ, Dept Pathol, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University	Kolachala, VL (corresponding author), Emory Univ, Div Digest Dis, Sch Med, Rm 265,615 Michael St,Whitehead Res Bldg, Atlanta, GA 30322 USA.	vkolach@emory.edu	Dalmasso, Guillaume/N-2443-2018	Dalmasso, Guillaume/0000-0002-3433-870X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064711] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK064711] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARRETT KE, 1989, AM J PHYSIOL, V256, pC197; BARRETT KE, 1990, AM J PHYSIOL, V258, pC902, DOI 10.1152/ajpcell.1990.258.5.C902; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; D'Haens G, 2003, CURR PHARM DESIGN, V9, P289, DOI 10.2174/1381612033391982; Hecht G, 1999, J CLIN INVEST, V104, P253, DOI 10.1172/JCI6373; Hilaire CS, 2008, J CELL BIOCHEM, V103, P1962, DOI 10.1002/jcb.21586; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Jobin C, 1998, GUT, V42, P779, DOI 10.1136/gut.42.6.779; Kolachala V, 2005, CELL MOL LIFE SCI, V62, P2647, DOI 10.1007/s00018-005-5328-4; Kolachala V, 2005, J BIOL CHEM, V280, P4048, DOI 10.1074/jbc.M409577200; Kolachala VL, 2008, BRIT J PHARMACOL, V155, P127, DOI 10.1038/bjp.2008.227; Kolachala VL, 2008, GASTROENTEROLOGY, V135, P861, DOI 10.1053/j.gastro.2008.05.049; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Malo MS, 2006, ANAL BIOCHEM, V350, P307, DOI 10.1016/j.ab.2005.12.018; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Merlin D, 1998, AM J PHYSIOL-CELL PH, V275, pC484, DOI 10.1152/ajpcell.1998.275.2.C484; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; STROHMEIER GR, 1995, J BIOL CHEM, V270, P2387, DOI 10.1074/jbc.270.5.2387; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Walia B, 2004, BIOCHEM J, V382, P589, DOI 10.1042/BJ20040021; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005049; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002	32	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18184	18190		10.1074/jbc.M109.066555	http://dx.doi.org/10.1074/jbc.M109.066555			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388705	hybrid, Green Published			2022-12-27	WOS:000278453900009
J	Wilson, JD; Barlowe, C				Wilson, Joshua D.; Barlowe, Charles			Yet1p and Yet3p, the Yeast Homologs of BAP29 and BAP31, Interact with the Endoplasmic Reticulum Translocation Apparatus and Are Required for Inositol Prototrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; CLASS-I MOLECULES; SACCHAROMYCES-CEREVISIAE; SECRETORY PROTEIN; QUALITY-CONTROL; TRANSPORT VESICLES; MEMBRANE-PROTEINS; SHUTTLE VECTORS; SEC PROTEINS	The mammalian B-cell receptor-associated proteins of 29 and 31 kDa (BAP29 and BAP31) are conserved integral membrane proteins that have reported roles in endoplasmic reticulum (ER) quality control, ER export of secretory cargo, and programmed cell death. In this study we investigated the yeast homologs of BAP29 and BAP31, known as Yet1p and Yet3p, to gain insight on cellular function. We found that Yet1p forms a complex with Yet3p (Yet complex) and that complex assembly was important for subunit stability and proper ER localization. The Yet complex was not efficiently packaged into ER-derived COPII vesicles and therefore does not appear to act as an ER export receptor. Instead, a fraction of the Yet complex was detected in association with the ER translocation apparatus (Sec complex). Specific mutations in the Sec complex or Yet complex influenced these interactions. Moreover, associations between the Yet complex and Sec complex were increased by ER stress and diminished when protein translocation substrates were depleted. Surprisingly, yet1 Delta and yet3 Delta mutant strains displayed inositol starvation-related growth defects. In accord with the biochemical data, these growth defects were exacerbated by a combination of certain mutations in the Sec complex with yet1 Delta or yet3 Delta mutations. We propose a model for the Yet-Sec complex interaction that places Yet1p and Yet3p at the translocation pore to manage biogenesis of specific transmembrane secretory proteins.	[Wilson, Joshua D.; Barlowe, Charles] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Barlowe, C (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	barlowe@dartmouth.edu			National Institutes of Health [GM052549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052549, R01GM052549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM052549.	Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; ESNAULT Y, 1994, J BIOL CHEM, V269, P27478; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; Ladasky JJ, 2006, J IMMUNOL, V177, P6172, DOI 10.4049/jimmunol.177.9.6172; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; NIKAWA J, 1994, GENE, V149, P367, DOI 10.1016/0378-1119(94)90178-3; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; Powers J, 2002, MOL BIOL CELL, V13, P880, DOI 10.1091/mbc.01-10-0499; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; Schamel WWA, 2003, P NATL ACAD SCI USA, V100, P9861, DOI 10.1073/pnas.1633363100; Scheper W, 2003, J BIOL CHEM, V278, P37998, DOI 10.1074/jbc.M300176200; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; SIKORSKI RS, 1989, GENETICS, V122, P19; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Szczesna-Skorupa E, 2006, J BIOL CHEM, V281, P4142, DOI 10.1074/jbc.M509522200; TOIKKANEN JH, 2006, J BIOL SCI, V6, P446; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; WOLF DH, 1975, J BACTERIOL, V123, P1150, DOI 10.1128/JB.123.3.1150-1156.1975; WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zhang Yimao, 2002, Methods Mol Med, V70, P257	64	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18252	18261		10.1074/jbc.M109.080382	http://dx.doi.org/10.1074/jbc.M109.080382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378542	hybrid, Green Published			2022-12-27	WOS:000278453900017
J	Boucher, J; Tseng, YH; Kahn, CR				Boucher, Jeremie; Tseng, Yu-Hua; Kahn, C. Ronald			Insulin and Insulin-like Growth Factor-1 Receptors Act as Ligand-specific Amplitude Modulators of a Common Pathway Regulating Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-I; MICROARRAY ANALYSIS; CYTOPLASMIC DOMAINS; SIGNAL-TRANSDUCTION; GLUCOSE-METABOLISM; BROWN ADIPOCYTES; CELL-CULTURES; MUSCLE-CELLS; MICE; EXPRESSION	Insulin and insulin-like growth factor-1 (IGF-1) act on highly homologous receptors, yet in vivo elicit distinct effects on metabolism and growth. To investigate how the insulin and IGF-1 receptors exert specificity in their biological responses, we assessed their role in the regulation of gene expression using three experimental paradigms: 1) preadipocytes before and after differentiation into adipocytes that express both receptors, but at different ratios; 2) insulin receptor (IR) or IGF1R knock-out preadipocytes that only express the complimentary receptor; and 3) IR/IGF1R double knock-out (DKO) cells reconstituted with the IR, IGF1R, or both. In wild-type preadipocytes, which express predominantly IGF1R, microarray analysis revealed similar to 500 IGF-1 regulated genes (p < 0.05). The largest of these were confirmed by quantitative PCR, which also revealed that insulin produced a similar effect, but with a smaller magnitude of response. After differentiation, when IR levels increase and IGF1R decrease, insulin became the dominant regulator of each of these genes. Measurement of the 50 most highly regulated genes by quantitative PCR did not reveal a single gene regulated uniquely via the IR or IGF1R using cells expressing exclusively IGF-1 or insulin receptors. Insulin and IGF-1 dose responses from 1 to 100 nM in WT, IRKO, IGFRKO, and DKO cells re-expressing IR, IGF1R, or both showed that insulin and IGF-1 produced effects in proportion to the concentration of ligand and the specific receptor on which they act. Thus, IR and IGF1R act as identical portals to the regulation of gene expression, with differences between insulin and IGF-1 effects due to a modulation of the amplitude of the signal created by the specific ligand-receptor interaction.	Joslin Diabet Ctr, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kahn, CR (corresponding author), 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021; Boucher, Jeremie/G-6602-2015; Tseng, Yu-Hua/AAE-6471-2021	Kahn, Ronald/0000-0002-7583-9228; Tseng, Yu-Hua/0000-0003-2053-9559	National Institutes of Health [DK31036, DK33201, DK077097]; Diabetes Genome Anatomy Project [DK60837]; Harvard Catalyst/The Harvard Clinical and Translational Science Center [UL1 RR 025758-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031036, P30DK036836, R01DK077097, R01DK033201, R01DK060837, R01DK031036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Genome Anatomy Project; Harvard Catalyst/The Harvard Clinical and Translational Science Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK31036, DK33201, and DK077097, Diabetes Genome Anatomy Project Grant DK60837, and Harvard Catalyst/The Harvard Clinical and Translational Science Center Grant UL1 RR 025758-01.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Back K, 2009, GROWTH HORM IGF RES, V19, P101, DOI 10.1016/j.ghir.2008.06.004; Baudry A, 2001, FEBS LETT, V488, P174, DOI 10.1016/S0014-5793(00)02435-2; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cheng CM, 2000, P NATL ACAD SCI USA, V97, P10236, DOI 10.1073/pnas.170008497; Ciaraldi TP, 2005, J CLIN ENDOCR METAB, V90, P5551, DOI 10.1210/jc.2005-1007; Clemmons DR, 2006, CURR OPIN PHARMACOL, V6, P620, DOI 10.1016/j.coph.2006.08.006; Clemmons DR, 2005, GROWTH HORM IGF RES, V15, P265, DOI 10.1016/j.ghir.2005.05.002; DiCola G, 1997, J CLIN INVEST, V99, P2538, DOI 10.1172/JCI119438; Dupont J, 2003, RECENT PROG HORM RES, V58, P325, DOI 10.1210/rp.58.1.325; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Entingh AJ, 2003, J BIOL CHEM, V278, P33377, DOI 10.1074/jbc.M303056200; Entingh-Pearsall A, 2004, J BIOL CHEM, V279, P38016, DOI 10.1074/jbc.M313201200; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; KallooHosein HE, 1997, J BIOL CHEM, V272, P24325, DOI 10.1074/jbc.272.39.24325; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; LAMMERS R, 1989, EMBO J, V8, P1369, DOI 10.1002/j.1460-2075.1989.tb03517.x; Lamothe B, 1998, FEBS LETT, V426, P381, DOI 10.1016/S0014-5793(98)00377-9; Laron Zvi, 2008, Archives of Physiology and Biochemistry, V114, P11, DOI 10.1080/13813450801928356 ; Le Roith D, 2002, CURR OPIN CLIN NUTR, V5, P371, DOI 10.1097/00075197-200207000-00004; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Moses AC, 1996, DIABETES, V45, P91, DOI 10.2337/diabetes.45.1.91; Mulligan C, 2002, J BIOL CHEM, V277, P42480, DOI 10.1074/jbc.M206206200; Mur C, 2002, DIABETES, V51, P743, DOI 10.2337/diabetes.51.3.743; Palsgaard J, 2009, GROWTH HORM IGF RES, V19, P168, DOI 10.1016/j.ghir.2008.09.004; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; Simpson HL, 1998, GROWTH HORM IGF RES, V8, P83, DOI 10.1016/S1096-6374(98)80098-1; Simpson HL, 2004, J CLIN ENDOCR METAB, V89, P425, DOI 10.1210/jc.2003-031274; TARTARE S, 1994, J BIOL CHEM, V269, P11449; Urso B, 1999, J BIOL CHEM, V274, P30864, DOI 10.1074/jbc.274.43.30864; Verleysdonk S, 2004, NEUROCHEM RES, V29, P127, DOI 10.1023/B:NERE.0000010441.08234.ca; WILSON CM, 1995, FEBS LETT, V368, P19, DOI 10.1016/0014-5793(95)00589-2	40	98	100	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17235	17245		10.1074/jbc.M110.118620	http://dx.doi.org/10.1074/jbc.M110.118620			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360006	Green Published, hybrid			2022-12-27	WOS:000277982600085
J	Lee, IO; Kim, JH; Choi, YJ; Pillinger, MH; Kim, SY; Blaser, MJ; Lee, YC				Lee, In Ohk; Kim, Jie Hyun; Choi, Yeun Jung; Pillinger, Michael H.; Kim, Seok-Yong; Blaser, Martin J.; Lee, Yong Chan			Helicobacter pylori CagA Phosphorylation Status Determines the gp130-activated SHP2/ERK and JAK/STAT Signal Transduction Pathways in Gastric Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; IV SECRETION; IN-VIVO; PHOSPHOTYROSINE PHOSPHATASE; HUMAN KERATINOCYTES; ACTIVATION; GP130; GENE; INTERLEUKIN-6; INFECTION	The Helicobacter pylori protein CagA may undergo tyrosine phosphorylation following its entry into human gastric epithelial cells with downstream effects on signal transduction. Disruption of the gp130 receptor that modulates the balance of the SHP2/ERK and JAK/STAT pathways enhanced peptic ulceration and gastric cancer in gp130 knock-out mice. In this study, we evaluated the effect of translocated CagA in relation to its tyrosine phosphorylation status on the gp130-mediated signal switch between the SHP2/ERK and JAK/STAT3 pathways. We showed that in the presence of CagA, SHP2 was recruited to gp130. Phosphorylated CagA showed enhanced SHP2 binding activity and ERK1/2 phosphorylation, whereas unphosphorylated CagA showed preferential STAT3 activation. These findings indicate that the phosphorylation status of CagA affects the signal switch between the SHP2/ERK and JAK/STAT3 pathways through gp130, providing a novel mechanism to explain H. pylori signaling.	[Lee, In Ohk; Kim, Jie Hyun; Choi, Yeun Jung; Lee, Yong Chan] Yonsei Univ, Dept Internal Med, Coll Med, Seoul 120752, South Korea; [Lee, In Ohk; Choi, Yeun Jung; Lee, Yong Chan] Yonsei Univ, Brain Korea Project Med Sci 21, Coll Med, Seoul 120752, South Korea; [Pillinger, Michael H.; Blaser, Martin J.] NYU, Dept Med, Langone Sch Med, New York, NY 10016 USA; [Pillinger, Michael H.] Hosp Joint Dis & Med Ctr, Dept Rheumatol, New York, NY 10003 USA; [Kim, Seok-Yong] Chungbuk Natl Univ, Coll Med, Dept Microbiol, Cheongju 361763, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; New York University; NYU Langone Medical Center; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Chungbuk National University	Lee, YC (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seodaemunku Shinchondong 134, Seoul 120752, South Korea.	leeyc@yuhs.ac	Kim, Jie-Hyun/Q-9061-2019	Kim, Jie-Hyun/0000-0002-9198-3326; Pillinger, Michael/0000-0003-3168-1542; Lee, Yong Chan/0000-0001-8800-6906	National Institutes of Health [R01GM63270]; Korea Research Foundation; Korean government (Ministry of Education and Human Resources Development, Basic Research Promotion Fund) [KRF-2004-015-C00444]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Korean government (Ministry of Education and Human Resources Development, Basic Research Promotion Fund)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM63270. This work was also supported by the Korea Research Foundation and Korean government (Ministry of Education and Human Resources Development, Basic Research Promotion Fund) Grant KRF-2004-015-C00444.	AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; Ando T, 1998, INFECT IMMUN, V66, P4742, DOI 10.1128/IAI.66.10.4742-4747.1998; Aras RA, 2003, J INFECT DIS, V188, P486, DOI 10.1086/377098; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; BLASER MJ, 1995, CANCER RES, V55, P2111; Bode JG, 2003, J IMMUNOL, V171, P257, DOI 10.4049/jimmunol.171.1.257; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Chatterjee M, 2002, BLOOD, V100, P3311, DOI 10.1182/blood-2002-01-0102; Chaturvedi P, 1997, MOL CELL BIOL, V17, P3295, DOI 10.1128/MCB.17.6.3295; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Dang CV, 1999, MOL CELL BIOL, V19, P1; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Jain N, 1998, ONCOGENE, V17, P3157, DOI 10.1038/sj.onc.1202238; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Kim SY, 2006, CELL MICROBIOL, V8, P97, DOI 10.1111/j.1462-5822.2005.00603.x; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; MATSUMOTO K, 1991, EXP CELL RES, V196, P114, DOI 10.1016/0014-4827(91)90462-4; Nomura AMY, 2002, J INFECT DIS, V186, P1138, DOI 10.1086/343808; Nomura AMY, 2002, AM J EPIDEMIOL, V155, P1054, DOI 10.1093/aje/155.11.1054; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Pillinger MH, 2007, J BIOL CHEM, V282, P18722, DOI 10.1074/jbc.M703022200; RAY R, 1991, MOL CELL BIOL, V11, P2154, DOI 10.1128/MCB.11.4.2154; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Schaper F, 1998, BIOCHEM J, V335, P557, DOI 10.1042/bj3350557; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Symes A, 1997, CURR BIOL, V7, P697, DOI 10.1016/S0960-9822(06)00298-3; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; Wang TC, 2002, NAT MED, V8, P1080, DOI 10.1038/nm1002-1080; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Yamazaki S, 2003, J INFECT DIS, V187, P334, DOI 10.1086/367807; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101	63	96	98	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16042	16050		10.1074/jbc.M110.111054	http://dx.doi.org/10.1074/jbc.M110.111054			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348091	Green Published, hybrid			2022-12-27	WOS:000277715900042
J	Vinci, CR; Clarke, SG				Vinci, Chris R.; Clarke, Steven G.			Homocysteine Methyltransferases Mht1 and Sam4 Prevent the Accumulation of Age-damaged (R,S)-AdoMet in the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; OXIDATIVE STRESS; ACTIVE-TRANSPORT; SULFONIUM CENTER; DNA-REPAIR; SPECIFICITY; CONFIGURATION; RECOGNITION	The biological methyl donor S-adenosyl-L-methionine (AdoMet) is spontaneously degraded by inversion of its sulfonium center to form the R,S diastereomer. Unlike its precursor, (S,S)AdoMet, (R,S)-AdoMet has no known cellular function and may have some toxicity. Although the rate of (R,S)-AdoMet formation under physiological conditions is significant, it has not been detected at substantial levels in vivo in a wide range of organisms. These observations imply that there are mechanisms that either dispose of (R,S)-AdoMet or convert it back to (S,S)-AdoMet. Previously, we identified two homocysteine methyl-transferases (Mht1 and Sam4) in yeast capable of recognizing and metabolizing (R,S)-AdoMet. We found similar activities in worms, plants, and flies. However, it was not established whether these activities could prevent R,S accumulation. In this work, we show that both the Mht1 and Sam4 enzymes are capable of preventing R,S accumulation in Saccharomyces cerevisiae grown to stationary phase; deletion of both genes results in significant (R,S)-AdoMet accumulation. To our knowledge, this is the first time that such an accumulation of (R,S)-AdoMet has been reported in any organism. We show that yeast cells can take up (R,S)-AdoMet from the medium using the same transporter (Sam3) used to import (S,S)-AdoMet. Our results suggest that yeast cells have evolved efficient mechanisms not only for dealing with the spontaneous intracellular generation of the (R,S)AdoMet degradation product but for utilizing environmental sources as a nutrient.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu			National Institutes of Health [GM026020, AG032303]; Ellison Medical Foundation; UCLA Older Americans Independence Center, NIA, National Institutes of Health [P30-AG028748]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); UCLA Older Americans Independence Center, NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 and AG032303. This work was also supported by the Ellison Medical Foundation.; Supported by the UCLA Older Americans Independence Center, NIA, National Institutes of Health Grant P30-AG028748. To whom correspondence should be addressed: UCLA Dept. of Chemistry and Biochemistry and the Molecular Biology Institute, 607 Charles E. Young Drive East, Los Angeles, CA 90095-1569. Tel.: 310-825-8754; Fax: 310-825-1968; E-mail: clarke@mbi.ucla.edu.	Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Barnett JA, 2008, YEAST, V25, P689, DOI 10.1002/yea.1630; Baynes JW, 2000, BIOGERONTOLOGY, V1, P235, DOI 10.1023/A:1010034213093; BEAUDOUIN C, 1993, J NEUROCHEM, V61, P928, DOI 10.1111/j.1471-4159.1993.tb03604.x; BORCHARDT RT, 1976, J MED CHEM, V19, P1099, DOI 10.1021/jm00231a004; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Cai H, 2001, BIOCHEMISTRY-US, V40, P2210, DOI 10.1021/bi0022902; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Chan SY, 2003, J BIOL CHEM, V278, P43051, DOI 10.1074/jbc.M308696200; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; CORNFORTH JW, 1977, J AM CHEM SOC, V99, P7292, DOI 10.1021/ja00464a032; CREASON GL, 1985, PHYTOCHEMISTRY, V24, P1151, DOI 10.1016/S0031-9422(00)81092-4; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; DELAHABA G, 1959, J AM CHEM SOC, V81, P3975, DOI 10.1021/ja01524a039; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Hanna GM, 2004, PHARMAZIE, V59, P251; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hipkiss AR, 2001, BIOGERONTOLOGY, V2, P173, DOI 10.1023/A:1011599321168; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Katju V, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r75; Kim I, 2007, J MICROBIOL BIOTECHN, V17, P207; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lopez-Villar E, 2006, PROTEOMICS, V6, pS107, DOI 10.1002/pmic.200500479; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; McCarthy DL, 2001, BIOCHEMISTRY-US, V40, P12276, DOI 10.1021/bi011050z; NAKAMURA KD, 1974, J BACTERIOL, V120, P482, DOI 10.1128/JB.120.1.482-487.1974; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; PETROTTASIMPSON TF, 1975, J BACTERIOL, V123, P516, DOI 10.1128/JB.123.2.516-522.1975; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; SATOH S, 1989, ARCH BIOCHEM BIOPHYS, V271, P107, DOI 10.1016/0003-9861(89)90260-9; SPENCE KD, 1971, J BACTERIOL, V106, P325, DOI 10.1128/JB.106.2.325-330.1971; UGARTE N, 2010, ANTIOXID RE IN PRESS; Veiga-Da-Cunha M, 2006, BIOCHEM J, V399, P257, DOI 10.1042/BJ20060684; Vinci CR, 2007, J BIOL CHEM, V282, P8604, DOI 10.1074/jbc.M610029200; Vinci CR, 2010, REJUV RES, V13, P362, DOI 10.1089/rej.2009.0956; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Woo DK, 2009, BBA-GENE REGUL MECH, V1789, P135, DOI 10.1016/j.bbagrm.2008.09.008; WU SE, 1983, BIOCHEMISTRY-US, V22, P2828, DOI 10.1021/bi00281a009; Yasokawa D, 2010, APPL BIOCHEM BIOTECH, V160, P1685, DOI 10.1007/s12010-009-8684-y; Yiu G, 2008, J GERONTOL A-BIOL, V63, P21, DOI 10.1093/gerona/63.1.21	44	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20526	20531		10.1074/jbc.M110.113076	http://dx.doi.org/10.1074/jbc.M110.113076			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421295	Green Published, hybrid			2022-12-27	WOS:000279228600014
J	Brannmark, C; Palmer, R; Glad, ST; Cedersund, G; Stralfors, P				Brannmark, Cecilia; Palmer, Robert; Glad, S. Torkel; Cedersund, Gunnar; Stralfors, Peter			Mass and Information Feedbacks through Receptor Endocytosis Govern Insulin Signaling as Revealed Using a Parameter-free Modeling Framework	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; HUMAN ADIPOCYTES; CAVEOLAE; LOCALIZATION; PATHWAYS; DYNAMICS; BINDING; LEVEL; IRS1; RAT	Insulin and other hormones control target cells through a network of signal-mediating molecules. Such networks are extremely complex due to multiple feedback loops in combination with redundancy, shared signal mediators, and cross-talk between signal pathways. We present a novel framework that integrates experimental work and mathematical modeling to quantitatively characterize the role and relation between coexisting submechanisms in complex signaling networks. The approach is independent of knowing or uniquely estimating model parameters because it only relies on (i) rejections and (ii) core predictions (uniquely identified properties in unidentifiable models). The power of our approach is demonstrated through numerous iterations between experiments, model-based data analyses, and theoretical predictions to characterize the relative role of co-existing feedbacks governing insulin signaling. We examined phosphorylation of the insulin receptor and insulin receptor substrate-1 and endocytosis of the receptor in response to various different experimental perturbations in primary human adipocytes. The analysis revealed that receptor endocytosis is necessary for two identified feedback mechanisms involving mass and information transfer, respectively. Experimental findings indicate that interfering with the feedback may substantially increase overall signaling strength, suggesting novel therapeutic targets for insulin resistance and type 2 diabetes. Because the central observations are present in other signaling networks, our results may indicate a general mechanism in hormonal control.	[Brannmark, Cecilia; Palmer, Robert; Cedersund, Gunnar; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Lab Diabet & Integrated Syst Biol, SE-58185 Linkoping, Sweden; [Glad, S. Torkel] Linkoping Univ, Dept Elect Engn, SE-58185 Linkoping, Sweden; [Cedersund, Gunnar] Univ Freiburg, Sch Life Sci, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany	Linkoping University; Linkoping University; University of Freiburg	Cedersund, G (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Lab Diabet & Integrated Syst Biol, SE-58185 Linkoping, Sweden.	gunnar.cedersund@liu.se; peter.stralfors@liu.se	Brännmark, Cecilia/K-2132-2012	Stralfors, Peter/0000-0002-1196-1806	European Commission Network of Excellence Biosim; Ostergotland County Council; Novo Nordisk Foundation; Lions; Swedish Diabetes Association; Swedish Research Council	European Commission Network of Excellence Biosim(European CommissionEuropean Commission Joint Research Centre); Ostergotland County Council; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lions; Swedish Diabetes Association; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the European Commission Network of Excellence Biosim, Ostergotland County Council, Novo Nordisk Foundation, Lions, Swedish Diabetes Association, and Swedish Research Council.	Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Cedersund G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000096; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Conzelmann H, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-78; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Hori SS, 2006, ANN BIOMED ENG, V34, P879, DOI 10.1007/s10439-005-9065-5; Karlsson M, 2004, EUR J BIOCHEM, V271, P2471, DOI 10.1111/j.1432-1033.2004.04177.x; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; KUISMANEN E, 1989, METHOD CELL BIOL, V32, P257; MARTIN TJ, 1986, J RECEPTOR RES, V6, P323, DOI 10.3109/10799898609074818; Nahmad M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000202; Ortegren U, 2006, FEBS J, V273, P3381, DOI 10.1111/j.1742-4658.2006.05345.x; PETTERSSON T, 2008, THESIS LINKOPING U L; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Stenkula KG, 2007, BIOCHEM BIOPH RES CO, V363, P840, DOI 10.1016/j.bbrc.2007.09.065; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Wanant S, 2000, J THEOR BIOL, V205, P355, DOI 10.1006/jtbi.2000.2069	24	52	53	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20171	20179		10.1074/jbc.M110.106849	http://dx.doi.org/10.1074/jbc.M110.106849			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421297	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000279012000052
J	Sen, P; Sahoo, S; Pendurthi, UR; Rao, LVM				Sen, Prosenjit; Sahoo, Sanghamitra; Pendurthi, Usha R.; Rao, L. Vijaya Mohan			Zinc Modulates the Interaction of Protein C and Activated Protein C with Endothelial Cell Protein C Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; THROMBIN-THROMBOMODULIN COMPLEX; WASHED HUMAN-PLATELETS; DIVALENT METAL-IONS; TISSUE FACTOR; FACTOR-VIIA; FACTOR-XII; FACTOR-IX; BINDING; PLASMA	Zinc is an essential trace element for human nutrition and is critical to the structure, stability, and function of many proteins. Zinc ions were shown to enhance activation of the intrinsic pathway of coagulation but down-regulate the extrinsic pathway of coagulation. The protein C pathway plays a key role in blood coagulation and inflammation. At present there is no information on whether zinc modulates the protein C pathway. In the present study we found that Zn2+ enhanced the binding of protein C/activated protein C (APC) to endothelial cell protein C receptor (EPCR) on endothelial cells. Binding kinetics revealed that Zn2+ increased the binding affinities of protein C/APC to EPCR. Equilibrium dialysis with Zn-65(2+) revealed that Zn2+ bound to the Gla domain as well as sites outside of the Gla domain of protein C/APC. Intrinsic fluorescence measurements suggested that Zn2+ binding induces conformational changes in protein C/APC. Zn2+ binding to APC inhibited the amidolytic activity of APC, but the inhibition was reversed by Ca2+. Zn2+ increased the rate of APC generation on endothelial cells in the presence of physiological concentrations of Ca2+ but did not further enhance increased APC generation obtained in the presence of physiological concentrations of Mg2+ with Ca2+. Zn2+ had no effect on the anticoagulant activity of APC. Zn2+ enhanced APC-mediated activation of protease activated receptor 1 and p44/42 MAPK. Overall, our data show that Zn2+ binds to proteinC/APC, which results in conformational changes in protein C/APC that favor their binding to EPCR.	[Sen, Prosenjit; Sahoo, Sanghamitra; Pendurthi, Usha R.; Rao, L. Vijaya Mohan] Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Tyler, TX 75708 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Rao, LVM (corresponding author), Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, 11937 US Highway 271, Tyler, TX 75708 USA.	Vijaya.Rao@uthct.edu			National Institutes of Health [HL58869, HL65500]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058869, R01HL065500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58869 ( to L. V. M. R.) and HL65500 ( to U. R. P.).	Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; BERNARDO MM, 1993, J BIOL CHEM, V268, P12468; Brewer G J, 1983, Prog Clin Biol Res, V129, P35; BUTENAS S, 1994, BIOCHEMISTRY-US, V33, P3449, DOI 10.1021/bi00177a039; BYRNE R, 1980, J BIOL CHEM, V255, P1430; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; CHURCH WR, 1989, J BIOL CHEM, V264, P17882; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; CSERMELY P, 1989, BIOCHEM BIOPH RES CO, V165, P838, DOI 10.1016/S0006-291X(89)80042-7; Esmon CT, 2004, CRIT CARE MED, V32, pS298, DOI 10.1097/01.CCM.0000126128.64614.81; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; ESMON NL, 1983, J BIOL CHEM, V258, P5548; Falchuk K H, 1993, Prog Clin Biol Res, V380, P91; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fukudome K, 1996, J BIOL CHEM, V271, P17491, DOI 10.1074/jbc.271.29.17491; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; GORDON PR, 1982, AM J CLIN NUTR, V35, P113, DOI 10.1093/ajcn/35.1.113; GORODETSKY R, 1993, AM J HEMATOL, V42, P278, DOI 10.1002/ajh.2830420307; GREENGARD JS, 1984, BIOCHEMISTRY-US, V23, P6863, DOI 10.1021/bi00321a090; GREENGARD JS, 1986, BIOCHEMISTRY-US, V25, P3884, DOI 10.1021/bi00361a022; He XH, 1999, J BIOL CHEM, V274, P4970, DOI 10.1074/jbc.274.8.4970; Heeb MJ, 2009, FASEB J, V23, P2244, DOI 10.1096/fj.08-123174; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; Liaw PCY, 2000, J BIOL CHEM, V275, P5447, DOI 10.1074/jbc.275.8.5447; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; PEDERSEN AH, 1991, THROMB HAEMOSTASIS, V65, P528; Petersen LC, 2000, PROTEIN SCI, V9, P859, DOI 10.1110/ps.9.5.859; Regan LM, 1997, J BIOL CHEM, V272, P26279, DOI 10.1074/jbc.272.42.26279; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; REZAIE AR, 1995, BIOCHEMISTRY-US, V34, P12221, DOI 10.1021/bi00038a016; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; SCHOUSBOE I, 1993, BLOOD COAGUL FIBRIN, V4, P671, DOI 10.1097/00001721-199304050-00002; Sekiya F, 1996, J BIOL CHEM, V271, P8541, DOI 10.1074/jbc.271.15.8541; SHIMADA T, 1987, J BIOCHEM-TOKYO, V102, P913, DOI 10.1093/oxfordjournals.jbchem.a122132; SHORE JD, 1987, BIOCHEMISTRY-US, V26, P2250, DOI 10.1021/bi00382a027; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Tubek S, 2008, BIOL TRACE ELEM RES, V121, P1, DOI 10.1007/s12011-007-8038-y; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Yang LK, 2004, J BIOL CHEM, V279, P38519, DOI 10.1074/jbc.M407304200	42	11	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20410	20420		10.1074/jbc.M110.111575	http://dx.doi.org/10.1074/jbc.M110.111575			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20413590	hybrid, Green Published			2022-12-27	WOS:000279012000074
J	Allewell, NM				Allewell, Norma M.			Thematic Minireview Series: Single-molecule Measurements in Biochemistry and Molecular Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ Maryland, Coll Chem & Life Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Allewell, NM (corresponding author), Univ Maryland, Coll Chem & Life Sci, College Pk, MD 20742 USA.	nallewell@asbmb.org							0	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18959	18960		10.1074/jbc.R110.132449	http://dx.doi.org/10.1074/jbc.R110.132449			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382736	Green Published, hybrid			2022-12-27	WOS:000278727800001
J	Takaku, T; Ogura, K; Kumeta, H; Yoshida, N; Inagaki, F				Takaku, Tomoyuki; Ogura, Kenji; Kumeta, Hiroyuki; Yoshida, Naoki; Inagaki, Fuyuhiko			Solution Structure of a Novel Cdc42 Binding Module of Bem1 and Its Interaction with Ste20 and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; P21-ACTIVATED KINASE STE20; SACCHAROMYCES-CEREVISIAE; PC MOTIF; NMR STRUCTURE; PROTEIN BEM1; SH3 DOMAINS; PB1 DOMAIN; CDC24; POLARITY	Bem1 is a scaffold protein essential for the establishment of cell polarity in Saccharomyces cerevisiae. This work reports the solution structure of a Cdc42 binding module of Bem1 comprising the second SH3 domain (SH3b) and its C-terminal flanking region termed Cdc42 interacting (CI). First, the structure of Bem1 SH3b-CI was determined by NMR spectroscopy, which shows that Bem1 SH3b-CI is a structurally and functionally related domain that binds Cdc42. Next, the solution structure of Bem1 SH3b-CI in complex with the proline-rich region of p21-activated kinase Ste20 (Ste20 PRR) was determined. Finally, the interaction surface of Bem1 SH3b-CI with Cdc42 was identified based on chemical shift perturbation studies which reveals that Bem1 SH3b-CI interacts simultaneously with both Ste20 PRR and Cdc42 using the opposite surfaces. Thus, Bem1 can tether Cdc42 and Ste20 in close proximity so that Cdc42 can efficiently interact with Ste20 Cdc42 and Rac interactive binding (CRIB). Based on the present results together with the previous biochemical studies (Lamson, R. E., Winters, M. J., and Pryciak, P. M. (2002) Mol. Cell. Biol. 22, 2939-2951 and Winters, M. J., and Pryciak, P. M. (2005) Mol. Cell. Biol. 25, 2177-2190), a model was suggested that the autoinhibition of Ste20 kinase activity by CRIB is released through the Cdc42-CRIB interaction, which is mediated by Bem1, and Ste20 is subsequently activated, an initial step for the establishment of the cell polarity.	[Ogura, Kenji; Kumeta, Hiroyuki; Inagaki, Fuyuhiko] Hokkaido Univ, Struct Biol Lab, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Hokkaido Univ, Grad Sch Life Sci, Struct Biol Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University; Hokkaido University	Inagaki, F (corresponding author), Hokkaido Univ, Struct Biol Lab, Grad Sch Pharmaceut Sci, Kita Ku, N-12,W-6, Sapporo, Hokkaido 0600812, Japan.	finagaki@pharm.hokudai.ac.jp		Kumeta, Hiroyuki/0000-0003-3713-2122	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research (Kiban S) and the National Projects on Targeted Proteins Research Program (TPRP) from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Benton BK, 1997, MOL CELL BIOL, V17, P5067, DOI 10.1128/MCB.17.9.5067; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Endo M, 2003, J BIOL CHEM, V278, P843, DOI 10.1074/jbc.M209714200; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Ito T, 2001, EMBO J, V20, P3938, DOI 10.1093/emboj/20.15.3938; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kneller D., 1997, SPARKY 3 105; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Mayer BJ, 2001, J CELL SCI, V114, P1253; Ogura K, 2009, J BIOCHEM, V146, P317, DOI 10.1093/jb/mvp075; Terasawa H, 2001, EMBO J, V20, P3947, DOI 10.1093/emboj/20.15.3947; Wheatley E, 2005, BIOCHEM J, V388, P177, DOI 10.1042/BJ20041838; Winters MJ, 2005, MOL CELL BIOL, V25, P2177, DOI 10.1128/MCB.25.6.2177-2190.2005; Yamaguchi Y, 2007, J BIOL CHEM, V282, P29, DOI 10.1074/jbc.M609308200; Yoshinaga S, 2003, EMBO J, V22, P4888, DOI 10.1093/emboj/cdg475; ZHENG Y, 1994, J BIOL CHEM, V269, P2369	23	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19346	19353		10.1074/jbc.M110.116749	http://dx.doi.org/10.1074/jbc.M110.116749			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410294	Green Published, hybrid			2022-12-27	WOS:000278727800045
J	Avila, ME; Sepulveda, FJ; Burgos, CF; Moraga-Cid, G; Parodi, J; Moon, RT; Aguayo, LG; Opazo, C; De Ferrari, GV				Avila, Miguel E.; Sepulveda, Fernando J.; Burgos, Carlos F.; Moraga-Cid, Gustavo; Parodi, Jorge; Moon, Randall T.; Aguayo, Luis G.; Opazo, Carlos; De Ferrari, Giancarlo V.			Canonical Wnt3a Modulates Intracellular Calcium and Enhances Excitatory Neurotransmission in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE CYCLE; BETA-CATENIN; SPINAL NEURONS; KINASE-C; RELEASE; PROTEIN; DIFFERENTIATION; PATHWAY; PHOSPHORYLATION; COLOCALIZATION	A role for Wnt signal transduction in the development and maintenance of brain structures is widely acknowledged. Recent studies have suggested that Wnt signaling may be essential for synaptic plasticity and neurotransmission. However, the direct effect of a Wnt protein on synaptic transmission had not been demonstrated. Here we show that nanomolar concentrations of purified Wnt3a protein rapidly increase the frequency of miniature excitatory synaptic currents in embryonic rat hippocampal neurons through a mechanism involving a fast influx of calcium from the extracellular space, induction of post-translational modifications on the machinery involved in vesicle exocytosis in the presynaptic terminal leading to spontaneous Ca2+ transients. Our results identify the Wnt3a protein and a member of its complex receptor at the membrane, the low density lipoprotein receptor-related protein 6 (LRP6) coreceptor, as key molecules in neurotransmission modulation and suggest crosstalk between canonical and Wnt/Ca2+ signaling in central neurons.	[De Ferrari, Giancarlo V.] Univ Andres Bello, Ctr Biomed Res, Fac Biol Sci, Santiago, Chile; [De Ferrari, Giancarlo V.] Univ Andres Bello, Fac Med, Santiago, Chile; [Avila, Miguel E.; Burgos, Carlos F.; De Ferrari, Giancarlo V.] Univ Concepcion, Fac Biol Sci, Dept Biochem & Mol Biol, Concepcion, Chile; [Sepulveda, Fernando J.; Moraga-Cid, Gustavo; Parodi, Jorge; Aguayo, Luis G.; Opazo, Carlos] Univ Concepcion, Fac Biol Sci, Dept Physiol, Concepcion, Chile; [Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Moon, Randall T.] Univ Washington, Inst Stem Cell & Regenerat Med, Sch Med, Seattle, WA 98195 USA	Universidad Andres Bello; Universidad Andres Bello; Universidad de Concepcion; Universidad de Concepcion; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	De Ferrari, GV (corresponding author), Univ Andres Bello, Ctr Biomed Res, Fac Biol Sci, POB 8370134, Santiago, Chile.	gdeferrari@unab.cl	Moon, Randall/M-5605-2019; Moraga-Cid, Gustavo/AAC-3314-2021; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Burgos, Carlos Felipe/0000-0001-6738-8589; Opazo, Carlos/0000-0003-3473-7548; De Ferrari, Giancarlo/0000-0003-0932-125X; Parodi, Jorge/0000-0002-9117-5433	Chilean government [ACT-04]; Howard Hughes Medical Institute	Chilean government; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by associative Comision Nacional de Investigacion Cientifica y Tecnologica Grant Programa Bicentenario en Ciencia y Tecnologia ACT-04 from the Chilean government (to G.V.D., C.O., and L.G.A.).; Supported as an Investigator of the Howard Hughes Medical Institute.	AGUAYO LG, 1994, J PHARMACOL EXP THER, V270, P61; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Beaumont V, 2007, MOL CELL NEUROSCI, V35, P513, DOI 10.1016/j.mcn.2007.03.004; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Carrasco MA, 2007, NEUROSCIENCE, V145, P484, DOI 10.1016/j.neuroscience.2006.12.019; Carrasco MA, 2007, J NEUROCHEM, V100, P1143, DOI 10.1111/j.1471-4159.2006.04306.x; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Grove EA, 1998, DEVELOPMENT, V125, P2315; GU XN, 1994, J NEUROSCI, V14, P6325; Halabisky B, 2000, J NEUROSCI, V20, P5124; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Kishida S, 2004, MOL CELL BIOL, V24, P4487, DOI 10.1128/MCB.24.10.4487-4501.2004; Kishida S, 2007, GENES CELLS, V12, P49, DOI 10.1111/j.1365-2443.2006.01030.x; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Roelink H, 2000, CURR BIOL, V10, pR279, DOI 10.1016/S0960-9822(00)00407-3; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Spinsanti P, 2008, J NEUROCHEM, V104, P1588, DOI 10.1111/j.1471-4159.2007.05111.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Wang JM, 2003, NAT NEUROSCI, V6, P1017, DOI 10.1038/nn1128; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhou CJ, 2004, J NEUROSCI, V24, P121, DOI 10.1523/JNEUROSCI.4071-03.2004	43	54	61	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18939	18947		10.1074/jbc.M110.103028	http://dx.doi.org/10.1074/jbc.M110.103028			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404321	hybrid, Green Published			2022-12-27	WOS:000278453900084
J	Boitz, JM; Ullman, B				Boitz, Jan M.; Ullman, Buddy			Amplification of Adenine Phosphoribosyltransferase Suppresses the Conditionally Lethal Growth and Virulence Phenotype of Leishmania donovani Mutants Lacking Both Hypoxanthine-guanine and Xanthine Phosphoribosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-ANALYSIS; PURINE METABOLISM; VISCERAL LEISHMANIASIS; NUCLEOSIDE HYDROLASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; ADENOSINE KINASE; IN-VITRO; PROMASTIGOTES; EXPRESSION	Leishmania donovani cannot synthesize purines de novo and obligatorily scavenge purines from the host. Previously, we described a conditional lethal Delta hgprt/Delta xprt mutant of L. donovani (Boitz, J. M., and Ullman, B. (2006) J. Biol. Chem. 281, 16084-16089) that establishes that L. donovani salvages purines primarily through hypoxanthine-guanine phosphoribosyltransferase (HGPRT) and xanthine phosphoribosyltransferase (XPRT). Unlike wild type L. donovani, the Delta hgprt/Delta xprt knockout cannot grow on 6-oxypurines and displays an absolute requirement for adenine or adenosine and 2'-deoxycoformycin, an inhibitor of parasite adenine aminohydrolase activity. Here, we demonstrate that the ability of Delta hgprt/Delta xprt parasites to infect mice was profoundly compromised. Surprisingly, mutant parasites that survived the initial passage through mice partially regained their virulence properties, exhibiting a >10-fold increase in parasite burden in a subsequent mouse infection. To dissect the mechanism by which Delta hgprt/Delta xprt parasites persisted in vivo, suppressor strains that had regained their capacity to grow under restrictive conditions were cloned from cultured Delta hgprt/Delta xprt parasites. The ability of these suppressor clones to grow in and metabolize 6-oxypurines could be ascribed to a marked amplification and overexpression of the adenine phosphoribosyltransferase (APRT) gene. Moreover, transfection of Delta hgprt/Delta xprt cells with an APRT episome recapitulated the suppressor phenotype in vitro and enabled growth on 6-oxypurines. Biochemical studies further showed that hypoxanthine, unexpectedly, was an inefficient substrate for APRT, evidence that could account for the ability of the suppressors to metabolize hypoxanthine. Subsequent analysis implied that APRT amplification was also a potential contributory mechanism by which Delta hgprt/Delta xprt parasites displayed persistence and increased virulence in mice.	[Boitz, Jan M.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Ullman, B (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ullmanb@ohsu.edu			National Institutes of Health [AI023682]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI023682.	Allen T, 1995, MOL BIOCHEM PARASIT, V74, P99, DOI 10.1016/0166-6851(95)02475-1; ALLEN T, 1989, MOL BIOCHEM PARASIT, V33, P273, DOI 10.1016/0166-6851(89)90089-3; ALLEN TE, 1995, MOL BIOCHEM PARASIT, V73, P133, DOI 10.1016/0166-6851(94)00105-V; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BEVERLEY SM, 1984, CELL, V38, P431, DOI 10.1016/0092-8674(84)90498-7; Boitz JM, 2006, MOL BIOCHEM PARASIT, V148, P24, DOI 10.1016/j.molbiopara.2006.02.015; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; Cui LW, 2001, GENE, V280, P153, DOI 10.1016/S0378-1119(01)00768-5; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DWYER DM, 1972, J PARASITOL, V58, P847, DOI 10.2307/3278338; ELLENBERGER TE, 1989, J BIOL CHEM, V264, P15094; Galazka J, 2006, MOL BIOCHEM PARASIT, V149, P223, DOI 10.1016/j.molbiopara.2006.06.001; Garg R, 2006, INDIAN J MED RES, V123, P439; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; HANSON S, 1992, MOL CELL BIOL, V12, P5499, DOI 10.1128/MCB.12.12.5499; HOLBROOK TW, 1975, AM J TROP MED HYG, V24, P704, DOI 10.4269/ajtmh.1975.24.704; Hwang HY, 1997, J BIOL CHEM, V272, P19488, DOI 10.1074/jbc.272.31.19488; Hwang HY, 1996, J BIOL CHEM, V271, P30840, DOI 10.1074/jbc.271.48.30840; IOVANNISCI DM, 1984, J BIOL CHEM, V259, P4617; IOVANNISCI DM, 1984, MOL BIOCHEM PARASIT, V12, P139, DOI 10.1016/0166-6851(84)90131-2; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Jardim A, 1999, J BIOL CHEM, V274, P34403, DOI 10.1074/jbc.274.48.34403; KIDDER GW, 1979, P NATL ACAD SCI USA, V76, P3670, DOI 10.1073/pnas.76.8.3670; KIDDER GW, 1977, ARCH BIOCHEM BIOPHYS, V183, P7, DOI 10.1016/0003-9861(77)90412-X; KOSZALKA GW, 1979, J BIOL CHEM, V254, P8185; Krenitsky T A, 1979, Adv Exp Med Biol, V122B, P51; LOOKER DL, 1983, MOL BIOCHEM PARASIT, V9, P15, DOI 10.1016/0166-6851(83)90053-1; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; Mullen AB, 1998, ANTIMICROB AGENTS CH, V42, P2722, DOI 10.1128/AAC.42.10.2722; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; Phillips CL, 1999, EMBO J, V18, P3533, DOI 10.1093/emboj/18.13.3533; Phillips CL, 1996, PROTEINS, V25, P510, DOI 10.1002/(SICI)1097-0134(199608)25:4<510::AID-PROT11>3.0.CO;2-K; ROBINSON N, 1984, J BIOL CHEM, V259, P7637; Sambrook J., 2002, MOL CLONING LAB MANU; Shi WX, 2002, J BIOL CHEM, V277, P39981, DOI 10.1074/jbc.M205596200; Shi WX, 2001, BIOCHEMISTRY-US, V40, P10800, DOI 10.1021/bi010465h; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Shih S, 1998, J BIOL CHEM, V273, P1534, DOI 10.1074/jbc.273.3.1534; Sillero MAG, 2001, EUR J BIOCHEM, V268, P3605, DOI 10.1046/j.1432-1327.2001.02271.x; Silva M, 2004, BBA-PROTEINS PROTEOM, V1696, P31, DOI 10.1016/j.bbapap.2003.09.003; SOBRAL BWS, 1989, NUCLEIC ACIDS RES, V17, P7359, DOI 10.1093/nar/17.18.7359; TUTTLE JV, 1980, J BIOL CHEM, V255, P909; WILSON K, 1991, J BIOL CHEM, V266, P1665; WILSON K, 1992, MOL BIOCHEM PARASIT, V55, P197, DOI 10.1016/0166-6851(92)90140-F; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Zarella-Boitz JM, 2004, MOL BIOCHEM PARASIT, V134, P43, DOI 10.1016/j.molbiopara.2003.08.016	50	12	13	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18555	18564		10.1074/jbc.M110.125393	http://dx.doi.org/10.1074/jbc.M110.125393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20363738	Green Published, hybrid			2022-12-27	WOS:000278453900049
J	Deguchi, A; Miyoshi, H; Kojima, Y; Okawa, K; Aoki, M; Taketo, MM				Deguchi, Atsuko; Miyoshi, Hiroyuki; Kojima, Yasushi; Okawa, Katsuya; Aoki, Masahiro; Taketo, Makoto M.			LKB1 Suppresses p21-activated Kinase-1 (PAK1) by Phosphorylation of Thr(109) in the p21-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; CANCER-CELLS; HEPATOCELLULAR-CARCINOMA; KNOCKOUT MICE; ACTIVATION; GENE; METASTASIS; EXPRESSION; POLYPOSIS	The serine/threonine protein kinase LKB1 is a tumor suppressor gene mutated in Peutz-Jeghers syndrome patients. The mutations are found also in several types of sporadic cancer. Although LKB1 is implicated in suppression of cell growth and metastasis, the detailed mechanisms have not yet been elucidated. In this study, we investigated the effect of LKB1 on cell motility, whose acquisition occurs in early metastasis. The knockdown of LKB1 enhanced cell migration and PAK1 activity in human colon cancer HCT116 cells, whereas forced expression of LKB1 in Lkb1-null mouse embryonic fibroblasts suppressed PAK1 activity and PAK1-mediated cell migration simultaneously. Notably, LKB1 directly phosphorylated PAK1 at Thr(109) inthep21-binding domain in vitro. The phosphomimetic T109E mutant showed significantly lower protein kinase activity than wild-type PAK1, suggesting that the phosphorylation at Thr(109) by LKB1 was responsible for suppression of PAK1. Consistently, the nonphosphorylatable T109A mutant was resistant to suppression by LKB1. Furthermore, we found that PAK1 was activated in the hepatocellular carcinomas and the precancerous liver lesions of Lkb1(+/-) mice. Taken together, these results suggest that PAK1 is a direct down-stream target of LKB1 and plays an essential role in LKB1-induced suppression of cell migration.	[Taketo, Makoto M.] Kyoto Univ, Dept Pharmacol, Grad Sch Med, Sakyo Ku, Kyoto 6058501, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co Ltd, Drug Discovery Res Labs, Shizuoka 4118731, Japan	Kyoto University; Kyowa Kirin Ltd	Taketo, MM (corresponding author), Kyoto Univ, Dept Pharmacol, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6058501, Japan.	taketo@mfour.med.kyoto-u.ac.jp	Aoki, Masahiro/A-5149-2016	Aoki, Masahiro/0000-0003-4316-9490; Miyoshi, Hiroyuki/0000-0001-7400-0714	Ministry of Education, Culture, Sports, Science and Technology of Japan; Littlefield-American Association for Cancer Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Littlefield-American Association for Cancer Research	This work was supported by a grant-in-aid for scientific research (to M. M. T.), a grant-in-aid for young scientist (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Littlefield-American Association for Cancer Research grants in metastatic colon cancer research (to M. M. T.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; BUTT E, 1994, J BIOL CHEM, V269, P14509; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Deguchi A, 2002, MOL CANCER THER, V1, P803; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Katajisto P, 2007, BBA-REV CANCER, V1775, P63, DOI 10.1016/j.bbcan.2006.08.003; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Launonen V, 2005, HUM MUTAT, V26, P291, DOI 10.1002/humu.20222; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Miyoshi H, 2002, CANCER RES, V62, P2261; Miyoshi H, 2009, CANCER SCI, V100, P2046, DOI 10.1111/j.1349-7006.2009.01284.x; Nakau M, 2002, CANCER RES, V62, P4549; PARTIN AW, 1988, CANCER RES, V48, P6050; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	44	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18283	18290		10.1074/jbc.M109.079137	http://dx.doi.org/10.1074/jbc.M109.079137			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400510	Green Published			2022-12-27	WOS:000278453900021
J	Hayashi, T; Funato, Y; Terabayashi, T; Morinaka, A; Sakamoto, R; Ichise, H; Fukuda, H; Yoshida, N; Miki, H				Hayashi, Tatsuya; Funato, Yosuke; Terabayashi, Takeshi; Morinaka, Akifumi; Sakamoto, Reiko; Ichise, Hirotake; Fukuda, Hiroyuki; Yoshida, Nobuaki; Miki, Hiroaki			Nucleoredoxin Negatively Regulates Toll-like Receptor 4 Signaling via Recruitment of Flightless-I to Myeloid Differentiation Primary Response Gene (88)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; GELSOLIN-LIKE; X-CHROMOSOME; PROTEIN; THIOREDOXIN; DOMAINS; DEGENERATION; SYNTENIN; ENCODES; PATHWAY	We previously characterized nucleoredoxin (NRX) as a negative regulator of the Wnt signaling pathway through Dishevelled (Dvl). We perform a comprehensive search for other NRX-interacting proteins and identify Flightless-I (Fli-I) as a novel NRX-binding partner. Fli-I binds to NRX and other related proteins, such as Rod-derived cone viability factor (RdCVF), whereas Dvl binds only to NRX. Endogenous NRX and Fli-I in vivo interactions are confirmed. Both NRX and RdCVF link Fli-I with myeloid differentiation primary response gene (88) (MyD88), an important adaptor protein for innate immune response. NRX and RdCVF also potentiate the negative effect of Fli-I upon lipopolysaccharide-induced activation of NF-kappa B through the Toll-like receptor 4/MyD88 pathway. Embryonic fibroblasts derived from NRX gene-targeted mice show aberrant NF-kappa B activation upon lipopolysaccharide stimulation. These results suggest that the NRX subfamily of proteins forms a link between MyD88 and Fli-I to mediate negative regulation of the Toll-like receptor 4/MyD88 pathway.	[Hayashi, Tatsuya; Funato, Yosuke; Terabayashi, Takeshi; Morinaka, Akifumi; Miki, Hiroaki] Osaka Univ, Lab Intracellular Signaling, Inst Prot Res, Suita, Osaka 5650871, Japan; [Sakamoto, Reiko; Ichise, Hirotake; Yoshida, Nobuaki] Univ Tokyo, Lab Dev Genet, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Fukuda, Hiroyuki] THERAVALUES Corp, Chiyoda Ku, Tokyo 1020094, Japan	Osaka University; University of Tokyo	Miki, H (corresponding author), Osaka Univ, Lab Intracellular Signaling, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiki@protein.osaka-u.ac.jp	Ichise, Hirotake/V-3536-2019	Ichise, Hirotake/0000-0002-3424-6637; Terabayashi, Takeshi/0000-0001-7102-784X	Ministry of Education, Culture, Sports, Science and Technology-Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology-Japan and the Japan Society for the Promotion of Science.	Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Davy DA, 2001, J CELL SCI, V114, P549; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2008, GENES CELLS, V13, P965, DOI 10.1111/j.1365-2443.2008.01220.x; Funato Y, 2007, ANTIOXID REDOX SIGN, V9, P1035, DOI 10.1089/ars.2007.1550; Goshima M, 1999, BIOCHEM BIOPH RES CO, V257, P111, DOI 10.1006/bbrc.1999.0420; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Jeong KW, 2009, J BIOL CHEM, V284, P29298, DOI 10.1074/jbc.M109.037010; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kurooka H, 1997, GENOMICS, V39, P331, DOI 10.1006/geno.1996.4493; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Lee YH, 2004, MOL CELL BIOL, V24, P2103, DOI 10.1128/MCB.24.5.2103-2117.2004; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; MIKLOS GLG, 1990, J NEUROGENET, V6, P133, DOI 10.3109/01677069009107106; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PERRIMON N, 1989, GENETICS, V121, P313; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; Terabayashi T, 2007, J NEUROSCI, V27, P13098, DOI 10.1523/JNEUROSCI.3986-07.2007; Wang TY, 2005, J PROTEOME RES, V4, P941, DOI 10.1021/pr050031z; Wang TY, 2006, J IMMUNOL, V176, P1355, DOI 10.4049/jimmunol.176.3.1355; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154	30	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18586	18593		10.1074/jbc.M110.106468	http://dx.doi.org/10.1074/jbc.M110.106468			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400501	hybrid, Green Published			2022-12-27	WOS:000278453900052
J	Veiga-da-Cunha, M; Tyteca, D; Stroobant, V; Courtoy, PJ; Opperdoes, FR; Van Schaftingen, E				Veiga-da-Cunha, Maria; Tyteca, Donatienne; Stroobant, Vincent; Courtoy, Pierre J.; Opperdoes, Fred R.; Van Schaftingen, Emile			Molecular Identification of NAT8 as the Enzyme That Acetylates Cysteine S-Conjugates to Mercapturic Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL N-ACETYLTRANSFERASE; INTERMEDIATE COMPARTMENT; ENDOPLASMIC-RETICULUM; RAT-LIVER; METABOLISM; KIDNEY; LEUKOTRIENES; PROTEIN; GENES; SPECIFICITY	Our goal was to identify the reaction catalyzed by NAT8 (N-acetyltransferase 8), a putative N-acetyltransferase homologous to the enzyme (NAT8L) that produces N-acetylaspartate in brain. The almost exclusive expression of NAT8 in kidney and liver and its predicted association with the endoplasmic reticulum suggested that it was cysteinyl-S-conjugate N-acetyltransferase, the microsomal enzyme that catalyzes the last step of mercapturic acid formation. In agreement, HEK293T extracts of cells overexpressing NAT8 catalyzed the N-acetylation of S-benzyl-L-cysteine and leukotriene E-4, two cysteine conjugates, but were inactive on other physiological amines or amino acids. Confocal microscopy indicated that NAT8 was associated with the endoplasmic reticulum. Neither of the two frequent single nucleotide polymorphisms found in NAT8, E104K nor F143S, changed the enzymatic activity or the expression of the protein by >= 2-fold, whereas a mutation (R149K) replacing an extremely conserved arginine suppressed the activity. Sequencing of genomic DNA and EST clones corresponding to the NAT8B gene, which resulted from duplication of the NAT8 gene in the primate lineage, disclosed the systematic presence of a premature stop codon at codon 16. Furthermore, truncated NAT8B and NAT8 proteins starting from the following methionine (Met-25) showed no cysteinyl-S-conjugate N-acetyltransferase activity when transfected in HEK293T cells. Taken together, these findings indicate that NAT8 is involved in mercapturic acid formation and confirm that NAT8B is an inactive gene in humans. NAT8 homologues are found in all vertebrate genomes, where they are often encoded by multiple, tandemly repeated genes as many other genes encoding xenobiotic metabolism enzymes.	[Veiga-da-Cunha, Maria; Van Schaftingen, Emile] de Duve Inst, Physiol Chem Lab, B-1200 Brussels, Belgium; [Tyteca, Donatienne; Courtoy, Pierre J.] de Duve Inst, CELL Unit, B-1200 Brussels, Belgium; [Stroobant, Vincent] de Duve Inst, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Opperdoes, Fred R.] de Duve Inst, Trop Dis Res Unit, B-1200 Brussels, Belgium; [Opperdoes, Fred R.] Catholic Univ Louvain, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain	Van Schaftingen, E (corresponding author), de Duve Inst, Physiol Chem Lab, 75 Av Hippocrate, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020; Opperdoes, Fred/N-9922-2019; Opperdoes, Frederik R/C-8897-2018	Opperdoes, Fred/0000-0003-1984-3764; Opperdoes, Frederik R/0000-0003-1984-3764; Van Schaftingen, Emile/0000-0002-6199-7647	Belgian "Fonds National de la Recherche Scientifique,"; Interuniversity Attraction Poles Programme-Belgian Science Policy [P6/05, P6/28]; Region Wallonne; Asco Industries	Belgian "Fonds National de la Recherche Scientifique,"(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme-Belgian Science Policy(Belgian Federal Science Policy Office); Region Wallonne; Asco Industries	This work was supported by grants from the Belgian "Fonds National de la Recherche Scientifique," the Interuniversity Attraction Poles Programme-Belgian Science Policy (Networks P6/05 and P6/28), the DIANE Center of Excellence Programme of the Region Wallonne and by Asco Industries.	Aigner A, 1996, BIOCHEM J, V317, P213, DOI 10.1042/bj3170213; Altuntas TG, 2001, TOXICOL APPL PHARM, V177, P85, DOI 10.1006/taap.2001.9302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-46; Cooper AJL, 2006, AMINO ACIDS, V30, P1, DOI 10.1007/s00726-005-0243-4; Cooper AJL, 2008, ARCH BIOCHEM BIOPHYS, V474, P72, DOI 10.1016/j.abb.2008.02.038; Dekant W, 2001, TOXICOL LETT, V124, P21, DOI 10.1016/S0378-4274(00)00285-X; DENZLINGER C, 1985, SCIENCE, V230, P330, DOI 10.1126/science.4048937; GREEN RM, 1975, BIOCHEM J, V147, P283, DOI 10.1042/bj1470283; HUBER M, 1990, EUR J BIOCHEM, V194, P309, DOI 10.1111/j.1432-1033.1990.tb19458.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; Josch C, 1998, BIOCHEM PHARMACOL, V56, P763, DOI 10.1016/S0006-2952(98)00065-3; Juhanson P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-25; Karp PD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-401; Keppler D, 2005, METHOD ENZYMOL, V400, P531, DOI 10.1016/S0076-6879(05)00029-7; Keppler D, 1997, BIOL CHEM, V378, P787; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Lespinet O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-436; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; MURPHY RC, 1988, ANN NY ACAD SCI, V524, P35; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; OKAJIMA K, 1984, EUR J BIOCHEM, V142, P281, DOI 10.1111/j.1432-1033.1984.tb08282.x; ORNING L, 1986, J BIOL CHEM, V261, P766; Ozaki K, 1998, J HUM GENET, V43, P255, DOI 10.1007/s100380050084; Popsueva AE, 2001, DEV BIOL, V234, P483, DOI 10.1006/dbio.2001.0261; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; SALA A, 1990, J BIOL CHEM, V265, P21771; STENE DO, 1988, J BIOL CHEM, V263, P2773; STIJNTJES GJ, 1993, TOXICOLOGY, V79, P67, DOI 10.1016/0300-483X(93)90206-8; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VILLA A, 1991, J CELL BIOL, V113, P779, DOI 10.1083/jcb.113.4.779; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006	39	44	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18888	18898		10.1074/jbc.M110.110924	http://dx.doi.org/10.1074/jbc.M110.110924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392701	Green Published, hybrid			2022-12-27	WOS:000278453900079
J	Wong, JK; Campbell, GR; Spector, SA				Wong, Justine K.; Campbell, Grant R.; Spector, Stephen A.			Differential Induction of Interleukin-10 in Monocytes by HIV-1 Clade B and Clade C Tat Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 SUBTYPE-C; PERIPHERAL-BLOOD MONOCYTES; DISEASE PROGRESSION; T-CELLS; ANTIRETROVIRAL THERAPY; KINASE INHIBITORS; IL-10; EXPRESSION; REPLICATION	The clade B human immunodeficiency virus, type 1 (HIV-1) Tat (trans-acting regulatory protein) induces interleukin-10 (IL-10) production in monocytes. IL-10, an anti-inflammatory cytokine, down-regulates proinflammatory cytokines and suppresses the immune response, leading to a rapid progression from HIV-1 infection to AIDS. Nine clades of HIV-1 are responsible for the majority of infections worldwide. Recent studies demonstrate that different HIV-1 clades have biological differences in relation to transmission, replication, and disease progression. In this study, we show that the cysteine to serine mutation at position 31, found in >90% of HIV-1 clade C Tat proteins, results in a marked decrease in IL-10 production in monocytes compared with clade B Tat. Additionally, the C31S mutation found in C Tat is responsible for the inability of these Tat proteins to produce high IL-10 levels in monocytes due to its inability to induce intracellular calcium flux through L-type calcium channels. Moreover, we show that p38 alpha/p38 beta and phosphoinositide 3-kinase are crucial to Tat-induced IL-10 production. These findings provide further evidence that HIV-1 clades differ in their biological properties that may impact HIV-1 pathogenesis and disease progression.	[Wong, Justine K.; Campbell, Grant R.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; [Wong, Justine K.] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; [Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA 92123 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	NIAID/National Institutes of Health [AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068632, U01AI068632] Funding Source: NIH RePORTER	NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID/National Institutes of Health Grant AI068632 to the IMPAACT Network.	AKRIDGE RE, 1994, J IMMUNOL, V153, P5782; Albini A, 1998, J BIOL CHEM, V273, P15895, DOI 10.1074/jbc.273.26.15895; ALBRAND JP, 1995, BIOCHEMISTRY-US, V34, P5923, DOI 10.1021/bi00017a022; AMEGLIO E, 1994, J BIOL REG HOMEOS AG, V8, P48; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Ancuta P, 2001, J IMMUNOL, V166, P4244, DOI 10.4049/jimmunol.166.6.4244; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennasser Y, 2002, FASEB J, V16, P546, DOI 10.1096/fj.01-0775com; Bennasser Yamina, 2001, Journal de la Societe de Biologie, V195, P319; BENNETT WE, 1966, J EXP MED, V123, P145, DOI 10.1084/jem.123.1.145; Bhoopat L, 2006, MODERN PATHOL, V19, P255, DOI 10.1038/modpathol.3800527; Campbell GR, 2005, J BIOL CHEM, V280, P38376, DOI 10.1074/jbc.M506630200; Campbell GR, 2007, J VIROL, V81, P5919, DOI 10.1128/JVI.01938-06; Campbell GR, 2010, J BIOL CHEM, V285, P1681, DOI 10.1074/jbc.M109.049957; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; Conant K, 1996, J VIROL, V70, P1384, DOI 10.1128/JVI.70.3.1384-1389.1996; Contreras X, 2005, VIROLOGY, V332, P316, DOI 10.1016/j.virol.2004.11.032; Cota-Gomez A, 2002, J BIOL CHEM, V277, P14390, DOI 10.1074/jbc.M108591200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Goodchild A, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-40; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JOHNSON WD, 1977, J EXP MED, V146, P1613, DOI 10.1084/jem.146.6.1613; Kaleebu P, 2001, AIDS, V15, P293, DOI 10.1097/00002030-200102160-00001; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; KOOTSTRA NA, 1994, J VIROL, V68, P6967, DOI 10.1128/JVI.68.11.6967-6975.1994; Leghmari K, 2008, EUR J CELL BIOL, V87, P947, DOI 10.1016/j.ejcb.2008.06.005; Li JCB, 2007, IMMUNOLOGY, V121, P337, DOI 10.1111/j.1365-2567.2007.02580.x; Li JCB, 2005, FEBS LETT, V579, P3055, DOI 10.1016/j.febslet.2005.04.060; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MASOOD R, 1994, BIOCHEM BIOPH RES CO, V202, P374, DOI 10.1006/bbrc.1994.1938; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Naif HM, 1996, AIDS RES HUM RETROV, V12, P1237, DOI 10.1089/aid.1996.12.1237; Novitsky VA, 1999, J VIROL, V73, P4427, DOI 10.1128/JVI.73.5.4427-4432.1999; Opi S, 2004, VACCINE, V22, P3105, DOI 10.1016/j.vaccine.2004.01.057; Orsilles MA, 2006, APMIS, V114, P55, DOI 10.1111/j.1600-0463.2006.apm_108.x; Ott M, 1998, J IMMUNOL, V160, P2872; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RAUTONEN J, 1994, AIDS RES HUM RETROV, V10, P781, DOI 10.1089/aid.1994.10.781; Saruta M, 2009, EUR J IMMUNOL, V39, P2195, DOI 10.1002/eji.200939216; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Ta TA, 2006, MOL PHARMACOL, V69, P532, DOI 10.1124/mol.105.019125; Tebit DM, 2007, AIDS REV, V9, P75; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Wang JH, 1998, J VIROL, V72, P7642, DOI 10.1128/JVI.72.9.7642-7647.1998; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466	56	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18319	18325		10.1074/jbc.M110.120840	http://dx.doi.org/10.1074/jbc.M110.120840			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378550	Green Published, hybrid			2022-12-27	WOS:000278453900025
J	Yamashita, Y; Yamashita, M				Yamashita, Yumiko; Yamashita, Michiaki			Identification of a Novel Selenium-containing Compound, Selenoneine, as the Predominant Chemical Form of Organic Selenium in the Blood of Bluefin Tuna	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; DEATH	A novel selenium-containing compound having a selenium atom in the imidazole ring, 2-selenyl-N-alpha,N-alpha,N-alpha-trimethyl-L-histidine, 3-(2-hydroseleno-1H-imidazol-5-yl)-2-(trimethylammonio)propanoate, was identified from the blood and other tissues of the bluefin tuna, Thunnus orientalis. The seleniumcontaining compound was purified from the tuna blood in several chromatographic steps. High resolution mass spectrometry and nuclear magnetic resonance spectroscopy showed that the exact mass of the [M + H](+) ion of the compound was 533.0562 and the molecular formula was C18H29N6O4Se2. Its gross structure was assigned as the oxidized dimeric form of an ergothioneine selenium analog in which the sulfur of ergothioneine is replaced by selenium. Therefore, we named this novel seleniumcontaining compound "selenoneine." By speciation analysis of organic selenium compounds using liquid chromatography inductively coupled plasma mass spectrometry, selenoneine was found widely distributed in various tissues of the tuna, with the highest concentration in blood; mackerel blood contained similar levels. Selenoneine was measurable at 2-4 orders of magnitude lower concentration in a limited set of tissues from squid, tilapia, pig, and chicken. Quantitatively, selenoneine is the predominant form of organic selenium in tuna tissues.	[Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 236, Japan	Japan Fisheries Research & Education Agency (FRA)	Yamashita, M (corresponding author), Natl Res Inst Fisheries Sci, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 236, Japan.	mic@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [BM-D2300]; Fisheries Research Agency	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Fisheries Research Agency	This work was supported in part by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Rural Biomass Research Project, BM-D2300) and the Fisheries Research Agency.	ARTHUR JR, 1993, AM J CLIN NUTR, V57, P236; Benedict SR, 1926, J BIOL CHEM, V67, P267; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Combs G.F., 1986, ROLE SELENIUM NUTR, P1; CUVINARALAR MLA, 1991, ECOTOX ENVIRON SAFE, V21, P348, DOI 10.1016/0147-6513(91)90074-Y; El-Bayoumy K, 2001, MUTAT RES-FUND MOL M, V475, P123, DOI 10.1016/S0027-5107(01)00075-6; ELGUERO J, 1976, ADV HETEROCYCLIC C S, V1; Ge HH, 1996, ANAL COMMUN, V33, P279, DOI 10.1039/ac9963300279; Ghose A, 2001, BIOFACTORS, V14, P127, DOI 10.1002/biof.5520140117; HATFIELD DL, 2006, SELENIUM ITS MOL BIO, P1; Himeno S, 2000, J HEALTH SCI, V46, P393; IMURA N, 1991, ROCH S ENV, P275; Kiremidjian-Schumacher L, 2001, BIOFACTORS, V14, P161, DOI 10.1002/biof.5520140121; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Oki T, 2003, BREEDING SCI, V53, P101, DOI 10.1270/jsbbs.53.101; Raymond LJ, 2020, NEUROTOXICOLOGY, V81, P294, DOI 10.1016/j.neuro.2020.09.020; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; SALONEN JT, 1982, LANCET, V2, P175; Sasakura C, 1998, J INORG BIOCHEM, V71, P159, DOI 10.1016/S0162-0134(98)10048-X; SAYATO Y, 1993, JPN J TOX ENV HEALTH, V39, P289; TANRET C, 1909, J PHARM CHIM PARIS, V30, P145; WATKINSON JH, 1966, ANAL CHEM, V38, P92; WHO, 1987, ENV HLTH CRIT; WILBER CG, 1980, CLIN TOXICOL, V17, P171, DOI 10.3109/15563658008985076; XU JZ, 1995, J ORG CHEM, V60, P6296, DOI 10.1021/jo00125a014	26	132	137	5	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18134	18138		10.1074/jbc.C110.106377	http://dx.doi.org/10.1074/jbc.C110.106377			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388714	Green Published			2022-12-27	WOS:000278453900003
J	Janbandhu, VC; Singh, AK; Mukherji, A; Kumar, V				Janbandhu, Vaibhao C.; Singh, Anup K.; Mukherji, Atish; Kumar, Vijay			p65 Negatively Regulates Transcription of the Cyclin E Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BIPARTITE REPRESSOR ELEMENT; CELL-CYCLE; RETINOBLASTOMA PROTEIN; DEPENDENT KINASES; HISTONE DEACETYLATION; DOWN-REGULATION; PHO5 PROMOTER; E EXPRESSION; TUMOR-CELLS	NF-kappa B family members play a pivotal role in many cellular and organismal functions, including the cell cycle. As an activator of cyclin D1 and p21(Waf1) genes, NF-kappa B has been regarded as a critical modulator of cell cycle. To study the involvement of NF-kappa B in G(1)/S phase regulation, the levels of selected transcriptional regulators were monitored following overexpression of NF-kappa B or its physiological induction by tumor necrosis factor-alpha. Cyclin E gene was identified as a major transcriptional target of NF-kappa B. Recruitment of NF-kappa B to the cyclin E promoter was correlated with the transrepression of cyclin E gene. Ligation-mediated PCR and micrococcal nuclease-Southern assays suggested the nucleosomal nature of this region while chromatin immunoprecipitation analysis confirmed the exchange of cofactors following tumor necrosis factor-alpha treatment or release from serum starvation. There was a progressive reduction in cyclin E transcription along with the accumulation of catalytically inactive cyclin E-cdk2 complexes and arrest of cells in G(1)/S-phase. Thus, our study clearly establishes NF-kappa B as a negative regulator of cell cycle through transcriptional repression of cyclin E.	[Janbandhu, Vaibhao C.; Singh, Anup K.; Mukherji, Atish; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, POB 10504,Aruna Asaf Ali Marg, New Delhi 110067, India.	vijay@icgeb.res.in		Janbandhu, Vaibhao/0000-0002-3837-1865	International Centre for Genetic Engineering and Biotechnology, New Delhi	International Centre for Genetic Engineering and Biotechnology, New Delhi	This project was supported by a core grant of the International Centre for Genetic Engineering and Biotechnology, New Delhi.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Ahn JH, 2001, J BIOL CHEM, V276, P47100, DOI 10.1074/jbc.M107385200; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BALDWIN AS, 1991, MOL CELL BIOL, V11, P4943, DOI 10.1128/MCB.11.10.4943; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Bash J, 1997, MOL CELL BIOL, V17, P6526, DOI 10.1128/MCB.17.11.6526; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; BOCQUEL MT, 1989, NUCLEIC ACIDS RES, V17, P2581, DOI 10.1093/nar/17.7.2581; Botz J, 1996, MOL CELL BIOL, V16, P3401; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Bresnahan WA, 1996, CELL GROWTH DIFFER, V7, P1283; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chen EY, 1998, BIOCHEM BIOPH RES CO, V249, P728, DOI 10.1006/bbrc.1998.9224; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chou MM, 2003, J BIOL CHEM, V278, P35241, DOI 10.1074/jbc.M305246200; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Donepudi M, 2001, J IMMUNOL, V166, P6491, DOI 10.4049/jimmunol.166.11.6491; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; GARRITY PA, 1992, P NATL ACAD SCI USA, V89, P1021, DOI 10.1073/pnas.89.3.1021; Geng Y, 1996, ONCOGENE, V12, P1173; Gudas JM, 1999, MOL CELL BIOL, V19, P612; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hassan AH, 2001, FRONT BIOSCI, V6, pD1054, DOI 10.2741/Hassan; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Henzinger T, 1998, J BIOL CHEM, V273, P14958, DOI 10.1074/jbc.273.24.14958; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Hulleman E, 1999, EXP CELL RES, V253, P422, DOI 10.1006/excr.1999.4677; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Javelaud D, 2000, ONCOGENE, V19, P61, DOI 10.1038/sj.onc.1203246; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KUPRASH DV, 1995, ONCOGENE, V11, P97; Le Cam L, 1999, EMBO J, V18, P1878, DOI 10.1093/emboj/18.7.1878; Loeb DM, 2002, J BIOL CHEM, V277, P19627, DOI 10.1074/jbc.M201336200; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; McAndrew PC, 1998, MOL CELL BIOL, V18, P5818, DOI 10.1128/MCB.18.10.5818; Morrison AJ, 2002, MOL CELL BIOL, V22, P856, DOI 10.1128/MCB.22.3.856-865.2002; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; Mullany LK, 2007, J BIOL CHEM, V282, P21244, DOI 10.1074/jbc.M702110200; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; PerezRoger I, 1997, ONCOGENE, V14, P2373, DOI 10.1038/sj.onc.1201197; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Polanowska J, 2001, ONCOGENE, V20, P4115, DOI 10.1038/sj.onc.1204514; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sambrook J., 2001, MOL CLONING LAB MANU; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sheehy AM, 1999, J BIOL CHEM, V274, P8708, DOI 10.1074/jbc.274.13.8708; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shih SC, 1996, CANCER RES, V56, P1591; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Steger David J., 1996, Bioessays, V18, P875, DOI 10.1002/bies.950181106; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	86	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17453	17464		10.1074/jbc.M109.058974	http://dx.doi.org/10.1074/jbc.M109.058974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385564	Green Published, hybrid			2022-12-27	WOS:000278133400023
J	Page, RM; Gutsmiedl, A; Fukumori, A; Winkler, E; Haass, C; Steiner, H				Page, Richard M.; Gutsmiedl, Amelie; Fukumori, Akio; Winkler, Edith; Haass, Christian; Steiner, Harald			beta-Amyloid Precursor Protein Mutants Respond to gamma-Secretase Modulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; FAMILIAL ALZHEIMERS-DISEASE; A-BETA; INTRAMEMBRANE CLEAVAGE; TRANSMEMBRANE DOMAIN; GXXXG MOTIFS; A-BETA-42; PRESENILIN; MUTATIONS; APP	Pathogenic generation of the 42-amino acid variant of the amyloid beta-peptide (A beta) by beta- and gamma-secretase cleavage of the beta-amyloid precursor protein (APP) is believed to be causative for Alzheimer disease (AD). Lowering of A beta(42) production by gamma-secretase modulators (GSMs) is a hopeful approach toward AD treatment. The mechanism of GSM action is not fully understood. Moreover, whether GSMs target the A beta domain is controversial. To further our understanding of the mode of action of GSMs and the cleavage mechanism of gamma-secretase, we analyzed mutations located at different positions of the APP transmembrane domain around or within the A beta domain regarding their response to GSMs. We found that A beta(42)-increasing familial AD mutations of the gamma-secretase cleavage site domain responded robustly to A beta(42)-lowering GSMs, especially to the potent compound GSM-1, irrespective of the amount of A beta(42) produced. We thus expect that familial AD patients carrying mutations at the gamma-secretase cleavage sites of APP should respond to GSM-based therapeutic approaches. Systematic phenylalanine-scanning mutagenesis of this region revealed a high permissiveness to GSM-1 and demonstrated a complex mechanism of GSM action as other A beta species (A beta(41), A beta(39)) could also be lowered besides A beta(42). Moreover, certain mutations simultaneously increased A beta(42) and the shorter peptide A beta(38), arguing that the proposed precursor-product relationship of these A beta species is not general. Finally, mutations of residues in the proposed GSM-binding site implicated in A beta(42) generation (Gly-29, Gly-33) and potentially in GSM-binding (Lys-28) were also responsive to GSMs, a finding that may question APP substrate targeting of GSMs.	[Steiner, Harald] Univ Munich, German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Steiner, Harald] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich	Steiner, H (corresponding author), Univ Munich, German Ctr Neurodegenerat Dis DZNE, Schillerstr 44, D-80336 Munich, Germany.	harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB596]; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie; Hans and Ilse Breuer Foundation; Center for Integrated Protein Science Munich; The LMUexcellent program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF)); Hans and Ilse Breuer Foundation; Center for Integrated Protein Science Munich; The LMUexcellent program	This work was supported by the Deutsche Forschungsgemeinschaft (Collaborative Research Center (SFB596) "Molecular Mechanisms of Neurodegeneration" (to H. S. and C. H.)) and the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie ("Degenerative Dementias: Target identification, Validation and Translation into Treatment Strategies" (to C. H. and H. S.)), the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.), and the Center for Integrated Protein Science Munich.; Supported by a research professorship from The LMUexcellent program. To whom correspondence may be addressed: German Center for Neurodegenerative Diseases (DZNE) and Adolf-Butenandt-Institute, Biochemistry, Ludwig-Maximilians-University, Schillerstr. 44, 80336 Munich, Germany. Tel.: 49-89-2180-75471; Fax: 49-89-2180-75415; E-mail: christian.haass@med.uni-muenchen.de.	Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Guardia-Laguarta C, 2010, J NEUROPATH EXP NEUR, V69, P53, DOI 10.1097/NEN.0b013e3181c6b84d; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Herl L, 2009, MOL CELL NEUROSCI, V41, P166, DOI 10.1016/j.mcn.2009.02.008; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Narlawar R, 2007, BIOORG MED CHEM LETT, V17, P5428, DOI 10.1016/j.bmcl.2007.07.044; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tan JX, 2008, J NEUROCHEM, V107, P722, DOI 10.1111/j.1471-4159.2008.05643.x; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006	47	55	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17798	17810		10.1074/jbc.M110.103283	http://dx.doi.org/10.1074/jbc.M110.103283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20348104	Green Published, hybrid			2022-12-27	WOS:000278133400058
J	Rickheit, G; Wartosch, L; Schaffer, S; Stobrawa, SM; Novarino, G; Weinert, S; Jentsch, TJ				Rickheit, Gesa; Wartosch, Lena; Schaffer, Sven; Stobrawa, Sandra M.; Novarino, Gaia; Weinert, Stefanie; Jentsch, Thomas J.			Role of ClC-5 in Renal Endocytosis Is Unique among ClC Exchangers and Does Not Require PY-motif-dependent Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; LYSOSOMAL STORAGE DISEASE; CHLORIDE CHANNEL; DENTS-DISEASE; PROXIMAL TUBULE; MEDIATED ENDOCYTOSIS; IMPAIRS ENDOCYTOSIS; ALBUMIN ENDOCYTOSIS; BINDING PROTEINS; LIDDLES-SYNDROME	Inactivation of the mainly endosomal 2Cl(-)/H+-exchanger ClC-5 severely impairs endocytosis in renal proximal tubules and underlies the human kidney stone disorder Dent's disease. In heterologous expression systems, interaction of the E3 ubiquitin ligases WWP2 and Nedd4-2 with a "PY-motif" in the cytoplasmic C terminus of ClC-5 stimulates its internalization from the plasma membrane and may influence receptor-mediated endocytosis. We asked whether this interaction is relevant in vivo and generated mice in which the PY-motif was destroyed by a point mutation. Unlike ClC-5 knock-out mice, these knock-in mice displayed neither low molecular weight proteinuria nor hyperphosphaturia, and both receptor-mediated and fluid-phase endocytosis were normal. The abundances and localizations of the endocytic receptor megalin and of the Na+-coupled phosphate transporter NaPi-2a (Npt2) were not changed, either. To explore whether the discrepancy in results from heterologous expression studies might be due to heteromerization of ClC-5 with ClC-3 or ClC-4 in vivo, we studied knock-in mice additionally deleted for those related transporters. Disruption of neither ClC-3 nor ClC-4 led to proteinuria or impaired proximal tubular endocytosis by itself, nor in combination with the PY-mutant of ClC-5. Endocytosis of cells lacking ClC-5 was not impaired further when ClC-3 or ClC-4 was additionally deleted. We conclude that ClC-5 is unique among CLC proteins in being crucial for proximal tubular endocytosis and that PY-motif-dependent ubiquitylation of ClC-5 is dispensable for this role.	[Rickheit, Gesa; Wartosch, Lena; Novarino, Gaia; Weinert, Stefanie; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Rickheit, Gesa; Wartosch, Lena; Novarino, Gaia; Weinert, Stefanie; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Rickheit, Gesa; Schaffer, Sven; Stobrawa, Sandra M.; Jentsch, Thomas J.] Univ Hamburg, ZMNH, D-20146 Hamburg, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Weinert, Stefanie/AAR-1481-2021	Weinert, Stefanie/0000-0003-3036-1440; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [FOR667, Je164/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in part, by the Deutsche Forschungsgemeinschaft Grant FOR667, Je164/6.	ABBATE M, 1994, J AM SOC NEPHROL, V4, P2003; Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Christensen EI, 2003, P NATL ACAD SCI USA, V100, P8472, DOI 10.1073/pnas.1432873100; Devuyst O, 1999, HUM MOL GENET, V8, P247, DOI 10.1093/hmg/8.2.247; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; KATO M, 1985, P NATL ACAD SCI USA, V82, P2488, DOI 10.1073/pnas.82.8.2488; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Loffing-Cueni D, 2006, J AM SOC NEPHROL, V17, P1264, DOI 10.1681/ASN.2005060659; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Mohammad-Panah R, 2009, J CELL SCI, V122, P1229, DOI 10.1242/jcs.037317; Murer H, 1999, AM J PHYSIOL-RENAL, V277, pF676, DOI 10.1152/ajprenal.1999.277.5.F676; Nagasawa Y, 2001, NEPHROL DIAL TRANSPL, V16, P923, DOI 10.1093/ndt/16.5.923; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Ponting CP, 1997, J MOL MED-JMM, V75, P160; Reed AAC, 2010, AM J PHYSIOL-RENAL, V298, pF365, DOI 10.1152/ajprenal.00038.2009; RUGARLI EI, 1995, NAT GENET, V10, P466, DOI 10.1038/ng0895-466; Sakamoto H, 1999, AM J PHYSIOL-RENAL, V277, pF957, DOI 10.1152/ajprenal.1999.277.6.F957; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Traebert M, 2000, AM J PHYSIOL-RENAL, V278, pF792, DOI 10.1152/ajprenal.2000.278.5.F792; Vandewalle A, 2001, AM J PHYSIOL-CELL PH, V280, pC373, DOI 10.1152/ajpcell.2001.280.2.C373; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Wilson Karen H S, 2005, BMC Nephrol, V6, P17, DOI 10.1186/1471-2369-6-17; Zhang YB, 1999, AM J PHYSIOL-RENAL, V276, pF711, DOI 10.1152/ajprenal.1999.276.5.F711; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	57	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17595	17603		10.1074/jbc.M110.115600	http://dx.doi.org/10.1074/jbc.M110.115600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351103	Green Published, hybrid			2022-12-27	WOS:000278133400038
J	Copple, IM; Lister, A; Obeng, AD; Kitteringham, NR; Jenkins, RE; Layfield, R; Foster, BJ; Goldring, CE; Park, BK				Copple, Ian M.; Lister, Adam; Obeng, Akua D.; Kitteringham, Neil R.; Jenkins, Rosalind E.; Layfield, Robert; Foster, Brian J.; Goldring, Christopher E.; Park, B. Kevin			Physical and Functional Interaction of Sequestosome 1 with Keap1 Regulates the Keap1-Nrf2 Cell Defense Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; UBIQUITIN LIGASE COMPLEX; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; PROTEIN; SUBSTRATE; AUTOPHAGY; GENES; ADAPTER; ACETAMINOPHEN	Nrf2 regulates the expression of numerous cytoprotective genes in mammalian cells. The activity of Nrf2 is regulated by the Cul3 adaptor Keap1, yet little is known regarding mechanisms of regulation of Keap1 itself. Here, we have used immunopurification of Keap1 and mass spectrometry, in addition to immunoblotting, to identify sequestosome 1 (SQSTM1) as a cellular binding partner of Keap1. SQSTM1 serves as a scaffold in various signaling pathways and shuttles polyubiquitinated proteins to the proteasomal and lysosomal degradation machineries. Ectopic expression of SQSTM1 led to a decrease in the basal protein level of Keap1 in a panel of cells. Furthermore, RNA interference (RNAi) depletion of SQSTM1 resulted in an increase in the protein level of Keap1 and a concomitant decrease in the protein level of Nrf2 in the absence of changes in Keap1 or Nrf2 mRNA levels. The increased protein level of Keap1 in cells depleted of SQSTM1 by RNAi was linked to a decrease in its rate of degradation; the half-life of Keap1 was almost doubled by RNAi depletion of SQSTM1. The decreased level of Nrf2 in cells depleted of SQSTM1 by RNAi was associated with decreases in the mRNA levels, protein levels, and function of several Nrf2-regulated cell defense genes. SQSTM1 was dispensable for the induction of the Keap1-Nrf2 pathway, as Nrf2 activation by tert-butylhydroquinone or iodoacetamide was not affected by RNAi depletion of SQSTM1. These findings demonstrate a physical and functional interaction between Keap1 and SQSTM1 and reveal an additional layer of regulation in the Keap1-Nrf2 pathway.	[Foster, Brian J.; Goldring, Christopher E.; Park, B. Kevin] Univ Liverpool, MRC, Ctr Drug Safety Sci, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England; [Layfield, Robert] Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2UH, England	University of Liverpool; University of Nottingham	Goldring, CE (corresponding author), Univ Liverpool, MRC, Ctr Drug Safety Sci, Dept Pharmacol & Therapeut, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	c.e.p.goldring@liv.ac.uk		Copple, Ian/0000-0003-4101-1913; Layfield, Robert/0000-0003-0702-3259	Medical Research Council (UK); Wellcome Trust; University of Liverpool; Medical Research Council [G0700654] Funding Source: researchfish; MRC [G0700654] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Liverpool; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (UK), the Wellcome Trust, and the University of Liverpool.	Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Copple IM, 2008, HEPATOLOGY, V48, P1292, DOI 10.1002/hep.22472; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Layfield R, 2008, BIOCHEM SOC T, V36, P469, DOI 10.1042/BST0360469; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Najat D, 2009, J BONE MINER RES, V24, P632, DOI 10.1359/JBMR.081204; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	29	182	193	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16782	16788		10.1074/jbc.M109.096545	http://dx.doi.org/10.1074/jbc.M109.096545			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20378532	Green Published, hybrid			2022-12-27	WOS:000277982600041
J	Wunderlich, K; Juozapaitis, M; Manz, B; Maye, D; Gotz, V; Zohner, A; Wolff, T; Schwemmle, M; Martin, A				Wunderlich, Kerstin; Juozapaitis, Mindaugas; Maenz, Benjamin; Maye, Daniel; Goetz, Veronika; Zoehner, Andrea; Wolff, Thorsten; Schwemmle, Martin; Martin, Arnold			Limited Compatibility of Polymerase Subunit Interactions in Influenza A and B Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; PA SUBUNIT; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; VIRAL-PROTEINS; BINDING; PB1; INTERFERENCE; COMPLEX; MODEL	Despite their close phylogenetic relationship, natural intertypic reassortants between influenza A (FluA) and B (FluB) viruses have not been described. Inefficient polymerase assembly of the three polymerase subunits may contribute to this incompatibility, especially because the known protein-protein interaction domains, including the PA-binding domain of PB1, are highly conserved for each virus type. Here we show that substitution of the FluA PA-binding domain (PB1-A(1-25)) with that of FluB (PB1-B1-25) is accompanied by reduced polymerase activity and viral growth of FluA. Consistent with these findings, surface plasmon resonance spectroscopy measurements revealed that PA of FluA exhibits impaired affinity to biotinylated PB1-B1-25 peptides. PA of FluB showed no detectable affinity to biotinylated PB1-A(1-25) peptides. Consequently, FluB PB1 harboring the PA-binding domain of FluA (PB1-AB) failed to assemble with PA and PB2 into an active polymerase complex. To regain functionality, we used a single amino acid substitution (T6Y) known to confer binding to PA of both virus types, which restored polymerase complex formation but surprisingly not polymerase activity for FluB. Taken together, our results demonstrate that the conserved virus type-specific PA-binding domains differ in their affinity to PA and thus might contribute to intertypic exclusion of reassortants between FluA and FluB viruses.	[Wunderlich, Kerstin; Schwemmle, Martin; Martin, Arnold] Univ Freiburg, Dept Virol, D-70104 Freiburg, Germany; [Wunderlich, Kerstin] Univ Freiburg, Spemann Grad Sch Biol & Med, D-70104 Freiburg, Germany; [Wunderlich, Kerstin] Univ Freiburg, Fac Biol, D-70104 Freiburg, Germany; [Juozapaitis, Mindaugas] Inst Biotechnol, LT-02241 Vilnius, Lithuania; [Zoehner, Andrea; Wolff, Thorsten] Robert Koch Inst, D-13353 Berlin, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Vilnius University; Robert Koch Institute	Schwemmle, M (corresponding author), Hermann Herder Str 11, D-70104 Freiburg, Germany.	martin.schwemmle@uniklinik-freiburg.de		Juozapaitis, Mindaugas/0000-0002-5112-5562	Deutsche Forschungsgemeinschaft; European Commission; FluResearchNet; German Research Foundation [GSC-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); FluResearchNet; German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft, the European Commission's Seventh Framework, and FluResearchNet.; Supported by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School).	BAINE WB, 1980, AM J MED, V68, P181, DOI 10.1016/0002-9343(80)90352-6; Biswas SK, 1996, J VIROL, V70, P6716, DOI 10.1128/JVI.70.10.6716-6722.1996; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Crescenzo-Chaigne B, 1999, VIROLOGY, V265, P342, DOI 10.1006/viro.1999.0059; Dauber B, 2004, J VIROL, V78, P1865, DOI 10.1128/JVI.78.4.1865-1872.2004; Dauber B, 2006, J VIROL, V80, P11667, DOI 10.1128/JVI.01142-06; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, J GEN VIROL, V89, P939, DOI 10.1099/vir.0.83449-0; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hemerka JN, 2009, J VIROL, V83, P3944, DOI 10.1128/JVI.02300-08; Horimoto T, 2003, J VIROL, V77, P8031, DOI 10.1128/JVI.77.14.8031-8038.2003; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Iwatsuki-Horimoto K, 2008, VIRUS RES, V135, P161, DOI 10.1016/j.virusres.2008.03.010; Jambrina E, 1997, VIROLOGY, V235, P209, DOI 10.1006/viro.1997.8682; KAVERIN NV, 1983, J GEN VIROL, V64, P2139, DOI 10.1099/0022-1317-64-10-2139; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; MIKHEEVA A, 1982, ARCH VIROL, V73, P287, DOI 10.1007/BF01318082; MUSTER T, 1991, P NATL ACAD SCI USA, V88, P5177, DOI 10.1073/pnas.88.12.5177; NOLAN TF, 1980, J INFECT DIS, V142, P360, DOI 10.1093/infdis/142.3.360; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; PEREZ DR, 1995, J VIROL, V69, P6932; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; SASNAUSKAS K, 1992, GENE, V116, P105, DOI 10.1016/0378-1119(92)90636-4; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; TOBITA K, 1983, ARCH VIROL, V75, P17, DOI 10.1007/BF01314124; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Wunderlich K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007517; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	36	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16704	16712		10.1074/jbc.M110.102533	http://dx.doi.org/10.1074/jbc.M110.102533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363752	Green Published, hybrid			2022-12-27	WOS:000277982600034
J	Yamada, C; Ozaki, T; Ando, K; Suenaga, Y; Inoue, K; Ito, Y; Okoshi, R; Kageyama, H; Kimura, H; Miyazaki, M; Nakagawara, A				Yamada, Chizu; Ozaki, Toshinori; Ando, Kiyohiro; Suenaga, Yusuke; Inoue, Ken-ichi; Ito, Yoshiaki; Okoshi, Rintaro; Kageyama, Hajime; Kimura, Hideki; Miyazaki, Masaru; Nakagawara, Akira			RUNX3 Modulates DNA Damage-mediated Phosphorylation of Tumor Suppressor p53 at Ser-15 and Acts as a Co-activator for p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-LINES; PROMOTER HYPERMETHYLATION; INDUCED APOPTOSIS; GENE-EXPRESSION; GASTRIC-CANCER; PROTEIN MISLOCALIZATION; INDUCE APOPTOSIS; FAMILY GENES; GROWTH; P21(WAF1/CIP1)	Although it has been shown that the gastric tumor suppressor RUNX3 has a growth inhibitory activity, the precise molecular mechanisms behind RUNX3-mediated tumor suppression remained unclear. In this study, we found that RUNX3 is closely involved in DNA damage-dependent phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53. The small interference RNA-mediated knockdown of RUNX3 inhibited adriamycin (ADR)-dependent apoptosis in p53-proficient cells but not in p53-deficient cells in association with a significant reduction of p53-target gene expression as well as phosphorylation of p53 at Ser-15. In response to ADR, RUNX3 was induced to accumulate in the cell nucleus and co-localized with p53. Immunoprecipitation experiments demonstrated that RUNX3 forms a complex with p53 in cells. In vitro pulldown assays revealed that the COOH-terminal portion of p53 is required for the interaction with RUNX3. Forced expression of RUNX3 enhanced p53-mediated transcriptional activation. Additionally, RUNX3 had an ability to induce the phosphorylation of p53 at Ser-15, thereby promoting p53-dependent apoptosis. Intriguingly, RUNX3 interacted with phosphorylated forms of ataxia telangiectasia-mutated in response to ADR; however, it did not affect the extent of DNA damage. From the clinical point of view, coordinated p53 mutation and decreased expression of RUNX3 in 105 human lung adenocarcinomas were significantly associated with the poor outcome of patients (p = 0.0203). Thus, our present results strongly suggest that RUNX3 acts as a novel co-activator for p53 through regulating its DNA damage-induced phosphorylation at Ser-15 and also provide a clue to understanding the molecular mechanisms underlying RUNX3-mediated tumor suppression.	[Yamada, Chizu; Ando, Kiyohiro; Suenaga, Yusuke; Nakagawara, Akira] Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh Ku, Chiba 2608717, Japan; [Yamada, Chizu; Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuoh Ku, Chiba 2600856, Japan; [Ozaki, Toshinori; Okoshi, Rintaro] Chiba Canc Ctr Res Inst, Lab Antitumor Res, Chuoh Ku, Chiba 2608717, Japan; [Inoue, Ken-ichi; Ito, Yoshiaki] Proteos, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Inoue, Ken-ichi; Ito, Yoshiaki] Natl Univ Singapore, Yong Loo Lin Sch Med, Oncol Res Inst, Singapore 117456, Singapore; [Kageyama, Hajime] Chiba Canc Ctr Res Inst, Div Chemotherapy & Canc Diag, Chuoh Ku, Chiba 2608717, Japan; [Kimura, Hideki] Chiba Canc Ctr Hosp, Div Resp Surg, Chuoh Ku, Chiba 2608717, Japan	Chiba Cancer Center; Chiba University; Chiba Cancer Center; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Chiba Cancer Center; Chiba Cancer Center	Nakagawara, A (corresponding author), Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chuoh Ku, 666-2 Nitona, Chiba 2608717, Japan.	akiranak@chiba-cc.jp		Suenaga, Yusuke/0000-0001-6902-5386	Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid from the Ministry of Health, Labor and Welfare for Third Term Comprehensive Control Research for Cancer, a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a grant-in-aid for scientific research from Japan Society for the Promotion of Science.	Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FRIEND S, 1994, SCIENCE, V265, P334, DOI 10.1126/science.8023155; Furuya K, 2007, J BIOL CHEM, V282, P18365, DOI 10.1074/jbc.M610522200; Goel A, 2004, INT J CANCER, V112, P754, DOI 10.1002/ijc.20472; Goldschneider D, 2006, NUCLEIC ACIDS RES, V34, P5603, DOI 10.1093/nar/gkl619; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Ikawa S, 1999, CELL DEATH DIFFER, V6, P1154, DOI 10.1038/sj.cdd.4400631; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kang GH, 2004, J PATHOL, V202, P233, DOI 10.1002/path.1503; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; LEVINE AJ, 1994, J LAB CLIN MED, V123, P817; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wada M, 2004, ONCOGENE, V23, P2401, DOI 10.1038/sj.onc.1207395; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yanagawa N, 2003, CANCER SCI, V94, P589, DOI 10.1111/j.1349-7006.2003.tb01487.x; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Yoshida K, 2008, ONCOGENE, V27, P1183, DOI 10.1038/sj.onc.1210722; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	43	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16693	16703		10.1074/jbc.M109.055525	http://dx.doi.org/10.1074/jbc.M109.055525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353948	Green Published, hybrid			2022-12-27	WOS:000277982600033
J	Altaf, M; Auger, A; Monnet-Saksouk, J; Brodeur, J; Piquet, S; Cramet, M; Bouchard, N; Lacoste, N; Utley, RT; Gaudreau, L; Cote, J				Altaf, Mohammed; Auger, Andreanne; Monnet-Saksouk, Julie; Brodeur, Joelle; Piquet, Sandra; Cramet, Myriam; Bouchard, Nathalie; Lacoste, Nicolas; Utley, Rhea T.; Gaudreau, Luc; Cote, Jacques			NuA4-dependent Acetylation of Nucleosomal Histones H4 and H2A Directly Stimulates Incorporation of H2A.Z by the SWR1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEX; SACCHAROMYCES-CEREVISIAE GENOME; VARIANT H2A.Z; DNA-DAMAGE; HETEROCHROMATIN BOUNDARIES; TELOMERIC HETEROCHROMATIN; ACETYLTRANSFERASE COMPLEX; DEPENDENT ACETYLATION; IN-VIVO; NUA4	Structural and functional analyses of nucleosomes containing histone variant H2A.Z have drawn a lot of interest over the past few years. Important work in budding yeast has shown that H2A.Z (Htz1)-containing nucleosomes are specifically located on the promoter regions of genes, creating a specific chromatin structure that is poised for disassembly during transcription activation. The SWR1 complex is responsible for incorporation of Htz1 into nucleosomes through ATP-dependent exchange of canonical H2A-H2B dimers for Htz1-H2B dimers. Interestingly, the yeast SWR1 complex is functionally linked to the NuA4 acetyltransferase complex in vivo. NuA4 and SWR1 are physically associated in higher eukaryotes as they are homologous to the TIP60/p400 complex, which encompasses both histone acetyltransferase (Tip60) and histone exchange (p400/Domino) activities. Here we present work investigating the impact of NuA4-dependent acetylation on SWR1-driven incorporation of H2A.Z into chromatin. Using in vitro histone exchange assays with native chromatin, we demonstrate that prior chromatin acetylation by NuA4 greatly stimulates the exchange of H2A for H2A. Z. Interestingly, we find that acetylation of H2A or H4 N-terminal tails by NuA4 can independently stimulate SWR1 activity. Accordingly, we demonstrate that mutations of H4 or H2A N-terminal lysine residues have similar effects on H2A. Z incorporation in vivo, and cells carrying mutations in both tails are nonviable. Finally, depletion experiments indicate that the bromodomain-containing protein Bdf1 is important for NuA4-dependent stimulation of SWR1. These results provide important mechanistic insight into the functional cross-talk between chromatin acetylation and ATP-dependent exchange of histone H2A variants.	[Altaf, Mohammed; Auger, Andreanne; Monnet-Saksouk, Julie; Piquet, Sandra; Cramet, Myriam; Bouchard, Nathalie; Lacoste, Nicolas; Utley, Rhea T.; Cote, Jacques] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec CHUQ, Quebec City, PQ G1R 2J6, Canada; [Brodeur, Joelle; Gaudreau, Luc] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	Laval University; University of Sherbrooke	Cote, J (corresponding author), 9 McMahon St, Quebec City, PQ G1R 2J6, Canada.	jacques.cote@crhdq.ulaval.ca	Cote, Jacques/I-8901-2014	Cote, Jacques/0000-0001-6751-555X; saksouk, julie/0000-0003-1885-1762	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to L. G. and J. C.).	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Altaf M, 2009, BIOCHEM CELL BIOL, V87, P35, DOI 10.1139/O08-140; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; Owen-Hughes T, 1999, METH MOL B, V119, P319; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Raisner RM, 2006, CURR OPIN GENET DEV, V16, P119, DOI 10.1016/j.gde.2006.02.005; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206; Svotelis A, 2009, BIOCHEM CELL BIOL, V87, P179, DOI 10.1139/O08-138; Vary JC, 2004, METHOD ENZYMOL, V375, P88; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	57	106	109	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15966	15977		10.1074/jbc.M110.117069	http://dx.doi.org/10.1074/jbc.M110.117069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332092	Green Published, hybrid			2022-12-27	WOS:000277715900034
J	Furukawa, Y; Kaneko, K; Yamanaka, K; Nukina, N				Furukawa, Yoshiaki; Kaneko, Kumi; Yamanaka, Koji; Nukina, Nobuyuki			Mutation-dependent Polymorphism of Cu,Zn-Superoxide Dismutase Aggregates in the Familial Form of Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN SUPEROXIDE-DISMUTASE; MOTOR-NEURON DEGENERATION; COPPER-BINDING-SITE; TRANSGENIC MICE; PROTEIN AGGREGATION; HUMAN-DISEASE; CELL-DEATH; SOD1; ALS; SUPEROXIDE-DISMUTASE-1	More than 100 different mutations in Cu, Zn-superoxide dismutase (SOD1) are linked to a familial form of amyotrophic lateral sclerosis (fALS). Pathogenic mutations facilitate fibrillar aggregation of SOD1, upon which significant structural changes of SOD1 have been assumed; in general, however, a structure of protein aggregate remains obscure. Here, we have identified a protease-resistant core in wild-type as well as fALS-causing mutant SOD1 aggregates. Three different regions within an SOD1 sequence are found as building blocks for the formation of an aggregate core, and fALS-causing mutations modulate interactions among these three regions to form a distinct core, namely SOD1 aggregates exhibit mutation-dependent structural polymorphism, which further regulates biochemical properties of aggregates such as solubility. Based upon these results, we propose a new pathomechanism of fALS in which mutation-dependent structural polymorphism of SOD1 aggregates can affect disease phenotypes.	[Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Yamanaka, Koji] RIKEN Brain Sci Inst, Lab Motor Neuron Dis, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Nukina, N (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nukina@brain.riken.jp	Nukina, Nobuyuki/GPP-6265-2022; Yamanaka, Koji/H-5806-2011; Yamanaka, Koji/ABD-1034-2020; Furukawa, Yoshiaki/F-2871-2014	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Furukawa, Yoshiaki/0000-0002-1918-372X	Scientific Research on Priority Areas [17025044]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20770130, 21390274]; Health and Labour Science Research	Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Science Research	This work was supported by Grant-in-aid for Scientific Research on Priority Areas (Research on Pathomechanisms of Brain Disorders) 17025044 (to N.N.), Grants-in-aid 20770130 (to Y.F.) and 21390274 (to K.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Health and Labour Science Research grant (to K.Y.).	Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Ghadge GD, 2006, NEUROBIOL DIS, V21, P194, DOI 10.1016/j.nbd.2005.07.006; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Khare SD, 2005, PROTEINS, V61, P617, DOI 10.1002/prot.20629; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	39	78	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22221	22231		10.1074/jbc.M110.113597	http://dx.doi.org/10.1074/jbc.M110.113597			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20404329	Green Published, hybrid			2022-12-27	WOS:000279702200035
J	Luong, P; Kinch, LN; Brautigam, CA; Grishin, NV; Tomchick, DR; Orth, K				Luong, Phi; Kinch, Lisa N.; Brautigam, Chad A.; Grishin, Nick V.; Tomchick, Diana R.; Orth, Kim			Kinetic and Structural Insights into the Mechanism of AMPylation by VopS Fic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-PARAHAEMOLYTICUS; AUTOPHAGY; PROTEINS; BINDING; MODEL	The bacterial pathogen Vibrio parahemeolyticus manipulates host signaling pathways during infections by injecting type III effectors into the cytoplasm of the target cell. One of these effectors, VopS, blocks actin assembly by AMPylation of a conserved threonine residue in the switch 1 region of Rho GTPases. The modified GTPases are no longer able to interact with downstream effectors due to steric hindrance by the covalently linked AMP moiety. Herein we analyze the structure of VopS and its evolutionarily conserved catalytic residues. Steady-state analysis of VopS mutants provides kinetic understanding on the functional role of each residue for AMPylation activity by the Fic domain. Further mechanistic analysis of VopS with its two substrates, ATP and Cdc42, demonstrates that VopS utilizes a sequential mechanism to AMPylate Rho GTPases. Discovery of a ternary reaction mechanism along with structural insight provides critical groundwork for future studies for the family of AMPylators that modify hydroxyl-containing residues with AMP.	[Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Brautigam, Chad A.; Grishin, Nick V.; Tomchick, Diana R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Tomchick, Diana/0000-0002-7529-4643; Brautigam, Chad/0000-0001-6563-1338; Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [R01-AI056404]; Welch Research Foundation [I-1561, I-1505]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI056404 (NIAID, to K.O. and P.L.). This work was also funded in part by Welch Research Foundation Grant I-1561 (to K.O.).; Supported by the Welch Foundation (I-1505).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Broberg CA, 2010, CURR OPIN MICROBIOL, V13, P34, DOI 10.1016/j.mib.2009.12.004; Burdette DL, 2008, P NATL ACAD SCI USA, V105, P12497, DOI 10.1073/pnas.0802773105; Burdette DL, 2009, MOL MICROBIOL, V73, P639, DOI 10.1111/j.1365-2958.2009.06798.x; Casselli T, 2008, INFECT IMMUN, V76, P2202, DOI 10.1128/IAI.01704-07; Chen GJ, 2000, BIOCHEMISTRY-US, V39, P2079, DOI 10.1021/bi9919495; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gill HS, 2002, BIOCHEMISTRY-US, V41, P9863, DOI 10.1021/bi020254s; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, NAT CHEM BIOL, V5, P378, DOI 10.1038/nchembio0609-378; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	30	62	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20155	20163		10.1074/jbc.M110.114884	http://dx.doi.org/10.1074/jbc.M110.114884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410310	Green Published, hybrid			2022-12-27	WOS:000279012000050
J	Gruschke, S; Grone, K; Heublein, M; Holz, S; Israel, L; Imhof, A; Herrmann, JM; Ott, M				Gruschke, Steffi; Groene, Kerstin; Heublein, Manfred; Hoelz, Stefanie; Israel, Lars; Imhof, Axel; Herrmann, Johannes M.; Ott, Martin			Proteins at the Polypeptide Tunnel Exit of the Yeast Mitochondrial Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUBUNIT; OXA1; TRANSLATION; COMPONENT; INSERTION; EVOLUTION; MBA1; YIDC	Oxidative phosphorylation in mitochondria requires the synthesis of proteins encoded in the mitochondrial DNA. The mitochondrial translation machinery differs significantly from that of the bacterial ancestor of the organelle. This is especially evident from many mitochondria-specific ribosomal proteins. An important site of the ribosome is the polypeptide tunnel exit. Here, nascent chains are exposed to an aqueous environment for the first time. Many biogenesis factors interact with the tunnel exit of pro-and eukaryotic ribosomes to help the newly synthesized proteins to mature. To date, nothing is known about the organization of the tunnel exit of mitochondrial ribosomes. We therefore undertook a comprehensive approach to determine the composition of the yeast mitochondrial ribosomal tunnel exit. Mitochondria contain homologues of the ribosomal proteins located at this site in bacterial ribosomes. Here, we identified proteins located in their proximity by chemical cross-linking and mass spectrometry. Our analysis revealed a complex network of interacting proteins including proteins and protein domains specific to mitochondrial ribosomes. This network includes Mba1, the membrane-bound ribosome receptor of the inner membrane, as well as Mrpl3, Mrpl13, and Mrpl27, which constitute ribosomal proteins exclusively found in mitochondria. This unique architecture of the tunnel exit is presumably an adaptation of the translation system to the specific requirements of the organelle.	[Herrmann, Johannes M.; Ott, Martin] Tech Univ Kaiserslautern, Abt Zellbiol, D-67663 Kaiserslautern, Germany; [Israel, Lars; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany	University of Kaiserslautern; University of Munich	Ott, M (corresponding author), Tech Univ Kaiserslautern, Abt Zellbiol, Erwin Schrodinger Str 13, D-67663 Kaiserslautern, Germany.	martin.ott@biologie.uni-kl.de	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; Ott, Martin/0000-0001-6367-3091	Stiftung Rheinland-Pfalz fur Innovation; Deutsche Forschungsgemeinschaft [FOR967]	Stiftung Rheinland-Pfalz fur Innovation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Stiftung Rheinland-Pfalz fur Innovation and by Deutsche Forschungsgemeinschaft (Research Unit FOR967).	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BORST P, 1978, CELL, V15, P705, DOI 10.1016/0092-8674(78)90257-X; DAUM G, 1982, J BIOL CHEM, V257, P3028; Houben ENG, 2005, J CELL BIOL, V170, P27, DOI 10.1083/jcb.200503035; Jia LX, 2009, EUKARYOT CELL, V8, P1792, DOI 10.1128/EC.00219-09; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lafontaine D, 1996, NUCLEIC ACIDS RES, V24, P3469, DOI 10.1093/nar/24.17.3469; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Prestele M, 2009, MOL BIOL CELL, V20, P2615, DOI 10.1091/mbc.E08-12-1162; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Preuss M, 2001, J CELL BIOL, V153, P1085, DOI 10.1083/jcb.153.5.1085; Sharma MR, 2009, P NATL ACAD SCI USA, V106, P9637, DOI 10.1073/pnas.0901631106; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Spremulli LL, 2004, PROG NUCLEIC ACID RE, V77, P211, DOI 10.1016/S0079-6603(04)77006-3; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Williams EH, 2005, EUKARYOT CELL, V4, P337, DOI 10.1128/EC.4.2.337-345.2005	23	49	50	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19022	19028		10.1074/jbc.M110.113837	http://dx.doi.org/10.1074/jbc.M110.113837			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404317	hybrid, Green Published			2022-12-27	WOS:000278727800010
J	Billen, B; Vassilevski, A; Nikolsky, A; Debaveye, S; Tytgat, J; Grishin, E				Billen, Bert; Vassilevski, Alexander; Nikolsky, Anton; Debaveye, Sarah; Tytgat, Jan; Grishin, Eugene			Unique Bell-shaped Voltage-dependent Modulation of Na+ Channel Gating by Novel Insect-selective Toxins from the Spider Agelena orientalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; FUNNEL-WEB SPIDER; SCORPION BETA-TOXINS; PEPTIDE TOXINS; FUNCTIONAL EXPRESSION; SELENOCOSMIA-HAINANA; MOLECULAR-MECHANISMS; MEMBRANE-PROTEIN; HOLOLENA-CURTA; ION CHANNELS	Spider venoms provide a highly valuable source of peptide toxins that act on a wide diversity of membrane-bound receptors and ion channels. In this work, we report isolation, biochemical analysis, and pharmacological characterization of a novel family of spider peptide toxins, designated beta/delta-agatoxins. These toxins consist of 36-38 amino acid residues and originate from the venom of the agelenid funnel-web spider Agelena orientalis. The presented toxins show considerable amino acid sequence similarity to other known toxins such as mu-agatoxins, curtatoxins, and delta-palutoxins-IT from the related spiders Agelenopsis aperta, Hololena curta, and Paracoelotes luctuosus. beta/delta-Agatoxins modulate the insect Na-V channel (DmNa(V)1/tipE) in a unique manner, with both the activation and inactivation processes being affected. The voltage dependence of activation is shifted toward more hyperpolarized potentials (analogous to site 4 toxins) and a non-inactivating persistent Na+ current is induced (site 3-likeaction). Interestingly, both effects take place in a voltage-dependent manner, producing a bell-shaped curve between -80 and 0 mV, and they are absent in mammalian Na-V channels. To the best of our knowledge, this is the first detailed report of peptide toxins with such a peculiar pharmacological behavior, clearly indicating that traditional classification of toxins according to their binding sites may not be as exclusive as previously assumed.	[Billen, Bert; Debaveye, Sarah; Tytgat, Jan] Univ Leuven, Toxicol Lab, KU Leuven, B-3000 Louvain, Belgium; [Vassilevski, Alexander; Nikolsky, Anton; Grishin, Eugene] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia	KU Leuven; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Tytgat, J (corresponding author), Univ Leuven, Toxicol Lab, KU Leuven, Campus Gasthuisberg O&N2,Herestr 49,POB 922, B-3000 Louvain, Belgium.	jan.tytgat@pharm.kuleuven.be; grev@ibch.ru	Vassilevski, Alexander/S-3824-2016; Tytgat, Jan/F-1560-2010	Vassilevski, Alexander/0000-0002-1359-0076; Tytgat, Jan/0000-0003-1778-6022	Federal Agency for Education of the Russian Federation [P1388]; Program of Cell and Molecular Biology of the Russian Academy of Sciences; Russian Foundation for Basic Research [05-04-50828, BIL05/50]; F.W.O. Vlaanderen) [G.0257.08, G.0330.06]; K.U. Leuven [OT-05-64]; Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy [UA P6/31]	Federal Agency for Education of the Russian Federation; Program of Cell and Molecular Biology of the Russian Academy of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); F.W.O. Vlaanderen)(FWO); K.U. Leuven(KU Leuven); Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Federal Agency for Education of the Russian Federation (State Contract P1388), the Program of Cell and Molecular Biology of the Russian Academy of Sciences, the Russian Foundation for Basic Research (Grant 05-04-50828), Grant BIL05/50 (bilateral collaboration between Flanders and the Russian Federation), Grants G.0257.08 and G.0330.06 (F.W.O. Vlaanderen), Grant OT-05-64 (K.U. Leuven), and Grant UA P6/31 (Interuniversity Attraction Poles Program, Belgian State, Belgian Science Policy).	ADAMS ME, 1989, J COMP PHYSIOL A, V164, P333, DOI 10.1007/BF00612993; Adams ME, 2004, TOXICON, V43, P509, DOI 10.1016/j.toxicon.2004.02.004; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; Billen B, 2008, TOXICON, V52, P309, DOI 10.1016/j.toxicon.2008.05.018; Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; Bosmans F, 2007, TOXICON, V49, P550, DOI 10.1016/j.toxicon.2006.11.029; Bosmans F, 2007, TOXICOL APPL PHARM, V218, P45, DOI 10.1016/j.taap.2006.10.009; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; COHEN CJ, 1993, BIOPHYS J, V64, pA4; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Corzo G, 2000, EUR J BIOCHEM, V267, P5783, DOI 10.1046/j.1432-1327.2000.01653.x; Corzo G, 2005, BIOCHEMISTRY-US, V44, P1542, DOI 10.1021/bi048434k; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; Corzo G, 2007, J BIOL CHEM, V282, P4643, DOI 10.1074/jbc.M605403200; De Lima ME, 2007, COMP BIOCHEM PHYS C, V146, P264, DOI 10.1016/j.cbpc.2006.10.010; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Ekberg J, 2008, INT J BIOCHEM CELL B, V40, P2363, DOI 10.1016/j.biocel.2007.08.017; Elinder F, 2007, PHYSIOL BEHAV, V92, P1, DOI 10.1016/j.physbeh.2007.05.058; Estrada G, 2007, NAT PROD REP, V24, P145, DOI 10.1039/b603083c; FAINZILBER M, 1994, J BIOL CHEM, V269, P2574; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Ferrat G, 2005, PROTEINS, V59, P368, DOI 10.1002/prot.20424; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Grishin E, 1999, EUR J BIOCHEM, V264, P276, DOI 10.1046/j.1432-1327.1999.00622.x; HONDEGHEM LM, 1984, ANNU REV PHARMACOL, V24, P387, DOI 10.1146/annurev.pa.24.040184.002131; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Leipold E, 2005, FEBS LETT, V579, P3881, DOI 10.1016/j.febslet.2005.05.077; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; NICHOLSON GM, 1994, PFLUG ARCH EUR J PHY, V428, P400, DOI 10.1007/BF00724524; Nicholson GM, 1998, PFLUG ARCH EUR J PHY, V436, P117, DOI 10.1007/s004240050612; Nicholson GM, 2004, TOXICON, V43, P587, DOI 10.1016/j.toxicon.2004.02.006; Nicholson GM, 2007, TOXICON, V49, P490, DOI 10.1016/j.toxicon.2006.11.027; Nikolsky AS, 2009, BIOCHEM MOSC SUPPL S, V3, P245, DOI 10.1134/S1990747809030027; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; Norris T. M., 1995, Society for Neuroscience Abstracts, V21, P1820; Omecinsky DO, 1996, BIOCHEMISTRY-US, V35, P2836, DOI 10.1021/bi952605r; Petrinos, 2009, PROTEIN BIOSYNTHESIS, P225; QUISTAD GB, 1991, TOXICON, V29, P329, DOI 10.1016/0041-0101(91)90286-Z; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; SHLYAPNIKOV YM, 2010, BIOORG KHIM, V36, P81; SKINNER WS, 1989, J BIOL CHEM, V264, P2150; STAPLETON A, 1990, J BIOL CHEM, V265, P2054; Tan JG, 2002, J NEUROSCI, V22, P5300; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Vassilevski AA, 2010, METHODS MOL BIOL, V615, P87, DOI 10.1007/978-1-60761-535-4_7; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2003, TOXICON, V41, P643, DOI 10.1016/S0041-0101(02)00280-5; Yamaji N, 2007, FEBS LETT, V581, P3789, DOI 10.1016/j.febslet.2007.06.077; Yamaji N, 2009, J BIOL CHEM, V284, P24568, DOI 10.1074/jbc.M109.030841; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	60	27	35	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18545	18554		10.1074/jbc.M110.125211	http://dx.doi.org/10.1074/jbc.M110.125211			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385552	hybrid, Green Published			2022-12-27	WOS:000278453900048
J	Ding, X; Deng, H; Wang, DM; Zhou, JJ; Huang, YJ; Zhao, XN; Yu, X; Wang, M; Wang, FS; Ward, T; Aikhionbare, F; Yao, XB				Ding, Xia; Deng, Hui; Wang, Dongmei; Zhou, Jiajia; Huang, Yuejia; Zhao, Xuannv; Yu, Xue; Wang, Ming; Wang, Fengsong; Ward, Tarsha; Aikhionbare, Felix; Yao, Xuebiao			Phospho-regulated ACAP4-Ezrin Interaction Is Essential for Histamine-stimulated Parietal Cell Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-ACID-SECRETION; APICAL MEMBRANE; HCL SECRETION; RECYCLING HYPOTHESIS; OXYNTIC CELLS; GLAND MODEL; EZRIN; PROTEIN; PHOSPHORYLATION; LOCALIZATION	The ezrin-radixin-moesin proteins provide a regulated linkage between membrane proteins and the cortical cytoskeleton and also participate in signal transduction pathways. Ezrin is localized to the apical membrane of parietal cells and couples the protein kinase A activation cascade to the regulated HCl secretion. Our recent proteomic study revealed a protein complex of ezrin-ACAP4-ARF6 essential for volatile membrane remodeling (Fang, Z., Miao, Y., Ding, X., Deng, H., Liu, S., Wang, F., Zhou, R., Watson, C., Fu, C., Hu, Q., Lillard, J. W., Jr., Powell, M., Chen, Y., Forte, J. G., and Yao, X. (2006) Mol. Cell Proteomics 5, 1437-1449). However, knowledge of whether ACAP4 physically interacts with ezrin and how their interaction is integrated into membrane-cytoskeletal remodeling has remained elusive. Here we provide the first evidence that ezrin interacts with ACAP4 in a protein kinase A-mediated phosphorylation-dependent manner through the N-terminal 400 amino acids of ACAP4. ACAP4 locates in the cytoplasmic membrane in resting parietal cells but translocates to the apical plasma membrane upon histamine stimulation. ACAP4 was precipitated with ezrin from secreting but not resting parietal cell lysates, suggesting a phospho-regulated interaction. Indeed, this interaction is abolished by phosphatase treatment and validated by an in vitro reconstitution assay using phospho-mimicking ezrin(S66D). Importantly, ezrin specifies the apical distribution of ACAP4 in secreting parietal cells because either suppression of ezrin or overexpression of non-phosphorylatable ezrin prevents the apical localization of ACAP4. In addition, overexpressing GTPase-activating protein-deficient ACAP4 results in an inhibition of apical membrane-cytoskeletal remodeling and gastric acid secretion. Taken together, these results define a novel molecular mechanism linking ACAP4-ezrin interaction to polarized epithelial secretion.	[Ding, Xia; Deng, Hui; Wang, Dongmei; Zhou, Jiajia; Huang, Yuejia; Zhao, Xuannv; Yu, Xue; Wang, Ming; Wang, Fengsong; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Ding, Xia] Beijing Univ Chinese Med, Dept Internal Med, Beijing 100029, Peoples R China; [Deng, Hui; Huang, Yuejia; Wang, Fengsong; Ward, Tarsha; Aikhionbare, Felix] Morehouse Sch Med, Dept Physiol & Med, Atlanta, GA 30310 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing University of Chinese Medicine; Morehouse School of Medicine	Yao, XB (corresponding author), Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014	Wang, Ming/0000-0002-7000-1063	National Institutes of Health (NIH) [DK-56292, CA132389]; NIH, National Center for Research Resources (NCRR) [UL1 RR025008, G12RR03034]; Chinese Natural Science Foundation [30500183, 30870990, 30900497, 90508002, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R195]; Chinese 973 Project [2006CB943603, 2007CB914503, 2010CB912103]; International Collaboration Grant [2009DFA31010]; Technology grant [2006BAI08B01-07]; China National Key Projects for Infectious Disease Grant [2008ZX10002-021]; Georgia Cancer Coalition breast cancer research grant; Atlanta Clinical and Translational Science Award Chemical Biology Grant [P20RR011104]; Anhui Province Key Project Grant [08040102005]; NATIONAL CANCER INSTITUTE [P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR011104, UL1RR025008, G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973 Project(National Basic Research Program of China); International Collaboration Grant; Technology grant; China National Key Projects for Infectious Disease Grant; Georgia Cancer Coalition breast cancer research grant; Atlanta Clinical and Translational Science Award Chemical Biology Grant; Anhui Province Key Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants DK-56292 and CA132389 and NIH, National Center for Research Resources (NCRR), Grant UL1 RR025008 from the Clinical and Translational Science Award program. This work was also supported by Chinese Natural Science Foundation Grants 30500183 and 30870990 (to X. D.), 30900497 (to F. W.), and 90508002 and 90913016 (to X. Y.); Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R195; Chinese 973 Project Grants 2006CB943603, 2007CB914503, and 2010CB912103; International Collaboration Grant 2009DFA31010 (to X. D.); and Technology grant 2006BAI08B01-07 (to X. D.); China National Key Projects for Infectious Disease Grant 2008ZX10002-021; a Georgia Cancer Coalition breast cancer research grant; Atlanta Clinical and Translational Science Award Chemical Biology Grant P20RR011104; and Anhui Province Key Project Grant 08040102005. The facilities used were supported in part by NCRR, NIH, Grant G12RR03034.	Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; BERRYMAN M, 1993, J CELL SCI, V105, P1025; BLACK JA, 1982, GASTROENTEROLOGY, V83, P595; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Ding Xia, 2008, V440, P217, DOI 10.1007/978-1-59745-178-9_16; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Forte JG, 1996, TRENDS CELL BIOL, V6, P45, DOI 10.1016/0962-8924(96)81009-9; FORTE TM, 1977, GASTROENTEROLOGY, V73, P941; GOLDENRING JR, 1994, AM J PHYSIOL, V267, P187; HANZEL DK, 1989, AM J PHYSIOL, V256, pG1082, DOI 10.1152/ajpgi.1989.256.6.G1082; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Liu D, 2007, FEBS LETT, V581, P3563, DOI 10.1016/j.febslet.2007.06.071; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Matsukawa J, 2003, J BIOL CHEM, V278, P36470, DOI 10.1074/jbc.M305444200; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; URUSHIDANI T, 1987, AM J PHYSIOL, V252, pG458, DOI 10.1152/ajpgi.1987.252.4.G458; URUSHIDANI T, 1987, BIOCHIM BIOPHYS ACTA, V930, P209, DOI 10.1016/0167-4889(87)90033-4; URUSHIDANI T, 1989, AM J PHYSIOL, V256, pG1070, DOI 10.1152/ajpgi.1989.256.6.G1070; Wang FS, 2008, J BIOL CHEM, V283, P26714, DOI 10.1074/jbc.M800527200; YAO X, 1993, AM J PHYSIOL, V265, P36; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; Yao XB, 1996, AM J PHYSIOL-CELL PH, V271, pC61, DOI 10.1152/ajpcell.1996.271.1.C61; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Yeaman C, 1999, CURR BIOL, V9, pR515, DOI 10.1016/S0960-9822(99)80324-8; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200; Zhu LX, 2009, AM J PHYSIOL-GASTR L, V296, pG185, DOI 10.1152/ajpgi.90597.2008	31	24	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18769	18780		10.1074/jbc.M110.129007	http://dx.doi.org/10.1074/jbc.M110.129007			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20360010	hybrid, Green Published			2022-12-27	WOS:000278453900068
J	Yao, JY; Zhang, L; Zhang, X; He, ZY; Ma, Y; Hui, LJ; Wang, X; Hu, YP				Yao, Jia-Yi; Zhang, Lei; Zhang, Xin; He, Zhi-Ying; Ma, Yue; Hui, Li-Jian; Wang, Xin; Hu, Yi-Ping			H3K27 Trimethylation Is an Early Epigenetic Event of p16(INK4a) Silencing for Regaining Tumorigenesis in Fusion Reprogrammed Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TUMOR-SUPPRESSOR GENES; SOMATIC-CELLS; HEPATOCELLULAR-CARCINOMA; HYBRID-CELLS; PLURIPOTENT CELLS; EPITHELIAL-CELLS; DNA METHYLATION; IN-VITRO; CANCER	Stable epigenetic silencing of p16(INK4a) is a common event in hepatocellular carcinoma (HCC) cells, which is associated with abnormal cell proliferation and liberation from cell cycle arrest. Understanding the early epigenetic events in silencing p16(INK4a) expression may illuminate a prognostic strategy to block HCC development. Toward this end, we created a reprogram cell model by the fusion mouse HCC cells with mouse embryonic stem cells, in which the ES-Hepa hybrids forfeited HCC cell characteristics along with reactivation of the silenced p16(INK4a). HCC characteristics, in terms of gene expression pattern and tumorigenic potential, was restored upon induced differentiation of these reprogrammed ES-Hepa hybrids. The histone methylation pattern relative to p16(INK4a) silencing during differentiation of the ES-Hepa hybrids was analyzed. H3K27 trimethylation at the p16(INK4a) promoter region, occurring in the early onset of p16(INK4a) silencing, was followed by H3K9 dimethylation at later stages. During the induced differentiation of the ES-Hepa hybrids, H3K4 di- and trimethylations were maintained at high levels during the silencing of p16(INK4a), strongly suggesting that H3K4 methylation events did not cause the silencing of p16(INK4a). Our results suggested that the enrichment of H3K27 trimethylation, independent of H3K9 dimethylation, trimethylation, and DNA methylation, was an early event in the silencing of p16(INK4a) during the tumor development. This unique chromatin pattern may be a heritable marker of epigenetic regulation for p16(INK4a) silencing during the developmental process of hepatocellular carcinogenesis.	[Yao, Jia-Yi; Zhang, Lei; Zhang, Xin; Hui, Li-Jian; Wang, Xin] Chinese Acad Sci, Key Lab Mol & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Yao, Jia-Yi; Zhang, Xin; He, Zhi-Ying; Hu, Yi-Ping] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China; [Ma, Yue] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Wang, Xin] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Naval Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Minnesota System; University of Minnesota Twin Cities	Wang, X (corresponding author), Chinese Acad Sci, Key Lab Mol & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	wangx@sibs.ac.cn; yphu@smmu.edu.cn	Ma, Yue/D-4343-2011	Ma, Yue/0000-0002-3922-594X; Zhang, Lei/0000-0002-0222-4417; Yao, Jiayi/0000-0001-9235-2406	National Institutes of Health [DK074561, AI065565]; National Natural Science Foundation of China [30671044, 30623003, 30801115, 30901449]; National Key Basic Research and Development Program of China [2005CB522701, 2006CB943901, 2007CB947903, 2007CB947102, 2009CB941100, 2010CB945602]; Chinese National 863 Plan Project [2006AA02Z474]; Chinese Academy of Sciences [KSCX2-YW-R-49]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI065565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); Chinese National 863 Plan Project(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK074561 and AI065565. This work was also supported by the National Natural Science Foundation of China (Grants 30671044, 30623003, 30801115, and 30901449), the National Key Basic Research and Development Program of China (Grants 2005CB522701, 2006CB943901, 2007CB947903, 2007CB947102, 2009CB941100, and 2010CB945602), the Chinese National 863 Plan Project (Grant 2006AA02Z474), and the Chinese Academy of Sciences (Grant KSCX2-YW-R-49).	Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Bonilla F, 1998, INT J ONCOL, V12, P583; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Do JT, 2006, STEM CELL REV, V2, P257, DOI 10.1007/BF02698052; Do JT, 2007, STEM CELLS, V25, P1013, DOI 10.1634/stemcells.2006-0691; Do JT, 2005, REPROD FERT DEVELOP, V17, P143, DOI 10.1071/RD04120; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Dynlacht BD, 1997, NATURE, V389, P149, DOI 10.1038/38225; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Holst CR, 2003, CANCER RES, V63, P1596; Hui AM, 1996, HEPATOLOGY, V24, P575, DOI 10.1002/hep.510240319; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Kita R, 1996, INT J CANCER, V67, P176, DOI 10.1002/(SICI)1097-0215(19960717)67:2<176::AID-IJC4>3.0.CO;2-Q; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Li L, 2003, CANCER RES, V63, P2733; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Matveeva NM, 1998, MOL REPROD DEV, V50, P128, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;128::AID-MRD2&gt;3.0.CO;2-M; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; MILLER SC, 1988, GENE DEV, V2, P330, DOI 10.1101/gad.2.3.330; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sherr CJ, 2000, CANCER RES, V60, P3689; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TOLLEFSBOL TO, 2009, CANC EPIGENETICS, P446; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Wong DJ, 1999, MOL CELL BIOL, V19, P5642	40	26	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18828	18837		10.1074/jbc.M109.077974	http://dx.doi.org/10.1074/jbc.M109.077974			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20382980	Green Published, hybrid			2022-12-27	WOS:000278453900073
J	Wu, BX; Rajagopalan, V; Roddy, PL; Clarke, CJ; Hannun, YA				Wu, Bill X.; Rajagopalan, Vinodh; Roddy, Patrick L.; Clarke, Christopher J.; Hannun, Yusuf A.			Identification and Characterization of Murine Mitochondria-associated Neutral Sphingomyelinase (MA-nSMase), the Mammalian Sphingomyelin Phosphodiesterase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; LUNG EPITHELIAL-CELLS; SPHINGOLIPID METABOLISM; BIOACTIVE SPHINGOLIPIDS; CERAMIDE CHANNELS; APOPTOSIS; GENE; CHROMATOGRAPHY; TRAFFICKING	Sphingolipids play important roles in regulating cellular responses. Although mitochondria contain sphingolipids, direct regulation of their levels in mitochondria or mitochondria-associated membranes is mostly unclear. Neutral SMase (N-SMase) isoforms, which catalyze hydrolysis of sphingomyelin (SM) to ceramide and phosphocholine, have been found in the mitochondria of yeast and zebrafish, yet their existence in mammalian mitochondria remains unknown. Here, we have identified and cloned a cDNA based on nSMase homologous sequences. This cDNA encodes a novel protein of 483 amino acids that displays significant homology to nSMase2 and possesses the same catalytic core residues as members of the extended N-SMase family. A transiently expressed V5-tagged protein co-localized with both mitochondria and endoplasmic reticulum markers in MCF-7 and HEK293 cells; accordingly, the enzyme is referred to as mitochondria-associated nSMase (MA-nSMase). MA-nSMase was highly expressed in testis, pancreas, epididymis, and brain. MA-nSMase had an absolute requirement for cations such as Mg2+ and Mn2+ and activation by the anionic phospholipids, especially phosphatidylserine and the mitochondrial cardiolipin. Importantly, overexpression of MA-nSMase in HEK293 cells significantly increased in vitro N-SMase activity and also modulated the levels of SM and ceramide, indicating that the identified cDNA encodes a functional SMase. Thus, these studies identify and characterize, for the first time, a mammalian MA-nSMase. The characterization of MA-nSMase described here will contribute to our understanding of pathways regulated by sphingolipid metabolites, particularly with reference to the mitochondria and associated organelles.	[Wu, Bill X.; Rajagopalan, Vinodh; Roddy, Patrick L.; Clarke, Christopher J.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu	Rajagopalan, Vinodh/AAG-4769-2020		National Institutes of Health [GM 43825, P20 RR0176677, P01-CA97132]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043825, R37GM043825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 43825 to (Y. A. H.).; We thank Drs. Cungui Mao and Ashley Snider for expert advice and assistance. We also thank the Lipidomics Core at the Medical University of South Carolina for mass spectrometry analysis of lipids. The core facility is supported by National Institutes of Health Grants P20 RR0176677 and P01-CA97132.	Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Butler A, 2002, AM J PATHOL, V161, P1061, DOI 10.1016/S0002-9440(10)64267-8; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Corcoran CA, 2008, MOL CANCER RES, V6, P795, DOI 10.1158/1541-7786.MCR-07-2097; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; Furland NE, 2007, J BIOL CHEM, V282, P18151, DOI 10.1074/jbc.M700709200; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Garcia-Ruiz C, 2002, J BIOL CHEM, V277, P36443, DOI 10.1074/jbc.M206021200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Martinez-Abundis E, 2009, FEBS J, V276, P5579, DOI 10.1111/j.1742-4658.2009.07239.x; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Modrak DE, 2006, MOL CANCER THER, V5, P200, DOI 10.1158/1535-7163.MCT-05-0420; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18; Noygorodov SA, 2009, J CARDIOVASC PHARM, V53, P198, DOI 10.1097/FJC.0b013e31819b52d5; Otala M, 2005, BIOL REPROD, V72, P86, DOI 10.1095/biolreprod.104.031278; Raimann PE, 1999, MOL CELL BIOCHEM, V201, P125, DOI 10.1023/A:1007046024246; Sawai H, 1999, J BIOL CHEM, V274, P38131, DOI 10.1074/jbc.274.53.38131; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; SPENCE MW, 1979, BRAIN RES, V168, P543, DOI 10.1016/0006-8993(79)90308-1; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; Yabu T, 2008, J BIOL CHEM, V283, P29971, DOI 10.1074/jbc.M805402200; Yabu T, 2009, J BIOL CHEM, V284, P20349, DOI 10.1074/jbc.M109.004580	46	82	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17993	18002		10.1074/jbc.M110.102988	http://dx.doi.org/10.1074/jbc.M110.102988			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378533	Green Published, hybrid			2022-12-27	WOS:000278133400075
J	Schmidt, A; Kimmel, DB; Bai, C; Scafonas, A; Rutledge, S; Vogel, RL; McElwee-Witmer, S; Chen, F; Nantermet, PV; Kasparcova, V; Leu, CT; Zhang, HZ; Duggan, ME; Gentile, MA; Hodor, P; Pennypacker, B; Masarachia, P; Opas, EE; Adamski, SA; Cusick, TE; Wang, JB; Mitchell, HJ; Kim, Y; Prueksaritanont, T; Perkins, JJ; Meissner, RS; Hartman, GD; Freedman, LP; Harada, S; Ray, WJ				Schmidt, Azriel; Kimmel, Donald B.; Bai, Chang; Scafonas, Angela; Rutledge, SuJane; Vogel, Robert L.; McElwee-Witmer, Sheila; Chen, Fang; Nantermet, Pascale V.; Kasparcova, Viera; Leu, Chih-tai; Zhang, Hai-Zhuan; Duggan, Mark E.; Gentile, Michael A.; Hodor, Paul; Pennypacker, Brenda; Masarachia, Patricia; Opas, Evan E.; Adamski, Sharon A.; Cusick, Tara E.; Wang, Jiabing; Mitchell, Helen J.; Kim, Yuntae; Prueksaritanont, Thomayant; Perkins, James J.; Meissner, Robert S.; Hartman, George D.; Freedman, Leonard P.; Harada, Shun-ichi; Ray, William J.			Discovery of the Selective Androgen Receptor Modulator MK-0773 Using a Rational Development Strategy Based on Differential Transcriptional Requirements for Androgenic Anabolism Versus Reproductive Physiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAN BODY-MASS; POSTMENOPAUSAL WOMEN; GENETIC PATHWAYS; MALE RATS; TESTOSTERONE; PROSTATE; BONE; INSENSITIVITY; EXPRESSION; MUTATIONS	Selective androgen receptor modulators (SARMs) are androgen receptor (AR) ligands that induce anabolism while having reduced effects in reproductive tissues. In various experimental contexts SARMs fully activate, partially activate, or even antagonize the AR, but how these complex activities translate into tissue selectivity is not known. Here, we probed receptor function using >1000 synthetic AR ligands. These compounds produced a spectrum of activities in each assay ranging from 0 to 100% of maximal response. By testing different classes of compounds in ovariectomized rats, we established that ligands that transactivated a model promoter 40-80% of an agonist, recruited the coactivator GRIP-1 <15%, and stabilized the N-/C-terminal interdomain interaction <7% induced bone formation with reduced effects in the uterus and in sebaceous glands. Using these criteria, multiple SARMs were synthesized including MK-0773, a 4-aza-steroid that exhibited tissue selectivity in humans. Thus, AR activated to moderate levels due to reduced cofactor recruitment, and N-/C-terminal interactions produce a fully anabolic response, whereas more complete receptor activation is required for reproductive effects. This bimodal activation provides a molecular basis for the development of SARMs.	[Schmidt, Azriel; Kimmel, Donald B.; Bai, Chang; Scafonas, Angela; Rutledge, SuJane; Vogel, Robert L.; McElwee-Witmer, Sheila; Chen, Fang; Nantermet, Pascale V.; Kasparcova, Viera; Leu, Chih-tai; Zhang, Hai-Zhuan; Gentile, Michael A.; Pennypacker, Brenda; Masarachia, Patricia; Opas, Evan E.; Adamski, Sharon A.; Cusick, Tara E.; Harada, Shun-ichi; Ray, William J.] Merck Res Labs, Dept Mol Endocrinol, West Point, PA 19486 USA; [Duggan, Mark E.; Wang, Jiabing; Mitchell, Helen J.; Kim, Yuntae; Perkins, James J.; Meissner, Robert S.; Hartman, George D.; Freedman, Leonard P.] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA; [Prueksaritanont, Thomayant] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA; [Hodor, Paul] Merck Res Labs, Dept Mol Profiling, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Schmidt, A (corresponding author), 54 Haymarket Lane, Bryn Mawr, PA 19010 USA.	azriel.schmidt@gmail.com; james_ray@merck.com	Ray, William J/E-9834-2016	Ray, William/0000-0002-4491-167X	Merck Co., Inc	Merck Co., Inc(Merck & Company)	This work was supported by the research and development budget of Merck & Co., Inc.	Allan G, 2008, J STEROID BIOCHEM, V110, P207, DOI 10.1016/j.jsbmb.2007.10.012; Allan GF, 2007, ENDOCRINE, V32, P41, DOI 10.1007/s12020-007-9005-2; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Bettoun DJ, 2005, J BIOL CHEM, V280, P38898, DOI 10.1074/jbc.C500324200; Bhasin S, 2003, J ENDOCRINOL INVEST, V26, P814, DOI 10.1007/BF03345230; Bhasin S, 2003, J GERONTOL A-BIOL, V58, P1002; Bhasin S, 2009, CURR OPIN CLIN NUTR, V12, P232, DOI 10.1097/MCO.0b013e32832a3d79; Bohl CE, 2004, J MED CHEM, V47, P3765, DOI 10.1021/jm0499007; Braunstein GD, 2007, FERTIL STERIL, V88, P1, DOI 10.1016/j.fertnstert.2007.01.118; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chang CY, 2002, MOL ENDOCRINOL, V16, P647, DOI 10.1210/me.16.4.647; Chen F, 2004, J STEROID BIOCHEM, V91, P247, DOI 10.1016/j.jsbmb.2004.04.009; Draper MW, 1996, J BONE MINER RES, V11, P835; Fuse H, 1997, J BONE MINER RES, V12, P590, DOI 10.1359/jbmr.1997.12.4.590; Gao WQ, 2005, ENDOCRINOLOGY, V146, P4887, DOI 10.1210/en.2005-0572; Gao WQ, 2004, ENDOCRINOLOGY, V145, P5420, DOI 10.1210/en.2004-0627; HALL RE, 1994, EUR J CANCER, V30A, P484, DOI 10.1016/0959-8049(94)90424-3; Hanada K, 2003, BIOL PHARM BULL, V26, P1563, DOI 10.1248/bpb.26.1563; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Holterhus PM, 2005, EXP CLIN ENDOCR DIAB, V113, P457, DOI 10.1055/s-2005-865770; Isidori A M, 2005, J Endocrinol Invest, V28, P73; KALLIO PJ, 1995, MOL ENDOCRINOL, V9, P1017, DOI 10.1210/me.9.8.1017; Kaufman J M, 2003, Aging Male, V6, P166, DOI 10.1080/713604787; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Li J, 2009, MATURITAS, V63, P142, DOI 10.1016/j.maturitas.2009.03.008; Manfredi MC, 2007, BIOORG MED CHEM LETT, V17, P4487, DOI 10.1016/j.bmcl.2007.06.007; MEISSNER RS, 2009, 237 ACS NAT M SALT L; Miner JN, 2007, ENDOCRINOLOGY, V148, P363, DOI 10.1210/en.2006-0793; Mohler ML, 2009, J MED CHEM, V52, P3597, DOI 10.1021/jm900280m; Nantermet P, 2008, ENDOCRINOLOGY, V149, P1551, DOI 10.1210/en.2007-1151; Nantermet PV, 2005, ENDOCRINOLOGY, V146, P564, DOI 10.1210/en.2004-1132; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Narayanan Ramesh, 2008, Nucl Recept Signal, V6, pe010, DOI 10.1621/nrs.06010; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; Quigley CA, 2004, MECH AGEING DEV, V125, P683, DOI 10.1016/j.mad.2004.08.007; Riedmaier I, 2009, J STEROID BIOCHEM, V114, P167, DOI 10.1016/j.jsbmb.2009.01.019; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Schmidt A, 2009, J BIOL CHEM, V284, P36367, DOI 10.1074/jbc.M109.049734; Segal S, 2006, EXPERT OPIN INV DRUG, V15, P377, DOI 10.1517/13543784.15.4.377; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Stanworth RD, 2009, FRONT HORM RES, V37, P74, DOI 10.1159/000176046; STOCH SA, 2008, 90 ANN M END SOC SAN; STOCH SA, 2009, 91 ANN M END SOC WAS; Thompson J, 2001, MOL ENDOCRINOL, V15, P923, DOI 10.1210/me.15.6.923; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998; Ye XC, 2005, P NATL ACAD SCI USA, V102, P9487, DOI 10.1073/pnas.0503577102; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	49	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17054	17064		10.1074/jbc.M109.099002	http://dx.doi.org/10.1074/jbc.M109.099002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356837	Green Published, hybrid			2022-12-27	WOS:000277982600069
J	Jee, J; Mizuno, T; Kamada, K; Tochio, H; Chiba, Y; Yanagi, K; Yasuda, G; Hiroaki, H; Hanaoka, F; Shirakawa, M				Jee, JunGoo; Mizuno, Takeshi; Kamada, Katsuhiko; Tochio, Hidehito; Chiba, Yasumasa; Yanagi, Ken-ichiro; Yasuda, Gentaro; Hiroaki, Hidekazu; Hanaoka, Fumio; Shirakawa, Masahiro			Structure and Mutagenesis Studies of the C-terminal Region of Licensing Factor Cdt1 Enable the Identification of Key Residues for Binding to Replicative Helicase Mcm Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; DNA-REPLICATION; ORIGIN RECOGNITION; EUKARYOTIC ORIGINS; RE-REPLICATION; COMPLEX; INHIBITION; GEMININ; CDC6; NMR	In eukaryotes, DNA replication is fired once in a single cell cycle before cell division starts to maintain stability of the genome. This event is tightly controlled by a series of proteins. Cdt1 is one of the licensing factors and is involved in recruiting replicative DNA helicase Mcm2-7 proteins into the pre-replicative complex together with Cdc6. In Cdt1, the C-terminal region serves as a binding site for Mcm2-7 proteins, although the details of these interactions remain largely unknown. Here, we report the structure of the region and the key residues for binding to Mcm proteins. We determined the solution structure of the C-terminal fragment, residues 450-557, of mouse Cdt1 by NMR. The structure consists of a winged-helix domain and shows unexpected similarity to those of the C-terminal domain of Cdc6 and the central fragment of Cdt1, thereby implying functional and evolutionary relationships. Structure-based mutagenesis and an in vitro binding assay enabled us to pinpoint the region that interacts with Mcm proteins. Moreover, by performing in vitro binding and budding yeast viability experiments, we showed that similar to 45 residues located in the N-terminal direction of the structural region are equally crucial for recognizing Mcm proteins. Our data suggest the possibility that winged-helix domain plays a role as a common module to interact with replicative helicase in the DNA replication-licensing process.	[Jee, JunGoo] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 1920397, Japan; [Mizuno, Takeshi; Kamada, Katsuhiko; Yanagi, Ken-ichiro; Yasuda, Gentaro; Hanaoka, Fumio] RIKEN, Discovery Res Inst, Cellular Physiol Lab, Wako, Saitama 3510198, Japan; [Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Chiba, Yasumasa] Ajinomoto Co Inc, Kawasaki, Kanagawa 2108681, Japan; [Hiroaki, Hidekazu] Kobe Univ, Grad Sch Med, Div Struct Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	Tokyo Metropolitan University; RIKEN; Kyoto University; Ajinomoto Co Inc; Kobe University; Gakushuin University	Jee, J (corresponding author), Tokyo Metropolitan Univ, Ctr Prior Areas, 1-1 Minami Osawa, Tokyo 1920397, Japan.	jee-jungoo@tmu.ac.jp; fumio.hanaoka@gakushuin.ac.jp	HIROAKI, HIDEKAZU/N-1658-2019; Mizuno, Takeshi/I-4432-2017; Kamada, Katsuhiko/M-3666-2017; Tochio, Hidehito/GWV-0429-2022; Hiroaki, Hidekazu/G-9564-2012; Tochio, Hidehito/F-6109-2011	HIROAKI, HIDEKAZU/0000-0003-1621-5893; Mizuno, Takeshi/0000-0003-3664-7212; Kamada, Katsuhiko/0000-0001-8523-3417; Tochio, Hidehito/0000-0003-3843-3330; 				Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Capaldi SA, 2004, NUCLEIC ACIDS RES, V32, P4821, DOI 10.1093/nar/gkh819; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cunningham EL, 2005, CURR OPIN STRUC BIOL, V15, P68, DOI 10.1016/j.sbi.2005.01.003; Cvetic C, 2005, SEMIN CELL DEV BIOL, V16, P343, DOI 10.1016/j.semcdb.2005.02.009; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kasiviswanathan R, 2005, NUCLEIC ACIDS RES, V33, P4940, DOI 10.1093/nar/gki807; Khayrutdinov BI, 2009, PROTEIN SCI, V18, P2252, DOI 10.1002/pro.236; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Wilce JA, 2001, NAT STRUCT BIOL, V8, P206, DOI 10.1038/84934; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You Z, 2005, NUCLEIC ACIDS RES, V33, P3033, DOI 10.1093/nar/gki607; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; You ZY, 1999, MOL CELL BIOL, V19, P8003	56	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15931	15940		10.1074/jbc.M109.075333	http://dx.doi.org/10.1074/jbc.M109.075333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335175	Green Published, hybrid			2022-12-27	WOS:000277715900030
J	Khatri, S; Yepiskoposyan, H; Gallo, CA; Tandon, P; Plas, DR				Khatri, Shikha; Yepiskoposyan, Hasmik; Gallo, Catherine A.; Tandon, Preeti; Plas, David R.			FOXO3a Regulates Glycolysis via Transcriptional Control of Tumor Suppressor TSC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS-SCLEROSIS; GENE-EXPRESSION; CELL-SURVIVAL; CANCER-CELLS; AKT; HOMEOSTASIS; APOPTOSIS; LIVER; PHOSPHORYLATION; DEPRIVATION	Akt signal transduction induces coordinated increases in glycolysis and apoptosis resistance in a broad spectrum of cancers. Downstream of Akt, the FoxO transcription factors regulate apoptosis via Bim, but the contributions of FoxOs in regulating Akt-induced glycolysis are not well described. We find that FoxO3a knockdown is sufficient to induce apoptosis resistance in conjunction with elevated glycolysis. Glycolysis in FoxO3a-deficient cells was associated with increased S6K1 phosphorylation and was sensitive to rapamycin, an inhibitor of the mTORC1 pathway that has been linked to glycolysis regulation. We show that mTORC1-dependent glycolysis is increased in FoxO3a knockdown cells due to decreased expression of the TSC1 tumor suppressor that opposes mTORC1 activation. FoxO3a binds to and transactivates the TSC1 promoter, indicating a key role for FoxO3a in regulating TSC1 expression. Together, these data demonstrate that FoxO3a regulates glycolysis downstream of Akt through transcriptional control of Tsc1.	[Khatri, Shikha; Yepiskoposyan, Hasmik; Gallo, Catherine A.; Tandon, Preeti; Plas, David R.] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Plas, DR (corresponding author), 3125 Eden Ave, Cincinnati, OH 45267 USA.	plasd@uc.edu		Yepiskoposyan, Hasmik/0000-0002-3687-1372	National Institutes of Health through the NCI [K01 CA98743, R01 CA133164]; American Cancer Society [RSG-08-293-01-CCG]; NATIONAL CANCER INSTITUTE [T32CA059268, R01CA133164, K01CA098743] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 CA98743 and R01 CA133164 through the NCI (to D. R. P.). This work was also supported by American Cancer Society Grant RSG-08-293-01-CCG.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; ATADJA P, 2004, NOVART FDN SYMP, V259, P266; ATADJA P, 2004, NOVART FDN SYMP, V259, P285; Atadja Peter, 2004, Novartis Found Symp, V259, P249; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bhaskar PT, 2009, MOL CELL BIOL, V29, P5136, DOI 10.1128/MCB.01946-08; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CAY O, 1992, CANCER RES, V52, P5794; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; KAPLAN O, 1990, CANCER RES, V50, P544; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park S, 2009, J BIOL CHEM, V284, P2187, DOI 10.1074/jbc.M806131200; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Pymar LS, 2008, HUM MOL GENET, V17, P2006, DOI 10.1093/hmg/ddn098; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	39	66	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15960	15965		10.1074/jbc.M110.121871	http://dx.doi.org/10.1074/jbc.M110.121871			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20371605	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000277715900033
J	Lechardeur, D; Fernandez, A; Robert, B; Gaudu, P; Trieu-Cuot, P; Lamberet, G; Gruss, A				Lechardeur, Delphine; Fernandez, Annabelle; Robert, Bruno; Gaudu, Philippe; Trieu-Cuot, Patrick; Lamberet, Gilles; Gruss, Alexandra			The 2-Cys Peroxiredoxin Alkyl Hydroperoxide Reductase C Binds Heme and Participates in Its Intracellular Availability in Streptococcus agalactiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; RESPIRATION METABOLISM; REGULATORY MOTIFS; ESCHERICHIA-COLI; IRON ACQUISITION; OXIDATIVE STRESS; RESONANCE RAMAN; PROTEIN PHUS; GENE; DETOXIFICATION	Heme is a redox-reactive molecule with vital and complex roles in bacterial metabolism, survival, and virulence. However, few intracellular heme partners were identified to date and are not well conserved in bacteria. The opportunistic pathogen Streptococcus agalactiae (group B Streptococcus) is a heme auxotroph, which acquires exogenous heme to activate an aerobic respiratory chain. We identified the alkyl hydroperoxide reductase AhpC, a member of the highly conserved thiol-dependent 2-Cys peroxiredoxins, as a heme-binding protein. AhpC binds hemin with a K-d of 0.5 mu M and a 1: 1 stoichiometry. Mutagenesis of cysteines revealed that hemin binding is dissociable from catalytic activity and multimerization. AhpC reductase activity was unchanged upon interaction with heme in vitro and in vivo. A group B Streptococcus ahpC mutant displayed attenuation of two heme-dependent functions, respiration and activity of a heterologous catalase, suggesting a role for AhpC in heme intracellular fate. In support of this hypothesis, AhpC-bound hemin was protected from chemical degradation in vitro. Our results reveal for the first time a role for AhpC as a heme-binding protein.	[Lechardeur, Delphine; Fernandez, Annabelle; Gaudu, Philippe; Lamberet, Gilles; Gruss, Alexandra] INRA, Inst Micalis, UMR 1319, F-78352 Jouy En Josas, France; [Robert, Bruno] Commissariat Energie Atom, Inst Biol & Technol Saclay, CNRS, URA 2096, F-91400 Gif Sur Yvette, France; [Trieu-Cuot, Patrick] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, CNRS, URA 2172, F-75015 Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lechardeur, D (corresponding author), INRA, Inst Micalis, UMR 1319, Batiment 222, F-78352 Jouy En Josas, France.	delphine.lechardeur@jouy.inra.fr	GAUDU, Philippe/AAE-9696-2022; Robert, Bruno/D-1264-2012; GAUDU, Philippe/AFE-8376-2022	Robert, Bruno/0000-0001-5999-4538; Gruss, Alexandra/0000-0001-7426-5229; Lechardeur, Delphine/0000-0002-5331-4607; TRIEU-CUOT, Patrick/0000-0002-2768-9587	Agence Nationale de la Recherche, France	Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was supported in part by a grant for the "StrepRespire" Project from the Agence Nationale de la Recherche, France.	BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Clancy A, 2006, MOL MICROBIOL, V59, P707, DOI 10.1111/j.1365-2958.2005.04974.x; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Enggist E, 2003, J BACTERIOL, V185, P175, DOI 10.1128/JB.185.1.175-183.2003; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Frankenberg L, 2002, J BACTERIOL, V184, P6351, DOI 10.1128/JB.184.22.6351-6356.2002; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Gaillot O, 1997, GENE, V204, P213, DOI 10.1016/S0378-1119(97)00548-9; Grinberg LN, 1999, FREE RADICAL BIO MED, V27, P214, DOI 10.1016/S0891-5849(99)00082-9; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Immenschuh S, 1997, BIOCHEM BIOPH RES CO, V231, P667, DOI 10.1006/bbrc.1997.6166; IMMENSCHUH S, 1995, BIOCHEMISTRY-US, V34, P13407, DOI 10.1021/bi00041a018; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kaur AP, 2009, J BIOL CHEM, V284, P56, DOI 10.1074/jbc.M806068200; Kawazu S, 2005, FEBS J, V272, P1784, DOI 10.1111/j.1742-4658.2005.04611.x; KERY V, 1995, ARCH BIOCHEM BIOPHYS, V316, P24, DOI 10.1006/abbi.1995.1005; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; KITAGAWA T, 1977, BIOCHIM BIOPHYS ACTA, V495, P1, DOI 10.1016/0005-2795(77)90234-3; KREMER ML, 1989, EUR J BIOCHEM, V185, P651, DOI 10.1111/j.1432-1033.1989.tb15162.x; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Lechardeur D, 2004, J CELL BIOL, V167, P851, DOI 10.1083/jcb.200404105; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Moore R W, 1978, Methods Enzymol, V52, P324; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; MULLEREBERHARD U, 1985, BIOCHEM PHARMACOL, V34, P719, DOI 10.1016/0006-2952(85)90749-X; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; Obinger C, 1997, ARCH BIOCHEM BIOPHYS, V342, P58, DOI 10.1006/abbi.1997.9988; OTHMAN S, 1994, BIOCHEMISTRY-US, V33, P15437, DOI 10.1021/bi00255a026; Perally S, 2008, J PROTEOME RES, V7, P4557, DOI 10.1021/pr800395x; POOLE RK, 1993, MOL MICROBIOL, V10, P421, DOI 10.1111/j.1365-2958.1993.tb02673.x; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Rochat T, 2005, MICROBIOL-SGM, V151, P3011, DOI 10.1099/mic.0.27861-0; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Schneider S, 2006, J BIOL CHEM, V281, P32606, DOI 10.1074/jbc.M607516200; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Smalley JW, 2001, CLIN DIAGN LAB IMMUN, V8, P509, DOI 10.1128/CDLI.8.3.509-514.2001; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Sutak R, 2008, TRENDS MICROBIOL, V16, P261, DOI 10.1016/j.tim.2008.03.005; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Tong Y, 2007, J BIOL INORG CHEM, V12, P735, DOI 10.1007/s00775-007-0226-x; TRIEUCUOT P, 1983, GENE, V23, P331, DOI 10.1016/0378-1119(83)90022-7; Uchida T, 2004, J BIOL CHEM, V279, P51981, DOI 10.1074/jbc.M408963200; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wang G, 2004, J BIOL CHEM, V279, P51908, DOI 10.1074/jbc.M408450200; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2001, ARCH BIOCHEM BIOPHYS, V387, P137, DOI 10.1006/abbi.2000.2250; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Winstedt L, 2000, J BACTERIOL, V182, P3863, DOI 10.1128/JB.182.13.3863-3866.2000; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	70	39	43	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16032	16041		10.1074/jbc.M109.024505	http://dx.doi.org/10.1074/jbc.M109.024505			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332091	Green Published, hybrid			2022-12-27	WOS:000277715900041
J	Wang, YJ; Solt, LA; Burris, TP				Wang, Yongjun; Solt, Laura A.; Burris, Thomas P.			Regulation of FGF21 Expression and Secretion by Retinoic Acid Receptor-related Orphan Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV-ERB-ALPHA; FIBROBLAST GROWTH FACTOR-21; FACTOR-BINDING SITES; ROR-ALPHA; NUCLEAR RECEPTOR; PPAR-ALPHA; GENE-EXPRESSION; CIRCADIAN TRANSCRIPTION; METABOLIC REGULATOR; LIPID-METABOLISM	Fibroblast growth factor 21 (FGF21) is a hormone produced by fat and the liver that plays an important role in lipid metabolism. FGF21 expression is induced by peroxisome proliferator-actived receptor alpha in response to physiological conditions requiring increased fatty acid oxidation. Retinoic acid receptor-related receptor alpha (ROR alpha) is another nuclear receptor that plays a critical role in lipid metabolism as well as in regulation of the circadian rhythm. In this study we demonstrate that ROR alpha directly regulates the expression and secretion of FGF21. A canonical ROR response element was identified in the proximal promoter of the FGF21 gene and shown to exhibit functional activity. Overexpression of ROR alpha in HepG2 cells resulted in increased expression and secretion of FGF21. Suppression of ROR alpha expression caused a decrease in FGF21 expression and secretion, suggesting that ROR alpha contributes to the basal expression of FGF21. These data suggest that one mechanism by which ROR alpha regulates lipid metabolism may be by modulation of FGF21 secretion. Furthermore, this study identifies a clear link between ROR alpha, a key regulator of the mammalian clock, and FGF21, an important hormone regulating glucose and lipid homeostasis.	[Wang, Yongjun; Solt, Laura A.; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute	Burris, TP (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	tburris@scripps.edu	Burris, Thomas P/B-3886-2016; Burris, Thomas/H-5078-2011	Burris, Thomas P/0000-0003-2922-4449; 	National Institutes of Health [DK080201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080201 ( to T. P. B.).	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; CARLBERG C, 1994, MOL ENDOCRINOL, V8, P757, DOI 10.1210/me.8.6.757; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, BIODRUGS, V22, P37, DOI 10.2165/00063030-200822010-00004; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; KNUTSSON A, 1988, SCAND J WORK ENV HEA, V14, P317, DOI 10.5271/sjweh.1913; KNUTSSON A, 1986, LANCET, V2, P89; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Mamontova A, 1998, CIRCULATION, V98, P2738, DOI 10.1161/01.CIR.98.24.2738; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Oishi K, 2008, FEBS LETT, V582, P3639, DOI 10.1016/j.febslet.2008.09.046; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Raspe E, 2001, J BIOL CHEM, V276, P2865, DOI 10.1074/jbc.M004982200; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; VuDac N, 1997, J BIOL CHEM, V272, P22401, DOI 10.1074/jbc.272.36.22401; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	44	85	91	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15668	15673		10.1074/jbc.M110.102160	http://dx.doi.org/10.1074/jbc.M110.102160			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332535	Green Published, hybrid			2022-12-27	WOS:000277715900002
J	Ullrich, S; Munch, A; Neumann, S; Kremmer, E; Tatzelt, J; Lichtenthaler, SF				Ullrich, Sylvia; Muench, Anna; Neumann, Stephanie; Kremmer, Elisabeth; Tatzelt, Joerg; Lichtenthaler, Stefan F.			The Novel Membrane Protein TMEM59 Modulates Complex Glycosylation, Cell Surface Expression, and Secretion of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; ALPHA-SECRETASE; BETA-SECRETASE; INTRAMEMBRANE PROTEOLYSIS; MEDIATED ENDOCYTOSIS; CONVERTING-ENZYME; CLEAVING ENZYME	Ectodomain shedding of the amyloid precursor protein (APP) by the two proteases alpha- and beta-secretase is a key regulatory event in the generation of the Alzheimer disease amyloid beta peptide (A beta). At present, little is known about the cellular mechanisms that control APP shedding and A beta generation. Here, we identified a novel protein, transmembrane protein 59 (TMEM59), as a new modulator of APP shedding. TMEM59 was found to be a ubiquitously expressed, Golgi-localized protein. TMEM59 transfection inhibited complex N- and O-glycosylation of APP in cultured cells. Additionally, TMEM59 induced APP retention in the Golgi and inhibited A beta generation as well as APP cleavage by alpha- and beta-secretase cleavage, which occur at the plasma membrane and in the endosomes, respectively. Moreover, TMEM59 inhibited the complex N-glycosylation of the prion protein, suggesting a more general modulation of Golgi glycosylation reactions. Importantly, TMEM59 did not affect the secretion of soluble proteins or the alpha-secretase like shedding of tumor necrosis factor alpha, demonstrating that TMEM59 did not disturb the general Golgi function. The phenotype of TMEM59 transfection on APP glycosylation and shedding was similar to the one observed in cells lacking conserved oligomeric Golgi (COG) proteins COG1 and COG2. Both proteins are required for normal localization and activity of Golgi glycosylation enzymes. In summary, this study shows that TMEM59 expression modulates complex N-and O-glycosylation and suggests that TMEM59 affects APP shedding by reducing access of APP to the cellular compartments, where it is normally cleaved by alpha- and beta-secretase.	[Ullrich, Sylvia; Muench, Anna; Neumann, Stephanie; Tatzelt, Joerg; Lichtenthaler, Stefan F.] Univ Munich, German Ctr Neurodegenerat Dis Munich DZNE, D-80336 Munich, Germany; [Ullrich, Sylvia; Muench, Anna; Neumann, Stephanie; Tatzelt, Joerg; Lichtenthaler, Stefan F.] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lichtenthaler, SF (corresponding author), Univ Munich, German Ctr Neurodegenerat Dis Munich DZNE, D-80336 Munich, Germany.	Stefan.Lichtenthaler@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft [SFB596, B12, B4, Z2]; Bundesministerium fur Bildung und Forschung; European Commission (NeuroNE); Friedrich-Baur-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Commission (NeuroNE)(European CommissionEuropean Commission Joint Research Centre); Friedrich-Baur-Stiftung	This work was supported by grants from Deutsche Forschungsgemeinschaft SFB596 Projects B12 (to S. F. L.), B4 (to J. T.), and Z2 (to E. K.), the competence network degenerative dementias (Bundesministerium fur Bildung und Forschung) (to S. F. L.), the European Commission (NeuroNE), and the Friedrich-Baur-Stiftung (to S. F. L.).	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Breen KC, 1998, MOL NEUROBIOL, V16, P163, DOI 10.1007/BF02740643; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Chatterton JE, 1999, P NATL ACAD SCI USA, V96, P915, DOI 10.1073/pnas.96.3.915; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Cisse MA, 2006, BIOCHEM BIOPH RES CO, V347, P254, DOI 10.1016/j.bbrc.2006.06.065; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Elson GCA, 1999, BIOCHEM BIOPH RES CO, V264, P55, DOI 10.1006/bbrc.1999.1481; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Gleeson PA, 1996, J CELL SCI, V109, P2811; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lefranc-Jullien S, 2005, BRIT J PHARMACOL, V145, P228, DOI 10.1038/sj.bjp.0706183; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 2006, NEURODEGENER DIS, V3, P262, DOI 10.1159/000095265; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; LINSTEDT AD, 1995, P NATL ACAD SCI USA, V92, P5102, DOI 10.1073/pnas.92.11.5102; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; MAGUIRE TM, 1995, DEMENTIA, V6, P185, DOI 10.1159/000106944; McFarlane I, 1999, NEUROSCIENCE, V90, P15, DOI 10.1016/S0306-4522(98)00361-3; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Nakagawa K, 2006, J NEUROCHEM, V96, P924, DOI 10.1111/j.1471-4159.2005.03595.x; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Oka T, 2005, J BIOCHEM, V137, P109, DOI 10.1093/jb/mvi024; Okita C, 2004, BIOTECHNIQUES, V36, P418, DOI 10.2144/04363ST01; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; PAHLSSON P, 1992, BIOCHEM BIOPH RES CO, V189, P1667, DOI 10.1016/0006-291X(92)90269-Q; Pahlsson P, 1996, ARCH BIOCHEM BIOPHYS, V331, P177, DOI 10.1006/abbi.1996.0296; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schobel S, 2006, INT J DEV NEUROSCI, V24, P141, DOI 10.1016/j.ijdevneu.2005.11.003; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Slack BE, 2001, BIOCHEM J, V357, P787, DOI 10.1042/0264-6021:3570787; Smith RD, 2008, CARBOHYD RES, V343, P2024, DOI 10.1016/j.carres.2008.01.034; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Sugiura H, 2004, J BIOL CHEM, V279, P23343, DOI 10.1074/jbc.M312607200; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Waldron E, 2008, NEUROBIOL DIS, V31, P188, DOI 10.1016/j.nbd.2008.04.006; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yazaki M, 1996, NEUROSCI LETT, V221, P57, DOI 10.1016/S0304-3940(96)13285-7; Zeevaert R, 2008, MOL GENET METAB, V93, P15, DOI 10.1016/j.ymgme.2007.08.118	72	53	63	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20664	20674		10.1074/jbc.M109.055608	http://dx.doi.org/10.1074/jbc.M109.055608			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427278	hybrid, Green Published			2022-12-27	WOS:000279228600030
J	Gomez-Mejiba, SE; Zhai, Z; Gimenez, MS; Ashby, MT; Chilakapati, J; Kitchin, K; Mason, RP; Ramirez, DC				Gomez-Mejiba, Sandra E.; Zhai, Zili; Gimenez, Maria S.; Ashby, Michael T.; Chilakapati, Jaya; Kitchin, Kirk; Mason, Ronald P.; Ramirez, Dario C.			Myeloperoxidase-induced Genomic DNA-centered Radicals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSOLUTE RATE CONSTANTS; HYPOCHLOROUS ACID; HUMAN-NEUTROPHILS; REACTIVE OXYGEN; RESPIRATORY BURST; RESVERATROL; DAMAGE; CARCINOGENESIS; INFLAMMATION; PROTEIN	Myeloperoxidase (MPO) released by activated neutrophils can initiate and promote carcinogenesis. MPO produces hypochlorous acid (HOCl) that oxidizes the genomic DNA in inflammatory cells as well as in surrounding epithelial cells. DNA-centered radicals are early intermediates formed during DNA oxidation. Once formed, DNA-centered radicals decay by mechanisms that are not completely understood, producing a number of oxidation products that are studied as markers of DNA oxidation. In this study we employed the 5,5-dimethyl-1-pyrroline N-oxide-based immuno-spin trapping technique to investigate the MPO-triggered formation of DNA-centered radicals in inflammatory and epithelial cells and to test whether resveratrol blocks HOCl-induced DNA-centered radical formation in these cells. We found that HOCl added exogenously or generated intracellularly by MPO that has been taken up by the cell or by MPO newly synthesized produces DNA-centered radicals inside cells. We also found that resveratrol passed across cell membranes and scavenged HOCl before it reacted with the genomic DNA, thus blocking DNA-centered radical formation. Taken together our results indicate that the formation of DNA-centered radicals by intracellular MPO may be a useful point of therapeutic intervention in inflammation-induced carcinogenesis.	[Gomez-Mejiba, Sandra E.; Zhai, Zili; Ramirez, Dario C.] Oklahoma Med Res Fdn, Expt Therapeut Res Program, Oklahoma City, OK 73104 USA; [Gimenez, Maria S.] Univ Nacl San Luis, Inst Multidisciplinario Invest Biol, Consejo Nacl Invest Cient & Tecn, RA-5700 San Luis, Argentina; [Ashby, Michael T.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Mason, Ronald P.] NIEHS, Pharmacol Lab, NIH, Res Triangle Pk, NC 27709 USA	Oklahoma Medical Research Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis; University of Oklahoma System; University of Oklahoma - Norman; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Gomez-Mejiba, SE (corresponding author), Oklahoma Med Res Fdn, Expt Therapeut Res Program, Oklahoma City, OK 73104 USA.	sandra-gomez-mejiba@omrf.org; dario-ramirez@omrf.org	Mason, Ronald P/G-5967-2019; RAMIREZ, DARIO C/K-3312-2013	Mason, Ronald P/0000-0002-1859-9109; RAMIREZ, DARIO C/0000-0001-6725-3326; GOMEZ MEJIBA, SANDRA/0000-0002-8515-0483; Gimenez, Maria Sofia/0000-0003-1312-0661; Zhai, Zili/0000-0001-5164-3696	National Institutes of Health [5R00ES015415-03]; Presbyterian Health Foundation; Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015415, ZIAES050139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Presbyterian Health Foundation; Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R00ES015415-03 (NIEHS). This work was also supported by a start-up grant from the Presbyterian Health Foundation and Oklahoma Medical Research Foundation (to D.C.R.).	Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; BABIOR BM, 1988, HEMATOL ONCOL CLIN N, V2, P201, DOI 10.1016/S0889-8588(18)30615-4; BERNOFSKY C, 1990, FREE RADICAL BIO MED, V8, P231, DOI 10.1016/0891-5849(90)90068-T; BILZER M, 1991, EUR J CLIN INVEST, V21, P316, DOI 10.1111/j.1365-2362.1991.tb01376.x; Birrell MA, 2005, FASEB J, V19, P840, DOI 10.1096/fj.04-2691fje; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1; Cheson Bruce D, 2009, Clin Adv Hematol Oncol, V7, P142; Dunforb HB, 1999, HEME PEROXIDASES, P349; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; Gomez-Mejiba SE, 2009, FREE RADICAL BIO MED, V46, P853, DOI 10.1016/j.freeradbiomed.2008.12.020; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Gungor N, 2010, MUTAGENESIS, V25, P149, DOI 10.1093/mutage/gep053; Hawkins CL, 2002, CHEM RES TOXICOL, V15, P83, DOI 10.1021/tx015548d; HENSLEY KL, 1999, Patent No. 1999059561; JANZEN EG, 1984, METHOD ENZYMOL, V105, P188; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; Knaapen AM, 2006, MUTAGENESIS, V21, P225, DOI 10.1093/mutage/gel032; Knaapen AM, 1999, FREE RADICAL BIO MED, V27, P234, DOI 10.1016/S0891-5849(98)00285-8; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; MURAO S, 1988, P NATL ACAD SCI USA, V85, P1232, DOI 10.1073/pnas.85.4.1232; Nagy P, 2007, CHEM RES TOXICOL, V20, P79, DOI 10.1021/tx060184g; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; NAUSEEF WM, 1983, BLOOD, V61, P483; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Park DW, 2009, EXP MOL MED, V41, P171, DOI 10.3858/emm.2009.41.3.020; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Pattison DI, 2002, J CHEM SOC PERK T 2, P1461, DOI 10.1039/b202526d; Prutz WA, 1996, ARCH BIOCHEM BIOPHYS, V332, P110, DOI 10.1006/abbi.1996.0322; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Ramirez DC, 2007, NAT PROTOC, V2, P512, DOI 10.1038/nprot.2007.5; Ramirez DC, 2006, NAT METHODS, V3, P123, DOI 10.1038/NMETH852; Sengottuvelan M, 2009, CHEM-BIOL INTERACT, V181, P193, DOI 10.1016/j.cbi.2009.06.004; Shen ZZ, 2000, BIOCHEMISTRY-US, V39, P5474, DOI 10.1021/bi992809y; Szewczuk LM, 2004, J BIOL CHEM, V279, P22727, DOI 10.1074/jbc.M314302200; WASHKO P, 1989, J BIOL CHEM, V264, P18996; WEITZMAN SA, 1981, SCIENCE, V212, P546, DOI 10.1126/science.6259738; WEITZMAN SA, 1985, SCIENCE, V227, P1231, DOI 10.1126/science.3975611; WEITZMAN SA, 1990, BLOOD, V76, P655; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85	46	67	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20062	20071		10.1074/jbc.M109.086579	http://dx.doi.org/10.1074/jbc.M109.086579			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406811	Green Published, hybrid			2022-12-27	WOS:000279012000040
J	Miki, H; Zhou, Z; Li, M; Hwang, TC; Bompadre, SG				Miki, Haruna; Zhou, Zhen; Li, Min; Hwang, Tzyh-Chang; Bompadre, Silvia G.			Potentiation of Disease-associated Cystic Fibrosis Transmembrane Conductance Regulator Mutants by Hydrolyzable ATP Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; CFTR CHLORIDE CHANNEL; DELTA-F508 MUTATION; AIRWAY EPITHELIA; PLASMA-MEMBRANE; CASSETTE DIMER; WILD-TYPE; PROTEIN; PHOSPHORYLATION; HYDROLYSIS	The cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel belonging to the ATP-binding cassette transporter superfamily. CFTR is gated by ATP binding and hydrolysis at its two nucleotide-binding domains (NBDs), which dimerize in the presence of ATP to form two ATP-binding pockets (ABP1 and ABP2). Mutations reducing the activity of CFTR result in the genetic disease cystic fibrosis. Two of the most common mutations causing a severe phenotype are G551D and Delta F508. Previously we found that the ATP analog N-6-(2-phenylethyl)-ATP (P-ATP) potentiates the activity of G551D by similar to 7-fold. Here we show that 2'-deoxy-ATP (dATP), but not 3'-deoxy-ATP, increases the activity of G551D-CFTR by similar to 8-fold. We custom synthesized N-6-(2-phenylethyl)-2'-deoxy-ATP (P-dATP), an analog combining the chemical modifications in dATP and P-ATP. This new analog enhances G551D current by 36.2 +/- 5.4-fold suggesting an independent but energetically additive action of these two different chemical modifications. We show that P-dATP binds to ABP1 to potentiate the activity of G551D, and mutations in both sides of ABP1 (W401G and S1347G) decrease its potentiation effect, suggesting that the action of P-dATP takes place at the interface of both NBDs. Interestingly, P-dATP completely rectified the gating abnormality of Delta F508-CFTR by increasing its activity by 19.5 +/- 3.8-fold through binding to both ABPs. This result highlights the severity of the gating defect associated with Delta F508, the most prevalent disease-associated mutation. The new analog P-dATP can be not only an invaluable tool to study CFTR gating, but it can also serve as a proof-of-principle that, by combining elements that potentiate the channel activity independently, the increase in chloride transport necessary to reach a therapeutic target is attainable.	[Miki, Haruna; Zhou, Zhen; Li, Min; Hwang, Tzyh-Chang; Bompadre, Silvia G.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Hwang, Tzyh-Chang] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Miki, Haruna] Osaka Univ Pharmaceut Sci, Osaka 5691094, Japan	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Osaka University of Pharmaceutical Sciences	Bompadre, SG (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, 134 Res Pk Dr, Columbia, MO 65211 USA.	bompadres@missouri.edu			National Institutes of Health [R01DK55835, R01HL53455, K01DK075408]; Cystic Fibrosis Foundation [BOMPAD06G0]; National Center for Research Resources, NIH [C06 RR-016489-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055835, K01DK075408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK55835, R01HL53455 (to T.-C.H.), and K01DK075408 (to S.G.B.). This work was also supported by the Cystic Fibrosis Foundation (Research Grant BOMPAD06G0 to S.G.B.). This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (Grant C06 RR-016489-01) from the National Center for Research Resources, NIH.	Aleksandrov AA, 2002, FEBS LETT, V518, P183, DOI 10.1016/S0014-5793(02)02698-4; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; CHENG SH, 1990, CELL, V65; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; GRAY MA, 1988, J MEMBRANE BIOL, V105, P131, DOI 10.1007/BF02009166; Haws CM, 1996, AM J PHYSIOL-CELL PH, V270, pC1544, DOI 10.1152/ajpcell.1996.270.5.C1544; Huang SY, 2009, J MOL GRAPH MODEL, V27, P822, DOI 10.1016/j.jmgm.2008.12.005; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; QUINTON PM, 1986, AM J PHYSIOL, V251, pC649, DOI 10.1152/ajpcell.1986.251.4.C649; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zhou Z, 2001, J PHYSIOL-LONDON, V532, P435, DOI 10.1111/j.1469-7793.2001.0435f.x; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	48	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19967	19975		10.1074/jbc.M109.092684	http://dx.doi.org/10.1074/jbc.M109.092684			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406820	Green Published, hybrid			2022-12-27	WOS:000279012000030
J	Ozawa, S; Onishi, T; Takahashi, Y				Ozawa, Shin-ichiro; Onishi, Takahito; Takahashi, Yuichiro			Identification and Characterization of an Assembly Intermediate Subcomplex of Photosystem I in the Green Alga Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; THYLAKOID MEMBRANE; ANGSTROM RESOLUTION; STATE TRANSITIONS; PROCESSING SITE; SUBUNIT-G; WILD-TYPE; PSI; CHLOROPLAST; PROTEIN	Photosystem I (PSI) is a multiprotein complex consisting of the PSI core and peripheral light-harvesting complex I (LHCI) that together form the PSI-LHCI supercomplex in algae and higher plants. The supercomplex is synthesized in steps during which 12-15 core and 4-9 LHCI subunits are assembled. Here we report the isolation of a PSI subcomplex that separated on a sucrose density gradient from the thylakoid membranes isolated from logarithmic growth phase cells of the green alga Chlamydomonas reinhardtii. Pulse-chase labeling of total cellular proteins revealed that the subcomplex was synthesized de novo within 1 min and was converted to the mature PSI-LHCI during the 2-h chase period, indicating that the subcomplex was an assembly intermediate. The subcomplex was functional; it photo-oxidized P700 and demonstrated electron transfer activity. The subcomplex lacked PsaK and PsaG, however, and it bound PsaF and PsaJ weakly and was not associated with LHCI. It seemed likely that LHCI had been integrated into the subcomplex unstably and was dissociated during solubilization and/or fractionation. We, thus, infer that PsaK and PsaG stabilize the association between PSI core and LHCI complexes and that PsaK and PsaG bind to the PSI core complex after the integration of LHCI in one of the last steps of PSI complex assembly.	[Ozawa, Shin-ichiro; Onishi, Takahito; Takahashi, Yuichiro] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Okayama University	Takahashi, Y (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Kita Ku, Okayama 7008530, Japan.	taka@cc.okayama-u.ac.jp	Ozawa, Shin-Ichiro/O-7408-2015; Takahashi, Yuichiro/B-2062-2011	Ozawa, Shin-Ichiro/0000-0001-7698-5350; Takahashi, Yuichiro/0000-0001-6410-0447	Japan Society for the Promotion of Science [18GSO318]; Japan Society for the Promotion of Science Research Fellowships [17003605]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science Research Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Japan Society for the Promotion of Science Grant-in-aid for General Research for Creative Scientific Research 18GSO318 (to Y.T.) and Japan Society for the Promotion of Science Research Fellowships for Young Scientists Grant 17003605 (to S.O.).	Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; CHUA NH, 1975, P NATL ACAD SCI USA, V72, P2175, DOI 10.1073/pnas.72.6.2175; During U, 2007, J BIOL CHEM, V282, P10915, DOI 10.1074/jbc.M609206200; FARAH J, 1995, EMBO J, V14, P4976, DOI 10.1002/j.1460-2075.1995.tb00180.x; Fischer N, 1999, BIOCHEMISTRY-US, V38, P5546, DOI 10.1021/bi982821a; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; GIRARDBASCOU J, 1987, CURR GENET, V12, P489, DOI 10.1007/BF00419557; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Haldrup A, 2000, J BIOL CHEM, V275, P31211, DOI 10.1074/jbc.M002933200; Hansson A, 2007, FEBS J, V274, P1734, DOI 10.1111/j.1742-4658.2007.05722.x; Hippler M, 2002, PROTIST, V153, P197, DOI 10.1078/1434-4610-00098; Hippler M, 1996, EMBO J, V15, P6374, DOI 10.1002/j.1460-2075.1996.tb01028.x; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Jensen PE, 2004, J BIOL CHEM, V279, P24212, DOI 10.1074/jbc.M403147200; Jensen PE, 2002, J BIOL CHEM, V277, P2798, DOI 10.1074/jbc.M110448200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; MANNAN RM, 1994, ARCH BIOCHEM BIOPHYS, V315, P68, DOI 10.1006/abbi.1994.1472; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Naver H, 2001, PLANT CELL, V13, P2731, DOI 10.1105/tpc.010253; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; NIELSEN VS, 1994, J BIOL CHEM, V269, P3762; Ohnishi N, 2001, J BIOL CHEM, V276, P33798, DOI 10.1074/jbc.M104454200; Onishi T, 2009, PLANT CELL PHYSIOL, V50, P1750, DOI 10.1093/pcp/pcp117; Ozawa S, 2009, PLANT CELL, V21, P2424, DOI 10.1105/tpc.108.063313; Rosgaard L, 2005, FEBS J, V272, P4002, DOI 10.1111/j.1742-4658.2005.04824.x; Schoettler Mark Aurel, 2008, V69, P89, DOI 10.1007/978-3-540-72954-9_4; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Sugimoto I, 2003, J BIOL CHEM, V278, P45004, DOI 10.1074/jbc.M307537200; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; TAKAHASHI Y, 1982, ARCH BIOCHEM BIOPHYS, V219, P209, DOI 10.1016/0003-9861(82)90151-5; TAKAHASHI Y, 1991, EMBO J, V10, P2033, DOI 10.1002/j.1460-2075.1991.tb07733.x; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Takahashi Y, 1996, PLANT CELL PHYSIOL, V37, P161, DOI 10.1093/oxfordjournals.pcp.a028927; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; Varotto C, 2002, PLANT PHYSIOL, V129, P616, DOI 10.1104/pp.002089; Wilde A, 2001, BIOCHEM J, V357, P211, DOI 10.1042/0264-6021:3570211; WILDE A, 1995, PLANT CELL, V7, P649, DOI 10.1105/tpc.7.5.649; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Wostrikoff K, 2004, EMBO J, V23, P2696, DOI 10.1038/sj.emboj.7600266; YU JP, 1995, PLANT MOL BIOL, V29, P331, DOI 10.1007/BF00043656	45	50	53	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20072	20079		10.1074/jbc.M109.098954	http://dx.doi.org/10.1074/jbc.M109.098954			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20413595	Green Published, hybrid			2022-12-27	WOS:000279012000041
J	Willoughby, D; Masada, N; Wachten, S; Pagano, M; Halls, ML; Everett, KL; Ciruela, A; Cooper, DMF				Willoughby, Debbie; Masada, Nanako; Wachten, Sebastian; Pagano, Mario; Halls, Michelle L.; Everett, Katy L.; Ciruela, Antonio; Cooper, Dermot M. F.			AKAP79/150 Interacts with AC8 and Regulates Ca2+-dependent cAMP Synthesis in Pancreatic and Neuronal Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CAPACITATIVE CA2+ ENTRY; NMDA RECEPTOR ACTIVATION; TYPE-8 ADENYLYL-CYCLASE; ENERGY-TRANSFER FRET; ANCHORING PROTEIN; BINDING-PROTEIN; MOUSE-BRAIN; CYCLIC-AMP; CELLS	Protein kinase A anchoring proteins (AKAPs) provide the backbone for targeted multimolecular signaling complexes that serve to localize the activities of cAMP. Evidence is accumulating of direct associations between AKAPs and specific adenylyl cyclase (AC) isoforms to facilitate the actions of protein kinase A on cAMP production. It happens that some of the AC isoforms (AC1 and AC5/6) that bind specific AKAPs are regulated by submicromolar shifts in intracellular Ca2+. However, whether AKAPs play a role in the control of AC activity by Ca2+ is unknown. Using a combination of co-immunoprecipitation and high resolution live cell imaging techniques, we reveal an association of the Ca2+-stimulable AC8 with AKAP79/150 that limits the sensitivity of AC8 to intracellular Ca2+ events. This functional interaction between AKAP79/150 and AC8 was observed in HEK293 cells overexpressing the two signaling molecules. Similar findings were made in pancreatic insulin-secreting cells and cultured hippocampal neurons that endogenously express AKAP79/150 and AC8, which suggests important physiological implications for this protein-protein interaction with respect to Ca2+-stimulated cAMP production.	[Willoughby, Debbie; Masada, Nanako; Wachten, Sebastian; Pagano, Mario; Halls, Michelle L.; Everett, Katy L.; Ciruela, Antonio; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk		Halls, Michelle/0000-0001-8555-8959	Wellcome Trust [RG31760]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant RG31760.; A Royal Society Wolfson Research Fellow.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; CARR DW, 1992, J BIOL CHEM, V267, P16816; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Conti AC, 2007, NEUROSCIENCE, V146, P713, DOI 10.1016/j.neuroscience.2007.01.045; Crossthwaite AJ, 2006, MOL PHARMACOL, V69, P608, DOI 10.1124/mol.105.018275; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Genin A, 2003, EUR J NEUROSCI, V17, P331, DOI 10.1046/j.1460-9568.2003.02462.x; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gu C, 2002, EUR J BIOCHEM, V269, P413, DOI 10.1046/j.0014-2956.2001.02708.x; Gu C, 1999, J BIOL CHEM, V274, P8012, DOI 10.1074/jbc.274.12.8012; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Nakahashi Y, 1997, J BIOL CHEM, V272, P18093, DOI 10.1074/jbc.272.29.18093; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Ostroveanu A, 2007, BRAIN RES, V1145, P97, DOI 10.1016/j.brainres.2007.01.117; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Simpson RE, 2006, J BIOL CHEM, V281, P17379, DOI 10.1074/jbc.M510992200; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Tu HP, 2004, J BIOL CHEM, V279, P19375, DOI 10.1074/jbc.M313476200; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Wang HB, 2003, J NEUROSCI, V23, P9710; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Willoughby D, 2002, J PHYSIOL-LONDON, V544, P487, DOI 10.1113/jphysiol.2002.027508; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Willoughby D, 2010, J CELL SCI, V123, P107, DOI 10.1242/jcs.062067; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Zhang M, 2008, J NEUROSCI, V28, P4736, DOI 10.1523/JNEUROSCI.1177-08.2008	49	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20328	20342		10.1074/jbc.M110.120725	http://dx.doi.org/10.1074/jbc.M110.120725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410303	Green Published, hybrid			2022-12-27	WOS:000279012000067
J	Chernov, AV; Baranovskaya, S; Golubkov, VS; Wakeman, DR; Snyder, EY; Williams, R; Strongin, AY				Chernov, Andrei V.; Baranovskaya, Svetlana; Golubkov, Vladislav S.; Wakeman, Dustin R.; Snyder, Evan Y.; Williams, Roy; Strongin, Alex Y.			Microarray-based Transcriptional and Epigenetic Profiling of Matrix Metalloproteinases, Collagens, and Related Genes in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3; LYSINE-9 METHYLATION; TISSUE INHIBITOR; CELL-MIGRATION; GROWTH-FACTOR; GLIOMA; EXPRESSION; SUPPRESSION; RECOGNITION; ACTIVATION	Epigenetic parameters (DNA methylation, histone modifications, and miRNAs) play a significant role in cancer. To identify the common epigenetic signatures of both the individual matrix metalloproteinases (MMPs) and the additional genes, the function of which is also linked to proteolysis, migration, and tumorigenesis, we performed epigenetic profiling of 486 selected genes in unrelated non-migratory MCF-7 breast carcinoma and highly migratory U251 glioma cells. Genome-wide transcriptional profiling, quantitative reverse transcription-PCR, and microRNA analyses were used to support the results of our epigenetic studies. Transcriptional silencing in both glioma and breast carcinoma cells predominantly involved the repressive histone H3 Lys-27 trimethylation (H3K27me3) mark. In turn, epigenetic stimulation was primarily performed through a gain in the histone H3 Lys-4 dimethylation (H3K4me2) and H3 hyperacetylation and by a global reduction of H3K27me3. Inactive pro-invasive genes in MCF-7 cells but not in U251 cells frequently exhibited a stem cell-like bivalent mark (enrichment in both H3K27me3 and H3K4me2), a characteristic of developmental genes. In contrast with other MMPs, MMP-8 was epigenetically silenced in both cell types, thus providing evidence for the strict epigenetic control of this anti-tumorigenic proteinase in cancer. Epigenetic stimulation of multiple collagen genes observed in cultured glioma cells was then directly confirmed using orthotopic xenografts and tumor specimens. We suggest that the epigenetic mechanisms allow gliomas to deposit an invasion-promoting collagen-enriched matrix and then to use this matrix to accomplish their rapid migration through the brain tissue.	[Chernov, Andrei V.; Golubkov, Vladislav S.; Wakeman, Dustin R.; Snyder, Evan Y.; Williams, Roy; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Baranovskaya, Svetlana] Agilent Technol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Agilent Technologies	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, N Torrey Pines Rd, La Jolla, CA 92037 USA.	strongin@burnham.org	Chernov, Andrei/I-1623-2019; Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016; Williams, Roy/0000-0002-5442-9166	NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER; NCI NIH HHS [CA77470, R01 CA077470, R01 CA083017, CA83017] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034; Chernov AV, 2009, J BIOL CHEM, V284, P12727, DOI 10.1074/jbc.M900273200; Chicoine E, 2002, BIOCHEM BIOPH RES CO, V297, P765, DOI 10.1016/S0006-291X(02)02283-0; Clark IM, 2007, FRONT BIOSCI, V12, P528, DOI 10.2741/2079; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Deryugina EI, 2002, CANCER RES, V62, P580; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Hau P, 2009, EXPERT REV ANTICANC, V9, P1663, DOI [10.1586/era.09.138, 10.1586/ERA.09.138]; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kassiri Z, 2009, J BIOL CHEM, V284, P29893, DOI 10.1074/jbc.M109.028449; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LEVY A, 1992, GENOMICS, V13, P881, DOI 10.1016/0888-7543(92)90175-R; Lingel A, 2005, CURR OPIN STRUC BIOL, V15, P107, DOI 10.1016/j.sbi.2005.01.010; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; Nacu N, 2008, J IMMUNOL, V180, P5036, DOI 10.4049/jimmunol.180.7.5036; Nagase H, 1997, BIOL CHEM, V378, P151; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Novakova J, 2009, BIOCHEM BIOPH RES CO, V386, P1, DOI 10.1016/j.bbrc.2009.06.034; Okano K, 2006, J BIOL CHEM, V281, P26196, DOI 10.1074/jbc.M606710200; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rozen S, 2000, Methods Mol Biol, V132, P365; Shelton L, 2009, INVEST OPHTH VIS SCI, V50, P3542, DOI 10.1167/iovs.09-3460; Shi L, 2010, BRAIN RES, V1312, P120, DOI 10.1016/j.brainres.2009.11.056; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Watson JA, 2009, HUM MOL GENET, V18, P3594, DOI 10.1093/hmg/ddp307; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zhang CZ, 2009, INT J ONCOL, V34, P1653, DOI 10.3892/ijo_00000296; Zhang JX, 2010, INT J ONCOL, V36, P913, DOI 10.3892/ijo_00000570; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	61	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19647	19659		10.1074/jbc.M109.088153	http://dx.doi.org/10.1074/jbc.M109.088153			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404328	hybrid, Green Published			2022-12-27	WOS:000278727800074
J	Dick, O; Bading, H				Dick, Oliver; Bading, Hilmar			Synaptic Activity and Nuclear Calcium Signaling Protect Hippocampal Neurons from Death Signal-associated Nuclear Translocation of FoxO3a Induced by Extrasynaptic N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; ACTIVITY-DEPENDENT NEUROPROTECTION; DUAL-SPECIFICITY PHOSPHATASES; GENE-EXPRESSION; KINASE-IV; OXIDATIVE STRESS; RESPONSE ELEMENT; CELL-SURVIVAL; ACTIVATION; PATHWAY	Synaptic activity and the generation of nuclear calcium signals promote neuronal survival through a transcription-dependent process that is not fully understood. Here we show that one mechanism of activity-induced acquired neuroprotection involves the Forkhead transcription factor, FoxO3a, which is known to induce genomic death responses upon translocation from the cytosol to the nucleus. Depletion of endogenous FoxO3a using RNA interference renders hippocampal neurons more resistant to excitotoxic cell death. Using a FoxO3a-green fluorescent protein (GFP) fusion protein to monitor in real time the localization of FoxO3a in hippocampal neurons, we found that several cell death inducing stimuli, including the stimulation of extrasynaptic N-methyl-D-aspartate receptors, growth factor withdrawal, and oxygen-glucose deprivation, caused a swift translocation of FoxO3a-GFP from the cytosol to the cell nucleus. This translocation was inhibited in hippocampal neurons that had undergone prolonged periods of synaptic activity before exposure to cell death-inducing conditions. The activity-dependent protection from death signal-induced FoxO3a-GFP nuclear translocation required synaptic N-methyl-D-aspartate receptor activation and was dependent on nuclear calcium signaling and calcium/calmodulin-dependent protein kinase IV. The modulation of nucleo-cytoplasmic shuttling of FoxO3a may represent one mechanism through which nuclear calcium-induced genomic responses affect cell death processes.	[Dick, Oliver; Bading, Hilmar] Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci IZN, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bading, H (corresponding author), Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	hilmar.bading@uni-hd.de			Alexander von Humboldt Foundation; European Union; Sonderforschungsbereich (SFB) 488; European Research Council	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Union(European Commission); Sonderforschungsbereich (SFB) 488(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Alexander von Humboldt Foundation (Wolfgang-Paul Prize (to H. B.), European Union Project GRIPANNT, the European Union Network of Excellence NeuroNE, the Sonderforschungsbereich (SFB) 488, and an European Research Council Advanced Grant (to H. B.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Al-Mubarak B, 2009, CHANNELS, V3, P233; Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Bengtson CP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-11; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chong ZZ, 2007, BRIT J PHARMACOL, V150, P839, DOI 10.1038/sj.bjp.0707161; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Davila D, 2008, MOL BIOL CELL, V19, P2014, DOI 10.1091/mbc.E07-08-0811; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Eder A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-57; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mattila J, 2008, P NATL ACAD SCI USA, V105, P14873, DOI 10.1073/pnas.0803022105; Means AR, 1997, RECENT PROG HORM RES, V52, P389; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; Won CK, 2006, NEUROSCI LETT, V398, P39, DOI 10.1016/j.neulet.2005.12.060; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	60	65	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19354	19361		10.1074/jbc.M110.127654	http://dx.doi.org/10.1074/jbc.M110.127654			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404335	Green Published, hybrid			2022-12-27	WOS:000278727800046
J	Finzi, L; Dunlap, DD				Finzi, Laura; Dunlap, David D.			Single-molecule Approaches to Probe the Structure, Kinetics, and Thermodynamics of Nucleoprotein Complexes That Regulate Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INTEGRATION HOST FACTOR; TETHERED PARTICLE MOTION; ATOMIC-FORCE MICROSCOPY; OPERATOR DNA; BACTERIOPHAGE-LAMBDA; MAGNETIC TWEEZERS; ESCHERICHIA-COLI; OPTICAL TWEEZERS; RNA-POLYMERASE; REPRESSOR	Single-molecule experimentation has contributed significantly to our understanding of the mechanics of nucleoprotein complexes that regulate epigenetic switches. In this minireview, we will discuss the application of the tethered-particle motion technique, magnetic tweezers, and atomic force microscopy to (i) directly visualize and thermodynamically characterize DNA loops induced by the lac, gal, and lambda repressors and (ii) understand the mechanistic role of DNA-supercoiling and DNA-bending cofactors in both prokaryotic and eukaryotic systems.	[Finzi, Laura] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Dunlap, David D.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Finzi, L (corresponding author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.	lfinzi@physics.emory.edu			National Institutes of Health [RGM084070A]; Italian Funding of Basic Research (FIRB); Human Frontier Science Program; Emory University Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Funding of Basic Research (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Human Frontier Science Program(Human Frontier Science Program); Emory University Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RGM084070A (to L. F.). This work was also supported by the Italian Funding of Basic Research (FIRB) (to L. F. and D. D. D.), the Human Frontier Science Program, and the Emory University Research Council. This is the third article in the Thematic Minireview Series on Single-molecule Measurements in Biochemistry and Molecular Biology. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	ADHYA S, 1993, GENE, V132, P1, DOI 10.1016/0378-1119(93)90507-Y; Aki T, 1996, GENES CELLS, V1, P179, DOI 10.1046/j.1365-2443.1996.d01-236.x; Aki T, 1997, EMBO J, V16, P3666, DOI 10.1093/emboj/16.12.3666; Anderson LM, 2008, P NATL ACAD SCI USA, V105, P5827, DOI 10.1073/pnas.0705570105; Beausang JF, 2007, BIOPHYS J, V92, pL64, DOI 10.1529/biophysj.107.104828; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Blumberg S, 2005, BIOPHYS J, V89, P1272, DOI 10.1529/biophysj.105.061242; Braslavsky I, 2001, APPL OPTICS, V40, P5650, DOI 10.1364/AO.40.005650; BUSTAMANTE C, 1994, CURR OPIN STRUC BIOL, V4, P750, DOI 10.1016/S0959-440X(94)90175-9; Chen YF, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048301; Chen YF, 2009, BIOPHYS J, V96, P4701, DOI 10.1016/j.bpj.2009.03.009; CLAVERIEMARTIN F, 1991, P NATL ACAD SCI USA, V88, P1631, DOI 10.1073/pnas.88.5.1631; Dietrich HRC, 2009, J NANOPHOTONICS, V3, DOI 10.1117/1.3174445; DIETRICH HR, 2007, P SPIE, V6444; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; DUNLAP D, 2010, SINGLE MOL ANAL METH; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; FREUNDLICH M, 1992, MOL MICROBIOL, V6, P2557, DOI 10.1111/j.1365-2958.1992.tb01432.x; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Goosen N, 1996, METHOD ENZYMOL, V274, P32; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Guerra RF, 2007, BIOPHYS J, V93, P176, DOI 10.1529/biophysj.106.099929; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; HOOVER TR, 1990, CELL, V63, P11, DOI 10.1016/0092-8674(90)90284-L; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lia G, 2003, P NATL ACAD SCI USA, V100, P11373, DOI 10.1073/pnas.2034851100; Lia G, 2008, NUCLEIC ACIDS RES, V36, P4204, DOI 10.1093/nar/gkn389; Lia G, 2008, J BIOPHOTONICS, V1, P280, DOI 10.1002/jbio.200810027; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; MANZO C, 2010, METHODS ENZ IN PRESS; MOSSING MC, 1986, SCIENCE, V233, P889, DOI 10.1126/science.3090685; Nash Howard A., 1996, P149; Nelson PC, 2006, J PHYS CHEM B, V110, P17260, DOI 10.1021/jp0630673; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Ptashne M, 2004, GENETIC SWITCH PHAGE; Qian H, 2000, J MATH BIOL, V41, P331, DOI 10.1007/s002850000055; Segall DE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088306; Semsey S, 2005, TRENDS BIOCHEM SCI, V30, P334, DOI 10.1016/j.tibs.2005.04.009; Semsey S, 2004, GENE DEV, V18, P1898, DOI 10.1101/gad.1209404; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; TRAVERS A, 1997, CURR BIOL, V7, P252; Tsodikov OV, 1999, J MOL BIOL, V294, P639, DOI 10.1006/jmbi.1999.3283; WERNER MH, 1995, BIOCHEMISTRY-US, V34, P11998, DOI 10.1021/bi00037a042; WHITSON PA, 1986, BIOCHEMISTRY-US, V25, P3852, DOI 10.1021/bi00361a017; WHITSON PA, 1986, BIOCHEMISTRY-US, V25, P3845, DOI 10.1021/bi00361a016; Wong OK, 2008, PLOS BIOL, V6, P2028, DOI 10.1371/journal.pbio.0060232; Yamamoto D, 2009, BIOPHYS J, V97, P2358, DOI 10.1016/j.bpj.2009.07.046; Zhang HY, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031916; Zurla C, 2006, J PHYS-CONDENS MAT, V18, pS225, DOI 10.1088/0953-8984/18/14/S07; Zurla C, 2007, BIOPHYS CHEM, V128, P245, DOI 10.1016/j.bpc.2007.04.012; Zurla C, 2009, NUCLEIC ACIDS RES, V37, P2789, DOI 10.1093/nar/gkp134	57	22	22	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18973	18978		10.1074/jbc.R109.062612	http://dx.doi.org/10.1074/jbc.R109.062612			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382734	hybrid, Green Published			2022-12-27	WOS:000278727800004
J	Hirota, S; Tanaka, N; Micetic, I; Di Muro, P; Nagao, S; Kitagishi, H; Kano, K; Magliozzo, RS; Peisach, J; Beltramini, M; Bubacco, L				Hirota, Shun; Tanaka, Naoki; Micetic, Ivan; Di Muro, Paolo; Nagao, Satoshi; Kitagishi, Hiroaki; Kano, Koji; Magliozzo, Richard S.; Peisach, Jack; Beltramini, Mariano; Bubacco, Luigi			Structural Basis of the Lactate-dependent Allosteric Regulation of Oxygen Binding in Arthropod Hemocyanin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALLINECTES-SAPIDUS HEMOCYANIN; CARCINUS-MAENAS HEMOCYANIN; CRYSTAL-STRUCTURE; RESOLUTION; MECHANISM; SCATTERING; TRANSPORT; PROTONS; O-2	Hemocyanin (Hc) is an oxygen carrier protein in which oxygen binding is regulated by allosteric effectors such as H+ and L-lactate. Isothermal titration calorimetric measurements showed that L-lactate binds to dodecameric and heterohexameric Hc and to the CaeSS3 homohexamer but not to the CaeSS2 monomer. The binding of lactate caused no change in the optical absorption and x-ray absorption spectra of either oxy- or deoxy-Hc, suggesting that no structural rearrangement of the active site occurred. At pH 6.5, the oxygen binding rate constant kappa(obs) obtained by flash photolysis showed a significant increase upon addition of L-lactate, whereas L-lactate addition had little effect at pH 8.3. Lactate binding caused a concentration-dependent shift in the interhexameric distances at pH 6.5 based on small angle x-ray scattering measurements. These results show that L-lactate affects oxygen affinity at pH 6.5 by modulating the global structure of Hc without affecting its binuclear copper center (the active site). In contrast to this, the active site structure of deoxy-Hc is affected by changes in pH (Hirota, S., Kawahara, T., Beltramini, M., Di Muro, P., Magliozzo, R. S., Peisach, J., Powers, L. S., Tanaka, N., Nagao, S., and Bubacco, L. (2008) J. Biol. Chem. 283, 31941-31948). Upon addiction of lactate, the kinetic behavior of oxygen rebinding for Hc was heterogeneous under low oxygen concentrations at pH 6.5 due to changes in the T and R state populations, and the equilibrium was found to shift from the T toward the R state with addition of lactate.	Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Micetic, Ivan; Di Muro, Paolo; Beltramini, Mariano; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Kitagishi, Hiroaki; Kano, Koji] Doshisha Univ, Fac Engn, Dept Mol Sci & Technol, Kyoto 6100321, Japan; [Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Peisach, Jack] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Nara Institute of Science & Technology; University of Padua; Doshisha University; City University of New York (CUNY) System; Brooklyn College (CUNY); Yeshiva University; Albert Einstein College of Medicine		hirota@ms.naist.jp; luigi.bubacco@unipd.it	Mičetić, Ivan/A-7146-2015; Bubacco, Luigi/B-5602-2012; Di Muro, Paolo/F-5811-2013; Hirota, Shun/AAD-2651-2021	Mičetić, Ivan/0000-0003-1691-8425; Bubacco, Luigi/0000-0001-7927-9208; Hirota, Shun/0000-0003-3227-8376; Kitagishi, Hiroaki/0000-0003-4682-7217; Nagao, Satoshi/0000-0003-1674-7697	National Institutes of Health [GM40168]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Fondo per gli Investimenti della Ricerca di Base; Ministero universita e ricerca; University of Padova [CPDA051777]; Executive Program of Cooperation in the Fields of Science and Technology between the Government of Italy and the Government of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040168, R37GM040168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministero universita e ricerca(Ministry of Education, Universities and Research (MIUR)); University of Padova; Executive Program of Cooperation in the Fields of Science and Technology between the Government of Italy and the Government of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM40168 (to J.P.). This work was also supported by Grants-in-aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology, Japan and Japan Society for the Promotion of Science (to S.H.), Fondo per gli Investimenti della Ricerca di Base, Ministero universita e ricerca, and "Progetto di Ateneo" CPDA051777 from the University of Padova (to L.B.and M.B.) and by the Executive Program of Cooperation in the Fields of Science and Technology between the Government of Italy and the Government of Japan(to L.B.andS.H.).	Beltramini M, 2005, FEBS J, V272, P2060, DOI 10.1111/j.1742-4658.2005.04634.x; Bruneaux M, 2009, PROTEINS, V77, P589, DOI 10.1002/prot.22471; BUBACCO L, 1992, BIOCHEMISTRY-US, V31, P9294, DOI 10.1021/bi00153a024; Cong Y, 2009, STRUCTURE, V17, P749, DOI 10.1016/j.str.2009.03.005; Dainese E, 1998, EUR J BIOCHEM, V256, P350, DOI 10.1046/j.1432-1327.1998.2560350.x; DECKER H, 1990, J MOL BIOL, V211, P281, DOI 10.1016/0022-2836(90)90027-J; Dimitrov D, 2009, COMP GEOM-THEOR APPL, V42, P772, DOI 10.1016/j.comgeo.2008.02.007; Dissanayake A, 2008, MAR ENVIRON RES, V66, P445, DOI 10.1016/j.marenvres.2008.07.006; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hartmann H, 2002, BBA-PROTEINS PROTEOM, V1601, P132, DOI 10.1016/S1570-9639(02)00459-4; Hartmann H, 2001, J BIOL CHEM, V276, P19954, DOI 10.1074/jbc.M010435200; HAZES B, 1993, PROTEIN SCI, V2, P597; Hirota S, 2005, J AM CHEM SOC, V127, P17966, DOI 10.1021/ja0541128; Hirota S, 2008, J BIOL CHEM, V283, P31941, DOI 10.1074/jbc.M803433200; JOHNSON BA, 1988, BIOCHEMISTRY-US, V27, P1995, DOI 10.1021/bi00406a028; JOHNSON BA, 1984, BIOCHEMISTRY-US, V23, P872, DOI 10.1021/bi00300a013; JOHNSON BA, 1987, BIOCHIM BIOPHYS ACTA, V916, P376, DOI 10.1016/0167-4838(87)90183-X; LALLIER F, 1989, RESP PHYSIOL, V77, P323, DOI 10.1016/0034-5687(89)90120-5; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; MANGUM CP, 1972, COMP BIOCHEM PHYSIOL, V42, P693, DOI 10.1016/0300-9629(72)90447-1; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; Markl J, 2009, J MOL BIOL, V392, P362, DOI 10.1016/j.jmb.2009.06.082; Martin AG, 2007, J MOL BIOL, V366, P1332, DOI 10.1016/j.jmb.2006.11.075; Menze MA, 2000, BIOCHEMISTRY-US, V39, P10806, DOI 10.1021/bi000008l; Metz M, 2001, J AM CHEM SOC, V123, P4938, DOI 10.1021/ja004166b; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Truchot J.P., 1992, Advances in Comparative and Environmental Physiology, V13, P377; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; Weber RE, 2008, J EXP BIOL, V211, P1057, DOI 10.1242/jeb.013433	30	7	7	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19338	19345		10.1074/jbc.M109.076067	http://dx.doi.org/10.1074/jbc.M109.076067			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406810	hybrid, Green Published			2022-12-27	WOS:000278727800044
J	Gambaryan, S; Kobsar, A; Rukoyatkina, N; Herterich, S; Geiger, J; Smolenski, A; Lohmann, SM; Walter, U				Gambaryan, Stepan; Kobsar, Anna; Rukoyatkina, Natalia; Herterich, Sabine; Geiger, Joerg; Smolenski, Albert; Lohmann, Suzanne M.; Walter, Ulrich			Thrombin and Collagen Induce a Feedback Inhibitory Signaling Pathway in Platelets Involving Dissociation of the Catalytic Subunit of Protein Kinase A from an NF kappa B-I kappa B Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED-PHOSPHOPROTEIN; GTPASE-ACTIVATING PROTEIN; TRANSCRIPTIONAL ACTIVITY; CYCLIC-NUCLEOTIDES; ADHESION MECHANISMS; BONE-MARROW; PPAR-GAMMA; C-SRC; CAMP; CGMP	Protein kinase A (PKA) activation by cAMP phosphorylates multiple target proteins in numerous platelet inhibitory pathways that have a very important role in maintaining circulating platelets in a resting state. Here we show that in thrombin-and collagen-stimulated platelets, PKA is activated by cAMP-independent mechanisms involving dissociation of the catalytic subunit of PKA (PKAc) from an NF kappa B-I kappa B alpha-PKAc complex. We demonstrate mRNA and protein expression for most of the NF kappa B family members in platelets. From resting platelets, PKAc was co-immunoprecipitated with I kappa B alpha, and conversely, I kappa B alpha was also co-immunoprecipitated with PKAc. This interaction was significantly reduced in thrombin-and collagen-stimulated platelets. Stimulation of platelets with thrombin-or collagen-activated IKK, at least partly by PI3 kinase-dependent pathways, leading to phosphorylation of I kappa B alpha, disruption of an I kappa B alpha-PKAc complex, and release of free, active PKAc, which phosphorylated VASP and other PKA substrates. IKK inhibitor inhibited thrombin-stimulated IkB alpha phosphorylation, PKA-IkB alpha dissociation, and VASP phosphorylation, and potentiated integrin alpha IIb beta 3 activation and the early phase of platelet aggregation. We conclude that thrombin and collagen not only cause platelet activation but also appear to fine-tune this response by initiating downstream NF kappa B-dependent PKAc activation, as a novel feedback inhibitory signaling mechanism for preventing undesired platelet activation.	[Gambaryan, Stepan; Kobsar, Anna; Rukoyatkina, Natalia; Herterich, Sabine; Geiger, Joerg; Lohmann, Suzanne M.; Walter, Ulrich] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany; [Gambaryan, Stepan; Rukoyatkina, Natalia] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia; [Smolenski, Albert] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland	University of Wurzburg; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; University College Dublin	Gambaryan, S (corresponding author), Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Grombuhlstr 12, D-97080 Wurzburg, Germany.	gambaryan@klin-biochem.uni-wuerzburg.de	Rukoyatkina, Natalia/AAN-2227-2020; Gambaryan, Stepan/I-3940-2016; Walter, ulrich/W-2478-2017; Geiger, Joerg/I-6661-2013	Gambaryan, Stepan/0000-0002-1470-0791; Walter, ulrich/0000-0001-6784-2307; Geiger, Joerg/0000-0002-7689-531X; Rukoyatkina, Natalia/0000-0002-3920-206X; Smolenski, Albert/0000-0001-9210-9406	DFG [SFB 688 TP A2, GA 1561/1-1]; Science Foundation Ireland	DFG(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the DFG (Grants SFB 688 TP A2 and GA 1561/1-1, to S. G. and U. W.) and by a grant from the Science Foundation Ireland (to A. S.).	Aguilera C, 2006, J CELL SCI, V119, P3695, DOI 10.1242/jcs.03086; Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Ali FY, 2006, FASEB J, V20, P326, DOI 10.1096/fj.05-4395fje; Beaulieu LM, 2009, J THROMB HAEMOST, V7, P1329, DOI 10.1111/j.1538-7836.2009.03505.x; Bijli KM, 2007, AM J PHYSIOL-LUNG C, V292, pL396, DOI 10.1152/ajplung.00163.2006; Boulaftali Y, 2010, BLOOD, V115, P97, DOI 10.1182/blood-2009-04-217240; Chang H, 2010, THROMB RES, V125, P159, DOI 10.1016/j.thromres.2009.11.006; Chitaley K, 2004, FEBS LETT, V556, P211, DOI 10.1016/S0014-5793(03)01435-2; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dittrich M, 2006, THROMB HAEMOSTASIS, V95, P643, DOI 10.1160/TH05-11-0764; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; Gambaryan S, 2008, J THROMB HAEMOST, V6, P1376, DOI 10.1111/j.1538-7836.2008.03014.x; Gambaryan S, 2004, BLOOD, V103, P2593, DOI 10.1182/blood-2003-09-3349; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmeister M, 2008, J BIOL CHEM, V283, P2297, DOI 10.1074/jbc.M706825200; Huang CL, 2006, J CELL SCI, V119, P4420, DOI 10.1242/jcs.03195; Hunter RW, 2009, J BIOL CHEM, V284, P12339, DOI 10.1074/jbc.M807536200; Italiano JE, 2007, J THROMB HAEMOST, V5, P18, DOI 10.1111/j.1538-7836.2007.02487.x; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kim KW, 2001, J BIOL CHEM, V276, P13186, DOI 10.1074/jbc.M008092200; Lee HS, 2010, EUR J PHARMACOL, V627, P85, DOI 10.1016/j.ejphar.2009.11.005; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Liu FQ, 2002, THROMB RES, V106, P199, DOI 10.1016/S0049-3848(02)00130-5; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Majka M, 2000, BLOOD, V96, P4142, DOI 10.1182/blood.V96.13.4142.h8004142_4142_4151; Malaver E, 2009, J THROMB HAEMOST, V7, P1333, DOI 10.1111/j.1538-7836.2009.03492.x; Moraes LA, 2010, J THROMB HAEMOST, V8, P577, DOI 10.1111/j.1538-7836.2009.03732.x; Moraes LA, 2007, BLOOD, V109, P3741, DOI 10.1182/blood-2006-05-022566; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Naseem KM, 2008, J THROMB HAEMOST, V6, P10; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Profirovic J, 2005, J BIOL CHEM, V280, P32866, DOI 10.1074/jbc.M501361200; Pula G, 2006, BLOOD, V108, P4035, DOI 10.1182/blood-2006-05-023739; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1031, DOI 10.1152/ajpendo.00204.2006; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Schwarz UR, 2001, BIOCHEM PHARMACOL, V62, P1153, DOI 10.1016/S0006-2952(01)00760-2; Spinelli SL, 2010, ARTERIOSCL THROM VAS, V30, P591, DOI 10.1161/ATVBAHA.109.197343; Steele BM, 2009, P NATL ACAD SCI USA, V106, P19836, DOI 10.1073/pnas.0906268106; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; WALTER U, 1993, ADV EXP MED BIOL, V344, P237; Walter Ulrich, 2009, V191, P533, DOI 10.1007/978-3-540-68964-5_23; Wentworth JKI, 2006, BIOCHEM J, V393, P555, DOI 10.1042/BJ20050796; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Yu SH, 2004, J MOL MED, V82, P621, DOI 10.1007/s00109-004-0559-7; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	56	110	116	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18352	18363		10.1074/jbc.M109.077602	http://dx.doi.org/10.1074/jbc.M109.077602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20356841	Green Published, hybrid			2022-12-27	WOS:000278453900029
J	Karna, P; Zughaier, S; Pannu, V; Simmons, R; Narayan, S; Aneja, R				Karna, Prasanthi; Zughaier, Susu; Pannu, Vaishali; Simmons, Robert; Narayan, Satya; Aneja, Ritu			Induction of Reactive Oxygen Species-mediated Autophagy by a Novel Microtubule-modulating Agent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMA-CELLS; MITOCHONDRIAL PERMEABILITY TRANSITION; CYTOCHROME-C; CANCER-CELLS; BREAST-CANCER; MOLECULAR-MECHANISMS; MULTIDRUG-RESISTANT; TUMOR PROGRESSION; UNDERGO APOPTOSIS; ACIDIC VESICLES	Autophagy is being increasingly implicated in both cell survival and death. However, the intricate relationships between drug-induced autophagy and apoptosis remain elusive. Here we demonstrate that a tubulin-binding noscapine analog, (R)-9-bromo-5-((S)-4,5-dimethoxy-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]-di-oxolo[4,5-g]isoquinoline (Red-Br-nos), exerts a novel autophagic response followed by apoptotic cell death in human prostate cancer PC-3 cells. Red-Br-nos-induced autophagy was an early event detectable within 12 h that displayed a wide array of characteristic features including double membranous vacuoles with entrapped organelles, acidic vesicular organelles, and increased expression of LC3-II and beclin-1. Red-Br-nos-triggered release of reactive oxygen species (ROS) and attenuation of ROS by ti-ron, a ROS scavenger, reduced the sub-G(1) population suggesting ROS-dependent apoptosis. Abrogation of ROS also reduced autophagy indicating that ROS triggers autophagy. Pharmacological and genetic approaches to inhibit autophagy uncovered the protective role of Red-Br-nos-induced autophagy in PC-3 cells. Direct effects of the drug on mitochondria viz. disruption of normal cristae architecture and dissipation of mitochondrial transmembrane potential revealed a functional link between ROS generation, autophagy, and apoptosis induction. This is the first report to demonstrate the protective role of ROS-mediated autophagy and induction of caspase-independent ROS-dependent apoptosis in PC-3 cells by Red-Br-nos, a member of the noscapinoid family of microtubule-modulating anticancer agents.	[Karna, Prasanthi; Pannu, Vaishali; Simmons, Robert; Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Zughaier, Susu] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30033 USA; [Narayan, Satya] Univ Florida, Shands Canc Ctr, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	University System of Georgia; Georgia State University; Emory University; State University System of Florida; University of Florida	Aneja, R (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30303 USA.	raneja@gsu.edu	Zughaier, Susu/N-3185-2019; Zughaier, Susu/GLQ-9288-2022	Zughaier, Susu/0000-0001-7487-8770; 	National Institutes of Health, NCI [1K99CA131489]; Department of Defense [PC073104]; Georgia Research Alliance; NATIONAL CANCER INSTITUTE [R00CA131489, K99CA131489] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Georgia Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1K99CA131489 from the NCI and Department of Defense Grant PC073104 (to R. A.) and a grant from the Georgia Research Alliance.	Aneja R, 2006, CANCER RES, V66, P3782, DOI 10.1158/0008-5472.CAN-05-2962; Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; Aneja R, 2008, CANCER RES, V68, P1495, DOI 10.1158/0008-5472.CAN-07-1874; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Heidemann S, 2006, BLOOD, V107, P2216, DOI 10.1182/blood-2005-12-5142; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee SB, 2007, DNA CELL BIOL, V26, P713, DOI 10.1089/dna.2007.0577; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Millot C, 1997, J HISTOCHEM CYTOCHEM, V45, P1255, DOI 10.1177/002215549704500909; Mizumachi T, 2008, ONCOGENE, V27, P831, DOI 10.1038/sj.onc.1210681; Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Perchellet EM, 2004, ANTI-CANCER DRUG, V15, P929, DOI 10.1097/00001813-200411000-00002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schneiders UM, 2009, MOL CANCER THER, V8, P2914, DOI 10.1158/1535-7163.MCT-08-1179; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200; Zhou J, 2005, CANCER CHEMOTH PHARM, V55, P461, DOI 10.1007/s00280-004-0903-1; Zhou J, 2004, BIOCHEM PHARMACOL, V68, P2435, DOI 10.1016/j.bcp.2004.08.032; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799	60	72	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18737	18748		10.1074/jbc.M109.091694	http://dx.doi.org/10.1074/jbc.M109.091694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404319	Green Published, hybrid			2022-12-27	WOS:000278453900065
J	Suzuki, Y; Yanagisawa, M; Yagi, H; Nakatani, Y; Yu, RK				Suzuki, Yusuke; Yanagisawa, Makoto; Yagi, Hirokazu; Nakatani, Yoshihiko; Yu, Robert K.			Involvement of beta 1-Integrin Up-regulation in Basic Fibroblast Growth Factor- and Epidermal Growth Factor-induced Proliferation of Mouse Neuroepithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; PRECURSOR CELLS; SIGNALING PATHWAY; FACTOR RECEPTOR; MEMBRANE DOMAINS; N-GLYCOSYLATION; MAPK PATHWAY; INTEGRIN; DIFFERENTIATION	In neural stem cells, basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF) promote cell proliferation and self-renewal. In the bFGF-and EGF-responsive neural stem cells, beta 1-integrin also plays important roles in crucial cellular processes, including proliferation, migration, and apoptosis. The cross-talk of the signaling pathways mediated by these growth factors and beta 1-integrin, however, has not been fully elucidated. Here we report a novel molecular mechanism through which bFGF or EGF promotes the proliferation of mouse neuroepithelial cells (NECs). In the NECs, total beta 1-integrin expression levels and proliferation were dose-dependently increased by bFGF but not by EGF. EGF rather than bFGF strongly induced the increase of beta 1-integrin localization on the NEC surface. bFGF-and EGF-induced beta 1-integrin up-regulation and proliferation were inhibited after treatment with a mitogen-activated protein kinase kinase inhibitor, U0126, which indicates the dependence on the mitogen-activated protein kinase pathway. Involvement of beta 1-integrin in bFGF-and EGF-induced proliferation was confirmed by the finding that NEC proliferation and adhesion to fibronectin-coated dishes were inhibited by knockdown of beta 1-integrin using small interfering RNA. On the other hand, apoptosis was induced in NECs treated with RGD peptide, a small beta 1-integrin inhibitor peptide with the Arg-Gly-Asp motif, but it was independent of beta 1-integrin expression levels. Those results suggest that regulation of beta 1-integrin expression/localization is involved in cellular processes, such as proliferation, induced by bFGF and EGF in NECs. The mechanism underlying the proliferation through beta 1-integrin would not be expected to be completely identical, however, for bFGF and EGF.	[Suzuki, Yusuke; Yanagisawa, Makoto; Yagi, Hirokazu; Nakatani, Yoshihiko; Yu, Robert K.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Suzuki, Yusuke; Yanagisawa, Makoto; Yagi, Hirokazu; Nakatani, Yoshihiko; Yu, Robert K.] Med Coll Georgia, Inst Neurosci, Augusta, GA 30912 USA; [Yagi, Hirokazu] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Nagoya City University	Yu, RK (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, 1120 15th St, Augusta, GA 30912 USA.	ryu@mcg.edu	Yagi, Hirokazu/ABH-6151-2020	Yagi, Hirokazu/0000-0001-9296-0225	National Institutes of Health [NS11853, NS26994]; Children's Medical Research Foundation (Chicago, IL); Medical College of Georgia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011853, R01NS026994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Medical Research Foundation (Chicago, IL); Medical College of Georgia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS11853 and NS26994. This work was also supported by a grant from the Children's Medical Research Foundation (Chicago, IL) (to R.K.Y.) and a start-up fund from the Medical College of Georgia (to M.Y.).	Andressen C, 2005, EUR J CELL BIOL, V84, P973, DOI 10.1016/j.ejcb.2005.09.017; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Campos LS, 2006, J BIOL CHEM, V281, P5300, DOI 10.1074/jbc.M511886200; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Dasgupta S, 2009, J NEUROSCI RES, V87, P3591, DOI 10.1002/jnr.22153; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Faraldo MM, 2001, EMBO REP, V2, P431, DOI 10.1093/embo-reports/kve086; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Fukuda Shinji, 2005, Anatomical Science International, V80, P12; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Kalyani AJ, 1999, J NEUROBIOL, V38, P207, DOI 10.1002/(SICI)1097-4695(19990205)38:2<207::AID-NEU4>3.0.CO;2-G; Kazui A, 2000, BIOCHEM BIOPH RES CO, V273, P159, DOI 10.1006/bbrc.2000.2903; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Learish RD, 2000, DEV BRAIN RES, V122, P97; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Martens DJ, 2000, J NEUROSCI, V20, P1085, DOI 10.1523/JNEUROSCI.20-03-01085.2000; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Murozuka Y, 2007, GLYCOCONJUGATE J, V24, P551, DOI 10.1007/s10719-007-9051-2; Nagato M, 2005, J NEUROSCI RES, V80, P456, DOI 10.1002/jnr.20442; Nakashima K, 1999, J NEUROSCI, V19, P5429; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; Singh RD, 2010, TRAFFIC, V11, P348, DOI 10.1111/j.1600-0854.2009.01022.x; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Suri SS, 2009, BIOMATERIALS, V30, P3084, DOI 10.1016/j.biomaterials.2009.02.014; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Watson PMD, 2007, MOL CELL NEUROSCI, V34, P147, DOI 10.1016/j.mcn.2006.10.007; Whittemore SR, 1999, EXP CELL RES, V252, P75, DOI 10.1006/excr.1999.4621; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yamada S, 2004, BIOCHEM BIOPH RES CO, V314, P1113, DOI 10.1016/j.bbrc.2004.01.009; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yanagisawa M, 2005, J BIOCHEM, V138, P285, DOI 10.1093/jb/mvi129; Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yanagisawa M, 2009, BIOCHEM BIOPH RES CO, V386, P101, DOI 10.1016/j.bbrc.2009.05.132; Yates AJ, 1998, ANN NY ACAD SCI, V845, P57, DOI 10.1111/j.1749-6632.1998.tb09662.x; Yu RK, 2007, J NEUROCHEM, V103, P39, DOI 10.1111/j.1471-4159.2007.04710.x; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200; Zhao M, 2008, MOL BIOTECHNOL, V40, P19, DOI 10.1007/s12033-008-9043-x; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	68	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18443	18451		10.1074/jbc.M110.114645	http://dx.doi.org/10.1074/jbc.M110.114645			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20371608	Green Published, hybrid			2022-12-27	WOS:000278453900038
J	Eyre, DR; Weis, MA; Wu, JJ				Eyre, David R.; Weis, Mary Ann; Wu, Jiann-Jiu			Maturation of Collagen Ketoimine Cross-links by an Alternative Mechanism to Pyridinoline Formation in Cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ARTICULAR-CARTILAGE; II COLLAGEN; IDENTIFICATION; GLYCATION; SITES; CHEMISTRY; RELEVANCE; TURNOVER; RESIDUES; LOCATION	The tensile strength of fibrillar collagens depends on stable intermolecular cross-links formed through the lysyl oxidase mechanism. Such cross-links based on hydroxylysine aldehydes are particularly important in cartilage, bone, and other skeletal tissues. In adult cartilages, the mature cross-linking structures are trivalent pyridinolines, which form spontaneously from the initial divalent ketoimines. We examined whether this was the complete story or whether other ketoimine maturation products also form, as the latter are known to disappear almost completely from mature tissues. Denatured, insoluble, bovine articular cartilage collagen was digested with trypsin, and cross-linked peptides were isolated by copper chelation chromatography, which selects for their histidine-containing sequence motifs. The results showed that in addition to the naturally fluorescent pyridinoline peptides, a second set of crosslinked peptides was recoverable at a high yield from mature articular cartilage. Sequencing and mass spectral analysis identified their origin from the same molecular sites as the initial ketoimine cross-links, but the latter peptides did not fluoresce and were nonreducible with NaBH4. On the basis of their mass spectra, they were identical to their precursor ketoimine crosslinked peptides, but the cross-linking residue had an M+ 188 adduct. Considering the properties of an analogous adduct of identical added mass on a glycated lysine-containing peptide from type II collagen, we predicted that similar dihydroxyimidazolidine structures would form from their ketoimine groups by spontaneous oxidation and free arginine addition. We proposed the trivial name arginoline for the ketoimine cross-link derivative. Mature bovine articular cartilage contains about equimolar amounts of arginoline and hydroxylysyl pyridinoline based on peptide yields.	[Eyre, David R.; Weis, Mary Ann; Wu, Jiann-Jiu] Univ Washington, Orthoped Res Labs, Dept Orthoped & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), 1959 NE Pacific St,HSB BB1052,Box 356500, Seattle, WA 98195 USA.	deyre@u.washington.edu			National Institutes of Health [AR37318, AR36794]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR036794, R37AR036794, R01AR037318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37318 and AR36794 (to D. R. E.).	Ahsan T, 2005, OSTEOARTHR CARTILAGE, V13, P709, DOI 10.1016/j.joca.2005.03.005; Avery NC, 2005, SCAND J MED SCI SPOR, V15, P231, DOI 10.1111/j.1600-0838.2005.00464.x; BAILEY AJ, 1977, BIOCHEM BIOPH RES CO, V78, P1403, DOI 10.1016/0006-291X(77)91448-6; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; BAILEY AJ, 1971, BIOCHEM J, V121, P257, DOI 10.1042/bj1210257; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Biemel KM, 2001, J BIOL CHEM, V276, P23405, DOI 10.1074/jbc.M102035200; Brock JWC, 2007, J MASS SPECTROM, V42, P89, DOI 10.1002/jms.1144; DAVIS NR, 1975, BIOCHEMISTRY-US, V14, P2031, DOI 10.1021/bi00680a034; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Eyre DR, 2004, CLIN ORTHOP RELAT R, pS118, DOI 10.1097/01.blo.0000144855.48640.b9; EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290; EYRE DR, 1973, BIOCHEM J, V135, P393, DOI 10.1042/bj1350393; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; EYRE DR, 1980, BIOCHEM BIOPH RES CO, V92, P403, DOI 10.1016/0006-291X(80)90347-2; EYRE DR, 1981, SEMIN ARTHRITIS RHEU, V11, P46, DOI 10.1016/0049-0172(81)90034-2; EYRE DR, 1975, BIOCHEM J, V151, P595, DOI 10.1042/bj1510595; EYRE DR, 1981, DEV BIOCHEM, V22, P51; Harding JJ, 2006, BBA-PROTEINS PROTEOM, V1764, P1436, DOI 10.1016/j.bbapap.2006.08.001; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Miyazaki K, 2002, J BIOCHEM, V132, P543, DOI 10.1093/oxfordjournals.jbchem.a003255; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P533, DOI 10.1196/annals.1333.061; Muir H, 1970, J Bone Joint Surg Br, V52, P554; ROBINS SP, 1983, BIOCHEM J, V215, P175, DOI 10.1042/bj2150175; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Weis MA, 1998, J BIOL CHEM, V273, P4761, DOI 10.1074/jbc.273.8.4761; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; WU JJ, 1984, BIOCHEMISTRY-US, V23, P1850, DOI 10.1021/bi00303a041; WU JJ, 1992, J BIOL CHEM, V267, P23007; WU JJ, 1985, ANN NY ACAD SCI, V460, P520, DOI 10.1111/j.1749-6632.1985.tb51228.x	33	34	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16675	16682		10.1074/jbc.M110.111534	http://dx.doi.org/10.1074/jbc.M110.111534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363745	Green Published, hybrid			2022-12-27	WOS:000277982600031
J	Pradhan, A; Lambert, QT; Griner, LN; Reuther, GW				Pradhan, Anuradha; Lambert, Que T.; Griner, Lori N.; Reuther, Gary W.			Activation of JAK2-V617F by Components of Heterodimeric Cytokine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; TYROSINE KINASE JAK2; COMMON BETA-SUBUNIT; HUMAN GM-CSF; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; CONSTITUTIVE ACTIVATION; HEMATOPOIETIC-CELLS; SIGNAL-TRANSDUCTION; V617F MUTATION	The JAK2-V617F mutation is an important etiologic factor for the development of myeloproliferative neoplasms. The mechanism by which this mutated tyrosine kinase initiates deregulated signals in cells is not completely understood. It is believed that JAK2-V617F requires interactions with homodimeric cytokine receptors to elicit its transforming signal. In this study, we demonstrate that components of heterodimeric cytokine receptors can also activate JAK2-V617F. Expression of IL27Ra, a heterodimeric receptor component, enhanced the activation of JAK2-V617F and subsequent downstream signaling to activation of STAT5 and ERK. In addition, expression of components of the interleukin-3 receptor, IL3Ra and the common beta chain, activated JAK2-V617F as well as STAT5 and ERK. Importantly, expression of IL27Ra functionally replaced the requirement of a homodimeric cytokine receptor to promote the activation and transforming activity of JAK2-V617F in BaF3 cells. Tyrosine phosphorylation of IL27Ra was not required to induce activation of JAK2-V617F or STAT5, or to enhance the transforming activity of JAK2-V617F. Expression of IL3Ra or the common beta chain in BaF3 cells also enhanced the ability of JAK2-V617F to transform these hematopoietic cells. However, the heterodimeric receptor component IL12RB1 did not enhance the activation or transforming signals of JAK2-V617F in BaF3 cells. IL27Ra also activated the K539L and R683G JAK2 mutants. Together our data demonstrate that in addition to homodimeric receptors, some heterodimeric receptor components can support the activation and transforming signals of JAK2-V617F and other JAK2 mutants. Therefore, heterodimeric receptors may play unappreciated roles in JAK2 activation in the development of hematopoietic diseases including myeloproliferative neoplasms.	H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Griner, Lori N.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Reuther, GW (corresponding author), MRC3E,12902 Magnolia Dr, Tampa, FL 33612 USA.	gary.reuther@moffitt.org	Reuther, Gary/AFR-2892-2022		National Institutes of Health [R01CA127250]; Molecular Biology Core Facility of the Moffitt Cancer Center; American Cancer Society [RSG-07-197-01-LIB]; Lauri Strauss Leukemia Foundation; Children's Leukemia Research Association; NATIONAL CANCER INSTITUTE [R01CA127250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biology Core Facility of the Moffitt Cancer Center; American Cancer Society(American Cancer Society); Lauri Strauss Leukemia Foundation; Children's Leukemia Research Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA127250 and the Molecular Biology Core Facility of the Moffitt Cancer Center, American Cancer Society Research Scholar Grant RSG-07-197-01-LIB, the Lauri Strauss Leukemia Foundation, and the Children's Leukemia Research Association (all to G. W. R.).	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chatti K, 2004, BIOCHEMISTRY-US, V43, P4272, DOI 10.1021/bi036109b; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fisher GM, 1999, CYTOKINE, V11, P111, DOI 10.1006/cyto.1998.0403; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Gakovic M, 2008, J BIOL CHEM, V283, P18522, DOI 10.1074/jbc.M801427200; Geijsen N, 2001, CYTOKINE GROWTH F R, V12, P19, DOI 10.1016/S1359-6101(00)00019-8; Grohmann U, 2001, J IMMUNOL, V167, P221, DOI 10.4049/jimmunol.167.1.221; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Hornakova T, 2009, J BIOL CHEM, V284, P6773, DOI 10.1074/jbc.M807531200; Huang HM, 2005, J CELL BIOCHEM, V96, P361, DOI 10.1002/jcb.20513; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Klingmuller U, 1996, P NATL ACAD SCI USA, V93, P8324, DOI 10.1073/pnas.93.16.8324; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Lee TS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-58; Lee TS, 2009, CANCER-AM CANCER SOC, V115, P1692, DOI 10.1002/cncr.24183; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Muto A, 1996, J EXP MED, V183, P1911, DOI 10.1084/jem.183.4.1911; Okuda K, 1997, BLOOD, V90, P4759, DOI 10.1182/blood.V90.12.4759.4759_4759_4766; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Reuther GW, 2008, CELL CYCLE, V7, P714, DOI 10.4161/cc.7.6.5567; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Seita J, 2008, BLOOD, V111, P1903, DOI 10.1182/blood-2007-06-093328; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; YODA A, 2007, P NATL ACAD SCI USA, V252, P257; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	66	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16651	16663		10.1074/jbc.M109.071191	http://dx.doi.org/10.1074/jbc.M109.071191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363735	Green Published, hybrid			2022-12-27	WOS:000277982600029
J	Sanjo, H; Zajonc, DM; Braden, R; Norris, PS; Ware, CF				Sanjo, Hideki; Zajonc, Dirk M.; Braden, Rebecca; Norris, Paula S.; Ware, Carl F.			Allosteric Regulation of the Ubiquitin: NIK and Ubiquitin: TRAF3 E3 Ligases by the Lymphotoxin-beta Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; ALPHA-DEPENDENT APOPTOSIS; TNF-ALPHA; TUMOR-CELLS; PROTEIN; DEGRADATION; PATHWAYS; COMPLEX; KINASE; VIRUS	The lymphotoxin-beta receptor (LT beta R) activates the NF-kappa B2 transcription factors, p100 and RelB, by regulating the NF-kappa B-inducing kinase (NIK). Constitutive proteosomal degradation of NIK limits NF-kappa B activation in unstimulated cells by the ubiquitin: NIK E3 ligase comprised of subunits TNFR-associated factors (TRAF) 3, TRAF2, and cellular inhibitor of apoptosis (cIAP). However, the mechanism releasing NIK from constitutive degradation remains unclear. We found that insertion of a charge-repulsion mutation in the receptor-binding crevice of TRAF3 ablated binding of both LT beta R and NIK suggesting a common recognition site. A homologous mutation in TRAF2 inhibited cIAP interaction and blocked NIK degradation. Furthermore, the recruitment of TRAF3 and TRAF2 to the ligated LT beta R competitively displaced NIK from TRAF3. Ligated LT beta R complexed with TRAF3 and TRAF2 redirected the specificity of the ubiquitin ligase reaction to polyubiquitinate TRAF3 and TRAF2, leading to their proteosomal degradation. Stimulus-dependent degradation of TRAF3 required the RING domain of TRAF2, but not of TRAF3, implicating TRAF2 as a key E3 ligase in TRAF turnover. The combined action of competitive displacement of NIK and TRAF degradation halted NIK turnover, and promoted its association with IKK alpha and signal transmission. These results indicate the LT beta R modifies the ubiquitin: NIK E3 ligase, and also acts as an allosteric regulator of the ubiquitin: TRAF E3 ligase.	[Sanjo, Hideki; Braden, Rebecca; Norris, Paula S.; Ware, Carl F.] La Jolla Inst Allergy & Immunol, Div Mol Immunol, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cellular Biol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology	Ware, CF (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	cware@liai.org			US Public Health Service, National Institutes of Healt [CA069381, R37AI033068, AI048073]; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048073, R37AI033068] Funding Source: NIH RePORTER	US Public Health Service, National Institutes of Healt(United States Department of Health & Human ServicesUnited States Public Health Service); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Grants CA069381, R37AI033068, and AI048073 (to C. F. W.) from the US Public Health Service, National Institutes of Health. This work was also supported by the Uehara Memorial Foundation.	Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Choi SH, 2006, MOL CELL BIOL, V26, P3048, DOI 10.1128/MCB.26.8.3048-3059.2006; Chung JY, 2002, J CELL SCI, V115, P679; Csomos RA, 2009, J BIOL CHEM, V284, P20531, DOI 10.1074/jbc.M109.029983; Csomos RA, 2009, BIOCHEM J, V420, P83, DOI 10.1042/BJ20082140; De Trez C, 2008, CYTOKINE GROWTH F R, V19, P277, DOI 10.1016/j.cytogfr.2008.04.013; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Ely KR, 2007, ADV EXP MED BIOL, V597, P114; Force WR, 1997, J BIOL CHEM, V272, P30835, DOI 10.1074/jbc.272.49.30835; Grammer A C, 2000, Adv Immunol, V76, P61; Guasparri I, 2006, EMBO REP, V7, P114, DOI 10.1038/sj.embor.7400580; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Kim YS, 2005, MOL CELL BIOL, V25, P2130, DOI 10.1128/MCB.25.6.2130-2137.2005; Li CL, 2003, J BIOL CHEM, V278, P50523, DOI 10.1074/jbc.M309381200; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Matsumoto M, 1997, J VIROL, V71, P1301, DOI 10.1128/JVI.71.2.1301-1309.1997; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Vondenhoff MFR, 2007, EUR J IMMUNOL, V37, pS46, DOI 10.1002/eji.200737528; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Wu SD, 2005, J BIOL CHEM, V280, P33620, DOI 10.1074/jbc.M502511200; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	39	54	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17148	17155		10.1074/jbc.M110.105874	http://dx.doi.org/10.1074/jbc.M110.105874			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20348096	Green Published, hybrid			2022-12-27	WOS:000277982600077
J	Job, V; Mattei, PJ; Lemaire, D; Attree, I; Dessen, A				Job, Viviana; Mattei, Pierre-Jean; Lemaire, David; Attree, Ina; Dessen, Andrea			Structural Basis of Chaperone Recognition of Type III Secretion System Minor Translocator Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; NEEDLE COMPLEX; TETRATRICOPEPTIDE REPEATS; SHIGELLA-FLEXNERI; PORE FORMATION; V-ANTIGEN; INJECTISOME; BINDING; TIP; FORMS	The type III secretion system (T3SS) is a complex nanomachine employed by many Gram-negative pathogens, including the nosocomial agent Pseudomonas aeruginosa, to inject toxins directly into the cytoplasm of eukaryotic cells. A key component of all T3SS is the translocon, a proteinaceous channel that is inserted into the target membrane, which allows passage of toxins into target cells. In most bacterial species, two distinct membrane proteins (the "translocators") are involved in translocon formation, whereas in the bacterial cytoplasm, however, they remain associated to a common chaperone. To date, the strategy employed by a single chaperone to recognize two distinct translocators is unknown. Here, we report the crystal structure of a complex between the Pseudomonas translocator chaperone PcrH and a short region from the minor translocator PopD. PcrH displays a 7-helical tetratricopeptide repeat fold that harbors the PopD peptide within its concave region, originally believed to be involved in recognition of the major translocator, PopB. Point mutations introduced into the PcrH-interacting region of PopD impede translocator-chaperone recognition in vitro and lead to impairment of bacterial cytotoxicity toward macrophages in vivo. These results indicate that T3SS translocator chaperones form binary complexes with their partner molecules, and the stability of their interaction regions must be strictly maintained to guarantee bacterial infectivity. The PcrH-PopD complex displays homologs among a number of pathogenic strains and could represent a novel, potential target for antibiotic development.	Univ Grenoble 1, Commissariat Energie Atom, Bacterial Pathogenesis Grp, Inst Biol Struct,CNRS,UMR 5075, F-38027 Grenoble, France; [Lemaire, David] Univ Aix Marseille, Commisariat Energie Atom, Lab Interact Prot Met, CNRS,IBEB,UMR 6191, F-13108 St Paul Les Durance, France; [Attree, Ina] Univ Grenoble 1, Commissariat Energie Atom, iRTSV, LBBSI,CNRS,UMR5092, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)		andrea.dessen@ibs.fr		Lemaire, David/0000-0001-6874-3685; Attree, Ina/0000-0002-2580-764X; Dessen, Andrea/0000-0001-6487-4020; Job, Viviana/0000-0001-8421-5292	Commissariat a l'Energie Atomique "Transport de Proteines Membranaires" program	Commissariat a l'Energie Atomique "Transport de Proteines Membranaires" program	This work was supported in part by a grant from the Commissariat a l'Energie Atomique "Transport de Proteines Membranaires" program (to A. D. and I. A.).	Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Broms JE, 2006, FEMS MICROBIOL LETT, V256, P57, DOI 10.1111/j.1574-6968.2005.00099.x; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Creasey EA, 2003, MOL MICROBIOL, V47, P209, DOI 10.1046/j.1365-2958.2003.03290.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; DeLano W.L, PYMOL MOL GRAPHICS S; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005	37	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 23	2010	285	30					23222	23230		10.1074/jbc.M110.111278	http://dx.doi.org/10.1074/jbc.M110.111278			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	626WX	20385547	Green Published, hybrid			2022-12-27	WOS:000279999900056
J	Choocheep, K; Hatano, S; Takagi, H; Watanabe, H; Kimata, K; Kongtawelert, P; Watanabe, H				Choocheep, Kanyamas; Hatano, Sonoko; Takagi, Hidekazu; Watanabe, Hiroki; Kimata, Koji; Kongtawelert, Prachya; Watanabe, Hideto			Versican Facilitates Chondrocyte Differentiation and Regulates Joint Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; GROWTH-FACTOR-BETA; SYNOVIAL JOINT; PG-M; TGF-BETA; MESENCHYMAL CONDENSATION; MOUSE LIMB; EXPRESSION; CHONDROGENESIS; HYALURONAN	Versican/PG-M is a large chondroitin sulfate proteoglycan in the extracellular matrix, which is transiently expressed in mesenchymal condensation areas during tissue morphogenesis. Here, we generated versican conditional knock-out mice Prx1-Cre/Vcan(flox/flox), in which Vcan is pruned out by site-specific Cre recombinase driven by the Prx1 promoter. Although Prx1-Cre/Vcan(flox/flox) mice are viable and fertile, they develop distorted digits. Histological analysis of newborn mice reveals hypertrophic chondrocytic nodules in cartilage, tilting of the joint, and a slight delay of chondrocyte differentiation in digits. By immunostaining, whereas the joint interzone of Prx1-Cre/Vcan(+/+) shows an accumulation of TGF-beta, concomitant with versican, that of Prx1-Cre/Vcan(flox/flox) without versican expression exhibits a decreased incorporation of TGF-beta. In a micro-mass culture system of mesenchymal cells from limb bud, whereas TGF-beta and versican are co-localized in the perinodular regions of developing cartilage in Prx1-Cre/Vcan(+/+), TGF-beta is widely distributed in Prx1-Cre/Vcan(flox/flox). These results suggest that versican facilitates chondrogenesis and joint morphogenesis, by localizing TGF-beta in the extracellular matrix and regulating its signaling.	[Choocheep, Kanyamas; Hatano, Sonoko; Takagi, Hidekazu; Watanabe, Hiroki; Kimata, Koji; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Karimata 21, Aichi 4801195, Japan; [Choocheep, Kanyamas; Kongtawelert, Prachya] Chiang Mai Univ, Fac Med, Dept Biochem, Thailand Excellence Ctr Tissue Engn, Chiang Mai 50200, Thailand	Aichi Medical University; Chiang Mai University	Watanabe, H (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Karimata 21, Aichi 4801195, Japan.	wannabee@aichi-med-u.ac.jp		kongtawelert, prachya/0000-0002-5963-2796; Watanabe, Hideto/0000-0001-5291-0696	KAKENHI; Royal Golden Jubilee Ph.D. Program [PHD/0183/2547]; Aikeikai scholarship	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Aikeikai scholarship	This work was supported by Grants-in-aid for Scientific Research (B) (KAKENHI) (to Hideto Watanabe) and grants-in-aid for priority areas (to Hideto Watanabe).r Recipient of Royal Golden Jubilee Ph.D. Program Grants PHD/0183/2547 and an Aikeikai scholarship.	Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; CRAIG FM, 1990, J ANAT, V171, P17; Daniels K, 1996, METHOD CELL BIOL, V51, P237, DOI 10.1016/S0091-679X(08)60631-7; Day JM, 2004, J BIOL CHEM, V279, P12511, DOI 10.1074/jbc.M400242200; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; EDWARDS JCW, 1994, J ANAT, V185, P355; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; HALL BK, 1992, ANAT EMBRYOL, V186, P107; Hamrick MW, 2001, EVOL DEV, V3, P355, DOI 10.1046/j.1525-142X.2001.01032.x; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; HOLDER N, 1977, J EMBRYOL EXP MORPH, V39, P115; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kamiya N, 2006, J BIOL CHEM, V281, P2390, DOI 10.1074/jbc.M509341200; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; KIMATA K, 1986, J BIOL CHEM, V261, P3517; Kishimoto J, 1999, P NATL ACAD SCI USA, V96, P7336, DOI 10.1073/pnas.96.13.7336; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; LEUSSINK B, 1995, MECH DEVELOP, V52, P51, DOI 10.1016/0925-4773(95)00389-I; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; PITSILLIDES AA, 1995, J HISTOCHEM CYTOCHEM, V43, P263, DOI 10.1177/43.3.7868856; Pitsillides AA, 2003, CELL BIOCHEM FUNCT, V21, P235, DOI 10.1002/cbf.1079; Shepard JB, 2007, INT J BIOL SCI, V3, P380; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; UJITA M, 1994, J BIOL CHEM, V269, P27603; Williams DR, 2005, BIOCHEM BIOPH RES CO, V334, P960, DOI 10.1016/j.bbrc.2005.06.189; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; YAMAGATA M, 1993, J CELL SCI, V106, P55; ZAKO M, 1995, J BIOL CHEM, V270, P3914, DOI 10.1074/jbc.270.8.3914	46	73	75	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21114	21125		10.1074/jbc.M109.096479	http://dx.doi.org/10.1074/jbc.M109.096479			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20404343	Green Published, hybrid			2022-12-27	WOS:000279228600074
J	Lieutaud, A; van Lis, R; Duval, S; Capowiez, L; Muller, D; Lebrun, R; Lignon, S; Fardeau, ML; Lett, MC; Nitschke, W; Schoepp-Cothenet, B				Lieutaud, Aurelie; van Lis, Robert; Duval, Simon; Capowiez, Line; Muller, Daniel; Lebrun, Regine; Lignon, Sabrina; Fardeau, Marie-Laure; Lett, Marie-Claire; Nitschke, Wolfgang; Schoepp-Cothenet, Barbara			Arsenite Oxidase from Ralstonia sp 22 CHARACTERIZATION OF THE ENZYME AND ITS INTERACTION WITH SOLUBLE CYTOCHROMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCALIGENES-FAECALIS; SIGNAL PEPTIDES; RIESKE-PROTEIN; SP NOV.; OXIDATION; ARSENATE; GENES; REDUCTION; SULFUR; PURIFICATION	We characterized the aro arsenite oxidation system in the novel strain Ralstonia sp. 22, a beta-proteobacterium isolated from soil samples of the Salsigne mine in southern France. The inducible aro system consists of a heterodimeric membrane-associated enzyme reacting with a dedicated soluble cytochrome c(554). Our biochemical results suggest that the weak association of the enzyme to the membrane probably arises from a still unknown interaction partner. Analysis of the phylogeny of the aro gene cluster revealed that it results from a lateral gene transfer from a species closely related to Achromobacter sp. SY8. This constitutes the first clear cut case of such a transfer in the Aro phylogeny. The biochemical study of the enzyme demonstrates that it can accommodate in vitro various cytochromes, two of which, c(552) and c(554), are from the parent species. Cytochrome c(552) belongs to the sox and not the aro system. Kinetic studies furthermore established that sulfite and sulfide, substrates of the sox system, are both inhibitors of Aro activity. These results reinforce the idea that sulfur and arsenic metabolism are linked.	[Nitschke, Wolfgang; Schoepp-Cothenet, Barbara] CNRS, Lab Bioenerget & Ingn Prot, UPR 9036, IFR88, F-13402 Marseille 20, France; [Muller, Daniel; Lett, Marie-Claire] Univ Strasbourg, CNRS, UMR7156, F-67083 Strasbourg, France; [Lebrun, Regine; Lignon, Sabrina] CNRS, Marseille Prote IBiSA, Plate Forme Prote IMM, F-13402 Marseille 20, France; [Fardeau, Marie-Laure] Univ Aix Marseille 1, LMBEC, IRD ESIL, F-13288 Marseille 9, France; [Fardeau, Marie-Laure] Univ Mediterranee, LMBEC, IRD ESIL, F-13288 Marseille 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Schoepp-Cothenet, B (corresponding author), CNRS, Lab Bioenerget & Ingn Prot, UPR 9036, IFR88, F-13402 Marseille 20, France.	schoepp@ifr88.cnrs-mrs.fr	Schoepp-Cothenet, Barbara/AAH-8911-2021; Muller, Daniel/C-6827-2008; Duval, Simon/ABS-5379-2022; Nitschke, Wolfgang/C-4812-2012	Schoepp-Cothenet, Barbara/0000-0002-6820-4478; Muller, Daniel/0000-0002-6619-4691; Duval, Simon/0000-0003-2946-6771; Nitschke, Wolfgang/0000-0003-2084-3032	ADEME/BRGM; Ministere Francais de la Recherche	ADEME/BRGM; Ministere Francais de la Recherche(Ministry of Research, France)	Supported by a Ph.D. grant from ADEME/BRGM.; Supported by a Ministere Francais de la Recherche Ph.D. grant.	ANDERSON GL, 1992, J BIOL CHEM, V267, P23674; Baymann F, 2001, BIOCHEMISTRY-US, V40, P13681, DOI 10.1021/bi011201y; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Branco R, 2009, APPL ENVIRON MICROB, V75, P5141, DOI 10.1128/AEM.02798-08; Cai L, 2009, APPL MICROBIOL BIOT, V83, P715, DOI 10.1007/s00253-009-1929-4; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Chang JS, 2010, ENVIRON GEOCHEM HLTH, V32, P95, DOI 10.1007/s10653-009-9268-z; Donahoe-Christiansen J, 2004, APPL ENVIRON MICROB, V70, P1865, DOI 10.1128/AEM.70.3.1865-1868.2004; Dowdle PR, 1996, APPL ENVIRON MICROB, V62, P1664, DOI 10.1128/AEM.62.5.1664-1669.1996; Duquesne K, 2008, ENVIRON MICROBIOL, V10, P228, DOI 10.1111/j.1462-2920.2007.01447.x; DUTTON PL, 1971, BIOCHIM BIOPHYS ACTA, V226, P63, DOI 10.1016/0005-2728(71)90178-2; DUVAL S, 2008, THESIS U PROVENCE MA; Duval S, 2010, J BIOL CHEM, V285, P20442, DOI 10.1074/jbc.M110.113811; Duval S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-206; Ellis PJ, 2001, STRUCTURE, V9, P125, DOI 10.1016/S0969-2126(01)00566-4; ENOCH HG, 1975, J BIOL CHEM, V250, P6693; Fisher JC, 2008, ENVIRON SCI TECHNOL, V42, P81, DOI 10.1021/es0713936; FORGET P, 1971, EUR J BIOCHEM, V18, P422; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; GARDLIK S, 1991, J BIOL CHEM, V266, P16627; Green H. H., 1918, S AFR J SCI, V14, P465; Hamamura N, 2009, ENVIRON MICROBIOL, V11, P421, DOI 10.1111/j.1462-2920.2008.01781.x; Handley KM, 2009, INT J SYST EVOL MICR, V59, P886, DOI 10.1099/ijs.0.003145-0; Hensen D, 2006, MOL MICROBIOL, V62, P794, DOI 10.1111/j.1365-2958.2006.05408.x; Hoeft SE, 2007, INT J SYST EVOL MICR, V57, P504, DOI 10.1099/ijs.0.64576-0; Inskeep WP, 2002, BOOK SOIL P, P183; Judd R. C., 2002, PROTEIN PROTOCOLS HD, P73; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kallas T, 1994, MOL BIOL CYANOBACTER, V1, P259, DOI DOI 10.1007/978-94-011-0227-8_9; Kashyap DR, 2006, J BACTERIOL, V188, P1081, DOI 10.1128/JB.188.3.1081-1088.2006; Kelly DP, 1997, ANTON LEEUW INT J G, V71, P95, DOI 10.1023/A:1000135707181; Kulp TR, 2008, SCIENCE, V321, P967, DOI 10.1126/science.1160799; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langner HW, 2001, ENVIRON SCI TECHNOL, V35, P3302, DOI 10.1021/es0105562; Lebrun E, 2003, MOL BIOL EVOL, V20, P686, DOI 10.1093/molbev/msg071; Lebrun E, 2006, MOL BIOL EVOL, V23, P1180, DOI 10.1093/molbev/msk010; LIM CK, 1993, J BACTERIOL, V175, P4492, DOI 10.1128/JB.175.14.4492-4498.1993; Malasarn D, 2008, J BACTERIOL, V190, P135, DOI 10.1128/JB.01110-07; Muller D, 2003, J BACTERIOL, V185, P135, DOI 10.1128/JB.185.1.135-141.2003; MULLER D, 2004, THESIS U STRASBOURG; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; NASSER D, 1967, J BACTERIOL, V94, P1706, DOI 10.1128/JB.94.5.1706-1714.1967; Newman DK, 1997, ARCH MICROBIOL, V168, P380, DOI 10.1007/s002030050512; NRIAGU JO, 1994, ARSENIC ENV; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; PHILLIPS SE, 1976, APPL ENVIRON MICROB, V32, P392, DOI 10.1128/AEM.32.3.392-399.1976; Prasad KS, 2009, BIOMETALS, V22, P711, DOI 10.1007/s10534-009-9215-6; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rochette EA, 2000, ENVIRON SCI TECHNOL, V34, P4714, DOI 10.1021/es000963y; Rother D, 2001, J BACTERIOL, V183, P4499, DOI 10.1128/JB.183.15.4499-4508.2001; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santini JM, 2004, J BACTERIOL, V186, P1614, DOI 10.1128/JB.186.6.1614-1619.2004; Santini JM, 2000, APPL ENVIRON MICROB, V66, P92, DOI 10.1128/AEM.66.1.92-97.2000; Santini JM, 2007, BBA-BIOENERGETICS, V1767, P189, DOI 10.1016/j.bbabio.2007.01.009; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Simeonova DD, 2004, FEMS MICROBIOL LETT, V237, P249, DOI 10.1111/j.1574-6968.2004.tb09703.x; Slyemi D, 2007, ADV MATER RES-SWITZ, V20-21, P427, DOI 10.4028/www.scientific.net/AMR.20-21.427; Stauder S, 2005, ENVIRON SCI TECHNOL, V39, P5933, DOI 10.1021/es048034k; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Sun WJ, 2009, FEMS MICROBIOL ECOL, V68, P72, DOI 10.1111/j.1574-6941.2009.00653.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valenzuela C, 2009, B ENVIRON CONTAM TOX, V82, P593, DOI 10.1007/s00128-009-9659-y; vanden Hoven RN, 2004, BBA-BIOENERGETICS, V1656, P148, DOI 10.1016/j.bbabio.2004.03.001; Weeger W, 1999, BIOMETALS, V12, P141, DOI 10.1023/A:1009255012328	66	42	44	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20433	20441		10.1074/jbc.M110.113761	http://dx.doi.org/10.1074/jbc.M110.113761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421652	Green Published, hybrid			2022-12-27	WOS:000279228600003
J	Harrison, CF; Lawson, VA; Coleman, BM; Kim, YS; Masters, CL; Cappai, R; Barnham, KJ; Hill, AF				Harrison, Christopher F.; Lawson, Victoria A.; Coleman, Bradley M.; Kim, Yong-Sun; Masters, Colin L.; Cappai, Roberto; Barnham, Kevin J.; Hill, Andrew F.			Conservation of a Glycine-rich Region in the Prion Protein Is Required for Uptake of Prion Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; CRYSTAL-STRUCTURE; SCRAPIE ISOFORM; CELL-SURFACE; GXXXG MOTIF; AMINO-ACIDS; RESISTANT; PRP; EXOSOMES; PROPAGATION	Prion diseases are associated with the misfolding of the endogenously expressed prion protein (designated PrPC) into an abnormal isoform (PrPSc) that has infectious properties. The hydrophobic domain of PrPC is highly conserved and contains a series of glycine residues that show perfect conservation among all species, strongly suggesting it has functional and evolutionary significance. These glycine residues appear to form repeats of the GXXXG protein-protein interaction motif (two glycines separated by any three residues); the retention of these residues is significant and presumably relates to the functionality of PrPC. Mutagenesis studies demonstrate that minor alterations to this highly conserved region of PrPC drastically affect the ability of cells to uptake and replicate prion infection in both cell and animal bioassay. The localization and processing of mutant PrPC are not affected, although in vitro and in vivo studies demonstrate that this region is not essential for interaction with PrPSc, suggesting these residues provide conformational flexibility. These data suggest that this region of PrPC is critical in the misfolding process and could serve as a novel, species-independent target for prion disease therapeutics.	[Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Harrison, Christopher F.; Lawson, Victoria A.; Coleman, Bradley M.; Cappai, Roberto; Barnham, Kevin J.; Hill, Andrew F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Lawson, Victoria A.; Masters, Colin L.; Barnham, Kevin J.; Hill, Andrew F.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, Kyounggi Do, South Korea	University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Hallym University	Hill, AF (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	a.hill@unimelb.edu.au	Hill, Andrew F./AAH-2854-2020; Hill, Andrew F./GZL-4124-2022; Lawson, Victoria/AAJ-7392-2021; Hill, Andrew F/B-4527-2009; Cappai, Roberto/B-3347-2010	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Lawson, Victoria/0000-0002-7362-7176; Cappai, Roberto/0000-0002-9505-8496	Australian Research Council [DP0987227]; National Health and Medical Research Council [400202]; Australian postgraduate award; University of Melbourne	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award(Australian Government); University of Melbourne(University of Melbourne)	This work was supported in part by Australian Research Council Discovery Project Grant DP0987227 and National Health and Medical Research Council Program Grant 400202.; Recipient of an Australian postgraduate award scholarship.; Recipient of a University of Melbourne CR Roper fellowship.; Recipient of a University of Melbourne research scholarship.; Recipient of a National Health and Medical Research Council senior research fellowship.; Recipient of National Health and Medical Research Council career development award (Level 2). A shareholder in and consultant to D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, therapeutics, and decontamination. D-Gen markets the ICSM18 antibody used in this study.	Alonso DOV, 2001, P NATL ACAD SCI USA, V98, P2985, DOI 10.1073/pnas.061555898; Americo TA, 2007, BIOCHEM BIOPH RES CO, V358, P620, DOI 10.1016/j.bbrc.2007.04.202; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Barnham KJ, 2006, TRENDS BIOCHEM SCI, V31, P465, DOI 10.1016/j.tibs.2006.06.006; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cervenakova L, 1998, P NATL ACAD SCI USA, V95, P13239, DOI 10.1073/pnas.95.22.13239; Chabry J, 1998, J BIOL CHEM, V273, P13203, DOI 10.1074/jbc.273.21.13203; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Choi JK, 2006, HYBRIDOMA, V25, P271, DOI 10.1089/hyb.2006.25.271; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; Collins SJ, 2005, NEUROBIOL DIS, V20, P336, DOI 10.1016/j.nbd.2005.03.014; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Guilbert C, 2000, BIOPOLYMERS, V54, P406, DOI 10.1002/1097-0282(200011)54:6<406::AID-BIP50>3.0.CO;2-6; Haire LF, 2004, J MOL BIOL, V336, P1175, DOI 10.1016/j.jmb.2003.12.059; Harrison CF, 2007, J NEUROCHEM, V103, P1709, DOI 10.1111/j.1471-4159.2007.04936.x; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 2009, NEUROPATH APPL NEURO, V35, P111, DOI 10.1111/j.1365-2990.2008.00964.x; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kovacs GG, 2001, NEUROBIOL DIS, V8, P881, DOI 10.1006/nbdi.2001.0418; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lawson VA, 2007, J GEN VIROL, V88, P2905, DOI 10.1099/vir.0.82961-0; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Mallucci GR, 1999, BRAIN, V122, P1823, DOI 10.1093/brain/122.10.1823; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2009, NEW ENGL J MED, V361, P2056, DOI 10.1056/NEJMoa0809716; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Panegyres PK, 2001, ARCH NEUROL-CHICAGO, V58, P1899, DOI 10.1001/archneur.58.11.1899; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Polymenidou M, 2008, VACCINE, V26, P2601, DOI 10.1016/j.vaccine.2008.03.035; Priola SA, 2001, EMBO J, V20, P6692, DOI 10.1093/emboj/20.23.6692; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Rodriguez MM, 2005, NEUROLOGY, V64, P1455, DOI 10.1212/01.WNL.0000158618.39527.93; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; Stockel J, 2001, J MOL BIOL, V313, P861, DOI 10.1006/jmbi.2001.5085; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; TATEISHI J, 1979, ANN NEUROL, V5, P581, DOI 10.1002/ana.410050616; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vorberg I, 2001, J VIROL, V75, P10024, DOI 10.1128/JVI.75.21.10024-10032.2001; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	66	23	25	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20213	20223		10.1074/jbc.M109.093310	http://dx.doi.org/10.1074/jbc.M109.093310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20356832	hybrid, Green Published			2022-12-27	WOS:000279012000056
J	Mistretta, N; Seguin, D; Thiebaud, J; Vialle, S; Blanc, F; Brossaud, M; Talaga, P; Norheim, G; Moreau, M; Rokbi, B				Mistretta, Noelle; Seguin, Delphine; Thiebaud, Jerome; Vialle, Sandrine; Blanc, Frederic; Brossaud, Marina; Talaga, Philippe; Norheim, Gunnstein; Moreau, Monique; Rokbi, Bachra			Genetic and Structural Characterization of L11 Lipooligosaccharide from Neisseria meningitidis Serogroup A Strains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE CORE OLIGOSACCHARIDES; INNER-CORE; MOLECULAR EPIDEMIOLOGY; PHASE VARIATION; SUBGROUP-III; IDENTIFICATION; BIOSYNTHESIS; PHOSPHOETHANOLAMINE; LOS; LOCALIZATION	The lipooligosaccharide (LOS) of immunotype L11 is unique within serogroup A meningococci. In order to resolve its molecular structure, we conducted LOS genotyping by PCR analysis of genes responsible for alpha-chain sugar addition (lgtA, -B, -C, -E, -H, and -F) and inner core substituents (lgtG, lpt-3, and lpt-6). For this study, we selected seven strains belonging to subgroup III, a major clonal complex responsible for meningococcal meningitis epidemics in Africa. In addition, we sequenced the homopolymeric tract regions of three phase-variable genes (lgtA, lgtG, and lot-3) to predict gene functionality. The fine structure of the L11 LOS of each strain was determined using composition and glycosyl linkage analyses, NMR, and mass spectrometry. The masses of the dephosphorylated oligosaccharides were consistent with an oligosaccharide composed of two hexoses, one N-acetyl-hexosamine, two heptoses, and one KDO, as proposed previously. The molar composition of LOS showed two glucose residues to be present, in agreement with lgtH sequence prediction. Despite phosphoethanolaminetransferase genes lpt-3 and lpt-6 being present in all seven Neisseria meningitidis strains, phosphoethanolamine (PEtn) was found at both O-3 and O-6 of HepII among the three ST-5 strains, whereas among the four ST-7 strains, only one PEtn was found and located at O-3 of the HepII. The L11 LOS was found to be O-acetylated, as was indicated by the presence of the lot-3 gene being in-frame in all of the seven N. meningitidis strains. To our knowledge, these studies represent the first full genetic and structural characterization of the L11 LOS of N. meningitidis. These investigations also suggest the presence of further regulatory mechanisms affecting LOS structure microheterogeneity in N. meningitidis related to PEtn decoration of the inner core.	[Mistretta, Noelle; Seguin, Delphine; Thiebaud, Jerome; Vialle, Sandrine; Blanc, Frederic; Brossaud, Marina; Talaga, Philippe; Moreau, Monique; Rokbi, Bachra] Sanofi Pasteur, F-69280 Marcy Letoile, France; [Norheim, Gunnstein] Univ Oxford, Dept Paediat, Oxford OX14, England	University of Oxford	Rokbi, B (corresponding author), Sanofi Pasteur, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.	bachra.rokbi@sanofipasteur.com						ACHTMAN M, 1992, J INFECT DIS, V165, P53, DOI 10.1093/infdis/165.1.53; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Berrington AW, 2002, FEMS IMMUNOL MED MIC, V34, P267, DOI 10.1016/S0928-8244(02)00369-3; Braun JM, 2004, VACCINE, V22, P898, DOI 10.1016/j.vaccine.2003.11.036; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Caugant DA, 2007, VACCINE, V25, pA8, DOI 10.1016/j.vaccine.2007.04.033; Choudhury B, 2008, CARBOHYD RES, V343, P2971, DOI 10.1016/j.carres.2008.08.026; Cox AD, 2002, CARBOHYD RES, V337, P1435, DOI 10.1016/S0008-6215(02)00161-1; Cox AD, 2002, EUR J BIOCHEM, V269, P4169, DOI 10.1046/j.1432-1033.2002.03131.x; DIFABIO JL, 1990, CAN J CHEM, V68, P1029, DOI 10.1139/v90-160; GAMIAN A, 1992, J BIOL CHEM, V267, P922; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; GOTSCHLICH EC, 1994, J EXP MED, V180, P2181, DOI 10.1084/jem.180.6.2181; Griffiss JM, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P179; Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; Kahler CM, 2005, GLYCOBIOLOGY, V15, P409, DOI 10.1093/glycob/cwi018; KIM JJ, 1994, INFECT IMMUN, V62, P1566, DOI 10.1128/IAI.62.5.1566-1575.1994; KIM JJ, 1988, INFECT IMMUN, V56, P2631, DOI 10.1128/IAI.56.10.2631-2638.1988; Kim JS, 2006, CARBOHYD RES, V341, P1061, DOI 10.1016/j.carres.2006.03.008; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; Lapeyssonnie L., 1963, B WHO              S, V28, P3; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MANDRELL RE, 1977, INFECT IMMUN, V16, P471, DOI 10.1128/IAI.16.2.471-475.1977; MICHON F, 1990, J BIOL CHEM, V265, P7243; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Norheim G, 2006, J CLIN MICROBIOL, V44, P861, DOI 10.1128/JCM.44.3.861-871.2006; Norheim G, 2008, CLIN VACCINE IMMUNOL, V15, P863, DOI 10.1128/CVI.00252-07; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; PAVLIAK V, 1993, J BIOL CHEM, V268, P14146; Rahman MM, 1998, CARBOHYD RES, V307, P311; Talaga P, 2002, VACCINE, V20, P2474, DOI 10.1016/S0264-410X(02)00183-4; Tsai CM, 2009, J BIOL CHEM, V284, P4616, DOI 10.1074/jbc.M808209200; Tsai CM, 2002, INFECT IMMUN, V70, P407, DOI 10.1128/IAI.70.1.407-411.2002; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vialle S, 2005, CARBOHYD RES, V340, P91, DOI 10.1016/j.carres.2004.10.021; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Wenzel CQ, 2010, J BACTERIOL, V192, P208, DOI 10.1128/JB.00558-09; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; Wright JC, 2004, J BACTERIOL, V186, P6970, DOI 10.1128/JB.186.20.6970-6982.2004; Wright JC, 2006, HDB MENINGOCOCCAL DI, P163, DOI DOI 10.1002/3527608508.CH9; Zhu PX, 2006, MICROBIOL-SGM, V152, P123, DOI 10.1099/mic.0.28327-0; Zhu PX, 2002, MICROBIOL-SGM, V148, P1833, DOI 10.1099/00221287-148-6-1833; Zhu PX, 2001, FEMS MICROBIOL LETT, V203, P173, DOI 10.1111/j.1574-6968.2001.tb10837.x; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098; ZOLLINGER WD, 1980, INFECT IMMUN, V28, P451; ZOLLINGER WD, 1977, INFECT IMMUN, V18, P424, DOI 10.1128/IAI.18.2.424-433.1977	50	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19874	19883		10.1074/jbc.M110.100636	http://dx.doi.org/10.1074/jbc.M110.100636			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421293	Green Published, hybrid			2022-12-27	WOS:000279012000020
J	Nurisso, A; Blanchard, B; Audfray, A; Rydner, L; Oscarson, S; Varrot, A; Imberty, A				Nurisso, Alessandra; Blanchard, Bertrand; Audfray, Aymeric; Rydner, Lina; Oscarson, Stefan; Varrot, Annabelle; Imberty, Anne			Role of Water Molecules in Structure and Energetics of Pseudomonas aeruginosa Lectin I Interacting with Disaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE-FIELD; PA-I; CARBOHYDRATE-BINDING; AUTOMATED DOCKING; FREE-ENERGIES; D-GALACTOSE; DYNAMICS; DERIVATIVES; MECHANICS; GLYCOSPHINGOLIPIDS	Calcium-dependent lectin I from Pseudomonas aeruginosa (PA-IL) binds specifically to oligosaccharides presenting an alpha-galactose residue at their nonreducing end, such as the disaccharides alpha Gal1-2 beta GalOMe, alpha Gal1-3 beta GalOMe, and alpha Gal1-4 beta GalOMe. This provides a unique model for studying the effect of the glycosidic linkage of the ligands on structure and thermodynamics of the complexes by means of experimental and theoretical tools. The structural features of PA-IL in complex with the three disaccharides were established by docking and molecular dynamics simulations and compared with those observed in available crystal structures, including PA-IL center dot alpha Gal1-2 beta GalOMe complex, which was solved at 2.4 angstrom resolution and reported herein. The role of a structural bridge water molecule in the binding site of PA-IL was also elucidated through molecular dynamics simulations and free energy calculations. This water molecule establishes three very stable hydrogen bonds with O6 of nonreducing galactose, oxygen from Pro-51 main chain, and nitrogen from Gln-53 main chain of the lectin binding site. Binding free energies for PA-IL in complex with the three disaccharides were investigated, and the results were compared with the experimental data determined by titration microcalorimetry. When the bridge water molecule was included in the free energy calculations, the simulations predicted the correct binding affinity trends with the 1-2-linked disaccharide presenting three times stronger affinity ligand than the other two. These results highlight the role of the water molecule in the binding site of PA-IL and indicate that it should be taken into account when designing glycoderivatives active against P. aeruginosa adhesion.	[Nurisso, Alessandra; Blanchard, Bertrand; Audfray, Aymeric; Varrot, Annabelle; Imberty, Anne] Univ Grenoble 1, CNRS, CERMAV, F-38041 Grenoble 09, France; [Nurisso, Alessandra; Blanchard, Bertrand; Audfray, Aymeric; Varrot, Annabelle; Imberty, Anne] Inst Chim Mol Grenoble, CNRS, CERMAV, F-38041 Grenoble 09, France; [Rydner, Lina; Oscarson, Stefan] Univ Coll Dublin, Sch Chem & Chem Biol, Ctr Synth & Chem Biol, Dublin 4, Ireland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University College Dublin	Imberty, A (corresponding author), Univ Grenoble 1, CNRS, CERMAV, BP53, F-38041 Grenoble 09, France.	Imberty@cermav.cnrs.fr	; Imberty, Anne/P-6451-2018	Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527; Oscarson, Stefan/0000-0002-8273-4918	CNRS; European Economic Community [MEST-CT-2004-503322, MRTN-CT-2006-035546]; French Ministry of Research; Science Foundation Ireland; Association Vaincre la Mucoviscidose; GDR Pseudomonas	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Economic Community; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Association Vaincre la Mucoviscidose; GDR Pseudomonas	This work was supported by CNRS. This work was also supported by European Economic Community Programs MEST-CT-2004-503322 (CermavTrain) and MRTN-CT-2006-035546 (NODPERCEPTION) (to A. N.) and funds from the French Ministry of Research (to B. B.), the Science Foundation Ireland (to L. R.), the Association Vaincre la Mucoviscidose, and the GDR Pseudomonas.	ALLINGER NL, 1989, J AM CHEM SOC, V111, P8551, DOI 10.1021/ja00205a001; Andersson C, 1999, J MOL GRAPH MODEL, V17, P101, DOI 10.1016/S1093-3263(99)00022-4; ANDREINI M, 2010, CARBOHYDR R IN PRESS; AVILA JL, 1992, AM J TROP MED HYG, V47, P413, DOI 10.4269/ajtmh.1992.47.413; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blanchard B, 2008, J MOL BIOL, V383, P837, DOI 10.1016/j.jmb.2008.08.028; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cecioni S, 2009, CHEM-EUR J, V15, P13232, DOI 10.1002/chem.200901799; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Cioci G, 2003, FEBS LETT, V555, P297, DOI 10.1016/S0014-5793(03)01249-3; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Corzana F, 2002, GLYCOBIOLOGY, V12, P241, DOI 10.1093/glycob/12.4.241; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DOGGETT RG, 1972, INFECT IMMUN, V6, P628, DOI 10.1128/IAI.6.4.628-635.1972; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fogolari F, 2003, BIOPHYS J, V85, P159, DOI 10.1016/S0006-3495(03)74462-2; GARBER N, 1992, BIOCHIM BIOPHYS ACTA, V1116, P331, DOI 10.1016/0304-4165(92)90048-Y; GAREGG PJ, 1982, CARBOHYD RES, V110, P261, DOI 10.1016/0008-6215(82)84007-X; GAREGG PJ, 1985, CARBOHYD RES, V137, P270, DOI 10.1016/0008-6215(85)85169-7; GILBOAGARBER N, 1982, METHOD ENZYMOL, V83, P378; GILBOAGARBER N, 1994, GLYCOCONJUGATE J, V11, P414, DOI 10.1007/BF00731276; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; IMBERTY A, 1999, PERSPECTIVES STRUCTU; Kadirvelraj R, 2008, J AM CHEM SOC, V130, P16933, DOI 10.1021/ja8039663; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; LANNE B, 1994, GLYCOCONJUGATE J, V11, P292, DOI 10.1007/BF00731201; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Lepsik M, 2004, PROTEINS, V57, P279, DOI 10.1002/prot.20192; LESLIE AG, 1992, JNT CCP4 ESF EACMB N, V26; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; MARCHESSAULT RH, 1979, BIOPOLYMERS, V18, P2369, DOI 10.1002/bip.1979.360180925; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mishra NK, 2008, PROTEINS, V72, P382, DOI 10.1002/prot.21935; Mitchell E, 2002, NAT STRUCT BIOL, V9, P918, DOI 10.1038/nsb865; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIDA Y, 1984, TETRAHEDRON LETT, V25, P1575, DOI 10.1016/S0040-4039(01)90014-0; Nurisso A, 2008, MOL SIMULAT, V34, P469, DOI 10.1080/08927020701697709; Perez S, 1998, CARBOHYD RES, V314, P141, DOI 10.1016/S0008-6215(98)00305-X; PREUSSER A, 1989, ACM T MATH SOFTWARE, V15, P79, DOI 10.1145/62038.69651; Rockey WM, 2000, PROTEINS, V40, P299, DOI 10.1002/(SICI)1097-0134(20000801)40:2<299::AID-PROT100>3.0.CO;2-G; RYCKAERT JP, 1977, J COMP CHEM, V23; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Treesuwan W, 2009, J MOL GRAPH MODEL, V27, P921, DOI 10.1016/j.jmgm.2009.02.007; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Wen X, 2005, BIOCHEMISTRY-US, V44, P6729, DOI 10.1021/bi0500426; Wong S, 2009, J CHEM THEORY COMPUT, V5, P422, DOI 10.1021/ct8003707	56	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20316	20327		10.1074/jbc.M110.108340	http://dx.doi.org/10.1074/jbc.M110.108340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410292	hybrid, Green Published			2022-12-27	WOS:000279012000066
J	Rothe, R; Liguori, L; Villegas-Mendez, A; Marques, B; Grunwald, D; Drouet, E; Lenormand, JL				Rothe, Romy; Liguori, Lavinia; Villegas-Mendez, Ana; Marques, Bruno; Grunwald, Didier; Drouet, Emmanuel; Lenormand, Jean-Luc			Characterization of the Cell-penetrating Properties of the Epstein-Barr Virus ZEBRA trans-Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAT-FUSION PROTEINS; DEPENDENT KINASE INHIBITORS; HIV-1 TAT; TRANSDUCTION DOMAIN; HEPARAN-SULFATE; GROWTH ARREST; HUMAN GAMMAHERPESVIRUSES; MEDIATED DELIVERY; CATIONIC PEPTIDES; ENDOSOMAL ESCAPE	The Epstein-Barr virus basic leucine zipper transcriptional activator ZEBRA was shown recently to cross the outer membrane of live cells and to accumulate in the nucleus of lymphocytes. We investigated the potential application of the EpsteinBarr virus trans-activator ZEBRA as a transporter protein to facilitate transduction of cargo proteins. Analysis of different truncated forms of ZEBRA revealed that the minimal domain (MD) required for internalization spans residues 170-220. MD efficiently transported reporter proteins such as enhanced green fluorescent protein (EGFP) and beta-galactosidase in several normal and tumor cell lines. Functionality of internalized cargo proteins was confirmed by beta-galactosidase activity in transduced cells, and no MD-associated cell toxicity was detected. Translocation of MD through the cell membrane required binding to cell surface-associated heparan sulfate proteoglycans as shown by strong inhibition of protein uptake in the presence of heparin. We found that internalization was blocked at 4 degrees C, whereas no ATP was required as shown by an only 25% decreased uptake efficiency in energy-depleted cells. Common endocytotic inhibitors such as nystatin, chlorpromazine, and wortmannin had no significant impact on MD-EGFP uptake. Only methyl-beta-cyclodextrin inhibited MD-EGFP uptake by 40%, implicating the lipid raft-mediated endocytotic pathway. These data suggest that MD-reporter protein transduction occurs mostly via direct translocation through the lipid bilayer and not by endocytosis. This mechanism of MD-mediated internalization is suitable for the efficient delivery of biologically active proteins and renders ZEBRA-MD a promising candidate for therapeutic protein delivery applications.	[Lenormand, Jean-Luc] Univ Grenoble 1, CNRS, UFR Med, UMR5525,TIMC IMAG Lab, F-38700 La Tronche, France; [Liguori, Lavinia] Univ Grenoble 1, Fdn RTRA Nanosci, TIMC GMCAO, F-38706 La Tronche, France; [Grunwald, Didier] Commissariat Energie Atom Grenoble, INSERM, U873, iRTSV TS, F-38054 Grenoble 9, France; [Drouet, Emmanuel] Univ Grenoble 1, CNRS, EMBL, Unit Virus Host Cell Interact,UMR5233, F-38042 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lenormand, JL (corresponding author), Univ Grenoble 1, CNRS, UFR Med, UMR5525,TIMC IMAG Lab, F-38700 La Tronche, France.	jllenormand@chu-grenoble.fr	Lenormand, Jean-Luc/ABF-3850-2021; Lenormand, Jean-Luc/M-6644-2014	villegas-mendez, ana/0000-0002-8363-680X; Lenormand, Jean-Luc/0000-0002-2766-9180	Marie Curie Excellence Grant [014320]	Marie Curie Excellence Grant(European Commission)	This work was supported by Marie Curie Excellence Grant 014320.	Abes S, 2007, NUCLEIC ACIDS RES, V35, P4495, DOI 10.1093/nar/gkm418; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Cayrol C, 1996, J BIOL CHEM, V271, P31799, DOI 10.1074/jbc.271.50.31799; Cayrol C, 1996, EMBO J, V15, P2748, DOI 10.1002/j.1460-2075.1996.tb00635.x; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Endoh T, 2008, BIOCONJUGATE CHEM, V19, P1017, DOI 10.1021/bc800020n; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Fuchs SM, 2006, CELL MOL LIFE SCI, V63, P1819, DOI 10.1007/s00018-006-6170-z; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Harada H, 2002, CANCER RES, V62, P2013; Ho A, 2001, CANCER RES, V61, P474; Joliot A, 2008, ADV DRUG DELIVER REV, V60, P608, DOI 10.1016/j.addr.2007.09.004; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Kramer SD, 2003, BBA-BIOMEMBRANES, V1609, P161, DOI 10.1016/S0005-2736(02)00683-1; Langel U, 2007, HDB CELL PENETRATING; Liguori L, 2008, J CONTROL RELEASE, V126, P217, DOI 10.1016/j.jconrel.2007.12.004; Lindgren M, 2000, BIOCONJUGATE CHEM, V11, P619, DOI 10.1021/bc990156s; Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630; Mahot S, 2005, VIRUS RES, V110, P187, DOI 10.1016/j.virusres.2005.01.014; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Mukai Y, 2006, BIOL PHARM BULL, V29, P1570, DOI 10.1248/bpb.29.1570; Murriel Christopher L, 2006, Expert Opin Drug Deliv, V3, P739, DOI 10.1517/17425247.3.6.739; Nishi K, 2007, J BIOL CHEM, V282, P27503, DOI 10.1074/jbc.M703810200; Oliveira S, 2008, CURR PHARM DESIGN, V14, P3686, DOI 10.2174/138161208786898789; Oliveira S, 2007, INT J PHARM, V331, P211, DOI 10.1016/j.ijpharm.2006.11.050; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Rodriguez A, 1999, J VIROL, V73, P9029, DOI 10.1128/JVI.73.11.9029-9038.1999; Rodriguez A, 2001, VIROLOGY, V284, P159, DOI 10.1006/viro.2001.0923; Rothe R, 2008, CURR PROTOC PROTEIN; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Shiraishi T, 2006, NAT PROTOC, V1, P633, DOI 10.1038/nprot.2006.92; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; Sinclair AJ, 2006, TRENDS MICROBIOL, V14, P289, DOI 10.1016/j.tim.2006.05.003; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Watson P, 2005, ADV DRUG DELIVER REV, V57, P43, DOI 10.1016/j.addr.2004.05.003; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	49	21	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20224	20233		10.1074/jbc.M110.101550	http://dx.doi.org/10.1074/jbc.M110.101550			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20385549	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000279012000057
J	Xia, M; Chen, YH; Wang, LC; Zandi, E; Yang, HP; Bemanian, S; Martinez-Chantar, ML; Mato, JM; Lu, SC				Xia, Meng; Chen, Yongheng; Wang, Ling-Chi; Zandi, Ebrahim; Yang, Heping; Bemanian, Sean; Luz Martinez-Chantar, M.; Mato, Jose M.; Lu, Shelly C.			Novel Function and Intracellular Localization of Methionine Adenosyltransferase 2 beta Splicing Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE; EXPRESSION; PROTEIN; CELLS	Human methionine adenosyltransferase 2 beta ( MAT2 beta) encodes for two major splicing variants, V1 and V2, which are differentially expressed in normal tissues. Both variants are induced in human liver cancer and positively regulate growth. The aim of this work was to identify interacting proteins of V1 and V2. His-tagged V1 and V2 were overexpressed in Rosetta pLysS cells, purified, and used in a pulldown assay to identify interacting proteins from human colon cancer cell line RKO cell lysates. The eluted lysates were subjected to Western blot and in solution proteomic analyses. HuR, an mRNA-binding protein known to stabilize the mRNA of several cyclins, was identified to interact with V1 and V2. Immunoprecipitation and Western blotting confirmed their interaction in both liver and colon cancer cells. These variant proteins are located in both nucleus and cytoplasm in liver and colon cancer cells and, when overexpressed, increased the cytoplasmic HuR content. This led to increased expression of cyclin D1 and cyclin A, known targets of HuR. When endogenous expression of V1 or V2 is reduced by small interference RNA, cytoplasmic HuR content fell and the expression of these HuR target genes also decreased. Knockdown of cyclin D1 or cyclin A blunted, whereas knockdown of HuR largely prevented, the ability of V1 or V2 overexpression to induce growth. In conclusion, MAT2 beta variants reside mostly in the nucleus and regulate HuR subcellular content to affect cell proliferation.	[Lu, Shelly C.] Univ So Calif, Div Gastrointestinal & Liver Dis, Dept Med, Keck Sch Med,Res Ctr Liver Dis,USC UCLA Res Ctr A, Los Angeles, CA 90033 USA; [Chen, Yongheng] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; [Wang, Ling-Chi; Zandi, Ebrahim] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Luz Martinez-Chantar, M.; Mato, Jose M.] Ctr Cooperat Res Biosci, Derio 48160, Bizkaia, Spain	University of Southern California; University of Southern California; University of Southern California; CIC bioGUNE	Lu, SC (corresponding author), Univ So Calif, Div Gastrointestinal & Liver Dis, Dept Med, Keck Sch Med,Res Ctr Liver Dis,USC UCLA Res Ctr A, HMR Bldg 415,2011 Zonal Ave, Los Angeles, CA 90033 USA.	shellylu@usc.edu	Lu, Shelly/AAH-5937-2021; MATO, JOSE/A-5187-2011; Chantar, Maria Luz Martinez/F-5190-2011	Lu, Shelly/0000-0003-2128-5407; MATO, JOSE/0000-0003-1264-3153; Chantar, Maria Luz Martinez/0000-0002-6446-9911	National Institutes of Health [DK51719, AT004896, GM065325]; Plan Nacional of I+D SAF [2008-04800, HEPADIP-EULSHM-CT-205]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051719, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional of I+D SAF; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51719 (to S.C.L.), AT004896 (to S.C.L. and J.M.M.), and GM065325 (to E.Z.). This work was also supported by Plan Nacional of I+D SAF 2008-04800 and HEPADIP-EULSHM-CT-205 (to J.M.M.). HepG2, HuH-7, and RKO cells were provided by the Cell Culture Core, confocal microscope was provided by the Cell and Tissue Imaging Core, and in solution proteomics was provided by USC and Mass Spectrometry-based Proteomics Core of the USC Research Center for Liver Diseases (Grant DK48522).	Chen H, 2007, GASTROENTEROLOGY, V133, P207, DOI 10.1053/j.gastro.2007.03.114; Chen J, 2006, BIOINFORMATICS, V22, P1998, DOI 10.1093/bioinformatics/btl335; Fukaya Y, 2008, J BIOL CHEM, V283, P18573, DOI 10.1074/jbc.M803115200; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Martinez-Chantar ML, 2006, GASTROENTEROLOGY, V131, P223, DOI 10.1053/j.gastro.2006.04.019; Martinez-Chantar ML, 2003, GASTROENTEROLOGY, V124, P940, DOI 10.1053/gast.2003.50151; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027	10	27	29	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20015	20021		10.1074/jbc.M109.094821	http://dx.doi.org/10.1074/jbc.M109.094821			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421296	Green Published, hybrid			2022-12-27	WOS:000279012000035
J	Fujita, Y; Kojima, K; Ohhashi, R; Hamada, N; Nozawa, Y; Kitamoto, A; Sato, A; Kondo, S; Kojima, T; Deguchi, T; Ito, M				Fujita, Yasunori; Kojima, Keitaro; Ohhashi, Riyako; Hamada, Nanako; Nozawa, Yoshinori; Kitamoto, Aya; Sato, Akira; Kondo, Shinji; Kojima, Toshio; Deguchi, Takashi; Ito, Masafumi			MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-ACTIVATED PROTEIN-KINASE-1; PROTEIN KINASE-1 MSK1; MICRORNA EXPRESSION; HISTONE H3; INDUCED PHOSPHORYLATION; C-FOS; POSTTRANSCRIPTIONAL REGULATION; LYSOPHOSPHATIDIC ACID; TUMOR-SUPPRESSOR; GENE-EXPRESSION	MicroRNAs are involved in cancer pathogenesis and act as tumor suppressors or oncogenes. It has been recently reported that miR-148a expression is down-regulated in several types of cancer. The functional roles and target genes of miR-148a in prostate cancer, however, remain unknown. In this report, we showed that miR-148a expression levels were lower in PC3 and DU145 hormone-refractory prostate cancer cells in comparison to PrEC normal human prostate epithelial cells and LNCaP hormone-sensitive prostate cancer cells. Transfection with miR-148a precursor inhibited cell growth, and cell migration and invasion, and increased the sensitivity to anti-cancer drug paclitaxel in PC3 cells. Computer-aided algorithms predicted mitogen-and stress-activated protein kinase, MSK1, as a potential target of miR-148a. Indeed, miR-148a overexpression decreased expression of MSK1. Using luciferase reporter assays, we identified MSK1 as a direct target of miR-148a. Suppression of MSK1 expression by siRNA, however, showed little or no effects on malignant phenotypes of PC3 cells. In PC3PR cells, a paclitaxel-resistant cell line established from PC3 cells, miR-148a inhibited cell growth, and cell migration and invasion, and also attenuated the resistance to paclitaxel. MiR-148a reduced MSK1 expression by directly targeting its 3'-UTR in PC3PR cells. Furthermore, MSK1 knockdown reduced paclitaxel-resistance of PC3PR cells, indicating that miR-148a attenuates paclitaxel-resistance of hormone-refractory, drug-resistant PC3PR cells in part by regulating MSK1 expression. Our findings suggest that miR-148a plays multiple roles as a tumor suppressor and can be a promising therapeutic target for hormone-refractory prostate cancer especially for drug-resistant prostate cancer.	[Fujita, Yasunori; Kojima, Keitaro; Ohhashi, Riyako; Hamada, Nanako; Nozawa, Yoshinori; Ito, Masafumi] Gifu Int Inst Biotechnol, Dept Longev & Aging Res, Gifu 5040838, Japan; [Kojima, Keitaro; Deguchi, Takashi] Gifu Univ, Grad Sch Med, Dept Urol, Gifu 5011193, Japan; [Nozawa, Yoshinori] Tokai Gakuin Univ, Dept Food & Hlth, Gifu 5048511, Japan; [Kitamoto, Aya; Sato, Akira; Kondo, Shinji; Kojima, Toshio] RIKEN Yokohama, Adv Sci Inst, Computat Syst Biol Res Grp, Konagawa 230045, Japan	Gifu University; RIKEN	Ito, M (corresponding author), 1-1 Naka Fudogaoka, Gifu 5040838, Japan.	mito@giib.or.jp		Kitamoto, Aya/0000-0002-0223-3874	Gifu prefecture, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [22700669] Funding Source: KAKEN	Gifu prefecture, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for Biological Research from Gifu prefecture, Japan and grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Clark DE, 2005, CANCER RES, V65, P3108; Davie James R, 2003, Sci STKE, V2003, pPE33; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Duncan EA, 2006, J BIOL CHEM, V281, P12521, DOI 10.1074/jbc.M513333200; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Funding AT, 2006, J INVEST DERMATOL, V126, P1784, DOI 10.1038/sj.jid.5700252; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kim HG, 2008, CANCER RES, V68, P2538, DOI 10.1158/0008-5472.CAN-07-6597; Lee CW, 2008, J CELL BIOCHEM, V104, P785, DOI 10.1002/jcb.21663; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Markou T, 2009, MOL CELL BIOCHEM, V322, P103, DOI 10.1007/s11010-008-9945-8; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mott JL, 2009, HEPATOLOGY, V50, P630, DOI 10.1002/hep.23010; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pathak SK, 2006, J IMMUNOL, V177, P7950, DOI 10.4049/jimmunol.177.11.7950; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Schiller M, 2006, ONCOGENE, V25, P4449, DOI 10.1038/sj.onc.1209479; Schuck S, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-6; Seux M, 2009, PANCREATOLOGY, V9, P66, DOI 10.1159/000178876; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Strelkov IS, 2002, CANCER RES, V62, P75; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yaqinuddin A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-13; Zhang H, 2009, SCI CHINA SER C, V52, P224, DOI 10.1007/s11427-009-0036-1; Zhong SP, 2001, J BIOL CHEM, V276, P33213, DOI 10.1074/jbc.M103973200	39	163	183	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19076	19084		10.1074/jbc.M109.079525	http://dx.doi.org/10.1074/jbc.M109.079525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406806	hybrid, Green Published			2022-12-27	WOS:000278727800017
J	Nawaratne, V; Leach, K; Felder, CC; Sexton, PM; Christopoulos, A				Nawaratne, Vindhya; Leach, Katie; Felder, Christian C.; Sexton, Patrick M.; Christopoulos, Arthur			Structural Determinants of Allosteric Agonism and Modulation at the M-4 Muscarinic Acetylcholine Receptor IDENTIFICATION OF LIGAND-SPECIFIC AND GLOBAL ACTIVATION MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; GALLAMINE; BINDING; MODELS; SWITCH; DRUG; SCHIZOPHRENIA; SELECTIVITY; MUTATIONS	The recently identified small molecule, 3-amino-5-chloro-6-methoxy-4-methylthieno[2,3-b]pyridine-2-carboxylic acid cyclopropylamide (LY2033298), is the first selective allosteric modulator of the muscarinic acetylcholine receptors (mAChRs) that mediates both receptor activation and positive modulation of the endogenous agonist, acetylcholine (ACh), via the same allosteric site on the M-4 mAChR. We thus utilized this novel chemical tool, as well as ACh, the bitopic (orthosteric/allosteric) agonist, McN-A-343, and the clinically efficacious M-1/M-4 mAChR-preferring agonist, xanomeline, in conjunction with site-directed mutagenesis of four different regions of the M-4 mAChR (extracellular loops 1, 2, and 3, and transmembrane domain 7), to identify regions that govern ligand-specific modes of binding, signaling, and allosteric modulation. In the first extracellular loop (E1), we identified Ile(93) and Lys(95) as key residues that specifically govern the signaling efficacy of LY2033298 and its binding cooperativity with ACh, whereas Phe(186) in the E2 loop was identified as a key contributor to the binding affinity of the modulator for the allosteric site, and Asp(432) in the E3 loop appears to be involved in the functional (activation) cooperativity between the modulator and the endogenous agonist. In contrast, the highly conserved transmembrane domain 7 residues, Tyr(439) and Tyr(443), were identified as contributing to a key activation switch utilized by all classes of agonists. These results provide new insights into the existence of multiple activation switches in G protein-coupled receptors (GPCRs), some of which can be selectively exploited by allosteric agonists, whereas others represent global activation mechanisms for all classes of ligand.	[Nawaratne, Vindhya; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Nawaratne, Vindhya; Leach, Katie; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Felder, Christian C.] Eli Lilly & Co, Indianapolis, IN 46285 USA	Monash University; Monash University; Eli Lilly	Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.	patrick.sexton@med.monash.edu.au; arthur.christopoulos@med.monash.edu.au	Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Leach, Katherine/0000-0002-9280-1803; Felder, Christian/0000-0003-1134-8881	National Health and Medical Research Council (NHMRC) of Australia [519461]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Program Grant 519461 of the National Health and Medical Research Council (NHMRC) of Australia.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; CHRISTOPOULOS A, 2004, FITTING MODELS BIOL; Gnagey AL, 1999, MOL PHARMACOL, V56, P1245, DOI 10.1124/mol.56.6.1245; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Hulme EC, 2003, BIOCHEM SOC T, V31, P29, DOI 10.1042/bst0310029; Jones CK, 2008, J NEUROSCI, V28, P10422, DOI 10.1523/JNEUROSCI.1850-08.2008; Krejci A, 2001, MOL PHARMACOL, V60, P761; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Spalding TA, 2002, MOL PHARMACOL, V61, P1297, DOI 10.1124/mol.61.6.1297; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006	31	57	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19012	19021		10.1074/jbc.M110.125096	http://dx.doi.org/10.1074/jbc.M110.125096			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406819	hybrid, Green Published			2022-12-27	WOS:000278727800009
J	Caballero, F; Fernandez, A; Matias, N; Martinez, L; Fucho, R; Elena, M; Caballeria, J; Morales, A; Fernandez-Checa, JC; Garcia-Ruiz, C				Caballero, Francisco; Fernandez, Anna; Matias, Nuria; Martinez, Laura; Fucho, Raquel; Elena, Montserrat; Caballeria, Joan; Morales, Albert; Fernandez-Checa, Jose C.; Garcia-Ruiz, Carmen			Specific Contribution of Methionine and Choline in Nutritional Nonalcoholic Steatohepatitis IMPACT ON MITOCHONDRIAL S-ADENOSYL-L-METHIONINE AND GLUTATHIONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; INSULIN-RESISTANCE; FREE-CHOLESTEROL; RAT HEPATOCYTES; DEFICIENT DIET; LIVER; MODEL; MICE; DISEASE; PHOSPHATIDYLCHOLINE	The pathogenesis and treatment of nonalcoholic steatohepatitis (NASH) are not well established. Feeding a diet deficient in both methionine and choline (MCD) is one of the most common models of NASH, which is characterized by steatosis, mitochondrial dysfunction, hepatocellular injury, oxidative stress, inflammation, and fibrosis. However, the individual contribution of the lack of methionine and choline in liver steatosis, advanced pathology and impact on mitochondrial S-adenosyl-L-methionine (SAM) and glutathione (GSH), known regulators of disease progression, has not been specifically addressed. Here, we examined the regulation of mitochondrial SAM and GSH and signs of disease in mice fed a MCD, methionine-deficient (MD), or choline-deficient (CD) diet. The MD diet reproduced most of the deleterious effects of MCD feeding, including weight loss, hepatocellular injury, oxidative stress, inflammation, and fibrosis, whereas CD feeding was mainly responsible for steatosis, characterized by triglycerides and free fatty acids accumulation. These findings were preceded by MCD- or MD-mediated SAM and GSH depletion in mitochondria due to decreased mitochondrial membrane fluidity associated with a lower phosphatidylcholine/phosphatidylethanolamine ratio. MCD and MD but not CD feeding resulted in increased ceramide levels by acid sphingomyelinase. Moreover, GSH ethyl ester or SAM therapy restored mitochondrial GSH and ameliorated hepatocellular injury in mice fed a MCD or MD diet. Thus, the depletion of SAM and GSH in mitochondria is an early event in the MCD model of NASH, which is determined by the lack of methionine. Moreover, therapy using permeable GSH prodrugs may be of relevance in NASH.	[Caballero, Francisco; Fernandez, Anna; Matias, Nuria; Martinez, Laura; Fucho, Raquel; Morales, Albert; Fernandez-Checa, Jose C.; Garcia-Ruiz, Carmen] IIBB CSIC, Dept Cell Death & Proliferat, Barcelona 08036, Spain; [Elena, Montserrat] Hosp Clin Barcelona, Ctr Diagnost Biomed, Barcelona 08936, Spain; [Fernandez-Checa, Jose C.] Univ So Calif, Keck Sch Med, Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90089 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Southern California	Fernandez-Checa, JC (corresponding author), IIBB CSIC, Dept Cell Death & Proliferat, C Rosello 161, Barcelona 08036, Spain.	checa229@yahoo.com; cgrbam@iibb.csic.es	Martinez-Gili, Laura/GPT-3558-2022; Garcia-Ruiz, Carmen/L-8211-2014; Fernández-Checa, José Carlos/L-8342-2014; Fernandez, Anna/M-4711-2015; Morales, Albert/E-2988-2013; Fucho, Raquel/A-6684-2016	Martinez-Gili, Laura/0000-0001-5271-9672; Garcia-Ruiz, Carmen/0000-0002-2652-6102; Fernández-Checa, José Carlos/0000-0003-3422-2990; Fernandez, Anna/0000-0002-0252-7442; Morales, Albert/0000-0001-8702-2269; Fucho, Raquel/0000-0002-1774-9099	Research Center for Liver and Pancreatic Diseases [P50-AA-11999]; Plan Nacional de I+D Grants [SAF2006-06780, SAF2008-02199, SAF2008-04974, SAF2009-11417]; Instituto de Salud Carlos III [PI070193, PI09/00056]; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas from the Intituto Carlos III, the Mutua Madrilena; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER	Research Center for Liver and Pancreatic Diseases; Plan Nacional de I+D Grants; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas from the Intituto Carlos III, the Mutua Madrilena; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism Center Grant P50-AA-11999 from the Research Center for Liver and Pancreatic Diseases. This work was also supported by Plan Nacional de I+D Grants SAF2006-06780, SAF2008-02199, SAF2008-04974, and SAF2009-11417, Instituto de Salud Carlos III Grants PI070193 and PI09/00056, by Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas from the Intituto Carlos III, the Mutua Madrilena.	Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2573, DOI 10.1089/ars.2009.2385; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baumgardner JN, 2008, J NUTR, V138, P1872, DOI 10.1093/jn/138.10.1872; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Colell A, 2003, J BIOL CHEM, V278, P33928, DOI 10.1074/jbc.M210943200; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fernandez A, 2009, ALCOHOL CLIN EXP RES, V33, P1169, DOI 10.1111/j.1530-0277.2009.00940.x; Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009; Garcia-Ruiz C, 2000, HEPATOLOGY, V32, P56, DOI 10.1053/jhep.2000.8267; GARCIARUIZ C, 1995, HEPATOLOGY, V21, P207, DOI 10.1016/0270-9139(95)90430-1; Henkel AS, 2009, J BIOL CHEM, V284, P31807, DOI 10.1074/jbc.M109.017970; Ji C, 2004, WORLD J GASTROENTERO, V10, P1699; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; Kulinski A, 2004, J BIOL CHEM, V279, P23916, DOI 10.1074/jbc.M312676200; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Llacuna L, 2006, HEPATOLOGY, V44, P561, DOI 10.1002/hep.21285; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Mari M, 2010, ANTIOXID REDOX SIGN, V12, P1295, DOI 10.1089/ars.2009.2634; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Oz HS, 2008, DIGEST DIS SCI, V53, P767, DOI 10.1007/s10620-007-9900-7; Oz HS, 2006, J BIOCHEM MOL TOXIC, V20, P39, DOI 10.1002/jbt.20109; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Ramos B, 2003, MOL PHARMACOL, V64, P502, DOI 10.1124/mol.64.2.502; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Serviddio G, 2008, GUT, V57, P957, DOI 10.1136/gut.2007.147496; TANG B, 2010, NUTRITION IN PRESS; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Vetelainen R, 2007, J GASTROEN HEPATOL, V22, P1526, DOI 10.1111/j.1440-1746.2006.04701.x; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Yen CLE, 2002, J NUTR, V132, P1840, DOI 10.1093/jn/132.7.1840	42	159	168	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18528	18536		10.1074/jbc.M109.099333	http://dx.doi.org/10.1074/jbc.M109.099333			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395294	Green Published, hybrid			2022-12-27	WOS:000278453900046
J	Guignard, TJP; Jin, MH; Pequignot, MO; Li, SH; Chassigneux, Y; Chekroud, K; Guillou, L; Richard, E; Hamel, CP; Brabet, P				Guignard, Thomas J. P.; Jin, Minghao; Pequignot, Marie O.; Li, Songhua; Chassigneux, Yolaine; Chekroud, Karim; Guillou, Laurent; Richard, Eric; Hamel, Christian P.; Brabet, Philippe			FATP1 Inhibits 11-cis Retinol Formation via Interaction with the Visual Cycle Retinoid Isomerase RPE65 and Lecithin:Retinol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID TRANSPORT PROTEIN-1; ACYL-COA SYNTHETASE; LEBERS CONGENITAL AMAUROSIS; PIGMENT EPITHELIAL-CELLS; ISOMEROHYDROLASE ACTIVITY; RHODOPSIN REGENERATION; EXPRESSION; MUTATIONS; LOCALIZATION; LIGHT	The isomerization of all-trans retinol (vitamin A) to 11-cis retinol in the retinal pigment epithelium (RPE) is a key step in the visual process for the regeneration of the visual pigment chromophore, 11-cis retinal. LRAT and RPE65 are recognized as the minimal isomerase catalytic components. However, regulators of this rate-limiting step are not fully identified and could account for the phenotypic variability associated with inherited retinal degeneration (RD) caused by mutations in the RPE65 gene. To identify new RPE65 partners, we screened a porcine RPE mRNA library using a yeast two-hybrid assay with full-length human RPE65. One identified clone (here named FATP1c), containing the cytosolic C-terminal sequence from the fatty acid transport protein 1 (FATP1 or SLC27A1, solute carrier family 27 member 1), was demonstrated to interact dose-dependently with the native RPE65 and with LRAT. Furthermore, these interacting proteins colocalize in the RPE. Cellular reconstitution of human interacting proteins shows that FATP1 markedly inhibits 11-cis retinol production by acting on the production of all-trans retinyl esters and the isomerase activity of RPE65. The identification of this new visual cycle inhibitory component in RPE may contribute to further understanding of retinal pathogenesis.	[Guignard, Thomas J. P.; Pequignot, Marie O.; Chassigneux, Yolaine; Chekroud, Karim; Guillou, Laurent; Hamel, Christian P.; Brabet, Philippe] INSERM, U583, Inst Neurosci Montpellier, F-34091 Montpellier, France; [Brabet, Philippe] Univ Montpellier 1, F-34967 Montpellier, France; [Brabet, Philippe] Univ Montpellier 2, F-34095 Montpellier, France; [Jin, Minghao; Li, Songhua] Louisiana State Univ, Sch Med, Dept Ophthalmol, Ctr Neurosci, New Orleans, LA 70112 USA; [Richard, Eric] INSERM, UMR 554, CNRS, Ctr Biochim Struct,UMR 5048,UM1, F-34090 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Louisiana State University System; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Brabet, P (corresponding author), INSERM, U583, Inst Neurosci Montpellier, F-34091 Montpellier, France.	philippe.brabet@inserm.fr	Pequignot, Marie O/P-1994-2017; Brabet, Philippe/AAO-8522-2020	Brabet, Philippe/0000-0003-2739-1622; Richard, Eric/0000-0003-0277-4141; Pequignot, Marie/0000-0002-8866-3778	private foundations (Fe de ration des Aveugles et Handicapes Visuels de France, IRRP, Retina France, SOS Retinite); Region Languedoc Roussillon; French Ministry for National Education; Inserm	private foundations (Fe de ration des Aveugles et Handicapes Visuels de France, IRRP, Retina France, SOS Retinite); Region Languedoc Roussillon(Region OccitanieRegion Ile-de-France); French Ministry for National Education; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported in part by private foundations (Fe de ration des Aveugles et Handicapes Visuels de France, IRRP, Retina France, SOS Retinite), Region Languedoc Roussillon, French Ministry for National Education, and Inserm.	Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Chen Y, 2006, FEBS LETT, V580, P4200, DOI 10.1016/j.febslet.2006.06.078; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; FISHER S, 1982, DEACYLATION ACYLATIO; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Martin G, 2000, GENOMICS, V66, P296, DOI 10.1006/geno.2000.6191; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Mondal MS, 2001, FEBS LETT, V489, P14, DOI 10.1016/S0014-5793(00)02428-5; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Rando RR, 2001, CHEM REV, V101, P1881, DOI 10.1021/cr960141c; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Saari J, 1994, RETINOIDS PHOTOSENSI; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schmuth M, 2005, J INVEST DERMATOL, V125, P1174, DOI 10.1111/j.0022-202X.2005.23934.x; Silva Eduardo, 2004, Ophthalmic Genet, V25, P205, DOI 10.1080/13816810490513451; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; STECHER H, 2000, MULTIENZYME ANAL VIS; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Wenzel A, 2005, J BIOL CHEM, V280, P29874, DOI 10.1074/jbc.M503603200; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Xue LL, 2006, BIOCHEMISTRY-US, V45, P10710, DOI 10.1021/bi060897y	40	11	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18759	18768		10.1074/jbc.M109.064329	http://dx.doi.org/10.1074/jbc.M109.064329			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20356843	Green Published, hybrid			2022-12-27	WOS:000278453900067
J	Lou, HY; Montoya, SE; Alerte, TNM; Wang, J; Wu, JJ; Peng, XM; Hong, CS; Friedrich, EE; Mader, SA; Pedersen, CJ; Marcus, BS; McCormack, AL; Di Monte, DA; Daubner, SC; Perez, RG				Lou, Haiyan; Montoya, Susana E.; Alerte, Tshianda N. M.; Wang, Jian; Wu, Jianjun; Peng, Xiangmin; Hong, Chang-Sook; Friedrich, Emily E.; Mader, Samantha A.; Pedersen, Courtney J.; Marcus, Brian S.; McCormack, Alison L.; Di Monte, Donato A.; Daubner, S. Colette; Perez, Ruth G.			Serine 129 Phosphorylation Reduces the Ability of alpha-Synuclein to Regulate Tyrosine Hydroxylase and Protein Phosphatase 2A in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ADRENAL CHROMAFFIN CELLS; INCLUSION-BODY FORMATION; CHAPERONE-LIKE ACTIVITY; PARKINSONS-DISEASE; KINASE-II; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; GENE-EXPRESSION; MEDIATED PHOSPHORYLATION	alpha-Synuclein (a-Syn), a protein implicated in Parkinson disease, contributes significantly to dopamine metabolism. a-Syn binding inhibits the activity of tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. Phosphorylation of TH stimulates its activity, an effect that is reversed by protein phosphatase 2A (PP2A). In cells, a-Syn overexpression activates PP2A. Here we demonstrate that a-Syn significantly inhibited TH activity in vitro and in vivo and that phosphorylation of a-Syn serine 129 (Ser-129) modulated this effect. In MN9D cells, a-Syn overexpression reduced TH serine 19 phosphorylation (Ser(P)-19). In dopaminergic tissues from mice overexpressing human a-Syn in catecholamine neurons only, TH-Ser-19 and TH-Ser-40 phosphorylation and activity were also reduced, whereas PP2A was more active. Cerebellum, which lacks excess a-Syn, had PP2A activity identical to controls. Conversely, a-Syn knock-out mice had elevated TH-Ser-19 phosphorylation and activity and less active PP2A in dopaminergic tissues. Using an a-Syn Ser-129 dephosphorylation mimic, with serine mutated to alanine, TH was more inhibited, whereas PP2A was more active in vitro and in vivo. Phosphorylation of a-Syn Ser-129 by Polo-like-kinase 2 in vitro reduced the ability of a-Syn to inhibit TH or activate PP2A, identifying a novel regulatory role for Ser-129 on a-Syn. These findings extend our understanding of normal a-Syn biology and have implications for the dopamine dysfunction of Parkinson disease.	[Lou, Haiyan; Montoya, Susana E.; Alerte, Tshianda N. M.; Wang, Jian; Wu, Jianjun; Peng, Xiangmin; Hong, Chang-Sook; Friedrich, Emily E.; Mader, Samantha A.; Pedersen, Courtney J.; Marcus, Brian S.; Perez, Ruth G.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15261 USA; [Lou, Haiyan] Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250012, Shandong, Peoples R China; [McCormack, Alison L.; Di Monte, Donato A.] Parkinsons Inst, Sunnyvale, CA 94085 USA; [Daubner, S. Colette] St Marys Univ, Dept Biol Sci, San Antonio, TX 78229 USA; [Perez, Ruth G.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Perez, Ruth G.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shandong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Perez, RG (corresponding author), 3501 5th Ave,BST3 7021, Pittsburgh, PA 15260 USA.	perezrg@pitt.edu	/AAO-5184-2020; Wu, Jian/AAU-5221-2020; Marcus, Brian/AGZ-1385-2022; Perez, Ruth G./AAK-9844-2020; Friedrich, Emily/R-3925-2017; Wu, Jian/AAU-5221-2020	/0000-0003-1869-7558; Wu, Jian/0000-0001-9933-7364; Marcus, Brian/0000-0001-5775-4143; Friedrich, Emily/0000-0003-1869-7558; Wu, Jian/0000-0002-3394-1507; Pedersen, Courtney/0000-0002-5917-2742; Di Monte, Donato/0000-0002-8296-836X	National Institutes of Health [NS42094, GM47291]; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS42094 (to R. G. P. with a supplement provided for S. E. M. (NINDS)) and GM47291 (to S. C. D.). This work was also supported by the China Scholarship Council (to H. L.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; Ahn M, 2006, BIOCHEM BIOPH RES CO, V346, P1142, DOI 10.1016/j.bbrc.2006.05.213; Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Baptista MJ, 2003, J NEUROCHEM, V85, P957, DOI 10.1046/j.1471-4159.2003.01742.x; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BERRESHEIM U, 1994, BRAIN RES, V637, P273, DOI 10.1016/0006-8993(94)91244-0; Bevilaqua LRM, 2003, J NEUROCHEM, V85, P1368, DOI 10.1046/j.1471-4159.2003.01792.x; Bobrovskaya L, 2004, J NEUROCHEM, V90, P857, DOI 10.1111/j.1471-4159.2004.02550.x; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; COLBRAN RJ, 1992, NEUROCHEM INT, V21, P469, DOI 10.1016/0197-0186(92)90080-B; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; DAUBNER SC, 1993, PROTEIN SCI, V2, P1452, DOI 10.1002/pro.5560020909; DAUBNER SC, 1992, J BIOL CHEM, V267, P12639; DAUBNER SC, 1993, ADV EXP MED BIOL, V338, P87; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fujita M, 2006, NEUROPATHOLOGY, V26, P383, DOI 10.1111/j.1440-1789.2006.00732.x; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; HAAVIK J, 1990, FEBS LETT, V262, P363, DOI 10.1016/0014-5793(90)80230-G; HAAVIK J, 1989, FEBS LETT, V251, P36, DOI 10.1016/0014-5793(89)81424-3; Haendeler J, 2003, FEBS LETT, V536, P180, DOI 10.1016/S0014-5793(03)00058-9; Hashimoto M, 2003, J NEUROCHEM, V85, P1468, DOI 10.1046/j.1471-4159.2003.01791.x; Haycock JW, 1998, J NEUROCHEM, V71, P1670; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; HAYCOCK JW, 1992, J NEUROCHEM, V58, P57, DOI 10.1111/j.1471-4159.1992.tb09276.x; Hirai Y, 2004, FEBS LETT, V572, P227, DOI 10.1016/j.febslet.2004.07.046; Hsu LJ, 1998, J NEUROCHEM, V71, P338; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Iwata A, 2001, J NEUROCHEM, V77, P239, DOI 10.1046/j.1471-4159.2001.t01-1-00232.x; Jakowec MW, 2001, DEV NEUROSCI-BASEL, V23, P91, DOI 10.1159/000048700; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kleppe R, 2001, J NEUROCHEM, V77, P1097, DOI 10.1046/j.1471-4159.2001.00318.x; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kumer SC, 1996, J NEUROCHEM, V67, P443; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Leal RB, 2002, NEUROCHEM RES, V27, P207, DOI 10.1023/A:1014880403970; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Liberini P, 2000, J NEUROL, V247, P88, DOI 10.1007/PL00007803; Liu DM, 2008, NEUROCHEM RES, V33, P1401, DOI 10.1007/s11064-008-9599-7; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; McCormack AL, 2004, J COMP NEUROL, V471, P387, DOI 10.1002/cne.20036; McCormack AL, 2008, J NEUROPATH EXP NEUR, V67, P793, DOI 10.1097/NEN.0b013e318180f0bd; McCormack AL, 2009, CURR PROTEIN PEPT SC, V10, P476, DOI 10.2174/138920309789351912; Mellick GD, 2005, NEUROSCI LETT, V375, P112, DOI 10.1016/j.neulet.2004.10.078; MILLER DW, 2006, SOC NEUR ABSTR; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Purisai MG, 2005, NEUROBIOL DIS, V20, P898, DOI 10.1016/j.nbd.2005.05.028; Ramsey AJ, 1998, BIOCHEMISTRY-US, V37, P8980, DOI 10.1021/bi980582l; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; Royo M, 2005, PROTEINS, V58, P14, DOI 10.1002/prot.20293; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Schweikl H, 2008, BIOMATERIALS, V29, P1377, DOI 10.1016/j.biomaterials.2007.11.049; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Sutoo D, 2002, BRAIN RES, V933, P1, DOI 10.1016/S0006-8993(02)02271-0; TANJI M, 1994, J NEUROCHEM, V63, P1908; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Toska K, 2002, ANN NY ACAD SCI, V971, P66, DOI 10.1111/j.1749-6632.2002.tb04435.x; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang J, 2009, J BIOL CHEM, V284, P14011, DOI 10.1074/jbc.M901310200; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; WU B, 2010, ACTA HISTOC IN PRESS; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	106	95	97	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17648	17661		10.1074/jbc.M110.100867	http://dx.doi.org/10.1074/jbc.M110.100867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356833	Green Published, hybrid			2022-12-27	WOS:000278133400043
J	Mata-Greenwood, E; Liao, WX; Wang, W; Zheng, J; Chen, DB				Mata-Greenwood, Eugenia; Liao, Wu-xiang; Wang, Wen; Zheng, Jing; Chen, Dong-bao			Activation of AP-1 Transcription Factors Differentiates FGF2 and Vascular Endothelial Growth Factor Regulation of Endothelial Nitric-oxide Synthase Expression in Placental Artery Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SIGNALING PATHWAYS; PROTEIN-KINASE CASCADE; UTERINE ARTERY; RESPONSIVE ELEMENT; GENE-EXPRESSION; UP-REGULATION; NO SYNTHASE; ENOS GENE; DUAL ROLE; IN-VITRO	FGF2 (fibroblast growth factor 2), but not vascular endothelial growth factor (VEGF), stimulates sustained activation of ERK2/1 for endothelial NOS3 (nitric-oxide synthase 3) protein expression in ovine fetoplacental artery endothelial cells (oFPAEC). We deciphered herein the downstream signaling of ERK2/1 responsible for NOS3 expression by FGF2 in oFPAEC. FGF2, but not VEGF, increased NOS3 mRNA levels without altering its degradation. FGF2, but not VEGF, trans-activated sheep NOS3 promoter, and this was dependent on ERK2/1 activation. FGF2 did not trans-activate NOS3 promoters with deletions upstream of the consensus AP-1 site(TGAGTCA, -678 to -685). Trans-activation of wild-type NOS3 promoter by FGF2 was significantly inhibited when either the AP-1 or the cAMP-response element (CRE)-like sequence (TGCGTCA, -752 to -758) was mutated and was completely blocked when both were mutated. EMSA analyses showed that FGF2, but not VEGF, stimulated AP-1 and CRE DNA-protein complexes primarily composed of JunB and Fra1. Chromatin immunoprecipitation assays confirmed JunB/Fra1 binding to NOS3 promoter AP-1 and CRE elements in intact cells. FGF2, but not VEGF, stimulated JunB and Fra1 expressions; all preceded NOS3 up-regulation and were inhibited by PD98059. Down-regulation of JunB or Fra-1, but not c-Jun, blocked FGF2 stimulation of NOS3 expression and NO production. AP-1 inhibition suppressed FGF2 stimulation of NOS3 expression in human umbilical vein EC and uterine artery endothelial cells. Thus, FGF2 induction of NOS3 expression is mainly mediated by AP-1-dependent transcription involving JunB and Fra1 up-regulation via sustained ERK2/1 activation in endothelial cells.	[Liao, Wu-xiang; Wang, Wen; Chen, Dong-bao] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92697 USA; [Mata-Greenwood, Eugenia; Liao, Wu-xiang; Chen, Dong-bao] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Zheng, Jing] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53715 USA	University of California System; University of California Irvine; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison	Chen, DB (corresponding author), Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92697 USA.	dongbaoc@uci.edu	Marta-Greenwood, Eugenia/AAR-9190-2020	Mata-Greenwood, Eugenia/0000-0002-6647-9048	National Institutes of Health [RO1 HL64703, RO1 HL74947, HL70562]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070562, R01HL074947, R01HL064703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL64703 (to J. Z.) and RO1 HL74947 and HL70562 (to D.-b. C.).	Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; BIELINSKA A, 1990, SCIENCE, V250, P997, DOI 10.1126/science.2237444; Borowicz PP, 2007, BIOL REPROD, V76, P259, DOI 10.1095/biolreprod.106.054684; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Ducsay CA, 2006, AM J PHYSIOL-REG I, V291, pR1406, DOI 10.1152/ajpregu.00077.2006; Fish JE, 2006, CELL MOL LIFE SCI, V63, P144, DOI 10.1007/s00018-005-5421-8; Fisslthaler B, 2003, NITRIC OXIDE-BIOL CH, V8, P253, DOI 10.1016/S1089-8603(03)00042-9; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hoffmann A, 2001, J CELL PHYSIOL, V188, P33, DOI 10.1002/jcp.1092; HSU JC, 1993, CANCER RES, V53, P3789; Hurd TW, 2002, BIOCHEM J, V368, P573, DOI 10.1042/BJ20020579; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Li Y, 2004, BIOL REPROD, V70, P785, DOI 10.1095/biolreprod.103.022293; Liao WX, 2009, MOL ENDOCRINOL, V23, P1428, DOI 10.1210/me.2008-0475; Liao WX, 2005, BIOL REPROD, V72, P530, DOI 10.1095/biolreprod.104.035949; Mata-Greenwood E, 2008, PLACENTA, V29, P708, DOI 10.1016/j.placenta.2008.05.005; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Min J, 2006, HYPERTENSION, V47, P1189, DOI 10.1161/01.HYP.0000222892.37375.4d; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Nelson SH, 2000, CIRC RES, V87, P406; Niwano K, 2003, CIRC RES, V93, P523, DOI 10.1161/01.RES.0000091336.55487.F7; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Qian XX, 2007, MOL CELL ENDOCRINOL, V279, P39, DOI 10.1016/j.mce.2007.08.017; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reynolds LP, 2006, J PHYSIOL-LONDON, V572, P51, DOI 10.1113/jphysiol.2005.104430; Rui T, 2005, CARDIOVASC RES, V65, P719, DOI 10.1016/j.cardiores.2004.11.019; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Varghese S, 2000, ENDOCRINOLOGY, V141, P2185, DOI 10.1210/en.141.6.2185; Wedgwood S, 2003, AM J PHYSIOL-LUNG C, V284, pL650, DOI 10.1152/ajplung.00252.2002; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; Young MR, 2002, MOL CELL BIOL, V22, P587, DOI 10.1128/MCB.22.2.587-598.2002; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320; Zheng J, 2005, BIOL REPROD, V72, P1421, DOI 10.1095/biolreprod.104.039172; Zheng J, 2005, J PHYSIOL-LONDON, V565, P59, DOI 10.1113/jphysiol.2004.082420; Zheng J, 1999, ENDOCRINOLOGY, V140, P1399, DOI 10.1210/en.140.3.1399; Zheng J, 2008, BIOL REPROD, V78, P143, DOI 10.1095/biolreprod.107.064477	43	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17348	17358		10.1074/jbc.M109.092791	http://dx.doi.org/10.1074/jbc.M109.092791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371606	hybrid, Green Published			2022-12-27	WOS:000278133400012
J	Wang, K; Li, PF				Wang, Kun; Li, Pei-Feng			Foxo3a Regulates Apoptosis by Negatively Targeting miR-21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA-21; P53; EXPRESSION; CANCER; TRANSCRIPTION; GENE; CONTRIBUTES; BINDING; PDCD4; INVASION	MicroRNAs are a class of small non-coding RNAs and participate in the regulation of apoptotic program. Although miR-21 is able to inhibit apoptosis, its expression regulation and downstream targets remain to be fully elucidated. Here we report that the transcriptional factor Foxo3a initiates apoptosis by transcriptionally repressing miR-21 expression. Our results showed that doxorubicin could simultaneously induce the translocation of Foxo3a to the cell nuclei and a reduction in miR-21 expression. Knockdown of Foxo3a resulted in an elevation in miR-21 levels, whereas enforced expression of Foxo3a led to a decrease in miR-21 expression. In exploring the molecular mechanism by which Foxo3a regulates miR-21, we observed that Foxo3a bound to the promoter region of miR-21 and suppressed its promoter activity. These results indicate that Foxo3a can transcriptionally repress miR-21 expression. In searching for the downstream targets of miR-21 in apoptosis, we found that miR-21 suppressed the translation of Fas ligand (FasL), a pro-apoptotic factor. Furthermore, Foxo3a was able to up-regulate FasL expression through down-regulating miR-21. Our data suggest that Foxo3a negatively regulates miR-21 in initiating apoptosis.	[Wang, Kun; Li, Pei-Feng] Chinese Acad Sci, Canc Res Grp, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, PF (corresponding author), Chinese Acad Sci, Canc Res Grp, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Li, Peifeng/ABD-5663-2021; Li, Peifeng/AHE-6906-2022	Li, Peifeng/0000-0002-0969-9407	National Natural Science Foundation of China [30730045, 30871243]; National Basic Research Program of China (973 Program) [2007CB512000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30730045 and 30871243 and by the National Basic Research Program of China (973 Program, Grant 2007CB512000).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Li PF, 1999, FEBS LETT, V448, P206, DOI 10.1016/S0014-5793(99)00370-1; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Wallach D, 2008, CELL DEATH DIFFER, V15, P1533, DOI 10.1038/cdd.2008.41; Wang JX, 2009, CANCER RES, V69, P492, DOI 10.1158/0008-5472.CAN-08-2962; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	49	85	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16958	16966		10.1074/jbc.M109.093005	http://dx.doi.org/10.1074/jbc.M109.093005			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371612	hybrid, Green Published			2022-12-27	WOS:000277982600059
J	Horta, BB; de Oliveira, MA; Discola, KF; Cussiol, JRR; Netto, LES				Horta, Bruno Brasil; de Oliveira, Marcos Antonio; Discola, Karen Fulan; Rosa Cussiol, Jose Renato; Soares Netto, Luis Eduardo			Structural and Biochemical Characterization of Peroxiredoxin Q beta from Xylella fastidiosa CATALYTIC MECHANISM AND HIGH REACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE PEROXIDASES; THIOREDOXIN PEROXIDASE; GENE FAMILY; CYSTEINE; EXPRESSION; PROTEINS; PEROXYNITRITE; TRYPAREDOXIN; OXIDATION; ANTIGEN	The phytopathogenic bacterium Xylella fastidiosa is the etiological agent of various plant diseases. To survive under oxidative stress imposed by the host, microorganisms express antioxidant proteins, including cysteine-based peroxidases named peroxiredoxins. This work is a comprehensive analysis of the catalysis performed by PrxQ from X. fastidiosa (XfPrxQ) that belongs to a peroxiredoxin class still poorly characterized and previously considered as moderately reactive toward hydroperoxides. Contrary to these assumptions, our competitive kinetics studies have shown that the second-order rate constants of the peroxidase reactions of XfPrxQ with hydrogen peroxide and peroxynitrite are in the order of 107 and 106 M-1 s(-1), respectively, which are as fast as the most efficient peroxidases. The XfPrxQ disulfides were only slightly reducible by dithiothreitol; therefore, the identification of a thioredoxin system as the probable biological reductant of XfPrxQ was a relevant finding. We also showed by site-specific mutagenesis and mass spectrometry that an intramolecular disulfide bond between Cys-47 and Cys-83 is generated during the catalytic cycle. Furthermore, we elucidated the crystal structure of XfPrxQ C47S in which Ser-47 and Cys-83 lie similar to 12.3 angstrom apart. Therefore, significant conformational changes are required for disulfide bond formation. In fact, circular dichroism data indicated that there was a significant redox-dependent unfolding of alpha-helices, which is probably triggered by the peroxidatic cysteine oxidation. Finally, we proposed a model that takes data from this work as well data as from the literature into account.	[Horta, Bruno Brasil; Discola, Karen Fulan; Rosa Cussiol, Jose Renato; Soares Netto, Luis Eduardo] Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias, BR-05508900 Sao Paulo, Brazil; [de Oliveira, Marcos Antonio] Univ Estadual Paulista, Dept Biol, BR-11330900 Sao Vicente, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Netto, LES (corresponding author), Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias, BR-05508900 Sao Paulo, Brazil.	nettoles@ib.usp.br	Discola, Karen F/J-5025-2014; de Oliveira, Marcos A/K-5746-2015; Netto, Luis/A-3783-2008; Cussiol, José Renato/E-5142-2015	de Oliveira, Marcos A/0000-0002-1192-7296; Netto, Luis/0000-0002-4250-9177; Cussiol, José Renato/0000-0001-5909-8215	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Brazilian Synchrotron Light Laboratory [D03B-MX1 7568]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Synchrotron Light Laboratory	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (as part of Projeto Milenio Redoxoma), and the Brazilian Synchrotron Light Laboratory under Proposal D03B-MX1 7568 (performed on beamline W01B-MX2).	Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; AMARO AA, 1998, CITRUS VARIEGATED CH, P123; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Copley SD, 2004, BIOCHEMISTRY-US, V43, P13981, DOI 10.1021/bi048947r; D'Ambrosio K, 2009, PROTEINS, V76, P995, DOI 10.1002/prot.22408; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flohe L, 2002, METHOD ENZYMOL, V347, P244; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hammad Y, 2001, CAN J MICROBIOL, V47, P541, DOI 10.1139/cjm-47-6-541; Hendson M, 2001, APPL ENVIRON MICROB, V67, P895, DOI 10.1128/AEM.67.2.895-903.2001; Herbette S, 2007, FEBS J, V274, P2163, DOI 10.1111/j.1742-4658.2007.05774.x; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Horling F, 2003, PLANT PHYSIOL, V131, P317, DOI 10.1104/pp.010017; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Koh CS, 2007, J MOL BIOL, V370, P512, DOI 10.1016/j.jmb.2007.04.031; Kong W, 2000, BIOCHEM J, V351, P107, DOI 10.1042/0264-6021:3510107; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Koszelak-Rosenblum M, 2008, J BIOL CHEM, V283, P24962, DOI 10.1074/jbc.M804358200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamkemeyer P, 2006, PLANT J, V45, P968, DOI 10.1111/j.1365-313X.2006.02665.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Liao SJ, 2009, J MOL BIOL, V390, P951, DOI 10.1016/j.jmb.2009.05.030; Link AJ, 1997, ELECTROPHORESIS, V18, P1259, DOI 10.1002/elps.1150180807; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; OTOOLE PW, 1991, J BACTERIOL, V173, P505, DOI 10.1128/jb.173.2.505-513.1991; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; POOLE LB, 2008, CURR PROTOC TOXICOL, V38; Poole Leslie B., 2007, V44, P61; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rouhier N, 2005, FREE RADICAL BIO MED, V38, P1413, DOI 10.1016/j.freeradbiomed.2004.07.037; Rouhier N, 2004, PLANT PHYSIOL, V134, P1027, DOI 10.1104/pp.103.035865; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Segel I.H., 1993, ENZYME KINETICS, P606; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Smolka MB, 2003, PROTEOMICS, V3, P224, DOI 10.1002/pmic.200390031; Netto LES, 2007, COMP BIOCHEM PHYS C, V146, P180, DOI 10.1016/j.cbpc.2006.07.014; Stork T, 2009, ARCH MICROBIOL, V191, P141, DOI 10.1007/s00203-008-0438-7; Sun CH, 1998, J MOL BIOL, V280, P687, DOI 10.1006/jmbi.1998.1913; TENHAKEN R, 1995, P NATL ACAD SCI USA, V92, P4158, DOI 10.1073/pnas.92.10.4158; TORIAN BE, 1990, P NATL ACAD SCI USA, V87, P6358, DOI 10.1073/pnas.87.16.6358; Trivelli X, 2003, BIOCHEMISTRY-US, V42, P14139, DOI 10.1021/bi035551r; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Trujillo Madia, 2007, V44, P83; Trujillo M, 2007, ARCH BIOCHEM BIOPHYS, V467, P95, DOI 10.1016/j.abb.2007.08.008; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714; Wakita M, 2007, J BIOL CHEM, V282, P27792, DOI 10.1074/jbc.M702855200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wrzaczek M, 2009, P NATL ACAD SCI USA, V106, P5412, DOI 10.1073/pnas.0808980106; YAMAGUCHI R, 1992, INFECT IMMUN, V60, P1210, DOI 10.1128/IAI.60.3.1210-1216.1992; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	65	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16051	16065		10.1074/jbc.M109.094839	http://dx.doi.org/10.1074/jbc.M109.094839			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335172	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000277715900043
J	Schwendener, S; Raynard, S; Paliwal, S; Cheng, A; Kanagaraj, R; Shevelev, I; Stark, JM; Sung, P; Janscak, P				Schwendener, Sybille; Raynard, Steven; Paliwal, Shreya; Cheng, Anita; Kanagaraj, Radhakrishnan; Shevelev, Igor; Stark, Jeremy M.; Sung, Patrick; Janscak, Pavel			Physical Interaction of RECQ5 Helicase with RAD51 Facilitates Its Anti-recombinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; STRAND EXCHANGE; DNA HELICASE; SRS2; PROTEIN; FILAMENT; COMPLEX; PROMOTES; ROLES; HOP2	Homologous recombination (HR) provides an efficient mechanism for error-free repair of DNA double-strand breaks (DSBs). However, HR can be also harmful as inappropriate or untimely HR events can give rise to lethal recombination intermediates and chromosome rearrangements. A critical step of HR is the formation of a RAD51 filament on single-stranded (ss) DNA, which mediates the invasion of a homologous DNA molecule. In mammalian cells, several DNA helicases have been implicated in the regulation of this process. RECQ5, a member of the RecQ family of DNA helicases, interacts physically with the RAD51 recombinase and disrupts RAD51 presynaptic filaments in a reaction dependent on ATP hydrolysis. Here, we have precisely mapped the RAD51-interacting domain of RECQ5 and generated mutants that fail to interact with RAD51. We show that although these mutants retain normal ATPase activity, they are impaired in their ability to displace RAD51 from ssDNA. Moreover, we show that ablation of RECQ5-RAD51 complex formation by a point mutation alleviates the inhibitory effect of RECQ5 on HR-mediated DSB repair. These findings provide support for the proposal that interaction with RAD51 is critical for the anti-recombinase attribute of RECQ5.	[Schwendener, Sybille; Paliwal, Shreya; Kanagaraj, Radhakrishnan; Janscak, Pavel] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Raynard, Steven; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Cheng, Anita; Stark, Jeremy M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Shevelev, Igor] Acad Sci Czech Republ, Inst Mol Genet, Prague 14300, Czech Republic	University of Zurich; Yale University; City of Hope; Beckman Research Institute of City of Hope; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Janscak, P (corresponding author), Winterthurerstr 190, CH-8057 Zurich, Switzerland.	pjanscak@imcr.uzh.ch	Kanagaraj, Raj R./O-3205-2016; Janscak, Pavel/G-6189-2014; Janscak, Pavel/Q-3795-2018	Janscak, Pavel/0000-0002-1748-7789; Radhakrishnan, Kanagaraj/0000-0003-0906-5399	National Institutes of Health [R01CA120954, ES015632]; Swiss National Science Foundation [3100A0-116008]; Stiftung zur Krebsbekaempfung; NATIONAL CANCER INSTITUTE [R01CA120954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung zur Krebsbekaempfung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA120954 (to J. M. S.) and ES015632 (to P. S.). This work was also supported by grants from the Swiss National Science Foundation (3100A0-116008) and Stiftung zur Krebsbekaempfung (to P. J.).	Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fugger K, 2009, J CELL BIOL, V186, P655, DOI 10.1083/jcb.200812138; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Le Breton C, 2008, NUCLEIC ACIDS RES, V36, P4964, DOI 10.1093/nar/gkn441; LYNN RM, 1989, PROTEINS, V6, P231, DOI 10.1002/prot.340060305; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Seong C, 2009, J BIOL CHEM, V284, P24363, DOI 10.1074/jbc.M109.032953; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Zheng L, 2009, NUCLEIC ACIDS RES, V37, P2645, DOI 10.1093/nar/gkp147	33	63	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15739	15745		10.1074/jbc.M110.110478	http://dx.doi.org/10.1074/jbc.M110.110478			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348101	Green Published, hybrid			2022-12-27	WOS:000277715900009
J	Tang, TTT; Badger, JD; Roche, PA; Roche, KW				Tang, Tina Tze-Tsang; Badger, John D., II; Roche, Paul A.; Roche, Katherine W.			Novel Approach to Probe Subunit-specific Contributions to N-Methyl-D-aspartate (NMDA) Receptor Trafficking Reveals a Dominant Role for NR2B in Receptor Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; C-TERMINUS; ENDOCYTOSIS; EXPRESSION; MOLECULES; SYNAPSES; BINDING	N-Methyl-D-aspartate (NMDA) receptors are expressed at excitatory synapses throughout the brain and are essential for neuronal development and synaptic plasticity. Functional NMDA receptors are tetramers, typically composed of NR1 and NR2 subunits (NR2A-D). NR2A and NR2B are expressed in the forebrain and are thought to assemble as diheteromers (NR1/NR2A, NR1/NR2B) and triheteromers (NR1/NR2A/NR2B). NR2A and NR2B contain cytosolic domains that regulate distinct postendocytic sorting events, with NR2A sorting predominantly into the degradation pathway, and NR2B preferentially trafficking through the recycling pathway. However, the interplay between these two subunits remains an open question. We have now developed a novel approach based on the dimeric feature of the alpha- and beta-chains of the human major histocompatibility complex class II molecule. We created chimeras of alpha- and beta-chains with the NR2A and NR2B C termini and evaluated endocytosis of dimers. Like chimeric proteins containing only a single NR2A or NR2B C-terminal domain, major histocompatibility complex class II-NR2A homodimers sort predominantly to late endosomes, whereas NR2B homodimers traffic to recycling endosomes. Interestingly, NR2A/NR2B heterodimers traffic preferentially through the recycling pathway, and NR2B is dominant in regulating dimer trafficking in both heterologous cells and neurons. In addition, the recycling of NR2B-containing NMDARs in wild-type neurons is not significantly different from NR2A(-/-) neurons. These data support a dominant role for NR2B in regulating the trafficking of triheteromeric NMDARs in vivo. Furthermore, our molecular approach allows for the direct and selective evaluation of dimeric assemblies and can be used to define dominant trafficking domains in other multisubunit protein complexes.	[Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA; [Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Tang, Tina Tze-Tsang] Univ Bristol, Sch Med Sci, Dept Anat, Med Res Council,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol	Roche, KW (corresponding author), NINDS, Receptor Biol Sect, NIH, Bldg 35,Rm 2C903, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Roche, Katherine/W-9893-2019; tang, tina/GRX-7859-2022	Roche, Paul/0000-0002-8949-9172; Roche, Katherine/0000-0001-7282-6539	NINDS, National Institutes of Health; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of NINDS and NCI, National Institutes of Health.	Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; RADKA SF, 1984, HUM IMMUNOL, V10, P177, DOI 10.1016/0198-8859(84)90038-7; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803	20	24	25	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20975	20981		10.1074/jbc.M110.102210	http://dx.doi.org/10.1074/jbc.M110.102210			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427279	Green Published, hybrid			2022-12-27	WOS:000279228600061
J	Charriere, GM; Ip, WKE; Dejardin, S; Boyer, L; Sokolovska, A; Cappillino, MP; Cherayil, BJ; Podolsky, DK; Kobayashi, KS; Silverman, N; Lacy-Hulbert, A; Stuart, LM				Charriere, Guillaume M.; Ip, W. K. Eddie; Dejardin, Stephanie; Boyer, Laurent; Sokolovska, Anna; Cappillino, Michael P.; Cherayil, Bobby J.; Podolsky, Daniel K.; Kobayashi, Koichi S.; Silverman, Neal; Lacy-Hulbert, Adam; Stuart, Lynda M.			Identification of Drosophila Yin and PEPT2 as Evolutionarily Conserved Phagosome-associated Muramyl Dipeptide Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTORS; NF-KAPPA-B; CROHNS-DISEASE; NOD2; RECOGNITION; ACTIVATION; CELLS; INTERNALIZATION; SUSCEPTIBILITY	NOD2 (nucleotide-binding oligomerization domain containing 2) is an important cytosolic pattern recognition receptor that activates NF-kappa B and other immune effector pathways such as autophagy and antigen presentation. Despite its intracellular localization, NOD2 participates in sensing of extracellular microbes such as Staphylococcus aureus. NOD2 ligands similar to the minimal synthetic ligand muramyl dipeptide (MDP) are generated by internalization and processing of bacteria in hydrolytic phagolysosomes. However, how these derived ligands exit this organelle and access the cytosol to activate NOD2 is poorly understood. Here, we address how phagosome-derived NOD2 ligands access the cytosol in human phagocytes. Drawing on data from Drosophila phagosomes, we identify an evolutionarily conserved role of SLC15A transporters, Drosophila Yin and PEPT2, as MDP transporters in fly and human phagocytes, respectively. We show that PEPT2 is highly expressed by human myeloid cells. Ectopic expression of both Yin and PEPT2 increases the sensitivity of NOD2-dependent NF-kappa B activation. Additionally, we show that PEPT2 associates with phagosome membranes. Together, these data identify Drosophila Yin and PEPT2 as evolutionarily conserved phagosome-associated transporters that are likely to be of particular importance in delivery of bacteria-derived ligands generated in phagosomes to cytosolic sensors recruited to the vicinity of these organelles.	[Cherayil, Bobby J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mucosal Immunol Lab, Boston, MA 02144 USA; [Podolsky, Daniel K.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Kobayashi, Koichi S.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Silverman, Neal] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Stuart, LM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Jackson 14,55 Fruit St, Boston, MA 02114 USA.	lstuart@partners.org	Ip, W. K. Eddie/C-3042-2012; BOYER, Laurent/AAH-4543-2021; Charriere, Guillaume M/O-8317-2014; Charriere, Guillaume/Z-1574-2019; Boyer, laurent/F-8921-2015	Ip, W. K. Eddie/0000-0003-1953-972X; BOYER, Laurent/0000-0002-1375-1706; Charriere, Guillaume M/0000-0002-4796-1488; Charriere, Guillaume/0000-0002-4796-1488; Boyer, laurent/0000-0002-1375-1706; Silverman, Neal/0000-0002-4259-456X; dejardin, stephanie/0000-0001-5328-1414; Kobayashi, Koichi/0000-0003-2930-0114; Lacy-Hulbert, Adam/0000-0003-2162-0156	NIAID NIH HHS [R01 AI074958, R01 AI079198, R01 AI079198-02] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-15, R01 DK074738, P30 DK043351, P30 DK040561, R01 DK074738-05] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198, R01AI074958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK043351, R01DK074738] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ismair MG, 2006, CAN J PHYSIOL PHARM, V84, P1313, DOI 10.1139/Y06-076; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kapetanovic R, 2007, INFECT IMMUN, V75, P830, DOI 10.1128/IAI.01199-06; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; SHIMADA T, CELL HOST MICROBE, V7, P38; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Swaan PW, 2008, AM J RESP CELL MOL, V39, P536, DOI 10.1165/rcmb.2008-0059OC; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Viala M, 2004, CR BIOL, V327, P551, DOI 10.1016/j.crvi.2004.02.010; Warren HS, 2009, J LEUKOCYTE BIOL, V86, P199, DOI 10.1189/jlb.0309210	36	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20147	20154		10.1074/jbc.M110.115584	http://dx.doi.org/10.1074/jbc.M110.115584			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406817	Green Published, hybrid			2022-12-27	WOS:000279012000049
J	Ramakrishnan, L; Muller-Steffner, H; Bosc, C; Vacquier, VD; Schuber, F; Moutin, MJ; Dale, L; Patel, S				Ramakrishnan, Latha; Muller-Steffner, Helene; Bosc, Christophe; Vacquier, Victor D.; Schuber, Francis; Moutin, Marie-Jo; Dale, Leslie; Patel, Sandip			A Single Residue in a Novel ADP-ribosyl Cyclase Controls Production of the Calcium-mobilizing Messengers Cyclic ADP-ribose and Nicotinic Acid Adenine Dinucleotide Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-SPECIFIC NADASE; ACTIVE-SITE; SEA-URCHIN; MOLECULAR CHARACTERIZATION; INOSITOL TRISPHOSPHATE; NAD(+) GLYCOHYDROLASE; 2ND-MESSENGER ENZYME; SCHISTOSOMA-MANSONI; XENOPUS DEVELOPMENT; CD38	Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate are ubiquitous calcium-mobilizing messengers produced by the same family of multifunctional enzymes, the ADP-ribosyl cyclases. Not all ADP-ribosyl cyclases have been identified, and how production of different messengers is achieved is incompletely understood. Here, we report the cloning and characterization of a novel ADP-ribosyl cyclase (SpARC4) from the sea urchin, a key model organism for the study of calcium-signaling pathways. Like several other members of the ADP-ribosyl cyclase superfamily, SpARC4 is a glycoprotein targeted to the plasma membrane via a glycosylphosphatidylinositol anchor. However, unlike most other members, SpARC4 shows a remarkable preference for producing cyclic ADP-ribose over nicotinic acid adenine dinucleotide phosphate. Mutation of a single residue (tyrosine 142) within a noncanonical active site reversed this striking preference. Our data highlight further diversification of this unusual enzyme family, provide mechanistic insight into multifunctionality, and suggest that different ADP-ribosyl cyclases are fine-tuned to produce specific calcium-mobilizing messengers.	[Ramakrishnan, Latha; Dale, Leslie; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Muller-Steffner, Helene; Schuber, Francis] Univ Strasbourg, Fac Pharm, F-67400 Illkirch Graffenstaden, France; [Bosc, Christophe; Moutin, Marie-Jo] Univ Grenoble 1, INSERM, U836, Grenoble Inst Neurosci,CEA iRTSV GPC, F-38042 Grenoble, France; [Vacquier, Victor D.] Univ Calif San Diego, Div Marine Biol Res, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of London; University College London; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of California System; University of California San Diego; Scripps Institution of Oceanography	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	patel.s@ucl.ac.uk	Bosc, Christophe/P-3401-2017; Bosc, Christophe/Q-8877-2019; Moutin, Marie-Jo/P-7518-2017; Patel, Sandip/O-9591-2015	Bosc, Christophe/0000-0002-3195-6692; Bosc, Christophe/0000-0002-3195-6692; Moutin, Marie-Jo/0000-0003-2681-9818; Patel, Sandip/0000-0001-7247-2013	Biotechnology and Biological Sciences Research Council [BB/D018110/1, BB/G013721/1]; Medical Research Council; BBSRC [BB/G013721/1, BB/D018110/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Grants BB/D018110/1 and BB/G013721/1 from the Biotechnology and Biological Sciences Research Council (to S.P.).; Recipient of a Ph.D. studentship from the Medical Research Council.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Berridge G, 2002, J BIOL CHEM, V277, P43717, DOI 10.1074/jbc.M203224200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; Billington RA, 2006, FERTIL STERIL, V86, P891, DOI 10.1016/j.fertnstert.2006.03.030; Birsoy B, 2005, DEVELOPMENT, V132, P591, DOI 10.1242/dev.01599; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Cakir-Kiefer C, 2000, BIOCHEM J, V349, P203, DOI 10.1042/0264-6021:3490203; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Ceni C, 2003, J BIOL CHEM, V278, P40670, DOI 10.1074/jbc.M301196200; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Fukushi Y, 2001, J BIOL CHEM, V276, P649, DOI 10.1074/jbc.M004469200; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; GLICK DL, 1991, CELL REGUL, V2, P211, DOI 10.1091/mbc.2.3.211; Goodrich SP, 2005, BIOCHEMISTRY-US, V44, P11082, DOI 10.1021/bi050704r; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; Graeff RM, 1998, J BIOL CHEM, V273, P118, DOI 10.1074/jbc.273.1.118; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; HELLMICH MR, 1991, CELL REGUL, V2, P193, DOI 10.1091/mbc.2.3.193; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kim SY, 2010, J BIOL CHEM, V285, P576, DOI 10.1074/jbc.M109.076216; Kuhn I, 2006, BIOCHEMISTRY-US, V45, P11867, DOI 10.1021/bi060930g; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 1999, MOL CELL BIOCHEM, V193, P89; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Matsumura N, 1998, BIOCHEM BIOPH RES CO, V253, P246, DOI 10.1006/bbrc.1998.9752; Meszaros LG, 1997, BIOCHEM BIOPH RES CO, V234, P252, DOI 10.1006/bbrc.1997.6620; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi C, 1999, J BIOL CHEM, V274, P30770, DOI 10.1074/jbc.274.43.30770; Nelsen S, 2005, DEV DYNAM, V233, P1038, DOI 10.1002/dvdy.20378; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Patel S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.295pe69; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Prasad GS, 1996, NAT STRUCT BIOL, V3, P957, DOI 10.1038/nsb1196-957; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Sternfeld L, 2003, J BIOL CHEM, V278, P33629, DOI 10.1074/jbc.M301043200; TOHGO A, 1994, J BIOL CHEM, V269, P28555; Vasudevan SR, 2008, BIOCHEM J, V411, P63, DOI 10.1042/BJ20071616; Wilson HL, 2001, J BIOL CHEM, V276, P11180, DOI 10.1074/jbc.M004849200; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Zhang B, 2007, BIOCHEMISTRY-US, V46, P4100, DOI 10.1021/bi061933w; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zocchi E, 1996, FEBS LETT, V396, P327, DOI 10.1016/0014-5793(96)01125-8	66	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19900	19909		10.1074/jbc.M110.105312	http://dx.doi.org/10.1074/jbc.M110.105312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20385553	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-27	WOS:000279012000023
J	Biswas-Fiss, EE; Kurpad, DS; Joshi, K; Biswas, SB				Biswas-Fiss, Esther E.; Kurpad, Deepa S.; Joshi, Kinjalben; Biswas, Subhasis B.			Interaction of Extracellular Domain 2 of the Human Retina-specific ATP-binding Cassette Transporter (ABCA4) with All-trans-retinal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; EYE PIGMENT PRECURSORS; MUTATIONAL ANALYSIS; SECONDARY STRUCTURE; SEQUENCE VARIATIONS; FUNCTIONAL-ANALYSIS; STARGARDT-DISEASE; ESTROGEN-RECEPTOR; GENE-THERAPY; RIM PROTEIN	The retina-specific ATP-binding cassette (ABC) transporter, ABCA4, is essential for transport of all-trans-retinal from the rod outer segment discs in the retina and is associated with a broad range of inherited retinal diseases, including Stargardt disease, autosomal recessive cone rod dystrophy, and fundus flavimaculatus. A unique feature of the ABCA subfamily of ABC transporters is the presence of highly conserved, long extracellular loops or domains (ECDs) with unknown function. The high degree of sequence conservation and mapped disease-associated mutations in these domains suggests an important physiological significance. Conformational analysis using CD spectroscopy of purified, recombinant ECD2 protein demonstrated that it has an ordered and stable structure composed of 27 +/- 3% alpha-helix, 20 +/- 3% beta-pleated sheet, and 53 +/- 3% coil. Significant conformational changes were observed in disease-associated mutant proteins. Using intrinsic tryptophan fluorescence emission spectrum of ECD2 polypeptide and fluorescence anisotropy, we have demonstrated that this domain specifically interacts with all-trans-retinal. Furthermore, the retinal interaction appeared preferential for the all-trans-isomer and was directly measurable through fluorescence anisotropy analysis. Our results demonstrate that the three macular degeneration-associated mutations lead to significant changes in the secondary structure of the ECD2 domain of ABCA4, as well as in its interaction with all-trans-retinal.	[Biswas-Fiss, Esther E.; Kurpad, Deepa S.; Joshi, Kinjalben] Thomas Jefferson Univ, Dept Biosci Technol, Program Biotechnol, Jefferson Sch Hlth Profess, Philadelphia, PA 19107 USA; [Biswas-Fiss, Esther E.; Kurpad, Deepa S.; Biswas, Subhasis B.] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA	Jefferson University; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Biswas-Fiss, EE (corresponding author), Thomas Jefferson Univ, Dept Biosci Technol, Program Biotechnol, Jefferson Sch Hlth Profess, Edison Bldg,Ste 1924,130 S 9th St, Philadelphia, PA 19107 USA.	esther.biswas@jefferson.edu			NEI [EY 013113]; NATIONAL EYE INSTITUTE [R15EY013113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI064974, R42AI064974] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant EY 013113 from NEI and an administrative supplement, Quantitative Physical Measurements at the Nanoscale (to E. E. B.- F.) and AI064974 (to S. B. B.).	Ahn J, 2000, METHOD ENZYMOL, V315, P864; Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arnell H, 1998, ACTA OPHTHALMOL SCAN, V76, P649, DOI 10.1034/j.1600-0420.1998.760602.x; Balan A, 2008, GENET MOL RES, V7, P117, DOI 10.4238/vol7-1gmr392; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Bennett J, 2009, NEW ENGL J MED, V361, P2483, DOI 10.1056/NEJMcibr0908643; BERKOWER C, 1991, EMBO J, V10, P3777, DOI 10.1002/j.1460-2075.1991.tb04947.x; Biswas EE, 2001, BIOCHEMISTRY-US, V40, P8181, DOI 10.1021/bi0106686; Biswas-Fiss EE, 2006, BIOCHEMISTRY-US, V45, P3813, DOI 10.1021/bi052059u; Biswas-Fiss EE, 2003, BIOCHEMISTRY-US, V42, P10683, DOI 10.1021/bi034481l; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Boyer M, 2000, NUCLEIC ACIDS RES, V28, P2494, DOI 10.1093/nar/28.13.2494; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs CE, 2001, INVEST OPHTH VIS SCI, V42, P2229; Brunkhorst C, 2005, RES MICROBIOL, V156, P322, DOI 10.1016/j.resmic.2004.10.016; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; CHEN WY, 1993, MOL CELL ENDOCRINOL, V91, P35, DOI 10.1016/0303-7207(93)90252-F; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Duffieux F, 2000, EUR J BIOCHEM, V267, P5306, DOI 10.1046/j.1432-1327.2000.01614.x; EWART GD, 1994, J BIOL CHEM, V269, P10370; Ewart GD, 1998, METHOD ENZYMOL, V292, P213; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504, DOI 10.1001/archopht.117.4.504; GRYCZYNSKI I, 1988, BIOPHYS CHEM, V32, P173, DOI 10.1016/0301-4622(88)87005-4; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Jaakson K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/humu.10263; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; Klevering BJ, 2005, GRAEF ARCH CLIN EXP, V243, P90, DOI 10.1007/s00417-004-1079-4; Klevering BJ, 2002, INVEST OPHTH VIS SCI, V43, P1980; KOTIK M, 1993, EUR J BIOCHEM, V211, P267, DOI 10.1111/j.1432-1033.1993.tb19895.x; Kreimer DI, 2000, EUR J BIOCHEM, V267, P4242; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz JR, 2006, PRINCIPALS FLUORESCE, P533; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P449; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Liao JH, 2009, MOL VIS, V15, P1429; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; Lugo MR, 2009, ARCH BIOCHEM BIOPHYS, V492, P17, DOI 10.1016/j.abb.2009.10.002; Mace PD, 2007, PROTEIN EXPRES PURIF, V52, P40, DOI 10.1016/j.pep.2006.07.025; Massiah MA, 1999, BIOCHEMISTRY-US, V38, P7453, DOI 10.1021/bi9903603; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pogenberg V, 2005, J BIOL CHEM, V280, P1625, DOI 10.1074/jbc.M409302200; Radu RA, 2004, P NATL ACAD SCI USA, V101, P5928, DOI 10.1073/pnas.0308302101; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Samanta U, 2001, PROTEIN ENG, V14, P7, DOI 10.1093/protein/14.1.7; SAMBROOK J, 1989, MOL CLONING LAB MANU, P391; September AV, 2004, INVEST OPHTH VIS SCI, V45, P1705, DOI 10.1167/iovs.03-1167; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Shroyer NF, 2001, HUM MOL GENET, V10, P2671, DOI 10.1093/hmg/10.23.2671; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Suarez T, 2002, J BIOL CHEM, V277, P21759, DOI 10.1074/jbc.M202053200; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Webster AR, 2001, INVEST OPHTH VIS SCI, V42, P1179; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Winterfeld S, 2009, BIOCHEMISTRY-US, V48, P6684, DOI 10.1021/bi9003809; Yatsenko AN, 2005, J MOL EVOL, V60, P72, DOI 10.1007/s00239-004-0118-4; Zhang GP, 2008, J IMMUNOL METHODS, V334, P21, DOI 10.1016/j.jim.2008.01.020; Zhang K, 1999, GENOMICS, V60, P234, DOI 10.1006/geno.1999.5896	73	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19372	19383		10.1074/jbc.M110.112896	http://dx.doi.org/10.1074/jbc.M110.112896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404325	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000278727800048
J	Hamdan, SM; van Oijen, AM				Hamdan, Samir M.; van Oijen, Antoine M.			Timing, Coordination, and Rhythm: Acrobatics at the DNA Replication Fork	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LAGGING-STRAND SYNTHESIS; BACTERIOPHAGE T7; OKAZAKI FRAGMENT; POLYMERASE-ACTIVITY; PRIMER SYNTHESIS; SINGLE-MOLECULE; BINDING PROTEIN; PRIMASE; PROCESSIVITY; HELICASE	In DNA replication, the antiparallel nature of the parental duplex imposes certain constraints on the activity of the DNA polymerases that synthesize new DNA. The leading-strand polymerase advances in a continuous fashion, but the lagging-strand polymerase is forced to restart at short intervals. In several prokaryotic systems studied so far, this problem is solved by the formation of a loop in the lagging strand of the replication fork to reorient the lagging-strand DNA polymerase so that it advances in parallel with the leading-strand polymerase. The replication loop grows and shrinks during each cycle of Okazaki fragment synthesis. The timing of Okazaki fragment synthesis and loop formation is determined by a subtle interplay of enzymatic activities at the fork. Recent developments in single-molecule techniques have enabled the direct observation of these processes and have greatly contributed to a better understanding of the dynamic nature of the replication fork. Here, we will review recent experimental advances, present the current models, and discuss some of the exciting developments in the field.	[Hamdan, Samir M.; van Oijen, Antoine M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	van Oijen, AM (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	antoine_van_oijen@hms.harvard.edu	van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161; Hamdan, Samir/0000-0001-5192-1852	National Science Foundation; National Institutes of Health	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the National Science Foundation and the National Institutes of Health. To whom correspondence should be addressed. E-mail: antoine_van_oijen@hms.harvard.edu.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Carver TE, 1997, BIOCHEMISTRY-US, V36, P14409, DOI 10.1021/bi971423p; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; De Saro FJL, 2003, P NATL ACAD SCI USA, V100, P14689, DOI 10.1073/pnas.2435454100; DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7; Frick DN, 1999, J BIOL CHEM, V274, P35899, DOI 10.1074/jbc.274.50.35899; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Georgescu RE, 2009, EMBO J, V28, P2981, DOI 10.1038/emboj.2009.233; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; He ZG, 2004, J BIOL CHEM, V279, P22190, DOI 10.1074/jbc.M401100200; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; Kadyrov FA, 2001, J BIOL CHEM, V276, P29559, DOI 10.1074/jbc.M101310200; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kusakabe T, 1997, J BIOL CHEM, V272, P12446, DOI 10.1074/jbc.272.19.12446; Kusakabe T, 1997, J BIOL CHEM, V272, P5943, DOI 10.1074/jbc.272.9.5943; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Qimron U, 2006, EMBO J, V25, P2199, DOI 10.1038/sj.emboj.7601112; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; TABOR S, 1987, J BIOL CHEM, V262, P16212; Tanner NA, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp006; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; 2008, ANN REV BIOCH, V77, P45	44	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18979	18983		10.1074/jbc.R109.022939	http://dx.doi.org/10.1074/jbc.R109.022939			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382733	hybrid, Green Published			2022-12-27	WOS:000278727800005
J	Hassani, BK; Astier, C; Nitschke, W; Ouchane, S				Hassani, Bahia Khalfaoui; Astier, Chantal; Nitschke, Wolfgang; Ouchane, Soufian			CtpA, a Copper-translocating P-type ATPase Involved in the Biogenesis of Multiple Copper-requiring Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; CBB(3) OXIDASES; BACTERIA; REDUCTASE; PHOTOSYNTHESIS; HOMEOSTASIS; MECHANISMS; COMPLEXES; PATHWAY; SYSTEM	The ctpA (ccoI) gene product, a putative inner membrane copper-translocating P1B-type ATPase present in many bacteria, has been shown to be involved only in the cbb(3) assembly in Rhodobacter capsulatus and Bradyrhizobium japonicum. ctpA was disrupted in Rubrivivax gelatinosus, and the mutants showed a drastic decrease in both cbb(3) and caa(3) oxidase activities. Inactivation of ctpA results also in a decrease in the amount of the nitrous oxide reductase, NosZ. This pleiotropic phenotype could be partially rescued by excess copper in the medium, indicating that CtpA is likely a copper transporter that supplies copper-requiring proteins in the membrane with this metal. Although CtpA shares significant sequence homologies with the homeostasis copper efflux P1B-type ATPases including the bacterial CopA and the human ATP7A and ATP7B, disruption of ctpA did not result in any sensitivity to excess copper. This indicates that the CtpA is not crucial for copper tolerance but is involved in the assembly of membrane and periplasmic copper enzymes in this bacterium. The potential roles of CtpA in bacteria in comparison with CopA are discussed.	CNRS, Ctr Genet Mol, FRE 3144, F-91198 Gif Sur Yvette, France; Univ Paris 11, F-91405 Orsay, France; [Nitschke, Wolfgang] CNRS, Lab Bioenerget & Ingn Prot UPR 9036, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite		souchane@cgm.cnrs-gif.fr	Nitschke, Wolfgang/C-4812-2012; Ouchane, Soufian/ABE-2609-2020; OUCHANE, Soufian/HHM-5430-2022; Johnson, Michael D. L./B-4352-2012	Ouchane, Soufian/0000-0002-8161-3866; Nitschke, Wolfgang/0000-0003-2084-3032	Agence Nationale de la Recherche [ANR BLAN06-2_147814]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (ANR BLAN06-2_147814).	Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Bayle D, 1998, J BACTERIOL, V180, P317, DOI 10.1128/JB.180.2.317-329.1998; Cox DW, 2002, J BIOENERG BIOMEMBR, V34, P333, DOI 10.1023/A:1021293818125; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hassani BK, 2010, J BIOL CHEM, V285, P19891, DOI 10.1074/jbc.M109.086066; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; LEE HS, 1991, J BACTERIOL, V173, P5406, DOI 10.1128/jb.173.17.5406-5413.1991; Lemaire Claire, 2008, V432, P65, DOI 10.1007/978-1-59745-028-7_5; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; MARRS B, 1973, J BACTERIOL, V114, P1045, DOI 10.1128/JB.114.3.1045-1051.1973; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Ostermeier C, 1996, CURR OPIN STRUC BIOL, V6, P460, DOI 10.1016/S0959-440X(96)80110-2; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Ouchane S, 2007, J BIOL CHEM, V282, P7690, DOI 10.1074/jbc.M605985200; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Preisig O, 1996, ARCH MICROBIOL, V165, P297, DOI 10.1007/s002030050330; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rasmussen T, 2000, BIOCHEMISTRY-US, V39, P12753, DOI 10.1021/bi001811i; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Sambrook J, 2010, MOL CLONING LAB MANU; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Swem DL, 2005, J BACTERIOL, V187, P8081, DOI 10.1128/JB.187.23.8081-8087.2005; TASHIRO H, 1995, J BIOCHEM-TOKYO, V117, P521, DOI 10.1093/oxfordjournals.jbchem.a124739; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; Wunsch P, 2003, J BACTERIOL, V185, P887, DOI 10.1128/JB.185.3.887-896.2003; Zumft WG, 2007, ADV MICROB PHYSIOL, V52, P107, DOI 10.1016/S0065-2911(06)52003-X	33	49	50	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19330	19337		10.1074/jbc.M110.116020	http://dx.doi.org/10.1074/jbc.M110.116020			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20363758	Green Published, hybrid			2022-12-27	WOS:000278727800043
J	Eshraghi, A; Maldonado-Arocho, FJ; Gargi, A; Cardwell, MM; Prouty, MG; Blanke, SR; Bradley, KA				Eshraghi, Aria; Maldonado-Arocho, Francisco J.; Gargi, Amandeep; Cardwell, Marissa M.; Prouty, Michael G.; Blanke, Steven R.; Bradley, Kenneth A.			Cytolethal Distending Toxin Family Members Are Differentially Affected by Alterations in Host Glycans and Membrane Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; HUMAN T-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; HAEMOPHILUS-DUCREYI; CAMPYLOBACTER-JEJUNI; N-ACETYLGLUCOSAMINYLTRANSFERASE; GLYCOSYLATION MUTANTS; POINT MUTATIONS; G(2) ARREST; HELA-CELLS	Cytolethal distending toxins (CDTs) are tripartite protein exotoxins produced by a diverse group of pathogenic Gram-negative bacteria. Based on their ability to induce DNA damage, cell cycle arrest, and apoptosis of cultured cells, CDTs are proposed to enhance virulence by blocking cellular division and/or directly killing epithelial and immune cells. Despite the widespread distribution of CDTs among several important human pathogens, our understanding of how these toxins interact with host cells is limited. Here we demonstrate that CDTs from Haemophilus ducreyi, Aggregatibacter actinomycetemcomitans, Escherichia coli, and Campylobacter jejuni differ in their abilities to intoxicate host cells with defined defects in host factors previously implicated in CDT binding, including glycoproteins, and glycosphingolipids. The absence of cell surface sialic acid sensitized cells to intoxication by three of the four CDTs tested. Surprisingly, fucosylated N-linked glycans and glycolipids, previously implicated in CDT-host interactions, were not required for intoxication by any of the CDTs tested. Finally, altering host-cellular cholesterol, also previously implicated in CDT binding, affected intoxication by only a subset of CDTs tested. The findings presented here provide insight into the molecular and cellular basis of CDT-host interactions.	[Eshraghi, Aria; Maldonado-Arocho, Francisco J.; Cardwell, Marissa M.; Bradley, Kenneth A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Gargi, Amandeep; Prouty, Michael G.; Blanke, Steven R.] Univ Illinois, Dept Microbiol, Inst Genom Biol, Urbana, IL 61801 USA	University of California System; University of California Los Angeles; University of Illinois System; University of Illinois Urbana-Champaign	Bradley, KA (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 609 Charles E Young Dr E, Los Angeles, CA 90095 USA.	kbradley@microbio.ucla.edu			National Institutes of Health [T32DE007296, F31AI061837, AI59095]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI061837, R21AI059095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants T32DE007296 (to A. E.), F31AI061837 (to F.J.M.-A.), and AI59095 (to S.R.B.).	Akifusa S, 2005, MICROBIOL-SGM, V151, P1395, DOI 10.1099/mic.0.27671-0; Akifusa S, 2001, INFECT IMMUN, V69, P5925, DOI 10.1128/IAI.69.9.5925-5930.2001; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Boesze-Battaglia K, 2006, CELL MICROBIOL, V8, P823, DOI 10.1111/j.1462-5822.2005.00669.x; Boesze-Battaglia Kathleen, 2006, V332, P169; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Bradley KA, 2003, J BIOL CHEM, V278, P49342, DOI 10.1074/jbc.M307900200; Cao L, 2005, MOL MICROBIOL, V58, P1303, DOI 10.1111/j.1365-2958.2005.04905.x; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Cope LD, 1997, P NATL ACAD SCI USA, V94, P4056, DOI 10.1073/pnas.94.8.4056; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Deng KP, 2003, INFECT IMMUN, V71, P6633, DOI 10.1128/IAI.71.11.6633-6640.2003; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Frisk A, 2001, MICROB PATHOGENESIS, V30, P313, DOI 10.1006/mpat.2000.0436; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hong Y, 2004, J BIOL CHEM, V279, P49894, DOI 10.1074/jbc.M410121200; Hu X, 2006, PROTEINS, V62, P421, DOI 10.1002/prot.20767; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P115, DOI 10.1016/0882-4010(88)90053-8; JOHNSON WM, 1988, MICROB PATHOGENESIS, V4, P103, DOI 10.1016/0882-4010(88)90052-6; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LIN AI, 1994, GLYCOBIOLOGY, V4, P895, DOI 10.1093/glycob/4.6.895; Lofling J, 2008, GLYCOBIOLOGY, V18, P494, DOI 10.1093/glycob/cwn030; Mathieu S, 2004, AM J PATHOL, V164, P371, DOI 10.1016/S0002-9440(10)63127-6; McSweeney LA, 2005, INFECT IMMUN, V73, P2051, DOI 10.1128/IAI.73.4.2051-2060.2005; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; Mise K, 2005, INFECT IMMUN, V73, P4846, DOI 10.1128/IAI.73.8.4846-4852.2005; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nesic D, 2005, PLOS PATHOG, V1, P214, DOI 10.1371/journal.ppat.0010028; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; Pickett CL, 1996, INFECT IMMUN, V64, P2070, DOI 10.1128/IAI.64.6.2070-2078.1996; Purdy D, 2000, J MED MICROBIOL, V49, P473, DOI 10.1099/0022-1317-49-5-473; Rabin SDP, 2009, INFECT IMMUN, V77, P3161, DOI 10.1128/IAI.01227-08; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; VOLPE JJ, 1983, J BIOL CHEM, V258, P9220; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	54	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18199	18207		10.1074/jbc.M110.112912	http://dx.doi.org/10.1074/jbc.M110.112912			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385557	Green Published, hybrid			2022-12-27	WOS:000278453900011
J	Shao, BH; Pennathur, S; Pagani, I; Oda, MN; Witztum, JL; Oram, JF; Heinecke, JW				Shao, Baohai; Pennathur, Subramaniam; Pagani, Ioanna; Oda, Michael N.; Witztum, Joseph L.; Oram, John F.; Heinecke, Jay W.			Modifying Apolipoprotein A-I by Malondialdehyde, but Not by an Array of Other Reactive Carbonyls, Blocks Cholesterol Efflux by the ABCA1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; HUMAN ATHEROSCLEROTIC LESIONS; SITE-SPECIFIC MODIFICATION; TANDEM MASS-SPECTROMETRY; CASSETTE TRANSPORTER A1; GLYCATION END-PRODUCTS; HUMAN-SERUM-ALBUMIN; C-TERMINAL DOMAIN; AMINO-ACIDS; DIABETIC COMPLICATIONS	Dysfunctional high density lipoprotein (HDL) is implicated in the pathogenesis of cardiovascular disease, but the underlying pathways remain poorly understood. One potential mechanism involves covalent modification by reactive carbonyls of apolipoprotein A-I (apoA-I), the major HDL protein. We therefore determined whether carbonyls resulting from lipid peroxidation (malondialdehyde (MDA) and hydroxynonenal) or carbohydrate oxidation (glycolaldehyde, glyoxal, and methylglyoxal) covalently modify lipid-free apoA-I and inhibit its ability to promote cellular cholesterol efflux by the ABCA1 pathway. MDA markedly impaired the ABCA1 activity of apoA-I. In striking contrast, none of the other four carbonyls were effective. Liquid chromatographyelectrospray ionization-tandem mass spectrometry of MDA-modified apoA-I revealed that Lys residues at specific sites had been modified. The chief adducts were MDA-Lys and a Lys-MDA-Lys cross-link. Lys residues in the C terminus of apoA-I were targeted for cross-linking in high yield, and this process may hinder the interaction of apoA-I with lipids and ABCA1, two key steps in reverse cholesterol transport. Moreover, levels of MDA-protein adducts were elevated in HDL isolated from human atherosclerotic lesions, suggesting that lipid peroxidation might render HDL dysfunctional in vivo. Taken together, our observations indicate that MDA damages apoA-I by a pathway that generates lysine adducts at specific sites on the protein. Such damage may facilitate the formation of macrophage foam cells by impairing cholesterol efflux by the ABCA1 pathway.	[Shao, Baohai; Heinecke, Jay W.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Pagani, Ioanna; Oda, Michael N.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Diego	Shao, BH (corresponding author), Univ Washington, Div Metab Endocrinol & Nutr, Dept Med, Box 358055,815 Mercer St, Seattle, WA 98109 USA.	bhshao@u.washington.edu	Pagani, Ioanna/E-7390-2012	Shao, Baohai/0000-0001-8832-2845	National Institutes of Health [HL086798, HL77268, P30ES07083, HL086559, P01HL088093, HL092237, P01HL030086, K99HL091055]; Diabetes Education and Research Center, University of Washington [P30DK017047]; Doris Duke Foundation; Tobacco-related Disease Research Program of California [16FT-0054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077268, P01HL088093, R01HL086559, R21HL092237, K99HL091055, P01HL030086, R01HL086798, R00HL091055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Education and Research Center, University of Washington(University of Washington); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Tobacco-related Disease Research Program of California(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL086798, HL77268, P30ES07083, HL086559, P01HL088093, HL092237, and P01HL030086. This work was also supported by Grant P30DK017047 from the Diabetes Education and Research Center, University of Washington.; 1Supported by National Institutes of Health K99/R00 Award K99HL091055 from the NHLBI. To whom correspondence should be addressed: Box 358055, Division of Metabolism, Endocrinology, and Nutrition, Dept. of Medicine, 815 Mercer St., University of Washington, South Lake Union, Seattle, WA 98109. E-mail: bhshao@u.washington.edu.; 2 Supported by a clinical scientist development award from The Doris Duke Foundation.; 3 Supported by Grant 16FT-0054 from the Tobacco-related Disease Research Program of California.	ACHARYA AS, 1983, P NATL ACAD SCI-BIOL, V80, P3590, DOI 10.1073/pnas.80.12.3590; Anderson MM, 2003, DIABETES, V52, P2137, DOI 10.2337/diabetes.52.8.2137; Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Burgess JW, 1999, BIOCHEMISTRY-US, V38, P14524, DOI 10.1021/bi990930z; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; HABERLAND ME, 1982, P NATL ACAD SCI-BIOL, V79, P1712, DOI 10.1073/pnas.79.6.1712; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; Heinecke JW, 1999, METHOD ENZYMOL, V300, P124; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; Ishii T, 2006, CHEM RES TOXICOL, V19, P122, DOI 10.1021/tx050231p; Ishii T, 2008, BIOCHEM BIOPH RES CO, V371, P28, DOI 10.1016/j.bbrc.2008.03.140; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; MCCALL M, 1995, ARTERIOSCL THROM VAS, V15, P1599, DOI 10.1161/01.ATV.15.10.1599; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; Movva R, 2009, ANN BIOL CLIN-PARIS, V67, P7, DOI [10.1373/clinchem.2007.101923, 10.1684/abc.2008.0284]; Nagai R, 2002, J BIOL CHEM, V277, P48905, DOI 10.1074/jbc.M205688200; Natarajan P, 2004, J BIOL CHEM, V279, P24044, DOI 10.1074/jbc.M400561200; Nobecourt E, 2007, DIABETOLOGIA, V50, P643, DOI 10.1007/s00125-006-0574-z; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P336, DOI 10.1161/01.ATV.10.3.336; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2006, CURR OPIN CARDIOL, V21, P322, DOI 10.1097/01.hco.0000231402.87232.aa; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Szapacs ME, 2008, J PROTEOME RES, V7, P4237, DOI 10.1021/pr8001222; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916	66	105	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18473	18484		10.1074/jbc.M110.118182	http://dx.doi.org/10.1074/jbc.M110.118182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378541	hybrid, Green Published			2022-12-27	WOS:000278453900041
J	Vitu, E; Kim, S; Sevier, CS; Lutzky, O; Heldman, N; Bentzur, M; Unger, T; Yona, M; Kaiser, CA; Fass, D				Vitu, Elvira; Kim, Sunghwan; Sevier, Carolyn S.; Lutzky, Omer; Heldman, Nimrod; Bentzur, Moran; Unger, Tamar; Yona, Meital; Kaiser, Chris A.; Fass, Deborah			Oxidative Activity of Yeast Ero1p on Protein Disulfide Isomerase and Related Oxidoreductases of the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; CRYSTAL-STRUCTURE; BOND FORMATION; REDOX ENVIRONMENT; MAMMALIAN-CELLS; IN-VIVO; SITES; DOMAIN; REDUCTION; OXIDASE	The sulfhydryl oxidase Ero1 oxidizes protein disulfide isomerase (PDI), which in turn catalyzes disulfide formation in proteins folding in the endoplasmic reticulum (ER). The extent to which other members of the PDI family are oxidized by Ero1 and thus contribute to net disulfide formation in the ER has been an open question. The yeast ER contains four PDI family proteins with at least one potential redox-active cysteine pair. We monitored the direct oxidation of each redox-active site in these proteins by yeast Ero1p in vitro. In this study, we found that the Pdi1p amino-terminal domain was oxidized most rapidly compared with the other oxidoreductase active sites tested, including the Pdi1p carboxyl-terminal domain. This observation is consistent with experiments conducted in yeast cells. In particular, the amino-terminal domain of Pdi1p preferentially formed mixed disulfides with Ero1p in vivo, and we observed synthetic lethality between a temperature-sensitive Ero1p variant and mutant Pdi1p lacking the amino-terminal active-site disulfide. Thus, the amino-terminal domain of yeast Pdi1p is on a preferred pathway for oxidizing the ER thiol pool. Overall, our results provide a rank order for the tendency of yeast ER oxidoreductases to acquire disulfides from Ero1p.	[Vitu, Elvira; Lutzky, Omer; Heldman, Nimrod; Bentzur, Moran; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Unger, Tamar; Yona, Meital] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-76100 Rehovot, Israel; [Kim, Sunghwan; Sevier, Carolyn S.; Kaiser, Chris A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Weizmann Institute of Science; Weizmann Institute of Science; Massachusetts Institute of Technology (MIT)	Fass, D (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	deborah.fass@weizmann.ac.il	Vitu, Elvira/V-8201-2017	Kim, Sunghwan/0000-0002-1927-9617; Sevier, Carolyn/0000-0003-3245-6988	National Institutes of Health [RO1 GM046941]; NIGMS; U.S.-Israel Binational Science Foundation; Kimmelman Center for Macromolecular Assemblies; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Kimmelman Center for Macromolecular Assemblies; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant RO1 GM046941 (to C. A. K.) from NIGMS. This work was also supported by a grant from the U.S.-Israel Binational Science Foundation (to D. F. and C. A. K.) and by the Kimmelman Center for Macromolecular Assemblies (to D. F.).	Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Darby NJ, 1996, BIOCHEMISTRY-US, V35, P10517, DOI 10.1021/bi960763s; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V70, P82; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Holst B, 1997, J CELL BIOL, V138, P1229, DOI 10.1083/jcb.138.6.1229; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kimura T, 2005, J BIOL CHEM, V280, P31438, DOI 10.1074/jbc.M503377200; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; LYLES MM, 1994, J BIOL CHEM, V269, P30946; MARQUARDT T, 1993, J BIOL CHEM, V268, P19618; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Mossner E, 1998, PROTEIN SCI, V7, P1233; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; THORPE C, 2010, ANTIOXID REDOX SIGNA; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Vitu E, 2008, J MOL BIOL, V384, P631, DOI 10.1016/j.jmb.2008.09.052; Westphal V, 1999, J MOL BIOL, V286, P1229, DOI 10.1006/jmbi.1999.2560; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200	41	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18155	18165		10.1074/jbc.M109.064931	http://dx.doi.org/10.1074/jbc.M109.064931			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20348090	hybrid, Green Published			2022-12-27	WOS:000278453900006
J	Wilson, A; Kinney, JN; Zwart, PH; Punginelli, C; D'Haene, S; Perreau, F; Klein, MG; Kirilovsky, D; Kerfeld, CA				Wilson, Adjele; Kinney, James N.; Zwart, Petrus H.; Punginelli, Claire; D'Haene, Sandrine; Perreau, Francois; Klein, Michael G.; Kirilovsky, Diana; Kerfeld, Cheryl A.			Structural Determinants Underlying Photoprotection in the Photoactive Orange Carotenoid Protein of Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL-BINDING PROTEIN; SHORT HYDROGEN-BONDS; BLUE-LIGHT; ENERGY-DISSIPATION; PHYCOBILISOME FLUORESCENCE; CRYSTAL-STRUCTURES; PHOTOTROPIN 1; MECHANISM; DOMAIN; FAMILY	The photoprotective processes of photosynthetic organisms involve the dissipation of excess absorbed light energy as heat. Photoprotection in cyanobacteria is mechanistically distinct from that in plants; it involves the orange carotenoid protein (OCP), a water-soluble protein containing a single carotenoid. The OCP is a new member of the family of blue light-photoactive proteins; blue-green light triggers the OCP-mediated photoprotective response. Here we report structural and functional characterization of the wild type and two mutant forms of the OCP, from the model organism Synechocystis PCC6803. The structural analysis provides high resolution detail of the carotenoid-protein interactions that underlie the optical properties of the OCP, unique among carotenoid-proteins in binding a single pigment per polypeptide chain. Collectively, these data implicate several key amino acids in the function of the OCP and reveal that the photoconversion and photoprotective responses of the OCP to blue-green light can be decoupled.	[Kinney, James N.; Zwart, Petrus H.; Klein, Michael G.; Kerfeld, Cheryl A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Wilson, Adjele; Punginelli, Claire; D'Haene, Sandrine; Kirilovsky, Diana] CEA, Inst Biol & Technol Saclay, Gif Sur Yvette, France; [Wilson, Adjele; Punginelli, Claire; D'Haene, Sandrine; Kirilovsky, Diana] CENS, Lab Leon Brillouin, CNRS, URA 2906, F-91191 Gif Sur Yvette, France; [Perreau, Francois] INRA Versailles Grignon, INRA AgroParisTech, UMR 1318, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Berkeley	Kerfeld, CA (corresponding author), 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	ckerfeld@berkeley.edu	Punginelli, Claire/M-1759-2014; Zwart, Peter/F-7123-2013; Kirilovsky, Diana/I-2359-2014	Kirilovsky, Diana/0000-0003-2146-3103; Wilson, Adjele Flore/0000-0003-2622-3600; Perreau, Francois/0000-0001-7873-9866	CNRS; Commissariat a l'Energie Atomique (Saclay, France); United States Department of Energy's Office of Science, Biological and Environmental Research; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; National Science Foundation [MCB-085170]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique (Saclay, France)(French Atomic Energy Commission); United States Department of Energy's Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	The work of these authors was supported by grants from l'Agence Nationale de la Recherche (Program CAROPROTECT) from CNRS and the Commissariat a l'Energie Atomique (Saclay, France).; The work of these authors was performed under the auspices of the United States Department of Energy's Office of Science, Biological and Environmental Research Program, and the University of California, Lawrence Berkeley National Laboratory under Contract DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344, and National Science Foundation Grant MCB-085170.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alexandre MTA, 2009, BIOPHYS J, V97, P238, DOI 10.1016/j.bpj.2009.03.047; Anderson S, 2004, ACTA CRYSTALLOGR D, V60, P1008, DOI 10.1107/S090744490400616X; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Boulay C, 2008, BBA-BIOENERGETICS, V1777, P1344, DOI 10.1016/j.bbabio.2008.07.002; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cleland WW, 2000, ARCH BIOCHEM BIOPHYS, V382, P1, DOI 10.1006/abbi.2000.2011; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; El Bissati K, 2000, BBA-BIOENERGETICS, V1457, P229, DOI 10.1016/S0005-2728(00)00104-3; El Bissati K, 2001, PLANT PHYSIOL, V125, P1988; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fulda S, 2006, PROTEOMICS, V6, P2733, DOI 10.1002/pmic.200500538; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; GILMORE AM, 1993, PHOTOSYNTH RES, V35, P67, DOI 10.1007/BF02185412; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; Hellingwerf KJ, 2003, J PHYS CHEM A, V107, P1082, DOI 10.1021/jp027005y; HERDMAN M, 1973, J GEN MICROBIOL, V79, P233, DOI 10.1099/00221287-79-2-233; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ihalainen JA, 2005, BIOCHEMISTRY-US, V44, P10846, DOI 10.1021/bi0510680; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kashino Y, 2001, ELECTROPHORESIS, V22, P1004, DOI 10.1002/1522-2683()22:6<1004::AID-ELPS1004>3.0.CO;2-Y; Kerfeld CA, 2003, STRUCTURE, V11, P55, DOI 10.1016/S0969-2126(02)00936-X; Kerfeld CA, 2010, CAROTENOIDS: PHYSICAL, CHEMICAL, AND BIOLOGICAL FUNCTIONS AND PROPERTIES, P3; Kirilovsky D, 2007, PHOTOSYNTH RES, V93, P7, DOI 10.1007/s11120-007-9168-y; Koyama T, 2009, BIOCHEMISTRY-US, V48, P7621, DOI 10.1021/bi9009192; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2008, P NATL ACAD SCI USA, V105, P7, DOI 10.1073/pnas.0710523105; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Mao LS, 2003, J PHYS CHEM B, V107, P3963, DOI 10.1021/jp0276496; Metz S, 2009, J BACTERIOL, V191, P4473, DOI 10.1128/JB.00262-09; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakasone Y, 2006, BIOPHYS J, V91, P645, DOI 10.1529/biophysj.106.084772; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal D, 2001, J BIOMOL STRUCT DYN, V19, P115, DOI 10.1080/07391102.2001.10506725; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Polivka T, 2005, BIOCHEMISTRY-US, V44, P3994, DOI 10.1021/bi047473t; Ponstingl H, 2000, PROTEINS, V41, P47; Punginelli C, 2009, BBA-BIOENERGETICS, V1787, P280, DOI 10.1016/j.bbabio.2009.01.011; Rajagopal S, 2005, FEBS J, V272, P1819, DOI 10.1111/j.1742-4658.2005.04604.x; Rakhimberdieva MG, 2007, FEBS LETT, V581, P2429, DOI 10.1016/j.febslet.2007.04.056; Rakhimberdieva MG, 2004, FEBS LETT, V574, P85, DOI 10.1016/j.febslet.2004.07.087; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Roszak AW, 2004, STRUCTURE, V12, P765, DOI 10.1016/j.str.2004.02.037; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; Scott M, 2006, BIOCHEMISTRY-US, V45, P8952, DOI 10.1021/bi060767p; Singh AK, 2008, PLANT PHYSIOL, V148, P467, DOI 10.1104/pp.108.123489; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Yamamoto A, 2009, BIOPHYS J, V96, P2771, DOI 10.1016/j.bpj.2008.12.3924; YAMAMOTO HY, 1979, PURE APPL CHEM, V51, P639, DOI 10.1351/pac197951030639; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l; Yuan H, 2006, BIOCHEMISTRY-US, V45, P12687, DOI 10.1021/bi061435n	81	120	122	1	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18364	18375		10.1074/jbc.M110.115709	http://dx.doi.org/10.1074/jbc.M110.115709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20368334	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000278453900030
J	Wu, JJ; Weis, MA; Kim, LS; Eyre, DR				Wu, Jiann-Jiu; Weis, Mary Ann; Kim, Lammy S.; Eyre, David R.			Type III Collagen, a Fibril Network Modifier in Articular Cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING SITES; OSTEOARTHRITIC CARTILAGE; EXTRACELLULAR-MATRIX; DERMAL COLLAGEN; IX COLLAGEN; BONE; XI; VERTEBRATE; MOLECULES; CLEAVAGE	The collagen framework of hyaline cartilages, including articular cartilage, consists largely of type II collagen that matures from a cross-linked heteropolymeric fibril template of types II, IX, and XI collagens. In the articular cartilages of adult joints, type III collagen makes an appearance in varying amounts superimposed on the original collagen fibril network. In a study to understand better the structural role of type III collagen in cartilage, we find that type III collagen molecules with unprocessed N-propeptides are present in the extracellular matrix of adult human and bovine articular cartilages as covalently crosslinked polymers extensively cross-linked to type II collagen. Cross-link analyses revealed that telopeptides from both N and C termini of type III collagen were linked in the tissue to helical cross-linking sites in type II collagen. Reciprocally, telopeptides from type II collagen were recovered cross-linked to helical sites in type III collagen. Cross-linked peptides were also identified in which a trifunctional pyridinoline linked both an alpha 1(II) and an alpha 1(III) telopeptide to the alpha 1(III) helix. This can only have arisen from a cross-link between three different collagen molecules, types II and III in register staggered by 4D from another type III molecule. Type III collagen is known to be prominent at sites of healing and repair in skin and other tissues. The present findings emphasize the role of type III collagen, which is synthesized in mature articular cartilage, as a covalent modifier that may add cohesion to a weakened, existing collagen type II fibril network as part of a chondrocyte healing response to matrix damage.	[Wu, Jiann-Jiu; Weis, Mary Ann; Kim, Lammy S.; Eyre, David R.] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wu, JJ (corresponding author), 1959 NE Pacific St,HSB BB1052, Seattle, WA 98195 USA.	wujj@u.washington.edu			National Institutes of Health [AR 37318, AR 36794]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036794, R01AR036794, R37AR037318, R01AR037318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants AR 37318 and AR 36794.	Ahsan T, 2005, OSTEOARTHR CARTILAGE, V13, P709, DOI 10.1016/j.joca.2005.03.005; Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3; AIGNER T, 1993, J CLIN INVEST, V91, P829, DOI 10.1172/JCI116303; Atley LM, 2000, BONE, V26, P241, DOI 10.1016/S8756-3282(99)00270-7; ATLEY LM, 1998, T ORTHOP RES SOC, V23, P850; BAILEY AJ, 1976, BIOCHEM J, V153, P211, DOI 10.1042/bj1530211; Bailey WJ, 1997, MOL BIOL EVOL, V14, P843, DOI 10.1093/oxfordjournals.molbev.a025825; BECKER J, 1991, J HISTOCHEM CYTOCHEM, V39, P103, DOI 10.1177/39.1.1983870; BONASSAR LJ, 1995, ARTHRITIS RHEUM, V38, P173, DOI 10.1002/art.1780380205; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; CHUNG E, 1974, SCIENCE, V183, P1200, DOI 10.1126/science.183.4130.1200; EPSTEIN EH, 1974, J BIOL CHEM, V249, P3225; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2006, EUR CELLS MATER, V12, P57, DOI 10.22203/eCM.v012a07; Eyre DR, 2010, J BIOL CHEM, V285, P16675, DOI 10.1074/jbc.M110.111534; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; EYRE DR, 1975, CONNECT TISSUE RES, V4, P11, DOI 10.3109/03008207509152192; EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4; EYRE DR, 1980, BIOCHEM BIOPH RES CO, V92, P403, DOI 10.1016/0006-291X(80)90347-2; Fernandes RJ, 2003, EUR J BIOCHEM, V270, P3243, DOI 10.1046/j.1432-1033.2003.03711.x; FLEISCHMAJER R, 1983, P NATL ACAD SCI-BIOL, V80, P3354, DOI 10.1073/pnas.80.11.3354; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; FLEISCHMAJER R, 1990, ANN NY ACAD SCI, V580, P161, DOI 10.1111/j.1749-6632.1990.tb17927.x; HANSON DA, 1992, J BONE MINER RES, V7, P1251; HENKEL W, 1982, EUR J BIOCHEM, V122, P205, DOI 10.1111/j.1432-1033.1982.tb05868.x; Henkel W, 1996, BIOCHEM J, V318, P497, DOI 10.1042/bj3180497; Huxley-Jones J, 2007, MATRIX BIOL, V26, P2, DOI 10.1016/j.matbio.2006.09.008; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; Kinter M, 2000, PROTEIN SEQUENCING I, V1st, P152; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHTO M, 1985, RES EXP MED, V185, P95, DOI 10.1007/BF01854894; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MILLER EJ, 1969, P NATL ACAD SCI USA, V64, P1264, DOI 10.1073/pnas.64.4.1264; MILLER EJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P631, DOI 10.1016/0003-9861(76)90300-3; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; NICHOLSON R, 1989, BIOCHEMISTRY-US, V28, P5195, DOI 10.1021/bi00438a042; Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819; SHAPIRO F, 1979, ARCH BIOCHEM BIOPHYS, V198, P205, DOI 10.1016/0003-9861(79)90411-9; Sicot FX, 1997, EUR J BIOCHEM, V246, P50, DOI 10.1111/j.1432-1033.1997.00050.x; SWANN DA, 1972, INVEST OPHTH VISUAL, V11, P735; TRELSTAD RL, 1974, BIOCHEM BIOPH RES CO, V57, P717, DOI 10.1016/0006-291X(74)90605-6; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; WOTTON SF, 1994, HISTOCHEM J, V26, P412, DOI 10.1007/BF00160053; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200; WU JJ, 1995, J BIOL CHEM, V270, P18865, DOI 10.1074/jbc.270.32.18865; WU JJ, 1984, BIOCHEMISTRY-US, V23, P1850, DOI 10.1021/bi00303a041; WU JJ, 1992, J BIOL CHEM, V267, P23007; WU JJ, 1991, J BIOL CHEM, V266, P5625; Young RD, 2000, J HISTOCHEM CYTOCHEM, V48, P423, DOI 10.1177/002215540004800312	57	58	59	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18537	18544		10.1074/jbc.M110.112904	http://dx.doi.org/10.1074/jbc.M110.112904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404341	Green Published, hybrid			2022-12-27	WOS:000278453900047
J	Ek-Ramos, MJ; Avila, J; Cheng, C; Martin, GB; Devarenne, TP				Ek-Ramos, Mara J.; Avila, Julian; Cheng, Cheng; Martin, Gregory B.; Devarenne, Timothy P.			The T-loop Extension of the Tomato Protein Kinase AvrPto-dependent Pto-interacting Protein 3 (Adi3) Directs Nuclear Localization for Suppression of Plant Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT HAIR-GROWTH; DISEASE RESISTANCE; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; AGC KINASES; HYPERSENSITIVE RESPONSE; POSITIVE REGULATOR; MOLECULAR-CLONING; ACTIVATION; APOPTOSIS	In tomato (Solanum lycopersicum), resistance to Pseudomonas syringae pv. tomato is elicited by the interaction of the host Pto kinase with the pathogen effector protein AvrPto, which leads to various immune responses including localized cell death termed the hypersensitive response. The AGC kinase Adi3 functions to suppress host cell death and interacts with Pto only in the presence of AvrPto. The cell death suppression (CDS) activity of Adi3 requires phosphorylation by 3-phospho-inositide-dependent protein kinase 1 (Pdk1) and loss of Adi3 function is associated with the hypersensitive response cell death initiated by the Pto/AvrPto interaction. Here we studied the relationship between Adi3 cellular localization and its CDS activity. Adi3 is a nuclear-localized protein, and this localization is dictated by a nuclear localization signal found in the Adi3 T-loop extension, an similar to 80 amino acid insertion into the T-loop, or activation loop, which is phosphorylated for kinase activation. Nuclear localization of Adi3 is required for its CDS activity and loss of nuclear localization causes elimination of Adi3 CDS activity and induction of cell death. This nuclear localization of Adi3 is dependent on Ser-539 phosphorylation by Pdk1 and nonnuclear Adi3 is found in punctate structures throughout the cell. Our data support a model in which Pdk1 phosphorylation of Adi3 directs nuclear localization for CDS and that disruption of Adi3 nuclear localization may be a mechanism for induction of cell death such as that during the Pto/AvrPto interaction.	[Ek-Ramos, Mara J.; Avila, Julian; Cheng, Cheng; Devarenne, Timothy P.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Martin, Gregory B.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Martin, Gregory B.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA	Texas A&M University System; Texas A&M University College Station; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Devarenne, TP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	tpd8@tamu.edu	Martin, Gregory B/F-6262-2011; Ramos, Maria Julissa Ek/W-1017-2018	Martin, Gregory B/0000-0003-0044-6830; Ramos, Maria Julissa Ek/0000-0002-1556-0823; Devarenne, Timothy/0000-0001-6032-8049; Avila, Julian/0000-0001-9388-3946	USDA-CSREES [2007-35319-17832]; USDA-AFRI [2010-65108-20526]; Texas A&M University Dept. of Biochemistry and Biophysics	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-AFRI(United States Department of Agriculture (USDA)); Texas A&M University Dept. of Biochemistry and Biophysics	This work was supported by USDA-CSREES Grant 2007-35319-17832 (to G. B. M. and T. P. D.), USDA-AFRI Grant 2010-65108-20526 (to T. P. D.), and by Texas A&M University Dept. of Biochemistry and Biophysics start-up funds (to T. P. D.).	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Anthony RG, 2006, J BIOL CHEM, V281, P37536, DOI 10.1074/jbc.M607341200; Arico S, 2002, J BIOL CHEM, V277, P27613, DOI 10.1074/jbc.M201119200; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bohm C, 2006, J BIOL CHEM, V281, P14547, DOI 10.1074/jbc.M601660200; Bogdanove AJ, 2000, P NATL ACAD SCI USA, V97, P8836, DOI 10.1073/pnas.97.16.8836; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Doukhanina EV, 2006, J BIOL CHEM, V281, P18793, DOI 10.1074/jbc.M511794200; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Haasen D, 1999, PLANT J, V20, P695, DOI 10.1046/j.1365-313X.1999.00644.x; Hergovich A, 2008, BBA-PROTEINS PROTEOM, V1784, P3, DOI 10.1016/j.bbapap.2007.07.017; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoeberichts FA, 2003, BIOESSAYS, V25, P47, DOI 10.1002/bies.10175; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; Kaneda T, 2009, EMBO J, V28, P926, DOI 10.1038/emboj.2009.39; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Lam E, 2008, CRIT REV PLANT SCI, V27, P413, DOI 10.1080/07352680802467744; LARN E, 2004, NAT REV MOL CELL BIO, V5, P305; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee C, 2006, VIROLOGY, V346, P238, DOI 10.1016/j.virol.2005.11.005; Lee SB, 2008, P NATL ACAD SCI USA, V105, P16584, DOI 10.1073/pnas.0807668105; Li ST, 2007, PLANT PHYSIOL, V145, P236, DOI 10.1104/pp.107.101741; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; MILLWARD T, 1995, P NATL ACAD SCI USA, V92, P5022, DOI 10.1073/pnas.92.11.5022; Miyamoto S, 2009, CARDIOVASC RES, V82, P272, DOI 10.1093/cvr/cvp087; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nguyen TLX, 2006, BIOCHEM BIOPH RES CO, V349, P789, DOI 10.1016/j.bbrc.2006.08.120; Oyama T, 2002, PLANT J, V30, P289, DOI 10.1046/j.1365-313X.2002.01290.x; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; RIZHSKY L, 2004, MEASURING PROGRAMMED, P179; Robert HS, 2008, CURR OPIN PLANT BIOL, V11, P495, DOI 10.1016/j.pbi.2008.06.004; Rodin S A, 2001, Dokl Biochem Biophys, V379, P235, DOI 10.1023/A:1011639531452; SALMERON JM, 1994, PLANT CELL, V6, P511, DOI 10.1105/tpc.6.4.511; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; SOBKO A, 2006, SCI STKE, pRE9; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Zegzouti H, 2006, P NATL ACAD SCI USA, V103, P6404, DOI 10.1073/pnas.0510283103; Zegzouti H, 2006, J BIOL CHEM, V281, P35520, DOI 10.1074/jbc.M605167200; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	73	26	27	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17584	17594		10.1074/jbc.M110.117416	http://dx.doi.org/10.1074/jbc.M110.117416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371603	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000278133400037
J	Gao, YJ; Balut, CM; Bailey, MA; Patino-Lopez, G; Shaw, S; Devor, DC				Gao, Yajuan; Balut, Corina M.; Bailey, Mark A.; Patino-Lopez, Genaro; Shaw, Stephen; Devor, Daniel C.			Recycling of the Ca2+-activated K+ Channel, KCa2.3, Is Dependent upon RME-1, Rab35/EPI64C, and an N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-CONDUCTANCE; INTERMEDIATE-CONDUCTANCE; HYPERPOLARIZING FACTOR; POTASSIUM CHANNEL; EDHF RESPONSES; SMOOTH-MUSCLE; CL-SECRETION; TRAFFICKING; RECEPTOR; RAB35	Regulation of the number of Ca2+-activated K+ channels at the endothelial cell surface contributes to control of the endothelium-derived hyperpolarizing factor response, although this process is poorly understood. To address the fate of plasma membrane-localized KCa2.3, we utilized an extracellular epitope-tagged channel in combination with fluorescence and biotinylation techniques in both human embryonic kidney cells and the human microvascular endothelial cell line, HMEC-1. KCa2.3 was internalized from the plasma membrane and degraded with a time constant of 18 h. Cell surface biotinylation demonstrated that KCa2.3 was rapidly endocytosed and recycled back to the plasma membrane. Consistent with recycling, expression of a dominant negative (DN) RME-1 or Rab35 as well as wild type EPI64C, the Rab35 GTPase-activating protein, resulted in accumulation of KCa2.3 in an intracellular compartment. Expression of DN RME-1, DN Rab35, or wild type EPI64C resulted in a decrease in steady-state plasma membrane expression. Knockdown of EPI64C increased cell surface expression of KCa2.3. Furthermore, the effect of EPI64C was dependent upon its GTPase-activating proteins activity. Co-immunoprecipitation studies confirmed an association between KCa2.3 and both Rab35 and RME-1. In contrast to KCa2.3, KCa3.1 was rapidly endocytosed and degraded in an RME-1 and Rab35-independent manner. A series of N-terminal deletions identified a 12-amino acid region, Gly(206)-Pro(217), as being required for the rapid recycling of KCa2.3. Deletion of Gly(206)-Pro(217) had no effect on the association of KCa2.3 with Rab35 but significantly decreased the association with RME-1. These represent the first studies elucidating the mechanisms by which KCa2.3 is maintained at the plasma membrane.	[Devor, Daniel C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Patino-Lopez, Genaro; Shaw, Stephen] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Devor, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S331 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	dd2@pitt.edu	Patiño López, Genaro/GQI-4414-2022; Patino-Lopez, Genaro/O-3484-2018	Patino-Lopez, Genaro/0000-0002-8716-722X	National Institutes of Health [HL083060, HL092157]; American Heart Fellowship [0825542D]; NATIONAL CANCER INSTITUTE [ZIABC009257] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092157, R01HL083060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL083060 and HL092157 (to D. C. D.). This work was also supported by American Heart Fellowship 0825542D (to C. M. B.).	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Balut CM, 2009, BIOPHYS J, V96, p472A, DOI 10.1016/j.bpj.2008.12.2445; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Crane GJ, 2004, BRIT J PHARMACOL, V142, P43, DOI 10.1038/sj.bjp.0705756; Crane GJ, 2003, J PHYSIOL-LONDON, V553, P183, DOI 10.1113/jphysiol.2003.051896; Devor DC, 1997, AM J PHYSIOL-CELL PH, V273, pC531, DOI 10.1152/ajpcell.1997.273.2.C531; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Eichler I, 2003, BRIT J PHARMACOL, V138, P594, DOI 10.1038/sj.bjp.0705075; Frei E, 2006, CELL PHYSIOL BIOCHEM, V18, P165, DOI 10.1159/000097665; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Griffith TM, 2004, BRIT J PHARMACOL, V141, P881, DOI 10.1038/sj.bjp.0705698; Hinton JM, 2003, BRIT J PHARMACOL, V138, P1031, DOI 10.1038/sj.bjp.0705171; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jones HM, 2007, CHANNELS, V1, P80, DOI 10.4161/chan.3999; Jones HM, 2005, J BIOL CHEM, V280, P37257, DOI 10.1074/jbc.M508601200; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Lewarchik CM, 2008, J BIOL CHEM, V283, P28401, DOI 10.1074/jbc.M800516200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Mather S, 2005, CIRC RES, V97, P399, DOI 10.1161/01.RES.0000178008.46759.d0; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Parkington HC, 2002, J PHYSIOL-LONDON, V542, P929, DOI 10.1113/jphysiol.2002.021030; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Roncarati R, 2005, MOL CELL NEUROSCI, V28, P314, DOI 10.1016/j.mcn.2004.09.015; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Rufo PA, 1996, J CLIN INVEST, V98, P2066, DOI 10.1172/JCI119012; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Wikstrom K, 2008, CELL SIGNAL, V20, P2332, DOI 10.1016/j.cellsig.2008.09.003; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060	47	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17938	17953		10.1074/jbc.M109.086553	http://dx.doi.org/10.1074/jbc.M109.086553			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20360009	Green Published, hybrid			2022-12-27	WOS:000278133400070
J	Matilla, I; Alfonso, C; Rivas, G; Bolt, EL; de la Cruz, F; Cabezon, E				Matilla, Inmaculada; Alfonso, Carlos; Rivas, German; Bolt, Edward L.; de la Cruz, Fernando; Cabezon, Elena			The Conjugative DNA Translocase TrwB Is a Structure-specific DNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; BACTERIAL CONJUGATION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; HELICASE; MECHANISM; GENE; FTSK; SUBSTRATE; TRANSPORT	TrwB is a DNA-dependent ATPase involved in DNA transport during bacterial conjugation. The protein presents structural similarity to hexameric molecular motors such as F1-ATPase, FtsK, or ring helicases, suggesting that TrwB also operates as a motor, using energy released from ATP hydrolysis to pump single-stranded DNA through its central channel. In this work, we have carried out an extensive analysis with various DNA substrates to determine the preferred substrate for TrwB. Oligonucleotides with G-rich sequences forming G4 DNA structures were the optimal substrates for TrwB ATPase activity. The protein bound with 100-fold higher affinity to G4 DNA than to single-stranded DNA of the same sequence. Moreover, TrwB formed oligomeric protein complexes only with oligonucleotides presenting such a G-quadruplex DNA structure, consistent with stoichiometry of six TrwB monomers to G4 DNA, as demonstrated by gel filtration chromatography and analytical ultracentrifugation experiments. A protein-DNA complex was also formed with unstructured oligonucleotides, but the molecular mass corresponded to one monomer protein bound to one oligonucleotide molecule. Sequences capable of forming G-quadruplex structures are widespread through genomes and are thought to play a biological function in transcriptional regulation. They form stable structures that can obstruct DNA replication, requiring the action of specific helicases to resolve them. Nevertheless, TrwB displayed no G4 DNA unwinding activity. These observations are discussed in terms of a possible role for TrwB in recognizing G-quadruplex structures as loading sites on the DNA.	[Matilla, Inmaculada; de la Cruz, Fernando; Cabezon, Elena] Univ Cantabria, Dept Mol Biol, Santander 39011, Spain; [Matilla, Inmaculada; de la Cruz, Fernando; Cabezon, Elena] CSIC UC IDICAN, IBBTEC, Santander 39011, Spain; [Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol, Dept Ciencia Prot, E-28040 Madrid, Spain; [Bolt, Edward L.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Nottingham	Cabezon, E (corresponding author), Univ Cantabria, Dept Mol Biol, Santander 39011, Spain.	cabezone@unican.es	Cabezon, Elena/K-5874-2014; Alfonso, Carlos/K-1316-2014; Rivas, German/AAG-7458-2022; de la Cruz, Fernando/L-2812-2014; Rivas, German/AFL-7528-2022	Alfonso, Carlos/0000-0001-7165-4800; Rivas, German/0000-0003-3450-7478; de la Cruz, Fernando/0000-0003-4758-6857; Rivas, German/0000-0003-3450-7478; Cabezon, Elena/0000-0002-6177-5016; Bolt, Edward/0000-0002-5656-7706	Ministerio de Ciencia e Innovacion (MCINN, Spain) [BFU2008-00806, BFU2008-00995/BMC]; Instituto de Salud Carlos III [RD06/0008/1012]; European VI Framework Program [LSHM-CT-2005_019023]; Biomedical Sciences (Nottingham) Research Fund; University of Cantabria	Ministerio de Ciencia e Innovacion (MCINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European VI Framework Program; Biomedical Sciences (Nottingham) Research Fund; University of Cantabria	This work was supported by Ministerio de Ciencia e Innovacion (MCINN, Spain) Grant BFU2008-00806 (to E. C.), Grants BFU2008-00995/BMC from MCINN, RD06/0008/1012 from Instituto de Salud Carlos III, and LSHM-CT-2005_019023 from the European VI Framework Program (to F.d.I.C.), and a grant from The Biomedical Sciences (Nottingham) Research Fund (to E. L. B.).; Supported by a fellowship from the University of Cantabria.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Baran N, 1997, NUCLEIC ACIDS RES, V25, P297, DOI 10.1093/nar/25.2.297; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Briggs GS, 2005, J BIOL CHEM, V280, P13921, DOI 10.1074/jbc.M412054200; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002; Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211; COHEN A, 1968, P NATL ACAD SCI USA, V61, P61, DOI 10.1073/pnas.61.1.61; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Cole JL, 2004, METHOD ENZYMOL, V384, P212; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; El Karoui M, 1999, RES MICROBIOL, V150, P579, DOI 10.1016/S0923-2508(99)00132-1; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Guy CP, 2005, NUCLEIC ACIDS RES, V33, P3678, DOI 10.1093/nar/gki685; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; Howlett GJ, 2000, METHOD ENZYMOL, V323, P231; IRINO N, 1986, MOL GEN GENET, V205, P298, DOI 10.1007/BF00430442; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lowe J, 2008, MOL CELL, V31, P498, DOI 10.1016/j.molcel.2008.05.027; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117; MYERS RS, 1994, ANNU REV GENET, V28, P49, DOI 10.1146/annurev.ge.28.120194.000405; OHKI M, 1968, COLD SPRING HARB SYM, V33, P651, DOI 10.1101/SQB.1968.033.01.074; Popuri V, 2008, J BIOL CHEM, V283, P17766, DOI 10.1074/jbc.M709749200; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Sivanathan V, 2006, NAT STRUCT MOL BIOL, V13, P965, DOI 10.1038/nsmb1158; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Tato I, 2007, J BIOL CHEM, V282, P25569, DOI 10.1074/jbc.M703464200; Versini G, 2003, EMBO J, V22, P1939, DOI 10.1093/emboj/cdg180; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X	42	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17537	17544		10.1074/jbc.M109.084137	http://dx.doi.org/10.1074/jbc.M109.084137			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375020	Green Published, hybrid			2022-12-27	WOS:000278133400032
J	Tao, Z; Rosental, N; Kanner, BI; Gameiro, A; Mwaura, J; Grewer, C				Tao, Zhen; Rosental, Noa; Kanner, Baruch I.; Gameiro, Armanda; Mwaura, Juddy; Grewer, Christof			Mechanism of Cation Binding to the Glutamate Transporter EAAC1 Probed with Mutation of the Conserved Amino Acid Residue Thr(101)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ASPARTATE TRANSPORTER; RAT-BRAIN; FUNCTIONAL-CHARACTERIZATION; PYROCOCCUS-HORIKOSHII; EXTRACELLULAR GATE; MEMBRANE-VESICLES; CHLORIDE CHANNEL; NA+ BINDING; SUBSTRATE; TRANSLOCATION	The glutamate transporter excitatory amino acid carrier 1 (EAAC1) catalyzes the co-transport of three Na+ ions, one H+ ion, and one glutamate molecule into the cell, in exchange for one K+ ion. Na+ binding to the glutamate-free form of the transporter generates a high affinity binding site for glutamate and is thus required for transport. Moreover, sodium binding to the transporters induces a basal anion conductance, which is further activated by glutamate. Here, we used the [Na+] dependence of this conductance as a read-out of Na+ binding to the substrate-free transporter to study the impact of a highly conserved amino acid residue, Thr(101), in transmembrane domain 3. The apparent affinity of substrate-free EAAC1 for Na+ was dramatically decreased by the T101A but not by the T101S mutation. Interestingly, in further contrast to EAAC1(WT), in the T101A mutant this [Na+] dependence was biphasic. This behavior can be explained by assuming that the binding of two Na+ ions prior to glutamate binding is required to generate a high affinity substrate binding site. In contrast to the dramatic effect of the T101A mutation on Na+ binding, other properties of the transporter, such as its ability to transport glutamate, were impaired but not eliminated. Our results are consistent with the existence of a cation binding site deeply buried in the membrane and involving interactions with the side chain oxygens of Thr(101) and Asp(367). A theoretical valence screening approach confirms that the predicted site of cation interaction has the potential to be a novel, so far undetected sodium binding site.	[Tao, Zhen; Gameiro, Armanda; Mwaura, Juddy; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Rosental, Noa; Kanner, Baruch I.] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Med, Dept Biochem, IL-91120 Jerusalem, Israel	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Hebrew University of Jerusalem; Hadassah University Medical Center	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu	Albers, Thomas/A-9082-2012		National Institutes of Health [2R01NS049335-06A1, NS 16708]; Binational Science Foundation [2007051]; American Heart Association [0525485B]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049335, R56NS049335, R56NS016708, R01NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01NS049335-06A1 (to C. G.) and NS 16708 (to B. I. K.). This work was also supported by Binational Science Foundation Grant 2007051 (to C. G. and B. I. K.) and American Heart Association Grant 0525485B (to Z. T.).	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bergles DE, 2002, J NEUROSCI, V22, P10153; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Grewer C, 2001, BIOCHEMISTRY-US, V40, P232, DOI 10.1021/bi0015919; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; HUANG Z, 2010, 54 ANN M BIOPHYS SOC; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1978, FEBS LETT, V94, P245, DOI 10.1016/0014-5793(78)80947-8; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Tao Z, 2008, BIOCHEMISTRY-US, V47, P12923, DOI 10.1021/bi8017174; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	49	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17725	17733		10.1074/jbc.M110.121798	http://dx.doi.org/10.1074/jbc.M110.121798			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378543	hybrid, Green Published			2022-12-27	WOS:000278133400050
J	Duval, S; Santini, JM; Nitschke, W; Hille, R; Schoepp-Cothenet, B				Duval, Simon; Santini, Joanne M.; Nitschke, Wolfgang; Hille, Russ; Schoepp-Cothenet, Barbara			The Small Subunit AroB of Arsenite Oxidase LESSONS ON THE [2Fe-2S] RIESKE PROTEIN SUPERFAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; ELECTRON-PARAMAGNETIC-RESONANCE; MULTIPLE SEQUENCE ALIGNMENTS; FORMING HYDROGEN-BONDS; CHLOROFLEXUS-AURANTIACUS; REDUCTION POTENTIALS; ALCALIGENES-FAECALIS; RESPIRATORY-CHAIN; OXIDATION-STATE	Here, we describe the characterization of the [2Fe-2S] clusters of arsenite oxidases from Rhizobium sp. NT-26 and Ralstonia sp. 22. Both reduced Rieske proteins feature EPR signals similar to their homologs from Rieske-cyt b complexes, with g values at 2.027, 1.88, and 1.77. Redox titrations in a range of pH values showed that both [2Fe-2S] centers have constant E-m values up to pH 8 at similar to+210 mV. Above this pH value, the E-m values of both centers are pH-dependent, similar to what is observed for the Rieske-cyt b complexes. The redox properties of these two proteins, together with the low E-m value (+160 mV) of the Alcaligenes faecalis arsenite oxidase Rieske (confirmed herein), are in line with the structural determinants observed in the primary sequences, which have previously been deduced from the study of Rieske-cyt b complexes. Since the published E-m value of the Chloroflexus aurantiacus Rieske (+100 mV) is in conflict with this sequence analysis, we re-analyzed membrane samples of this organism and obtain a new value (+200 mV). Arsenite oxidase activity was affected by quinols and quinol analogs, which is similar to what is found with the Rieske-cyt b complexes. Together, these results show that the Rieske protein of arsenite oxidase shares numerous properties with its counterpart in the Rieske-cyt b complex. However, two cysteine residues, strictly conserved in the Rieske-cyt b-Rieske and considered to be crucial for its function, are not conserved in the arsenite oxidase counterpart. We discuss the role of these residues.	[Duval, Simon; Nitschke, Wolfgang; Schoepp-Cothenet, Barbara] CNRS, Inst Biol Struct & Microbiol, Lab Bioenerget & Ingn Prot, UPR 9036, F-13402 Marseille 20, France; [Santini, Joanne M.] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England; [Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of London; Birkbeck University London; University College London; University of California System; University of California Riverside	Schoepp-Cothenet, B (corresponding author), CNRS, Inst Biol Struct & Microbiol, Lab Bioenerget & Ingn Prot, UPR 9036, F-13402 Marseille 20, France.	schoepp@ifr88.cnrs-mrs.fr	Duval, Simon/ABS-5379-2022; Schoepp-Cothenet, Barbara/AAH-8911-2021; Nitschke, Wolfgang/C-4812-2012	Duval, Simon/0000-0003-2946-6771; Schoepp-Cothenet, Barbara/0000-0002-6820-4478; Nitschke, Wolfgang/0000-0003-2084-3032				ANDERSON GL, 1992, J BIOL CHEM, V267, P23674; Baymann F, 2003, PHILOS T ROY SOC B, V358, P267, DOI 10.1098/rstb.2002.1184; BERTRAND P, 1987, BIOCHIM BIOPHYS ACTA, V916, P24, DOI 10.1016/0167-4838(87)90206-8; Brugna M, 1999, J BIOL CHEM, V274, P16766, DOI 10.1074/jbc.274.24.16766; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Colbert CL, 2000, STRUCTURE, V8, P1267, DOI 10.1016/S0969-2126(00)00536-0; DAVIDSON E, 1992, BIOCHEMISTRY-US, V31, P3342, DOI 10.1021/bi00128a006; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; DUTTON PL, 1971, BIOCHIM BIOPHYS ACTA, V226, P63, DOI 10.1016/0005-2728(71)90178-2; DUVAL S, 2008, THESIS U PROVENCE MA; Duval S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-206; Ellis PJ, 2001, STRUCTURE, V9, P125, DOI 10.1016/S0969-2126(01)00566-4; Green H. H., 1918, S AFR J SCI, V14, P465; Henninger T, 1999, J BIOENERG BIOMEMBR, V31, P119, DOI 10.1023/A:1005447710894; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Hoeft SE, 2007, INT J SYST EVOL MICR, V57, P504, DOI 10.1099/ijs.0.64576-0; Hoke KR, 2004, BIOCHEMISTRY-US, V43, P1667, DOI 10.1021/bi0357154; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; IWASAKI T, 1995, J BACTERIOL, V177, P2576, DOI 10.1128/jb.177.9.2576-2582.1995; Iwasaki T, 1996, J BIOL CHEM, V271, P27659, DOI 10.1074/jbc.271.44.27659; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Kallas T, 1994, MOL BIOL CYANOBACTER, V1, P259, DOI DOI 10.1007/978-94-011-0227-8_9; Kashyap DR, 2006, J BACTERIOL, V188, P1081, DOI 10.1128/JB.188.3.1081-1088.2006; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kolling DJ, 2007, STRUCTURE, V15, P29, DOI 10.1016/j.str.2006.11.012; Kulp TR, 2008, SCIENCE, V321, P967, DOI 10.1126/science.1160799; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lebrun E, 2006, MOL BIOL EVOL, V23, P1180, DOI 10.1093/molbev/msk010; Leggate EJ, 2005, BIOCHEMISTRY-US, V44, P7048, DOI 10.1021/bi050189x; Liebl U, 1997, BIOCHEMISTRY-US, V36, P11675, DOI 10.1021/bi970776l; LIEUTAUD A, 2007, THESIS U PROVENCE MA; Lieutaud A, 2010, J BIOL CHEM, V285, P20433, DOI 10.1074/jbc.M110.113761; Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; Merbitz-Zahradnik T, 2003, BIOCHEMISTRY-US, V42, P13637, DOI 10.1021/bi035344r; Muller D, 2003, J BACTERIOL, V185, P135, DOI 10.1128/JB.185.1.135-141.2003; Nitscke W, 1995, PHOTOSYNTHESIS LIGHT, V1, P945; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; RIEDEL A, 1991, J BIOL CHEM, V266, P17838; RIESKE JS, 1964, J BIOL CHEM, V239, P3017; Santini JM, 2004, J BACTERIOL, V186, P1614, DOI 10.1128/JB.186.6.1614-1619.2004; Schmidt CL, 2001, J BIOENERG BIOMEMBR, V33, P9, DOI 10.1023/A:1005616505962; Schoepp B, 1999, FEBS LETT, V450, P245, DOI 10.1016/S0014-5793(99)00511-6; Schoepp B, 1999, ADV INORG CHEM, V47, P335, DOI 10.1016/S0898-8838(08)60082-3; Schoepp-Cothenet B, 2009, P NATL ACAD SCI USA, V106, P8549, DOI 10.1073/pnas.0813173106; Schroter T, 1998, EUR J BIOCHEM, V255, P100, DOI 10.1046/j.1432-1327.1998.2550100.x; Schutz M, 2003, BIOCHEMISTRY-US, V42, P10800, DOI 10.1021/bi034452a; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; SLATER EC, 1980, NATURE, V288, P717, DOI 10.1038/288717a0; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; THIERBACH G, 1984, BIOCHIM BIOPHYS ACTA, V765, P227, DOI 10.1016/0005-2728(84)90017-3; Ugulava NB, 1998, FEBS LETT, V440, P409, DOI 10.1016/S0014-5793(98)01493-8; vanden Hoven RN, 2004, BBA-BIOENERGETICS, V1656, P148, DOI 10.1016/j.bbabio.2004.03.001; VONJAGOW G, 1985, FEBS LETT, V185, P311, DOI 10.1016/0014-5793(85)80929-7; ZANNONI D, 1985, FEBS LETT, V193, P93, DOI 10.1016/0014-5793(85)80086-7; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zu YB, 2003, BIOCHEMISTRY-US, V42, P12400, DOI 10.1021/bi0350957	61	27	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20442	20451		10.1074/jbc.M110.113811	http://dx.doi.org/10.1074/jbc.M110.113811			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421651	hybrid, Green Published			2022-12-27	WOS:000279228600004
J	Vest, RS; O'Leary, H; Coultrap, SJ; Kindy, MS; Bayer, KU				Vest, Rebekah S.; O'Leary, Heather; Coultrap, Steven J.; Kindy, Mark S.; Bayer, K. Ulrich			Effective Post-insult Neuroprotection by a Novel Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTOR; INDUCED CELL-DEATH; TISSUE-PLASMINOGEN ACTIVATOR; ISCHEMIC BRAIN-DAMAGE; NMDA RECEPTOR; GLUTAMATE NEUROTOXICITY; HIPPOCAMPAL-NEURONS; CEREBRAL-ISCHEMIA; SELF-ASSOCIATION; GLUCOSE DEPRIVATION	Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) is a major mediator of physiological glutamate signaling involved in higher brain functions. Here, we show CaMKII involvement in pathological glutamate signaling relevant in stroke. The novel inhibitor tatCN21 was neuroprotective even when added hours after glutamate insults. By contrast, the "traditional" inhibitor KN93 attenuated excitotoxicity only when present during the insult. Both inhibitors efficiently blocked Ca2+/CaM-stimulated CaMKII activity, CaMKII interaction with NR2B and aggregation of CaMKII holoenzymes. However, only tatCN21 but not KN93 blocked the Ca2+-independent "autonomous" activity generated by Thr-286 autophosphorylation, the hallmark feature of CaMKII regulation. Mutational analysis further validated autonomous CaMKII activity as the drug target crucial for post-insult neuroprotection. Overexpression of CaMKII wild type but not the autonomy-deficient T286A mutant significantly increased glutamate-induced neuronal death. Maybe most importantly, tatCN21 also significantly reduced infarct size in a mouse stroke model (middle cerebral arterial occlusion) when injected (1 mg/kg intravenously) 1 h after onset of arterial occlusion. Together, these data demonstrate that inhibition of autonomous CaMKII activity provides a promising therapeutic avenue for post-insult neuro-protection after stroke.	Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Kindy, Mark S.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Kindy, Mark S.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center		ulli.bayer@ucdenver.edu			National Institutes of Health [P30NS048154, F31NS061584, T32GM007635]; Veterans Affairs Merit Review; State of Colorado TTO BDEGP; University of Colorado, Denver [P20RR017677-08, R01NS052644]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052644, P30NS048154, F31NS061584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); State of Colorado TTO BDEGP; University of Colorado, Denver; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30NS048154 (University of Colorado, Denver, center grant), P20RR017677-08, and R01NS052644 (to K. U. B.). This work was also supported by Veterans Affairs Merit Review (to M. S. K.) and State of Colorado TTO BDEGP. The University of Colorado is currently seeking patent protection for tatCN21 and its uses.; Supported by National Institutes of Health Training Grant F31NS061584.; Supported by National Institutes of Health Training Grant T32GM007635.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Aarts MM, 2004, CURR MOL MED, V4, P137, DOI 10.2174/1566524043479202; Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Antonelli T, 2008, CEREB CORTEX, V18, P1748, DOI 10.1093/cercor/bhm217; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buddle M, 2003, BRAIN RES, V978, P38, DOI 10.1016/S0006-8993(03)02758-6; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1987, J NEUROSCI, V7, P357; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Fan W, 2006, BRAIN RES, V1067, P48, DOI 10.1016/j.brainres.2005.10.030; FELIPO V, 1993, J NEUROCHEM, V60, P1626, DOI 10.1111/j.1471-4159.1993.tb13384.x; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; FRANDSEN A, 1989, J NEUROCHEM, V53, P297, DOI 10.1111/j.1471-4159.1989.tb07327.x; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Govindaswami M, 2008, ACAD EMERG MED, V15, P250, DOI 10.1111/j.1553-2712.2008.00048.x; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; HAJIMOHAMMADREZA I, 1995, J NEUROSCI, V15, P4093; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Huang C, 2009, BRAIN RES, V1257, P75, DOI 10.1016/j.brainres.2008.11.088; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Hudmon A, 2001, J NEUROCHEM, V76, P1364, DOI 10.1046/j.1471-4159.2001.00119.x; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Laabich A, 2000, MOL BRAIN RES, V85, P32, DOI 10.1016/S0169-328X(00)00226-6; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; LI GD, 1992, MOL PHARMACOL, V42, P489; Li GL, 2000, APMIS, V108, P98; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SMITH MK, 1990, J BIOL CHEM, V265, P1837; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Sun HS, 2008, STROKE, V39, P2544, DOI 10.1161/STROKEAHA.107.506048; Takano H, 2003, BRAIN RES, V962, P41, DOI 10.1016/S0006-8993(02)03932-X; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; Tremper-Wells B, 2002, J NEUROCHEM, V81, P314, DOI 10.1046/j.1471-4159.2002.00829.x; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2009, FEBS LETT, V583, P3577, DOI 10.1016/j.febslet.2009.10.028; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Yu CZ, 2009, NEUROCHEM RES, V34, P2008, DOI 10.1007/s11064-009-9990-z; Yu J, 2008, BRAIN RES, V1238, P143, DOI 10.1016/j.brainres.2008.08.053; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200	72	82	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20675	20682		10.1074/jbc.M109.088617	http://dx.doi.org/10.1074/jbc.M109.088617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20424167	Green Published, hybrid			2022-12-27	WOS:000279228600031
J	Hegazy, SA; Wang, P; Anand, M; Ingham, RJ; Gelebart, P; Lai, R				Hegazy, Samar A.; Wang, Peng; Anand, Mona; Ingham, Robert J.; Gelebart, Pascal; Lai, Raymond			The Tyrosine 343 Residue of Nucleophosmin (NPM)-Anaplastic Lymphoma Kinase (ALK) Is Important for Its Interaction with SHP1, a Cytoplasmic Tyrosine Phosphatase with Tumor Suppressor Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; GROWTH-FACTOR RECEPTOR; ANAPLASTIC LYMPHOMA; NPM-ALK; DOWN-REGULATION; NEGATIVE REGULATION; CATALYTIC-ACTIVITY; JAK/STAT PATHWAY; FUSION PROTEIN	The cytoplasmic tyrosine phosphatase SHP1 has been shown to inhibit the oncogenic fusion protein nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK), and loss of SHP1 contributes to NPM-ALK-mediated tumorigenesis. In this study, we aimed to further understand how SHP1 interacts and regulates NPM-ALK. We employed an in vitro model in which GP293 cells were transfected with various combinations of NPM-ALK (or mutants) and SHP1 (or mutants) expression vectors. We found that SHP1 co-immunoprecipitated with NPM-ALK, but not the enzymatically inactive NPM-ALK(K210R) mutant, or the mutant in which all three functionally important tyrosine residues (namely, Tyr(338), Tyr(342), and Tyr(343)) in the kinase activation loop (KAL) of ALK were mutated. Interestingly, whereas mutation of Tyr(338) or Tyr(342) did not result in any substantial change in the NPM-ALK/SHP1 binding (assessed by co-immunoprecipitation), mutation of Tyr(343) abrogated this interaction. Furthermore, the NPM-ALK/SHP1 binding was readily detectable when each of the remaining 8 tyrosine residues known to be phosphorylated were mutated. Although the expression of SHP1 effectively reduced the level of tyrosine phosphorylation of NPM-ALK, it did not affect that of the NPM-ALK(Y343F) mutant. In soft agar clonogenic assay, SHP1 expression significantly reduced the tumorigenicity of NPM-ALK but not that of NPM-ALK(Y343F). In conclusion, we identified Tyr(343) of NPM-ALK as the crucial site for mediating the NPM-ALK/SHP1 interaction. Our results also support the notion that the tumor suppressor effects of SHP1 on NPM-ALK are dependent on its ability to bind to this oncogenic protein.	[Lai, Raymond] Univ Alberta, Dept Lab Med & Pathol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Ingham, Robert J.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Lai, R (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada.	rlai@ualberta.ca	Gelebart, Pascal/AAI-1439-2020	Gelebart, Pascal/0000-0003-2434-8987	Canadian Institutes of Health Research; Alberta Cancer Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute	This work was supported by grants from the Canadian Institutes of Health Research and the Alberta Cancer Research Institute (to R.L.).	Adachi T, 1998, J IMMUNOL, V160, P4662; Ambrogio C, 2005, BLOOD, V106, P3907, DOI 10.1182/blood-2005-03-1204; Amin HM, 2007, J PATHOL, V212, P402, DOI 10.1002/path.2178; Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Amin HM, 2003, ONCOGENE, V22, P5399, DOI 10.1038/sj.onc.1206849; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Bard JD, 2009, AM J PATHOL, V175, P825, DOI 10.2353/ajpath.2009.080982; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Bonvini P, 2002, CANCER RES, V62, P1559; Chim CS, 2004, LEUKEMIA, V18, P356, DOI 10.1038/sj.leu.2403216; Cussac D, 2004, BLOOD, V103, P1464; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Delsol G, 2008, ANN PATHOL, V28, pS20, DOI 10.1016/j.annpat.2008.09.002; Hampel K, 2006, CHEMMEDCHEM, V1, P869, DOI 10.1002/cmdc.200600037; Han Y, 2006, LEUKEMIA, V20, P1602, DOI 10.1038/sj.leu.2404323; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Hennige AM, 2001, ENDOCRINOLOGY, V142, P4441, DOI 10.1210/en.142.10.4441; Honorat JF, 2006, BLOOD, V107, P4130, DOI 10.1182/blood-2005-06-2421; Khoury JD, 2004, BLOOD, V104, P1580, DOI 10.1182/blood-2004-03-1151; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Kosugi A, 2001, IMMUNITY, V14, P669, DOI 10.1016/S1074-7613(01)00146-7; Koyama M, 2003, LAB INVEST, V83, P1849, DOI 10.1097/01.LAB.0000106503.65258.2B; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; LEBEAU MM, 1989, LEUKEMIA, V3, P866; Lim YM, 2000, P NATL ACAD SCI USA, V97, P12233, DOI 10.1073/pnas.210253497; Lorenz U, 1996, J EXP MED, V184, P1111, DOI 10.1084/jem.184.3.1111; Mathew P, 1997, BLOOD, V89, P1678, DOI 10.1182/blood.V89.5.1678.1678_1678_1685; Migone TS, 1998, P NATL ACAD SCI USA, V95, P3845, DOI 10.1073/pnas.95.7.3845; MORGAN R, 1986, NEW ENGL J MED, V314, P1322; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Oka T, 2002, CANCER RES, V62, P6390; Otipoby KL, 2001, J BIOL CHEM, V276, P44315, DOI 10.1074/jbc.M105446200; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; Qiu L, 2006, BLOOD, V108, P2407, DOI 10.1182/blood-2006-04-020305; RIMOKH R, 1989, BRIT J HAEMATOL, V71, P31, DOI 10.1111/j.1365-2141.1989.tb06270.x; Roccato E, 2005, J BIOL CHEM, V280, P3382, DOI 10.1074/jbc.M407522200; SHIOTA M, 1994, ONCOGENE, V9, P1567; Tartari CJ, 2008, J BIOL CHEM, V283, P3743, DOI 10.1074/jbc.M706067200; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; UCHIDA T, 1994, J BIOL CHEM, V269, P12220; Voena C, 2007, CANCER RES, V67, P4278, DOI 10.1158/0008-5472.CAN-06-4350; Wang P, 2010, J BIOL CHEM, V285, P95, DOI 10.1074/jbc.M109.059758; Witkiewicz A, 2007, HUM PATHOL, V38, P462, DOI 10.1016/j.humpath.2006.09.012; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Wu YJ, 1998, CURR BIOL, V8, P1009, DOI 10.1016/S0960-9822(07)00421-6; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; YI TL, 1995, BLOOD, V85, P87, DOI 10.1182/blood.V85.1.87.bloodjournal85187; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang Q, 2000, AM J PATHOL, V157, P1137, DOI 10.1016/S0002-9440(10)64629-9	55	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19813	19820		10.1074/jbc.M110.121988	http://dx.doi.org/10.1074/jbc.M110.121988			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424160	Green Published, hybrid			2022-12-27	WOS:000279012000014
J	Hill, BG; Dranka, BP; Bailey, SM; Lancaster, JR; Darley-Usmar, VM				Hill, Bradford G.; Dranka, Brian P.; Bailey, Shannon M.; Lancaster, Jack R., Jr.; Darley-Usmar, Victor M.			What Part of NO Don't You Understand? Some Answers to the Cardinal Questions in Nitric Oxide Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							REACTIVE OXYGEN; SIGNAL-TRANSDUCTION; MITOCHONDRIAL RESPIRATION; GUANYLATE-CYCLASE; IN-VIVO; PEROXYNITRITE; PHYSIOLOGY; HEMOGLOBIN; BIOCHEMISTRY; ENOS	Nitric oxide (NO) regulates biological processes through signaling mechanisms that exploit its unique biochemical properties as a free radical. For the last several decades, the key aspects of the chemical properties of NO relevant to biological systems have been defined, but it has been a challenge to assign these to specific cellular processes. Nevertheless, it is now clear that the high affinity of NO for transition metal centers, particularly iron, and the rapid reaction of NO with oxygen-derived free radicals can explain many of its biological and pathological properties. Emerging studies also highlight a growing importance of the secondary metabolites of NO-dependent reactions in the post-translational modification of key metabolic and signaling proteins. In this minireview, we emphasize the current understanding of the biochemistry of NO and place it in a biological context.	[Hill, Bradford G.; Dranka, Brian P.; Bailey, Shannon M.; Lancaster, Jack R., Jr.; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Hill, Bradford G.; Dranka, Brian P.; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Bailey, Shannon M.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Darley-Usmar, VM (corresponding author), Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA.	darley@uab.edu	Hill, Bradford/F-9228-2011; Dranka, Brian/B-9725-2011; Darley-Usmar, Victor/F-7656-2010; Hill, Bradford/I-4154-2013; Dranka, Brian/B-8701-2016	Hill, Bradford/0000-0001-5332-8286; Darley-Usmar, Victor/0000-0001-8921-7086; Bailey, Shannon/0000-0003-0002-3424; Dranka, Brian/0000-0002-1377-377X	National Institutes of Health [AA15172, AA18841, DK73775, CA131653, AA13395, ES/HL10167, DK75865, T32 HL007918, T32 HL07457]; NATIONAL CANCER INSTITUTE [R01CA131653] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007457, F32HL010167, T32HL007918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK075865, R21DK073775, R01DK075865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018841, R01AA015172, R01AA013395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA15172, AA18841, and DK73775 (to S. M. B.); CA131653 (to J.R.L.); AA13395, ES/HL10167, and DK75865 (to V.M.D.-U.); T32 HL007918 (to B. P. D.); and T32 HL07457 (to B. G. H.). This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Angelo M, 2008, METHOD ENZYMOL, V436, P131, DOI 10.1016/S0076-6879(08)36008-X; Antunes F, 2007, ANTIOXID REDOX SIGN, V9, P1569, DOI 10.1089/ars.2007.1677; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Beckman JS, 2009, ARCH BIOCHEM BIOPHYS, V484, P114, DOI 10.1016/j.abb.2009.03.013; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brookes PS, 2002, FREE RADICAL BIO MED, V33, P755, DOI 10.1016/S0891-5849(02)00901-2; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; Butler AR, 2006, J ROY COLL PHYS EDIN, V36, P185; Butler AR, 2002, CHEM REV, V102, P1155, DOI 10.1021/cr000076d; Cooper CE, 2002, TRENDS BIOCHEM SCI, V27, P489, DOI 10.1016/S0968-0004(02)02191-6; Cooper CE, 2007, AM J PHYSIOL-CELL PH, V292, pC1993, DOI 10.1152/ajpcell.00310.2006; DarleyUsmar V, 1996, PHARM RES-DORDR, V13, P649, DOI 10.1023/A:1016079012214; Demple B, 2002, MOL CELL BIOCHEM, V234, P11, DOI 10.1023/A:1015933216079; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Erusalimsky JD, 2007, ARTERIOSCL THROM VAS, V27, P2524, DOI 10.1161/ATVBAHA.107.151167; Finocchietto PV, 2009, EXP BIOL MED, V234, P1020, DOI 10.3181/0902-MR-81; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Garthwaite J, 2010, MOL CELL BIOCHEM, V334, P221, DOI 10.1007/s11010-009-0318-8; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2006, ADV EXP MED BIOL, V588, P189; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Kato K, 2006, FRONT BIOSCI-LANDMRK, V11, P2725, DOI 10.2741/2002; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kleppisch Thomas, 2009, V191, P549, DOI 10.1007/978-3-540-68964-5_24; Koeck T, 2005, BIOCHEM SOC T, V33, P1399, DOI 10.1042/BST0331399; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Koppenol WH, 2001, REDOX REP, V6, P339, DOI 10.1179/135100001101536517; Lancaster JR, 2004, SCIENCE, V304, P1905; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Lopez-Sanchez LM, 2009, PROTEOMICS, V9, P808, DOI 10.1002/pmic.200800546; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; McAndrew J, 1997, SEMIN PERINATOL, V21, P351, DOI 10.1016/S0146-0005(97)80002-X; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Moller MN, 2007, IUBMB LIFE, V59, P243, DOI 10.1080/15216540701311147; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; MONCADA S, 1991, PHARMACOL REV, V43, P109; Neumann H, 2008, J AM CHEM SOC, V130, P4028, DOI 10.1021/ja710100d; O'Donnell VB, 2001, CIRC RES, V88, P12, DOI 10.1161/01.RES.88.1.12; Oess S, 2006, BIOCHEM J, V396, P401, DOI 10.1042/BJ20060321; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Rodriguez-Juarez F, 2007, BIOCHEM J, V405, P223, DOI 10.1042/BJ20070033; Schoneich C, 2006, FREE RADICAL BIO MED, V41, P1507, DOI 10.1016/j.freeradbiomed.2006.08.013; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shiva S, 2005, FREE RADICAL BIO MED, V38, P297, DOI 10.1016/j.freeradbiomed.2004.10.037; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Stamler JS, 2008, NAT MED, V14, P1008, DOI 10.1038/nm1008-1008; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Thomas DD, 2003, ANTIOXID REDOX SIGN, V5, P307, DOI 10.1089/152308603322110887; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Trujillo M, 2008, ANTIOXID REDOX SIGN, V10, P1607, DOI 10.1089/ars.2008.2060; Venkatraman A, 2004, HEPATOLOGY, V40, P565, DOI 10.1002/hep.20326; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016	68	218	227	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19699	19704		10.1074/jbc.R110.101618	http://dx.doi.org/10.1074/jbc.R110.101618			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410298	Green Published, hybrid			2022-12-27	WOS:000279012000001
J	Shao, CL; Lawrence, MC; Cobb, MH				Shao, Chunli; Lawrence, Michael C.; Cobb, Melanie H.			Regulation of CCAAT/Enhancer-binding Protein Homologous Protein (CHOP) Expression by Interleukin-1 beta in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; INSULIN GENE-EXPRESSION; OXIDATIVE STRESS; INDUCED APOPTOSIS; TERMINAL KINASE; NOD MICE; TRANSCRIPTION; DEATH; PATHWAY	Apoptosis contributes to immune-mediated pancreatic beta cell destruction in type I diabetes. Exposure of beta cells to interleukin-1 beta (IL-1 beta) causes endoplasmic reticulum stress and activates proapoptotic networks. Here, we show that nuclear factor kappa B (NF-kappa B) and mitogen-activated protein kinase (MAPK) signaling pathways regulate the expression of CCAAT/enhancer-binding protein homologous protein (CHOP), which mediates endoplasmic reticulum stress-induced apoptosis. Both CHOP mRNA and protein increase in beta cells treated with IL-1 beta. In addition, prolonged exposure to high glucose further increases IL-1 beta-triggered CHOP expression. IL-1 beta also causes increased expression of C/EBP-beta and a reduction of MafA, NFATc2, and Pdx-1 expression in beta cells. Inhibition of the NF-kappa B and MAPK signaling pathways differentially attenuates CHOP expression. Knocking down CHOP by RNA interference protects beta cells from IL-1 beta-induced apoptosis. These studies provide direct mechanistic links between cytokine-induced signaling pathways and CHOP-mediated apoptosis of beta cells.	[Shao, Chunli; Lawrence, Michael C.; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	melanie.cobb@utsouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [DK55310]; Robert A. Welch Foundation [I1243]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55310. This work was also supported by Robert A. Welch Foundation Grant I1243.	Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; Augstein P, 2004, J AUTOIMMUN, V23, P301, DOI 10.1016/j.jaut.2004.09.006; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chin-Chance CVT, 2006, J INVEST MED, V54, P132, DOI 10.2310/6650.2006.05035; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Ferdaoussi M, 2008, DIABETES, V57, P1205, DOI 10.2337/db07-1214; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Glauser DA, 2007, FASEB J, V21, P3240, DOI 10.1096/fj.06-7798com; Gurzov EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003030; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; Lamhamedi-Cherradi SE, 2003, J IMMUNOL, V171, P4886, DOI 10.4049/jimmunol.171.9.4886; Larsen L, 2005, DIABETOLOGIA, V48, P2582, DOI 10.1007/s00125-005-0039-9; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Lawrence MC, 2007, P NATL ACAD SCI USA, V104, P11518, DOI 10.1073/pnas.0704618104; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee MS, 2004, MOL GENET METAB, V83, P82, DOI 10.1016/j.ymgme.2004.08.002; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Naamane N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-55; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pavlovic D, 2000, EUR CYTOKINE NETW, V11, P267; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Shao CL, 2009, J BIOL CHEM, V284, P3117, DOI 10.1074/jbc.M806286200; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001	48	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19710	19719		10.1074/jbc.M109.087486	http://dx.doi.org/10.1074/jbc.M109.087486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424162	Green Published, hybrid			2022-12-27	WOS:000279012000003
J	Gabbay, KH; Bohren, KM; Morello, R; Bertin, T; Liu, J; Vogel, P				Gabbay, Kenneth H.; Bohren, Kurt M.; Morello, Roy; Bertin, Terry; Liu, Jeff; Vogel, Peter			Ascorbate Synthesis Pathway DUAL ROLE OF ASCORBATE IN BONE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINERAL DENSITY; VITAMIN-C; GULONOLACTONE-OXIDASE; ALDOSE REDUCTASE; SORBITOL PATHWAY; GENE-EXPRESSION; ACID; DEFICIENCY; MICE; DIFFERENTIATION	Using mouse gene knock-out models, we identify aldehyde reductase (EC 1.1.1.2, Akr1a4 (GR)) and aldose reductase (EC 1.1.1.21, Akr1b3 (AR)) as the enzymes responsible for conversion of D-glucuronate to L-gulonate, a key step in the ascorbate (ASC) synthesis pathway in mice. The gene knock-out (KO) mice show that the two enzymes, GR and AR, provide similar to 85 and similar to 15% of L-gulonate, respectively. GRKO/ARKO double knockout mice are unable to synthesize ASC (>95% ASC deficit) and develop scurvy. The GRKO mice (similar to 85% ASC deficit) develop and grow normally when fed regular mouse chow (ASC content = 0) but suffer severe osteopenia and spontaneous fractures with stresses that increase ASC requirements, such as pregnancy or castration. Castration greatly increases osteoclast numbers and activity in GRKO mice and promotes increased bone loss as compared with wild-type controls and additionally induces proliferation of immature dysplastic osteoblasts likely because of an ASC-sensitive block(s) in early differentiation. ASC and the antioxidants pycnogenol and resveratrol block osteoclast proliferation and bone loss, but only ASC feeding restores osteoblast differentiation and prevents their dysplastic proliferation. This is the first in vivo demonstration of two independent roles for ASC as an antioxidant suppressing osteoclast activity and number as well as a cofactor promoting osteoblast differentiation. Although humans have lost the ability to synthesize ASC, our mouse models suggest the mechanisms by which suboptimal ASC availability facilitates the development of osteoporosis, which has important implications for human osteoporosis.	[Gabbay, Kenneth H.; Bohren, Kurt M.] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Morello, Roy; Bertin, Terry] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Liu, Jeff; Vogel, Peter] Lexicon Pharmaceut Inc, The Woodlands, TX 77381 USA	Baylor College of Medicine; Baylor College of Medicine; Lexicon Pharmaceuticals	Gabbay, KH (corresponding author), Harry B & Aileen B Gordon Diabet Res Ctr, 1102 Bates,Suite 550,MC3-2353, Houston, TX 77030 USA.	kgabbay@bcm.tmc.edu	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545; Bohren, Kurt/0000-0002-3183-4118	Harry B & Aileen B Gordon Foundation; Jacob & Louise Gabbay Foundation; Agar Corporation; USDA [ARS 6250-51000-051]	Harry B & Aileen B Gordon Foundation; Jacob & Louise Gabbay Foundation; Agar Corporation; USDA(United States Department of Agriculture (USDA))	This work was supported by grants (to K. H. G.) from the Harry B & Aileen B Gordon Foundation, the Jacob & Louise Gabbay Foundation, the Agar Corporation, and USDA ARS 6250-51000-051.	Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beamer WG, 2000, BONE, V27, P619, DOI 10.1016/S8756-3282(00)00369-0; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BOHREN KM, 1991, J BIOL CHEM, V266, P24031; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; FRANCESCHI RT, 1992, NUTR REV, V50, P65; GABBAY KH, 1966, SCIENCE, V151, P209, DOI 10.1126/science.151.3707.209; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; HEINEGAR.D, 1973, CLIN CHIM ACTA, V43, P305, DOI 10.1016/0009-8981(73)90466-X; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; KAWAI T, 1992, J BIOL CHEM, V267, P21973; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Lean J, 2004, BIOCHEM BIOPH RES CO, V321, P845, DOI 10.1016/j.bbrc.2004.07.035; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; MacKinnon R, 2004, BIOSCIENCE REP, V24, P75, DOI 10.1007/s10540-004-7190-2; Mohan S, 2005, J BONE MINER RES, V20, P1597, DOI 10.1359/JBMR.050406; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Morton DJ, 2001, J BONE MINER RES, V16, P135, DOI 10.1359/jbmr.2001.16.1.135; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Pan YP, 2008, J BIOL CHEM, V283, P8634, DOI 10.1074/jbc.M709304200; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parsons KK, 2006, AM J PHYSIOL-ENDOC M, V290, pE1131, DOI 10.1152/ajpendo.00339.2005; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; Sahni S, 2009, OSTEOPOROSIS INT, V20, P1853, DOI 10.1007/s00198-009-0897-y; Sahni S, 2008, J NUTR, V138, P1931, DOI 10.1093/jn/138.10.1931; SATO P, 1978, ARCH BIOCHEM BIOPHYS, V187, P158, DOI 10.1016/0003-9861(78)90018-8; Schnitzler CM, 2005, CALCIFIED TISSUE INT, V76, P79, DOI 10.1007/s00223-004-0053-9; SILVER J, 1989, J VIROL, V63, P1924, DOI 10.1128/JVI.63.5.1924-1928.1989; Simon JA, 2001, AM J EPIDEMIOL, V154, P427, DOI 10.1093/aje/154.5.427; SULLIVAN TA, 1994, J BIOL CHEM, V269, P22500; van den Hoogen BM, 1998, ANAL BIOCHEM, V257, P107, DOI 10.1006/abio.1997.2538; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Wolf RL, 2005, AM J CLIN NUTR, V82, P581, DOI 10.1093/ajcn/82.3.581; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xing WR, 2007, J BIOL CHEM, V282, P22052, DOI 10.1074/jbc.M702614200; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	43	79	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19510	19520		10.1074/jbc.M110.110247	http://dx.doi.org/10.1074/jbc.M110.110247			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410296	hybrid, Green Published			2022-12-27	WOS:000278727800061
J	Sage, JM; Gildemeister, OS; Knight, KL				Sage, Jay M.; Gildemeister, Otto S.; Knight, Kendall L.			Discovery of a Novel Function for Human Rad51 MAINTENANCE OF THE MITOCHONDRIAL GENOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; REPAIR; PROTEIN; LOCALIZATION; BREAKS; BRCA2; XRCC3; CELLS	Homologous recombination (HR) plays a critical role in facilitating replication fork progression when the polymerase complex encounters a blocking DNA lesion, and it also serves as the primary mechanism for error-free repair of DNA double strand breaks. Rad51 is the central catalyst of HR in all eukaryotes, and to this point studies of human Rad51 have focused exclusively on events occurring within the nucleus. However, substantial amounts of HR proteins exist in the cytoplasm, yet the function of these protein pools has not been addressed. Here, we provide the first demonstration that Rad51 and the related HR proteins Rad51C and Xrcc3 exist in human mitochondria. We show stress-induced increases in both the mitochondrial levels of each protein and, importantly, the physical interaction between Rad51 and mitochondrial DNA (mtDNA). Depletion of Rad51, Rad51C, or Xrcc3 results in a dramatic decrease in mtDNA copy number as well as the complete suppression of a characteristic oxidative stress-induced copy number increase. Our results identify human mtDNA as a novel Rad51 substrate and reveal an important role for HR proteins in the maintenance of the human mitochondrial genome.	[Sage, Jay M.; Gildemeister, Otto S.; Knight, Kendall L.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Knight, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Aaron Lazare Med Res Bldg,364 Plantat St, Worcester, MA 01605 USA.	kendall.knight@umassmed.edu			National Institutes of Health [GM65851, GM44772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065851, R01GM044772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM65851 and GM44772 (to K. L. K.).	Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Bennett BT, 2005, J CELL BIOCHEM, V96, P1095, DOI 10.1002/jcb.20640; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Flores-Rozas H, 2000, TRENDS BIOCHEM SCI, V25, P196, DOI 10.1016/S0968-0004(00)01568-1; Forget AL, 2004, J CELL BIOCHEM, V93, P429, DOI 10.1002/jcb.20232; Frossi B, 2002, J CELL PHYSIOL, V193, P180, DOI 10.1002/jcp.10159; Gildemeister OS, 2009, J BIOL CHEM, V284, P31945, DOI 10.1074/jbc.M109.024646; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Henson SE, 2006, MUTAT RES-FUND MOL M, V601, P113, DOI 10.1016/j.mrfmmm.2006.06.016; Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kraakman-van der Zwet M, 2002, MOL CELL BIOL, V22, P669, DOI 10.1128/MCB.22.2.669-679.2002; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liu N, 2005, J CELL BIOCHEM, V95, P942, DOI 10.1002/jcb.20457; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Mladenov E, 2006, GENES CELLS, V11, P513, DOI 10.1111/j.1365-2443.2006.00958.x; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; Stuart JA, 2006, BBA-BIOENERGETICS, V1757, P79, DOI 10.1016/j.bbabio.2006.01.003; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Tembe V, 2007, CELL SIGNAL, V19, P1113, DOI 10.1016/j.cellsig.2007.03.001; Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536; Trzeciak AR, 2004, CARCINOGENESIS, V25, P1359, DOI 10.1093/carcin/bgh144; Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	37	75	80	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18984	18990		10.1074/jbc.M109.099846	http://dx.doi.org/10.1074/jbc.M109.099846			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20413593	hybrid, Green Published			2022-12-27	WOS:000278727800006
J	Yang, ZG; Kahn, BB; Shi, H; Xue, BZ				Yang, Zhenggang; Kahn, Barbara B.; Shi, Hang; Xue, Bing-zhong			Macrophage alpha 1 AMP-activated Protein Kinase (alpha 1AMPK) Antagonizes Fatty Acid-induced Inflammation through SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; PERIPHERAL-TISSUES; ADIPOSE-TISSUE; ENERGY-BALANCE; PPAR-GAMMA; IKK-BETA; IN-VIVO; OBESITY; SENSITIVITY; DIET	In this study, we aim to determine cellular mechanisms linking nutrient metabolism to the regulation of inflammation and insulin resistance. The nutrient sensors AMP-activated protein kinase (AMPK) and SIRT1 show striking similarities in nutrient sensing and regulation of metabolic pathways. We find that the expression, activity, and signaling of the major isoform alpha 1AMPK in adipose tissue and macrophages are substantially down-regulated by inflammatory stimuli and in nutrient-rich conditions, such as exposure to lipopolysaccharide (LPS), free fatty acids (FFAs), and diet-induced obesity. Activating AMPK signaling in macrophages by 5-aminoimidazole-4-carboxamide-1-beta 4-ribofuranoside or constitutively active alpha 1AMPK (CA alpha 1) significantly inhibits; although inhibiting alpha 1AMPK by short hairpin RNA knock-down or dominant-negative alpha 1AMPK (DN-alpha 1) increases LPS- and FFA-induced tumor necrosis factor alpha expression. Chromatin immunoprecipitation and luciferase reporter assays show that activation of AMPK by CA-alpha 1 in macrophages significantly inhibits LPS- or FFA-induced NF-kappa B signaling. More importantly, in a macrophage-adipocyte co-culture system, we find that inactivation of macrophage AMPK signaling inhibits adipocyte insulin signaling and glucose uptake. Activation of AMPK by CA-alpha 1 increases the SIRT1 activator NAD(+) content and SIRT1 expression in macrophages. Furthermore, alpha 1AMPK activation mimics the effect of SIRT1 on deacetylating NF-kappa B, and the full capacity of AMPK to deacetylate NF-kappa B and inhibit its signaling requires SIRT1. In conclusion, AMPK negatively regulates lipid-induced inflammation, which acts through SIRT1, thereby contributing to the protection against obesity, inflammation, and insulin resistance. Our study defines a novel role for AMPK in bridging the signaling between nutrient metabolism and inflammation.	[Yang, Zhenggang; Shi, Hang; Xue, Bing-zhong] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Kahn, Barbara B.] Harvard Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab,Beth Israel Deacone, Boston, MA 02115 USA	Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Harvard Medical School	Shi, H (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	hshi@wfubmc.edu; bxue@wfubmc.edu			National Institutes of Health [R01DK084172, P01DK56116]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056116, R37DK043051, R01DK084172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK084172 (to H. S.) and P01DK56116 (to B. B. K.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Fisher JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE18, DOI 10.1152/ajpendo.2002.282.1.E18; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	41	313	330	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19051	19059		10.1074/jbc.M110.123620	http://dx.doi.org/10.1074/jbc.M110.123620			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20421294	Green Published, hybrid			2022-12-27	WOS:000278727800014
J	Langelier, MF; Ruhl, DD; Planck, JL; Kraus, WL; Pascal, JM				Langelier, Marie-France; Ruhl, Donald D.; Planck, Jamie L.; Kraus, W. Lee; Pascal, John M.			The Zn3 Domain of Human Poly(ADP-ribose) Polymerase-1 (PARP-1) Functions in Both DNA-dependent Poly(ADP-ribose) Synthesis Activity and Chromatin Compaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME ACTIVATION; ZINC-FINGERS; BINDING; REPAIR; TRANSCRIPTION; BREAKS; RECOGNITION; INHIBITION; MODULATION; INSULATION	PARP-1 is involved in multiple cellular processes, including transcription, DNA repair, and apoptosis. PARP-1 attaches ADP-ribose units to target proteins, including itself as a post-translational modification that can change the biochemical properties of target proteins and mediate recruitment of proteins to sites of poly(ADP-ribose) synthesis. Independent of its catalytic activity, PARP-1 binds to chromatin and promotes compaction affecting RNA polymerase II transcription. PARP-1 has a modular structure composed of six independent domains. Two homologous zinc fingers, Zn1 and Zn2, form the DNA-binding module. Zn1-Zn2 binding to DNA breaks triggers catalytic activity. Recently, we have identified a third zinc binding domain in PARP-1, the Zn3 domain, which is essential for DNA-dependent PARP-1 activity. The crystal structure of the Zn3 domain revealed a novel zinc-ribbon fold and a homodimeric Zn3 structure that formed in the crystal lattice. Structure-guided mutagenesis was used here to investigate the roles of these two features of the Zn3 domain. Our results indicate that the zinc-ribbon fold of the Zn3 domain mediates an interdomain contact crucial to assembly of the DNA-activated conformation of PARP-1. In contrast, residues located at the Zn3 dimer interface are not required for DNA-dependent activation but rather make important contributions to the chromatin compaction activity of PARP-1. Thus, the Zn3 domain has dual roles in regulating the functions of PARP-1.	[Langelier, Marie-France; Planck, Jamie L.; Pascal, John M.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Ruhl, Donald D.; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Jefferson University; Cornell University	Pascal, JM (corresponding author), 233 S 10th St,BLSB 804, Philadelphia, PA 19107 USA.	john.pascal@mail.jci.tju.edu			NIDDK, National Institutes of Health [DK069710]; American Cancer Society [IRG0806001, RSG0918301DMC]; Emerald Foundation, Inc.; Susan G. Komen Breast Cancer Foundation; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK069710, R01DK069710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087282] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); Emerald Foundation, Inc.; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK069710 from NIDDK (to W. L. K). This work was also supported by American Cancer Society Grants IRG0806001 and RSG0918301DMC, The Emerald Foundation, Inc. (to J.M.P.), and The Susan G. Komen Breast Cancer Foundation (to D. D. R.).; Recipient of postdoctoral fellowships from the Canadian Institutes of Health Research.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gamble MJ, 2007, CELL, V128, P433, DOI 10.1016/j.cell.2007.01.017; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Mendoza-Alvarez H, 1999, BIOCHEMISTRY-US, V38, P3948, DOI 10.1021/bi982148p; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Trucco C, 1996, FEBS LETT, V399, P313, DOI 10.1016/S0014-5793(96)01347-6; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zhang J, 1997, METHOD ENZYMOL, V280, P255	39	119	124	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18877	18887		10.1074/jbc.M110.105668	http://dx.doi.org/10.1074/jbc.M110.105668			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388712	Green Published, hybrid			2022-12-27	WOS:000278453900078
J	Coultrap, SJ; Buard, I; Kulbe, JR; Dell'Acqua, ML; Bayer, KU				Coultrap, Steven J.; Buard, Isabelle; Kulbe, Jaqueline R.; Dell'Acqua, Mark L.; Bayer, K. Ulrich			CaMKII Autonomy Is Substrate-dependent and Further Stimulated by Ca2+/Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; CALMODULIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; ACTIVATION; DOMAIN; AUTOREGULATION; ASSOCIATION; CONDUCTANCE	A hallmark feature of Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) regulation is the generation of Ca2+-independent autonomous activity by Thr-286 autophosphorylation. CaMKII autonomy has been regarded a form of molecular memory and is indeed important in neuronal plasticity and learning/memory. Thr-286-phosphorylated CaMKII is thought to be essentially fully active (similar to 70-100%), implicating that it is no longer regulated and that its dramatically increased Ca2+/CaM affinity is of minor functional importance. However, this study shows that autonomy greater than 15-25% was the exception, not the rule, and required a special mechanism (T-site binding; by the T-substrates AC2 or NR2B). Autonomous activity toward regular R-substrates (including tyrosine hydroxylase and GluR1) was significantly further stimulated by Ca2+/CaM, both in vitro and within cells. Altered K-m and V-max made autonomy also substrate- (and ATP) concentration-dependent, but only over a narrow range, with remarkable stability at physiological concentrations. Such regulation still allows molecular memory of previous Ca2+ signals, but prevents complete uncoupling from subsequent cellular stimulation.	[Coultrap, Steven J.; Buard, Isabelle; Kulbe, Jaqueline R.; Dell'Acqua, Mark L.; Bayer, K. Ulrich] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Bayer, KU (corresponding author), Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu		Kulbe, Jacqueline/0000-0002-7070-9264; Dell'Acqua, Mark/0000-0003-3798-3461	National Institutes of Health [P30NS048154, R01NS040701, R01NS052644]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701, R01NS052644, P30NS048154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30NS048154 (UCD Center Grant), R01NS040701 (to M. L. D.), and R01NS052644 (to K. U. B.).	Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bobrovskaya L, 2004, J NEUROCHEM, V90, P857, DOI 10.1111/j.1471-4159.2004.02550.x; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; DE KP, 1998, SCIENCE, V279, P227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	38	72	73	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17930	17937		10.1074/jbc.M109.069351	http://dx.doi.org/10.1074/jbc.M109.069351			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353941	Green Published, hybrid			2022-12-27	WOS:000278133400069
J	Dweck, D; Reynaldo, DP; Pinto, JR; Potter, JD				Dweck, David; Reynaldo, Daniel P.; Pinto, Jose R.; Potter, James D.			A Dilated Cardiomyopathy Troponin C Mutation Lowers Contractile Force by Reducing Strong Myosin-Actin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN; CALCIUM REGULATION; G159D MUTATION; CROSS-BRIDGES; T MUTATIONS; CA2+; SUBFRAGMENT-1; AFFINITY; SITES	In this study we explore the mechanisms by which a double mutation (E59D/D75Y) in cardiac troponin C (CTnC) associated with dilated cardiomyopathy reduces the Ca2+-activated maximal tension of cardiac muscle. Studying the single mutants (i.e. E59D or D75Y) indicates that D75Y, but not E59D, causes a reduction in the calcium affinity of CTnC in troponin complex, regulated thin filaments (RTF), and the Ca2+ sensitivity of contraction and ATPase in cardiac muscle preparations. However, both D75Y and E59D are required to reduce the actomyosin ATPase activity and maximal force in muscle fibers, indicating that E59D enhances the effects of D75Y. Part of the reduction in force/ATPase may be due to a defect in the interactions between CTnC and cardiac troponin T, which are known to be necessary for ATPase activation. An additional mechanism for the reduction in force/ATPase comes from measurements of the binding stoichiometry of myosin subfragment-1 (S-1) to the RTF. Using wild type RTFs, 4.8 mol S-1 was bound per mol filament (seven actins), whereas with E59D/D75Y RTFs, the number of binding sites was reduced by similar to 23% to 3.7. Altogether, these results suggest that the reduction in force and ATPase activation is possibly due to a thin filament conformation that promotes fewer accessible S-1-binding sites. In the absence of any family segregation data, the functional results presented here support the concept that this is likely a dilated cardiomyopathy-causing mutation.	[Dweck, David; Reynaldo, Daniel P.; Pinto, Jose R.; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave R-189, Miami, FL 33136 USA.	jdpotter@miami.edu	Pinto, Jose Renato/H-2631-2017	Pinto, Jose Renato/0000-0001-9092-4976; Pereira Reynaldo, Daniel/0000-0003-2531-2097	National Institutes of Health [HL042325]; American Heart Association [AHA 0315164B, AHA 0825368E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R37HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL042325 (to J. D. P.).; Supported by American Heart Association Grant AHA 0315164B.; Supported by American Heart Association Grant AHA 0825368E.	Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; BOREJDO J, 1980, BIOCHEMISTRY-US, V19, P4913, DOI 10.1021/bi00562a033; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; GUTH K, 1987, J BIOL CHEM, V262, P13627; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; INGRAHAM RH, 1984, J BIOL CHEM, V259, P9544; Jain M, 1998, CIRCULATION, V98, P179; Kaski JP, 2007, CARDIOL YOUNG, V17, P675, DOI 10.1017/S1047951107001291; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Margossian SS, 1999, MOL CELL BIOCHEM, V194, P301, DOI 10.1023/A:1006980405359; Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; Regnier M, 1995, AM J PHYSIOL-CELL PH, V269, pC1532, DOI 10.1152/ajpcell.1995.269.6.C1532; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Wang Y, 2002, J APPL PHYSIOL, V92, P2409, DOI 10.1152/japplphysiol.00376.2001; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	30	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17371	17379		10.1074/jbc.M109.064105	http://dx.doi.org/10.1074/jbc.M109.064105			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371872	Green Published, hybrid			2022-12-27	WOS:000278133400014
J	Hassinen, A; Rivinoja, A; Kauppila, A; Kellokumpu, S				Hassinen, Antti; Rivinoja, Antti; Kauppila, Annika; Kellokumpu, Sakari			Golgi N-Glycosyltransferases Form Both Homo- and Heterodimeric Enzyme Complexes in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PATHWAY; KIN RECOGNITION; MEDIAL-GOLGI; GLYCOSYLATION; LOCALIZATION; ORGANIZATION; APPARATUS; PH; GALACTOSYLTRANSFERASE; MISLOCALIZATION	Glycans (i.e. oligosaccharide chains attached to cellular proteins and lipids) are crucial for nearly all aspects of life, including the development of multicellular organisms. They come in multiple forms, and much of this diversity between molecules, cells, and tissues is generated by Golgi-resident glycosidases and glycosyltransferases. However, their exact mode of functioning in glycan processing is currently unclear. Here we investigate the supramolecular organization of the N-glycosylation pathway in live cells by utilizing the bimolecular fluorescence complementation approach. We show that all four N-glycosylation enzymes tested (beta-1,2-N-acetylglucosaminyltransferase I, beta-1,2-N-acetylglucosaminyltransferase II, 1,4-galactosyltransferaseI,and alpha-2,6-sialyltransferaseI)form Golgi-localizedhomodimers. Intriguingly, the same enzymes also formed two distinct and functionally relevant heterodimers between the medial Golgi enzymes beta-1,2-N-acetylglucosaminyltransferase I and beta-1,2-N-acetylglucosaminyltransferase II and the trans-Golgi enzymes 1,4-galactosyltransferase I and alpha-2,6-sialyltransferase I. Given their strict Golgi localization and sequential order of function, the two heterodimeric complexes are probably responsible for the processing and maturation of N-glycans in live cells.	[Kellokumpu, Sakari] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; Glycosci Grad Sch Finland, FIN-90014 Oulu, Finland	Finland National Institute for Health & Welfare; University of Oulu	Kellokumpu, S (corresponding author), Univ Oulu, Dept Biochem, POB 3000,Door J,Rm MN 212-1, FIN-90014 Oulu, Finland.	sakari.kellokumpu@oulu.fi		Hassinen, Antti/0000-0001-9491-2868	Academy of Finland; University of Oulu; Finnish Glycoscience Graduate School	Academy of Finland(Academy of Finland); University of Oulu; Finnish Glycoscience Graduate School	This work was supported by grants from the Academy of Finland, the University of Oulu, and the Finnish Glycoscience Graduate School.	Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; Chen C, 2000, J BIOL CHEM, V275, P13819, DOI 10.1074/jbc.275.18.13819; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; DUNPHY WG, 1985, CELL, V42, P13, DOI 10.1016/S0092-8674(85)80097-0; DUNPHY WG, 1981, P NATL ACAD SCI-BIOL, V78, P7453, DOI 10.1073/pnas.78.12.7453; FARQUHAR MG, 1981, J CELL BIOL, V91, pS77, DOI 10.1083/jcb.91.3.77s; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; Freeze HH, 2001, GLYCOBIOLOGY, V11, p37G; Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gleeson PA, 1998, HISTOCHEM CELL BIOL, V109, P517, DOI 10.1007/s004180050252; Glick BS, 2000, CURR OPIN CELL BIOL, V12, P450, DOI 10.1016/S0955-0674(00)00116-2; Grunewald S, 2002, PEDIATR RES, V52, P618, DOI 10.1203/01.PDR.0000031921.02259.35; Holappa K, 2001, J HISTOCHEM CYTOCHEM, V49, P259, DOI 10.1177/002215540104900213; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Ma JY, 1996, J BIOL CHEM, V271, P7758, DOI 10.1074/jbc.271.13.7758; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; NILSSON T, 1993, J CELL BIOL, V120, P5, DOI 10.1083/jcb.120.1.5; Noffz C, 2009, GLYCOBIOLOGY, V19, P472, DOI 10.1093/glycob/cwp001; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rivinoja A, 2006, J CELL PHYSIOL, V208, P167, DOI 10.1002/jcp.20653; Rivinoja A, 2009, J CELL PHYSIOL, V220, P144, DOI 10.1002/jcp.21744; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; TEASDALE RD, 1994, GLYCOBIOLOGY, V4, P917, DOI 10.1093/glycob/4.6.917; Ungar D, 2009, SEMIN CELL DEV BIOL, V20, P762, DOI 10.1016/j.semcdb.2009.03.004; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; Yang W, 1997, CELL BIOL INT, V21, P223, DOI 10.1006/cbir.1997.0138; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5	50	58	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17771	17777		10.1074/jbc.M110.103184	http://dx.doi.org/10.1074/jbc.M110.103184			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378551	hybrid, Green Published			2022-12-27	WOS:000278133400055
J	Palaima, E; Leymarie, N; Stroud, D; Mizanur, RM; Hodgkin, J; Gravato-Nobre, MJ; Costello, CE; Cipollo, JF				Palaima, Elizabeth; Leymarie, Nancy; Stroud, Dave; Mizanur, Rahman M.; Hodgkin, Jonathan; Gravato-Nobre, Maria J.; Costello, Catherine E.; Cipollo, John F.			The Caenorhabditis elegans bus-2 Mutant Reveals a New Class of O-Glycans Affecting Bacterial Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGEN; TOXIN; ATTACHMENT; DIVERSITY; INFECTION; ANTIGENS; FEATURES; BINDING; GENES	Microbacterium nematophilum causes a deleterious infection of the C. elegans hindgut initiated by adhesion to rectal and anal cuticle. C. elegans bus-2 mutants, which are resistant to M. nematophilum and also to the formation of surface biofilms by Yersinia sp., carry genetic lesions in a putative glycosyltransferase containing conserved domains of core-1 beta 1,3-galactosyltransferases. bus-2 is predicted to act in the synthesis of core-1 type O-glycans. This observation implies that the infection requires the presence of host core-1 O-glycoconjugates and is therefore carbohydrate-dependent. Chemical analysis reported here reveals that bus-2 is indeed deficient in core-1 O-glycans. These mutants also exhibit a new subclass of O-glycans whose structures were determined by high performance tandem mass spectrometry; these are highly fucosylated and have a novel core that contains internally linked GlcA. Lectin studies showed that core-1 glycans and this novel class of O-glycans are both expressed in the tissue that is infected in the wild type worms. In worms having the bus-2 genetic background, core-1 glycans are decreased, whereas the novel fucosyl O-glycans are increased in abundance in this region. Expression analysis using a red fluorescent protein marker showed that bus-2 is expressed in the posterior gut, cuticle seam cells, and spermatheca, the first two of which are likely to be involved in secreting the carbohydrate-rich surface coat of the cuticle. Therefore, in the bus-2 background of reduced core-1 O-glycans, the novel fucosyl glycans likely replace or mask remaining core-1 ligands, leading to the resistance phenotype. There are more than 35 Microbacterium species, some of which are pathogenic in man. This study is the first to analyze the biochemistry of adhesion to a host tissue by a Microbacterium species.	[Mizanur, Rahman M.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Palaima, Elizabeth; Leymarie, Nancy; Costello, Catherine E.; Cipollo, John F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Palaima, Elizabeth; Leymarie, Nancy; Costello, Catherine E.; Cipollo, John F.] Boston Univ, Sch Med, Dept Mol Med, Boston, MA 02118 USA; [Stroud, Dave; Hodgkin, Jonathan; Gravato-Nobre, Maria J.] Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	US Food & Drug Administration (FDA); Boston University; Boston University; University of Oxford	Cipollo, JF (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bldg 29,Rm 126,8800 Rockville Pike, Bethesda, MD 20892 USA.	john.cipollo@fda.hhs.gov		Gravato-Nobre, Maria Joao/0000-0002-8032-2565; Costello, Catherine/0000-0003-1594-5122	National Institutes of Health [P41RR010888, S10RR015942, S10RR020946]; Medical Research Council (United Kingdom) [G0600238]; Medical Research Council [G0600238] Funding Source: researchfish; MRC [G0600238] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020946, P41RR010888, S10RR015942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants P41RR010888 and S10RR015942 (to C. E. C.) and S10RR020946 (to J. Zaia). This work was also supported by Medical Research Council (United Kingdom) Grant G0600238 (to J. H.).	Barrows BD, 2007, J BIOL CHEM, V282, P3302, DOI 10.1074/jbc.M606621200; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BORGONIE G, 1994, HISTOCHEMISTRY, V101, P379, DOI 10.1007/BF00269000; BRENNER S, 1974, GENETICS, V77, P71; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; CHUNGJATUPORNCHAI W, 1988, EUR J BIOCHEM, V173, P9, DOI 10.1111/j.1432-1033.1988.tb13960.x; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; Costello CE, 2007, J AM SOC MASS SPECTR, V18, P1799, DOI 10.1016/j.jasms.2007.07.016; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Darby C, 2007, GENETICS, V176, P221, DOI 10.1534/genetics.106.067496; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Gneiding K, 2008, J CLIN MICROBIOL, V46, P3646, DOI 10.1128/JCM.01202-08; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Hoflich J, 2004, J BIOL CHEM, V279, P30440, DOI 10.1074/jbc.M402429200; KAMERLING JP, 1975, BIOCHEM J, V151, P491, DOI 10.1042/bj1510491; Ko FC, 2000, DEV GROWTH DIFFER, V42, P69, DOI 10.1046/j.1440-169x.2000.00487.x; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; LINK CD, 1992, GENETICS, V131, P867; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Rajamohan F, 1998, PROG NUCLEIC ACID RE, V60, P1, DOI 10.1016/S0079-6603(08)60887-9; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087	37	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17662	17672		10.1074/jbc.M109.065433	http://dx.doi.org/10.1074/jbc.M109.065433			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385555	hybrid, Green Published			2022-12-27	WOS:000278133400044
J	Bal, NC; Sharon, A; Gupta, SC; Jena, N; Shaikh, S; Gyorke, S; Periasamy, M				Bal, Naresh C.; Sharon, Ashoke; Gupta, Subash C.; Jena, Nivedita; Shaikh, Sana; Gyorke, Sandor; Periasamy, Muthu			The Catecholaminergic Polymorphic Ventricular Tachycardia Mutation R33Q Disrupts the N-terminal Structural Motif That Regulates Reversible Calsequestrin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARDIAC CALSEQUESTRIN; CALCIUM-RELEASE CHANNEL; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; RYANODINE RECEPTOR; CA2+ REGULATION; LUMINAL CA2+; PROTEIN; MECHANISM; ARRHYTHMIAS	Calsequestrin undergoes dynamic polymerization with increasing calcium concentration by front-to-front dimerization and back-to-back packing, forming wire-shaped structures. A recent finding that point mutation R33Q leads to lethal catecholaminergic polymorphic ventricular tachycardia (CPVT) implies a crucial role for the N terminus. In this study, we demonstrate that this mutation resides in a highly conserved alternately charged residue cluster (DGKDR; cluster 1) in the N-terminal end of calsequestrin. We further show that this cluster configures itself as a ring system and that the dipolar arrangement within the cluster brings about a critical conformational flip of Lys(31)-Asp(32) essential for dimer stabilization by formation of a H-bond network. We additionally show that Ca2+-induced calsequestrin aggregation is nonlinear and reversible and can regain the native conformation by Ca2+ chelation with EGTA. This study suggests that cluster 1 works as a molecular switch and governs the bidirectional transition between the CASQ2 monomer and dimer. We further demonstrate that mutations disrupting the alternating charge pattern of the cluster, including R33Q, impair Ca2+-CASQ2 interaction, leading to altered polymerization-depolymerization dynamics. This study provides new mechanistic insight into the functional effects of the R33Q mutation and its potential role in CPVT.	[Bal, Naresh C.; Gupta, Subash C.; Jena, Nivedita; Shaikh, Sana; Gyorke, Sandor; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bal, Naresh C.; Gupta, Subash C.; Jena, Nivedita; Shaikh, Sana; Gyorke, Sandor; Periasamy, Muthu] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Sharon, Ashoke] Birla Inst Technol, Dept Appl Chem, Ranchi 835215, Jharkhand, India; [Sharon, Ashoke] Birla Inst Technol, Dept Pharmaceut Sci, Ranchi 835215, Jharkhand, India	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Birla Institute of Technology Mesra; Birla Institute of Technology Mesra	Periasamy, M (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Gupta, Subash/AAF-2563-2019; Jena, Nivedita/F-4945-2012; Sharon, Ashoke/GYU-7600-2022; Sharon, Ashoke/C-3916-2009	Gupta, Subash/0000-0002-0418-1940; Sharon, Ashoke/0000-0001-5738-1607; Sharon, Ashoke/0000-0001-5738-1607; Periasamy, Muthu/0000-0001-8834-5975	National Institutes of Health [R01 HL64014]; Department of Science and Technology, Government of India	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL64014 (to M. P.). This work was also supported by a Fund for Improvement of Science and Technology Infrastructure grant from the Department of Science and Technology, Government of India (to A. S.).	Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Bers DM, 1997, BASIC RES CARDIOL, V92, P1, DOI 10.1007/BF00794062; Blayney LM, 2009, PHARMACOL THERAPEUT, V123, P151, DOI 10.1016/j.pharmthera.2009.03.006; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chopra N, 2007, CIRC RES, V101, P617, DOI 10.1161/CIRCRESAHA.107.157552; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Franzini-Armstrong C, 2009, APPL PHYSIOL NUTR ME, V34, P323, DOI 10.1139/H09-017; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Kalyanasundaram A, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.053892; Kim E, 2007, J MOL BIOL, V373, P1047, DOI 10.1016/j.jmb.2007.08.055; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Liu N, 2008, CARDIOVASC RES, V77, P293, DOI 10.1093/cvr/cvm004; Ma JP, 1997, P NATL ACAD SCI USA, V94, P11905, DOI 10.1073/pnas.94.22.11905; MacLennan D., 1983, CALCIUM CELL FUNCT, V4, P151; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MAURER A, 1985, P NATL ACAD SCI USA, V82, P4036, DOI 10.1073/pnas.82.12.4036; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Pape PC, 2007, J PHYSIOL-LONDON, V581, P319, DOI 10.1113/jphysiol.2006.126474; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Qin J, 2008, J GEN PHYSIOL, V131, P325, DOI 10.1085/jgp.200709907; Renken C, 2009, J STRUCT BIOL, V165, P53, DOI 10.1016/j.jsb.2008.09.011; Restrepo JG, 2008, BIOPHYS J, V95, P3767, DOI 10.1529/biophysj.108.130419; Rizzi N, 2008, CIRC RES, V103, P298, DOI 10.1161/CIRCRESAHA.108.171660; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Scheinman MM, 2006, ANNU REV MED, V57, P473, DOI 10.1146/annurev.med.57.081704.090151; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; SLUPSKY JR, 1987, BIOCHEMISTRY-US, V26, P6539, DOI 10.1021/bi00394a038; Terentyev D, 2008, BIOPHYS J, V95, P2037, DOI 10.1529/biophysj.107.128249; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; Valle G, 2008, BIOCHEM J, V413, P291, DOI 10.1042/BJ20080163; Wagenknecht T, 2002, BIOPHYS J, V83, P2491, DOI 10.1016/S0006-3495(02)75260-0; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; WILLIAMS RW, 1986, J BIOL CHEM, V261, P2408	42	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17188	17196		10.1074/jbc.M109.096354	http://dx.doi.org/10.1074/jbc.M109.096354			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353949	hybrid, Green Published			2022-12-27	WOS:000277982600081
J	Barry, C; Key, T; Haddad, R; Duncan, R				Barry, Christopher; Key, Tim; Haddad, Rami; Duncan, Roy			Features of a Spatially Constrained Cystine Loop in the p10 FAST Protein Ectodomain Define a New Class of Viral Fusion Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STOMATITIS-VIRUS GLYCOPROTEIN; SMALL TRANSMEMBRANE PROTEIN; CELL-CELL FUSION; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; ENVELOPE GLYCOPROTEIN; CONFORMATIONAL-CHANGE; DISULFIDE-ISOMERASE; SYNCYTIUM FORMATION; MUTATIONAL ANALYSIS	The reovirus fusion-associated small transmembrane (FAST) proteins are the smallest known viral membrane fusion proteins. With ectodomains of only similar to 20-40 residues, it is unclear how such diminutive fusion proteins can mediate cell-cell fusion and syncytium formation. Contained within the 40-residue ectodomain of the p10 FAST protein resides an 11-residue sequence of moderately apolar residues, termed the hydrophobic patch (HP). Previous studies indicate the p10 HP shares operational features with the fusion peptide motifs found within the enveloped virus membrane fusion proteins. Using biotinylation assays, we now report that two highly conserved cysteine residues flanking the p10 HP form an essential intramolecular disulfide bond to create a cystine loop. Mutagenic analyses revealed that both formation of the cystine loop and p10 membrane fusion activity are highly sensitive to changes in the size and spatial arrangement of amino acids within the loop. The p10 cystine loop may therefore function as a cystine noose, where fusion peptide activity is dependent on structural constraints within the noose that force solvent exposure of key hydrophobic residues. Moreover, inhibitors of cell surface thioreductase activity indicate that disruption of the disulfide bridge is important for p10-mediated membrane fusion. This is the first example of a viral fusion peptide composed of a small, spatially constrained cystine loop whose function is dependent on altered loop formation, and it suggests the p10 cystine loop represents a new class of viral fusion peptides.	[Barry, Christopher; Key, Tim; Haddad, Rami; Duncan, Roy] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [Duncan, Roy] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 1X5, Canada	Dalhousie University; Dalhousie University	Duncan, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, 5850 Coll St,Tupper Med Bldg,Rm 7S-1, Halifax, NS B3H 1X5, Canada.	roy.duncan@dal.ca	Barry, Christopher/G-5843-2015	Barry, Christopher/0000-0002-5413-5918; Duncan, Roy/0000-0002-5162-5081	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported in part by a grant from the Canadian Institutes of Health Research (to R.D.).	Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Balliet JW, 2000, J VIROL, V74, P3731, DOI 10.1128/JVI.74.8.3731-3739.2000; Barry C, 2009, J VIROL, V83, P12185, DOI 10.1128/JVI.01667-09; Cheng LTT, 2005, J VIROL, V79, P1853, DOI 10.1128/JVI.79.3.1853-1860.2005; Cheng SF, 2004, EUR J BIOCHEM, V271, P4725, DOI 10.1111/j.1432-1033.2004.04436.x; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Clancy EK, 2010, VIROLOGY, V397, P119, DOI 10.1016/j.virol.2009.10.039; Clancy EK, 2009, J VIROL, V83, P2941, DOI 10.1128/JVI.01869-08; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Dawe S, 2005, J VIROL, V79, P6216, DOI 10.1128/JVI.79.10.6216-6226.2005; Delos SE, 2000, J VIROL, V74, P9738, DOI 10.1128/JVI.74.20.9738-9741.2000; Delos SE, 2000, J VIROL, V74, P1686, DOI 10.1128/JVI.74.4.1686-1693.2000; Dowling W, 2000, J VIROL, V74, P6368, DOI 10.1128/JVI.74.14.6368-6376.2000; Duncan R, 2004, VIROLOGY, V319, P131, DOI 10.1016/j.virol.2003.10.025; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; FALCONER MM, 1995, J VIROL, V69, P5582, DOI 10.1128/JVI.69.9.5582-5591.1995; FEENER EP, 1990, J BIOL CHEM, V265, P18780; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Freitas MS, 2007, J BIOL CHEM, V282, P27306, DOI 10.1074/jbc.M611864200; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GOLDENBERG DP, 1993, BIOCHEMISTRY-US, V32, P2835, DOI 10.1021/bi00062a015; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hannah BP, 2009, J VIROL, V83, P6825, DOI 10.1128/JVI.00301-09; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Ito H, 1999, J VIROL, V73, P8907, DOI 10.1128/JVI.73.10.8907-8912.1999; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; JANES RW, 1994, NAT STRUCT BIOL, V1, P311, DOI 10.1038/nsb0594-311; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; LAPTHORN AJ, 1995, NAT STRUCT BIOL, V2, P266, DOI 10.1038/nsb0495-266; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Martin FL, 2008, REV CARDIOVASC MED, V9, P39; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mou YL, 1998, J IMMUNOL, V161, P6323; Pecheur EI, 1999, J MEMBRANE BIOL, V167, P1, DOI 10.1007/s002329900466; Putz MM, 2003, EUR J BIOCHEM, V270, P1515, DOI 10.1046/j.1432-1033.2003.03517.x; Racine T, 2007, J BIOL CHEM, V282, P25613, DOI 10.1074/jbc.M703708200; Racine T, 2009, J VIROL, V83, P5951, DOI 10.1128/JVI.00171-09; Reichert J, 2007, EUR BIOPHYS J BIOPHY, V36, P405, DOI 10.1007/s00249-006-0106-2; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Salsman J, 2005, J VIROL, V79, P8090, DOI 10.1128/JVI.79.13.8090-8100.2005; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000016; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Shmulevitz M, 2004, J VIROL, V78, P5996, DOI 10.1128/JVI.78.11.5996-6004.2004; Shmulevitz M, 2004, J VIROL, V78, P2808, DOI 10.1128/JVI.78.6.2808-2818.2004; Shmulevitz M, 2003, J VIROL, V77, P9769, DOI 10.1128/JVI.77.18.9769-9779.2003; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0; Sugawara M, 2002, J PEPT RES, V60, P271, DOI 10.1034/j.1399-3011.2002.21027.x; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Top D, 2005, EMBO J, V24, P2980, DOI 10.1038/sj.emboj.7600767; Top D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000331; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]	64	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16424	16433		10.1074/jbc.M110.118232	http://dx.doi.org/10.1074/jbc.M110.118232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363742	hybrid, Green Published			2022-12-27	WOS:000277982600004
J	Barton, ER				Barton, Elisabeth R.			Restoration of gamma-Sarcoglycan Localization and Mechanical Signal Transduction Are Independent in Murine Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; PROTEIN REFERENCE DATABASE; MEDIATED GENE-TRANSFER; MUSCULAR-DYSTROPHY; DEFICIENT MICE; EXPRESSION; IDENTIFICATION; RESCUE; SYSTEM	Limb girdle muscular dystrophy 2C is caused by mutations in the gamma-sarcoglycan gene (gsg) that results in loss of this protein, and disruption of the sarcoglycan (SG) complex. Signal transduction after mechanical perturbation is mediated, in part, through the SG complex and leads to phosphorylation of tyrosines on the intracellular portions of the sarcoglycans. This study tested if the Tyr(6) in the intracellular region of gamma-sarcoglycan protein (gamma-SG) was necessary for proper localization of the protein in skeletal muscle membranes or for the normal pattern of ERK1/2 phosphorylation after eccentric contractions. Viral mediated gene transfer of wild type gsg (WTgsg) and mutant gsg lacking Tyr(6) (Y6Agsg) was performed into the muscles of gsg(-/-) mice. Muscles were examined for production and stability of the gamma-SG, as well as the level of ERK1/2 phosphorylation before and after eccentric contraction. Sarcolemmal localization of gamma-SG was achieved regardless of which construct was expressed. However, only expression of WTgsg corrected the aberrant ERK1/2 phosphorylation associated with the absence of gamma-SG, whereas Y6Agsg failed to have any effect. This study shows that localization of gamma-SG does not require Tyr(6), but localization alone is insufficient for restoration of normal signal transduction patterns after mechanical perturbation.	[Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Barton, ER (corresponding author), 240 S 40th St,441A Levy Bldg, Philadelphia, PA 19104 USA.	erbarton@dental.upenn.edu			American Heart Association [0235157N]; Paul Wellstone Muscular Dystrophy Cooperative Research Center [U54 AR052646]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Paul Wellstone Muscular Dystrophy Cooperative Research Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by American Heart Association Grant 0235157N and the Paul Wellstone Muscular Dystrophy Cooperative Research Center (U54 AR052646).	Allikian MJ, 2004, J CELL SCI, V117, P3821, DOI 10.1242/jcs.01234; Anastasi G, 2003, CELLS TISSUES ORGANS, V175, P151, DOI 10.1159/000074631; Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Aronson D, 1997, J CLIN INVEST, V99, P1251, DOI 10.1172/JCI119282; Barton ER, 2006, J APPL PHYSIOL, V100, P1778, DOI 10.1152/japplphysiol.01405.2005; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Bonnemann Carsten G, 2002, Semin Pediatr Neurol, V9, P81, DOI 10.1053/spen.2002.33795; Carlson CJ, 2001, J APPL PHYSIOL, V91, P2079, DOI 10.1152/jappl.2001.91.5.2079; Chamberlain JS, 2002, HUM MOL GENET, V11, P2355, DOI 10.1093/hmg/11.20.2355; Cordier L, 2000, MOL THER, V1, P119, DOI 10.1006/mthe.1999.0019; Cordier L, 2001, HUM GENE THER, V12, P205, DOI 10.1089/104303401750061267; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Hack AA, 2000, MICROSC RES TECHNIQ, V48, P167, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hack AA, 1999, P NATL ACAD SCI USA, V96, P10723, DOI 10.1073/pnas.96.19.10723; Hayashi T, 1999, AM J PHYSIOL-CELL PH, V277, pC701, DOI 10.1152/ajpcell.1999.277.4.C701; Herzog Roland W, 2004, Methods Mol Biol, V246, P179; Heydemann A, 2005, NEUROMUSCULAR DISORD, V15, P601, DOI 10.1016/j.nmd.2005.05.004; Holt KH, 1998, J BIOL CHEM, V273, P34667, DOI 10.1074/jbc.273.52.34667; Holt KH, 1998, MOL CELL, V1, P841, DOI 10.1016/S1097-2765(00)80083-0; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Kefi M, 2003, NEUROMUSCULAR DISORD, V13, P779, DOI 10.1016/S0960-8966(03)00136-6; KESHAVA, 2009, NUCLEIC ACIDS RES, V37, pD767; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; LI Z, 1993, DEVELOPMENT, V117, P947; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Wagner KR, 2002, NEUROL CLIN, V20, P645, DOI 10.1016/S0733-8619(02)00002-6; Wang P, 2002, BIOCHEMISTRY-US, V41, P6202, DOI 10.1021/bi025591f; Yoshida T, 1998, J BIOL CHEM, V273, P1583, DOI 10.1074/jbc.273.3.1583; Zhu XL, 2001, J BIOL CHEM, V276, P21785, DOI 10.1074/jbc.M101877200	34	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17263	17270		10.1074/jbc.M109.063990	http://dx.doi.org/10.1074/jbc.M109.063990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371873	Green Published, hybrid			2022-12-27	WOS:000277982600088
J	Taube, JH; Allton, K; Duncan, SA; Shen, LL; Barton, MC				Taube, Joseph H.; Allton, Kendra; Duncan, Stephen A.; Shen, Lanlan; Barton, Michelle Craig			Foxa1 Functions as a Pioneer Transcription Factor at Transposable Elements to Activate Afp during Differentiation of Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-FETOPROTEIN GENE; GROWTH-FACTOR-BETA; SMAD INTERACTION MOTIF; RETINOIC ACID; CHROMATIN-STRUCTURE; IN-VIVO; DEVELOPMENTAL REGULATORS; SIGNALING PATHWAYS; SELF-RENEWAL; TGF-BETA	Epigenetic control of genes that are silent in embryonic stem cells, but destined for expression during differentiation, includes distinctive hallmarks, such as simultaneous activating/repressing (bivalent) modifications of chromatin and DNA hypomethylation at enhancers of gene expression. Although alpha-fetoprotein (Afp) falls into this class of genes, as it is silent in pluripotent stem cells and activated during differentiation of endoderm, we find that Afp chromatin lacks bivalent histone modifications. However, critical regulatory sites for Afp activation, overlapping Foxa1/p53/Smad-binding elements, are located within a 300-bp region lacking DNA methylation, due to transposed elements underrepresented in CpG sequences: a short interspersed transposable element and a medium reiterated sequence 1 element. Forkhead family member Foxa1 is activated by retinoic acid treatment of embryonic stem cells, binds its DNA consensus site within the short interspersed transposable/medium reiterated sequence 1 elements, and displaces linker histone H1 from silent Afp chromatin. Small interfering RNA depletion of Foxa1 showed that Foxa1 is essential in providing chromatin access to transforming growth factor beta-activated Smad2 and Smad4 and their subsequent DNA binding. Together these transcription factors establish highly acetylated chromatin and promote expression of Afp. Foxa1 acts as a pioneer transcription factor in de novo activation of Afp, by exploiting a lack of methylation at juxtaposed transposed elements, to bind and poise chromatin for intersection with transforming growth factor beta signaling during differentiation of embryonic stem cells.	[Taube, Joseph H.; Allton, Kendra; Barton, Michelle Craig] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Grad Sch Biomed Sci, Dept Biochem & Mol Biol,Program Genes & Dev, Houston, TX 77030 USA; [Shen, Lanlan] Baylor Coll Med, USDA Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA; [Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; United States Department of Agriculture (USDA); Medical College of Wisconsin	Barton, MC (corresponding author), 1515 Holcombe Blvd,Box 1000, Houston, TX 77030 USA.	mbarton@mdanderson.org		Duncan, Stephen/0000-0002-2507-7827; Taube, Joseph/0000-0002-3636-5189; Barton, Michelle/0000-0002-4042-1374; Allton, KENDRA/0000-0002-4204-0807	National Institutes of Health [GM53683, GM081627, T32 HD007325]; National Institutes of Health NCI Cancer Center; American Legion Auxiliary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053683, P01GM081627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Legion Auxiliary; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM53683 and GM081627 (to M. C. B.) and a National Institutes of Health NCI Cancer Center Support grant to the University of Texas M. D. Anderson Cancer Center.; Supported by National Institutes of Health Training Grant T32 HD007325 and the American Legion Auxiliary.	ALEXANDER F, 1984, J MOL BIOL, V173, P159, DOI 10.1016/0022-2836(84)90187-6; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borger DR, 2000, VIROLOGY, V270, P397, DOI 10.1006/viro.2000.0282; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Carnell AN, 2003, TOXICOL SCI, V75, P229, DOI 10.1093/toxsci/kfg138; CASCIO S, 1991, DEVELOPMENT, V113, P217; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Crowe AJ, 1999, J BIOL CHEM, V274, P25113, DOI 10.1074/jbc.274.35.25113; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; Defacque H, 1997, LEUKEMIA, V11, P221, DOI 10.1038/sj.leu.2400568; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Germain S, 2000, GENE DEV, V14, P435; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; GORIN MB, 1981, J BIOL CHEM, V256, P1954; Grandel H, 2002, DEVELOPMENT, V129, P2851; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jacob A, 1999, EXP CELL RES, V250, P1, DOI 10.1006/excr.1999.4512; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Langton S, 2008, DEV BIOL, V315, P331, DOI 10.1016/j.ydbio.2007.12.021; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; MEREAU A, 1993, J CELL BIOL, V122, P713, DOI 10.1083/jcb.122.3.713; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minoo P, 2008, NUCLEIC ACIDS RES, V36, P179, DOI 10.1093/nar/gkm871; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nguyen TT, 2005, MOL CELL BIOL, V25, P2147, DOI 10.1128/MCB.25.6.2147-2157.2005; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nunes I, 1996, CANCER RES, V56, P495; Ogden SK, 2001, J BIOL CHEM, V276, P42057, DOI 10.1074/jbc.C100381200; PIQUETPELLORCE C, 1994, EXP CELL RES, V213, P340, DOI 10.1006/excr.1994.1208; Polavarapu N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-226; Puceat M, 2007, CARDIOVASC RES, V74, P256, DOI 10.1016/j.cardiores.2006.12.012; Randall RA, 2004, MOL CELL BIOL, V24, P1106, DOI 10.1128/MCB.24.3.1106-1121.2004; SCHMID P, 1990, DIFFERENTIATION, V45, P96, DOI 10.1111/j.1432-0436.1990.tb00462.x; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; SHIOJIRI N, 1981, J EMBRYOL EXP MORPH, V62, P139; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Teratani T, 2005, HEPATOLOGY, V41, P836, DOI 10.1002/hep.20629; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wilkinson DS, 2008, MOL CELL BIOL, V28, P1988, DOI 10.1128/MCB.01442-07; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	72	54	57	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16135	16144		10.1074/jbc.M109.088096	http://dx.doi.org/10.1074/jbc.M109.088096			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348100	Green Published, hybrid			2022-12-27	WOS:000277715900051
J	Colnaghi, R; Wheatley, SP				Colnaghi, Rita; Wheatley, Sally P.			Liaisons between Survivin and Plk1 during Cell Division and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-1; AURORA-B; MITOTIC ROLES; IN-VIVO; PHOSPHORYLATION; APOPTOSIS; REVEALS; PROTEIN; MITOSIS; CYTOKINESIS	Survivin and Plk1 kinase are important mediators of cell survival that are required for chromosome alignment, cytokinesis, and protection from apoptosis. Interference with either survivin or Plk1 activity manifests many similar outcomes: prometaphase delay/arrest, multinucleation, and increased apoptosis. Moreover, the expression of both survivin and Plk1 is deregulated in cancer. Given these similarities, we speculated that these two proteins may cooperate during mitosis and/or in cell death pathways. Here we report that survivin and Plk1 interact during mitosis and that Plk1 phosphorylates survivin at serine 20. Importantly, we find that overexpression of a non-phosphorylatable version, S20A, is unable to correct chromosomes connected to the spindle in a syntelic manner during prometaphase and allows cells harboring these maloriented chromosomes to enter anaphase, evading the spindle tension checkpoint. By contrast, the constitutive phosphomimic, S20D, completes congression and division ahead of schedule and, unlike S20A, is able to support proliferation in the absence of the endogenous protein. Despite the importance of this residue in mitosis, its mutation does not appear to affect the anti-apoptotic activity of survivin in response to TRAIL. Together, these data suggest that phosphorylation of survivin at Ser(20) by Plk1 kinase is essential for accurate chromosome alignment and cell proliferation but is dispensable for its anti-apoptotic activity in cancer cells.	[Wheatley, Sally P.] Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England; [Colnaghi, Rita] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Nottingham; University of Sussex	Wheatley, SP (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England.	sally.wheatley@nottingham.ac.uk			Cancer Research-UK	Cancer Research-UK(Cancer Research UK)	The majority of this work was supported by Cancer Research-UK via a senior fellowship (to S. P. W.).	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Barrett RMA, 2009, CELL CYCLE, V8, P278, DOI 10.4161/cc.8.2.7587; Beardmore VA, 2004, J CELL SCI, V117, P4033, DOI 10.1242/jcs.01242; Bourhis E, 2007, J BIOL CHEM, V282, P35018, DOI 10.1074/jbc.M706233200; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Feng YB, 2009, INT J CANCER, V124, P578, DOI 10.1002/ijc.23990; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Jones MK, 2008, J CELL PHYSIOL, V215, P750, DOI 10.1002/jcp.21358; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Liu XQ, 2007, BIOCHEM BIOPH RES CO, V353, P960, DOI 10.1016/j.bbrc.2006.12.142; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; McKay TR, 2003, ONCOGENE, V22, P3539, DOI 10.1038/sj.onc.1206417; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Noton EA, 2006, J BIOL CHEM, V281, P1286, DOI 10.1074/jbc.M508773200; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Qian YW, 2001, MOL BIOL CELL, V12, P1791, DOI 10.1091/mbc.12.6.1791; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Scutt PJ, 2009, J BIOL CHEM, V284, P15880, DOI 10.1074/jbc.M109.005694; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; SUNKEL CE, 1988, J CELL SCI, V89, P25; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wheatley SP, 2007, CELL CYCLE, V6, P1220, DOI 10.4161/cc.6.10.4179; Wheatley SP, 2005, INT REV CYTOL, V247, P35, DOI 10.1016/S0074-7696(05)47002-3; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118	45	31	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22592	22604		10.1074/jbc.M109.065003	http://dx.doi.org/10.1074/jbc.M109.065003			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20427271	Green Published, hybrid			2022-12-27	WOS:000279702200070
J	Vivar, OI; Zhao, XY; Saunier, EF; Griffin, C; Mayba, OS; Tagliaferri, M; Cohen, I; Speed, TP; Leitman, DC				Vivar, Omar I.; Zhao, Xiaoyue; Saunier, Elise F.; Griffin, Chandi; Mayba, Oleg S.; Tagliaferri, Mary; Cohen, Isaac; Speed, Terence P.; Leitman, Dale C.			Estrogen Receptor beta Binds to and Regulates Three Distinct Classes of Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ALPHA; CHIP-SEQ; CANCER CELLS; PROLIFERATION; TRANSCRIPTION; EXPRESSION; TAMOXIFEN; SYSTEM; RECRUITMENT; DISRUPTION	Estrogen receptor beta (ER beta) has potent antiproliferative and anti-inflammatory properties, suggesting that ER beta-selective agonists might be a new class of therapeutic and chemopreventative agents. To understand how ER beta regulates genes, we identified genes regulated by the unliganded and liganded forms of ER alpha and ER beta in U2OS cells. Microarray data demonstrated that virtually no gene regulation occurred with unliganded ER alpha, whereas many genes were regulated by estradiol (E-2). These results demonstrated that ER alpha requires a ligand to regulate a single class of genes. In contrast, ER beta regulated three classes of genes. Class I genes were regulated primarily by unliganded ER beta. Class II genes were regulated only with E-2, whereas class III genes were regulated by both unliganded ER beta and E-2. There were 453 class I genes, 258 class II genes, and 83 class III genes. To explore the mechanism whereby ER beta regulates different classes of genes, chromatin immunoprecipitation-sequencing was performed to identify ER beta binding sites and adjacent transcription factor motifs in regulated genes. AP1 binding sites were more enriched in class I genes, whereas ERE, NF kappa B1, and SP1 sites were more enriched in class II genes. ER beta bound to all three classes of genes, demonstrating that ER beta binding is not responsible for differential regulation of genes by unliganded and liganded ER beta. The coactivator NCOA2 was differentially recruited to several target genes. Our findings indicate that the unliganded and liganded forms of ER beta regulate three classes of genes by interacting with different transcription factors and coactivators.	[Vivar, Omar I.; Leitman, Dale C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Zhao, Xiaoyue; Saunier, Elise F.; Griffin, Chandi; Tagliaferri, Mary; Cohen, Isaac] Bionovo Inc, Emeryville, CA 94608 USA; [Mayba, Oleg S.; Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Speed, Terence P.] Walter & Eliza Hall Inst Med Res, Div Bioinformat, Parkville, Vic 3052, Australia	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Walter & Eliza Hall Institute	Leitman, DC (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 44 Morgan Hall, Berkeley, CA 94720 USA.	dale@leitmanlab.com	Speed, Terence P/B-8085-2009	Speed, Terence P/0000-0002-5403-7998	American Cancer Society; Bionovo, Inc.	American Cancer Society(American Cancer Society); Bionovo, Inc.	This work was supported by a grant from the American Cancer Society (to D. C. L.).; Recipient of a gift of financial support for research from Bionovo, Inc. To whom correspondence should be addressed: University of California, Dept. of Nutritional Science and Toxicology, 44 Morgan Hall, Berkeley, CA 94720. Tel.: 510-642-0862; E-mail: dale@leitmanlab.com.	Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hartman J, 2006, CANCER RES, V66, P11207, DOI 10.1158/0008-5472.CAN-06-0017; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; KIAN TM, 2004, MOL BIOL CELL, V15, P1262; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Levy N, 2010, MOL CELL ENDOCRINOL, V315, P201, DOI 10.1016/j.mce.2009.08.030; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shim GJ, 2003, P NATL ACAD SCI USA, V100, P6694, DOI 10.1073/pnas.0731830100; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Vivar OI, 2010, ENDOCRINOLOGY, V151, P1662, DOI 10.1210/en.2009-1028; Vivar OI, 2009, BIOCHEM PHARMACOL, V78, P469, DOI 10.1016/j.bcp.2009.05.008; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Westin S, 2000, ADV PHARMACOL, V47, P89; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	86	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22059	22066		10.1074/jbc.M110.114116	http://dx.doi.org/10.1074/jbc.M110.114116			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20404318	Green Published, hybrid			2022-12-27	WOS:000279702200018
J	Adrover, M; Pauwels, K; Prigent, S; de Chiara, C; Xu, Z; Chapuis, C; Pastore, A; Rezaei, H				Adrover, Miquel; Pauwels, Kris; Prigent, Stephanie; de Chiara, Cesira; Xu, Zhou; Chapuis, Celine; Pastore, Annalisa; Rezaei, Human			Prion Fibrillization Is Mediated by a Native Structural Element That Comprises Helices H2 and H3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAUSSLER-SCHEINKER-DISEASE; CREUTZFELDT-JAKOB-DISEASE; PROTEIN NMR STRUCTURES; IN-VITRO; HYDROGEN/DEUTERIUM EXCHANGE; AMYLOID FIBRILS; ALPHA-HELIX; CONVERSION; STABILITY; GENE	Aggregation and misfolding of the prion protein (PrP) are thought to be the cause of a family of lethal neurodegenerative diseases affecting humans and other animals. Although the structures of PrP from several species have been solved, still little is known about the mechanisms that lead to the misfolded species. Here, we show that the region of PrP comprising the hairpin formed by the helices H2 and H3 is a stable independently folded unit able to retain its secondary and tertiary structure also in the absence of the rest of the sequence. We also prove that the isolated H2H3 is highly fibrillogenic and forms amyloid fibers morphologically similar to those obtained for the full-length protein. Fibrillization of H2H3 but not of full-length PrP is concomitant with formation of aggregates. These observations suggest a "banana-peeling" mechanism for misfolding of PrP in which H2H3 is the aggregation seed that needs to be first exposed to promote conversion from a helical to a beta-rich structure.	[Adrover, Miquel; Pauwels, Kris; de Chiara, Cesira; Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England; [Adrover, Miquel] Univ Illes Balears, Dept Quim, E-07122 Palma de Mallorca, Spain; [Prigent, Stephanie; Xu, Zhou; Chapuis, Celine; Pastore, Annalisa; Rezaei, Human] INRA, F-78352 Jouy En Josas, France; [Xu, Zhou] Commissariat Energie Atom, F-92265 Fontenay Aux Roses, France	MRC National Institute for Medical Research; Universitat de les Illes Balears; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Pastore, A (corresponding author), Natl Inst Med Res, MRC, Ridgeway, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk; human.rezaei@jouy.inra.fr	Xu, Zhou/F-8513-2011	Xu, Zhou/0000-0001-9468-1406; de Chiara, Cesira/0000-0002-9766-2515; Adrover, Miquel/0000-0002-4211-9013; Pauwels, Kris/0000-0002-7341-0890	MRC [U117584256]; Spanish Ministerio de Ciencia e Innovacion for a Jose Castillejo [JC2009-00284]; EMBO; Institut National de la Recherche Agronomique; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: researchfish; MRC [MC_U117533887, MC_U117584256] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministerio de Ciencia e Innovacion for a Jose Castillejo(Ministry of Science and Innovation, Spain (MICINN)); EMBO(European Molecular Biology Organization (EMBO)); Institut National de la Recherche Agronomique; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MRC Grant U117584256.; Supported by the Spanish Ministerio de Ciencia e Innovacion for a Jose Castillejo fellowship (Grant JC2009-00284).; Supported by an EMBO long term postdoctoral fellowship.; Recipients of a package grant from Institut National de la Recherche Agronomique.	Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Barducci A, 2006, J AM CHEM SOC, V128, P2705, DOI 10.1021/ja057076l; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; CHAPMAN J, 1994, NEUROLOGY, V44, P1683, DOI 10.1212/WNL.44.9.1683; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; DeMarco ML, 2007, BIOCHEMISTRY-US, V46, P3045, DOI 10.1021/bi0619066; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Dima RI, 2004, P NATL ACAD SCI USA, V101, P15335, DOI 10.1073/pnas.0404235101; Eghiaian F, 2004, P NATL ACAD SCI USA, V101, P10254, DOI 10.1073/pnas.0400014101; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Heller J, 1996, PROTEIN SCI, V5, P1655, DOI 10.1002/pro.5560050819; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; HSIAO K, 1992, NAT GENET, V1, P68, DOI 10.1038/ng0492-68; Julien O, 2009, PROTEIN SCI, V18, P2172, DOI 10.1002/pro.231; KAMTEKAR S, 1995, FASEB J, V9, P1013, DOI 10.1096/fasebj.9.11.7649401; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Mastrianni JA, 1996, NEUROLOGY, V47, P1305, DOI 10.1212/WNL.47.5.1305; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; Nazabal A, 2009, J MASS SPECTROM, V44, P965, DOI 10.1002/jms.1572; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pastore A, 2007, PRION, V1, P185, DOI 10.4161/pri.1.3.5281; Peoc'h K, 2000, HUM MUTAT, V15; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; POCCHIARI M, 1993, ANN NEUROL, V34, P802, DOI 10.1002/ana.410340608; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Shindoh R, 2009, J VIROL, V83, P3852, DOI 10.1128/JVI.01740-08; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Thomas D, 2005, ACTA CRYSTALLOGR D, V61, P112, DOI 10.1107/S0907444904027684; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wille H, 1996, J MOL BIOL, V259, P608, DOI 10.1006/jmbi.1996.0343; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Xian WJ, 2006, PROTEIN SCI, V15, P2062, DOI 10.1110/ps.062297006	61	69	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21004	21012		10.1074/jbc.M110.111815	http://dx.doi.org/10.1074/jbc.M110.111815			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20375014	Green Published, hybrid			2022-12-27	WOS:000279228600064
J	Bartoi, T; Rigbolt, KTG; Du, D; Kohr, G; Blagoev, B; Kornau, HC				Bartoi, Tudor; Rigbolt, Kristoffer T. G.; Du, Dan; Koehr, Georg; Blagoev, Blagoy; Kornau, Hans-Christian			GABA(B) Receptor Constituents Revealed by Tandem Affinity Purification from Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; STRUCTURAL-ANALYSIS; STRESS INDUCTION; MESSENGER-RNA; T1 DOMAIN; PROTEINS; CLONING; GENE; EXPRESSION; RAT	GABA(B) receptors function as heterodimeric G-protein-coupled receptors for the neurotransmitter gamma-aminobutyric acid (GABA). Receptor subtypes, based on isoforms of the ligand-binding subunit GABA(B1), are thought to involve a differential set of associated proteins. Here, we describe two mouse lines that allow a straightforward biochemical isolation of GABA(B) receptors. The transgenic mice express GABA(B1) isoforms that contain sequences for a two-step affinity purification, in addition to their endogenous subunit repertoire. Comparative analyses of purified samples from the transgenic mice and wild-type control animals revealed two novel components of the GABA(B1) complex. One of the identified proteins, potassium channel tetramerization domain-containing protein 12, associates with heterodimeric GABA(B) receptors via the GABA(B2) subunit. In transfected hippocampal neurons, potassium channel tetramerization domain-containing protein 12 augmented axonal surface targeting of GABA(B2). The mice equipped with tags on GABA(B1) facilitate validation and identification of native binding partners of GABA(B) receptors, providing insight into the molecular mechanisms of synaptic modulation.	Univ Hamburg, Ctr Mol Neurobiol ZMNH, D-20251 Hamburg, Germany; [Rigbolt, Kristoffer T. G.; Blagoev, Blagoy] Univ So Denmark, Dept Biochem & Mol Biol, CEBI, DK-5230 Odense M, Denmark; [Du, Dan; Koehr, Georg] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	University of Hamburg; University of Southern Denmark; Max Planck Society		hckornau@zmnh.uni-hamburg.de		Blagoev, Blagoy/0000-0002-3596-0066	Deutsche Forschungsgemeinschaft [SFB444]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft (SFB444).	Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Bischoff S, 1999, J COMP NEUROL, V412, P1; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blein S, 2004, J BIOL CHEM, V279, P48292, DOI 10.1074/jbc.M406540200; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Chang WH, 2007, J BIOL CHEM, V282, P25030, DOI 10.1074/jbc.M700924200; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; DEAN D, 1981, GENE, V15, P99, DOI 10.1016/0378-1119(81)90108-6; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GAY P, 1983, J BACTERIOL, V153, P1424, DOI 10.1128/JB.153.3.1424-1431.1983; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Gregan J, 2007, NAT PROTOC, V2, P1145, DOI 10.1038/nprot.2007.172; Grunewald S, 2002, MOL PHARMACOL, V61, P1070, DOI 10.1124/mol.61.5.1070; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HARTMANN D, 1995, DEV NEUROSCI-BASEL, V17, P246, DOI 10.1159/000111293; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kornau HC, 2006, CELL TISSUE RES, V326, P517, DOI 10.1007/s00441-006-0264-7; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Kulik A, 2003, J NEUROSCI, V23, P11026; Lamp K, 2001, CYTOGENET CELL GENET, V92, P116, DOI 10.1159/000056880; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nagy A., 2003, MANIPULATING MOUSE E; Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901; Nefedov M, 2000, Nucleic Acids Res, V28, pE79, DOI 10.1093/nar/28.17.e79; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peters HC, 1998, NEUROGENETICS, V2, P47, DOI 10.1007/s100480050051; Prokhorova TA, 2009, MOL CELL PROTEOMICS, V8, P959, DOI 10.1074/mcp.M800287-MCP200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Resendes BL, 2004, JARO-J ASSOC RES OTO, V5, P185, DOI 10.1007/s10162-003-4042-x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rivera JF, 2005, EUR J NEUROSCI, V22, P1853, DOI 10.1111/j.1460-9568.2005.04384.x; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Suehara Y, 2008, CLIN CANCER RES, V14, P1707, DOI 10.1158/1078-0432.CCR-07-1478; Tabata T, 2004, P NATL ACAD SCI USA, V101, P16952, DOI 10.1073/pnas.0405387101; Takada T, 2003, GENOME RES, V13, P589, DOI 10.1101/gr.975303; Tiao JY, 2008, J BIOL CHEM, V283, P31005, DOI 10.1074/jbc.M804464200; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	56	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20625	20633		10.1074/jbc.M109.049700	http://dx.doi.org/10.1074/jbc.M109.049700			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20406808	Green Published, hybrid			2022-12-27	WOS:000279228600026
J	Bacik, JP; Walker, JR; Ali, M; Schimmer, AD; Dhe-Paganon, S				Bacik, John-Paul; Walker, John R.; Ali, Mohsin; Schimmer, Aaron D.; Dhe-Paganon, Sirano			Crystal Structure of the Human Ubiquitin-activating Enzyme 5 (UBA5) Bound to ATP MECHANISTIC INSIGHTS INTO A MINIMALISTIC E1 ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYMES; PROTEIN-ACTIVATION; CYSTEINE RESIDUES; SYSTEM; E1; INSIGHTS; PATHWAYS; AFFINITY; COMPLEX; CASCADE	E1 ubiquitin-activating enzymes (UBAs) are large multidomain proteins that catalyze formation of a thioester bond between the terminal carboxylate of a ubiquitin or ubiquitin-like modifier (UBL) and a conserved cysteine in an E2 protein, producing reactive ubiquityl units for subsequent ligation to substrate lysines. Two important E1 reaction intermediates have been identified: a ubiquityl-adenylate phosphoester and a ubiquityl-enzyme thioester. However, the mechanism of thioester bond formation and its subsequent transfer to an E2 enzyme remains poorly understood. We have determined the crystal structure of the human UFM1 (ubiquitin-fold modifier 1) E1-activating enzyme UBA5, bound to ATP, revealing a structure that shares similarities with both large canonical E1 enzymes and smaller ancestral E1-like enzymes. In contrast to other E1 active site cysteines, which are in a variably sized domain that is separate and flexible relative to the adenylation domain, the catalytic cysteine of UBA5 (Cys(250)) is part of the adenylation domain in an alpha-helical motif. The novel position of the UBA5 catalytic cysteine and conformational changes associated with ATP binding provides insight into the possible mechanisms through which the ubiquityl-enzyme thioester is formed. These studies reveal structural features that further our understanding of the UBA5 enzyme reaction mechanism and provide insight into the evolution of ubiquitin activation.	[Bacik, John-Paul; Walker, John R.; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Bacik, John-Paul; Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Ali, Mohsin; Schimmer, Aaron D.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Dhe-Paganon, S (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	sirano.dhepaganon@utoronto.ca	Ali, Mohsin/GRY-0476-2022	Bacik, John-Paul/0000-0001-9315-5332; /0000-0002-5255-895X; Schimmer, Aaron/0000-0003-4023-3899	Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The Structural Genomics Consortium is a registered charity (1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; A Leukemia and Lymphoma Society Scholar in Clinical Research.; We thank Yanjun Li, Lianet Lopez, Patrick J. Finerty, Jr., and Taras Makhnevych for technical assistance. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Charbonnier JB, 1999, PROTEIN SCI, V8, P96; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Dou TH, 2005, MOL BIOL REP, V32, P265, DOI 10.1007/s11033-005-4822-y; Duda DM, 2005, J MOL BIOL, V349, P774, DOI 10.1016/j.jmb.2005.04.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miranda JJL, 2003, PROTEIN SCI, V12, P73, DOI 10.1110/ps.0224203; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Senisterra GA, 2009, MOL BIOSYST, V5, P217, DOI 10.1039/b814377c; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; Tang ZS, 2008, FEBS J, V275, P3003, DOI 10.1111/j.1742-4658.2008.06459.x; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zheng M, 2008, J CELL BIOCHEM, V104, P2324, DOI 10.1002/jcb.21791	35	44	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20273	20280		10.1074/jbc.M110.102921	http://dx.doi.org/10.1074/jbc.M110.102921			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20368332	Green Published, hybrid			2022-12-27	WOS:000279012000062
J	Hassani, BK; Steunou, AS; Liotenberg, S; Reiss-Husson, F; Astier, C; Ouchane, S				Hassani, Bahia Khalfaoui; Steunou, Anne-Soisig; Liotenberg, Sylviane; Reiss-Husson, Francoise; Astier, Chantal; Ouchane, Soufian			Adaptation to Oxygen ROLE OF TERMINAL OXIDASES IN PHOTOSYNTHESIS INITIATION IN THE PURPLE PHOTOSYNTHETIC BACTERIUM, RUBRIVIVAX GELATINOSUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; RHODOBACTER-SPHAEROIDES 2.4.1; GENE-EXPRESSION; NITROGENASE ACTIVITY; CAPSULATUS; PROKARYOTES; COMPLEXES; EVOLUTION; SUBUNITS; PROTEIN	The appearance of oxygen in the Earth's atmosphere via oxygenic photosynthesis required strict anaerobes and obligate phototrophs to cope with the presence of this toxic molecule. Here we show that in the anoxygenic phototroph Rubrivivax gelatinosus, the terminal oxidases (cbb(3), bd, and caa(3)) expand the range of ambient oxygen tensions under which the organism can initiate photosynthesis. Unlike the wild type, the cbb(3)(-)/bd(-) double mutant can start photosynthesis only in deoxygenated medium or when oxygen is removed, either by sparging cultures with nitrogen or by co-inoculation with strict aerobes bacteria. In oxygenated environments, this mutant survives nonphoto-synthetically until the O-2 tension is reduced. The cbb(3) and bd oxidases are therefore required not only for respiration but also for reduction of the environmental O-2 pressure prior to anaerobic photosynthesis. Suppressor mutations that restore respiration simultaneously restore photosynthesis in nondeoxygenated medium. Furthermore, induction of photosystem in the cbb(3)(-) mutant led to a highly unstable strain. These results demonstrate that photosynthetic metabolism in environments exposed to oxygen is critically dependent on the O-2 -detoxifying action of terminal oxidases.	[Ouchane, Soufian] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Univ Paris 11, F-91405 Orsay, France; Univ Paris 06, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Ouchane, S (corresponding author), CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.	souchane@cgm.cnrs-gif.fr	OUCHANE, Soufian/HHM-5430-2022; Ouchane, Soufian/ABE-2609-2020	Ouchane, Soufian/0000-0002-8161-3866; Steunou, Anne Soisig/0000-0002-0731-0226; LIOTENBERG, Sylviane/0000-0003-4510-8608	French Agence Nationale de la Recherche [ANR BLAN06-2_147814]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was financially supported by French Agence Nationale de la Recherche Grant ANR BLAN06-2_147814).	Allen JF, 2007, NATURE, V445, P610, DOI 10.1038/445610a; Bauer C, 2003, PHILOS T R SOC B, V358, P147, DOI 10.1098/rstb.2002.1189; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Canfield DE, 2006, PHILOS T R SOC B, V361, P1819, DOI 10.1098/rstb.2006.1906; DALDAL F, 1987, J MOL BIOL, V195, P1, DOI 10.1016/0022-2836(87)90322-6; Falkowski PG, 2006, SCIENCE, V311, P1724, DOI 10.1126/science.1125937; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Jones KM, 2002, J BACTERIOL, V184, P2491, DOI 10.1128/JB.184.9.2491-2499.2002; Koch HG, 1998, J BACTERIOL, V180, P969, DOI 10.1128/JB.180.4.969-978.1998; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lemaire Claire, 2008, V432, P65, DOI 10.1007/978-1-59745-028-7_5; Oh JI, 2001, MOL MICROBIOL, V39, P1116, DOI 10.1046/j.1365-2958.2001.02299.x; Ouchane S, 2005, MOL MICROBIOL, V57, P261, DOI 10.1111/j.1365-2958.2005.04685.x; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Ouchane S, 2007, J BIOL CHEM, V282, P7690, DOI 10.1074/jbc.M605985200; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Raymond J, 2004, GEOBIOLOGY, V2, P199, DOI 10.1111/j.1472-4677.2004.00037.x; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Steunou AS, 2008, ISME J, V2, P364, DOI 10.1038/ismej.2007.117; Steunou AS, 2004, J BACTERIOL, V186, P3133, DOI 10.1128/JB.186.10.3133-3142.2004; Swem DL, 2005, J BACTERIOL, V187, P8081, DOI 10.1128/JB.187.23.8081-8087.2005; Swem LR, 2006, J BIOL CHEM, V281, P6768, DOI 10.1074/jbc.M509687200; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; Valladares A, 2003, MOL MICROBIOL, V47, P1239, DOI 10.1046/j.1365-2958.2003.03372.x; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Zeilstra-Ryalls JH, 1998, METHOD ENZYMOL, V297, P151; ZeilstraRyalls JH, 1996, J BACTERIOL, V178, P985, DOI 10.1128/jb.178.4.985-993.1996; ZeilstraRyalls JH, 1997, J BACTERIOL, V179, P7264, DOI 10.1128/jb.179.23.7264-7273.1997; Zeller T, 2005, J BACTERIOL, V187, P7232, DOI 10.1128/JB.187.21.7232-7242.2005; Zufferey R, 1996, J BIOL CHEM, V271, P9114, DOI 10.1074/jbc.271.15.9114	35	29	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19891	19899		10.1074/jbc.M109.086066	http://dx.doi.org/10.1074/jbc.M109.086066			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20335164	Green Published, hybrid			2022-12-27	WOS:000279012000022
J	Watanabe, N; Takagi, S; Tominaga, A; Tomita, T; Iwatsubo, T				Watanabe, Naoto; Takagi, Shizuka; Tominaga, Aya; Tomita, Taisuke; Iwatsubo, Takeshi			Functional Analysis of the Transmembrane Domains of Presenilin 1 PARTICIPATION OF TRANSMEMBRANE DOMAINS 2 AND 6 IN THE FORMATION OF INITIAL SUBSTRATE-BINDING SITE OF gamma-SECRETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; CATALYTIC PORE; ACTIVE-SITE; C-TERMINUS; CELL-SURFACE; COMPLEX; NICASTRIN; STABILIZATION; TRAFFICKING; INHIBITOR	gamma-Secretase is a multimeric membrane protein complex composed of presenilin ( PS), nicastrin, Aph-1, and Pen-2, which mediates intramembrane proteolysis of a range of type I transmembrane proteins. We previously analyzed the functional roles of the N-terminal transmembrane domains (TMDs) 1-6 of PS1 in the assembly and proteolytic activity of the gamma-secretase using a series of TMD-swap PS1 mutants. Here we applied the TMD-swap method to all the TMDs of PS1 for the structure-function analysis of the proteolytic mechanism of gamma-secretase. We found that TMD2- or -6-swapped mutant PS1 failed to bind the helical peptide-based, substrate-mimic gamma-secretase inhibitor. Cross-linking experiments revealed that both TMD2 and TMD6 of PS1 locate in proximity to the TMD9, the latter being implicated in the initial substrate binding. Taken together, our data suggest that TMD2 and the luminal side of TMD6 are involved in the formation of the initial substrate-binding site of the gamma-secretase complex.	[Tomita, Taisuke] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo 1130033, Japan; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Tomita, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Corporation (JST); Core Research for Evolutional Science and Technology of JST, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology of JST, Japan(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by grants-in-aid for young scientists (S) from the Japan Society for the Promotion of Science (JSPS), Scientific Research on Priority Areas "Research on Pathomechanisms of Brain Disorders" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), by the Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST), and by the Core Research for Evolutional Science and Technology of JST, Japan.	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Brunkan AL, 2005, J NEUROCHEM, V94, P1315, DOI 10.1111/j.1471-4159.2005.03278.x; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Hayashi I, 2009, J BIOL CHEM, V284, P27838, DOI 10.1074/jbc.M109.055061; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200	39	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19738	19746		10.1074/jbc.M110.101287	http://dx.doi.org/10.1074/jbc.M110.101287			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20418378	Green Published, hybrid			2022-12-27	WOS:000279012000006
J	Alegre-Cebollada, J; Perez-Jimenez, R; Kosuri, P; Fernandez, JM				Alegre-Cebollada, Jorge; Perez-Jimenez, Raul; Kosuri, Pallav; Fernandez, Julio M.			Single-molecule Force Spectroscopy Approach to Enzyme Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIHYDROFOLATE-REDUCTASE; THIOREDOXIN CATALYSIS; CLAMP SPECTROSCOPY; ENERGY LANDSCAPE; DISULFIDE BONDS; DYNAMICS; MECHANISM; KINETICS; PERSPECTIVE; UBIQUITIN	Enzyme catalysis has been traditionally studied using a diverse set of techniques such as bulk biochemistry, x-ray crystallography, and NMR. Recently, single-molecule force spectroscopy by atomic force microscopy has been used as a new tool to study the catalytic properties of an enzyme. In this approach, a mechanical force ranging up to hundreds of piconewtons is applied to the substrate of an enzymatic reaction, altering the conformational energy of the substrate-enzyme interactions during catalysis. From these measurements, the force dependence of an enzymatic reaction can be determined. The force dependence provides valuable new information about the dynamics of enzyme catalysis with sub-angstrom resolution, a feat unmatched by any other current technique. To date, single-molecule force spectroscopy has been applied to gain insight into the reduction of disulfide bonds by different enzymes of the thioredoxin family. This minireview aims to present a perspective on this new approach to study enzyme catalysis and to summarize the results that have already been obtained from it. Finally, the specific requirements that must be fulfilled to apply this new methodology to any other enzyme will be discussed.	[Alegre-Cebollada, Jorge; Perez-Jimenez, Raul; Kosuri, Pallav] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Kosuri, Pallav] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA	Columbia University; Columbia University		jfernandez@columbia.edu	Alegre-Cebollada, Jorge/I-4301-2014; Perez-Jimenez, Raul/C-3085-2017; Kosuri, Pallav/J-8279-2012	Alegre-Cebollada, Jorge/0000-0003-0542-0170; Perez-Jimenez, Raul/0000-0001-7094-6799; Kosuri, Pallav/0000-0002-7025-3543	National Institutes of Health [HL66030, HL61228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL66030 and HL61228 (to J. M. F.). This is the first article in the Thematic Minireview Series on Single-molecule Measurements in Biochemistry and Molecular Biology. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu SRK, 2008, J AM CHEM SOC, V130, P6479, DOI 10.1021/ja800180u; Ainavarapu SRK, 2008, J AM CHEM SOC, V130, P436, DOI 10.1021/ja077851s; Antikainen NM, 2005, BIOCHEMISTRY-US, V44, P16835, DOI 10.1021/bi051378i; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Dougan L, 2008, CHEMPHYSCHEM, V9, P2836, DOI 10.1002/cphc.200800572; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Frey P. A., 2007, ENZYMATIC REACTION M; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; KARPLUS M, 1983, ANNU REV BIOCHEM, V52, P263, DOI 10.1146/annurev.bi.52.070183.001403; Kern D, 2005, METHOD ENZYMOL, V394, P507, DOI 10.1016/S0076-6879(05)94021-4; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Lide D.R., 1994, CRC HDB CHEM PHYS; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PAPPAS JA, 1977, J AM CHEM SOC, V99, P2926, DOI 10.1021/ja00451a013; Perez-Jimenez R, 2008, J BIOL CHEM, V283, P27121, DOI 10.1074/jbc.M803746200; Perez-Jimenez R, 2009, NAT STRUCT MOL BIOL, V16, P890, DOI 10.1038/nsmb.1627; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; ROSENFIELD RE, 1977, J AM CHEM SOC, V99, P4860, DOI 10.1021/ja00456a072; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Schramm VL, 2005, CURR OPIN STRUC BIOL, V15, P604, DOI 10.1016/j.sbi.2005.10.017; Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684; Szoszkiewicz R, 2008, LANGMUIR, V24, P1356, DOI 10.1021/la702368b; WAGNER G, 1978, NATURE, V275, P247, DOI 10.1038/275247a0; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Zhong DP, 2007, CURR OPIN CHEM BIOL, V11, P174, DOI 10.1016/j.cbpa.2007.02.034	50	54	58	2	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18961	18966		10.1074/jbc.R109.011932	http://dx.doi.org/10.1074/jbc.R109.011932			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382731	Green Published, hybrid			2022-12-27	WOS:000278727800002
J	Galloux, M; Libersou, S; Alves, ID; Marquant, R; Salgado, GF; Rezaei, H; Lepault, J; Delmas, B; Bouaziz, S; Morellet, N				Galloux, Marie; Libersou, Sonia; Alves, Isabel D.; Marquant, Rodrigue; Salgado, Gilmar F.; Rezaei, Human; Lepault, Jean; Delmas, Bernard; Bouaziz, Serge; Morellet, Nelly			NMR Structure of a Viral Peptide Inserted in Artificial Membranes A VIEW ON THE EARLY STEPS OF THE BIRNAVIRUS ENTRY PROCESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANTIMICROBIAL PEPTIDE; BURSAL DISEASE VIRUS; DIFFERENTIAL SCANNING CALORIMETRY; GUIDE RESONANCE SPECTROSCOPY; ICOSAHEDRAL ANIMAL VIRUS; LIPID-BILAYER MEMBRANES; FLOCK HOUSE VIRUS; NONENVELOPED VIRUS; PORE FORMATION; DODECYLPHOSPHOCHOLINE MICELLES	Nonenveloped virus must penetrate the cellular membrane to access the cytoplasm without the benefit of membrane fusion. For birnavirus, one of the peptides present in the virus capsid, pep46 for infectious bursal disease virus, is able to induce pores into membranes as an intermediate step of the birnavirus-penetration pathway. Using osmotic protection experiments, we demonstrate here that pep46 and its pore-forming N-terminal moiety (pep22) form pores of different diameters, 5-8 and 2-4 nm, respectively, showing that both pep46 moieties participate to pore formation. The solution structures of pep46, pep22, and pep24 (the pep46 C-terminal moiety) in different hydrophobic environments and micelles determined by H-1 NMR studies provide structural insights of the pep46 domain interaction. In CDCl3/CD3OH mixture and in dodecylphosphocholine micelles, the N-terminal domain of pep46 is structured in a long kinked helix, although the C terminus is structured in one or two helices depending upon the solvents used. We also show that the folding and the proline isomerization status of pep46 depend on the type of hydrophobic environment. NMR spectroscopy with labeled phospholipid micelles, differential scanning calorimetry, and plasmon waveguide resonance studies show the peptides lie parallel to the lipid-water interface, perturbing the fatty acid chain packing. All these data lead to a model in which the two domains of pep46 interact with the membrane to form pores.	[Galloux, Marie; Marquant, Rodrigue; Bouaziz, Serge; Morellet, Nelly] Univ Paris 05, CNRS, Unite Pharmacol Chim & Genet, Fac Sci Pharmaceut & Biol,UMR 8151, F-75270 Paris 06, France; [Galloux, Marie; Rezaei, Human; Delmas, Bernard] INRA, UR892, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France; [Alves, Isabel D.; Salgado, Gilmar F.] Univ Paris 06, CNRS, UMR 7203, Lab BioMol,FR 2769, F-75252 Paris 05, France; [Libersou, Sonia; Lepault, Jean] CNRS, UMR 2472, INRA 1157, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Morellet, N (corresponding author), Univ Paris 05, CNRS, Unite Pharmacol Chim & Genet, Fac Sci Pharmaceut & Biol,UMR 8151, 4 Ave Observ, F-75270 Paris 06, France.	nelly.morellet@icsn.cnrs-gif.fr	Lepault, Jean/AAN-8859-2020; bouaziz, serge/C-1401-2014; SALGADO, Gilmar/AAQ-8734-2020; Salgado, Gilmar/M-1081-2016; Bouaziz, Serge/ABA-8712-2020; Salgado, Gilmar/M-5476-2019; Alves, Isabel D/R-9613-2016	Bouaziz, Serge/0000-0001-7792-8307; Salgado, Gilmar/0000-0002-0296-5979; Alves, Isabel D/0000-0003-3193-2436; morellet, nelly/0000-0001-5076-8884	French Ministere de la Recherche et Technologie (MRT); Agence Nationale de la Recherche	French Ministere de la Recherche et Technologie (MRT); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a grant of the Action Concertee Incitative (ACI) "Microbiologie" from the French Ministere de la Recherche et Technologie (MRT) and the Agence Nationale de la Recherche "Projets blancs" programs.	Agosto MA, 2006, P NATL ACAD SCI USA, V103, P16496, DOI 10.1073/pnas.0605835103; ALTENBACH C, 1988, PROTEINS, V3, P230, DOI 10.1002/prot.340030404; Andrushchenko VV, 2008, BBA-BIOMEMBRANES, V1778, P1004, DOI 10.1016/j.bbamem.2007.12.022; Arias CF, 1996, J VIROL, V70, P5832, DOI 10.1128/JVI.70.9.5832-5839.1996; ARNOLD E, 1987, P NATL ACAD SCI USA, V84, P21, DOI 10.1073/pnas.84.1.21; Banerjee M, 2009, J VIROL, V83, P6929, DOI 10.1128/JVI.02299-08; Basanez G, 2002, FEBS LETT, V532, P115, DOI 10.1016/S0014-5793(02)03651-7; BAZZO R, 1988, EUR J BIOCHEM, V173, P139, DOI 10.1111/j.1432-1033.1988.tb13977.x; BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208; Beswick V, 1998, BIOCHIMIE, V80, P451, DOI 10.1016/S0300-9084(00)80012-7; Beswick V, 1998, EUR BIOPHYS J BIOPHY, V28, P48, DOI 10.1007/s002490050182; Biggin PC, 1999, BIOPHYS CHEM, V76, P161, DOI 10.1016/S0301-4622(98)00233-6; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bong DT, 1999, CHEM BIOL, V6, P473, DOI 10.1016/S1074-5521(99)80065-9; Bong DT, 2000, BIOPHYS J, V78, P839, DOI 10.1016/S0006-3495(00)76641-0; BROWN LR, 1981, BIOCHIM BIOPHYS ACTA, V642, P296, DOI 10.1016/0005-2736(81)90447-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Burkhart BM, 1999, BIOPOLYMERS, V51, P129, DOI 10.1002/(SICI)1097-0282(1999)51:2<129::AID-BIP3>3.0.CO;2-Y; Campagna S, 2007, BIOCHEMISTRY-US, V46, P1771, DOI 10.1021/bi0620297; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; CHENG RH, 1994, STRUCTURE, V2, P271; Chevalier C, 2005, J VIROL, V79, P12253, DOI 10.1128/JVI.79.19.12253-12263.2005; Chia BCS, 2000, EUR J BIOCHEM, V267, P1894, DOI 10.1046/j.1432-1327.2000.01089.x; COHEN J, 1975, BIOCHEM BIOPH RES CO, V62, P689, DOI 10.1016/0006-291X(75)90454-4; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Damberg P, 2001, METHOD ENZYMOL, V339, P271, DOI 10.1016/S0076-6879(01)39318-7; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; Epand RM, 2007, BIOPHYS CHEM, V126, P197, DOI 10.1016/j.bpc.2006.05.008; ESTES MK, 1981, J VIROL, V39, P879, DOI 10.1128/JVI.39.3.879-888.1981; FISHER AJ, 1993, NATURE, V361, P176, DOI 10.1038/361176a0; FREEDMAN JC, 1979, J GEN PHYSIOL, V74, P157, DOI 10.1085/jgp.74.2.157; Galloux M, 2007, J BIOL CHEM, V282, P20774, DOI 10.1074/jbc.M701048200; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Gesell J, 1997, J BIOMOL NMR, V9, P127, DOI 10.1023/A:1018698002314; Glaser RW, 2004, J MAGN RESON, V168, P153, DOI 10.1016/j.jmr.2004.02.008; Greber UF, 1996, EMBO J, V15, P1766, DOI 10.1002/j.1460-2075.1996.tb00525.x; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6; Huang HW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198304; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Joanne P, 2009, BBA-BIOMEMBRANES, V1788, P1772, DOI 10.1016/j.bbamem.2009.05.001; Latal A, 1997, EUR J BIOCHEM, V248, P938, DOI 10.1111/j.1432-1033.1997.00938.x; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Lee MT, 2004, BIOCHEMISTRY-US, V43, P3590, DOI 10.1021/bi036153r; Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7; LUDTKE SJ, 1994, BBA-BIOMEMBRANES, V1190, P181, DOI 10.1016/0005-2736(94)90050-7; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Maia LF, 2006, J BIOL CHEM, V281, P29278, DOI 10.1074/jbc.M604689200; Malev VV, 2002, BIOPHYS J, V82, P1985, DOI 10.1016/S0006-3495(02)75547-1; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y; MATSUZAKI K, 1991, BIOCHIM BIOPHYS ACTA, V1063, P162, DOI 10.1016/0005-2736(91)90366-G; MUELLER P, 1968, NATURE, V217, P713, DOI 10.1038/217713a0; Naito A, 2000, BIOPHYS J, V78, P2405, DOI 10.1016/S0006-3495(00)76784-1; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Orekhov VY, 2000, J BIOMOL NMR, V17, P257, DOI 10.1023/A:1008346414720; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park SH, 2002, BIOCHEM J, V368, P171, DOI 10.1042/BJ20020385; Pashkov VS, 1999, FEBS LETT, V457, P117, DOI 10.1016/S0014-5793(99)01023-6; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Plesniak LA, 2004, PROTEIN SCI, V13, P1988, DOI 10.1110/ps.04853204; Poranen MM, 2002, ANNU REV MICROBIOL, V56, P521, DOI 10.1146/annurev.micro.56.012302.160643; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Prenner EJ, 1999, BBA-BIOMEMBRANES, V1417, P211, DOI 10.1016/S0005-2736(99)00004-8; Quijano JC, 2008, BBA-BIOMEMBRANES, V1778, P2775, DOI 10.1016/j.bbamem.2008.07.009; Reid C, 1997, BIOPHYS J, V73, P1692, DOI 10.1016/S0006-3495(97)78201-8; Ruiz MC, 2000, CELL CALCIUM, V28, P137, DOI 10.1054/ceca.2000.0142; Saint N, 2002, BBA-BIOMEMBRANES, V1564, P359, DOI 10.1016/S0005-2736(02)00470-4; Salamon Z, 2004, BIOPHYS J, V86, P2508, DOI 10.1016/S0006-3495(04)74306-4; Salamon Z, 1998, BIOPHYS J, V75, P1874, DOI 10.1016/S0006-3495(98)77628-3; SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; SPIES U, 1987, VIRUS RES, V8, P127, DOI 10.1016/0168-1702(87)90024-4; Takei J, 1998, BIOCHEMISTRY-US, V37, P5699, DOI 10.1021/bi9729007; TERWILLIGER TC, 1982, BIOPHYS J, V37, P353, DOI 10.1016/S0006-3495(82)84683-3; Vinogradova O, 1998, J BIOMOL NMR, V11, P381, DOI 10.1023/A:1008289624496; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; ZLOTNICK A, 1994, J BIOL CHEM, V269, P13680	90	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19409	19421		10.1074/jbc.M109.076083	http://dx.doi.org/10.1074/jbc.M109.076083			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20385550	Green Published, hybrid			2022-12-27	WOS:000278727800052
J	Bialkowska, K; Ma, YQ; Bledzka, K; Sossey-Alaoui, K; Izem, L; Zhang, XX; Malinin, N; Qin, J; Byzova, T; Plow, EF				Bialkowska, Katarzyna; Ma, Yan-Qing; Bledzka, Kamila; Sossey-Alaoui, Khalid; Izem, Lahoucine; Zhang, Xiaoxia; Malinin, Nikolay; Qin, Jun; Byzova, Tatiana; Plow, Edward F.			The Integrin Co-activator Kindlin-3 Is Expressed and Functional in a Non-hematopoietic Cell, the Endothelial Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE ADHESION; MATRIX ADHESION; ACTIVATION; BINDING; MIG-2; TALIN; ALPHA(IIB)BETA(3); IDENTIFICATION; LOCALIZATION; MUTATIONS	Integrin activation is crucial for numerous cellular responses, including cell adhesion, migration, and survival. Recent studies in mice have specifically emphasized the vital role of kindlin-3 in integrin activation. Kindlin-3 deficiency in humans also has now been documented and includes symptoms of bleeding, frequent infections, and osteopetrosis, which are consequences of an inability to activate beta 1, beta 2, and beta 3 integrins. To date, kindlin-3 was thought to be restricted to hematopoietic cells. In this article, we demonstrate that kindlin-3 is present in human endothelial cells derived from various anatomical origins. The mRNA and protein for KINDLIN-3 was detected in endothelial cells by reverse transcription-PCR and Western blots. When subjected to sequencing by mass spectrometry, the protein was identified as authentic kindlin-3 and unequivocally distinguished from KINDLIN-1 and KINDLIN-2 or any other known protein. By quantitative real time PCR, the level of kindlin-3 in endothelial cells was 20-50% of that of kindlin-2. Using knockdown approaches, we show that kindlin-3 plays a role in integrin-mediated adhesion of endothelial cells. This function depends upon the integrin and substrate and is distinct from that of kindlin-2. Formation of tube-like structures in Matrigel also was impaired by kindlin-3 knockdown. Mechanistically, the distinct functions of the kindlins can be traced to differences in their subcellular localization in integrin-containing adhesion structures. Thus, the prevailing view that individual kindlins exert their functions in a cell type-specific manner must now be modified to consider distinct functions of the different family members within the same cell type.	[Bialkowska, Katarzyna; Ma, Yan-Qing; Bledzka, Kamila; Sossey-Alaoui, Khalid; Zhang, Xiaoxia; Malinin, Nikolay; Qin, Jun; Byzova, Tatiana; Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; [Izem, Lahoucine] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Plow, EF (corresponding author), Dept Mol Cardiol NB5 50, 9500 Euclid Ave, Cleveland, OH 44195 USA.	plowe@ccf.org	Malinin, Nikolay/Z-5308-2019; Malinin, Nikolay/J-4271-2012	Malinin, Nikolay/0000-0002-2654-1783; Byzova, Tatiana/0000-0002-2615-875X; Qin, Jun/0000-0002-2647-9270	National Institutes of Health, NHLBI [P01HL073311, R01 HL096062-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096062, P01HL073311] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL073311 and R01 HL096062-01 from the NHLBI.	Alon R, 2003, TRENDS IMMUNOL, V24, P561, DOI 10.1016/j.it.2003.08.001; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Ehlers R, 2003, J EXP MED, V198, P1077, DOI 10.1084/jem.20022181; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Kato K, 2004, HUM PATHOL, V35, P55, DOI 10.1016/j.humpath.2003.08.019; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; McDowall A, 2003, J CLIN INVEST, V111, P51, DOI 10.1172/JCI200314076; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mori D, 2007, J ATHEROSCLER THROMB, V14, P213, DOI 10.5551/jat.E492; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Postea O, 2006, ARTERIOSCL THROM VAS, V26, P508, DOI 10.1161/01.ATV.0000201039.21705.dc; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6	34	78	79	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18640	18649		10.1074/jbc.M109.085746	http://dx.doi.org/10.1074/jbc.M109.085746			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378539	Green Published, hybrid			2022-12-27	WOS:000278453900057
J	Zraika, S; Aston-Mourney, K; Marek, P; Hull, RL; Green, PS; Udayasankar, J; Subramanian, SL; Raleigh, DP; Kahn, SE				Zraika, Sakeneh; Aston-Mourney, Kathryn; Marek, Peter; Hull, Rebecca L.; Green, Pattie S.; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Raleigh, Daniel P.; Kahn, Steven E.			Neprilysin Impedes Islet Amyloid Formation by Inhibition of Fibril Formation Rather Than Peptide Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-DEGRADING ENZYME; NEUTRAL ENDOPEPTIDASE; DIABETES-MELLITUS; POLYPEPTIDE IAPP; IN-VITRO; TRANSGENIC MICE; MOUSE ISLETS; A-BETA; CELL; SECRETION	Deposition of islet amyloid polypeptide (IAPP) as islet amyloid in type 2 diabetes contributes to loss of beta-cell function and mass, yet the mechanism for its occurrence is unclear. Neprilysin is a metallopeptidase known to degrade amyloid in Alzheimer disease. We previously demonstrated neprilysin to be present in pancreatic islets and now sought to determine whether it plays a role in degrading islet amyloid. We used an in vitro model where cultured human IAPP (hIAPP) transgenic mouse islets develop amyloid and thereby have increased beta-cell apoptosis. Islet neprilysin activity was inhibited or up-regulated using a specific inhibitor or adenovirus encoding neprilysin, respectively. Following neprilysin inhibition, islet amyloid deposition and beta-cell apoptosis increased by 54 and 75%, respectively, whereas when neprilysin was up-regulated islet amyloid deposition and beta-cell apoptosis both decreased by 79%. To determine if neprilysin modulated amyloid deposition by cleaving hIAPP, analysis of hIAPP incubated with neprilysin was performed by mass spectrometry, which failed to demonstrate neprilysin-induced cleavage. Rather, neprilysin may act by reducing hIAPP fibrillogenesis, which we showed to be the case by fluorescence-based thioflavin T binding studies and electron microscopy. In summary, neprilysin decreases islet amyloid deposition by inhibiting hIAPP fibril formation, rather than degrading hIAPP. These findings suggest that targeting the role of neprilysin in IAPP fibril assembly, in addition to IAPP cleavage by other peptidases, may provide a novel approach to reduce and/or prevent islet amyloid deposition in type 2 diabetes.	[Zraika, Sakeneh; Aston-Mourney, Kathryn; Hull, Rebecca L.; Green, Pattie S.; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Kahn, Steven E.] Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Seattle, WA 98108 USA; [Zraika, Sakeneh; Aston-Mourney, Kathryn; Hull, Rebecca L.; Green, Pattie S.; Udayasankar, Jayalakshmi; Subramanian, Shoba L.; Kahn, Steven E.] Univ Washington, Seattle, WA 98108 USA; [Marek, Peter; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zraika, S (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Dept Med, 1660 S Columbian Way 151, Seattle, WA 98108 USA.	zraikas@u.washington.edu	Hull-Meichle, Rebecca L./CAG-5879-2022; Aston-Mourney, Kathryn/AGY-5164-2022	Aston-Mourney, Kathryn/0000-0003-1412-6715; Hull, Rebecca/0000-0001-9690-4087; Kahn, Steven/0000-0001-7307-9002; raleigh, daniel/0000-0003-3248-7493	National Institutes of Health [DK-080945, DK-074404, GM-078114]; Dept. of Veterans Affairs, Virginia; NIH [DK-017047]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK080945, K01DK074404, R00DK080945, P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs, Virginia(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-080945 (to S. Z.), DK-074404 (to R. L. H.), and GM-078114 (to D. P. R.). This work was also supported by the Dept. of Veterans Affairs, Virginia Affairs Puget Sound Health Care System, Seattle, WA. Mass spectrometry work was performed at the University of Washington's Diabetes Endocrinology Research Center Mass Spectrometry Core, which is supported by NIH Grant DK-017047.	Andrikopoulos S, 2000, DIABETES, V49, P2056, DOI 10.2337/diabetes.49.12.2056; Aston-Mourney K, 2008, DIABETES, V57, pA457; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; BETSHOLTZ C, 1989, FEBS LETT, V251, P261, DOI 10.1016/0014-5793(89)81467-X; BETSHOLTZ C, 1989, EXP CELL RES, V183, P484, DOI 10.1016/0014-4827(89)90407-2; CLARK A, 1990, DIABETOLOGIA, V33, P285, DOI 10.1007/BF00403322; DALESSIO DA, 1994, DIABETES, V43, P1457, DOI 10.2337/diabetes.43.12.1457; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; ENOKI S, 1992, DIABETES RES CLIN PR, V15, P97, DOI 10.1016/0168-8227(92)90074-2; Fukami S, 2002, NEUROSCI RES, V43, P39, DOI 10.1016/S0168-0102(02)00015-9; Ganju RK, 1996, BLOOD, V88, P4159; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Hersh LB, 2008, CURR ALZHEIMER RES, V5, P225, DOI 10.2174/156720508783954703; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Iwase A, 2004, J BIOL CHEM, V279, P11898, DOI 10.1074/jbc.M212737200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; KAHN SE, 1991, HORM METAB RES, V23, P577, DOI 10.1055/s-2007-1003759; KAUTZKYWILLER A, 1994, DIABETOLOGIA, V37, P188, DOI 10.1007/s001250050092; Lau T, 2004, DIABETOLOGIA, V47, P240, DOI 10.1007/s00125-003-1295-1; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Maloyan A, 2007, P NATL ACAD SCI USA, V104, P5995, DOI 10.1073/pnas.0609202104; Marr RA, 2003, J NEUROSCI, V23, P1992; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; Raharjo SB, 2001, J BIOL CHEM, V276, P25612, DOI 10.1074/jbc.M101703200; ROQUES BP, 1995, METHOD ENZYMOL, V248, P263; Rose C, 2002, BIOCHEM J, V363, P697, DOI 10.1042/0264-6021:3630697; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Shen RQ, 2002, ANTICANCER RES, V22, P2533; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Trebbien R, 2004, AM J PHYSIOL-ENDOC M, V287, pE431, DOI 10.1152/ajpendo.00353.2003; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zraika S, 2002, ARCH BIOCHEM BIOPHYS, V405, P275, DOI 10.1016/S0003-9861(02)00397-1; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x; Zraika S, 2007, BIOCHEM BIOPH RES CO, V354, P234, DOI 10.1016/j.bbrc.2006.12.187; Zraika S, 2007, DIABETES, V56, P304, DOI 10.2337/db06-0430	44	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18177	18183		10.1074/jbc.M109.082032	http://dx.doi.org/10.1074/jbc.M109.082032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400513	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000278453900008
J	Li, HX; Han, M; Bernier, M; Zheng, B; Sun, SG; Su, M; Zhang, R; Fu, JR; Wen, JK				Li, Hui-xuan; Han, Mei; Bernier, Michel; Zheng, Bin; Sun, Shao-guang; Su, Ming; Zhang, Rui; Fu, Jian-ran; Wen, Jin-kun			Kruppel-like Factor 4 Promotes Differentiation by Transforming Growth Factor-beta Receptor-mediated Smad and p38 MAPK Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; DOWN-REGULATION; MARKER GENES; ACTIVATION; INHIBITION; EXPRESSION; PROLIFERATION; PROTEIN; KRUPPEL-LIKE-FACTOR-4; MECHANISM	KLF4 (Kruppel-like factor 4) has been implicated in vascular smooth muscle cell (VSMC) differentiation induced by transforming growth factor beta (TGF-beta). However, the role of KLF4 and mechanism of KLF4 actions in regulating TGF-beta signaling in VSMCs remain unclear. In this study, we showed that TGF-beta 1 inhibited cell cycle progression and induced differentiation in cultured rat VSMCs. This activity of TGF-beta 1 was accompanied by up-regulation of KLF4, with concomitant increase in T beta RI (TGF-beta type I receptor) expression. KLF4 was found to transduce TGF-beta 1 signals via phosphorylation-mediated activation of Smad2, Smad3, and p38 MAPK. The activation of both pathways, in turn, increased the phosphorylation of KLF4, which enabled the formation of KLF4-Smad2 complex in response to TGF-beta 1. Chromatin immunoprecipitation studies and oligonucleotide pull-down assays showed the direct binding of KLF4 to the KLF4-binding sites 2 and 3 of the T beta RI promoter and the recruitment of Smad2 to the Smad-responsive region. Formation of a stable KLF4-Smad2 complex in the promoter's Smad-responsive region mediated cooperative T beta RI promoter transcription in response to TGF-beta 1. These results suggest that KLF4-dependent regulation of Smad and p38 MAPK signaling via T beta RI requires prior phosphorylation of KLF4 through Smad and p38 MAPK pathways. This study demonstrates a novel mechanism by which TGF-beta 1 regulates VSMC differentiation.	[Li, Hui-xuan; Han, Mei; Zheng, Bin; Sun, Shao-guang; Su, Ming; Zhang, Rui; Fu, Jian-ran; Wen, Jin-kun] Hebei Med Univ, China Minist Educ, Key Lab Neural & Vasc Biol, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [Li, Hui-xuan] Hebei Univ Econ & Business, Coll Biol Sci & Engn, Shijiazhuang 050061, Peoples R China; [Bernier, Michel] NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA	Hebei Medical University; Hebei University of Economics & Business; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wen, JK (corresponding author), Hebei Med Univ, China Minist Educ, Key Lab Neural & Vasc Biol, Dept Biochem & Mol Biol, 361 Zhongshan E Rd, Shijiazhuang 050017, Peoples R China.	wjk@hebmu.edu.cn	Bernier, Michel/AAO-3983-2021; Han, Mei/GXH-8347-2022; Cheng, Yunhui/A-5668-2010; Bernier, Michel/Y-7139-2019	Bernier, Michel/0000-0002-5948-368X; Sun, Shao-Guang/0000-0002-2827-0948; Wen, Jinkun/0000-0002-8453-4549	National Institutes of Health, NIA; National Natural Science Foundation of China [30971457, 90919035]; Ministry of Science and Technology of China [2008CB517402]; Natural Science Foundation of Hebei Province [C2008001049]	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was supported, in whole or in part, by the National Institutes of Health, NIA, Intramural Research Program. This work is also supported by National Natural Science Foundation of China Grants 30971457 and 90919035, Special Fund for Preliminary Research of Key Basic Research Project of the Ministry of Science and Technology of China Grant 2008CB517402, and Natural Science Foundation of Hebei Province Grant C2008001049.	Autieri MV, 2008, CIRC RES, V102, P1455, DOI 10.1161/CIRCRESAHA.108.178954; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Boon RA, 2007, ARTERIOSCL THROM VAS, V27, P532, DOI 10.1161/01.ATV.0000256466.65450.ce; Botella LM, 2009, BIOCHEM J, V419, P485, DOI 10.1042/BJ20081434; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Feinberg MW, 2004, J BIOL CHEM, V279, P16388, DOI 10.1074/jbc.M309664200; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Fujiu K, 2005, CIRC RES, V97, P1132, DOI 10.1161/01.RES.0000190613.22565.13; Giordano A, 2008, CARDIOVASC RES, V79, P519, DOI 10.1093/cvr/cvn079; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Han M, 2006, AM J PHYSIOL-CELL PH, V291, pC50, DOI 10.1152/ajpcell.00524.2005; Han M, 2009, FEBS J, V276, P1720, DOI 10.1111/j.1742-4658.2009.06902.x; He M, 2009, J BIOCHEM, V146, P683, DOI 10.1093/jb/mvp115; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Ji CH, 1997, J BIOL CHEM, V272, P21260, DOI 10.1074/jbc.272.34.21260; Kamiya K, 2007, MOL CELL BIOL, V27, P3489, DOI 10.1128/MCB.00665-06; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; King-Briggs KE, 2000, DIFFERENTIATION, V66, P43, DOI 10.1046/j.1432-0436.2000.066001043.x; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meng F, 2009, BIOCHEM BIOPH RES CO, V387, P13, DOI 10.1016/j.bbrc.2009.05.112; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pal R, 2006, STEM CELLS DEV, V15, P29, DOI 10.1089/scd.2006.15.29; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007; Venkatasubbarao K, 2001, CANCER RES, V61, P6239; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wassmann S, 2007, J MOL CELL CARDIOL, V43, P301, DOI 10.1016/j.yjmcc.2007.06.001; Wassmer SC, 2006, J IMMUNOL, V176, P1180, DOI 10.4049/jimmunol.176.2.1180; Weber DS, 2008, CIRC RES, V102, P1448, DOI 10.1161/CIRCRESAHA.108.179044; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yang HB, 2008, AM J PHYSIOL-GASTR L, V295, pG170, DOI 10.1152/ajpgi.00492.2007; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zhang XH, 2009, FEBS LETT, V583, P1231, DOI 10.1016/j.febslet.2009.03.016; Zheng B, 2008, BIOCHEMISTRY-MOSCOW+, V73, P353, DOI 10.1134/S0006297908030188; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989	50	73	82	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17846	17856		10.1074/jbc.M109.076992	http://dx.doi.org/10.1074/jbc.M109.076992			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375011	Green Published, hybrid			2022-12-27	WOS:000278133400062
J	Vranka, JA; Pokidysheva, E; Hayashi, L; Zientek, K; Mizuno, K; Ishikawa, Y; Maddox, K; Tufa, S; Keene, DR; Klein, R; Bachinger, HP				Vranka, Janice A.; Pokidysheva, Elena; Hayashi, Lauren; Zientek, Keith; Mizuno, Kazunori; Ishikawa, Yoshihiro; Maddox, Kerry; Tufa, Sara; Keene, Douglas R.; Klein, Robert; Baechinger, Hans Peter			Prolyl 3-Hydroxylase 1 Null Mice Display Abnormalities in Fibrillar Collagen-rich Tissues Such as Tendons, Skin, and Bones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; AMINO-ACID SEQUENCE; COVALENT STRUCTURE; DEFICIENCY; PEPTIDES; MUTATIONS; MODEL; CRTAP; MASS	Osteogenesis imperfecta (OI) is a skeletal disorder primarily caused by mutations in the type I collagen genes. However, recent investigations have revealed that mutations in the genes encoding for cartilage-associated protein (CRTAP) or prolyl 3-hydroxylase 1 (P3H1) can cause a severe, recessive form of OI. These reports show minimal 3-hydroxylation of key proline residues in type I collagen as a result of CRTAP or P3H1 deficiency and demonstrate the importance of P3H1 and CRTAP to bone structure and development. P3H1 and CRTAP have previously been shown to form a stable complex with cyclophilin B, and P3H1 was shown to catalyze the 3-hydroxylation of specific proline residues in procollagen I in vitro. Here we describe a mouse model in which the P3H1 gene has been inactivated. Our data demonstrate abnormalities in collagen fibril ultrastructure in tendons from P3H1 null mice by electron microscopy. Differences are also seen in skin architecture, as well as in developing limbs by histology. Additionally bone mass and strength were significantly lower in the P3H1 mice as compared with wild-type littermates. Altogether these investigations demonstrate disturbances of collagen fiber architecture in tissues rich in fibrillar collagen, including bone, tendon, and skin. This model system presents a good opportunity to study the underlying mechanisms of recessive OI and to better understand its effects in humans.	[Vranka, Janice A.; Pokidysheva, Elena; Hayashi, Lauren; Zientek, Keith; Mizuno, Kazunori; Ishikawa, Yoshihiro; Maddox, Kerry; Tufa, Sara; Keene, Douglas R.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Pokidysheva, Elena; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Klein, Robert] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SWSam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Tufa, Sara/0000-0002-6447-8041; Ishikawa, Yoshihiro/0000-0003-2013-0518	Osteogenesis Imperfecta Foundation; Shriners Hospitals for Children; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030498, R01GM032335] Funding Source: NIH RePORTER	Osteogenesis Imperfecta Foundation; Shriners Hospitals for Children; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Osteogenesis Imperfecta Foundation (to J. A. V.) and by grants from the Shriners Hospitals for Children (to H. P. B. and D. R. K.).	Aoyama C, 2004, BIOMED CHROMATOGR, V18, P630, DOI 10.1002/bmc.365; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Cabral WA, 2007, HUM MUTAT, V28, P396, DOI 10.1002/humu.20456; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; FIETZEK PP, 1973, EUR J BIOCHEM, V38, P396, DOI 10.1111/j.1432-1033.1973.tb03072.x; FIETZEK PP, 1972, FEBS LETT, V26, P74, DOI 10.1016/0014-5793(72)80545-3; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; KEFALIDE.NA, 1972, BIOCHEM BIOPH RES CO, V47, P1151, DOI 10.1016/0006-291X(72)90955-2; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; REXRODT FW, 1975, EUR J BIOCHEM, V59, P105, DOI 10.1111/j.1432-1033.1975.tb02430.x; RHODES RK, 1978, BIOCHEMISTRY-US, V17, P3442, DOI 10.1021/bi00610a003; ROYCE PM, 2002, CONNECTIVE TISSUE IT, P385; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SILLENCE DO, 1987, AM J MED GENET, V27, P75, DOI 10.1002/ajmg.1320270109; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Yadav VK, 2009, AGING-US, V1, P954, DOI 10.18632/aging.100100; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051	27	68	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17253	17262		10.1074/jbc.M110.102228	http://dx.doi.org/10.1074/jbc.M110.102228			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363744	Green Published, hybrid			2022-12-27	WOS:000277982600087
J	Ekanayake, DK; Andi, B; Bobyk, KD; West, AH; Cook, PF				Ekanayake, Devi K.; Andi, Babak; Bobyk, Kostyantyn D.; West, Ann H.; Cook, Paul F.			Glutamates 78 and 122 in the Active Site of Saccharopine Dehydrogenase Contribute to Reactant Binding and Modulate the Basicity of the Acid-Base Catalysts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE PATHWAY; LYSINE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; ENZYME; FUNGI; AUXOTROPHS; MECHANISM	Saccharopine dehydrogenase catalyzes the NAD-dependent oxidative deamination of saccharopine to give L-lysine and alpha-ketoglutarate. There are a number of conserved hydrophilic, ionizable residues in the active site, all of which must be important to the overall reaction. In an attempt to determine the contribution to binding and rate enhancement of each of the residues in the active site, mutations at each residue are being made, and double mutants are being made to estimate the interrelationship between residues. Here, we report the effects of mutations of active site glutamate residues, Glu(78) and Glu(122), on reactant binding and catalysis. Site-directed mutagenesis was used to generate E78Q, E122Q, E78Q/E122Q, E78A, E122A, and E78A/E122A mutant enzymes. Mutation of these residues increases the positive charge of the active site and is expected to affect the pK(a) values of the catalytic groups. Each mutant enzyme was completely characterized with respect to its kinetic and chemical mechanism. The kinetic mechanism remains the same as that of wild type enzymes for all of the mutant enzymes, with the exception of E78A, which exhibits binding of alpha-ketoglutarate to E and E.NADH. Large changes in V/K-Lys, but not V, suggest that Glu(78) and Glu(122) contribute binding energy for lysine. Shifts of more than a pH unit to higher and lower pH of the pK(a) values observed in the V/K-Lys pH-rate profile of the mutant enzymes suggests that the presence of Glu(78) and Glu(122) modulates the basicity of the catalytic groups.	[Ekanayake, Devi K.; Andi, Babak; Bobyk, Kostyantyn D.; West, Ann H.; Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Cook, PF (corresponding author), Univ Oklahoma, Dept Chem & Biochem, 620 Parrington Oval, Norman, OK 73019 USA.	pcook@ou.edu		Andi, Babak/0000-0002-7666-639X	National Institutes of Health [GM071417]; Grayce B. Kerr Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grayce B. Kerr Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071417 (to P. F. C. and A. H. W.). This work was also supported by the Grayce B. Kerr Endowment to the University of Oklahoma (for P. F. C.).	Andi B, 2007, BIOCHEMISTRY-US, V46, P12512, DOI 10.1021/bi701428m; BHATTACHARJEE JK, 1985, CRC CR REV MICROBIOL, V12, P131, DOI 10.3109/10408418509104427; BISHOP CM, 1995, NEURAL NETWORKS PATT, P290; BRADFORD MM, 1976, FED PROC, V35, P274; Burk DL, 2007, J MOL BIOL, V373, P745, DOI 10.1016/j.jmb.2007.08.044; Chen YI, 2003, BIOCHEM J, V374, P633, DOI 10.1042/BJ20030268; Cleland W W, 1979, Methods Enzymol, V63, P103; Cook P. F., 2007, ENZYME KINETICS MECH; DeLano WL, 2004, PYMOL MOL GRAPHICS S; GARRAD RC, 1992, J BACTERIOL, V174, P7379, DOI 10.1128/jb.174.22.7379-7384.1992; Johansson E, 2000, STRUCTURE, V8, P1037, DOI 10.1016/S0969-2126(00)00512-8; KLINMAN JP, 1985, J AM CHEM SOC, V107, P1058, DOI 10.1021/ja00290a052; OGAWA H, 1978, J BIOL CHEM, V253, P3666; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; Xu HY, 2007, BIOCHEMISTRY-US, V46, P871, DOI 10.1021/bi061980o; Xu HY, 2006, BIOCHEMISTRY-US, V45, P12156, DOI 10.1021/bi0610808; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; YE ZH, 1988, J BACTERIOL, V170, P5968, DOI 10.1128/jb.170.12.5968-5970.1988; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d	20	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20756	20768		10.1074/jbc.M110.119826	http://dx.doi.org/10.1074/jbc.M110.119826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427272	Green Published, hybrid			2022-12-27	WOS:000279228600040
J	Bergstrom, R; Savary, K; Moren, A; Guibert, S; Heldin, CH; Ohlsson, R; Moustakas, A				Bergstrom, Rosita; Savary, Katia; Moren, Anita; Guibert, Sylvain; Heldin, Carl-Henrik; Ohlsson, Rolf; Moustakas, Aristidis			Transforming Growth Factor beta Promotes Complexes between Smad Proteins and the CCCTC-binding Factor on the H19 Imprinting Control Region Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; MH1 DOMAIN; CTCF; METHYLATION; GENOME; GENE; DNA; TRANSCRIPTION; REPLICATION; ASSOCIATION	Whether signal transduction pathways regulate epigenetic states in response to environmental cues remains poorly understood. We demonstrate here that Smad3, signaling downstream of transforming growth factor beta, interacts with the zinc finger domain of CCCTC-binding factor (CTCF), a nuclear protein known to act as "the master weaver of the genome." This interaction occurs via the Mad homology 1 domain of Smad3. Although Smad2 and Smad4 fail to interact, an alternatively spliced form of Smad2 lacking exon 3 interacts with CTCF. CTCF does not perturb well established transforming growth factor beta gene responses. However, Smads and CTCF co-localize to the H19 imprinting control region (ICR), which emerges as an insulator in cis and regulator of transcription and replication in trans via direct CTCF binding to the ICR. Smad recruitment to the ICR requires intact CTCF binding to this locus. Smad2/3 binding to the ICR requires Smad4, which potentially provides stability to the complex. Because the CTCF-Smad complex is not essential for the chromatin insulator function of the H19 ICR, we propose that it can play a role in chromatin cross-talk organized by the H19 ICR.	[Bergstrom, Rosita; Savary, Katia; Moren, Anita; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, SE-75124 Uppsala, Sweden; [Bergstrom, Rosita; Guibert, Sylvain; Ohlsson, Rolf] Uppsala Univ, Dept Genet & Dev, Evolut Biol Ctr, SE-75236 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Ohlsson, R (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Nobels Vag 16,Box 280, SE-17177 Stockholm, Sweden.	rolf.ohlsson@ki.se; aris.moustakas@licr.uu.se			Ludwig Institute for Cancer Research; Swedish Cancer Society [4855-B03-01XAC]; Natural Sciences Foundation of Sweden [K2004-32XD-14936-01A]; Swedish Science Research Council; Swedish Pediatric Cancer Foundation; Lundberg Foundation; HEROIC European Union	Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Natural Sciences Foundation of Sweden; Swedish Science Research Council; Swedish Pediatric Cancer Foundation; Lundberg Foundation(European Commission); HEROIC European Union	This work was supported by grants from the Ludwig Institute for Cancer Research, Swedish Cancer Society Project 4855-B03-01XAC, and Natural Sciences Foundation of Sweden Project K2004-32XD-14936-01A (to A. M.) and grants from the Swedish Science Research Council, the Swedish Cancer Society, the Swedish Pediatric Cancer Foundation, the Lundberg Foundation, and the HEROIC European Union integrated project (to R.O.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bergstrom R, 2007, CELL CYCLE, V6, P450, DOI 10.4161/cc.6.4.3854; Burton T, 2002, BIOCHEM BIOPH RES CO, V295, P713, DOI 10.1016/S0006-291X(02)00725-8; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dean W, 1998, DEVELOPMENT, V125, P2273; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; Lutz M, 2000, NUCLEIC ACIDS RES, V28, P1707, DOI 10.1093/nar/28.8.1707; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Ohlsson R, 2001, TRENDS GENET, V17, P136, DOI 10.1016/S0168-9525(00)02211-3; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xu GX, 2002, BIOCHEM BIOPH RES CO, V294, P1079, DOI 10.1016/S0006-291X(02)00605-8; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	38	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19727	19737		10.1074/jbc.M109.088385	http://dx.doi.org/10.1074/jbc.M109.088385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427289	hybrid, Green Published			2022-12-27	WOS:000279012000005
J	Daher, W; Pierrot, C; Kalamou, H; Pinder, JC; Margos, G; Dive, D; Franke-Fayard, B; Janse, CJ; Khalife, J				Daher, Wassim; Pierrot, Christine; Kalamou, Hadidjatou; Pinder, Jennifer C.; Margos, Gabriele; Dive, Daniel; Franke-Fayard, Blandine; Janse, Chris J.; Khalife, Jamal			Plasmodium falciparum Dynein Light Chain 1 Interacts with Actin/Myosin during Blood Stage Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH REPEAT PROTEIN; OUTER ARM DYNEIN; MALARIA PARASITES; MOLECULAR MOTOR; TOXOPLASMA-GONDII; CELL INVASION; LIFE-CYCLE; XIV MYOSIN; ACTIN; IDENTIFICATION	Dynein light chain 1 (LC1), a member of the leucine-rich repeat protein family, has been shown to be engaged in controlling flagellar motility in Chlamydomonas reinhardtii and Trypanosoma brucei via its interaction with the dynein gamma heavy chain. In Plasmodium falciparum, we have identified the LC1 ortholog, designated Pfdlc1. Negative attempts to disrupt the dlc1 gene by reverse genetic approaches in both P. falciparum and P. berghei suggest either its essentiality for parasite survival or the inaccessibility of its locus. Expression studies revealed high levels of DLC1 protein in late trophozoites and schizonts, pointing to an unexpected role of this protein in blood-stage parasites as they do not have flagella. Interactions studies and co-immunoprecipitation experiments revealed that PfDLC1 was able to bind to P. falciparum myosin A and actin 1. The PfDLC1 interacting domains present in P. falciparum myosin A and actin 1 were mapped to sequences containing SDIE and/or EEMKT motifs present in the upper 50-kDa segment of the myosin A head domain and in the subdomain IV of actin 1, respectively. Detection of PfDLC1 by fluorescence tagging and immunofluorescence staining using specific antibodies showed a cytoplasmic location similar to actin and immunofluorescence studies showed a co-localization of PfDLC1 and myosin A. Taken together, these findings suggest that PfDLC1 might play an important role in P. falciparum erythrocytic stages by its interaction with myosin A and actin 1, known to be essential for parasite development.	[Khalife, Jamal] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM,U1019,CNRS,UMR 8204, F-59019 Lille, France; [Khalife, Jamal] Univ Lille Nord France, Inst Pasteur Lille, CNRS, INSERM,U547,UMR 8204, F-59019 Lille, France; [Pinder, Jennifer C.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Margos, Gabriele] Kings Coll London, Sch Med, Dept Immunobiol, Guys Hosp, London SE1 9RT, England; [Margos, Gabriele] Kings Coll London, Sch Med, Dept Immunobiol, Univ London Kings Coll Hosp, London SE1 9RT, England; [Margos, Gabriele] Kings Coll London, Sch Med, Dept Immunobiol, St Thomas Hosp, London SE1 9RT, England; [Franke-Fayard, Blandine; Janse, Chris J.] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Parasitol,Leiden Malaria Res Grp, NL-2300 RC Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Khalife, J (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM,U1019,CNRS,UMR 8204, 1 Rue Prof Calmette, F-59019 Lille, France.	jamal.khalife@pasteur-lille.fr	DAHER, Wassim/AAB-6720-2019; Khalife, Jamal/AAZ-2833-2020; DAHER, Wassim/M-7166-2017	DAHER, Wassim/0000-0001-9026-5333; DAHER, Wassim/0000-0001-9026-5333; Khalife, Jamal/0000-0002-4359-8976; MARGOS, Gabriele/0000-0001-5304-9615; Pierrot, Christine/0000-0002-6835-6789; Janse, Chris J/0000-0002-6410-6205; , Blandine/0000-0001-6041-4182	INSERM; Institut Pasteur de Lille; Universite Lille Nord de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur de Lille; Universite Lille Nord de France	This work was supported by INSERM, Institut Pasteur de Lille, and Universite Lille Nord de France.	Augustijn KD, 2007, INFECT IMMUN, V75, P1116, DOI 10.1128/IAI.00902-06; Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Benashski SE, 1999, BIOCHEMISTRY-US, V38, P7253, DOI 10.1021/bi990466y; Chaparro-Olaya J, 2005, CELL MOTIL CYTOSKEL, V60, P200, DOI 10.1002/cm.20055; Daher W, 2006, MOL MICROBIOL, V60, P578, DOI 10.1111/j.1365-2958.2006.05119.x; Daher W, 2007, MOL BIOCHEM PARASIT, V155, P161, DOI 10.1016/j.molbiopara.2007.07.001; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; de Koning-Ward TF, 2009, TRENDS PARASITOL, V25, P4, DOI 10.1016/j.pt.2008.09.009; de Koning-Ward TF, 2000, ANNU REV MICROBIOL, V54, P157, DOI 10.1146/annurev.micro.54.1.157; Downing KH, 2007, CURR OPIN STRUC BIOL, V17, P253, DOI 10.1016/j.sbi.2007.03.013; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fowler RE, 2001, MOL BIOCHEM PARASIT, V117, P187, DOI 10.1016/S0166-6851(01)00351-6; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gilk SD, 2009, EUKARYOT CELL, V8, P190, DOI 10.1128/EC.00201-08; GINSBURG H, 1987, ANN PARASIT HUM COMP, V62, P418, DOI 10.1051/parasite/1987625418; Githui EK, 2009, INFECT GENET EVOL, V9, P337, DOI 10.1016/j.meegid.2008.03.002; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KAGAMI O, 1992, J CELL SCI, V103, P653; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; KING SM, 1995, J CELL SCI, V108, P3757; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; MOHANTY JG, 1989, COMP IMMUNOL MICROB, V12, P153, DOI 10.1016/0147-9571(89)90064-7; Patel-King RS, 2009, J CELL BIOL, V186, P283, DOI 10.1083/jcb.200905083; Pierrot C, 2006, INFECT IMMUN, V74, P3347, DOI 10.1128/IAI.01724-05; Pinder JC, 1998, J CELL SCI, V111, P1831; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Saeki K, 2000, BIOCHEM BIOPH RES CO, V275, P428, DOI 10.1006/bbrc.2000.3321; Santos JM, 2009, INT J PARASITOL, V39, P153, DOI 10.1016/j.ijpara.2008.10.007; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Smythe WA, 2008, CELL MICROBIOL, V10, P452, DOI 10.1111/j.1462-5822.2007.01058.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UMLAS J, 1971, AM J TROP MED HYG, V20, P527, DOI 10.4269/ajtmh.1971.20.527; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VERNES A, 1984, AM J TROP MED HYG, V33, P197, DOI 10.4269/ajtmh.1984.33.197; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; Wu HW, 2000, NAT STRUCT BIOL, V7, P575	49	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20180	20191		10.1074/jbc.M110.102806	http://dx.doi.org/10.1074/jbc.M110.102806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421304	Green Published, hybrid			2022-12-27	WOS:000279012000053
J	von Kampen, O; Lipinski, S; Till, A; Martin, SJ; Nietfeld, W; Lehrach, H; Schreiber, S; Rosenstiel, P				von Kampen, Oliver; Lipinski, Simone; Till, Andreas; Martin, Seamus J.; Nietfeld, Wilfried; Lehrach, Hans; Schreiber, Stefan; Rosenstiel, Philip			Caspase Recruitment Domain-containing Protein 8 (CARD8) Negatively Regulates NOD2-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; KAPPA-B ACTIVATION; INFLAMMATORY CASPASES; CROHNS-DISEASE; IMMUNE-SYSTEM; FAMILY MEMBER; NOD2 GENE; MUTATION; ASSOCIATION; EXPRESSION	Caspase activating and recruitment domain 8 (CARD8) has been implicated as a co-regulator of several pro-inflammatory and apoptotic signaling pathways. In the present study, we demonstrate a specific modulation of NOD2-induced signaling by CARD8 in intestinal epithelial cells. We show that CARD8 physically interacts with NOD2 and inhibits nodosome assembly and subsequent signaling upon muramyl-dipeptide stimulation. Furthermore, CARD8 inhibits the direct bactericidal effect of NOD2 against intracellular infection by Listeria monocytogenes. Thus, CARD8 represents a novel molecular switch involved in the endogenous regulation of NOD2-dependent inflammatory processes in epithelial cells.	[von Kampen, Oliver; Lipinski, Simone; Till, Andreas; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Martin, Seamus J.] Univ Dublin Trinity Coll, Smurfit Inst, Mol Cell Biol Lab, Dept Genet, Dublin 2, Ireland; [Nietfeld, Wilfried; Lehrach, Hans] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Kiel; Trinity College Dublin; Max Planck Society	Rosenstiel, P (corresponding author), Univ Kiel, Inst Clin Mol Biol, Schittenhelmstr 12, D-24105 Kiel, Germany.	p.rosenstiel@mucosa.de	Rosenstiel, Philip/A-5137-2009; Lipinski, Simone/L-9818-2017; Till, Andreas/AAO-6375-2021; Till, Andreas/E-9661-2013	Rosenstiel, Philip/0000-0002-9692-8828; Lipinski, Simone/0000-0002-9322-7372; Martin, Seamus/0000-0002-8539-3143; Till, Andreas/0000-0002-0139-9143	DFG (Deutsche Forschungsgemeinschaft) [SCHR512/11-1]; Clusters of Excellence Inflammation at Interfaces and The Future Ocean; German Federal Ministry of Education and Research BMBF through the NGFN plus Network on Environment-related diseases	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Clusters of Excellence Inflammation at Interfaces and The Future Ocean; German Federal Ministry of Education and Research BMBF through the NGFN plus Network on Environment-related diseases(Federal Ministry of Education & Research (BMBF))	This work was supported by the DFG (Deutsche Forschungsgemeinschaft) SCHR512/11-1, the Clusters of Excellence Inflammation at Interfaces and The Future Ocean and by the German Federal Ministry of Education and Research BMBF through the NGFN plus Network on Environment-related diseases.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; Checinska A, 2006, ANTICANCER RES, V26, P3819; Dinarello CA, 2004, IMMUNITY, V20, P243, DOI 10.1016/S1074-7613(04)00055-X; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Gattin Z, 2008, CHEMBIOCHEM, V9, P923, DOI 10.1002/cbic.200700434; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Lala S, 2003, GASTROENTEROLOGY, V125, P47, DOI 10.1016/S0016-5085(03)00661-9; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; ROSENSTIEL P, 2006, P NATL ACAD SCI USA; Rosenstiel P, 2007, MICROBES INFECT, V9, P648, DOI 10.1016/j.micinf.2007.01.015; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Till A, 2008, J CELL SCI, V121, P487, DOI 10.1242/jcs.016980; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Verma UN, 2004, J BIOL CHEM, V279, P3509, DOI 10.1074/jbc.M309300200	36	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19921	19926		10.1074/jbc.M110.127480	http://dx.doi.org/10.1074/jbc.M110.127480			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20385562	Green Published			2022-12-27	WOS:000279012000025
J	Erlich, P; Dumestre-Perard, C; Ling, WL; Lemaire-Vieille, C; Schoehn, G; Arlaud, GJ; Thielens, NM; Gagnon, J; Cesbron, JY				Erlich, Paul; Dumestre-Perard, Chantal; Ling, Wai Li; Lemaire-Vieille, Catherine; Schoehn, Guy; Arlaud, Gerard J.; Thielens, Nicole M.; Gagnon, Jean; Cesbron, Jean-Yves			Complement Protein C1q Forms a Complex with Cytotoxic Prion Protein Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRILS; SOLUBLE OLIGOMERS; TERMINAL DOMAIN; BETA; ACTIVATION; COMPONENT; BINDING; CONVERSION; PATHWAY; CASCADE	A growing number of studies have investigated the interaction between C1q and PrP, but the oligomeric form of PrP involved in this interaction remains to be determined. Aggregation of recombinant full-length murine PrP in the presence of 100 mM NaCl allowed us to isolate three different types of oligomers by size-exclusion chromatography. In contrast to PrP monomers and fibrils, these oligomers activate the classical complement pathway, the smallest species containing 8-15 PrP protomers being the most efficient. We used Thioflavine T fluorescence to monitor PrP aggregation and showed that, when added to the reaction, C1q has a cooperative effect on PrP aggregation and leads to the formation of C1q-PrP complexes. In these complexes, C1q interacts through its globular domains preferentially with the smallest oligomers, as shown by electron microscopy, and retains the ability to activate the classical complement pathway. Using two cell lines, we also provide evidence that C1q inhibits the cytotoxicity induced by the smallest PrP oligomers. The cooperative interaction between C1q and PrP could represent an early step in the disease, where it prevents elimination of the prion seed, leading to further aggregation.	[Cesbron, Jean-Yves] Univ Grenoble 1, Lab Adaptat & Pathogenie Microorganisme, UMR 5163, F-38042 Grenoble 9, France; [Erlich, Paul; Dumestre-Perard, Chantal; Lemaire-Vieille, Catherine; Gagnon, Jean; Cesbron, Jean-Yves] CNRS, UMR 5163, F-38042 Grenoble 9, France; [Dumestre-Perard, Chantal; Cesbron, Jean-Yves] CHU Grenoble, Dept Biol, Immunol Lab, F-38043 Grenoble 9, France; [Ling, Wai Li; Schoehn, Guy; Arlaud, Gerard J.; Thielens, Nicole M.] Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 9, France; [Ling, Wai Li; Schoehn, Guy; Arlaud, Gerard J.; Thielens, Nicole M.] CNRS, UMR 5075, F-38042 Grenoble 9, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Cesbron, JY (corresponding author), Univ Grenoble 1, Lab Adaptat & Pathogenie Microorganisme, UMR 5163, F-38042 Grenoble 9, France.	jean-yves.cesbron@ujf-grenoble.fr	Gagnon, Jean/C-3136-2008; Ling, Wai Li W/F-9823-2012; Lemaire-Vieille, Catherine/C-1495-2009; Thielens, Nicole M/F-2512-2013	Gagnon, Jean/0000-0002-0177-824X; Ling, Wai Li W/0000-0002-4264-5750; Thielens, Nicole M/0000-0002-7354-0302; Schoehn, Guy/0000-0002-1459-3201				ARLAUD GJ, 1979, MOL IMMUNOL, V16, P445, DOI 10.1016/0161-5890(79)90069-5; Bailly Y, 2004, J COMP NEUROL, V473, P244, DOI 10.1002/cne.20117; Baskakov IV, 2009, FEBS LETT, V583, P2618, DOI 10.1016/j.febslet.2009.05.044; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; Biro A, 2007, MOL IMMUNOL, V44, P1169, DOI 10.1016/j.molimm.2006.06.013; Blanquet-Grossard F, 2005, BIOCHEMISTRY-US, V44, P4349, DOI 10.1021/bi047370a; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Carrell RW, 2008, FEBS LETT, V582, P2537, DOI 10.1016/j.febslet.2008.06.021; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Dumestre-Perard C, 2007, CELL MICROBIOL, V9, P2870, DOI 10.1111/j.1462-5822.2007.01002.x; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Erlich P, 2008, BIOCHEM BIOPH RES CO, V365, P478, DOI 10.1016/j.bbrc.2007.10.202; Flores-Langarica A, 2009, J IMMUNOL, V182, P1305, DOI 10.4049/jimmunol.182.3.1305; Fourgeaud L, 2007, CELL, V131, P1034, DOI 10.1016/j.cell.2007.11.031; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; Graham JF, 2010, J BIOL CHEM, V285, P9868, DOI 10.1074/jbc.M109.093484; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Jain S, 2008, J MOL BIOL, V382, P1228, DOI 10.1016/j.jmb.2008.07.052; Kazlauskaite J, 2005, BIOCHEM BIOPH RES CO, V328, P292, DOI 10.1016/j.bbrc.2004.12.172; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Perry VH, 2008, NAT REV NEUROSCI, V9, P807, DOI 10.1038/nrn2394; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rezaei H, 2008, CURR ALZHEIMER RES, V5, P572, DOI 10.2174/156720508786898497; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sim RB, 2007, IMMUNOBIOLOGY, V212, P355, DOI 10.1016/j.imbio.2007.04.001; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Sjoberg AP, 2008, MOL IMMUNOL, V45, P3213, DOI 10.1016/j.molimm.2008.02.023; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; Valazquez P, 1997, NAT MED, V3, P77, DOI 10.1038/nm0197-77; Vendrely C, 2005, BBA-GEN SUBJECTS, V1724, P355, DOI 10.1016/j.bbagen.2005.05.017	44	22	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19267	19276		10.1074/jbc.M109.071860	http://dx.doi.org/10.1074/jbc.M109.071860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410306	Green Published, hybrid			2022-12-27	WOS:000278727800036
J	Zhang, LP; Tran, DT; Ten Hagen, KG				Zhang, Liping; Tran, Duy T.; Ten Hagen, Kelly G.			An O-Glycosyltransferase Promotes Cell Adhesion during Development by Influencing Secretion of an Extracellular Matrix Integrin Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; HYPEROSTOSIS-HYPERPHOSPHATEMIA SYNDROME; DROSOPHILA-MELANOGASTER; UDP-GALNAC; MEDIATED ADHESION; GENETIC-ANALYSIS; PS INTEGRINS; GLYCOSYLATION; PROTEIN; EXPRESSION	Protein secretion and localization are crucial during eukaryotic development, establishing local cell environments as well as mediating cell interactions, signaling, and adhesion. In this study, we demonstrate that the glycosyltransferase, pgant3, specifically modulates integrin-mediated cell adhesion by influencing the secretion and localization of the integrin ligand, Tiggrin. We demonstrate that Tiggrin is normally O-glycosylated and localized to the basal matrix where the dorsal and ventral cell layers adhere in wild type Drosophila wings. In pgant3 mutants, Tiggrin is no longer O-glycosylated and fails to be properly secreted to this basal cell layer interface, resulting in disruption of integrin-mediated cell adhesion in the wing. pgant3-mediated effects are dependent on enzymatic activity, as mutations that form a stable protein yet abrogate O-glycosyltransferase activity result in Tiggrin accumulation within the dorsal and ventral cells comprising the wing. Our results provide the first in vivo evidence for the role of O-glycosylation in the secretion of specific extracellular matrix proteins, thus altering the composition of the cellular "microenvironment" and thereby modulating developmentally regulated cell adhesion events. As alterations in cell adhesion are a hallmark of cancer progression, this work provides insight into the long-standing association between aberrant O-glycosylation and tumorigenesis.	[Zhang, Liping; Tran, Duy T.; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	kelly.tenhagen@nih.gov			National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIDCR.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Araujo H, 2003, DEVELOPMENT, V130, P3851, DOI 10.1242/dev.00613; Avichezer D, 1997, INT J CANCER, V72, P119, DOI 10.1002/(SICI)1097-0215(19970703)72:1<119::AID-IJC17>3.3.CO;2-5; Bloor JW, 1998, GENETICS, V148, P1127; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; BROWER DL, 1995, DEVELOPMENT, V121, P1311; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Bunch TA, 1998, DEVELOPMENT, V125, P1679; Chanana B, 2007, MECH DEVELOP, V124, P463, DOI 10.1016/j.mod.2007.03.005; Delannoy P, 1996, GLYCOCONJUGATE J, V13, P717, DOI 10.1007/BF00702335; Devenport D, 2007, DEV BIOL, V308, P294, DOI 10.1016/j.ydbio.2007.02.046; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; FOGERTY FJ, 1994, DEVELOPMENT, V120, P1747; Frishberg Y, 2007, J BONE MINER RES, V22, P235, DOI 10.1359/JBMR.061105; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Funes M, 2006, J BIOL CHEM, V281, P19310, DOI 10.1074/jbc.M603225200; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gouyer V, 2001, J CELL SCI, V114, P1455; Graner MW, 1998, J BIOL CHEM, V273, P18235, DOI 10.1074/jbc.273.29.18235; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Ichikawa S, 2007, J CLIN ENDOCR METAB, V92, P1943, DOI 10.1210/jc.2006-1825; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Narasimha M, 2004, CURR BIOL, V14, P381, DOI 10.1016/j.cub.2004.02.033; O'Keefe DD, 2007, DEV BIOL, V311, P25, DOI 10.1016/j.ydbio.2007.08.003; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Prout M, 1997, GENETICS, V146, P275; Schock F, 2003, GENE DEV, V17, P597, DOI 10.1101/gad.1068403; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Subramanian A, 2007, DEVELOPMENT, V134, P1269, DOI 10.1242/dev.000406; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Walsh EP, 1998, GENETICS, V150, P791; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	60	39	42	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19491	19501		10.1074/jbc.M109.098145	http://dx.doi.org/10.1074/jbc.M109.098145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20371600	Green Published, hybrid			2022-12-27	WOS:000278727800059
J	Okamura-Ikeda, K; Hosaka, H; Maita, N; Fujiwara, K; Yoshizawa, AC; Nakagawa, A; Taniguchi, H				Okamura-Ikeda, Kazuko; Hosaka, Harumi; Maita, Nobuo; Fujiwara, Kazuko; Yoshizawa, Akiyasu C.; Nakagawa, Atsushi; Taniguchi, Hisaaki			Crystal Structure of Aminomethyltransferase in Complex with Dihydrolipoyl-H-Protein of the Glycine Cleavage System IMPLICATIONS FOR RECOGNITION OF LIPOYL PROTEIN SUBSTRATE, DISEASE-RELATED MUTATIONS, AND REACTION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI T-PROTEIN; UNDERSTANDING NONKETOTIC HYPERGLYCINEMIA; LIPOAMIDE DEHYDROGENASE; TERMINAL REGION; RESOLUTION; BINDING; IDENTIFICATION; INTERMEDIATE; COMPONENT	Aminomethyltransferase, a component of the glycine cleavage system termed T-protein, reversibly catalyzes the degradation of the aminomethyl moiety of glycine attached to the lipoate cofactor of H-protein, resulting in the production of ammonia, 5,10-methylenetetrahydrofolate, and dihydrolipoate-bearing H-protein in the presence of tetrahydrofolate. Several mutations in the human T-protein gene are known to cause nonketotic hyperglycinemia. Here, we report the crystal structure of Escherichia coli T-protein in complex with dihydrolipoate-bearing H-protein and 5-methyltetrahydrofolate, a complex mimicking the ternary complex in the reverse reaction. The structure of the complex shows a highly interacting intermolecular interface limited to a small area and the protein-bound dihydrolipoyllysine arm inserted into the active site cavity of the T-protein. Invariant Arg(292) of the T-protein is essential for complex assembly. The structure also provides novel insights in understanding the disease-causing mutations, in addition to the disease-related impairment in the cofactor-enzyme interactions reported previously. Furthermore, structural and mutational analyses suggest that the reversible transfer of the methylene group between the lipoate and tetrahydrofolate should proceed through the electron relay-assisted iminium intermediate formation.	[Okamura-Ikeda, Kazuko; Maita, Nobuo; Fujiwara, Kazuko; Yoshizawa, Akiyasu C.; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan; [Hosaka, Harumi; Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Tokushima University; Osaka University	Okamura-Ikeda, K (corresponding author), Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan.	ikeda@ier.tokushima-u.ac.jp	Maita, Nobuo/J-1443-2012; Nakagawa, Atsushi/D-4329-2009; Taniguchi, Hisaaki/I-9171-2012; Nakagawa, Atsushi/M-5731-2019	Maita, Nobuo/0000-0003-2260-5783; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (to H. T.) and by the National Project on Protein Structural and Functional Analyses from Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; COHENADDAD C, 1995, NAT STRUCT BIOL, V2, P63, DOI 10.1038/nsb0195-63; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUJIWARA K, 1984, J BIOL CHEM, V259, P664; Guilhaudis L, 2000, BIOCHEMISTRY-US, V39, P4259, DOI 10.1021/bi992674w; KALLEN RG, 1966, J BIOL CHEM, V241, P5851; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee HH, 2004, J BIOL CHEM, V279, P50514, DOI 10.1074/jbc.M409672200; Lokanath NK, 2005, PROTEINS, V58, P769, DOI 10.1002/prot.20345; MATTEVI A, 1991, J MOL BIOL, V220, P975, DOI 10.1016/0022-2836(91)90367-F; MOTOKAWA Y, 1995, BIOTHIOLS HLTH DIS, P389; Nakai T, 2005, EMBO J, V24, P1523, DOI 10.1038/sj.emboj.7600632; NANAO K, 1994, HUM GENET, V93, P655; Okamura-Ikeda K, 1999, EUR J BIOCHEM, V264, P446, DOI 10.1046/j.1432-1327.1999.00637.x; Okamura-Ikeda K, 2005, J MOL BIOL, V351, P1146, DOI 10.1016/j.jmb.2005.06.056; Okamura-Ikeda K, 2003, J BIOL CHEM, V278, P10067, DOI 10.1074/jbc.M210853200; Okamura-Ikeda K, 1999, J BIOL CHEM, V274, P17471, DOI 10.1074/jbc.274.25.17471; OKAMURAIKEDA K, 1987, J BIOL CHEM, V262, P6746; OKAMURAIKEDA K, 1982, J BIOL CHEM, V257, P135; OKAMURAIKEDA K, 1993, EUR J BIOCHEM, V216, P539, DOI 10.1111/j.1432-1033.1993.tb18172.x; Rizzi M, 1998, STRUCTURE, V6, P1129, DOI 10.1016/S0969-2126(98)00114-2; TADA K, 1987, EUR J PEDIATR, V146, P221, DOI 10.1007/BF00716464; Toyoda T, 1998, J BIOCHEM-TOKYO, V123, P668; Watanabe K, 2007, NATURE, V449, P867, DOI 10.1038/nature06167	26	23	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18684	18692		10.1074/jbc.M110.110718	http://dx.doi.org/10.1074/jbc.M110.110718			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20375021	hybrid, Green Published			2022-12-27	WOS:000278453900061
J	Lee, HH; Vo, MT; Kim, HJ; Lee, UH; Kim, CW; Kim, HK; Ko, MS; Lee, WH; Cha, SJ; Min, YJ; Choi, DH; Suh, HS; Lee, BJ; Park, JW; Cho, WJ				Lee, Hyun Hee; Vo, Mai-Tram; Kim, Hyo Jeong; Lee, Unn Hwa; Kim, Chae Won; Kim, Hong Kyeung; Ko, Myoung Seok; Lee, Won Hyuck; Cha, Seung Joo; Min, Young Joo; Choi, Dae Hwa; Suh, Ho Seok; Lee, Byung Ju; Park, Jeong Woo; Cho, Wha Ja			Stability of the LATS2 Tumor Suppressor Gene Is Regulated by Tristetraprolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA TURNOVER; AU-RICH ELEMENTS; DOWN-REGULATION; HUMAN HOMOLOG; PROMOTER HYPERMETHYLATION; DROSOPHILA LATS; PROTEIN; EXPRESSION; PROLIFERATION	LATS2 is a tumor suppressor gene implicated in the control of cell growth and the cell cycle. Here, we investigated the post-transcriptional regulation of LATS2 expression by tristetraprolin (TTP). Our results show that the expression level of LATS2 is inversely correlated with TTP expression in human cancer cell lines. Overexpression of TTP reduced the expression level of LATS2. Conversely, treatment with small interfering RNA against TTP increased the expression level of LATS2 through stabilization of LATS2 mRNA and suppressed the proliferation of A549 human lung cancer cells. LATS2 mRNA contains AU-rich elements (AREs) within the 3'-untranslated region, and TTP destabilized a luciferase mRNA containing LATS2 ARE. In addition, RNA electrophoretic mobility shift assay revealed that TTP directly bound to the ARE of LATS2 mRNA. These results establish LATS2 mRNA as a physiological target of TTP and suggest the possibility that TTP controls cell growth through regulation of LATS2 mRNA stability.	[Ko, Myoung Seok; Lee, Won Hyuck] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Cha, Seung Joo; Min, Young Joo; Cho, Wha Ja] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, Ulsan 682060, South Korea; [Min, Young Joo] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan 682060, South Korea; [Choi, Dae Hwa] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Surg, Ulsan 682060, South Korea; [Suh, Ho Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Dermatol, Ulsan 682060, South Korea	University of Ulsan; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital		jwpark@ulsan.ac.kr; wjcho26@ulsan.ac.kr			Ministry of Health and Welfare (Republic of Korea) [0720220]; Korea Research Foundation [KRF-2005-C00009]; National Research Foundation of Korea, Ministry of Education, Science, and Technology [2009-0070260, 2009-0094051]; Ministry of Education and Human Resources Development [BRL-2009-0087350]; Ulsan University Hospital [UUH-2006-8]	Ministry of Health and Welfare (Republic of Korea)(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); National Research Foundation of Korea, Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Ministry of Education and Human Resources Development(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ulsan University Hospital	This work was supported in part by National R&D Program for Cancer Control Grant 0720220 from the Ministry of Health and Welfare (Republic of Korea), Korea Research Foundation Grant KRF-2005-C00009, National Research Foundation of Korea Priority Research Center Program Grants 2009-0070260 and 2009-0094051 from the Ministry of Education, Science, and Technology, Korea Research Foundation Grant BRL-2009-0087350 from the Korean Government (Ministry of Education and Human Resources Development), and Biomedical Research Center Promotion Fund Grant UUH-2006-8 from Ulsan University Hospital.	Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cho WJ, 2009, MOL CELLS, V28, P521, DOI 10.1007/s10059-009-0158-0; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; Jiang Z, 2006, NEUROSCI RES, V56, P450, DOI 10.1016/j.neures.2006.09.006; Jimenez-Velasco A, 2005, LEUKEMIA, V19, P2347, DOI 10.1038/sj.leu.2403974; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Ke HN, 2004, EXP CELL RES, V298, P329, DOI 10.1016/j.yexcr.2004.04.031; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Roman-Gomez J, 2004, BLOOD, V104, P2492, DOI 10.1182/blood-2004-03-0954; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shim SY, 2002, CYTOTECHNOLOGY, V40, P75, DOI 10.1023/A:1023918206060; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Snee M, 2002, J CELL SCI, V115, P4661, DOI 10.1242/jcs.00137; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Takahashi Y, 2007, J CANCER RES CLIN, V133, P501, DOI 10.1007/s00432-007-0194-0; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Xia H, 2002, ONCOGENE, V21, P1233, DOI 10.1038/sj.onc.1205174; XU TA, 1995, DEVELOPMENT, V121, P1053; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Young LE, 2009, GASTROENTEROLOGY, V136, P1669, DOI 10.1053/j.gastro.2009.01.010	46	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17329	17337		10.1074/jbc.M109.094235	http://dx.doi.org/10.1074/jbc.M109.094235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20335167	Green Published, hybrid			2022-12-27	WOS:000278133400010
J	Li, H; Liu, JW				Li, Hai; Liu, Jingwen			Identification of Heterogeneous Nuclear Ribonucleoprotein K as a Transactivator for Human Low Density Lipoprotein Receptor Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT REGULATORY ELEMENT; SINGLE-STRANDED-DNA; HNRNP-K; MESSENGER-RNA; POLY(C)-BINDING PROTEINS; LDL RECEPTOR; PROMOTER; BINDING; CHOLESTEROL; COMPLEX	hnRNP K, a member of the family of heterogeneous ribonucleoproteins, is known to exert various functional roles in the nucleus, cytoplasm, and mitochondria to affect different cellular processes including chromatin remodeling, transcription, splicing, and translation. Here we report, for the first time, that hnRNP K is specifically involved in human LDL receptor (LDLR) gene transcription in HepG2 cells. We show that depletion of hnRNP K by siRNA transfection reduces the expression of LDLR mRNA and protein by more than 50% as measured by quantitative real-time PCR and Western blot analysis. Importantly, we show that the decay rate of LDLR mRNA is not affected by hnRNP K siRNA transfection, whereas the LDLR promoter activity is significantly decreased. Furthermore, overexpression of hnRNP K increased the LDLR promoter activity by the luciferase reporter assay. By utilizing a series of mutational and deletional constructs of LDLR promoter luciferase reporters, we mapped the K-responsive element to the repeat 3 (R3) sequence of the LDLR promoter. Electrophoretic mobility shift assays show that the K protein binds to a single-stranded DNA probe containing the CT-rich element of R3, which is in contrast to the requirement of double-stranded DNA for Sp1 to bind to R3. Finally, chromatin immunoprecipitation assays reveal a direct interaction of hnRNP K with the LDLR promoter in intact HepG2 cells. These new findings provide strong evidence demonstrating that hnRNP K is an important transactivator for human LDLR gene transcription. This work sheds new light on our current understanding of how LDLR gene expression is controlled at the transcriptional level.	[Li, Hai; Liu, Jingwen] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Liu, JW (corresponding author), VA Palo Alto Hlth Care Syst 154P, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	jingwen.liu@va.gov			National Institutes of Health, NCCAM [1R01 AT002543-01A1, 1R21AT003195-01A2]; Dept. of Veterans Affairs (Office of Research and Development, Medical Research Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002543, R21AT003195] Funding Source: NIH RePORTER	National Institutes of Health, NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Dept. of Veterans Affairs (Office of Research and Development, Medical Research Service)(US Department of Veterans Affairs); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health (Grants 1R01 AT002543-01A1 and 1R21AT003195-01A2, to J. L.) from NCCAM. This study was also supported by the Dept. of Veterans Affairs (Office of Research and Development, Medical Research Service, to J. L.).	Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352; Choi HS, 2009, BIOCHEM BIOPH RES CO, V380, P431, DOI 10.1016/j.bbrc.2009.01.136; Da Silva N, 2002, BLOOD, V100, P3536, DOI 10.1182/blood.V100.10.3536; Davidson MH, 2009, CURR ATHEROSCLER REP, V11, P67, DOI 10.1007/s11883-009-0011-0; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Expert-Bezancon A, 2002, J BIOL CHEM, V277, P16614, DOI 10.1074/jbc.M201083200; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; Klimek-Tomczak K, 2004, J MOL BIOL, V342, P1131, DOI 10.1016/j.jmb.2004.07.099; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; Li Hai, 2009, Recent Pat DNA Gene Seq, V3, P201; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Li H, 2009, J LIPID RES, V50, P820, DOI 10.1194/jlr.M800375-JLR200; Liu JW, 2000, J BIOL CHEM, V275, P5214, DOI 10.1074/jbc.275.7.5214; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Miau LH, 1998, J BIOL CHEM, V273, P10784, DOI 10.1074/jbc.273.17.10784; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostrowski J, 2002, J BIOL CHEM, V277, P6303, DOI 10.1074/jbc.M110267200; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; SMITH JR, 1990, J BIOL CHEM, V265, P2306; Stains JP, 2005, BIOCHEM J, V385, P613, DOI 10.1042/BJ20040680; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Zhang F, 2002, J LIPID RES, V43, P1477, DOI 10.1194/jlr.M200126-JLR200	42	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17789	17797		10.1074/jbc.M109.082057	http://dx.doi.org/10.1074/jbc.M109.082057			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371611	Green Published, hybrid			2022-12-27	WOS:000278133400057
J	Martinez, K; Kennedy, A; West, T; Milatovic, D; Aschner, M; McIntosh, M				Martinez, Kristina; Kennedy, Arion; West, Tiffany; Milatovic, Dejan; Aschner, Michael; McIntosh, Michael			trans-10,cis-12-Conjugated Linoleic Acid Instigates Inflammation in Human Adipocytes Compared with Preadipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE ADIPOSE-TISSUE; TYPE-2 DIABETES-MELLITUS; LEAN BODY-MASS; INSULIN-RESISTANCE; POSTMENOPAUSAL WOMEN; 3T3-L1 PREADIPOCYTES; ENERGY-EXPENDITURE; PRIMARY CULTURES; GENE-EXPRESSION; OBESE HUMANS	We showed previously in cultures of primary human adipocytes and preadipocytes that lipopolysaccharide and trans-10, cis-12-conjugated linoleic acid (10,12-CLA) activate the inflammatory signaling that promotes insulin resistance. Because our published data demonstrated that preadipocytes are the primary instigators of inflammatory signaling in lipopolysaccharide-treated cultures, we hypothesized that they played the same role in 10,12-CLA-mediated inflammation. To test this hypothesis, we employed four distinct models. In model 1, a differentiation model, CLA activation of MAPK and induction of interleukin-8 (IL-8), IL-6, IL-1 beta, and cyclo-oxygenase-2 COX-2) were greatest in differentiated compared with undifferentiated cultures. In model 2, a cell separation model, the mRNA levels of these inflammatory proteins were increased by 10,12-CLA compared with bovine serum albumin vehicle in the adipocyte fraction and the preadipocyte fraction. In model 3, a co-culture insert model, inserts containing similar to 50% adipocytes AD50) or similar to 100% preadipocytes (AD0) were suspended over wells containing AD50 or AD0 cultures. 10,12-CLA-induced IL-8, IL-6, IL-1 beta, and COX-2 mRNA levels were highest in AD50 cultures when co-cultured with AD0 inserts. In model 4, a conditioned medium (CM) model, CM collected from CLA-treated AD50 but not AD0 cultures induced IL-8 and IL-6 mRNA levels and activated phosphorylation of MAPK in naive AD0 and AD50 cultures. Consistent with these data, 10,12-CLA-mediated secretions of IL-8 and IL-6 from AD50 cultures were higher than from AD0 cultures. Notably, blocking adipocytokine secretion prevented the inflammatory capacity of CM from 10,12-CLA-treated cultures. These data suggest that CLA instigates the release of inflammatory signals from adipocytes that subsequently activate adjacent preadipocytes.	[Martinez, Kristina; West, Tiffany; McIntosh, Michael] Univ N Carolina, Dept Nutr, Greensboro, NC 27402 USA; [Kennedy, Arion] Vanderbilt Univ, Med Ctr, Dept Mol Physiol, Nashville, TN 37232 USA; [Milatovic, Dejan; Aschner, Michael] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	University of North Carolina; University of North Carolina Greensboro; Vanderbilt University; Vanderbilt University	McIntosh, M (corresponding author), Univ N Carolina, Dept Nutr, 318 Stone Bldg,POB 26170, Greensboro, NC 27402 USA.	mkmcinto@uncg.edu		Kennedy, Arion/0000-0002-8443-3131; Martinez, Kristina/0000-0002-9676-0009	National Institutes of Health [5R01 DK063070-07, F31DK084812-01]; North Carolina Agricultural Research Service [NCARS 06771]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063070, F31DK084812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Agricultural Research Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01 DK063070-07 (to M. M.) and F31DK084812-01 (to K. M.). This work was also supported by North Carolina Agricultural Research Service Grant NCARS 06771 (to M. M.).	AWAS JA, 1996, TRANSPLANTATION, V61, P1624; Azain MJ, 2000, J NUTR, V130, P1548; Banu J, 2008, J BONE MINER METAB, V26, P436, DOI 10.1007/s00774-008-0863-3; Bhattacharya A, 2005, J NUTR, V135, P1124, DOI 10.1093/jn/135.5.1124; Brodie AE, 1999, J NUTR, V129, P602; Brown JM, 2004, J BIOL CHEM, V279, P26735, DOI 10.1074/jbc.M401766200; Brown JM, 2003, J LIPID RES, V44, P1287, DOI 10.1194/jlr.M300001-JLR200; Brown JM, 2001, J NUTR, V131, P2316, DOI 10.1093/jn/131.9.2316; Chung SK, 2005, J BIOL CHEM, V280, P38445, DOI 10.1074/jbc.M508159200; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Chung SY, 2005, J LIPID RES, V46, P885, DOI 10.1194/jlr.M400476-JLR200; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Close RN, 2007, AM J CLIN NUTR, V86, P797, DOI 10.1093/ajcn/86.3.797; Evans M, 2000, LIPIDS, V35, P899, DOI 10.1007/S11745-000-0599-6; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Gaullier JM, 2007, BRIT J NUTR, V97, P550, DOI 10.1017/S0007114507381324; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gil A, 2007, BRIT J NUTR, V98, pS121, DOI 10.1017/S0007114507838050; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; House RL, 2005, PHYSIOL GENOMICS, V21, P351, DOI 10.1152/physiolgenomics.00244.2004; Houseknecht KL, 1998, BIOCHEM BIOPH RES CO, V244, P678, DOI 10.1006/bbrc.1998.8303; Kang KW, 2004, BIOCHEM BIOPH RES CO, V315, P532, DOI 10.1016/j.bbrc.2004.01.087; Kennedy A, 2008, J NUTR, V138, P455, DOI 10.1093/jn/138.3.455; Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003; Kennedy A, 2009, J LIPID RES, V50, P225, DOI 10.1194/jlr.M800258-JLR200; Khan Laura Kettel, 2009, Morbidity and Mortality Weekly Report, V58, P1; LaRosa PC, 2006, PHYSIOL GENOMICS, V27, P282, DOI 10.1152/physiolgenomics.00076.2006; Milatovic D, 2007, TOXICOL SCI, V98, P198, DOI 10.1093/toxsci/kfm095; Miner JL, 2001, OBES RES, V9, P129, DOI 10.1038/oby.2001.16; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Nagao K, 2003, NUTRITION, V19, P652, DOI 10.1016/S0899-9007(03)00060-1; Norris LE, 2009, AM J CLIN NUTR, V90, P468, DOI 10.3945/ajcn.2008.27371; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Raff M, 2009, J NUTR, V139, P1347, DOI 10.3945/jn.109.104471; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Riserus U, 2002, CIRCULATION, V106, P1925, DOI 10.1161/01.CIR.0000033589.15413.48; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; So MHH, 2009, J NUTR, V139, P145, DOI 10.3945/jn.108.093849; Steck SE, 2007, J NUTR, V137, P1188, DOI 10.1093/jn/137.5.1188; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Tchoukalova Y, 2007, DIABETOLOGIA, V50, P151, DOI 10.1007/s00125-006-0496-9; Terpstra AHM, 2002, J NUTR, V132, P940, DOI 10.1093/jn/132.5.940; Tholstrup T, 2008, J NUTR, V138, P1445, DOI 10.1093/jn/138.8.1445; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Wendel AA, 2008, J LIPID RES, V49, P98, DOI 10.1194/jlr.M700195-JLR200; West DB, 2000, J NUTR, V130, P2471, DOI 10.1093/jn/130.10.2471	50	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17701	17712		10.1074/jbc.M109.043976	http://dx.doi.org/10.1074/jbc.M109.043976			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353947	Green Published, hybrid			2022-12-27	WOS:000278133400048
J	Tokunaga, A; Tsukimoto, M; Harada, H; Moriyama, Y; Kojima, S				Tokunaga, Akihiro; Tsukimoto, Mitsutoshi; Harada, Hitoshi; Moriyama, Yoshinori; Kojima, Shuji			Involvement of SLC17A9-dependent Vesicular Exocytosis in the Mechanism of ATP Release during T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE TRANSPORTER; P2X(7) RECEPTORS; ASTROCYTES; PATHWAY; DIFFERENTIATION; IDENTIFICATION; HEMICHANNELS; LYMPHOCYTES; CHANNEL; P2Y(6)	Recent reports have shown that T cell receptor (TCR)-dependent ATP release from T cells is involved in production of interleukin-2 (IL-2) through activation of P2 receptors. Stimulation of TCR induces ATP release from T cells through gap junction hemichannels and maxianion channels, at least in part. However, the mechanisms of ATP release from activated T cells are not fully understood. Here, we studied the mechanisms of ATP release during TCR-dependent T cell activation by investigating the effects of various inhibitors on TCR-dependent ATP release from murine T cells. We found that not only anion channel and gap junction hemichannel inhibitors, but also exocytosis inhibitors suppressed the ATP release. These results suggest that ATP release from murine T cells is regulated by various mechanisms, including exocytosis. An inhibitor of exocytosis, bafilomycin A, significantly blocked TCR signaling, such as Ca2+ elevation and IL-2 production. Furthermore, bafilomycin A, ectonucleotidase, and P2Y(6) receptor antagonist significantly inhibited production of pro-inflammatory cytokines from external antigen-restimulated splenocytes, indicating that vesicular exocytosis-mediated purinergic signaling has a significant role in TCR-dependent cytokine production. We also detected vesicular ATP in murine T cells and human T lymphoma Jurkat cells, both of which also expressed mRNA of SLC17A9, a vesicular nucleotide transporter. Knockdown of SLC17A9 in Jurkat cells markedly reduced ATP release and cytosolic Ca2+ elevation after TCR stimulation, suggesting involvement of SLC17A9-dependent vesicular exocytosis in ATP release and T cell activation. In conclusion, vesicular exocytosis of ATP appears to play a role in T cell activation and immune responses.	Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Radiat Biosci, Noda, Chiba 278, Japan; [Harada, Hitoshi] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie 5138670, Japan; [Moriyama, Yoshinori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan	Tokyo University of Science; Okayama University	Tokunaga, A (corresponding author), 2641 Yamazaki, Noda, Chiba 2788510, Japan.	tsukim@rs.noda.tus.ac.jp						Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bal-Price A, 2002, GLIA, V40, P312, DOI 10.1002/glia.10124; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Burnstock G, 2009, BRAZ J MED BIOL RES, V42, P3, DOI 10.1590/S0100-879X2008005000037; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; D'Acquisto F, 2007, BLOOD, V109, P1095, DOI 10.1182/blood-2006-05-022798; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Hisadome K, 2002, J GEN PHYSIOL, V119, P511, DOI 10.1085/jgp.20028540; Iwatsuki K, 2009, BIOCHEM BIOPH RES CO, V388, P1, DOI 10.1016/j.bbrc.2009.07.069; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Oh-hora M, 2009, IMMUNOL REV, V231, P210, DOI 10.1111/j.1600-065X.2009.00819.x; Ohshima Y, 2010, BBA-GEN SUBJECTS, V1800, P40, DOI 10.1016/j.bbagen.2009.10.008; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pitcher LA, 2003, TRENDS IMMUNOL, V24, P554, DOI 10.1016/j.it.2003.08.003; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Tsukimoto M, 2005, J BIOL CHEM, V280, P2653, DOI 10.1074/jbc.M411072200; Tsukimoto M., 2007, DRUG DISCOV TODAY TH, V1, P33; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Tsukimoto M, 2009, BIOCHEM BIOPH RES CO, V384, P512, DOI 10.1016/j.bbrc.2009.05.011; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	35	71	73	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17406	17416		10.1074/jbc.M110.112417	http://dx.doi.org/10.1074/jbc.M110.112417			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20382737	hybrid, Green Published			2022-12-27	WOS:000278133400018
J	Papale, LA; Paul, KN; Sawyer, NT; Manns, JR; Tufik, S; Escayg, A				Papale, Ligia A.; Paul, Ketema N.; Sawyer, Nikki T.; Manns, Joseph R.; Tufik, Sergio; Escayg, Andrew			Dysfunction of the Scn8a Voltage-gated Sodium Channel Alters Sleep Architecture, Reduces Diurnal Corticosterone Levels, and Enhances Spatial Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE MYOCLONIC EPILEPSY; CENTRAL NUCLEUS; MOUSE MODEL; MUTATION; SCN1A; MICE; GENE; SEIZURES; NA(V)1.6; ATAXIA	Voltage-gated sodium channels (VGSCs) are responsible for the initiation and propagation of transient depolarizing currents and play a critical role in the electrical signaling between neurons. A null mutation in the VGSC gene SCN8A, which encodes the transmembrane protein Na(v)1.6, was identified previously in a human family. Heterozygous mutation carriers displayed a range of phenotypes, including ataxia, cognitive deficits, and emotional instability. A possible role for SCN8A was also proposed in studies examining the genetic basis of attempted suicide and bipolar disorder. In addition, mice with a Scn8a loss-of-function mutation (Scn8a(med-Tg/+)) show altered anxiety and depression-like phenotypes. Because psychiatric abnormalities are often associated with altered sleep and hormonal patterns, we evaluated heterozygous Scn8a(med-jo/+) mutants for alterations in sleep-wake architecture, diurnal corticosterone levels, and behavior. Compared with their wild-type littermates, Scn8a(med-jo/+) mutants experience more non-rapid eye movement (non-REM) sleep, a chronic impairment of REM sleep generation and quantity, and a lowered and flattened diurnal rhythm of corticosterone levels. No robust differences were observed between mutants and wild-type littermates in locomotor activity or in behavioral paradigms that evaluate anxiety or depression-like phenotypes; however, Scn8a(med-jo/+) mutants did show enhanced spatial memory. This study extends the spectrum of phenotypes associated with mutations in Scn8a and suggests a novel role for altered sodium channel function in human sleep disorders.	[Papale, Ligia A.; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psychobiol, BR-04024002 Sao Paulo, Brazil; [Papale, Ligia A.; Sawyer, Nikki T.; Escayg, Andrew] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Manns, Joseph R.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Paul, Ketema N.] Morehouse Sch Med, Dept Anat & Neurobiol, Atlanta, GA 30310 USA	Universidade Federal de Sao Paulo (UNIFESP); Emory University; Emory University; Morehouse School of Medicine	Escayg, A (corresponding author), Whitehead Bldg,Suite 301, Atlanta, GA 30322 USA.	aescayg@emory.edu	Tufik, Sergio/D-7606-2012	Sawyer, Nikki/0000-0002-8601-6497	National Institutes of Health [NS046484, NS065187, NS060659]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065187, U54NS060659, R01NS046484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS046484 and NS065187 (to A.E.) and NS060659 (to K.N.P.).	Andersen ML, 2005, J SLEEP RES, V14, P83, DOI 10.1111/j.1365-2869.2004.00428.x; Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Blumenfeld H, 2009, EPILEPSIA, V50, P44, DOI 10.1111/j.1528-1167.2008.01710.x; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Bourgeois JA, 2009, J CLIN PSYCHIAT, V70, P852, DOI 10.4088/JCP.08m04476; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Douglas CL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-42; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; FEHM HL, 1993, EXP CLIN ENDOCRINOL, V101, P267, DOI 10.1055/s-0029-1211243; Friess E, 2008, J PSYCHIATR RES, V42, P1154, DOI 10.1016/j.jpsychires.2008.01.005; Goder R, 2004, J PSYCHIATR RES, V38, P591, DOI 10.1016/j.jpsychires.2004.04.005; Herlenius E, 2007, EPILEPSIA, V48, P1138, DOI 10.1111/j.1528-1167.2007.01049.x; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Holland KD, 2008, NEUROSCI LETT, V433, P65, DOI 10.1016/j.neulet.2007.12.064; Kimura M, 2010, MOL PSYCHIATR, V15, P154, DOI 10.1038/mp.2009.46; Kohrman DC, 1996, J NEUROSCI, V16, P5993; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Martin MS, 2010, J BIOL CHEM, V285, P9823, DOI 10.1074/jbc.M109.078568; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; McKinney BC, 2008, GENES BRAIN BEHAV, V7, P629, DOI 10.1111/j.1601-183X.2008.00399.x; Meisler MH, 2001, NEUROSCIENTIST, V7, P136, DOI 10.1177/107385840100700208; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Papale LA, 2009, HUM MOL GENET, V18, P1633, DOI 10.1093/hmg/ddp081; Paul KN, 2004, EUR J NEUROSCI, V19, P2808, DOI 10.1111/j.0953-816X.2004.03387.x; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Rauchs G, 2004, SLEEP, V27, P395, DOI 10.1093/sleep/27.3.395; Sanford LD, 2006, BRAIN RES, V1084, P80, DOI 10.1016/j.brainres.2006.02.020; Smith MR, 1999, NEUROREPORT, V10, P3027, DOI 10.1097/00001756-199909290-00028; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Striano P, 2006, EPILEPSIA, V47, P218, DOI 10.1111/j.1528-1167.2006.00392.x; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Tang XD, 2005, SLEEP, V28, P923, DOI 10.1093/sleep/28.8.923; Touma C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004325; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Vyazovskiy VV, 2002, BRAIN RES, V947, P204, DOI 10.1016/S0006-8993(02)02925-6; Walker E, 2008, ANNU REV CLIN PSYCHO, V4, P189, DOI 10.1146/annurev.clinpsy.4.022007.141248; Wang Y, 2008, PROG NEURO-PSYCHOPH, V32, P1902, DOI 10.1016/j.pnpbp.2008.09.003; Wasserman D, 2005, AM J MED GENET B, V133B, P116, DOI 10.1002/ajmg.b.30128; Young AH, 2004, STRESS, V7, P205, DOI 10.1080/10253890500069189; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	48	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16553	16561		10.1074/jbc.M109.090084	http://dx.doi.org/10.1074/jbc.M109.090084			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353942	hybrid, Green Published			2022-12-27	WOS:000277982600018
J	Reyes, ED; Patidar, PL; Uranga, LA; Bortoletto, AS; Lusetti, SL				Reyes, Emigdio D.; Patidar, Praveen L.; Uranga, Lee A.; Bortoletto, Angelina S.; Lusetti, Shelley L.			RecN Is a Cohesin-like Protein That Stimulates Intermolecular DNA Interactions in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; BACTERIUM DEINOCOCCUS-RADIODURANS; BACILLUS-SUBTILIS RECN; ESCHERICHIA-COLI; SMC PROTEINS; REPLICATION FORKS; CHROMOSOME CONDENSATION; REPAIR; COMPLEX; DAMAGE	The bacterial RecN protein is involved in the recombinational repair of DNA double-stranded breaks, and recN mutants are sensitive to DNA-damaging agents. Little is known about the biochemical function of RecN. Protein sequence analysis suggests that RecN is related to the SMC(structural maintenance of chromosomes) family of proteins, predicting globular N- and C-terminal domains connected by an extensive coil-coiled domain. The N- and C-domains contain the nucleotide-binding sequences Walker A and Walker B, respectively. We have purified the RecN protein from Deinococcus radiodurans and characterized its DNA-dependent and DNA-independent ATPase activity. The RecN protein hydrolyzes ATP with a k(cat) of 24 min(-1), and this rate is stimulated 4-fold by duplex DNA but not by single-stranded DNA. This DNA-dependent ATP turnover rate exhibits a dependence on the concentration of RecN protein, suggesting that RecN-RecN interactions are required for efficient ATP hydrolysis, and those interactions are stabilized only by duplex DNA. Finally, we show that RecN stimulates the intermolecular ligation of linear DNA molecules in the presence of DNA ligase. This DNA bridging activity is strikingly similar to that of the cohesin complex, an SMC family member, to which RecN is related.	[Reyes, Emigdio D.; Patidar, Praveen L.; Uranga, Lee A.; Bortoletto, Angelina S.; Lusetti, Shelley L.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Lusetti, SL (corresponding author), POB 30001,MSC 3C, Las Cruces, NM 88003 USA.	slusetti@nmsu.edu		Bortoletto, Angelina/0000-0001-7033-4274	National Institutes of Health [SC2 GM083697, P20 RR016480, R25 GM06122, F31 GM090483, P20 RR016464]; Howard Hughes Medical Institute [52005881]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464, P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM083697, F31GM090483, R25GM061222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants SC2 GM083697 and P20 RR016480 (to S.L.L.), R25 GM06122 (to E.D.R. and L.A.U.), and F31 GM090483 (to E.D.R.). This work was also supported by Howard Hughes Medical Institute Undergraduate Science Education Grant 52005881 (to A.S.B.). Research support was also provided by the proteomics facility of the Nevada-INBRE Program, National Institutes of Health Grant P20 RR016464.	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Arumugam P, 2006, CURR BIOL, V16, P1998, DOI 10.1016/j.cub.2006.09.002; Blasius M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-69; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Cortes-Ledesma F, 2007, CELL CYCLE, V6, P914, DOI 10.4161/cc.6.8.4107; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; FINCH PW, 1985, J BACTERIOL, V164, P653, DOI 10.1128/JB.164.2.653-658.1985; Funayama T, 1999, MUTAT RES-DNA REPAIR, V435, P151, DOI 10.1016/S0921-8777(99)00044-0; GARGER SJ, 1983, BIOCHEM BIOPH RES CO, V117, P835, DOI 10.1016/0006-291X(83)91672-8; Grove JI, 2009, DNA REPAIR, V8, P1434, DOI 10.1016/j.dnarep.2009.09.015; Hiraga S, 2000, ANNU REV GENET, V34, P21, DOI 10.1146/annurev.genet.34.1.21; Hirano M, 2004, EMBO J, V23, P2664, DOI 10.1038/sj.emboj.7600264; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Jessberger R, 2002, NAT REV MOL CELL BIO, V3, P767, DOI 10.1038/nrm930; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; LLOYD RG, 1983, MOL GEN GENET, V190, P162, DOI 10.1007/BF00330340; Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; Mascarenhas J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-20; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; MERTENS N, 1995, BIO-TECHNOL, V13, P175, DOI 10.1038/nbt0295-175; Nagashima K, 2006, J BIOL CHEM, V281, P30941, DOI 10.1074/jbc.M606566200; PICKSLEY SM, 1984, MOL GEN GENET, V195, P267, DOI 10.1007/BF00332758; PUGH BF, 1989, J MOL BIOL, V205, P487, DOI 10.1016/0022-2836(89)90219-2; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; ROSTAS K, 1987, NUCLEIC ACIDS RES, V15, P5041, DOI 10.1093/nar/15.13.5041; Sanchez H, 2005, NUCLEIC ACIDS RES, V33, P2343, DOI 10.1093/nar/gki533; Sanchez H, 2006, J BACTERIOL, V188, P353, DOI 10.1128/JB.188.2.353-360.2006; SARGENTINI NJ, 1986, RADIAT RES, V107, P58, DOI 10.2307/3576850; SARGENTINI NJ, 1983, RADIAT RES, V93, P461, DOI 10.2307/3576026; SARGENTINI NJ, 1988, J BACTERIOL, V170, P2392, DOI 10.1128/jb.170.5.2392-2394.1988; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; Soppa J, 2002, MOL MICROBIOL, V45, P59, DOI 10.1046/j.1365-2958.2002.03012.x; Stohl EA, 2005, MOL MICROBIOL, V58, P520, DOI 10.1111/j.1365-2958.2005.04839.x; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; van der Linden E, 2009, NUCLEIC ACIDS RES, V37, P1580, DOI 10.1093/nar/gkn1072; Wang G, 2008, INFECT IMMUN, V76, P153, DOI 10.1128/IAI.00791-07; Watrin E, 2006, EXP CELL RES, V312, P2687, DOI 10.1016/j.yexcr.2006.06.024; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069	54	28	29	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16521	16529		10.1074/jbc.M110.119164	http://dx.doi.org/10.1074/jbc.M110.119164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360008	Green Published, hybrid			2022-12-27	WOS:000277982600014
J	Shimahara, A; Yamakawa, N; Nishikata, I; Morishita, K				Shimahara, Akiko; Yamakawa, Norio; Nishikata, Ichiro; Morishita, Kazuhiro			Acetylation of Lysine 564 Adjacent to the C-terminal Binding Protein-binding Motif in EVI1 Is Crucial for Transcriptional Activation of GATA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; ACUTE MYELOID-LEUKEMIA; KRUPPEL-LIKE FACTOR; CELL-LINE; REVERSIBLE ACETYLATION; DNA-BINDING; GENE; EXPRESSION; SEQUENCE; CTBP	Ecotropic viral integration site 1 (EVI1) is an important transcription factor for leukemogenesis. EVI1 is a member of a group of transcription factors with C-terminal binding protein (CtBP)-binding motifs that act as transcriptional co-repressors; however, we recently found that EVI1 directly activates GATA2 transcription, which is an important gene for the maintenance of hematopoietic stem cells. We show here that EVI1-activated GATA2 transcripts derive from exon 1S of GATA2, which is specifically activated in neural and hematopoietic cells. EVI1 was acetylated by the histone acetyltransferase p300/CBP association factor (P/CAF) in myeloid leukemia cells and hematopoietic progenitor cells. Acetylation at Lys(564), which is adjacent to the CtBP-binding consensus sequence of EVI1, was found to be important for transcriptional activation of GATA2. Mutation of Lys(564) to alanine (K564A) markedly reduced the ability of EVI1 to bind DNA and activate transcription of GATA2. Furthermore, we confirmed that Lys(564) in EVI1 was specifically acetylated in leukemia and primary hematopoietic cells by using an antibody directed against an acetylated Lys(564) EVI1 peptide. Moreover, co-transfection of P/CAF with EVI1 overcame the suppressive effect of the CtBP co-repressor and resulted in GATA2 transcriptional activation; nonetheless, CtBP2 was still included in the protein complex with EVI1 and P/CAF on the EVI1-binding site in the GATA2 promoter region. Thus, acetylation of EVI1 at Lys(564) by P/CAF enhances the DNA binding capacity of EVI1 and thereby contributes to the activation of GATA2.	[Shimahara, Akiko; Yamakawa, Norio; Nishikata, Ichiro; Morishita, Kazuhiro] Miyazaki Univ, Div Tumor & Cellular Biochem, Dept Med Sci, Fac Med, Miyazaki 8891692, Japan	University of Miyazaki	Shimahara, A (corresponding author), 5200 Kihara Kiyotale, Miyazaki 5200, Japan.	kmorishi@med.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research of priority areas from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	Asou H, 1996, JPN J CANCER RES, V87, P269, DOI 10.1111/j.1349-7006.1996.tb00216.x; Chakraborty S, 2001, J BIOL CHEM, V276, P44936, DOI 10.1074/jbc.M106733200; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Huang SM, 1999, ONCOGENE, V18, P4958, DOI 10.1038/sj.onc.1202889; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Hung HL, 2001, J BIOL CHEM, V276, P10715, DOI 10.1074/jbc.M007846200; Huo XF, 2005, J CELL MOL MED, V9, P103, DOI 10.1111/j.1582-4934.2005.tb00340.x; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Matsuo Y, 1991, Hum Cell, V4, P261; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; MITANI K, 1994, EMBO J, V13, P504, DOI 10.1002/j.1460-2075.1994.tb06288.x; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Molloy D, 2006, VIROLOGY, V355, P115, DOI 10.1016/j.virol.2006.05.004; MORISHITA K, 1990, ONCOGENE, V5, P963; MORISHITA K, 1995, ONCOGENE, V10, P1961; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; OVAL J, 1990, BLOOD, V76, P1369; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Tomita A, 2000, ONCOGENE, V19, P444, DOI 10.1038/sj.onc.1203329; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	38	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16967	16977		10.1074/jbc.M110.102046	http://dx.doi.org/10.1074/jbc.M110.102046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363750	Green Published, hybrid			2022-12-27	WOS:000277982600060
J	Li, CY; Chen, SZ; Yue, P; Deng, XM; Lonial, S; Khuri, FR; Sun, SY				Li, Chunyang; Chen, Shuzhen; Yue, Ping; Deng, Xingming; Lonial, Sagar; Khuri, Fadlo R.; Sun, Shi-Yong			Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent I kappa B alpha Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC RETINOID CD437; LUNG-CARCINOMA CELLS; CANCER-CELLS; ACTIVATION; APOPTOSIS; DEATH; CALPASTATIN; THERAPY; TARGET; PROTEOLYSIS	The proteasome, a key component of the ubiquitin-proteasome pathway, has emerged as an important cancer therapeutic target. PS-341 (also called Bortezomib or Velcade) is the first proteasome inhibitor approved for newly diagnosed and relapsed multiple myeloma and is currently being tested in many clinical trials against other types of cancers. One proposed mechanism by which PS-341 exerts its anticancer effect is inactivation of nuclear factor-kappa B (NF-kappa B) through prevention of I kappa B alpha degradation. In this study, we show that PS-341 at concentrations that effectively inhibited the growth of human cancer cells, instead of increasing I kappa B alpha stability, paradoxically induced I kappa B alpha degradation. As a result, PS-341 facilitated p65 nuclear translocation and increased NF-kappa B activity. Moreover, I kappa B alpha degradation by PS-341 occurred early before induction of apoptosis and could not be inhibited by a pan-caspase inhibitor or caspase-8 silencing; however, it could be prevented with calpain inhibitors, calcium-chelating agents, calpain knockdown, or calpastatin overexpression. In agreement, PS-341 increased calpain activity. These data together indicate that PS-341 induces a calpain-mediated I kappa B alpha degradation independent of caspases. In the presence of a calpain inhibitor, the apoptosis-inducing activity of PS-341 was dramatically enhanced. Collectively, these unexpected findings suggest not only a novel paradigm regarding the relationship between proteasome inhibition and NF-kappa B activity but also a strategy to enhance the anticancer efficacy of PS-341.	[Sun, Shi-Yong] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Sch Med, Atlanta, GA 30322 USA; [Deng, Xingming] Emory Univ, Dept Radiat Oncol, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University	Sun, SY (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, Sch Med, 1365-C Clifton Rd NE,Ste C3088, Atlanta, GA 30322 USA.	ssun@emory.edu	Chen, Shuzhen/GXG-9004-2022; Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Chen, Shu-zhen/0000-0003-4881-0558	National Institutes of Health [CA128613]; Department of Defense [W81XWH-04-1-0142]; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA128613 (to S.-Y.S. and F. R. K. for Project 2). This work was also supported by Department of Defense VITAL Grant W81XWH-04-1-0142 (to S.-Y.S. for Project 4).	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Calvaruso G, 2006, MOL CELL BIOCHEM, V287, P13, DOI 10.1007/s11010-005-9016-3; Delobel P, 2005, FEBS LETT, V579, P1, DOI 10.1016/j.febslet.2004.11.018; Dolcet X, 2006, J BIOL CHEM, V281, P22118, DOI 10.1074/jbc.M601350200; Grynspan F, 1997, J NEUROSCI RES, V48, P181; Han YQ, 1999, J BIOL CHEM, V274, P787, DOI 10.1074/jbc.274.2.787; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hu XT, 2003, CYTOKINE, V21, P286, DOI 10.1016/S1043-4666(03)00107-8; Jin FS, 2005, CANCER RES, V65, P6354, DOI 10.1158/0008-5472.CAN-04-4061; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawakami H, 2005, INT J CANCER, V115, P967, DOI 10.1002/ijc.20954; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lamkanfi M, 2006, J CELL BIOL, V173, P165, DOI 10.1083/jcb.200509092; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Nemeth ZH, 2004, MOL PHARMACOL, V65, P342, DOI 10.1124/mol.65.2.342; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; ROSSER BG, 1993, J BIOL CHEM, V268, P23593; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Scagliotti G, 2006, CRIT REV ONCOL HEMAT, V58, P177, DOI 10.1016/j.critrevonc.2005.12.001; Schaecher K, 2004, NEUROCHEM RES, V29, P1443, DOI 10.1023/B:NERE.0000026410.56000.dd; Schenkein David P, 2005, Clin Lung Cancer, V7 Suppl 2, pS49, DOI 10.3816/CLC.2005.s.008; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 1997, CANCER RES, V57, P4931; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Xu LJ, 2004, J BIOL CHEM, V279, P53683, DOI 10.1074/jbc.M409889200; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225; Zavrski I, 2005, ANTI-CANCER DRUG, V16, P475, DOI 10.1097/00001813-200506000-00002; Zou W, 2006, CLIN CANCER RES, V12, P273, DOI 10.1158/1078-0432.CCR-05-0503	36	82	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16096	16104		10.1074/jbc.M109.072694	http://dx.doi.org/10.1074/jbc.M109.072694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335171	Green Published, hybrid			2022-12-27	WOS:000277715900047
J	Carius, Y; Christian, H; Faust, A; Zander, U; Klink, BU; Kornberger, P; Kohring, GW; Giffhorn, F; Scheidig, AJ				Carius, Yvonne; Christian, Henning; Faust, Annette; Zander, Ulrich; Klink, Bjoern U.; Kornberger, Petra; Kohring, Gert-Wieland; Giffhorn, Friedrich; Scheidig, Axel J.			Structural Insight into Substrate Differentiation of the Sugar-metabolizing Enzyme Galactitol Dehydrogenase from Rhodobacter sphaeroides D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; BIOCATALYTIC KETONE REDUCTION; CRYSTAL-STRUCTURE; DIFFRACTION DATA; 1,5-ANHYDRO-D-FRUCTOSE REDUCTASE; BIOCHEMICAL-CHARACTERIZATION; SINORHIZOBIUM-MORELENSE; SORBITOL DEHYDROGENASE; ANGSTROM RESOLUTION; PYRANOSE 2-OXIDASE	Galactitol 2-dehydrogenase (GatDH) belongs to the protein superfamily of short-chain dehydrogenases. As an enzyme capable of the stereo- and regioselective modification of carbohydrates, it exhibits a high potential for application in biotechnology as a biocatalyst. We have determined the crystal structure of the binary form of GatDH in complex with its cofactor NAD(H) and of the ternary form in complex with NAD(H) and three different substrates. The active form of GatDH constitutes a homo-tetramer with two magnesium-ion binding sites each formed by two opposing C termini. The catalytic tetrad is formed by Asn(116), Ser(144), Tyr(159), and Lys(163). GatDH structurally aligns well with related members of the short-chain dehydrogenase family. The substrate binding pocket can be divided into two parts of different size and polarity. In the smaller part, the side chains of amino acids Ser(144), Ser(146), and Asn(151) are important determinants for the binding specificity and the orientation of (pro-) chiral compounds. The larger part of the pocket is elongated and flanked by polar and non-polar residues, enabling a rather broad substrate spectrum. The presented structures provide valuable information for a rational design of this enzyme to improve its stability against pH, temperature, or solvent concentration and to optimize product yield in bioreactors.	[Kornberger, Petra; Kohring, Gert-Wieland; Giffhorn, Friedrich] Univ Saarland, Inst Appl Microbiol, D-66123 Saarbrucken, Germany; [Carius, Yvonne; Christian, Henning; Faust, Annette; Zander, Ulrich; Scheidig, Axel J.] Univ Kiel, Dept Biol Struct, Inst Zool, D-24118 Kiel, Germany; [Klink, Bjoern U.] Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany; [Christian, Henning] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Struct Biol, D-37077 Gottingen, Germany; [Carius, Yvonne; Zander, Ulrich; Klink, Bjoern U.; Scheidig, Axel J.] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany	Saarland University; University of Kiel; Helmholtz Association; Helmholtz-Center for Infection Research; University of Gottingen; Saarland University	Kohring, GW (corresponding author), Univ Saarland, Inst Appl Microbiol, D-66123 Saarbrucken, Germany.	gkohring@mx.uni-saarland.de; axel.scheidig@strubio.uni-kiel.de	Scheidig, Axel/C-9141-2011	Carius, Yvonne/0000-0003-3902-3122	European Union [NMP3-SL-2008-213487]	European Union(European Commission)	This work was supported by the Seventh Framework Programme of the European Union for the Small Scale Collaborative Project Electrochemical Reactors Using Dehydrogenases for Enantiopure Synthon Preparations (ERUDESP) under Contract NMP3-SL-2008-213487.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bannwarth M, 2006, BIOCHEMISTRY-US, V45, P6587, DOI 10.1021/bi052465d; Bastian S, 2005, APPL MICROBIOL BIOT, V67, P654, DOI 10.1007/s00253-004-1813-1; Benach J, 2002, BIOCHEMISTRY-US, V41, P14659, DOI 10.1021/bi0203684; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Dambe TR, 2006, BIOCHEMISTRY-US, V45, P10030, DOI 10.1021/bi052589q; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Duax WL, 2003, PROTEINS, V53, P931, DOI 10.1002/prot.10512; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; FREIMUND S, 2000, CARBOHYDR LETT, V3, P1585; FURNEAUX RH, 1993, TETRAHEDRON LETT, V34, P3609, DOI 10.1016/S0040-4039(00)73649-5; Gajdizik J, 2007, J SOLID STATE ELECTR, V11, P144, DOI 10.1007/s10008-006-0213-0; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Goldberg K, 2007, APPL MICROBIOL BIOT, V76, P237, DOI 10.1007/s00253-007-1002-0; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hummel W, 1997, Adv Biochem Eng Biotechnol, V58, P145; Huwig A, 1997, CARBOHYD RES, V305, P337, DOI 10.1016/S0008-6215(97)00265-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Jornvall H, 2008, CELL MOL LIFE SCI, V65, P3875, DOI 10.1007/s00018-008-8586-0; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KLASEN R, 1995, J BACTERIOL, V177, P2637, DOI 10.1128/jb.177.10.2637-2643.1995; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kohring G. W., 2003, Communications in Agricultural and Applied Biological Sciences, V68, P309; Kornberger P, 2009, LANGMUIR, V25, P12380, DOI 10.1021/la9010168; Krishnakumar AM, 2006, BIOCHEMISTRY-US, V45, P8831, DOI 10.1021/bi0603569; Kuhn A, 2006, APPL ENVIRON MICROB, V72, P1248, DOI 10.1128/AEM.72.2.1248-1257.2006; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE LG, 1985, J AM CHEM SOC, V107, P6999, DOI 10.1021/ja00310a043; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liao DI, 2001, BIOCHEMISTRY-US, V40, P8696, DOI 10.1021/bi0107243; MCREE DE, 1993, PRACTICAL PROTEIN CR, P223; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niefind K, 2003, J MOL BIOL, V327, P317, DOI 10.1016/S0022-2836(03)00081-0; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Panke S, 2004, CURR OPIN BIOTECH, V15, P272, DOI 10.1016/j.copbio.2004.06.011; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Philippsen A, 2005, ACTA CRYSTALLOGR D, V61, P374, DOI 10.1107/S0907444904034390; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; ROSSMANN MG, 1973, J MOL BIOL, V76, P533, DOI 10.1016/0022-2836(73)90491-9; Rotinen M, 2009, J ENDOCRINOL, V200, P85, DOI 10.1677/JOE-08-0134; SCHNEIDER KH, 1995, MICROBIOL-SGM, V141, P1865, DOI 10.1099/13500872-141-8-1865; SCHNEIDER KH, 1989, EUR J BIOCHEM, V184, P15, DOI 10.1111/j.1432-1033.1989.tb14984.x; SCHUTTE H, 1976, EUR J BIOCHEM, V62, P151, DOI 10.1111/j.1432-1033.1976.tb10108.x; Stein MA, 1997, J BACTERIOL, V179, P6335, DOI 10.1128/jb.179.20.6335-6340.1997; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Zaccai NR, 2008, PROTEINS, V70, P562, DOI 10.1002/prot.21624; Zhang QM, 2009, PROTEIN SCI, V18, P294, DOI 10.1002/pro.32	65	14	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20006	20014		10.1074/jbc.M110.113738	http://dx.doi.org/10.1074/jbc.M110.113738			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410293	Green Published, hybrid			2022-12-27	WOS:000279012000034
J	Yang, SNY; Takeda, AAS; Fontes, MRM; Harris, JM; Jans, DA; Kobe, B				Yang, Sundy N. Y.; Takeda, Agnes A. S.; Fontes, Marcos R. M.; Harris, Jonathan M.; Jans, David A.; Kobe, Bostjan			Probing the Specificity of Binding to the Major Nuclear Localization Sequence-binding Site of Importin-alpha Using Oriented Peptide Library Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SV40 T-ANTIGEN; STRUCTURAL BASIS; KARYOPHERIN ALPHA; PROTEIN IMPORT; CRYSTALLOGRAPHIC ANALYSIS; DIFFERENTIAL EXPRESSION; IN-VIVO; SIGNAL; RECOGNITION; TRANSPORT	Importin-alpha is the nuclear import receptor that recognizes the classic monopartite and bipartite nuclear localization sequences (cNLSs), which contain one or two clusters of basic amino acids, respectively. Different importin-alpha paralogs in a single organism are specific for distinct repertoires of cargos. Structural studies revealed that monopartite cNLSs and the C-terminal basic clusters of the bipartite cNLSs bind to the same site on importin-alpha, termed the major cNLS-binding site. We used an oriented peptide library approach with five degenerate positions to probe the specificity of the major cNLS-binding site in importin-alpha. We identified the sequences KKKRR, KKKRK, and KKRKK as the optimal sequences for binding to this site for mouse importin-alpha 2, human importin-alpha 1, and human importin-alpha 5, respectively. The crystal structure of mouse importin-alpha 2 with its optimal peptide confirmed the expected binding mode resembling the binding of simian virus 40 large tumor-antigen cNLS. Binding assays confirmed that the peptides containing these sequences bound to the corresponding proteins with low nanomolar affinities. Nuclear import assays showed that the sequences acted as functional cNLSs, with specificity for particular importin-alpha s. This is the first time that structural information has been linked to an oriented peptide library screening approach for importin-alpha; the results will contribute to understanding of the sequence determinants of cNLSs, and may help identify as yet unidentified cNLSs in novel proteins.	[Yang, Sundy N. Y.; Takeda, Agnes A. S.; Fontes, Marcos R. M.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Yang, Sundy N. Y.; Takeda, Agnes A. S.; Fontes, Marcos R. M.; Kobe, Bostjan] Univ Queensland, Ctr Infect Dis Res, Brisbane, Qld 4072, Australia; [Yang, Sundy N. Y.; Jans, David A.] Monash Univ, Nucl Signalling Lab, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia; [Takeda, Agnes A. S.; Fontes, Marcos R. M.] Univ Estadual Paulista, Dept Fis & Biofis, Inst Biociencias, BR-18618000 Sao Paulo, Brazil; [Harris, Jonathan M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Fac Sci, Brisbane, Qld 4059, Australia; [Harris, Jonathan M.] Queensland Univ Technol, Sch Life Sci, Fac Sci, Brisbane, Qld 4059, Australia	University of Queensland; University of Queensland; Monash University; Universidade de Sao Paulo; Universidade Estadual Paulista; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Kobe, B (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	b.kobe@uq.edu.au	Takeda, Agnes/A-1352-2014; Kobe, Bostjan/D-1292-2009; Fontes, Marcos Roberto/B-1941-2009; Takeda, Agnes/AAH-3413-2020	Takeda, Agnes/0000-0001-5000-6652; Kobe, Bostjan/0000-0001-9413-9166; Fontes, Marcos Roberto/0000-0002-4634-6221; Takeda, Agnes/0000-0001-5000-6652; Jans, David/0000-0001-5115-4745; yang, sundy/0000-0003-2418-1611; Harris, Jonathan/0000-0003-4209-2380	Australian Research Council (ARC); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Australian Research Council (ARC)(Australian Research Council); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by grants from the Australian Research Council (ARC, to B.K.) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil, to M.R.M.F.).	Aitchison JD, 2007, NATURE, V450, P621, DOI 10.1038/450621a; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Efthymiadis A, 1997, J BIOL CHEM, V272, P22134, DOI 10.1074/jbc.272.35.22134; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guillemain G, 2002, BIOCHEM J, V364, P201, DOI 10.1042/bj3640201; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hu W, 2005, J CELL BIOCHEM, V95, P782, DOI 10.1002/jcb.20439; Hu W, 1999, J BIOL CHEM, V274, P15820, DOI 10.1074/jbc.274.22.15820; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Jiang CJ, 2001, J BIOL CHEM, V276, P9322, DOI 10.1074/jbc.M006430200; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kohler M, 2002, CELL PHYSIOL BIOCHEM, V12, P335; Kohler M, 2001, VIROLOGY, V289, P186, DOI 10.1006/viro.2001.1151; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Malik HS, 1997, P NATL ACAD SCI USA, V94, P13738, DOI 10.1073/pnas.94.25.13738; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadler SG, 1997, J BIOL CHEM, V272, P4310, DOI 10.1074/jbc.272.7.4310; OBryan JP, 1996, J BIOL CHEM, V271, P11787, DOI 10.1074/jbc.271.20.11787; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; SIMONS K, 1987, EMBO J, V6, P2241, DOI 10.1002/j.1460-2075.1987.tb02496.x; Stryhn A, 1996, EUR J IMMUNOL, V26, P1911, DOI 10.1002/eji.1830260836; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tsuji L, 1997, FEBS LETT, V416, P30, DOI 10.1016/S0014-5793(97)01092-2; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhou SY, 2001, METHOD ENZYMOL, V332, P183	61	51	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19935	19946		10.1074/jbc.M109.079574	http://dx.doi.org/10.1074/jbc.M109.079574			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406804	Green Published, hybrid			2022-12-27	WOS:000279012000027
J	Arnot, CJ; Gay, NJ; Gangloff, M				Arnot, Christopher J.; Gay, Nicholas J.; Gangloff, Monique			Molecular Mechanism That Induces Activation of Spatzle, the Ligand for the Drosophila Toll Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CYTOKINE SPATZLE; IMMUNE-RESPONSE; INNATE IMMUNITY; HORSESHOE-CRAB; PROTEIN; EMBRYO; FRAGMENT; SYSTEM	The Drosophila Toll receptor is activated by an endogenous cytokine ligand Spatzle. Active ligand is generated in response to positional cues in embryonic dorso-ventral patterning and microbial pathogens in the insect immune response. Spatzle is secreted as a pro-protein and is processed into an active form by the serine endoproteases Easter and Spatzle-processing enzyme during dorso-ventral patterning and infection, respectively. Here, we provide evidence for the molecular mechanism of this activation process. We show that the Spatzle prodomain masks a predominantly hydrophobic region of Spatzle and that proteolysis causes a conformational change that exposes determinants that are critical for binding to the Toll receptor. We also gather that a conserved sequence motif in the prodomain presents features of an amphipathic helix likely to bind a hydrophobic cleft in Spatzle thereby occluding the putative Toll binding region. This mechanism of activation has a striking similarity to that of coagulogen, a clotting factor of the horseshoe crab, an invertebrate that has changed little in 400 million years. Taken together, our findings demonstrate that an ancient passive defense system has been adapted during evolution and converted for use in a critical pathway of innate immune signaling and embryonic morphogenesis.	[Arnot, Christopher J.; Gay, Nicholas J.; Gangloff, Monique] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	njg11@cam.ac.uk; mg308@cam.ac.uk		Gangloff, Monique/0000-0001-6131-0115	BBSRC [BB/G002797/1] Funding Source: UKRI; MRC [G1000133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G002797/1] Funding Source: Medline; Medical Research Council [G1000133] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; Eftink MR, 1996, BIOCHEMISTRY-US, V35, P8084, DOI 10.1021/bi9530090; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Hoffmann A, 2008, J BIOL CHEM, V283, P32598, DOI 10.1074/jbc.M801815200; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; Paoletti F, 2006, BIOCHEM SOC T, V34, P605, DOI 10.1042/BST0340605; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; PERMYAKOV EA, 1993, LUMINESCENT SPECTROS, P21; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Turcotte CL, 2002, DEV DYNAM, V224, P51, DOI 10.1002/dvdy.10081; Wang LH, 2006, EMBO J, V25, P5005, DOI 10.1038/sj.emboj.7601363; Wang Y, 2009, CELL MOL LIFE SCI, V66, P1595, DOI 10.1007/s00018-009-9028-3; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	28	52	55	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19502	19509		10.1074/jbc.M109.098186	http://dx.doi.org/10.1074/jbc.M109.098186			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20378549	Green Published, hybrid			2022-12-27	WOS:000278727800060
J	Snodgrass, RG; Collier, AC; Coon, AE; Pritsos, CA				Snodgrass, Ryan G.; Collier, Abby C.; Coon, Amy E.; Pritsos, Chris A.			Mitomycin C Inhibits Ribosomal RNA A NOVEL CYTOTOXIC MECHANISM FOR BIOREDUCTIVE DRUGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XANTHINE OXIDOREDUCTASE; REDUCTIVE ACTIVATION; ESCHERICHIA-COLI; DT-DIAPHORASE; DNA; CELLS; TARGET; ADDUCT; BIOACTIVATION; PORFIROMYCIN	Mitomycin C (MMC) is a commonly used and extensively studied chemotherapeutic agent requiring biological reduction for activity. Damage to nuclear DNA is thought to be its primary mechanism of cell death. Due to a lack of evidence for significant MMC activation in the nucleus and for in vivo studies demonstrating the formation of MMC-DNA adducts, we chose to investigate alternative nucleic acid targets. Real-time reverse transcription-PCR was used to determine changes in mitochondrial gene expression induced by MMC treatment. Although no consistent effects on mitochondrial mRNA expression were observed, complementary results from reverse transcription PCR experiments and gel-shift and binding assays demonstrated that MMC rapidly decreased the transcript levels of 18S ribosomal RNA in a concentration-dependent manner. Under hypoxic conditions, transcript levels of 18S rRNA decreased by 1.5-fold compared with untreated controls within 30 min. Recovery to base line required several hours, indicating that de novo synthesis of 18S was necessary. Addition of MMC to an in vitro translation reaction significantly decreased protein production in the cell-free system. Functional assays performed using a luciferase reporter construct in vivo determined that protein translation was inhibited, further confirming this mechanism of toxicity. The interaction of MMC with ribosomal RNA and subsequent inhibition of protein translation is consistent with mechanisms proposed for other natural compounds.	[Collier, Abby C.; Pritsos, Chris A.] Univ Nevada, Grad Program Environm Sci & Hlth, Reno, NV 89557 USA; [Snodgrass, Ryan G.; Collier, Abby C.; Coon, Amy E.; Pritsos, Chris A.] Univ Nevada, Dept Nutr, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Pritsos, CA (corresponding author), 1664 N Virginia MS 142, Reno, NV 89557 USA.	pritsos@cabnr.unr.edu	Snodgrass, Ryan G./AAH-5110-2021; Snodgrass, Ryan G/U-1031-2018	Snodgrass, Ryan G./0000-0001-9896-5297; Snodgrass, Ryan G/0000-0001-9896-5297; Collier, Abby/0000-0002-5382-2644	Nevada Agricultural Experiment Station	Nevada Agricultural Experiment Station	This work was supported in part by the Nevada Agricultural Experiment Station.	Bianchi NO, 2001, MUTAT RES-REV MUTAT, V488, P9, DOI 10.1016/S1383-5742(00)00063-6; BIZANEK R, 1993, CANCER RES, V53, P5127; Briggs LA, 1999, BIOCHEM PHARMACOL, V58, P1609, DOI 10.1016/S0006-2952(99)00254-3; CANTATORE P, 1987, FEBS LETT, V213, P144, DOI 10.1016/0014-5793(87)81480-1; COOPER HL, 1973, J CELL BIOL, V59, P250, DOI 10.1083/jcb.59.1.250; Cullinane C, 1998, CANCER RES, V58, P1400; Danson S, 2004, CANCER TREAT REV, V30, P437, DOI 10.1016/j.ctrv.2004.01.002; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Ecker DJ, 1999, DRUG DISCOV TODAY, V4, P420, DOI 10.1016/S1359-6446(99)01389-6; EMERSON CP, 1971, NATURE-NEW BIOL, V232, P101, DOI 10.1038/newbio232101a0; FEIGON J, 1982, NUCLEIC ACIDS RES, V10, P749, DOI 10.1093/nar/10.2.749; Fitzsimmons SA, 1996, J NATL CANCER I, V88, P259, DOI 10.1093/jnci/88.5.259; GATTI C, 1975, BIOCHIM BIOPHYS ACTA, V407, P308, DOI 10.1016/0005-2787(75)90098-2; GUSTAFSON DL, 1992, JNCI-J NATL CANCER I, V84, P1180, DOI 10.1093/jnci/84.15.1180; HODNICK WF, 1993, CANCER RES, V53, P4907; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Iyer V.N., 1964, MICROBIAL GENETICS B, V21, P16; IYER VN, 1963, P NATL ACAD SCI USA, V50, P355, DOI 10.1073/pnas.50.2.355; IYER VN, 1964, SCIENCE, V145, P55, DOI 10.1126/science.145.3627.55; KATO N, 1970, J BIOCHEM, V67, P175, DOI 10.1093/oxfordjournals.jbchem.a129241; KEOHANE A, 1990, BRIT J CANCER, V61, P722, DOI 10.1038/bjc.1990.162; Linder N, 2006, J CLIN PATHOL, V59, P965, DOI 10.1136/jcp.2005.032524; Linder N, 2005, CLIN CANCER RES, V11, P4372, DOI 10.1158/1078-0432.CCR-04-2280; MARSHALL RS, 1991, BIOCHEM PHARMACOL, V41, P1351, DOI 10.1016/0006-2952(91)90108-H; MATSUMOTO I, 1963, EXP CELL RES, V32, P192, DOI 10.1016/0014-4827(63)90089-2; MAUCK JC, 1973, P NATL ACAD SCI USA, V70, P2819, DOI 10.1073/pnas.70.10.2819; McKeown SR, 2007, CLIN ONCOL-UK, V19, P427, DOI 10.1016/j.clon.2007.03.006; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; PAN SS, 1984, J BIOL CHEM, V259, P959; Park SJ, 2003, MUTAT RES-GEN TOX EN, V536, P131, DOI 10.1016/S1383-5718(03)00041-X; Perry R P, 1973, Basic Life Sci, V1, P149; Perry R P, 1973, Biochem Soc Symp, V37, P105; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pritsos CA, 1997, ONCOL RES, V9, P333; RAUTH AM, 1983, CANCER RES, V43, P4154; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; SCHMID M, 1994, HUM GENET, V93, P375; Seow HA, 2005, MOL PHARMACOL, V67, P417, DOI 10.1124/mol.104.004929; Seow HA, 2004, J BIOL CHEM, V279, P31606, DOI 10.1074/jbc.M404910200; SIEGEL D, 1992, BIOCHEMISTRY-US, V31, P7879, DOI 10.1021/bi00149a019; SIEGEL D, 1990, CANCER RES, V50, P7483; Spanswick VJ, 1996, BIOCHEM PHARMACOL, V51, P1623, DOI 10.1016/0006-2952(96)00104-9; SUZUKI H, 1967, J BACTERIOL, V94, P666, DOI 10.1128/JB.94.3.666-676.1967; TEICHER BA, 1981, CANCER RES, V41, P73; TENG SP, 1989, BIOCHEMISTRY-US, V28, P3901, DOI 10.1021/bi00435a041; TOMASZ M, 1991, CANCER COMMUN, V3, P213, DOI 10.3727/095535491820873227; TOMASZ M, 1987, SCIENCE, V235, P1204, DOI 10.1126/science.3103215; VERWEIJ J, 1990, Anti-Cancer Drugs, V1, P5, DOI 10.1097/00001813-199010000-00002; WEISSBAC.A, 1965, BIOCHEMISTRY-US, V4, P196, DOI 10.1021/bi00878a003	50	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19068	19075		10.1074/jbc.M109.040477	http://dx.doi.org/10.1074/jbc.M109.040477			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20418373	Green Published, hybrid			2022-12-27	WOS:000278727800016
J	Flegg, CP; Sharma, M; Medina-Palazon, C; Jamieson, C; Galea, M; Brocardo, MG; Mills, K; Henderson, BR				Flegg, Cameron P.; Sharma, Manisha; Medina-Palazon, Cahora; Jamieson, Cara; Galea, Melanie; Brocardo, Mariana G.; Mills, Kate; Henderson, Beric R.			Nuclear Export and Centrosome Targeting of the Protein Phosphatase 2A Subunit B56 alpha ROLE OF B56 alpha IN NUCLEAR EXPORT OF THE CATALYTIC SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; B56 REGULATORY SUBUNIT; BETA-CATENIN; LOCALIZES; FAMILY; IDENTIFICATION; ACCUMULATION; SEQUENCE; DOMAIN	Protein phosphatase (PP) 2A is a heterotrimeric enzyme regulated by specific subunits. The B56 (or B'/PR61/PPP2R5) class of B-subunits direct PP2A or its substrates to different cellular locations, and the B56 alpha, -beta, and -epsilon isoforms are known to localize primarily in the cytoplasm. Here we studied the pathways that regulate B56 alpha subcellular localization. We detected B56 alpha in the cytoplasm and nucleus, and at the nuclear envelope and centrosomes, and show that cytoplasmic localization is dependent on CRM1-mediated nuclear export. The inactivation of CRM1 by leptomycin B or by siRNA knockdown caused nuclear accumulation of ectopic and endogenous B56 alpha. Conversely, CRM1 overexpression shifted B56 alpha to the cytoplasm. We identified a functional nuclear export signal at the C terminus (NES; amino acids 451-469), and site-directed mutagenesis of the NES (L461A) caused nuclear retention of full-length B56 alpha. Active NESs were identified at similar positions in the cytoplasmic B56-beta and epsilon isoforms, but not in the nuclear-localized B56-delta or gamma isoforms. The transient expression of B56 alpha induced nuclear export of the PP2A catalytic (C) subunit, and this was blocked by the L461A NES mutation. In addition, B56 alpha co-located with the PP2A active (A) subunit at centrosomes, and its centrosome targeting involved sequences that bind to the A-subunit. Fluorescence Recovery after Photobleaching (FRAP) assays revealed dynamic and immobile pools of B56 alpha-GFP, which was rapidly exported from the nucleus and subject to retention at centrosomes. We propose that B56 alpha can act as a PP2A C-subunit chaperone and regulates PP2A activity at diverse subcellular locations.	[Flegg, Cameron P.; Sharma, Manisha; Medina-Palazon, Cahora; Jamieson, Cara; Galea, Melanie; Brocardo, Mariana G.; Mills, Kate; Henderson, Beric R.] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead Hosp, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Henderson, BR (corresponding author), Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead Hosp, Darcy Rd,POB 412, Westmead, NSW 2145, Australia.	beric_henderson@sydney.edu.au	Galea, Melanie A/I-2236-2014	Brocardo, Mariana/0000-0002-3962-7308; Sharma, Manisha/0000-0003-1892-9865	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC) and the Australian Research Council.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Cadot B, 2009, CANCER RES, V69, P6074, DOI 10.1158/0008-5472.CAN-08-2796; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Don ASA, 2006, EXP CELL RES, V312, P4181, DOI 10.0116/j.yexcr.2006.09.023; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Galea MA, 2001, J BIOL CHEM, V276, P45833, DOI 10.1074/jbc.M107149200; Gigena MS, 2005, AM J PHYSIOL-HEART C, V289, pH285, DOI 10.1152/ajpheart.01291.2004; Gillingham AK, 2000, EMBO REP, V1, P524; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Johnson M, 2009, CELL SIGNAL, V21, P339, DOI 10.1016/j.cellsig.2008.11.004; Li XH, 2002, EUR J BIOCHEM, V269, P546, DOI 10.1046/j.0014-2956.2001.02680.x; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Lubert EJ, 2003, BIOCHEM BIOPH RES CO, V303, P908, DOI 10.1016/S0006-291X(03)00434-0; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Tsuchiya A, 2007, ONCOGENE, V26, P1522, DOI 10.1038/sj.onc.1209962; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; VIRSHUP DM, 1989, EMBO J, V8, P3891, DOI 10.1002/j.1460-2075.1989.tb08568.x; Yamamoto H, 2001, J BIOL CHEM, V276, P26875, DOI 10.1074/jbc.M100443200	34	20	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18144	18154		10.1074/jbc.M109.093294	http://dx.doi.org/10.1074/jbc.M109.093294			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378546	Green Published, hybrid			2022-12-27	WOS:000278453900005
J	Iwamoto, T; Nakamura, T; Doyle, A; Ishikawa, M; de Vega, S; Fukumoto, S; Yamada, Y				Iwamoto, Tsutomu; Nakamura, Takashi; Doyle, Andrew; Ishikawa, Masaki; de Vega, Susana; Fukumoto, Satoshi; Yamada, Yoshihiko			Pannexin 3 Regulates Intracellular ATP/cAMP Levels and Promotes Chondrocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; GAP-JUNCTION PROTEINS; BONE MORPHOGENETIC PROTEIN-2; PARATHYROID-HORMONE; PTH/PTHRP RECEPTOR; GROWTH-PLATE; ATDC5 CELLS; CYCLIN D1; EXPRESSION; FAMILY	Pannexin 3 (Panx3) is a new member of the gap junction pannexin family, but its expression profiles and physiological function are not yet clear. We demonstrate in this study that Panx3 is expressed in cartilage and regulates chondrocyte proliferation and differentiation. Panx3 mRNA was expressed in the prehypertrophic zone in the developing growth plate and was induced during the differentiation of chondrogenic ATDC5 and N1511 cells. Panx3-transfected ATDC5 and N1511 cells promoted chondrogenic differentiation, but the suppression of endogenous Panx3 inhibited differentiation of ATDC5 cells and primary chondrocytes. Panx3-transfected ATDC5 cells reduced parathyroid hormone-induced cell proliferation and promoted the release of ATP into the extracellular space, possibly by action of Panx3 as a hemichannel. Panx3 expression in ATDC5 cells reduced intracellular cAMP levels and the activation of cAMP-response element-binding, a protein kinase A downstream effector. These Panx3 activities were blocked by anti-Panx3 antibody. Our results suggest that Panx3 functions to switch the chondrocyte cell fate from proliferation to differentiation by regulating the intracellular ATP/cAMP levels.	[Iwamoto, Tsutomu; Nakamura, Takashi; Doyle, Andrew; Ishikawa, Masaki; de Vega, Susana; Yamada, Yoshihiko] NIDCR, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Iwamoto, Tsutomu; Nakamura, Takashi; Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Pediat Dent, Sendai, Miyagi 9808576, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tohoku University	Yamada, Y (corresponding author), NIDCR, Lab Cell & Dev Biol, NIH, Bldg 30,Rm 407,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	yoshi.yamada@nih.gov	Iwamoto, Tsutomu/AAA-6597-2019; Iwamoto, Tsutomu/AAI-8952-2021; Nakamura, Takashi/P-7796-2016; Nakamura, Takashi/A-8931-2012; de Vega, Susana/AAH-4775-2020	Iwamoto, Tsutomu/0000-0001-8472-605X; Nakamura, Takashi/0000-0001-9904-1037; Nakamura, Takashi/0000-0001-9904-1037; Fukumoto, Satoshi/0000-0002-5046-6891	National Institutes of Health, NIDCR; Japan Society for the Promotion of Science [20791583]; Ministry of Education, Science, and Culture of Japan [20679006]; Grants-in-Aid for Scientific Research [22659373] Funding Source: KAKEN; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524, ZIADE000483, ZIADE000720] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by a National Institutes of Health grant from Intramural Research Program of NIDCR (to Y. Y.). This work was also supported by Grant-in-aid for Research Fellows 20791583 from the Japan Society for the Promotion of Science (to T. I.) and Grant-in-aid from the Ministry of Education, Science, and Culture of Japan 20679006 (to S. F.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Beier F, 2002, MOL ENDOCRINOL, V16, P2163, DOI 10.1210/me.2001-0103; Beier F, 2001, MOL BIOL CELL, V12, P3852, DOI 10.1091/mbc.12.12.3852; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; Ionescu AM, 2001, J BIOL CHEM, V276, P11639, DOI 10.1074/jbc.M006564200; Kamiya N, 2002, J BONE MINER RES, V17, P1832, DOI 10.1359/jbmr.2002.17.10.1832; Kaplan AD, 1996, ENDOCRINOLOGY, V137, P4757, DOI 10.1210/en.137.11.4757; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kjaer AW, 2004, AM J MED GENET A, V127A, P152, DOI 10.1002/ajmg.a.20614; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2008, CELL COMMUN ADHES, V15, P133, DOI 10.1080/15419060802014115; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Richardson RR, 2004, J MED GENET, V41, P60, DOI 10.1136/jmg.2003.012005; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; Schwindinger WF, 1998, ENDOCRINE, V8, P201, DOI 10.1385/ENDO:8:2:201; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Singh ATK, 2005, ENDOCRINOLOGY, V146, P2171, DOI 10.1210/en.2004-1283; Tonon R, 2000, J BONE MINER RES, V15, P1669, DOI 10.1359/jbmr.2000.15.9.1669; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Wang XH, 2009, J COMP NEUROL, V512, P336, DOI 10.1002/cne.21898; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; Zhang W, 2002, J CELL PHYSIOL, V193, P233, DOI 10.1002/jcp.10168	40	107	110	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18948	18958		10.1074/jbc.M110.127027	http://dx.doi.org/10.1074/jbc.M110.127027			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404334	Green Published, hybrid			2022-12-27	WOS:000278453900085
J	Chang, JS; Huypens, P; Zhang, YB; Black, C; Kralli, A; Gettys, TW				Chang, Ji Suk; Huypens, Peter; Zhang, Yubin; Black, Chelsea; Kralli, Anastasia; Gettys, Thomas W.			Regulation of NT-PGC-1 alpha Subcellular Localization and Function by Protein Kinase A-dependent Modulation of Nuclear Export by CRM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1; PPAR-GAMMA COACTIVATOR-1; MITOCHONDRIAL BIOGENESIS; RECEPTOR-ALPHA; HEPATIC GLUCONEOGENESIS; ADAPTIVE THERMOGENESIS; ENERGY-METABOLISM; KAPPA-B; C-FOS; PGC-1-ALPHA	Peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC-1 alpha) plays a central role in the regulation of cellular energy metabolism and metabolic adaptation to environmental and nutritional stimuli. We recently described a novel, biologically active splice variant of PGC-1 alpha (NT-PGC-1 alpha, amino acids 1-270) that retains the ability to interact with and transactivate nuclear hormone receptors through its N-terminal transactivation domain. Whereas PGC-1 alpha is an unstable nuclear protein sensitive to ubiquitin-mediated targeting to the proteasome, NT-PGC-1 alpha is relatively stable and predominantly cytoplasmic, suggesting that its ability to interact with and activate nuclear receptors and transcription factors is dependent upon regulated access to the nucleus. We provide evidence that NT-PGC-1 alpha interacts with the nuclear exportin, CRM1, through a specific leucine-rich domain (nuclear export sequence) that regulates its export to the cytoplasm. The nuclear export of NT-PGC-1 alpha is inhibited by protein kinase A-dependent phosphorylation of Ser-194, Ser-241, and Thr-256 on NT-PGC-1 alpha, which effectively increases its nuclear concentration. Using site-directed mutagenesis to prevent or mimic phosphorylation at these sites, we show that the transcriptional activity of NT-PGC-1 alpha is regulated in part through regulation of its subcellular localization. These findings suggest that the function of NT-PGC-1 alpha as a transcriptional co-activator is regulated by protein kinase A-dependent inhibition of CRM1-mediated export from the nucleus.	[Chang, Ji Suk; Huypens, Peter; Zhang, Yubin; Black, Chelsea; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA; [Kralli, Anastasia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Zhang, Yubin] China Pharmaceut Univ, Dept Biochem, Nanjing 210009, Peoples R China	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Scripps Research Institute; China Pharmaceutical University	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Chang, Ji Suk/N-1957-2017; Gettys, Thomas W/N-1964-2017	Gettys, Thomas W/0000-0001-7125-7995; Huypens, Peter/0000-0001-7922-5787	National Institutes of Health [RO1 DK 074772, P20-RR021945, DK064951]; NIH Clinical Nutrition Research Unit Center [1P30 DK072476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074772, P30DK072476, R01DK064951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, P30GM118430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Clinical Nutrition Research Unit Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 074772 and P20-RR021945 (to T. W. G.), NIH Clinical Nutrition Research Unit Center Grant 1P30 DK072476, and NIH Grant DK064951 (to A. K.).	Bereziat V, 2005, BIOCHIMIE, V87, P951, DOI 10.1016/j.biochi.2005.05.010; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kilstrup-Nielsen C, 2003, EMBO J, V22, P89, DOI 10.1093/emboj/cdg010; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; Sachdev S, 2000, MOL CELL BIOL, V20, P1571, DOI 10.1128/MCB.20.5.1571-1582.2000; Sadana P, 2007, BIOCHEM J, V403, P511, DOI 10.1042/BJ20061526; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	55	58	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18039	18050		10.1074/jbc.M109.083121	http://dx.doi.org/10.1074/jbc.M109.083121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351112	Green Published, hybrid			2022-12-27	WOS:000278133400079
J	Fernandez-Sanchez, ME; Sechet, E; Margottin-Goguet, F; Rogge, L; Bianchi, E				Fernandez-Sanchez, Maria Elena; Sechet, Emmanuel; Margottin-Goguet, Florence; Rogge, Lars; Bianchi, Elisabetta			The Human COP9 Signalosome Protects Ubiquitin-conjugating Enzyme 3 (UBC3/Cdc34) from beta-Transducin Repeat-containing Protein (beta TrCP)-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-CYCLE; E3 LIGASE; OXIDATIVE STRESS; FISSION YEAST; DNA-DAMAGE; E2 ENZYME; CDC34; NEDD8; TRCP	The COP9 signalosome (CSN) is an essential multisubunit complex that regulates the activity of cullin-RING ubiquitin ligases by removing the ubiquitin-like peptide NEDD8 from cullins. Here, we demonstrate that the CSN can affect other components of the ubiquitination cascade. Down-regulation of human CSN4 or CSN5 induced proteasome-mediated degradation of the ubiquitin-conjugating enzyme UBC3/Cdc34. UBC3 was targeted for ubiquitination by the cullin-RING ubiquitin ligase SCF beta TrCP. This interaction required the acidic C-terminal extension of UBC3, which is absent in ubiquitin-conjugating enzymes of the UBCH5 family. Conversely, the UBC3 acidic domain was sufficient to impart sensitivity to SCF beta TrCP-mediated ubiquitination to UBCH5 enzymes. Our work indicates that the CSN is necessary to ensure the stability of selected ubiquitin-conjugating enzymes and uncovers a novel pathway of regulation of ubiquitination processes.	[Fernandez-Sanchez, Maria Elena; Sechet, Emmanuel; Rogge, Lars; Bianchi, Elisabetta] Inst Pasteur, Immunoregulat Unit, F-75724 Paris, France; [Fernandez-Sanchez, Maria Elena; Sechet, Emmanuel; Rogge, Lars; Bianchi, Elisabetta] CNRS, URA1961, F-75724 Paris, France; [Margottin-Goguet, Florence] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Margottin-Goguet, Florence] INSERM, U1016, F-75014 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bianchi, E (corresponding author), Inst Pasteur, Immunoregulat Unit, 25 Rue Dr Roux, F-75724 Paris, France.	ebianchi@pasteur.fr	Rogge, Lars/GYJ-6142-2022; Margottin-Goguet, Florence/F-9272-2013	Margottin-Goguet, Florence/0000-0002-3124-6690; Rogge, Lars/0000-0003-1262-9204; Fernandez Sanchez, Maria Elena/0000-0001-8083-8863	Canceropole, Ile-de-France	Canceropole, Ile-de-France(Region Ile-de-France)	This work was supported by Canceropole, Ile-de-France.	Asada S, 2008, INT J MOL MED, V22, P95; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Block K, 2001, J BIOL CHEM, V276, P41049, DOI 10.1074/jbc.M106453200; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gewurz BE, 2006, CURR BIOL, V16, pR932, DOI 10.1016/j.cub.2006.09.046; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Harari-Steinberg O, 2007, GENES CELLS, V12, P183, DOI 10.1111/j.1365-2443.2007.01049.x; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Huang XH, 2009, J MOL BIOL, V391, P691, DOI 10.1016/j.jmb.2009.06.066; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Pearce C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-31; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian X, 2005, BIOCHEM J, V389, P389, DOI 10.1042/BJ20050297; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Raymond F, 2000, J CELL SCI, V113, P1687; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Semplici F, 2002, ONCOGENE, V21, P3978, DOI 10.1038/sj.onc.1205574; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Su HB, 2009, INT J BIOCHEM CELL B, V41, P615, DOI 10.1016/j.biocel.2008.07.008; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Uchida S, 2009, CANCER RES, V69, P6438, DOI 10.1158/0008-5472.CAN-09-0869; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wu JT, 2006, TRENDS CELL BIOL, V16, P362, DOI 10.1016/j.tcb.2006.05.001; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9	54	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17390	17397		10.1074/jbc.M109.076661	http://dx.doi.org/10.1074/jbc.M109.076661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378537	Green Published, hybrid			2022-12-27	WOS:000278133400016
J	Alcazar-Roman, AR; Bolger, TA; Wente, SR				Alcazar-Roman, Abel R.; Bolger, Timothy A.; Wente, Susan R.			Control of mRNA Export and Translation Termination by Inositol Hexakisphosphate Requires Specific Interaction with Gle1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX PROTEIN DBP5; NUCLEAR-PORE COMPLEX; NUCLEOPORIN NUP214; POLY(A)(+) RNA; HUMAN HOMOLOG; YEAST; PATHWAY; CELLS; MRNP; HELICASE	The unidirectional translocation of messenger RNA (mRNA) through the aqueous channel of the nuclear pore complex (NPC) is mediated by interactions between soluble mRNA export factors and distinct binding sites on the NPC. At the cytoplasmic side of the NPC, the conserved mRNA export factors Gle1 and inositol hexakisphosphate (IP6) play an essential role in mRNA export by activating the ATPase activity of the DEAD-box protein Dbp5, promoting localized messenger ribonucleoprotein complex remodeling, and ensuring the directionality of the export process. In addition, Dbp5, Gle1, and IP6 are also required for proper translation termination. However, the specificity of the IP6-Gle1 interaction in vivo is unknown. Here, we characterize the biochemical interaction between Gle1 and IP6 and the relationship to Dbp5 binding and stimulation. We identify Gle1 residues required for IP6 binding and show that these residues are needed for IP6-dependent Dbp5 stimulation in vitro. Furthermore, we demonstrate that Gle1 is the primary target of IP6 for both mRNA export and translation termination in vivo. In Saccharomyces cerevisiae cells, the IP6-binding mutants recapitulate all of the mRNA export and translation termination defects found in mutants depleted of IP6. We conclude that Gle1 specifically binds IP6 and that this interaction is required for the full potentiation of Dbp5 ATPase activity during both mRNA export and translation termination.	[Alcazar-Roman, Abel R.; Bolger, Timothy A.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, U-3209 MRBIII, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu		Alcazar-Roman, Abel R./0000-0003-1668-1886	National Institutes of Health [R01-GM51219, F32-GM082065]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082065, R37GM051219, R01GM051219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM51219 (to S. R. W.) and F32-GM082065 (to T. A. B.).	Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; DelPriore V, 1996, MOL BIOL CELL, V7, P1601, DOI 10.1091/mbc.7.10.1601; Dossani ZY, 2009, P NATL ACAD SCI USA, V106, P16251, DOI 10.1073/pnas.0902251106; Du J, 1998, GENETICS, V150, P987; Estruch F, 2003, MOL BIOL CELL, V14, P1664, DOI 10.1091/mbc.E02-09-0602; Fan JS, 2009, J MOL BIOL, V388, P1, DOI 10.1016/j.jmb.2009.03.004; Feng YC, 2001, P NATL ACAD SCI USA, V98, P875, DOI 10.1073/pnas.021558098; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Iglesias N, 2008, FEBS LETT, V582, P1987, DOI 10.1016/j.febslet.2008.03.038; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mckee AE, 2007, CELL RES, V17, P581, DOI 10.1038/cr.2007.54; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Moon D, 2008, J MICROBIOL, V46, P422, DOI 10.1007/s12275-008-0177-0; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Sarmah B, 2009, EUKARYOT CELL, V8, P134, DOI 10.1128/EC.00279-08; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Tuite MF, 2007, PRION, V1, P101, DOI 10.4161/pri.1.2.4665; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177	53	64	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16683	16692		10.1074/jbc.M109.082370	http://dx.doi.org/10.1074/jbc.M109.082370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371601	hybrid, Green Published			2022-12-27	WOS:000277982600032
J	Brechbuhl, HM; Gould, N; Kachadourian, R; Riekhof, WR; Voelker, DR; Day, BJ				Brechbuhl, Heather M.; Gould, Neal; Kachadourian, Remy; Riekhof, Wayne R.; Voelker, Dennis R.; Day, Brian J.			Glutathione Transport Is a Unique Function of the ATP-binding Cassette Protein ABCG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONDUCTANCE REGULATOR PROTEIN; ALVEOLAR FLUID GLUTATHIONE; SIDE POPULATION; EXPRESSION CONFERS; CENTRAL MODULATOR; OXIDATIVE STRESS; REDOX STATE; STEM-CELLS; RESISTANCE; DEFICIENCY	Glutathione (GSH) transport is vital for maintenance of intracellular and extracellular redox balance. Only a few human proteins have been identified as transporters of GSH, glutathione disulfide (GSSG) and/or GSH conjugates (GS-X). Human epithelial MDA1586, A549, H1975, H460, HN4, and H157 cell lines were exposed to 2',5'-dihydroxychalcone, which induces a GSH efflux response. A real-time gene superarray for 84 proteins found in families that have a known role in GSH, GSSG, and/or GS-X transport was employed to help identify potential GSH transporters. ABCG2 was identified as the only gene in the array that closely corresponded with the magnitude of 2',5'-dihydroxychalcone (2',5'-DHC)-induced GSH efflux. The role of human ABCG2 as a novel GSH transporter was verified in a Saccharomyces cerevisiae galactose-inducible gene expression system. Yeast expressing human ABCG2 had 2.5-fold more extracellular GSH compared with those not expressing ABCG2. GSH efflux in ABCG2-expressing yeast was abolished by the ABCG2 substrate methotrexate (10 mu M), indicating competitive inhibition. In contrast, 2',5'-DHC treatment of ABCG2-expressing yeast increased extracellular GSH levels in a dose-dependent manner with a maximum 3.5-fold increase in GSH after 24 h. In addition, suppression of ABCG2 with short hairpin RNA or ABCG2 overexpression in human epithelial cells decreased or increased extracellular GSH levels, respectively. Our data indicate that ABCG2 is a novel GSH transporter.	[Kachadourian, Remy; Riekhof, Wayne R.; Voelker, Dennis R.; Day, Brian J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Day, Brian J.] Univ Colorado Denver & Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA; [Day, Brian J.] Univ Colorado Denver & Hlth Sci Ctr, Dept Immunol, Aurora, CO 80045 USA; [Gould, Neal; Day, Brian J.] Univ Colorado Denver & Hlth Sci Ctr, Dept Pharmaceut Sci, Aurora, CO 80045 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Day, BJ (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	dayb@njhealth.org			National Institutes of Health [R01 HL084469, R01 HL075523, R01 ES0175825, R37-GM32453, 1F32-GM076798]; American Cancer Society [PF-06-288-01-CSM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075523, R01HL084469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076798, R37GM032453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL084469 (to B.J.D.), R01 HL075523 (to B.J.D), R01 ES0175825, R37-GM32453 (to D.R.V), and 1F32-GM076798 (to W.R.R.). This work was also supported by American Cancer Society Great-West Division Postdoctoral Fellowship Award PF-06-288-01-CSM (to W.R.R.).	Adachi T, 2007, J EXP THER ONCOL, V6, P335; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; CANTIN AM, 1989, AM REV RESPIR DIS, V139, P370, DOI 10.1164/ajrccm/139.2.370; Day BJ, 2004, INFECT IMMUN, V72, P2045, DOI 10.1128/IAI.72.4.2045-2051.2004; Day Regina M., 2005, Dose-Response, V3, P425, DOI 10.2203/dose-response.003.03.010; Eisenblatter T, 2003, BRAIN RES, V971, P221, DOI 10.1016/S0006-8993(03)02401-6; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Hagiya Yuichiro, 2008, J Exp Ther Oncol, V7, P153; Hagmann W, 1999, EUR J BIOCHEM, V265, P281, DOI 10.1046/j.1432-1327.1999.00735.x; Han Y, 2008, EUR J PHARM SCI, V35, P30, DOI 10.1016/j.ejps.2008.06.001; Hardwick LJA, 2007, BRIT J PHARMACOL, V151, P163, DOI 10.1038/sj.bjp.0707218; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; ISHIKAWA T, 1989, J BIOL CHEM, V264, P17343; JEDLITSCHKY G, 1994, CANCER RES, V54, P4833; Kachadourian R, 2006, FREE RADICAL BIO MED, V41, P65, DOI 10.1016/j.freeradbiomed.2006.03.002; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Lash LH, 2006, CHEM-BIOL INTERACT, V163, P54, DOI 10.1016/j.cbi.2006.03.001; Majka SM, 2005, STEM CELLS, V23, P1073, DOI 10.1634/stemcells.2005-0039; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Martin CM, 2008, CIRC RES, V102, P1075, DOI 10.1161/CIRCRESAHA.107.161729; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Miyake K, 1999, CANCER RES, V59, P8; Mogi M, 2003, J BIOL CHEM, V278, P39068, DOI 10.1074/jbc.M306362200; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Naylor CS, 2005, BONE MARROW TRANSPL, V35, P353, DOI 10.1038/sj.bmt.1704762; Noble M, 2003, ANN NY ACAD SCI, V991, P251; PACHT ER, 1991, CHEST, V100, P1397, DOI 10.1378/chest.100.5.1397; Pacht ER, 1997, CHEST, V112, P785, DOI 10.1378/chest.112.3.785; Pfister O, 2008, CIRC RES, V103, P825, DOI 10.1161/CIRCRESAHA.108.174615; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Rothnie A, 2008, MOL PHARMACOL, V74, P1630, DOI 10.1124/mol.108.049080; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Sadzuka Y, 2001, TOXICOL LETT, V123, P159, DOI 10.1016/S0378-4274(01)00391-5; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; SMITH TK, 1995, P NATL ACAD SCI USA, V92, P2360, DOI 10.1073/pnas.92.6.2360; Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Tamura A, 2006, MOL PHARMACOL, V70, P287, DOI 10.1124/mol.106.023556; Ueda T, 2005, J BIOL CHEM, V280, P991, DOI 10.1074/jbc.M409796200; Urquhart BL, 2008, PHARMACOGENET GENOM, V18, P439, DOI 10.1097/FPC.0b013e3282f974dc; Velsor LW, 2006, AM J RESP CELL MOL, V35, P579, DOI 10.1165/rcmb.2005-0473OC; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Yeboah D, 2006, CAN J PHYSIOL PHARM, V84, P1251, DOI 10.1139/Y06-078; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200	50	54	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16582	16587		10.1074/jbc.M109.090506	http://dx.doi.org/10.1074/jbc.M109.090506			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20332504	Green Published, hybrid			2022-12-27	WOS:000277982600021
J	Queiroga, CSF; Almeida, AS; Martel, C; Brenner, C; Alves, PM; Vieira, HLA				Queiroga, Claudia S. F.; Almeida, Ana S.; Martel, Cecile; Brenner, Catherine; Alves, Paula M.; Vieira, Helena L. A.			Glutathionylation of Adenine Nucleotide Translocase Induced by Carbon Monoxide Prevents Mitochondrial Membrane Permeabilization and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE; TRANSITION PORE; BRAIN; INHIBITION; BAX; RESPIRATION; ASTROCYTES; EXPRESSION; OXIDATION; DEPLETION	The present work demonstrates the ability of CO to prevent apoptosis in a primary culture of astrocytes. For the first time, the antiapoptotic behavior can be clearly attributed to the inhibition of mitochondrial membrane permeabilization (MMP), a key event in the intrinsic apoptotic pathway. In isolated non-synaptic mitochondria, CO partially inhibits (i) loss of potential, (ii) the opening of a nonspecific pore through the inner membrane, (iii) swelling, and (iv) cytochrome c release, which are induced by calcium, diamide, or atractyloside (a ligand of ANT). CO directly modulates ANT function by enhancing ADP/ATP exchange and prevents its pore-forming activity. Additionally, CO induces reactive oxygen species (ROS) generation, and its prevention by beta-carotene decreases CO cytoprotection in intact cells as well as in isolated mitochondria, revealing the key role of ROS. On the other hand, CO induces a slight increase in mitochondrial oxidized glutathione, which is essential for apoptosis modulation by (i) delaying astrocytic apoptosis, (ii) decreasing MMP, and (iii) enhancing ADP/ATP translocation activity of ANT. Moreover, CO and GSSG trigger ANT glutathionylation, a post-translational process regulating protein function in response to redox cellular changes. In conclusion, CO protects astrocytes from apoptosis by preventing MMP, acting on ANT (glutathionylation and inhibition of its pore activity) via a preconditioning-like process mediated by ROS and GSSG.	[Vieira, Helena L. A.] Inst Tecnol Quim & Biol, IBET, P-2781901 Oeiras, Portugal; [Queiroga, Claudia S. F.; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Martel, Cecile; Brenner, Catherine] Univ Versailles St Quentin, CNRS, UMR 8159, F-78035 Versailles, France; [Martel, Cecile] Hop Paul Brousse, PRES UniverSud Paris, INSERM, U602, F-94805 Villejuif, France	Universidade Nova de Lisboa; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Vieira, HLA (corresponding author), Inst Tecnol Quim & Biol, IBET, Apartado 12, P-2781901 Oeiras, Portugal.	hvieira@itqb.unl.pt	Vieira, Helena/AAZ-9562-2021; Alves, Paula M/C-1070-2008	Alves, Paula M/0000-0003-1445-3556; Vieira, Helena/0000-0001-9415-3742; Queiroga, Claudia/0000-0002-3984-9576; Almeida, Ana Sofia/0000-0001-7654-9049	Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/SAU-NEU/64327/2006]; Helena L. A. Vieira Fellowship [SFRH/BPD/27125/2006]; Claudia S. F. Queiroga Fellowship [SFRH/BD/43387/2008]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Helena L. A. Vieira Fellowship; Claudia S. F. Queiroga Fellowship	This work was supported by the Portuguese Fundacao para a Ciencia e Tecnologia Project PTDC/SAU-NEU/64327/2006, Helena L. A. Vieira Fellowship SFRH/BPD/27125/2006, and Claudia S. F. Queiroga Fellowship SFRH/BD/43387/2008.	Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Belzacq AS, 2003, CANCER RES, V63, P541; Belzacq-Casagrande AS, 2009, FRONT BIOSCI-LANDMRK, V14, P3550, DOI 10.2741/3470; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BRANDOLIN G, 1993, J BIOENERG BIOMEMBR, V25, P459, DOI 10.1007/BF01108403; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Busija DW, 2008, ADV DRUG DELIVER REV, V60, P1471, DOI 10.1016/j.addr.2008.03.020; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Choi YS, 2007, EXP MOL MED, V39, P556, DOI 10.1038/emm.2007.61; Costantini P, 2000, ONCOGENE, V19, P307, DOI 10.1038/sj.onc.1203299; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Crompton M, 1999, BIOCHEM SOC SYMP, V66, P167, DOI 10.1042/bss0660167; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Di Noia MA, 2006, J BIOL CHEM, V281, P15687, DOI 10.1074/jbc.M510595200; Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017; Dore S, 2002, FREE RADICAL BIO MED, V32, P1276, DOI 10.1016/S0891-5849(02)00805-5; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Hirrlinger J, 2005, METHOD ENZYMOL, V400, P395, DOI 10.1016/S0076-6879(05)00023-6; Huang Z, 2008, BIOCHEM PHARMACOL, V75, P2234, DOI 10.1016/j.bcp.2008.02.026; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Kristian T, 2000, J NEUROCHEM, V74, P1999, DOI 10.1046/j.1471-4159.2000.0741999.x; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Le Bras M, 2006, CANCER RES, V66, P9143, DOI 10.1158/0008-5472.CAN-05-4407; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Muyderman H, 2004, J NEUROSCI, V24, P8019, DOI 10.1523/JNEUROSCI.1103-04.2004; Piantadosi CA, 2006, FREE RADICAL BIO MED, V40, P1332, DOI 10.1016/j.freeradbiomed.2005.11.020; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sandouka A, 2005, CELL MOL BIOL, V51, P425, DOI 10.1170/T646; Santos SS, 2005, J NEUROSCI RES, V79, P26, DOI 10.1002/jnr.20279; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Stroev SA, 2005, NEUROSCI RES, V53, P39, DOI 10.1016/j.neures.2005.05.010; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Vaillancourt F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2503; Verrier F, 2004, ONCOGENE, V23, P8049, DOI 10.1038/sj.onc.1208001; Vesce S, 2005, J BIOL CHEM, V280, P38720, DOI 10.1074/jbc.M506575200; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778; Wiegand F, 1999, J CEREBR BLOOD F MET, V19, P1229, DOI 10.1097/00004647-199911000-00007; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	48	106	107	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17077	17088		10.1074/jbc.M109.065052	http://dx.doi.org/10.1074/jbc.M109.065052			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20348099	Green Published, hybrid			2022-12-27	WOS:000277982600071
J	Lammich, S; Buell, D; Zilow, S; Ludwig, AK; Nuscher, B; Lichtenthaler, SF; Prinzen, C; Fahrenholz, F; Haass, C				Lammich, Sven; Buell, Dominik; Zilow, Sonja; Ludwig, Ann-Katrin; Nuscher, Brigitte; Lichtenthaler, Stefan F.; Prinzen, Claudia; Fahrenholz, Falk; Haass, Christian			Expression of the Anti-amyloidogenic Secretase ADAM10 Is Suppressed by Its 5 '-Untranslated Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; OPEN READING FRAMES; MESSENGER-RNA; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; BETA-SECRETASE; DISINTEGRIN-METALLOPROTEASE; UPSTREAM AUGS; TRANSLATIONAL REGULATION; 5-UNTRANSLATED REGION	Proteolytic processing of the amyloid precursor protein by alpha-secretase prevents formation of the amyloid beta-peptide (A beta),which is the main constituent of amyloid plaques in brains of Alzheimer disease (AD) patients. alpha-Secretase activity is decreased in AD, and overexpression of the alpha-secretase ADAM10 (a disintegrin and metalloprotease 10) in an AD animal model prevents amyloid pathology. ADAM10 has a 444-nucleotide-long, very GC-rich 5'-untranslated region (5'-UTR) with two upstream open reading frames. Because similar properties of 5'-UTRs are found in transcripts of many genes, which are regulated by translational control mechanisms, we asked whether ADAM10 expression is translationally controlled by its 5'-UTR. We demonstrate that the 5'-UTR of ADAM10 represses the rate of ADAM10 translation. In the absence of the 5'-UTR, we observed a significant increase of ADAM10 protein levels in HEK293 cells, whereas mRNA levels were not changed. Moreover, the 5'-UTR of ADAM10 inhibits translation of a luciferase reporter in an in vitro transcription/translation assay. Successive deletion of the first half of the ADAM10 5'-UTR revealed a striking increase in ADAM10 protein expression in HEK293 cells, suggesting that this part of the 5'-UTR contains inhibitory elements for translation. Moreover, we detect an enhanced alpha-secretase activity and consequently reduced A beta levels in the conditioned medium of HEK293 cells expressing both amyloid precursor protein and a 5'-UTR-ADAM10 deletion construct lacking the first half of the 5'-UTR. Thus, we provide evidence that the 5'-UTR of ADAM10 may have an important role for post-transcriptional regulation of ADAM10 expression and consequently A beta production.	[Lammich, Sven; Buell, Dominik; Zilow, Sonja; Ludwig, Ann-Katrin; Nuscher, Brigitte; Lichtenthaler, Stefan F.; Haass, Christian] Univ Munich, German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Lammich, Sven; Buell, Dominik; Zilow, Sonja; Ludwig, Ann-Katrin; Nuscher, Brigitte; Lichtenthaler, Stefan F.; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Prinzen, Claudia] Johannes Gutenberg Univ Mainz, Inst Biochem, D-55099 Mainz, Germany; [Fahrenholz, Falk] Johannes Gutenberg Univ Mainz, Dept Psychiat & Psychotherapy, Clin Res Grp, D-55131 Mainz, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Lammich, S (corresponding author), Univ Munich, German Ctr Neurodegenerat Dis DZNE, Schillerstr 44, D-80336 Munich, Germany.	sven.lammich@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575	Deutsche Forschungsgemeinschaft [SFB596]; Hans and Ilse Breuer Foundation; Ludwig-Maximilians-University, Munich; Bundesministerium fur Bildung und Forschung; Center of Integrated Protein Science Munich (CIPSM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans and Ilse Breuer Foundation; Ludwig-Maximilians-University, Munich; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Center of Integrated Protein Science Munich (CIPSM)	This work was supported by the Deutsche Forschungsgemeinschaft (Collaborative Research Center SFB596 "Molecular Mechanisms of Neurodegeneration," to S. L., S. F. L., and C. H.), a fellowship of the Hans and Ilse Breuer Foundation (S. Z.), a predoctoral fellowship (Molekulare Medizin-Forrderung der Forschung und Lehre, FoFoLe) by the Ludwig-Maximilians-University, Munich (D. B.), the Bundesministerium fur Bildung und Forschung ("Degenerative Dementias: Target Identification, Validation, and Translation into Treatment Strategies" (S. F. L. and C. H.)), and by the Center of Integrated Protein Science Munich (CIPSM).	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Bech-Serra JJ, 2006, MOL CELL BIOL, V26, P5086, DOI 10.1128/MCB.02380-05; Bernstein HG, 2003, J NEUROCYTOL, V32, P153, DOI 10.1023/B:NEUR.0000005600.61844.a6; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; de la Torre TV, 2004, BIOCHEM BIOPH RES CO, V314, P1028, DOI 10.1016/j.bbrc.2003.12.186; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; GRAY NK, 1994, MOL BIOL REP, V19, P195, DOI 10.1007/BF00986961; HAASS C, 1992, NATURE, V359, P325; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hernandez-Sanchez C, 2003, EMBO J, V22, P5582, DOI 10.1093/emboj/cdg515; HORVATH P, 1995, CELL GROWTH DIFFER, V6, P1103; Howard L, 1996, BIOCHEM J, V317, P45, DOI 10.1042/bj3170045; Ko SY, 2007, CANCER LETT, V245, P33, DOI 10.1016/j.canlet.2005.10.019; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Lee J, 2002, NUCLEIC ACIDS RES, V30, P5110, DOI 10.1093/nar/gkf664; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li Y, 2008, MOL CELL BIOL, V28, P939, DOI 10.1128/MCB.01727-07; Li Y, 2009, NUCLEIC ACIDS RES, V37, P2227, DOI 10.1093/nar/gkp087; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mezyk-Kopec R, 2009, CYTOKINE, V46, P309, DOI 10.1016/j.cyto.2009.03.002; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oh ST, 2009, J CUTAN PATHOL, V36, P395, DOI 10.1111/j.1600-0560.2008.01082.x; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wen YR, 2009, NAT GENET, V41, P228, DOI 10.1038/ng.276; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; Willem M, 2009, SEMIN CELL DEV BIOL, V20, P175, DOI 10.1016/j.semcdb.2009.01.003; Wood MW, 1996, J BIOL CHEM, V271, P8115, DOI 10.1074/jbc.271.14.8115; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yavari R, 1998, HUM MOL GENET, V7, P1161, DOI 10.1093/hmg/7.7.1161; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15753	15760		10.1074/jbc.M110.110742	http://dx.doi.org/10.1074/jbc.M110.110742			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348102	Green Published, hybrid			2022-12-27	WOS:000277715900011
J	Kaieda, S; Shin, K; Nigrovic, PA; Seki, K; Lee, RT; Stevens, RL; Lee, DM				Kaieda, Shinjiro; Shin, Kichul; Nigrovic, Peter A.; Seki, Kenjiro; Lee, Richard T.; Stevens, Richard L.; Lee, David M.			Synovial Fibroblasts Promote the Expression and Granule Accumulation of Tryptase via Interleukin-33 and Its Receptor ST-2 (IL1RL1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MAST-CELL; GROWTH-FACTOR; COMPLEMENTARY-DNA; SURFACE MOLECULE; HUMAN BASOPHILS; IL-33; CYTOKINE; TISSUE; MICE; GENE	A characteristic feature of tissue resident human mast cells (MCs) is their hTryptase-beta-rich cytoplasmic granules. Mouse MC protease-6 (mMCP-6) is the ortholog of hTryptase-beta, and we have shown that this tetramer-forming tryptase has beneficial roles in innate immunity but adverse roles in inflammatory disorders like experimental arthritis. Because the key tissue factors that control tryptase expression in MCs have not been identified, we investigated the mechanisms by which fibroblasts mediate the expression and granule accumulation of mMCP-6. Immature mouse bone marrow-derived MCs (mBMMCs) co-cultured with fibroblast-like synoviocytes (FLS) or mouse 3T3 fibroblasts markedly increased their levels of mMCP-6. This effect was caused by an undefined soluble factor whose levels could be increased by exposing FLS to tumor necrosis factor-alpha or interleukin (IL)-1 beta. Gene expression profiling of mBMMCs and FLS for receptor ligand pairs of potential relevance raised the possibility that IL-33 was a sought after fibroblast-derived factor that promotes tryptase expression and granule maturation via its receptor IL1RL1/ST2. MCs lacking IL1RL1 exhibited defective fibroblast-driven tryptase accumulation, whereas recombinant IL-33 induced mMCP-6 mRNA and protein accumulation in wild-type mBMMCs. In agreement with these data, synovial MCs from IL1RL1-null mice exhibited a marked reduction in mMCP-6 expression. IL-33 is the first factor shown to modulate tryptase expression in MCs at the mRNA and protein levels. We therefore have identified a novel pathway by which mesenchymal cells exposed to inflammatory cytokines modulate the phenotype of local MCs to shape their immune responses.	[Kaieda, Shinjiro; Shin, Kichul; Nigrovic, Peter A.; Stevens, Richard L.; Lee, David M.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Nigrovic, Peter A.] Childrens Hosp, Dept Med, Div Immunol, Boston, MA 02115 USA; [Seki, Kenjiro; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Kaieda, Shinjiro; Shin, Kichul; Nigrovic, Peter A.; Seki, Kenjiro; Lee, Richard T.; Stevens, Richard L.; Lee, David M.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lee, DM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 552B,1 Jimmy Fund Way, Boston, MA 02115 USA.	dlee@rics.bwh.harvard.edu	Seki, Kenjiro/AAI-3220-2020	Lee, Richard/0000-0003-4687-1381	National Institutes of Health [AI059746, AI065858, HL036610]; Cogan Family Foundation; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059746, P01AI065858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cogan Family Foundation; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059746, AI065858, and HL036610. This work was also supported by research grants from The Cogan Family Foundation and the Harvard Club of Australia Foundation.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; CRISP AJ, 1984, ARTHRITIS RHEUM, V27, P845, DOI 10.1002/art.1780270802; DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Funaba M, 2005, CELL SIGNAL, V17, P121, DOI 10.1016/j.cellsig.2004.06.005; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; GHILDYAL N, 1993, J IMMUNOL, V151, P3206; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; GRUBER B, 1986, ARTHRITIS RHEUM, V29, P944, DOI 10.1002/art.1780290802; GURISH MF, 1995, IMMUNITY, V3, P175, DOI 10.1016/1074-7613(95)90087-X; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; GURISH MF, 2001, J EXP MED, V194, P1; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; KANAKURA Y, 1988, BLOOD, V72, P877; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; KITAMURA Y, 1979, BLOOD, V53, P492; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEE DM, 2005, KELLEYS TXB RHEUMATO, P175; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P3431; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P494; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; LEVISCHAFFER F, 1985, J IMMUNOL, V135, P3454; Liu XJ, 2009, BIOCHEM BIOPH RES CO, V386, P181, DOI 10.1016/j.bbrc.2009.06.008; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; MCNEIL HP, 1992, J IMMUNOL, V149, P2466; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; Moritz DR, 1998, J IMMUNOL, V161, P4866; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Nigrovic PA, 2005, ARTHRITIS RES THER, V7, P1, DOI 10.1186/ar1446; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Rittner HL, 2006, J LEUKOCYTE BIOL, V79, P1022, DOI 10.1189/jlb.0805452; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2006, ARTHRITIS RHEUM-US, V54, P2863, DOI 10.1002/art.22058; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; STEVENS RL, 1992, ARTHRITIS RHEUM, V35, P325, DOI 10.1002/art.1780350312; STEVENS RL, 1982, J BIOL CHEM, V257, P253; Suzukawa Maho, 2008, Lab Invest, V88, P1245, DOI 10.1038/labinvest.2008.82; Tajima S, 2007, EXP LUNG RES, V33, P81, DOI 10.1080/01902140701198583; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; TOMINAGA S, 1992, BIOCHIM BIOPHYS ACTA, V1171, P215, DOI 10.1016/0167-4781(92)90125-J; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Ugajin T, 2009, INTERNAL MED, V48, P693, DOI 10.2169/internalmedicine.48.1736; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	75	52	53	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21478	21486		10.1074/jbc.M110.114991	http://dx.doi.org/10.1074/jbc.M110.114991			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20427273	hybrid, Green Published			2022-12-27	WOS:000279516100034
J	Serchov, T; Dubois-Pot-Schneider, H; Charlot, C; Rosl, F; Wasylyk, B				Serchov, Tsvetan; Dubois-Pot-Schneider, Helene; Charlot, Celine; Roesl, Frank; Wasylyk, Bohdan			Involvement of Net and Hif1 alpha in Distinct yet Intricately Linked Hypoxia-induced Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX FACTOR NET; TRANSCRIPTION FACTOR; HIF-ALPHA; PROLYL HYDROXYLASES; OXYGEN SENSOR; CELLS; RAS; HIF-1-ALPHA; INHIBITION; CANCER	The present study compares negative Ets transcription factor (Net) and hypoxia-inducible factor 1 alpha (HIF1 alpha) regulation by hypoxia. Their protein stabilities are differently regulated by hypoxia, defining three periods in the kinetics: normoxia (high Net levels and low HIF1 alpha levels), early hypoxia (high levels of Net and HIF1 alpha), and late hypoxia (degradation of Net and HIF1 alpha). Modulators of prolyl hydroxylase domain protein (PHD) activity induce a mobility shift of Net, similar to HIF1 alpha, suggesting that post-translational modifications of both factors depend on PHD activity. The three PHD shave different roles in the regulation of Net protein levels; PHD1 and PHD3 are involved in the stabilization of Net, whereas PHD2 controls its degradation in late hypoxia. Net physically interacts with PHD2 in hypoxia, whereas PHD1 and PHD3 bind to Net in normoxia and hypoxia. Under the same conditions, PHD2 and PHD3 regulate both HIF1 alpha stabilization in early hypoxia and its degradation at late hypoxia, whereas PHD1 is involved in HIF1 alpha degradation in late hypoxia. We describe interconnections between the regulation of both Net and HIF1 alpha at the protein level. Evidence is provided for a direct physical interaction between Net and HIF1 alpha and indirect transcriptional regulation loops that involve the PHDs. Taken together our results indicate that Net and HIF1 alpha are components of distinct signaling pathways that are intricately linked.	[Serchov, Tsvetan; Dubois-Pot-Schneider, Helene; Charlot, Celine; Wasylyk, Bohdan] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM,UMR 7104,U964, F-67404 Illkirch Graffenstaden, Graffenstaden, France; [Roesl, Frank] Deutsch Krebsforschungszentrum, Abt Virale Transformationsmechanismen, D-69120 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; German Cancer Research Center (DKFZ)	Wasylyk, B (corresponding author), Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM,UMR 7104,U964, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, Graffenstaden, France.	boh@igbmc.u-strasbg.fr	Wasylyk, Bohdan/ABG-6778-2020	Wasylyk, Bohdan/0000-0002-1718-1237; Serchov, Tsvetan/0000-0002-2234-2875	Association pour la Recherche Contre le Cancer; Ligue Regionale (Bas-Rhin) Contre le Cancer; Ligue Regionale (Haut-Rhin) Contre le Cancer, Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; European Union [504587]; l'Institut National du Cancer (INCa); Regional Council of Alsace; Ministere de l'Education Nationale, de la Recherche et de la Technologie; Wasylyk laboratory	Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Regionale (Bas-Rhin) Contre le Cancer; Ligue Regionale (Haut-Rhin) Contre le Cancer, Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Union(European Commission); l'Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Regional Council of Alsace(Region Grand-Est); Ministere de l'Education Nationale, de la Recherche et de la Technologie; Wasylyk laboratory	This work was supported by grants from the Association pour la Recherche Contre le Cancer, the Ligue Regionale (Bas-Rhin) Contre le Cancer and the Ligue Regionale (Haut-Rhin) Contre le Cancer, Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer, the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the European Union (FP6 Prima Project 504587), and l'Institut National du Cancer (INCa) (AxeIV and DKFZ-Canceropole du Grande Est (CGE) projects).; Recipient of a fellowship from the Regional Council of Alsace.; Recipient of a fellowship from the Ministere de l'Education Nationale, de la Recherche et de la Technologie.; Recipient of a fellowship from l'Institut National du Cancer.; We thank Prof. Eric Stanbridge for providing the 444 cells, Dr. Alain Jung for critical reading of the manuscript, the Wasylyk laboratory members for support and encouragement, and the IGBMC core facilities.	Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Ayadi A, 2001, MECH DEVELOP, V102, P205, DOI 10.1016/S0925-4773(01)00289-1; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Buchwalter G, 2005, MOL CELL BIOL, V25, P10853, DOI 10.1128/MCB.25.24.10853-10862.2005; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cioffi CL, 2003, BIOCHEM BIOPH RES CO, V303, P947, DOI 10.1016/S0006-291X(03)00453-4; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Ducret C, 2000, ONCOGENE, V19, P5063, DOI 10.1038/sj.onc.1203892; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Gross C, 2008, ONCOGENE, V27, P1333, DOI 10.1038/sj.onc.1210736; Gross C, 2007, MOL CELL BIOL, V27, P4133, DOI 10.1128/MCB.01867-06; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; STANBRIDGE EJ, 1976, LANCET, V2, P525; STANBRIDGE EJ, 1976, NATURE, V260, P17, DOI 10.1038/260017a0; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; van Riggelen J, 2005, J BIOL CHEM, V280, P3286, DOI 10.1074/jbc.M409915200; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Zheng H, 2003, GENE DEV, V17, P2283, DOI 10.1101/gad.272503; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51	35	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21223	21232		10.1074/jbc.M110.121723	http://dx.doi.org/10.1074/jbc.M110.121723			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20427288	Green Published, hybrid			2022-12-27	WOS:000279516100007
J	Jiang, YQ; Bernard, D; Yu, YK; Xie, YH; Zhang, T; Li, YY; Burnett, JP; Fu, XQ; Wang, SM; Sun, DX				Jiang, Yiqun; Bernard, Denzil; Yu, Yanke; Xie, Yehua; Zhang, Tao; Li, Yanyan; Burnett, Joseph P.; Fu, Xueqi; Wang, Shaomeng; Sun, Duxin			Split Renilla Luciferase Protein Fragment-assisted Complementation (SRL-PFAC) to Characterize Hsp90-Cdc37 Complex and Identify Critical Residues in Protein/Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 INHIBITORS; LIVING SUBJECTS; KINASE CHAPERONE; ATPASE CYCLE; CANCER-CELLS; BINDING SITE; CO-CHAPERONE; CDC37; IDENTIFICATION; EXPRESSION	Hsp90 requires cochaperone Cdc37 to load its clients to the Hsp90 superchaperone complex. The purpose of this study was to utilize split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) bioluminescence to study the full-length human Hsp90-Cdc37 complex and to identity critical residues and their contributions for Hsp90/Cdc37 interaction in living cells. SRL-PFAC showed that full-length human Hsp90/Cdc37 interaction restored dramatically high luciferase activity through Hsp90-Cdc37-assisted complementation of the N and C termini of luciferase (compared with the set of controls). Immunoprecipitation confirmed that the expressed fusion proteins (NRL-Hsp90 and Cdc37-CRL) preserved their ability to interact with each other and also with native Hsp90 or Cdc37. Molecular dynamic simulation revealed several critical residues in the two interaction patches (hydrophobic and polar) at the interface of Hsp90/Cdc37. Mutagenesis confirmed the critical residues for Hsp90-Cdc37 complex formation. SRL-PFAC bioluminescence evaluated the contributions of these critical residues in Hsp90/Cdc37 interaction. The results showed that mutations in Hsp90 (Q133A, F134A, and A121N) and mutations in Cdc37 (M164A, R167A, L205A, and Q208A) reduced the Hsp90/Cdc37 interaction by 70-95% as measured by the resorted luciferase activity through Hsp90-Cdc37-assisted complementation. In comparison, mutations in Hsp90 (E47A and S113A) and a mutation in Cdc37 (A204E) decreased the Hsp90/Cdc37 interaction by 50%. In contrast, mutations of Hsp90 (R46A, S50A, C481A, and C598A) and mutations in Cdc37 (C54S, C57S, and C64S) did not change Hsp90/Cdc37 interactions. The data suggest that single amino acid mutation in the interface of Hsp90/Cdc37 is sufficient to disrupt its interaction, although Hsp90/Cdc37 interactions are through large regions of hydrophobic and polar interactions. These findings provides a rationale to develop inhibitors for disruption of the Hsp90/Cdc37 interaction.	[Jiang, Yiqun; Yu, Yanke; Xie, Yehua; Zhang, Tao; Li, Yanyan; Burnett, Joseph P.; Sun, Duxin] Univ Michigan, Dept Pharmaceut Sci, Coll Pharm, Ann Arbor, MI 48109 USA; [Bernard, Denzil; Wang, Shaomeng] Univ Michigan, Ctr Comprehens Canc, Dept Internal Med, Dept Pharmacol & Med Chem, Ann Arbor, MI 48109 USA; [Jiang, Yiqun; Fu, Xueqi] Jilin Univ, Coll Life Sci, Edmond H Fischer Signal Transduct Lab, Changchun 130023, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Jilin University	Fu, XQ (corresponding author), Univ Michigan, Dept Pharmaceut Sci, Coll Pharm, Ann Arbor, MI 48109 USA.	fxq@jlu.edu.cn; shaomeng@umich.edu; duxins@umich.edu	Sun, Duxin/AAA-1774-2022; Zhang, Tao/A-7339-2012; Yu, Yanke/E-4919-2012	Bernard, Denzil/0000-0001-7529-3336; Wang, Shaomeng/0000-0002-8782-6950; Burnett, Joseph/0000-0002-4844-6613	National Institutes of Health [RO1 CA120023, R21 CA143474]; University of Michigan Cancer Center; Chinese Scholarship Council; NATIONAL CANCER INSTITUTE [R21CA143474, R01CA120023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); Chinese Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the National Institutes of Health (RO1 CA120023 and R21 CA143474); University of Michigan Cancer Center Research Grant (Munn); and University of Michigan Cancer Center Core Grant (to D. S.). This study was also partially supported by Chinese Scholarship Council (to Y. J.) (2009).	Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Chan CT, 2008, CANCER RES, V68, P216, DOI 10.1158/0008-5472.CAN-07-2268; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; FINKELSTEIN DB, 1983, J BIOL CHEM, V258, P1908; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Kaihara A, 2003, ANAL CHEM, V75, P4176, DOI 10.1021/ac0300800; Kaihara A, 2008, CHEM-ASIAN J, V3, P38, DOI 10.1002/asia.200700186; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; LAI BT, 1984, MOL CELL BIOL, V4, P2802, DOI 10.1128/MCB.4.12.2802; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Massoud TF, 2004, FASEB J, V18, P1105, DOI 10.1096/fj.03-1128fje; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Pascale RM, 2005, HEPATOLOGY, V42, P1310, DOI 10.1002/hep.20962; Paulmurugan R, 2004, CANCER RES, V64, P2113, DOI 10.1158/0008-5472.CAN-03-2972; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REED SI, 1980, GENETICS, V95, P561; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Shao JY, 2003, BIOCHEMISTRY-US, V42, P12577, DOI 10.1021/bi035138j; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Sreeramulu S, 2009, J BIOL CHEM, V284, P3885, DOI 10.1074/jbc.M806715200; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Stepanova L, 2000, MOL CELL BIOL, V20, P4462, DOI 10.1128/MCB.20.12.4462-4473.2000; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	44	33	33	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21023	21036		10.1074/jbc.M110.103390	http://dx.doi.org/10.1074/jbc.M110.103390			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20413594	Green Published, hybrid			2022-12-27	WOS:000279228600066
J	Kaizuka, T; Hara, T; Oshiro, N; Kikkawa, U; Yonezawa, K; Takehana, K; Iemura, S; Natsume, T; Mizushima, N				Kaizuka, Takeshi; Hara, Taichi; Oshiro, Noriko; Kikkawa, Ushio; Yonezawa, Kazuyoshi; Takehana, Kenji; Iemura, Shun-ichiro; Natsume, Tohru; Mizushima, Noboru			Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; KINASE-ACTIVITY; MTOR; CHECKPOINT; RAPTOR; AUTOPHAGY; PROTEIN; RICTOR; PATHWAY; DEFINES	Mammalian target of rapamycin (mTOR) is a member of the phosphatidylinositol 3-kinase-related kinase (PIKK) family and is a major regulator of translation, cell growth, and autophagy. mTOR exists in two distinct complexes, mTORC1 and mTORC2, that differ in their subunit composition. In this study, we identified KIAA0406 as a novel mTOR-interacting protein. Because it has sequence homology with Schizosaccharomyces pombe Tti1, we named it mammalian Tti1. Tti1 constitutively interacts with mTOR in both mTORC1 and mTORC2. Knockdown of Tti1 suppresses phosphorylation of both mTORC1 substrates (S6K1 and 4F-BP1) and an mTORC2 substrate (Akt) and also induces autophagy. S. pombe Tti1 binds to Tel2, a protein whose mammalian homolog was recently reported to regulate the stability of PIKKs. We confirmed that Tti1 binds to Tel2 also in mammalian cells, and Tti1 interacts with and stabilizes all six members of the PIKK family of proteins (mTOR, ATM, ATR, DNA-PKcs, SMG-1, and TRRAP). Furthermore, using immuno-precipitation and size-exclusion chromatography analyses, we found that knockdown of either Tti1 or Tel2 causes disassembly of mTORC1 and mTORC2. These results indicate that Tti1 and Tel2 are important not only for mTOR stability but also for assembly of the mTOR complexes to maintain their activities.	[Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Oshiro, Noriko; Kikkawa, Ushio; Yonezawa, Kazuyoshi] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan; [Takehana, Kenji] Ajinomoto Co Inc, Exploratory Res, Pharmacol Res Lab, Kawasaki, Kanagawa 2108681, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Syst Control Team, Biomed Informat Res Ctr, Tokyo 1350064, Japan	Tokyo Medical & Dental University (TMDU); Kobe University; Ajinomoto Co Inc; National Institute of Advanced Industrial Science & Technology (AIST)	Mizushima, N (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	nmizu.phy2@tmd.ac.jp	Mizushima, Noboru/C-3635-2009; Natsume, Tohru/M-7627-2018	Mizushima, Noboru/0000-0002-6258-6444; Natsume, Tohru/0000-0002-1510-2582; Kaizuka, Takeshi/0000-0002-5253-1896	Ministry of Education, Culture, Sports, Science and Technology, Japan; Toray Science Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Toray Science Foundation, and the Takeda Science Foundation (to N.M.).	Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Danielsen JMR, 2009, J BIOL CHEM, V284, P4140, DOI 10.1074/jbc.M808174200; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; HARTMAN PS, 1982, GENETICS, V102, P159; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanoh J, 2007, GENES CELLS, V12, P1301, DOI 10.1111/j.1365-2443.2007.01142.x; Kanu N, 2007, EMBO J, V26, P2933, DOI 10.1038/sj.emboj.7601733; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishiuma T, 1998, BIOCHEM BIOPH RES CO, V252, P440, DOI 10.1006/bbrc.1998.9671; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	41	178	196	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20109	20116		10.1074/jbc.M110.121699	http://dx.doi.org/10.1074/jbc.M110.121699			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427287	Green Published, hybrid			2022-12-27	WOS:000279012000045
J	Kobayashi, Y; Zhuang, JL; Peltz, S; Dougherty, J				Kobayashi, Yoshifumi; Zhuang, Jianling; Peltz, Stuart; Dougherty, Joseph			Identification of a Cellular Factor That Modulates HIV-1 Programmed Ribosomal Frameshifting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; STRANDED-RNA VIRUS; POL FUSION PROTEIN; STIMULATORY SIGNAL; IN-VIVO; TYPE-1; YEAST; TRANSLATION; EFFICIENCY	Programmed -1 ribosomal frameshifting (PRF) is a distinctive mode of gene expression utilized by some viruses, including human immunodeficiency virus type 1 (HIV-1), to produce multiple proteins from a single mRNA. -1 PRF induces a subset of elongating ribosomes to shift their translational reading frame by 1 base in the 5' direction. The appropriate ratio of Gag to Gag-Pol synthesis is tightly regulated by the PRF signal which promotes ribosomes to shift frame, and even small changes in PRF efficiency, either up or down, have significant inhibitory effects upon virus production, making PRF essential for HIV-1 replication. Although little has been reported about the cellular factors that modulate HIV-1 PRF, the cis-acting elements regulating PRF have been extensively investigated, and the PRF signal of HIV-1 was shown to include a slippery site and frameshift stimulatory signal. Recently, a genome-wide screen performed to identify cellular factors that affect HIV-1 replication demonstrated that down-regulation of eukaryotic release factor 1 (eRF1) inhibited HIV-1 replication. Because of the eRF1 role in translation, we hypothesized that eRF1 is important for HIV-1 PRF. Using a dual luciferase reporter system harboring a HIV-1 PRF signal, results showed that depletion or inhibition of eRF1 enhanced PRF in yeast, rabbit reticulocyte lysates, and mammalian cells. Consistent with the eRF1 role in modulating HIV PRF, depleting eRF1 increased the Gag-Pol to Gag ratio in cells infected with replication-competent virus. The increase in PRF was independent of a proximal termination codon and did not result from increased ribosomal pausing at the slippery site. This is the first time that a cellular factor has been identified which can promote HIV-1 PRF and highlights HIV-1 PRF as essential for replication and an important but under exploited antiviral drug target.	[Kobayashi, Yoshifumi; Zhuang, Jianling; Dougherty, Joseph] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Peltz, Stuart] PTC Therapeut Inc, Plainfield, NJ 07080 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Dougherty, J (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	doughejp@umdnj.edu			National Institutes of Health [P01AI057596]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant P01AI057596.	Baril M, 2003, RNA, V9, P1246, DOI 10.1261/rna.5113603; Baril M, 2003, J MOL BIOL, V331, P571, DOI 10.1016/S0022-2836(03)00784-8; Bidou L, 1997, RNA, V3, P1153; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Dinman J. D., 2007, TRANSLATIONAL CONTRO, P625; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dulude D, 2002, NUCLEIC ACIDS RES, V30, P5094, DOI 10.1093/nar/gkf657; FELSENSTEIN KM, 1988, J VIROL, V62, P2179, DOI 10.1128/JVI.62.6.2179-2182.1988; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Freed Eric O., 2001, Somatic Cell and Molecular Genetics, V26, P13, DOI 10.1023/A:1021070512287; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gaudin C, 2005, J MOL BIOL, V349, P1024, DOI 10.1016/j.jmb.2005.04.045; Gould PS, 2005, BIOTECHNIQUES, V38, P397, DOI 10.2144/05383ST02; Grentzmann G, 1998, RNA, V4, P479; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Hayes S, 1999, ACTA BIOCHIM POL, V46, P879, DOI 10.18388/abp.1999_4109; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; Hung M, 1998, J VIROL, V72, P4819, DOI 10.1128/JVI.72.6.4819-4824.1998; Inge-Vechtomov S, 2003, BIOL CELL, V95, P195, DOI 10.1016/S0248-4900(03)00035-2; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JACKS T, 1990, CURR TOP MICROBIOL, V157, P93; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; KOLLMUS H, 1994, J VIROL, V68, P6087, DOI 10.1128/JVI.68.9.6087-6091.1994; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; MORIKAWA S, 1992, VIROLOGY, V186, P389, DOI 10.1016/0042-6822(92)90004-9; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Orlova M, 2003, CELL, V115, P319, DOI 10.1016/S0092-8674(03)00805-5; Park HJ, 2009, FEBS LETT, V583, P665, DOI 10.1016/j.febslet.2009.01.015; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; Paulus C, 2004, VIROLOGY, V330, P271, DOI 10.1016/j.virol.2004.09.013; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; SOMOGYI P, 1993, MOL CELL BIOL, V13, P6931, DOI 10.1128/MCB.13.11.6931; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Stansfield I, 1997, EUR J BIOCHEM, V245, P557, DOI 10.1111/j.1432-1033.1997.00557.x; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; Staple DW, 2003, NUCLEIC ACIDS RES, V31, P4326, DOI 10.1093/nar/gkg654; Tan M, 2001, J EUKARYOT MICROBIOL, V48, P575, DOI 10.1111/j.1550-7408.2001.tb00193.x; Telenti A, 2002, J VIROL, V76, P7868, DOI 10.1128/JVI.76.15.7868-7873.2002; TU CL, 1992, P NATL ACAD SCI USA, V89, P8636, DOI 10.1073/pnas.89.18.8636; Vimaladithan A, 1998, METH MOL B, V77, P399; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7	49	26	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19776	19784		10.1074/jbc.M109.085621	http://dx.doi.org/10.1074/jbc.M109.085621			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20418372	Green Published, hybrid			2022-12-27	WOS:000279012000010
J	Marino, F; Pelc, LA; Vogt, A; Gandhi, PS; Di Cera, E				Marino, Francesca; Pelc, Leslie A.; Vogt, Austin; Gandhi, Prafull S.; Di Cera, Enrico			Engineering Thrombin for Selective Specificity toward Protein C and PAR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOVALENT CATION SPECIFICITY; XIII ACTIVATION PEPTIDE; ANTICOAGULANT ACTIVITY; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; POTENT ANTICOAGULANT; MUTANT W215A/E217A; BLOOD-COAGULATION; STRUCTURAL BASIS; ALPHA-THROMBIN	Thrombin elicits functional responses critical to blood homeostasis by interacting with diverse physiological substrates. Ala-scanning mutagenesis of 97 residues covering 53% of the solvent accessible surface area of the enzyme identifies Trp(215) as the single most important determinant of thrombin specificity. Saturation mutagenesis of Trp(215) produces constructs featuring k(cat)/K-m values for the hydrolysis of fibrinogen, protease-activated receptor PAR1, and protein C that span five orders of magnitude. Importantly, the effect of Trp(215) replacement is context dependent. Mutant W215E is 10-fold more specific for protein C than fibrinogen and PAR1, which represents a striking shift in specificity relative to wild-type that is 100-fold more specific for fibrinogen and PAR1 than protein C. However, when the W215E mutation is combined with deletion of nine residues in the autolysis loop, which by itself shifts the specificity of the enzyme from fibrinogen and PAR1 to protein C, the resulting construct features significant activity only toward PAR1. These findings demonstrate that thrombin can be re-engineered for selective specificity toward protein C and PAR1. Mutations of Trp(215) provide important reagents for dissecting the multiple functional roles of thrombin in the blood and for clinical applications.	[Marino, Francesca; Pelc, Leslie A.; Vogt, Austin; Gandhi, Prafull S.; Di Cera, Enrico] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Vogt, Austin/E-9731-2012		National Institutes of Health Research [HL49413, HL58141, HL73813, HL95315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073813, R29HL049413, R01HL058141, R01HL049413, R44HL095315] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grants HL49413, HL58141, HL73813, and HL95315 (to E. D. C.).	Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Bah A, 2009, J BIOL CHEM, V284, P20034, DOI 10.1074/jbc.M109.012344; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Berny MA, 2008, ARTERIOSCL THROM VAS, V28, P329, DOI 10.1161/ATVBAHA.107.156273; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; BODE W, 1992, PROTEIN SCI, V1, P426; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Busch M, 2004, EUR J MED RES, V9, P199; Bush-Pelc LA, 2007, J BIOL CHEM, V282, P27165, DOI 10.1074/jbc.M703202200; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dang QD, 1997, J BIOL CHEM, V272, P19649, DOI 10.1074/jbc.272.32.19649; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2008, NAT CHEM BIOL, V4, P270, DOI 10.1038/nchembio0508-270; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; FENTON JW, 1986, ANN NY ACAD SCI, V485, P5, DOI 10.1111/j.1749-6632.1986.tb34563.x; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gandhi PS, 2009, J BIOL CHEM, V284, P24098, DOI 10.1074/jbc.M109.025403; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093; GRIFFIN JH, 1995, NATURE, V378, P337, DOI 10.1038/378337a0; Grinnell BW, 1997, NAT BIOTECHNOL, V15, P124, DOI 10.1038/nbt0297-124; Gruber A, 2006, J THROMB HAEMOST, V4, P392, DOI 10.1111/j.1538-7836.2006.01760.x; Gruber A, 2002, J BIOL CHEM, V277, P27581, DOI 10.1074/jbc.C200237200; Gruber A, 2007, BLOOD, V109, P3733, DOI 10.1182/blood-2006-07-035147; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Isetti G, 2007, BIOCHEMISTRY-US, V46, P2444, DOI 10.1021/bi0622120; Krem MM, 2002, J BIOL CHEM, V277, P40260, DOI 10.1074/jbc.M206173200; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2009, BLOOD, V113, P5970, DOI 10.1182/blood-2008-10-183327; Niu WL, 2009, J BIOL CHEM, V284, P36175, DOI 10.1074/jbc.M109.069500; Padma Vasantha, 2005, Expert Rev Neurother, V5, P223, DOI 10.1586/14737175.5.2.223; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P1943, DOI 10.1007/s00018-008-8179-y; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Prasad S, 2003, P NATL ACAD SCI USA, V100, P13785, DOI 10.1073/pnas.2333109100; Prasad S, 2004, J BIOL CHEM, V279, P10103, DOI 10.1074/jbc.M312614200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Sadasivan C, 2000, J BIOL CHEM, V275, P36942, DOI 10.1074/jbc.M006076200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; TSIANG M, 1995, J BIOL CHEM, V270, P16854, DOI 10.1074/jbc.270.28.16854; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; Varadarajan N, 2008, NAT CHEM BIOL, V4, P290, DOI 10.1038/nchembio.80; Vindigni A, 1996, BIOCHEMISTRY-US, V35, P4417, DOI 10.1021/bi952834d; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200	59	34	40	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19145	19152		10.1074/jbc.M110.119875	http://dx.doi.org/10.1074/jbc.M110.119875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404340	Green Published, hybrid			2022-12-27	WOS:000278727800024
J	Mukhopadhyay, B; Liu, J; Osei-Hyiaman, D; Godlewski, G; Mukhopadhyay, P; Wang, L; Jeong, WI; Gao, B; Duester, G; Mackie, K; Kojima, S; Kunos, G				Mukhopadhyay, Bani; Liu, Jie; Osei-Hyiaman, Douglas; Godlewski, Grzegorz; Mukhopadhyay, Partha; Wang, Lei; Jeong, Won-Il; Gao, Bin; Duester, Gregg; Mackie, Ken; Kojima, Soichi; Kunos, George			Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC CB1 RECEPTORS; DIET-INDUCED OBESITY; METABOLIC SYNDROME; RESPONSE ELEMENTS; RISK-FACTORS; CELLS; GENE; RIMONABANT; MICE; ACTIVATION	Alcoholism can result in fatty liver that can progress to steatohepatitis, cirrhosis, and liver cancer. Mice fed alcohol develop fatty liver through endocannabinoid activation of hepatic CB1 cannabinoid receptors (CB1R), which increases lipogenesis and decreases fatty acid oxidation. Chronic alcohol feeding also up-regulates CB1R in hepatocytes in vivo, which could be replicated in vitro by co-culturing control hepatocytes with hepatic stellate cells (HSC) isolated from ethanol-fed mice, implicating HSC-derived mediator(s) in the regulation of hepatic CB1R (Jeong, W. I., Osei-Hyiaman, D., Park, O., Liu, J., Batkai, S., Mukhopadhyay, P., Horiguchi, N., Harvey-White, J., Marsicano, G., Lutz, B., Gao, B., and Kunos, G. (2008) Cell Metab. 7, 227-235). HSC being a rich source of retinoic acid (RA), we tested whether RA and its receptors may regulate CB1R expression in cultured mouse hepatocytes. Incubation of hepatocytes with RA or RA receptor (RAR) agonists increased CB1R mRNA and protein, the most efficacious being the RAR gamma agonist CD437 and the pan-RAR agonist TTNPB. The endocannabinoid 2-arachidonoylglycerol (2-AG) also increased hepatic CB1R expression, which was mediated indirectly via RA, because it was absent in hepatocytes from mice lacking retinaldehyde dehydrogenase 1, the enzyme catalyzing the generation of RA from retinaldehyde. The binding of RAR gamma to the CB1R gene 5' upstream domain in hepatocytes treated with RAR agonists or 2-AG was confirmed by chromatin immunoprecipitation and electrophoretic mobility shift and antibody supershift assays. Finally, TTNPB-induced CB1R expression was attenuated by small interfering RNA knockdown of RAR gamma in hepatocytes. We conclude that RAR gamma regulates CB1R expression and is thus involved in the control of hepatic fat metabolism by endocannabinoids.	[Mukhopadhyay, Bani; Liu, Jie; Osei-Hyiaman, Douglas; Godlewski, Grzegorz; Mukhopadhyay, Partha; Wang, Lei; Jeong, Won-Il; Gao, Bin; Kunos, George] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA; [Duester, Gregg] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Mackie, Ken] Indiana Univ, Gill Ctr Biomol Sci, Bloomington, IN 47405 USA; [Kojima, Soichi] RIKEN, Adv Sci Inst, Dept Biol Chem, Mol Ligand Biol Res Team,Chem Genom Res Grp, Wako, Saitama 3510198, Japan	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Sanford Burnham Prebys Medical Discovery Institute; Indiana University System; Indiana University Bloomington; RIKEN	Mukhopadhyay, B (corresponding author), NIAAA, Lab Physiol Studies, NIH, 5625 Fishers Ln,MSC 9413, Bethesda, MD 20892 USA.	mukhopadhyayb@mail.nih.gov; gkunos@mail.nih.gov	Kojima, Soichi/N-7104-2015; Mackie, Kenneth P/B-7358-2011; Mackie, Ken/E-3715-2013; MUKHOPADHYAY, PARTHA/G-3890-2010; JEONG, WON IL/B-6615-2011	Kojima, Soichi/0000-0002-5252-1612; Mackie, Ken/0000-0001-8501-6199; MUKHOPADHYAY, PARTHA/0000-0002-1178-1274; Duester, Gregg/0000-0003-4335-3650; Osei-Hyiaman, Douglas/0000-0002-2725-5519	National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse [DA11322, DA21696]; RIKEN; NATIONAL EYE INSTITUTE [R01EY013969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350, ZIAAA000368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021696, R01DA011322] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); RIKEN; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health intramural funds from the National Institute on Alcohol Abuse and Alcoholism (to G. K.) and National Institute on Drug Abuse Grants DA11322 and DA21696 (to K. M.). This work was also supported by the Chemical Genomics Research Program from RIKEN (to S. K.).	Alique M, 2007, PHARMACOLOGY, V79, P57, DOI 10.1159/000097785; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Bodor AL, 2005, J NEUROSCI, V25, P6845, DOI 10.1523/JNEUROSCI.0442-05.2005; Borner C, 2008, MOL PHARMACOL, V73, P1013, DOI 10.1124/mol.107.042945; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Falanga A, 1998, BLOOD, V92, P143, DOI 10.1182/blood.V92.1.143.413k18_143_151; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Hauksdottir H, 2003, MOL ENDOCRINOL, V17, P373, DOI 10.1210/me.2002-0340; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McCaw EA, 2004, EUR J BIOCHEM, V271, P4909, DOI 10.1111/j.1432-1033.2004.04460.x; Mukhopadhyay B, 2003, MOL MICROBIOL, V47, P171, DOI 10.1046/j.1365-2958.2003.03286.x; Osei-Hyiaman D, 2005, NEUROENDOCRINOLOGY, V81, P273, DOI 10.1159/000087925; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shimada T, 1997, ARCH BIOCHEM BIOPHYS, V344, P220, DOI 10.1006/abbi.1997.0209; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Sun R, 2005, BIOCHEM BIOPH RES CO, V338, P1943, DOI 10.1016/j.bbrc.2005.10.171; Svensson AC, 2006, J NEUROSCI RES, V83, P1128, DOI 10.1002/jnr.20792; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	42	76	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19002	19011		10.1074/jbc.M109.068460	http://dx.doi.org/10.1074/jbc.M109.068460			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410309	Green Published, hybrid			2022-12-27	WOS:000278727800008
J	Tabatabaian, F; Dougherty, K; Di Fulvio, M; Gomez-Cambronero, J				Tabatabaian, Farnaz; Dougherty, Kevin; Di Fulvio, Mauricio; Gomez-Cambronero, Julian			Mammalian Target of Rapamycin (mTOR) and S6 Kinase Down-regulate Phospholipase D2 Basal Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; ACTIVATION; BINDING; PLD1; INTERLEUKIN-8; TRANSLATION; INVOLVEMENT; DOMAIN	The mammalian target of rapamycin (mTOR) and S6 kinase (S6K) pathway is essential for cell differentiation, growth, and survival. Phospholipase D2 (PLD2) plays a key role in mTOR/S6K mitogenic signaling. However, the impact of PLD on mTOR/S6K gene expression is not known. Here we show that interleukin-8 (IL-8) increases mRNA expression levels for PLD2, mTOR, and S6K, with PLD2 preceding mTOR/S6K in time. Silencing of PLD2 gene expression abrogated IL-8-induced mTOR/S6K mRNA expression, whereas silencing of mTOR or S6K gene expression resulted in large (>3-fold and >5-fold, respectively) increased levels of PLD2 RNA, which was paralleled by increases in protein expression and lipase activity. Treatment of cells with 0.5 nM rapamycin induced a similar trend. These results suggest that, under basal conditions, PLD2 expression and concomitant activity is negatively regulated by the mTOR/S6K signaling pathway. Down-regulation of PLD2 was confirmed in differentiated HL-60 leukocytes overexpressing an mTOR-wild type, but not an mTOR kinase-dead construct. At the cellular level, overexpression of mTOR-wild type resulted in lower basal cell migration, which was reversed by treatment with IL-8. We propose that IL-8 reverses an mTOR/S6K-led down-regulation of PLD2 expression and enables PLD2 to fully function as a facilitator for cell migration.	[Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Di Fulvio, Mauricio] Wright State Univ, Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	Wright State University Dayton; Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 (to J.G.-C.).	BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bautista MV, 2009, J IMMUNOL, V183, P2159, DOI 10.4049/jimmunol.0803022; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Di Fulvio M, 2006, ONCOGENE, V25, P3032, DOI 10.1038/sj.onc.1209340; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gomez-Cambronero J, 2003, FEBS LETT, V550, P94, DOI 10.1016/S0014-5793(03)00828-7; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kikuchi R, 2007, ONCOGENE, V26, P1802, DOI 10.1038/sj.onc.1209973; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; LARSEN CG, 1989, SCIENCE, V243, P1464, DOI 10.1126/science.2648569; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; LEE J, 1992, J BIOL CHEM, V267, P16283; Lehman JA, 2001, AM J PHYSIOL-CELL PH, V280, pC183, DOI 10.1152/ajpcell.2001.280.1.C183; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Martinez FO, 2004, EUR J IMMUNOL, V34, P2286, DOI 10.1002/eji.200324481; Murooka TT, 2008, BLOOD, V111, P4892, DOI 10.1182/blood-2007-11-125039; SEBOK K, 1993, J IMMUNOL, V150, P1524; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015	33	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18991	19001		10.1074/jbc.M110.111542	http://dx.doi.org/10.1074/jbc.M110.111542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410302	Green Published, hybrid			2022-12-27	WOS:000278727800007
J	Yang, KL; Moldovan, GL; D'Andrea, AD				Yang, Kailin; Moldovan, George-Lucian; D'Andrea, Alan D.			RAD18-dependent Recruitment of SNM1A to DNA Repair Complexes by a Ubiquitin-binding Zinc Finger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FANCONI-ANEMIA PATHWAY; HOMOLOGOUS RECOMBINATION; TRANSLESION SYNTHESIS; POLYMERASE-ETA; PCNA; PROTEIN; DAMAGE; RAD18; CELLS; FAMILY	SNM1A is a member of the SNM1 family of nucleases required for cellular processing of interstrand DNA crosslinks (ICLs). Little is known about the molecular function of SNM1A, in terms of its recruitment to ICL lesions or its DNA damage processing activity. Here we show that SNM1A contains a functional PIP box (PCNA-interacting protein box) and a UBZ (ubiquitin binding zinc finger), required for assembly of SNM1A into nuclear focus. Moreover, RAD18-dependent monoubiquitination of PCNA is required for Mitomycin C and Ultraviolet Light inducible SNM1A nuclear focus assembly. Taken together, our results identify a novel RAD18-PCNA(Ub)-SNM1A pathway required for nuclear focus formation and ICL resistance.	[D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Yang, Kailin] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Leder Human Biol Program, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Yang, Kailin/D-7966-2013; Classen, Scott/AAY-8176-2020; Yang, Kailin/L-2205-2013	Yang, Kailin/0000-0001-5968-6738; George-Lucian, Moldovan/0000-0003-3825-149X	National Institutes of Health [R01DK43889, R01HL52725, P01CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725, R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK43889, R01HL52725, and P01CA092584 (to A. D. D.).	Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Crosetto N, 2008, J BIOL CHEM, V283, P35173, DOI 10.1074/jbc.M803219200; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Guo C, 2008, J BIOL CHEM, V283, P4658, DOI 10.1074/jbc.M709275200; Hazrati A, 2008, DNA REPAIR, V7, P230, DOI 10.1016/j.dnarep.2007.09.013; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; Hemphill AW, 2008, MOL GENET METAB, V94, P38, DOI 10.1016/j.ymgme.2007.11.012; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Richie CT, 2002, MOL CELL BIOL, V22, P8635, DOI 10.1128/MCB.22.24.8635-8647.2002; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383	34	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19085	19091		10.1074/jbc.M109.100032	http://dx.doi.org/10.1074/jbc.M109.100032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20385554	hybrid, Green Published			2022-12-27	WOS:000278727800018
J	Sprehe, M; Fisk, JC; McEvoy, SM; Read, LK; Schumacher, MA				Sprehe, Mareen; Fisk, John C.; McEvoy, Sarah M.; Read, Laurie K.; Schumacher, Maria A.			Structure of the Trypanosoma brucei p22 Protein, a Cytochrome Oxidase Subunit II-specific RNA-editing Accessory Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL MESSENGER-RNAS; INDUCIBLE EXPRESSION SYSTEM; TYPE-1 TAT TRANSACTIVATOR; IN-VITRO INTERACTION; LAMIN-B RECEPTOR; GUIDE-RNA; CELLULAR-PROTEIN; SPLICING FACTOR; BINDING-PROTEIN; HUMAN P-32	Kinetoplastid RNA (k-RNA) editing is a complex process in the mitochondria of kinetoplastid protozoa, including Trypanosoma brucei, that involves the guide RNA-directed insertion and deletion of uridines from precursor-mRNAs to produce mature, translatable mRNAs. k-RNA editing is performed by multiprotein complexes called editosomes. Additional non-editosome components termed k-RNA-editing accessory factors affect the extent of editing of specific RNAs or classes of RNAs. The T. brucei p22 protein was identified as one such accessory factor. Here we show that p22 contributes to cell growth in the procyclic form of T. brucei and functions as a cytochrome oxidase subunit II-specific k-RNA-editing accessory factor. To gain insight into its functions, we solved the crystal structure of the T. brucei p22 protein to 2.0-angstrom resolution. The p22 structure consists of a six-stranded, antiparallel beta-sheet flanked by five alpha-helices. Three p22 subunits combine to form a tight trimer that is primarily stabilized by interactions between helical residues. One side of the trimer is strikingly acidic, while the opposite face is more neutral. Database searches show p22 is structurally similar to human p32, which has a number of functions, including regulation of RNA splicing. p32 interacts with a number of target proteins via its alpha 1 N-terminal helix, which is among the most conserved regions between p22 and p32. Co-immunoprecipitation studies showed that p22 interacts with the editosome and the k-RNA accessory protein, TbRGG2, and alpha 1 of p22 was shown to be important for the p22-TbRGG2 interaction. Thus, these combined studies suggest that p22 mediates its role in k-RNA editing by acting as an adaptor protein.	[Schumacher, Maria A.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, Houston, TX 77030 USA; [Fisk, John C.; McEvoy, Sarah M.; Read, Laurie K.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol & Immunol, Buffalo, NY 14214 USA	University of Texas System; UTMD Anderson Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Schumacher, MA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, 1515 Holcombe Blvd, Houston, TX 77030 USA.	maschuma@mdanderson.org			National Institutes of Health [RO1 GM074815, RO1 AI061580, F32 AI07718501]; Office of science, Office of Basic Energy Sciences, Material Sciences Division, of the US Dept. of Energy at Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of science, Office of Basic Energy Sciences, Material Sciences Division, of the US Dept. of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM074815 (to M. A. S.), RO1 AI061580 (to L. K. R.), and F32 AI07718501 (to J.C.F.). The Advanced Light Source is supported by the Director, Office of science, Office of Basic Energy Sciences, Material Sciences Division, of the US Dept. of Energy under contract DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory.	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2002, CELL, V108, P637, DOI 10.1016/S0092-8674(02)00647-5; Aphasizheva I, 2004, J BIOL CHEM, V279, P24123, DOI 10.1074/jbc.M401234200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beatch MD, 2005, J VIROL, V79, P10807, DOI 10.1128/JVI.79.16.10807-10820.2005; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Berro R, 2006, J VIROL, V80, P3189, DOI 10.1128/JVI.80.7.3189-3204.2006; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruni R, 1996, P NATL ACAD SCI USA, V93, P10423, DOI 10.1073/pnas.93.19.10423; Bryant HE, 2000, J VIROL, V74, P11322, DOI 10.1128/JVI.74.23.11322-11328.2000; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Chattopadhyay C, 2004, NUCLEIC ACIDS RES, V32, P3632, DOI 10.1093/nar/gkh692; CORELL RA, 1993, NUCLEIC ACIDS RES, V21, P4313, DOI 10.1093/nar/21.18.4313; Corell RA, 1996, MOL CELL BIOL, V16, P1410; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; DeLano W.L, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Golden DE, 2005, RNA, V11, P29, DOI 10.1261/rna.7170705; Goulah CC, 2007, J BIOL CHEM, V282, P7181, DOI 10.1074/jbc.M609485200; Goulah CC, 2006, RNA, V12, P1545, DOI 10.1261/rna.90106; Hall KT, 2002, J VIROL, V76, P11612, DOI 10.1128/JVI.76.22.11612-11622.2002; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; Hayman ML, 2001, NUCLEIC ACIDS RES, V29, P5216, DOI 10.1093/nar/29.24.5216; Hermann T, 1997, NUCLEIC ACIDS RES, V25, P2311, DOI 10.1093/nar/25.12.2311; Herwald H, 1996, J BIOL CHEM, V271, P13040, DOI 10.1074/jbc.271.22.13040; Horvath A, 2000, SCIENCE, V287, P1639, DOI 10.1126/science.287.5458.1639; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Joseph K, 1996, P NATL ACAD SCI USA, V93, P8552, DOI 10.1073/pnas.93.16.8552; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Klingbeil MM, 2004, P NATL ACAD SCI USA, V101, P4333, DOI 10.1073/pnas.0401400101; Klingbeil MM, 2001, PROTIST, V152, P255, DOI 10.1078/1434-4610-00066; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Liang XZ, 2004, J VIROL, V78, P12416, DOI 10.1128/JVI.78.22.12416-12427.2004; Lim BL, 1996, BIOCHEM BIOPH RES CO, V218, P260, DOI 10.1006/bbrc.1996.0046; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; LUO Y, 1994, J VIROL, V68, P3850, DOI 10.1128/JVI.68.6.3850-3856.1994; Mallick J, 2005, EXP CELL RES, V309, P250, DOI 10.1016/j.yexcr.2005.05.025; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363; Nguyen T, 2000, INFECT IMMUN, V68, P2061, DOI 10.1128/IAI.68.4.2061-2068.2000; Nikolakaki E, 1996, J BIOL CHEM, V271, P8365, DOI 10.1074/jbc.271.14.8365; Okagaki T, 2000, J CELL BIOL, V148, P653, DOI 10.1083/jcb.148.4.653; Osato D, 2009, RNA, V15, P1338, DOI 10.1261/rna.1642809; Panigrahi AK, 2003, J AM SOC MASS SPECTR, V14, P728, DOI 10.1016/S1044-0305(03)00126-0; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Robles-Flores M, 2002, J BIOL CHEM, V277, P5247, DOI 10.1074/jbc.M109333200; Schmid B, 1996, EUR J BIOCHEM, V240, P721, DOI 10.1111/j.1432-1033.1996.0721h.x; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; Seytter T, 1998, YEAST, V14, P303, DOI 10.1002/(SICI)1097-0061(19980315)14:4<303::AID-YEA217>3.0.CO;2-N; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; Sheikh MA, 2008, PROTEINS, V71, P1563, DOI 10.1002/prot.21993; SIMOS G, 1994, FEBS LETT, V346, P225, DOI 10.1016/0014-5793(94)00479-X; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; Stuart K, 2002, MOL MICROBIOL, V45, P591, DOI 10.1046/j.1365-2958.2002.03028.x; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Sunayama J, 2004, CELL DEATH DIFFER, V11, P771, DOI 10.1038/sj.cdd.4401418; Tange TO, 1996, J BIOL CHEM, V271, P10066, DOI 10.1074/jbc.271.17.10066; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Van den Brulle J, 1999, APPL ENVIRON MICROB, V65, P5222; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Wang YL, 1997, VIROLOGY, V236, P18, DOI 10.1006/viro.1997.8739; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yanagida M, 2004, J BIOL CHEM, V279, P1607, DOI 10.1074/jbc.M305604200; YU L, 1995, J VIROL, V69, P3007, DOI 10.1128/JVI.69.5.3007-3016.1995; YU L, 1995, J VIROL, V69, P3017, DOI 10.1128/JVI.69.5.3017-3023.1995	94	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18899	18908		10.1074/jbc.M109.066597	http://dx.doi.org/10.1074/jbc.M109.066597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392699	Green Published, hybrid			2022-12-27	WOS:000278453900080
J	Wu, T; Zhang, XL; Huang, XH; Yang, YQ; Hua, XX				Wu, Ting; Zhang, Xiuli; Huang, Xiaohua; Yang, Yuqing; Hua, Xianxin			Regulation of Cyclin B2 Expression and Cell Cycle G(2)/M Transition by Menin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR MENIN; MITOSIS-SPECIFIC PHOSPHORYLATION; HISTONE H3; NF-Y; DNA-REPLICATION; PROTEIN-KINASE; GENE; TRANSCRIPTION; CDC2; IDENTIFICATION	Multiple endocrine neoplasia type 1 (MEN1) results from mutations in tumor suppressor gene Men1, which encodes nuclear protein menin. Menin up-regulates certain cyclin-dependent kinase inhibitors through increasing histone H3 lysine 4 (H3K4) methylation and inhibits G(0)/G(1) to S phase transition. However, little is known as to whether menin controls G(2)/M-phase transition, another important cell cycle checkpoint. Here, we show that menin expression delays G(2)/M phase transition and reduces expression of Ccnb2 (encoding cyclin B2). Menin associates with the promoter of Ccnb2 and reduces histone H3 acetylation, a positive chromatin marker for gene transcription, at the Ccnb2 locus. Moreover, Men1 ablation leads to an increase in cyclin B2 expression, histone H3 acetylation at the Ccnb2 locus, and G(2)/Mtransition. In contrast, knockdown of cyclin B2 diminishes the number of cells at M phase and reduces cell proliferation. Furthermore, menin interferes with binding of certain positive transcriptional regulators, such as nuclear factor Y (NF-Y), E2 factors (E2Fs), and histone acetyltransferase CREB (cAMP-response element-binding protein)binding protein (CBP) to the Ccnb2 locus. Notably, MEN1 disease-related mutations, A242V and L22R, abrogate the ability of menin to repress cyclin B2 expression and G(2)/M transition. Both of the mutants fail to reduce the acetylated level of the Ccnb2 locus. Together, these results suggest that menin-mediated repression of cyclin B2 is crucial for inhibiting G(2)/M transition and cell proliferation through a previously unrecognized molecular mechanism for menin-induced suppression of MEN1 tumorigenesis.	[Yang, Yuqing; Hua, Xianxin] Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Wu, Ting] Xiamen Univ, Dept Biomed Sci, Sch Life Sci, Xiamen 361005, Peoples R China; [Zhang, Xiuli; Huang, Xiaohua] Xiamen Univ, Dept Basic Med Sci, Coll Med, Xiamen 361005, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Xiamen University; Xiamen University	Hua, XX (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, 421 Curie Blvd, Philadelphia, PA 19104 USA.	huax@mail.med.upenn.edu	Yang, YQ/G-4122-2010	Huang, Xiaohua/0000-0003-4150-0477	National Institutes of Health [R01-CA-100912, R01-CA-113962]; American Diabetes Association [7-07-RA-60]; NATIONAL CANCER INSTITUTE [R01CA100912, R01CA113962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA-100912 and R01-CA-113962 (to Xianxin H.). This work was also supported by American Diabetes Association Grant 7-07-RA-60 (to Xianxin H.).	Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; Balogh K, 2006, TRENDS ENDOCRIN MET, V17, P357, DOI 10.1016/j.tem.2006.09.004; Bolognese F, 1999, ONCOGENE, V18, P1845, DOI 10.1038/sj.onc.1202494; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; DAGLE JM, 1990, NUCLEIC ACIDS RES, V18, P4751, DOI 10.1093/nar/18.16.4751; Dohna CLZ, 2000, FEBS LETT, V484, P77, DOI 10.1016/S0014-5793(00)02133-5; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; Fajas L, 2000, FEBS LETT, V471, P29, DOI 10.1016/S0014-5793(00)01363-6; FISHER D, 1995, SEMIN CELL BIOL, V6, P73, DOI 10.1016/1043-4682(95)90003-9; Fontaniere S, 2006, ENDOCR-RELAT CANCER, V13, P1223, DOI 10.1677/erc.1.01294; Gao SB, 2009, ONCOGENE, V28, P4095, DOI 10.1038/onc.2009.273; Gardner DG, 1997, ADV INTERNAL MED, V42, P597; GAUTIER J, 1989, NATURE, V339, P626, DOI 10.1038/339626a0; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; Gobl AE, 1999, BBA-GENE STRUCT EXPR, V1447, P51, DOI 10.1016/S0167-4781(99)00132-3; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Harper Jane V., 2004, V296, P157; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jin SH, 2003, CANCER RES, V63, P4204; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kim H, 2003, CANCER RES, V63, P6135; La P, 2006, ONCOGENE, V25, P3537, DOI 10.1038/sj.onc.1209400; La P, 2004, J BIOL CHEM, V279, P49045, DOI 10.1074/jbc.M409358200; La P, 2004, ENDOCRINOLOGY, V145, P3443, DOI 10.1210/en.2004-0124; La P, 2007, J BIOL CHEM, V282, P31332, DOI 10.1074/jbc.M609555200; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Myslinski E, 2007, NUCLEIC ACIDS RES, V35, P3453, DOI 10.1093/nar/gkm239; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; NEVINS JR, 1992, SCIENCE, V258, P424; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schnepp RW, 2004, J BIOL CHEM, V279, P10685, DOI 10.1074/jbc.M308073200; Song NM, 2009, SCI CHINA SER C, V52, P551, DOI 10.1007/s11427-009-0077-5; TOMMASI S, 1995, MOL CELL BIOL, V15, P6901; Tschop K, 2007, FEBS J, V274, P5235, DOI 10.1111/j.1742-4658.2007.06045.x; Wasner M, 2003, GENE, V312, P225, DOI 10.1016/S0378-1119(03)00618-8; Yang YQ, 2007, MOL CELL ENDOCRINOL, V265, P34, DOI 10.1016/j.mce.2006.12.032; Zerfass K, 1996, J VIROL, V70, P2637, DOI 10.1128/JVI.70.4.2637-2642.1996; ZWICKER J, 1995, EMBO J, V14, P4514, DOI 10.1002/j.1460-2075.1995.tb00130.x	50	47	50	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18291	18300		10.1074/jbc.M110.106575	http://dx.doi.org/10.1074/jbc.M110.106575			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20404349	hybrid, Green Published			2022-12-27	WOS:000278453900022
J	Kawaguchi, H; Yamanaka, A; Uchida, K; Shibasaki, K; Sokabe, T; Maruyama, Y; Yanagawa, Y; Murakami, S; Tominaga, M				Kawaguchi, Hitoshi; Yamanaka, Akihiro; Uchida, Kunitoshi; Shibasaki, Koji; Sokabe, Takaaki; Maruyama, Yutaka; Yanagawa, Yuchio; Murakami, Shingo; Tominaga, Makoto			Activation of Polycystic Kidney Disease-2-like 1 (PKD2L1)-PKD1L3 Complex by Acid in Mouse Taste Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOUR TASTE; RECEPTOR; CHANNELS; PKD2L1	Five basic tastes (bitter, sweet, umami, salty, and sour) are detected in the four taste areas where taste buds reside. Although molecular mechanisms for detecting bitter, sweet, and umami have been well clarified, those for sour and salty remain poorly understood. Several channels including acid-sensing ion channels have been proposed as candidate sour receptors, but they do not encompass all sour-sensing abilities in vivo. We recently reported a novel candidate for sour sensing, the polycystic kidney disease-2-like 1 (PKD2L1)-PKD1L3 channel complex. This channel is not a traditional ligand-gated channel and is gated open only after removal of an acid stimulus, called an off response. Here we show that off responses upon acid stimulus are clearly observed in native taste cells from circumvallate, but not fungiform papillae, of glutamate decarboxylase 67-green fluorescent protein (GAD67-GFP) knock-in mice, from which Type III taste cells can be visualized, using Ca2+ imaging and patch clamp methods. Off responses were detected in most cells where PKD2L1 immunoreactivity was observed. Interestingly, the pH threshold for acid-evoked intracellular Ca2+ increase was around 5.0, a value much higher than that observed in HEK293 cells expressing the PKD2L1-PKD1L3 complex. Thus, PKD2L1-PKD1L3-mediated acid-evoked off responses occurred both in HEK293 cells and in native taste cells, suggesting the involvement of the PKD2L1-PKD1L3 complex in acid sensing in vivo.	[Kawaguchi, Hitoshi; Yamanaka, Akihiro; Uchida, Kunitoshi; Shibasaki, Koji; Sokabe, Takaaki; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Kawaguchi, Hitoshi; Murakami, Shingo] Nagoya City Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Nagoya, Aichi 4678601, Japan; [Yamanaka, Akihiro; Uchida, Kunitoshi; Shibasaki, Koji; Sokabe, Takaaki; Tominaga, Makoto] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; [Shibasaki, Koji] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurol, Maebashi, Gunma 3718511, Japan; [Maruyama, Yutaka] Ajinomoto Co Inc, Kawasaki, Kanagawa 2108681, Japan; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 3718511, Japan; [Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; Graduate University for Advanced Studies - Japan; Gunma University; Ajinomoto Co Inc; Gunma University; Japan Science & Technology Agency (JST)	Tominaga, M (corresponding author), Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	tominaga@nips.ac.jp	Shibasaki, Koji/U-8674-2018; Yamanaka, Akihiro/AAD-8641-2021	Shibasaki, Koji/0000-0003-2330-1749; Yamanaka, Akihiro/0000-0001-6099-7306; Sokabe, Takaaki/0000-0003-1280-9424	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan (to M. T.).	Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Herness MS, 1999, ANNU REV PHYSIOL, V61, P873, DOI 10.1146/annurev.physiol.61.1.873; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kim S, 2006, J NEUROSCI, V26, P2403, DOI 10.1523/JNEUROSCI.4691-05.2006; Medler KF, 2003, J NEUROSCI, V23, P2608; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; *NIH, 1985, PUBL NIH, V8523; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; ROPER SD, 1989, ANNU REV NEUROSCI, V12, P329, DOI 10.1146/annurev.ne.12.030189.001553; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Stevens JC, 1997, PHYSIOL BEHAV, V62, P1137, DOI 10.1016/S0031-9384(97)00270-9; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Yang RB, 2000, J COMP NEUROL, V425, P139, DOI 10.1002/1096-9861(20000911)425:1<139::AID-CNE12>3.0.CO;2-#; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075	27	35	38	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17277	17281		10.1074/jbc.C110.132944	http://dx.doi.org/10.1074/jbc.C110.132944			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20406802	Green Published, hybrid			2022-12-27	WOS:000278133400002
J	Li, A; Yu, YP; Lee, SC; Ishibashi, T; Lees-Miller, SP; Ausio, J				Li, Andra; Yu, Yaping; Lee, Sheng-Chun; Ishibashi, Toyotaka; Lees-Miller, Susan P.; Ausio, Juan			Phosphorylation of Histone H2A.X by DNA-dependent Protein Kinase Is Not Affected by Core Histone Acetylation, but It Alters Nucleosome Stability and Histone H1 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; IONIZING-RADIATION; DAMAGE RESPONSE; CHROMATIN-STRUCTURE; GAMMA-H2AX FOCI; REPAIR; YEAST; COMPLEX; ATM; PK	Phosphorylation of the C-terminal end of histone H2A.X is the most characterized histone post-translational modification in DNA double-stranded breaks (DSB). DNA-dependent protein kinase (DNA-PK) is one of the three phosphatidylinositol 3 kinase-like family of kinase members that is known to phosphorylate histone H2A.X during DNA DSB repair. There is a growing body of evidence supporting a role for histone acetylation in DNA DSB repair, but the mechanism or the causative relation remains largely unknown. Using bacterially expressed recombinant mutants and stably and transiently transfected cell lines, we find that DNA-PK can phosphorylate Thr-136 in addition to Ser-139 both in vitro and in vivo. Furthermore, the phosphorylation reaction is not inhibited by the presence of H1, which in itself is a substrate of the reaction. We also show that, in contrast to previous reports, the ability of the enzyme to phosphorylate these residues is not affected by the extent of acetylation of the core histones. In vitro assembled nucleosomes and HeLa S3 native oligonucleosomes consisting of non-acetylated and acetylated histones are equally phosphorylated by DNA-PK. We demonstrate that the apparent differences in the extent of phosphorylation previously observed can be accounted for by the differential chromatin solubility under the MgCl2 concentrations required for the phosphorylation reaction in vitro. Finally, we show that although H2A.X does not affect nucleosome conformation, it has a de-stabilizing effect that is enhanced by the DNA-PK-mediated phosphorylation and results in an impaired histone H1 binding.	[Li, Andra; Ishibashi, Toyotaka; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Yu, Yaping; Lees-Miller, Susan P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Lee, Sheng-Chun] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei, Taiwan; [Lee, Sheng-Chun] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	University of Victoria; University of Calgary; National Taiwan University; Academia Sinica - Taiwan	Ausio, J (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055,Petch Bldg 220, Victoria, BC V8W 3P6, Canada.	jausio@uvic.ca	Ishibashi, Toyotaka/AAW-2687-2020	Ishibashi, Toyotaka/0000-0001-8015-2319; Lees-Miller, Susan/0000-0001-5809-2516	Canadian Institute of Health Research [MOP-97878, MOP-57718]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grants MOP-97878 (to S. P. L.-M.) and MOP-57718 (to J. A.).	Abbott DW, 2005, J BIOL CHEM, V280, P16437, DOI 10.1074/jbc.M500170200; Abbott DW, 2004, BIOCHEMISTRY-US, V43, P1352, DOI 10.1021/bi035859i; An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Ausio J, 2001, BIOCHEM CELL BIOL, V79, P693, DOI 10.1139/bcb-79-6-693; AUSIO J, 1984, J MOL BIOL, V176, P77, DOI 10.1016/0022-2836(84)90383-8; Ausio J, 1998, METHODS, V15, P333, DOI 10.1006/meth.1998.0637; Ausio J, 2000, BIOPHYS CHEM, V86, P141, DOI 10.1016/S0301-4622(00)00144-7; BENNETZEN MV, 2010, MOL CELL PR IN PRESS; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; COSTES SV, 2010, MUTAT RES IN PRESS; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; DEMELER B, 2005, ULTRSCAN COMPREHENSI; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fink M, 2007, MOL CELL BIOL, V27, P3589, DOI 10.1128/MCB.02077-06; Gautier T, 2004, EMBO REP, V5, P715, DOI 10.1038/sj.embor.7400182; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Harvey AC, 2005, GENETICS, V170, P543, DOI 10.1534/genetics.104.038570; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Ismail IH, 2008, ENVIRON MOL MUTAGEN, V49, P73, DOI 10.1002/em.20358; Javaheri A, 2006, P NATL ACAD SCI USA, V103, P13771, DOI 10.1073/pnas.0511192103; Krebs JE, 2007, MOL BIOSYST, V3, P590, DOI 10.1039/b703923a; Kysela B, 2005, P NATL ACAD SCI USA, V102, P1877, DOI 10.1073/pnas.0401179102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li A, 2005, BIOCHEM CELL BIOL, V83, P505, DOI 10.1139/O05-114; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maffey AH, 2007, MOL CELL ENDOCRINOL, V268, P10, DOI 10.1016/j.mce.2007.01.009; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Marino-Ramirez L, 2005, EXPERT REV PROTEOMIC, V2, P719, DOI 10.1586/14789450.2.5.719; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Moore JD, 2007, GENETICS, V176, P15, DOI 10.1534/genetics.106.063792; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Morrison AJ, 2005, CELL CYCLE, V4, P568; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; PERRY M, 1982, J BIOL CHEM, V257, P7336; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; PINEIRO M, 1991, BIOCHEMISTRY-US, V30, P5805, DOI 10.1021/bi00237a025; Pinto DMS, 2010, SUBCELL BIOCHEM, V50, P55, DOI 10.1007/978-90-481-3471-7_4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saperas N, 2006, FEBS J, V273, P4548, DOI 10.1111/j.1742-4658.2006.05461.x; Shechter D, 2009, P NATL ACAD SCI USA, V106, P749, DOI 10.1073/pnas.0812207106; Siino JS, 2002, BIOCHEM BIOPH RES CO, V297, P1318, DOI 10.1016/S0006-291X(02)02383-5; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Vasireddy RS, 2010, CELL MOL LIFE SCI, V67, P291, DOI 10.1007/s00018-009-0181-5; Wang XY, 2000, J BIOL CHEM, V275, P35013, DOI 10.1074/jbc.M004998200; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; YAGER TD, 1984, J BIOL CHEM, V259, P4212	64	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17778	17788		10.1074/jbc.M110.116426	http://dx.doi.org/10.1074/jbc.M110.116426			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356835	hybrid, Green Published			2022-12-27	WOS:000278133400056
J	Odegaard, ML; Joseph, JW; Jensen, MV; Lu, DH; Ilkayeva, O; Ronnebaum, SM; Becker, TC; Newgard, CB				Odegaard, Matthew L.; Joseph, Jamie W.; Jensen, Mette V.; Lu, Danhong; Ilkayeva, Olga; Ronnebaum, Sarah M.; Becker, Thomas C.; Newgard, Christopher B.			The Mitochondrial 2-Oxoglutarate Carrier Is Part of a Metabolic Pathway That Mediates Glucose- and Glutamine-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR ISOTOPOMER ANALYSIS; PANCREATIC BETA-CELLS; ISOCITRATE DEHYDROGENASE; REGULATORY ROLE; CHANNELS; ISLETS; SUPPRESSION; MECHANISMS; EXPRESSION; ADENOVIRUS	Glucose-stimulated insulin secretion from pancreatic islet beta-cells is dependent in part on pyruvate cycling through the pyruvate/isocitrate pathway, which generates cytosolic alpha-ketoglutarate, also known as 2-oxoglutarate (2OG). Here, we have investigated if mitochondrial transport of 2OG through the 2-oxoglutarate carrier (OGC) participates in control of nutrient-stimulated insulin secretion. Suppression of OGC in clonal pancreatic beta-cells (832/13 cells) and isolated rat islets by adenovirus-mediated delivery of small interfering RNA significantly decreased glucose-stimulated insulin secretion. OGC suppression also reduced insulin secretion in response to glutamine plus the glutamate dehydrogenase activator 2-amino-2-norbornane carboxylic acid. Nutrient-stimulated increases in glucose usage, glucose oxidation, glutamine oxidation, or ATP: ADP ratio were not affected by OGC knockdown, whereas suppression of OGC resulted in a significant decrease in the NADPH: NADP(+) ratio during stimulation with glucose but not glutamine + 2-amino-2-norbornane carboxylic acid. Finally, OGC suppression reduced insulin secretion in response to a membrane-permeant 2OG analog, dimethyl-2OG. These data reveal that the OGC is part of a mechanism of fuel-stimulated insulin secretion that is commonto glucose, amino acid, and organic acid secretagogues, involving flux through the pyruvate/isocitrate cycling pathway. Although the components of this pathway must remain intact for appropriate stimulus-secretion coupling, production of NADPH does not appear to be the universal second messenger signal generated by these reactions.	[Newgard, Christopher B.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Med Ctr, Duke Independence Pk Facil, Durham, NC 27704 USA; [Odegaard, Matthew L.; Jensen, Mette V.; Lu, Danhong; Ilkayeva, Olga; Ronnebaum, Sarah M.; Becker, Thomas C.; Newgard, Christopher B.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27704 USA; [Joseph, Jamie W.] Univ Waterloo, Sch Pharm, Waterloo, ON N2G 1C5, Canada	Duke University; Duke University; University of Waterloo	Newgard, CB (corresponding author), Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Med Ctr, Duke Independence Pk Facil, 4321 Med Pk Dr,Ste 200, Durham, NC 27704 USA.	newga002@mc.duke.edu		Ronnebaum, Sarah/0000-0003-4787-754X	National Institutes of Health [DK-42583, DK-58398]; Canadian Institute of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DK-42583 and DK-58398 (to C.B.N.). This work was also supported by a Canadian Institute of Health Research grant (to J.W.J.).	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Fallon MJ, 2008, METABOLISM, V57, P1148, DOI 10.1016/j.metabol.2008.03.022; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; INDIVERI C, 1987, BIOCHIM BIOPHYS ACTA, V890, P310, DOI 10.1016/0005-2728(87)90158-7; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Kanao T, 2002, EUR J BIOCHEM, V269, P1926, DOI 10.1046/j.1432-1033.2002.02849.x; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim JY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1014, DOI 10.1152/ajpendo.00233.2001; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Matschinsky F.M., 2001, HDB PHYSL 7, P125; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PALMIERI F, 1993, J BIOENERG BIOMEMBR, V25, P493, DOI 10.1007/BF01108406; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572	36	58	59	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16530	16537		10.1074/jbc.M109.092593	http://dx.doi.org/10.1074/jbc.M109.092593			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356834	Green Published, hybrid			2022-12-27	WOS:000277982600015
J	Riegelhaupt, PM; Frame, IJ; Akabas, MH				Riegelhaupt, Paul M.; Frame, I. J.; Akabas, Myles H.			Transmembrane Segment 11 Appears to Line the Purine Permeation Pathway of the Plasmodium falciparum Equilibrative Nucleoside Transporter 1 (PfENT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE ACCESSIBILITY METHOD; INTRAERYTHROCYTIC MALARIA PARASITE; MAJOR FACILITATOR SUPERFAMILY; PLASMA-MEMBRANE; S-6-(4-NITROBENZYL)-MERCAPTOPURINE RIBOSIDE; LINING RESIDUES; CELLULAR UPTAKE; CHANNEL; NITROBENZYLTHIOINOSINE; IDENTIFICATION	Purine transport is essential for malaria parasites to grow because they lack the enzymes necessary for de novo purine biosynthesis. The Plasmodium falciparum Equilibrative Nucleoside Transporter 1 (PfENT1) is a member of the equilibrative nucleoside transporter (ENT) gene family. PfENT1 is a primary purine transport pathway across the P. falciparum plasma membrane because PfENT1 knock-out parasites are not viable at physiologic extracellular purine concentrations. Topology predictions and experimental data indicate that ENT family members have eleven transmembrane (TM) segments although their tertiary structure is unknown. In the current work, we showed that a naturally occurring polymorphism, F394L, in TM11 affects transport substrate K-m. We investigated the structure and function of the TM11 segment using the substituted cysteine accessibility method. We showed that mutation to Cys of two highly conserved glycine residues in a GXXXG motif significantly reduces PfENT1 protein expression levels. We speculate that the conserved TM11 GXXXG glycines may be critical for folding and/or assembly. Small, cysteine-specific methanethiosulfonate (MTS) reagents reacted with four TM11 Cys substitution mutants, L393C, I397C, T400C, and Y403C. Larger MTS reagents do not react with the more cytoplasmic positions. Hypoxanthine, a transported substrate, protected L393C, I397C, and T400C from covalent modification by the MTS reagents. Plotted on an alpha-helical wheel, Leu-393, Ile-397, and Thr-400 lie on one face of the helix in a 60 degrees arc suggesting that TM11 is largely alpha helical. We infer that they line a water-accessible surface, possibly the purine permeation pathway. These results advance our understanding of the ENT structure.	[Riegelhaupt, Paul M.; Frame, I. J.; Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Akabas, MH (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	myles.akabas@einstein.yu.edu		Akabas, Myles/0000-0001-8781-7846; Frame, I.J./0000-0002-7560-7427	National Institutes of Health [T32-GM007288]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NIGMS Medical Scientist Training Program Grant T32-GM007288 (to P.M.R.).	Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Arendt CS, 2010, J BIOL CHEM, V285, P6024, DOI 10.1074/jbc.M109.074351; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; Cassera MB, 2008, J BIOL CHEM, V283, P32889, DOI 10.1074/jbc.M804497200; Cox J, 2007, TRENDS PARASITOL, V23, P142, DOI 10.1016/j.pt.2007.02.002; Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Endres CJ, 2005, MOL PHARMACOL, V67, P837, DOI 10.1124/mol.104.008102; Endres CJ, 2004, BIOCHEM J, V380, P131, DOI 10.1042/BJ20031880; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Harrington SE, 2009, STRUCTURE, V17, P1092, DOI 10.1016/j.str.2009.06.009; Hoque KM, 2008, AM J PHYSIOL-REG I, V294, pR1988, DOI 10.1152/ajpregu.00016.2008; Hou ZJ, 2006, J BIOL CHEM, V281, P33588, DOI 10.1074/jbc.M607049200; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Martin RE, 2009, MOL MICROBIOL, V74, P519, DOI 10.1111/j.1365-2958.2009.06863.x; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Plowe Christopher V, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS11, DOI 10.1016/j.trstmh.2008.11.002; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Riegelhaupt PM, 2010, MOL BIOCHEM PARASIT, V169, P40, DOI 10.1016/j.molbiopara.2009.10.001; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Robillard KR, 2008, MOL PHARMACOL, V74, P264, DOI 10.1124/mol.107.041871; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schramm VL, 2004, NUCLEOS NUCLEOT NUCL, V23, P1305, DOI 10.1081/NCN-200027564; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; SenGupta DJ, 2004, BIOCHEM PHARMACOL, V67, P453, DOI 10.1016/j.bcp.2003.09.018; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Slugoski MD, 2009, J BIOL CHEM, V284, P17281, DOI 10.1074/jbc.M109.009704; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Wang XC, 2008, BIOCHEMISTRY-US, V47, P5709, DOI 10.1021/bi8001314; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; Wellems TE, 2009, J CLIN INVEST, V119, P2496, DOI 10.1172/JCI38307; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387	56	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17001	17010		10.1074/jbc.M110.115758	http://dx.doi.org/10.1074/jbc.M110.115758			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20335165	Green Published, hybrid			2022-12-27	WOS:000277982600063
J	Smith, L; Page, RC; Xu, Z; Kohli, E; Litman, P; Nix, JC; Ithychanda, SS; Liu, JM; Qin, J; Misra, S; Liedtke, CM				Smith, Laura; Page, Richard C.; Xu, Zhen; Kohli, Ekta; Litman, Paul; Nix, Jay C.; Ithychanda, Sujay S.; Liu, Jianmin; Qin, Jun; Misra, Saurav; Liedtke, Carole M.			Biochemical Basis of the Interaction between Cystic Fibrosis Transmembrane Conductance Regulator and Immunoglobulin-like Repeats of Filamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL ACTIVITY; AIRWAY EPITHELIAL-CELLS; STRUCTURAL BASIS; PLASMA-MEMBRANE; MOLECULAR-BASIS; CFTR; PROTEIN; BINDING; NMR; PHOSPHORYLATION	Mutations in the chloride channel cystic fibrosis transmembrane regulator (CFTR) cause cystic fibrosis, a genetic disorder characterized by defects in CFTR biosynthesis, localization to the cell surface, or activation by regulatory factors. It was discovered recently that surface localization of CFTR is stabilized by an interaction between the CFTR N terminus and the multidomain cytoskeletal protein filamin. The details of the CFTR-filamin interaction, however, are unclear. Using x-ray crystallography, we show how the CFTR N terminus binds to immunoglobulin-like repeat 21 of filamin A (FlnA-Ig21). CFTR binds to beta-strands C and D of FlnA-Ig21 using backbone-backbone hydrogen bonds, a linchpin serine residue, and hydrophobic side-chain packing. We use NMR to determine that the CFTR N terminus also binds to several other immunoglobulin-like repeats from filamin A in vitro. Our structural data explain why the cystic fibrosis-causing S13F mutation disrupts CFTR-filamin interaction. We show that FlnA-Ig repeats transfected into cultured Calu-3 cells disrupt CFTR-filamin interaction and reduce surface levels of CFTR. Our findings suggest that filamin A stabilizes surface CFTR by anchoring it to the actin cytoskeleton through interactions with multiple filamin Ig repeats. Such an interaction mode may allow filamins to cluster multiple CFTR molecules and to promote colocalization of CFTR and other filamin-binding proteins in the apical plasma membrane of epithelial cells.	[Page, Richard C.; Xu, Zhen; Kohli, Ekta; Ithychanda, Sujay S.; Liu, Jianmin; Qin, Jun; Misra, Saurav] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Smith, Laura; Litman, Paul; Liedtke, Carole M.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Willard Alan Bernbaum Ctr Cyst Fibrosis Res, Cleveland, OH 44106 USA; [Smith, Laura; Litman, Paul; Liedtke, Carole M.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Biol Consortium, Adv Light Source, Berkeley, CA 94720 USA	Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Misra, S (corresponding author), Cleveland Clin, Dept Mol Cardiol, NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	misras@ccf.org; carole.liedtke@case.edu	Ithychanda, Sujay Subbayya/C-7792-2011	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Page, Richard/0000-0002-3006-3171; Misra, Saurav/0000-0002-1385-8554; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [HL 58598]; Ralph Wilson Medical Research Foundation; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph Wilson Medical Research Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL 58598 (to C. M. L.). This work was also supported by the Ralph Wilson Medical Research Foundation (S. M.) and by funds from a Cystic Fibrosis Foundation Research Development Program (C. M. L.).	Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Auerbach M, 2007, AM J PHYSIOL-CELL PH, V293, pC294, DOI 10.1152/ajpcell.00413.2006; Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang SY, 2002, J CELL SCI, V115, P783; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eaton J.W., 2007, GNU OCTAVE HIGH LEVE; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gene GG, 2008, HUM MUTAT, V29, P738, DOI 10.1002/humu.20721; GODDARD TD, 2006, SPARKY3; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; HARTWIG JH, 1986, J CELL BIOL, V103, P1007, DOI 10.1083/jcb.103.3.1007; Heikkinen O, 2009, BIOMOL NMR ASSIGN, V3, P53, DOI 10.1007/s12104-008-9140-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Liedtke CM, 2003, AM J PHYSIOL-CELL PH, V284, pC487, DOI 10.1152/ajpcell.00357.2002; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Nguyen TD, 2006, BIOCHEM BIOPH RES CO, V342, P245, DOI 10.1016/j.bbrc.2006.01.127; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Playford MP, 2010, J BIOL CHEM, V285, P17156, DOI 10.1074/jbc.M109.080523; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Rasband W., 2006, IMAGEJ; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Schillers H, 2004, CELL PHYSIOL BIOCHEM, V14, P1, DOI 10.1159/000076921; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sjekloca L, 2007, J MOL BIOL, V368, P1011, DOI 10.1016/j.jmb.2007.02.018; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; van Holde K.E., 1998, PRINCIPLES PHYS BIOC, Vsecond; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	58	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17166	17176		10.1074/jbc.M109.080911	http://dx.doi.org/10.1074/jbc.M109.080911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351101	hybrid, Green Published			2022-12-27	WOS:000277982600079
J	Kuznetsova, E; Xu, LD; Singer, A; Brown, G; Dong, AP; Flick, R; Cui, H; Cuff, M; Joachimiak, A; Savchenko, A; Yakunin, AF				Kuznetsova, Ekaterina; Xu, Linda; Singer, Alexander; Brown, Greg; Dong, Aiping; Flick, Robert; Cui, Hong; Cuff, Marianne; Joachimiak, Andrzej; Savchenko, Alexei; Yakunin, Alexander F.			Structure and Activity of the Metal-independent Fructose-1,6-bisphosphatase YK23 from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTOSE 1,6-BISPHOSPHATASE; CRYSTAL-STRUCTURE; BACILLUS-STEAROTHERMOPHILUS; FUNCTIONAL-ANALYSIS; ACID-PHOSPHATASE; INTRACELLULAR PH; PROTEIN; ENZYME; DEGRADATION; MODEL	Fructose-1,6-bisphosphatase (FBPase), a key enzyme of gluconeogenesis and photosynthetic CO2 fixation, catalyzes the hydrolysis of fructose 1,6-bisphosphate (FBP) to produce fructose 6-phosphate, an important precursor in various bio-synthetic pathways. All known FBPases are metal-dependent enzymes, which are classified into five different classes based on their amino acid sequences. Eukaryotes are known to contain only the type-I FBPases, whereas all five types exist in various combinations in prokaryotes. Here we demonstrate that the uncharacterized protein YK23 from Saccharomyces cerevisiae efficiently hydrolyzes FBP in a metal-independent reaction. YK23 is a member of the histidine phosphatase (phosphoglyceromutase) superfamily with homologues found in all organisms. The crystal structure of the YK23 apo-form was solved at 1.75-angstrom resolution and revealed the core domain with the alpha/beta/alpha-fold covered by two small cap domains. Two liganded structures of this protein show the presence of two phosphate molecules (an inhibitor) or FBP (a substrate) bound to the active site. FBP is bound in its linear, open conformation with the cleavable C1-phosphate positioned deep in the active site. Alanine replacement mutagenesis of YK23 identified six conserved residues absolutely required for activity and suggested that His(13) and Glu(99) are the primary catalytic residues. Thus, YK23 represents the first family of metal-independent FBPases and a second FBPase family in eukaryotes.	[Kuznetsova, Ekaterina; Xu, Linda; Singer, Alexander; Brown, Greg; Flick, Robert; Cui, Hong; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Banting & Best Dept Med Res, Ctr Struct Prote Toronto, Toronto, ON M5G 1L6, Canada; [Kuznetsova, Ekaterina; Xu, Linda; Singer, Alexander; Brown, Greg; Flick, Robert; Cui, Hong; Savchenko, Alexei; Yakunin, Alexander F.] Max Bell Res Ctr, Ontario Canc Inst, Toronto, ON M5G 2C4, Canada; [Dong, Aiping] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Cuff, Marianne; Joachimiak, Andrzej] Midwest Ctr Struct Genom, Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Structural Genomics Consortium; United States Department of Energy (DOE); Argonne National Laboratory	Yakunin, AF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Ctr Struct Prote Toronto, 112 Coll St, Toronto, ON M5G 1L6, Canada.	a.iakounine@utoronto.ca	Yakunin, Alexander/J-1519-2014	Yakunin, Alexander/0000-0003-0813-6490	National Institutes of Health [GM074942]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Genome Canada through Ontario Genomics Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Genome Canada through Ontario Genomics Institute(Genome Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942, United States Department of Energy, Office of Biological and Environmental Research contract DE-AC02-06CH11357, and Genome Canada (through the Ontario Genomics Institute).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BABUL J, 1983, ARCH BIOCHEM BIOPHYS, V225, P944, DOI 10.1016/0003-9861(83)90109-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Becker J, 2005, APPL ENVIRON MICROB, V71, P8587, DOI 10.1128/AEM.71.12.8587-8596.2005; BENKOVIC SJ, 1982, ADV ENZYMOL RAMB, V53, P45; Bond CS, 2001, J BIOL CHEM, V276, P3247, DOI 10.1074/jbc.M007318200; Brown G, 2009, J BIOL CHEM, V284, P3784, DOI 10.1074/jbc.M808186200; CAMPBELL JW, 1974, NATURE, V250, P301, DOI 10.1038/250301a0; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Choi KH, 2004, J AM CHEM SOC, V126, P3402, DOI 10.1021/ja038540u; DAIE J, 1993, PHOTOSYNTH RES, V38, P5, DOI 10.1007/BF00015056; Dang Q, 2007, J AM CHEM SOC, V129, P15491, DOI 10.1021/ja074871l; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENTIAN KD, 1988, FEBS LETT, V236, P195, DOI 10.1016/0014-5793(88)80313-2; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; FUNAYAMA S, 1979, ARCH BIOCHEM BIOPHYS, V197, P170, DOI 10.1016/0003-9861(79)90233-9; Grazulis S, 2005, P NATL ACAD SCI USA, V102, P15797, DOI 10.1073/pnas.0507949102; Hamada K, 2005, GENES CELLS, V10, P1, DOI 10.1111/j.1365-2443.2005.00817.x; Heering HA, 1997, J AM CHEM SOC, V119, P11628, DOI 10.1021/ja9723242; Hines JK, 2007, J BIOL CHEM, V282, P36121, DOI 10.1074/jbc.M707302200; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; Ho CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006993; Hoffman M, 1996, GENETICS, V143, P1555; Horak J, 2002, J BIOL CHEM, V277, P8248, DOI 10.1074/jbc.M107255200; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; Jardon R, 2008, EUKARYOT CELL, V7, P1742, DOI 10.1128/EC.00169-08; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Johnson KA, 2001, BIOCHEMISTRY-US, V40, P618, DOI 10.1021/bi0016422; Kimber MS, 2003, PROTEINS, V51, P562, DOI 10.1002/prot.10340; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee YH, 1996, BIOCHEMISTRY-US, V35, P6010, DOI 10.1021/bi9600613; Li H, 2009, J BIOL CHEM, V284, P1748, DOI 10.1074/jbc.M807821200; Li L, 1997, BIOCHEM J, V328, P751, DOI 10.1042/bj3280751; LIANG JY, 1993, P NATL ACAD SCI USA, V90, P2132, DOI 10.1073/pnas.90.6.2132; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; MARCUS F, 1982, METHOD ENZYMOL, V90, P352; MARCUS F, 1984, BIOCHEM BIOPH RES CO, V119, P1103, DOI 10.1016/0006-291X(84)90888-X; Meyerhof O, 1935, BIOCHEM Z, V276, P239; MIDELFORT CF, 1976, BIOCHEMISTRY-US, V15, P2178, DOI 10.1021/bi00655a023; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; Nobeli I, 2006, BIOESSAYS, V28, P534, DOI 10.1002/bies.20414; Patel S, 2002, J MOL BIOL, V320, P1087, DOI 10.1016/S0022-2836(02)00564-8; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PILKIS SJ, 1988, ANNU REV BIOCHEM, V57, P755, DOI 10.1146/annurev.bi.57.070188.003543; Proudfoot Michael, 2008, V426, P331, DOI 10.1007/978-1-60327-058-8_21; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Raines CA, 1999, J EXP BOT, V50, P1, DOI 10.1093/jexbot/50.330.1; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rigden DJ, 2003, J MOL BIOL, V325, P411, DOI 10.1016/S0022-2836(02)01229-9; SAHEKI S, 1985, ANAL BIOCHEM, V148, P277, DOI 10.1016/0003-2697(85)90229-5; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SEDIVY JM, 1985, J MOL BIOL, V186, P307, DOI 10.1016/0022-2836(85)90107-X; Singh H, 2009, J MOL BIOL, V394, P893, DOI 10.1016/j.jmb.2009.10.009; Tamoi M, 1996, ARCH BIOCHEM BIOPHYS, V334, P27, DOI 10.1006/abbi.1996.0425; Valli M, 2005, APPL ENVIRON MICROB, V71, P1515, DOI 10.1128/AEM.71.3.1515-1521.2005; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P2861; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Walter RA, 1999, BIOCHEM J, V337, P89, DOI 10.1042/0264-6021:3370089; Wang YL, 2006, J BIOL CHEM, V281, P39642, DOI 10.1074/jbc.M606421200; Watkins HA, 2006, J BACTERIOL, V188, P3589, DOI 10.1128/JB.188.10.3589-3599.2006; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WOODROW IE, 1988, ANNU REV PLANT PHYS, V39, P533, DOI 10.1146/annurev.pp.39.060188.002533; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; ZHANG YP, 1993, BIOCHEM BIOPH RES CO, V190, P1080, DOI 10.1006/bbrc.1993.1159	77	17	19	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21049	21059		10.1074/jbc.M110.118315	http://dx.doi.org/10.1074/jbc.M110.118315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427268	Green Published, hybrid			2022-12-27	WOS:000279228600068
J	Chandak, PG; Radovic, B; Aflaki, E; Kolb, D; Buchebner, M; Frohlich, E; Magnes, C; Sinner, F; Haemmerle, G; Zechner, R; Tabas, I; Levak-Frank, S; Kratky, D				Chandak, Prakash G.; Radovic, Branislav; Aflaki, Elma; Kolb, Dagmar; Buchebner, Marlene; Froehlich, Eleonore; Magnes, Christoph; Sinner, Frank; Haemmerle, Guenter; Zechner, Rudolf; Tabas, Ira; Levak-Frank, Sanja; Kratky, Dagmar			Efficient Phagocytosis Requires Triacylglycerol Hydrolysis by Adipose Triglyceride Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; LIPID DROPLETS; CHOLESTEROL ACCUMULATION; RICH LIPOPROTEINS; ENERGY-METABOLISM; J774 MACROPHAGES; ATHEROSCLEROSIS; LIPOLYSIS	Macrophage phagocytosis is an essential biological process in host defense and requires large amounts of energy. To date, glucose is believed to represent the prime substrate for ATP production in macrophages. To investigate the relative contribution of free fatty acids (FFAs) in this process, we determined the phagocytosis rates in normal mouse macrophages and macrophages of adipose triglyceride lipase (ATGL)-deficient mice. ATGL was shown to be the rate-limiting enzyme for the hydrolysis of lipid droplet-associated triacylglycerol (TG) in many tissues. Here, we demonstrate that Atgl(-/-) macrophages fail to efficiently hydrolyze cellular TG stores leading to decreased cellular FFA concentrations and concomitant accumulation of lipid droplets, even in the absence of exogenous lipid loading. The reduced availability of FFAs results in decreased cellular ATP concentrations and impaired phagocytosis suggesting that fatty acids must first go through a cycle of esterification and re-hydrolysis before they are available as energy substrate. Exogenously added glucose cannot fully compensate for the phagocytotic defect in Atgl(-/-) macrophages. Hence, phagocytosis was also decreased in vivo when Atgl(-/-) mice were challenged with bacterial particles. These findings imply that phagocytosis in macrophages depends on the availability of FFAs and that ATGL is required for their hydrolytic release from cellular TG stores. This novel mechanism links ATGL-mediated lipolysis to macrophage function in host defense and opens the way to explore possible roles of ATGL in immune response, inflammation, and atherosclerosis.	[Levak-Frank, Sanja] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Kolb, Dagmar; Haemmerle, Guenter; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Froehlich, Eleonore] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Magnes, Christoph; Sinner, Frank] Inst Med Technol & Hlth Management, A-8010 Graz, Austria; [Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Medical University of Graz; University of Graz; Medical University of Graz; Columbia University; Columbia University; Columbia University		dagmar.kratky@medunigraz.at	Kratky, Dagmar/ABF-5699-2021; Fröhlich, Eleonore/M-8943-2014	Fröhlich, Eleonore/0000-0002-6056-6829; Zechner, Rudolf/0000-0001-5483-1182; Haemmerle, Guenter/0000-0001-9900-5896; Kratky, Dagmar/0000-0003-1357-7573; Sinner, Frank Michael/0000-0002-9292-4512; Magnes, Christoph/0000-0002-5153-7444	National Institutes of Health [HL54591, HL75662]; Austrian Science Fund FWF [SFB-LIPOTOX F30, P19186]; Austrian Federal Ministry of Science and Research; Medical University of Graz; Austrian Science Fund (FWF) [F 3002, F 3004, Z 136] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, P01HL054591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research; Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54591 and HL75662. This work was also supported by the Austrian Science Fund FWF SFB-LIPOTOX F30 and P19186, the Austrian Federal Ministry of Science and Research GEN-AU Project Genomics of Lipid-associated Disorders, and the Medical University of Graz (Ph.D. Program for Molecular Medicine).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BATES SR, 1984, ARTERIOSCLEROSIS, V4, P103, DOI 10.1161/01.ATV.4.2.103; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Contreras JA, 2002, BIOCHEM BIOPH RES CO, V292, P900, DOI 10.1006/bbrc.2002.6757; Escary JL, 1999, J LIPID RES, V40, P397; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Galluhn D, 2004, J BIOL CHEM, V279, P38338, DOI 10.1074/jbc.M405871200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Holm C, 1999, METH MOL B, V109, P109; HUFF MW, 1991, ARTERIOSCLER THROMB, V11, P221, DOI 10.1161/01.ATV.11.2.221; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jong MC, 2000, ARTERIOSCL THROM VAS, V20, P144, DOI 10.1161/01.ATV.20.1.144; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; LINDQVIST P, 1983, J BIOL CHEM, V258, P9086; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Magnes C, 2008, ANAL CHEM, V80, P5736, DOI 10.1021/ac800031u; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; RENIER G, 1993, ARTERIOSCLER THROMB, V13, P190, DOI 10.1161/01.ATV.13.2.190; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Sekiya M, 2009, CELL METAB, V10, P219, DOI 10.1016/j.cmet.2009.08.004; SIMON LM, 1973, J EXP MED, V138, P1413, DOI 10.1084/jem.138.6.1413; SPEERT DP, 1992, J CLIN INVEST, V90, P1085, DOI 10.1172/JCI115924; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tabas I, 2007, CURR DRUG TARGETS, V8, P1288, DOI 10.2174/138945007783220623; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; XU XX, 1991, J BIOL CHEM, V266, P24849; Yin BY, 1997, J CLIN INVEST, V100, P649, DOI 10.1172/JCI119576; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	42	105	108	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20192	20201		10.1074/jbc.M110.107854	http://dx.doi.org/10.1074/jbc.M110.107854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424161	Green Published, hybrid			2022-12-27	WOS:000279012000054
J	Brault, JJ; Jespersen, JG; Goldberg, AL				Brault, Jeffrey J.; Jespersen, Jakob G.; Goldberg, Alfred L.			Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha or 1 beta Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; METABOLIC-CONTROL; PGC-1-ALPHA; EXERCISE; EXPRESSION; KINASE; DENERVATION; PGC-1	Overexpression of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha), like exercise, increases mitochondrial content and inhibits muscle atrophy. To understand these actions, we tested whether PGC-1 alpha or its close homolog, PGC-1 alpha, influences muscle protein turnover. In myotubes, overexpression of either coactivator increased protein content by decreasing overall protein degradation without altering protein synthesis rates. Elevated PGC-1 alpha or PGC-1 alpha also prevented the acceleration of proteolysis induced by starvation or FoxO transcription factors and prevented the induction of autophagy and atrophy-specific ubiquitin ligases by a constitutively active FoxO3. In mouse muscles, overexpression of PGC-1 alpha (like PGC-1 alpha) inhibited denervation atrophy, ubiquitin ligase induction, and transcription by NF kappa B. However, increasing muscle PGC-1 alpha levels pharmacologically by treatment of mice with 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside failed to block loss of muscle mass or induction of ubiquitin ligases upon denervation atrophy, although it prevented loss of mitochondria. This capacity of PGC-1 alpha and PGC-1 alpha to inhibit FoxO3 and NF kappa B actions and proteolysis helps explain how exercise prevents muscle atrophy.	[Brault, Jeffrey J.; Jespersen, Jakob G.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu	Brault, Jeffrey/AAH-3293-2021	Brault, Jeffrey/0000-0003-3503-0528	National Institutes of Health [AR055255, F32AR054699]; Muscular Dystrophy Association; Copenhagen Graduate School of Health Sciences; A. P. Moeller Foundation for the Advancement of Medical Science; Knud Hoejgaard Foundation; Lundbeck Foundation; Augustinus Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR054699, R01AR055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Copenhagen Graduate School of Health Sciences; A. P. Moeller Foundation for the Advancement of Medical Science; Knud Hoejgaard Foundation; Lundbeck Foundation(Lundbeckfonden); Augustinus Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR055255 (to A. L. G.). This work was also supported by the Muscular Dystrophy Association (to A. L. G.).; Supported by a Kirschstein National Research Service Award from the National Institutes of Health (F32AR054699).; Supported by the Copenhagen Graduate School of Health Sciences, The A. P. Moeller Foundation for the Advancement of Medical Science, the Knud Hoejgaard Foundation, a Christian & Otilla Brorson's Travel Grant for Young Scientists, the Lundbeck Foundation, and the Augustinus Foundation.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Adams GR, 2007, J APPL PHYSIOL, V103, P1644, DOI 10.1152/japplphysiol.00669.2007; Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bdolah Y, 2007, AM J PHYSIOL-REG I, V292, pR971, DOI 10.1152/ajpregu.00617.2006; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Coussens LM, 2008, CURR OPIN GENET DEV, V18, P1, DOI 10.1016/j.gde.2008.04.001; Cuthbertson DJ, 2007, DIABETES, V56, P2078, DOI 10.2337/db06-1716; Dodd SL, 2009, FASEB J, V23, P3415, DOI 10.1096/fj.08-124602; FURUNO K, 1990, J BIOL CHEM, V265, P8550; GOLDBERG AL, 1969, J BIOL CHEM, V244, P3223; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Goodyear LJ, 2008, NEW ENGL J MED, V359, P1842, DOI 10.1056/NEJMcibr0806723; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; GREEN JD, 1980, J HISTOCHEM CYTOCHEM, V28, P408, DOI 10.1177/28.5.6966645; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Murakami T, 1998, BBA-GEN SUBJECTS, V1381, P113, DOI 10.1016/S0304-4165(98)00018-X; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; O'Leary MFN, 2008, J APPL PHYSIOL, V105, P114, DOI 10.1152/japplphysiol.00724.2007; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Patterson MF, 2006, AM J PHYSIOL-CELL PH, V291, pC518, DOI 10.1152/ajpcell.00013.2006; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Richter EA, 2008, CELL METAB, V8, P96, DOI 10.1016/j.cmet.2008.07.004; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wehling M, 2000, FASEB J, V14, P103, DOI 10.1096/fasebj.14.1.103; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; WICKS KL, 1991, AM J PHYSIOL, V260, pC841, DOI 10.1152/ajpcell.1991.260.4.C841; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zinna EM, 2003, CURR OPIN CLIN NUTR, V6, P87, DOI 10.1097/00075197-200301000-00013	71	162	169	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19460	19471		10.1074/jbc.M110.113092	http://dx.doi.org/10.1074/jbc.M110.113092			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404331	hybrid, Green Published			2022-12-27	WOS:000278727800056
J	Tang, QY; Zhang, Z; Xia, JS; Ren, DJ; Logothetis, DE				Tang, Qiong-Yao; Zhang, Zhe; Xia, Jingsheng; Ren, Dejian; Logothetis, Diomedes E.			Phosphatidylinositol 4,5-Bisphosphate Activates Slo3 Currents and Its Hydrolysis Underlies the Epidermal Growth Factor-induced Current Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+ CHANNELS; POTASSIUM CHANNELS; KIR CHANNELS; ION CHANNELS; MOUSE SPERM; SIGNALING PATHWAYS; ACROSOME REACTION; PIP2; PH; SPERMATOZOA	The Slo3 gene encodes a high conductance potassium channel, which is activated by both voltage and intracellular alkalinization. Slo3 is specifically expressed in mammalian sperm cells, where it gives rise to pH-dependent outwardly rectifying K+ currents. Sperm Slo3 is the main current responsible for the capacitation-induced hyperpolarization, which is required for the ensuing acrosome reaction, an exocytotic process essential for fertilization. Here we show that in intact spermatozoa and in a heterologous expression system, the activation of Slo3 currents is regulated by phosphatidylinositol 4,5-bisphosphate (PIP2). Depletion of endogenous PIP2 in inside-out macropatches from Xenopus oocytes inhibited heterologously expressed Slo3 currents. Whole-cell recordings of sperm Slo3 currents or of Slo3 channels co-expressed in Xenopus oocytes with epidermal growth factor receptor, demonstrated that stimulation by epidermal growth factor (EGF) could inhibit channel activity in a PIP2-dependent manner. High concentrations of PIP2 in the patch pipette not only resulted in a strong increase in sperm Slo3 current density but also prevented the EGF-induced inhibition of this current. Mutation of positively charged residues involved in channel-PIP2 interactions enhanced the EGF-induced inhibition of Slo3 currents. Overall, our results suggest that PIP2 is an important regulator for Slo3 activation and that receptor-mediated hydrolysis of PIP2 leads to inhibition of Slo3 currents both in native and heterologous expression systems.	[Tang, Qiong-Yao; Zhang, Zhe; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Xia, Jingsheng; Ren, Dejian] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Virginia Commonwealth University; University of Pennsylvania	Logothetis, DE (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA.	delogothetis@vcu.edu	Tang, Qiong-Yao/G-6051-2012; Zhang, Zhe/C-2685-2011		National Institutes of Health [HL059949, HL090882]; discretionary institutional funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090882, R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); discretionary institutional funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL059949 and HL090882 (to D.E.L.).This work was also supported by discretionary institutional funds (to D.E.L.).	Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Breitbart H, 2003, CELL MOL BIOL, V49, P321; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Fujita A, 2000, J CELL SCI, V113, P103; Furuya S, 1993, Nihon Sanka Fujinka Gakkai Zasshi, V45, P1313; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jungnickel MK, 2007, DEV BIOL, V304, P116, DOI 10.1016/j.ydbio.2006.12.023; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; LAX Y, 1994, FEBS LETT, V339, P234, DOI 10.1016/0014-5793(94)80422-2; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOGOTHETIS DE, 2010, EUR J PHYSL IN PRESS; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lopes CMB, 2007, CHANNELS, V1, P124, DOI 10.4161/chan.4322; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; Martinez-Lopez P, 2009, BIOCHEM BIOPH RES CO, V381, P204, DOI 10.1016/j.bbrc.2009.02.008; MURASE T, 1995, FEBS LETT, V360, P242, DOI 10.1016/0014-5793(95)00114-O; NagDas SK, 2002, BIOL REPROD, V67, P1058, DOI 10.1095/biolreprod67.4.1058; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Oliva-Hernandez J, 2008, THERIOGENOLOGY, V70, P1159, DOI 10.1016/j.theriogenology.2008.06.090; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tang QY, 2010, CHANNELS, V4, P22, DOI 10.4161/chan.4.1.10481; Tang QY, 2003, J MEMBRANE BIOL, V196, P185, DOI 10.1007/s00232-003-0637-8; Vaithianathan T, 2008, J GEN PHYSIOL, V132, P13, DOI 10.1085/jgp.200709913; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xie LH, 2007, PROG BIOPHYS MOL BIO, V94, P320, DOI 10.1016/j.pbiomolbio.2006.04.001; Xie LH, 2005, J GEN PHYSIOL, V126, P541, DOI 10.1085/jgp.200509380; Yang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006135; Zhang D, 2005, J ANDROL, V26, P643, DOI 10.2164/jandrol.05009; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang X, 2006, J GEN PHYSIOL, V128, P317, DOI 10.1085/jgp.200609552; Zhang X, 2006, J GEN PHYSIOL, V128, P301, DOI 10.1085/jgp.200609551	54	24	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19259	19266		10.1074/jbc.M109.100156	http://dx.doi.org/10.1074/jbc.M109.100156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392696	Green Published, hybrid			2022-12-27	WOS:000278727800035
J	Morita, YS; Yamaryo-Botte, Y; Miyanagi, K; Callaghan, JM; Patterson, JH; Crellin, PK; Coppel, RL; Billman-Jacobe, H; Kinoshita, T; McConville, MJ				Morita, Yasu S.; Yamaryo-Botte, Yoshiki; Miyanagi, Kana; Callaghan, Judy M.; Patterson, John H.; Crellin, Paul K.; Coppel, Ross L.; Billman-Jacobe, Helen; Kinoshita, Taroh; McConville, Malcolm J.			Stress-induced Synthesis of Phosphatidylinositol 3-Phosphate in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; BIOSYNTHESIS; PHOSPHOLIPIDS; GROWTH; TUBERCULOSIS; 4-PHOSPHATE; METABOLISM; 3-KINASES; KINASE; LIPIDS	Phosphoinositides play key roles in regulating membrane dynamics and intracellular signaling in eukaryotic cells. However, comparable lipid-based signaling pathways have not been identified in bacteria. Here we show that Mycobacterium smegmatis and other Actinomycetes bacteria can synthesize the phosphoinositide, phosphatidylinositol 3-phosphate (PI3P). This lipid was transiently labeled with [H-3]inositol. Sensitivity of the purified lipid to alkaline phosphatase, headgroup analysis by high-pressure liquid chromatography, and mass spectrometry demonstrated that it had the structure 1,2-[tuberculostearoyl, octadecenoyl]-sn-glycero 3-phosphoinositol 3-phosphate. Synthesis of PI3P was elevated by salt stress but not by exposure to high concentrations of non-ionic solutes. Synthesis of PI3P in a cell-free system was stimulated by the synthesis of CDP-diacylglycerol, a lipid substrate for phosphatidylinositol (PI) biosynthesis, suggesting that efficient cell-free PI3P synthesis is dependent on de novo PI synthesis. In vitro experiments further indicated that the rapid turnover of this lipid was mediated, at least in part, by a vanadate-sensitive phosphatase. This is the first example of de novo synthesis of PI3P in bacteria, and the transient synthesis in response to environmental stimuli suggests that some bacteria may have evolved similar lipid-mediated signaling pathways to those observed in eukaryotic cells.	[McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Billman-Jacobe, Helen] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Yamaryo-Botte, Yoshiki; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Yamaryo-Botte, Yoshiki; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Victorian Bioinformat Consortium, Dept Microbiol, Clayton, Vic 3800, Australia; [Miyanagi, Kana; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Miyanagi, Kana; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	University of Melbourne; University of Melbourne; Monash University; Monash University; Osaka University; Osaka University	Morita, YS (corresponding author), Osaka Univ, Dept Immunoregulat, Microbial Dis Res Inst, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ymorita@biken.osaka-u.ac.jp	Coppel, Ross L/A-6626-2008; Kinoshita, Taroh/C-7353-2009	Coppel, Ross L/0000-0002-4476-9124; Morita, Yasu/0000-0002-4514-9242; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411; Crellin, Paul K/0000-0002-2017-4935; Billman-Jacobe, Helen/0000-0001-5713-4657	International Human Frontier Science Program; JSPS [KAKENHI 20590441]; National Health and Medical Research Council; Ministry of Education, Culture, Sports, Science, and Technology, Japan	International Human Frontier Science Program(Human Frontier Science Program); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the International Human Frontier Science Program and JSPS (Grant KAKENHI 20590441). To whom correspondence may be addressed: Dept. of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan. Tel.: 81-6-6879-8329; Fax: 81-6-6875-5233; E-mail: ymorita@biken.osaka-u.ac.jp.; Supported by a National Health and Medical Research Council project grant.; Supported by the Knowledge Cluster Initiative of Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Basu SS, 1999, J BIOL CHEM, V274, P11139, DOI 10.1074/jbc.274.16.11139; BREARLEY CA, 1997, SIGNALLING INOSITIDE, P1; BRENNAN P, 1968, BIOCHEM BIOPH RES CO, V30, P69, DOI 10.1016/0006-291X(68)90714-6; BRENNAN PJ, 1971, LIPIDS, V6, P401, DOI 10.1007/BF02531377; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cameroni E, 2006, J BIOL CHEM, V281, P38139, DOI 10.1074/jbc.M601060200; Doering TL, 1996, EMBO J, V15, P182, DOI 10.1002/j.1460-2075.1996.tb00346.x; DOVE SK, 1999, SIGNAL TRANSDUCTION, P255; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Falasca Marco, 2006, Archives of Physiology and Biochemistry, V112, P274, DOI 10.1080/13813450601094664; FINNERTY WR, 1979, ANN INTERN MED, V90, P631, DOI 10.7326/0003-4819-90-4-631; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Hatzios SK, 2008, BIOCHEMISTRY-US, V47, P5823, DOI 10.1021/bi702453s; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; KATAOKA T, 1967, BIOCHIM BIOPHYS ACTA, V144, P681, DOI 10.1016/0005-2760(67)90058-6; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lemke LE, 1999, CANCER CHEMOTH PHARM, V44, P491, DOI 10.1007/s002800051123; LENNARZ WJ, 1962, J BIOL CHEM, V237, P664; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lymn JS, 2003, FEBS LETT, V555, P591, DOI 10.1016/S0014-5793(03)01350-4; Milne SB, 2005, J LIPID RES, V46, P1796, DOI 10.1194/jlr.D500010-JLR200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Ralton JE, 1998, J BIOL CHEM, V273, P4245, DOI 10.1074/jbc.273.7.4245; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; SAHA AK, 1989, J BACTERIOL, V171, P5103, DOI 10.1128/jb.171.9.5103-5110.1989; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Spielman MA, 1934, J BIOL CHEM, V106, P87; TABAUD H, 1971, BIOCHIMIE, V53, P55, DOI 10.1016/S0300-9084(71)80083-4; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; YANO I, 1969, J BACTERIOL, V98, P124, DOI 10.1128/JB.98.1.124-130.1969	38	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16643	16650		10.1074/jbc.M110.119263	http://dx.doi.org/10.1074/jbc.M110.119263			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20364020	hybrid, Green Published			2022-12-27	WOS:000277982600028
J	Nguyen, TT; Johnsen, IB; Knetter, CF; Drablos, F; Fitzgerald, KA; Lien, E; Anthonsen, MW				Nguyen, Thuy Thanh; Johnsen, Ingvild B.; Knetter, Cathrine F.; Drablos, Finn; Fitzgerald, Katherine A.; Lien, Egil; Anthonsen, Marit W.			Differential Gene Expression Downstream of Toll-like Receptors (TLRs) ROLE OF c-Src AND ACTIVATING TRANSCRIPTION FACTOR 3 (ATF3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR; INNATE IMMUNE-RESPONSE; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; TYROSINE KINASE; DAI DLM-1/ZBP1; IRF FAMILY; IN-VIVO; INFECTION; PROMOTER	Interferon regulatory factors (IRFs) are crucial for transcription during innate immune responses. We have previously shown that the tyrosine kinase c-Src enhances IRF-3-dependent transcription in response to viral double-stranded RNA. In this study, we show that c-Src has distinct roles in Toll-like receptor (TLR)-mediated activation of IRF-5 and IRF-3. Surprisingly, c-Src inhibition markedly enhanced IRF-5 activation after treatment with unmethylated CpG, while suppressing IRF-3 activation. Also, CpG-elicited interleukin-6 mRNA production was increased, whereas IP10 mRNA synthesis was reduced in cells deficient in c-Src. Interestingly, c-Src regulated TLR-stimulated induction of activating transcription factor 3 (ATF3), a transcriptional repressor. Depletion of ATF3 by small interfering RNA markedly enhanced interleukin-6 production after CpG treatment, whereas IP10 production was reduced. These results demonstrate functional specificity for c-Src in TLR-stimulated responses and suggest that c-Src modulation and ATF3 activity may contribute to differential regulation of IRF-3-versus IRF-5-mediated gene expression.	[Anthonsen, Marit W.] Norwegian Univ Sci & Technol, Lab Ctr, Fac Med, Dept Lab Med Childrens & Womens Hlth, N-7006 Trondheim, Norway; [Drablos, Finn] Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7006 Trondheim, Norway; [Knetter, Cathrine F.; Fitzgerald, Katherine A.; Lien, Egil] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Massachusetts System; University of Massachusetts Worcester	Anthonsen, MW (corresponding author), Norwegian Univ Sci & Technol, Lab Ctr, Fac Med, Dept Lab Med Childrens & Womens Hlth, Losgt 3, N-7006 Trondheim, Norway.	marit.w.anthonsen@ntnu.no	Drablos, Finn/L-4970-2019; Fitzgerald, Katherine/ABE-6317-2020	Drablos, Finn/0000-0001-5794-828X; Fitzgerald, Kate/0000-0003-3175-609X; Bjellmo Johnsen, Ingvild/0000-0002-3520-6776	National Programme for Research in Functional Genomics in Norway and Mid-Norway; Research Council of Norway; Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075318] Funding Source: NIH RePORTER	National Programme for Research in Functional Genomics in Norway and Mid-Norway; Research Council of Norway(Research Council of Norway); Faculty of Medicine, Norwegian University of Science and Technology; Cancer Fund at St. Olavs Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Programme for Research in Functional Genomics in Norway and Mid-Norway (to M. W. A.), the Research Council of Norway (to M. W. A.), the Faculty of Medicine, Norwegian University of Science and Technology (to I. B. J. and M. W. A.), and the Cancer Fund at St. Olavs Hospital (to M. W. A.).	Aas PA, 2009, DNA REPAIR, V8, P822, DOI 10.1016/j.dnarep.2009.03.008; Altmayr F, 2010, J BIOL CHEM, V285, P3525, DOI 10.1074/jbc.M109.066787; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Johnsen IB, 2009, J BIOL CHEM, V284, P19122, DOI 10.1074/jbc.M808233200; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melchjorsen J, 2003, J LEUKOCYTE BIOL, V74, P331, DOI 10.1189/jlb.1102577; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; Rosenberger CM, 2008, P NATL ACAD SCI USA, V105, P2544, DOI 10.1073/pnas.0712182105; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Turchi L, 2009, CELL DEATH DIFFER, V16, P728, DOI 10.1038/cdd.2009.2; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	35	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17011	17019		10.1074/jbc.M109.068817	http://dx.doi.org/10.1074/jbc.M109.068817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351107	hybrid, Green Published			2022-12-27	WOS:000277982600064
J	Playford, MP; Nurminen, E; Pentikainen, OT; Milgram, SL; Hartwig, JH; Stossel, TP; Nakamura, F				Playford, Martin P.; Nurminen, Elisa; Pentikainen, Olli T.; Milgram, Sharon L.; Hartwig, John H.; Stossel, Thomas P.; Nakamura, Fumihiko			Cystic Fibrosis Transmembrane Conductance Regulator Interacts with Multiple Immunoglobulin Domains of Filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CHLORIDE CHANNELS; PLASMA-MEMBRANE; MOLECULAR-BASIS; CFTR; BINDING; CELLS; CYTOSKELETON; COMPETITION; EXPRESSION	Mutations of the chloride channel cystic fibrosis transmembrane conductance regulator (CFTR) that impair its apical localization and function cause cystic fibrosis. A previous report has shown that filamin A (FLNa), an actin-cross-linking and -scaffolding protein, interacts directly with the cytoplasmic N terminus of CFTR and that this interaction is necessary for stability and confinement of the channel to apical membranes. Here, we report that the CFTR N terminus has sequence similarity to known FLNa-binding partner-binding sites. FLNa has 24 Ig (IgFLNa) repeats, and a CFTR peptide pulled down repeats 9, 12, 17, 19, 21, and 23, which share sequence similarity yet differ from the other FLNa Ig domains. Using known structures of IgFLNa.partner complexes as templates, we generated in silico models of IgFLNa.CFTR peptide complexes. Point and deletion mutants of IgFLNa and CFTR informed by the models, including disease-causing mutations L15P and W19C, disrupted the binding interaction. The model predicted that a P5L CFTR mutation should not affect binding, but a synthetic P5L mutant peptide had reduced solubility, suggesting a different disease-causing mechanism. Taken together with the fact that FLNa dimers are elongated (similar to 160 nm) strands, whereas CFTR is compact (6 similar to 8 nm), we propose that a single FLNa molecule can scaffold multiple CFTR partners. Unlike previously defined dimeric FLNa.partner complexes, the FLNa-monomeric CFTR interaction is relatively weak, presumptively facilitating dynamic clustering of CFTR at cell membranes. Finally, we show that deletion of all CFTR interacting domains from FLNa suppresses the surface expression of CFTR on baby hamster kidney cells.	[Hartwig, John H.; Stossel, Thomas P.; Nakamura, Fumihiko] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA; [Nurminen, Elisa; Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Nurminen, Elisa; Pentikainen, Olli T.] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Playford, Martin P.; Milgram, Sharon L.] NHLBI, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Jyvaskyla; University of Jyvaskyla; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Nakamura, F (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA.	fnakamura@rics.bwh.harvard.edu	Pentikäinen, Olli T/E-1980-2012; Nakamura, Fumihiko/N-5476-2016	Pentikäinen, Olli T/0000-0001-7188-4016; Nakamura, Fumihiko/0000-0002-6872-4246	National Institutes of Health [HL-19429, HL-56252]; HUSEC Seed Fund for Interdisciplinary Science; Sigrid Juselius Foundation; University of Jyvaskyla; Finnish IT Center for Science Computational Grant [jyy2516]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HUSEC Seed Fund for Interdisciplinary Science; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Jyvaskyla; Finnish IT Center for Science Computational Grant(Finnish IT center for science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL-19429 (to T. P. S.) and HL-56252 (to J. H. H.). This work was also supported by the HUSEC Seed Fund for Interdisciplinary Science (T. P. S. and F. N.), the Sigrid Juselius Foundation (O. T. P.), the University of Jyvaskyla (E. N.), and the Finnish IT Center for Science Computational Grant for Project jyy2516 (to O. T. P.).	Awayn NH, 2005, BIOCHEM SOC T, V33, P996, DOI 10.1042/BST0330996; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Cantiello HF, 1996, EXP PHYSIOL, V81, P505, DOI 10.1113/expphysiol.1996.sp003953; Chen JH, 2002, J MEMBRANE BIOL, V188, P55, DOI 10.1007/s00232-001-0174-2; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Haggie PM, 2008, J BIOL CHEM, V283, P23510, DOI 10.1074/jbc.C800100200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; Jurkuvenaite A, 2010, AM J RESP CELL MOL, V42, P363, DOI 10.1165/rcmb.2008-0434OC; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Prat AG, 1999, AM J PHYSIOL-CELL PH, V277, pC1160, DOI 10.1152/ajpcell.1999.277.6.C1160; Ramjeesingh M, 2003, BIOCHEM J, V375, P633, DOI 10.1042/BJ20030774; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Smith L, 2010, J BIOL CHEM, V285, P17166, DOI 10.1074/jbc.M109.080911; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780	32	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17156	17165		10.1074/jbc.M109.080523	http://dx.doi.org/10.1074/jbc.M109.080523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351098	hybrid, Green Published			2022-12-27	WOS:000277982600078
J	Sako, D; Grinberg, AV; Liu, J; Davies, MV; Castonguay, R; Maniatis, S; Andreucci, AJ; Pobre, EG; Tomkinson, KN; Monnell, TE; Ucran, JA; Martinez-Hackert, E; Pearsall, RS; Underwood, KW; Seehra, J; Kumar, R				Sako, Dianne; Grinberg, Asya V.; Liu, June; Davies, Monique V.; Castonguay, Roselyne; Maniatis, Silas; Andreucci, Amy J.; Pobre, Eileen G.; Tomkinson, Kathleen N.; Monnell, Travis E.; Ucran, Jeffrey A.; Martinez-Hackert, Erik; Pearsall, R. Scott; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra			Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; BETA SUPERFAMILY; MYOSTATIN GENE; GROWTH; MUSCLE; MICE; DIFFERENTIATION; MUTATIONS; FAMILY; CATTLE	The single transmembrane domain serine/threonine kinase activin receptor type IIB (ActRIIB) has been proposed to bind key regulators of skeletal muscle mass development, including the ligands GDF-8 (myostatin) and GDF-11 (BMP-11). Here we provide a detailed kinetic characterization of ActRIIB binding to several low and high affinity ligands using a soluble activin receptor type IIB-Fc chimera (ActRIIB.Fc). We show that both GDF-8 and GDF-11 bind the extracellular domain of ActRIIB with affinities comparable with those of activin A, a known high affinity ActRIIB ligand, whereas BMP-2 and BMP-7 affinities for ActRIIB are at least 100-fold lower. Using site-directed mutagenesis, we demonstrate that ActRIIB binds GDF-11 and activin A in different ways such as, for example, substitutions in ActRIIB Leu(79) effectively abolish ActRIIB binding to activin A yet not to GDF-11. Native ActRIIB has four isoforms that differ in the length of the C-terminal portion of their extracellular domains. We demonstrate that the C terminus of the ActRIIB extracellular domain is crucial for maintaining biological activity of the ActRIIB.Fc receptor chimera. In addition, we show that glycosylation of ActRIIB is not required for binding to activin A or GDF-11. Together, our findings reveal binding specificity and activity determinants of the ActRIIB receptor that combine to effect specificity in the activation of distinct signaling pathways.	[Sako, Dianne; Grinberg, Asya V.; Liu, June; Davies, Monique V.; Castonguay, Roselyne; Andreucci, Amy J.; Pobre, Eileen G.; Tomkinson, Kathleen N.; Monnell, Travis E.; Ucran, Jeffrey A.; Martinez-Hackert, Erik; Pearsall, R. Scott; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra] Acceleron Pharma Inc, Cambridge, MA 02139 USA; [Maniatis, Silas] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Acceleron Pharma; Harvard University	Kumar, R (corresponding author), Acceleron Pharma Inc, 128 Sidney St, Cambridge, MA 02139 USA.	rkumar@acceleronpharma.com		Martinez-Hackert, Erik/0000-0002-6182-7023	Acceleron Pharma	Acceleron Pharma	We thank Tim Ahern, a medical writer supported by Acceleron Pharma, who provided editorial assistance during preparation of the manuscript. We also thank John Knopf and John Quisel for critical review of the manuscript and all members of Acceleron Pharma's Cell Biology and Protein Purification Groups for contributions in support of this work.	ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; del Re E, 2004, J BIOL CHEM, V279, P53126, DOI 10.1074/jbc.M408090200; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Goetschy JF, 1996, EUR J BIOCHEM, V241, P355, DOI 10.1111/j.1432-1033.1996.00355.x; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Greenwald J, 1998, BIOCHEMISTRY-US, V37, P16711, DOI 10.1021/bi981939o; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; HILDEN K, 1994, BLOOD, V83, P2163; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; MATHEWS LS, 1993, RECEPTOR, V3, P173; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; Patel SR, 2005, TRENDS MOL MED, V11, P512, DOI 10.1016/j.molmed.2005.09.007; Pearsall RS, 2008, P NATL ACAD SCI USA, V105, P7082, DOI 10.1073/pnas.0711263105; Reddi AH, 1998, CLIN ORTHOP RELAT R, pS66; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; ten Dijke P, 2006, CURR MED RES OPIN, V22, pS7, DOI 10.1185/030079906X80576; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100	41	106	145	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21037	21048		10.1074/jbc.M110.114959	http://dx.doi.org/10.1074/jbc.M110.114959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20385559	Green Published, hybrid			2022-12-27	WOS:000279228600067
J	Asim, M; Chaturvedi, R; Hoge, S; Lewis, ND; Singh, K; Barry, DP; Algood, HS; de Sablet, T; Gobert, AP; Wilson, KT				Asim, Mohammad; Chaturvedi, Rupesh; Hoge, Svea; Lewis, Nuruddeen D.; Singh, Kshipra; Barry, Daniel P.; Algood, Holly S.; de Sablet, Thibaut; Gobert, Alain P.; Wilson, Keith T.			Helicobacter pylori Induces ERK-dependent Formation of a Phospho-c-Fos.c-Jun Activator Protein-1 Complex That Causes Apoptosis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; KAPPA-B ACTIVATION; GROWTH-FACTOR; HOST-DEFENSE; DNA-BINDING; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSE; AP-1 COMPLEX; ARGINASE-II; MAP KINASE	Macrophages are essential components of innate immunity, and apoptosis of these cells impairs mucosal defense to microbes. Helicobacter pylori is a gastric pathogen that infects half of the world population and causes peptic ulcer disease and gastric cancer. The host inflammatory response fails to eradicate the organism. We have reported that H. pylori induces apoptosis of macrophages by generation of polyamines from ornithine decarboxylase (ODC), which is dependent on c-Myc as a transcriptional enhancer. We have now demonstrated that expression of c-Myc requires phosphorylation and nuclear translocation of ERK,which results in phosphorylation of c-Fos and formation of a specific activator protein (AP)-1 complex. Electromobility shift assay and immunoprecipitation revealed a previously unrecognized complex of phospho-c-Fos (pc-Fos) and c-Jun in the nucleus. Fluorescence resonance energy transfer demonstrated the interaction of pc-Fos and c-Jun. The capacity of this AP-1 complex to bind to putative AP-1 sequences was demonstrated by oligonucleotide pulldown and fluorescence polarization. Binding of the pc-Fos center dot c-Jun complex to the c-Myc promoter was demonstrated by chromatin immunoprecipitation. A dominant-negative c-Fos inhibited H. pylori-induced expression of c-Myc and ODC and apoptosis. H. pylori infection of mice induced a rapid infiltration of macrophages into the stomach. Concomitant apoptosis depleted these cells, and this was associated with formation of a pc-Fos center dot c-Jun complex. Treatment of mice with an inhibitor of ERK phosphorylation attenuated phosphorylation of c-Fos, expression of ODC, and apoptosis in gastric macrophages. A unique AP-1 complex in gastric macrophages contributes to the immune escape of H. pylori.	[Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Sch Med, Div Gastroenterol, Nashville, TN 37232 USA; [Algood, Holly S.] Vanderbilt Univ, Med Ctr, Dept Med, Dept Infect Dis, Nashville, TN 37232 USA; [Lewis, Nuruddeen D.; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Asim, Mohammad; Chaturvedi, Rupesh; Singh, Kshipra; Algood, Holly S.; de Sablet, Thibaut; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Hoge, Svea] Otto Von Guericke Univ, Dept Gen Abdominal & Vasc Surg, D-39120 Magdeburg, Germany; [Gobert, Alain P.] INRA, Unite Microbiol UR454, F-63122 St Genes Champanelle, France	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Otto von Guericke University; INRAE	Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Div Gastroenterol, 1030C MRB 4,2215B Garland Ave, Nashville, TN 37232 USA.	keith.wilson@vanderbilt.edu	de Sablet, Thibaut/AAI-4513-2020; Gobert, Alain P/AHB-1368-2022; Barry, Daniel P/B-5647-2008	Barry, Daniel P/0000-0002-3972-3914; Wilson, Keith/0000-0003-4421-1830; Lewis, Nuruddeen/0000-0002-1233-6607	National Institutes of Health [R01DK053620, R01AT004821, P01CA116087, P01CA028842, F31GM083500, T32CA009592, T32DK007673, P30DK058404]; Vanderbilt University Digestive Disease Research Center; Office of Medical Research, Department of Veterans Affairs; Philippe Foundation; NATIONAL CANCER INSTITUTE [P01CA116087, T32CA009592, P01CA028842] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053620, P30DK058404, T32DK007673, P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM083500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Digestive Disease Research Center; Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); Philippe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK053620 and R01AT004821 (to K. T. W.), P01CA116087 (to K. T. W.), P01CA028842 (to K. T. W.), F31GM083500 (to N. D. L.), T32CA009592 (to N. D. L.), and T32DK007673 (D. P. B.). This work was also supported by the Flow Cytometry Core and the Cell Imaging Core of the Vanderbilt University Digestive Disease Research Center, which was supported by National Institutes of Health Grant P30DK058404, a Merit Review Grant from the Office of Medical Research, Department of Veterans Affairs (to K. T. W.), and the Philippe Foundation (to T. d. S. and A. P. G.).	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Bhattacharyya A, 2002, BIOCHEM J, V368, P121, DOI 10.1042/BJ20020555; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Bussiere FI, 2006, CANCER RES, V66, P6834, DOI 10.1158/0008-5472.CAN-05-4197; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen RH, 1996, ONCOGENE, V12, P1493; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Ding SZ, 2008, FEMS IMMUNOL MED MIC, V53, P385, DOI 10.1111/j.1574-695X.2008.00439.x; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Grill C, 2004, BIOCHEM J, V381, P635, DOI 10.1042/BJ20031688; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; Iavarone C, 2003, J BIOL CHEM, V278, P50024, DOI 10.1074/jbc.M308617200; Kao JY, 2006, AM J PHYSIOL-GASTR L, V291, pG73, DOI 10.1152/ajpgi.00139.2005; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Keates S, 1999, J IMMUNOL, V163, P5552; Kudo T, 2007, GASTROENTEROLOGY, V132, P1024, DOI 10.1053/j.gastro.2007.01.009; Kyriakis JM, 2001, NATURE, V414, P265, DOI 10.1038/35104735; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Lewis ND, 2010, J IMMUNOL, V184, P2572, DOI 10.4049/jimmunol.0902436; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Naumann M, 1999, J BIOL CHEM, V274, P31655, DOI 10.1074/jbc.274.44.31655; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Preston GA, 1996, MOL CELL BIOL, V16, P211; Rishi V, 2005, ANAL BIOCHEM, V340, P259, DOI 10.1016/j.ab.2005.02.012; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rusinova E, 2002, ANAL BIOCHEM, V308, P18, DOI 10.1016/S0003-2697(02)00325-1; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; SZABO E, 1991, CELL GROWTH DIFFER, V2, P475; Teixeiro E, 2010, FEBS J, V277, P30, DOI 10.1111/j.1742-4658.2009.07368.x; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Wilson KT, 1996, GASTROENTEROLOGY, V111, P1524, DOI 10.1016/S0016-5085(96)70014-8; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yamauchi K, 2008, J IMMUNOL, V180, P1207, DOI 10.4049/jimmunol.180.2.1207; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4	62	58	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20343	20357		10.1074/jbc.M110.116988	http://dx.doi.org/10.1074/jbc.M110.116988			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20410304	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000279012000068
J	Dridi, L; Ouameur, AA; Ouellette, M				Dridi, Larbi; Ouameur, Amin Ahmed; Ouellette, Marc			High Affinity S-Adenosylmethionine Plasma Membrane Transporter of Leishmania Is a Member of the Folate Biopterin Transporter (FBT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOZOAN PARASITE LEISHMANIA; METHOTREXATE-RESISTANT LEISHMANIA; TRYPANOSOMA-BRUCEI-RHODESIENSE; AMPLIFIED H-CIRCLE; GENE-EXPRESSION; METHIONINE ADENOSYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; PLASMODIUM-FALCIPARUM; MITOCHONDRIAL CARRIER	S-Adenosylmethionine (AdoMet) is an important methyl group donor that plays a central role in many essential biochemical processes. The parasite Leishmania can both synthesize and transport AdoMet. Leishmania cells resistant to the antifolate methotrexate due to a rearrangement in folate biopterin transporter (FBT) genes were cross-resistant to sinefungin, an AdoMet analogue. FBT gene rearrangements were also observed in Leishmania major cells selected for sinefungin resistance. One of the rearranged FBT genes corresponded to the main AdoMet transporter (AdoMetT1) of Leishmania as determined by gene transfection and gene inactivation experiments. AdoMetT1 was determined to be a high affinity plasma membrane transporter expressed constitutively throughout the growth phases of the parasite. Leishmania cells selected for resistance or naturally insensitive to sinefungin had lower expression of AdoMetT1. A new function in one carbon metabolism, also a pathway of interest for chemotherapeutic interventions, is described for a novel class of membrane proteins found in diverse organisms.	[Dridi, Larbi; Ouameur, Amin Ahmed; Ouellette, Marc] Univ Laval, Ctr Rech Infectiol, CHUL, Quebec City, PQ G1V 4G2, Canada	Laval University	Ouellette, M (corresponding author), Univ Laval, Ctr Rech Infectiol, CHUL, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	marc.ouellette@crchul.ulaval.ca	Ouellette, Marc/K-8694-2017	Ouellette, Marc/0000-0002-6743-9646	Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research group and operating grants (to M.O.).; Recipient of a Canadian Institutes of Health Research studentship.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Al-Salabi MI, 2003, MOL PHARMACOL, V63, P814, DOI 10.1124/mol.63.4.814; AVILA JL, 1987, MOL BIOCHEM PARASIT, V26, P69, DOI 10.1016/0166-6851(87)90131-9; AVILA JL, 1993, MOL BIOCHEM PARASIT, V58, P123, DOI 10.1016/0166-6851(93)90096-G; Bacchi CJ, 2009, ANTIMICROB AGENTS CH, V53, P3269, DOI 10.1128/AAC.00076-09; BACHRACH U, 1980, FEBS LETT, V121, P287, DOI 10.1016/0014-5793(80)80364-4; Barker RH, 2009, ANTIMICROB AGENTS CH, V53, P2052, DOI 10.1128/AAC.01674-08; Bouvier F, 2006, PLANT CELL, V18, P3088, DOI 10.1105/tpc.105.040741; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cunningham ML, 2001, MOL BIOCHEM PARASIT, V113, P199, DOI 10.1016/S0166-6851(01)00213-4; Dridi L, 2010, BIOCHEM PHARMACOL, V79, P30, DOI 10.1016/j.bcp.2009.07.019; Drummelsmith J, 2004, J BIOL CHEM, V279, P33273, DOI 10.1074/jbc.M405183200; DUBE DK, 1983, AM J TROP MED HYG, V32, P31, DOI 10.4269/ajtmh.1983.32.31; El Fadili A, 2002, MOL BIOCHEM PARASIT, V124, P63, DOI 10.1016/S0166-6851(02)00163-9; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Foucher AL, 2006, J PROTEOME RES, V5, P1741, DOI 10.1021/pr060081j; Gagnon D, 2006, MOL BIOCHEM PARASIT, V150, P63, DOI 10.1016/j.molbiopara.2006.06.009; Goldberg B, 1997, FASEB J, V11, P256, DOI 10.1096/fasebj.11.4.9068614; Goldberg B, 1998, BIOCHEM PHARMACOL, V56, P95, DOI 10.1016/S0006-2952(98)00118-X; Goldberg B, 1999, ARCH BIOCHEM BIOPHYS, V364, P13, DOI 10.1006/abbi.1999.1098; Guimond C, 2003, NUCLEIC ACIDS RES, V31, P5886, DOI 10.1093/nar/gkg806; Haferkamp I, 2007, FEBS LETT, V581, P2375, DOI 10.1016/j.febslet.2007.02.020; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hirth B, 2009, BIOORG MED CHEM LETT, V19, P2916, DOI 10.1016/j.bmcl.2009.04.096; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Lemley C, 1999, MOL BIOCHEM PARASIT, V104, P93, DOI 10.1016/S0166-6851(99)00132-2; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Massimine KM, 2005, MOL BIOCHEM PARASIT, V144, P44, DOI 10.1016/j.molbiopara.2005.07.006; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Merali S, 2000, J BIOL CHEM, V275, P14958, DOI 10.1074/jbc.275.20.14958; Merali S, 2004, FEMS MICROBIOL LETT, V237, P179, DOI 10.1016/j.femsle.2004.06.039; Moreira W, 2009, FREE RADICAL BIO MED, V46, P367, DOI 10.1016/j.freeradbiomed.2008.10.034; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; NOLAN LL, 1987, ANTIMICROB AGENTS CH, V31, P1542, DOI 10.1128/AAC.31.10.1542; Ouameur AA, 2008, MOL BIOCHEM PARASIT, V162, P155, DOI 10.1016/j.molbiopara.2008.08.007; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; Palmieri L, 2006, PLANT PHYSIOL, V142, P855, DOI 10.1104/pp.106.086975; PAOLANTONACCI P, 1985, ANTIMICROB AGENTS CH, V28, P528, DOI 10.1128/AAC.28.4.528; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305; Perez-Pertejo Y, 2006, BBA-GEN SUBJECTS, V1760, P10, DOI 10.1016/j.bbagen.2005.09.003; PHELOUZAT MA, 1995, BIOCHEM J, V305, P133, DOI 10.1042/bj3050133; Reguera RM, 2002, J BIOL CHEM, V277, P3158, DOI 10.1074/jbc.M105512200; Reguera RM, 2007, MOL BIOCHEM PARASIT, V152, P1, DOI 10.1016/j.molbiopara.2006.11.013; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Richard D, 2002, J BIOL CHEM, V277, P29460, DOI 10.1074/jbc.M204796200; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Sambrook J., 2002, MOL CLONING LAB MANU; TRAGER W, 1980, EXP PARASITOL, V50, P83, DOI 10.1016/0014-4894(80)90010-7; Tucker AM, 2003, J BACTERIOL, V185, P3031, DOI 10.1128/JB.185.10.3031-3035.2003; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Wang P, 2007, MOL BIOCHEM PARASIT, V154, P40, DOI 10.1016/j.molbiopara.2007.04.002; Zheng S, 2007, NUCLEIC ACIDS RES, V35, P6895, DOI 10.1093/nar/gkm817	65	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19767	19775		10.1074/jbc.M110.114520	http://dx.doi.org/10.1074/jbc.M110.114520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406813	Green Published, hybrid			2022-12-27	WOS:000279012000009
J	Hanzelmann, P; Stingele, J; Hofmann, K; Schindelin, H; Raasi, S				Haenzelmann, Petra; Stingele, Julian; Hofmann, Kay; Schindelin, Hermann; Raasi, Shahri			The Yeast E4 Ubiquitin Ligase Ufd2 Interacts with the Ubiquitin-like Domains of Rad23 and Dsk2 via a Novel and Distinct Ubiquitin-like Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							63-LINKED POLYUBIQUITIN CHAINS; STRUCTURAL BASIS; UBA DOMAIN; PROTEASOME PATHWAY; PROTEIN-STRUCTURE; SUBUNIT S5A; RECOGNITION; DETERMINANTS; DEGRADATION; MULTIUBIQUITYLATION	Proteins containing ubiquitin-like (UBL) and ubiquitin-associated (UBA) domains interact with various binding partners and function as hubs during ubiquitin-mediated protein degradation. A common interaction of the budding yeast UBL-UBA proteins Rad23 and Dsk2 with the E4 ubiquitin ligase Ufd2 has been described in endoplasmic reticulum-associated degradation among other pathways. The UBL domains of Rad23 and Dsk2 play a prominent role in this process by interacting with Ufd2 and different subunits of the 26 S proteasome. Here, we report crystal structures of Ufd2 in complex with the UBL domains of Rad23 and Dsk2. The N-terminal UBL-interacting region of Ufd2 exhibits a unique sequence pattern, which is distinct from any known ubiquitin-or UBL-binding domain identified so far. Residue-specific differences exist in the interactions of these UBL domains with Ufd2, which are coupled to subtle differences in their binding affinities. The molecular details of their differential interactions point to a role for adaptive evolution in shaping these interfaces.	[Haenzelmann, Petra; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Stingele, Julian; Raasi, Shahri] Univ Konstanz, Dept Biol, Lab Cellular Biochem, D-78457 Constance, Germany; [Hofmann, Kay] Miltenyi Biotec GmbH, Bioinformat Grp, D-51429 Bergisch Gladbach, Germany	University of Wurzburg; University of Konstanz; Miltenyi Biotec	Schindelin, H (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	hermann.schindelin@virchow.uni-wuerzburg.de; shahri.raasi@uni-konstanz.de	Schindelin, Hermann/Q-2697-2019; Hofmann, Kay/D-6714-2011; Stingele, Julian/K-7490-2012	Hofmann, Kay/0000-0002-2289-9083; Stingele, Julian/0000-0001-6020-2075	Deutsche Forschungsgemeinschaft [RA1643/2-1]; Rudolf Virchow Center for Experimental Biomedicine [FZ 82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rudolf Virchow Center for Experimental Biomedicine	This work was supported by Deutsche Forschungsgemeinschaft Grant RA1643/2-1 (to S. R.) and Rudolf Virchow Center for Experimental Biomedicine Grant FZ 82 (to H. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hunter CA, 2003, CHEM BIOL, V10, P1023, DOI 10.1016/j.chembiol.2003.10.009; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ishii T, 2006, EMBO J, V25, P5492, DOI 10.1038/sj.emboj.7601418; Ivantsiv Y, 2006, MOL CELL BIOL, V26, P1579, DOI 10.1128/MCB.26.5.1579-1588.2006; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-75; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Velthuis AJWT, 2008, CURR GENOMICS, V9, P88, DOI 10.2174/138920208784139537; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012	65	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20390	20398		10.1074/jbc.M110.112532	http://dx.doi.org/10.1074/jbc.M110.112532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427284	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000279012000072
J	Tsutsumi, R; Mistry, D; Webster, NJG				Tsutsumi, Rie; Mistry, Devendra; Webster, Nicholas J. G.			Signaling Responses to Pulsatile Gonadotropin-releasing Hormone in L beta T2 Gonadotrope Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ADENYLYL-CYCLASE; GNRH RECEPTOR; DEPENDENT PHOSPHORYLATION; BETA-PROMOTER; LIVING CELLS; ACTIVATION; EXPRESSION; INDUCTION; PATHWAYS	The hypothalamic neuropeptide gonadotropin-releasing hormone ( GnRH) is secreted in a pulsatile fashion by hypothalamic neurons, and alterations in pulse frequency and amplitude differentially regulate gonadotropin synthesis and release. In this study, we investigated the kinetics of G(s) and G(q) signaling in response to continuous or pulsatile GnRH using fluorescence resonance energy transfer reporters in live mouse L beta T2 gonadotrope cells. cAMP and protein kinase A-dependent reporters showed a rapid but transient increase in fluorescence resonance energy transfer signal with increasing doses of constant GnRH, and in contrast diacylglycerol (DAG) and calcium reporters showed a rapid and sustained signal. Multiple pulses of GnRH caused multiple pulses of cAMP and protein kinase A activation without desensitization, but the DAG and calcium reporters were rapidly desensitized resulting in inhibition of calcium and DAG responses. At the transcriptional level, both a cAMP-dependent cAMP-response element reporter and a DAG/calcium-dependent AP-1 reporter showed a pulse frequency-dependent increase in luciferase activity. However, constant GnRH stimulation gave very little cAMP-response element activation but very strong AP-1 activation. Based on these data, we propose that both the GnRH-R-G(s) and G(q) pathways are responsive to pulses of GnRH, but only the G(q) pathway is responsive to constant GnRH. Furthermore, the G(q) pathway is subject to desensitization with multiple GnRH pulses, but the G(s) pathway is not.	[Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mistry, Devendra; Webster, Nicholas J. G.] Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA; [Mistry, Devendra] Univ Calif San Diego, Interfaces Grad Program, La Jolla, CA 92093 USA; Vet Affairs San Diego Healthcare Syst, Med Res Serv, San Diego, CA 92161 USA; [Tsutsumi, Rie] Univ Tokushima, Tokushima 7708503, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Tokushima University	Webster, NJG (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,M-C 0673, La Jolla, CA 92093 USA.	nwebster@ucsd.edu	Webster, Nick/AAI-8410-2021	Tsutsumi, Rie/0000-0001-6362-5823	National Institutes of Health [R01 HD047400, SCCPIR U54 HD012303]; Ruth L. Kirschstein National Research Service Award [T32 EB009380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047400] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD047400 and SCCPIR U54 HD012303 ( to N. J. G. W.). This work was also supported by Ruth L. Kirschstein National Research Service Award T32 EB009380 ( to D. M.).	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Caunt CJ, 2004, ENDOCRINOLOGY, V145, P3594, DOI 10.1210/en.2004-0092; Ciccone NA, 2008, MOL ENDOCRINOL, V22, P1908, DOI 10.1210/me.2007-0455; Clark MA, 2006, MOL PHARMACOL, V69, P1280, DOI 10.1124/mol.105.019059; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Ferris HA, 2007, BIOL REPROD, V77, P1073, DOI 10.1095/biolreprod.107.064139; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Han XB, 1999, ENDOCRINOLOGY, V140, P2241, DOI 10.1210/en.140.5.2241; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Huang HC, 2010, J BONE MINER RES, V25, P819, DOI 10.1359/jbmr.091019; Kaiser UB, 1997, ENDOCR REV, V18, P46, DOI 10.1210/er.18.1.46; Kaufmann K, 2001, BIOL CHEM, V382, P1077, DOI 10.1515/BC.2001.135; Komi N, 2007, BBA-BIOMEMBRANES, V1768, P3001, DOI 10.1016/j.bbamem.2007.10.015; Kraus S, 2001, ARCH MED RES, V32, P499, DOI 10.1016/S0188-4409(01)00331-9; Krsmanovic LZ, 2001, MOL ENDOCRINOL, V15, P429, DOI 10.1210/me.15.3.429; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Litosch I, 1997, BIOCHEM J, V326, P701, DOI 10.1042/bj3260701; Liu FJ, 2003, ENDOCRINOLOGY, V144, P4354, DOI 10.1210/en.2003-0204; Liu FJ, 2002, J BIOL CHEM, V277, P32099, DOI 10.1074/jbc.M203639200; Liu FJ, 2002, MOL ENDOCRINOL, V16, P419, DOI 10.1210/me.16.3.419; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Marshall JC, 2001, MOL CELL ENDOCRINOL, V183, P29, DOI 10.1016/S0303-7207(01)00611-6; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Shacham S, 2005, J BIOL CHEM, V280, P28981, DOI 10.1074/jbc.M500312200; SHAH BH, 1995, P NATL ACAD SCI USA, V92, P1886, DOI 10.1073/pnas.92.6.1886; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140	37	35	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20262	20272		10.1074/jbc.M110.132662	http://dx.doi.org/10.1074/jbc.M110.132662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406815	hybrid, Green Published			2022-12-27	WOS:000279012000061
J	Zhao, CH; Coughlin, JM; Ju, JH; Zhu, DQ; Wendt-Pienkowski, E; Zhou, XF; Wang, ZJ; Shen, B; Deng, ZX				Zhao, Chunhua; Coughlin, Jane M.; Ju, Jianhua; Zhu, Dongqing; Wendt-Pienkowski, Evelyn; Zhou, Xiufen; Wang, Zhijun; Shen, Ben; Deng, Zixin			Oxazolomycin Biosynthesis in Streptomyces albus JA3453 Featuring an "Acyltransferase-less" Type I Polyketide Synthase That Incorporates Two Distinct Extender Units	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; NONRIBOSOMAL PEPTIDE SYNTHETASE; SITE-DIRECTED MUTAGENESIS; GENE-CLUSTER; CRYSTAL-STRUCTURE; BETA-KETOACYL; SORANGIUM-CELLULOSUM; BOND FORMATION; STARTER UNIT; SORAPHEN-A	The oxazolomycins (OZMs) are a growing family of antibiotics produced by several Streptomyces species that show diverse and important antibacterial, antitumor, and anti-human immunodeficiency virus activity. Oxazolomycin A is a peptide-polyketide hybrid compound containing a unique spiro-linked beta-lactone/gamma-lactam, a 5-substituted oxazole ring. The oxazolomycin biosynthetic gene cluster (ozm) was identified from Streptomyces albus JA3453 and localized to 79.5-kb DNA, consisting of 20 open reading frames that encode non-ribosomal peptide synthases, polyketide synthases (PKSs), hybrid non-ribosomal peptide synthase-PKS, trans-acyltransferases (trans-ATs), enzymes for methoxymalonyl-acyl carrier protein (ACP) synthesis, putative resistance genes, and hypothetical regulation genes. In contrast to classical type I polyketide or fatty acid biosynthases, all 10 PKS modules in the gene cluster lack cognate ATs. Instead, discrete ATs OzmM (with tandem domains OzmM-AT1 and OzmM-AT2) and OzmC were equipped to carry out all of the loading functions of both malonyl-CoA and methoxymalonyl-ACP extender units. Strikingly, only OzmM-AT2 is required for OzmM activity for OZM biosynthesis, whereas OzmM-AT1 seemed to be a cryptic AT domain. The above findings, together with previous results using isotope-labeled precursor feeding assays, are assembled for the OZM biosynthesis model to be proposed. The incorporation of both malonyl-CoA (by OzmM-AT2) and methoxymalonyl-ACP (by OzmC) extender units seemed to be unprecedented for this class of trans-AT type I PKSs, which might be fruitfully manipulated to create structurally diverse novel compounds.	[Coughlin, Jane M.; Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Ju, Jianhua; Wendt-Pienkowski, Evelyn; Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Zhao, Chunhua; Zhu, Dongqing; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin] Shanghai Jiao Tong Univ, Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhao, Chunhua; Zhu, Dongqing; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, B (corresponding author), Univ Wisconsin, Dept Chem, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu; zxdeng@sjtu.edu.cn			National Institutes of Health [CA113297]; Ministry of Science and Technology of China 973 and 863 [2003CB114205]; National Science Foundation of China; Chinese Ministry of Education; Shanghai Municipal Council of Science and Technology; NATIONAL CANCER INSTITUTE [U19CA113297, R01CA106150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China 973 and 863; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Shanghai Municipal Council of Science and Technology(Shanghai Leading Academic Discipline Project); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA113297 (to B.S.). This work was also supported by the Ministry of Science and Technology of China 973 (2003CB114205) and 863 programs, the National Science Foundation of China, the Chinese Ministry of Education, and the Shanghai Municipal Council of Science and Technology (to Z.D.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bagwell CL, 2008, BIOORG MED CHEM LETT, V18, P4081, DOI 10.1016/j.bmcl.2008.05.105; Bao WL, 1999, BIOCHEMISTRY-US, V38, P9752, DOI 10.1021/bi990751h; Calderone CT, 2007, CHEM BIOL, V14, P835, DOI 10.1016/j.chembiol.2007.06.008; Carroll BJ, 2002, J AM CHEM SOC, V124, P4176, DOI 10.1021/ja0124764; Chan YA, 2006, P NATL ACAD SCI USA, V103, P14349, DOI 10.1073/pnas.0603748103; Cheng YQ, 2009, METHOD ENZYMOL, V459, P165, DOI 10.1016/S0076-6879(09)04608-4; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Dorrestein PC, 2006, J AM CHEM SOC, V128, P10386, DOI 10.1021/ja0639362; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; GRAFE U, 1992, LIEBIGS ANN CHEM, P429; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; He M, 2000, J BACTERIOL, V182, P2619, DOI 10.1128/JB.182.9.2619-2623.2000; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Jakobi K, 2004, J AM CHEM SOC, V126, P2298, DOI 10.1021/ja0390698; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Klauck E, 1997, MOL MICROBIOL, V25, P559, DOI 10.1046/j.1365-2958.1997.4911852.x; Kumar P, 2003, J AM CHEM SOC, V125, P14307, DOI 10.1021/ja037429l; Li TL, 2004, CHEM BIOL, V11, P107, DOI 10.1016/j.chembiol.2004.01.001; Li WL, 2006, J BACTERIOL, V188, P4148, DOI 10.1128/JB.00172-06; Li WL, 2008, J BIOL CHEM, V283, P28607, DOI 10.1074/jbc.M804279200; Ligon J, 2002, GENE, V285, P257, DOI 10.1016/S0378-1119(02)00396-7; Lim SK, 2009, J BIOL CHEM, V284, P29746, DOI 10.1074/jbc.M109.046805; Lin SJ, 2009, P NATL ACAD SCI USA, V106, P4183, DOI 10.1073/pnas.0808880106; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; O'Keeffe T, 1999, APPL ENVIRON MICROB, V65, P1506; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Perlova O, 2006, J BIOTECHNOL, V121, P174, DOI 10.1016/j.jbiotec.2005.10.011; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Rajgarhia VB, 2001, METAB ENG, V3, P49, DOI 10.1006/mben.2000.0173; Rascher A, 2003, FEMS MICROBIOL LETT, V218, P223, DOI 10.1016/S0378-1097(02)01148-5; Reeves CD, 2001, BIOCHEMISTRY-US, V40, P15464, DOI 10.1021/bi015864r; Rouhiainen L, 2000, MOL MICROBIOL, V37, P156, DOI 10.1046/j.1365-2958.2000.01982.x; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; Schoenafinger G, 2006, J AM CHEM SOC, V128, P7406, DOI 10.1021/ja0611240; Song DF, 2008, ACTA BIOCH BIOPH SIN, V40, P319, DOI 10.1111/j.1745-7270.2008.00408.x; Stachelhaus T, 1998, J BIOL CHEM, V273, P22773, DOI 10.1074/jbc.273.35.22773; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Vrljic M, 1996, MOL MICROBIOL, V22, P815, DOI 10.1046/j.1365-2958.1996.01527.x; Weber T, 2008, CHEM BIOL, V15, P175, DOI 10.1016/j.chembiol.2007.12.009; Wenzel SC, 2006, J AM CHEM SOC, V128, P14325, DOI 10.1021/ja064408t; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; Zaleta-Rivera K, 2006, BIOCHEMISTRY-US, V45, P2561, DOI 10.1021/bi052085s; Zhao CH, 2006, J BACTERIOL, V188, P4142, DOI 10.1128/JB.00173-06	52	60	62	2	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20097	20108		10.1074/jbc.M109.090092	http://dx.doi.org/10.1074/jbc.M109.090092			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20406823	hybrid, Green Published			2022-12-27	WOS:000279012000044
J	Deshpande, AS; Fang, PA; Simmer, JP; Margolis, HC; Beniash, E				Deshpande, Atul S.; Fang, Ping-An; Simmer, James P.; Margolis, Henry C.; Beniash, Elia			Amelogenin-Collagen Interactions Regulate Calcium Phosphate Mineralization in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN-ENAMEL JUNCTION; DENTINOENAMEL JUNCTION; HUMAN TEETH; MECHANICAL-PROPERTIES; PORCINE AMELOGENIN; HYDROXYAPATITE CRYSTALS; IMPERFECTA PHENOTYPE; SECONDARY STRUCTURE; BONE SIALOPROTEIN; PROTEIN	Collagen and amelogenin are two major extracellular organic matrix proteins of dentin and enamel, the mineralized tissues comprising a tooth crown. They both are present at the dentin-enamel boundary (DEB), a remarkably robust interface holding dentin and enamel together. It is believed that interactions of dentin and enamel protein assemblies regulate growth and structural organization of mineral crystals at the DEB, leading to a continuum at the molecular level between dentin and enamel organic and mineral phases. To gain insight into the mechanisms of the DEB formation and structural basis of its mechanical resiliency we have studied the interactions between collagen fibrils, amelogenin assemblies, and forming mineral in vitro, using electron microscopy. Our data indicate that collagen fibrils guide assembly of amelogenin into elongated chain or filament-like structures oriented along the long axes of the fibrils. We also show that the interactions between collagen fibrils and amelogenin-calcium phosphate mineral complexes lead to oriented deposition of elongated amorphous mineral particles along the fibril axes, triggering mineralization of the bulk of collagen fibril. The resulting structure was similar to the mineralized collagen fibrils found at the DEB, with arrays of smaller well organized crystals inside the collagen fibrils and bundles of larger crystals on the outside of the fibrils. These data suggest that interactions between collagen and amelogenin might play an important role in the formation of the DEB providing structural continuity between dentin and enamel.	[Beniash, Elia] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial Regenerat, Pittsburgh, PA 15261 USA; [Simmer, James P.] Univ Michigan, Dept Biol & Mat Sci, Sch Dent, Ann Arbor, MI 48109 USA; [Margolis, Henry C.] Forsyth Inst, Dept Biomineralizat, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Harvard University; Forsyth Institute	Beniash, E (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial Regenerat, 589 Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.	ebeniash@pitt.edu	Deshpande, Atul S./AAQ-8330-2020; Fang, PINGAN/A-2461-2009; Deshpande, Atul/B-2993-2008; Deshpande, Atul S./G-4568-2015	Deshpande, Atul S./0000-0003-0874-9502; Simmer, James/0000-0002-7192-6105	National Institutes of Health NIDCR [DE016703]; UPSOM Department of Structural Biology [SAP 4100031302]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE016703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016703] Funding Source: NIH RePORTER	National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); UPSOM Department of Structural Biology; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health NIDCR Grant DE016703 (to E.B.).; We thank Dr. Peijun Zhang for her help in the analysis of the tomographic data. Electron microscopy studies were conducted at the Center for Biological Imaging, the Department of Structural Biology at the University of Pittsburgh and the Department of Materials Science and Engineering, Carnegie Mellon University, Pittsburgh. Support for electron tomography studies was provided by Dr. James Conway of the UPSOM Department of Structural Biology, including Commonwealth of Pennsylvania Grant SAP 4100031302, with assistance from Drs. Peijun Zhang and Alexander Makhov.	ARSENAULT AL, 1989, CALCIFIED TISSUE INT, V45, P111, DOI 10.1007/BF02561410; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001; Beniash E, 2000, J STRUCT BIOL, V132, P212, DOI 10.1006/jsbi.2000.4320; Beniash E, 2006, EUR J ORAL SCI, V114, P24, DOI 10.1111/j.1600-0722.2006.00293.x; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Bleicher F, 1999, MATRIX BIOL, V18, P133, DOI 10.1016/S0945-053X(99)00007-4; Bodier-Houlle P, 2000, CELL TISSUE RES, V301, P389, DOI 10.1007/s004410000241; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Brodsky B, 1995, FASEB J, V9, P1537, DOI 10.1096/fasebj.9.15.8529832; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; CHAPMAN JA, 1974, CONNECT TISSUE RES, V2, P137, DOI 10.3109/03008207409152099; Dahl T, 1998, J STRUCT BIOL, V123, P162, DOI 10.1006/jsbi.1998.4025; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Dong XD, 2003, J BIOMED MATER RES A, V66A, P103, DOI 10.1002/jbm.a.10541; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GOTO Y, 1993, J BIOCHEM-TOKYO, V113, P55, DOI 10.1093/oxfordjournals.jbchem.a124003; Hart PS, 2002, ARCH ORAL BIOL, V47, P261, DOI 10.1016/S0003-9969(02)00003-1; HAYASHI Y, 1992, J ELECTRON MICROSC, V41, P387; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; Hunter GK, 2001, J BIOMED MATER RES, V55, P496, DOI 10.1002/1097-4636(20010615)55:4<496::AID-JBM1042>3.0.CO;2-2; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; Kadler KE, 1996, BIOCHEM J, V316, P1; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kwak SY, 2009, J BIOL CHEM, V284, P18972, DOI 10.1074/jbc.M109.020370; Lakshminarayanan R, 2007, BIOPHYS J, V93, P3664, DOI 10.1529/biophysj.107.113936; Lakshminarayanan R, 2009, PROTEINS, V76, P560, DOI 10.1002/prot.22369; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; LESTER KS, 1967, CALCIFIED TISSUE INT, V1, P273; LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z; Matsushima N, 1998, J BIOCHEM, V123, P150; MCCROSKERY PA, 1973, SCIENCE, V182, P70, DOI 10.1126/science.182.4107.70; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Moradian-Oldak J, 1998, BIOPOLYMERS, V46, P225, DOI 10.1002/(SICI)1097-0282(19981005)46:4<225::AID-BIP4>3.0.CO;2-R; Moradian-Oldak J, 2006, EUR J ORAL SCI, V114, P289, DOI 10.1111/j.1600-0722.2006.00285.x; Nanci A, 1998, J HISTOCHEM CYTOCHEM, V46, P911, DOI 10.1177/002215549804600806; Nanci A, 2007, 10 CATES ORAL HISTOL; Papagerakis P, 2003, BONE, V32, P228, DOI 10.1016/S8756-3282(02)00978-X; Papagerakis P, 2008, J DENT RES, V87, P56, DOI 10.1177/154405910808700109; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Silverman L, 2004, CALCIFIED TISSUE INT, V75, P494, DOI 10.1007/s00223-004-0019-y; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; TUCKWELL DS, 1994, J CELL SCI, V107, P993; Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440; VEIS A, 1960, NATURE, V186, P720, DOI 10.1038/186720a0; Wang RZ, 1998, J BIOMECH, V31, P135, DOI 10.1016/S0021-9290(97)00131-0; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007; Xu HHK, 1998, J DENT RES, V77, P472, DOI 10.1177/00220345980770030601; Zaman MH, 2007, BIOPHYS J, V92, pL17, DOI 10.1529/biophysj.106.097519; Zaslansky P, 2006, J STRUCT BIOL, V153, P188, DOI 10.1016/j.jsb.2005.10.010	65	41	45	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19277	19287		10.1074/jbc.M109.079939	http://dx.doi.org/10.1074/jbc.M109.079939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404336	hybrid, Green Published			2022-12-27	WOS:000278727800037
J	He, DY; Neasta, J; Ron, D				He, Dao-Yao; Neasta, Jeremie; Ron, Dorit			Epigenetic Regulation of BDNF Expression via the Scaffolding Protein RACK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR EXPRESSION; RECEPTOR-INTERACTING PROTEIN; ANTI-ADDICTION DRUG; DNA METHYLATION; WD REPEAT; TRANSCRIPTION; MECP2; PHOSPHORYLATION; PROMOTERS; RIBOSOME	Scaffolding proteins are major contributors to the spatial and temporal orchestration of signaling cascades and hence cellular functions. RACK1 is a scaffolding protein that plays an important role in the regulation of, and cross-talk between, various signaling pathways. Here we report that RACK1 is a mediator of chromatin remodeling, resulting in an exon-specific expression of the brain-derived neurotrophic factor (BDNF) gene. Specifically, we found that following the activation of the cAMP pathway, nuclear RACK1 localizes at the promoter IV region of the BDNF gene by its association with histones H3 and H4, leading to the dissociation of the transcription repressor methyl-CpG-binding protein 2 (MeCP2) from the promoter, resulting in the acetylation of histone H4. These chromatin modifications lead to the activation of the promoter and to the subsequent promoter-controlled transcription of BDNF exon IV. Our findings expand our knowledge regarding the function of scaffolding proteins such as RACK1. Furthermore, this novel mechanism for the regulation of exon-specific expression of the BDNF gene by RACK1 could have implications on the neuronal functions of the growth factor including synaptic plasticity, learning, and memory.	Univ Calif, Ernest Gallo Res Ctr, Oakland, CA 94608 USA; [Ron, Dorit] Univ Calif, Dept Neurol, Oakland, CA 94608 USA	University of California System; University of California Berkeley; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California Berkeley	Ron, D (corresponding author), 5858 Horton St,Ste 200, Emeryville, CA 94608 USA.	dron@gallo.ucsf.edu		Neasta, Jeremie/0000-0002-7801-4176	National Institutes of Health through the National Institute on Alcohol Abuse and Alcoholism [R01 AA016848]; Department of the Army through the United States Army Medical Research Acquisition Activity [W81XWH-05-1-0212]; U.S. Army Medical Research Acquisition Activity; State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016848] Funding Source: NIH RePORTER	National Institutes of Health through the National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of the Army through the United States Army Medical Research Acquisition Activity; U.S. Army Medical Research Acquisition Activity; State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AA016848 (to D. R.) through the National Institute on Alcohol Abuse and Alcoholism. This work was also supported by the Department of the Army, Grant W81XWH-05-1-0212 through the United States Army Medical Research Acquisition Activity (to D. R.), for which the U.S. Army Medical Research Acquisition Activity is the awarding and administering acquisition office, and a grant from the State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco (to D.R).	Ai E, 2009, MOL BIOL CELL, V20, P1629, DOI 10.1091/mbc.E08-09-0917; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chern YJ, 2000, CELL SIGNAL, V12, P195, DOI 10.1016/S0898-6568(99)00084-4; *CLONT LAB, 2003, AD X EXPR SYST 1 US; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; GHITZA UE, 2009, NEUROSCI BIOBEH 1113, DOI DOI 10.1016/J.NEUBIOREV.2009.1011.1009; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; He DY, 2005, J NEUROSCI, V25, P619, DOI 10.1523/JNEUROSCI.3959-04.2005; He DY, 2002, MOL PHARMACOL, V62, P272, DOI 10.1124/mol.62.2.272; Hennig L, 2005, TRENDS CELL BIOL, V15, P295, DOI 10.1016/j.tcb.2005.04.004; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kuczewski N, 2009, MOL NEUROBIOL, V39, P37, DOI 10.1007/s12035-009-8050-7; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu QR, 2005, AM J MED GENET B, V134B, P93, DOI 10.1002/ajmg.b.30109; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; Moonat S, 2010, CELL MOL LIFE SCI, V67, P73, DOI 10.1007/s00018-009-0135-y; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ou LC, 2007, MOL PHARMACOL, V72, P350, DOI 10.1124/mol.107.034934; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; Tian F, 2009, J NEUROCHEM, V109, P1375, DOI 10.1111/j.1471-4159.2009.06058.x; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Wong J, 2009, EUR J NEUROSCI, V29, P1311, DOI 10.1111/j.1460-9568.2009.06669.x; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	64	47	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19043	19050		10.1074/jbc.M110.100693	http://dx.doi.org/10.1074/jbc.M110.100693			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410295	hybrid, Green Published			2022-12-27	WOS:000278727800013
J	Petkova, MI; Pujol-Carrion, N; Arroyo, J; Garcia-Cantalejo, J; de la Torre-Ruiz, MA				Ivanova Petkova, Mima; Pujol-Carrion, Nuria; Arroyo, Javier; Garcia-Cantalejo, Jesus; Angeles de la Torre-Ruiz, Maria			Mtl1 Is Required to Activate General Stress Response through Tor1 and Ras2 Inhibition under Conditions of Glucose Starvation and Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL INTEGRITY PATHWAY; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; NUCLEAR-LOCALIZATION; BUDDING YEAST; GLYCOGEN ACCUMULATION; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; GROWTH CONTROL; CYCLIC-AMP	Mtl1 is a member of the cell wall integrity (CWI) pathway of Saccharomyces cerevisiae, which functions as a cell wall sensor for oxidative stress. Genome-wide transcriptional analysis revealed a cluster of genes that were down-regulated in the absence of Mtl1. Many of these genes were potentially regulated by the general stress response factor Msn2/Msn4. In response to rapamycin, caffeine, glucose starvation and oxidative stress provoked by H2O2, mtl1 presents a significant loss of viability as well as a deficiency in the transcriptional response mediated by Msn2/Msn4. The Mtl1 function was required (i) to induce ribosomal gene repression, (ii) to induce the general stress response driven by the transcription factor Msn2/Msn4, and (iii) to activate the CWI pathway in response to both glucose starvation and oxidative stress. We also detected higher cAMP levels in the mtl1 mutant than in wild type cells indicative of up-regulated RAS2-PKA activity. Disruption of TOR1, disruption of RAS2, or hyperactivation of Rho1 restored both the viability and the transcriptional function (both ribosomal and Msn2/Msn4-dependent gene expression) in the mtl1 mutant to almost wild type levels when cells were starved of glucose or stressed with H2O2. Taking our results together, we propose an essential role for Mtl1 in signaling oxidative stress and quiescence to the CWI pathway and to the general stress response through Rho1 and the inhibition of either the TOR1 or RAS2 functions. These mechanisms would be required to allow cells to adapt to both oxidative and nutritional stresses.	[Ivanova Petkova, Mima; Pujol-Carrion, Nuria; Angeles de la Torre-Ruiz, Maria] Univ Lleida, Fac Med, Dept Ciencies Med Basiques IRBLleida, Lleida 25008, Spain; [Arroyo, Javier] Univ Complutense, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain; [Garcia-Cantalejo, Jesus] Univ Complutense, Univ Complutense Madrid, Unidad Genom Campus Moncloa, E-28040 Madrid, Spain	Universitat de Lleida; Complutense University of Madrid; Complutense University of Madrid	de la Torre-Ruiz, MA (corresponding author), Univ Lleida, Fac Med, Dept Ciencies Med Basiques IRBLleida, Lleida 25008, Spain.	madelatorre@cmb.udl.es	Ivanova Petkova, Mima/C-5594-2011; Arroyo, Javier/E-9308-2016; de la Torre, M Angeles/A-7357-2010; Carrión, Nuria Pujol/H-9929-2015	Arroyo, Javier/0000-0002-1971-1721; de la Torre, M Angeles/0000-0002-6111-1359; Carrión, Nuria Pujol/0000-0003-3345-2743; Garcia-Cantalejo, Jesus/0000-0001-6465-1273	Ministerio de Educacion y Ciencia (Spanish government) [BFU2009-11215, BIO2007-67821]; Comunidad de Madrid (Spain) [S-SAL-0246/2006]	Ministerio de Educacion y Ciencia (Spanish government)(Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid)	This work was supported by Ministerio de Educacion y Ciencia (Spanish government) Grants BFU2009-11215 and BIO2007-67821 and Comunidad de Madrid (Spain) Grant S-SAL-0246/2006.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; BROACH JR, 1991, TRENDS GENET, V7, P28, DOI 10.1016/0168-9525(91)90018-L; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chen JCY, 2006, CURR GENET, V49, P281, DOI 10.1007/s00294-005-0055-9; Coleman ST, 2001, J BIOL CHEM, V276, P244, DOI 10.1074/jbc.M007103200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; de Bettignies G, 2001, GENETICS, V159, P1435; de la Torre-Ruiz MA, 2002, J BIOL CHEM, V277, P33468, DOI 10.1074/jbc.M203515200; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; FRANCOIS JM, 1992, EMBO J, V11, P87, DOI 10.1002/j.1460-2075.1992.tb05031.x; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Garreau H, 2000, MICROBIOL-UK, V146, P2113, DOI 10.1099/00221287-146-9-2113; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; HARDY TA, 1994, J BIOL CHEM, V269, P27907; Hasan R, 2002, MOL MICROBIOL, V45, P233, DOI 10.1046/j.1365-2958.2002.03011.x; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Kaiser C., 1994, METHODS YEAST GENETI; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Matsumoto K, 1985, Yeast, V1, P25, DOI 10.1002/yea.320010104; Motizuki M, 2008, BBA-GEN SUBJECTS, V1780, P179, DOI 10.1016/j.bbagen.2007.10.003; Park JI, 2005, J BIOL CHEM, V280, P2529, DOI 10.1074/jbc.M407900200; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Reiling JH, 2008, MOL CELL, V29, P533, DOI 10.1016/j.molcel.2008.02.011; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; RUIS H, 1995, BIOESSAYS, V17, P959, DOI 10.1002/bies.950171109; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Sekiya-Kawasaki M, 2002, GENETICS, V162, P663; Serrano R, 2006, J BIOL CHEM, V281, P39785, DOI 10.1074/jbc.M604497200; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Steinboeck F, 2006, J BIOCHEM, V139, P741, DOI 10.1093/jb/mvj080; Swiegers JH, 2006, CURR GENET, V50, P161, DOI 10.1007/s00294-006-0084-z; TATCHELL K, 1985, P NATL ACAD SCI USA, V82, P3785, DOI 10.1073/pnas.82.11.3785; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05; Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005	63	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19521	19531		10.1074/jbc.M109.085282	http://dx.doi.org/10.1074/jbc.M109.085282			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20388713	hybrid, Green Published			2022-12-27	WOS:000278727800062
J	Jani, TS; DeVecchio, J; Mazumdar, T; Agyeman, A; Houghton, JA				Jani, Tanvi S.; DeVecchio, Jennifer; Mazumdar, Tapati; Agyeman, Akwasi; Houghton, Janet A.			Inhibition of NF-kappa B Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED SOLID TUMORS; METASTATIC COLORECTAL-CANCER; FADD-DEPENDENT APOPTOSIS; MULTIPLE-MYELOMA CELLS; PHASE-I; MEDIATED APOPTOSIS; CONSTITUTIVE ACTIVATION; TRANSCRIPTION FACTOR; ANTITUMOR-ACTIVITY; BREAST-CANCER	Colorectal cancer is the third most common malignancy in the United States. Modest advances with therapeutic approaches that include oxaliplatin (L-OHP) have brought the median survival rate to 22 months, with drug resistance remaining a significant barrier. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is undergoing clinical evaluation. Although human colon carcinomas express TRAIL receptors, they can also demonstrate TRAIL resistance. Constitutive NF-kappa B activation has been implicated in resistance to TRAIL and to cytotoxic agents. We have demonstrated constitutive NF-kappa B activation in five of six human colon carcinoma cell lines; this activation is inhibited by quinacrine. Quinacrine induced apoptosis in colon carcinomas and potentiated the cytotoxic activity of TRAIL in RKO and HT29 cells and that of L-OHP in HT29 cells. Similarly, overexpression of I kappa B alpha mutant (I kappa B alpha M) or treatment with the IKK inhibitor, BMS-345541, also sensitized these cells to TRAIL and l-OHP. Importantly, 2 h of quinacrine pretreatment resulted in decreased expression of c-FLIP and Mcl-1, which were determined to be transcriptional targets of NF-kappa B. Extended exposure for 24 h to quinacrine did not further sensitize these cells to TRAIL- or L-OHP-induced cell death; however, exposure caused the down-regulation of additional NF-kappa B-dependent survival factors. Short hairpin RNA-mediated knockdown of c-FLIP or Mcl-1 significantly sensitized these cells to TRAIL andL-OHP. Taken together, data demonstrate that NF-kappa B is constitutively active in colon cancer cell lines and NF-kappa B, and its downstream targets may constitute an important target for the development of therapeutic approaches against this disease	[Jani, Tanvi S.; DeVecchio, Jennifer; Mazumdar, Tapati; Agyeman, Akwasi; Houghton, Janet A.] Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Houghton, JA (corresponding author), Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.	houghtj@ccf.org						Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; *AM CANC SOC, 2008, CANC FACTS FIG 2008, P1; *AM CANC SOC, 2009, CANC FACTS FIG 2009, P3; Ammann JU, 2009, INT J CANCER, V124, P1301, DOI 10.1002/ijc.24068; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Assef Y, 2009, LEUKEMIA RES, V33, P710, DOI 10.1016/j.leukres.2008.09.024; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Ballestrero A, 2004, CLIN CANCER RES, V10, P1463, DOI 10.1158/1078-0432.CCR-1365-02; Banerjee S, 2009, CANCER RES, V69, P5575, DOI 10.1158/0008-5472.CAN-08-4235; BEG AA, 1996, SCIENCE, V274, P784; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Cohen SJ, 2008, AM J CLIN ONCOL-CANC, V31, P1, DOI 10.1097/COC.0b013e31805c142f; Culy CR, 2000, DRUGS, V60, P895, DOI 10.2165/00003495-200060040-00005; Cusack JC, 2006, CLIN CANCER RES, V12, P6758, DOI 10.1158/1078-0432.CCR-06-1151; Cusack JC, 2001, CANCER RES, V61, P3535; Cusack JC, 1999, DRUG RESIST UPDATE, V2, P271, DOI 10.1054/drup.1999.0094; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; Diaz-Rubio E, 1998, ANN ONCOL, V9, P105, DOI 10.1023/A:1008200825886; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Gliniak B, 1999, CANCER RES, V59, P6153; Goldberg R, 2000, ONCOLOGY-NY, V14, P42; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Haller DG, 2000, ONCOLOGY-NY, V14, P15; Harwood FG, 2000, J BIOL CHEM, V275, P10023, DOI 10.1074/jbc.275.14.10023; HAVELL EA, 1988, J EXP MED, V167, P1067, DOI 10.1084/jem.167.3.1067; Hernandez A, 2001, J GASTROINTEST SURG, V5, P56, DOI 10.1016/S1091-255X(01)80014-7; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hind D, 2008, Health Technol Assess, V12, piii; Houghton JA, 1997, P NATL ACAD SCI USA, V94, P8144, DOI 10.1073/pnas.94.15.8144; Houghton JA, 1997, CLIN CANCER RES, V3, P2205; Huang S, 2000, CLIN CANCER RES, V6, P2573; Jin H, 2004, CANCER RES, V64, P4900, DOI 10.1158/0008-5472.CAN-04-0408; Keane MM, 2000, BREAST CANCER RES TR, V64, P211, DOI 10.1023/A:1006458407515; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Koschny R, 2010, J NEURO-ONCOL, V97, P171, DOI 10.1007/s11060-009-0010-6; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lagunas Vilma Maldonado, 2008, Metal-Based Drugs, P576104, DOI 10.1155/2008/576104; Lee CH, 2007, BIOFACTORS, V29, P19, DOI 10.1002/biof.5520290103; Li XX, 2002, EXP HEMATOL, V30, P285, DOI 10.1016/S0301-472X(02)00777-4; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Louvet Christophe, 2003, Curr Treat Options Oncol, V4, P405, DOI 10.1007/s11864-003-0041-8; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; McConkey DJ, 2009, BLOOD, V114, P931, DOI 10.1182/blood-2009-06-223230; Menoret E, 2006, BLOOD, V108, P1346, DOI 10.1182/blood-2005-12-007971; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Mitsiades N, 2001, EXPERT OPIN INV DRUG, V10, P1521, DOI 10.1517/13543784.10.8.1521; Morales JC, 2007, MOL IMMUNOL, V44, P2587, DOI 10.1016/j.molimm.2006.12.015; Mori N, 1999, BLOOD, V93, P2360; Mufti AR, 2006, MOL CELL, V21, P775, DOI 10.1016/j.molcel.2006.01.033; Nagy K, 2006, PATHOL ONCOL RES, V12, P133, DOI 10.1007/BF02893359; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; NORTH RJ, 1988, J EXP MED, V167, P1086, DOI 10.1084/jem.167.3.1086; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Petak I, 2003, CELL DEATH DIFFER, V10, P729, DOI 10.1038/sj.cdd.4401232; Petak I, 2000, CLIN CANCER RES, V6, P4432; Petak I, 2000, CANCER RES, V60, P2643; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Pukac L, 2005, BRIT J CANCER, V92, P1430, DOI 10.1038/sj.bjc.6602487; Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367; Rakitina TV, 2003, CANCER RES, V63, P8600; Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.e04-03-0184; Rieger J, 1998, FEBS LETT, V427, P124, DOI 10.1016/S0014-5793(98)00409-8; Roue G, 2007, J IMMUNOL, V178, P1923, DOI 10.4049/jimmunol.178.3.1923; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Russo SM, 2001, INT J RADIAT ONCOL, V50, P183, DOI 10.1016/S0360-3016(01)01446-8; Ryan DP, 2006, CANCER-AM CANCER SOC, V107, P2482, DOI 10.1002/cncr.22264; Ryan DR, 2006, CANCER, V107, P2688, DOI 10.1002/cncr.22280; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; SCHWARTZBERG L, 2008, 99 ANN M AM ASS CANC; Schwartzberg LS, 2002, CLIN CANCER RES, V8, P2488; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Simpson D, 2003, DRUGS, V63, P2127, DOI 10.2165/00003495-200363190-00013; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Strater J, 2002, CLIN CANCER RES, V8, P3734; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Tillman DM, 1998, CELL DEATH DIFFER, V5, P450, DOI 10.1038/sj.cdd.4400369; Tillman DM, 1999, CLIN CANCER RES, V5, P425; Tolcher AW, 2007, J CLIN ONCOL, V25, P1390, DOI 10.1200/JCO.2006.08.8898; Toscano F, 2008, ONCOGENE, V27, P4161, DOI 10.1038/onc.2008.52; VAN AD, 1996, SCIENCE, V274, P787; van Geelen CMM, 2003, BRIT J CANCER, V89, P363, DOI 10.1038/sj.bjc.6601065; Wakelee HA, 2010, ANN ONCOL, V21, P376, DOI 10.1093/annonc/mdp292; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang WX, 1999, CLIN CANCER RES, V5, P119; Watanabe M, 2005, INT J CANCER, V114, P32, DOI 10.1002/ijc.20688; Weaver KD, 2003, J NEURO-ONCOL, V61, P187, DOI 10.1023/A:1022554824129; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilson C, 2008, J PHARMACOL EXP THER, V327, P746, DOI 10.1124/jpet.108.143826; Wilson TR, 2009, ONCOGENE, V28, P63, DOI 10.1038/onc.2008.366; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Xu L, 2009, FEBS LETT, V583, P943, DOI 10.1016/j.febslet.2009.02.014; Xu Y, 2002, ANN ONCOL, V13, P1841, DOI 10.1093/annonc/mdf337; Yeh PY, 2002, BIOCHEM PHARMACOL, V63, P1423, DOI 10.1016/S0006-2952(02)00908-5; Yoshimura FK, 2008, P NATL ACAD SCI USA, V105, P5543, DOI 10.1073/pnas.0710526105; Zisman A, 2001, J IMMUNOTHER, V24, P459, DOI 10.1097/00002371-200111000-00003	108	80	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19162	19172		10.1074/jbc.M109.091645	http://dx.doi.org/10.1074/jbc.M109.091645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20424169	Green Published, hybrid			2022-12-27	WOS:000278727800026
J	Kannan-Thulasiraman, P; Seachrist, DD; Mahabeleshwar, GH; Jain, MK; Noy, N				Kannan-Thulasiraman, Padmamalini; Seachrist, Darcie D.; Mahabeleshwar, Ganapati H.; Jain, Mukesh K.; Noy, Noa			Fatty Acid-binding Protein 5 and PPAR beta/delta Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; NF-KAPPA-B; RETINOIC ACID; TRANSGENIC MICE; MAMMARY-CARCINOMA; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; TUMOR-SUPPRESSOR; PROSTATE-CANCER	Epidermal growth factors and their receptors (EGFRs) promote breast cancer cell proliferation and can drive tumorigenesis. However, the molecular mechanisms that mediate these effects are incompletely understood. We previously showed that mammary tumor development in the mouse model of breast cancer MMTV-neu, a model characterized by amplification of the EGFR ErbB2 in mammary tissue, correlates with a marked up-regulation of fatty acid-binding protein 5 (FABP5). FABP5 functions to deliver ligands to and enhance the transcriptional activity of the nuclear receptor peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta), a receptor whose target genes include genes involved in cell growth and survival. We show here that in MCF-7 mammary carcinoma cells, EGFR signaling directly up-regulates the expression of FABP5. The data demonstrate that treatment of these cells with the EGFR ligand heregulin-beta 1 signals through the ERK and the phophatidylinositol-3-kinase cascades, resulting in activation of the transcription factor NF-kappa B. In turn, NF-kappa B induces the expression of FABP5 through two cognate response elements in the promoter of this gene. The observations further demonstrate that FABP5 and PPAR beta/delta are critical mediators of the ability of EGFR to enhance cell proliferation, indicating that this transcriptional pathway plays a key role in EGFR-induced tumorigenesis. Additional observations indicate that the expression of FABP5 is down-regulated by the Kruppel-like factor KLF2, suggesting a tumor suppressor activity for this factor.	[Kannan-Thulasiraman, Padmamalini; Seachrist, Darcie D.; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Mahabeleshwar, Ganapati H.; Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, W333 10900 Euclid Ave, Cleveland, OH 44106 USA.	noa.noy@case.edu			National Institutes of Health [DK060684, CA068150]; NATIONAL CANCER INSTITUTE [R01CA068150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK060684 and CA068150 (to N. N.).	Adamson J, 2003, ONCOGENE, V22, P2739, DOI 10.1038/sj.onc.1206341; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Biswas DK, 2006, J CELL PHYSIOL, V209, P645, DOI 10.1002/jcp.20785; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; DI FP, 1987, CELL, V51, P1063; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; HUNG MC, 1995, GENE, V159, P65, DOI 10.1016/0378-1119(94)00459-6; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jing C, 2000, CANCER RES, V60, P2390; Jing C, 2001, CANCER RES, V61, P4357; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lewis GD, 1996, CANCER RES, V56, P1457; Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155; Lorusso V, 2008, BIOL-TARGETS THER, V2, P813; Lupu R, 1996, BREAST CANCER RES TR, V38, P57, DOI 10.1007/BF01803784; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Manor D, 2003, CANCER RES, V63, P4426; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; Mazumdar A, 2001, CANCER RES, V61, P400; Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E; Morgan EA, 2008, INT J ONCOL, V32, P767; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Reese DM, 1997, STEM CELLS, V15, P1, DOI 10.1002/stem.150001; ROBBINS DJ, 1993, J AM SOC NEPHROL, V4, P1104; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shultz DB, 2007, J INTERF CYTOK RES, V27, P875, DOI 10.1089/jir.2007.0031; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; Singh S, 2007, MOL CANCER THER, V6, P1973, DOI 10.1158/1535-7163.MCT-07-0063; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sledge GW, 2003, EUR J CANCER, V39, P1668, DOI 10.1016/S0959-8049(03)00273-9; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Tan NS, 2004, EXPERT OPIN THER TAR, V8, P39, DOI 10.1517/eott.8.1.39.26404; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Yao J, 2001, ONCOGENE, V20, P8066, DOI 10.1038/sj.onc.1204944	73	71	73	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19106	19115		10.1074/jbc.M109.099770	http://dx.doi.org/10.1074/jbc.M109.099770			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20424164	Green Published, hybrid			2022-12-27	WOS:000278727800020
J	Koh, WWL; Steffensen, S; Gonzalez-Pajuelo, M; Hoorelbeke, B; Gorlani, A; Szynol, A; Forsman, A; Aasa-Chapman, MMI; de Haard, H; Verrips, T; Weiss, RA				Koh, Willie W. L.; Steffensen, Soren; Gonzalez-Pajuelo, Maria; Hoorelbeke, Bart; Gorlani, Andrea; Szynol, Agnieszka; Forsman, Anna; Aasa-Chapman, Marlen M. I.; de Haard, Hans; Verrips, Theo; Weiss, Robin A.			Generation of a Family-specific Phage Library of Llama Single Chain Antibody Fragments That Neutralize HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; FUSION INHIBITOR T-20; SUBTYPE-B; PASSIVE-IMMUNIZATION; TYPE-1 INFECTION; DOMAIN ANTIBODY; HIGH-AFFINITY; ENV CLONES; RECEPTOR	Recently, we described llama antibody fragments (VHH) that can neutralize human immunodeficiency virus, type 1 (HIV-1). These VHH were obtained after selective elution of phages carrying an immune library raised against gp120 of HIV-1 subtype B/C CN54 with soluble CD4. We describe here a new, family-specific approach to obtain the largest possible diversity of related VHH that compete with soluble CD4 for binding to the HIV-1 envelope glycoprotein. The creation of this family-specific library of homologous VHH has enabled us to isolate phages carrying similar nucleotide sequences as the parental VHH. These VHH displayed varying binding affinities and neutralization phenotypes to a panel of different strains and subtypes of HIV-1. Sequence analysis of the homologs showed that the C-terminal three amino acids of the CDR3 loop were crucial in determining the specificity of these VHH for different subtype C HIV-1 strains. There was a positive correlation between affinity of VHH binding to gp120 of HIV-1 IIIB and the breadth of neutralization of diverse HIV-1 envelopes. The family-specific approach has therefore allowed us to better understand the interaction of the CD4-binding site antibodies with virus strain specificity and has potential use for the bioengineering of antibodies and HIV-1 vaccine development.	[Gorlani, Andrea; Szynol, Agnieszka; de Haard, Hans; Verrips, Theo] Univ Utrecht, Dept Mol & Cellular Biol Cellular Architecture &, NL-3584 CH Utrecht, Netherlands; [Forsman, Anna; Aasa-Chapman, Marlen M. I.; Weiss, Robin A.] UCL, Div Infect & Immun, Ctr Med Mol Virol, MRC, London W1T 4JF, England; [Steffensen, Soren; Gonzalez-Pajuelo, Maria; Hoorelbeke, Bart] Ablynx NV, B-9052 Ghent, Belgium	Utrecht University; University of London; University College London	Verrips, T (corresponding author), Univ Utrecht, Dept Mol & Cellular Biol Cellular Architecture &, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	c.t.verrips@bio.uu.nl; r.weiss@ucl.ac.uk	gorlani, andrea/C-5678-2014		University College London Graduate School; Overseas Research Student Award Scheme; European Union; Bill and Melinda Gates Foundation [38637]; United Kingdom Medical Research Council; MRC [G0801176] Funding Source: UKRI; Medical Research Council [G0801176] Funding Source: researchfish	University College London Graduate School; Overseas Research Student Award Scheme; European Union(European Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the University College London Graduate School, Overseas Research Student Award Scheme, European Microbicides Project (European Union Framework 6), Collaboration for AIDS Vaccine Discovery Grant 38637 of the Bill and Melinda Gates Foundation, and the United Kingdom Medical Research Council.	Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 1997, AIDS, V11, pS87; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; De Haard HJW, 2005, J BACTERIOL, V187, P4531, DOI 10.1128/JB.187.13.4531-4541.2005; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; GAO F, 1994, AIDS RES HUM RETROV, V10, P1359, DOI 10.1089/aid.1994.10.1359; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, VET MICROBIOL, V120, P193, DOI 10.1016/j.vetmic.2006.10.029; Hinz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010482; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; McKeating JA, 1996, VIROLOGY, V220, P450, DOI 10.1006/viro.1996.0332; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Muyldermans S, 2001, J Biotechnol, V74, P277; Nuttall S. D., 2000, Current Pharmaceutical Biotechnology, V1, P253, DOI 10.2174/1389201003378906; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PUTKONEN P, 1991, NATURE, V352, P436, DOI 10.1038/352436a0; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Willey S, 2008, TRENDS MICROBIOL, V16, P596, DOI 10.1016/j.tim.2008.08.008; Yamamoto H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000540; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	57	34	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19116	19124		10.1074/jbc.M110.116699	http://dx.doi.org/10.1074/jbc.M110.116699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20400507	Green Published, hybrid			2022-12-27	WOS:000278727800021
J	Motiani, RK; Abdullaev, IF; Trebak, M				Motiani, Rajender K.; Abdullaev, Iskandar F.; Trebak, Mohamed			A Novel Native Store-operated Calcium Channel Encoded by Orai3 SELECTIVE REQUIREMENT OF Orai3 VERSUS Orai1 IN ESTROGEN RECEPTOR-POSITIVE VERSUS ESTROGEN RECEPTOR-NEGATIVE BREAST CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER INCIDENCE; CURRENT I-CRAC; 2-AMINOETHOXYDIPHENYL BORATE; TRPC3 CHANNELS; 2-AMINOETHYLDIPHENYL BORATE; ESTROGEN-RECEPTOR; PORE SUBUNIT; MICE LACKING; CA2+ INFLUX; ENTRY	Store-operated calcium (Ca2+) entry (SOCE) mediated by STIM/Orai proteins is a ubiquitous pathway that controls many important cell functions including proliferation and migration. STIM proteins are Ca2+ sensors in the endoplasmic reticulum and Orai proteins are channels expressed at the plasma membrane. The fall in endoplasmic reticulum Ca2+ causes translocation of STIM1 to subplasmalemmal puncta where they activate Orai1 channels that mediate the highly Ca2+-selective Ca2+ release-activated Ca2+ current (I-CRAC). Whereas Orai1 has been clearly shown to encode SOCE channels in many cell types, the role of Orai2 and Orai3 in native SOCE pathways remains elusive. Here we analyzed SOCE in ten breast cell lines picked in an unbiased way. We used a combination of Ca2+ imaging, pharmacology, patch clamp electrophysiology, and molecular knockdown to show that native SOCE and I-CRAC in estrogen receptor-positive (ER+) breast cancer cell lines are mediated by STIM1/2 and Orai3 while estrogen receptor-negative (ER-) breast cancer cells use the canonical STIM1/Orai1 pathway. The ER+ breast cancer cells represent the first example where the native SOCE pathway and I-CRAC are mediated by Orai3. Future studies implicating Orai3 in ER+ breast cancer progression might establish Orai3 as a selective target in therapy of ER+ breast tumors.	[Motiani, Rajender K.; Abdullaev, Iskandar F.; Trebak, Mohamed] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Trebak, M (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, 47 New Scotland Ave,MC8, Albany, NY 12208 USA.	trebakm@mail.amc.edu	Abdullaev, Iskandar/AAH-2478-2021; Trebak, Mohamed/E-7405-2014		National Institutes of Health [5K22 ES014729]; American Recovery and Reinvestment Act (ARRA) [3K22ES014729-03S1, 3K22ES014729-03S2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES014729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act (ARRA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by an early career National Institutes of Health Grant 5K22 ES014729 and funds allocated through the American Recovery and Reinvestment Act (ARRA) supplements 3K22ES014729-03S1 and 3K22ES014729-03S2 (to M. T.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Bai ZL, 2009, ARCH PHARM, V342, P133, DOI 10.1002/ardp.200800174; Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; BISAILLON JM, AM J PHYSL CELL PHYS, V298, P993; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; Braun FJ, 2003, MOL PHARMACOL, V63, P1304, DOI 10.1124/mol.63.6.1304; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Colton C. K., 2007, V179, P173; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Gu QH, 2005, AM J PHYSIOL-LUNG C, V288, pL932, DOI 10.1152/ajplung.00439.2004; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hurvitz SA, 2009, FUTURE ONCOL, V5, P1015, DOI 10.2217/FON.09.68; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Jones BF, 2008, HEPATOLOGY, V48, P1273, DOI 10.1002/hep.22461; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Ohana L, 2009, CHANNELS, V3, P129, DOI 10.4161/chan.3.2.8609; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RITCHIE MF, J BIOL CHEM, V285, P10591; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	49	232	238	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19173	19183		10.1074/jbc.M110.102582	http://dx.doi.org/10.1074/jbc.M110.102582			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20395295	Green Published, hybrid			2022-12-27	WOS:000278727800027
J	Neuman, KC				Neuman, Keir C.			Single-molecule Measurements of DNA Topology and Topoisomerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI; II TOPOISOMERASES; SUPERCOILED DNA; RNA-POLYMERASE; MECHANISM; TORQUE; IV; TRANSLOCATION; RELAXATION; ELASTICITY	Topological properties of DNA influence its mechanical and biochemical interactions. Genomic DNA is maintained in a state of topological homeostasis by topoisomerases and is subjected to mechanical stress arising from replication and segregation. Despite their fundamental roles, the effects of topology and force have been difficult to ascertain. Developments in single-molecule manipulation techniques have enabled precise control and measurement of the topology of individual DNA molecules under tension. This minireview provides an overview of these single-molecule techniques and illustrates their unique capabilities through a number of specific examples of single-molecule measurements of DNA topology and topoisomerase activity.	NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Neuman, KC (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	neumankc@mail.nih.gov	Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671	NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001056] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NHLBI Intramural Research Program of the National Institutes of Health. This is the second article in the Thematic Minireview Series on Single-molecule Measurements in Biochemistry and Molecular Biology. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Allemand JF, 1998, P NATL ACAD SCI USA, V95, P14152, DOI 10.1073/pnas.95.24.14152; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bates A. D., 2005, DNA TOPOLOGY; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Charvin G, 2005, BIOPHYS J, V88, P4124, DOI 10.1529/biophysj.104.056945; Charvin G, 2005, ANNU REV BIOPH BIOM, V34, P201, DOI 10.1146/annurev.biophys.34.040204.144433; Charvin G, 2004, CONTEMP PHYS, V45, P383, DOI 10.1080/00107510410001697279; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; Deufel C, 2007, NAT METHODS, V4, P223, DOI 10.1038/nmeth1013; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; Espeli O, 2004, MOL MICROBIOL, V52, P925, DOI 10.1111/j.1365-2958.2004.04047.x; Forth S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.148301; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; La Porta A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190801; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; LIONNET T, 2008, SINGLE MOL TECHNIQUE, P347; Marko JF, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021926; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; Neuman KC, 2007, ANNU REV MATER RES, V37, P33, DOI 10.1146/annurev.matsci.37.052506.084336; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; Saleh OA, 2004, EMBO J, V23, P2430, DOI 10.1038/sj.emboj.7600242; Seidel R, 2004, NAT STRUCT MOL BIOL, V11, P838, DOI 10.1038/nsmb816; Stone MD, 2003, P NATL ACAD SCI USA, V100, P8654, DOI 10.1073/pnas.1133178100; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; VINOGRAD J, 1965, P NATL ACAD SCI USA, V53, P1104, DOI 10.1073/pnas.53.5.1104; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG JC, 1971, J MOL BIOL, V55, P523, DOI 10.1016/0022-2836(71)90334-2; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WHITE JH, 1969, AM J MATH, V91, P693, DOI 10.2307/2373348	44	23	24	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					18967	18971		10.1074/jbc.R109.092437	http://dx.doi.org/10.1074/jbc.R109.092437			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20382732	hybrid, Green Published			2022-12-27	WOS:000278727800003
J	Kraus, A; Groenendyk, J; Bedard, K; Baldwin, TA; Krause, KH; Dubois-Dauphin, M; Dyck, J; Rosenbaum, EE; Korngut, L; Colley, NJ; Gosgnach, S; Zochodne, D; Todd, K; Agellon, LB; Michalak, M				Kraus, Allison; Groenendyk, Jody; Bedard, Karen; Baldwin, Troy A.; Krause, Karl-Heinz; Dubois-Dauphin, Michel; Dyck, Jason; Rosenbaum, Erica E.; Korngut, Lawrence; Colley, Nansi J.; Gosgnach, Simon; Zochodne, Douglas; Todd, Kathryn; Agellon, Luis B.; Michalak, Marek			Calnexin Deficiency Leads to Dysmyelination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; CALRETICULIN; CHAPERONE; ASSOCIATION; BINDING; OPSIN; DEATH; MICE; ER	Calnexin is a molecular chaperone and a component of the quality control of the secretory pathway. We have generated calnexin gene-deficient mice (cnx(-/)) and showed that calnexin deficiency leads to myelinopathy. Calnexin-deficient mice were viable with no discernible effects on other systems, including immune function, and instead they demonstrated dysmyelination as documented by reduced conductive velocity of nerve fibers and electron microscopy analysis of sciatic nerve and spinal cord. Myelin of the peripheral and central nervous systems of cnx(-/-) mice was disorganized and decompacted. There were no abnormalities in neuronal growth, no loss of neuronal fibers, and no change in fictive locomotor pattern in the absence of calnexin. This work reveals a previously unrecognized and important function of calnexin in myelination and provides new insights into the mechanisms responsible for myelin diseases.	[Kraus, Allison; Groenendyk, Jody; Bedard, Karen; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Dyck, Jason; Gosgnach, Simon] Univ Alberta, Dept Physiol, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Baldwin, Troy A.] Univ Alberta, Dept Med Microbiol & Immunol, Sch Clin & Lab Sci, Edmonton, AB T6G 2H7, Canada; [Todd, Kathryn] Univ Alberta, Dept Psychiat, Ctr Neurosci, Edmonton, AB T6G 2H7, Canada; [Krause, Karl-Heinz; Dubois-Dauphin, Michel] Univ Geneva, Dept Pathol, CH-1211 Geneva 4, Switzerland; [Krause, Karl-Heinz; Dubois-Dauphin, Michel] Univ Geneva, Dept Immunol, CH-1211 Geneva 4, Switzerland; [Krause, Karl-Heinz; Dubois-Dauphin, Michel] Univ Geneva, Dept Clin Pathol, CH-1211 Geneva 4, Switzerland; [Rosenbaum, Erica E.; Colley, Nansi J.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Dept Genet & Neurosci, Madison, WI 53792 USA; [Rosenbaum, Erica E.; Colley, Nansi J.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53792 USA; [Korngut, Lawrence; Zochodne, Douglas] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Agellon, Luis B.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Geneva; University of Geneva; University of Geneva; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Calgary; McGill University	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	marek.michalak@ualberta.ca	Krause, Karl-Heinz/E-8030-2011	Krause, Karl-Heinz/0000-0002-9033-6768; Bedard, Karen/0000-0001-5864-5344	National Institutes of Health [EYEY008768, F31AG032176]; Canadian Institutes of Health Research [MOP-15291, MOP-8659, MOP-86470]; Swiss National Science Foundation; Retina Research Foundation; Alberta Innovates-Health Solutions; March of Dimes; Davey Fund for Brain Research; Multiple Sclerosis Society of Canada; Heart and Stroke Foundation of Canada; Membrane Protein Cardiovascular Disease Training Program; NATIONAL EYE INSTITUTE [R01EY008768, R03EY014378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Retina Research Foundation; Alberta Innovates-Health Solutions; March of Dimes(March of Dimes); Davey Fund for Brain Research; Multiple Sclerosis Society of Canada; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Membrane Protein Cardiovascular Disease Training Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EYEY008768 (to N.J.C.) and F31AG032176 (to E. E. R.). This work was also supported by Grants MOP-15291 (to M. M.), MOP-8659 (to T. A. B.), and MOP-86470 (to S. G.) and other grants (to D.Z. and K. T.) from the Canadian Institutes of Health Research and grants from the Swiss National Science Foundation (to K.-H. K.), the Retina Research Foundation (to N.J.C.), Alberta Innovates-Health Solutions (to S. G.), the March of Dimes (to S. G.), and the Davey Fund for Brain Research (to K. T.).; Supported by a fellowship from the Multiple Sclerosis Society of Canada and by Alberta Innovates-Health Solutions.; Supported by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada Membrane Protein and the Cardiovascular Disease Training Program.	Bennett MK, 1998, J BIOL CHEM, V273, P23674, DOI 10.1074/jbc.273.37.23674; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Fajardo M, 2004, MICROBIOL-SGM, V150, P2825, DOI 10.1099/mic.0.27111-0; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jantzie LL, 2005, J CEREBR BLOOD F MET, V25, P314, DOI 10.1038/sj.jcbfm.9600025; Kosmaoglou M, 2008, MOL VIS, V14, P2466; Lee W, 2006, PROTEOMICS, V6, P1329, DOI 10.1002/pmic.200500320; Lozyk MD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-54; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Nakamura K, 2001, J CLIN INVEST, V107, P1245, DOI 10.1172/JCI12412; PARLATI F, 1995, EMBO J, V14, P3064, DOI 10.1002/j.1460-2075.1995.tb07309.x; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Toth C, 2008, NEUROSCIENCE, V154, P767, DOI 10.1016/j.neuroscience.2008.03.052; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	30	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18928	18938		10.1074/jbc.M110.107201	http://dx.doi.org/10.1074/jbc.M110.107201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400506	Green Published, hybrid			2022-12-27	WOS:000278453900083
J	Reid, HM; Mulvaney, EP; Turner, EC; Kinsella, BT				Reid, Helen M.; Mulvaney, Eamon P.; Turner, Elizebeth C.; Kinsella, B. Therese			RETRACTED: Interaction of the Human Prostacyclin Receptor with Rab11 CHARACTERIZATION OF A NOVEL Rab11 BINDING DOMAIN WITHIN alpha-HELIX 8 THAT IS REGULATED BY PALMITOYLATION (Retracted article. See vol. 293, pg. 12287, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							PROTEIN-COUPLED RECEPTOR; ALPHA-5-BETA-1 INTEGRIN; 3D MICROENVIRONMENTS; STRUCTURE PREDICTION; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; MYOSIN VB; I-TASSER; PALMITOYLATION; EFFECTOR	The human prostacyclin receptor (hIP) undergoes agonist-induced internalization and subsequent recyclization in slowly recycling endosomes involving its direct physical interaction with Rab11a. Moreover, interaction with Rab11a localizes to a 22-residue putative Rab11 binding domain (RBD) within the carboxyl-terminal tail of the hIP, proximal to the transmembrane 7 (TM7) domain. Because the proposed RBD contains Cys(308) and Cys(311), in addition to Cys(309), that are known to undergo palmitoylation, we sought to identify the structure/function determinants of the RBD, including the influence of palmitoylation, on agonist-induced trafficking of the hIP. Through complementary approaches in yeast and mammalian cells along with computational structural studies, the RBD was localized to a 14-residue domain, between Val(299) and Leu(312), and proposed to be organized into an eighth alpha-helical domain (alpha-helix 8), comprising Val(299)-Val(307), adjacent to the palmitoylated residues at Cys(308)-Cys(311). From mutational and [H-3] palmitate metabolic labeling studies, it is proposed that palmitoylation at Cys(311) in addition to agonist-regulated deacylation at Cys(309) > Cys(308) may dynamically position alpha-helix 8 in proximity to Rab11a, to regulate agonist-induced intracellular trafficking of the hIP. Moreover, Ala-scanning mutagenesis identified several hydrophobic residues within alpha-helix 8 as necessary for the interaction with Rab11a. Given the diverse membership of the G protein-coupled receptor superfamily, of which many members are also predicted to contain an alpha-helical 8 domain proximal to TM7 and, often, adjacent to palmitoylable cysteine(s), the identification of a functional role for alpha-helix 8, as exemplified as an RBD for the hIP, is likely to have broader significance for certain members of the superfamily.	[Reid, Helen M.; Mulvaney, Eamon P.; Turner, Elizebeth C.; Kinsella, B. Therese] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland	University College Dublin	Kinsella, BT (corresponding author), Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland.	therese.kinsella@ucd.ie		Kinsella, B. Therese/0000-0003-3072-941X; Mulvaney, Eamon/0000-0003-3661-2116	Science Foundation of Ireland [SFI: 05/IN.1/B19]	Science Foundation of Ireland(Science Foundation Ireland)	This work was supported by Science Foundation of Ireland Grant SFI: 05/IN.1/B19.	Borer JS, 2005, ARTHRITIS RES THER, V7, pS14, DOI 10.1186/ar1794; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Fetalvero KM, 2007, PROSTAG OTH LIPID M, V82, P109, DOI 10.1016/j.prostaglandins.2006.05.011; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Gryglewski RJ, 2008, PHARMACOL REP, V60, P3; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Hayes JS, 1999, J BIOL CHEM, V274, P23707, DOI 10.1074/jbc.274.34.23707; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200; Lawler OA, 2001, BRIT J PHARMACOL, V132, P1639, DOI 10.1038/sj.bjp.0704033; Mammoto A, 1999, J BIOL CHEM, V274, P25517, DOI 10.1074/jbc.274.36.25517; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Miggin SM, 2003, J BIOL CHEM, V278, P6947, DOI 10.1074/jbc.M210637200; Miggin SM, 2002, EUR J BIOCHEM, V269, P1714, DOI 10.1046/j.1432-1327.2002.02817.x; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Mukhopadhyay S, 1999, BIOCHEMISTRY-US, V38, P3447, DOI 10.1021/bi981767v; MUNCH G, 1991, EUR J BIOCHEM, V198, P357, DOI 10.1111/j.1432-1033.1991.tb16023.x; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; O'Keeffe MB, 2008, BBA-MOL CELL RES, V1783, P1914, DOI 10.1016/j.bbamcr.2008.04.010; O'Meara SJ, 2004, BRIT J PHARMACOL, V143, P318, DOI 10.1038/sj.bjp.0705956; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Prekeris Rytis, 2003, ScientificWorldJournal, V3, P870; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Reid HM, 2007, CELL SIGNAL, V19, P1056, DOI 10.1016/j.cellsig.2006.12.001; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; SAKAI A, 1990, LIFE SCI, V47, P711, DOI 10.1016/0024-3205(90)90626-3; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; SHIRAI H, 1995, HYPERTENSION, V25, P726, DOI 10.1161/01.HYP.25.4.726; Smyth EM, 2000, J BIOL CHEM, V275, P32037, DOI 10.1074/jbc.M003873200; Takahashi M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/10767; Topiol S, 2009, BIOCHEM PHARMACOL, V78, P11, DOI 10.1016/j.bcp.2009.02.012; Turner EC, 2010, J MOL BIOL, V396, P473, DOI 10.1016/j.jmb.2010.01.010; VANE JR, 1995, AM J CARDIOL, V75, pA3, DOI 10.1016/S0002-9149(99)80377-4; Welsh GI, 2007, J CELL SCI, V120, P4197, DOI 10.1242/jcs.007310; Wikstrom K, 2008, CELL SIGNAL, V20, P2332, DOI 10.1016/j.cellsig.2008.09.003; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P808, DOI 10.1016/j.bbamem.2006.10.002; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zeng JB, 1999, P NATL ACAD SCI USA, V96, P2840, DOI 10.1073/pnas.96.6.2840; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	59	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18709	18726		10.1074/jbc.M110.106476	http://dx.doi.org/10.1074/jbc.M110.106476			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395296	Green Published, hybrid			2022-12-27	WOS:000278453900063
J	Shepherd, M; Sanguinetti, G; Cook, GM; Poole, RK				Shepherd, Mark; Sanguinetti, Guido; Cook, Gregory M.; Poole, Robert K.			Compensations for Diminished Terminal Oxidase Activity in Escherichia coli CYTOCHROME bd-II-MEDIATED RESPIRATION AND GLUTAMATE METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN H-NS; ACID RESISTANCE; GENE-EXPRESSION; TRANSCRIPTIONAL RESPONSES; OXYGEN AVAILABILITY; CRYSTAL-STRUCTURE; ACTIVATOR APPY; QUINOL OXIDASE; SIGMA-FACTOR; LOW PH	Escherichia coli possesses cytochrome bo' (CyoABCDE), cytochrome bd-I (CydAB), and cytochrome bd-II (AppBC) quinol oxidases, all of which can catalyze the terminal step in the aerobic respiratory chain, the reduction of oxygen by ubiquinol. Although CydAB has a role in the generation of Delta pH, AppBC has been proposed to alleviate the accumulation of electrons in the quinone pool during respiratory stress via electroneutral ubiquinol oxidation. A cydB mutant strain exhibited lower respiration rates while maintaining a wild type growth rate. Transcriptomic analysis revealed a dramatic up-regulation of AppBC in the cydB strain, accompanied by the induction of genes involved in glutamate/gamma-aminobutyric acid (GABA) antiport, the GABA shunt, the glyoxylate shunt, respiration (including appBC), motility, and osmotic stress. Transcription factor modeling suggests that the underpinning regulation is largely controlled by H-NS, GadX, FlhDC, and AppY. The transcriptional adaptations imply that cydB cells contribute to the proton motive force via consumption of intracellular protons and glutamate/GABA antiport. Indeed, supplementation of culture medium with L-glutamate stimulates growth in a cydB strain. Phenotype analyses of the cydB strain confirm decreased motility and elevated acid resistance and also an elevated cytochrome d spectroscopic signal in cells grown at low pH. We propose a mechanism via which E. coli can compensate for the loss of cytochrome bd-I activity; cytochrome bd-II-mediated quinol oxidation prevents the accumulation of NADH, whereas GABA synthesis/antiport maintains the proton motive force for ATP production.	[Shepherd, Mark; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Sanguinetti, Guido] Univ Edinburgh, Sch Informat, Edinburgh EH8 9AB, Midlothian, Scotland; [Cook, Gregory M.] Univ Otago, Dept Microbiol & Immunol, Dunedin 9054, New Zealand	University of Sheffield; University of Edinburgh; University of Otago	Shepherd, M (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	m.shepherd@sheffield.ac.uk	Cook, Gregory/E-5665-2011	Shepherd, Mark/0000-0002-7472-2300	Biotechnology and Biological Sciences Research Council [BB/C514174/1, BB/F003463/1]; BBSRC [BB/F003463/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/C514174/1 and via Systems Biology of Microorganisms Grant BB/F003463/1 (to R. K. P.).	Andrade SLA, 2007, J BACTERIOL, V189, P9101, DOI 10.1128/JB.01336-07; Atlung T, 1997, J BACTERIOL, V179, P2141, DOI 10.1128/jb.179.7.2141-2146.1997; Atlung T, 1996, J BACTERIOL, V178, P3418, DOI 10.1128/jb.178.12.3418-3425.1996; Baba Tomoya, 2006, Mol Syst Biol, V2; BARTH M, 1995, J BACTERIOL, V177, P3455, DOI 10.1128/jb.177.12.3455-3464.1995; Bekker M, 2009, J BACTERIOL, V191, P5510, DOI 10.1128/JB.00562-09; Boulanger A, 2005, J BACTERIOL, V187, P3282, DOI 10.1128/JB.187.9.3282-3286.2005; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI [DOI 10.1128/jb.172.11.6333-6338.1990, 10.1128/jb.172.11.6333-6338.1990]; DASSA J, 1991, MOL GEN GENET, V229, P341, DOI 10.1007/BF00267454; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; DMELLO R, 1995, J BACTERIOL, V177, P867, DOI 10.1128/jb.177.3.867-870.1995; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; FU HA, 1991, MOL GEN GENET, V226, P209, DOI 10.1007/BF00273605; GENNIS RB, 1987, FEMS MICROBIOL LETT, V46, P387; Giangrossi M, 2005, J BIOL CHEM, V280, P21498, DOI 10.1074/jbc.M413255200; Gilberthorpe NJ, 2008, J BIOL CHEM, V283, P11146, DOI 10.1074/jbc.M708019200; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; GUNSALUS RP, 1992, J BACTERIOL, V174, P7069, DOI 10.1128/jb.174.22.7069-7074.1992; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; IUCHI S, 1991, CELL, V66, P5, DOI 10.1016/0092-8674(91)90130-Q; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; King PW, 1999, J BACTERIOL, V181, P5250, DOI 10.1128/JB.181.17.5250-5256.1999; Kruse T, 2009, INT J PEPT RES THER, V15, P17, DOI 10.1007/s10989-008-9157-9; LOEWEN PC, 1993, BIOCHEMISTRY-US, V32, P10159, DOI 10.1021/bi00089a035; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mason MG, 2009, NAT CHEM BIOL, V5, P94, DOI 10.1038/nchembio.135; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; MCCANN MP, 1991, J BACTERIOL, V173, P4188, DOI 10.1128/jb.173.13.4188-4194.1991; MOROLLO AA, 1993, P NATL ACAD SCI USA, V90, P9983, DOI 10.1073/pnas.90.21.9983; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Nagarajavel V, 2007, J BIOL CHEM, V282, P23622, DOI 10.1074/jbc.M702753200; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Pittman MS, 2002, J BIOL CHEM, V277, P49841, DOI 10.1074/jbc.M205615200; POOLE RK, 1989, J GEN MICROBIOL, V135, P1865; POOLE RK, 1980, BIOCHIM BIOPHYS ACTA, V591, P471, DOI 10.1016/0005-2728(80)90177-2; PUUSTINEN A, 1989, FEBS LETT, V249, P163, DOI 10.1016/0014-5793(89)80616-7; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Ramseier TM, 1996, CURR MICROBIOL, V33, P270, DOI 10.1007/s002849900112; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; RIEBELING V, 1975, EUR J BIOCHEM, V55, P445, DOI 10.1111/j.1432-1033.1975.tb02181.x; Rowbury RJ, 1997, LETT APPL MICROBIOL, V24, P319, DOI 10.1046/j.1472-765X.1997.00065.x; SALERNO JC, 1989, FEBS LETT, V247, P101, DOI 10.1016/0014-5793(89)81249-9; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; SCHELLHORN HE, 1992, J BACTERIOL, V174, P4769, DOI 10.1128/JB.174.14.4769-4776.1992; SCHULTZ A, 1990, APPL ENVIRON MICROB, V56, P1; Soutourina OA, 2002, MICROBIOL-SGM, V148, P1543, DOI 10.1099/00221287-148-5-1543; Sturr MG, 1996, J BACTERIOL, V178, P1742, DOI 10.1128/jb.178.6.1742-1749.1996; Tramonti A, 2002, J BACTERIOL, V184, P2603, DOI 10.1128/JB.184.10.2603-2613.2002; Tramonti A, 2008, MOL MICROBIOL, V70, P965, DOI 10.1111/j.1365-2958.2008.06458.x; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WIKSTROM, 1994, BIOCHIM BIOPHYS ACTA, V1187, P106; Yamamoto K, 2008, J BIOTECHNOL, V133, P196, DOI 10.1016/j.jbiotec.2007.08.002; YAMASHINO T, 1995, EMBO J, V14, P594, DOI 10.1002/j.1460-2075.1995.tb07035.x; YANG WP, 1993, P NATL ACAD SCI USA, V90, P5796, DOI 10.1073/pnas.90.12.5796	65	33	34	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18464	18472		10.1074/jbc.M110.118448	http://dx.doi.org/10.1074/jbc.M110.118448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392690	Green Published, hybrid			2022-12-27	WOS:000278453900040
J	Sutanto, MM; Ferguson, KK; Sakuma, H; Ye, HG; Brady, MJ; Cohen, RN				Sutanto, Maria M.; Ferguson, Kelly K.; Sakuma, Hiroya; Ye, Honggang; Brady, Matthew J.; Cohen, Ronald N.			The Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) Regulates Adipose Tissue Accumulation and Adipocyte Insulin Sensitivity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OB GENE-EXPRESSION; HIGH-FAT DIET; PLASMA LEPTIN; PPAR-GAMMA; TRANSCRIPTIONAL ACTIVITY; BODY-FAT; OBESITY; REPRESSION; THIAZOLIDINEDIONE; IDENTIFICATION	The silencing mediator of retinoid and thyroid hormone receptors (SMRT) serves as a corepressor for nuclear receptors and other factors. Recent evidence suggests that SMRT is an important regulator of metabolism, but its role in adipocyte function in vivo remains unclear. We generated heterozygous SMRT knock-out (SMRT+/-) mice to investigate the function of SMRT in the adipocyte and the regulation of adipocyte insulin sensitivity. We show that SMRT+/- mice are normal weight on a regular diet, but develop increased adiposity on a high-fat diet (HFD). The mechanisms underlying this phenotype are complex, but appear to be due to a combination of an increased number of smaller subcutaneous adipocytes as well as decreased leptin expression, resulting in greater caloric intake. In addition, adipogenesis of mouse embryonic fibroblasts (MEFs) derived from these mice was increased. However, adipocyte insulin sensitivity, measured by insulin-induced Akt phosphorylation and insulin-mediated suppression of lipolysis, was enhanced in SMRT+/- adipocytes. These finding suggest that SMRT regulates leptin expression and limits the ability of fat mass to expand with increased caloric intake, but that SMRT also negatively regulates adipocyte insulin sensitivity.	[Ferguson, Kelly K.; Sakuma, Hiroya; Ye, Honggang; Brady, Matthew J.; Cohen, Ronald N.] Univ Chicago, Sect Endocrinol Diabet & Metab, Dept Med, Chicago, IL 60637 USA; [Sutanto, Maria M.; Brady, Matthew J.; Cohen, Ronald N.] Univ Chicago, Comm Mol Metab & Nutr, Div Biol Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cohen, RN (corresponding author), Univ Chicago, Sect Endocrinol Diabet & Metab, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.	roncohen@medicine.bsd.uchicago.edu	Ferguson, Kelly/C-3745-2019	Ferguson, Kelly/0000-0001-8467-3250	National Institutes of Health [NIDDK R01 DK078125]; Endocrine Society Bridge; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R01DK078125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society Bridge; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant NIDDK R01 DK078125 and an Endocrine Society Bridge Grant.	Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Balint B. L., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P33; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DE VP, 1996, J CLIN INVEST, V98, P1004; Di Cosmo C, 2009, ENDOCRINOLOGY, V150, P4450, DOI 10.1210/en.2009-0209; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fruhbeck G, 1997, BIOCHEM BIOPH RES CO, V240, P590, DOI 10.1006/bbrc.1997.7716; Gauthier MS, 2004, INT J OBESITY, V28, P1064, DOI 10.1038/sj.ijo.0802628; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jurczak MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE952, DOI 10.1152/ajpendo.00559.2006; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; Kelly IE, 1999, DIABETES CARE, V22, P288, DOI 10.2337/diacare.22.2.288; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kolaczynski JW, 1996, DIABETES, V45, P1511, DOI 10.2337/diabetes.45.11.1511; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mori Y, 1999, DIABETES CARE, V22, P908, DOI 10.2337/diacare.22.6.908; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pohlenz J, 1999, THYROID, V9, P1001, DOI 10.1089/thy.1999.9.1001; Rocchini AP, 2002, NEW ENGL J MED, V346, P854, DOI 10.1056/NEJM200203143461112; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sande S, 1996, MOL ENDOCRINOL, V10, P813, DOI 10.1210/me.10.7.813; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Sewter CP, 2002, DIABETES, V51, P718, DOI 10.2337/diabetes.51.3.718; Shimizu H, 1998, DIABETES CARE, V21, P1470, DOI 10.2337/diacare.21.9.1470; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; TRAYHURN P, 1995, FEBS LETT, V368, P488, DOI 10.1016/0014-5793(95)00719-P; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu JJ, 2006, CANCER RES, V66, P9316, DOI 10.1158/0008-5472.CAN-06-1902; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P6386, DOI 10.1073/pnas.94.12.6386	45	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18485	18495		10.1074/jbc.M110.107680	http://dx.doi.org/10.1074/jbc.M110.107680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20371609	Green Published, hybrid			2022-12-27	WOS:000278453900042
J	Vogel, M; Lawson, M; Sippl, W; Conrad, U; Roos, W				Vogel, Matthias; Lawson, Michael; Sippl, Wolfgang; Conrad, Udo; Roos, Werner			Structure and Mechanism of Sanguinarine Reductase, an Enzyme of Alkaloid Detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID SUBSTITUTION MATRICES; IX-BETA REDUCTASE; BENZOPHENANTHRIDINE ALKALOIDS; PHYTOALEXIN BIOSYNTHESIS; METABOLISM; CALIFORNICA; INDUCTION; MOLECULES; DNA	Sanguinarine reductase is a plant enzyme that prevents the cytotoxic effects of benzophenanthridine alkaloids, which are the main phytoalexins of Papaveraceae. The enzyme catalyzes the reduction of sanguinarine, the most toxic benzophenanthridine, which re-enters the cytoplasm after its primary accumulation in the cell wall region has reached a threshold concentration. We present the sequence of the gene and protein of sanguinarine reductase isolated from cell cultures of Eschscholzia californica. High sequence similarities indicate that the enzyme evolved from a plant-specific branch of the ubiquitous Rossmann fold NAD(P)H/NAD(P)(+) binding reductases, with NADP-dependent epimerases or hydroxysteroid reductases as the most likely ancestors. Based on the x-ray structure of a close homolog, a three-dimensional model of the spatial conformation and catalytic site of sanguinarine reductase was established and used for in silico screening of known three-dimensional structures. Surprisingly, the enzyme shares high structural similarity with enzymes of human and bacterial origin, which have similar functions as the plant homologs but bear little amino acid sequence similarity. Using site-directed mutagenesis, a series of recombinant enzymes was generated and assayed to reveal the impact of individual amino acids and peptides in the catalytic process. It appears that relatively few innovations were required to generate this selective catalyst for alkaloid detoxication, notably an insertion of 13 amino acids and the generation of a novel catalytic triad of Cys-Asp-His were sufficient.	[Vogel, Matthias; Roos, Werner] Univ Halle Wittenberg, Dept Pharmaceut Biol, Mol Cell Biol Lab, D-06120 Halle, Saale, Germany; [Lawson, Michael; Sippl, Wolfgang] Univ Halle Wittenberg, Dept Pharmaceut Chem, D-06120 Halle, Saale, Germany; [Conrad, Udo] Inst Plant Genet & Crop Plant Res, D-06446 Gatersleben, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Roos, W (corresponding author), Kurt Mothes Str 3, D-06120 Halle, Germany.	werner.roos@pharmazie.uni-halle.de	Sippl, Wolfgang/P-5944-2014	Sippl, Wolfgang/0000-0002-5985-9261	German Research Council (Deutsche Forschungsgemeinschaft)	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the German Research Council (Deutsche Forschungsgemeinschaft).	Bartak P, 2003, J PHYS ORG CHEM, V16, P803, DOI 10.1002/poc.659; BLECHERT S, 1995, P NATL ACAD SCI USA, V92, P4099, DOI 10.1073/pnas.92.10.4099; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen ZJ, 2009, FASEB J, V23, P3682, DOI 10.1096/fj.09-133587; Faddeeva M D, 1997, Tsitologiia, V39, P181; Haider G, 1997, BIOCHEM BIOPH RES CO, V241, P606, DOI 10.1006/bbrc.1997.7842; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Herrmann S, 2003, THESIS M LUTHER U HA; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Klein M, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P229, DOI 10.1007/978-0-387-85498-4_11; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lukacik P, 2006, MOL CELL ENDOCRINOL, V248, P61, DOI 10.1016/j.mce.2005.12.007; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Pellegrini E, 2002, J PHYS CHEM A, V106, P1316, DOI 10.1021/jp0135050; Pereira PJB, 2001, NAT STRUCT BIOL, V8, P215, DOI 10.1038/84948; Roos W, 1998, PLANT PHYSIOL, V118, P349, DOI 10.1104/pp.118.2.349; Schmeller T, 1997, PHYTOCHEMISTRY, V44, P257, DOI 10.1016/S0031-9422(96)00545-6; SCHWARTZE W, 2007, THESIS M LUTHER U HA; Smith LJ, 2008, BIOCHEM J, V411, P475, DOI 10.1042/BJ20071495; TANAHASHI T, 1990, PHYTOCHEMISTRY, V29, P1113, DOI 10.1016/0031-9422(90)85414-B; Ulrichova J, 2001, TOXICOL LETT, V125, P125, DOI 10.1016/S0378-4274(01)00430-1; Viehweger K, 2006, PLANT CELL, V18, P1510, DOI 10.1105/tpc.105.035121; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Weiss D, 2006, PLANT CELL ENVIRON, V29, P291, DOI 10.1111/j.1365-3040.2005.01421.x; Wink M, 1998, J CHEM ECOL, V24, P1881, DOI 10.1023/A:1022315802264; ZENK MH, 1994, PURE APPL CHEM, V66, P2023, DOI 10.1351/pac199466102023; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	29	31	32	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18397	18406		10.1074/jbc.M109.088989	http://dx.doi.org/10.1074/jbc.M109.088989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20378534	hybrid, Green Published			2022-12-27	WOS:000278453900033
J	Yi, SM; Narasimhulu, KV; Samoilova, RI; Gennis, RB; Dikanov, SA				Yi, Sophia M.; Narasimhulu, Kuppala V.; Samoilova, Rimma I.; Gennis, Robert B.; Dikanov, Sergei A.			Characterization of the Semiquinone Radical Stabilized by the Cytochrome aa(3)-600 Menaquinol Oxidase of Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; NUCLEAR DOUBLE-RESONANCE; SITE-DIRECTED MUTAGENESIS; UBIQUINONE BINDING-SITE; COLI QUINOL OXIDASE; ESCHERICHIA-COLI; PHOTOSYSTEM-I; Q(H) SITE; HYDROGEN-BOND; Q(H)(CENTER-DOT-) UBISEMIQUINONE	Cytochrome aa(3)-600 is one of the principle respiratory oxidases from Bacillus subtilis and is a member of the heme-copper superfamily of oxygen reductases. This enzyme catalyzes the two-electron oxidation of menaquinol and the four-electron reduction of O-2 to 2H(2)O. Cytochrome aa(3)-600 is of interest because it is a very close homologue of the cytochrome bo(3) ubiquinol oxidase from Escherichia coli, except that it uses menaquinol instead of ubiquinol as a substrate. One question of interest is how the proteins differ in response to the differences in structure and electrochemical properties between ubiquinol and menaquinol. Cytochrome bo(3) has a high affinity binding site for ubiquinol that stabilizes a ubi-semiquinone. This has permitted the use of pulsed EPR techniques to investigate the protein interaction with the ubiquinone. The current work initiates studies to characterize the equivalent site in cytochrome aa(3)-600. Cytochrome aa(3)-600 has been cloned and expressed in a His-tagged form in B. subtilis. After isolation of the enzyme in dodecylmaltoside, it is shown that the pure enzyme contains 1 eq of menaquinone-7 and that the enzyme stabilizes a menasemiquinone. Pulsed EPR studies have shown that there are both similarities as well as significant differences in the interactions of the mena-semiquinone with cytochrome aa(3)-600 in comparison with the ubi-semiquinone in cytochrome bo(3). Our data indicate weaker hydrogen bonds of the menaquinone in cytochrome aa(3)-600 in comparison with ubiquinone in cytochrome bo(3). In addition, the electronic structure of the semiquinone cyt aa(3)-600 is more shifted toward the anionic form from the neutral state in cyt bo(3).	[Yi, Sophia M.; Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Narasimhulu, Kuppala V.; Dikanov, Sergei A.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Samoilova, Rimma I.] Russian Acad Sci, Inst Chem Kinet & Combust, Novosibirsk 630090, Russia	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Russian Academy of Sciences; Voevodsky Institute of Chemical Kinetics & Combustion SB RAS	Gennis, RB (corresponding author), Univ Illinois, Dept Biochem, 600 S Goodwin Ave, Urbana, IL 61801 USA.	r-gennis@illinois.edu; dikanov@illinois.edu	Samoilova, Rimma Ivanovna/T-7956-2017	Samoilova, Rimma Ivanovna/0000-0002-1649-1487; Yi, Sophia/0000-0001-9219-9536	National Institutes of Health [GM062954, S10-RR15878]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy [DE-FG02-08ER15960, DE-FG02-87ER13716]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM062954 (to S. A. D.) and S10-RR15878 (National Center for Research Resources) for instrumentation. This work was also supported by Grants DE-FG02-08ER15960 (to S. A. D.) and DE-FG02-87ER13716 (to R. B. G.) from Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Sciences, United States Department of Energy.	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; DAS MR, 1970, J AM CHEM SOC, V92, P2258, DOI 10.1021/ja00711a011; Dikanov SA, 2004, J BIOL CHEM, V279, P15814, DOI 10.1074/jbc.M313417200; DIKANOV SA, 1982, CHEM PHYS LETT, V90, P149, DOI 10.1016/0009-2614(82)83630-0; Dikanov SA, 1996, J AM CHEM SOC, V118, P8408, DOI 10.1021/ja960781x; DikanovO SA, 2007, J BIOL CHEM, V282, P25831, DOI 10.1074/jbc.M702333200; DOWNEY RJ, 1964, J BACTERIOL, V88, P904, DOI 10.1128/JB.88.4.904-911.1964; Epel B, 2006, J PHYS CHEM B, V110, P11549, DOI 10.1021/jp060548d; FANN YC, 1995, BIOCHEMISTRY-US, V34, P10245, DOI 10.1021/bi00032a019; Flores M, 2007, BIOPHYS J, V92, P671, DOI 10.1529/biophysj.106.092460; Flores M, 2003, CHEM PHYS, V294, P401, DOI 10.1016/S0301-0104(03)00321-5; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Gardiner AT, 1999, BIOCHEMISTRY-US, V38, P11773, DOI 10.1021/bi990661c; Grimaldi S, 2005, BIOCHEMISTRY-US, V44, P1300, DOI 10.1021/bi048009r; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Grimaldi S, 2001, BIOCHEMISTRY-US, V40, P1037, DOI 10.1021/bi001641+; Grimaldi S, 2010, J BIOL CHEM, V285, P179, DOI 10.1074/jbc.M109.060251; Hanley J, 1997, BIOCHEMISTRY-US, V36, P11543, DOI 10.1021/bi971360a; Hastings SF, 2000, EUR J BIOCHEM, V267, P5638, DOI 10.1046/j.1432-1327.2000.01643.x; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P10675, DOI 10.1021/bi012146w; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INGLEDEW WJ, 1995, EUR J BIOCHEM, V227, P903, DOI 10.1111/j.1432-1033.1995.tb20217.x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kobayashi K, 2009, BIOSCI BIOTECH BIOCH, V73, P1599, DOI 10.1271/bbb.90105; LAURAEUS M, 1993, J BIOL CHEM, V268, P11470; LAURAEUS M, 1993, BIOCHEMISTRY-US, V32, P2664, DOI 10.1021/bi00061a026; LEMMA E, 1993, ARCH MICROBIOL, V159, P574, DOI 10.1007/BF00249037; Lin MT, 2008, J AM CHEM SOC, V130, P15768, DOI 10.1021/ja805906a; LUBTITZ W, 1999, APPL MAGN RESON, V17, P1; Ma JX, 1998, BIOCHEMISTRY-US, V37, P11806, DOI 10.1021/bi9809977; MacMillan F, 1995, MAGN RESON CHEM, V33, pS81, DOI 10.1002/mrc.1260331314; Matsumoto Y, 2006, J BIOL CHEM, V281, P1905, DOI 10.1074/jbc.M508206200; Matsuura K, 2004, BIOCHEMISTRY-US, V43, P2288, DOI 10.1021/bi0355490; Mattatall NR, 2001, BIOCHEMISTRY-US, V40, P13331, DOI 10.1021/bi011116q; MCCONNELL HM, 1956, J CHEM PHYS, V24, P764, DOI 10.1063/1.1742605; Mogi T, 1999, FEBS LETT, V457, P61, DOI 10.1016/S0014-5793(99)01007-8; Niklas J, 2009, J PHYS CHEM B, V113, P10367, DOI 10.1021/jp901890z; O'Malley PJ, 1998, CHEM PHYS LETT, V291, P367, DOI 10.1016/S0009-2614(98)00571-5; OMALLEY PJ, 1986, J AM CHEM SOC, V108, P3995, DOI 10.1021/ja00274a024; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pushkar YN, 2004, J MOL STRUCT, V700, P233, DOI 10.1016/j.molstruc.2004.02.015; Puustinen A, 1996, P NATL ACAD SCI USA, V93, P1545, DOI 10.1073/pnas.93.4.1545; Rigby SEJ, 1996, BIOCHEMISTRY-US, V35, P6651, DOI 10.1021/bi952619x; SAFIN IA, 1977, NUCL QUADUPOLE RESON; SANTANA M, 1992, J BIOL CHEM, V267, P10225; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P5356, DOI 10.1021/bi9727592; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P12744, DOI 10.1021/bi981184l; SATOWATANABE M, 1995, FEBS LETT, V374, P265, DOI 10.1016/0014-5793(95)01125-X; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; Schweiger A., 2001, PRINCIPLES PULSE ELE, P359; Sinnecker S, 2004, J AM CHEM SOC, V126, P3280, DOI 10.1021/ja0392014; Teutloff C, 2004, APPL MAGN RESON, V26, P5, DOI 10.1007/BF03166559; Veselov AV, 2000, BIOCHEMISTRY-US, V39, P3169, DOI 10.1021/bi9926835; Villani G, 1999, BIOCHEMISTRY-US, V38, P2287, DOI 10.1021/bi980774g; WELTER R, 1994, J BIOL CHEM, V269, P28834; White GF, 2007, BIOCHEMISTRY-US, V46, P2355, DOI 10.1021/bi062265h; Winstedt L, 2000, J BACTERIOL, V182, P6557, DOI 10.1128/JB.182.23.6557-6564.2000; Yap LL, 2007, J BIOL CHEM, V282, P8777, DOI 10.1074/jbc.M611595200; Yap LL, 2006, J BIOL CHEM, V281, P16879, DOI 10.1074/jbc.M602544200	60	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18241	18251		10.1074/jbc.M110.116186	http://dx.doi.org/10.1074/jbc.M110.116186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20351111	Green Published, hybrid			2022-12-27	WOS:000278453900016
J	Brillet, T; Baudin-Creuza, V; Vasseur, C; Domingues-Hamdi, E; Kiger, L; Wajcman, H; Pissard, S; Marden, MC				Brillet, Thomas; Baudin-Creuza, Veronique; Vasseur, Corinne; Domingues-Hamdi, Elisa; Kiger, Laurent; Wajcman, Henri; Pissard, Serge; Marden, Michael C.			alpha-Hemoglobin Stabilizing Protein (AHSP), a Kinetic Scheme of the Action of a Human Mutant, AHSP(V56G)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CHAINS; GENE; EXPRESSION; CHAPERONE; MECHANISM	A kinetic analysis has been made of the interaction of alpha-Hb chains with a mutant alpha-hemoglobin stabilizing protein, AHSP(V56G), which is the first case of an AHSP mutation associated with clinical symptoms of mild thalassemia syndrome. The chaperone AHSP is thought to protect nascent alpha chains until final binding to the partner beta-Hb. Rather than protecting alpha chains, the mutant chaperone is partially unfolded but recovers its secondary structure via interaction with alpha-Hb. For both AHSP(WT) and AHSP(V56G), the binding to alpha-Hb is quite rapid relative to the alpha-beta reaction, as expected because the chaperone binding must be quite competitive to complete the alpha chain folding process before alpha-Hb binds irreversibly to beta-Hb. The main kinetic difference is a dissociation rate of AHSP(V56G).alpha-Hb some four times faster relative to AHSP.alpha-Hb. Considering a role of protein folding, the AHSPV56G apparently does not bind long enough (0.5 s versus 2 s for the WT) to complete the structural modifications. The overall replacement reaction (AHSP.alpha-Hb + beta-Hb -> AHSP + alpha beta) can be quite long, especially if there is an excess of AHSP relative to beta-Hb monomers.	[Marden, Michael C.] Univ Paris 07, INSERM, U779, CHU Bicetre, F-94275 Le Kremlin Bicetre, France; [Wajcman, Henri; Pissard, Serge] Univ Paris 12, U955 Eq 11, INSERM, IMRB, F-94010 Creteil, France; [Wajcman, Henri; Pissard, Serge] Univ Paris 12, AP HP, Hop Henri Mondor, Serv Biochim & Genet, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Marden, MC (corresponding author), Univ Paris 07, INSERM, U779, CHU Bicetre, 11,78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	michael.marden@inserm.fr	Kiger, Laurent/Q-1686-2018; Pissard, Serge/F-8621-2010; BAUDIN-CREUZA, Véronique/K-7309-2017; Vasseur, Corinne/AAV-1384-2021; Marden, Michael C/G-3139-2012; Marden, Michael/AAA-5923-2020	BAUDIN-CREUZA, Véronique/0000-0003-1032-3236; Vasseur, Corinne/0000-0002-4422-7069; Marden, Michael C/0000-0002-5254-6385; 	Institut National de la Sante et de la Recherche Medicale (INSERM); Delegation Generale pour l'Armement (DGA); University of Paris 7, 11, and 12 (France)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Delegation Generale pour l'Armement (DGA); University of Paris 7, 11, and 12 (France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Delegation Generale pour l'Armement (DGA), and the University of Paris 7, 11, and 12 (France).	Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; dos Santos CO, 2008, AM J HEMATOL, V83, P103, DOI 10.1002/ajh.21041; dos Santos CO, 2004, EXP HEMATOL, V32, P157, DOI 10.1016/j.exphem.2003.11.002; dos Santos CO, 2005, BLOOD, V106, p1010A; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; GALANELLO R, 2003, BLOOD, V102; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; GERACI G, 1969, J BIOL CHEM, V244, P4664; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Lai MI, 2006, BRIT J HAEMATOL, V133, P675, DOI 10.1111/j.1365-2141.2006.06075.x; MARDEN MC, 1988, BIOCHEMISTRY-US, V27, P1659, DOI 10.1021/bi00405a041; MCGOVERN P, 1976, J BIOL CHEM, V251, P7871; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; PARKHURST KM, 1992, INT J BIOCHEM, V24, P993, DOI 10.1016/0020-711X(92)90109-E; Pissard S, 2009, BLOOD, V114, P191, DOI 10.1182/blood.V114.22.462.462; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664	20	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17986	17992		10.1074/jbc.M109.098491	http://dx.doi.org/10.1074/jbc.M109.098491			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371604	Green Published, hybrid			2022-12-27	WOS:000278133400074
J	Kosaka, N; Iguchi, H; Yoshioka, Y; Takeshita, F; Matsuki, Y; Ochiya, T				Kosaka, Nobuyoshi; Iguchi, Haruhisa; Yoshioka, Yusuke; Takeshita, Fumitaka; Matsuki, Yasushi; Ochiya, Takahiro			Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-DERIVED EXOSOMES; SMALL RNAS; DIAGNOSTIC BIOMARKERS; APOPTOTIC BODIES; PROSTATE-CANCER; SERUM; PLASMA	The existence of circulating microRNAs (miRNAs) in the blood of cancer patients has raised the possibility that miRNAs may serve as a novel diagnostic marker. However, the secretory mechanism and biological function of extracellular miRNAs remain unclear. Here, we show that miRNAs are released through a ceramide-dependent secretory machinery and that the secretory miRNAs are transferable and functional in the recipient cells. Ceramide, whose biosynthesis is regulated by neutral sphingomyelinase 2 (nSMase2), triggers secretion of small membrane vesicles called exosomes. The decreased activity of nSMase2 with a chemical inhibitor, GW4869, and a specific small interfering RNA resulted in the reduced secretion of miRNAs. Complementarily, overexpression of nSMase2 increased extracellular amounts of miRNAs. We also revealed that the endosomal sorting complex required for transport system is unnecessary for the release of miRNAs. Furthermore, a tumor-suppressive miRNA secreted via this pathway was transported between cells and exerted gene silencing in the recipient cells, thereby leading to cell growth inhibition. Our findings shed a ray of light on the physiological relevance of secretory miRNAs.	[Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Sect Studies Metastasis, Chuo Ku, Tokyo 1040045, Japan; [Iguchi, Haruhisa; Matsuki, Yasushi] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Konohana Ku, Osaka 5540022, Japan	National Cancer Center - Japan; Dainippon Sumitomo Pharmaceutical Company	Ochiya, T (corresponding author), Natl Canc Ctr, Res Inst, Sect Studies Metastasis, Chuo Ku, 1-1 Tsukiji,5 Chome, Tokyo 1040045, Japan.	tochiya@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019		Ministry of Education, Culture, Sports, Science and Technology; National Institute of Biomedical Innovation (NiBio)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation)	This work was supported in part by a grant-in-aid for the third-term comprehensive 10-year strategy for cancer control, a grant-in-aid for scientific research on priority areas cancer from the Ministry of Education, Culture, Sports, Science and Technology, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; El-Hefnawy T, 2004, CLIN CHEM, V50, P564, DOI 10.1373/clinchem.2003.028506; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hasselmann DO, 2001, CLIN CHEM, V47, P1488; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mignot G, 2006, J CELL MOL MED, V10, P376, DOI 10.1111/j.1582-4934.2006.tb00406.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Rechavi O, 2009, GENE DEV, V23, P1971, DOI 10.1101/gad.1789609; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	29	1402	1468	3	220	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17442	17452		10.1074/jbc.M110.107821	http://dx.doi.org/10.1074/jbc.M110.107821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353945	hybrid, Green Published			2022-12-27	WOS:000278133400022
J	Martin, R; Durroux, T; Ciruela, F; Torres, M; Pin, JP; Sanchez-Prieto, J				Martin, Ricardo; Durroux, Thierry; Ciruela, Francisco; Torres, Magdalena; Pin, Jean-Philippe; Sanchez-Prieto, Jose			The Metabotropic Glutamate Receptor mGlu7 Activates Phospholipase C, Translocates Munc-13-1 Protein, and Potentiates Glutamate Release at Cerebrocortical Nerve Terminals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; KINASE-C; PHORBOL ESTERS; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; CALCIUM-CHANNELS; RAT HIPPOCAMPUS; CA2+ CHANNELS; MICE LACKING; PLC-ETA	At synaptic boutons, metabotropic glutamate receptor 7 (mGlu7 receptor) serves as an autoreceptor, inhibiting glutamate release. In this response, mGlu7 receptor triggers pertussis toxin-sensitive G protein activation, reducing presynaptic Ca2+ influx and the subsequent depolarization evoked release. Here we report that receptor coupling to signaling pathways that potentiate release can be seen following prolonged exposure of nerve terminals to the agonist L-(+)-phosphonobutyrate, L-AP4. This novel mGlu7 receptor response involves an increase in the release induced by the Ca2+ ionophore ionomycin, suggesting a mechanism that is independent of Ca2+ channel activity, but dependent on the downstream exocytotic release machinery. The mGlu7 receptor-mediated potentiation resists exposure to pertussis toxin, but is dependent on phospholipase C, and increased phosphatidylinositol (4,5)-bisphosphate hydrolysis. Furthermore, the potentiation of release does not depend on protein kinase C, although it is blocked by the diacylglycerol-binding site antagonist calphostin C. We also found that activation of mGlu7 receptors translocate the active zone protein essential for synaptic vesicle priming, munc13-1, from soluble to particulate fractions. We propose that the mGlu7 receptor can facilitate or inhibit glutamate release through multiple pathways, thereby exerting homeostatic control of presynaptic function.	[Martin, Ricardo; Torres, Magdalena; Sanchez-Prieto, Jose] Univ Complutense Madrid, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain; [Durroux, Thierry; Pin, Jean-Philippe] CNRS, UMR 5203, Inst Genom Fonct, F-34000 Montpellier, France; [Ciruela, Francisco] Univ Barcelona, Fac Med, Dept Patol & Terapeut Expt, Unitat Farmacol, Barcelona 08907, Spain	Complutense University of Madrid; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Barcelona	Sanchez-Prieto, J (corresponding author), Univ Complutense Madrid, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain.	jsprieto@vet.ucm	Martín, Ricardo/J-1408-2018; Ciruela, F./A-5096-2013; Torres, Magdalena/E-6150-2017; Pin, Jean-Philippe/Y-6668-2019	Martín, Ricardo/0000-0002-7645-4901; Ciruela, F./0000-0003-0832-3739; Torres, Magdalena/0000-0002-3893-8569; Pin, Jean-Philippe/0000-0002-1423-345X; Sanchez-Prieto, Jose/0000-0002-8513-3501; Durroux, Thierry/0000-0003-1091-6066	Spanish Ministerio de Educacion y Ciencia [BFU2007-64154/BFI]; Instituto de Salud Carlos III [RD06/0026]; Comunidad de Madrid [S-BIO-0170/2006, SAF2008-01462]; Ministerio de Ciencia e Innovacion [CSD2008-00005]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Spanish Ministerio de Educacion y Ciencia Grant BFU2007-64154/BFI, Instituto de Salud Carlos III Grant RD06/0026, and Comunidad de Madrid Grants S-BIO-0170/2006 (to J.S.-P.) and SAF2008-01462, and Consolider-Ingenio CSD2008-00005 from the Ministerio de Ciencia e Innovacion (to F. C.).	Andrews-Zwilling YS, 2006, J BIOL CHEM, V281, P19720, DOI 10.1074/jbc.M601421200; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Bauer CS, 2007, J NEUROSCI, V27, P212, DOI 10.1523/JNEUROSCI.4201-06.2007; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Cockcroft S, 2006, TRENDS BIOCHEM SCI, V31, P4, DOI 10.1016/j.tibs.2005.11.003; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1; GEREAU RW, 1995, J NEUROSCI, V15, P6879; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HERRERO I, 1991, NEUROSCI LETT, V126, P41, DOI 10.1016/0304-3940(91)90366-2; Herrero I, 1996, EUR J NEUROSCI, V8, P700, DOI 10.1111/j.1460-9568.1996.tb01255.x; HERRERO I, 1992, J NEUROCHEM, V59, P1574, DOI 10.1111/j.1471-4159.1992.tb08478.x; Hwang JI, 2005, BIOCHEM J, V389, P181, DOI 10.1042/BJ20041677; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Ladera C, 2007, J NEUROCHEM, V103, P2314, DOI 10.1111/j.1471-4159.2007.04964.x; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Martin R, 2008, NEUROPHARMACOLOGY, V55, P464, DOI 10.1016/j.neuropharm.2008.04.011; Millan C, 2003, J BIOL CHEM, V278, P23955, DOI 10.1074/jbc.M211471200; Millan C, 2002, J BIOL CHEM, V277, P47796, DOI 10.1074/jbc.M207531200; Millan C, 2002, J BIOL CHEM, V277, P14092, DOI 10.1074/jbc.M109044200; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Pelkey KA, 2008, NEURON, V60, P980, DOI 10.1016/j.neuron.2008.11.018; Perroy J, 2000, J NEUROSCI, V20, P7896; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Sorensen SD, 2002, MOL PHARMACOL, V61, P1303, DOI 10.1124/mol.61.6.1303; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; Zhang CS, 2008, J NEUROSCI, V28, P8604, DOI 10.1523/JNEUROSCI.0628-08.2008; Zhang YH, 2001, J NEUROPHYSIOL, V85, P362, DOI 10.1152/jn.2001.85.1.362	47	50	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17907	17917		10.1074/jbc.M109.080838	http://dx.doi.org/10.1074/jbc.M109.080838			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375012	Green Published, hybrid			2022-12-27	WOS:000278133400067
J	Yi, TF; Tan, KR; Cho, SG; Wang, Y; Luo, J; Zhang, WZ; Li, DL; Liu, MY				Yi, Tingfang; Tan, Kunrong; Cho, Sung-Gook; Wang, Ying; Luo, Jian; Zhang, Wenzheng; Li, Dali; Liu, Mingyao			Regulation of Embryonic Kidney Branching Morphogenesis and Glomerular Development by KISS1 Receptor (Gpr54) through NFAT2-and Sp1-mediated Bmp7 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS SUPPRESSOR GENE; ACTIVATED T-CELLS; HORMONE-RELEASING ACTIVITY; NUCLEAR FACTOR; TRANSCRIPTION FACTORS; DOWN-REGULATION; CANCER; KISSPEPTINS; PEPTIDE; LIGAND	G-protein-coupled receptor 54 (Gpr54, KISS1 receptor) plays critical roles in puberty regulation, tumor metastasis suppression, and vasoconstriction. Bone morphogenetic protein-7 (Bmp7) is required for kidney organogenesis. However, whether Gpr54 is involved in embryonic kidney development and how Bmp7 expression is regulated in the kidney are largely unknown. Here we report that Gpr54 deletion leads to kidney branching morphogenesis and glomerular development retardation in embryonic kidneys in vivo and in explanted kidneys in vitro. Gpr54 inactivation results in a high risk of low glomerular number in adult kidneys. Gpr54 is expressed in condensed mesenchyme at E12.5 and epithelial cells of proximal and distal tubules and collecting ducts at E17.5 and P0 mouse kidney. Deletion of Gpr54 decreases Bmp7 expression and Smad1 phosphorylation in the developing kidney. Using chromatin immunoprecipitation and luciferase assays, we demonstrate that Gpr54 regulates NFAT2- and Sp1-mediated Bmp7 transcription. Furthermore, we show that NFAT2 cooperates with Sp1 to promote Bmp7 transcription activation. Together, these data suggest that Gpr54 regulates Bmp7 expression through NFAT2 and Sp1 and plays an important role in embryonic kidney branching morphogenesis and glomerular development.	[Yi, Tingfang; Tan, Kunrong; Cho, Sung-Gook; Wang, Ying; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol,Dept Mol & Cellular Med, Houston, TX 77030 USA; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Zhang, Wenzheng] Univ Texas Hlth Sci Ctr, Dept Internal Med, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; East China Normal University; East China Normal University; University of Texas System; University of Texas Health Science Center Houston	Liu, MY (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mliu@ibt.tamhsc.edu	Luo, Jian/H-3362-2016	Luo, Jian/0000-0003-3583-0154; Cho, Sung-Gook/0000-0002-8791-9532; Liu, Mingyao/0000-0001-7339-5048	National Institutes of Health (NCI) [1R01CA106479]; NATIONAL CANCER INSTITUTE [R01CA106479] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA106479 (NCI).	Adams D, 2007, DEV BIOL, V311, P679, DOI 10.1016/j.ydbio.2007.08.036; Alfonso-Jaume MA, 2004, BIOCHEM J, V380, P735, DOI 10.1042/BJ20031281; Bates CM, 2000, MOL GENET METAB, V71, P391, DOI 10.1006/mgme.2000.3072; Brailoiu GC, 2005, J COMP NEUROL, V481, P314, DOI 10.1002/cne.20350; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; CHEN J, 1994, P NATL ACAD SCI USA, V91, P2611, DOI 10.1073/pnas.91.7.2611; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colledge WH, 2004, TRENDS ENDOCRIN MET, V15, P448, DOI 10.1016/j.tem.2004.09.008; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Tassigny XD, 2008, ENDOCRINOLOGY, V149, P3926, DOI 10.1210/en.2007-1487; Dhar DK, 2004, INT J CANCER, V111, P868, DOI 10.1002/ijc.20357; Dittmer A, 2006, J BIOL CHEM, V281, P14563, DOI 10.1074/jbc.M510527200; Dressler GR, 2002, TRENDS CELL BIOL, V12, P390, DOI 10.1016/S0962-8924(02)02334-6; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Elliott WJ, 2007, NAT CLIN PRACT CARD, V4, P538, DOI 10.1038/ncpcardio0989; FULOP T, 1993, CELL SIGNAL, V5, P593, DOI 10.1016/0898-6568(93)90054-P; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Godin RE, 1998, DEVELOPMENT, V125, P3473; Godin RE, 1999, INT J DEV BIOL, V43, P405; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; GROBSTEIN C, 1955, ANN NY ACAD SCI, V60, P1095, DOI 10.1111/j.1749-6632.1955.tb40091.x; Ikeguchi M, 2004, CLIN CANCER RES, V10, P1379, DOI 10.1158/1078-0432.CCR-1519-02; Jena N, 1997, EXP CELL RES, V230, P28, DOI 10.1006/excr.1996.3411; Jiang Tao, 2005, Zhonghua Zhongliu Zazhi, V27, P229; Jiang Y, 2005, CLIN EXP METASTAS, V22, P369, DOI 10.1007/s10585-005-8186-4; Kazama I, 2008, J AM SOC NEPHROL, V19, P2181, DOI 10.1681/ASN.2007111212; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li DL, 2007, ENDOCRINOLOGY, V148, P4821, DOI 10.1210/en.2007-0154; Li DL, 2009, PEPTIDES, V30, P130, DOI 10.1016/j.peptides.2008.09.025; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Martinez G, 2002, INT J DEV BIOL, V46, P525; Marumo T, 2008, J AM SOC NEPHROL, V19, P1311, DOI 10.1681/ASN.2007091040; Masui T, 2004, BIOCHEM BIOPH RES CO, V315, P85, DOI 10.1016/j.bbrc.2004.01.021; Mitu GM, 2007, AM J PHYSIOL-RENAL, V293, pF1641, DOI 10.1152/ajprenal.00179.2007; Nash KT, 2007, JNCI-J NATL CANCER I, V99, P309, DOI 10.1093/jnci/djk053; Navarro VM, 2005, ENDOCRINOLOGY, V146, P156, DOI 10.1210/en.2004-0836; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; Nicolle G, 2007, ANN ONCOL, V18, P605, DOI 10.1093/annonc/mdl421; Ohta S, 2005, INT J CANCER, V114, P139, DOI 10.1002/ijc.20670; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Paralkar VM, 2002, J CELL PHYSIOL, V190, P207, DOI 10.1002/JCP.10048; Patel SR, 2005, TRENDS MOL MED, V11, P512, DOI 10.1016/j.molmed.2005.09.007; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; Popa SM, 2008, ANNU REV PHYSIOL, V70, P213, DOI 10.1146/annurev.physiol.70.113006.100540; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Qiao JZ, 1999, P NATL ACAD SCI USA, V96, P7330, DOI 10.1073/pnas.96.13.7330; Sakaguchi M, 2004, J CELL BIOL, V164, P979, DOI 10.1083/jcb.200312041; Sanchez-Carbayo M, 2003, LAB INVEST, V83, P507, DOI 10.1097/01.LAB.0000064702.63200.94; Sanchez-Carbayo M, 2003, AM J PATHOL, V162, P609, DOI 10.1016/S0002-9440(10)63854-0; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Seminara SB, 2005, ENDOCRINOLOGY, V146, P1686, DOI 10.1210/en.2005-0070; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; Simon N, 1999, AM J PHYSIOL-RENAL, V276, pF382, DOI 10.1152/ajprenal.1999.276.3.F382; Stafford LJ, 2002, CANCER RES, V62, P5399; Sugimoto T, 2001, J AM SOC NEPHROL, V12, P1359, DOI 10.1681/ASN.V1271359; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Terao Y, 2004, BBA-GENE STRUCT EXPR, V1678, P102, DOI 10.1016/j.bbaexp.2004.02.005; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; van Adelsberg J, 1999, DEV GENET, V24, P299, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<299::AID-DVG13>3.0.CO;2-J; Wetzel P, 2006, KIDNEY INT, V70, P717, DOI 10.1038/sj.ki.5001653; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Wu XY, 2009, GENE EXPR PATTERNS, V9, P224, DOI 10.1016/j.gep.2008.12.005; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347; Zhang CG, 2008, J NEUROSCI, V28, P4423, DOI 10.1523/JNEUROSCI.5352-07.2008; Zhang J, 2007, CANCER, V109, P1478, DOI 10.1002/cncr.22554; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201	79	24	24	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17811	17820		10.1074/jbc.M110.130740	http://dx.doi.org/10.1074/jbc.M110.130740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375015	Green Published, hybrid			2022-12-27	WOS:000278133400059
J	Bevilacqua, E; Wang, XL; Majumder, M; Gaccioli, F; Yuan, CL; Wang, CP; Zhu, XW; Jordan, LE; Scheuner, D; Kaufman, RJ; Koromilas, AE; Snider, MD; Holcik, M; Hatzoglou, M				Bevilacqua, Elena; Wang, Xinglong; Majumder, Mithu; Gaccioli, Francesca; Yuan, Celvie L.; Wang, Chuanping; Zhu, Xiongwei; Jordan, Lindsay E.; Scheuner, Donalyn; Kaufman, Randal J.; Koromilas, Antonis E.; Snider, Martin D.; Holcik, Martin; Hatzoglou, Maria			eIF2 alpha Phosphorylation Tips the Balance to Apoptosis during Osmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRES-MEDIATED TRANSLATION; AMINO-ACID TRANSPORTER; NF-KAPPA-B; GENE-EXPRESSION; MESSENGER-RNA; HNRNP A1; CELLULAR-RESPONSE; PROTEIN; KINASE; RELOCALIZATION	Regulation of cell volume is of great importance because persistent swelling or shrinkage leads to cell death. Tissues experience hypertonicity in both physiological (kidney medullar cells) and pathological states (hypernatremia). Hypertonicity induces an adaptive gene expression program that leads to cell volume recovery or apoptosis under persistent stress. We show that the commitment to apoptosis is controlled by phosphorylation of the translation initiation factor eIF2 alpha, the master regulator of the stress response. Studies with cultured mouse fibroblasts and cortical neurons show that mutants deficient in eIF2 alpha phosphorylation are protected from hypertonicity-induced apoptosis. A novel link is revealed between eIF2 alpha phosphorylation and the subcellular distribution of the RNA-binding protein heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1). Stress-induced phosphorylation of eIF2 alpha promotes apoptosis by inducing the cytoplasmic accumulation of hnRNP A1, which attenuates internal ribosome entry site-mediated translation of anti-apoptotic mRNAs, including Bcl-xL that was studied here. Hypertonic stress induced the eIF2 alpha phosphorylation-independent formation of cytoplasmic stress granules (SGs, structures that harbor translationally arrested mRNAs) and the eIF2 alpha phosphorylation-dependent accumulation of hnRNP A1 in SGs. The importance of hnRNP A1 was demonstrated by induction of apoptosis in eIF2 alpha phosphorylation-deficient cells that express exogenous cytoplasmic hnRNP A1. We propose that eIF2 alpha phosphorylation during hypertonic stress promotes apoptosis by sequestration of specific mRNAs in SGs in a process mediated by the cytoplasmic accumulation of hnRNP A1.	[Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Wang, Xinglong; Zhu, Xiongwei] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Snider, Martin D.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Jordan, Lindsay E.; Holcik, Martin] Childrens Hosp Eastern Ontario, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Scheuner, Donalyn; Kaufman, Randal J.] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Howard Hughes Med Inst, Sch Med, Ann Arbor, MI 48109 USA; [Koromilas, Antonis E.] McGill Univ, Fac Med, Dept Oncol, Montreal, PQ H3T 1E2, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; McGill University	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxh8@case.edu	Holcik, Martin/E-5372-2011; Zhu, Xiongwei/A-9629-2009; /C-1310-2010; Holcik, Martin/AAC-6660-2019	Zhu, Xiongwei/0000-0003-2092-6508; Holcik, Martin/0000-0002-1922-5299; Gaccioli, Francesca/0000-0001-7178-8921; Wang, Xinglong/0000-0001-8657-0159	National Institutes of Health [DK60596, DK53307, DK42304, HL52173, HL057346]; Canadian Cancer Society Research Institute [CCRSI 17285]; Canadian Institutes of Health Research [MOP 89737, FRN 74740]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R01DK060596, R37DK060596, R01DK042304, R37DK042394, R01DK088227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60596 and DK53307 (to M. H.) and DK42304, HL52173, and HL057346 (to R. J. K.). This work was also supported by the Canadian Cancer Society Research Institute Grant CCRSI 17285 (to A. E. K.) and the Canadian Institutes of Health Research Grants MOP 89737 and FRN 74740 (to M. H.).	Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Aulak KS, 1999, J BIOL CHEM, V274, P30424, DOI 10.1074/jbc.274.43.30424; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brigotti M, 2003, BIOCHEM J, V369, P369, DOI 10.1042/BJ20021056; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Franchi-Gazzola R, 2001, AM J PHYSIOL-CELL PH, V280, pC1465, DOI 10.1152/ajpcell.2001.280.6.C1465; Fritsch RM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702673200; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Harding HP, 2001, COLD SPRING HARB SYM, V66, P499, DOI 10.1101/sqb.2001.66.499; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Johnson CE, 2007, P NATL ACAD SCI USA, V104, P20820, DOI 10.1073/pnas.0709101105; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kneller ELP, 2009, J VIROL, V83, P770, DOI 10.1128/JVI.01279-08; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lin M, 2005, EMERG MED CLIN N AM, V23, P749, DOI 10.1016/j.emc.2005.03.001; Loyher ML, 2004, NEUROSCIENCE, V124, P89, DOI 10.1016/j.neuroscience.2003.10.025; Maallem S, 2008, NEUROSCIENCE, V153, P95, DOI 10.1016/j.neuroscience.2008.01.047; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Marash L, 2005, CELL DEATH DIFFER, V12, P554, DOI 10.1038/sj.cdd.4401609; Morley SJ, 2002, J BIOL CHEM, V277, P32855, DOI 10.1074/jbc.C200376200; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhao TT, 2009, CELL DEATH DIFFER, V16, P244, DOI 10.1038/cdd.2008.146	57	70	72	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17098	17111		10.1074/jbc.M110.109439	http://dx.doi.org/10.1074/jbc.M110.109439			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20338999	hybrid, Green Published			2022-12-27	WOS:000277982600073
J	Niemeyer, MI; Cid, LP; Pena-Munzenmayer, G; Sepulveda, FV				Isabel Niemeyer, Maria; Pablo Cid, L.; Pena-Munzenmayer, Gaspar; Sepulveda, Francisco V.			Separate Gating Mechanisms Mediate the Regulation of K-2P Potassium Channel TASK-2 by Intra- and Extracellular pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNELS; 2-PORE DOMAIN; SELECTIVITY FILTER; INTRACELLULAR PH; FATTY-ACIDS; SENSITIVITY; PORE; SENSOR; ROMK; HISTIDINE	TASK-2 (KCNK5 or K(2P)5.1) is a background K+ channel that is opened by extracellular alkalinization and plays a role in renal bicarbonate reabsorption and central chemoreception. Here, we demonstrate that in addition to its regulation by extracellular protons (pH(o)) TASK-2 is gated open by intracellular alkalinization. The following pieces of evidence suggest that the gating process controlled by intracellular pH (pH(i)) is independent from that under the command of pH(o). It was not possible to overcome closure by extracellular acidification by means of intracellular alkalinization. The mutant TASK-2-R224A that lacks sensitivity to pH(o) had normal pH(i)-dependent gating. Increasing extracellular K+ concentration acid shifts pH(o) activity curve of TASK-2 yet did not affect pH(i) gating of TASK-2. pH(o) modulation of TASK-2 is voltage-dependent, whereas pH(i) gating was not altered by membrane potential. These results suggest that pH(o), which controls a selectivity filter external gate, and pH(i) act at different gating processes to open and close TASK-2 channels. We speculate that pH(i) regulates an inner gate. We demonstrate that neutralization of a lysine residue (Lys(245)) located at the C-terminal end of transmembrane domain 4 by mutation to alanine abolishes gating by pH(i). We postulate that this lysine acts as an intracellular pH sensor as its mutation to histidine acid-shifts the pH(i)-dependence curve of TASK-2 as expected from its lower pK(a). We conclude that intracellular pH, together with pH(o), is a critical determinant of TASK-2 activity and therefore of its physiological function.	[Isabel Niemeyer, Maria; Sepulveda, Francisco V.] Ctr Estudios Cient, Ctr Ingn Innovac Asociado, Valdivia 5110466, Chile; [Pena-Munzenmayer, Gaspar] Univ Austral Chile, Valdivia 5110566, Chile	Universidad Austral de Chile	Niemeyer, MI (corresponding author), Ctr Estudios Cient, Ctr Ingn Innovac Asociado, Av Arturo Prat 514, Valdivia 5110466, Chile.	miniemeyer@cecs.cl	Pena-Munzenmayer, Gaspar/ABD-2296-2021	Pena-Munzenmayer, Gaspar/0000-0001-6633-0545; Cid, Pablo/0000-0003-0394-0498; Sepulveda Valenzuela, Francisco Leandro/0000-0003-0022-6598	Fondo Nacional de Ciencia y Tecnologia [1090478]; Comision Nacional de Ciencia y Tecnologia [24081049]; Chilean Government through the Millennium Science Initiative; Gobierno Regional de Los Rios	Fondo Nacional de Ciencia y Tecnologia; Comision Nacional de Ciencia y Tecnologia; Chilean Government through the Millennium Science Initiative; Gobierno Regional de Los Rios	This work was supported by Fondo Nacional de Ciencia y Tecnologia Grant 1090478 and Comision Nacional de Ciencia y Tecnologia Grant 24081049.; We are grateful to Drs. Jurgen Daut (Philipps-Universitat, Marburg, Germany) and Donghee Kim (Rosalind Franklin University, Chicago, IL) for generously providing some of the cDNAs used in our experiments and to Robert W. Putnam (Wright State University, Dayton, OH) for advice on changing intracellular pH. F. Danilo Gonzalez-Nilo and Valeria Marquez (Universidad de Talca, Chile) are gratefully acknowledged for insightful discussions concerning the structure of TASK-2. The Centro de Estudios Cientificos (CECS) is funded by the Chilean Government through the Millennium Science Initiative and the Centers of Excellence Base Financing Program of Conicyt. Centro de Ingenieria de la Innovacion asociado al CECS is funded by Conicyt and the Gobierno Regional de Los Rios.	Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Cid LP, 2000, AM J PHYSIOL-CELL PH, V279, pC1198, DOI 10.1152/ajpcell.2000.279.4.C1198; Cohen A, 2009, EUR BIOPHYS J BIOPHY, V39, P61, DOI 10.1007/s00249-009-0457-6; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Dedman A, 2009, EUR BIOPHYS J BIOPHY, V38, P293, DOI 10.1007/s00249-008-0318-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Fakler B, 1996, EMBO J, V15, P4093, DOI 10.1002/j.1460-2075.1996.tb00784.x; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; GRINSTEIN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1152, DOI 10.1152/ajpcell.1994.267.4.C1152; GUYENET PG, 2010, RESP PHYSL IN PRESS; Hartzler LK, 2008, ADV EXP MED BIOL, V605, P333; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Leng Q, 2006, P NATL ACAD SCI USA, V103, P1982, DOI 10.1073/pnas.0510610103; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Mulkey DK, 2007, J NEUROSCI, V27, P14049, DOI 10.1523/JNEUROSCI.4254-07.2007; Niemeyer MI, 2006, BIOCHEM SOC T, V34, P899, DOI 10.1042/BST0340899; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Niemeyer MI, 2001, J BIOL CHEM, V276, P43166, DOI 10.1074/jbc.M107192200; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rapedius M, 2006, EMBO REP, V7, P611, DOI 10.1038/sj.embor.7400678; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; ROOS A, 1981, PHYSIOL REV, V61, P294; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Stansfeld PJ, 2008, BIOCHEMISTRY-US, V47, P7414, DOI 10.1021/bi800475j; Thompson J, 2005, J GEN PHYSIOL, V125, P619, DOI 10.1085/jgp.200509251; Thompson J, 2003, J GEN PHYSIOL, V122, P239, DOI 10.1085/jgp.200308848; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Yuan YK, 2003, J PHYSIOL-LONDON, V549, P429, DOI 10.1113/jphysiol.2003.042341; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	51	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16467	16475		10.1074/jbc.M110.107060	http://dx.doi.org/10.1074/jbc.M110.107060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351106	Green Published, hybrid			2022-12-27	WOS:000277982600008
J	Smith, KJ; Twal, WO; Soodavar, F; Virella, G; Lopes-Virella, MF; Hammad, SM				Smith, Kent J.; Twal, Waleed O.; Soodavar, Farzan; Virella, Gabriel; Lopes-Virella, Maria F.; Hammad, Samar M.			Heat Shock Protein 70B ' (HSP70B ') Expression and Release in Response to Human Oxidized Low Density Lipoprotein Immune Complexes in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U937 MONOCYTIC CELLS; SPHINGOSINE KINASE; CYTOKINE PRODUCTION; PLASMA-MEMBRANE; STRESS-PROTEINS; LDL; HEAT-SHOCK-PROTEIN-70; SURVIVAL; PATHWAY; ATHEROSCLEROSIS	Heat shock proteins (HSPs) have been implicated in the activation and survival of macrophages. This study examined the role of HSP70B', a poorly characterized member of the HSP70 family, in response to oxidatively modified LDL (oxLDL) and immune complexes prepared with human oxLDL and purified human antibodies to oxLDL (oxLDL-IC) in monocytic and macrophage cell lines. Immunoblot analysis of cell lysates and conditioned medium from U937 cells treated with oxLDL alone revealed an increase in intracellular HSP70B' protein levels accompanied by a concomitant increase in HSP70B' extracellular levels. Fluorescence immunohistochemistry and confocal microscopy, however, demonstrated that oxLDL-IC stimulated the release of HSP70B', which co-localized with cell-associated oxLDL-IC. In HSP70B'-green fluorescent protein-transfected mouse RAW 264.7 cells, oxLDL-IC-induced HSP70B' co-localized with membrane-associated oxLDL-IC as well as the lipid moiety of internalized oxLDL-IC. Furthermore, the data demonstrated that HSP70B' is involved in cell survival, and this effect could be mediated by sphingosine kinase 1 (SK1) activation. An examination of regularly implicated cytokines revealed a significant relationship between HSP70B' and the release of the anti-inflammatory cytokine interleukin-10 (IL-10). Small interfering RNA knockdown of HSP70B' resulted in a corresponding decrease in SK1 mRNA levels and SK1 phosphorylation as well as increased release of IL-10. In conclusion, these findings suggest that oxLDL-IC induce the synthesis and release of HSP70B', and once stimulated, HSP70B' binds to the cell-associated and internalized lipid moiety of oxLDL-IC. The data also implicate HSP70B' in key cellular functions, such as regulation of SK1 activity and release of IL-10, which influence macrophage activation and survival.	[Smith, Kent J.; Twal, Waleed O.; Soodavar, Farzan; Hammad, Samar M.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Virella, Gabriel] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Lopes-Virella, Maria F.] Med Univ S Carolina, Div Endocrinol, Dept Med, Charleston, SC 29425 USA; [Lopes-Virella, Maria F.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hammad, SM (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 114 Doughty St,630B,POB 250776, Charleston, SC 29425 USA.	hammadsm@musc.edu		Hammad, Samar/0000-0002-1313-2542	National Institutes of Health (NIH) [HL079274]; NIH (American Recovery and Investment Act (ARRA)) [R01 HL079274-04S1]; NIH (National Center for Research Resources) [P20 RR17677]; NIH [P01 HL55782, R01 DK081352, R01 DK081352-02S1]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055782, R01HL079274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081352] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (American Recovery and Investment Act (ARRA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant HL079274 and NIH (American Recovery and Investment Act (ARRA)) Grant R01 HL079274-04S1 (to S. M. H.); NIH (National Center for Research Resources) Grant P20 RR17677 (South Carolina Center of Biomedical Research Excellence in Lipidomics and Pathobiology) (to S. M. H.); and NIH Grants P01 HL55782, R01 DK081352, and R01 DK081352-02S1 (ARRA) (to M. F. L.-V.). This work was also supported by funding from the Department of Veterans Affairs (to M. F. L.-V.).	ARAI T, 1995, BIOCHEM BIOPH RES CO, V213, P600, DOI 10.1006/bbrc.1995.2174; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asmis R, 2003, CIRC RES, V92, pE20, DOI 10.1161/01.RES.0000051886.43510.90; Atchley DH, 2002, DIABETOLOGIA, V45, P1562, DOI 10.1007/s00125-002-0962-y; BERBERIAN PA, 1990, AM J PATHOL, V136, P71; Bianchi G, 2007, ANN NY ACAD SCI, V1095, P209, DOI 10.1196/annals.1397.025; Brown AJ, 2000, J LIPID RES, V41, P226; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; DAVIDOFF AM, 1992, P NATL ACAD SCI USA, V89, P3439, DOI 10.1073/pnas.89.8.3439; Detanico T, 2004, CLIN EXP IMMUNOL, V135, P336, DOI 10.1111/j.1365-2249.2004.02351.x; DING XZ, 2010, PROSTAGLAND IN PRESS; GRIFFITH RL, 1988, J EXP MED, V168, P1041, DOI 10.1084/jem.168.3.1041; Hammad SM, 2009, ATHEROSCLEROSIS, V202, P394, DOI 10.1016/j.atherosclerosis.2008.05.032; Hammad SM, 2006, PROSTAG OTH LIPID M, V79, P126, DOI 10.1016/j.prostaglandins.2005.12.004; Hengst JA, 2009, ARCH BIOCHEM BIOPHYS, V492, P62, DOI 10.1016/j.abb.2009.09.013; Hirvonen MR, 1996, BIOCHEM J, V315, P845, DOI 10.1042/bj3150845; Huang Y, 1999, ARTERIOSCL THROM VAS, V19, P1600, DOI 10.1161/01.ATV.19.7.1600; JOHNSON AD, 1995, ARTERIOSCL THROM VAS, V15, P27, DOI 10.1161/01.ATV.15.1.27; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Kirkeby S, 2005, J IMMUNOL METHODS, V301, P102, DOI 10.1016/j.jim.2005.04.006; KUSHER DI, 1990, J IMMUNOL, V145, P2925; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; LEUNG TKC, 1990, BIOCHEM J, V267, P125, DOI 10.1042/bj2670125; Li W, 1998, FREE RADICAL RES, V29, P389, DOI 10.1080/10715769800300431; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; Lopes-Virella MF, 2000, ATHEROSCLEROSIS, V152, P107, DOI 10.1016/S0021-9150(99)00456-6; Luo XJ, 2008, CELL STRESS CHAPERON, V13, P365, DOI 10.1007/s12192-008-0036-2; MANDER EL, 1994, BBA-LIPID LIPID MET, V1212, P80, DOI 10.1016/0005-2760(94)90192-9; Martinet W, 2001, CURR OPIN LIPIDOL, V12, P535, DOI 10.1097/00041433-200110000-00009; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mehta TA, 2005, EUR J VASC ENDOVASC, V29, P395, DOI 10.1016/j.ejvs.2005.01.005; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Multhoff G, 1999, EXP HEMATOL, V27, P1627, DOI 10.1016/S0301-472X(99)00104-6; Noonan E, 2008, EXP CELL RES, V314, P2468, DOI 10.1016/j.yexcr.2008.05.002; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P393, DOI 10.1379/CSC-278e.1; Oksjoki R, 2006, ARTERIOSCL THROM VAS, V26, P576, DOI 10.1161/01.ATV.0000201041.14438.8d; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Parsian AJ, 2000, BBA-GENE STRUCT EXPR, V1494, P201, DOI 10.1016/S0167-4781(00)00203-7; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Roma P, 1996, ATHEROSCLEROSIS, V127, P147, DOI 10.1016/S0021-9150(96)05952-7; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Svensson PA, 2006, ATHEROSCLEROSIS, V185, P32, DOI 10.1016/j.atherosclerosis.2005.05.007; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Vicca SP, 2003, FREE RADICAL BIO MED, V35, P603, DOI 10.1016/S0891-5849(03)00361-7; Virella G, 2000, CLIN IMMUNOL, V95, P135, DOI 10.1006/clim.2000.4857; Virella G, 2004, J LIPID RES, V45, P1859, DOI 10.1194/jlr.M400095-JLR200; Virella G, 2003, CLIN DIAGN LAB IMMUN, V10, P499, DOI 10.1128/CDLI.10.4.499-505.2003; VIRELLA G, 1995, CLIN IMMUNOL IMMUNOP, V75, P179, DOI 10.1006/clin.1995.1069; WILLIAMS RS, 1993, J CLIN INVEST, V92, P503, DOI 10.1172/JCI116594; Xu QB, 1996, MOL MED TODAY, V2, P372, DOI 10.1016/S1357-4310(96)10034-4; Yancey PG, 1998, J LIPID RES, V39, P1349	58	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15985	15993		10.1074/jbc.M110.113605	http://dx.doi.org/10.1074/jbc.M110.113605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348092	Green Published, hybrid			2022-12-27	WOS:000277715900036
J	Flier, SN; Tanjore, H; Kokkotou, EG; Sugimoto, H; Zeisberg, M; Kalluri, R				Flier, Sarah N.; Tanjore, Harikrishna; Kokkotou, Efi G.; Sugimoto, Hikaru; Zeisberg, Michael; Kalluri, Raghu			Identification of Epithelial to Mesenchymal Transition as a Novel Source of Fibroblasts in Intestinal Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; BONE MORPHOGENIC PROTEIN-7; TNF-ALPHA THERAPY; CROHNS-DISEASE; SUBEPITHELIAL MYOFIBROBLASTS; RENAL FIBROBLASTS; MOUSE MODELS; TGF-BETA; KIDNEY; TRANSFORMATION	Intestinal fibrosis is a major complication of Crohn disease (CD), but the precise mechanism by which it occurs is incompletely understood. As a result, specific therapies to halt or even reverse fibrosis have not been explored. Here, we evaluated the contribution of epithelial to mesenchymal transition (EMT) to intestinal fibrosis associated with a mouse model of CD and also human inflammatory bowel disease. Mice administered intrarectal 2,4,6-trinitrobenzene sulfonic acid (TNBS) develop inflammation and fibrosis that resembles CD both histologically and by immunologic profile. We utilized this model to molecularly probe the contribution of EMT to intestinal fibrosis. Additionally, we utilized double-transgenic VillinCre; R26Rosa-lox-STOP-lox-LacZ mice, in which removal of the STOP cassette by Cre recombinase in villin(+) intestinal epithelial cells activates permanent LacZ expression, to lineage trace epithelial cells that might undergo EMT upon TNBS administration. TNBS-induced fibrosis is associated with the presence of a significant number of cells that express both epithelial and mesenchymal markers. In the lineage tagged transgenic mice, the appearance of LacZ(+) cells that also express the fibroblast marker FSP1 unequivocally demonstrates EMT. Transforming growth factor (TGF)-beta 1, a known inducer of EMT in epithelial cells, induces EMT in rat intestinal epithelial cells in vitro, and bone morphogenic protein-7, an antagonist of TGF-beta 1, inhibits EMT and fibrosis both in vitro and in the TNBS-treated mice. Our study demonstrates that EMT contributes to intestinal fibrosis associated with the TNBS-induced model of Crohn colitis and that inhibition of TGF-beta 1 with recombinant human bone morphogenic protein-7 prevents this process and prevents fibrosis.	[Kalluri, Raghu] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Life Sci,Dept Med,Div Matrix Biol, Boston, MA 02215 USA; [Flier, Sarah N.; Kokkotou, Efi G.] Beth Israel Deaconess Med Ctr, Dept Med, Dept Gastroenterol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Mit Div Hlth Sci & Technol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University	Kalluri, R (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Life Sci,Dept Med,Div Matrix Biol, 3 Blackfan Circle,Rm 11090, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X	National Institutes of Health [DK62987, DK55001, AA13913, DK080058, CA125550, DK61688, T32DK07760, 5K08DK074558, R03DK081687]; Harvard Digestive Diseases Center; Beth Israel Deaconess Medical Center for the Division of Matrix Biology; NATIONAL CANCER INSTITUTE [R01CA125550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080058, R01DK062987, K08DK074558, R03DK081687, R01DK061688, T32DK007760, R01DK055001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; Beth Israel Deaconess Medical Center for the Division of Matrix Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62987, DK55001, AA13913, DK080058 (to E. G. K.), and CA125550 and DK61688 (to R. K.). This work was also supported by a research fund from the Beth Israel Deaconess Medical Center for the Division of Matrix Biology.; Supported by National Institutes of Health Grant T32DK07760.; Supported by National Institutes of Health Grants 5K08DK074558 and R03DK081687 and by a grant from the Harvard Digestive Diseases Center Pilot and Feasibility Awards Program.	Andoh A, 2007, PHARMACOL THERAPEUT, V114, P94, DOI 10.1016/j.pharmthera.2006.12.004; Bataille F, 2008, INFLAMM BOWEL DIS, V14, P1514, DOI 10.1002/ibd.20590; Cook SD, 1996, CLIN ORTHOP RELAT R, P29, DOI 10.1097/00003086-199603000-00005; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; FIOCCHI C, 1997, AM J PHYSIOL, V273, P769; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Froehlich F, 2007, DIGESTION, V76, P113, DOI 10.1159/000111025; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Hay ED, 1995, ACTA ANAT, V154, P8; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Lichtenstein GR, 2006, AM J GASTROENTEROL, V101, P1030, DOI 10.1111/j.1572-0241.2006.00463.x; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Maric I, 2003, J CELL PHYSIOL, V196, P258, DOI 10.1002/jcp.10275; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Scheiffele Frank, 2002, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1519s49; Schuppan D, 2001, SEMIN LIVER DIS, V21, P351, DOI 10.1055/s-2001-17556; Sorrentino D, 2007, DIGESTION, V75, P22, DOI 10.1159/000101563; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Wang Y, 2006, J CLIN INVEST, V116, P1535, DOI 10.1172/JCI25442; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zeisberg M, 2006, NEPHROL DIAL TRANSPL, V21, P568, DOI 10.1093/ndt/gfk010; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	48	190	198	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20202	20212		10.1074/jbc.M110.102012	http://dx.doi.org/10.1074/jbc.M110.102012			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20363741	hybrid, Green Published			2022-12-27	WOS:000279012000055
J	Smythies, LE; Shen, RZ; Bimczok, D; Novak, L; Clements, RH; Eckhoff, DE; Bouchard, P; George, MD; Hu, WK; Dandekar, S; Smith, PD				Smythies, Lesley E.; Shen, Ruizhong; Bimczok, Diane; Novak, Lea; Clements, Ronald H.; Eckhoff, Devin E.; Bouchard, Phillipe; George, Michael D.; Hu, William K.; Dandekar, Satya; Smith, Phillip D.			Inflammation Anergy in Human Intestinal Macrophages Is Due to Smad-induced I kappa B alpha Expression and NF-kappa B Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BRUTONS TYROSINE KINASE; DOWN-REGULATION; CD14; GUT; ACTIVATION; CELLS; MONOCYTES; PATHWAY; STROMA	Human intestinal macrophages contribute to tissue homeostasis in noninflamed mucosa through profound down-regulation of pro-inflammatory cytokine release. Here, we show that this down-regulation extends to Toll-like receptor (TLR)-induced cytokine release, as intestinal macrophages expressed TLR3-TLR9 but did not release cytokines in response to TLR-specific ligands. Likely contributing to this unique functional profile, intestinal macrophages expressed markedly down-regulated adapter proteins MyD88 and Toll interleukin receptor 1 domain-containing adapter-inducing interferon, which together mediate all TLR MyD88-dependent and -independent NF-kappa B signaling, did not phosphorylate NF-kappa B p65 or Smadinduced I kappa B alpha, and did not translocate NF-kappa B into the nucleus. Importantly, transforming growth factor-beta released from intestinal extracellular matrix (stroma) induced identical down-regulation in the NF-kappa B signaling and function of blood monocytes, the exclusive source of intestinal macrophages. Our findings implicate stromal transforming growth factor-beta-induced dysregulation of NF-kappa B proteins and Smad signaling in the differentiation of pro-inflammatory blood monocytes into noninflammatory intestinal macrophages.	[Smythies, Lesley E.; Shen, Ruizhong; Bimczok, Diane; Bouchard, Phillipe; Smith, Phillip D.] Univ Alabama Birmingham, Dept Med Gastroenterol, Birmingham, AL 35294 USA; [Novak, Lea] Univ Alabama Birmingham, Dept Pathol & Surg, Birmingham, AL 35294 USA; [Clements, Ronald H.] Univ Alabama Birmingham, Dept Gastrointestinal, Birmingham, AL 35294 USA; [Eckhoff, Devin E.] Univ Alabama Birmingham, Dept Transplantat, Birmingham, AL 35294 USA; [George, Michael D.; Hu, William K.; Dandekar, Satya] Univ Calif Davis, Dept Med Microbiol, Davis, CA 95616 USA; [Smith, Phillip D.] Vet Adm Med Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Smythies, LE (corresponding author), Univ Alabama Birmingham, Dept Med, 1530 3rd Ave S,SHEL 606, Birmingham, AL 35294 USA.	lesmy@uab.edu; pdsmith@uab.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083027, R21AI083539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054495, R01DK061297, R01DK047322, R01DK043183, R24DK064400, R21DK074033] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000372] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-20136, C06 RR020136] Funding Source: Medline; NIAID NIH HHS [AI-83027, AI-83539, P01 AI083027, R21 AI083539] Funding Source: Medline; NIDDK NIH HHS [R01 DK047322, R01 DK043183, R01 DK061297, DK-61297, DK-47322, DK-64400, DK-54495, R24 DK064400, DK-74033, DK-43183, R21 DK074033, R01 DK054495] Funding Source: Medline; CSRD VA [I01 CX000372] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CSRD VA		Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Imai K, 2000, INFECT IMMUN, V68, P2418, DOI 10.1128/IAI.68.5.2418-2423.2000; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Li L, 1999, GASTROENTEROLOGY, V116, P1043, DOI 10.1016/S0016-5085(99)70007-7; Maheshwari A, 2006, J LEUKOCYTE BIOL, V80, P1111, DOI 10.1189/jlb.0306230; MAI UEH, 1991, J CLIN INVEST, V87, P894, DOI 10.1172/JCI115095; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Meng G, 2000, J INFECT DIS, V182, P785, DOI 10.1086/315790; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Monteleone G, 2005, GASTROENTEROLOGY, V129, P1420, DOI 10.1053/j.gastro.2005.09.005; Monteleone I, 2008, EUR J IMMUNOL, V38, P1533, DOI 10.1002/eji.200737909; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rugtveit J, 1997, CLIN EXP IMMUNOL, V110, P104, DOI 10.1046/j.1365-2249.1997.5071404.x; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Schenk M, 2005, J IMMUNOL, V174, P517, DOI 10.4049/jimmunol.174.1.517; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Smith PD, 1997, J IMMUNOL METHODS, V202, P1, DOI 10.1016/S0022-1759(96)00204-9; Smith PD, 2001, J IMMUNOL, V167, P2651, DOI 10.4049/jimmunol.167.5.2651; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Smith PD, 2009, MUCOSAL IMMUNOL, V2, P378, DOI 10.1038/mi.2009.94; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; SMYTHIES LE, 2006, CURR PROTOC IMMUNO B, P1; Smythies LE, 2006, J LEUKOCYTE BIOL, V80, P492, DOI 10.1189/jlb.1005566; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; WAHL LM, 2006, CURR PROTOCOL IMMUNO, P1; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270; ZHANG DE, 1994, J BIOL CHEM, V269, P11425	41	134	135	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19593	19604		10.1074/jbc.M109.069955	http://dx.doi.org/10.1074/jbc.M109.069955			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20388715	Green Published, hybrid			2022-12-27	WOS:000278727800069
J	Hu, DQ; Liu, SW; Shi, L; Li, C; Wu, LF; Fan, ZS				Hu, Deqing; Liu, Shengwu; Shi, Lei; Li, Chong; Wu, Lianfeng; Fan, Zusen			Cleavage of Survivin by Granzyme M Triggers Degradation of the Survivin-X-linked Inhibitor of Apoptosis Protein (XIAP) Complex to Free Caspase Activity Leading to Cytolysis of Target Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NK-CELL; T-CELL; MEDIATED APOPTOSIS; NATURAL-KILLER; LYMPHOCYTES; ACTIVATION; DEATH; IAP; EXPRESSION; INDUCTION	Granzyme M (GzmM) is a chymotrypsin-like serine protease that preferentially cuts its substrates after Met or Leu. GzmM is constitutively expressed in activated innate effector natural killer (NK) cells. GzmM-induced cell death is consistent with the kinetics of cytotoxicity of NK cells. These suggest that GzmM may play an important role in innate immunity. Our previous work demonstrated that GzmM induces caspase-dependent apoptosis. However, it is unknown about how GzmM causes caspase activation. Here, we showed that the inhibitor of the apoptosis gene family member Survivin is a physiological substrate for GzmM. GzmM hydrolyzes Survivin at Leu-138 to remove the last four C-terminal residues. The truncated form (sur-TF) is more rapidly hydrolyzed through proteasome-mediated degradation. In addition, Survivin is in complex with X-linked inhibitor of apoptosis protein (XIAP) to inhibit caspase activation as an endogenous inhibitor. Survivin cleavage by GzmM abolishes the stability of the Survivin-XIAP complex and enhances XIAP hydrolysis, which amplifies caspase-9 and 3 activation of target tumor cells. The noncleavable L138A Survivin overexpression can significantly inhibit GzmM-mediated XIAP degradation, caspase activation, and GzmM- and NK cell-induced cytotoxicity. Moreover, Survivin silencing promotes XIAP degradation and enhances GzmM-induced caspase activation as well as GzmM- and NK cell-induced cytolysis of target tumor cells.	[Fan, Zusen] Chinese Acad Sci, Natl Lab Biomacromol, Beijing 100101, Peoples R China; Chinese Acad Sci, Ctr Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	fanz@moon.ibp.ac.cn			National Natural Science Foundation of China [30830030, 30972676, 30772496]; 973 Program [2010CB911902, 2006CB910901]; Chinese Academy of Sciences [KSCX2-YW-R-42, KSCX1-YW-22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30830030, 30972676, and 30772496, 973 Program Grants 2010CB911902 and 2006CB910901, and the Innovative Program Grants KSCX2-YW-R-42 and KSCX1-YW-22 from the Chinese Academy of Sciences.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fan ZS, 2006, BLOOD, V107, P1342, DOI 10.1182/blood-2005-08-3485; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Kelly JM, 2004, J BIOL CHEM, V279, P22236, DOI 10.1074/jbc.M401670200; Kelly JM, 2002, NAT IMMUNOL, V3, P83, DOI 10.1038/ni746; Krenacs L, 2003, BLOOD, V101, P3590, DOI 10.1182/blood-2002-09-2908; Lu HX, 2006, J IMMUNOL, V177, P1171, DOI 10.4049/jimmunol.177.2.1171; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; PILAT D, 1994, GENOMICS, V24, P445, DOI 10.1006/geno.1994.1651; Plesca D, 2008, J BIOL CHEM, V283, P30796, DOI 10.1074/jbc.M804642200; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sayers TJ, 2001, J IMMUNOL, V166, P765, DOI 10.4049/jimmunol.166.2.765; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Suck G, 2005, EXP HEMATOL, V33, P1160, DOI 10.1016/j.exphem.2005.06.024; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wu LF, 2009, J IMMUNOL, V183, P421, DOI 10.4049/jimmunol.0803088; Zhao T, 2007, CELL DEATH DIFFER, V14, P489, DOI 10.1038/sj.cdd.4402040	29	38	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18326	18335		10.1074/jbc.M109.083170	http://dx.doi.org/10.1074/jbc.M109.083170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20406824	Green Published, hybrid			2022-12-27	WOS:000278453900026
J	Sammels, E; Devogelaere, B; Mekahli, D; Bultynck, G; Missiaen, L; Parys, JB; Cai, YQ; Somlo, S; De Smedt, H				Sammels, Eva; Devogelaere, Benoit; Mekahli, Djalila; Bultynck, Geert; Missiaen, Ludwig; Parys, Jan B.; Cai, Yiqiang; Somlo, Stefan; De Smedt, Humbert			Polycystin-2 Activation by Inositol 1,4,5-Trisphosphate-induced Ca2+ Release Requires Its Direct Association with the Inositol 1,4,5-Trisphosphate Receptor in a Signaling Microdomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; ENDOPLASMIC-RETICULUM; EPITHELIAL-CELLS; LIGAND-BINDING; CHANNEL; CALCIUM; TRPP2; COMPLEX; DOMAIN; GENE	Autosomal dominant polycystic kidney disease is characterized by the loss-of-function of a signaling complex involving polycystin-1 and polycystin-2 (TRPP2, an ion channel of the TRP superfamily), resulting in a disturbance in intracellular Ca2+ signaling. Here, we identified the molecular determinants of the interaction between TRPP2 and the inositol 1,4,5-trisphosphate receptor (IP3R), an intracellular Ca2+ channel in the endoplasmic reticulum. Glutathione S-transferase pulldown experiments combined with mutational analysis led to the identification of an acidic cluster in the C-terminal cytoplasmic tail of TRPP2 and a cluster of positively charged residues in the N-terminal ligand-binding domain of the IP3R as directly responsible for the interaction. To investigate the functional relevance of TRPP2 in the endoplasmic reticulum, we re-introduced the protein in TRPP2(-/-) mouse renal epithelial cells using an adenoviral expression system. The presence of TRPP2 resulted in an increased agonist-induced intracellular Ca2+ release in intact cells and IP3-induced Ca2+ release in permeabilized cells. Using pathological mutants of TRPP2, R740X and D509V, and competing peptides, we demonstrated that TRPP2 amplified the Ca2+ signal by a local Ca2+-induced Ca2+-release mechanism, which only occurred in the presence of the TRPP2-IP3R interaction, and not via altered IP3R channel activity. Moreover, our results indicate that this interaction was instrumental in the formation of Ca2+ microdomains necessary for initiating Ca2+-induced Ca2+ release. The data strongly suggest that defects in this mechanism may account for the altered Ca2+ signaling associated with pathological TRPP2 mutations and therefore contribute to the development of autosomal dominant polycystic kidney disease.	[Sammels, Eva; Devogelaere, Benoit; Mekahli, Djalila; Bultynck, Geert; Missiaen, Ludwig; Parys, Jan B.; De Smedt, Humbert] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Mol & Cellular Signaling, B-3000 Louvain, Belgium; [Cai, Yiqiang; Somlo, Stefan] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06510 USA	KU Leuven; Yale University	De Smedt, H (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Mol & Cellular Signaling, Campus Gasthuisberg O&N1,Herestr 49 Bus 802, B-3000 Louvain, Belgium.	humbert.desmedt@med.kuleuven.be		Parys, Jan/0000-0002-3591-4967; Mekahli, Djalila/0000-0003-0954-6088; Bultynck, Geert/0000-0002-5968-4828	K.U. Leuven [GOA/09/012]; Flemish National Science Foundation [G.0210.03]; Interuniversity Attraction Poles Programme [P6/28]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328, P30DK079310] Funding Source: NIH RePORTER	K.U. Leuven(KU Leuven); Flemish National Science Foundation; Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grant GOA/09/012 from the Concerted Actions of the K.U. Leuven (to L. M., H. D. S., and J. B. P.), Grant G.0210.03 from the Flemish National Science Foundation (to H. D. S. and J. B. P.), and Grant P6/28 from the Interuniversity Attraction Poles Programme (to H. D. S., L. M., and J. B. P.).	Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; Devogelaere B, 2008, CELL CALCIUM, V43, P17, DOI 10.1016/j.ceca.2007.04.005; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; GABOW PA, 1997, DIS KIDNEY, P521; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Geng L, 2008, P NATL ACAD SCI USA, V105, P15920, DOI 10.1073/pnas.0805062105; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Harris PC, 2009, J AM SOC NEPHROL, V20, P1188, DOI 10.1681/ASN.2009010014; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Kasri NN, 2004, MOL PHARMACOL, V66, P276, DOI 10.1124/mol.66.2.276; Kottgen M, 2007, BBA-MOL BASIS DIS, V1772, P836, DOI 10.1016/j.bbadis.2007.01.003; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kottgen M, 2005, PFLUG ARCH EUR J PHY, V451, P286, DOI 10.1007/s00424-005-1417-3; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Laude AJ, 2005, CELL CALCIUM, V38, P45, DOI 10.1016/j.ceca.2005.04.001; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Li Y, 2009, J BIOL CHEM, V284, P36431, DOI 10.1074/jbc.M109.068916; Miyagi K, 2009, J BIOL CHEM, V284, P34400, DOI 10.1074/jbc.M109.015149; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; PARYS JB, 1995, CELL CALCIUM, V17, P239, DOI 10.1016/0143-4160(95)90070-5; RICHARDSON A, 1993, J BIOL CHEM, V268, P11528; Schumann F, 2009, J BIOL CHEM, V284, P24372, DOI 10.1074/jbc.M109.025635; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 2007, CELL SIGNAL, V19, P444, DOI 10.1016/j.cellsig.2006.09.005; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106	46	82	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18794	18805		10.1074/jbc.M109.090662	http://dx.doi.org/10.1074/jbc.M109.090662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20375013	Green Published, hybrid			2022-12-27	WOS:000278453900070
J	Feltham, R; Moulin, M; Vince, JE; Mace, PD; Wong, WWL; Anderton, H; Day, CL; Vaux, DL; Silke, J				Feltham, Rebecca; Moulin, Maryline; Vince, James E.; Mace, Peter D.; Wong, Wendy Wei-Lynn; Anderton, Holly; Day, Catherine L.; Vaux, David L.; Silke, John			Tumor Necrosis Factor (TNF) Signaling, but Not TWEAK (TNF-like Weak Inducer of Apoptosis)-triggered cIAP1 (Cellular Inhibitor of Apoptosis Protein 1) Degradation, Requires cIAP1 RING Dimerization and E2 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRAF2; ACTIVATION; ALPHA; COMPLEX; UBIQUITINATION; DOMAIN; SURVIVAL; C-IAP1; CELLS	Cellular inhibitor of apoptosis (cIAP) proteins, cIAP1 and cIAP2, are important regulators of tumor necrosis factor (TNF) superfamily (SF) signaling and are amplified in a number of tumor types. They are targeted by IAP antagonist compounds that are undergoing clinical trials. IAP antagonist compounds trigger cIAP autoubiquitylation and degradation. The TNFSF member TWEAK induces lysosomal degradation of TRAF2 and cIAPs, leading to elevated NIK levels and activation of non-canonical NF-kappa B. To investigate the role of the ubiquitin ligase RING domain of cIAP1 in these pathways, we used cIAP-deleted cells reconstituted with cIAP1 point mutants designed to interfere with the ability of the RING to dimerize or to interact with E2 enzymes. We show that RING dimerization and E2 binding are required for IAP antagonists to induce cIAP1 degradation and protect cells from TNF-induced cell death. The RING functions of cIAP1 are required for full TNF-induced activation of NF-kappa B, however, delayed activation of NF-kappa B still occurs in cIAP1 and -2 double knock-out cells. The RING functions of cIAP1 are also required to prevent constitutive activation of non-canonical NF-kappa B by targeting NIK for proteasomal degradation. However, in cIAP double knock-out cells TWEAK was still able to increase NIK levels demonstrating that NIK can be regulated by cIAP-independent pathways. Finally we show that, unlike IAP antagonists, TWEAK was able to induce degradation of cIAP1 RING mutants. These results emphasize the critical importance of the RING of cIAP1 in many signaling scenarios, but also demonstrate that in some pathways RING functions are not required.	[Feltham, Rebecca; Moulin, Maryline; Wong, Wendy Wei-Lynn; Anderton, Holly; Vaux, David L.; Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Vince, James E.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Mace, Peter D.; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	La Trobe University; University of Lausanne; University of Otago	Silke, J (corresponding author), La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia.	j.silke@latrobe.edu.au	Silke, John/B-7622-2008; Vaux, David L/C-7249-2013; Wong, W. Wei-Lynn/A-6851-2015	Silke, John/0000-0002-7611-5774; Vaux, David L/0000-0003-2703-1651; Wong, W. Wei-Lynn/0000-0003-3155-1211; Day, Catherine/0000-0003-1571-4367; Anderton, Holly/0000-0003-3913-9686; Moulin, Maryline/0000-0002-1851-8727; Mace, Peter/0000-0003-2175-9537; Feltham, Rebecca/0000-0001-8376-6869	Human Frontiers Science Program Fellowship; Marsden Fund (New Zealand); Leukemia and Lymphoma Society; National Health and Medical Research Council [461221, 433013, 541901, 541902]	Human Frontiers Science Program Fellowship(Human Frontier Science Program); Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Supported by a Human Frontiers Science Program Fellowship.; Supported by the Marsden Fund (New Zealand).; Australian Fellow, funded by the Leukemia and Lymphoma Society and National Health and Medical Research Council Grant 461221.; Supported by National Health and Medical Research Council Grants 433013, 541901, and 541902.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; Bellon SF, 1997, NAT STRUCT BIOL, V4, P586, DOI 10.1038/nsb0797-586; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wicovsky A, 2009, CELL DEATH DIFFER, V16, P1445, DOI 10.1038/cdd.2009.80; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang LQ, 2009, J MOL BIOL, V389, P495, DOI 10.1016/j.jmb.2009.04.054	52	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17525	17536		10.1074/jbc.M109.087635	http://dx.doi.org/10.1074/jbc.M109.087635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356846	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000278133400031
J	Kusama, N; Harding, AMS; Benson, CJ				Kusama, Nobuyoshi; Harding, Anne Marie S.; Benson, Christopher J.			Extracellular Chloride Modulates the Desensitization Kinetics of Acid-sensing Ion Channel 1a (ASIC1a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPREADING DEPRESSION; SENSORY NEURONS; ISCHEMIA; CONTRIBUTES; SUBUNITS; MUSCLE; ANIONS; PH; AMYGDALA; CURRENTS	Acid-sensing ion channels (ASICs) are sodium channels gated by extracellular protons. The recent crystallization of ASIC1a identified potential binding sites for Cl- in the extracellular domain that are highly conserved between ASIC isoforms. However, the significance of Cl- binding is unknown. We investigated the effect of Cl- substitution on heterologously expressed ASIC1a current and H+-gated currents from hippocampal neurons recorded by whole-cell patch clamp. Replacement of extracellular Cl- with the impermeable and inert anion methanesulfonate (MeSO3-) caused ASIC1a currents to desensitize at a faster rate and attenuated tachyphylaxis. However, peak current amplitude, pH sensitivity, and selectivity were unchanged. Other anions, including Br-, I-, and thiocyanate, also altered the kinetics of desensitization and tachyphylaxis. Mutation of the residues that form the Cl--binding site in ASIC1a abolished the modulatory effects of anions. The results of anion substitution on native ASIC channels in hippocampal neurons mirrored those in heterologously expressed ASIC1a and altered acid-induced neuronal death. Anion modulation of ASICs provides new insight into channel gating and may prove important in pathological brain conditions associated with changes in pH and Cl-.	[Kusama, Nobuyoshi; Harding, Anne Marie S.; Benson, Christopher J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Benson, CJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	chris-benson@uiowa.edu		Benson, Christopher/0000-0001-6600-8193	National Institutes of Health [HL076419]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL076419 (to C. J. B.).	Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; ARMSTRONG CM, 1991, P NATL ACAD SCI USA, V88, P6528, DOI 10.1073/pnas.88.15.6528; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; DANI JA, 1983, J GEN PHYSIOL, V81, P255, DOI 10.1085/jgp.81.2.255; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gitterman DP, 2005, J PHYSIOL-LONDON, V562, P759, DOI 10.1113/jphysiol.2004.075069; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HILLE B, 1992, IONIC CHANNELS EXCIT, P261; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; JIANG C, 1992, J PHYSIOL-LONDON, V448, P697, DOI 10.1113/jphysiol.1992.sp019065; KAO CY, 1968, J PHYSIOL-LONDON, V198, P291, DOI 10.1113/jphysiol.1968.sp008607; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; Naves LA, 2005, BRAZ J MED BIOL RES, V38, P1561, DOI 10.1590/S0100-879X2005001100001; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Sherwood TW, 2009, J NEUROSCI, V29, P14371, DOI 10.1523/JNEUROSCI.2186-09.2009; Smith SS, 1999, J GEN PHYSIOL, V114, P799, DOI 10.1085/jgp.114.6.799; SOMJEN GG, 1984, BRAIN RES, V311, P186, DOI 10.1016/0006-8993(84)91416-1; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	37	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17425	17431		10.1074/jbc.M109.091561	http://dx.doi.org/10.1074/jbc.M109.091561			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385551	hybrid, Green Published			2022-12-27	WOS:000278133400020
J	Newton, SM; Trinh, V; Pi, HL; Klebba, PE				Newton, Salete M.; Trinh, Vy; Pi, Hualiang; Klebba, Phillip E.			Direct Measurements of the Outer Membrane Stage of Ferric Enterobactin Transport POSTUPTAKE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ENERGY TRANSDUCTION; IRON TRANSPORT; TONB PROTEIN; VITAMIN-B12; COMPONENTS; HOMOLOGY; KINETICS; MUTANTS; PHI-80	When Gram-negative bacteria acquire iron, the metal crosses both the outer membrane (OM) and the inner membrane, but existing radioisotopic uptake assays only measure its passage through the latter bilayer, as the accumulation of the radionuclide in the cytoplasm. We devised a methodology that exclusively observes OM transport and used it to study the uptake of ferric enterobactin (FeEnt) by Escherichia coli FepA. This technique, called postuptake binding, revealed previously unknown aspects of TonB-dependent transport reactions. The experiments showed, for the first time, that despite the discrepancy in cell envelope concentrations of FepA and TonB (similar to 35:1), all FepA proteins were active and equivalent in FeEnt uptake, with a maximum turnover number of similar to 5/min. FepA-mediated transport of FeEnt progressed through three distinct phases with successively decreasing rates, and from its temperature dependence, the activation energy of the OM stage was 33-35 kcal/mol. The accumulation of FeEnt in the periplasm required the binding protein and inner membrane permease components of its overall transport system; postuptake binding assays on strains devoid of FepB, FepD, or FepG did not show uptake of FeEnt through the OM. However, fluorescence labeling data implied that FepA was active in the Delta fepB strain, suggesting that FeEnt entered the periplasm but then leaked out. Further experiments confirmed this futile cycle; cells without FepB transported FeEnt across the OM, but it immediately escaped through TolC.	[Newton, Salete M.; Trinh, Vy; Pi, Hualiang; Klebba, Phillip E.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Klebba, PE (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	peklebba@ou.edu			National Institutes of Health [GM53836]; National Science Foundation [MCB0417694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53836. This work was also supported by National Science Foundation Grant MCB0417694 (to P. E. K. and S. M. N.).	AMES GFL, 1974, J BIOL CHEM, V249, P634; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; BASSFORD PJ, 1976, J BACTERIOL, V128, P242, DOI 10.1128/JB.128.1.242-247.1976; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Bowen H.J.M., 1966, TRACE ELEMENTS BIOCH; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; BRADBEER C, 1976, J BACTERIOL, V128, P99, DOI 10.1128/JB.128.1.99-104.1976; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Braun V, 2007, BIOMETALS, V20, P219, DOI 10.1007/s10534-006-9072-5; Breidenstein E, 2006, J BACTERIOL, V188, P6440, DOI 10.1128/JB.00741-06; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cabrales P, 2007, ANTIOXID REDOX SIGN, V9, P375, DOI 10.1089/ars.2006.1379; Cao ZH, 2000, MOL MICROBIOL, V37, P1306, DOI 10.1046/j.1365-2958.2000.02093.x; Cao ZH, 2003, J BIOL CHEM, V278, P1022, DOI 10.1074/jbc.M210360200; Chang CS, 2001, J BIOL CHEM, V276, P27535, DOI 10.1074/jbc.M102778200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GUDMUNDSDOTTIR A, 1989, J BACTERIOL, V171, P6526, DOI 10.1128/jb.171.12.6526-6533.1989; GUTERMAN SK, 1973, J BACTERIOL, V114, P1225, DOI 10.1128/JB.114.3.1225-1230.1973; GUTFREUND H, 1995, KINETICS LIFE SCI RE, P233; HANCOCK REW, 1976, J BACTERIOL, V125, P409, DOI 10.1128/JB.125.2.409-415.1976; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; KADNER RJ, 1990, MOL MICROBIOL, V4, P2027, DOI 10.1111/j.1365-2958.1990.tb00562.x; Kaserer WA, 2008, J BACTERIOL, V190, P4001, DOI 10.1128/JB.00135-08; Khursigara CM, 2005, BIOCHEMISTRY-US, V44, P3441, DOI 10.1021/bi047882p; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Klebba PE, 2004, IRON TRANSPORT IN BACTERIA, P147; Klebba PE, 2003, FRONT BIOSCI, V8, pS1422, DOI 10.2741/1233; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; KONISKY J, 1979, BACTERIAL OUTER MEMB, P359; KONOPKA K, 1982, BIOCHEMISTRY-US, V21, P6503, DOI 10.1021/bi00268a028; KREWULAK KD, 2008, J BIOCH BIOPHYS ACTA, V1778, P1781; Larsen RA, 2003, MOL MICROBIOL, V49, P211, DOI 10.1046/j.1365-2958.2003.03579.x; Letain TE, 1997, MOL MICROBIOL, V24, P271, DOI 10.1046/j.1365-2958.1997.3331703.x; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Miller J. H., 1972, EXPT MOL GENETICS, P433; MURPHY CK, 1990, J BACTERIOL, V172, P2736, DOI 10.1128/jb.172.5.2736-2746.1990; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; NEILANDS JB, 1974, MICROBIAL IRON METAB, V1, P4; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NORTH ML, 1984, NOUV REV FR HEMATOL, V26, P317; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Payne MA, 1997, J BIOL CHEM, V272, P21950, DOI 10.1074/jbc.272.35.21950; PIERCE JR, 1983, J BACTERIOL, V155, P330, DOI 10.1128/JB.155.1.330-336.1983; POLLACK JR, 1970, BIOCHEM BIOPH RES CO, V38, P989, DOI 10.1016/0006-291X(70)90819-3; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; POSTLE K, 1993, J BIOENERG BIOMEMBR, V25, P591; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; SHEA CM, 1991, MOL MICROBIOL, V5, P1415, DOI 10.1111/j.1365-2958.1991.tb00788.x; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Smallwood CR, 2009, MOL MICROBIOL, V72, P1171, DOI 10.1111/j.1365-2958.2009.06715.x; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; STEPHENS DL, 1995, MICROBIOL-SGM, V141, P1647, DOI 10.1099/13500872-141-7-1647; TIDMARSH GF, 1983, J INORG BIOCHEM, V18, P161, DOI 10.1016/0162-0134(83)80019-1; Udho E, 2009, P NATL ACAD SCI USA, V106, P21990, DOI 10.1073/pnas.0910023106; WANG CC, 1971, J BIOL CHEM, V246, P2147; WANG CC, 1969, J BACTERIOL, V98, P1142, DOI 10.1128/JB.98.3.1142-1150.1969; WAYNE R, 1975, J BACTERIOL, V121, P497, DOI 10.1128/JB.121.2.497-503.1975; Zhai YF, 2003, BBA-BIOMEMBRANES, V1614, P201, DOI 10.1016/S0005-2736(03)00176-7	67	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17488	17497		10.1074/jbc.M109.100206	http://dx.doi.org/10.1074/jbc.M109.100206			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20335169	hybrid, Green Published			2022-12-27	WOS:000278133400027
J	Sim, L; Willemsma, C; Mohan, S; Naim, HY; Pinto, BM; Rose, DR				Sim, Lyann; Willemsma, Carly; Mohan, Sankar; Naim, Hassan Y.; Pinto, B. Mario; Rose, David R.			Structural Basis for Substrate Selectivity in Human Maltase-Glucoamylase and Sucrase-Isomaltase N-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSIDASE INHIBITORS; PROTEIN; GLUCOSIDASE; TRANSPORT; SALACINOL; ANALOGS; BINDING	Human maltase-glucoamylase (MGAM) and sucrase-isomaltase (SI) are small intestinal enzymes that work concurrently to hydrolyze the mixture of linear alpha-1,4- and branched alpha-1,6-oligosaccharide substrates that typically make up terminal starch digestion products. MGAM and SI are each composed of duplicated catalytic domains, N- and C-terminal, which display overlapping substrate specificities. The N-terminal catalytic domain of human MGAM (ntMGAM) has a preference for short linear alpha-1,4-oligosaccharides, whereas N-terminal SI (ntSI) has a broader specificity for both alpha-1,4- and alpha-1,6-oligosaccharides. Here we present the crystal structure of the human ntSI, in apo form to 3.2 angstrom and in complex with the inhibitor kotalanol to 2.15 angstrom resolution. Structural comparison with the previously solved structure of ntMGAM reveals key active site differences in ntSI, including a narrow hydrophobic +1 subsite, which may account for its additional substrate specificity for alpha-1,6 substrates.	[Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Sim, Lyann; Willemsma, Carly; Rose, David R.] Univ Toronto, Dept Med Biophys, Toronto, ON M56 2M9, Canada; [Sim, Lyann; Willemsma, Carly; Rose, David R.] Univ Toronto, Ontario Canc Inst, Toronto, ON M56 2M9, Canada; [Mohan, Sankar; Pinto, B. Mario] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Naim, Hassan Y.] Univ Vet Med, Dept Physiol Chem, D-3059 Hannover, Germany	University of Waterloo; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Simon Fraser University; University of Veterinary Medicine Hannover, Foundation	Rose, DR (corresponding author), Univ Waterloo, Dept Biol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	drrose@uwaterloo.ca	Mohan, Sankar/A-7669-2011		Canadian Institutes for Health Research (CIHR) [FRN79400]; Heart and Stroke Foundation of Ontario [NA-6305]; Natural Sciences and Engineering Research Council of Canada (NSERC); National Science Foundation (NSF); NIGMS, National Institutes of Health (NIH), under NSF [DMR-0225180]; National Center for Research Resources, National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation (NSF)(National Science Foundation (NSF)); NIGMS, National Institutes of Health (NIH), under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Canadian Institutes for Health Research (CIHR) Grant FRN79400 and Heart and Stroke Foundation of Ontario Grant NA-6305.; Recipient of funding through a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC).; The pMT-TEVA vector was a generous gift from Dr. Peter L. Davies (Department of Biochemistry, Queens University, Kingston, Ontario, Canada). This work is based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation (NSF) and NIGMS, National Institutes of Health (NIH), under NSF award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Center for Research Resources, National Institutes of Health Grant RR-01646.	Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; Coutinho PM, 1997, CARBOHYD RES, V297, P309, DOI 10.1016/S0008-6215(96)00283-2; COWELL GM, 1986, BIOCHEM J, V237, P455, DOI 10.1042/bj2370455; DAHLQVIST A, 1964, ANAL BIOCHEM, V7, P18, DOI 10.1016/0003-2697(64)90115-0; DANIELSEN EM, 1994, BIOCHEMISTRY-US, V33, P1599, DOI 10.1021/bi00172a041; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DOWD MK, 1994, BIOPOLYMERS, V34, P625, DOI 10.1002/bip.360340505; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; GRAY GM, 1979, J BIOL CHEM, V254, P6038; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; HEYMANN H, 1995, BIOL CHEM H-S, V376, P249; JASCUR T, 1991, BIOCHEMISTRY-US, V30, P1908, DOI 10.1021/bi00221a025; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li CM, 2005, BIOCHEMISTRY-US, V44, P3347, DOI 10.1021/bi048334e; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0; Mohan S, 2007, CARBOHYD RES, V342, P1551, DOI 10.1016/j.carres.2007.05.014; Mohan S, 2009, COLLECT CZECH CHEM C, V74, P1117, DOI 10.1135/cccc2009024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Quezada-Calvillo R, 2008, J NUTR, V138, P685, DOI 10.1093/jn/138.4.685; Rossi EJ, 2006, FEBS J, V273, P2673, DOI 10.1111/j.1742-4658.2006.05283.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scotter AJ, 2006, PROTEIN EXPRES PURIF, V47, P374, DOI 10.1016/j.pep.2005.10.028; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, BIOCHEMISTRY-US, V49, P443, DOI 10.1021/bi9016457; VANBEERS EH, 1995, CRIT REV BIOCHEM MOL, V30, P197, DOI 10.3109/10409239509085143; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	36	141	145	3	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17763	17770		10.1074/jbc.M109.078980	http://dx.doi.org/10.1074/jbc.M109.078980			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356844	Green Published, hybrid			2022-12-27	WOS:000278133400054
J	Cen, S; Peng, ZG; Li, XY; Li, ZR; Ma, J; Wang, YM; Fan, B; You, XF; Wang, YP; Liu, F; Shao, RG; Zhao, LX; Yu, LY; Jiang, JD				Cen, Shan; Peng, Zong-Gen; Li, Xiao-Yu; Li, Zhuo-Rong; Ma, Jing; Wang, Yue-Ming; Fan, Bo; You, Xue-Fu; Wang, Yu-Ping; Liu, Fei; Shao, Rong-Guang; Zhao, Li-Xun; Yu, Liyan; Jiang, Jian-Dong			Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL VIF PROTEIN; SOR GENE; TYPE-1 VIF; LYMPHOCYTES; INFECTIVITY	APOBEC3G (hA3G) is a host inhibitor for human immunodeficiency virus, type 1 (HIV-1). However, HIV-1 Vif binds hA3G and induces its degradation. We have established a screening system to discover inhibitors that protect hA3G from Vif-mediated degradation. Through screening, compounds IMB-26 and IMB-35 were identified to be specific inhibitors for the degradation of hA3G by Vif. The inhibitors suppressed HIV-1 replication in hA3G-containing cells but not in those without hA3G. The anti-HIV effect correlated with the endogenous hA3G level. HIV-1 particles from hA3G(+) cells treated with IMB-26/35 contained a hA3G level higher than that from those without IMB-26/35 treatment and showed decreased infectivity. IMB26/35 bound directly to the hA3G protein, suppressed Vif/hA3G interaction, and therefore protected hA3G from Vif-mediated degradation. The compounds were safe with an anti-HIV therapeutic index >200 in vitro. LD50 of IMB-26 in mice was >1000 mg/kg (intraperitoneally). Therefore, IMB-26 and IMB-35 are novel anti-HIV leads working through specific stabilization of hA3G.	[Wang, Yu-Ping; Liu, Fei; Shao, Rong-Guang; Zhao, Li-Xun; Yu, Liyan; Jiang, Jian-Dong] Chinese Acad Med Sci, Inst Med Biotechnol, Dept Virol, Beijing 100050, Peoples R China; [Cen, Shan; Li, Xiao-Yu; Ma, Jing] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Cen, Shan; Li, Xiao-Yu; Ma, Jing] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Lady Davis Institute; McGill University; McGill University	Yu, LY (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Dept Virol, Beijing 100050, Peoples R China.	yuliyan_2000@yahoo.com; jiang.jdong@163.com	yu, liyan/GYD-2950-2022; LIU, FEI/H-2783-2013; Wang, Yueming/B-4658-2015; Peng, Zong-Gen/GVU-2327-2022	yu, liyan/0000-0002-8861-9806; Peng, Zong-Gen/0000-0001-7662-6892	Bill & Melinda Gates Foundation; NIH [GC10577]; Ministry of Science and Technology [2009ZX09301-003]; National S&T Major Special Project on Major New Drug Innovation [2009ZX09103-138, 2009ZX09303-005]; National Natural Science Foundation of China [30973569]; Canadian Institutes of Health Research [HVI-93435]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National S&T Major Special Project on Major New Drug Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Grand Challenges in Global Health Initiatives of the Bill & Melinda Gates Foundation and Foundation of NIH (GC10577 to J.-D.J.), 11th 5-year New Drug R& D Program of the Ministry of Science and Technology (2009ZX09301-003 to J.-D.J.), National S&T Major Special Project on Major New Drug Innovation (2009ZX09103-138 and 2009ZX09303-005 to S.C.), National Natural Science Foundation of China (30973569), and Canadian Institutes of Health Research Grant HVI-93435 (to S.C.).	Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Hu K, 2005, J VIROL METHODS, V128, P93, DOI 10.1016/j.jviromet.2005.04.012; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Rose KM, 2005, AIDS RES HUM RETROV, V21, P611, DOI 10.1089/aid.2005.21.611; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; SODROSKI J, 1986, SCIENCE, V231, P1549, DOI 10.1126/science.3006244; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Xiao ZX, 2007, FASEB J, V21, P217, DOI 10.1096/fj.06-6773com; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	20	84	92	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16546	16552		10.1074/jbc.M109.085308	http://dx.doi.org/10.1074/jbc.M109.085308			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363737	Green Published, hybrid			2022-12-27	WOS:000277982600017
J	Patel, N; Sundaram, N; Yang, MY; Madigan, C; Kalra, VK; Malik, P				Patel, Nitin; Sundaram, Nambirajan; Yang, Mingyan; Madigan, Catherine; Kalra, Vijay K.; Malik, Punam			Placenta Growth Factor (PlGF), a Novel Inducer of Plasminogen Activator Inhibitor-1 (PAI-1) in Sickle Cell Disease (SCD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; GENE-EXPRESSION; RESPONSE ELEMENT; FACTOR-I; INDUCTION; TRANSCRIPTION; COAGULATION; INSULIN; IDENTIFICATION; INFLAMMATION	Sickle cell disease (SCD) is characterized by a prothrombotic state. Plasminogen activator inhibitor-1 (PAI-1) is known to modulate fibrinolysis, lung injury/fibrosis, and angiogenesis. However, its role in SCD is less understood, and the molecular mechanisms underlying increased PAI-1 are unknown. Herein, we show a novel link between PAI-1 and sickle erythropoiesis. Plasma PAI-1 levels were high in SCD patients at steady state and in two humanized sickle mouse models, with increased PAI-1 immunolabeling in sickle mouse lung, bronchial epithelial cells, alveolar macrophages, and pulmonary microvascular endothelial cells. Placenta growth factor (PlGF), released at high levels by sickle erythroblasts, induced PAI-1 expression in primary human pulmonary microvascular endothelial cells and monocytes through activation of c-Jun N-terminal kinase (JNK), NADPH oxidase, and hypoxia-inducible factor-1 alpha (HIF-1 alpha). Analysis of the human PAI-1 promoter revealed this induction was mediated by hypoxia-response element (HRE)-1, HRE-2, and distal activator protein (AP-1) sites. We also identify the involvement of c-Jun, c-Jun/c-Fos, and JunD, but not JunB, in binding with AP-1 sites of the PAI-1 promoter upon PlGF induction. Consistent with these findings, levels of PAI-1 were low in PlGF knock-out mice and sickle-PlGF knock-out mice; overexpression of PlGF in normal mice increased circulating PAI-1. In conclusion, we identify a novel mechanism of PAI-1 elevation in SCD.	Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90089 USA; [Sundaram, Nambirajan; Yang, Mingyan; Malik, Punam] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; [Malik, Punam] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Cincinnati, OH 45229 USA; [Madigan, Catherine] Univ Calif San Diego, Rady Childrens Hosp, Div Hematol, San Diego, CA 92123 USA	University of Southern California; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Kalra, VK (corresponding author), HMR-611,2011 Zonal Ave, Los Angeles, CA 90089 USA.	Punam.Malik@cchmc.org	Patel, Nitin/C-9625-2010	Malik, Punam/0000-0002-8942-2108	National Institutes of Health [R01-HL-079916, HL-070595, P30-DK 048522]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL070595, R01HL079916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL-079916 and HL-070595 (to P. M.).; We thank Dr. Peter Carmeliet (Vesalius Research Center, VIB-Vlaams Instituut voor Biotechnologie, Leuven, Belgium) for kindly providing PlGF knock-out mice. We also thank Dr. Timothy Townes (University of Alabama, Birmingham, AL) for providing knock-in sickle mice and AA control mice, Dr. Trine Fink (University of Aalborg, Aalborg, Denmark) for kindly providing PAI-1 WT and individual HRE mutant promoter constructs, Dr. Michael Karin (University of California San Diego, La Jolla, CA) for providing c-Fos, c-Jun, and JunD expression plasmids, Dr. Anupam Agarwal (University of Alabama, Birmingham, AL) for JunB expression plasmid, and Dr. Debbie Johnson (USC Keck School of Medicine, Los Angeles, CA) for providing DnPI3K and phosphatase and tensin homolog plasmids. We thank Dr. Jeffrey Molkentin, Division of Cardiology, Heart Institute, Cincinnati Children's Hospital Medical Center, for providing us with the Ad-PlGF and Ad-GFP vector constructs. We are grateful to Jeff Bailey and Victoria Summey of the Comprehensive Mouse Core, Cincinnati Children's Hospital Medical Center for their assistance with murine injections and the Hematology Repository and the Translational Core Laboratory at the Cincinnati Children's Hospital Medical Center for processing and providing human samples. We also thank the Institutional Core of USC Research Center for Liver Disease for the use of a sequence detection instrument (supported by National Institutes of Health Grant P30-DK 048522) and Dr. Susan Wert, Perinatal Institute, CCHMC, for assistance with immunohistochemistry.	Andrew AS, 2001, AM J PHYSIOL-LUNG C, V281, pL616, DOI 10.1152/ajplung.2001.281.3.L616; Arndt PG, 2005, J IMMUNOL, V175, P4049, DOI 10.4049/jimmunol.175.6.4049; Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; BERNEY SI, 1992, AM J HEMATOL, V40, P290, DOI 10.1002/ajh.2830400409; BEVILACQUA MP, 1986, J CLIN INVEST, V78, P587, DOI 10.1172/JCI112613; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dimova EY, 2006, ANN NY ACAD SCI, V1090, P355, DOI 10.1196/annals.1378.039; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; Fink T, 2002, BLOOD, V99, P2077, DOI 10.1182/blood.V99.6.2077; FRANCIS RB, 1991, BLOOD, V77, P1405; GELEHRTER TD, 1986, J CLIN INVEST, V77, P165, DOI 10.1172/JCI112271; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gordeuk VR, 2006, SEMIN THROMB HEMOST, V32, P289, DOI 10.1055/s-2006-939441; Hillery CA, 2004, MICROCIRCULATION, V11, P195, DOI 10.1080/10739680490278600; Hock TD, 2007, J BIOL CHEM, V282, P6875, DOI 10.1074/jbc.M608456200; Holmes DIR, 2004, FEBS LETT, V557, P93, DOI 10.1016/S0014-5793(03)01452-2; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Key NS, 1998, BLOOD, V91, P4216, DOI 10.1182/blood.V91.11.4216.411k15_4216_4223; Kietzmann T, 2003, BLOOD, V101, P907, DOI 10.1182/blood-2002-06-1693; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; NACHMAN RL, 1986, J EXP MED, V163, P1595, DOI 10.1084/jem.163.6.1595; Nsiri B, 1997, HEMATOL CELL THER, V39, P229, DOI 10.1007/s00282-997-0229-7; Nsiri B, 1996, HEMATOL CELL THER, V38, P279, DOI 10.1007/s00282-996-0279-2; Olman MA, 1999, BLOOD, V94, P2029, DOI 10.1182/blood.V94.6.2029.418k25_2029_2038; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Patel N, 2009, BLOOD, V113, P1129, DOI 10.1182/blood-2008-07-169821; Perelman N, 2003, BLOOD, V102, P1506, DOI 10.1182/blood-2002-11-3422; Petzelbauer E, 1996, AM J PATHOL, V149, P923; Rose P, 2008, AM J PHYSIOL-HEART C, V294, pH1075, DOI 10.1152/ajpheart.00913.2007; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SIMPSON AJ, 1991, J CLIN PATHOL, V44, P139, DOI 10.1136/jcp.44.2.139; Soeda S, 1998, BBA-MOL CELL RES, V1448, P37, DOI 10.1016/S0167-4889(98)00112-8; SPRENGERS ED, 1987, BLOOD, V69, P381; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; Vulin AI, 2004, J BIOL CHEM, V279, P25172, DOI 10.1074/jbc.M403184200; Westerman MP, 1999, J LAB CLIN MED, V134, P352, DOI 10.1016/S0022-2143(99)90149-X; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	49	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16713	16722		10.1074/jbc.M110.101691	http://dx.doi.org/10.1074/jbc.M110.101691			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351105	Green Published, hybrid			2022-12-27	WOS:000277982600035
J	Chi, CW; Zhu, HH; Han, M; Zhuang, YA; Wu, XH; Xu, TA				Chi, Congwu; Zhu, Huanhu; Han, Min; Zhuang, Yuan; Wu, Xiaohui; Xu, Tian			Disruption of Lysosome Function Promotes Tumor Growth and Metastasis in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEEP-ORANGE; PROTEIN-DEGRADATION; MOLECULAR CHARACTERIZATION; VACUOLAR BIOGENESIS; ASCITES HEPATOMA; RAT HEPATOCYTES; GENETIC SCREEN; CATHEPSIN-D; FAT-BODY; AUTOPHAGY	Lysosome function is essential to many physiological processes. It has been suggested that deregulation of lysosome function could contribute to cancer. Through a genetic screen in Drosophila, we have discovered that mutations disrupting lysosomal degradation pathway components contribute to tumor development and progression. Loss-of-function mutations in the Class C vacuolar protein sorting (VPS) gene, deep orange (dor), dramatically promote tumor overgrowth and invasion of the Ras(V12) cells. Knocking down either of the two other components of the Class C VPS complex, carnation (car) and vps16A, also renders Ras(V12) cells capable for uncontrolled growth and metastatic behavior. Finally, chemical disruption of the lysosomal function by feeding animals with antimalarial drugs, chloroquine or monensin, leads to malignant tumor growth of the Ras(V12) cells. Taken together, our data provide evidence for a causative role of lysosome dysfunction in tumor growth and invasion and indicate that members of the Class C VPS complex behave as tumor suppressors.	Fudan Univ, Sch Life Sci, Fudan Yale Ctr Biomed Res, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; [Han, Min] Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Zhuang, Yuan] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27701 USA; [Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06536 USA	Fudan University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Duke University; Howard Hughes Medical Institute; Yale University		xiaohui_wu@fudan.edu.cn; tian.xu@yale.edu		zhuang, yuan/0000-0002-2964-3654	National Natural Science Foundation of China [30270694]; Chinese Key Projects for Basic Research [2006CB806702]; Hi-tech Research and Development Project [2007AA022101]; Chinese Ministry of Education [05PJ14024]; Shanghai Rising-Star Program [06QA14006]; National Institutes of Health NCI [R01 CA069408]; NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Key Projects for Basic Research; Hi-tech Research and Development Project(National High Technology Research and Development Program of China); Chinese Ministry of Education(Ministry of Education, China); Shanghai Rising-Star Program; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Natural Science Foundation of China (Grant 30270694), Chinese Key Projects for Basic Research (973) (Grant 2006CB806702), Hi-tech Research and Development Project (863) (Grant 2007AA022101), 211 and 985 projects of Chinese Ministry of Education, Shanghai Pujiang Program (Grant 05PJ14024), and Shanghai Rising-Star Program (Grant 06QA14006). This work was also supported in part by National Institutes of Health NCI Grant R01 CA069408 (to T. X.).	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; BRADLEY MO, 1977, J BIOL CHEM, V252, P5310; Brouillet JP, 1997, CANCER, V79, P2132, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2132::AID-CNCR10>3.3.CO;2-L; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DUTTA P, 1994, CANCER LETT, V76, P113, DOI 10.1016/0304-3835(94)90386-7; GRINDE B, 1983, EXP CELL RES, V149, P27, DOI 10.1016/0014-4827(83)90377-4; HIRANO T, 1993, CANCER LETT, V70, P41, DOI 10.1016/0304-3835(93)90072-H; Huizing M, 2001, GENE, V264, P241, DOI 10.1016/S0378-1119(01)00333-X; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Kim BY, 2001, J BIOL CHEM, V276, P29393, DOI 10.1074/jbc.M101778200; KISEN GO, 1993, CARCINOGENESIS, V14, P2501, DOI 10.1093/carcin/14.12.2501; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, EXP CELL RES, V312, P2018, DOI 10.1016/j.yexcr.2006.03.002; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; Maldonado E, 2006, PIGM CELL RES, V19, P315, DOI 10.1111/j.1600-0749.2006.00320.x; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; PRESTON RA, 1991, MOL CELL BIOL, V11, P5801, DOI 10.1128/MCB.11.12.5801; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; ROCHEFORT H, 1990, CANCER METAST REV, V9, P321, DOI 10.1007/BF00049522; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Shestopal SA, 1997, MOL GEN GENET, V253, P642; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; TESSITORE L, 1988, BIOCHEM J, V251, P483, DOI 10.1042/bj2510483; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Yogosawa S, 2005, J BIOL CHEM, V280, P41619, DOI 10.1074/jbc.M508397200; Yu JF, 2006, PIGM CELL RES, V19, P628, DOI 10.1111/j.1600-0749.2006.00346.x	43	37	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21817	21823		10.1074/jbc.M110.131714	http://dx.doi.org/10.1074/jbc.M110.131714			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20418542	hybrid, Green Published			2022-12-27	WOS:000279516100066
J	Koike, M; Fukushi, J; Ichinohe, Y; Higashimae, N; Fujishiro, M; Sasaki, C; Yamaguchi, M; Uchihara, T; Yagishita, S; Ohizumi, H; Hori, S; Kakizuka, A				Koike, Masaaki; Fukushi, Junpei; Ichinohe, Yuzuru; Higashimae, Naoki; Fujishiro, Masahiko; Sasaki, Chiyomi; Yamaguchi, Masahiro; Uchihara, Toshiki; Yagishita, Saburo; Ohizumi, Hiroshi; Hori, Seiji; Kakizuka, Akira			Valosin-containing Protein (VCP) in Novel Feedback Machinery between Abnormal Protein Accumulation and Transcriptional Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOPATHY; AMYOTROPHIC-LATERAL-SCLEROSIS; MACHADO-JOSEPH-DISEASE; CREB-BINDING PROTEIN; NEURONAL CELL-DEATH; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; P97/VALOSIN-CONTAINING PROTEIN; NEURODEGENERATIVE DISORDERS; EXPANDED POLYGLUTAMINE	Abnormal protein accumulation is often observed in human neurodegenerative disorders such as polyglutamine diseases and Parkinson disease. Genetic and biochemical analyses indicate that valosin-containing protein (VCP) is a crucial molecule in the pathogenesis of human neurodegenerative disorders. We report here that VCP was specifically modified in neuronal cells with abnormal protein accumulation; this modification caused the translocation of VCP into the nucleus. Modification-mimic forms of VCP induced transcriptional suppression with deacetylation of core histones, leading to cell atrophy and the decrease of de novo protein synthesis. Preventing VCP nuclear translocation in polyglutamine-expressing neuronal cells and Drosophila eyes mitigated neurite retraction and eye degenerations, respectively, concomitant with the recovery of core histone acetylation. This represents a novel feedback mechanism that regulates abnormal protein levels in the cytoplasm during physiological processes, as well as in pathological conditions such as abnormal protein accumulation in neurodegenerations.	[Koike, Masaaki; Fukushi, Junpei; Ichinohe, Yuzuru; Higashimae, Naoki; Fujishiro, Masahiko; Sasaki, Chiyomi; Ohizumi, Hiroshi; Hori, Seiji; Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Lab Funct Biol, Kyoto 6068501, Japan; [Yamaguchi, Masahiro] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan; [Uchihara, Toshiki] Tokyo Metropolitan Inst Neurosci, Dept Neurol, Tokyo 1838526, Japan; [Yagishita, Saburo] Kanagawa Rehabil Ctr, Dept Pathol, Atsugi, Kanagawa 2430121, Japan	Kyoto University; University of Tokyo; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Kakizuka, A (corresponding author), Kyoto Univ, Grad Sch Biostudies & Solut Oriented Res Sci & Te, Lab Funct Biol, Kyoto 6068501, Japan.	kakizuka@lif.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Edmondson DG, 2002, J BIOL CHEM, V277, P29496, DOI 10.1074/jbc.M200651200; Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Ishigaki S, 2004, J BIOL CHEM, V279, P51376, DOI 10.1074/jbc.M406683200; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kakizuka A, 1998, TRENDS GENET, V14, P396, DOI 10.1016/S0168-9525(98)01559-5; Kakizuka A, 2008, BIOCHEM SOC T, V36, P105, DOI 10.1042/BST0360105; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; Kobayashi T, 2003, CYTOGENET GENOME RES, V100, P261, DOI 10.1159/000072862; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Mizuno Y, 2003, NEUROSCI LETT, V343, P77, DOI 10.1016/S0304-3940(03)00280-5; Mori S, 2006, MOL CELL BIOCHEM, V288, P47, DOI 10.1007/s11010-006-9117-7; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Whiteheart SW, 2004, J STRUCT BIOL, V146, P32, DOI 10.1016/j.jsb.2003.09.015; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yasuda S, 1999, GENES CELLS, V4, P743, DOI 10.1046/j.1365-2443.1999.00294.x; Yu ZX, 2002, HUM MOL GENET, V11, P905, DOI 10.1093/hmg/11.8.905	50	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21736	21749		10.1074/jbc.M109.099283	http://dx.doi.org/10.1074/jbc.M109.099283			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20410307	hybrid, Green Published			2022-12-27	WOS:000279516100060
J	Clausen, JD; Andersen, JP				Clausen, Johannes D.; Andersen, Jens Peter			Glutamate 90 at the Luminal Ion Gate of Sarcoplasmic Reticulum Ca2+-ATPase Is Critical for Ca2+ Binding on Both Sides of the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL CONSEQUENCES; CALCIUM-PUMP; ADENOSINE-TRIPHOSPHATASE; INORGANIC-PHOSPHATE; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURES; AMINO-ACIDS; PHOSPHORYLATION; TRANSPORT; DOMAIN	The roles of Ser(72), Glu(90), and Lys(297) at the luminal ends of transmembrane helices M1, M2, and M4 of sarcoplasmic reticulum Ca2+-ATPase were examined by transient and steady-state kinetic analysis of mutants. The dependence on the luminal Ca2+ concentration of phosphorylation by P-i ("Ca2+ gradient-dependent E2P formation") showed a reduction of the apparent affinity for luminal Ca2+ in mutants with alanine or leucine replacement of Glu(90), whereas arginine replacement of Glu(90) or Ser(72) allowed E2P formation from P-i even at luminal Ca2+ concentrations much too small to support phosphorylation in wild type. The latter mutants further displayed a blocked dephosphorylation of E2P and an increased rate of conversion of the ADP-sensitive E1P phosphoenzyme intermediate to ADP-insensitive E2P as well as insensitivity of the E2.BeF3- complex to luminal Ca2+. Altogether, these findings, supported by structural modeling, indicate that the E2P intermediate is stabilized in the mutants with arginine replacement of Glu(90) or Ser(72), because the positive charge of the arginine side chain mimics Ca2+ occupying a luminally exposed low affinity Ca2+ site of E2P, thus identifying an essential locus (a "leaving site") on the luminal Ca2+ exit pathway. Mutants with alanine or leucine replacement of Glu(90) further displayed a marked slowing of the Ca2+ binding transition as well as slowing of the dissociation of Ca2+ from Ca(2)E1 back toward the cytoplasm, thus demonstrating that Glu(90) is also critical for the function of the cytoplasmically exposed Ca2+ sites on the opposite side of the membrane relative to where Glu(90) is located.	[Clausen, Johannes D.; Andersen, Jens Peter] Aarhus Univ, Dept Physiol & Biophys, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Disease PUMPKIN, DK-8000 Aarhus C, Denmark	Aarhus University; Danmarks Grundforskningsfond	Andersen, JP (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Disease PUMPKIN, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council; Danish National Research Foundation (PUMPKIN Centre); Novo Nordisk Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported in part by grants from the Danish Medical Research Council, the Danish National Research Foundation (PUMPKIN Centre), and the Novo Nordisk Foundation.	ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; Andersen JP, 2001, J BIOL CHEM, V276, P23312, DOI 10.1074/jbc.M102384200; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BEIL FU, 1977, EUR J BIOCHEM, V81, P151, DOI 10.1111/j.1432-1033.1977.tb11936.x; BISHOP JE, 1988, J BIOL CHEM, V263, P1886; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; Clausen JD, 2006, J BIOL CHEM, V281, P9471, DOI 10.1074/jbc.M512371200; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; GUILLAIN F, 1981, J BIOL CHEM, V256, P6140; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P5553, DOI 10.1021/bi00415a025; PICK U, 1982, J BIOL CHEM, V257, P6111; PUNZENGRUBER C, 1978, EUR J BIOCHEM, V92, P349, DOI 10.1111/j.1432-1033.1978.tb12754.x; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; VILSEN B, 1991, J BIOL CHEM, V266, P16157; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1989, J BIOL CHEM, V264, P21024	41	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20780	20792		10.1074/jbc.M110.116459	http://dx.doi.org/10.1074/jbc.M110.116459			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421308	Green Published, hybrid			2022-12-27	WOS:000279228600042
J	Cobucci-Ponzano, B; Aurilia, V; Riccio, G; Henrissat, B; Coutinho, PM; Strazzulli, A; Padula, A; Corsaro, MM; Pieretti, G; Pocsfalvi, G; Fiume, I; Cannio, R; Rossi, M; Moracci, M				Cobucci-Ponzano, Beatrice; Aurilia, Vincenzo; Riccio, Gennaro; Henrissat, Bernard; Coutinho, Pedro M.; Strazzulli, Andrea; Padula, Anna; Corsaro, Maria Michela; Pieretti, Giuseppina; Pocsfalvi, Gabriella; Fiume, Immacolata; Cannio, Raffaele; Rossi, Mose; Moracci, Marco			A New Archaeal beta-Glycosidase from Sulfolobus solfataricus SEEDING A NOVEL RETAINING beta-GLYCAN-SPECIFIC GLYCOSIDE HYDROLASE FAMILY ALONG WITH THE HUMAN NON-LYSOSOMAL GLUCOSYLCERAMIDASE GBA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NONLYSOSOMAL GLUCOSYLCERAMIDASE; CATALYTIC NUCLEOPHILE; GAUCHER DISEASE; IDENTIFICATION; GLUCOSIDASE; MECHANISMS; GENERATION; MIGLUSTAT; BINDING	Carbohydrate active enzymes (CAZymes) are a large class of enzymes, which build and breakdown the complex carbohydrates of the cell. On the basis of their amino acid sequences they are classified in families and clans that show conserved catalytic mechanism, structure, and active site residues, but may vary in substrate specificity. We report here the identification and the detailed molecular characterization of a novel glycoside hydrolase encoded from the gene sso1353 of the hyperthermophilic archaeon Sulfolobus solfataricus. This enzyme hydrolyzes aryl beta-gluco- and beta-xylosides and the observation of transxylosylation reactions products demonstrates that SSO1353 operates via a retaining reaction mechanism. The catalytic nucleophile (Glu-335) was identified through trapping of the 2-deoxy-2-fluoroglucosyl enzyme intermediate and subsequent peptide mapping, while the general acid/base was identified as Asp-462 through detailed mechanistic analysis of a mutant at that position, including azide rescue experiments. SSO1353 has detectable homologs of unknown specificity among Archaea, Bacteria, and Eukarya and shows distant similarity to the non-lysosomal bile acid beta-glucosidase GBA2 also known as glucocerebrosidase. On the basis of our findings we propose that SSO1353 and its homologs are classified in a new CAZy family, named GH116, which so far includes beta-glucosidases (EC 3.2.1.21), beta-xylosidases (EC 3.2.1.37), and glucocerebrosidases (EC 3.2.1.45) as known enzyme activities.	[Strazzulli, Andrea; Padula, Anna; Pocsfalvi, Gabriella; Fiume, Immacolata; Cannio, Raffaele; Rossi, Mose; Moracci, Marco] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 1, CNRS, UMR6098, F-13288 Marseille, France; [Henrissat, Bernard; Coutinho, Pedro M.] Univ Aix Marseille 2, CNRS, UMR6098, F-13288 Marseille, France; [Corsaro, Maria Michela; Pieretti, Giuseppina] Univ Naples Federico II, Dipartimento Chim Organ & Biochim, I-80126 Naples, Italy; [Rossi, Mose] Univ Naples Federico II, Dipartimento Biol Strut & Funz, I-80126 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Naples Federico II; University of Naples Federico II	Moracci, M (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.	m.moracci@ibp.cnr.it	Cobucci-Ponzano, Beatrice/B-7654-2015; Pocsfalvi, Gabriella/K-3753-2013; Corsaro, Maria Michela/T-6190-2019; Pocsfalvi, Gabriella/C-4948-2015; Fiume, Immacolata/D-9018-2013; Aurilia, Vincenzo/C-1969-2015; Cobucci-Ponzano, Beatrice/AAX-7630-2020; Fiume, Immacolata/W-7951-2019; Strazzulli, Andrea/E-1343-2017; Henrissat, Bernard/J-2475-2012; Riccio, Gennaro/AAH-6275-2020; Moracci, Marco/B-8444-2015; Strazzulli, Andrea/P-5145-2016	Corsaro, Maria Michela/0000-0002-6834-8682; Pocsfalvi, Gabriella/0000-0001-6065-3853; Fiume, Immacolata/0000-0002-4160-528X; Aurilia, Vincenzo/0000-0002-4858-6616; Cobucci-Ponzano, Beatrice/0000-0002-8211-2297; Fiume, Immacolata/0000-0002-4160-528X; Henrissat, Bernard/0000-0002-3434-8588; Moracci, Marco/0000-0002-9846-2531; Padula, Anna/0000-0002-4779-9660; Riccio, Gennaro/0000-0003-2541-5790; Strazzulli, Andrea/0000-0002-9690-149X	Agenzia Spaziale Italiana [MoMa 1/014/06/0]	Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	This work was supported by Project MoMa 1/014/06/0 of the Agenzia Spaziale Italiana.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amory JK, 2007, HUM REPROD, V22, P702, DOI 10.1093/humrep/del414; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; Bone W, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-1; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; DeMarco ML, 2008, GLYCOBIOLOGY, V18, P426, DOI 10.1093/glycob/cwn026; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elferink MGL, 2001, MOL MICROBIOL, V39, P1494, DOI 10.1046/j.1365-2958.2001.02336.x; GRABOWSKI GA, 1990, CRIT REV BIOCHEM MOL, V25, P385, DOI 10.3109/10409239009090616; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Huang YW, 2005, BIOCHEM J, V385, P581, DOI 10.1042/BJ20041388; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Mackenzie LF, 1997, J BIOL CHEM, V272, P3161, DOI 10.1074/jbc.272.6.3161; Matern H, 2001, J BIOL CHEM, V276, P37929; Maurelli L, 2008, EXTREMOPHILES, V12, P689, DOI 10.1007/s00792-008-0175-5; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Moracci M, 2001, METHOD ENZYMOL, V330, P201; NICOLAUS B, 1993, FEMS MICROBIOL LETT, V109, P203, DOI 10.1111/j.1574-6968.1993.tb06168.x; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Perugino G, 2006, BIOCATAL BIOTRANSFOR, V24, P23, DOI 10.1080/10242420500518581; Saxon E, 2001, ANNU REV CELL DEV BI, V17, P1, DOI 10.1146/annurev.cellbio.17.1.1; Shaikh FA, 2007, FEBS LETT, V581, P2441, DOI 10.1016/j.febslet.2007.04.053; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; Torarinsson E, 2005, ENVIRON MICROBIOL, V7, P47, DOI 10.1111/j.1462-2920.2004.00674.x; van der Spoel AC, 2002, P NATL ACAD SCI USA, V99, P17173, DOI 10.1073/pnas.262586099; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zolghadr B, 2010, J BACTERIOL, V192, P104, DOI 10.1128/JB.01061-09	39	34	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20691	20703		10.1074/jbc.M109.086470	http://dx.doi.org/10.1074/jbc.M109.086470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427274	Green Published, hybrid			2022-12-27	WOS:000279228600033
J	Gomez, V; Sese, M; Santamaria, A; Martinez, JD; Castellanos, E; Soler, M; Thomson, TM; Paciucci, R				Gomez, Valenti; Sese, Marta; Santamaria, Anna; Martinez, Juan D.; Castellanos, Elisabet; Soler, Marta; Thomson, Timothy M.; Paciucci, Rosanna			Regulation of Aurora B Kinase by the Lipid Raft Protein Flotillin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 PHOSPHORYLATION; CHROMOSOMAL PASSENGERS; REGGIE/FLOTILLIN PROTEINS; MEMBRANE MICRODOMAINS; CELL-DIVISION; SPINDLE; INCENP; REGGIE-1/FLOTILLIN-2; PROHIBITINS; CYTOKINESIS	The lipid raft protein Flotillin-1 was previously shown to be required for cell proliferation. Here we show that it is critical for the maintenance of the levels of the mitotic regulator Aurora B. Knock-down of Flotillin-1 induced aberrant mitotic events similar to those produced by Aurora B depletion and led to a marked decline in Aurora B levels and activity. Transfection of wild-type full-length Flotillin-1 or forms directed to the nucleus increased Aurora B levels and activity. Flotillin-1 interacted with Aurora B directly through its SPFH domain in a complex distinct from the chromosomal passenger protein complex, and the two proteins co-purified in nuclear, non-raft fractions. These observations are the first evidence for a function of Flotillin-1 outside of lipid rafts and suggest its critical role in the maintenance of a pool of active Aurora B.	[Paciucci, Rosanna] Hosp Valle De Hebron, Inst Recerca, Unitat Recerca Biomed, Barcelona 08035, Spain; [Martinez, Juan D.; Soler, Marta; Thomson, Timothy M.] CSIC, Inst Biol Mol Barcelona, Dept Biol Celular, ES-08034 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Paciucci, R (corresponding author), Hosp Valle De Hebron, Inst Recerca, Unitat Recerca Biomed, Pg Vall Hebron 119-129, Barcelona 08035, Spain.	rpaciucci@ir.vhebron.net	Sese, Marta/AAH-9749-2021; Castellanos, Elisabeth/F-9609-2016; Paciucci, Rosanna/AGP-3844-2022	Sese, Marta/0000-0003-1473-4833; Castellanos, Elisabeth/0000-0002-8133-5325; Paciucci, Rosanna/0000-0001-5651-5933; Gomez, Valenti/0000-0002-2162-6462	Ministry of Science and Education [SAF2005-05848, SAF2008-03936, SAF2008-04136-C02-01]; Ministry of Science and Technology [SAF2005-05109-C02-01]; Fundacio Marato TV3 [052610, 053130]; Institut de Recerca Vall d'Hebron; Centre de Referencia en Biotecnologia de Catalunya	Ministry of Science and Education; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Fundacio Marato TV3; Institut de Recerca Vall d'Hebron; Centre de Referencia en Biotecnologia de Catalunya	This work was supported by the Ministry of Science and Education (Grants SAF2005-05848, SAF2008-03936, and SAF2008-04136-C02-01), the Ministry of Science and Technology (Grant SAF2005-05109-C02-01), the Fundacio Marato TV3 (Grants 052610 and 053130), the Institut de Recerca Vall d'Hebron, and the Centre de Referencia en Biotecnologia de Catalunya.	Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lange BMH, 2002, EMBO J, V21, P5364, DOI 10.1093/emboj/cdf531; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santamaria A, 2005, MOL CELL BIOL, V25, P1900, DOI 10.1128/MCB.25.5.1900-1911.2005; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Winter A, 2007, PROTEINS, V68, P353, DOI 10.1002/prot.21355	31	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20683	20690		10.1074/jbc.M110.130591	http://dx.doi.org/10.1074/jbc.M110.130591			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430883	hybrid, Green Published			2022-12-27	WOS:000279228600032
J	Zhao, W; Wang, LJ; Zhang, L; Yuan, C; Kuo, PC; Gao, CJ				Zhao, Wei; Wang, Lijuan; Zhang, Lei; Yuan, Chao; Kuo, Paul C.; Gao, Chengjiang			Differential Expression of Intracellular and Secreted Osteopontin Isoforms by Murine Macrophages in Response to Toll-like Receptor Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; ACTIVATION; SURVIVAL; MIGRATION; COMPONENT; CD44; A/B	Osteopontin (OPN), expressed by various immune cells, modulates both innate and adaptive immune responses. Different immune cells have shown differential expression of the two isoforms of OPN: secreted form of OPN (sOPN) and intracellular form of OPN (iOPN). However, the molecular mechanisms that control opn gene expression and the OPN isoforms produced by immune cells remain largely unknown. In this study, we demonstrate that OPN mRNA and protein expression are significantly up-regulated upon stimulation with TLR agonists in macrophages. Interestingly, we find that macrophages constitutively express the secreted form of OPN (sOPN), while the intracellular form of OPN (iOPN) is induced following the stimulation with TLR agonists. Phosphoinositide 3-kinase (PI3K), extracellular signal-regulated kinase (ERK), and c-Jun NH2-terminal kinase (JNK) that are activated by LPS stimulation were shown to upregulate OPN expression. In addition, chromatin immunoprecipitation (CHIP) assays showed that AP-1 binds to the proximal AP-1 site in the OPN promoter from LPS-stimulated macrophages. Mutation of the AP-1 site in OPN promoter completely ablates LPS-induced OPN promoter activation. Knockdown of c-Jun and c-Fos expression by small interfering RNA (siRNA) significantly decreases LPS-induced OPN expression. Stable cell lines with iOPN overexpression and knockdown showed that TLR-induced iOPN expression is a negative regulator for interferon-beta (IFN-beta) production. Our findings provide new insight into the transcriptional regulation of opn gene and further clarify the isoforms and functions of OPN produced by macrophages.	[Zhao, Wei; Wang, Lijuan; Zhang, Lei; Yuan, Chao; Gao, Chengjiang] Shandong Univ, Dept Immunol, Sch Med, Minist Educ, Jinan 250012, Shandong, Peoples R China; [Zhao, Wei; Wang, Lijuan; Zhang, Lei; Yuan, Chao; Gao, Chengjiang] Shandong Univ, Key Lab Expt Teratol, Sch Med, Minist Educ, Jinan 250012, Shandong, Peoples R China; [Zhao, Wei] Jinan Gen Hosp Jinan Command, Dept Expt Diag, Jinan 250014, Shandong, Peoples R China; [Kuo, Paul C.] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA	Shandong University; Shandong University; Duke University	Gao, CJ (corresponding author), Shandong Univ, Dept Immunol, Sch Med, Minist Educ, 44 Wenhua Western Rd, Jinan 250012, Shandong, Peoples R China.	cgao@sdu.edu.cn	ZHAO, WEI/C-9163-2011	Gao, Chengjiang/0000-0002-9365-4497	Taishan Scholar Program of Shandong Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry	Taishan Scholar Program of Shandong Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by the Taishan Scholar Program of Shandong Province and the Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry (to C.G.).	An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Cantor H, 2009, NAT REV IMMUNOL, V9, P137, DOI 10.1038/nri2460; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gao CJ, 2005, J IMMUNOL, V175, P523, DOI 10.4049/jimmunol.175.1.523; Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200; Helluin O, 2000, J BIOL CHEM, V275, P18337, DOI 10.1074/jbc.M001529200; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Khan SA, 2002, J CELL BIOCHEM, V85, P728, DOI 10.1002/jcb.10170; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin YH, 2000, MOL CELL BIOL, V20, P2734, DOI 10.1128/MCB.20.8.2734-2742.2000; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Mi ZY, 2004, J BIOL CHEM, V279, P46659, DOI 10.1074/jbc.M407952200; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Packer L, 2006, CARCINOGENESIS, V27, P1778, DOI 10.1093/carcin/bgl016; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Weiss JM, 2001, J EXP MED, V194, P1219, DOI 10.1084/jem.194.9.1219; Zhao W, 2007, IMMUNOL LETT, V108, P137, DOI 10.1016/j.imlet.2006.11.008; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	35	39	44	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20452	20461		10.1074/jbc.M110.110312	http://dx.doi.org/10.1074/jbc.M110.110312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20427276	Green Published, hybrid			2022-12-27	WOS:000279228600005
J	Genkov, T; Meyer, M; Griffiths, H; Spreitzer, RJ				Genkov, Todor; Meyer, Moritz; Griffiths, Howard; Spreitzer, Robert J.			Functional Hybrid Rubisco Enzymes with Plant Small Subunits and Algal Large Subunits ENGINEERED rbcS cDNA FOR EXPRESSION IN CHLAMYDOMONAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; CHLOROPLAST RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; THERMAL-STABILITY; CATALYTIC-PROPERTIES; SPECIFICITY FACTOR; CRYSTAL-STRUCTURE; 1,5-BISPHOSPHATE CARBOXYLASE; CONCENTRATING MECHANISMS; SUPPRESSOR MUTATIONS; CO2/O-2 SPECIFICITY	There has been much interest in the chloroplast-encoded large subunit of ribulose-1,5-bisphosphate carboxylase/oxygenase ( Rubisco) as a target for engineering an increase in net CO2 fixation in photosynthesis. Improvements in the enzyme would lead to an increase in the production of food, fiber, and renewable energy. Although the large subunit contains the active site, a family of rbcS nuclear genes encodes the Rubisco small subunits, which can also influence the carboxylation catalytic efficiency and CO2/O-2 specificity of the enzyme. To further define the role of the small subunit in Rubisco function, small subunits from spinach, Arabidopsis, and sunflower were assembled with algal large subunits by transformation of a Chlamydomonas reinhardtii mutant that lacks the rbcS gene family. Foreign rbcS cDNAs were successfully expressed in Chlamydomonas by fusing them to a Chlamydomonas rbcS transit peptide sequence engineered to contain rbcS introns. Although plant Rubisco generally has greater CO2/O-2 specificity but a lower carboxylation V-max than Chlamydomonas Rubisco, the hybrid enzymes have 3-11% increases in CO2/O-2 specificity and retain near normal Vmax values. Thus, small subunits may make a significant contribution to the overall catalytic performance of Rubisco. Despite having normal amounts of catalytically proficient Rubisco, the hybrid mutant strains display reduced levels of photosynthetic growth and lack chloroplast pyrenoids. It appears that small subunits contain the structural elements responsible for targeting Rubisco to the algal pyrenoid, which is the site where CO2 is concentrated for optimal photosynthesis.	[Genkov, Todor; Spreitzer, Robert J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Meyer, Moritz; Griffiths, Howard] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Nebraska System; University of Nebraska Lincoln; University of Cambridge	Spreitzer, RJ (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	rspreitzer1@unl.edu	Meyer, Moritz/K-6540-2012; Meyer, Moritz Thomas/AAP-2161-2021		United States Department of Energy [DE-FG02-00ER15044]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported in part by Grant DE-FG02-00ER15044 from the United States Department of Energy.	Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; Borkhsenious ON, 1998, PLANT PHYSIOL, V116, P1585, DOI 10.1104/pp.116.4.1585; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN Z, 1988, P NATL ACAD SCI USA, V85, P4696, DOI 10.1073/pnas.85.13.4696; CHEN ZX, 1992, PHOTOSYNTH RES, V31, P157, DOI 10.1007/BF00028792; CHEN ZX, 1993, PLANT PHYSIOL, V101, P1189, DOI 10.1104/pp.101.4.1189; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; CHUA NH, 1978, P NATL ACAD SCI USA, V75, P6110, DOI 10.1073/pnas.75.12.6110; CLONEY LP, 1993, PLANT MOL BIOL, V23, P1285, DOI 10.1007/BF00042362; Dhingra A, 2004, P NATL ACAD SCI USA, V101, P6315, DOI 10.1073/pnas.0400981101; DOBBERSTEIN B, 1977, P NATL ACAD SCI USA, V74, P1082, DOI 10.1073/pnas.74.3.1082; Du YC, 2000, P NATL ACAD SCI USA, V97, P14206, DOI 10.1073/pnas.260503997; Du YC, 2000, J BIOL CHEM, V275, P19844, DOI 10.1074/jbc.M002321200; FLUHR R, 1986, P NATL ACAD SCI USA, V83, P2358, DOI 10.1073/pnas.83.8.2358; Genkov T, 2006, ARCH BIOCHEM BIOPHYS, V451, P167, DOI 10.1016/j.abb.2006.04.012; Genkov T, 2009, J BIOL CHEM, V284, P30105, DOI 10.1074/jbc.M109.044081; Getzoff TP, 1998, PLANT PHYSIOL, V116, P695, DOI 10.1104/pp.116.2.695; GOLDSCHMIDTCLERMONT M, 1986, J MOL BIOL, V191, P421, DOI 10.1016/0022-2836(86)90137-3; Grimm R, 1997, FEBS LETT, V408, P350, DOI 10.1016/S0014-5793(97)00462-6; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Invernizzi C, 2002, BIOCHEM J, V366, P989, DOI 10.1042/BJ20020378; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; JORDAN DB, 1981, PLANT PHYSIOL, V67, P237, DOI 10.1104/pp.67.2.237; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P9851, DOI 10.1021/bi050537v; Khrebtukova I, 1996, P NATL ACAD SCI USA, V93, P13689, DOI 10.1073/pnas.93.24.13689; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Kostov RV, 1997, PHOTOSYNTH RES, V54, P127, DOI 10.1023/A:1005967106993; KREBBERS E, 1988, PLANT MOL BIOL, V11, P745, DOI 10.1007/BF00019515; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUEHN GD, 1978, BIOCHEM J, V175, P909, DOI 10.1042/bj1750909; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; Larson EM, 1997, J BIOL CHEM, V272, P17033, DOI 10.1074/jbc.272.27.17033; LEE BG, 1991, ARCH BIOCHEM BIOPHYS, V291, P263, DOI 10.1016/0003-9861(91)90133-4; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; MARTIN PG, 1979, AUST J PLANT PHYSIOL, V6, P401; Martin W, 1996, PLANT MOL BIOL, V32, P485, DOI 10.1007/BF00019100; MAZUR BJ, 1985, NUCLEIC ACIDS RES, V13, P2373, DOI 10.1093/nar/13.7.2373; Meyer M, 2008, PHILOS T R SOC B, V363, P2767, DOI 10.1098/rstb.2008.0039; Moroney JV, 2007, EUKARYOT CELL, V6, P1251, DOI 10.1128/EC.00064-07; Ott CM, 2000, J BIOL CHEM, V275, P26241, DOI 10.1074/jbc.M004580200; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; PARRY MAJ, 1989, J EXP BOT, V40, P317, DOI 10.1093/jxb/40.3.317; Pollock SV, 2003, PLANT PHYSIOL, V133, P1854, DOI 10.1104/pp.103.032078; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; PRICE GD, 1989, PLANT PHYSIOL, V91, P505, DOI 10.1104/pp.91.2.505; Raven JA, 2008, PHILOS T R SOC B, V363, P2641, DOI 10.1098/rstb.2008.0020; Rawat M, 1996, PLANTA, V198, P263; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; READ BA, 1994, ARCH BIOCHEM BIOPHYS, V312, P210, DOI 10.1006/abbi.1994.1301; Satagopan S, 2004, J BIOL CHEM, V279, P14240, DOI 10.1074/jbc.M313215200; Sharwood RE, 2008, PLANT PHYSIOL, V146, P83, DOI 10.1104/pp.107.109058; Shimogawara K, 1998, GENETICS, V148, P1821; Silflow Carolyn D., 1998, Advances in Photosynthesis, V7, P25; SMRCKA AV, 1991, ARCH BIOCHEM BIOPHYS, V286, P6, DOI 10.1016/0003-9861(91)90002-Z; Spalding MH, 2008, J EXP BOT, V59, P1463, DOI 10.1093/jxb/erm128; SPALDING MH, 1983, PLANT PHYSIOL, V73, P273, DOI 10.1104/pp.73.2.273; SPALDING MH, 1983, PLANT PHYSIOL, V73, P268, DOI 10.1104/pp.73.2.268; Spreitzer RJ, 2005, P NATL ACAD SCI USA, V102, P17225, DOI 10.1073/pnas.0508042102; SPREITZER RJ, 1981, PLANT PHYSIOL, V67, P565, DOI 10.1104/pp.67.3.565; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Spreitzer RJ, 2001, BIOCHEMISTRY-US, V40, P5615, DOI 10.1021/bi002943e; SPREITZER RJ, 1982, FEBS LETT, V148, P117, DOI 10.1016/0014-5793(82)81255-6; SPREITZER RJ, 1987, CURR GENET, V11, P611, DOI 10.1007/BF00393924; SPREITZER RJ, 1993, ANNU REV PLANT PHYS, V44, P411, DOI 10.1146/annurev.pp.44.060193.002211; SU QX, 1994, BIOCHEM J, V300, P787, DOI 10.1042/bj3000787; Su QX, 1999, BIOCHEM J, V344, P391, DOI 10.1042/0264-6021:3440391; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; VANDERVIES SM, 1986, EMBO J, V5, P2439, DOI 10.1002/j.1460-2075.1986.tb04519.x; WAKSMAN G, 1987, NUCLEIC ACIDS RES, V15, P7181, DOI 10.1093/nar/15.17.7181; Wang YL, 2001, ARCH BIOCHEM BIOPHYS, V396, P35, DOI 10.1006/abbi.2001.2555; Whitney SM, 2007, J BIOL CHEM, V282, P3809, DOI 10.1074/jbc.M610479200; Whitney SM, 2009, PLANT PHYSIOL, V149, P1887, DOI 10.1104/pp.109.135210; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058	81	98	101	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19833	19841		10.1074/jbc.M110.124230	http://dx.doi.org/10.1074/jbc.M110.124230			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20424165	Green Published, hybrid			2022-12-27	WOS:000279012000016
J	Tatematsu, M; Ishii, A; Oshiumi, H; Horiuchi, M; Inagaki, F; Seya, T; Matsumoto, M				Tatematsu, Megumi; Ishii, Akihiro; Oshiumi, Hiroyuki; Horiuchi, Masataka; Inagaki, Fuyuhiko; Seya, Tsukasa; Matsumoto, Misako			A Molecular Mechanism for Toll-IL-1 Receptor Domain-containing Adaptor Molecule-1-mediated IRF-3 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR-3; REGULATORY FACTOR-3 ACTIVATION; DENDRITIC CELLS; INTERFERON-BETA; ANTIVIRAL RESPONSE; SIGNALING PATHWAY; TRIF; INDUCTION; TOLL-LIKE-RECEPTOR-4	The Toll-IL-1 receptor (TIR) domain-containing adaptor molecule-1 (TICAM-1, also called TRIF) is a signaling adaptor for TLR3 and TLR4 that activates the transcription factors IRF-3, NF-kappa B, and AP-1, leading to induction of type I interferon and cytokines. The N-terminal region of TICAM-1 participates in IRF-3 activation, although the C-terminal region is involved in NF-kappa B activation. However, the mechanism by which TICAM-1 is activated and transmits signals is largely unknown. In this study, we identified Leu(194) as a critical amino acid for TICAM-1-mediated IRF-3 activation. When Leu(194) was substituted with Ala, the mutant TICAM-1 failed to recruit the IRF-3 kinase TBK1, resulting in lack of IRF-3 phosphorylation, although TRAF3 and NAP1 appeared to be recruited. The N-terminal 176 amino acids of TICAM-1 (N-terminal domain (NTD)) form a protease-resistant structural domain. A TICAM-1 mutant lacking the N-terminal 180 amino acids showed greater interferon-beta promoter activation than wildtype TICAM-1. Furthermore, immunoprecipitation and protein-protein interaction analysis revealed that the NTD interacted with the N terminus of TICAM-1-TIR. These results suggest that the NTD folds into the TIR domain structure to maintain the naive conformation of TICAM-1. Upon stimulation of TLR3/4, TICAM-1 oligomerizes through the TIR domain and the C-terminal region, which may break the intramolecular association and induce a conformational change that allows TBK1 access to TICAM-1.	[Tatematsu, Megumi; Ishii, Akihiro; Oshiumi, Hiroyuki; Seya, Tsukasa; Matsumoto, Misako] Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Horiuchi, Masataka; Inagaki, Fuyuhiko] Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University	Matsumoto, M (corresponding author), Hokkaido Univ, Dept Microbiol & Immunol, Grad Sch Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	matumoto@pop.med.hokudai.ac.jp	Funami, Kenji/A-4284-2012; 美佐子, 松本/A-4497-2012; Oshiumi, Hiroyuki/G-1645-2012; Horiuchi, Masataka/D-5491-2012; Ishii, Akihiro/F-6878-2012; Seya, Tsukasa/A-4336-2012	Ishii, Akihiro/0000-0003-4032-3691; Oshiumi, Hiroyuki/0000-0003-1567-8722	Ministry of Education, Science, and Culture; The North Tec Foundation; The Akiyama Life Science Foundation; Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The North Tec Foundation; The Akiyama Life Science Foundation; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Culture, the Ministry of Health, Labor, and Welfare of Japan, The North Tec Foundation, The Akiyama Life Science Foundation, Sapporo Biocluster "Bio-S" (Knowledge Cluster Initiative of Ministry of Education, Culture, Sports, Science and Technology), and the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, Ministry of Education, Culture, Sports, Science and Technology.	Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; HORIUCHI M, 2008, BIOCH MOL BIOL ABSTR, V31, P533; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Salem ML, 2005, J IMMUNOTHER, V28, P220, DOI 10.1097/01.cji.0000156828.75196.0d; Sasai M, 2005, J IMMUNOL, V174, P27, DOI 10.4049/jimmunol.174.1.27; Sasai M, 2010, MOL IMMUNOL, V47, P1283, DOI 10.1016/j.molimm.2009.12.002; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seya T, 2009, CANCER IMMUNOL IMMUN, V58, P1175, DOI 10.1007/s00262-008-0652-9; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	33	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20128	20136		10.1074/jbc.M109.099101	http://dx.doi.org/10.1074/jbc.M109.099101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20418377	hybrid, Green Published			2022-12-27	WOS:000279012000047
J	Wang, SB; Dale, GL; Song, P; Viollet, B; Zou, MH				Wang, Shaobin; Dale, George L.; Song, Ping; Viollet, Benoit; Zou, Ming-hui			AMPK alpha 1 Deletion Shortens Erythrocyte Life Span in Mice ROLE OF OXIDATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RED-CELL MEMBRANE; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; HEMOLYTIC-ANEMIA; IN-VIVO; EXPRESSION; SURVIVAL; BLOOD	AMP-activated protein kinase (AMPK) is an energy sensor essential for maintaining cellular energy homeostasis. Here, we report that AMPK alpha 1 is the predominant isoform of AMPK in murine erythrocytes and mice globally deficient in AMPK alpha 1 (AMPK alpha 1(-/-)), but not in those lacking AMPK alpha 2, and the mice had markedly enlarged spleens with dramatically increased proportions of Ter119-positive erythroid cells. Blood tests revealed significantly decreased erythrocyte and hemoglobin levels with increased reticulocyte counts and elevated plasma erythropoietin concentrations in AMPK alpha 1(-/-) mice. The life span of erythrocytes from AMPK alpha 1(-/-) mice was less than that in wild-type littermates, and the levels of reactive oxygen species and oxidized proteins were significantly increased in AMPK alpha 1(-/-) erythrocytes. In keeping with the elevated oxidative stress, treatment of AMPK alpha 1(-/-) mice with the antioxidant, tempol, resulted in decreased reticulocyte counts and improved erythrocyte survival. Furthermore, the expression of Foxo3 and reactive oxygen species scavenging enzymes was significantly decreased in erythroblasts from AMPK alpha 1(-/-) mice. Collectively, these results establish an essential role for AMPK alpha 1 in regulating oxidative stress and life span in erythrocytes.	[Zou, Ming-hui] Univ Oklahoma, Sect Endocrinol & Diabet, Dept Med, Hlth Sci Ctr,Div Hematol, Oklahoma City, OK 73104 USA; [Wang, Shaobin; Song, Ping; Zou, Ming-hui] Univ Oklahoma, Hlth Sci Ctr, Div Endocrinol & Diabet, Oklahoma City, OK 73104 USA; [Wang, Shaobin; Zou, Ming-hui] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Viollet, Benoit] Inst Cochin, F-75014 Paris, France; [Viollet, Benoit] Univ Paris 05, CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit] INSERM, Paris U567, F-75654 Paris 13, France	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Zou, MH (corresponding author), Univ Oklahoma, Sect Endocrinol & Diabet, Dept Med, Hlth Sci Ctr,Div Hematol, BSEB 325, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Song, Ping/D-6972-2011; wang, shaobin/D-7168-2011; wang, shaobin/L-8539-2015; Song, Ping/N-8456-2018; wang, shaobin/A-2415-2015; Wang, Shaobin/C-5507-2008	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Song, Ping/0000-0002-2654-6162; Song, Ping/0000-0002-6143-4270; wang, shaobin/0000-0002-0931-7210; Wang, Shaobin/0000-0002-1751-9162	National Institutes of Health [HL079584, HL074399, HL080499, HL089920, HL096032]; American Diabetes Association; Juvenile Diabetes Research Foundation; Oklahoma Center for Advancement of Science and Technology; Travis Endowed Chair in Endocrinology, University of Oklahoma Health Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL105157, R01HL096032, R01HL080499, R01HL089920, R01HL079584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oklahoma Center for Advancement of Science and Technology; Travis Endowed Chair in Endocrinology, University of Oklahoma Health Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL074399, HL080499, HL089920, and HL096032. This work was also supported by research awards from the American Diabetes Association, Juvenile Diabetes Research Foundation, Oklahoma Center for Advancement of Science and Technology, and a Travis Endowed Chair in Endocrinology, University of Oklahoma Health Sciences Center.	An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; BEUTLER E, 1976, J LAB CLIN MED, V88, P328; BEUTLER E, 2005, WILLIAMS HEMATOLOGY, P405; Bogdanova A, 2007, BLOOD, V110, P762, DOI 10.1182/blood-2006-12-063602; Bratosin D, 1997, CR ACAD SCI III-VIE, V320, P811, DOI 10.1016/S0764-4469(97)85017-2; Castro L, 2001, NUTRITION, V17, P161, DOI 10.1016/S0899-9007(00)00570-0; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Friedman JS, 2004, BLOOD, V104, P2565, DOI 10.1182/blood-2003-11-3858; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; HEBBEL RP, 1990, BLOOD, V76, P1015; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; ITANO HA, 1975, NATURE, V256, P665, DOI 10.1038/256665a0; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Johnson RM, 2005, FREE RADICAL BIO MED, V39, P1407, DOI 10.1016/j.freeradbiomed.2005.07.002; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; McMullin MF, 1999, J CLIN PATHOL, V52, P241, DOI 10.1136/jcp.52.4.241; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MOHANDAS N, 1979, SEMIN HEMATOL, V16, P95; MOHANDAS N, 1980, J CLIN INVEST, V66, P563, DOI 10.1172/JCI109888; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; SNYDER LM, 1985, J CLIN INVEST, V76, P1971, DOI 10.1172/JCI112196; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; SUZUKI T, 1987, BLOOD, V70, P791; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; TURGEON ML, 2005, CLIN HEMATOLOGY THEO, P455; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2007, PROSTAG OTH LIPID M, V82, P119, DOI 10.1016/j.prostaglandins.2006.05.005	50	80	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19976	19985		10.1074/jbc.M110.102467	http://dx.doi.org/10.1074/jbc.M110.102467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20392689	Green Published, hybrid			2022-12-27	WOS:000279012000031
J	Blanc, V; Sessa, KJ; Kennedy, S; Luo, JY; Davidson, NO				Blanc, Valerie; Sessa, Kimberly J.; Kennedy, Susan; Luo, Jianyang; Davidson, Nicholas O.			Apobec-1 Complementation Factor Modulates Liver Regeneration by Post-transcriptional Regulation of Interleukin-6 mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; BINDING PROTEIN; HEPATOCYTE PROLIFERATION; PARTIAL-HEPATECTOMY; STEM-LOOP; IDENTIFICATION; IL-6; GENE; DOMAINS; ELEMENT	Apobec-1 complementation factor (ACF) is the RNA binding subunit of a core complex that mediates C to U RNA editing of apolipoprotein B (apoB) mRNA. Targeted deletion of the murine Acf gene is early embryonic lethal and Acf(-/-) blastocysts fail to implant and proliferate, suggesting that ACF plays a key role in cell growth and differentiation. Here we demonstrate that heterozygous Acf(+/-) mice exhibit decreased proliferation and impaired liver mass restitution following partial hepatectomy (PH). To pursue the mechanism of impaired liver regeneration we examined activation of interleukin-6 (IL-6) a key cytokine required for induction of hepatocyte proliferation following PH. Peak induction of hepatic IL-6 mRNA abundance post PH was attenuated >80% in heterozygous Acf(+/-) mice, along with decreased serum IL-6 levels. IL-6 secretion from isolated Kupffer cells (KC) was 2-fold greater in wild-type compared with heterozygous Acf(+/-) mice. Recombinant ACF bound an AU-rich region in the IL-6 3'-untranslated region with high affinity and IL-6 mRNA half-life was significantly shorter in KC isolated from Acf(+/-) mice compared with wild-type controls. These findings suggest that ACF regulates liver regeneration following PH at least in part by controlling the stability of IL-6 mRNA. The results further suggest a new RNA target and an unanticipated physiological function for ACF beyond apoB RNA editing.	[Davidson, Nicholas O.] Washington Univ, Sch Med, Div Gastroenterol, Dept Med, St Louis, MO 63110 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Davidson, NO (corresponding author), Washington Univ, Sch Med, Div Gastroenterol, Dept Med, Box 8124,660 Euclid Ave, St Louis, MO 63110 USA.	nod@wustl.edu			National Institutes of Health [HL-38180, DK-56260, DK-52574]; American Heart Association [910115]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-38180, DK-56260, and DK-52574 (to N.O.D.) and American Heart Association Graduate Student Fellowship 910115 (to K.J.S.).	Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Bihl MP, 2002, AM J RESP CELL MOL, V27, P48, DOI 10.1165/ajrcmb.27.1.4637; Blanc V, 2005, MOL CELL BIOL, V25, P7260, DOI 10.1128/MCB.25.16.7260-7269.2005; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Blanc V, 2001, J BIOL CHEM, V276, P46386, DOI 10.1074/jbc.M107654200; Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Bultinck J, 2006, CYTOKINE, V36, P160, DOI 10.1016/j.cyto.2006.11.010; Chester A, 2004, RNA, V10, P1399, DOI 10.1261/rna.7490704; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; GIANNONI F, 1994, J BIOL CHEM, V269, P5932; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GREEVE J, 1993, J LIPID RES, V34, P1367; Henderson JO, 2001, BBA-GENE STRUCT EXPR, V1522, P22, DOI 10.1016/S0167-4781(01)00295-0; HOYLE GW, 1991, J BIOL CHEM, V266, P1850; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Maris C, 2005, RNA, V11, P173, DOI 10.1261/rna.7190705; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Mehta A, 2002, RNA, V8, P69, DOI 10.1017/S1355838202015649; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Ren XD, 2003, J CLIN INVEST, V112, P1407, DOI 10.1172/JCI200317391; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; Sowden MP, 2004, J BIOL CHEM, V279, P197, DOI 10.1074/jbc.M307920200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tumanov AV, 2009, GASTROENTEROLOGY, V136, P694, DOI 10.1053/j.gastro.2008.09.015; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wuestefeld T, 2003, J BIOL CHEM, V278, P11281, DOI 10.1074/jbc.M208470200; Yatsenko OP, 2004, B EXP BIOL MED+, V138, P73, DOI 10.1023/B:BEBM.0000046944.85314.bf; Zimmers TA, 2003, HEPATOLOGY, V38, P1590, DOI 10.1016/j.hep.2003.09.021	36	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19184	19192		10.1074/jbc.M110.115147	http://dx.doi.org/10.1074/jbc.M110.115147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406809	Green Published, hybrid			2022-12-27	WOS:000278727800028
J	Courville, P; Quick, M; Reimer, RJ				Courville, Pascal; Quick, Matthias; Reimer, Richard J.			Structure-Function Studies of the SLC17 Transporter Sialin Identify Crucial Residues and Substrate-induced Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID STORAGE DISEASES; VESICULAR GLUTAMATE TRANSPORTER; ESCHERICHIA-COLI; LACTOSE PERMEASE; TRANSLOCATION PATHWAY; MISSENSE MUTATIONS; SODIUM SYMPORTER; CHARGED RESIDUES; BINDING-SITE; MEMBRANE	Salla disease and infantile sialic acid storage disorder are human diseases caused by loss of function of sialin, a lysosomal transporter that mediates H+-coupled symport of acidic sugars N-acetylneuraminic acid and glucuronic acid out of lysosomes. Along with the closely related vesicular glutamate transporters, sialin belongs to the SLC17 transporter family. Despite their critical role in health and disease, these proteins remain poorly understood both structurally and mechanistically. Here, we use substituted cysteine accessibility screening and radiotracer flux assays to evaluate experimentally a computationally generated three-dimensional structure model of sialin. According to this model, sialin consists of 12 transmembrane helices (TMs) with an overall architecture similar to that of the distantly related glycerol 3-phosphate transporter GlpT. We show that TM4 in sialin lines a large aqueous cavity that forms a part of the substrate permeation pathway and demonstrate substrate-induced alterations in accessibility of substituted cysteine residues in TM4. In addition, we demonstrate that one mutant, F179C, has a dramatically different effect on the apparent affinity and transport rate for N-acetylneuraminic acid and glucuronic acid, suggesting that it may be directly involved in substrate recognition and/or translocation. These findings offer a basis for further defining the transport mechanism of sialin and other SLC17 family members.	[Courville, Pascal; Reimer, Richard J.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Stanford University; Columbia University; New York State Psychiatry Institute	Reimer, RJ (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, 1201 Welch Rd, Stanford, CA 94305 USA.	rjreimer@stanford.edu	courville, pascal/A-5170-2009		National Institutes of Health [NS050417, NS045634]; Fonds de la Recherche en Sante du Quebec; Stanford University School of Medicine Dean Fellowship Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS045634, R01NS050417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Stanford University School of Medicine Dean Fellowship Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS050417 and NS045634 (to R.J.R.). This work was also supported by the Fonds de la Recherche en Sante du Quebec and the Stanford University School of Medicine Dean Fellowship Program (to P.C.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Almqvist J, 2007, PROTEIN SCI, V16, P1819, DOI 10.1110/ps.072944707; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Eswar N., 2006, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0506-15; Fann MC, 1998, J MEMBRANE BIOL, V164, P187, DOI 10.1007/s002329900404; Fei H, 2007, J NEUROCHEM, V101, P1662, DOI 10.1111/j.1471-4159.2007.04518.x; Furuhata K, 2004, TRENDS GLYCOSCI GLYC, V16, P143, DOI 10.4052/tigg.16.143; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guan L, 2001, J BACTERIOL, V183, P1734, DOI 10.1128/JB.183.5.1734-1739.2001; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Havelaar AC, 1998, J BIOL CHEM, V273, P34568, DOI 10.1074/jbc.273.51.34568; Holm L., 2006, CURR PROTOC BIOINFOR; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Javitch JA, 1998, METHOD ENZYMOL, V296, P331; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Jung SK, 2006, BIOL PHARM BULL, V29, P547, DOI 10.1248/bpb.29.547; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MANCINI GMS, 1991, J CLIN INVEST, V87, P1329, DOI 10.1172/JCI115136; Matos M, 1996, J BIOL CHEM, V271, P18571, DOI 10.1074/jbc.271.31.18571; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Morin P, 2004, EMBO J, V23, P4560, DOI 10.1038/sj.emboj.7600464; Myall NJ, 2007, MOL GENET METAB, V92, P371, DOI 10.1016/j.ymgme.2007.08.121; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Ruivo R, 2008, BIOL CELL, V100, P551, DOI 10.1042/BC20070166; Sahin-Toth M, 2000, P NATL ACAD SCI USA, V97, P10729, DOI 10.1073/pnas.200351797; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Schmitt KC, 2010, J NEUROCHEM, V112, P1605, DOI 10.1111/j.1471-4159.2010.06583.x; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WANG HM, 1991, BIOCHEM J, V278, P689, DOI 10.1042/bj2780689; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264	46	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19316	19323		10.1074/jbc.M110.130716	http://dx.doi.org/10.1074/jbc.M110.130716			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20424173	Green Published, hybrid			2022-12-27	WOS:000278727800041
J	Bobkova, EV; Weber, MJ; Xu, ZW; Zhang, YL; Jung, J; Blume-Jensen, P; Northrup, A; Kunapuli, P; Andersen, JN; Kariv, I				Bobkova, Ekaterina V.; Weber, Michael J.; Xu, Zangwei; Zhang, Yan-Ling; Jung, Joon; Blume-Jensen, Peter; Northrup, Alan; Kunapuli, Priya; Andersen, Jannik N.; Kariv, Ilona			Discovery of PDK1 Kinase Inhibitors with a Novel Mechanism of Action by Ultrahigh Throughput Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC COLORECTAL-CANCER; PIF-BINDING POCKET; PROTEIN-KINASE; DRUG DISCOVERY; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; DOMAIN; ASSAYS; STABILITY	The phosphoinositide 3-kinase/AKT signaling pathway plays a key role in cancer cell growth, survival, and angiogenesis. Phosphoinositide-dependent protein kinase-1 (PDK1) acts at a focal point in this pathway immediately downstream of phosphoinositide 3-kinase and PTEN, where it phosphorylates numerous AGC kinases. The PDK1 kinase domain has at least three ligand-binding sites: the ATP-binding pocket, the peptide substrate-binding site, and a groove in the N-terminal lobe that binds the C-terminal hydrophobic motif of its kinase substrates. Based on the unique PDK1 substrate recognition system, ultra-high throughput TR-FRET and Alphascreen (R) screening assays were developed using a biotinylated version of the PDK1-tide substrate containing the activation loop of AKT fused to a pseudo-activated hydrophobic motif peptide. Using full-length PDK1, K-m values were determined as 5.6 mu M for ATP and 40 nM for the fusion peptide, revealing 50-fold higher affinity compared with the classical AKT(Thr-308)-tide. Kinetic and biophysical studies confirmed the PDK1 catalytic mechanism as a rapid equilibrium random bireactant reaction. Following an ultrahigh throughput screen of a large library, 2,000 compounds were selected from the reconfirmed hits by computational analysis with a focus on novel scaffolds. ATP-competitive hits were deconvoluted by dose-response studies at 1 x and 10 x K-m concentrations of ATP, and specificity of binding was assessed in thermal shift assay. Inhibition studies using fusion PDK1-tide1 substrate versus AKT(Thr-308)-tide and kinase selectivity profiling revealed a novel selective alkaloid scaffold that evidently binds to the PDK1-interacting fragment pocket. Molecular modeling suggests a structural paradigm for the design of inhibitory versus activating allosteric ligands of PDK1.	[Bobkova, Ekaterina V.; Xu, Zangwei; Zhang, Yan-Ling; Jung, Joon; Blume-Jensen, Peter; Northrup, Alan; Andersen, Jannik N.; Kariv, Ilona] Merck Res Labs, Boston, MA 02115 USA; [Weber, Michael J.; Kunapuli, Priya] Merck Res Labs, N Wales, PA 19454 USA	Merck & Company; Merck & Company	Bobkova, EV (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ebobkova@burnham.org		Andersen, Jannik/0000-0003-4528-2120				Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Boyle R. G., 2005, PCT Int. Appl., Patent No. [2005028474, WO 2005028474 A2]; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Engel M, 2006, EMBO J, V25, P5469, DOI 10.1038/sj.emboj.7601416; Fang L, 2008, J CHEM INF MODEL, V48, P2030, DOI 10.1021/ci800104s; Gao XX, 2006, J BIOL CHEM, V281, P21670, DOI 10.1074/jbc.M602448200; GOULET JL, 2003, Patent No. 2003011285; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Harris TK, 2003, IUBMB LIFE, V55, P117, DOI 10.1080/1521654031000115951; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Komander D, 2004, STRUCTURE, V12, P215, DOI 10.1016/j.str.2004.01.005; KOZINA E, 2008, Patent No. 2008112217; Lind K. E., 2008, Patent No. 2008005457; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Segel I. H., 1993, ENZYME KINETICS BEHA, P274; Stockman BJ, 2009, CHEM BIOL DRUG DES, V73, P179, DOI 10.1111/j.1747-0285.2008.00768.x; Stroba A, 2009, J MED CHEM, V52, P4683, DOI 10.1021/jm9001499; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Xu ZW, 2009, J BIOMOL SCREEN, V14, P1257, DOI 10.1177/1087057109349356; YOUNG J, 2007, Patent No. 2007145957; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	38	43	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18838	18846		10.1074/jbc.M109.089946	http://dx.doi.org/10.1074/jbc.M109.089946			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20385558	Green Published, hybrid			2022-12-27	WOS:000278453900074
J	Guglielmi, KM; McDonald, SM; Patton, JT				Guglielmi, Kristen M.; McDonald, Sarah M.; Patton, John T.			Mechanism of Intraparticle Synthesis of the Rotavirus Double-stranded RNA Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BLUETONGUE VIRUS CORE; NONSTRUCTURAL PROTEIN NSP2; IN-VITRO RECONSTITUTION; MESSENGER-RNA; CRYOELECTRON MICROSCOPY; 3-DIMENSIONAL STRUCTURE; IMAGE-RECONSTRUCTION; ANGSTROM RESOLUTION; STRUCTURAL-ANALYSIS; REPLICASE PARTICLE	Rotaviruses perform the remarkable tasks of transcribing and replicating 11 distinct double-stranded RNA genome segments within the confines of a subviral particle. Multiple viral polymerases are tethered to the interior of a particle, each dedicated to a solitary genome segment but acting in synchrony to synthesize RNA. Although the rotavirus polymerase specifically recognizes RNA templates in the absence of other proteins, its enzymatic activity is contingent upon interaction with the viral capsid. This intraparticle strategy of RNA synthesis helps orchestrate the concerted packaging and replication of the viral genome. Here, we review our current understanding of rotavirus RNA synthetic mechanisms.	[Guglielmi, Kristen M.; McDonald, Sarah M.; Patton, John T.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Patton, JT (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.	jpatton@niaid.nih.gov	Ogden, Kristen/AAO-9276-2020; Patton, John T/P-1390-2014; Patton, John/V-7651-2018	Ogden, Kristen/0000-0002-2670-4335; Patton, John/0000-0003-1572-0732	National Institutes of Health Intramural Research Program; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000754] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIAID. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Ayala-Breton C, 2009, J VIROL, V83, P8819, DOI 10.1128/JVI.02308-08; Barro M, 2001, VIROLOGY, V288, P71, DOI 10.1006/viro.2001.1054; Boyce M, 2004, J VIROL, V78, P3994, DOI 10.1128/JVI.78.8.3994-4002.2004; Carpio RVD, 2006, J MOL BIOL, V362, P539, DOI 10.1016/j.jmb.2006.07.050; Charpilienne A, 2002, J VIROL, V76, P7822, DOI 10.1128/JVI.76.15.7822-7831.2002; Chen D, 1998, J VIROL, V72, P7387, DOI 10.1128/JVI.72.9.7387-7396.1998; Chen D, 2001, VIROLOGY, V282, P221, DOI 10.1006/viro.2001.0825; Chen DY, 1999, VIROLOGY, V265, P120, DOI 10.1006/viro.1999.0029; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; COHEN J, 1977, J GEN VIROL, V36, P395, DOI 10.1099/0022-1317-36-3-395; COHEN J, 1979, BIOCHEM BIOPH RES CO, V88, P791, DOI 10.1016/0006-291X(79)91477-3; CRAWFORD SE, 1994, J VIROL, V68, P5945, DOI 10.1128/JVI.68.9.5945-5952.1994; Dormitzer PR, 2004, NATURE, V430, P1053, DOI 10.1038/nature02836; Eichwald C, 2002, J VIROL, V76, P3461, DOI 10.1128/JVI.76.7.3461-3470.2002; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Fujii K, 2009, J GEN VIROL, V90, P1734, DOI 10.1099/vir.0.010355-0; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; HELMBERGERJONES M, 1986, VIROLOGY, V155, P655, DOI 10.1016/0042-6822(86)90225-4; HEWAT EA, 1992, VIROLOGY, V189, P10, DOI 10.1016/0042-6822(92)90676-G; IMAI M, 1983, J VIROL, V47, P125, DOI 10.1128/JVI.47.1.125-136.1983; Jayaram H, 2004, VIRUS RES, V101, P67, DOI 10.1016/j.virusres.2003.12.007; Jayaram H, 2002, NATURE, V417, P311, DOI 10.1038/417311a; KOHLI E, 1993, ARCH VIROL, V133, P451, DOI 10.1007/BF01313782; KOHLI E, 1994, ARCH VIROL, V135, P193, DOI 10.1007/BF01309778; LABBE M, 1994, J GEN VIROL, V75, P3423, DOI 10.1099/0022-1317-75-12-3423; LABBE M, 1991, J VIROL, V65, P2946; Lawton JA, 1997, J VIROL, V71, P7353, DOI 10.1128/JVI.71.10.7353-7360.1997; Lawton JA, 2000, ADV VIRUS RES, V55, P185, DOI 10.1016/S0065-3527(00)55004-0; Lawton JA, 1999, P NATL ACAD SCI USA, V96, P5428, DOI 10.1073/pnas.96.10.5428; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Lawton JA, 2001, J VIROL, V75, P1632, DOI 10.1128/JVI.75.4.1632-1642.2001; Li ZL, 2009, J VIROL, V83, P1754, DOI 10.1128/JVI.01855-08; Libersou S, 2008, J VIROL, V82, P2844, DOI 10.1128/JVI.02268-07; LIU M, 1992, VIROLOGY, V188, P77, DOI 10.1016/0042-6822(92)90736-9; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; MANSELL EA, 1990, J VIROL, V64, P4988, DOI 10.1128/JVI.64.10.4988-4996.1990; McClain B, 2010, J MOL BIOL, V397, P587, DOI 10.1016/j.jmb.2010.01.055; McDonald SM, 2009, CURR OPIN STRUC BIOL, V19, P775, DOI 10.1016/j.sbi.2009.10.007; McDonald SM, 2009, VIRAL GENOME REPLICATION, P201, DOI 10.1007/b135974_11; Mertens PPC, 2004, VIRUS RES, V101, P29, DOI 10.1016/j.virusres.2003.12.004; MITCHELL DB, 1990, VIROLOGY, V177, P324, DOI 10.1016/0042-6822(90)90487-C; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Ozawa M, 2009, J VIROL, V83, P3384, DOI 10.1128/JVI.02513-08; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; Patton JT, 2007, ADV VIRUS RES, V69, P167, DOI 10.1016/S0065-3527(06)69004-0; Patton JT, 1996, J VIROL, V70, P3961, DOI 10.1128/JVI.70.6.3961-3971.1996; Patton JT, 1999, J VIROL, V73, P1382, DOI 10.1128/JVI.73.2.1382-1391.1999; PATTON JT, 1988, VIROLOGY, V166, P358, DOI 10.1016/0042-6822(88)90506-5; Patton JT, 1997, J VIROL, V71, P9618, DOI 10.1128/JVI.71.12.9618-9626.1997; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; PATTON JT, 1990, J GEN VIROL, V71, P1087, DOI 10.1099/0022-1317-71-5-1087; Patton JT, 2000, VIROLOGY, V277, P217, DOI 10.1006/viro.2000.0645; Pesavento JB, 2006, CURR TOP MICROBIOL, V309, P189; Poncet D, 1997, J VIROL, V71, P34, DOI 10.1128/JVI.71.1.34-41.1997; Prasad BVV, 1996, NATURE, V382, P471, DOI 10.1038/382471a0; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; PRASAD BVV, 1990, NATURE, V343, P476, DOI 10.1038/343476a0; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Schuck P, 2001, J BIOL CHEM, V276, P9679, DOI 10.1074/jbc.M009398200; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Taraporewala ZF, 2004, VIRUS RES, V101, P57, DOI 10.1016/j.virusres.2003.12.006; Taraporewala ZF, 2001, J VIROL, V75, P4519, DOI 10.1128/JVI.75.10.4519-4527.2001; Tihova M, 2001, J MOL BIOL, V314, P985, DOI 10.1006/jmbi.2000.5238; Tortorici MA, 2006, RNA, V12, P133, DOI 10.1261/rna.2122606; Tortorici MA, 2003, J BIOL CHEM, V278, P32673, DOI 10.1074/jbc.M305358200; VALENZUELA S, 1991, J VIROL, V65, P3964, DOI 10.1128/JVI.65.7.3964-3967.1991; VASQUEZ M, 1993, J GEN VIROL, V74, P937, DOI 10.1099/0022-1317-74-5-937; Vende P, 2002, J VIROL, V76, P5291, DOI 10.1128/JVI.76.10.5291-5299.2002; Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003; Wentz MJ, 1996, ARCH VIROL, P59; Wentz MJ, 1996, J VIROL, V70, P7833, DOI 10.1128/JVI.70.11.7833-7841.1996; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133; Zeng CQY, 1998, J VIROL, V72, P201, DOI 10.1128/JVI.72.1.201-208.1998; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002	80	41	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18123	18128		10.1074/jbc.R110.117671	http://dx.doi.org/10.1074/jbc.R110.117671			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20351108	hybrid, Green Published			2022-12-27	WOS:000278453900001
J	Lowe, EC; Bydder, S; Hartshorne, RS; Tape, HLU; Dridge, EJ; Debieux, CM; Paszkiewicz, K; Singleton, I; Lewis, RJ; Santini, JM; Richardson, DJ; Butler, CS				Lowe, Elisabeth C.; Bydder, Sarah; Hartshorne, Robert S.; Tape, Hannah L. U.; Dridge, Elizabeth J.; Debieux, Charles M.; Paszkiewicz, Konrad; Singleton, Ian; Lewis, Richard J.; Santini, Joanne M.; Richardson, David J.; Butler, Clive S.			Quinol-cytochrome c Oxidoreductase and Cytochrome c(4) Mediate Electron Transfer during Selenate Respiration in Thauera selenatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL SULFIDE DEHYDROGENASE; NITRITE REDUCTASE GENES; NITRATE REDUCTASE; REDOX CENTERS; ETHYLBENZENE DEHYDROGENASE; THIOBACILLUS-FERROOXIDANS; RHODOVULUM-SULFIDOPHILUM; THIOCAPSA-ROSEOPERSICINA; IDEONELLA-DECHLORATANS; PSEUDOMONAS-STUTZERI	Selenatereductase(SER) from Thaueraselenatis is a periplasmic enzyme that has been classified as a type II molybdoenzyme. The enzyme comprises three subunits SerABC, where SerC is an unusual b-heme cytochrome. In the present work the spectropotentiometric characterization of the SerC component and the identification of redox partners to SER are reported. The mid-point redox potential of the b-heme was determined by optical titration (E-m + 234 +/- 10 mV). A profile of periplasmic c-type cytochromes expressed in T. selenatis under selenate respiring conditions was undertaken. Two c-type cytochromes were purified (similar to 24 and similar to 6 kDa), and the 24-kDa protein (cytc-Ts4) was shown to donate electrons to SerABC in vitro. Protein sequence of cytc-Ts4 was obtained by N-terminal sequencing and liquid chromatography-tandem mass spectrometry analysis, and based upon sequence similarities, was assigned as a member of cytochrome c(4) family. Redox potentiometry, combined with UV-visible spectroscopy, showed that cytc-Ts4 is a diheme cytochrome with a redox potential of + 282 +/- 10 mV, and both hemes are predicted to have His-Met ligation. To identify the membrane-bound electron donors to cytc-Ts4, growth of T. selenatis in the presence of respiratory inhibitors was monitored. The specific quinol-cytochrome c oxidoreductase (QCR) inhibitors myxothiazol and antimycin A partially inhibited selenate respiration, demonstrating that some electron flux is via the QCR. Electron transfer via a QCR and a diheme cytochrome c(4) is a novel route for a member of the DMSO reductase family of molybdoenzymes.	[Lowe, Elisabeth C.; Tape, Hannah L. U.; Dridge, Elizabeth J.; Debieux, Charles M.; Paszkiewicz, Konrad; Butler, Clive S.] Univ Exeter, Sch Biosci, Ctr Biocatalysis, Exeter EX4 4QD, Devon, England; [Bydder, Sarah] La Trobe Univ, Dept Microbiol, Bundoora, Vic 3086, Australia; [Hartshorne, Robert S.; Richardson, David J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Singleton, Ian] Newcastle Univ, Inst Res Environm & Sustainabil, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Lewis, Richard J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Santini, Joanne M.] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England	University of Exeter; La Trobe University; University of East Anglia; Newcastle University - UK; Newcastle University - UK; University of London; Birkbeck University London; University College London	Butler, CS (corresponding author), Univ Exeter, Sch Biosci, Ctr Biocatalysis, Stocker Rd, Exeter EX4 4QD, Devon, England.	c.s.butler@exeter.ac.uk	Singleton, Ian/G-1174-2010; Richardson, David J/E-2275-2011	lewis, richard/0000-0003-2641-8643; Singleton, Ian/0000-0002-3866-668X; Lowe, Elisabeth/0000-0001-9812-0614	Biotechnology and Biological Sciences Research Council (BBSRC) [P17219, BBS/B/10110]; BBSRC/Engineering and Physical Sciences Research Council [BB/D00781X/1]; Systems Biology Theme, University of Exeter; La Trobe University; BBSRC [BB/D00781X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D00781X/2] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC/Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); Systems Biology Theme, University of Exeter; La Trobe University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in part by Biotechnology and Biological Sciences Research Council (BBSRC) Grants P17219 and BBS/B/10110 (to C. S. B. and D. J. R.) and BBSRC/Engineering and Physical Sciences Research Council (life science interface) Grant BB/D00781X/1 (to C. S. B., R. J. L., and D. J. R.). Sequencing of the T. selenatis genome was funded by the Systems Biology Theme, University of Exeter.; A recipient of a BBSRC Agri-food committee studentship.; Supported by a La Trobe University postgraduate award.	Abergel C, 2003, STRUCTURE, V11, P547, DOI 10.1016/S0969-2126(03)00072-8; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Backlund AS, 2009, APPL ENVIRON MICROB, V75, P2439, DOI 10.1128/AEM.01325-08; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; BOHLIN J, 2009, MICROBIOL R IN PRESS; Branca RMM, 2007, J MASS SPECTROM, V42, P1569, DOI 10.1002/jms.1337; Branca RMM, 2007, ARCH BIOCHEM BIOPHYS, V467, P174, DOI 10.1016/j.abb.2007.07.031; Brondijk THC, 2004, BIOCHEM J, V379, P47, DOI 10.1042/BJ20031115; Cavazza C, 1996, EUR J BIOCHEM, V242, P308, DOI 10.1111/j.1432-1033.1996.0308r.x; CHRISTENSEN HEM, 1994, GENE, V144, P139, DOI 10.1016/0378-1119(94)90219-4; CRASKE A, 1986, EUR J BIOCHEM, V158, P429, DOI 10.1111/j.1432-1033.1986.tb09771.x; Creevey NL, 2008, BIOCHEMISTRY-US, V47, P3770, DOI 10.1021/bi702444r; Danielsson H, 2003, APPL ENVIRON MICROB, V69, P5585, DOI 10.1128/AEM.69.9.5585-5592.2003; DeLano W.L, PYMOL MOL GRAPHICS S; Dridge EJ, 2007, BIOCHEM J, V408, P19, DOI 10.1042/BJ20070669; Dutton P L, 1978, Methods Enzymol, V54, P411; Etchebehere C, 2005, APPL ENVIRON MICROB, V71, P5642, DOI 10.1128/AEM.71.9.5642-5645.2005; Giudici-Orticoni MT, 2000, BIOCHEMISTRY-US, V39, P7205, DOI 10.1021/bi992846p; Johnson HA, 2001, J BACTERIOL, V183, P4536, DOI 10.1128/JB.183.15.4536-4542.2001; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Kadziola A, 1997, STRUCTURE, V5, P203, DOI 10.1016/S0969-2126(97)00179-2; Karlsson J, 2005, PROTEIN EXPRES PURIF, V41, P306, DOI 10.1016/j.pep.2005.02.002; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Krafft T, 2000, DNA Seq, V10, P365, DOI 10.3109/10425170009015604; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MACY JM, 1993, INT J SYST BACTERIOL, V43, P135, DOI 10.1099/00207713-43-1-135; Magalon A, 1998, J BIOL CHEM, V273, P10851, DOI 10.1074/jbc.273.18.10851; Maher MJ, 2004, INORG CHEM, V43, P402, DOI 10.1021/ic035136n; Martinez-Espinosa RM, 2007, FEMS MICROBIOL LETT, V276, P129, DOI 10.1111/j.1574-6968.2007.00887.x; McCrindle SL, 2005, ADV MICROB PHYSIOL, V50, P147, DOI 10.1016/S0065-2911(05)50004-3; McDevitt CA, 2002, BIOCHEMISTRY-US, V41, P15234, DOI 10.1021/bi026221u; McDevitt CA, 2002, MOL MICROBIOL, V44, P1575, DOI 10.1046/j.1365-2958.2002.02978.x; McEwan AG, 2002, GEOMICROBIOL J, V19, P3, DOI 10.1080/014904502317246138; MOIR JWB, 1993, EUR J BIOCHEM, V212, P377, DOI 10.1111/j.1432-1033.1993.tb17672.x; MONOD J., 1942, Research on the Glowth of Bacterial Cultures.; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Ohmine M, 2009, BIOCHEMISTRY-US, V48, P9132, DOI 10.1021/bi901202m; Pettigrew G.W., 1987, CYTOCHROMES C BIOL A; PETTIGREW GW, 1988, BIOCHEM J, V252, P427, DOI 10.1042/bj2520427; Potter L, 2001, ADV MICROB PHYSIOL, V45, P51, DOI 10.1016/S0065-2911(01)45002-8; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Ridley H, 2006, APPL ENVIRON MICROB, V72, P5173, DOI 10.1128/AEM.00568-06; Roldan MD, 1998, J BIOL CHEM, V273, P28785, DOI 10.1074/jbc.273.44.28785; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; Schroder I, 1997, J BIOL CHEM, V272, P23765, DOI 10.1074/jbc.272.38.23765; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; Song BK, 2003, FEMS MICROBIOL ECOL, V43, P349, DOI 10.1111/j.1574-6941.2003.tb01075.x; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; SWANK RT, 1969, BIOCHIM BIOPHYS ACTA, V180, P473, DOI 10.1016/0005-2728(69)90026-7; THIERBACH G, 1981, BIOCHIM BIOPHYS ACTA, V638, P282, DOI 10.1016/0005-2728(81)90238-3; VANARK G, 1977, BIOCHIM BIOPHYS ACTA, V459, P119, DOI 10.1016/0005-2728(77)90014-7; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; ZWIETERING MH, 1992, J APPL BACTERIOL, V72, P139, DOI 10.1111/j.1365-2672.1992.tb01815.x	54	34	34	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18433	18442		10.1074/jbc.M110.115873	http://dx.doi.org/10.1074/jbc.M110.115873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388716	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000278453900037
J	Luo, DH; Wei, N; Doan, DN; Paradkar, PN; Chong, YW; Davidson, AD; Kotaka, M; Lescar, J; Vasudevan, SG				Luo, Dahai; Wei, Na; Doan, Danny N.; Paradkar, Prasad N.; Chong, Yuwen; Davidson, Andrew D.; Kotaka, Masayo; Lescar, Julien; Vasudevan, Subhash G.			Flexibility between the Protease and Helicase Domains of the Dengue Virus NS3 Protein Conferred by the Linker Region and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; HELICASE/NUCLEOSIDE TRIPHOSPHATASE; CATALYTIC DOMAIN; REPLICATION; ASSOCIATION; PREDICTION; RESOLUTION; SYSTEM; NS2B	The dengue virus (DENV) NS3 protein is essential for viral polyprotein processing and RNA replication. It contains an N-terminal serine protease region (residues 1-168) joined to an RNA helicase (residues 180-618) by an 11-amino acid linker (169-179). The structure at 3.15 angstrom of the soluble NS3 protein from DENV4 covalently attached to 18 residues of the NS2B cofactor region (NS2B(18)NS3) revealed an elongated molecule with the protease domain abutting subdomains I and II of the helicase (Luo, D., Xu, T., Hunke, C., Gruber, G., Vasudevan, S. G., and Lescar, J. (2008) J. Virol. 82, 173-183). Unexpectedly, using similar crystal growth conditions, we observed an alternative conformation where the protease domain has rotated by similar to 161 degrees with respect to the helicase domain. We report this new crystal structure bound to ADP-Mn2+ refined to a resolution of 2.2 angstrom. The biological significance for interdomain flexibility conferred by the linker region was probed by either inserting a Gly residue between Glu(173) and Pro174 or replacing Pro174 with a Gly residue. Both mutations resulted in significantly lower ATPase and helicase activities. We next increased flexibility in the linker by introducing a Pro(176) to Gly mutation in a DENV2 replicon system. A 70% reduction in luciferase reporter signal and a similar reduction in the level of viral RNA synthesis were observed. Our results indicate that the linker region has evolved to an optimum length to confer flexibility to the NS3 protein that is required both for polyprotein processing and RNA replication.	[Luo, Dahai; Kotaka, Masayo; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Wei, Na; Doan, Danny N.; Paradkar, Prasad N.; Chong, Yuwen; Vasudevan, Subhash G.] Duke Natl Univ Singapore Grad Med Sch, Program Emerging Infect Dis, Singapore 637551, Singapore; [Davidson, Andrew D.] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Lescar, Julien] CNRS, UMR 6098, F-13288 Marseille, France	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Bristol; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Vasudevan, SG (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore.	subhash.vasudevan@duke-nus.edu.sg	Paradkar, Prasad/ABA-5851-2020; Luo, Dahai/J-6022-2012; Kotaka, Masayo/C-4483-2009	Paradkar, Prasad/0000-0002-6553-2214; Luo, Dahai/0000-0001-7637-7275; Kotaka, Masayo/0000-0001-9692-3843; Vasudevan, Subhash/0000-0002-5083-3831	Biomedical Research Council [06/1/22/19/447, 09/1/22/19/599]; CNRS; Agency for Sciences, Technology and Research, Singapore; Ministry of Health, Singapore;  [ARC5/07]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agency for Sciences, Technology and Research, Singapore; Ministry of Health, Singapore(Ministry of Health-Singapore); 	Recipient of Biomedical Research Council Grants 06/1/22/19/447 and 09/1/22/19/599, an ARC5/07 grant, and an Action Thematique d'Incitation sur Programme from the CNRS.; Recipient of support from the Duke-National University of Singapore Signature Research Program (funded by the Agency for Sciences, Technology and Research, Singapore, and the Ministry of Health, Singapore).	Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804; Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DeLano WL, 2002, PYMOL USERS MANUAL; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055; Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2; Westaway EG, 1999, VIROLOGY, V258, P108, DOI 10.1006/viro.1999.9683; Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Xu T., 2006, NOVART FDN SYMP, V277, P251; Xu T., 2006, NOVART FDN SYMP, V277, P97; Xu Ting, 2006, Novartis Found Symp, V277, P87, DOI 10.1002/0470058005.ch7; Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018; Yan YW, 1998, PROTEIN SCI, V7, P837; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200	43	115	121	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18817	18827		10.1074/jbc.M109.090936	http://dx.doi.org/10.1074/jbc.M109.090936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20375022	Green Published, hybrid			2022-12-27	WOS:000278453900072
J	Marq, JB; Kolakofsky, D; Garcin, D				Marq, Jean-Baptiste; Kolakofsky, Daniel; Garcin, Dominique			Unpaired 5 ' ppp-Nucleotides, as Found in Arenavirus Double-stranded RNA Panhandles, Are Not Recognized by RIG-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5'-TRIPHOSPHATE RNA; DNA-REPLICATION; BACK MECHANISM; VIRUS; INITIATION; PROTEIN; GENOME; POLYMERASE; HELICASE; VITRO	Arenavirus and bunyavirus RNA genomes are unusual in that they are found in circular nucleocapsids, presumably due to the annealing of their complementary terminal sequences. Moreover, arenavirus genome synthesis initiates with GTP at position +2 of the template rather than at the precise 3' end (position +1). After formation of a dinucleotide, 5' pppGpC(OH) is then realigned on the template before this primer is extended. The net result of this "prime and realign" mechanism of genome initiation is that 5' pppG is found as an unpaired 5' nucleotide when the complementary genome ends anneal to form a double-stranded (dsRNA) panhandle. Using 5' pppRNA made in vitro and purified so that all dsRNA side products are absent, we have determined that both this 5' nucleotide overhang, as well as mismatches within the dsRNA (as found in some arenavirus genomes), clearly reduce the ability of these model dsRNAs to induce interferon upon transfection into cells. The presence of this unpaired 5' ppp-nucleotide is thus another way that some viruses appear to use to avoid detection by cytoplasmic pattern recognition receptors.	[Marq, Jean-Baptiste; Kolakofsky, Daniel; Garcin, Dominique] Univ Geneva, Dept Microbiol & Mol Med, Sch Med, CMU, CH-1211 Geneva, Switzerland	University of Geneva	Kolakofsky, D (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, Sch Med, CMU, 9 Ave Champel, CH-1211 Geneva, Switzerland.	daniel.kolakofsky@unige.ch			Swiss National Science Fund	Swiss National Science Fund(Swiss National Science Foundation (SNSF))	This work was supported by a grant from the Swiss National Science Fund.	Albarino CG, 2009, J VIROL, V83, P5606, DOI 10.1128/JVI.00276-09; CALDENTEY J, 1993, NUCLEIC ACIDS RES, V21, P3725, DOI 10.1093/nar/21.16.3725; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; Chen M, 2008, J GEN VIROL, V89, P1421, DOI 10.1099/vir.0.83464-0; COLBY C, 1969, P NATL ACAD SCI USA, V63, P160, DOI 10.1073/pnas.63.1.160; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Flatz L, 2006, P NATL ACAD SCI USA, V103, P4663, DOI 10.1073/pnas.0600652103; GARCIN D, 1990, J VIROL, V64, P6196, DOI 10.1128/JVI.64.12.6196-6203.1990; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; IAPALUCCI S, 1989, VIROLOGY, V173, P357, DOI 10.1016/0042-6822(89)90257-2; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KING AJ, 1994, EMBO J, V13, P5786, DOI 10.1002/j.1460-2075.1994.tb06917.x; KING P, 1994, J BIOL CHEM, V269, P30609; KOLAKOFSKY D, 1976, CELL, V8, P547, DOI 10.1016/0092-8674(76)90223-3; Lukashevich IS, 2005, J VIROL, V79, P13934, DOI 10.1128/JVI.79.22.13934-13942.2005; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; Marq JB, 2009, J BIOL CHEM, V284, P25471, DOI 10.1074/jbc.M109.018895; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; OBIJESKI JF, 1976, J VIROL, V20, P664, DOI 10.1128/JVI.20.3.664-675.1976; PALMER EL, 1977, J GEN VIROL, V36, P541, DOI 10.1099/0022-1317-36-3-541; Paul AV, 2003, J BIOL CHEM, V278, P43951, DOI 10.1074/jbc.M307441200; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prehaud C, 1997, VIROLOGY, V227, P189, DOI 10.1006/viro.1996.8324; RAJU R, 1989, J VIROL, V63, P122, DOI 10.1128/JVI.63.1.122-128.1989; ROBERTSON HD, 1982, CELL, V30, P669, DOI 10.1016/0092-8674(82)90270-7; SALVATO M, 1988, VIROLOGY, V164, P517, DOI 10.1016/0042-6822(88)90566-1; SALVATO MS, 1989, VIROLOGY, V173, P1, DOI 10.1016/0042-6822(89)90216-X; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Steil BP, 2009, VIRUS RES, V139, P240, DOI 10.1016/j.virusres.2008.07.027; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	41	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18208	18216		10.1074/jbc.M109.089425	http://dx.doi.org/10.1074/jbc.M109.089425			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400512	Green Published, hybrid			2022-12-27	WOS:000278453900012
J	Wu, N; Siow, YL; Karmin, O				Wu, Nan; Siow, Yaw L.; Karmin, O.			Ischemia/Reperfusion Reduces Transcription Factor Sp1-mediated Cystathionine beta-Synthase Expression in the Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; DNA-BINDING ACTIVITY; HYDROGEN-SULFIDE; SP1 PHOSPHORYLATION; GENE-TRANSCRIPTION; CARDIOVASCULAR-DISEASE; SERUM HOMOCYSTEINE; PROTEIN; ACTIVATION; RAT	Cystathionine beta-synthase (CBS) is a key enzyme that catalyzes the rate-limiting step for homocysteine (Hcy) metabolism via the trans-sulfuration pathway and is also responsible for the production of H2S through the desulfhydration reaction. Our recent studies demonstrate that renal ischemia/reperfusion decreased the CBS activity leading to Hcy accumulation and H2S reduction in the kidney, which in turn contributed to kidney injury. Both Hcy and H2S play important roles in physiological and pathological processes. In this study we investigated the molecular mechanism by which CBS activity was regulated in the kidney. The left kidney of Sprague-Dawley rat was subjected to 45 min of ischemia followed by 6 h of reperfusion. Ischemia/reperfusion caused a significant decrease in CBS mRNA and protein levels in the kidney. As a consequence, there was a marked reduction in the CBS enzyme activity. Transfection of kidney proximal tubular cells with transcription factor (Sp1) small interfering RNA caused a marked reduction in CBS mRNA, indicating a pivotal role for Sp1 in regulating CBS expression in kidney cells. Electrophoretic mobility shift assay and chromatin immunoprecipitation assay detected a lower Sp1 activity in kidneys subjected to ischemia/reperfusion as compared with that in a sham-operated group. ERK-mediated phosphorylation of Sp1 was responsible for a decreased transcriptional activity of Sp1 in the kidney upon ischemia/reperfusion. These results suggest that reduced kidney CBS gene expression during ischemia/reperfusion is mediated via a decrease in Sp1 transcriptional activity. Regulation of CBS-mediated Hcy and H2S homeostasis may offer a renal protective effect against ischemia/reperfusion injury.	[Wu, Nan; Siow, Yaw L.; Karmin, O.] Univ Manitoba, Lab Integrat Biol, Dept Anim Sci, Dept Physiol,St Boniface Hosp Res Ctr, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba	Karmin, O (corresponding author), Univ Manitoba, Lab Integrat Biol, Dept Anim Sci, Dept Physiol,St Boniface Hosp Res Ctr, 351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	karmino@sbrc.ca		Siow, Yaw/0000-0001-6623-2881; O, Karmin/0000-0002-2163-9458	Natural Sciences and Engineering Research Council of Canada; St. Boniface Hospital & Research Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); St. Boniface Hospital & Research Foundation	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the St. Boniface Hospital & Research Foundation.	Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Au-Yeung KKW, 2004, CIRC RES, V94, P28, DOI 10.1161/01.RES.0000108264.67601.2C; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Daniel S, 1996, J BIOL CHEM, V271, P14692, DOI 10.1074/jbc.271.25.14692; Deng WB, 2003, P NATL ACAD SCI USA, V100, P6801, DOI 10.1073/pnas.1136624100; Distrutti E, 2008, HEPATOLOGY, V47, P659, DOI 10.1002/hep.22037; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Eto K, 2002, BIOCHEM BIOPH RES CO, V293, P1485, DOI 10.1016/S0006-291X(02)00422-9; Eto K, 2002, J BIOL CHEM, V277, P42680, DOI 10.1074/jbc.M205835200; Francis ME, 2004, KIDNEY INT, V66, P303, DOI 10.1111/j.1523-1755.2004.00732.x; Friedman AN, 2001, J AM SOC NEPHROL, V12, P2181, DOI 10.1681/ASN.V12102181; Ge YB, 2001, BIOCHEM J, V357, P97, DOI 10.1042/0264-6021:3570097; Ge YB, 2001, J BIOL CHEM, V276, P43570, DOI 10.1074/jbc.M104930200; House JD, 1997, BIOCHEM J, V328, P287; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kraus JP, 1998, GENOMICS, V52, P312, DOI 10.1006/geno.1998.5437; Lacroix I, 2002, J BIOL CHEM, V277, P9598, DOI 10.1074/jbc.M111444200; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Lentz SR, 2005, J THROMB HAEMOST, V3, P1646, DOI 10.1111/j.1538-7836.2005.01364.x; Liao MJ, 2008, MOL ENDOCRINOL, V22, P1449, DOI 10.1210/me.2008-0035; Maclean KN, 2004, J BIOL CHEM, V279, P8558, DOI 10.1074/jbc.M310211200; Maclean KN, 2002, J CELL PHYSIOL, V192, P81, DOI 10.1002/jcp.10118; Majumdar G, 2006, J BIOL CHEM, V281, P3642, DOI 10.1074/jbc.M511223200; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Mockridge JW, 2000, BIOCHEM BIOPH RES CO, V270, P947, DOI 10.1006/bbrc.2000.2522; Moore PK, 2003, TRENDS PHARMACOL SCI, V24, P609, DOI 10.1016/j.tips.2003.10.007; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496; Prathapasinghe GA, 2008, AM J PHYSIOL-RENAL, V295, pF912, DOI 10.1152/ajprenal.00040.2008; Prathapasinghe GA, 2007, AM J PHYSIOL-RENAL, V292, pF1354, DOI 10.1152/ajprenal.00301.2006; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Roper MD, 1996, MAMM GENOME, V7, P754, DOI 10.1007/s003359900226; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; WEINBERG JM, 1991, KIDNEY INT, V39, P476, DOI 10.1038/ki.1991.58; Woo CWH, 2008, J BIOL CHEM, V283, P1282, DOI 10.1074/jbc.M707886200; Woo CWH, 2006, BBA-MOL BASIS DIS, V1762, P656, DOI 10.1016/j.bbadis.2006.05.012; Woo CWH, 2006, ARTERIOSCL THROM VAS, V26, P1043, DOI 10.1161/01.ATV.0000214981.58499.32; Woo CWH, 2005, AM J PHYSIOL-ENDOC M, V288, pE1002, DOI 10.1152/ajpendo.00518.2004; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Xu ZB, 2009, AM J PHYSIOL-RENAL, V297, pF27, DOI 10.1152/ajprenal.00096.2009; Yi F, 2008, AM J NEPHROL, V28, P254, DOI 10.1159/000110876; Yun SS, 2002, J BIOL CHEM, V277, P34808, DOI 10.1074/jbc.M205417200; Zhu T, 2002, CLIN EXP PHARMACOL P, V29, P852, DOI 10.1046/j.1440-1681.2002.03736.x; Zou CG, 2003, J BIOL CHEM, V278, P16802, DOI 10.1074/jbc.M212376200	55	48	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18225	18233		10.1074/jbc.M110.132142	http://dx.doi.org/10.1074/jbc.M110.132142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392694	hybrid, Green Published			2022-12-27	WOS:000278453900014
J	Arnold, T; Zeth, K; Linke, D				Arnold, Thomas; Zeth, Kornelius; Linke, Dirk			Omp85 from the Thermophilic Cyanobacterium Thermosynechococcus elongatus Differs from Proteobacterial Omp85 in Structure and Domain Composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARREL MEMBRANE-PROTEINS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURE PREDICTION; SERRATIA-MARCESCENS; OUTER ENVELOPE; SECRETION; FAMILY; BIOGENESIS; EVOLUTION	Omp85 proteins are essential proteins located in the bacterial outer membrane. They are involved in outer membrane biogenesis and assist outer membrane protein insertion and folding by an unknown mechanism. Homologous proteins exist in eukaryotes, where they mediate outer membrane assembly in organelles of endosymbiotic origin, the mitochondria and chloroplasts. We set out to explore the homologous relationship between cyanobacteria and chloroplasts, studying the Omp85 protein from the thermophilic cyanobacterium Thermosynechococcus elongatus. Using state-of-the art sequence analysis and clustering methods, we show how this protein is more closely related to its chloroplast homologue Toc75 than to proteobacterial Omp85, a finding supported by single channel conductance measurements. We have solved the structure of the periplasmic part of the protein to 1.97 angstrom resolution, and we demonstrate that in contrast to Omp85 from Escherichia coli the protein has only three, not five, polypeptide transport-associated (POTRA) domains, which recognize substrates and generally interact with other proteins in bigger complexes. We model how these POTRA domains are attached to the outer membrane, based on the relationship of Omp85 to two-partner secretion system proteins, which we show and analyze. Finally, we discuss how Omp85 proteins with different numbers of POTRA domains evolved, and evolve to this day, to accomplish an increasing number of interactions with substrates and helper proteins.	[Arnold, Thomas; Zeth, Kornelius; Linke, Dirk] Max Planck Inst Dev Biol, Dept 1, D-72076 Tubingen, Germany	Max Planck Society	Zeth, K (corresponding author), Max Planck Inst Dev Biol, Dept 1, Spemannstr 35, D-72076 Tubingen, Germany.	kornelius.zeth@tuebingen.mpg.de; dirk.linke@tuebingen.mpg.de	Linke, Dirk/F-9147-2010	Linke, Dirk/0000-0003-3150-6752	Max Planck Society; German Science Foundation [SFB766/B4, ZE522/2-3]; Landesstiftung Baden-Wurttemberg, Functional Nanostructures	Max Planck Society(Max Planck Society); German Science Foundation(German Research Foundation (DFG)); Landesstiftung Baden-Wurttemberg, Functional Nanostructures	This work was supported by institutional funding from the Max Planck Society, German Science Foundation Grants SFB766/B4 (to D. L.) and ZE522/2-3 (to K. Z.), and the Landesstiftung Baden-Wurttemberg, Functional Nanostructures (to D. L.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Braun V., 1992, FEMS MICROBIOL LETT, V79, P299; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Duret G, 2008, J BIOL CHEM, V283, P15771, DOI 10.1074/jbc.M708970200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Eswar N., 2007, CURR PROTOC PROTEIN; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hertle R, 2005, CURR PROTEIN PEPT SC, V6, P313, DOI 10.2174/1389203054546370; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mira A, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-50; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesper J, 2008, J BACTERIOL, V190, P4568, DOI 10.1128/JB.00369-08; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Patel R, 2008, PLANT PHYSIOL, V148, P235, DOI 10.1104/pp.108.122754; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petty K.J., 2001, CURR PROTOC PROTEIN; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; REMMERT M, 2010, MOL BIOL EV IN PRESS; Reumann S, 2005, MOL MEMBR BIOL, V22, P73, DOI 10.1080/09687860500041916; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; SCHIEBEL E, 1989, J BIOL CHEM, V264, P16311; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stegmeier JF, 2007, BIOL CHEM, V388, P37, DOI 10.1515/BC.2007.004; Stegmeier JF, 2006, J BIOCHEM, V140, P275, DOI 10.1093/jb/mvj147; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yang FL, 2000, INT J MED MICROBIOL, V290, P529	59	52	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18003	18015		10.1074/jbc.M110.112516	http://dx.doi.org/10.1074/jbc.M110.112516			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20351097	hybrid, Green Published			2022-12-27	WOS:000278133400076
J	Doyle, K; Fitzpatrick, FA				Doyle, Kelly; Fitzpatrick, F. A.			Redox Signaling, Alkylation (Carbonylation) of Conserved Cysteines Inactivates Class I Histone Deacetylases 1, 2, and 3 and Antagonizes Their Transcriptional Repressor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION PRODUCT; KAPPA-B KINASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); CYCLOPENTENONE PROSTAGLANDINS; PROTEIN CARBONYLATION; GROWTH-INHIBITION; COVALENT MODIFICATION; OXIDATIVE STRESS; INFLAMMATION; MECHANISM	Cells use redox signaling to adapt to oxidative stress. For instance, certain transcription factors exist in a latent state that may be disrupted by oxidative modifications that activate their transcription potential. We hypothesized that DNA-binding sites (response elements) for redox-sensitive transcription factors may also exist in a latent state, maintained by co-repressor complexes containing class I histone deacetylase (HDAC) enzymes, and that HDAC inactivation by oxidative stress may antagonize deacetylase activity and unmask electrophile-response elements, thus activating transcription. Electrophiles suitable to test this hypothesis include reactive carbonyl species, often derived from peroxidation of arachidonic acid. We report that alpha,beta-unsaturated carbonyl compounds, e.g. the cyclopentenone prostaglandin, 15-deoxy-Delta 12,14-PGJ(2) (15d-PGJ(2)), and 4-hydroxy-2-nonenal (4HNE), alkylate (carbonylate), a subset of class I HDACs including HDAC1, -2, and -3, but not HDAC8. Covalent modification at two conserved cysteine residues, corresponding to Cys(261) and Cys(273) in HDAC1, coincided with attenuation of histone deacetylase activity, changes in histone H3 and H4 acetylation patterns, derepression of a LEF1 center dot beta-catenin model system, and transcription of HDAC-repressed genes, e. g. heme oxygenase-1 (HO-1), Gadd45, and HSP70. Identification of particular class I HDACs as components of the redox/electrophile-responsive proteome offers a basis for understanding how cells stratify their responses to varying degrees of pathophysiological oxidative stress associated with inflammation, cancer, and metabolic syndrome.	[Doyle, Kelly; Fitzpatrick, F. A.] Univ Utah, Sch Pharm, Dept Med Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Fitzpatrick, FA (corresponding author), Kansas City Univ Med & Biosci, Dept Pharmacol & Microbiol, SEP 429,1750 Independence Ave, Kansas City, MO 64106 USA.	ffitzpatrick@kcumb.edu			National Institutes of Health [R01 AI 26730]; Dee Glen and Ida Smith Chair for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dee Glen and Ida Smith Chair for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI 26730 (to F. A. F.). This work was also supported by the Dee Glen and Ida Smith Chair for Cancer Research.	Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Cattaruzza M, 2008, CIRC RES, V102, P273, DOI 10.1161/CIRCRESAHA.108.172148; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Codreanu SG, 2009, MOL CELL PROTEOMICS, V8, P670, DOI 10.1074/mcp.M800070-MCP200; Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105; Cordray P, 2007, J BIOL CHEM, V282, P32623, DOI 10.1074/jbc.M704369200; Courey AJ, 2001, GENE DEV, V15, P2786; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Gayarre J, 2005, FEBS LETT, V579, P5803, DOI 10.1016/j.febslet.2005.09.069; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Jepsen K, 2002, J CELL SCI, V115, P689; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Lu CB, 2002, J BIOL CHEM, V277, P24368, DOI 10.1074/jbc.M201924200; McCulloch MWB, 2009, BIOORGAN MED CHEM, V17, P2189, DOI 10.1016/j.bmc.2008.10.077; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P500; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P506; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; NOYORI R, 1993, SCIENCE, V259, P44, DOI 10.1126/science.8418493; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; ROBERTS LJ, 1985, PROSTAGLANDINS, V30, P383, DOI 10.1016/0090-6980(85)90114-5; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Stamatakis K, 2006, ANN NY ACAD SCI, V1091, P548, DOI 10.1196/annals.1378.096; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sun JM, 2003, METHODS, V31, P12, DOI 10.1016/S1046-2023(03)00083-5; Suzuki M, 1997, J AM CHEM SOC, V119, P2376, DOI 10.1021/ja9628359; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Valacchi G, 2005, ANTIOXID REDOX SIGN, V7, P25, DOI 10.1089/ars.2005.7.25; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; Wang DF, 2005, J MED CHEM, V48, P6936, DOI 10.1021/jm0505011; West JD, 2006, CHEM RES TOXICOL, V19, P173, DOI 10.1021/tx050321u; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	65	110	112	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17417	17424		10.1074/jbc.M109.089250	http://dx.doi.org/10.1074/jbc.M109.089250			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20385560	Green Published, hybrid			2022-12-27	WOS:000278133400019
J	Goncalves, S; Borges, N; Esteves, AM; Victor, BL; Soares, CM; Santos, H; Matias, PM				Goncalves, Susana; Borges, Nuno; Esteves, Ana M.; Victor, Bruno L.; Soares, Claudio M.; Santos, Helena; Matias, Pedro M.			Structural Analysis of Thermus thermophilus HB27 Mannosyl-3-phosphoglycerate Synthase Provides Evidence for a Second Catalytic Metal Ion and New Insight into the Retaining Mechanism of Glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GENETIC-CHARACTERIZATION; DIFFRACTION DATA; MANNOSYLGLYCERATE; ROTATION; DONOR; CLASSIFICATION; IDENTIFICATION; BIOSYNTHESIS; EFFICIENT	Mannosyl-3-phosphoglycerate synthase is a glycosyltransferase involved in the two-step synthetic pathway of mannosylglycerate, a compatible solute that accumulates in response to salt and/or heat stresses in many microorganisms thriving in hot environments. The three-dimensional structure of mannosyl-3-phosphoglycerate synthase from Thermus thermophilus HB27 in its binary complex form, with GDP-alpha-D-mannose and Mg2+, shows a second metal binding site, about 6 angstrom away from the mannose moiety. Kinetic and mutagenesis studies have shown that this metal site plays a role in catalysis. Additionally, Asp(167) in the DXD motif is found within van der Waals contact distance of the C1' atom in the mannopyranose ring, suggesting its action as a catalytic nucleophile, either in the formation of a glycosylenzyme intermediate according to the double-displacement S(N)2 reaction mechanism or in the stabilization of the oxocarbenium ion-like intermediate according to the D-N*A(Nss) (S(N)i-like) reaction mechanism. We propose that either mechanism may occur in retaining glycosyltransferases with a GT-A fold, and, based on the gathered structural information, we identified an extended structural signature toward a common scaffold between the inverting and retaining glycosyltransferases.	[Goncalves, Susana; Borges, Nuno; Esteves, Ana M.; Victor, Bruno L.; Soares, Claudio M.; Santos, Helena; Matias, Pedro M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal	Universidade Nova de Lisboa	Matias, PM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Apartado 127, P-2781901 Oeiras, Portugal.	matias@itqb.unl.pt	Victor, Bruno L./L-2649-2016; Da Silva Esteves, Ana Maria/N-9216-2019; Soares, Claudio M/E-2675-2012; Matias, Pedro M/B-7180-2008; Borges, Nuno/Q-3515-2019; Borges, Nuno/A-1427-2011; Santos, Helena/B-9141-2011; da Silva Esteves, Ana Maria/O-9427-2014	Victor, Bruno L./0000-0002-6472-5700; Da Silva Esteves, Ana Maria/0000-0002-4932-4431; Soares, Claudio M/0000-0003-1154-556X; Matias, Pedro M/0000-0001-6170-451X; Borges, Nuno/0000-0002-3277-8517; Borges, Nuno/0000-0002-3277-8517; Santos, Helena/0000-0002-8050-9485; da Silva Esteves, Ana Maria/0000-0002-4932-4431	Diamond Light Source [226716]; Fundacao para a Ciencia e Tecnologia [PTDC/QUI/71142/2006, SFRH/BPD/29708/2006, SFRH/BD/23222/2005]	Diamond Light Source; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was carried out with the support of the Diamond Light Source, funded by Seventh Framework Programme Grant 226716, and Fundacao para a Ciencia e Tecnologia Grants PTDC/QUI/71142/2006, SFRH/BPD/29708/2006, and SFRH/BD/23222/2005.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Alarico S, 2007, EXTREMOPHILES, V11, P833, DOI 10.1007/s00792-007-0106-x; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Pereira PJB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003748; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borges N, 2004, J BIOL CHEM, V279, P9892, DOI 10.1074/jbc.M312186200; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bulter T, 1999, GLYCOCONJUGATE J, V16, P147, DOI 10.1023/A:1026444726698; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Empadinhas N, 2003, APPL ENVIRON MICROB, V69, P3272, DOI 10.1128/AEM.69.6.3272-3279.2003; Empadinhas N, 2001, J BIOL CHEM, V276, P43580, DOI 10.1074/jbc.M108054200; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faria TQ, 2008, CARBOHYD RES, V343, P3025, DOI 10.1016/j.carres.2008.08.030; Flint J, 2005, NAT STRUCT MOL BIOL, V12, P608, DOI 10.1038/nsmb950; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Goncalves S, 2009, ACTA CRYSTALLOGR F, V65, P1014, DOI 10.1107/S1744309109032576; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Martins LO, 1999, J BIOL CHEM, V274, P35407, DOI 10.1074/jbc.274.50.35407; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; RICHARDSON JS, 1977, NATURE, V268, P495, DOI 10.1038/268495a0; Sa-Moura B, 2008, ACTA CRYSTALLOGR F, V64, P760, DOI 10.1107/S1744309108021490; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Santos H, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P86; Santos Helena, 2008, P9; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; TOM DH, 1999, ANGEW CHEM INT EDIT, V38, P750; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	59	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17857	17868		10.1074/jbc.M109.095976	http://dx.doi.org/10.1074/jbc.M109.095976			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356840	Green Published, hybrid			2022-12-27	WOS:000278133400063
J	Hervas-Aguilar, A; Galindo, A; Penalva, MA				Hervas-Aguilar, America; Galindo, Antonio; Penalva, Miguel A.			Receptor-independent Ambient pH Signaling by Ubiquitin Attachment to Fungal Arrestin-like PalF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; TRANSCRIPTION FACTOR; ESCRT MACHINERY; CANDIDA-ALBICANS; GENE-EXPRESSION; RIM101 PATHWAY; BETA-ARRESTIN; CELL-SURFACE; PROTEIN	The seven-transmembrane receptor PalH and its coupled, positive-acting arrestin-like protein PalF are key components of a molecular sensor that in Aspergillus nidulans and other ascomycete fungi mediates activation of an intracellular signaling cascade by alkaline ambient pH. PalF is ubiquitinated in an alkaline pH-and PalH-dependent manner. We show here that PalF assists the plasma membrane localization of PalH and that PalF overexpression slightly hypersensitizes the pathway to alkaline pH but does not bypass the need for the ambient pH signal receptor in signaling. In contrast, covalent attachment of Ub to PalF activates the signaling pathway under acidic pH conditions in which the pathway is normally inactive, demonstrating a positive role for ubiquitination. We further show that PalF acts upstream of, or in concert with, the Bro1 domain-containing pH signaling protein PalC, which is normally recruited to cortical structures likely to represent active pH signaling foci under neutral/alkaline pH conditions. In agreement with its pathway-activating consequences, expression of PalF-Ub also promotes PalC cortical recruitment under acidic conditions. Notably, our data establish that expression of PalF-Ub, at approximately physiological levels, in a null palH background leads to a considerable degree of signaling even in the complete absence of the receptor. Thus PalF ubiquitination is a key, perhaps the sole, molecular trigger required for transmitting the alkaline pH signal to the downstream elements of the pathway.	[Hervas-Aguilar, America; Galindo, Antonio; Penalva, Miguel A.] CSIC, Ctr Invest Biol, Dept Mol & Cellular Med, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Penalva, MA (corresponding author), Ramiro de Maeztu 9, Madrid 28040, Spain.	penalva@cib.csic.es	Galindo, Antonio/A-9991-2018; Penalva, Miguel A/G-2295-2015	Galindo, Antonio/0000-0002-1108-652X; Penalva, Miguel A/0000-0002-3102-2806	Direccion General de Investigacion (Spain) [BIO2009-7281]; Comunidad de Madrid [SAL/0246/2006]	Direccion General de Investigacion (Spain)(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Grant BIO2009-7281 from Direccion General de Investigacion (Spain) and by Comunidad de Madrid Grant SAL/0246/2006 (to M. A. P.).	Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; Calcagno-Pizarelli AM, 2007, EUKARYOT CELL, V6, P2365, DOI 10.1128/EC.00275-07; Castrejon F, 2006, EUKARYOT CELL, V5, P507, DOI 10.1128/EC.5.3.507-517.2006; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Galindo A, 2007, TRAFFIC, V8, P1346, DOI 10.1111/j.1600-0854.2007.00620.x; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hervas-Aguilar A, 2007, J BIOL CHEM, V282, P34735, DOI 10.1074/jbc.M706723200; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Negrete-Urtasun S, 1999, MOL MICROBIOL, V33, P994, DOI 10.1046/j.1365-2958.1999.01540.x; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; OREJAS M, 1995, GENE DEV, V9, P1622, DOI 10.1101/gad.9.13.1622; Pantazopoulou A, 2009, MOL BIOL CELL, V20, P4335, DOI 10.1091/mbc.E09-03-0254; Penalva MA, 2002, MICROBIOL MOL BIOL R, V66, P426, DOI 10.1128/MMBR.66.3.426-446.2002; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Penas MM, 2007, EUKARYOT CELL, V6, P960, DOI 10.1128/EC.00047-07; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rodriguez-Galan O, 2009, J BIOL CHEM, V284, P4404, DOI 10.1074/jbc.M808645200; Serrano R, 2006, J BIOL CHEM, V281, P39785, DOI 10.1074/jbc.M604497200; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666	36	47	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18095	18102		10.1074/jbc.M110.114371	http://dx.doi.org/10.1074/jbc.M110.114371			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368671	Green Published, hybrid			2022-12-27	WOS:000278133400084
J	Kong, W; He, LL; Coppola, M; Guo, JP; Esposito, NN; Coppola, D; Cheng, JQ				Kong, William; He, Lili; Coppola, Marc; Guo, Jianping; Esposito, Nicole N.; Coppola, Domenico; Cheng, Jin Q.			MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO3A; B-CELL; PROMOTES TUMORIGENESIS; GENE-EXPRESSION; PATHWAY; ACTIVATION; APOPTOSIS; KINASE; RESISTANCE; MIR-155	Breast cancer is the second leading cause of cancer death in women. Despite improvement in treatment over the past few decades, there is an urgent need for development of targeted therapies. miR-155 (microRNA-155) is frequently up-regulated in breast cancer. In this study, we demonstrate the critical role of miR-155 in regulation of cell survival and chemosensitivity through down-regulation of FOXO3a in breast cancer. Ectopic expression of miR-155 induces cell survival and chemoresistance to multiple agents, whereas knockdown of miR-155 renders cells to apoptosis and enhances chemosensitivity. Further, we identified FOXO3a as a direct target of miR-155. Sustained overexpression of miR-155 resulted in repression of FOXO3a protein without changing mRNA levels, and knockdown of miR-155 increases FOXO3a. Introduction of FOXO3a cDNA lacking the 3'-untranslated region abrogates miR-155-induced cell survival and chemoresistance. Finally, inverse correlation between miR-155 and FOXO3a levels were observed in a panel of breast cancer cell lines and tumors. In conclusion, our study reveals a molecular link between miR-155 and FOXO3a and presents evidence that miR-155 is a critical therapeutic target in breast cancer.	[Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Esposito, Nicole N.; Coppola, Domenico] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Cheng, JQ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org	He, Lili/A-6356-2012		National Institutes of Health [CA137041]; Department of Defense [W81XWH-08-2-0101]; Bankhead-Coley Grant [09BB-05]; NATIONAL CANCER INSTITUTE [R01CA137041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Bankhead-Coley Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA137041. This work was also supported by Department of Defense Grant W81XWH-08-2-0101 and Bankhead-Coley Grant 09BB-05.	Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Belguise K, 2007, CANCER RES, V67, P5763, DOI 10.1158/0008-5472.CAN-06-4327; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krol J, 2007, MOL CANCER THER, V6, P3169, DOI 10.1158/1535-7163.MCT-07-0507; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE EYHP, 1985, P NATL ACAD SCI USA, V82, P1419, DOI 10.1073/pnas.82.5.1419; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Morelli C, 2010, MOL CELL BIOL, V30, P857, DOI 10.1128/MCB.00824-09; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park S, 2009, J BIOL CHEM, V284, P2187, DOI 10.1074/jbc.M806131200; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Radisavljevic Z, 2003, CANCER, V97, P1358, DOI 10.1002/cncr.10081; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Turner M, 2008, BIOCHEM SOC T, V36, P531, DOI 10.1042/BST0360531; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	66	281	302	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17869	17879		10.1074/jbc.M110.101055	http://dx.doi.org/10.1074/jbc.M110.101055			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371610	Green Published, hybrid			2022-12-27	WOS:000278133400064
J	Kunii, S; Morimoto, K; Nagai, K; Saito, T; Sato, K; Tonomura, B				Kunii, Saori; Morimoto, Koichi; Nagai, Kouhei; Saito, Takuya; Sato, Kenji; Tonomura, Ben'ichiro			Actinidain-hydrolyzed Type I Collagen Reveals a Crucial Amino Acid Sequence in Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; BINDING-SITES; C-TELOPEPTIDE; FIBRILLOGENESIS; INVITRO; CONFORMATION; PROTEIN; ENZYME; STABILIZE; PEPTIDES	We investigated the ability of type I collagen telopeptides to bind neighboring collagen molecules, which is thought to be the initial event in fibrillogenesis. Limited hydrolysis by actinidain protease produced monomeric collagen, which consisted almost entirely of alpha 1 and alpha 2 chains. As seen with ultrahigh resolution scanning electron microscopy, actinidain-hydrolyzed collagen exhibited unique self-assembly, as if at an intermediate stage, and formed a novel suprastructure characterized by poor fibrillogenesis. Then, the N- and C-terminal sequences of chicken type I collagen hydrolyzed by actinidain or pepsin were determined by Edman degradation and de novo sequence analysis with matrix-assisted laser desorption ionization-tandem time-of-flight mass spectrometry, respectively. In the C-telopeptide region of the alpha 1 chain, pepsin cleaved between Asp(1035) and Phe(1036), and actinidain between Gly(1032) and Gly(1033). Thus, the actinidain-hydrolyzed alpha 1 chain is shorter at the C terminus by three residues, Gly(1033), Phe(1034), and Asp(1035). In the alpha 2 chain, both proteases cleaved between Glu(1030) and Val(1031). We demonstrated that a synthetic nonapeptide mimicking the alpha 1 C-terminal sequence including GFD weakly inhibited the self-assembly of pepsin-hydrolyzed collagen, whereas it remarkably accelerated that of actinidain-hydrolyzed collagen. We conclude that the specific GFD sequence of the C-telopeptide of the alpha 1 chain plays a crucial role in stipulating collagen suprastructure and in subsequent fibril formation.	Kinki Univ, Dept Biotechnol Sci, Wakayama 6496493, Japan; [Nagai, Kouhei] St Marianna Univ, Sch Med, Grad Sch Med, Kawasaki Ku, Kanagawa 2168511, Japan; [Sato, Kenji] Kyoto Prefectural Univ, Div Appl Life Sci, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan	Kindai University (Kinki University); Saint Marianna University; Kyoto Prefectural University		morimoto@waka.kindai.ac.jp	Morimoto, Koichi/ABI-2606-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [16500307]; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by Grant-in-aid for Scientific Research 16500307 (to K. M.), a grant-in-aid for the 21st Century COE Program "Centers of Excellence" of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Wakayama Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence of the Japan Science and Technology Agency.	Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200; Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5; Cabral WA, 2002, J BIOL CHEM, V277, P4215, DOI 10.1074/jbc.M109048200; CAPALDI MJ, 1982, BIOPOLYMERS, V21, P2291, DOI 10.1002/bip.360211115; CARNE A, 1978, BIOCHEM J, V173, P73, DOI 10.1042/bj1730073; Chung HJ, 2008, J BIOL CHEM, V283, P25879, DOI 10.1074/jbc.M804272200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; GELMAN RA, 1979, J BIOL CHEM, V254, P180; GELMAN RA, 1979, J BIOL CHEM, V254, P1741; HELSETH DL, 1979, BIOPOLYMERS, V18, P3005, DOI 10.1002/bip.1979.360181208; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; HULMES DJS, 1980, INT J BIOL MACROMOL, V2, P338, DOI 10.1016/0141-8130(80)90015-X; JONES EY, 1987, BIOPOLYMERS, V26, P463, DOI 10.1002/bip.360260403; Kadler KE, 1996, BIOCHEM J, V316, P1; Kuznetsova N, 1999, J BIOL CHEM, V274, P36083, DOI 10.1074/jbc.274.51.36083; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Malone JP, 2004, BIOCHEMISTRY-US, V43, P15358, DOI 10.1021/bi048304b; Malone JP, 2004, PROTEINS, V54, P206, DOI 10.1002/prot.10526; MCDOWALL MA, 1970, EUR J BIOCHEM, V14, P214, DOI 10.1111/j.1432-1033.1970.tb00280.x; Morimoto K, 2004, BIOSCI BIOTECH BIOCH, V68, P861, DOI 10.1271/bbb.68.861; Morimoto K, 2006, J BIOCHEM, V139, P1065, DOI 10.1093/jb/mvj106; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; Nagai K, 2008, ELECTROPHORESIS, V29, P672, DOI 10.1002/elps.200700461; Nakayama T, 2006, VIROLOGY, V350, P484, DOI 10.1016/j.virol.2006.03.004; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Paige MF, 1998, BIOPHYS J, V74, P3211, DOI 10.1016/S0006-3495(98)78027-0; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; Slatter DA, 2003, J MOL BIOL, V329, P175, DOI 10.1016/S0022-2836(03)00380-2; SNOWDEN JM, 1979, BIOCHIM BIOPHYS ACTA, V580, P372, DOI 10.1016/0005-2795(79)90149-1; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Veis A., 1994, EXTRACELLULAR MATRIX, P15, DOI DOI 10.1016/B978-0-12-775170-2.50007-X; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172	37	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17465	17470		10.1074/jbc.M110.110759	http://dx.doi.org/10.1074/jbc.M110.110759			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20392700	Green Published, hybrid			2022-12-27	WOS:000278133400024
J	Galdiero, S; Falanga, A; Vitiello, M; Raiola, L; Russo, L; Pedone, C; Isernia, C; Galdiero, M				Galdiero, Stefania; Falanga, Annarita; Vitiello, Mariateresa; Raiola, Luca; Russo, Luigi; Pedone, Carlo; Isernia, Carla; Galdiero, Massimiliano			The Presence of a Single N-terminal Histidine Residue Enhances the Fusogenic Properties of a Membranotropic Peptide Derived from Herpes Simplex Virus Type 1 Glycoprotein H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEINS; SURFACE-PLASMON RESONANCE; CELL-FUSION; SYNTHETIC PEPTIDES; CRYSTAL-STRUCTURE; CYTOPLASMIC TAIL; LYTIC PEPTIDES; HEPTAD-REPEAT; ALPHA-HELIX; DOMAINS	Herpes simplex virus type 1 (HSV-1)-induced membrane fusion remains one of the most elusive mechanisms to be deciphered in viral entry. The structure resolution of glycoprotein gB has revealed the presence of fusogenic domains in this protein and pointed out the key role of gB in the entry mechanism of HSV-1. A second putative fusogenic glycoprotein is represented by the heterodimer comprising the membrane-anchored glycoprotein H (gH) and the small secreted glycoprotein L, which remains on the viral envelope in virtue of its non-covalent interaction with gH. Different domains scattered on the ectodomain of HSV-1 gH have been demonstrated to display membranotropic characteristics. The segment from amino acid 626 to 644 represents the most fusogenic region identified by studies with synthetic peptides and model membranes. Herein we have identified the minimal fusogenic sequence present on gH. An enlongation at the N terminus of a single histidine (His) has proved to profoundly increase the fusogenic activity of the original sequence. Nuclear magnetic resonance (NMR) studies have shown that the addition of the N-terminal His contributes to the formation and stabilization of an alpha-helical domain with high fusion propensity.	[Galdiero, Stefania; Falanga, Annarita; Pedone, Carlo] Univ Naples Federico II, Dept Biol Sci, Div Biostruct, I-80134 Naples, Italy; [Galdiero, Stefania; Pedone, Carlo; Galdiero, Massimiliano] Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioattivi, I-80134 Naples, Italy; [Vitiello, Mariateresa; Galdiero, Massimiliano] Univ Naples 2, Dept Expt Med, I-80138 Naples, Italy; [Galdiero, Stefania; Pedone, Carlo] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Raiola, Luca; Russo, Luigi; Isernia, Carla] Univ Naples 2, Dept Environm Sci, I-81100 Caserta, Italy	University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Universita della Campania Vanvitelli	Galdiero, S (corresponding author), Univ Naples Federico II, Dept Biol Sci, Div Biostruct, Via Mezzocannone 16, I-80134 Naples, Italy.	sgaldier@unina.it	Isernia, Carla/ABD-8156-2021; Galdiero, Stefania/M-3225-2019; galdiero, stefania/B-1357-2010	Galdiero, Stefania/0000-0002-7849-7024; Galdiero, Massimiliano/0000-0002-1576-6290; Isernia, Carla/0000-0002-1504-2479; RUSSO, Luigi/0000-0002-1577-176X; FALANGA, Annarita/0000-0001-6538-8585				Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Avitabile E, 2009, J VIROL, V83, P10752, DOI 10.1128/JVI.01287-09; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Brasseur R, 1997, TRENDS BIOCHEM SCI, V22, P167, DOI 10.1016/S0968-0004(97)01047-5; Cairns TM, 2005, VIROLOGY, V332, P550, DOI 10.1016/j.virol.2004.12.006; CAL WH, 1988, J VIROL, V62, P2596, DOI 10.1128/JVI.62.8.2596-2604.1988; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chanel-Vos C, 2004, J VIROL, V78, P13543, DOI 10.1128/JVI.78.24.13543-13552.2004; DEGRADO WF, 1990, BIOPOLYMERS, V29, P205, DOI 10.1002/bip.360290125; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; Durell SR, 1997, MOL MEMBR BIOL, V14, P97, DOI 10.3109/09687689709048170; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; GAGE PJ, 1993, J VIROL, V67, P2191, DOI 10.1128/JVI.67.4.2191-2201.1993; Galdiero M, 1997, J VIROL, V71, P2163, DOI 10.1128/JVI.71.3.2163-2170.1997; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; GALDIERO S, 2009, Patent No. 61285619; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Galdiero S, 2010, BBA-BIOMEMBRANES, V1798, P579, DOI 10.1016/j.bbamem.2010.01.006; Gianni T, 2005, J VIROL, V79, P7042, DOI 10.1128/JVI.79.11.7042-7049.2005; Gianni T, 2005, J VIROL, V79, P2931, DOI 10.1128/JVI.79.5.2931-2940.2005; GORDON LM, 1992, BIOCHIM BIOPHYS ACTA, V1139, P257, DOI 10.1016/0925-4439(92)90099-9; Guillen J, 2008, BBA-BIOMEMBRANES, V1778, P2765, DOI 10.1016/j.bbamem.2008.07.021; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; Hannah BP, 2007, J VIROL, V81, P4858, DOI 10.1128/JVI.02755-06; Harman A, 2002, J VIROL, V76, P10708, DOI 10.1128/JVI.76.21.10708-10716.2002; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krishnan A, 2009, J VIROL, V83, P1727, DOI 10.1128/JVI.02026-08; LEAR JD, 1987, J BIOL CHEM, V262, P6500; Lopper M, 2004, J VIROL, V78, P8333, DOI 10.1128/jvi.78.15.8333-8341.2004; LUNEBERG J, 1995, J BIOL CHEM, V270, P27606; Madu IG, 2009, J VIROL, V83, P7411, DOI 10.1128/JVI.00079-09; Martin I, 2000, BIOSCIENCE REP, V20, P483, DOI 10.1023/A:1010454803579; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Mozsolits H, 2001, BBA-BIOMEMBRANES, V1512, P64, DOI 10.1016/S0005-2736(01)00303-0; Papo N, 2003, BIOCHEMISTRY-US, V42, P458, DOI 10.1021/bi0267846; PARENTE RA, 1990, BIOCHEMISTRY-US, V29, P8713, DOI 10.1021/bi00489a030; RAFALSKI M, 1990, BIOCHEMISTRY-US, V29, P7917, DOI 10.1021/bi00486a020; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Schibli DJ, 2004, MOL MEMBR BIOL, V21, P361, DOI 10.1080/09687860400017784; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2000, BIOSCIENCE REP, V20, P535, DOI 10.1023/A:1010411021326; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; STEINHAUER DA, 1995, J VIROL, V69, P6643, DOI 10.1128/JVI.69.11.6643-6651.1995; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Tamm LK, 2000, BIOSCIENCE REP, V20, P501, DOI 10.1023/A:1010406920417; Vitiello M, 2009, PROTEIN PEPTIDE LETT, V16, P786, DOI 10.2174/092986609788681742; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILSON DW, 1994, J VIROL, V68, P6985, DOI 10.1128/JVI.68.11.6985-6993.1994; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhu NL, 1998, J VIROL, V72, P1632, DOI 10.1128/JVI.72.2.1632-1639.1998	70	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17123	17136		10.1074/jbc.M110.114819	http://dx.doi.org/10.1074/jbc.M110.114819			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20348105	Green Published, hybrid			2022-12-27	WOS:000277982600075
J	Timofeev, O; Cizmecioglu, O; Settele, F; Kempf, T; Hoffmann, I				Timofeev, Oleg; Cizmecioglu, Onur; Settele, Florian; Kempf, Tore; Hoffmann, Ingrid			Cdc25 Phosphatases Are Required for Timely Assembly of CDK1-Cyclin B at the G(2)/M Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK-ACTIVATING KINASE; HUMAN CYCLIN-A; CELL-CYCLE; S-PHASE; DEPENDENT PHOSPHORYLATION; DNA-DAMAGE; IN-VIVO; T-LOOP; MITOSIS; COMPLEX	Progression through mitosis requires the coordinated regulation of Cdk1 kinase activity. Activation of Cdk1 is a multistep process comprising binding of Cdk1 to cyclin B, relocation of cyclin-kinase complexes to the nucleus, activating phosphorylation of Cdk1 on Thr(161) by the Cdk-activating kinase (CAK; Cdk7 in metazoans), and removal of inhibitory Thr(14) and Tyr(15) phosphorylations. This dephosphorylation is catalyzed by the dual specific Cdc25 phosphatases, which occur in three isoforms in mammalian cells, Cdc25A, -B, and -C. We find that expression of Cdc25A leads to an acceleratedG(2)/Mphase transition. In Cdc25A-overexpressing cells, Cdk1 exhibits high kinase activity despite being phosphorylated on Tyr(15). In addition, Tyr(15)-phosphorylated Cdk1 binds more cyclinBin Cdc25A-overexpressing cells compared with control cells. Consistent with this observation, we demonstrate that in human transformed cells, Cdc25A and Cdc25B, but not Cdc25C phosphatases have an effect on timing and efficiency of cyclin-kinase complex formation. Overexpression of Cdc25A or Cdc25B promotes earlier assembly and activation of Cdk1-cyclin B complexes, whereas repression of these phosphatases by short hairpin RNA has a reverse effect, leading to a substantial decrease in amounts of cyclin B-bound Cdk1 in G(2) and mitosis. Importantly, we find that Cdc25A overexpression leads to an activation of Cdk7 and increase in Thr161 phosphorylation of Cdk1. In conclusion, our data suggest that complex assembly and dephosphorylation of Cdk1 at G(2)/M is tightly coupled and regulated by Cdc25 phosphatases.	[Timofeev, Oleg; Cizmecioglu, Onur; Settele, Florian; Kempf, Tore; Hoffmann, Ingrid] German Canc Res Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Hoffmann, I (corresponding author), German Canc Res Ctr, F045,Neuenheimer Feld 242, D-69120 Heidelberg, Germany.	ingrid.hoffmann@dkfz.de	Cizmecioglu, Onur/AAA-6289-2020; Cizmecioglu, Onur/AAF-5874-2020	Cizmecioglu, Onur/0000-0002-7608-6950; Timofeev, Oleg/0000-0002-3114-6403	Deutsche Krebshilfe [107058]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Deutsche Krebshilfe Grant 107058 (to I.H.).	ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Coulonval K, 2003, J BIOL CHEM, V278, P52052, DOI 10.1074/jbc.M307012200; Crasta K, 2006, EMBO J, V25, P2551, DOI 10.1038/sj.emboj.7601136; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Gabrielli BG, 1997, J BIOL CHEM, V272, P28607, DOI 10.1074/jbc.272.45.28607; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Garrett S, 2001, MOL CELL BIOL, V21, P88, DOI 10.1128/MCB.21.1.88-99.2001; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hu B, 2001, MOL CELL BIOL, V21, P2755, DOI 10.1128/MCB.21.8.2755-2766.2001; Lammer C, 1998, J CELL SCI, V111, P2445; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Larochelle S, 2001, EMBO J, V20, P3749, DOI 10.1093/emboj/20.14.3749; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Liu F, 1999, MOL CELL BIOL, V19, P5113; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mitra J, 2004, ONCOGENE, V23, P3361, DOI 10.1038/sj.onc.1207446; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; PINES J, 1992, CIBA F SYMP, V170, P187; POON RYC, 1994, J CELL SCI, V107, P2789; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; Rudolph J, 2001, ANAL BIOCHEM, V289, P43, DOI 10.1006/abio.2000.4906; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Timofeev O, 2009, FEBS LETT, V583, P841, DOI 10.1016/j.febslet.2009.01.044; WELCH PJ, 1992, P NATL ACAD SCI USA, V89, P3093, DOI 10.1073/pnas.89.7.3093	48	98	103	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16978	16990		10.1074/jbc.M109.096552	http://dx.doi.org/10.1074/jbc.M109.096552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360007	hybrid, Green Published			2022-12-27	WOS:000277982600061
J	Xu, LH; Fushinobu, S; Takamatsu, S; Wakagi, T; Ikeda, H; Shoun, H				Xu, Lian-Hua; Fushinobu, Shinya; Takamatsu, Satoshi; Wakagi, Takayoshi; Ikeda, Haruo; Shoun, Hirofumi			Regio- and Stereospecificity of Filipin Hydroxylation Sites Revealed by Crystal Structures of Cytochrome P450 105P1 and 105D6 from Streptomyces avermitilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYENE ANTIBIOTICS; DIOXYGEN COMPLEX; WILD-TYPE; CONFIGURATION; BIOSYNTHESIS; ACTIVATION; MOLECULES; MECHANISM; P450ERYF; NADH	The polyene macrolide antibiotic filipin is widely used as a probe for cholesterol and a diagnostic tool for type C Niemann-Pick disease. Two position-specific P450 enzymes are involved in the post-polyketide modification of filipin during its biosynthesis, thereby providing molecular diversity to the "filipin complex." CYP105P1 and CYP105D6 from Streptomyces avermitilis, despite their high sequence similarities, catalyze filipin hydroxylation at different positions, C26 and C1', respectively. Here, we determined the crystal structure of the CYP105P1-filipin I complex. The distal pocket of CYP105P1 has the second largest size among P450 hydroxylases that act on macrolide substrates. Compared with previously determined substrate-free structures, the FG helices showed significant closing motion on substrate binding. The long BC loop region adopts a unique extended conformation without a B' helix. The binding site is essentially hydrophobic, but numerous water molecules are involved in recognizing the polyol side of the substrate. Therefore, the distal pocket of CYP105P1 provides a specific environment for the large filipin substrate to bind with its pro-S side of position C26 directed toward the heme iron. The ligand-free CYP105D6 structure was also determined. A small sub-pocket accommodating the long alkyl side chain of filipin I was observed in the CYP105P1 structure but was absent in the CYP105D6 structure, indicating that filipin cannot bind to CYP105D6 with a similar orientation due to steric hindrance. This observation can explain the strict regiospecificity of these enzymes.	[Xu, Lian-Hua; Fushinobu, Shinya; Wakagi, Takayoshi; Shoun, Hirofumi] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Takamatsu, Satoshi; Ikeda, Haruo] Kitasato Univ, Kitasato Inst Life Sci, Kanagawa 2288555, Japan	University of Tokyo; Kitasato University	Shoun, H (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahshoun@mail.ecc.u-tokyo.ac.jp	Wakagi, Takayoshi/AAJ-4145-2021; Takamatsu, Satoshi/AAW-5197-2020; Fushinobu, Shinya/E-4987-2011	Takamatsu, Satoshi/0000-0001-5620-6196; Fushinobu, Shinya/0000-0003-1346-6435	Japan Society for the Promotion of Science [20248009, 20310122]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research 20248009 (to H. S.) and 20310122 (to H. I.) from the Japan Society for the Promotion of Science.	BERGY ME, 1968, BIOCHEMISTRY-US, V7, P653, DOI 10.1021/bi00842a021; BUTLER JD, 1987, P NATL ACAD SCI USA, V84, P556, DOI 10.1073/pnas.84.2.556; BUTLER JD, 1992, J BIOL CHEM, V267, P23797; Chen L, 2009, FEMS MICROBIOL LETT, V298, P199, DOI 10.1111/j.1574-6968.2009.01721.x; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; EDWARDS DMF, 1989, J ANTIBIOT, V42, P322, DOI 10.7164/antibiotics.42.322; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fjaervik E, 2005, APPL MICROBIOL BIOT, V67, P436, DOI 10.1007/s00253-004-1802-4; Gimpl G, 2007, BIOSCIENCE REP, V27, P335, DOI 10.1007/s10540-007-9060-1; Guengerich FP, 2002, NAT REV DRUG DISCOV, V1, P359, DOI 10.1038/nrd792; Ho WW, 2008, BIOCHEMISTRY-US, V47, P2071, DOI 10.1021/bi702240k; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Lamb DC, 2007, CURR OPIN BIOTECH, V18, P504, DOI 10.1016/j.copbio.2007.09.010; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; McLean KJ, 2005, BIOCHEM SOC T, V33, P796, DOI 10.1042/BST0330796; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2003, J BIOL CHEM, V278, P44886, DOI 10.1074/jbc.M308115200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; NAKAHARA K, 1993, J BIOL CHEM, V268, P8350; Omura S., 2002, MACROLIDE ANTIBIOTIC; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Oshima R, 2004, J MOL BIOL, V342, P207, DOI 10.1016/j.jmb.2004.07.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PANDEY RC, 1970, J ANTIBIOT, V23, P414, DOI 10.7164/antibiotics.23.414; PANDEY RC, 1972, J AM CHEM SOC, V94, P4306, DOI 10.1021/ja00767a045; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Poulos TL, 2007, DRUG METAB REV, V39, P557, DOI 10.1080/03602530701498240; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Richardson TI, 1996, J ORG CHEM, V61, P4219, DOI 10.1021/jo960218x; ROSE IA, 1980, P NATL ACAD SCI-BIOL, V77, P2439, DOI 10.1073/pnas.77.5.2439; RYCHNOVSKY SD, 1995, ANGEW CHEM INT EDIT, V34, P1227, DOI 10.1002/anie.199512271; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Sugimoto H, 2008, BIOCHEMISTRY-US, V47, P4017, DOI 10.1021/bi7023767; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volpon L, 2000, FEBS LETT, V478, P137, DOI 10.1016/S0014-5793(00)01824-X; Wachtler V, 2006, TRENDS CELL BIOL, V16, P1, DOI 10.1016/j.tcb.2005.11.008; WHITFIELD GB, 1955, J AM CHEM SOC, V77, P4799, DOI 10.1021/ja01623a032; Xu LH, 2009, J BACTERIOL, V191, P1211, DOI 10.1128/JB.01276-08; Xue YQ, 2001, METAB ENG, V3, P15, DOI 10.1006/mben.2000.0167; Yasutake Y, 2007, BIOCHEM BIOPH RES CO, V361, P876, DOI 10.1016/j.bbrc.2007.07.062; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200; Zhao B, 2005, J BIOL CHEM, V280, P42188, DOI 10.1074/jbc.M509220200	50	48	48	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16844	16853		10.1074/jbc.M109.092460	http://dx.doi.org/10.1074/jbc.M109.092460			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20375018	hybrid, Green Published			2022-12-27	WOS:000277982600048
J	Rajakumari, S; Daum, G				Rajakumari, Sona; Daum, Guenther			Multiple Functions as Lipase, Steryl Ester Hydrolase, Phospholipase, and Acyltransferase of Tgl4p from the Yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MICROSOMES; PHOSPHATIDIC-ACID; TRIACYLGLYCEROL LIPASE; LIPID PARTICLES; FATTY-ACID; LYSOPHOSPHATIDIC ACID; PROTEIN; METABOLISM; PHOSPHATIDYLCHOLINE; ENCODES	Triacylglycerol (TAG) hydrolysis, membrane lipid biosynthesis, and lipid turnover are largely interlinked processes. In yeast, TAG is mobilized by three TAG lipases named Tgl3p, Tgl4p, and Tgl5p, which are localized to lipid particles/droplets. These TAG lipases posses a conserved GXSXG motif that is characteristic of hydrolytic enzymes. Here, we demonstrated that the yeast TAG lipase Tgl4p, the functional ortholog of the adipose TAG lipase, ATGL, catalyzes multiple functions in lipid metabolism. An extended domain and motif search analysis revealed that Tgl4p bears not only a lipase consensus domain but also a conserved motif for calcium-independent phospholipase A(2). We show that Tgl4p exhibits TAG lipase, steryl ester hydrolase, and phospholipase A(2) activities, but surprisingly it also catalyzed the acyl-CoA-dependent acylation of lysophosphatidic acid to phosphatidic acid (PA). Heterologous overexpression of Tgl4p in Pichia pastoris increased total phospholipid and specifically PA synthesis. Moreover, deletion of TGL4 in Saccharomyces cerevisiae showed an altered pattern of phosphatidylcholine and PA molecular species. Altogether, our data suggest that yeast Tgl4p functions as a hydrolytic enzyme in lipid degradation but also contributes to fatty acid channeling and phospholipid remodeling.	[Rajakumari, Sona; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-II, A-8010 Graz, Austria.	guenther.daum@tugraz.at			Fonds zur Forderung der wissenschaftlichen Forschung in Osterreich [18857, W901-B05]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung in Osterreich(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Fonds zur Forderung der wissenschaftlichen Forschung in Osterreich, Projects 18857 and W901-B05 ( to G. D.).	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Caviglia JM, 2004, J LIPID RES, V45, P1500, DOI 10.1194/jlr.M400079-JLR200; COOK HW, 1985, CAN J BIOCHEM CELL B, V63, P919, DOI 10.1139/o85-114; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; DAUM G, 1980, MONATSH CHEM, V111, P355, DOI 10.1007/BF00903231; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fyrst H, 1999, BIOCHEMISTRY-US, V38, P5864, DOI 10.1021/bi9824590; Gao JG, 2009, MOL GENET METAB, V96, P253, DOI 10.1016/j.ymgme.2008.12.007; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Ghosh AK, 2009, PLANT PHYSIOL, V151, P869, DOI 10.1104/pp.109.144261; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; HAID A, 1983, METHOD ENZYMOL, V96, P192; Holub B J, 1978, Adv Lipid Res, V16, P1; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; INOUE M, 1984, ARCH BIOCHEM BIOPHYS, V231, P29, DOI 10.1016/0003-9861(84)90359-X; IRVINE RF, 1979, BIOCHEM BIOPH RES CO, V91, P1399, DOI 10.1016/0006-291X(79)91222-1; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDS WEM, 1958, J BIOL CHEM, V231, P883; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; LANDS WEM, 1963, J BIOL CHEM, V238, P898; LEE KS, 1994, J BIOL CHEM, V269, P19725; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Mullner H, 2005, J BIOL CHEM, V280, P13321, DOI 10.1074/jbc.M409914200; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Nakanishi H, 2006, J CELL SCI, V119, P1406, DOI 10.1242/jcs.02841; Pinsirodom P, 2000, J AGR FOOD CHEM, V48, P155, DOI 10.1021/jf990338g; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rudge SA, 2004, MOL BIOL CELL, V15, P207, DOI 10.1091/mbc.e03-04-0245; Saarela J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-281; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shan T, 2008, J ANIM SCI, V86, P1781, DOI 10.2527/jas.2007-0659; Stymne S., 1987, Biochemistry of Plants, V9, P175; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wagner A, 2009, BBA-MOL CELL BIOL L, V1791, P118, DOI 10.1016/j.bbalip.2008.11.004; WAGNER S, 1994, YEAST, V10, P1429, DOI 10.1002/yea.320101106; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Xie ZH, 2001, MOL BIOL CELL, V12, P1117, DOI 10.1091/mbc.12.4.1117; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	63	60	62	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15769	15776		10.1074/jbc.M109.076331	http://dx.doi.org/10.1074/jbc.M109.076331			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20332534	Green Published, hybrid			2022-12-27	WOS:000277715900014
J	Han, J; Goldstein, LA; Hou, W; Froelich, CJ; Watkins, SC; Rabinowich, H				Han, Jie; Goldstein, Leslie A.; Hou, Wen; Froelich, Christopher J.; Watkins, Simon C.; Rabinowich, Hannah			Deregulation of Mitochondrial Membrane Potential by Mitochondrial Insertion of Granzyme B and Direct Hax-1 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HS1-ASSOCIATED PROTEIN X-1; CYTOTOXIC T-LYMPHOCYTES; CYTOCHROME-C RELEASE; CELL-DEATH; PERMEABILITY TRANSITION; CYCLOPHILIN-D; CYTOSOLIC DELIVERY; APOPTOTIC EVENTS; EBNA-LP; BAX	The cytoplasm and the nucleus have been identified as activity sites for granzyme B (GrB) following its delivery from cytotoxic lymphocyte granules into target cells. Here we report on the ability of exogenous GrB to insert into and function within a proteinase K-resistant mitochondrial compartment. We identified Hax-1 (HS-1-associated protein X-1), a mitochondrial protein involved in the maintenance of mitochondrial membrane potential, as a GrB substrate within the mitochondrion. GrB cleaves Hax-1 into two major fragments: an N-terminal fragment that localizes to mitochondria and a C-terminal fragment that localizes to the cytosol after being released from GrB-treated mitochondria. The N-terminal Hax-1 fragment major cellular impact is on the regulation of mitochondrial polarization. Overexpression of wild-type Hax-1 or its uncleavable mutant form protects the mitochondria against GrB or valinomycin-mediated depolarization. The N-terminal Hax-1 fragment functions as a dominant negative form of Hax-1, mediating mitochondrial depolarization in a cyclophilin D-dependent manner. Thus, induced expression of the N-terminal Hax-1 fragment results in mitochondrial depolarization and subsequent lysosomal degradation of such altered mitochondria. This study is the first to demonstrate GrB activity within the mitochondrion and to identify Hax-1 cleavage as a novel mechanism for GrB-mediated mitochondrial depolarization.	[Rabinowich, Hannah] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Han, Jie; Goldstein, Leslie A.; Hou, Wen; Rabinowich, Hannah] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Froelich, Christopher J.] Evanston NW Res Inst, Evanston, IL 60201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rabinowich, H (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavil Rm G17C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	rabinow@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [RO1 CA109285, RO1 CA111786]; NATIONAL CANCER INSTITUTE [R01CA109285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA109285 and RO1 CA111786 (to H. R.).	Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Besenicar MP, 2008, BIOCHEM BIOPH RES CO, V371, P391, DOI 10.1016/j.bbrc.2008.04.071; Bots M, 2006, J CELL SCI, V119, P5011, DOI 10.1242/jcs.03239; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Casciola-Rosen L, 2007, J BIOL CHEM, V282, P4545, DOI 10.1074/jbc.M606564200; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Galluzzi L, 2007, NAT CELL BIOL, V9, P487, DOI 10.1038/ncb0507-487; Goping IS, 2008, BLOOD, V111, P2142, DOI 10.1182/blood-2007-08-105221; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Han J, 2004, LEUKEMIA, V18, P1671, DOI 10.1038/sj.leu.2403496; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; Han YC, 2006, CIRC RES, V99, P415, DOI 10.1161/01.RES.0000237387.05259.a5; HANNA WL, 1993, PROTEIN EXPRES PURIF, V4, P398, DOI 10.1006/prep.1993.1052; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Kang HT, 2009, AGING CELL, V8, P426, DOI 10.1111/j.1474-9726.2009.00487.x; Kawaguchi Y, 2000, J VIROL, V74, P10104, DOI 10.1128/JVI.74.21.10104-10111.2000; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Lieberman J, 2003, CURR OPIN IMMUNOL, V15, P553, DOI 10.1016/S0952-7915(03)00108-0; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Matsuda G, 2003, MICROBIOL IMMUNOL, V47, P91, DOI 10.1111/j.1348-0421.2003.tb02790.x; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Packard BZ, 2007, J IMMUNOL, V179, P3812, DOI 10.4049/jimmunol.179.6.3812; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Vafiadaki E, 2007, J MOL BIOL, V367, P65, DOI 10.1016/j.jmb.2006.10.057; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Waterhouse NJ, 2006, IMMUNOL CELL BIOL, V84, P72, DOI 10.1111/j.1440-1711.2005.01416.x; Yedavalli VSRK, 2005, J VIROL, V79, P13735, DOI 10.1128/JVI.79.21.13735-13746.2005; ZHAO W, 2010, P NATL ACAD IN PRESS; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	53	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 16	2010	285	29					22461	22472		10.1074/jbc.M109.086587	http://dx.doi.org/10.1074/jbc.M109.086587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	622YF	20388708	hybrid, Green Published			2022-12-27	WOS:000279702200058
J	Hutnick, LK; Huang, XH; Loo, TC; Ma, ZC; Fan, GP				Hutnick, Leah K.; Huang, Xinhua; Loo, Tao-Chuan; Ma, Zhicheng; Fan, Guoping			Repression of Retrotransposal Elements in Mouse Embryonic Stem Cells Is Primarily Mediated by a DNA Methylation-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACISTERNAL-A-PARTICLE; GENE-EXPRESSION; ENDOGENOUS RETROVIRUSES; PRE-IMPLANTATION; IAP-LTR; GENOME; TRANSCRIPTION; SEQUENCE; TISSUE	In defense of deleterious retrotransposition of intracisternal A particle (IAP) elements, IAP loci are heavily methylated and silenced in mouse somatic cells. To determine whether IAP is also repressed in pluripotent stem cells by DNA methylation, we examined IAP expression in demethylated mouse embryonic stem cells (mESCs) and epiblast-derived stem cells. Surprisingly, in demethylated ESC cultures carrying mutations of DNA methyltransferase I (Dnmt1), no IAP transcripts and proteins are detectable in undifferentiated Oct4(+) ESCs. In contrast, similar to 3.6% of IAP-positive cells are detected in Oct4(-) Dnmt1(-/-) cells, suggesting that the previously observed increase in IAP transcripts in the population of Dnmt1(-/-) ESCs could be accounted for by this subset of Oct4(-) Dnmt1(-/-) ESCs undergoing spontaneous differentiation. Consistent with this possibility, a dramatic increase of IAP mRNA (>100-fold) and protein expression was observed in Dnmt1(-/-) ESC cultures upon induction of differentiation through the withdrawal of leukemia-inhibitory factor for 6 or more days. Interestingly, both mRNAs and proteins of IAP can be readily detected in demethylated Oct4(+) epiblast-derived stem cells as well as differentiated mouse embryo fibroblasts, neurons, and glia upon conditional Dnmt1 gene deletion. These data suggest that mESCs are a unique stem cell type possessing a DNA methylation-independent IAP repression mechanism. This methylation-independent mechanism does not involve Dicer-mediated action of microRNAs or RNA interference because IAP expression remains repressed in Dnmt1(-/-); Dicer(-/-) double mutant ESCs. We suggest that mESCs possess a unique DNA methylation-independent mechanism to silence retrotransposons to safeguard genome stability while undergoing rapid cell proliferation for self-renewal.	[Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Hutnick, Leah K.] Univ Calif Los Angeles, David Geffen Sch Med, Neurosci Interdept Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fan, GP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, 695 Charles Young Dr S, Los Angeles, CA 90095 USA.	gfan@mednet.ucla.edu	Albertini, David/AAD-3856-2021	Albertini, David/0000-0001-6536-2828; Fan, Guoping/0000-0001-5235-6410	National Institutes of Health [RO1 NS051411, P01 GM081621]; California Institute of Regenerative Medicine [RC1-0111]; National Research Service Award [5F31NS051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS051411 and P01 GM081621 (to G. F.). This work was also supported by California Institute of Regenerative Medicine Grant RC1-0111 (to G. F.) and National Research Service Award 5F31NS051 (to L. K. H.).	Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; CALARCO PG, 1979, INTERVIROLOGY, V11, P321, DOI 10.1159/000149053; CONNELLY MA, 1994, P NATL ACAD SCI USA, V91, P1337, DOI 10.1073/pnas.91.4.1337; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Feng JA, 2007, PEDIATR RES, V61, p58R, DOI 10.1203/pdr.0b013e3180457635; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; KUFF EL, 1980, J VIROL, V33, P1211, DOI 10.1128/JVI.33.3.1211-1214.1980; KUFF EL, 1968, CANCER RES, V28, P2137; KUFF EL, 1985, MOL CELL BIOL, V5, P474, DOI 10.1128/MCB.5.3.474; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lee JS, 1999, J VIROL, V73, P5166, DOI 10.1128/JVI.73.6.5166-5171.1999; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Lei H, 1996, DEVELOPMENT, V122, P3195; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; MIETZ JA, 1987, J VIROL, V61, P3020, DOI 10.1128/JVI.61.10.3020-3029.1987; Morita S, 2007, GENOMICS, V89, P687, DOI 10.1016/j.ygeno.2007.01.004; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; POZNANSKI AA, 1991, DEV BIOL, V143, P271, DOI 10.1016/0012-1606(91)90077-G; Ramirez MA, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-55; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sugino H, 2004, GENE, V337, P91, DOI 10.1016/j.gene.2004.04.011; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Ukai H, 2003, MOL CARCINOGEN, V37, P110, DOI 10.1002/mc.10128; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850	45	61	62	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21082	21091		10.1074/jbc.M110.125674	http://dx.doi.org/10.1074/jbc.M110.125674			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20404320	Green Published, hybrid			2022-12-27	WOS:000279228600071
J	Olson, BJSC; Wang, QA; Osteryoung, KW				Olson, Bradley J. S. C.; Wang, Qiang; Osteryoung, Katherine W.			GTP-dependent Heteropolymer Formation and Bundling of Chloroplast FtsZ1 and FtsZ2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSZ; BACTERIAL-CELL-DIVISION; PLASTID DIVISION; ESCHERICHIA-COLI; Z-RING; IN-VITRO; ASSEMBLY DYNAMICS; FORCE GENERATION; GENE FAMILIES; HIGHER-PLANTS	Bacteria and chloroplasts require the ring-forming cytoskeletal protein FtsZ for division. Although bacteria accomplish division with a single FtsZ, plant chloroplasts require two FtsZ types for division, FtsZ1 and FtsZ2. These proteins colocalize to a mid-plastid Z ring, but their biochemical relationship is poorly understood. We investigated the in vitro behavior of recombinant FtsZ1 and FtsZ2 separately and together. Both proteins bind and hydrolyze GTP, although GTPase activities are low compared with the activity of Escherichia coli FtsZ. Each protein undergoes GTP-dependent assembly into thin protofilaments in the presence of calcium as a stabilizing agent, similar to bacterial FtsZ. In contrast, when mixed without calcium, FtsZ1 and FtsZ2 exhibit slightly elevated GTPase activity and coassembly into extensively bundled protofilaments. Coassembly is enhanced by FtsZ1, suggesting that it promotes lateral interactions between protofilaments. Experiments with GTPase-deficient mutants reveal that FtsZ1 and FtsZ2 form heteropolymers. Maximum coassembly occurs in reactions containing equimolar FtsZ1 and FtsZ2, but significant coassembly occurs at other stoichiometries. The FtsZ1: FtsZ2 ratio in coassembled structures mirrors their input ratio, suggesting plasticity in protofilament and/or bundle composition. This behavior contrasts with that of alpha- and beta-tubulin and the bacterial tubulin-like proteins BtubA and BtubB, which coassemble in a strict 1:1 stoichiometry. Our findings raise the possibility that plasticity in FtsZ filament composition and heteropolymerization-induced bundling could have been a driving force for the coevolution of FtsZ1 and FtsZ2 in the green lineage, perhaps arising from an enhanced capacity for the regulation of Z ring composition and activity in vivo.	[Wang, Qiang; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; Michigan State Univ, Biochem & Mol Biol Grad Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Osteryoung, KW (corresponding author), Michigan State Univ, Dept Plant Biol, 166 Plant Biol Bldg, E Lansing, MI 48824 USA.	osteryou@msu.edu	Olson, Bradley J S C/A-4532-2013; Wang, Qiang/P-7806-2016	Olson, Bradley J S C/0000-0002-4751-8347; Wang, Qiang/0000-0002-7388-4703	Michigan State University Plant Sciences; National Science Foundation [0544676]	Michigan State University Plant Sciences; National Science Foundation(National Science Foundation (NSF))	This work was supported by Michigan State University Plant Sciences and N. E. Tolbert Memorial Fellowships (to B. J. S. C. O.) and by National Science Foundation Grant 0544676 (to K. W. O.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Allard JF, 2009, P NATL ACAD SCI USA, V106, P145, DOI 10.1073/pnas.0808657106; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; El-Kafafi ES, 2008, BIOCHEM J, V409, P87, DOI 10.1042/BJ20070543; El-Kafafi ES, 2005, BIOCHEM J, V387, P669, DOI 10.1042/BJ20041281; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Glynn JM, 2007, TRAFFIC, V8, P451, DOI 10.1111/j.1600-0854.2007.00545.x; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Jeong KJ, 2003, APPL ENVIRON MICROB, V69, P1295, DOI 10.1128/AEM.69.2.1295-1298.2003; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lohse S, 2006, PLANT CELL PHYSIOL, V47, P1124, DOI 10.1093/pcp/pcj083; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Lu CL, 1998, METHOD ENZYMOL, V298, P305, DOI 10.1016/S0076-6879(98)98027-2; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Maple J, 2007, EMBO REP, V8, P293, DOI 10.1038/sj.embor.7400902; Marrington R, 2004, J BIOL CHEM, V279, P48821, DOI 10.1074/jbc.M404944200; McAndrew RS, 2008, BIOCHEM J, V412, P367, DOI 10.1042/BJ20071354; McAndrew RS, 2001, PLANT PHYSIOL, V127, P1656, DOI 10.1104/pp.010542; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Mukherjee A, 2001, J BACTERIOL, V183, P7190, DOI 10.1128/JB.183.24.7190-7197.2001; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Osteryoung KW, 2001, ANNU REV PLANT PHYS, V52, P315, DOI 10.1146/annurev.arplant.52.1.315; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rensing SA, 2004, J MOL EVOL, V58, P154, DOI 10.1007/s00239-003-2535-1; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Scheffers DJ, 2000, MOL MICROBIOL, V35, P1211, DOI 10.1046/j.1365-2958.2000.01791.x; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Smith AG, 2010, FEBS LETT, V584, P166, DOI 10.1016/j.febslet.2009.11.044; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; Sontag CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007253; Stokes KD, 2003, GENE, V320, P97, DOI 10.1016/S0378-1119(03)00814-X; Stokes KD, 2000, PLANT PHYSIOL, V124, P1668, DOI 10.1104/pp.124.4.1668; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Wang X, 1996, MOL MICROBIOL, V21, P313, DOI 10.1046/j.1365-2958.1996.6421360.x; Yang Y, 2008, CURR OPIN PLANT BIOL, V11, P577, DOI 10.1016/j.pbi.2008.10.001; Yoder DW, 2007, PLANT CELL PHYSIOL, V48, P775, DOI 10.1093/pcp/pcm049; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	64	51	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20634	20643		10.1074/jbc.M110.122614	http://dx.doi.org/10.1074/jbc.M110.122614			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20421292	Green Published, hybrid			2022-12-27	WOS:000279228600027
J	Cavanaugh, A; McKenna, J; Stepanchick, A; Breitwieser, GE				Cavanaugh, Alice; McKenna, Jennifer; Stepanchick, Ann; Breitwieser, Gerda E.			Calcium-sensing Receptor Biosynthesis Includes a Cotranslational Conformational Checkpoint and Endoplasmic Reticulum Retention	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; PROTEIN-COUPLED RECEPTORS; KAPPA-OPIOID-RECEPTOR; HUMAN CA2+ RECEPTOR; SIGNAL-TRANSDUCTION; PHARMACOLOGICAL CHAPERONES; EXTRACELLULAR DOMAIN; CALCIMIMETIC R-568; DOWN-REGULATION; QUALITY-CONTROL	Metabolic labeling with [S-35] cysteine was used to characterize early events in CaSR biosynthesis. [S-35] CaSR is relatively stable (half-life similar to 8 h), but maturation to the final glycosylated form is slow and incomplete. Incorporation of [S-35] cysteine is linear over 60 min, and the rate of [S-35] CaSR biosynthesis is significantly increased by the membrane-permeant allosteric agonist NPS R-568, which acts as a cotranslational pharmacochaperone. The [S-35] CaSR biosynthetic rate also varies as a function of conformational bias induced by loss- or gain-of-function mutations. In contrast, [S-35] CaSR maturation to the plasma membrane was not significantly altered by exposure to the pharmacochaperone NPS R-568, the allosteric agonist neomycin, or the orthosteric agonist Ca2+ (0.5 or 5 mM), suggesting that CaSR does not control its own release from the endoplasmic reticulum. A CaSR chimera containing the mGluR1 alpha carboxyl terminus matures completely (half-time of similar to 8 h) and without a lag period, as does the truncation mutant CaSR Delta 868 (half-time of similar to 16 h). CaSR Delta 898 exhibits maturation comparable with full-length CaSR, suggesting that the CaSR carboxyl terminus between residues Thr(868) and Arg(898) limits maturation. Overall, these results suggest that CaSR is subject to cotranslational quality control, which includes a pharmacochaperone-sensitive conformational checkpoint. The CaSR carboxyl terminus is the chief determinant of intracellular retention of a significant fraction of total CaSR. Intracellular CaSR may reflect a rapidly mobilizable "storage form" of CaSR and/or may subserve distinct intracellular signaling roles that are sensitive to signaling-dependent changes in endoplasmic reticulum Ca2+ and/or glutathione.	[Cavanaugh, Alice; McKenna, Jennifer; Stepanchick, Ann; Breitwieser, Gerda E.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Breitwieser, GE (corresponding author), Weis Ctr Res, Geisinger Clin, 100 N Acad Ave, Danville, PA 17822 USA.	gebreitwieser@geisinger.edu		Breitwieser, Gerda/0000-0001-9081-0362	National Institutes of Health [R01 GM077563]; Geisinger Clinic; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geisinger Clinic; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM077563. This work was also supported by funds from the Geisinger Clinic (to G.E.B.).	Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Blaukat A, 2003, AM J PHYSIOL-HEART C, V284, pH1909, DOI 10.1152/ajpheart.00034.2003; Bradbury FA, 1997, J BIOL CHEM, V272, P5921, DOI 10.1074/jbc.272.9.5921; Breitwieser GE, 2004, CELL CALCIUM, V35, P209, DOI 10.1016/j.ceca.2003.10.013; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; Brennan SC, 2009, CURR PHARM BIOTECHNO, V10, P270, DOI 10.2174/138920109787847484; Brown E. M., 2007, V45, P139; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chattopadhyay N, 1997, DEV BRAIN RES, V100, P13, DOI 10.1016/S0165-3806(97)00009-6; Chen Y, 2006, J PHARMACOL EXP THER, V319, P765, DOI 10.1124/jpet.106.107987; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Conn PM, 2006, MOL ENDOCRINOL, V20, P3035, DOI 10.1210/me.2006-0066; Csala M, 2006, FEBS LETT, V580, P2160, DOI 10.1016/j.febslet.2006.03.050; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Fan GF, 1998, FEBS LETT, V436, P353, DOI 10.1016/S0014-5793(98)01165-X; Felder CB, 1999, AAPS PHARMSCI, V1; Gama L, 1998, J BIOL CHEM, V273, P29712, DOI 10.1074/jbc.273.45.29712; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Huang Y, 2006, J BIOL CHEM, V281, P11610, DOI 10.1074/jbc.M513552200; Huang Y, 2007, J BIOL CHEM, V282, P9517, DOI 10.1074/jbc.M609045200; Janovick JA, 2007, MOL CELL ENDOCRINOL, V272, P77, DOI 10.1016/j.mce.2007.04.012; Janovick JA, 2009, MOL ENDOCRINOL, V23, P157, DOI 10.1210/me.2008-0384; Jiang YF, 2004, J BIOL CHEM, V279, P14147, DOI 10.1074/jbc.M307422200; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2009, J BIOL CHEM, V284, P35827, DOI 10.1074/jbc.M109.046276; KATZ CL, 1992, ENDOCRINOLOGY, V131, P903, DOI 10.1210/en.131.2.903; Kawata T, 2008, KIDNEY INT, V74, P1270, DOI 10.1038/ki.2008.407; Koleganova N, 2009, KIDNEY INT, V75, P60, DOI 10.1038/ki.2008.490; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Landolfi B, 1998, J CELL BIOL, V142, P1235, DOI 10.1083/jcb.142.5.1235; Lee DK, 2004, J BIOL CHEM, V279, P7901, DOI 10.1074/jbc.M306377200; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Li JG, 2007, BIOCHEMISTRY-US, V46, P10960, DOI 10.1021/bi700443j; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; Mauro TM, 2007, J INVEST DERMATOL, V127, P991, DOI 10.1038/sj.jid.5700696; Mendoza FJ, 2009, AM J PHYSIOL-RENAL, V296, pF605, DOI 10.1152/ajprenal.90272.2008; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Mizobuchi M, 2004, J AM SOC NEPHROL, V15, P2579, DOI 10.1097/01.ASN.0000141016.20133.33; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Piecha G, 2008, AM J PHYSIOL-RENAL, V294, pF748, DOI 10.1152/ajprenal.00220.2007; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ray K, 1999, J BIOL CHEM, V274, P27642, DOI 10.1074/jbc.274.39.27642; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611, DOI 10.1152/ajprenal.1998.274.3.F611; Riccardi D, 2000, PFLUG ARCH EUR J PHY, V441, P379, DOI 10.1007/s004240000436; Robben JH, 2007, AM J PHYSIOL-RENAL, V292, pF253, DOI 10.1152/ajprenal.00247.2006; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Schwieger I, 2008, MOL PHARMACOL, V73, P697, DOI 10.1124/mol.107.040931; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Ward DT, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015623.73739.B8; White E, 2009, MOL ENDOCRINOL, V23, P1115, DOI 10.1210/me.2009-0041; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200	64	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19854	19864		10.1074/jbc.M110.124792	http://dx.doi.org/10.1074/jbc.M110.124792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421307	Green Published, hybrid			2022-12-27	WOS:000279012000018
J	Galvin, KE; Travis, ED; Yee, D; Magnuson, T; Vivian, JL				Galvin, Katherine E.; Travis, Emily D.; Yee, Della; Magnuson, Terry; Vivian, Jay L.			Nodal Signaling Regulates the Bone Morphogenic Protein Pluripotency Pathway in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; SELF-RENEWAL; DEFINITIVE ENDODERM; DIRECT BINDING; SMAD PROTEINS; ID PROTEINS; DIFFERENTIATION; TROPHOBLAST; INHIBITOR	Members of the transforming growth factor-beta superfamily play essential roles in both the pluripotency and differentiation of embryonic stem (ES) cells. Although bone morphogenic proteins (BMPs) maintain pluripotency of undifferentiated mouse ES cells, the role of autocrine Nodal signaling is less clear. Pharmacological, molecular, and genetic methods were used to further understand the roles and potential interactions of these pathways. Treatment of undifferentiated ES cells with SB431542, a pharmacological inhibitor of Smad2 signaling, resulted in a rapid reduction of phosphorylated Smad2 and altered the expression of several putative downstream targets. Unexpectedly, inhibition of the Nodal signaling pathway resulted in enhanced BMP signaling, as assessed by Smad1/5 phosphorylation. SB431542-treated cells also demonstrated significant induction of the Id genes, which are known direct targets of BMP signaling and important factors in ES cell pluripotency. Inhibition of BMP signaling decreased the SB431542-mediated phosphorylation of Smad1/5 and induction of Id genes, suggesting that BMP signaling is necessary for some Smad2-mediated activity. Because Smad7, a known inhibitory factor to both Nodal and BMP signaling, was down-regulated following inhibition of Nodal-Smad2 signaling, the contribution of Smad7 to the cross-talk between the transforming growth factor-beta pathways in ES cells was examined. Biochemical manipulation of Smad7 expression, through shRNA knockdown or inducible gene expression, significantly reduced the SB431542-mediated phosphorylation of Smad1/5 and induction of the Id genes. We conclude that autocrine Nodal signaling in undifferentiated mouse ES cells modulates the vital pluripotency pathway of BMP signaling.	[Galvin, Katherine E.; Travis, Emily D.; Vivian, Jay L.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Galvin, Katherine E.; Travis, Emily D.; Vivian, Jay L.] Univ Kansas, Med Ctr, Div Canc & Dev Biol, Kansas City, KS 66160 USA; [Galvin, Katherine E.; Travis, Emily D.; Vivian, Jay L.] Univ Kansas, Med Ctr, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA; [Yee, Della; Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Vivian, JL (corresponding author), 3901 Rainbow Blvd,Mail Stop 3045, Kansas City, KS 66160 USA.	jvivian@kumc.edu			National Institutes of Health [RR022888]; COBRE [P20RR024214]; NIH [T32HD007455]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024214, R21RR022888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant RR022888 and COBRE P20RR024214 (to J.L.V.) and by NIH postdoctoral training grant T32HD007455 (to K. E. G.).	Amthor H, 2002, DEV BIOL, V243, P115, DOI 10.1006/dbio.2001.0555; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; He SY, 2008, STEM CELLS, V26, P842, DOI 10.1634/stemcells.2007-0356; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma GT, 2001, DEV BIOL, V236, P124, DOI 10.1006/dbio.2001.0334; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; MIYAZONO K, 2002, SCI STKE, pPE40; Nagy A., 2003, MANIPULATING MOUSE E; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pierre A, 2005, REPROD NUTR DEV, V45, P419, DOI 10.1051/rnd:2005031; Puceat M, 2007, CARDIOVASC RES, V74, P256, DOI 10.1016/j.cardiores.2006.12.012; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Ro S, 2005, BIOTECHNIQUES, V38, P625, DOI 10.2144/05384RN01; SEIFINEJAD A, 2010, STEM CELL R IN PRESS; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Takaoka K, 2006, DEV CELL, V10, P451, DOI 10.1016/j.devcel.2006.02.017; Takenaga M, 2007, J CELL SCI, V120, P2078, DOI 10.1242/jcs.004127; TEN DP, 2004, TRENDS BIOCHEM SCI, V29, P265; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Tournay O, 1996, MOL CELL BIOL, V16, P2418; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vivian JL, 1999, BIOTECHNIQUES, V27, P154, DOI 10.2144/99271rr04; Vivian JL, 2002, P NATL ACAD SCI USA, V99, P15542, DOI 10.1073/pnas.242474199; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu Z, 2008, J BIOL CHEM, V283, P24991, DOI 10.1074/jbc.M803893200; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200; Zhong W, 2006, MOL REPROD DEV, V73, P540, DOI 10.1002/mrd.20417	72	46	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19747	19756		10.1074/jbc.M109.077347	http://dx.doi.org/10.1074/jbc.M109.077347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427282	Green Published, hybrid			2022-12-27	WOS:000279012000007
J	Gurzov, EN; Germano, CM; Cunha, DA; Ortis, F; Vanderwinden, JM; Marchetti, P; Zhang, L; Eizirik, DL				Gurzov, Esteban N.; Germano, Carla M.; Cunha, Daniel A.; Ortis, Fernanda; Vanderwinden, Jean-Marie; Marchetti, Piero; Zhang, Lin; Eizirik, Decio L.			p53 Up-regulated Modulator of Apoptosis (PUMA) Activation Contributes to Pancreatic beta-Cell Apoptosis Induced by Proinflammatory Cytokines and Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ER STRESS; MEMBRANE PERMEABILIZATION; BAX; DEATH; FAMILY; TYPE-1; GENE; DYSFUNCTION; INHIBITION	Type 1 diabetes is an autoimmune disorder characterized by chronic inflammation and pancreatic beta-cell loss. Here, we demonstrate that the proinflammatory cytokine interleukin-1 beta, combined with interferon-gamma, induces the expression of the Bcl-2 homology 3 ( BH3)-only activator PUMA (p53 up-regulated modulator of apoptosis) in beta-cells. Transcriptional activation of PUMA is regulated by nuclear factor-kappa B and endoplasmic reticulum stress but is independent of p53. PUMA activation leads to mitochondrial Bax translocation, cytochrome c release, and caspase-3 cleavage resulting in beta-cell demise. The antiapoptotic Bcl-XL protein is localized mainly at the mitochondria of the beta-cells and antagonizes PUMA action, but Bcl-XL is inactivated by the BH3-only sensitizer DP5/Hrk in cytokine-exposed beta-cells. Moreover, a pharmacological mimic of the BH3-only sensitizer Bad, which inhibits Bcl-XL and Bcl-2, induces PUMA-dependent beta-cell death and potentiates cytokine-induced apoptosis. Our data support a hierarchical activation of BH3-only proteins controlling the intrinsic pathway of beta-cell apoptosis in the context of inflammation and type 1 diabetes.	[Gurzov, Esteban N.; Germano, Carla M.; Cunha, Daniel A.; Ortis, Fernanda; Eizirik, Decio L.] Univ Libre Bruxelles, Expt Med Lab, B-1070 Brussels, Belgium; [Vanderwinden, Jean-Marie] Univ Libre Bruxelles, Neurophysiol Lab, B-1070 Brussels, Belgium; [Marchetti, Piero] Univ Pisa, Metab Unit, Dept Endocrinol & Metab, I-5610 Pisa, Italy; [Zhang, Lin] Univ Pittsburgh, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15232 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Pisa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gurzov, EN (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Route Lennik 808,CP 618, B-1070 Brussels, Belgium.	egurzov@ulb.ac.be	GERMANO, CARLA MARIA RAMOS/S-5312-2019; Zhang, Lin/A-7389-2009; Ortis, Fernanda/K-7917-2014; Marchetti, Piero/J-7439-2013; germano, carla/N-1736-2015; Ortis, Fernanda/M-7190-2019	GERMANO, CARLA MARIA RAMOS/0000-0001-5030-7164; Zhang, Lin/0000-0003-0018-3903; Marchetti, Piero/0000-0003-4907-0635; Gurzov, Esteban/0000-0003-4642-0273; Ortis, Fernanda/0000-0002-9551-2839	Communaute Francaise de Belgique; Actions de Recherche Concertees; National de la Recherche Scientifique Belgium; Fonds National de la Recherche Scientifique Belgium; Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State [IUAP P6/40]; Juvenile Diabetes Research Foundation [17-2009-106]; European Union; European Community; Naimit; Belgian Federal Science Policy Office; European Molecular Biology Organization (EMBO)	Communaute Francaise de Belgique(Australian Research Council); Actions de Recherche Concertees(University of Liege); National de la Recherche Scientifique Belgium; Fonds National de la Recherche Scientifique Belgium(Fonds de la Recherche Scientifique - FNRS); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); European Community(European Commission); Naimit; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported by grants from the Communaute Francaise de Belgique, Actions de Recherche Concertees and the Fonds National de la Recherche Scientifique Belgium; Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State, Grant IUAP P6/40, Juvenile Diabetes Research Foundation International Grant 17-2009-106, and the European Union projects Eurodia, in the Framework Programme 6 of the European Community, and Naimit, in the Framework Programme 7 of the European Community.; Supported by a research fellowship of the Belgian Federal Science Policy Office and by an European Molecular Biology Organization (EMBO) long term fellowship. To whom correspondence should be addressed: Laboratory of Experimental Medicine, Universite Libre de Bruxelles, Route de Lennik, 808, CP-618, 1070 Brussels, Belgium. Tel.: 32 2 555 6092; Fax: 32 2 555 6239; E-mail: egurzov@ulb.ac.be.; Supported by a postdoctoral fellowship from the National Council for Scientific and Technological Development, Brazil.	Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bardwell PD, 2009, J IMMUNOL, V182, P7482, DOI 10.4049/jimmunol.0802813; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GOEGER DE, 1988, BIOCHEM PHARMACOL, V37, P978, DOI 10.1016/0006-2952(88)90195-5; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003030; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Holohan C, 2008, J CELL MOL MED, V12, P591, DOI 10.1111/j.1582-4934.2007.00191.x; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2009, J CELL BIOL, V185, P189, DOI 10.1083/jcb.200903134; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P41271, DOI 10.1074/jbc.C400360200; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Smith MI, 2007, CELL DEATH DIFFER, V14, P1011, DOI 10.1038/sj.cdd.4402089; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	43	99	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19910	19920		10.1074/jbc.M110.122374	http://dx.doi.org/10.1074/jbc.M110.122374			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421300	hybrid, Green Published			2022-12-27	WOS:000279012000024
J	Yi, L; Morgan, JT; Ragsdale, SW				Yi, Li; Morgan, Jeffrey T.; Ragsdale, Stephen W.			Identification of a Thiol/Disulfide Redox Switch in the Human BK Channel That Controls Its Affinity for Heme and CO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+-CHANNELS; CARBON-MONOXIDE; LARGE-CONDUCTANCE; REGULATORY MOTIFS; CAROTID-BODY; RCK DOMAIN; CA2+; SENSITIVITY; BINDING	Heme is a required prosthetic group in many electron transfer proteins and redox enzymes. The human BK channel, which is a large-conductance Ca2+ and voltage-activated K+ channel, is involved in the hypoxic response in the carotid body. The BK channel has been shown to bind and undergo inhibition by heme and activation by CO. Furthermore, evidence suggests that human heme oxygenase-2 (HO2) acts as an oxygen sensor and CO donor that can form a protein complex with the BK channel. Here we describe a thiol/disulfide redox switch in the human BK channel and biochemical experiments of heme, CO, and HO2 binding to a 134-residue region within the cytoplasmic domain of the channel. This region, called the heme binding domain (HBD) forms a linker segment between two Ca2+-sensing domains (called RCK1 and RCK2) of the BK channel. The HBD includes a CXXCH motif in which histidine serves as the axial heme ligand and the two cysteine residues can form a reversible thiol/disulfide redox switch that regulates affinity of the HBD for heme. The reduced dithiol state binds heme (K-d = 210 nM) 14-fold more tightly than the oxidized disulfide state. Furthermore, the HBD is shown to tightly bindCO(K-d = 50 nM) with the Cys residues in the CXXCH motif regulating affinity of the HBD for CO. This HBD is also shown to interact with heme oxygenase-2. We propose that the thiol/disulfide switch in the HBD is a mechanism by which activity of the BK channel can respond quickly and reversibly to changes in the redox state of the cell, especially as it switches between hypoxic and normoxic conditions.	[Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	Yi, Li/A-3967-2013		National Institutes of Health [R21HL089837]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089837, R01HL102662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21HL089837.	ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Benda R, 2003, J BIOL INORG CHEM, V8, P787, DOI 10.1007/s00775-003-0472-5; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; Brazier SP, 2009, ADV EXP MED BIOL, V648, P49, DOI 10.1007/978-90-481-2259-2_5; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dong DL, 2007, HYPERTENSION, V50, P643, DOI 10.1161/HYPERTENSIONAHA.107.096057; Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; FrancoObregon A, 1996, ADV EXP MED BIOL, V410, P97; Garrick MD, 1999, BBA-MOL CELL RES, V1449, P125, DOI 10.1016/S0167-4889(99)00006-3; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Horrigan FT, 2005, J GEN PHYSIOL, V126, P7, DOI 10.1085/jgp.200509262; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2008, P NATL ACAD SCI USA, V105, P4039, DOI 10.1073/pnas.0800304105; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; Jaggar JH, 2005, CIRC RES, V97, P805, DOI 10.1161/01.RES.0000186180.47148.7b; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Kumar P, 2007, ESSAYS BIOCHEM, V43, P43, DOI 10.1042/bse0430043; Lewis A, 2002, J PHYSIOL-LONDON, V540, P771, DOI 10.1113/jphysiol.2001.013888; Liu HJ, 1999, J CLIN INVEST, V104, P577, DOI 10.1172/JCI7291; LIU SC, 1988, BLOOD, V71, P1755; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; MacAuley SR, 2009, BIOCHEMISTRY-US, V48, P817, DOI 10.1021/bi802246s; Maines MD, 2005, ANTIOXID REDOX SIGN, V7, P1761, DOI 10.1089/ars.2005.7.1761; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Qiu Y, 1998, J BIOL CHEM, V273, P23426, DOI 10.1074/jbc.273.36.23426; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Sassa S, 2006, J CLIN BIOCHEM NUTR, V38, P138, DOI 10.3164/jcbn.38.138; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Tang XD, 2001, J GEN PHYSIOL, V117, P253, DOI 10.1085/jgp.117.3.253; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yamashita T, 2004, J BIOL CHEM, V279, P21394, DOI 10.1074/jbc.M400512200; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105	52	70	75	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20117	20127		10.1074/jbc.M110.116483	http://dx.doi.org/10.1074/jbc.M110.116483			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427280	Green Published, hybrid			2022-12-27	WOS:000279012000046
J	Guo, RF; Chen, J; Zhu, F; Biswas, AK; Berton, TR; Mitchell, DL; Johnson, DG				Guo, Ruifeng; Chen, Jie; Zhu, Feng; Biswas, Anup K.; Berton, Thomas R.; Mitchell, David L.; Johnson, David G.			E2F1 Localizes to Sites of UV-induced DNA Damage to Enhance Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENTOSUM VARIANT CELLS; ATAXIA-TELANGIECTASIA; TRANSCRIPTION FACTOR; RNA-POLYMERASE; ATR KINASE; IN-VIVO; GROUP-A; TOPBP1; PROTEIN; IRRADIATION	The E2F1 transcription factor is a well known regulator of cell proliferation and apoptosis, but its role in the DNA damage response is less clear. Using a local UV irradiation technique and immunofluorescence staining, E2F1 is shown to accumulate at sites of DNA damage. Localization of E2F1 to UV-damaged DNA requires the ATM and Rad3-related (ATR) kinase and serine 31 of E2F1 but not an intact DNA binding domain. E2F1 deficiency does not appear to affect the expression of nucleotide excision repair (NER) factors, such as XPC and XPA. However, E2F1 depletion does impair the recruitment of NER factors to sites of damage and reduces the efficiency of DNA repair. E2F1 mutants unable to bindDNAor activate transcription retain the ability to stimulate NER. These findings demonstrate that E2F1 has a direct, non-transcriptional role in DNA repair involving increased recruitment of NER factors to sites of damage.	Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Dept Carcinogenesis, Smithville, TX 78957 USA; [Guo, Ruifeng; Chen, Jie; Mitchell, David L.; Johnson, David G.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Johnson, DG (corresponding author), POB 389, Smithville, TX 78957 USA.	djohnson@mdanderson.org	Guo, Ruifeng/AAK-2072-2020	Johnson, David/0000-0002-6223-1790	National Institutes of Health through Anderson Cancer Center [CA016672, CA079648, K01-CA106603, CA105345, ES007784, ES007247]; The University of Texas Graduate School of Biomedical Sciences at Houston; University of Texas M. D. Anderson Cancer Center, Houston, TX; NATIONAL CANCER INSTITUTE [U01CA105345, K01CA106603, R01CA079648, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784, T32ES007247] Funding Source: NIH RePORTER	National Institutes of Health through Anderson Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The University of Texas Graduate School of Biomedical Sciences at Houston; University of Texas M. D. Anderson Cancer Center, Houston, TX; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA016672 and CA079648 (to D.G.J.) K01-CA106603 (to T. R. B.) and CA105345, ES007784, and ES007247 through the M. D. Anderson Cancer Center. This research was performed in partial fulfillment of the requirements for the Ph.D. degree from The University of Texas Graduate School of Biomedical Sciences at Houston; University of Texas M. D. Anderson Cancer Center, Houston, TX.	Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Blattner C, 1999, MOL CELL BIOL, V19, P3704; Bosco EE, 2005, NUCLEIC ACIDS RES, V33, P1581, DOI 10.1093/nar/gki283; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; DeGregori J, 2006, CURR MOL MED, V6, P739; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Greer DA, 2003, CANCER RES, V63, P4829; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hayes S, 1998, MOL CELL BIOL, V18, P240, DOI 10.1128/MCB.18.1.240; Hofferer M, 1999, NUCLEIC ACIDS RES, V27, P491, DOI 10.1093/nar/27.2.491; Ianari A, 2009, CANCER CELL, V15, P184, DOI 10.1016/j.ccr.2009.01.026; Johnson DG, 2006, CURR MOL MED, V6, P731; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lin PS, 2009, DNA REPAIR, V8, P795, DOI 10.1016/j.dnarep.2009.03.003; Lin WC, 2001, GENE DEV, V15, P1833; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MITCHELL DL, 1995, MUTAT RES-DNA REPAIR, V337, P161, DOI 10.1016/0921-8777(95)00020-K; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; O'Connor DJ, 2000, ONCOGENE, V19, P2369, DOI 10.1038/sj.onc.1203540; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Prost S, 2007, ONCOGENE, V26, P3572, DOI 10.1038/sj.onc.1210151; Rounbehler RJ, 2002, CANCER RES, V62, P3276; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Stiff T, 2008, HUM MOL GENET, V17, P3247, DOI 10.1093/hmg/ddn220; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Wikonkal NM, 2003, NAT CELL BIOL, V5, P655, DOI 10.1038/ncb1001; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yoshida K, 2004, ONCOGENE, V23, P6250, DOI 10.1038/sj.onc.1207829; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	44	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19308	19315		10.1074/jbc.M110.121939	http://dx.doi.org/10.1074/jbc.M110.121939			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20413589	Green Published, hybrid			2022-12-27	WOS:000278727800040
J	Castegna, A; Scarcia, P; Agrimi, G; Palmieri, L; Rottensteiner, H; Spera, I; Germinario, L; Palmieri, F				Castegna, Alessandra; Scarcia, Pasquale; Agrimi, Gennaro; Palmieri, Luigi; Rottensteiner, Hanspeter; Spera, Iolanda; Germinario, Lucrezia; Palmieri, Ferdinando			Identification and Functional Characterization of a Novel Mitochondrial Carrier for Citrate and Oxoglutarate in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL BETA-OXIDATION; RAT-LIVER MITOCHONDRIA; BACTERIAL EXPRESSION; TRANSPORT PROTEIN; FATTY-ACIDS; TRICARBOXYLATE CARRIER; BOVINE MITOCHONDRIA; CYTOSOLIC SOURCES; GENE DISRUPTION; COMPLEX-I	Mitochondrial carriers are a family of transport proteins that shuttle metabolites, nucleotides, and coenzymes across the mitochondrial membrane. The function of only a few of the 35 Saccharomyces cerevisiae mitochondrial carriers still remains to be uncovered. In this study, we have functionally defined and characterized the S. cerevisiae mitochondrial carrier Yhm2p. The YHM2 gene was overexpressed in S. cerevisiae, and its product was purified and reconstituted into liposomes. Its transport properties, kinetic parameters, and targeting to mitochondria show that Yhm2p is a mitochondrial transporter for citrate and oxoglutarate. Reconstituted Yhm2p also transported oxaloacetate, succinate, and fumarate to a lesser extent, but virtually not malate and isocitrate. Yhm2p catalyzed only a counter-exchange transport that was saturable and inhibited by sulfhydryl-blocking reagents but not by 1,2,3-benzenetricarboxylate (a powerful inhibitor of the citrate/malate carrier). The physiological role of Yhm2p is to increase the NADPH reducing power in the cytosol (required for biosynthetic and antioxidant reactions) and probably to act as a key component of the citrate-oxoglutarate NADPH redox shuttle between mitochondria and cytosol. This protein function is based on observations documenting a decrease in the NADPH/NADP(+) and GSH/GSSG ratios in the cytosol of Delta YHM2 cells as well as an increase in the NADPH/NADP(+) ratio in their mitochondria compared with wildtype cells. Our proposal is also supported by the growth defect displayed by the Delta YHM2strain and more so by the Delta YHM2 Delta ZWF1 strain upon H2O2 exposure, implying that Yhm2p has an antioxidant function.	[Castegna, Alessandra; Scarcia, Pasquale; Agrimi, Gennaro; Palmieri, Luigi; Spera, Iolanda; Germinario, Lucrezia; Palmieri, Ferdinando] Univ Bari, Biochem & Mol Biol Lab, Dept Pharmacobiol, I-70125 Bari, Italy; [Rottensteiner, Hanspeter] Ruhr Univ Bochum, Abt Syst Biochem, Inst Physiol Chem, D-44780 Bochum, Germany; [Palmieri, Luigi; Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Ruhr University Bochum; Consiglio Nazionale delle Ricerche (CNR)	Palmieri, F (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	fpalm@farmbiol.uniba.it	castegna, alessandra/AAH-6668-2020; castegna, alessandra/M-5106-2013; Scarcia, Pasquale/A-8830-2010; Scarcia, Pasquale/O-9550-2019; Agrimi, Gennaro/D-4001-2018	Scarcia, Pasquale/0000-0001-6216-0411; Scarcia, Pasquale/0000-0001-6216-0411; Agrimi, Gennaro/0000-0002-5219-4412; CASTEGNA, Alessandra/0000-0003-0235-6847	Ministero dell'Universita e della Ricerca; Center of Excellence in Genomics, Apulia Region; University of Bari; Italian Human ProteomeNet [RBRN07BMCT_009]	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics, Apulia Region; University of Bari; Italian Human ProteomeNet	This work was supported by grants from the Ministero dell'Universita e della Ricerca, the Center of Excellence in Genomics, Apulia Region, the University of Bari, and the Italian Human ProteomeNet No. RBRN07BMCT_009.	BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BISACCIA F, 1989, BIOCHIM BIOPHYS ACTA, V977, P171, DOI 10.1016/S0005-2728(89)80068-4; Cho JH, 1998, MOL CELL BIOL, V18, P5712, DOI 10.1128/MCB.18.10.5712; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; DAUM G, 1982, J BIOL CHEM, V257, P3075; ElMoualij B, 1997, YEAST, V13, P573, DOI 10.1002/(SICI)1097-0061(199705)13:6<573::AID-YEA107>3.0.CO;2-I; EVANS CT, 1983, EUR J BIOCHEM, V130, P195; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Fiermonte G, 1998, J BIOL CHEM, V273, P24754, DOI 10.1074/jbc.273.38.24754; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Henke B, 1998, J BIOL CHEM, V273, P3702, DOI 10.1074/jbc.273.6.3702; Hiltunen JK, 2009, J BIOL CHEM, V284, P9011, DOI 10.1074/jbc.R800068200; HOEK JB, 1974, ALCOHOL ALDEHYDE MET, P351; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; Marobbio CMT, 2008, J BIOL CHEM, V283, P28445, DOI 10.1074/jbc.M804637200; Minard KI, 1999, J BIOL CHEM, V274, P3402, DOI 10.1074/jbc.274.6.3402; Minard KI, 2005, J BIOL CHEM, V280, P39890, DOI 10.1074/jbc.M509461200; Minard KL, 2001, FREE RADICAL BIO MED, V31, P832, DOI 10.1016/S0891-5849(01)00666-9; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1972, EUR J BIOCHEM, V26, P587, DOI 10.1111/j.1432-1033.1972.tb01801.x; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri F, 2010, FEBS LETT, V584, P1931, DOI 10.1016/j.febslet.2009.10.063; Palmieri L, 1999, J BIOL CHEM, V274, P22184, DOI 10.1074/jbc.274.32.22184; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; Salmon' TB, 2004, NUCLEIC ACIDS RES, V32, P3712, DOI 10.1093/nar/gkh696; Schafer H, 2001, ELECTROPHORESIS, V22, P2955, DOI 10.1002/1522-2683(200108)22:14<2955::AID-ELPS2955>3.0.CO;2-U; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; STJOHN PA, 1986, J NEUROSCI, V6, P1492; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; van Roermund CWT, 1998, EMBO J, V17, P677, DOI 10.1093/emboj/17.3.677; Visser WF, 2006, BIOCHEM BIOPH RES CO, V348, P1224, DOI 10.1016/j.bbrc.2006.07.049; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; WILLIAMSON JR, 1980, FEBS LETT, V117, P73	51	91	95	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17359	17370		10.1074/jbc.M109.097188	http://dx.doi.org/10.1074/jbc.M109.097188			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371607	Green Published, hybrid			2022-12-27	WOS:000278133400013
J	Clouet-d'Orval, B; Rinaldi, D; Quentin, Y; Carpousis, AJ				Clouet-d'Orval, Beatrice; Rinaldi, Dana; Quentin, Yves; Carpousis, Agamemnon J.			Euryarchaeal beta-CASP Proteins with Homology to Bacterial RNase J Have 5 '- to 3 '-Exoribonuclease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX C/D RNA; ESCHERICHIA-COLI; MESSENGER-RNA; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; PYROCOCCUS-FURIOSUS; ARCHAEAL EXOSOME; LACTAMASE FOLD; GUIDE RNAS; TRANSLATION	In the Archaea only a handful of ribonucleases involved in RNA processing and degradation have been characterized. One potential group of archaeal ribonucleases are homologues of the bacterial RNase J family, which have a beta-CASP metallo-beta-lactamase fold. Here we show that beta-CASP proteins encoded in the genomes of the hyperthermophilic Euryarchaeota Pyrococcus abyssi and Thermococcus kodakaraensis are processive exoribonucleases with a 5' end dependence and a 5' to 3' directionality. We named these enzymes Pab-RNase J and Tk-RNase J, respectively. RNAs with 5'-monophosphate or 5'-hydroxyl ends are preferred substrates of Pab-RNase J, whereas circularized RNA is resistant to Pab-RNase J activity. Degradation of a 3' end-labeled synthetic RNA in which an internal nucleoside is substituted by three ethylene glycol units generates intermediates demonstrating 5' to 3' directionality. The substitution of conserved residues in Pab-RNase J predicted to be involved in the coordination of metal ions demonstrates their importance for ribonuclease activity, although the detailed geometry of the catalytic site is likely to differ from bacterial RNase J. This is the first identification of a 5'-exoribonuclease encoded in the genomes of the Archaea. Phylogenetic analysis shows that euryarchaeal RNase J has been inherited vertically, suggesting an ancient origin predating the separation of the Bacteria and the Archaea.	[Clouet-d'Orval, Beatrice] CNRS, Lab Microbiol & Genet Mol, UMR 5100, F-31062 Toulouse, France; Univ Toulouse 3, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Clouet-d'Orval, B (corresponding author), CNRS, Lab Microbiol & Genet Mol, UMR 5100, 118 Route Narbonne, F-31062 Toulouse, France.	beatrice.clouet-dorval@ibcg.biotoul.fr	Carpousis, Agamemnon/S-2098-2019	Carpousis, Agamemnon/0000-0002-1774-2102; Quentin, Yves/0000-0001-8248-0586; Clouet-d'Orval, Beatrice/0000-0002-3591-8538	CNRS; Agence Nationale de la Recherche (ANR) [BLAN08-1_329396]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the CNRS with additional funding from the Agence Nationale de la Recherche (ANR) (Grant BLAN08-1_329396).	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Bortolin ML, 2003, NUCLEIC ACIDS RES, V31, P6524, DOI 10.1093/nar/gkg860; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; BROWN JW, 1985, J BACTERIOL, V162, P909, DOI 10.1128/JB.162.3.909-917.1985; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Collins JA, 2007, GENE DEV, V21, P3356, DOI 10.1101/gad.1605307; Condon C, 1997, J MOL BIOL, V268, P235, DOI 10.1006/jmbi.1997.0971; d'Orval BC, 2001, NUCLEIC ACIDS RES, V29, P4518, DOI 10.1093/nar/29.22.4518; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Daou-Chabo R, 2009, MOL MICROBIOL, V71, P1538, DOI 10.1111/j.1365-2958.2009.06620.x; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; French SL, 2007, MOL BIOL EVOL, V24, P893, DOI 10.1093/molbev/msm007; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hasenohrl D, 2008, P NATL ACAD SCI USA, V105, P2146, DOI 10.1073/pnas.0708894105; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; JOHNSON AW, 1991, J BIOL CHEM, V266, P14046; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Kanai A, 2003, BIOCHEM J, V372, P253, DOI 10.1042/BJ20021968; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; Portnoy V, 2006, NUCLEIC ACIDS RES, V34, P5923, DOI 10.1093/nar/gkl763; Ramos CRR, 2006, J BIOL CHEM, V281, P6751, DOI 10.1074/jbc.M512495200; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Tang TH, 2002, NUCLEIC ACIDS RES, V30, P921, DOI 10.1093/nar/30.4.921; Tsai HY, 2006, P NATL ACAD SCI USA, V103, P16147, DOI 10.1073/pnas.0608000103; Viswanathan M, 1998, J BIOL CHEM, V273, P35126, DOI 10.1074/jbc.273.52.35126; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Yang XC, 2009, MOL CELL BIOL, V29, P31, DOI 10.1128/MCB.00776-08; Zhang J, 2009, RNA, V15, P1909, DOI 10.1261/rna.1715209	49	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17574	17583		10.1074/jbc.M109.095117	http://dx.doi.org/10.1074/jbc.M109.095117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20375016	Green Published, hybrid			2022-12-27	WOS:000278133400036
J	de Jong, SJ; Albrecht, JC; Schmidt, M; Muller-Fleckenstein, I; Biesinger, B				de Jong, Sarah Jill; Albrecht, Jens-Christian; Schmidt, Monika; Mueller-Fleckenstein, Ingrid; Biesinger, Brigitte			Activation of Noncanonical NF-kappa B Signaling by the Oncoprotein Tio	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN T-CELLS; HERPESVIRUS-SAIMIRI; GROWTH TRANSFORMATION; MULTIPLE-MYELOMA; TRANSCRIPTION FACTORS; KINASE INHIBITOR; TARGET GENES; IKK-ALPHA; PATHWAY; PROTEIN	NF-kappa B transcription factors are key regulators of cellular proliferation and frequently contribute to oncogenesis. The herpes-viral oncoprotein Tio, which promotes growth transformation of human T cells in a recombinant herpesvirus saimiri background, potently induces canonical NF-kappa B signaling through membrane recruitment of the ubiquitin ligase tumor necrosis factor receptor-associated factor 6 (TRAF6). Here, we show that, in addition to Tio-TRAF6 interaction, the Tio-induced canonical NF-kappa B signal requires the presence of the regulatory subunit of the inhibitor of kappa B kinase (IKK) complex, NF-kappa B essential modulator (NEMO), and the activity of its key kinase, IKK beta, to up-regulate expression of endogenous cellular inhibitor of apoptosis 2 (cIAP2) and interleukin 8 (IL-8) proteins. Dependent on TRAF6 and NEMO, Tio enhances the expression of the noncanonical NF-kappa B proteins, p100 and RelB. Independent of TRAF6 and NEMO, Tio mediates stabilization of the noncanonical kinase, NF-kappa B-inducing kinase (NIK). Concomitantly, Tio induces efficient processing of the p100 precursor molecule to its active form, p52, as well as DNA binding of nuclear p52 and RelB. In human T cells transformed by infection with a Tio-recombinant virus, sustained expression of p100, RelB, and cIAP2 depends on IKK beta activity, yet processing to p52 remains largely unaffected by IKK beta inhibition. However, long term inhibition of IKK beta disrupts the continuous growth of the transformed cells and induces cell death. Hence, the Tio oncoprotein triggers noncanonical NF-kappa B signaling through NEMO-dependent up-regulation of p100 precursor and RelB, as well as through NEMO-independent generation of p52 effector.	[de Jong, Sarah Jill; Albrecht, Jens-Christian; Schmidt, Monika; Mueller-Fleckenstein, Ingrid; Biesinger, Brigitte] Univ Erlangen Nurnberg, Inst Klin & Mol Virol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Biesinger, B (corresponding author), Schlossgarten 4, D-91054 Erlangen, Germany.	brigitte.biesinger@viro.med.uni-erlangen.de			DFG [BI465/5-1, GRK 1071]	DFG(German Research Foundation (DFG))	This work was supported by DFG Grants BI465/5-1 and GRK 1071.	Albrecht JC, 2005, J VIROL, V79, P10507, DOI 10.1128/JVI.79.16.10507-10513.2005; Albrecht JC, 2004, J VIROL, V78, P9814, DOI 10.1128/JVI.78.18.9814-9819.2004; Albrecht JC, 1999, J VIROL, V73, P4631, DOI 10.1128/JVI.73.6.4631-4639.1999; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; BIESINGER B, 1995, J BIOL CHEM, V270, P4729, DOI 10.1074/jbc.270.9.4729; BIESINGER B, 1992, P NATL ACAD SCI USA, V89, P3116, DOI 10.1073/pnas.89.7.3116; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Britanova LV, 2008, BIOCHEM BIOPH RES CO, V365, P583, DOI 10.1016/j.bbrc.2007.10.200; Cesarman E, 2007, CURR TOP MICROBIOL, V312, P263; Duboise SM, 1998, J VIROL, V72, P1308, DOI 10.1128/JVI.72.2.1308-1313.1998; Eliopoulos AG, 2003, ONCOGENE, V22, P7557, DOI 10.1038/sj.onc.1207120; FALK LA, 1974, INT J CANCER, V14, P473, DOI 10.1002/ijc.2910140407; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Glanz A, 2008, IMMUNOL CELL BIOL, V86, P622, DOI 10.1038/icb.2008.43; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Heck E, 2006, J VIROL, V80, P9934, DOI 10.1128/JVI.01112-06; Heinemann S, 2006, J BIOL CHEM, V281, P8565, DOI 10.1074/jbc.M510891200; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hong SY, 2000, J BIOL CHEM, V275, P18022, DOI 10.1074/jbc.M001202200; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Lee H, 1999, J VIROL, V73, P3913, DOI 10.1128/JVI.73.5.3913-3919.1999; LOMBARDI L, 1995, NUCLEIC ACIDS RES, V23, P2328, DOI 10.1093/nar/23.12.2328; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Murata T, 2004, BIOORG MED CHEM LETT, V14, P4019, DOI 10.1016/j.bmcl.2004.05.041; Packham G, 2008, BRIT J HAEMATOL, V143, P3, DOI 10.1111/j.1365-2141.2008.07284.x; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Sanda T, 2006, LEUKEMIA, V20, P590, DOI 10.1038/sj.leu.2404129; Sanda T, 2005, CLIN CANCER RES, V11, P1974, DOI 10.1158/1078-0432.CCR-04-1936; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Sorokina EM, 2004, J BIOL CHEM, V279, P13469, DOI 10.1074/jbc.M305250200; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Essen D, 2009, PLOS BIOL, V7, P549, DOI 10.1371/journal.pbio.1000073; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Wies E, 2009, J BIOL CHEM, V284, P8525, DOI 10.1074/jbc.M809252200; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	44	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16495	16503		10.1074/jbc.M110.102848	http://dx.doi.org/10.1074/jbc.M110.102848			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353939	Green Published, hybrid			2022-12-27	WOS:000277982600011
J	Barbu, EA; Zhang, J; Siraganian, RP				Barbu, Emilia Alina; Zhang, Juan; Siraganian, Reuben P.			The Limited Contribution of Fyn and Gab2 to the High Affinity IgE Receptor Signaling in Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; ACTIVATED PROTEIN-KINASE; BASOPHILIC LEUKEMIA-CELLS; TYROSINE KINASE; CYTOKINE PRODUCTION; T-CELLS; NUCLEAR-FACTOR; KAPPA-B; ALLERGIC RESPONSES; SH2 DOMAIN	Several studies with mast cells from knock-out mice have suggested that the tyrosine kinase Fyn and its downstream substrate Gab2 may play a role in high affinity IgE receptor (Fc epsilon RI)-mediated mast cell activation. To better understand the role of these two molecules and of Syk, we transiently transfected mast cells with small interference RNA (siRNA) targeted to Fyn, Gab2, or Syk to specifically decrease their expression. The siRNA suppression of Gab2 but not Fyn reduced activation of the phosphoinositide-3-kinase (PI3K) pathway as demonstrated by the change in phosphorylation of Akt; this indicates that Gab2 but not Fyn regulates this pathway. The decreased expression of Gab2 and Fyn had minor effects on degranulation. There were also some minor changes in activation of the NFAT or NF kappa B transcription factors in cells with reduced expression of Fyn or Gab2. Decreased Gab2 but not Fyn reduced the Fc epsilon RI-induced activation of the Erk, Jnk, and p38 MAP kinases and the release of TNF-alpha. In contrast, decreased expression of Syk dramatically reduced Fc epsilon RI-induced degranulation, activation of NFAT and NF kappa B. Therefore, the reduction in expression of these proteins in mast cells indicates that Syk is the major regulator of Fc epsilon RI-mediated reactions, whereas Fyn has minor if any effects and Gab2 regulates primarily late events including MAP kinase activation and release of cytokines.	[Barbu, Emilia Alina; Zhang, Juan; Siraganian, Reuben P.] NIH, Receptors & Signal Transduct Sect, Oral Infect & Immun Branch, NIDCR, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Barbu, EA (corresponding author), NIH, Receptors & Signal Transduct Sect, Oral Infect & Immun Branch, NIDCR, Bldg 49-1A16,49 Convent Dr, Bethesda, MD 20892 USA.	barbue@mail.nih.gov			National Institutes of Health, NIDCR; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000696] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIDCR.	Barker SA, 1999, J LEUKOCYTE BIOL, V65, P321, DOI 10.1002/jlb.65.3.321; BARSUMIAN EL, 1985, CELL IMMUNOL, V90, P131, DOI 10.1016/0008-8749(85)90175-3; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Costello PS, 1996, ONCOGENE, V13, P2595; Crouin C, 2001, FEBS LETT, V495, P148, DOI 10.1016/S0014-5793(01)02373-0; Frossi B, 2007, J IMMUNOL, V178, P2549, DOI 10.4049/jimmunol.178.4.2549; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Honda ZI, 2000, MOL CELL BIOL, V20, P1759, DOI 10.1128/MCB.20.5.1759-1771.2000; HUTCHINSON LE, 1995, J BIOL CHEM, V270, P16333, DOI 10.1074/jbc.270.27.16333; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Klein M, 2006, J IMMUNOL, V177, P6667, DOI 10.4049/jimmunol.177.10.6667; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marquardt DL, 2000, J ALLERGY CLIN IMMUN, V105, P500, DOI 10.1067/mai.2000.104942; Nadler M J, 2000, Adv Immunol, V76, P325; Nadler MJS, 2002, NAT IMMUNOL, V3, P707, DOI 10.1038/ni0802-707; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Nishizumi H, 1997, J IMMUNOL, V158, P2350; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; OFFERMANNS S, 1994, J IMMUNOL, V152, P250; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Sada K, 2003, CURR MOL MED, V3, P85, DOI 10.2174/1566524033361618; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Sugie K, 2004, P NATL ACAD SCI USA, V101, P14859, DOI 10.1073/pnas.0406168101; Tsygankov AY, 1996, J BIOL CHEM, V271, P27130, DOI 10.1074/jbc.271.43.27130; Welke J, 2002, HUM IMMUNOL, V63, P834, DOI 10.1016/S0198-8859(02)00455-X; Xie ZH, 2002, J IMMUNOL, V168, P4682, DOI 10.4049/jimmunol.168.9.4682; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	47	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15761	15768		10.1074/jbc.M110.109413	http://dx.doi.org/10.1074/jbc.M110.109413			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335178	hybrid, Green Published			2022-12-27	WOS:000277715900012
J	Harper, MT; Poole, AW				Harper, Matthew T.; Poole, Alastair W.			Protein Kinase C theta Negatively Regulates Store-independent Ca2+ Entry and Phosphatidylserine Exposure Downstream of Glycoprotein VI in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CURRENTS; THROMBUS FORMATION; CALCIUM-ENTRY; IN-VIVO; INFARCT VOLUME; PKC-THETA; KEY ROLE; CHANNEL; ACTIVATION; MEMBRANE	Platelet activation must be tightly controlled to provide an effective, but not excessive, response to vascular injury. Cytosolic calcium is a critical regulator of platelet function, including granule secretion, integrin activation, and phosphatidylserine (PS) exposure. Here we report that the novel protein kinase C isoform, PKC theta, plays an important role in negatively regulating Ca2+ signaling downstream of the major collagen receptor, glycoprotein VI (GPVI). This limits PS exposure and so may prevent excessive platelet procoagulant activity. Stimulation of GPVI resulted in significantly higher and more sustained Ca2+ signals in PKC theta(-/-) platelets. PKC theta acts at multiple distinct sites. PKC theta limits secretion, reducing autocrine ADP signaling that enhances Ca2+ release from intracellular Ca2+ stores. PKC theta thereby indirectly regulates activation of store-operated Ca2+ entry. However, PKC theta also directly and negatively regulates store-independent Ca2+ entry. This pathway, activated by the diacylglycerol analogue, 1-oleoyl-2-acetyl-sn-glycerol, was enhanced in PKC theta(-/-) platelets, independently of ADP secretion. Moreover, LOE-908, which blocks 1-oleoyl-2-acetyl-sn-glycerol-induced Ca2+ entry but not store-operated Ca2+ entry, blocked the enhanced GPVI-dependent Ca2+ signaling and PS exposure seen in PKC theta(-/-) platelets. We propose that PKC theta normally acts to restrict store-independent Ca2+ entry during GPVI signaling, which results in reduced PS exposure, limiting platelet procoagulant activity during thrombus formation.	[Harper, Matthew T.; Poole, Alastair W.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol	Poole, AW (corresponding author), Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Univ Walk, Bristol BS8 1TD, Avon, England.	a.poole@bris.ac.uk	Harper, Matthew T/G-5630-2013	Harper, Matthew T/0000-0002-4740-637X; Poole, Alastair/0000-0002-0868-297X	British Heart Foundation [RG/05/015]	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation Programme Grant RG/05/015.	Arachiche A, 2009, ARTERIOSCL THROM VAS, V29, P1883, DOI 10.1161/ATVBAHA.109.190926; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Carter RN, 2006, J PHYSIOL-LONDON, V576, P151, DOI 10.1113/jphysiol.2006.113886; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Christensen T, 2005, BASIC CLIN PHARMACOL, V96, P316, DOI 10.1111/j.1742-7843.2005.pto960407.x; Cosemans JMEM, 2008, J THROMB HAEMOST, V6, P1253, DOI 10.1111/j.1538-7836.2008.03041.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hall KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003277; Harper AGS, 2009, CELL CALCIUM, V45, P413, DOI 10.1016/j.ceca.2009.02.003; Harper MT, 2007, BIOCHEM SOC T, V35, P1005, DOI 10.1042/BST0351005; Harper MT, 2009, BLOOD, V114, P489, DOI 10.1182/blood-2009-03-208454; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; KRAUTWURST D, 1993, MOL PHARMACOL, V43, P655; KRAUTWURST D, 1994, N-S ARCH PHARMACOL, V349, P301; Kuijpers MJE, 2008, MICROCIRCULATION, V15, P269, DOI 10.1080/10739680701653517; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liu DY, 2008, ARTERIOSCL THROM VAS, V28, P746, DOI 10.1161/ATVBAHA.108.162222; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; SAGE SO, 1989, BIOCHEM J, V258, P923, DOI 10.1042/bj2580923; Salido GM, 2009, CELL SIGNAL, V21, P457, DOI 10.1016/j.cellsig.2008.11.005; SMEETS EF, 1993, THROMB HAEMOSTASIS, V70, P1024; Solum NO, 1999, ARTERIOSCL THROM VAS, V19, P2841, DOI 10.1161/01.ATV.19.12.2841; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Strehl A, 2007, J BIOL CHEM, V282, P7046, DOI 10.1074/jbc.M611367200; Tatlisumak T, 2000, J NEUROL SCI, V178, P107, DOI 10.1016/S0022-510X(00)00380-4; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Vorndran C, 1995, BIOPHYS J, V69, P2112, DOI 10.1016/S0006-3495(95)80082-2; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	40	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19865	19873		10.1074/jbc.M109.085654	http://dx.doi.org/10.1074/jbc.M109.085654			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20388711	Green Published, hybrid			2022-12-27	WOS:000279012000019
J	Silkstone, G; Kapetanaki, SM; Husu, I; Vos, MH; Wilson, MT				Silkstone, Gary; Kapetanaki, Sofia M.; Husu, Ivan; Vos, Marten H.; Wilson, Michael T.			Nitric Oxide Binds to the Proximal Heme Coordination Site of the Ferrocytochrome c/Cardiolipin Complex FORMATION MECHANISM AND DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLATE-CYCLASE; XYLOSOXIDANS CYTOCHROME C'; CARBON-MONOXIDE; CARDIOLIPIN COMPLEX; PEROXIDASE-ACTIVITY; MOLECULAR-BASIS; APOPTOSIS; PROTEIN; NO; MITOCHONDRIA	Mammalian mitochondrial cytochrome c interacts with cardiolipin to form a complex (cyt. c/CL) important in apoptosis. Here we show that this interaction leads to structural changes in ferrocytochrome c that leads to an open coordinate site on the central iron, resulting from the dissociation of the intrinsic methionine residue, where NO can rapidly bind (k = 1.2 x 10(7) M-1 s(-1)). Accompanying NO binding, the proximal histidine dissociates leaving the heme pentacoordinate, in contrast to the hexacoordinate nitrosyl adducts of native ferrocytochrome c or of the protein in which the coordinating methionine is removed by chemical modification or mutation. We present the results of stopped-flow and photolysis experiments that show that following initial NO binding to the heme, there ensues an unusually complex set of kinetic steps. The spectral changes associated with these kinetic transitions, together with their dependence on NO concentration, have been determined and lead us to conclude that NO binding to cyt. c/CL takes place via an overall scheme comparable to that described for cytochrome c' and guanylate cyclase, the final product being one in which NO resides on the proximal side of the heme. In addition, novel features not observed before in other heme proteins forming pentacoordinate nitrosyl species, include a high yield of NO escape after dissociation, rapid (< 1 ms) dissociation of proximal histidine upon NO binding and its very fast binding (60 ps) after NO dissociation, and the formation of a hexacoordinate intermediate. These features all point at a remarkable mobility of the proximal heme environment induced by cardiolipin.	[Silkstone, Gary; Husu, Ivan; Wilson, Michael T.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Kapetanaki, Sofia M.; Vos, Marten H.] Ecole Polytech, CNRS, Lab Opt Biosci, F-91128 Palaiseau, France; [Kapetanaki, Sofia M.; Vos, Marten H.] INSERM, U696, F-91128 Palaiseau, France	University of Essex; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Wilson, MT (corresponding author), Univ Essex, Dept Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	wilsmt@essex.ac.uk	Kapetanaki, Sofia Maria/W-5156-2019	Kapetanaki, Sofia Maria/0000-0003-1286-9929; Vos, Marten/0000-0003-0493-4831	Region Ile-de-France; Italian Government; BBSRC, UK	Region Ile-de-France(Region Ile-de-France); Italian Government; BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the Region Ile-de-France (to S. M. K.), from the Italian Government (to I. H.), and from BBSRC, UK (to M. T. W. and G. S.).	Andrew CR, 2003, J AM CHEM SOC, V125, P9548, DOI 10.1021/ja035105r; Andrew CR, 2002, BIOCHEMISTRY-US, V41, P2353, DOI 10.1021/bi011419k; Andrew CR, 2001, BIOCHEMISTRY-US, V40, P4115, DOI 10.1021/bi0023652; ANTONINI E, 1978, FEBS LETT, V86, P209, DOI 10.1016/0014-5793(78)80564-X; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Chung HT, 2001, BIOCHEM BIOPH RES CO, V282, P1075, DOI 10.1006/bbrc.2001.4670; COLETTA M, 1988, FEBS LETT, V236, P127, DOI 10.1016/0014-5793(88)80299-0; Franzen S, 2001, BIOPHYS J, V80, P2372, DOI 10.1016/S0006-3495(01)76207-8; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Giuffre A, 2005, FEBS LETT, V579, P2528, DOI 10.1016/j.febslet.2005.03.067; Godoy LC, 2009, P NATL ACAD SCI USA, V106, P2653, DOI 10.1073/pnas.0809279106; Haynes V, 2004, J BIOENERG BIOMEMBR, V36, P341, DOI 10.1023/B:JOBB.0000041765.27145.08; IGNARRO LJ, 1990, PHARMACOL TOXICOL, V67, P1, DOI 10.1111/j.1600-0773.1990.tb00772.x; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; Kapetanaki SM, 2009, BIOCHEMISTRY-US, V48, P1613, DOI 10.1021/bi801817v; Kruglik SG, 2007, J BIOL CHEM, V282, P5053, DOI 10.1074/jbc.M604327200; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Mannick JB, 2004, FREE RADICAL RES, V38, P1, DOI 10.1080/10715760310001629065; Negrerie M, 2006, J BIOL CHEM, V281, P10389, DOI 10.1074/jbc.M513375200; Negrerie M, 2001, J BIOL CHEM, V276, P46815, DOI 10.1074/jbc.M102224200; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; PERUTZ MF, 1976, BIOCHEMISTRY-US, V15, P378, DOI 10.1021/bi00647a022; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; Pixton DA, 2009, J AM CHEM SOC, V131, P4846, DOI 10.1021/ja809587q; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Schonhoff CM, 2003, J BIOL CHEM, V278, P18265, DOI 10.1074/jbc.M212459200; Silkstone G, 2005, DALTON T, P3489, DOI 10.1039/b508183c; Silkstone G, 2007, J BIOL CHEM, V282, P1638, DOI 10.1074/jbc.M605760200; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Vlasova II, 2006, J BIOL CHEM, V281, P14554, DOI 10.1074/jbc.M509507200; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Ye X, 2002, J AM CHEM SOC, V124, P5914, DOI 10.1021/ja017359n; YOO BK, 2010, ULTRAFAST PHENOMENA, V16; YOSHIMURA T, 1986, BIOCHEMISTRY-US, V25, P2436, DOI 10.1021/bi00357a021; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	39	35	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19785	19792		10.1074/jbc.M109.067736	http://dx.doi.org/10.1074/jbc.M109.067736			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20395293	Green Published, hybrid			2022-12-27	WOS:000279012000011
J	Ventrella-Lucente, LF; Unnikrishnan, A; Pilling, AB; Patel, HV; Kushwaha, D; Dombkowski, AA; Schmelz, EM; Cabelof, DC; Heydari, AR				Ventrella-Lucente, Lisa F.; Unnikrishnan, Archana; Pilling, Amanda B.; Patel, Hiral V.; Kushwaha, Deepa; Dombkowski, Alan A.; Schmelz, Eva M.; Cabelof, Diane C.; Heydari, Ahmad R.			Folate Deficiency Provides Protection against Colon Carcinogenesis in DNA Polymerase beta Haploinsufficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HAMSTER OVARY CELLS; ABERRANT CRYPT FOCI; FOLIC-ACID DEFICIENCY; URACIL MISINCORPORATION; IN-VITRO; DIETARY-FOLATE; STRAND BREAKS; ALKYLATING-AGENTS; OXIDATIVE STRESS	Aging and DNA polymerase beta deficiency (beta-pol(+/)-) interact to accelerate the development of malignant lymphomas and adenocarcinoma and increase tumor bearing load in mice. Folate deficiency (FD) has been shown to induce DNA damage repaired via the base excision repair (BER) pathway. We anticipated that FD and BER deficiency would interact to accelerate aberrant crypt foci (ACF) formation and tumor development in beta-pol haploinsufficient animals. FD resulted in a significant increase in ACF formation in wild type (WT) animals exposed to 1,2-dimethylhydrazine, a known colon and liver carcinogen; however, FD reduced development of ACF in beta-pol haploinsufficient mice. Prolonged feeding of the FD diet resulted in advanced ACF formation and liver tumors in wild type mice. However, FD attenuated onset and progression of ACF and prevented liver tumorigenesis in beta-pol haploinsufficient mice, i.e. FD provided protection against tumorigenesis in a BER-deficient environment in all tissues where 1,2-dimethylhydrazine exerts its damage. Here we show a distinct down-regulation in DNA repair pathways, e.g. BER, nucleotide excision repair, and mismatch repair, and decline in cell proliferation, as well as an up-regulation in poly(ADP-ribose) polymerase, proapoptotic genes, and apoptosis in colons of FD beta-pol haploinsufficient mice.	[Heydari, Ahmad R.] Wayne State Univ, Dept Nutr & Food Sci, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48202 USA; [Cabelof, Diane C.; Heydari, Ahmad R.] Wayne State Univ, Dept Nutr & Food, Sch Med, Sci Coll Liberal Arts & Sci, Detroit, MI 48202 USA; [Dombkowski, Alan A.] Wayne State Univ, Sch Med, Inst Environm Hlth Sci, Detroit, MI 48202 USA; [Schmelz, Eva M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Virginia Polytechnic Institute & State University	Heydari, AR (corresponding author), Wayne State Univ, Dept Nutr & Food Sci, Sch Med, Barbara Ann Karmanos Canc Inst, 3009 Sci Hall, Detroit, MI 48202 USA.	ahmad.heydari@wayne.edu	Schmelz, Eva M/E-6579-2012	Dombkowski, Alan/0000-0002-0312-8750	National Institutes of Health [R01 CA121298]; American Institute for Cancer Research [03A061]; NATIONAL CANCER INSTITUTE [R01CA121298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA121298 (to A.R.H.).This work was also supported by American Institute for Cancer Research Grant 03A061 (to A.R.H.).	BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Branda RF, 1999, MUTAT RES-FUND MOL M, V427, P79, DOI 10.1016/S0027-5107(99)00095-0; Branda RF, 1998, ENVIRON MOL MUTAGEN, V32, P33, DOI 10.1002/(SICI)1098-2280(1998)32:1&lt;33::AID-EM4&gt;3.0.CO;2-C; Branda RF, 2007, MUTAT RES-FUND MOL M, V615, P12, DOI 10.1016/j.mrfmmm.2006.09.007; Cabelof DC, 2004, J BIOL CHEM, V279, P36504, DOI 10.1074/jbc.M405185200; Cabelof DC, 2003, CANCER RES, V63, P5799; Cabelof DC, 2006, CANCER RES, V66, P7460, DOI 10.1158/0008-5472.CAN-06-1177; Chapkin RS, 2009, J NUTR BIOCHEM, V20, P649, DOI 10.1016/j.jnutbio.2008.07.001; Choi SW, 1998, GUT, V43, P93, DOI 10.1136/gut.43.1.93; CRAVO ML, 1992, CANCER RES, V52, P5002; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; Duthie SJ, 2000, BRIT J CANCER, V83, P1532, DOI 10.1054/bjoc.2000.1481; Duthie SJ, 2002, J NUTR, V132, p2444S, DOI 10.1093/jn/132.8.2444S; Duthie SJ, 2000, NUTR CANCER, V37, P245, DOI 10.1207/S15327914NC372_18; Duthie SJ, 1998, FASEB J, V12, P1491, DOI 10.1096/fasebj.12.14.1491; Duthie SJ, 2008, J PROTEOME RES, V7, P3254, DOI 10.1021/pr700751y; EVERSON RB, 1988, JNCI-J NATL CANCER I, V80, P525, DOI 10.1093/jnci/80.7.525; Fenoglio-Preiser CM, 1999, TOXICOL PATHOL, V27, P632, DOI 10.1177/019262339902700604; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Holmquist GP, 1998, MUTAT RES-FUND MOL M, V400, P59, DOI 10.1016/S0027-5107(98)00051-7; Huang Q, 2009, CELL DEATH DIFFER, V16, P264, DOI 10.1038/cdd.2008.151; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; KIM YI, 1995, AM J CLIN NUTR, V61, P1083, DOI 10.1093/ajcn/61.5.1083; Kim YI, 1996, GUT, V39, P732, DOI 10.1136/gut.39.5.732; Kim YI, 2000, GASTROENTEROLOGY, V119, P151, DOI 10.1053/gast.2000.8518; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Lawrance AK, 2009, GUT, V58, P805, DOI 10.1136/gut.2007.143107; LIBBUS BL, 1990, CANCER GENET CYTOGEN, V46, P231, DOI 10.1016/0165-4608(90)90108-M; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; MacGregor JT, 1997, MUTAT RES-FUND MOL M, V377, P125, DOI 10.1016/S0027-5107(97)00070-5; MCLELLAN EA, 1991, CANCER RES, V51, P5270; Melnyk S, 1999, CANCER LETT, V146, P35, DOI 10.1016/S0304-3835(99)00213-X; Miknyoczki S, 2007, MOL CANCER THER, V6, P2290, DOI 10.1158/1535-7163.MCT-07-0062; No HN, 2007, NUTR RES, V27, P659, DOI 10.1016/j.nutres.2007.08.001; Ochs K, 2002, CANCER RES, V62, P1524; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; Rime M, 2004, MOL CANCER THER, V3, P955; SOKAL RR, 1981, BIOMETRY, P169; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Taverna P, 2001, MUTAT RES-DNA REPAIR, V485, P269, DOI 10.1016/S0921-8777(01)00076-3; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Unnikrishnan A, 2009, FREE RADICAL BIO MED, V46, P1488, DOI 10.1016/j.freeradbiomed.2009.02.021; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zhu HP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-128	46	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19246	19258		10.1074/jbc.M109.069807	http://dx.doi.org/10.1074/jbc.M109.069807			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404327	Green Published, hybrid			2022-12-27	WOS:000278727800034
J	Wang, GX; Gao, XA; Huang, Y; Yao, Z; Shi, QH; Wu, MA				Wang, Guoxing; Gao, Xiang; Huang, Yun; Yao, Zhan; Shi, Qinghua; Wu, Mian			Nucleophosmin/B23 Inhibits Eg5-mediated Microtubule Depolymerization by Inactivating Its ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CENTROSOME DUPLICATION; DOWN-REGULATION; CELLS; EXPRESSION; PROTEINS; NUCLEUS; SHUTTLE; TUBULIN; BINDING	Nucleophosmin/B23, an abundant nucleolar protein, plays multiple roles in cell growth and proliferation, and yet, little has been studied about its function in regulating dynamics of microtubules. Here, we report that B23 directly interacts with Eg5, a member of the kinesin family, in the cytosol. The DNA/RNA binding domain of B23 and the motor domain of Eg5 were found to be involved in their interaction. Both in vivo and in vitro evidences showed that B23 acts as an upstream regulator of Eg5 in promoting microtubule polymerization. Moreover, we further demonstrated that B23 regulates microtubule dynamics by directly inhibiting Eg5 ATPase activity.	[Wu, Mian] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, MA (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	wumian@ustc.edu.cn	Yao, Zhan/K-1839-2013; Wu, Mian/H-2494-2018; XIANG, GAO/ABH-4277-2020; Yao, Zhan/AAK-6756-2020; Huang, Yun/AGX-8953-2022	Huang, Yun/0000-0001-5987-1319; YAO, ZHAN/0000-0001-5391-5691; Wu, Mian/0000-0002-2714-0500	National Natural Science Foundation of China [30530200, 30871290, 30728003]; Ministry of Science and Technology of China [2006CB910300, 2010CB912804]; Chinese Academy of Sciences [KSCX1-YW-R-57]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (30530200, 30871290, and 30728003), the Ministry of Science and Technology of China (2006CB910300 and 2010CB912804), and the Chinese Academy of Sciences (KSCX1-YW-R-57).	Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; Belmont L, 1996, TRENDS BIOCHEM SCI, V21, P197, DOI 10.1016/S0968-0004(96)80013-2; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Daire V, 2009, J BIOL CHEM, V284, P31992, DOI 10.1074/jbc.M109.007906; den Besten W, 2005, CELL CYCLE, V4, P1593; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jiang PS, 1999, BIOCHEM BIOPH RES CO, V257, P865, DOI 10.1006/bbrc.1999.0551; Koller E, 2006, CANCER RES, V66, P2059, DOI 10.1158/0008-5472.CAN-05-1531; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Myers KA, 2007, J CELL BIOL, V178, P1081, DOI 10.1083/jcb.200702074; Neben K, 2003, BLOOD, V101, P289, DOI 10.1182/blood-2002-04-1188; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Runge M S, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 1, P483; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Vulevic B, 1997, BIOPHYS J, V72, P1357, DOI 10.1016/S0006-3495(97)78782-4; Walczak CE, 1996, CELL, V85, P943, DOI 10.1016/S0092-8674(00)81295-7; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wordeman L, 2009, DEV CELL, V17, P437, DOI 10.1016/j.devcel.2009.10.002; Wu HL, 1999, INT J CANCER, V81, P923, DOI 10.1002/(SICI)1097-0215(19990611)81:6<923::AID-IJC14>3.0.CO;2-D; Yao Z, 2007, EMBO J, V26, P1068, DOI 10.1038/sj.emboj.7601571; Yun JP, 2003, J CELL BIOCHEM, V90, P1140, DOI 10.1002/jcb.10706	33	14	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19060	19067		10.1074/jbc.M110.100396	http://dx.doi.org/10.1074/jbc.M110.100396			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404347	Green Published, hybrid			2022-12-27	WOS:000278727800015
J	Fletcher, TC; DiGiandomenico, A; Hawiger, J				Fletcher, Tynetta C.; DiGiandomenico, Antonio; Hawiger, Jacek			Extended Anti-inflammatory Action of a Degradation-resistant Mutant of Cell-penetrating Suppressor of Cytokine Signaling 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR DELIVERY; FUNCTIONAL PEPTIDES; UBIQUITIN LIGASE; PEST SEQUENCES; SOCS PROTEINS; SH2 DOMAIN; RECEPTOR; INFLAMMATION; IMMUNITY; BINDING	Suppressor of cytokine signaling 3 (SOCS3) regulates the proinflammatory cytokine signaling mediated by the JAK/STAT signaling pathway. SOCS3 is rapidly induced and then targeted to the ubiquitin-proteasome pathway via a mechanism that requires the C-terminal SOCS box. Due to its rapid turnover, the intracellular stores of SOCS3 seem insufficient to control acute or protracted inflammatory diseases. Previously, we developed an intracellular protein therapy that uses a recombinant cell-penetrating form of SOCS3 (CP-SOCS3) to inhibit the JAK/STAT pathway and prevent cytokine-mediated lethal inflammation and apoptosis of the liver (Jo, D., Liu, D., Yao, S., Collins, R. D., and Hawiger, J. (2005) Nat. Med. 11, 892-898). The potent anti-inflammatory and cytoprotective activity of CP-SOCS3 prompted us to analyze its intracellular turnover, as compared with that of endogenous SOCS3 protein induced in macrophages by the proinflammatory agonists, interferon-gamma and lipopolysaccharide. We found that the half-life (t(1/2)) of endogenous SOCS3 is 0.7 h in activated macrophages, compared with a t(1/2) of 6.2 h for recombinant CP-SOCS3. Deletion of the SOCS box in CP-SOCS3 renders it more resistant to proteasomal degradation, extending its t(1/2) to 29 h. Consequently, this SOCS box-deleted form of CP-SOCS3 displays persistent inhibitory activity for 24 h toward interferon-gamma-and lipopolysaccharide-induced cytokine and chemokine production. Compared with the wild-type suppressor, this gain-of-function CP-SOCS3 mutant provides a longer acting inhibitor of cytokine signaling, a feature that offers a clear advantage for the intracellular delivery of proteins to treat acute or protracted inflammatory diseases.	[DiGiandomenico, Antonio; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Fletcher, Tynetta C.] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA	Vanderbilt University; Meharry Medical College	Hawiger, J (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, A-5321 MCN,1161 21st Ave S, Nashville, TN 37232 USA.	jacek.hawiger@vanderbilt.edu		DiGiandomenico, Antonio/0000-0003-1745-647X	National Institutes of Health, United States Public Health Service [HL069452, AA015752, T32 AI007281, T32 HL069765]; Kirschstein National Research Service Award Individual Fellowship [F31-GM077030]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069452, T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U24DK059637, P30DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM077030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015752] Funding Source: NIH RePORTER	National Institutes of Health, United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Kirschstein National Research Service Award Individual Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL069452 and AA015752 from the United States Public Health Service, and Training Grants T32 AI007281 and T32 HL069765.; Supported by Ruth L. Kirschstein National Research Service Award Individual Fellowship F31-GM077030. Submitted as partial fulfillment of the requirements for the degree of Doctor of Philosophy, Meharry Medical College.	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Badi I, 2009, FEBS LETT, V583, P2486, DOI 10.1016/j.febslet.2009.07.001; BARNES JA, 1995, MOL CELL BIOCHEM, V149, P17, DOI 10.1007/BF01076559; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; DiGiandomenico A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1162191; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dunn SL, 2005, MOL ENDOCRINOL, V19, P925, DOI 10.1210/me.2004-0353; Hawiger J, 1999, CURR OPIN CHEM BIOL, V3, P89, DOI 10.1016/S1367-5931(99)80016-7; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hortner M, 2002, J IMMUNOL, V169, P1219, DOI 10.4049/jimmunol.169.3.1219; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kiu H, 2009, GROWTH FACTORS, V27, P384, DOI 10.3109/08977190903210954; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; MOLINARI M, 1995, J BIOL CHEM, V270, P2032, DOI 10.1074/jbc.270.5.2032; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Siewert E, 1999, EUR J BIOCHEM, V265, P251, DOI 10.1046/j.1432-1327.1999.00719.x; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200	33	19	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18727	18736		10.1074/jbc.M109.095216	http://dx.doi.org/10.1074/jbc.M109.095216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400504	Green Published, hybrid			2022-12-27	WOS:000278453900064
J	Green, SM; Coyne, HJ; McIntosh, LP; Graves, BJ				Green, Sean M.; Coyne, H. Jerome, III; McIntosh, Lawrence P.; Graves, Barbara J.			DNA Binding by the ETS Protein TEL (ETV6) Is Regulated by Autoinhibition and Self-association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; COMPLEX-FORMATION; MULTIPLE DOMAINS; AUTO-INHIBITION; NUCLEAR EXPORT; FAMILY; GENE; YAN; ACTIVATION	The ETS protein TEL, a transcriptional repressor, contains a PNT domain that, as an isolated fragment in vitro, self-associates to form a head-to-tail polymer. How such polymerization might affect the DNA-binding properties of full-length TEL is unclear. Here we report that monomeric TEL binds to a consensus ETS site with unusually low affinity (K-d = 2.8 x 10(-8) M). A deletion analysis demonstrated that the low affinity was caused by a C-terminal inhibitory domain (CID) that attenuates DNA binding by similar to 10-fold. An NMR spectroscopically derived structure of a TEL fragment, deposited in the Protein Data Bank, revealed that the CID consists of two alpha-helices, one of which appears to block the DNA binding surface of the TEL ETS domain. Based on this structure, we substituted two conserved glutamic acids (Glu-431 and Glu-434) with alanines and found that this activated DNA binding and enhanced trypsin sensitivity in the CID. We propose that TEL displays a conformational equilibrium between inhibited and activated states and that electrostatic interactions involving these negatively charged residues play a role in stabilizing the inhibited conformation. Using a TEL dimer as a model polymer, we show that self-association facilitates cooperative binding to DNA. Cooperativity was observed on DNA duplexes containing tandem consensus ETS sites at variable spacing and orientations, suggesting flexibility in the region of TEL linking its self-associating PNT domain and DNA-binding ETS domain. We speculate that TEL compensates for the low affinity, which is caused by autoinhibition, by binding to DNA as a cooperative polymer.	[Green, Sean M.; Graves, Barbara J.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Sch Med, Salt Lake City, UT 84112 USA; [Coyne, H. Jerome, III; McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Coyne, H. Jerome, III; McIntosh, Lawrence P.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of British Columbia; University of British Columbia	Graves, BJ (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Sch Med, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	barbara.graves@hci.utah.edu			National Institutes of Health [R01GM38663, P50CA42014]; Canadian Cancer Society Research Institute; Canadian Institutes for Health Research; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; UBC Blusson Fund; Michael Smith Foundation for Health Research; Huntsman Cancer Institute/Huntsman Cancer Foundation; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; UBC Blusson Fund; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Huntsman Cancer Institute/Huntsman Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM38663 (to B. J. G.) and P50CA42014 (to the Huntsman Cancer Institute for support of shared resources). This work was also supported by funds from the Canadian Cancer Society Research Institute (to L. P. M.). Received instrument support from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, the British Columbia Knowledge Development Fund, the UBC Blusson Fund, and the Michael Smith Foundation for Health Research. Supported by the Huntsman Cancer Institute/Huntsman Cancer Foundation. To whom correspondence should be addressed: Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112-5550. Tel.: 801-581-7308; Fax: 801-585-6410; E-mail: barbara. graves@hci.utah.edu.	Agarkar VB, 2010, J MOL BIOL, V397, P278, DOI 10.1016/j.jmb.2010.01.017; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; Fenrick R, 1999, MOL CELL BIOL, V19, P6566; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Golub TR, 1997, CURR TOP MICROBIOL, V220, P67; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Irvin BJ, 2003, J BIOL CHEM, V278, P46378, DOI 10.1074/jbc.M305189200; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Kopp JL, 2007, J BIOL CHEM, V282, P3027, DOI 10.1074/jbc.M609907200; Kwiatkowski BA, 1998, J BIOL CHEM, V273, P17525, DOI 10.1074/jbc.273.28.17525; Lee GM, 2008, J MOL BIOL, V382, P1014, DOI 10.1016/j.jmb.2008.07.064; LIM F, 1992, EMBO J, V11, P643, DOI 10.1002/j.1460-2075.1992.tb05096.x; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Mackereth CD, 2004, J MOL BIOL, V342, P1249, DOI 10.1016/j.jmb.2004.07.094; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Poirel H, 2000, ONCOGENE, V19, P4802, DOI 10.1038/sj.onc.1203830; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Qiao F, 2006, EMBO J, V25, P70, DOI 10.1038/sj.emboj.7600924; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Song HY, 2005, GENE DEV, V19, P1767, DOI 10.1101/gad.1327405; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tran Hoang H, 2002, BMC Struct Biol, V2, P5, DOI 10.1186/1472-6807-2-5; Uchida H, 1999, ONCOGENE, V18, P1015, DOI 10.1038/sj.onc.1202383; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yang SH, 2002, MOL CELL BIOL, V22, P5036, DOI 10.1128/MCB.22.14.5036-5046.2002; Zhang J, 2010, MOL CELL BIOL, V30, P1158, DOI 10.1128/MCB.01225-09	56	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18496	18504		10.1074/jbc.M109.096958	http://dx.doi.org/10.1074/jbc.M109.096958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400516	Green Published, hybrid			2022-12-27	WOS:000278453900043
J	Jones, KL; Roche, M; Gantier, MP; Begum, NA; Honjo, T; Caradonna, S; Williams, BRG; Mak, J				Jones, Kate L.; Roche, Michael; Gantier, Michael P.; Begum, Nasim A.; Honjo, Tasuku; Caradonna, Salvatore; Williams, Bryan R. G.; Mak, Johnson			X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD MONONUCLEAR-CELLS; REPAIR ENZYME; IN-VIVO; REVERSE TRANSCRIPTION; MITOCHONDRIAL FORMS; CYCLE REGULATION; VIRAL PARTICLES; MUTATION-RATE; ABASIC SITES	It has been assumed that R5 and X4 HIV utilize similar strategies to support viral cDNA synthesis post viral entry. In this study, we provide evidence to show that R5 and X4 HIV have distinct requirements for host cell uracil DNA glycosylase (UNG2) during the early stage of infection. UNG2 has been previously implicated in HIV infection, but its precise role remains controversial. In this study we show that, although UNG2 is highly expressed in different cell lines, UNG2 levels are low in the natural host cells of HIV. Short interfering RNA knockdown of endogenous UNG2 in primary cells showed that UNG2 is required for R5 but not X4 HIV infection and that this requirement is bypassed when HIV enters the target cell via vesicular stomatitis virus envelope-glycoprotein-mediated endocytosis. We also show that short interfering RNA knockdown of UNG2 in virus-producing primary cells leads to defective R5 HIV virions that are unable to complete viral cDNA synthesis. Quantitative PCR analysis revealed that endogenous UNG2 levels are transiently up-regulated post HIV infection, and this increase in UNG2 mRNA is similar to 10-20 times higher in R5 versus X4 HIV-infected cells. Our data show that both virion-associated UNG2 and HIV infection-induced UNG2 expression are critical for reverse transcription during R5 but not X4 HIV infection. More importantly, we have made the novel observation that R5 and X4 HIV have distinct host cell factor requirements and differential capacities to induce gene expression during the early stages of infection. These differences may result from activation of distinct signaling cascades and/or infection of divergent T-lymphocyte subpopulations.	[Jones, Kate L.; Roche, Michael; Mak, Johnson] Burnet Inst, Ctr Virol, Melbourne, Vic 3004, Australia; [Jones, Kate L.; Mak, Johnson] Monash Univ, Dept Biochem, Clayton, Vic 3168, Australia; [Roche, Michael; Mak, Johnson] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Gantier, Michael P.; Williams, Bryan R. G.] Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Begum, Nasim A.; Honjo, Tasuku] Kyoto Univ, Dept Med Chem, Kyoto 6068501, Japan; [Caradonna, Salvatore] Univ Med & Dent New Jersey, Dept Mol Biol, Stratford, NJ 08084 USA	Burnet Institute; Monash University; Monash University; Monash University; Kyoto University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mak, J (corresponding author), Burnet Inst, Ctr Virol, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	mak@burnet.edu.au	Gantier, Michael/H-7954-2019; mak, johnson/S-2457-2019; Williams, Bryan R. G./A-5021-2009; mak, johnson/H-4605-2014; Gantier, Michael/B-7512-2011; Caradonna, Salvatore/AFU-8514-2022; Honjo, Tasuku/N-4470-2016	Gantier, Michael/0000-0003-3740-698X; mak, johnson/0000-0002-5229-5707; Williams, Bryan R. G./0000-0002-4969-1151; mak, johnson/0000-0002-5229-5707; Gantier, Michael/0000-0003-3740-698X; Caradonna, Salvatore/0000-0002-2104-581X; Begum, Nasim/0000-0001-7177-188X; Roche, Michael/0000-0001-8819-0096				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; APRELIKOVA ON, 1982, FEBS LETT, V137, P193, DOI 10.1016/0014-5793(82)80347-5; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Bjorndal A, 1997, J VIROL, V71, P7478; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; Briant L, 1996, J IMMUNOL, V156, P3994; CARADONNA S, 1987, J VIROL, V61, P3040, DOI 10.1128/JVI.61.10.3040-3047.1987; Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; Fischer JA, 2004, DNA REPAIR, V3, P505, DOI 10.1016/j.dnarep.2004.01.012; Fischer JA, 2006, CANCER RES, V66, P8829, DOI 10.1158/0008-5472.CAN-06-0540; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Haug T, 1998, NUCLEIC ACIDS RES, V26, P1449, DOI 10.1093/nar/26.6.1449; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jones Kate L., 2005, Current Pharmacogenomics, V3, P97, DOI 10.2174/1570160054022962; Jones KL, 2008, NUCLEIC ACIDS RES, V36, P1578, DOI 10.1093/nar/gkm1149; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Kariko K, 2004, CELLS TISSUES ORGANS, V177, P132, DOI 10.1159/000079987; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; LERNER DL, 1995, P NATL ACAD SCI USA, V92, P7480, DOI 10.1073/pnas.92.16.7480; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; McGeehan JE, 2001, CURR PROTEIN PEPT SC, V2, P325, DOI 10.2174/1389203013380964; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; NAGELHUS TA, 1995, EXP CELL RES, V220, P292, DOI 10.1006/excr.1995.1318; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Payne SL, 2001, CURR PROTEIN PEPT SC, V2, P381, DOI 10.2174/1389203013381008; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Priet S, 2005, MOL CELL, V17, P479, DOI 10.1016/j.molcel.2005.01.016; Priet S, 2003, VIROLOGY, V307, P283, DOI 10.1016/S0042-6822(02)00073-9; PU WT, 1992, NUCLEIC ACIDS RES, V20, P771, DOI 10.1093/nar/20.4.771; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; SchmidAntomarchi H, 1996, EUR J IMMUNOL, V26, P717, DOI 10.1002/eji.1830260331; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; SLUPPHAUG G, 1991, NUCLEIC ACIDS RES, V19, P5131, DOI 10.1093/nar/19.19.5131; SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Studebaker AW, 2001, CURR PROTEIN PEPT SC, V2, P371, DOI 10.2174/1389203013380946; Turelli P, 1997, J VIROL, V71, P4522, DOI 10.1128/JVI.71.6.4522-4530.1997; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; van Rij RP, 2000, J CLIN INVEST, V106, P1569, DOI 10.1172/JCI7953C1; Verani Alessia, 2002, Current Molecular Medicine (Hilversum), V2, P691, DOI 10.2174/1566524023361862; VILPO JA, 1988, MUTAT RES, V193, P207, DOI 10.1016/0167-8817(88)90031-4; Willetts KE, 1999, J VIROL, V73, P1682, DOI 10.1128/JVI.73.2.1682-1688.1999; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zaitseva M, 2003, BBA-BIOMEMBRANES, V1614, P51, DOI 10.1016/S0005-2736(03)00162-7	79	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18603	18614		10.1074/jbc.M109.090126	http://dx.doi.org/10.1074/jbc.M109.090126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20371602	Green Published, hybrid			2022-12-27	WOS:000278453900054
J	Liu, N; Li, H; Li, SX; Shen, MY; Xiao, N; Chen, YF; Wang, Y; Wang, WC; Wang, R; Wang, QA; Sun, JH; Wang, P				Liu, Ning; Li, Hui; Li, Shuangxi; Shen, Mingyue; Xiao, Ning; Chen, Yunfei; Wang, Yan; Wang, Weichao; Wang, Rui; Wang, Qian; Sun, Jianhua; Wang, Ping			The Fbw7/Human CDC4 Tumor Suppressor Targets Proproliferative Factor KLF5 for Ubiquitination and Degradation through Multiple Phosphodegron Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-5; PHOSPHORYLATION-DEPENDENT DEGRADATION; C-MYC; TRANSCRIPTION FACTORS; MEDIATED PROTEOLYSIS; CELL-PROLIFERATION; EPITHELIAL-CELLS; LIPID-METABOLISM; PROSTATE-CANCER; BREAST-CANCER	The proproliferative transcription factor KLF5 plays an important role in promoting cell proliferation and tumorigenesis. KLF5 is a short-lived protein that can be rapidly degraded through the ubiquitin-proteasome pathway in cancer cells. However, the mechanisms regulating protein stability remain poorly understood. In this study, the tumor suppressor Fbw7, a component of the SCF complex (SCFFbw7) E3 ubiquitin ligase, specifically promoted the degradation and ubiquitination of KLF5 but had little effect on the stability of KLF4. Fbw7 interacted with KLF5 in a CDC4 phosphodegron (CPD)-dependent manner. Three CPDs were found in the KLF5 protein. Simultaneous mutation of these CPDs significantly abolished Fbw7-mediated ubiquitination and degradation. Furthermore, Fbw7 deficiency dramatically delayed KLF5 turnover and led to the accumulation of KLF5 protein in cancer cells. Glycogen synthase kinase-3 beta could phosphorylate and promote Fbw7-mediated KLF5 degradation. More importantly, Fbw7 negatively regulated the biological activity of KLF5 in gene regulation and cell proliferation. Taken together, these data indicate that Fbw7 is a key negative regulator controlling KLF5-mediated cell proliferation and suggest an additional mechanism linking the loss of Fbw7 function to tumorigenesis.	[Wang, Ping] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	East China Normal University; East China Normal University	Wang, P (corresponding author), E China Normal Univ, Inst Biomed Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	pwang@bio.ecnu.edu.cn		Liu, Ning/0000-0002-7009-9187	Research Platform of Cell Signaling Networks of the Science and Technology Commission of Shanghai Municipality [06DZ22923]; National Natural Science Foundation of China [30800587, 30971521]; National Basic Research Program of China [2010CB529704]	Research Platform of Cell Signaling Networks of the Science and Technology Commission of Shanghai Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by Grant 06DZ22923 from the Research Platform of Cell Signaling Networks of the Science and Technology Commission of Shanghai Municipality, Grants 30800587 and 30971521 from the National Natural Science Foundation of China, and 973 Program Grant 2010CB529704 from the National Basic Research Program of China.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Bateman NW, 2004, J BIOL CHEM, V279, P12093, DOI 10.1074/jbc.M311532200; Bialkowska AB, 2009, MOL CANCER THER, V8, P563, DOI 10.1158/1535-7163.MCT-08-0767; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CS, 2009, INT J CANCER, V124, P2829, DOI 10.1002/ijc.24266; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; McConnell BB, 2008, GASTROENTEROLOGY, V134, P1007, DOI 10.1053/j.gastro.2008.01.013; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rajagopalan H, 2004, CELL CYCLE, V3, P693; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Usui S, 2004, J BIOL CHEM, V279, P12300, DOI 10.1074/jbc.M305025200; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310; Zheng HQ, 2009, ONCOGENE, V28, P3702, DOI 10.1038/onc.2009.235; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200; Ziemer LT, 2001, MOL CELL BIOL, V21, P562, DOI 10.1128/MCB.21.2.562-574.2001	53	91	96	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18858	18867		10.1074/jbc.M109.099440	http://dx.doi.org/10.1074/jbc.M109.099440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20388706	hybrid, Green Published			2022-12-27	WOS:000278453900076
J	Iwaya, N; Kuwahara, Y; Fujiwara, Y; Goda, N; Tenno, T; Akiyama, K; Mase, S; Tochio, H; Ikegami, T; Shirakawa, M; Hiroaki, H				Iwaya, Naoko; Kuwahara, Yohta; Fujiwara, Yoshie; Goda, Natsuko; Tenno, Takeshi; Akiyama, Kohei; Mase, Shogo; Tochio, Hidehito; Ikegami, Takahisa; Shirakawa, Masahiro; Hiroaki, Hidekazu			A Common Substrate Recognition Mode Conserved between Katanin p60 and VPS4 Governs Microtubule Severing and Membrane Skeleton Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ESCRT-III RECOGNITION; STRUCTURAL BASIS; MIT DOMAIN; AAA ATPASE; PROTEIN; TUBULIN; IDENTIFICATION; ASSIGNMENT; DATABASE	Katanin p60 (kp60), a microtubule-severing enzyme, plays a key role in cytoskeletal reorganization during various cellular events in an ATP-dependent manner. We show that a single domain isolated from the N terminus of mouse katanin p60 (kp60-NTD) binds to tubulin. The solution structure of kp60-NTD was determined by NMR. Although their sequence similarities were as low as 20%, the structure of kp60-NTD revealed a striking similarity to those of the microtubule interacting and trafficking (MIT) domains, which adopt anti-parallel three-stranded helix bundle. In particular, the arrangement of helices 2 and 3 is well conserved between kp60-NTD and the MIT domain from Vps4, which is a homologous protein that promotes disassembly of the endosomal sorting complexes required for transport III membrane skeleton complex. Mutation studies revealed that the positively charged surface formed by helices 2 and 3 binds tubulin. This binding mode resembles the interaction between the MIT domain of Vps4 and Vps2/CHMP1a, a component of endosomal sorting complexes required for transport III. Our results show that both the molecular architecture and the binding modes are conserved between two AAA-ATPases, kp60 and Vps4. A common mechanism is evolutionarily conserved between two distinct cellular events, one that drives microtubule severing and the other involving membrane skeletal reorganization.	[Iwaya, Naoko; Kuwahara, Yohta; Fujiwara, Yoshie; Goda, Natsuko; Tenno, Takeshi; Mase, Shogo; Hiroaki, Hidekazu] Kobe Univ, Dept Biochem & Mol Biol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Iwaya, Naoko; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Dept Mol Engn, Grad Sch Engn, Nishikyo Ku, Kyoto 6158530, Japan; [Iwaya, Naoko; Kuwahara, Yohta; Akiyama, Kohei; Hiroaki, Hidekazu] Yokohama City Univ, Field Supramol Biol, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan; [Kuwahara, Yohta; Goda, Natsuko; Tenno, Takeshi; Mase, Shogo; Hiroaki, Hidekazu] Japan Sci & Technol Corp, Inst Bioinformat Res & Dev, Tokyo 1020081, Japan; [Fujiwara, Yoshie; Hiroaki, Hidekazu] Kobe Univ, Global Ctr Excellence Program Integrat Membrane B, Kobe, Hyogo 6500017, Japan; [Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Osaka 5650871, Japan	Kobe University; Kyoto University; Yokohama City University; Japan Science & Technology Agency (JST); Kobe University; Osaka University	Hiroaki, H (corresponding author), Kobe Univ, Dept Biochem & Mol Biol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan.	hiroakih@med.kobe-u.ac.jp	Hiroaki, Hidekazu/G-9564-2012; Ikegami, Takahisa/I-9626-2017; HIROAKI, HIDEKAZU/N-1658-2019; Tochio, Hidehito/GWV-0429-2022; Tochio, Hidehito/F-6109-2011	Ikegami, Takahisa/0000-0002-1429-1844; HIROAKI, HIDEKAZU/0000-0003-1621-5893; Tochio, Hidehito/0000-0003-3843-3330; 	Cooperative Research Program of Institute for Protein Research, Osaka University	Cooperative Research Program of Institute for Protein Research, Osaka University	Apart of this work was performed under the Cooperative Research Program of Institute for Protein Research, Osaka University.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P533, DOI 10.1016/B978-012164491-8/50009-9; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Frohlich KU, 2001, J CELL SCI, V114, P1601; Goda N, 2004, PROTEIN SCI, V13, P652, DOI 10.1110/ps.03439004; GODDARD TD, 2004, SPARKY VERSION 3; Guasch A, 2002, J MOL BIOL, V318, P1139, DOI 10.1016/S0022-2836(02)00185-7; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Iwaya N, 2007, J BIOMOL NMR, V37, P53, DOI 10.1007/s10858-006-9103-0; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally FJ, 1996, J CELL SCI, V109, P561; McNally KP, 2000, J CELL SCI, V113, P1623; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Stoppin-Mellet V, 2007, PLANT PHYSIOL BIOCH, V45, P867, DOI 10.1016/j.plaphy.2007.09.005; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	63	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16822	16829		10.1074/jbc.M110.108365	http://dx.doi.org/10.1074/jbc.M110.108365			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20339000	Green Published, hybrid			2022-12-27	WOS:000277982600046
J	Kim, EM; Shin, EJ; Choi, JH; Son, HJ; Park, IS; Joh, TH; Hwang, O				Kim, Eun-Mee; Shin, Eun-Jung; Choi, Ji Hyun; Son, Hyo Jin; Park, Il-Seon; Joh, Tong H.; Hwang, Onyou			Matrix Metalloproteinase-3 Is Increased and Participates in Neuronal Apoptotic Signaling Downstream of Caspase-12 during Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE INHIBITOR; CELL-DEATH; PARKINSONS-DISEASE; INTRINSIC PATHWAY; TUMOR PROGRESSION; OXIDATIVE STRESS; NERVOUS-SYSTEM; ACTIVATION; STROMELYSIN; TIMP-1	Although endoplasmic reticulum (ER) stress-induced apoptosis has been associated with pathogenesis of neurodegenerative diseases, the cellular components involved have not been well delineated. The present study shows that matrix metalloproteinase (MMP)-3 plays a role in the ER stress-induced apoptosis. ER stress induced by brefeldin A (BFA) or tunicamycin (TM) increases gene expression of MMP-3, selectively among various MMP subtypes, and the active form of MMP-3 (actMMP-3) in the brain-derived CATH. a cells. Pharmacological inhibition of enzyme activity, small interference RNA-mediated gene knockdown, and gene knock-out of MMP-3 all provide protection against ER stress. MMP-3 acts downstream of caspase-12, because both pharmacological inhibition and gene knockdown of caspase-12 attenuate the actMMP-3 increase, but inhibition and knock-out of MMP-3 do not alter caspase-12. Furthermore, independently of the increase in the protein level, the catalytic activity of MMP-3 enzyme can be increased via lowering of its endogenous inhibitor protein TIMP-1. Caspase-12 causes liberation of MMP-3 enzyme activity by degrading TIMP-1 that is already bound to actMMP-3. TIMP-1 is decreased in response to ER stress, and TIMP-1 overexpression leads to cell protection and a decrease in MMP-3 activity. Taken together, actMMP-3 protein level and catalytic activity are increased following caspase-12 activation during ER stress, and this in turn plays a role in the downstream apoptotic signaling in neuronal cells. MMP-3 and TIMP-1 may therefore serve as cellular targets for therapy against neurodegenerative diseases.	[Kim, Eun-Mee; Shin, Eun-Jung; Choi, Ji Hyun; Son, Hyo Jin; Hwang, Onyou] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul 138736, South Korea; [Hwang, Onyou] Asan Inst Life Sci, Ctr Brain Res, Seoul 138736, South Korea; [Park, Il-Seon] Chosun Univ, Res Ctr Proteineous Mat, Kwangju 501759, South Korea; [Park, Il-Seon] Chosun Univ, Dept Biomat Engn, Kwangju 501759, South Korea; [Joh, Tong H.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	University of Ulsan; Chosun University; Chosun University; Cornell University	Hwang, O (corresponding author), Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, 388-1 Pungnap Dong, Seoul 138736, South Korea.	oyhwang@amc.seoul.kr			Ministry of Education, Science, and Technology, Republic of Korea [2009K001251]	Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Brain Research Center 21st Century Frontier Research Program of the Ministry of Education, Science, and Technology, Republic of Korea Grant 2009K001251 (to O.H.).	Aoki T, 2007, STROKE, V38, P2337, DOI 10.1161/STROKEAHA.107.481838; Arboleda G, 2005, J MOL NEUROSCI, V27, P65, DOI 10.1385/JMN:27:1:065; Boulday G, 2004, ANN NY ACAD SCI, V1030, P28, DOI 10.1196/annals.1329.004; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; Choi HJ, 2000, MOL PHARMACOL, V58, P633, DOI 10.1124/mol.58.3.633; Choi HJ, 2003, J NEUROCHEM, V86, P143, DOI 10.1046/j.1471-4159.2003.01808.x; Crocker SJ, 2004, J NEUROSCI RES, V75, P1, DOI 10.1002/jnr.10836; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fujita E, 2002, CELL DEATH DIFFER, V9, P1108, DOI 10.1038/sj.cdd.4401080; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; HAMMANI K, 1992, GENE, V120, P321, DOI 10.1016/0378-1119(92)90116-7; Han JM, 2007, J PHARMACOL EXP THER, V321, P249, DOI 10.1124/jpet.106.110866; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hornebeck W, 2005, BIOCHIMIE, V87, P377, DOI 10.1016/j.biochi.2004.09.022; Hwang O, 2001, MOL PHARMACOL, V59, P1249, DOI 10.1124/mol.59.5.1249; Kerkela E, 2003, EXP DERMATOL, V12, P109, DOI 10.1034/j.1600-0625.2003.120201.x; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Kim YS, 2005, J NEUROSCI, V25, P3701, DOI 10.1523/JNEUROSCI.4346-04.2005; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; Mao WK, 2006, AM J PHYSIOL-CELL PH, V290, pC1373, DOI 10.1152/ajpcell.00369.2005; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Mudgett JS, 1998, ARTHRITIS RHEUM-US, V41, P110, DOI 10.1002/1529-0131(199801)41:1<110::AID-ART14>3.0.CO;2-G; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Murphy G, 1995, ACTA ORTHOP SCAND, V66, P55, DOI 10.3109/17453679509157648; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SURI C, 1993, J NEUROSCI, V13, P1280; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Tan HK, 2003, MOL CELL NEUROSCI, V22, P98, DOI 10.1016/S1044-7431(02)00024-6; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959; Thorne M, 2009, J NEUROIMMUNOL, V211, P92, DOI 10.1016/j.jneuroim.2009.04.003; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang HQ, 2007, ANTIOXID REDOX SIGN, V9, P553, DOI 10.1089/ars.2006.1524; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	43	55	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16444	16452		10.1074/jbc.M109.093799	http://dx.doi.org/10.1074/jbc.M109.093799			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20368330	Green Published, hybrid			2022-12-27	WOS:000277982600006
J	Sinha, D; Shogren-Knaak, MA				Sinha, Divya; Shogren-Knaak, Michael A.			Role of Direct Interactions between the Histone H4 Tail and the H2A Core in Long Range Nucleosome Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES CHROMATIN COMPACTION; TRANSCRIPTIONAL REPRESSION; ANGSTROM RESOLUTION; SELF-ASSOCIATION; FIBER STRUCTURE; SURFACE; ARRAYS; DNA; DOMAINS; OCTAMER	In eukaryotic nuclei the majority of genomic DNA is believed to exist in higher order chromatin structures. Nonetheless, the nature of direct, long range nucleosome interactions that contribute to these structures is poorly understood. To determine whether these interactions are directly mediated by contacts between the histone H4 amino-terminal tail and the acidic patch of the H2A/H2B interface, as previously demonstrated for short range nucleosomal interactions, we have characterized the extent and effect of disulfide cross-linking between residues in histones contained in different strands of nucleosomal arrays. We show that in 208-12 5 S rDNA and 601-177-12 nucleosomal array systems, direct interactions between histones H4-V21C and H2A-E64C can be captured. This interaction depends on the extent of initial cross-strand association but does not require these specific residues, because interactions with residues flanking H4-V21C can also be captured. Additionally, we find that trapping H2A-H4 intra-array interactions antagonizes the ability of these arrays to undergo intermolecular self-association.	[Sinha, Divya; Shogren-Knaak, Michael A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Shogren-Knaak, MA (corresponding author), 4214 Mol Biol Bldg, Ames, IA 50011 USA.	knaak@iastate.edu	Sinha, Divya/AAW-4488-2021		National Institutes of Health [GM79663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM79663 (to M.A.S.-K.).	Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; HANSEN JC, 1994, P NATL ACAD SCI USA, V91, P2339, DOI 10.1073/pnas.91.6.2339; Horn PJ, 2002, NAT STRUCT BIOL, V9, P167, DOI 10.1038/nsb762; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu X, 2006, BIOCHEM CELL BIOL, V84, P411, DOI 10.1139/O06-068; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; McBryant SJ, 2009, J BIOL CHEM, V284, P16716, DOI 10.1074/jbc.M109.011288; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; van Holde K.E., 1988, CHROMATIN; van Holde K, 2007, SEMIN CELL DEV BIOL, V18, P651, DOI 10.1016/j.semcdb.2007.08.005; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	31	50	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16572	16581		10.1074/jbc.M109.091298	http://dx.doi.org/10.1074/jbc.M109.091298			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20351095	Green Published, hybrid			2022-12-27	WOS:000277982600020
J	Agle, KA; Vongsa, RA; Dwinell, MB				Agle, Kimberle A.; Vongsa, Rebecca A.; Dwinell, Michael B.			Calcium Mobilization Triggered by the Chemokine CXCL12 Regulates Migration in Wounded Intestinal Epithelial Monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; CELL-DERIVED FACTOR-1-ALPHA; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; FOCAL ADHESION KINASE; TYROSINE KINASE; IN-VITRO; BARRIER DYSFUNCTION; ION-TRANSPORT; RHO KINASE	Restitution of intestinal epithelial barrier damage involves the coordinated remodeling of focal adhesions in actively migrating enterocytes. Defining the extracellular mediators and the intracellular signaling pathways regulating those dynamic processes is a key step in developing restitution-targeted therapies. Previously we have determined that activation of the chemokine receptor CXCR4 by the cognate ligand CXCL12 enhances intestinal epithelial restitution through reorganization of the actin cytoskeleton. The aim of these studies was to investigate the role of calcium effectors in CXCL12-mediated restitution. CXCL12 stimulated release of intracellular calcium in a dose-dependent manner. Inhibition of intracellular calcium flux impaired CXCL12-mediated migration of IEC-6 and CaCo2 cells. Pharmacological blockade and specific shRNA depletion of the phospholipase-C (PLC beta 3) isoform attenuated CXCL12-enhanced migration, linking receptor activation with intracellular calcium flux. Immunoblot analyses demonstrated CXCL12 activated the calcium-regulated focal adhesion protein proline-rich tyrosine kinase-2 (Pyk2) and the effector proteins paxillin and p130(Cas). Interruption of Pyk2 signaling potently blocked CXCL12-induced wound closure. CXCL12-stimulated epithelial cell migration was enhanced on laminin and abrogated by intracellular calcium chelation. These results suggest CXCL12 regulates restitution through calcium-activated Pyk2 localized to active focal adhesions. Calcium signaling pathways may therefore provide a novel avenue for enhancing barrier repair.	[Agle, Kimberle A.; Vongsa, Rebecca A.; Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Dwinell, MB (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu			National Institutes of Health [DK062066]; American Recovery and Reinvestment Act of 2009; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062066, R56DK062066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act of 2009; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK062066. This work was also supported by the American Recovery and Reinvestment Act of 2009.	Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Astier A, 1997, J BIOL CHEM, V272, P228; Basson MD, 2002, AM J PATHOL, V161, P1101, DOI 10.1016/S0002-9440(10)64385-4; BASSON MD, 1992, J CLIN INVEST, V90, P15, DOI 10.1172/JCI115828; Beck PL, 2003, AM J PATHOL, V162, P597, DOI 10.1016/S0002-9440(10)63853-9; BOUCEK MM, 1976, SCIENCE, V193, P905, DOI 10.1126/science.948752; Brand S, 2002, GASTROENTEROLOGY, V122, P166, DOI 10.1053/gast.2002.30329; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Charrier L, 2007, J BIOL CHEM, V282, P16948, DOI 10.1074/jbc.M700158200; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Dwinell MB, 1999, GASTROENTEROLOGY, V117, P359, DOI 10.1053/gast.1999.0029900359; Dwinell MB, 2004, AM J PHYSIOL-GASTR L, V286, pG844, DOI 10.1152/ajpgi.00112.2003; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Glogauer M, 1997, J CELL SCI, V110, P11; Hyun JG, 2005, INFLAMM BOWEL DIS, V11, P799, DOI 10.1097/01.MIB.0000178263.34099.89; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; Jordan NJ, 1999, J CLIN INVEST, V104, P1061, DOI 10.1172/JCI6685; Kagimoto Y, 2008, J LEUKOCYTE BIOL, V83, P165, DOI 10.1189/jlb.0307137; Keely S, 2009, FASEB J, V23, P1338, DOI 10.1096/fj.08-125344; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V290, P1470, DOI 10.1006/bbrc.2002.6350; Kiselyov K, 2003, CELL SIGNAL, V15, P243, DOI 10.1016/S0898-6568(02)00074-8; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Litvak V, 2000, J BIOL CHEM, V275, P32736, DOI 10.1074/jbc.M004200200; Liu JY, 2009, J CELL SCI, V122, P324, DOI 10.1242/jcs.033720; Liu YW, 1998, J SURG RES, V77, P112, DOI 10.1006/jsre.1998.5369; Loh SA, 2009, PLAST RECONSTR SURG, V123, p65S, DOI 10.1097/PRS.0b013e318191bdf4; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; Lotz MM, 1997, AM J PATHOL, V150, P747; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Mahoney ZX, 2008, J CELL SCI, V121, P2493, DOI 10.1242/jcs.025528; Malinda KM, 2008, INT J BIOCHEM CELL B, V40, P2771, DOI 10.1016/j.biocel.2008.05.025; Mammen JMV, 2003, CRIT CARE MED, V31, pS532, DOI 10.1097/01.CCM.0000081429.89277.AF; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Owen CR, 2008, LAB INVEST, V88, P1101, DOI 10.1038/labinvest.2008.77; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; Polk DB, 1999, AM J PHYSIOL-CELL PH, V277, pC1149, DOI 10.1152/ajpcell.1999.277.6.C1149; Rao JN, 2006, AM J PHYSIOL-GASTR L, V290, pG782, DOI 10.1152/ajpgi.00441.2005; Rao JN, 2001, AM J PHYSIOL-CELL PH, V280, pC993, DOI 10.1152/ajpcell.2001.280.4.C993; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rufanova VA, 2009, J CELL PHYSIOL, V219, P45, DOI 10.1002/jcp.21649; Russo JM, 2005, GASTROENTEROLOGY, V128, P987, DOI 10.1053/j.gastro.2005.01.004; Saha C, 1998, J BIOL CHEM, V273, P21629, DOI 10.1074/jbc.273.34.21629; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Sorokin A, 2001, J BIOL CHEM, V276, P21521, DOI 10.1074/jbc.M008869200; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Sturm A, 2005, CYTOKINE, V29, P42, DOI 10.1016/j.cyto.2004.09.007; SVANES K, 1982, GASTROENTEROLOGY, V82, P1409; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; Turner JR, 1999, AM J PHYSIOL-CELL PH, V277, pC554, DOI 10.1152/ajpcell.1999.277.3.C554; Veldkamp CT, 2007, PROTEIN EXPRES PURIF, V52, P202, DOI 10.1016/j.pep.2006.09.009; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Vongsa RA, 2009, J BIOL CHEM, V284, P10034, DOI 10.1074/jbc.M805289200; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Wu SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1432, DOI 10.1152/ajpcell.00323.2001; Wu SS, 2006, CELL SIGNAL, V18, P1932, DOI 10.1016/j.cellsig.2006.02.013; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yang CC, 2005, AM J PHYSIOL-CELL PH, V288, pC321, DOI 10.1152/ajpcell.00171.2004; Yassin RR, 1998, PEPTIDES, V19, P47, DOI 10.1016/S0196-9781(97)00276-3; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480	74	39	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16066	16075		10.1074/jbc.M109.061416	http://dx.doi.org/10.1074/jbc.M109.061416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348095	hybrid, Green Published			2022-12-27	WOS:000277715900044
J	McNaughton, L; Tikhonenko, I; Banavali, NK; LeMaster, DM; Koonce, MP				McNaughton, Lynn; Tikhonenko, Irina; Banavali, Nilesh K.; LeMaster, David M.; Koonce, Michael P.			A Low Affinity Ground State Conformation for the Dynein Microtubule Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; NMR CHEMICAL-SHIFTS; IMPROVED SENSITIVITY; COILED-COIL; BACKBONE DYNAMICS; MOTOR; STALK; C-13; N-15	Dynein interacts with microtubules through a dedicated binding domain that is dynamically controlled to achieve high or low affinity, depending on the state of nucleotide bound in a distant catalytic pocket. The active sites for microtubule binding and ATP hydrolysis communicate via conformational changes transduced through a similar to 10-nm length antiparallel coiled-coil stalk, which connects the binding domain to the roughly 300kDa motor core. Recently, an x-ray structure of the murine cytoplasmic dynein microtubule binding domain (MTBD) in a weak affinity conformation was published, containing a covalently constrained beta(+) registry for the coiled-coil stalk segment (Carter, A. P., Garbarino, J. E., Wilson-Kubalek, E. M., Shipley, W. E., Cho, C., Milligan, R. A., Vale, R. D., and Gibbons, I. R. (2008) Science 322, 1691-1695). We here present an NMR analysis of the isolated MTBD from Dictyostelium discoideum that demonstrates the coiled-coil beta(+) registry corresponds to the low energy conformation for this functional region of dynein. Addition of sequence encoding roughly half of the coiled-coil stalk proximal to the binding tip results in a decreased affinity of the MTBD for microtubules. In contrast, addition of the complete coiled-coil sequence drives the MTBD to the conformationally unstable, high affinity binding state. These results suggest a thermodynamic coupling between conformational free energy differences in the alpha and beta(+) registries of the coiled-coil stalk that acts as a switch between high and low affinity conformations of the MTBD. A balancing of opposing conformations in the stalk and MTBD enables potentially modest long-range interactions arising from ATP binding in the motor core to induce a relaxation of the MTBD into the stable low affinity state.	[McNaughton, Lynn; Tikhonenko, Irina; LeMaster, David M.; Koonce, Michael P.] Wadsworth Ctr, Div Translat Med, Albany, NY 12201 USA; [Banavali, Nilesh K.] Wadsworth Ctr, Div Genet, Albany, NY 12201 USA; [Banavali, Nilesh K.; LeMaster, David M.; Koonce, Michael P.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	Wadsworth Center; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Koonce, MP (corresponding author), Wadsworth Ctr, Div Translat Med, Empire State Plaza,POB 509, Albany, NY 12201 USA.	koonce@wadsworth.org		Banavali, Nilesh/0000-0003-2206-7049	National Institutes of Health [GM51532]; National Science Foundation l [MCB-0542731]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051532, P41GM066354, R01GM051532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation l; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51532 and National Science Foundation Grant MCB-0542731 (to M. P. K.).	Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Hook P, 2009, BIOCHEMISTRY-US, V48, P2710, DOI 10.1021/bi900223x; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shimizu Y, 2008, J BIOMOL NMR, V41, P89, DOI 10.1007/s10858-008-9242-6; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	45	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15994	16002		10.1074/jbc.M109.083535	http://dx.doi.org/10.1074/jbc.M109.083535			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20351100	Green Published, hybrid			2022-12-27	WOS:000277715900037
J	Wang, AM; Morishima, Y; Clapp, KM; Peng, HM; Pratt, WB; Gestwicki, JE; Osawa, Y; Lieberman, AP				Wang, Adrienne M.; Morishima, Yoshihiro; Clapp, Kelly M.; Peng, Hwei-Ming; Pratt, William B.; Gestwicki, Jason E.; Osawa, Yoichi; Lieberman, Andrew P.			Inhibition of Hsp70 by Methylene Blue Affects Signaling Protein Function and Ubiquitination and Modulates Polyglutamine Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; BULBAR MUSCULAR-ATROPHY; HEAT-SHOCK PROTEINS; HSP90/HSP70-BASED CHAPERONE MACHINERY; ANDROGEN RECEPTOR PROTEIN; SMALL-MOLECULE MODULATORS; TRANSGENIC MOUSE MODEL; IN-VITRO; AMELIORATES PHENOTYPES; DEPENDENT DEGRADATION	The Hsp90/Hsp70-based chaperone machinery regulates the activity and degradation of many signaling proteins. Cycling with Hsp90 stabilizes client proteins, whereas Hsp70 interacts with chaperone-dependent E3 ubiquitin ligases to promote protein degradation. To probe these actions, small molecule inhibitors of Hsp70 would be extremely useful; however, few have been identified. Here we test the effects of methylene blue, a recently described inhibitor of Hsp70 ATPase activity, in three well established systems of increasing complexity. First, we demonstrate that methylene blue inhibits the ability of the purified Hsp90/Hsp70-based chaperone machinery to enable ligand binding by the glucocorticoid receptor and show that this effect is due to specific inhibition of Hsp70. Next, we establish that ubiquitination of neuronal nitric-oxide synthase by the native ubiquitinating system of reticulocyte lysate is dependent upon both Hsp70 and the E3 ubiquitin ligase CHIP and is blocked by methylene blue. Finally, we demonstrate that methylene blue impairs degradation of the polyglutamine expanded androgen receptor, an Hsp90 client mutated in spinal and bulbar muscular atrophy. In contrast, degradation of an amino-terminal fragment of the receptor, which lacks the ligand binding domain and, therefore, is not a client of the Hsp90/Hsp70-based chaperone machinery, is enhanced through homeostatic induction of autophagy that occurs when Hsp70-dependent proteasomal degradation is inhibited by methylene blue. Our data demonstrate the utility of methylene blue in defining Hsp70-dependent functions and reveal divergent effects on polyglutamine protein degradation depending on whether the substrate is an Hsp90 client.	[Wang, Adrienne M.; Gestwicki, Jason E.; Lieberman, Andrew P.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Morishima, Yoshihiro; Clapp, Kelly M.; Peng, Hwei-Ming; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lieberman, AP (corresponding author), 3510 MSRB 1,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	liebermn@umich.edu			National Institutes of Health [GM77430, NS055746]; McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401, R01NS055746, R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM77430 (to Y. O.) and NS055746 (to A. P. L.). This work was also supported by a McKnight Foundation Neuroscience of Brain Disorders Award (to A. P. L.).	Adachi H, 2003, J NEUROSCI, V23, P2203; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kanelakis KC, 2003, METHOD ENZYMOL, V364, P159; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; LUO D, 1995, EUR J PHARM-MOLEC PH, V290, P247, DOI 10.1016/0922-4106(95)00084-4; MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Mitsui K, 2002, J NEUROSCI, V22, P9267; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Noguchi S, 2000, J BIOL CHEM, V275, P2376, DOI 10.1074/jbc.275.4.2376; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Thomas M, 2004, J BIOL CHEM, V279, P8389, DOI 10.1074/jbc.M311761200; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Wisen S, 2008, ANAL BIOCHEM, V374, P371, DOI 10.1016/j.ab.2007.12.009; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	57	72	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15714	15723		10.1074/jbc.M109.098806	http://dx.doi.org/10.1074/jbc.M109.098806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348093	Green Published, hybrid			2022-12-27	WOS:000277715900006
J	Yanagihara, I; Nakahira, K; Yamane, T; Kaieda, S; Mayanagi, K; Hamada, D; Fukui, T; Ohnishi, K; Kajiyama, S; Shimizu, T; Sato, M; Ikegami, T; Ikeguchi, M; Honda, T; Hashimoto, H				Yanagihara, Itaru; Nakahira, Kumiko; Yamane, Tsutomu; Kaieda, Shuji; Mayanagi, Kouta; Hamada, Daizo; Fukui, Takashi; Ohnishi, Kiyouhisa; Kajiyama, Shin'ichiro; Shimizu, Toshiyuki; Sato, Mamoru; Ikegami, Takahisa; Ikeguchi, Mitsunori; Honda, Takeshi; Hashimoto, Hiroshi			Structure and Functional Characterization of Vibrio parahaemolyticus Thermostable Direct Hemolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMATION; 3-DIMENSIONAL RECONSTRUCTION; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; SINGLE PARTICLES; ALPHA-HEMOLYSIN; SCATTERING; SYSTEM; MACROMOLECULES; SOFTWARE	Thermostable direct hemolysin (TDH) is a major virulence factor of Vibrio parahaemolyticus that causes pandemic foodborne enterocolitis mediated by seafood. TDH exists as a tetramer in solution, and it possesses extreme hemolytic activity. Here, we present the crystal structure of the TDH tetramer at 1.5 angstrom resolution. The TDH tetramer forms a central pore with dimensions of 23 angstrom in diameter and similar to 50 angstrom in depth. pi-Cation interactions between protomers comprising the tetramer were indispensable for hemolytic activity of TDH. The N-terminal region was intrinsically disordered outside of the pore. Molecular dynamic simulations suggested that water molecules permeate freely through the central and side channel pores. Electron micrographs showed that tetrameric TDH attached to liposomes, and some of the tetramer associated with liposome via one protomer. These findings imply a novel membrane attachment mechanism by a soluble tetrameric pore-forming toxin.	[Yanagihara, Itaru; Nakahira, Kumiko; Hamada, Daizo; Fukui, Takashi; Ohnishi, Kiyouhisa] Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Dev Med, Izumi, Osaka 5941101, Japan; [Yamane, Tsutomu; Shimizu, Toshiyuki; Sato, Mamoru; Ikeguchi, Mitsunori; Hashimoto, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Yokohama, Kanagawa 2300045, Japan; [Kaieda, Shuji; Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Lab Struct Prote, Suita, Osaka 5650871, Japan; [Mayanagi, Kouta] Osaka Univ, Inst Prot Res, Takara Bio Endowed Div, Suita, Osaka 5650871, Japan; [Mayanagi, Kouta] Japan Sci & Technol Agcy, Nagahama Inst Biosci & Technol, Shiga 5260829, Japan; [Mayanagi, Kouta] Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev, Shiga 5260829, Japan; [Hamada, Daizo] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Struct Biol, Kobe, Hyogo 6500017, Japan; [Kajiyama, Shin'ichiro] Kinki Univ, Sch Biol Oriented Sci & Technol, Wakayama 6496493, Japan; [Honda, Takeshi] Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Suita, Osaka 5650871, Japan	Yokohama City University; Osaka University; Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kobe University; Kindai University (Kinki University); Osaka University	Hashimoto, H (corresponding author), 1-7-29 Suehiro, Yokohama, Kanagawa 2300045, Japan.	hash@tsurumi.yokohama-cu.ac.jp	Hamada, Daizo/F-3307-2011; Ikegami, Takahisa/I-9626-2017; Hamada, Daizo/N-1118-2016	Ikegami, Takahisa/0000-0002-1429-1844; Hamada, Daizo/0000-0002-1799-5476; Hashimoto, Hiroshi/0000-0003-1503-6789	Ministry of Education, Culture, Sports, Science and Technology of Japan; Research on Child Health and Development, National Center for Child Health and Development, Japan; Next Generation Supercomputer Project	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research on Child Health and Development, National Center for Child Health and Development, Japan; Next Generation Supercomputer Project	This study was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by a grant for Research on Child Health and Development, National Center for Child Health and Development, Japan. To whom correspondence may be addressed: 840 Murodo-cho, Izumi City, Osaka 5941101, Japan. Fax: 81-725-57-3021. E-mail: itaruy@mch.pref.osaka.jp. 2; Supported by a national project on the next generation integrated life science stimulation (Next Generation Supercomputer Project).	Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727; ARRHENIUS S, 1907, IMMUNOCHEMISTRY, P187; BABA K, 1992, MICROB PATHOGENESIS, V12, P279, DOI 10.1016/0882-4010(92)90046-Q; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fukui T, 2005, BIOCHEMISTRY-US, V44, P9825, DOI 10.1021/bi050311s; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Hamada D, 2007, J MOL BIOL, V365, P187, DOI 10.1016/j.jmb.2006.09.070; Hardy SP, 2004, FEMS MICROBIOL LETT, V240, P81, DOI 10.1016/j.femsle.2004.09.015; Hashido M, 2005, FEBS LETT, V579, P5549, DOI 10.1016/j.febslet.2005.09.018; Honda T., 2008, MICROBE, V3, P462; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iida T, 1997, J TOXICOL-TOXIN REV, V16, P215, DOI 10.3109/15569549709016457; Ikeguchi M, 2004, J COMPUT CHEM, V25, P529, DOI 10.1002/jcc.10402; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; MIWATANI T, 1972, INFECT IMMUN, V6, P1031, DOI 10.1128/IAI.6.6.1031-1033.1972; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Takahashi A, 2006, INT J TOXICOL, V25, P409, DOI 10.1080/10915810600868181; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vora GJ, 2005, P NATL ACAD SCI USA, V102, P19109, DOI 10.1073/pnas.0505033102; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Yamaichi Y, 1999, MOL MICROBIOL, V31, P1513, DOI 10.1046/j.1365-2958.1999.01296.x; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025	38	46	52	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16267	16274		10.1074/jbc.M109.074526	http://dx.doi.org/10.1074/jbc.M109.074526			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20335168	hybrid, Green Published			2022-12-27	WOS:000277715900063
J	Wiederhold, K; Kloepper, TH; Walter, AM; Stein, A; Kienle, N; Sorensen, JB; Fasshauer, D				Wiederhold, Katrin; Kloepper, Tobias H.; Walter, Alexander M.; Stein, Alexander; Kienle, Nickias; Sorensen, Jakob B.; Fasshauer, Dirk			A Coiled Coil Trigger Site Is Essential for Rapid Binding of Synaptobrevin to the SNARE Acceptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE FUSION; MEMBRANE-FUSION; REGULATED EXOCYTOSIS; SECRETORY VESICLES; CRYSTAL-STRUCTURE; PROTEINS; SEQUENCE; CONSERVATION; MECHANISMS; PRINCIPLES	Exocytosis from synaptic vesicles is driven by stepwise formation of a tight alpha-helical complex between the fusing membranes. The complex is composed of the three SNAREs: synaptobrevin 2, SNAP-25, and syntaxin 1a. An important step in complex formation is fast binding of vesicular synaptobrevin to the preformed syntaxin 1.SNAP-25 dimer. Exactly how this step relates to neurotransmitter release is not well understood. Here, we combined different approaches to gain insights into this reaction. Using computational methods, we identified a stretch in synaptobrevin 2 that may function as a coiled coil "trigger site." This site is also present in many synaptobrevin homologs functioning in other trafficking steps. Point mutations in this stretch inhibited binding to the syntaxin 1.SNAP-25 dimer and slowed fusion of liposomes. Moreover, the point mutations severely inhibited secretion from chromaffin cells. Altogether, this demonstrates that the trigger site in synaptobrevin is crucial for productive SNARE zippering.	[Fasshauer, Dirk] Max Planck Inst Biophys Chem, Res Grp Struct Biochem, D-37077 Gottingen, Germany; [Kloepper, Tobias H.; Stein, Alexander] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Walter, Alexander M.; Sorensen, Jakob B.] Max Planck Inst Biophys Chem, Res Grp Mol Mech Exocytosis, D-37077 Gottingen, Germany; [Sorensen, Jakob B.] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Fasshauer, Dirk] Univ Lausanne, Dept Cellular Biol & Morphol, CH-1005 Lausanne, Switzerland	Max Planck Society; Max Planck Society; Max Planck Society; University of Copenhagen; University of Lausanne	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Res Grp Struct Biochem, D-37077 Gottingen, Germany.	dfassha@gwdg.de	Stein, Alexander/I-4950-2012; Walter, Alexander M/O-1824-2015; Fasshauer, Dirk/B-1563-2013	Stein, Alexander/0000-0002-2696-0611; Walter, Alexander M/0000-0001-5646-4750; Fasshauer, Dirk/0000-0002-1040-4282; Sorensen, Jakob/0000-0001-5465-3769	Deutsche Forschungsgemeinschaft [SFB523-B11, SFB523-B16]; Lundbeck Foundation; Lundbeck Foundation [R28-2008-1976] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB523-B11 (to D. F.) and SFB523-B16 (to J.B.S.) and by a Lundbeck Foundation Junior Group Leader Fellowship (to J.B.S.).	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 2007, NAT STRUCT MOL BIOL, V14, P360, DOI 10.1038/nsmb0507-360; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Holt M, 2008, CURR BIOL, V18, P715, DOI 10.1016/j.cub.2008.04.069; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Kienle N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-19; Kloepper TH, 2008, MOL BIOL EVOL, V25, P2055, DOI 10.1093/molbev/msn151; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Lee DL, 2001, J MOL BIOL, V306, P539, DOI 10.1006/jmbi.2000.4351; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Neher E, 2006, PFLUG ARCH EUR J PHY, V453, P261, DOI 10.1007/s00424-006-0143-9; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; Sorensen JB, 2009, ANNU REV CELL DEV BI, V25, P513, DOI 10.1146/annurev.cellbio.24.110707.175239; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2004, PFLUG ARCH EUR J PHY, V448, P347, DOI 10.1007/s00424-004-1247-8; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Yang CM, 2001, MOL CELL BIOL, V21, P1573, DOI 10.1128/MCB.21.5.1573-1580.2001; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	47	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21549	21559		10.1074/jbc.M110.105148	http://dx.doi.org/10.1074/jbc.M110.105148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20406821	Green Published, hybrid			2022-12-27	WOS:000279516100041
J	Yi, Y; Kamata-Sakurai, M; Denda-Nagai, K; Itoh, T; Okada, K; Ishii-Schrade, K; Iguchi, A; Sugiura, D; Irimura, T				Yi, Yuri; Kamata-Sakurai, Mika; Denda-Nagai, Kaori; Itoh, Tomoko; Okada, Kyoko; Ishii-Schrade, Katrin; Iguchi, Akihiro; Sugiura, Daisuke; Irimura, Tatsuro			Mucin 21/Epiglycanin Modulates Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MAMMARY ADENOCARCINOMA; SIALOMUCIN COMPLEX; CARCINOMA-CELLS; EPISIALIN MUC1; CANCER CELL; EPIGLYCANIN; GLYCOPROTEIN; TA3; SURFACE; OVEREXPRESSION	The molecular structure of mouse Mucin 21 (Muc21)/epiglycanin is proposed to have 98 tandem repeats of 15 amino acids and three exceptional repeats with 12 or 13 amino acids each, followed by a stem domain, a transmembrane domain, and a cytoplasmic tail. A cDNA of Muc21 having 84 tandem repeats of 15 amino acids was constructed and transfected using a Venus vector into HEK 293T cells. The fluorescent cells, which were considered to express Muc21, were nonadherent. This anti-adhesion effect was lessened when constructs with smaller numbers of tandem repeats were used, suggesting that the tandem repeat domain plays a crucial role. Cells expressing Muc21 were significantly less adherent to each other and to extracellular matrix components than control cells. Antibody binding to the cell surface integrin subunits alpha 5, alpha 6, and beta 1 was reduced in Muc21 transfectants in a tandem repeat-dependent manner, whereas equal amounts of proteins were detected by Western blot analysis. Muc21 was expressed as a large glycoprotein that was highly glycosylated with O-glycans at the cell surface, as detected by flow cytometry, Western blotting, and lectin blotting. Although at least a portion of Muc21 was glycosylated with sialylated glycans, removal of sialic acid did not influence the prevention of adhesion.	[Yi, Yuri; Kamata-Sakurai, Mika; Denda-Nagai, Kaori; Itoh, Tomoko; Okada, Kyoko; Ishii-Schrade, Katrin; Iguchi, Akihiro; Sugiura, Daisuke; Irimura, Tatsuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo 1130033, Japan	University of Tokyo	Irimura, T (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	irimura@mol.f.u-tokyo.ac.jp		Sugiura, Daisuke/0000-0002-3865-3889; Denda-Nagai, Kaori/0000-0001-8325-3289				ARDMAN B, 1992, P NATL ACAD SCI USA, V89, P5001, DOI 10.1073/pnas.89.11.5001; Chervenak JL, 2000, BIOL REPROD, V63, P294, DOI 10.1095/biolreprod63.1.294; CODINGTON JF, 1979, J NATL CANCER I, V63, P153; CODINGTON JF, 1975, CARBOHYD RES, V40, P171, DOI 10.1016/S0008-6215(00)82679-8; CODINGTON JF, 1972, BIOCHEMISTRY-US, V11, P2559, DOI 10.1021/bi00764a001; CODINGTON JF, 1992, GLYCOBIOLOGY, V2, P173, DOI 10.1093/glycob/2.3.173; COOPER AG, 1979, JNCI-J NATL CANCER I, V63, P163; FRIBERG S, 1972, JNCI-J NATL CANCER I, V48, P1463; FUNG PYS, 1991, CANCER RES, V51, P1170; Gipson IK, 2008, BIOL REPROD, V78, P134, DOI 10.1095/biolreprod.106.058347; HAUSCHKA TS, 1971, JNCI-J NATL CANCER I, V47, P343; Itoh Y, 2008, GLYCOBIOLOGY, V18, P74, DOI 10.1093/glycob/cwm118; Kalra AV, 2009, EUR J CANCER, V45, P164, DOI 10.1016/j.ejca.2008.10.008; KEMPERMAN H, 1994, J CELL BIOL, V127, P2071, DOI 10.1083/jcb.127.6.2071; KLEIN G, 1951, EXP CELL RES, V2, P291, DOI 10.1016/0014-4827(51)90097-3; Komatsu M, 1997, J BIOL CHEM, V272, P33245, DOI 10.1074/jbc.272.52.33245; Komatsu M, 1999, CANCER RES, V59, P2229; LIGTENBERG MJL, 1992, CANCER RES, V52, P2318; MILLER SC, 1977, J CELL BIOL, V72, P511, DOI 10.1083/jcb.72.3.511; MILLER SC, 1982, J NATL CANCER I, V68, P981; Nagy P, 2005, CANCER RES, V65, P473; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Wesseling J, 1996, MOL BIOL CELL, V7, P565, DOI 10.1091/mbc.7.4.565	24	21	22	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 9	2010	285	28					21233	21240		10.1074/jbc.M109.082875	http://dx.doi.org/10.1074/jbc.M109.082875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	620RD	20388707	hybrid, Green Published			2022-12-27	WOS:000279516100008
J	Thoms, BL; Murphy, CL				Thoms, Brendan L.; Murphy, Christopher L.			Inhibition of Hypoxia-inducible Factor-targeting Prolyl Hydroxylase Domain-containing Protein 2 (PHD2) Enhances Matrix Synthesis by Human Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-TENSION; ARTICULAR CHONDROCYTES; TRANSCRIPTIONAL ACTIVITY; PROLINE HYDROXYLATION; HIF-ALPHA; EXPRESSION; CARTILAGE; 4-HYDROXYLASES; HIF-1-ALPHA; PHENOTYPE	Human articular cartilage is an avascular tissue, and therefore it functions in a hypoxic environment. Cartilage cells, the chondrocytes, have adapted to this and actually use hypoxia to drive tissue-specific functions. We have previously shown that human chondrocytes enhance cartilage matrix synthesis in response to hypoxia specifically through hypoxia-inducible factor 2 alpha (HIF-2 alpha)-mediated up-regulation of master regulator transcription factor SOX9, which in turn drives expression of the main cartilage-specific extracellular matrix genes. HIF-alpha isoforms are themselves regulated by specific prolyl hydroxylase domain-containing proteins, which target them for proteosomal degradation. In fact, prolyl hydroxylase domains are the direct oxygen sensors because they require molecular oxygen as a co-substrate. Here, we have identified PHD2 as the dominant isoenzyme regulating HIF-2 alpha stability in human chondrocytes. Moreover, specific inhibition of PHD2 using RNA interference-mediated depletion caused an up-regulation of SOX9 and enhanced extracellular matrix protein production. Depletion of PHD2 resulted in greater HIF-2 alpha levels and therefore enhanced SOX9-induced cartilage matrix production compared with the levels normally found in hypoxia (1% oxygen) implying that PHD2 inhibition offers a novel means to enhance cartilage repair in vivo. The need for HIF-specific hydroxylase inhibition was highlighted because treatment with the 2-oxoglutarate analogue dimethyloxalylglycine (which also inhibits the collagen prolyl 4-hydroxylases) prevented secretion of type II collagen, a critical cartilage matrix component.	[Thoms, Brendan L.; Murphy, Christopher L.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, Fac Med, London W6 8LH, England	Imperial College London; University of Oxford	Murphy, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, Fac Med, 65 Aspenlea Rd, London W6 8LH, England.	c.murphy@imperial.ac.uk			Arthritis Research United Kingdom	Arthritis Research United Kingdom(Versus Arthritis)	This work was supported by Arthritis Research United Kingdom.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Gelse K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2508; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Katopodi T, 2009, BIOMATERIALS, V30, P535, DOI 10.1016/j.biomaterials.2008.09.064; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Milner PJ, 2006, ARTHRITIS RHEUM-US, V54, P3523, DOI 10.1002/art.22209; Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; MURPHY CL, 2009, GENE DEV, V11, P213; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Poole AR, 2002, ANN RHEUM DIS, V61, P78, DOI 10.1136/ard.61.suppl_2.ii78; Semenza GL, 2000, GENE DEV, V14, P1983; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Terkhorn SP, 2007, J CELL PHYSIOL, V210, P257, DOI 10.1002/jcp.20873; Willam C, 2006, J MOL CELL CARDIOL, V41, P68, DOI 10.1016/j.yjmcc.2006.04.009; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	38	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20472	20480		10.1074/jbc.M110.115238	http://dx.doi.org/10.1074/jbc.M110.115238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20404338	hybrid, Green Published			2022-12-27	WOS:000279228600007
J	Hong, C; Duit, S; Jalonen, P; Out, R; Scheer, L; Sorrentino, V; Boyadjian, R; Rodenburg, KW; Foley, E; Korhonen, L; Lindholm, D; Nimpf, J; van Berkel, TJC; Tontonoz, P; Zelcer, N				Hong, Cynthia; Duit, Sarah; Jalonen, Pilvi; Out, Ruud; Scheer, Lilith; Sorrentino, Vincenzo; Boyadjian, Rima; Rodenburg, Kees W.; Foley, Edan; Korhonen, Laura; Lindholm, Dan; Nimpf, Johannes; van Berkel, Theo J. C.; Tontonoz, Peter; Zelcer, Noam			The E3 Ubiquitin Ligase IDOL Induces the Degradation of the Low Density Lipoprotein Receptor Family Members VLDLR and ApoER2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTORS; LEUCINE ZIPPER PROTEIN; LDL RECEPTOR; BRAIN; HYPERCHOLESTEROLEMIA; REELIN; PCSK9; MICE; GENE; MUTATIONS	We have previously identified the E3 ubiquitin ligase-inducible degrader of the low density lipoprotein receptor ( LDLR) ( Idol) as a post-translational modulator of LDLR levels. Idol is a direct target for regulation by liver X receptors (LXRs), and its expression is responsive to cellular sterol status independent of the sterol-response element-binding proteins. Here we demonstrate that Idol also targets two closely related LDLR family members, VLDLR and ApoE receptor 2 (ApoER2), proteins implicated in both neuronal development and lipid metabolism. Idol triggers ubiquitination of the VLDLR and ApoER2 on their cytoplasmic tails, leading to their degradation. We further show that the level of endogenous VLDLR is sensitive to cellular sterol content, Idol expression, and activation of the LXR pathway. Pharmacological activation of the LXR pathway in mice leads to increased Idol expression and to decreased Vldlr levels in vivo. Finally, we establish an unexpected functional link between LXR and Reelin signaling. We demonstrate that LXR activation results in decreased Reelin binding to VLDLR and reduced Dab1 phosphorylation. The identification of VLDLR and ApoER2 as Idol targets suggests potential roles for this LXR-inducible E3 ligase in the central nervous system in addition to lipid metabolism.	[Hong, Cynthia; Boyadjian, Rima; Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Hong, Cynthia; Boyadjian, Rima; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Duit, Sarah; Nimpf, Johannes] Med Univ Vienna, Max F Perutz Lab, Dept Med Biochem, A-1030 Vienna, Austria; [Jalonen, Pilvi; Korhonen, Laura; Lindholm, Dan] Minerva Med Res Inst, Helsinki 00290, Finland; [Out, Ruud; van Berkel, Theo J. C.; Zelcer, Noam] Leiden Univ, Div Biopharmaceut, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands; [Foley, Edan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada; [Rodenburg, Kees W.] Univ Utrecht, Dept Biol, Div Endocrinol & Metab, NL-3584 CH Utrecht, Netherlands; [Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem, FIN-00014 Helsinki, Finland; [Scheer, Lilith; Sorrentino, Vincenzo; Zelcer, Noam] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Medical University of Vienna; Leiden University; Leiden University - Excl LUMC; University of Alberta; Utrecht University; University of Helsinki; University of Amsterdam; Academic Medical Center Amsterdam	Zelcer, N (corresponding author), Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	n.zelcer@amc.uva.nl	Korhonen, Laura/AAW-3256-2020; Van Berkel, Theo/ABD-7677-2021; Lindholm, Dan/B-3777-2014; Sorrentino, Vincenzo/R-4403-2018	Zelcer, Noam/0000-0001-6935-7532; Sorrentino, Vincenzo/0000-0002-7212-370X; Nimpf, Johannes/0000-0002-9273-3492; Korhonen, Laura/0000-0002-1837-5930	National Institutes of Health [HL066088, HL090553]; Canadian Institutes of Health Research; Alberta Heritage Foundation; Canada Research Chair in Innate Immunity; Academy of Finland; Sigrid Juselius Foundation; Fonds zur Forderung der Wissenschaftlichen Forschung; Herzfelder'sche Familienstiftung; Human Frontier Science Program Organization; Netherlands Organization for Scientific Research (NWO); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088, P01HL090553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Canada Research Chair in Innate Immunity; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Herzfelder'sche Familienstiftung; Human Frontier Science Program Organization(Human Frontier Science Program); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL066088 and HL090553 (to P.T.).; Supported by the Canadian Institutes of Health Research. Alberta Heritage Foundation for Medical Research Scholar. Canada Research Chair in Innate Immunity.; Supported by grants from the Academy of Finland and the Sigrid Juselius Foundation.; Supported by the Fonds zur Forderung der Wissenschaftlichen Forschung and the Herzfelder'sche Familienstiftung.; Supported by a Career Development Award from the Human Frontier Science Program Organization and by a VIDI grant from the Netherlands Organization for Scientific Research (NWO). To whom correspondence should be addressed: Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. Tel.: 31-20-566-5131; Fax: 31-20-6915519; E-mail: n.zelcer@amc.uva.nl.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Fan X, 2008, P NATL ACAD SCI USA, V105, P13445, DOI 10.1073/pnas.0806974105; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; Morales JR, 2008, CIRCULATION, V118, P1450, DOI 10.1161/CIRCULATIONAHA.108.782300; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Primrose DA, 2007, J CELL SCI, V120, P1189, DOI 10.1242/jcs.03417; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Sakai K, 2009, BRAIN RES, V1276, P11, DOI 10.1016/j.brainres.2009.04.030; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sironi L, 2008, FEBS LETT, V582, P3396, DOI 10.1016/j.febslet.2008.08.035; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Tacken PJ, 2001, CURR OPIN LIPIDOL, V12, P275, DOI 10.1097/00041433-200106000-00006; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Van Hoof D, 2002, J CELL SCI, V115, P4001, DOI 10.1242/jcs.00113; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	43	99	108	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19720	19726		10.1074/jbc.M110.123729	http://dx.doi.org/10.1074/jbc.M110.123729			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427281	Green Published, hybrid			2022-12-27	WOS:000279012000004
J	Huang, X; Dementiev, A; Olson, ST; Gettins, PGW				Huang, Xin; Dementiev, Alexey; Olson, Steven T.; Gettins, Peter G. W.			Basis for the Specificity and Activation of the Serpin Protein Z-dependent Proteinase Inhibitor (ZPI) as an Inhibitor of Membrane-associated Factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TICK ANTICOAGULANT PEPTIDE; COAGULATION FACTOR-XA; AMINO-ACID-SEQUENCE; ACTIVE-SITE; ALPHA(1)-PROTEINASE INHIBITOR; BINDING; PROTHROMBIN; SUBSTRATE; EXOSITE; COMPLEX	The serpin ZPI is a protein Z (PZ)-dependent specific inhibitor of membrane-associated factor Xa (fXa) despite having an unfavorable P1 Tyr. PZ accelerates the inhibition reaction similar to 2000-fold in the presence of phospholipid and Ca2+. To elucidate the role of PZ, we determined the x-ray structure of Gladomainless PZ (PZ(Delta GD)) complexed with protein Z-dependent proteinase inhibitor (ZPI). The PZ pseudocatalytic domain bound ZPI at a novel site through ionic and polar interactions. Mutation of four ZPI contact residues eliminated PZ binding and membrane-dependent PZ acceleration of fXa inhibition. Modeling of the ternary Michaelis complex implicated ZPI residues Glu-313 and Glu-383 in fXa binding. Mutagenesis established that only Glu-313 is important, contributing similar to 5-10-fold to rate acceleration of fXa and fXIa inhibition. Limited conformational change in ZPI resulted from PZ binding, which contributed only similar to 2-fold to rate enhancement. Instead, template bridging from membrane association, together with previously demonstrated interaction of the fXa and ZPI Gla domains, resulted in an additional similar to 1000-fold rate enhancement. To understand why ZPI has P1 tyrosine, we examined a P1 Arg variant. This reacted at a diffusion-limited rate with fXa, even without PZ, and predominantly as substrate, reflecting both rapid acylation and deacylation. P1 tyrosine thus ensures that reaction with fXa or most other arginine-specific proteinases is insignificant unless PZ binds and localizes ZPI and fXa on the membrane, where the combined effects of Gla-Gla interaction, template bridging, and interaction of fXa with Glu-313 overcome the unfavorability of P1 Tyr and ensure a high rate of reaction as an inhibitor.	[Huang, Xin; Olson, Steven T.; Gettins, Peter G. W.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60607 USA; [Dementiev, Alexey; Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Olson, Steven T.; Gettins, Peter G. W.] Univ Illinois, Struct Biol Ctr, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60607 USA.	stolson@uic.edu; pgettins@uic.edu		Huang, Xin/0000-0002-4730-9318	National Institutes of Health [HL49234, HL79430, HL78827]; American Heart Association [0920029G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888, R37HL049234, R01HL078827, R01HL079430, R01HL049234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49234 and HL79430 ( to P. G. W. G.) and HL78827 ( to S. T. O.). This work was also supported by American Heart Association Fellowship 0920029G ( to X. H.).	Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Calugaru SV, 2001, J BIOL CHEM, V276, P32446, DOI 10.1074/jbc.M104731200; Chandrasekaran V, 2008, PROTEIN SCI, V17, P1354, DOI 10.1110/ps.034801.108; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Futamura A, 1998, BIOCHEMISTRY-US, V37, P13110, DOI 10.1021/bi981234m; Gettins PGW, 2009, FEBS LETT, V583, P3397, DOI 10.1016/j.febslet.2009.10.005; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; ICHINOSE A, 1990, BIOCHEM BIOPH RES CO, V172, P1139, DOI 10.1016/0006-291X(90)91566-B; JORDAN SP, 1992, BIOCHEMISTRY-US, V31, P5374, DOI 10.1021/bi00138a019; Lee CJ, 2007, J THROMB HAEMOST, V5, P1558, DOI 10.1111/j.1538-7836.2007.02597.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4164, DOI 10.1021/bi00638a005; NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; Olson Steven T., 1994, Perspectives in Drug Discovery and Design, V1, P479, DOI 10.1007/BF02171861; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P9427, DOI 10.1021/bi060820+; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021	39	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20399	20409		10.1074/jbc.M110.112748	http://dx.doi.org/10.1074/jbc.M110.112748			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427285	hybrid, Green Published			2022-12-27	WOS:000279012000073
J	Kos, V; Whitfield, C				Kos, Veronica; Whitfield, Chris			A Membrane-located Glycosyltransferase Complex Required for Biosynthesis of the D-Galactan I Lipopolysaccharide O Antigen in Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE-ASSOCIATED COMPLEX; SIGNAL RECOGNITION PARTICLE; LARGE RIBOSOMAL-SUBUNIT; NASCENT CHAINS; ENDOPLASMIC-RETICULUM; TRANSLATING RIBOSOME; TRANSCRIPTION FACTOR; PROTEIN IMPORT; ALPHA-SUBUNIT; BETA-NAC	D-Galactan I is a polysaccharide with the disaccharide repeat unit structure [-> 3-beta-D-Galf-(1-3)-alpha-D-Galp-(1 ->]. This glycan represents the lipopolysaccharide O antigen found in many Gram-negative bacteria, including several Klebsiella pneumoniae O serotypes. The polysaccharide is synthesized in the cytoplasm prior to its export via an ATP-binding cassette transporter. Sequence analysis predicts three galactosyltransferases in the D-galactan I genetic locus. They are WbbO (belonging to glycosyltransferase (GT) family 4), WbbM (GT-family 8), and WbbN (GT-family 2). The WbbO and WbbM proteins are each predicted to contain two domains, with the GT modules located toward their C termini. The N-terminal domains of WbbO and WbbM exhibit no similarity to proteins with known function. In vivo complementation assays suggest that all three glycosyltransferases are required for D-galactan I biosynthesis. Using a bacterial two-hybrid system and confirmatory co-purification strategies, evidence is provided for protein-protein interactions among the glycosyltransferases, creating a membrane-located enzyme complex dedicated to D-galactan I biosynthesis.	[Kos, Veronica; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca						Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Bingel-Erlenmeyer R, 2008, NATURE, V452, P108, DOI 10.1038/nature06683; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Creagh EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005055; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Franke J, 2001, J CELL SCI, V114, P2641; Funfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289; George R, 2002, FEBS LETT, V516, P213, DOI 10.1016/S0014-5793(02)02528-0; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hotokezaka Y, 2009, CELL DEATH DIFFER, V16, P1505, DOI 10.1038/cdd.2009.90; Kim SH, 2002, J INVEST MED, V50, P293, DOI 10.2310/6650.2002.33287; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kroes RA, 2000, CANCER LETT, V156, P191, DOI 10.1016/S0304-3835(00)00462-6; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lauring B, 1995, COLD SPRING HARB SYM, V60, P47, DOI 10.1101/SQB.1995.060.01.008; LAURING B, 1995, P NATL ACAD SCI USA, V92, P5411, DOI 10.1073/pnas.92.12.5411; LAURING B, 1995, P NATL ACAD SCI USA, V92, P9435, DOI 10.1073/pnas.92.21.9435; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Lithgow T, 2000, FEBS LETT, V476, P22, DOI 10.1016/S0014-5793(00)01663-X; Makarova KS, 1999, GENOME RES, V9, P608; Markesich DC, 2000, DEVELOPMENT, V127, P559; Moller I, 1998, P NATL ACAD SCI USA, V95, P13425, DOI 10.1073/pnas.95.23.13425; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Reimann B, 1999, YEAST, V15, P397, DOI 10.1002/(SICI)1097-0061(19990330)15:5<397::AID-YEA384>3.3.CO;2-L; Rospert S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-208; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sambrook J., 2002, MOL CLONING LAB MANU; Scheuring UJ, 1998, AIDS, V12, P563, DOI 10.1097/00002030-199806000-00004; Spreter T, 2005, J BIOL CHEM, V280, P15849, DOI 10.1074/jbc.M500160200; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yogev O, 2007, J BIOL CHEM, V282, P29222, DOI 10.1074/jbc.M704201200; Yotov WV, 1998, MOL CELL BIOL, V18, P1303, DOI 10.1128/MCB.18.3.1303; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763	48	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19668	19687		10.1074/jbc.M110.122598	http://dx.doi.org/10.1074/jbc.M110.122598			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20410291	Green Published, hybrid			2022-12-27	WOS:000278727800076
J	Leugers, CJ; Lee, G				Leugers, Chad J.; Lee, Gloria			Tau Potentiates Nerve Growth Factor-induced Mitogen-activated Protein Kinase Signaling and Neurite Initiation without a Requirement for Microtubule Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PAIRED HELICAL FILAMENTS; CELL-CYCLE REENTRY; ALZHEIMERS-DISEASE; PC12 CELLS; LIPID RAFTS; PHOSPHORYLATES TAU; AXONAL-TRANSPORT; IN-VIVO; C-FOS	Microtubule-associated protein Tau is known to bind to and stabilize microtubules, thereby regulating microtubule dynamics. However, recent evidence has indicated that Tau can also interact with various components of intracellular signaling pathways, leading to the possibility that Tau might have a role in signal transduction. Here we provide evidence that during growth factor stimulation of neuronal cells, Tau has functions in advance of the neurite elongation stage. Using Tau-depleted neuronal cell lines, we demonstrate that Tau is required for neurite initiation in a manner that does not involve its microtubule binding function. In addition, we demonstrate that Tau potentiates AP-1 transcription factor activation in response to nerve growth factor (NGF). The effect of Tau on AP-1 activation is mediated through its ability to potentiate the activation of mitogen-activated protein kinase (MAPK), which occurs in response to both NGF and epidermal growth factor. Phosphorylation of Tau at Thr-231 also occurs in response to NGF and is required for Tau to impact on MAPK signaling, whereas the ability of Tau to bind to microtubules is not required. Together, these findings indicate a new functional role for Tau in early neuronal development independent of its established role in microtubule stabilization.	[Leugers, Chad J.; Lee, Gloria] Univ Iowa, Roy J & Lucille Carver Coll Med, Program Neurosci, Iowa City, IA 52242 USA; [Lee, Gloria] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Lee, G (corresponding author), 500 Newton Rd,B191 ML, Iowa City, IA 52242 USA.	gloria-lee@uiowa.edu	Lee, Gloria/F-5965-2011	Lee, Gloria/0000-0002-8633-1534	National Institutes of Health, NIA [AG 017753]; NATIONAL INSTITUTE ON AGING [R01AG017753] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG 017753 from the NIA.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; ANDERSON AJ, 1994, EXP NEUROL, V125, P286, DOI 10.1006/exnr.1994.1031; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; BLANCHARD BJ, 1994, BIOCHEM BIOPH RES CO, V200, P187, DOI 10.1006/bbrc.1994.1432; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Delobel P, 2006, AM J PATHOL, V168, P878, DOI 10.2353/ajpath.2006.050540; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; DERRY WB, 1995, BIOCHEMISTRY-US, V34, P2203, DOI 10.1021/bi00007a014; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Dubey M, 2008, CELL MOTIL CYTOSKEL, V65, P89, DOI 10.1002/cm.20243; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Garcia-Sierra F, 2003, J ALZHEIMERS DIS, V5, P65, DOI 10.3233/JAD-2003-5201; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Golub T, 2004, CURR OPIN NEUROBIOL, V14, P542, DOI 10.1016/j.conb.2004.08.003; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hall GF, 1997, P NATL ACAD SCI USA, V94, P4733, DOI 10.1073/pnas.94.9.4733; HANEMAAIJER R, 1991, J NEUROSCI RES, V30, P163, DOI 10.1002/jnr.490300117; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; Hernandez P, 2009, J ALZHEIMERS DIS, V16, P149, DOI 10.3233/JAD-2009-0933; Hernandez-Hernandez O, 2006, J NEUROSCI RES, V84, P841, DOI 10.1002/jnr.20989; Hoerndli FJ, 2007, EUR J NEUROSCI, V26, P60, DOI 10.1111/j.1460-9568.2007.05618.x; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Jenkins SM, 1998, NEUROREPORT, V9, P67, DOI 10.1097/00001756-199801050-00014; Jicha GA, 1997, J NEUROCHEM, V69, P2087; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Kleijn M, 1998, J BIOL CHEM, V273, P5536, DOI 10.1074/jbc.273.10.5536; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Lee G, 1998, J CELL SCI, V111, P3167; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; LEGER JG, 1994, J CELL SCI, V107, P3403; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lin YT, 2007, J NEUROCHEM, V103, P802, DOI 10.1111/j.1471-4159.2007.04792.x; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Marcus DL, 1998, NEUROBIOL AGING, V19, P393, DOI 10.1016/S0197-4580(98)00077-3; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Oyama F, 2004, J BIOL CHEM, V279, P27272, DOI 10.1074/jbc.M401634200; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Reynolds CH, 1997, J NEUROCHEM, V68, P1736; RODER HM, 1993, BIOCHEM BIOPH RES CO, V193, P639, DOI 10.1006/bbrc.1993.1672; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P92, DOI 10.1111/j.1601-183X.2007.00377.x; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Sharma VM, 2007, J CELL SCI, V120, P748, DOI 10.1242/jcs.03378; SONG JS, 1995, J PROTEIN CHEM, V14, P95, DOI 10.1007/BF01888367; Souter S, 2009, J CELL BIOCHEM, V108, P555, DOI 10.1002/jcb.22287; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Sui Z, 2006, BIOCHEM BIOPH RES CO, V345, P1643, DOI 10.1016/j.bbrc.2006.05.087; Thurston VC, 1996, CHROMOSOMA, V105, P20, DOI 10.1007/BF02510035; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Vincent I, 1998, NEUROBIOL AGING, V19, P287, DOI 10.1016/S0197-4580(98)00071-2; WATANABE A, 1993, J BIOL CHEM, V268, P25712; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200; Zamora-Leon SP, 2001, J BIOL CHEM, V276, P39950, DOI 10.1074/jbc.M107807200	87	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19125	19134		10.1074/jbc.M110.105387	http://dx.doi.org/10.1074/jbc.M110.105387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20375017	Green Published, hybrid			2022-12-27	WOS:000278727800022
J	Orlichenko, L; Geyer, R; Yanagisawa, M; Khauv, D; Radisky, ES; Anastasiadis, PZ; Radisky, DC				Orlichenko, Lidiya; Geyer, Rory; Yanagisawa, Masahiro; Khauv, Davitte; Radisky, Evette S.; Anastasiadis, Panos Z.; Radisky, Derek C.			The 19-Amino Acid Insertion in the Tumor-associated Splice Isoform Rac1b Confers Specific Binding to p120 Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; COLORECTAL-CANCER CELLS; HUMAN P120(CTN) CATENIN; NUCLEAR-LOCALIZATION; BETA-CATENIN; RHO-GTPASES; CRYSTALLOGRAPHIC ANALYSIS; ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE GELS; INTRINSIC DISORDER	The Rac1b splice isoform contains a 19-amino acid insertion not found in Rac1; this insertion leads to decreased GTPase activity and reduced affinity for GDP, resulting in the intracellular predominance of GTP-bound Rac1b. Here, using co-precipitation and proteomic methods, we find that Rac1b does not bind to many common regulators of Rho family GTPases but that it does display enhanced binding to SmgGDS, RACK1, and p120 catenin (p120(ctn)), proteins involved in cell-cell adhesion, motility, and transcriptional regulation. We use molecular modeling and structure analysis approaches to determine that the interaction between Rac1b and p120(ctn) is dependent upon protein regions that are predicted to be unstructured in the absence of molecular complex formation, suggesting that the interaction between these two proteins involves coupled folding and binding. We also find that directed cell movement initiated by Rac1b is dependent upon p120. These results define a distinct binding functionality of Rac1b and provide insight into how the distinct phenotypic program activated by this protein may be implemented through molecular recognition of effectors distinct from those of Rac1.	[Orlichenko, Lidiya; Geyer, Rory; Yanagisawa, Masahiro; Khauv, Davitte; Radisky, Evette S.; Anastasiadis, Panos Z.; Radisky, Derek C.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Radisky, DC (corresponding author), Mayo Clin, Dept Canc Biol, Griffin 331,4500 San Pablo Rd S, Jacksonville, FL 32224 USA.	radisky.derek@mayo.edu	Radisky, Evette S/C-8526-2012; Radisky, Derek/B-6569-2018	Radisky, Evette S/0000-0003-3121-109X; Radisky, Derek/0000-0002-1962-8784	National Institutes of Health [CA122086, CA128660, CA100467]; Susan B. Komen Foundation [FAS0703855]; Mayo Clinic [CA116201]; NATIONAL CANCER INSTITUTE [P50CA116201, R01CA100467, R21CA128660, R01CA122086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan B. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122086 (to D. C. R.), CA128660 (to Celeste M. Nelson and D. C. R.), and CA100467 (to P. Z. A.). This work was also supported by Susan B. Komen Foundation Grant FAS0703855 (to Celeste M. Nelson and D. C. R.) and by the Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) Grant CA116201 (to James Ingle).	Aho S, 1999, J CELL BIOCHEM, V73, P390, DOI 10.1002/(SICI)1097-4644(19990601)73:3<390::AID-JCB10>3.3.CO;2-T; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Choi HJ, 2005, J MOL BIOL, V346, P367, DOI 10.1016/j.jmb.2004.11.048; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Esufali S, 2007, FEBS LETT, V581, P4850, DOI 10.1016/j.febslet.2007.09.013; Esufali S, 2007, CANCER RES, V67, P2469, DOI 10.1158/0008-5472.CAN-06-2843; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Graham TA, 2002, MOL CELL, V10, P563, DOI 10.1016/S1097-2765(02)00637-8; Graham TA, 2001, NAT STRUCT BIOL, V8, P1048, DOI 10.1038/nsb718; Grosheva I, 2001, J CELL SCI, V114, P695; Hirai Y, 2007, BLOOD, V110, P3082, DOI 10.1182/blood-2007-06-095372; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lozano E, 2008, J CELL SCI, V121, P933, DOI 10.1242/jcs.016121; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Matos P, 2006, J BIOL CHEM, V281, P13724, DOI 10.1074/jbc.M513243200; Matos P, 2005, EXP CELL RES, V305, P292, DOI 10.1016/j.yexcr.2004.12.029; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Matos P, 2008, GASTROENTEROLOGY, V135, P899, DOI 10.1053/j.gastro.2008.05.052; Matos P, 2008, MOL CANCER RES, V6, P1178, DOI 10.1158/1541-7786.MCR-08-0008; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Orlichenko L, 2006, J BIOL CHEM, V281, P4570, DOI 10.1074/jbc.M512088200; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sprang S R, 2000, Sci STKE, V2000, ppe1; Stallings-Mann M, 2007, CELLS TISSUES ORGANS, V185, P104, DOI 10.1159/000101310; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vikis HG, 2002, ONCOGENE, V21, P2425, DOI 10.1038/sj.onc.1205306; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022	68	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19153	19161		10.1074/jbc.M109.099382	http://dx.doi.org/10.1074/jbc.M109.099382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20395297	Green Published, hybrid			2022-12-27	WOS:000278727800025
J	Sadre, R; Frentzen, M; Saeed, M; Hawkes, T				Sadre, Radin; Frentzen, Margrit; Saeed, Mansoor; Hawkes, Tim			Catalytic Reactions of the Homogentisate Prenyl Transferase Involved in Plastoquinone-9 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUINONE BIOSYNTHESIS; POLYPRENYLTRANSFERASE	Homogentisate solanesyl transferase (HST) catalyzes the prenylation and decarboxylation of homogentisate to form 2-methyl6-solanesyl-1,4-benzoquinol, the first intermediate in plastoquinone-9 biosynthesis. In vitro, HST from Spinacia oleracea L., Arabidopsis thaliana, and Chlamydomonas reinhardtii were all found to use not only solanesyl diphosphate but also short chain prenyl diphosphates of 10-20 carbon atoms as prenyl donors. Surprisingly, with these donors, prenyl transfer was largely decoupled from decarboxylation, and thus the major products were 6-prenyl-1,4-benzoquinol-2-methylcarboxylates rather than the expected 2-methyl-6-prenyl-1,4-benzoquinols. The 6-prenyl-1,4-benzoquinol-2-methylcarboxylates were not substrates for HST-catalyzed decarboxylation, and the enzyme kinetics associated with forming these products appeared quite distinct from those for 2-methyl-6-prenyl-1,4-benzoquinol formation in respect of catalytic rate, substrate K-m value, and the pattern of inhibition by haloxydine, a molecule that appeared to act as a dead end mimic of homogentisate. These observations were reconciled into a simple model for the HST mechanism. Here, prenyl diphosphate binds to HST to form at least two alternative complexes that go on to react differently with homogentisate and prenylate it either with or without it first being decarboxylated. It is supposed that solanesyl diphosphate binds tightly and preferentially in the mode that compels prenylation with decarboxylation.	[Sadre, Radin; Frentzen, Margrit] Rhein Westfal TH Aachen, Inst Biol 1, D-52056 Aachen, Germany; [Saeed, Mansoor; Hawkes, Tim] Syngenta Ltd, Dept Biosci, Jealotts Hill Res Stn, Bracknell RG42 6EY, Berks, England	RWTH Aachen University; Syngenta	Sadre, R (corresponding author), Rhein Westfal TH Aachen, Inst Biol 1, Worringerweg 1, D-52056 Aachen, Germany.	rsadre@bio1.rwth-aachen.de		Sadre, Radin/0000-0002-8412-2579				[Anonymous], METHODS CHLOROPLAST; Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; CLELAND WW, 1982, CRC CR REV BIOCH MOL, V13, P385; FISHER KJ, 1995, Patent No. 5728650; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; HAWKES TR, 2007, MODERN CROP PROTECTI, P211; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; KAWAHARA K, 1991, AGR BIOL CHEM TOKYO, V55, P2307, DOI 10.1080/00021369.1991.10870951; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; MISITI D, 1965, J AM CHEM SOC, V87, P1402, DOI 10.1021/ja01084a058; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Ohara K, 2006, PLANT CELL PHYSIOL, V47, P581, DOI 10.1093/pcp/pcj025; Sadre R, 2006, FEBS LETT, V580, P5357, DOI 10.1016/j.febslet.2006.09.002; SOLL J, 1985, ARCH BIOCHEM BIOPHYS, V238, P290, DOI 10.1016/0003-9861(85)90167-5; Tian L, 2007, PLANTA, V226, P1067, DOI 10.1007/s00425-007-0564-5; TOMLIN CDS, 1969, Patent No. 1161491	17	23	25	7	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18191	18198		10.1074/jbc.M110.117929	http://dx.doi.org/10.1074/jbc.M110.117929			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20400515	Green Published, hybrid			2022-12-27	WOS:000278453900010
J	Chou, ST; Yen, YC; Lee, CM; Chen, MS				Chou, Sung-Tau; Yen, Yi-Chen; Lee, Chin-Mei; Chen, Mei-Shya			Pro-apoptotic Role of Cdc25A ACTIVATION OF CYCLIN B1/Cdc2 BY THE Cdc25A C-TERMINAL DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; CELL-CYCLE; BETA-TRCP; ACTIVATION; PHOSPHORYLATION; DEGRADATION; PHOSPHATASE; CHECKPOINT; INACTIVATION; PROTEOLYSIS	Cdc25A is a dual specificity protein phosphatase that activates cyclin/cyclin-dependent protein kinase (Cdk) complexes by removing inhibitory phosphates from conserved threonine and tyrosine in Cdks. To address how Cdc25A promotes apoptosis, Jurkat cells were treated with staurosporine, an apoptosis inducer. Upon staurosporine treatment, a Cdc25A C-terminal 37-kDa fragment, designated C37, was generated by caspase cleavage at Asp-223. Thr-507 in C37 became dephosphorylated, which prevented 14-3-3 binding, as shown previously. C37 exhibited higher phosphatase activity than full-length Cdc25A. C37 with alanine substitution for Thr-507 (C37/T507A) that imitated the cleavage product during staurosporine treatment interacted with Cdc2, Cdk2, cyclin A, and cyclin B1 and markedly activated cyclin B1/Cdc2. The dephosphorylation of Thr-507 might expose the Cdc2/Cdk2-docking site in C37. C37/T507A also induced apoptosis in Jurkat and K562 cells, resulting from activating cyclin B1/Cdc2 but not Cdk2. Thus, this study reveals that Cdc25A is a pro-apoptotic protein that amplifies staurosporine-induced apoptosis through the activation of cyclin B1/Cdc2 by its C-terminal domain.	[Chou, Sung-Tau; Yen, Yi-Chen; Lee, Chin-Mei; Chen, Mei-Shya] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Chen, MS (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	mschen@gate.sinica.edu.tw		Lee, Chin-Mei/0000-0003-3870-4268	National Institutes of Health [CA-094-PP-13, CA-095-PP-19, CA-096-PP-21]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants CA-094-PP-13, CA-095-PP-19, and CA-096-PP-21.	Andreau K, 2004, J BIOL CHEM, V279, P55937, DOI 10.1074/jbc.M406411200; Berndtsson M, 2005, FEBS LETT, V579, P3090, DOI 10.1016/j.febslet.2005.04.067; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; Jackson JR, 2000, CANCER RES, V60, P566; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mazars A, 2009, CELL DEATH DIFFER, V16, P208, DOI 10.1038/cdd.2008.142; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; Roy S, 2001, P NATL ACAD SCI USA, V98, P6132, DOI 10.1073/pnas.111085198; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Saha P, 1997, MOL CELL BIOL, V17, P4338, DOI 10.1128/MCB.17.8.4338; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Sohn R, 2005, BIOCHEMISTRY-US, V44, P16563, DOI 10.1021/bi0516879; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Svingen PA, 2004, CLIN CANCER RES, V10, P6807, DOI 10.1158/1078-0432.CCR-0778-02; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785	35	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17833	17845		10.1074/jbc.M109.078386	http://dx.doi.org/10.1074/jbc.M109.078386			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20368335	Green Published, hybrid			2022-12-27	WOS:000278133400061
J	Shadrick, WR; Julin, DA				Shadrick, William R.; Julin, Douglas A.			Kinetics of DNA Unwinding by the RecD2 Helicase from Deinococcus radiodurans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; BACTERIOPHAGE-T4 DDA HELICASE; MONOMERIC MOLECULAR MOTOR; ESCHERICHIA-COLI RECBCD; VIRUS NS3 HELICASE; PCRA HELICASE; STEP-SIZE; IN-VITRO; TRANSLOCATION; MECHANISM	RecD2 from Deinococcus radiodurans is a superfamily 1DNA helicase that is homologous to the Escherichia coli RecD protein but functions outside the context of RecBCD enzyme. We report here on the kinetics of DNA unwinding by RecD2 under single and multiple turnover conditions. There is little unwinding of 20-bp substrates by preformed RecD2-dsDNA complexes when excess ssDNA is present to trap enzyme molecules not bound to the substrate. A shorter 12-bp substrate is unwound rapidly under single turnover conditions. The 12-bp unwinding reaction could be simulated with a mechanism in which the DNA is unwound in two kinetic steps with rate constant of k(unw) = 5.5 s(-1) and a dissociation step from partially unwound DNA of k(off) = 1.9 s(-1). These results indicate a kinetic step size of about 3-4 bp, unwinding rate of about 15-20 bp/s, and low processivity (p = 0.74). The reaction time courses with 20-bp substrates, determined under multiple turnover conditions, could be simulated with a four-step mechanism and rate constant values very similar to those for the 12-bp substrate. The results indicate that the faster unwinding of a DNA substrate with a forked end versus only a 5'-terminal single-stranded extension can be accounted for by a difference in the rate of enzyme binding to the DNA substrates. Analysis of reactions done with different RecD2 concentrations indicates that the enzyme forms an inactive dimer or other oligomer at high enzyme concentrations. RecD2 oligomers can be detected by glutaraldehyde cross-linking but not by size exclusion chromatography.	[Shadrick, William R.; Julin, Douglas A.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Julin, DA (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	djulin@umd.edu						Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Cao Z, 2010, DNA REPAIR, V9, P66, DOI 10.1016/j.dnarep.2009.10.009; Chen HW, 1997, J BIOL CHEM, V272, P10072; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; GUTMAN PD, 1994, GENE, V141, P31, DOI 10.1016/0378-1119(94)90124-4; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Montague M, 2009, J MOL EVOL, V69, P360, DOI 10.1007/s00239-009-9290-x; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Servinsky MD, 2007, J BACTERIOL, V189, P5101, DOI 10.1128/JB.00409-07; Sikora B, 2006, J BIOL CHEM, V281, P36110, DOI 10.1074/jbc.M604412200; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang JL, 2004, J BIOL CHEM, V279, P52024, DOI 10.1074/jbc.M408645200; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wu CG, 2008, J MOL BIOL, V382, P312, DOI 10.1016/j.jmb.2008.07.012; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhou Q, 2007, FEMS MICROBIOL LETT, V271, P118, DOI 10.1111/j.1574-6968.2007.00703.x	41	13	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17292	17300		10.1074/jbc.M110.111427	http://dx.doi.org/10.1074/jbc.M110.111427			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20360003	hybrid, Green Published			2022-12-27	WOS:000278133400006
J	Vivona, S; Liu, CW; Strop, P; Rossi, V; Filippini, F; Brunger, AT				Vivona, Sandro; Liu, Corey W.; Strop, Pavel; Rossi, Valeria; Filippini, Francesco; Brunger, Axel T.			The Longin SNARE VAMP7/TI-VAMP Adopts a Closed Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; COATED VESICLES; COMPLEX; PROTEIN; YKT6; SYNTAXIN-1; ARCHITECTURE; MECHANISM	SNARE protein complexes are key mediators of exocytosis by juxtaposing opposing membranes, leading to membrane fusion. SNAREs generally consist of one or two core domains that can form a four-helix bundle with other SNARE core domains. Some SNAREs, such as syntaxin target-SNAREs and longin vesicular-SNAREs, have independent, folded N-terminal domains that can interact with their respective SNARE core domains and thereby affect the kinetics of SNARE complex formation. This autoinhibition mechanism is believed to regulate the role of the longin VAMP7/TI-VAMP in neuronal morphogenesis. Here we use nuclear magnetic resonance spectroscopy to study the longin-SNARE core domain interaction for VAMP7. Using complete backbone resonance assignments, chemical shift perturbations analysis, and hydrogen/deuterium exchange experiments, we conclusively show that VAMP7 adopts a preferentially closed conformation in solution. Taken together, the closed conformation of longins is conserved, in contrast to the syntaxin family of SNAREs for which mixtures of open and closed states have been observed. This may indicate different regulatory mechanisms for SNARE complexes containing syntaxins and longins, respectively.	[Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Vivona, Sandro; Rossi, Valeria; Filippini, Francesco] Univ Padua, Dept Biol, Mol Biol & Bioinformat Unit MOLBINFO, I-35131 Padua, Italy; [Liu, Corey W.] Stanford Univ, Sch Med, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Padua; Stanford University	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	brunger@stanford.edu	Filippini, Francesco/AAH-2897-2021	Brunger, Axel/0000-0001-5121-2036; FILIPPINI, FRANCESCO/0000-0001-5672-0726	National Institutes of Health [RO1-MH63105]; MIUR [PRIN2005]; Padua University [CPDA077345/07]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIUR(Ministry of Education, Universities and Research (MIUR)); Padua University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-MH63105 (to A. T. B.). This work was also supported by grants from the MIUR-PRIN2005 and the Padua University (PRAT2007 Project CPDA077345/07) (to F. F.).	Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Goddard T. D, 2007, SPARKY 3; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Hasegawa H, 2004, J CELL SCI, V117, P4495, DOI 10.1242/jcs.01314; Hasegawa H, 2003, MOL BIOL CELL, V14, P698, DOI 10.1091/mbc.E02-09-0556; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kinch LN, 2006, PROTEIN SCI, V15, P2669, DOI 10.1110/ps.062419006; Liu Wei, 2009, Front Neuroenergetics, V1, P5, DOI 10.3389/neuro.14.005.2009; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pylypenko O, 2008, J MOL BIOL, V377, P1334, DOI 10.1016/j.jmb.2008.01.099; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Vedovato M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-510; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Wen WY, 2010, MOL CELL, V37, P383, DOI 10.1016/j.molcel.2010.01.024; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	39	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17965	17973		10.1074/jbc.M110.120972	http://dx.doi.org/10.1074/jbc.M110.120972			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378544	Green Published, hybrid			2022-12-27	WOS:000278133400072
J	Bohme, S; Meyer, S; Kruger, A; Steinhoff, HJ; Wittinghofer, A; Klare, JP				Boehme, Sabine; Meyer, Simon; Krueger, Andre; Steinhoff, Heinz-Juergen; Wittinghofer, Alfred; Klare, Johann P.			Stabilization of G Domain Conformations in the tRNA-modifying MnmE-GidA Complex Observed with Double Electron Electron Resonance Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; GENE; MTO1; BIOMACROMOLECULES; EXPRESSION; INSIGHTS; POSITION; MUTANTS; CODES	MnmE is a GTP-binding protein conserved between bacteria and eukarya. It is a dimeric three-domain protein where the two G domains have to approach each other for activation of the potassium-stimulated GTPase reaction. Together with GidA, in a heterotetrameric alpha(2)beta(2) complex, it is involved in the modification of the wobble uridine base U34 of the first anticodon position of particular tRNAs. Here we show, using various spin-labeled MnmE mutants and EPR spectroscopy, that GidA binding induces large conformational and dynamic changes in MnmE. It stimulates the GTPase reaction by stabilizing the GTP-bound conformation in a potassium-independent manner. Surprisingly, GidA binding influences not only the GTP-but also the GDP-bound conformation. Thus GidA is a new type of regulator for a G protein activated by dimerization.	[Meyer, Simon; Krueger, Andre; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany; [Boehme, Sabine; Steinhoff, Heinz-Juergen; Klare, Johann P.] Univ Osnabruck, Dept Phys, D-49076 Osnabruck, Germany	Max Planck Society; University Osnabruck	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, Otto Hahn Str 11, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de; jklare@uos.de	Klare, Johann P./C-1428-2009; Steinhoff, Heinz-Juergen/H-3791-2014	Klare, Johann P./0000-0002-5761-5968; Steinhoff, Heinz-Juergen/0000-0002-5888-0157	Fond der Chemischen Industrie; International Max-Planck Research School; Deutsche Forschungsgemeinschaft [STE640/7-2]; Graduate College [612]	Fond der Chemischen Industrie(Fonds der Chemischen Industrie); International Max-Planck Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate College	This work was supported by funds from the Fond der Chemischen Industrie (to S.M.) and the International Max-Planck Research School (to S.M.), Deutsche Forschungsgemeinschaft Grant STE640/7-2 (to S.B., J.P.K., and H.-J.S.), and Graduate College Grant 612 (to S.B.).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; AGRIS PF, 1992, J AM CHEM SOC, V114, P2652, DOI 10.1021/ja00033a044; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Bykhovskaya Y, 2004, MOL GENET METAB, V83, P199, DOI 10.1016/j.ymgme.2004.07.009; Cabedo H, 1999, EMBO J, V18, P7063, DOI 10.1093/emboj/18.24.7063; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; ELSEVIERS D, 1984, NUCLEIC ACIDS RES, V12, P3521, DOI 10.1093/nar/12.8.3521; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Martin RE, 1998, ANGEW CHEM INT EDIT, V37, P2834, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2833::AID-ANIE2833>3.0.CO;2-7; Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072; Meyer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000212; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Sakamoto K, 1996, BIOCHEMISTRY-US, V35, P6533, DOI 10.1021/bi9526490; Schiemann O, 2007, Q REV BIOPHYS, V40, P1, DOI 10.1017/S003358350700460X; Scrima A, 2005, EMBO J, V24, P23, DOI 10.1038/sj.emboj.7600507; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09; Steinhoff HJ, 2004, BIOL CHEM, V385, P913, DOI 10.1515/BC.2004.119; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Villarroya M, 2008, MOL CELL BIOL, V28, P7514, DOI 10.1128/MCB.00946-08; Wittinghofer A, 1997, CURR BIOL, V7, pR682, DOI 10.1016/S0960-9822(06)00355-1; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752; YOKOYAMA S, 1995, STRUCTURE BIOSYNTHES, P207; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	37	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16991	17000		10.1074/jbc.M109.096131	http://dx.doi.org/10.1074/jbc.M109.096131			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353943	hybrid, Green Published			2022-12-27	WOS:000277982600062
J	Brower, CS; Veiga, L; Jones, RH; Varshavsky, A				Brower, Christopher S.; Veiga, Lucia; Jones, Richard H.; Varshavsky, Alexander			Mouse Dfa Is a Repressor of TATA-box Promoters and Interacts with the Abt1 Activator of Basal Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; BIDIRECTIONAL PROMOTER; HUMAN GENOME; GENE ORGANIZATION; UBIQUITIN LIGASE; PATHWAY; IDENTIFICATION; PROTEIN; EXPRESSION; SPERMATOGENESIS	Our study of the mouse Ate1 arginyltransferase, a component of the N-end rule pathway, has shown that Ate1 pre-mRNA is produced from a bidirectional promoter that also expresses, in the opposite direction, a previously uncharacterized gene (Hu, R. G., Brower, C. S., Wang, H., Davydov, I. V., Sheng, J., Zhou, J., Kwon, Y. T., and Varshavsky, A. (2006) J. Biol. Chem. 281, 32559-32573). In this work, we began analyzing this gene, termed Dfa (divergent from Ate1). Mouse Dfa was found to be transcribed from both the bidirectional PAte1/Dfa promoter and other nearby promoters. The resulting transcripts are alternatively spliced, yielding a complex set of Dfa mRNAs that are present largely, although not exclusively, in the testis. A specific Dfa mRNA encodes, via its 3'-terminal exon, a 217-residue protein termed Dfa(A). Other Dfa mRNAs also contain this exon. Dfa(A) is sequelogous (similar in sequence) to a region of the human/mouse HTEX4 protein, whose physiological function is unknown. We produced an affinity-purified antibody to recombinant mouse Dfa(A) that detected a 35-kDa protein in the mouse testis and in several cell lines. Experiments in which RNA interference was used to down-regulate Dfa indicated that the 35-kDa protein was indeed Dfa(A). Furthermore, Dfa(A) was present in the interchromatin granule clusters and was also found to bind to the Ggnbp1 gametogenetin-binding protein-1 and to the Abt1 activator of basal transcription that interacts with the TATA-binding protein. Given these results, RNA interference was used to probe the influence of Dfa levels in luciferase reporter assays. We found that Dfa(A) acts as a repressor of TATA-box transcriptional promoters.	[Brower, Christopher S.; Veiga, Lucia; Jones, Richard H.; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Jones, Richard/0000-0002-7570-2141	National Institutes of Health [GM31530, DK39520]; March of Dimes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK039520, R01DK039520, R37DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31530 and DK39520 (to A. V.). This work was also supported by a grant from the March of Dimes Foundation.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Aihara T, 2009, BIOL REPROD, V80, P762, DOI 10.1095/biolreprod.108.074013; Ausubel F.M., 2006, CURRENT PROTOCOLS MO; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Coriton O, 2000, MAMM GENOME, V11, P1127, DOI 10.1007/s003350010213; Elnitski L, 2005, CURR PROTOC BIOINFOR, P1041, DOI DOI 10.4.1-10.4.12; Elnitski L, 2003, CURR PROTOC BIOINFOR; Emoto M, 2005, GENE, V357, P47, DOI 10.1016/j.gene.2005.05.009; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lepourcelet M, 1998, IMMUNOGENETICS, V47, P491, DOI 10.1007/s002510050388; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Lu BS, 2003, J BIOL CHEM, V278, P16289, DOI 10.1074/jbc.M211023200; Meier-Noorden M, 2004, GENE, V338, P197, DOI 10.1016/j.gene.2004.05.006; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Oda T, 2000, MOL CELL BIOL, V20, P1407, DOI 10.1128/MCB.20.4.1407-1418.2000; Patton J, 2006, GENE, V369, P35, DOI 10.1016/j.gene.2005.10.009; Piontkivska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-189; Prioleau MN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000454; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; Saleh A, 2004, IMMUNITY, V21, P55, DOI 10.1016/j.immuni.2004.06.005; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Takai D, 2004, MOL BIOL EVOL, V21, P463, DOI 10.1093/molbev/msh040; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Teodorovic S, 2007, NUCLEIC ACIDS RES, V35, P2544, DOI 10.1093/nar/gkm105; Travers MT, 2005, GENOMICS, V85, P71, DOI 10.1016/j.ygeno.2004.10.001; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2008, NAT STRUCT MOL BIOL, V15, P1238, DOI 10.1038/nsmb1208-1238; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wang IF, 2006, EXP CELL RES, V312, P3796, DOI 10.1016/j.yexcr.2006.07.028; West AB, 2003, J MOL BIOL, V326, P11, DOI 10.1016/S0022-2836(02)01376-1; Whitehouse C, 2004, GENE, V326, P87, DOI 10.1016/j.gene.2003.10.008; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang J, 2005, FEBS LETT, V579, P559, DOI 10.1016/j.febslet.2004.10.112; Zhou Y, 2005, MOL REPROD DEV, V70, P301, DOI 10.1002/mrd.20214	55	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17218	17234		10.1074/jbc.M110.118638	http://dx.doi.org/10.1074/jbc.M110.118638			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356838	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000277982600084
J	Griner, EM; Caino, MC; Sosa, MS; Colon-Gonzalez, F; Chalmers, MJ; Mischak, H; Kazanietz, MG				Griner, Erin M.; Caino, M. Cecilia; Sosa, Maria Soledad; Colon-Gonzalez, Francheska; Chalmers, Michael J.; Mischak, Harald; Kazanietz, Marcelo G.			A Novel Cross-talk in Diacylglycerol Signaling THE RAC-GAP beta 2-CHIMAERIN IS NEGATIVELY REGULATED BY PROTEIN KINASE C delta-MEDIATED PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GTPASE-ACTIVATING PROTEIN; PHORBOL ESTER RECEPTOR; SUBCELLULAR-LOCALIZATION; TUMOR PROMOTERS; BETA-2-CHIMAERIN; PHOSPHORYLATION; DOMAIN; ALPHA-2-CHIMAERIN; BINDING	Although the family of chimaerin Rac-GAPs has recently gained significant attention for their involvement in development, cancer, and neuritogenesis, little is known about their molecular regulation. Chimaerins are activated by the lipid second messenger diacylglycerol via their C1 domain upon activation of tyrosine kinase receptors, thereby restricting the magnitude of Rac signaling in a receptor-regulated manner. Here we identified a novel regulatory mechanism for beta 2-chimaerin via phosphorylation. Epidermal growth factor or the phorbol ester phorbol 12-myristate 13-acetate caused rapid phosphorylation of beta 2-chimaerin on Ser(169) located in the SH2-C1 domain linker region via protein kinase C delta, which retained beta 2-chimaerin in the cytosol and prevented its C1 domain-mediated translocation to membranes. Furthermore, despite the fact that Ser(169) phosphorylation did not alter intrinsic Rac-GAP activity in vitro, a non-phosphorylatable beta 2-chimaerin mutant was highly sensitive to translocation, and displayed enhanced association with activated Rac, enhanced Rac-GAP activity, and anti-migratory properties when expressed in cells. Our results not only revealed a novel regulatory mechanism that facilitates Rac activation, but also identified a novel mechanism of cross-talk between diacylglycerol receptors that restricts beta 2-chimaerin relocalization and activation.	[Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Chalmers, Michael J.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Mischak, Harald] Mosaiques Diagnost GmbH, D-30625 Hannover, Germany	University of Pennsylvania; Scripps Research Institute; Mosaiques Diagnostics GmbH (MOS)	Kazanietz, MG (corresponding author), 1256 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Mischak, Harald/E-8685-2011	Mischak, Harald/0000-0003-0323-0306; Caino, M. Cecilia/0000-0001-8294-8070; Chalmers, Michael/0000-0002-2139-6089	National Institutes of Health [CA09677, CA74197]; NATIONAL CANCER INSTITUTE [R01CA074197, T32CA009677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA09677 and CA74197.	Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; BLUMBERG PM, 1983, ANN NY ACAD SCI, V407, P303, DOI 10.1111/j.1749-6632.1983.tb47836.x; Bruinsma SP, 2007, P NATL ACAD SCI USA, V104, P7098, DOI 10.1073/pnas.0701686104; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Caloca MJ, 2001, J BIOL CHEM, V276, P18303, DOI 10.1074/jbc.M011368200; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Kai M, 2007, BBA-MOL CELL RES, V1773, P1407, DOI 10.1016/j.bbamcr.2007.05.004; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Leskow FC, 2006, P NATL ACAD SCI USA, V103, P5373, DOI 10.1073/pnas.0508585103; LEUNG T, 1994, J BIOL CHEM, V269, P12888; Menna PL, 2003, CANCER RES, V63, P2284; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Siliceo M, 2009, J BIOL CHEM, V284, P11354, DOI 10.1074/jbc.M806098200; Sosa MS, 2009, BIOCHEMISTRY-US, V48, P8171, DOI 10.1021/bi9010623; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; YUAN SX, 1995, CANCER RES, V55, P3456; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	39	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16931	16941		10.1074/jbc.M109.099036	http://dx.doi.org/10.1074/jbc.M109.099036			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20335173	hybrid, Green Published			2022-12-27	WOS:000277982600056
J	Klink, BU; Barden, S; Heidler, TV; Borchers, C; Ladwein, M; Stradal, TEB; Rottner, K; Heinz, DW				Klink, Bjoern U.; Barden, Stephan; Heidler, Thomas V.; Borchers, Christina; Ladwein, Markus; Stradal, Theresia E. B.; Rottner, Klemens; Heinz, Dirk W.			Structure of Shigella IpgB2 in Complex with Human RhoA IMPLICATIONS FOR THE MECHANISM OF BACTERIAL GUANINE NUCLEOTIDE EXCHANGE FACTOR MIMICRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIFFRACTION DATA; STRESS FIBERS; PROTEIN; GTPASES; BINDING; ACTIVATION; MEMBRANE; FAMILY; GDP	A common theme in bacterial pathogenesis is the manipulation of eukaryotic cells by targeting the cytoskeleton. This is in most cases achieved either by modifying actin, or indirectly via activation of key regulators controlling actin dynamics such as Rho-GTPases. A novel group of bacterial virulence factors termed the WXXXE family has emerged as guanine nucleotide exchange factors (GEFs) for these GTPases. The precise mechanism of nucleotide exchange, however, has remained unclear. Here we report the structure of the WXXXE-protein IpgB2 from Shigella flexneri and its complex with human RhoA. We unambiguously identify IpgB2 as a bacterial RhoA-GEF and dissect the molecular mechanism of GDP release, an essential prerequisite for GTP binding. Our observations uncover that IpgB2 induces conformational changes on RhoA mimicking DbI-but not DOCK family GEFs. We also show that dissociation of the GDP.Mg2+ complex is preceded by the displacement of the metal ion to the alpha-phosphate of the nucleotide, diminishing its affinity to the GTPase. These data refine our understanding of the mode of action not only of WXXXE GEFs but also of mammalian GEFs of the DH/PH family.	[Heinz, Dirk W.] Helmholtz Zentrum Infekt Forsch, Div Struct Biol, D-38124 Braunschweig, Germany; [Ladwein, Markus; Rottner, Klemens] Helmholtz Zentrum Infekt Forsch, Cytoskeleton Dynam Grp, D-38124 Braunschweig, Germany; [Borchers, Christina; Stradal, Theresia E. B.] Helmholtz Zentrum Infekt Forsch, Signaling & Motil Grp, D-38124 Braunschweig, Germany; [Stradal, Theresia E. B.] Univ Munster, Inst Gen Zool & Genet, D-48149 Munster, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Munster	Heinz, DW (corresponding author), Helmholtz Zentrum Infekt Forsch, Div Struct Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany.	dirk.heinz@helmholtz-hzi.de		Barden, Stephan/0000-0003-2118-3371; Stradal, Theresia/0000-0002-0352-9474; Rottner, Klemens/0000-0003-4244-4198	Deutsche Forschungsgemeinschaft [SFB621, SPP1150]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded in part by the Deutsche Forschungsgemeinschaft (Grants SFB621 to K. R. and SPP1150 to T. E. B. S.).	Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; ARBELOA A, 2009, CELL MICROB IN PRESS; Arbeloa A, 2008, CELL MICROBIOL, V10, P1429, DOI 10.1111/j.1462-5822.2008.01136.x; Arbeloa A, 2009, J MED MICROBIOL, V58, P988, DOI 10.1099/jmm.0.010231-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boquet P, 2003, TRENDS CELL BIOL, V13, P238, DOI 10.1016/S0962-8924(03)00037-0; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Bulgin RR, 2009, CELL MICROBIOL, V11, P217, DOI 10.1111/j.1462-5822.2008.01248.x; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; DeLano W.L, PYMOL MOL GRAPHICS S; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Diacovich L, 2009, J BIOL CHEM, V284, P33151, DOI 10.1074/jbc.M109.034975; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; EBERTH A, 2009, CURR PROTOC CELL BIO, pCH4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freymann DM, 1999, NAT STRUCT BIOL, V6, P793, DOI 10.1038/11572; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; HAUSLER LC, 2004, THESIS RUHR U BOCHUM; Hayward RD, 2006, CELL, V124, P15, DOI 10.1016/j.cell.2005.12.024; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; Rudolph MG, 1999, J BIOL CHEM, V274, P30501, DOI 10.1074/jbc.274.43.30501; Shames SR, 2009, INT J BIOCHEM CELL B, V41, P380, DOI 10.1016/j.biocel.2008.08.013; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200	55	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17197	17208		10.1074/jbc.M110.107953	http://dx.doi.org/10.1074/jbc.M110.107953			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363740	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000277982600082
J	Limpert, AS; Carter, BD				Limpert, Allison S.; Carter, Bruce D.			Axonal Neuregulin 1 Type III Activates NF-kappa B in Schwann Cells during Myelin Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PERIPHERAL-NERVE; CANCER-CELLS; KINASE; RECEPTOR; PATHWAY; GROWTH; PROLIFERATION; AKT; DIFFERENTIATION	The formation of myelin requires a series of complex signaling events initiated by the axon to surrounding glial cells, which ultimately respond by tightly wrapping the axon with layers of specialized plasma membrane thereby allowing for saltatory conduction. Activation of the transcription factor NF-kappa B in Schwann cells has been suggested to be critical for these cells to differentiate into a myelinating phenotype; however, the mechanisms by which it is activated have yet to be elucidated. Here, we demonstrate that axonal membranes are sufficient to promote NF-kappa B activation in cultured Schwann cells and identify neuregulin 1 (NRG1), specifically the membrane-bound type III isoform, as the signal responsible for activating this transcription factor. Surprisingly, neither membrane-bound type I nor the soluble NRG1 EGF domain could activate NF-kappa B, indicating that type III induces a qualitatively unique signal. The transcriptional activity of NF-kappa B was significantly enhanced by treatment with forskolin, indicating these two signals converge for maximal activation. Both ErbB2 and -3 receptors were required for transducing the NRG1 signal, because gene deletion of ErbB3 in Schwann cells or treatment with the ErbB2 selective inhibitor, PKI-166, prevented the stimulation of NF-kappa B by axonal membranes. Finally, PKI-166 blocked the activation of the transcription factor in myelinating neuron/Schwann cell co-cultures and in vivo, in developing sciatic nerves. Taken together, these data establish NRG1 type III as the activator of NF-kappa B during myelin formation.	[Carter, Bruce D.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Carter, BD (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 625 Light Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu			National Institutes of Health [NS048249]; Muscular Dystrophy Association [MDA115761]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064278, R01NS048249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS048249 (to B.D.C.). This work was also supported by Muscular Dystrophy Association Grant MDA115761 (to A.S.L.).	Baseia Iuri Goulart, 2002, Acta Bot. Bras., V16, P01; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Cho HH, 2008, FEBS LETT, V582, P616, DOI 10.1016/j.febslet.2008.01.029; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Crovello CS, 1998, J BIOL CHEM, V273, P26954, DOI 10.1074/jbc.273.41.26954; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gedey R, 2006, J VIROL, V80, P8676, DOI 10.1128/JVI.00935-06; Gentry JJ, 2000, J BIOL CHEM, V275, P7558, DOI 10.1074/jbc.275.11.7558; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grinspan JB, 1996, J NEUROSCI, V16, P6107; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Kirillova I, 1999, CELL GROWTH DIFFER, V10, P819; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; LEVI ADO, 1995, J NEUROSCI, V15, P1329; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mattson MP, 2003, NAT NEUROSCI, V6, P105, DOI 10.1038/nn0203-105; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Ozes ON, 1999, NATURE, V401, P82; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; PODUSLO JF, 1995, J NEUROCHEM, V65, P149; Qu SM, 2006, GENESIS, V44, P477, DOI 10.1002/dvg.20243; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; SALZER JL, 1980, J CELL BIOL, V84, P753, DOI 10.1083/jcb.84.3.753; Sweeney C, 2000, J BIOL CHEM, V275, P19803, DOI 10.1074/jbc.C901015199; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; Walikonis RS, 1998, J BIOL CHEM, V273, P9070, DOI 10.1074/jbc.273.15.9070; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200; WHITE FV, 1983, EXP CELL RES, V148, P183, DOI 10.1016/0014-4827(83)90198-2; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289	50	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16614	16622		10.1074/jbc.M109.098780	http://dx.doi.org/10.1074/jbc.M109.098780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360002	Green Published, hybrid			2022-12-27	WOS:000277982600025
J	Singarapu, KK; Radek, JT; Tonelli, M; Markley, JL; Lan, Q				Singarapu, Kiran K.; Radek, James T.; Tonelli, Marco; Markley, John L.; Lan, Que			Differences in the Structure and Dynamics of the Apo- and Palmitate-ligated Forms of Aedes aegypti Sterol Carrier Protein 2 (AeSCP-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YELLOW-FEVER MOSQUITO; FATTY-ACID-BINDING; BACKBONE DYNAMICS; NMR; GENE; PROGRAM; EXPRESSION; DATABASE; REVEALS; DOMAIN	Sterol carrier protein-2 (SCP-2) is a nonspecific lipid-binding protein expressed ubiquitously in most organisms. Knockdown of SCP-2 expression in mosquitoes has been shown to result in high mortality in developing adults and significantly lowered fertility. Thus, it is of interest to determine the structure of mosquito SCP-2 and to identify its mechanism of lipid binding. We report here high quality three-dimensional solution structures of SCP-2 from Aedes aegypti determined by NMR spectroscopy in its ligand-free state (AeSCP-2) and in complex with palmitate. Both structures have a similar mixed alpha/beta fold consisting of a five-stranded beta-sheet and four alpha-helices arranged on one side of the beta-sheet. Ligand-free AeSCP-2 exhibited regions of structural heterogeneity, as evidenced by multiple two-dimensional N-15 heteronuclear single-quantum coherence peaks for certain amino acids; this heterogeneity disappeared upon complex formation with palmitate. The binding of palmitate to AeSCP-2 was found to decrease the backbone mobility of the protein but not to alter its secondary structure. Complex formation is accompanied by chemical shift differences and a loss of mobility for residues in the loop between helix alpha I and strand beta A. The structural differences between the alpha I and beta A of the mosquito and the vertebrate SCP-2s may explain the differential specificity (insect versus vertebrate) of chemical inhibitors of the mosquito SCP-2.	[Singarapu, Kiran K.; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Singarapu, Kiran K.; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Radek, James T.; Lan, Que] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA.	markley@nmrfam.wisc.edu; qlan@entomology.wisc.edu	Singarapu, Kiran/AAU-3435-2020		National Institutes of Health [5R01AI067422, P41 RR02301, P41 GM66326]; United States Armed Force Pest Management Board [W913M-05-1-0006]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Armed Force Pest Management Board; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01AI067422 (to Q. L.) and P41 RR02301 (to J. L. M.). This work was also supported by Grant W913M-05-1-0006 from the Deployed War Fighter Protection Research Program administered by the United States Armed Force Pest Management Board. NMR data were collected at the National Magnetic Resonance Facility (Madison, WI) and supported by National Institutes of Health Grants P41 RR02301 and P41 GM66326 (to J. L. M.).	Atshaves BP, 2007, AM J PHYSIOL-GASTR L, V292, pG939, DOI 10.1152/ajpgi.00308.2006; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x; Choinowski T, 2000, BIOCHEMISTRY-US, V39, P1897, DOI 10.1021/bi992742e; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dyer DH, 2008, J LIPID RES, V49, P644, DOI 10.1194/jlr.M700460-JLR200; Dyer DH, 2009, MOL CELL BIOCHEM, V326, P67, DOI 10.1007/s11010-008-0007-z; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferdinandusse S, 2006, AM J HUM GENET, V78, P1046, DOI 10.1086/503921; Filipp FV, 2007, BIOCHEMISTRY-US, V46, P7980, DOI 10.1021/bi6025616; Fuchs M, 2001, J BIOL CHEM, V276, P48058, DOI 10.1074/jbc.M106732200; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Garcia FL, 2000, J MOL BIOL, V295, P595, DOI 10.1006/jmbi.1999.3355; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hagelueken G, 2006, P NATL ACAD SCI USA, V103, P7631, DOI 10.1073/pnas.0510501103; Hodsdon ME, 1996, J MOL BIOL, V264, P585, DOI 10.1006/jmbi.1996.0663; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kannenberg F, 1999, J BIOL CHEM, V274, P35455, DOI 10.1074/jbc.274.50.35455; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim MS, 2005, J LIPID RES, V46, P650, DOI 10.1194/jlr.M400389-JLR200; Ko MH, 2007, J BIOL CHEM, V282, P19742, DOI 10.1074/jbc.M611426200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x; Larson RT, 2010, J MED ENTOMOL, V47, P249, DOI 10.1603/ME09160; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lucke C, 2001, BIOCHEM J, V354, P259, DOI 10.1042/0264-6021:3540259; Lucke C, 1996, STRUCTURE, V4, P785, DOI 10.1016/S0969-2126(96)00086-X; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; OHBA T, 1994, GENOMICS, V24, P370, DOI 10.1006/geno.1994.1630; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stolowich NJ, 1997, BIOCHEMISTRY-US, V36, P1719, DOI 10.1021/bi962317a; Stuart AC, 1999, J AM CHEM SOC, V121, P5346, DOI 10.1021/ja984172w; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; SZYPERSKI T, 1993, FEBS LETT, V335, P18, DOI 10.1016/0014-5793(93)80431-S; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	48	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17046	17053		10.1074/jbc.M110.101154	http://dx.doi.org/10.1074/jbc.M110.101154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356842	hybrid, Green Published			2022-12-27	WOS:000277982600068
J	von Roretz, C; Gallouzi, IE				von Roretz, Christopher; Gallouzi, Imed-Eddine			Protein Kinase RNA/FADD/Caspase-8 Pathway Mediates the Proapoptotic Activity of the RNA-binding Protein Human Antigen R (HuR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; MESSENGER-RNA; TRANSLATIONAL CONTROL; PROTHYMOSIN-ALPHA; IN-VIVO; PKR; APOPTOSIS; DEATH; ACTIVATION; STRESS	The RNA-binding protein human antigen R (HuR) has been implicated in apoptosis in multiple ways. Several studies have shown that in response to a variety of stresses HuR promotes the expression of proapoptotic mRNAs, whereas others reported its regulatory effect on antiapoptotic messages. We recently showed that in response to severe stress, HuR is cleaved to generate two cleavage products (CPs), HuR-CP1 (24 kDa) and HuR-CP2 (8 kDa), by which it promotes apoptotic cell death. Here, we show that this cleavage event is dependent on protein kinase RNA (PKR). Surprisingly, although in response to the apoptotic inducer staurosporine PKR itself is not phosphorylated, PKR triggers the cleavage of HuR via its downstream effector FADD that in turn activates the caspase-8/caspase-3 pathway. This effect, however, does not require the phosphorylation of the eukaryotic translation initiation factor 2 alpha. Additionally, we observed that these HuR-CPs are sufficient to trigger cell death in the absence of activation of the PKR pathway. Therefore, our results support a model whereby in response to lethal stress, PKR, without being phosphorylated, activates the FADD/caspase-8/caspase-3 pathway to trigger HuR cleavage, and the HuR-CPs are then capable of promoting apoptosis.	[Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Gallouzi, IE (corresponding author), McGill Univ, Dept Biochem, McIntyre Bldg,Rm 904,3655 Promenade Sir William O, Montreal, PQ H3G 1Y6, Canada.	imed.gallouzi@mcgill.ca			National Cancer Institute of Canada (NCIC) [016247, 018125]; Canadian Institutes of Health Research; Tier II Canada Research Chair	National Cancer Institute of Canada (NCIC)(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Tier II Canada Research Chair	This work was supported in part by National Cancer Institute of Canada (NCIC) Operating Grants 016247 and 018125 (to I.-E.G.).; Recipient of a Canadian Institutes of Health Research doctoral research award.; Recipient of a Tier II Canada Research Chair. To whom correspondence should be addressed: Dept. of Biochemistry, McGill University, McIntyre Bldg., Rm. 904, 3655 Promenade Sir William Osler, Montreal, Quebec H3G 1Y6, Canada. Fax: 1-514-398-7384; E-mail: imed.gallouzi@mcgill.ca.	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; BEAUCHAMP P, 2010, CELL DEATH IN PRESS; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; CASILLAS AM, 1993, BIOCHEM J, V290, P545, DOI 10.1042/bj2900545; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Donze O, 2004, EMBO J, V23, P564, DOI 10.1038/sj.emboj.7600078; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, ONCOGENE, V19, P3665, DOI 10.1038/sj.onc.1203710; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Peters GA, 2009, BIOCHEMISTRY-US, V48, P7441, DOI 10.1021/bi900433y; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Vaishnav D, 2003, BIOCHEM BIOPH RES CO, V307, P855, DOI 10.1016/S0006-291X(03)01287-7; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; van der Giessen K, 2007, MOL BIOL CELL, V18, P2619, DOI 10.1091/mbc.E07-02-0167; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16806	16813		10.1074/jbc.M109.087320	http://dx.doi.org/10.1074/jbc.M109.087320			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20353946	Green Published, hybrid			2022-12-27	WOS:000277982600044
J	Yori, JL; Johnson, E; Zhou, GJ; Jain, MK; Keri, RA				Yori, Jennifer L.; Johnson, Emhonta; Zhou, Guangjin; Jain, Mukesh K.; Keri, Ruth A.			Kruppel-like Factor 4 Inhibits Epithelial-to-Mesenchymal Transition through Regulation of E-cadherin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR KLF4; TUMOR-CELL INVASION; BREAST-CANCER; MEDIATED ADHESION; STEM-CELLS; NUCLEAR-LOCALIZATION; DOWN-REGULATION; MAMMARY-GLAND; GOBLET CELLS; P120 CATENIN	The Kruppel-like factor 4 (KLF4) is a transcriptional regulator of proliferation and differentiation in epithelial cells, both during development and tumorigenesis. Although KLF4 functions as a tumor suppressor in several tissues, including the colon, the role of KLF4 in breast cancer is less clear. Here, we show that KLF4 is necessary for maintenance of the epithelial phenotype in non-transformed MCF-10A mammary epithelial cells. KLF4 silencing led to alterations in epithelial cell morphology and migration, indicative of an epithelial-to-mesenchymal transition. Consistent with these changes, decreased levels of KLF4 also resulted in the loss of E-cadherin protein and mRNA. Promoter/reporter analyses revealed decreased E-cadherin promoter activity with KLF4 silencing, while chromatin immuno-precipitation identified endogenous KLF4 binding to the GC-rich/E-box region of this promoter. Furthermore, forced expression of KLF4 in the highly metastatic MDA-MB-231 breast tumor cell line was sufficient to restore E-cadherin expression and suppress migration and invasion. These findings identify E-cadherin as a novel transcriptional target of KLF4. The clear requirement for KLF4 to maintain E-cadherin expression and prevent epithelial-to-mesenchymal transition in mammary epithelial cells supports a metastasis suppressive role for KLF4 in breast cancer.	[Keri, Ruth A.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Div Gen Med Sci, Cleveland, OH 44106 USA; [Zhou, Guangjin; Jain, Mukesh K.; Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst & Univ Hosp, Harrington McLaughlin Heart & Vasc Inst,Dept Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Keri, RA (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	keri@case.edu	zhou, guangjin/F-9031-2011; Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	National Institutes of Health [CA090398, HL075427, HL086548]; Susan G. Komen Foundation [BCTR0601083]; Case Comprehensive Cancer Center [P30 CA043703]; Dept. of Defense [DAMD17-03-1-0302]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA090398] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075427, R01HL086548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Case Comprehensive Cancer Center; Dept. of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA090398 (to R. A. K.), CURE supplement to Grant CA090398 (to E. J.), and Grants HL075427 and HL086548 (to M. K. J.). This work was also supported by the Susan G. Komen Foundation (Grant BCTR0601083 to R. A. K.) and by the Case Comprehensive Cancer Center core facilities (Grant P30 CA043703).; Recipient of a Dept. of Defense pre-doctoral fellowship (DAMD17-03-1-0302).	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Baranwal S, 2009, BIOCHEM BIOPH RES CO, V384, P6, DOI 10.1016/j.bbrc.2009.04.051; Bennett HL, 2008, ONCOGENE, V27, P2693, DOI 10.1038/sj.onc.1210928; Boecker W, 2002, J PATHOL, V198, P458, DOI 10.1002/path.1241; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; DUYEN TD, 2000, INT J BIOCHEM CELL B, V32, P1103; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Foster KW, 2000, CANCER RES, V60, P6488; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Imbalzano KM, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-7; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Johnson E, 2004, J BIOL CHEM, V279, P31041, DOI 10.1074/jbc.M400024200; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Katz JP, 2002, DEVELOPMENT, V129, P2619; Knudsen KA, 2005, J CELL BIOCHEM, V95, P488, DOI 10.1002/jcb.20419; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mbalaviele G, 1996, CANCER RES, V56, P4063; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Miller KA, 2001, J BIOL CHEM, V276, P42863, DOI 10.1074/jbc.M108130200; Mo YY, 1996, CANCER RES, V56, P2633; Montanez-Wiscovich ME, 2009, ONCOGENE, V28, P3608, DOI 10.1038/onc.2009.221; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orsulic S, 1999, J CELL SCI, V112, P1237; Paccione RJ, 2008, MOL CANCER THER, V7, P2894, DOI 10.1158/1535-7163.MCT-08-0450; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; THOMPSON EW, 1994, CLIN EXP METASTAS, V12, P181, DOI 10.1007/BF01753886; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yancy Haile F, 2007, J Carcinog, V6, P8; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Zhang H, 2009, J BIOL CHEM, V284, P2867, DOI 10.1074/jbc.M807526200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	84	122	130	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16854	16863		10.1074/jbc.M110.114546	http://dx.doi.org/10.1074/jbc.M110.114546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20356845	Green Published, hybrid			2022-12-27	WOS:000277982600049
J	Jao, CC; Hegde, BG; Gallop, JL; Hegde, PB; McMahon, HT; Haworth, IS; Langen, R				Jao, Christine C.; Hegde, Balachandra G.; Gallop, Jennifer L.; Hegde, Prabhavati B.; McMahon, Harvey T.; Haworth, Ian S.; Langen, Ralf			Roles of Amphipathic Helices and the Bin/Amphiphysin/Rvs (BAR) Domain of Endophilin in Membrane Curvature Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; DISTANCE; SIMULATIONS; REFINEMENT; MECHANISMS; INSIGHTS; MUTANTS	Control of membrane curvature is required in many important cellular processes, including endocytosis and vesicular trafficking. Endophilin is a bin/amphiphysin/rvs (BAR) domain protein that induces vesicle formation by promotion of membrane curvature through membrane binding as a dimer. Using site-directed spin labeling and EPR spectroscopy, we show that the overall BAR domain structure of the rat endophilin A1 dimer determined crystallographically is maintained under predominantly vesiculating conditions. Spin-labeled side chains on the concave surface of the BAR domain do not penetrate into the acyl chain interior, indicating that the BAR domain interacts only peripherally with the surface of a curved bilayer. Using a combination of EPR data and computational refinement, we determined the structure of residues 63-86, a region that is disordered in the crystal structure of rat endophilin A1. Upon membrane binding, residues 63-75 in each subunit of the endophilin dimer form a slightly tilted, amphipathic alpha-helix that directly interacts with the membrane. In their predominant conformation, these helices are located orthogonal to the long axis of the BAR domain. In this conformation, the amphipathic helices are positioned to act as molecular wedges that induce membrane curvature along the concave surface of the BAR domain.	[Jao, Christine C.; Hegde, Balachandra G.; Hegde, Prabhavati B.; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Gallop, Jennifer L.; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Haworth, Ian S.] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	University of Southern California; MRC Laboratory Molecular Biology; University of Southern California	Langen, R (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.	langen@usc.edu	Hegde, Balachandra/GPS-6028-2022	Gallop, Jennifer Louise/0000-0002-9978-1382	National Institutes of Health [GM063915, T32 GM067587]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067587, R01GM063915] Funding Source: NIH RePORTER; MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant GM063915 ( to R. L.).; Recipient of National Institutes of Health Predoctoral Training Grant T32 GM067587.	ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Arkhipov A, 2008, BIOPHYS J, V95, P2806, DOI 10.1529/biophysj.108.132563; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Ayton GS, 2009, BIOPHYS J, V97, P1616, DOI 10.1016/j.bpj.2009.06.036; Bhatnagar J, 2007, METHOD ENZYMOL, V423, P117, DOI 10.1016/S0076-6879(07)23004-6; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; CASE DA, 2004, AMBER 8; Cui HS, 2009, BIOPHYS J, V97, P2746, DOI 10.1016/j.bpj.2009.08.043; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fischer T, 2007, J BIOL CHEM, V282, P9996, DOI 10.1074/jbc.M611180200; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; JUNG AG, PLOS ONE, V5, pE9492; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Yin Y, 2009, STRUCTURE, V17, P882, DOI 10.1016/j.str.2009.03.016; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	32	59	59	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20164	20170		10.1074/jbc.M110.127811	http://dx.doi.org/10.1074/jbc.M110.127811			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20418375	hybrid, Green Published			2022-12-27	WOS:000279012000051
J	Linke, C; Young, PG; Kang, HJ; Bunker, RD; Middleditch, MJ; Caradoc-Davies, TT; Proft, T; Baker, EN				Linke, Christian; Young, Paul G.; Kang, Hae Joo; Bunker, Richard D.; Middleditch, Martin J.; Caradoc-Davies, Tom T.; Proft, Thomas; Baker, Edward N.			Crystal Structure of the Minor Pilin FctB Reveals Determinants of Group A Streptococcal Pilus Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; ISOPEPTIDE BONDS; CORYNEBACTERIUM-DIPHTHERIAE; STABILIZING ISOPEPTIDE; SURFACE-PROTEINS; CELL-ADHESION; PYOGENES; SOFTWARE; SORTASE; REGION	Cell surface pili are polymeric protein assemblies that enable bacteria to adhere to surfaces and to specific host tissues. The pili expressed by Gram-positive bacteria constitute a unique paradigm in which sortase-mediated covalent linkages join successive pilin subunits like beads on a string. These pili are formed from two or three distinct types of pilin subunit, typically encoded in small gene clusters, often with their cognate sortases. In Group A streptococci (GAS), a major pilin forms the polymeric backbone, whereas two minor pilins are located at the tip and the base. Here, we report the 1.9-angstrom resolution crystal structure of the GAS basal pilin FctB, revealing an immunoglobulin (Ig)-like N-terminal domain with an extended proline-rich tail. Unexpected structural homology between the FctB Ig-like domain and the N-terminal domain of the GAS shaft pilin helps explain the use of the same sortase for polymerization of the shaft and its attachment to FctB. It also enabled the identification, from mass spectral data, of the lysine residue involved in the covalent linkage of FctB to the shaft. The proline-rich tail forms a polyproline-II helix that appears to be a common feature of the basal (cell wall-anchoring) pilins. Together, our results indicate distinct structural elements in the pilin proteins that play a role in selecting for the appropriate sortases and thereby help orchestrate the ordered assembly of the pilus.	[Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Auckland 1142, New Zealand; [Linke, Christian; Young, Paul G.; Kang, Hae Joo; Bunker, Richard D.; Middleditch, Martin J.; Proft, Thomas; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; [Proft, Thomas] Univ Auckland, Sch Med Sci, Auckland 1142, New Zealand; [Caradoc-Davies, Tom T.] Australian Synchrotron, Clayton, Vic 3168, Australia	University of Auckland; University of Auckland; University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Auckland Mail Ctr, Private Bag 92019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz	Linke-Winnebeck, Christian/F-4091-2010; Proft, Thomas/H-4686-2019; Linke-Winnebeck, Christian/P-1585-2019	Linke-Winnebeck, Christian/0000-0002-2306-247X; Proft, Thomas/0000-0002-9275-5042; Linke-Winnebeck, Christian/0000-0002-2306-247X; Bunker, Richard/0000-0001-8866-5290; Baker, Edward/0000-0003-2456-7661	Marsden Fund of New Zealand; Health Research Council of New Zealand; Tertiary Education Commission; Maurice Wilkins Centre for Molecular Biodiscovery; New Zealand International Doctoral Research Scholarship (Education New Zealand); University of Auckland New Zealand	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission; Maurice Wilkins Centre for Molecular Biodiscovery; New Zealand International Doctoral Research Scholarship (Education New Zealand); University of Auckland New Zealand	This work was supported in part by the Marsden Fund of New Zealand, the Health Research Council of New Zealand, and the Tertiary Education Commission through funding of the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by a New Zealand International Doctoral Research Scholarship (Education New Zealand) and a University of Auckland New Zealand International Doctoral Research Scholarship Plus Scholarship.; Supported by a University of Auckland Doctoral Scholarship.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Barnett TC, 2004, J BACTERIOL, V186, P5865, DOI 10.1128/JB.186.17.5865-5875.2004; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Hollingsworth SA, 2009, PROTEIN SCI, V18, P1321, DOI 10.1002/pro.133; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Linke C, 2010, ACTA CRYSTALLOGR F, V66, P177, DOI 10.1107/S1744309109051951; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Okuyama K, 2007, BIOPOLYMERS, V86, P212, DOI 10.1002/bip.20724; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Solovyova AS, 2010, EUR BIOPHYS J BIOPHY, V39, P469, DOI 10.1007/s00249-009-0432-2; Stapley BJ, 1999, PROTEIN SCI, V8, P587; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398	54	55	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20381	20389		10.1074/jbc.M109.089680	http://dx.doi.org/10.1074/jbc.M109.089680			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20427291	hybrid, Green Published			2022-12-27	WOS:000279012000071
J	Bidinosti, M; Martineau, Y; Frank, F; Sonenberg, N				Bidinosti, Michael; Martineau, Yvan; Frank, Filipp; Sonenberg, Nahum			Repair of Isoaspartate Formation Modulates the Interaction of Deamidated 4E-BP2 with mTORC1 in Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CARBOXYL METHYLTRANSFERASE; CAP-DEPENDENT TRANSLATION; DAMAGED PROTEINS; INITIATION; PEPTIDES; RAPTOR; GROWTH; TOR; METHYLATION; BINDING	In eukaryotes, a rate-limiting step of translation initiation is recognition of the mRNA 5' m(7)GpppN cap structure by the eukaryotic initiation factor 4F (eIF4F), a heterotrimeric complex consisting of the cap-binding protein, eIF4E, along with eIF4G, and eIF4A. The eIF4E-binding proteins (4E-BPs) repress translation by disrupting eIF4F formation, thereby preventing ribosome recruitment to the mRNA. Of the three 4E-BPs, 4E-BP2 is the predominant paralog expressed in the mammalian brain and plays an important role in synaptic plasticity and learning and memory. 4E-BP2 undergoes asparagine deamidation, solely in the brain, during early postnatal development. Deamidation spontaneously converts asparagines into a mixture of aspartates or isoaspartates, the latter of which may be destabilizing to proteins. The enzyme protein L-isoaspartyl methyltransferase (PIMT) prevents isoaspartate accumulation by catalyzing the conversion of isoaspartates to aspartates. PIMTexhibits high activity in the brain, relative to other tissues. We report here that 4E-BP2 is a substrate for PIMT. In vitro deamidated 4E-BP2 accrues isoapartyl residues and is methylated by recombinant PIMT. Using an antibody that recognizes 4E-BP2, which harbors isoaspartates at the deamidation sites, Asn(99) and Asn(102), we demonstrate that 4E-BP2 in PIMT-/- brain lysates contains isoaspartate residues. Further, we show that 4E-BP2 containing isoaspartates lacks the augmented association with raptor that is a feature of deamidated 4E-BP2.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Sonenberg, N (corresponding author), 1160 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	nahum.sonenberg@mcgill.ca	Martineau, Yvan/G-2387-2017	Martineau, Yvan/0000-0002-0575-4085; Frank, Filipp/0000-0001-8680-2757	Canadian Institutes of Health Research (CIHR); Howard Hughes Medical Institute; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Canadian Institutes of Health Research (CIHR) Team grant and a Howard Hughes Medical Institute grant (to N.S.).; Recipient of a postgraduate doctoral scholarship from the Natural Sciences and Engineering Research Council of Canada.	ASWAD DW, 1984, J BIOL CHEM, V259, P714; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Bohme L, 2008, BIOL CHEM, V389, P1043, DOI 10.1515/BC.2008.123; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; FLATMARK T, 1967, J BIOL CHEM, V242, P2454; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1996, P NATL ACAD SCI USA, V93, P5578, DOI 10.1073/pnas.93.11.5578; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; HALEY EE, 1966, BIOCHEMISTRY-US, V5, P3229, DOI 10.1021/bi00874a024; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1990, BIOCHEMISTRY-US, V29, P4373, DOI 10.1021/bi00470a017; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Lee VHY, 2008, FEBS J, V275, P2185, DOI 10.1111/j.1742-4658.2008.06372.x; Lindner H, 1999, J CANCER RES CLIN, V125, P182, DOI 10.1007/s004320050261; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; MIDELFORT CF, 1972, P NATL ACAD SCI USA, V69, P1816, DOI 10.1073/pnas.69.7.1816; MURRAY ED, 1984, J BIOL CHEM, V259, P722; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; PATEL K, 1990, PHARMACEUT RES, V7, P703, DOI 10.1023/A:1015807303766; Pepperkok R, 2000, J CELL BIOL, V148, P715, DOI 10.1083/jcb.148.4.715; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Radkiewicz JL, 2001, J AM CHEM SOC, V123, P3499, DOI 10.1021/ja0026814; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; ROBINSON AB, 1970, P NATL ACAD SCI USA, V66, P753, DOI 10.1073/pnas.66.3.753; ROBINSON AB, 1991, P NATL ACAD SCI USA, V88, P8880, DOI 10.1073/pnas.88.20.8880; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Shimizu T, 2002, J NEUROSCI RES, V70, P451, DOI 10.1002/jnr.10350; SHIRASAWA T, 1995, NEUROSCI LETT, V188, P37, DOI 10.1016/0304-3940(95)11389-E; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tarcsa E, 2000, J BIOL CHEM, V275, P20295, DOI 10.1074/jbc.M001555200; Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200; WEINTRAUB SJ, 2007, SCI STKE, pRE7; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ML, 1999, J PHARM SCI, V88, P8, DOI 10.1021/js9802493; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yonezawa K, 2003, CURR TOP MICROBIOL, V279, P271; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200	60	13	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19402	19408		10.1074/jbc.M110.120774	http://dx.doi.org/10.1074/jbc.M110.120774			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20424163	Green Published, hybrid			2022-12-27	WOS:000278727800051
J	Li, M; Wang, W; Soroka, CJ; Mennone, A; Harry, K; Weinman, EJ; Boyer, JL				Li, Man; Wang, Wei; Soroka, Carol J.; Mennone, Albert; Harry, Kathy; Weinman, Edward J.; Boyer, James L.			NHERF-1 Binds to Mrp2 and Regulates Hepatic Mrp2 Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; MULTIDRUG-RESISTANCE PROTEIN-2; APICAL MEMBRANE LOCALIZATION; DOMAIN INTERACTION CONTROLS; RAT HEPATOCYTE COUPLETS; DUBIN-JOHNSON SYNDROME; HEPATOCELLULAR TRANSPORTERS; OXIDIZED GLUTATHIONE; TARGETED DISRUPTION; ADAPTER PROTEINS	Multidrug resistance-associated protein 2 (Mrp2, Abcc2) is an ATP-binding cassette transporter localized at the canalicular membrane of hepatocytes that plays an important role in bile formation and detoxification. Prior in vitro studies suggest that Mrp2 can bind to Na+/H+ exchanger regulatory factor 1 (NHERF-1), a PDZ protein that cross-links membrane proteins to actin filaments. However the role of NHERF-1 in the expression and functional regulation of Mrp2 remains largely unknown. Here we examine the interaction of Mrp2 and NHERF-1 and its physiological significance in HEK293 cells and NHERF-1 knock-out mice. Mrp2 co-precipitated with NHERF-1 in co-transfected HEK293 cells, an interaction that required the PDZ-binding motif of Mrp2. In NHERF-1(-/-) mouse liver, Mrp2 mRNA was unchanged but Mrp2 protein was reduced in whole cell lysates and membrane-enriched fractions to similar to 50% (p < 1 x 10(-6)) and similar to 70% (p < 0.05), respectively, compared with wild-type mice, suggesting that the down-regulation of Mrp2 expression was caused by post-transcriptional events. Mrp2 remained localized at the apical/canalicular membrane of NHERF-1(-/-) mouse hepatocytes, although its immunofluorescent labeling was noticeably weaker. Bile flow in NHERF-1(-/-) mice was reduced to similar to 70% (p < 0.001) in association with a 50% reduction in glutathione excretion (p < 0.05) and a 60% reduction in glutathione-methylfluorescein (GS-MF) excretion in isolated mouse hepatocyte (p < 0.01). Bile acid and bilirubin excretion remained unchanged compared with wild-type mice. These findings strongly suggest that NHERF-1 binds to Mrp2, and plays a critical role in the canalicular expression of Mrp2 and its function as a determinant of glutathione-dependent, bile acid-independent bile flow.	[Boyer, James L.] Yale Univ, Sch Med, Dept Med, Ctr Liver, New Haven, CT 06520 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Yale University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Boyer, JL (corresponding author), Yale Univ, Sch Med, Dept Med, Ctr Liver, 333 Cedar St,1080 LMP,POB 208019, New Haven, CT 06520 USA.	james.boyer@yale.edu			National Institutes of Health [DK34989, DK25636, DK55881]; Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881, R37DK025636, P30DK034989, R01DK025636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK34989 and DK25636 (to J.L.B.) and DK55881 (to E.J.W.). This work was also supported by a grant from the Research Service, Department of Veterans Affairs (to E.J.W.).	BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617; Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Bandler PE, 2008, MOL PHARMACOL, V74, P9, DOI 10.1124/mol.108.045674; Borst P, 2006, CANCER LETT, V234, P51, DOI 10.1016/j.canlet.2005.05.051; BOYER JL, 1995, GASTROENTEROLOGY, V109, P1600, DOI 10.1016/0016-5085(95)90649-5; Broere N, 2007, J BIOL CHEM, V282, P37575, DOI 10.1074/jbc.M704878200; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cunningham R, 2007, J AM SOC NEPHROL, V18, P1419, DOI 10.1681/ASN.2006090980; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Fouassier L, 2009, AM J PATHOL, V174, P869, DOI 10.2353/ajpath.2009.080079; Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Harris MJ, 2001, J BIOL CHEM, V276, P20876, DOI 10.1074/jbc.M010566200; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hoque MT, 2009, BIOCHEM BIOPH RES CO, V379, P60, DOI 10.1016/j.bbrc.2008.12.014; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Jedlitschky G, 2006, EXPERT OPIN DRUG MET, V2, P351, DOI 10.1517/17425255.2.3.351; Kartenbeck J, 1996, HEPATOLOGY, V23, P1061; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 1999, LAB INVEST, V79, P1161; Kojima H, 2003, J HEPATOL, V39, P693, DOI 10.1016/S0168-8278(03)00410-0; Kojima H, 2008, J GASTROEN HEPATOL, V23, pE120, DOI 10.1111/j.1440-1746.2007.05109.x; Konno T, 2003, J BIOL CHEM, V278, P22908, DOI 10.1074/jbc.M302868200; Kubitz R, 1999, GASTROENTEROLOGY, V116, P401, DOI 10.1016/S0016-5085(99)70138-1; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Mottino AD, 2002, HEPATOLOGY, V35, P1409, DOI 10.1053/jhep.2002.33327; Mottino AD, 2008, WORLD J GASTROENTERO, V14, P7068, DOI 10.3748/wjg.14.7068; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Paulusma CC, 1997, HEPATOLOGY, V25, P1539, DOI 10.1002/hep.510250635; Paulusma CC, 2000, HEPATOLOGY, V31, P684, DOI 10.1002/hep.510310319; Pietrement C, 2008, J BIOL CHEM, V283, P2986, DOI 10.1074/jbc.M704678200; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Roelofsen H, 1998, J CELL SCI, V111, P1137; Roma MG, 2008, WORLD J GASTROENTERO, V14, P6786, DOI 10.3748/wjg.14.6786; Roma MG, 2000, HEPATOLOGY, V32, P1342, DOI 10.1053/jhep.2000.20519; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sekine S, 2006, FREE RADICAL BIO MED, V40, P2166, DOI 10.1016/j.freeradbiomed.2006.02.015; Shaik IH, 2006, ANAL BIOANAL CHEM, V385, P105, DOI 10.1007/s00216-006-0375-8; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wade JB, 2001, AM J PHYSIOL-CELL PH, V280, pC192, DOI 10.1152/ajpcell.2001.280.1.C192; Wang W, 2006, GASTROENTEROLOGY, V131, P878, DOI 10.1053/j.gastro.2006.06.013; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903	57	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19299	19307		10.1074/jbc.M109.096081	http://dx.doi.org/10.1074/jbc.M109.096081			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404332	hybrid, Green Published			2022-12-27	WOS:000278727800039
J	Yagi, H; Ozawa, D; Sakurai, K; Kawakami, T; Kuyama, H; Nishimura, O; Shimanouchi, T; Kuboi, R; Naiki, H; Goto, Y				Yagi, Hisashi; Ozawa, Daisaku; Sakurai, Kazumasa; Kawakami, Toru; Kuyama, Hiroki; Nishimura, Osamu; Shimanouchi, Toshinori; Kuboi, Ryoichi; Naiki, Hironobu; Goto, Yuji			Laser-induced Propagation and Destruction of Amyloid beta Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOFLAVIN-T; PHOTODYNAMIC THERAPY; DISEASE; GROWTH; INSULIN; FIBRILLOGENESIS; FLUORESCENCE; ASSEMBLIES; NUCLEATION; MECHANISM	The amyloid deposition of amyloid beta (A beta) peptides is a critical pathological event in Alzheimer disease (AD). Preventing the formation of amyloid deposits and removing preformed fibrils in tissues are important therapeutic strategies against AD. Previously, we reported the destruction of amyloid fibrils of beta 2-microglobulin K3 fragments by laser irradiation coupled with the binding of amyloid-specific thioflavin T. Here, we studied the effects of a laser beam on A beta fibrils. As was the case for K3 fibrils, extensive irradiation destroyed the preformed A beta fibrils. However, irradiation during spontaneous fibril formation resulted in only the partial destruction of growing fibrils and a subsequent explosive propagation of fibrils. The explosive propagation was caused by an increase in the number of active ends due to breakage. The results not only reveal a case of fragmentation-induced propagation of fibrils but also provide insights into therapeutic strategies for AD.	[Yagi, Hisashi; Ozawa, Daisaku; Sakurai, Kazumasa; Kawakami, Toru; Kuyama, Hiroki; Nishimura, Osamu; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Shimanouchi, Toshinori; Kuboi, Ryoichi] Osaka Univ, Grad Sch Chem Sci & Engn, Dept Engn Sci, Osaka 5608531, Japan; [Naiki, Hironobu] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Fukui 9101193, Japan	Osaka University; Osaka University; University of Fukui	Goto, Y (corresponding author), Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Kuyama, Hiroki/B-4687-2012; Naiki, Hironobu/G-5599-2014; Kuyama, Hiroki/W-8450-2019; Kuyama, Hiroki/D-1297-2009					Allsop D, 2008, BIOCHEM SOC T, V36, P1293, DOI 10.1042/BST0361293; Andersen CB, 2009, BIOPHYS J, V96, P1529, DOI 10.1016/j.bpj.2008.11.024; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Ban T, 2006, ACCOUNTS CHEM RES, V39, P663, DOI 10.1021/ar050074l; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Dahlgren PR, 2005, NANOMED-NANOTECHNOL, V1, P52, DOI 10.1016/j.nano.2004.11.004; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Giuliano EA, 2007, VET OPHTHALMOL, V10, P337, DOI 10.1111/j.1463-5224.2007.00578.x; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Krebs MRH, 2004, P NATL ACAD SCI USA, V101, P14420, DOI 10.1073/pnas.0405933101; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Librizzi F, 2005, PROTEIN SCI, V14, P3129, DOI 10.1110/ps.051692305; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narimoto T, 2004, FEBS LETT, V576, P313, DOI 10.1016/j.febslet.2004.09.024; Olteanu A, 2004, PROTEIN SCI, V13, P2852, DOI 10.1110/ps.04947204; Ono K, 2006, BBA-MOL BASIS DIS, V1762, P575, DOI 10.1016/j.bbadis.2006.03.002; Ozawa D, 2009, J BIOL CHEM, V284, P1009, DOI 10.1074/jbc.M805118200; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Wazawa T, 2005, ADV BIOCHEM ENG BIOT, V95, P77, DOI 10.1007/b102211; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n	37	44	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19660	19667		10.1074/jbc.M109.076505	http://dx.doi.org/10.1074/jbc.M109.076505			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20406822	Green Published, hybrid			2022-12-27	WOS:000278727800075
J	McMahon, M; Ayllon, V; Panov, KI; O'Connor, R				McMahon, Mary; Ayllon, Veronica; Panov, Kostya I.; O'Connor, Rosemary			Ribosomal 18 S RNA Processing by the IGF-I-responsive WDR3 Protein Is Integrated with p53 Function in Cancer Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOPROTEIN MDM2; TRANSCRIPTION; GROWTH; GENE; BIOGENESIS; ACTIVATION; BINDING; CYCLE; STABILIZATION; TRANSLOCATION	Insulin-like growth factor-I (IGF-I) signaling is strongly associated with cell growth and regulates the rate of synthesis of the rRNA precursor, the first and the key stage of ribosome biogenesis. In a screen for mediators of IGF-I signaling in cancer, we recently identified several ribosome-related proteins, including NEP1 (nucleolar essential protein 1) and WDR3 (WD repeat 3), whose homologues in yeast function in ribosome processing. The WDR3 gene and its locus on chromosome 1p12-13 have previously been linked with malignancy. Here we show that IGF-I induces expression of WDR3 in transformed cells. WDR3 depletion causes defects in ribosome biogenesis by affecting 18 S rRNA processing and also causes a transient down-regulation of precursor rRNA levels with moderate repression of RNA polymerase I activity. Suppression of WDR3 in cells expressing functional p53 reduced proliferation and arrested cells in the G(1) phase of the cell cycle. This was associated with activation of p53 and sequestration of MDM2 by ribosomal protein L11. Cells lacking functional p53 did not undergo cell cycle arrest upon suppression of WDR3. Overall, the data indicate that WDR3 has an essential function in 40 S ribosomal subunit synthesis and in ribosomal stress signaling to p53-mediated regulation of cell cycle progression in cancer cells.	[McMahon, Mary; Ayllon, Veronica; O'Connor, Rosemary] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cell Biol Lab, BioSci Inst, Cork, Ireland; [Panov, Kostya I.] Queens Univ Belfast, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland	University College Cork; Queens University Belfast	O'Connor, R (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cell Biol Lab, BioSci Inst, Cork, Ireland.	r.oconnor@ucc.ie	Ayllon, Veronica/L-7069-2014; O'Connor, Rosemary/B-7902-2014; McMahon, Mary/ABC-3576-2021	Ayllon, Veronica/0000-0002-7322-9282; O'Connor, Rosemary/0000-0002-0687-3422; McMahon, Mary/0000-0001-5548-2949; Panov, Konstantin/0000-0003-1375-7814	Science Foundation Ireland; Irish Research Council for Science, Engineering, and Technology; Health Research Board	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Health Research Board	This work was supported by Science Foundation Ireland, the Irish Research Council for Science, Engineering, and Technology, and the Health Research Board.	Baida A, 2008, CANCER EPIDEM BIOMAR, V17, P1499, DOI 10.1158/1055-9965.EPI-07-0235; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Claudio JO, 1999, GENOMICS, V59, P85, DOI 10.1006/geno.1999.5858; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Eschrich D, 2002, CURR GENET, V40, P326, DOI 10.1007/s00294-001-0269-4; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mertens F, 1997, CANCER RES, V57, P2765; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Panov KI, 2001, MOL CELL BIOL, V21, P2641, DOI 10.1128/MCB.21.8.2641-2649.2001; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; SCHNAPP A, 1990, EMBO J, V9, P2857, DOI 10.1002/j.1460-2075.1990.tb07475.x; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Skarie JM, 2008, HUM MOL GENET, V17, P2474, DOI 10.1093/hmg/ddn147; Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O; Steilen-Gimbel H, 1999, GENE CHROMOSOME CANC, V26, P270, DOI 10.1002/(SICI)1098-2264(199911)26:3<270::AID-GCC14>3.0.CO;2-W; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Thomas G, 2000, NAT CELL BIOL, V2, pE71, DOI 10.1038/35010581; Tu X, 2002, J BIOL CHEM, V277, P44357, DOI 10.1074/jbc.M208001200; Turner AJ, 2009, MOL CELL BIOL, V29, P3007, DOI 10.1128/MCB.00029-09; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wu A, 2005, J BIOL CHEM, V280, P2863, DOI 10.1074/jbc.M406138200; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	45	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18309	18318		10.1074/jbc.M110.108555	http://dx.doi.org/10.1074/jbc.M110.108555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20392698	hybrid, Green Published			2022-12-27	WOS:000278453900024
J	Xu, XA; Vatsyayan, J; Gao, CX; Bakkenist, CJ; Hu, J				Xu, Xiang; Vatsyayan, Jaya; Gao, Chenxi; Bakkenist, Christopher J.; Hu, Jing			HDAC2 Promotes eIF4E Sumoylation and Activates mRNA Translation Gene Specifically	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; EXPRESSION; INITIATION; PHOSPHORYLATION; MEF2; SUMO	Histone deacetylases (HDACs) are best known as transcription corepressors through deacetylating histone tails. Here we show that HDAC2 is also involved in cap-dependent mRNA translation by promoting sumoylation of eukaryotic translation initiation factor 4E (eIF4E), which is independent of its deacetylase activity. By stimulating eIF4E sumoylation, HDAC2 induces the formation of the active eukaryotic initiation factor 4F (eIF4F) complex and induces the protein synthesis of a subset of eIF4E-responsive genes that are essential for cell proliferation and preventing apoptosis. These data demonstrate that HDAC2 has an unexpected sumoylation-promoting activity and regulates cap-dependent mRNA translation.	[Xu, Xiang; Vatsyayan, Jaya; Gao, Chenxi; Bakkenist, Christopher J.; Hu, Jing] Univ Pittsburgh, Sch Med, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Bakkenist, Christopher J.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; [Xu, Xiang] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Inst Surg Res, Daping Hosp, Chongqing 400042, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Army Medical University	Hu, J (corresponding author), 2-42D Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	huj3@upmc.edu	Hu, Jing/M-3130-2014; xu, xiang/L-2579-2014	xu, xiang/0000-0002-1026-2210	National Institutes of Health through the United States Public Health Service [CA128681]; Hillman Foundation; Pittsburgh Foundation; NATIONAL CANCER INSTITUTE [R21CA128681] Funding Source: NIH RePORTER	National Institutes of Health through the United States Public Health Service; Hillman Foundation; Pittsburgh Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA128681 through the United States Public Health Service (to J. H.). This work was also supported in part by grants from the Hillman Foundation fellowship and The Pittsburgh Foundation (to J. H.).	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Cullen BR, 2009, CELL, V136, P592, DOI 10.1016/j.cell.2009.01.048; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Di Bacco A, 2006, CELL CYCLE, V5, P2310, DOI 10.4161/cc.5.20.3367; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Kee HJ, 2008, CIRC RES, V103, P1259, DOI 10.1161/01.RES.0000338570.27156.84; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Nie M, 2006, NUCLEIC ACIDS RES, V34, P5528, DOI 10.1093/nar/gkl584; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Vatsyayan J, 2008, EMBO REP, V9, P885, DOI 10.1038/embor.2008.122; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xu X, 2010, EMBO REP, V11, P299, DOI 10.1038/embor.2010.18; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zimmermann S, 2007, CANCER RES, V67, P9047, DOI 10.1158/0008-5472.CAN-07-0312	22	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18139	18143		10.1074/jbc.C110.131599	http://dx.doi.org/10.1074/jbc.C110.131599			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20421305	hybrid, Green Published			2022-12-27	WOS:000278453900004
J	Roger, S; Gillet, L; Baroja-Mazo, A; Surprenant, A; Pelegrin, P				Roger, Sebastien; Gillet, Ludovic; Baroja-Mazo, Alberto; Surprenant, Annmarie; Pelegrin, Pablo			C-terminal Calmodulin-binding Motif Differentially Controls Human and Rat P2X(7) Receptor Current Facilitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; OF-FUNCTION; NUCLEOTIDE RECEPTOR; EXTRACELLULAR ATP; PORE FORMATION; ION-CHANNEL; POLYMORPHISM; GENE; EXPRESSION; RELEASE	P2X(7) receptors (P2X(7)R) are ATP-gated calcium-permeable cationic channels structurally unique among the P2X family by their much longer intracellular C-terminal tail. P2X(7)Rs show several unusual biophysical properties, in particular marked facilitation of currents and leftward shift in agonist affinity in response to repeated or prolonged agonist applications. We previously found the facilitation at rat P2X(7)R resulted from a Ca2+-calmodulin-dependent process and a distinct calcium-independent process. However, P2X(7)Rs show striking species differences; thus, this study compared the properties of ATP-evoked facilitation of currents in HEK293 cells transiently expressing the human or rat P2X(7)R as well as rat/human, human/rat chimeric, and mutated P2X(7)Rs. Facilitation at the human P2X(7)R was 5-fold slower than at the rat P2X(7)R. Facilitation did not resulting from an increase of receptor addressing the plasma membrane. We found the human P2X(7)R shows only calcium-independent facilitation with no evidence for calmodulin-dependent processes, nor does it contain the novel 1-5-16 calmodulin binding domain present in the C terminus of rat P2X(7)R. Replacement of three critical residues of this binding domain from the rat into the human P2X(7)R (T541I, C552S, and G559V) reconstituted the Ca2+-calmodulin-dependent facilitation, leaving the calcium-independent facilitation unaltered. The leftward shift in the ATP concentration-response curve with repeated agonist applications appears to be a property of the calcium-independent facilitation process because it was not altered in any of the chimeric or mutated P2X(7)Rs. The absence of Ca2+-dependent facilitation at the human P2X(7)R may represent a protective adaptation of the innate immune response in which P2X(7)R plays significant roles.	[Roger, Sebastien; Gillet, Ludovic] Univ Tours, INSERM, U921, F-37032 Tours, France; [Surprenant, Annmarie; Pelegrin, Pablo] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Baroja-Mazo, Alberto; Pelegrin, Pablo] Univ Hosp Virgen Arrixaca FFIS, Inflammat & Expt Surg Grp, Murcia 30120, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Manchester	Roger, S (corresponding author), Univ Tours, INSERM, U921, 10 Blvd Tonnelle, F-37032 Tours, France.	sebastien.roger@univ-tours.fr	Baroja-Mazo, Alberto/E-6270-2016; Pelegrin, Pablo/M-2007-2014	Baroja-Mazo, Alberto/0000-0001-5212-5006; Pelegrin, Pablo/0000-0002-9688-1804; Roger, Sebastien/0000-0002-9852-5248; Gillet, Ludovic/0000-0002-4990-6212	Biotechnology and Biological Sciences Research Council; French Foreign and European Ministry and the French Embassy in the United Kingdom; Isciii Grants [EMER07/049, PFIS0009/120]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French Foreign and European Ministry and the French Embassy in the United Kingdom; Isciii Grants	This work was supported by the Biotechnology and Biological Sciences Research Council, the "Partenariat Hubert Curien-Alliance" from the French Foreign and European Ministry and the French Embassy in the United Kingdom, and Isciii Grants EMER07/049 (to A. B.-M.) and PFIS0009/120 (to P. P.).	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Alcaraz L, 2003, BIOORG MED CHEM LETT, V13, P4043, DOI 10.1016/j.bmcl.2003.08.033; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Dardano A, 2009, J CLIN ENDOCR METAB, V94, P695, DOI 10.1210/jc.2008-1322; Denlinger LC, 2005, J IMMUNOL, V174, P4424, DOI 10.4049/jimmunol.174.7.4424; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Erhardt A, 2007, J AFFECT DISORDERS, V101, P159, DOI 10.1016/j.jad.2006.11.016; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; HALLING DB, 2006, SCI STKE, pER1, DOI DOI 10.1126/STKE.3152005RE15; Hibell AD, 2000, BRIT J PHARMACOL, V130, P167, DOI 10.1038/sj.bjp.0703302; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Kiselyov K, 2005, PFLUG ARCH EUR J PHY, V451, P116, DOI 10.1007/s00424-005-1442-2; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; Romagnoli R, 2008, EXPERT OPIN THER TAR, V12, P647, DOI 10.1517/14728222.12.5.647 ; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Sim JA, 2004, J NEUROSCI, V24, P6307, DOI 10.1523/JNEUROSCI.1469-04.2004; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Smart ML, 2003, J BIOL CHEM, V278, P8853, DOI 10.1074/jbc.M211094200; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Thunberg U, 2002, LANCET, V360, P1935, DOI 10.1016/S0140-6736(02)11917-9; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Young MT, 2006, BRIT J PHARMACOL, V149, P261, DOI 10.1038/sj.bjp.0706880; Young MT, 2007, MOL PHARMACOL, V71, P92, DOI 10.1124/mol.106.030163; Zhang XF, 2005, BRAIN RES, V1052, P63, DOI 10.1016/j.brainres.2005.06.022; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	51	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17514	17524		10.1074/jbc.M109.053082	http://dx.doi.org/10.1074/jbc.M109.053082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20378545	Green Published, hybrid			2022-12-27	WOS:000278133400030
J	Wang, XF; Lee, J; Di Jeso, B; Treglia, AS; Comoletti, D; Dubi, N; Taylor, P; Arvan, P				Wang, Xiaofan; Lee, Jaemin; Di Jeso, Bruno; Treglia, A. Sonia; Comoletti, Davide; Dubi, Noga; Taylor, Palmer; Arvan, Peter			Cis and Trans Actions of the Cholinesterase-like Domain within the Thyroglobulin Dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISSENSE MUTATION G2320R; ENDOPLASMIC-RETICULUM; HUMAN ACETYLCHOLINESTERASE; CONGENITAL HYPOTHYROIDISM; GOITROUS HYPOTHYROIDISM; THYROID PEROXIDASE; GENE; TRAFFICKING; SECRETION; PROTEINS	Thyroglobulin (Tg, precursor for thyroid hormone synthesis) is a large secreted glycoprotein composed of upstream regions I-II-III, followed by the similar to 570 residue cholinesterase-like (ChEL) domain. ChEL has two identified functions: 1) homodimerization, and 2) binding to I-II-III that facilitates I-II-III oxidative maturation required for intracellular protein transport. Like its homologs in the acetylcholinesterase (AChE) family, ChEL possesses two carboxyl-terminal alpha-helices. We find that a Tg-AChE chimera (swapping AChE in place of ChEL) allows for dimerization with monomeric AChE, proving exposure of the carboxyl-terminal helices within the larger context of Tg. Further, we establish that perturbing trans-helical interaction blocks homodimerization of the Tg ChEL domain. Additionally, ChEL can associate with neuroligins (a related family of cholinesterase-like proteins), demonstrating potential for Tg cross-dimerization between non-identical partners. Indeed, when mutant rdw-Tg (Tg-G2298R, defective for protein secretion) is co-expressed with wild-type Tg, the two proteins cross-dimerize and secretion of rdw-Tg is partially restored. Moreover, we find that AChE and soluble neuroligins also can bind to the upstream Tg regions I-II-III; however, they cannot rescue secretion, because they cannot facilitate oxidative maturation of I-II-III. These data suggest that specific properties of distinct Tg ChEL mutants may result in distinct patterns of Tg monomer folding, cross-dimerization with wild-type Tg, and variable secretion behavior in heterozygous patients.	[Wang, Xiaofan; Lee, Jaemin; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48109 USA; [Lee, Jaemin; Arvan, Peter] Univ Michigan, Program Cell & Mol Biol, Med Ctr, Ann Arbor, MI 48109 USA; [Di Jeso, Bruno; Treglia, A. Sonia] Univ Lecce, Fac Sci MFN, Dipartimento Sci & Tecnol Biol & Ambientali, I-73100 Lecce, Italy; [Comoletti, Davide; Dubi, Noga; Taylor, Palmer] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Salento; University of California System; University of California San Diego	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, 5560 MSRB2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umich.edu	Lee, Jaemin/AAP-4875-2021	di jeso, bruno/0000-0001-8713-5984; Lee, Jaemin/0000-0002-0224-7141	National Institutes of Health [R01-DK40344, P42-ES010337, R37-GM18360]; Ministero dell'Universita e della Ricerca [2006069102_004]; University of Michigan Diabetes Research and Training Center [NIH5P60 DK20572]; University of Michigan Cancer Center Core laboratories [P30 CA46592]; University of Michigan; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P60DK020572, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Michigan Diabetes Research and Training Center(University of Michigan System); University of Michigan Cancer Center Core laboratories; University of Michigan(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK40344 (to P. A.) and P42-ES010337 and R37-GM18360 (to P. T.). This work was also supported by the Ministero dell'Universita e della Ricerca PRIN 2006069102_004 (to B. D. J.), by University of Michigan Diabetes Research and Training Center Grant NIH5P60 DK20572 for the Molecular Biology and Sequencing Cores, and by the University of Michigan Cancer Center Core laboratories (Grant P30 CA46592). This work was performed in partial fulfillment of the requirements for Ph.D. (for J. L.) in the Cellular and Molecular Biology program at the University of Michigan.	Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Arvan P, 1997, THYROID, V7, P89, DOI 10.1089/thy.1997.7.89; Caputo M, 2007, CLIN ENDOCRINOL, V67, P351, DOI 10.1111/j.1365-2265.2007.02889.x; Caron P, 2003, J CLIN ENDOCR METAB, V88, P3546, DOI 10.1210/jc.2002-021744; Comoletti D, 2008, CHEM-BIOL INTERACT, V175, P150, DOI 10.1016/j.cbi.2008.04.040; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; De Jaco A, 2008, CHEM-BIOL INTERACT, V175, P349, DOI 10.1016/j.cbi.2008.04.023; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Di Jeso B, 2003, BIOCHEM J, V370, P449, DOI 10.1042/BJ20021257; Di Jeso B, 1998, EUR J BIOCHEM, V252, P583, DOI 10.1046/j.1432-1327.1998.2520583.x; DIJESO B, 2004, THYROID, P77; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Gilbert MM, 2005, FRONT BIOSCI-LANDMRK, V10, P2177, DOI 10.2741/1689; Hishinuma A, 2000, ENDOCRINOLOGY, V141, P4050, DOI 10.1210/en.141.11.4050; KEREM A, 1993, J BIOL CHEM, V268, P180; KIM PS, 1991, J BIOL CHEM, V266, P12412; Kim PS, 2000, MOL ENDOCRINOL, V14, P1944, DOI 10.1210/me.14.12.1944; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Kitanaka S, 2006, J HUM GENET, V51, P379, DOI 10.1007/s10038-006-0360-2; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; Massoulie J, 2005, CHEM-BIOL INTERACT, V157, P3, DOI 10.1016/j.cbi.2005.10.002; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; Menon S, 2007, J BIOL CHEM, V282, P6183, DOI 10.1074/jbc.M608863200; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; MORI N, 1987, P NATL ACAD SCI USA, V84, P2813, DOI 10.1073/pnas.84.9.2813; Pardo V, 2008, THYROID, V18, P783, DOI 10.1089/thy.2007.0321; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Renault L, 2005, CHEM-BIOL INTERACT, V157, P339, DOI 10.1016/j.cbi.2005.10.100; Rivolta CM, 2006, CLIN CHIM ACTA, V374, P8, DOI 10.1016/j.cca.2006.05.043; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; Srivatsan M, 2006, BIOINFORMATION, V1, P281, DOI 10.6026/97320630001281; SWILLENS S, 1986, BIOCHEM BIOPH RES CO, V137, P142, DOI 10.1016/0006-291X(86)91187-3; TARGOVNIK HM, 2010, MOL CELL EN IN PRESS; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Turakulov Ia Kh, 1976, Biokhimiia, V41, P1004; van de Graaf SAR, 2001, J ENDOCRINOL, V170, P307, DOI 10.1677/joe.0.1700307; Veneziani BM, 1999, BIOCHIMIE, V81, P517, DOI 10.1016/S0300-9084(99)80104-7; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	46	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17564	17573		10.1074/jbc.M110.111641	http://dx.doi.org/10.1074/jbc.M110.111641			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20353937	Green Published, hybrid			2022-12-27	WOS:000278133400035
J	Kozlov, AG; Cox, MM; Lohman, TM				Kozlov, Alexander G.; Cox, Michael M.; Lohman, Timothy M.			Regulation of Single-stranded DNA Binding by the C Termini of Escherichia coli Single-stranded DNA-binding (SSB) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 32 PROTEIN; NEGATIVE COOPERATIVITY; BACTERIOPHAGE T7; NUCLEIC-ACIDS; OLIGONUCLEOTIDE INTERACTIONS; DEINOCOCCUS-RADIODURANS; LIMITED PROTEOLYSIS; CRYSTAL-STRUCTURE; TETRAMER BINDING; MODE TRANSITIONS	The homotetrameric Escherichia coli single-stranded DNA-binding (SSB) protein plays a central role in DNA replication, repair, and recombination. In addition to its essential activity of binding to transiently formed single-stranded (ss) DNA, SSB also binds an array of partner proteins and recruits them to their sites of action using its four intrinsically disordered C-terminal tails. Here we show that the binding of ssDNA to SSB is inhibited by the SSB C-terminal tails, specifically by the last 8 highly acidic amino acids that comprise the binding site for its multiple partner proteins. We examined the energetics of ssDNA binding to short oligodeoxynucleotides and find that at moderate salt concentration, removal of the acidic C-terminal ends increases the intrinsic affinity for ssDNA and enhances the negative cooperativity between ssDNA binding sites, indicating that the C termini exert an inhibitory effect on ssDNA binding. This inhibitory effect decreases as the salt concentration increases. Binding of ssDNA to approximately half of the SSB subunits relieves the inhibitory effect for all of the subunits. The inhibition by the C termini is due primarily to a less favorable entropy change upon ssDNA binding. These observations explain why ssDNA binding to SSB enhances the affinity of SSB for its partner proteins and suggest that the C termini of SSB may interact, at least transiently, with its ssDNA binding sites. This inhibition and its relief by ssDNA binding suggest a mechanism that enhances the ability of SSB to selectively recruit its partner proteins to sites on DNA.	[Kozlov, Alexander G.; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Lohman, TM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231,660 S Euclid Ave, St Louis, MO 63110 USA.	lohman@biochem.wustl.edu			National Institutes of Health [GM30498, GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, U01GM032335, R01GM030498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM30498 (to T. M. L.) and GM32335 (to M. M. C.).	Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; BUJALOWSKI W, 1989, J MOL BIOL, V207, P269, DOI 10.1016/0022-2836(89)90455-5; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1989, J MOL BIOL, V207, P249, DOI 10.1016/0022-2836(89)90454-3; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; BUJALOWSKI W, 1991, J BIOL CHEM, V266, P1616; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; FERRARI ME, 1994, J MOL BIOL, V236, P106, DOI 10.1006/jmbi.1994.1122; FERRARI ME, 1994, BIOCHEMISTRY-US, V33, P12896, DOI 10.1021/bi00209a022; GRAY DM, 1992, METHOD ENZYMOL, V211, P389; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; HOSODA J, 1978, J BIOL CHEM, V253, P7547; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; Kozlov AG, 1998, J MOL BIOL, V278, P999, DOI 10.1006/jmbi.1998.1738; Kozlov AG, 1999, BIOCHEMISTRY-US, V38, P7388, DOI 10.1021/bi990309z; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Kuznetsov SV, 2006, J MOL BIOL, V359, P55, DOI 10.1016/j.jmb.2006.02.070; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P424; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, BIOCHEMISTRY-US, V33, P6167, DOI 10.1021/bi00186a016; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lohman TM., 1990, BIOL NONSPECIFIC DNA, P131; LONBERG N, 1981, J MOL BIOL, V145, P123, DOI 10.1016/0022-2836(81)90337-5; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Marintcheva B, 2008, P NATL ACAD SCI USA, V105, P1855, DOI 10.1073/pnas.0711919105; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MicroCal, 2004, ITC DAT AN OR TUT GU; MOISE H, 1976, NATURE, V259, P455, DOI 10.1038/259455a0; OVERMAN LB, 1994, J MOL BIOL, V236, P165, DOI 10.1006/jmbi.1994.1126; OVERMAN LB, 1988, BIOCHEMISTRY-US, V27, P456, DOI 10.1021/bi00401a067; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; SANCAR A, 1981, P NATL ACAD SCI-BIOL, V78, P4274, DOI 10.1073/pnas.78.7.4274; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	52	67	73	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					17246	17252		10.1074/jbc.M110.118273	http://dx.doi.org/10.1074/jbc.M110.118273			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20360609	Green Published, hybrid			2022-12-27	WOS:000277982600086
J	Oh, M; Dey, A; Gerard, RD; Hill, JA; Rothermel, BA				Oh, Misook; Dey, Asim; Gerard, Robert D.; Hill, Joseph A.; Rothermel, Beverly A.			The CCAAT/Enhancer Binding Protein beta (C/EBP beta) Cooperates with NFAT to Control Expression of the Calcineurin Regulatory Protein RCAN1-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION-1; ENDOTHELIAL GROWTH-FACTOR; CARDIAC-HYPERTROPHY; TRANSCRIPTION FACTORS; NUCLEAR FACTOR; DIFFERENTIAL ACTIVATION; INHIBITOR DSCR1; GENE-EXPRESSION; TUMOR-GROWTH; PROLIFERATION	Regulator of calcineurin 1 (RCAN1) inhibits the protein phosphatase calcineurin and is required for appropriate immune responses, synaptic plasticity, vascular tone, angiogenesis, and cardiac remodeling. Expression of the RCAN1-4 isoform is under the control of the calcineurin-responsive transcription factor NFAT. Typically, NFATs act in cooperation with other transcription factors to achieve maximal activation of gene expression. In this study, we identify the CCAAT/enhancer binding protein beta (C/EBP beta) as an NFAT binding partner that cooperates with NFAT to regulate RCAN1-4 expression. Numerous C/EBP beta binding sites are conserved in the RCAN1-4 proximal promoter. Overexpression of C/EBP beta increased activity of both the endogenous mouse Rcan1-4 gene and a human RCAN1-4 luciferase reporter. Binding of C/EBP beta to multiple sites in the promoter was verified using electrophoretic mobility shift assays and chromatin immunoprecipitation. Adirect interaction between C/EBP beta and NFAT was demonstrated by co-immunoprecipitation of proteins and complex formation at NFAT-C/EBP beta composite sites. Depletion of endogenous C/EBP beta decreased maximal activation of RCAN1-4 expression by calcineurin, whereas inhibition of calcineurin did not alter the ability of C/EBP beta to activate RCAN1-4 expression. Together, these findings suggest that calcineurin/NFAT activation of RCAN1-4 expression is in part dependent upon C/EBP beta, whereas activation by C/EBP beta is not dependent on calcineurin and may provide a calcineurin-independent pathway for regulating RCAN1-4 expression. Importantly, nuclear localization, C/EBP beta DNA binding activity and occupancy of the Rcan1-4 promoter increased in mouse models of heart failure demonstrating in vivo activation of this pathway to regulate Rcan1-4 expression and ultimately shape the dynamics of calcineurin-dependent signaling.	[Oh, Misook; Dey, Asim; Gerard, Robert D.; Hill, Joseph A.; Rothermel, Beverly A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rothermel, BA (corresponding author), 5323 Harry Hines Blvd,NB11-200, Dallas, TX 75390 USA.	beverly.rothermel@utsouthwestern.edu			National Institute of Health [HL072016, HL097768, HL075173, HL080144, HL090842]; American Heart Association [0655202Y, 0970518N, 0640084N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080144, R01HL072016, R01HL097768, R01HL075173, R01HL090842] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grants HL072016 and HL097768 (to B. A. R.) and HL075173, HL080144, and HL090842 (to J. A. H.). This work was also supported by American Heart Association Grants 0655202Y (to B. A. R.), 0970518N, and 0640084N (to J. A. H.).	Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Bush E, 2004, P NATL ACAD SCI USA, V101, P2870, DOI 10.1073/pnas.0308723101; Cui TX, 2005, MOL ENDOCRINOL, V19, P2175, DOI 10.1210/me.2004-0502; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hill JA, 2002, J BIOL CHEM, V277, P10251, DOI 10.1074/jbc.M110722200; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2005, PHYSIOL GENOMICS, V23, P18, DOI 10.1152/physiolgenomics.00061.2005; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Schabbauer G, 2007, THROMB HAEMOSTASIS, V97, P988, DOI 10.1160/TH07-01-0037; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; Tremblay JJ, 2002, ENDOCRINOLOGY, V143, P3935, DOI 10.1210/en.2002-220413; Van Riper D, 2008, ARCH BIOCHEM BIOPHYS, V472, P43, DOI 10.1016/j.abb.2008.01.029; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Wu H, 2007, J BIOL CHEM, V282, P30673, DOI 10.1074/jbc.M703622200; Yan SF, 1997, J BIOL CHEM, V272, P4287, DOI 10.1074/jbc.272.7.4287; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yang TTC, 2006, J BIOL CHEM, V281, P11541, DOI 10.1074/jbc.M511214200; Yang TTC, 2003, J BIOL CHEM, V278, P15874, DOI 10.1074/jbc.M211560200; Zhang F, 2003, J BIOL CHEM, V278, P44246, DOI 10.1074/jbc.M305564200; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	39	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16623	16631		10.1074/jbc.M109.098236	http://dx.doi.org/10.1074/jbc.M109.098236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20371871	Green Published, hybrid			2022-12-27	WOS:000277982600026
J	Zhang, AS; Gao, JW; Koeberl, DD; Enns, CA				Zhang, An-Sheng; Gao, Junwei; Koeberl, Dwight D.; Enns, Caroline A.			The Role of Hepatocyte Hemojuvelin in the Regulation of Bone Morphogenic Protein-6 and Hepcidin Expression in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1Q-LINKED JUVENILE HEMOCHROMATOSIS; DISEASE TYPE-II; IRON-METABOLISM; SOLUBLE HEMOJUVELIN; GENE-THERAPY; MOUSE-LIVER; NEOGENIN; OVERLOAD; STORAGE; BMP6	Both hemojuvelin (HJV) and bone morphogenic protein-6 (BMP6) are essential for hepcidin expression. Hepcidin is the key peptide hormone in iron homeostasis, and is secreted predominantly by hepatocytes. HJV expression is detected in hepatocytes, as well as in skeletal and heart muscle. HJV binds BMP6 and increases hepcidin expression presumably by acting as a BMP co-receptor. We characterized the role of hepatocyte HJV in the regulation of BMP6 and hepcidin expression. In HJV-null (Hjv(-/-)) mice that have severe iron overload and marked suppression of hepcidin expression, we detected 4-fold higher hepatic BMP6 mRNA than in wild-type counterparts. These results indicate that Hjv(-/-) mice do not lack BMP6. Furthermore, iron depletion in Hjv(-/-) mice decreased hepatic BMP6 mRNA. Expression of HJV in hepatocytes of Hjv(-/-) mice using an AAV2/8 vector, increased hepatic hepcidin mRNA by 65-fold and phosphorylated Smad1/5/8 in the liver by about 2.5-fold. However, no significant change in BMP6 mRNA was detected in either the liver or the small intestine of these animals. Our results revealed a close correlation of hepatic BMP6 mRNA expression with hepatic iron-loading. Together, our data indicate that the regulation of hepatic BMP6 expression by iron is independent of HJV, and that expression of HJV in hepatocytes plays an essential role in hepcidin expression by potentiating the BMP6-mediated signaling.	[Zhang, An-Sheng; Gao, Junwei; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Koeberl, Dwight D.] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA	Oregon Health & Science University; Duke University	Zhang, AS (corresponding author), OR Hlth & Sci Univ, Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [DK080765]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080765, T32DK067864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080765 (to A.-S.Z.).	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Franco LM, 2005, MOL THER, V12, P876, DOI 10.1016/j.ymthe.2005.04.024; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Ganz T, 2008, CELL METAB, V7, P288, DOI 10.1016/j.cmet.2008.03.008; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Harding CO, 2006, GENE THER, V13, P457, DOI 10.1038/sj.gt.3302678; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Krijt J, 2010, PHYSIOL RES, V59, P53, DOI 10.33549/physiolres.931706; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Sun B, 2007, AM J HUM GENET, V81, P1042, DOI 10.1086/522236; Sun BD, 2005, MOL THER, V11, P57, DOI 10.1016/j.ymthe.2004.10.004; TORRANCE JD, 1968, S AFR J MED SCI, V3, P9; Wang LL, 1999, P NATL ACAD SCI USA, V96, P3906, DOI 10.1073/pnas.96.7.3906; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	33	63	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16416	16423		10.1074/jbc.M110.109488	http://dx.doi.org/10.1074/jbc.M110.109488			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363739	Green Published, hybrid			2022-12-27	WOS:000277982600003
J	Kelly, P; Bailey, CL; Fueger, PT; Newgard, CB; Casey, PJ; Kimple, ME				Kelly, Patrick; Bailey, Candice L.; Fueger, Patrick T.; Newgard, Christopher B.; Casey, Patrick J.; Kimple, Michelle E.			Rap1 Promotes Multiple Pancreatic Islet Cell Functions and Signals through Mammalian Target of Rapamycin Complex 1 to Enhance Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; S6 KINASE; CYCLIC-AMP; BETA-CELLS; DIABETES-MELLITUS; INSULIN-RESISTANCE; GENE-PRODUCTS; CAMP; ACTIVATION; PATHWAYS	Recent studies have implicated Epac2, a guanine-nucleotide exchange factor for the Rap subfamily of monomeric G proteins, as an important regulator of insulin secretion from pancreatic beta-cells. Although the Epac proteins were originally identified as cAMP-responsive activators of Rap1 GTPases, the role of Rap1 in beta-cell biology has not yet been defined. In this study, we examined the direct effects of Rap1 signaling on beta-cell biology. Using the Ins-1 rat insulinoma line, we demonstrate that activated Rap1A, but not related monomeric G proteins, promotes ribosomal protein S6 phosphorylation. Using isolated rat islets, we show that this signaling event is rapamycin-sensitive, indicating that it is mediated by the mammalian target of rapamycin complex 1-p70 S6 kinase pathway, a known growth regulatory pathway. This newly defined beta-cell signaling pathway acts downstream of cAMP, in parallel with the stimulation of cAMP-dependent protein kinase, to drive ribosomal protein S6 phosphorylation. Activated Rap1A promotes glucose-stimulated insulin secretion, islet cell hypertrophy, and islet cell proliferation, the latter exclusively through mammalian target of rapamycin complex 1, suggesting that Rap1 is an important regulator of beta-cell function. This newly defined signaling pathway may yield unique targets for the treatment of beta-cell dysfunction in diabetes.	[Kelly, Patrick; Bailey, Candice L.; Fueger, Patrick T.; Newgard, Christopher B.; Casey, Patrick J.; Kimple, Michelle E.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Newgard, Christopher B.; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Fueger, Patrick T.; Newgard, Christopher B.; Kimple, Michelle E.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Kimple, ME (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	michelle.kimple@duke.edu	Fueger, Patrick/G-8956-2013	Casey, Patrick/0000-0002-7366-9309	National Institutes of Health [DK078732, DK058398, DK076488, DK080845]; Duke University Medical School Alumni Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, K01DK080845, R01DK076488, R00DK078732, K99DK078732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University Medical School Alumni Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078732 (to P. T. F.), DK058398 (to C. B. N.), DK076488 (to P. J. C.), and DK080845 (to M. E.; Supported in part by a Duke University Medical School Alumni Scholarship. Present address: Dept. of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BAEDER WL, 1992, CLIN EXP IMMUNOL, V89, P174; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Bragado MJ, 1997, AM J PHYSIOL-CELL PH, V273, pC101, DOI 10.1152/ajpcell.1997.273.1.C101; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Cass LA, 1998, ENDOCRINOLOGY, V139, P1991, DOI 10.1210/en.139.4.1991; Cass LA, 1999, MOL CELL BIOL, V19, P5882; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Jesus ML, 2006, J BIOL CHEM, V281, P21837, DOI 10.1074/jbc.M604156200; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Fueger PT, 2008, MOL ENDOCRINOL, V22, P1251, DOI 10.1210/me.2007-0500; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Furman B, 2004, J PHARM PHARMACOL, V56, P1477, DOI 10.1211/0022357044805; Hohmeier HE, 2005, NAT BIOTECHNOL, V23, P1231, DOI 10.1038/nbt1005-1231; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kimple ME, 2005, J BIOL CHEM, V280, P31708, DOI 10.1074/jbc.M506700200; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; Kwon G, 2004, J BIOL CHEM, V279, P8938, DOI 10.1074/jbc.M310330200; Lecureuil C, 2005, MOL ENDOCRINOL, V19, P1812, DOI 10.1210/me.2004-0289; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sabbatini ME, 2008, J BIOL CHEM, V283, P23884, DOI 10.1074/jbc.M800754200; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shelly C, 2002, J CELL SCI, V115, P1985; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; WITHERS DJ, 1995, J BIOL CHEM, V270, P21411, DOI 10.1074/jbc.270.36.21411; Wittchen ES, 2005, J BIOL CHEM, V280, P11675, DOI 10.1074/jbc.M412595200; Xie T, 2007, P NATL ACAD SCI USA, V104, P19601, DOI 10.1073/pnas.0704796104; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256	55	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15777	15785		10.1074/jbc.M109.069112	http://dx.doi.org/10.1074/jbc.M109.069112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20339002	Green Published, hybrid			2022-12-27	WOS:000277715900015
J	Donato, DM; Ryzhova, LM; Meenderink, LM; Kaverina, I; Hanks, SK				Donato, Dominique M.; Ryzhova, Larisa M.; Meenderink, Leslie M.; Kaverina, Irina; Hanks, Steven K.			Dynamics and Mechanism of p130Cas Localization to Focal Adhesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRK-ASSOCIATED SUBSTRATE; BREAST-CANCER CELLS; PHOSPHOTYROSINE-CONTAINING PROTEINS; DOMAIN TYROSINE PHOSPHORYLATION; SRC-TRANSFORMED CELLS; V-CRK; ANTIESTROGEN RESISTANCE; EXTRACELLULAR-MATRIX; KINASE-ACTIVITY; P130(CAS)	The docking protein p130Cas is a major Src substrate involved in integrin signaling and mechanotransduction. Tyrosine phosphorylation of p130Cas in focal adhesions (FAs) has been linked to enhanced cell migration, invasion, proliferation, and survival. However, the mechanism of p130Cas targeting to FAs is uncertain, and dynamic aspects of its localization have not been explored. Using live cell microscopy, we show that fluorophore-tagged p130Cas is a component of FAs throughout the FA assembly and disassembly stages, although it resides transiently in FAs with a high mobile fraction. Deletion of either the N-terminal Src homology 3 (SH3) domain or the Cas-family C-terminal homology (CCH) domain significantly impaired p130Cas FA localization, and deletion of both domains resulted in full exclusion. Focal adhesion kinase was implicated in the FA targeting function of the p130Cas SH3 domain. Consistent with their roles in FA targeting, both the SH3 and CCH domains were found necessary for p130Cas to fully undergo tyrosine phosphorylation and promote cell migration. By revealing the capacity of p130Cas to function in FAs throughout their lifetime, clarifying FA targeting mechanism, and demonstrating the functional importance of the highly conserved CCH domain, our results advance the understanding of an important aspect of integrin signaling.	[Hanks, Steven K.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, MRBIII,Learned Lab U4206, Nashville, TN 37232 USA	Vanderbilt University	Hanks, SK (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, MRBIII,Learned Lab U4206, 1161 21st Ave S, Nashville, TN 37232 USA.	steve.hanks@vanderbilt.edu	Donato, Dominique/C-1058-2012	Donato, Dominique/0000-0002-0495-4376; Meenderink, Leslie/0000-0003-3943-4079	National Institutes of Health [R01-GM049882, R01-GM78373, T32-CA09592, T32-GM07347, P30-DK058404]; American Heart Association [0815136E]; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM078373, R01GM049882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM049882, R01-GM78373, T32-CA09592, T32-GM07347, and P30-DK058404. This work was also supported by American Heart Association Predoctoral Fellowship 0815136E (to L. M. M.).	Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; CANTLEY LC, 1994, J CELL SCI, P121; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Fonseca PM, 2004, CELL SIGNAL, V16, P621, DOI 10.1016/j.cellsig.2003.10.004; Garron ML, 2009, J MOL BIOL, V386, P190, DOI 10.1016/j.jmb.2008.12.010; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Harte MT, 2000, BBA-MOL CELL RES, V1499, P34, DOI 10.1016/S0167-4889(00)00104-X; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Law SF, 1999, EXP CELL RES, V252, P224, DOI 10.1006/excr.1999.4609; Law SF, 1996, MOL CELL BIOL, V16, P3327; Liu GH, 2002, MOL CELL BIOL, V22, P2751, DOI 10.1128/MCB.22.8.2751-2760.2002; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MATSUDA M, 1991, MOL CELL BIOL, V11, P1607, DOI 10.1128/MCB.11.3.1607; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; NOJIMA Y, 1995, CELL IMMUNOL, V161, P8, DOI 10.1006/cimm.1995.1002; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Owen JD, 1999, MOL CELL BIOL, V19, P4806; PATCH LA, 1995, J CELL SCI, V108, P1371; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P3951, DOI 10.1128/MCB.9.9.3951; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sakai R, 1997, ONCOGENE, V14, P1419, DOI 10.1038/sj.onc.1200954; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Singh MK, 2008, MOL BIOL CELL, V19, P1627, DOI 10.1091/mbc.E07-09-0953; Soni S, 2009, J CELL BIOCHEM, V107, P364, DOI 10.1002/jcb.22136; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Vuori K, 1996, MOL CELL BIOL, V16, P2606; VUORI K, 1995, J BIOL CHEM, V270, P22259, DOI 10.1074/jbc.270.38.22259; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792	58	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					20769	20779		10.1074/jbc.M109.091207	http://dx.doi.org/10.1074/jbc.M109.091207			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20430882	Green Published, hybrid			2022-12-27	WOS:000279228600041
J	Harris, HJ; Davis, C; Mullins, JGL; Hu, K; Goodall, M; Farquhar, MJ; Mee, CJ; McCaffrey, K; Young, S; Drummer, H; Balfe, P; McKeating, JA				Harris, Helen J.; Davis, Christopher; Mullins, Jonathan G. L.; Hu, Ke; Goodall, Margaret; Farquhar, Michelle J.; Mee, Christopher J.; McCaffrey, Kitty; Young, Stephen; Drummer, Heidi; Balfe, Peter; McKeating, Jane A.			Claudin Association with CD81 Defines Hepatitis C Virus Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PROTEINS; RECEPTOR CLASS-B; SCAVENGER-RECEPTOR; TETRASPANIN SUPERFAMILY; CELL ENTRY; IN-VITRO; INFECTION; CHOLESTEROL; CORECEPTOR; EXPRESSION	Viruses initiate infection by attaching to molecules or receptors at the cell surface. Hepatitis C virus (HCV) enters cells via a multistep process involving tetraspanin CD81, scavenger receptor class B member I, and the tight junction proteins Claudin-1 and Occludin. CD81 and scavenger receptor class B member I interact with HCV-encoded glycoproteins, suggesting an initial role in mediating virus attachment. In contrast, there are minimal data supporting Claudin-1 association with HCV particles, raising questions as to its role in the virus internalization process. In the present study we demonstrate a relationship between receptor active Claudins and their association and organization with CD81 at the plasma membrane by fluorescence resonance energy transfer and stoichiometric imaging methodologies. Mutation of residues 32 and 48 in the Claudin-1 first extracellular loop ablates CD81 association and HCV receptor activity. Furthermore, mutation of the same residues in the receptor-inactive Claudin-7 molecule enabled CD81 complex formation and virus entry, demonstrating an essential role for Claudin-CD81 complexes in HCV infection. Importantly, Claudin-1 associated with CD81 at the basolateral membrane of polarized HepG2 cells, whereas tight junction-associated pools of Claudin-1 demonstrated a minimal association with CD81. In summary, we demonstrate an essential role for Claudin-CD81 complexes in HCV infection and their localization at the basolateral surface of polarized hepatoma cells, consistent with virus entry into the liver via the sinusoidal blood and association with basal expressed forms of the receptors.	[Harris, Helen J.; Davis, Christopher; Hu, Ke; Goodall, Margaret; Farquhar, Michelle J.; Mee, Christopher J.; Young, Stephen; Balfe, Peter; McKeating, Jane A.] Univ Birmingham, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Mullins, Jonathan G. L.] Swansea Univ, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales; [McCaffrey, Kitty; Drummer, Heidi] Burnet Inst, Melbourne, Vic 3001, Australia	University of Birmingham; Swansea University; Burnet Institute	Balfe, P (corresponding author), Univ Birmingham, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	p.balfe@bham.ac.uk		Balfe, Peter/0000-0002-6246-0876; Drummer, Heidi/0000-0002-0042-6277; Mullins, Jonathan/0000-0003-0144-2962; McKeating, Jane/0000-0002-7229-5886; Mee, Christopher/0000-0002-6359-2694; McCaffrey, Kathleen/0000-0002-6544-2649; davis, chris/0000-0002-7317-3266	Medical Research Council [G0801976, G0400802] Funding Source: Medline; MRC [G0400802, G0801976] Funding Source: UKRI; Medical Research Council [G9818340B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Barth H, 2008, J VIROL, V82, P3466, DOI 10.1128/JVI.02478-07; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Cukierman L, 2009, J VIROL, V83, P5477, DOI 10.1128/JVI.02262-08; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; Meertens L, 2008, J VIROL, V82, P3555, DOI 10.1128/JVI.01977-07; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Stamataki Z, 2008, CLIN LIVER DIS, V12, P693, DOI 10.1016/j.cld.2008.03.008; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Timpe JM, 2008, GUT, V57, P1728, DOI 10.1136/gut.2007.141630; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	57	160	169	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 2	2010	285	27					21092	21102		10.1074/jbc.M110.104836	http://dx.doi.org/10.1074/jbc.M110.104836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	616SH	20375010	Green Published, hybrid			2022-12-27	WOS:000279228600072
J	Gahring, LC; Vasquez-Opazo, GA; Rogers, SW				Gahring, Lorise C.; Vasquez-Opazo, Gustavo A.; Rogers, Scott W.			Choline Promotes Nicotinic Receptor alpha 4+beta 2 Up-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HIPPOCAMPAL SLICES; ACETYLCHOLINE-RECEPTORS; DIETARY CHOLINE; BINDING-SITES; DIFFERENTIAL DEVELOPMENT; BRAIN-DEVELOPMENT; MAMMALIAN-CELLS; IN-VIVO; EXPRESSION; EXPOSURE	Neuronal nicotinic acetylcholine receptors ( nAChR) composed of alpha 4 + beta 2 subunits, the high affinity nicotine-binding site in the mammalian brain, up-regulate in response to chronic nicotine exposure. The identities of endogenous mediators of this process are unknown. We find that choline also up-regulates alpha 4 + beta 2 nAChRs stably expressed by HEK293 cells as measured by increased [H-3] epibatidine density. Choline-mediated up-regulation is dose-dependent and corresponds with an increase in beta 2 subunit protein expression. The choline kinase inhibitor hemicholinium-3 inhibits similar to 60% of choline-mediated up-regulation revealing both an HC3-dependent and -independent pathway. Furthermore, choline-mediated up-regulation is not additive with up-regulation agents such as nicotine, but it is additive with weaker promoters of the up-regulation process. When co-applied with the pro-inflammatory cytokine tumor necrosis factor alpha, choline- mediated up- regulation is increased further through a mechanism that includes an increase in both alpha 4 and beta 2 protein expression, and this is inhibited by the p38 MAPK inhibitor SB202190. These findings extend the view that up- regulation of alpha 4 + beta 2 nAChRs is a normal physiological response to altered metabolic and inflammatory conditions.	[Rogers, Scott W.] Univ Utah, Sch Med, Salt Lake City Vet Affairs Geriatr Res Educ & Cli, Salt Lake City, UT 84132 USA; [Gahring, Lorise C.; Vasquez-Opazo, Gustavo A.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA; [Rogers, Scott W.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Univ Utah, Sch Med, Salt Lake City Vet Affairs Geriatr Res Educ & Cli, 2C132,30 North 1900 East, Salt Lake City, UT 84132 USA.	Scott.Rogers@hsc.utah.edu			National Institutes of Health [AG017517, AG029838, DA025057]; Veterans Affairs Merit award; NATIONAL INSTITUTE ON AGING [R01AG029838, R01AG017517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AG017517 (to S.W.R.), AG029838 (to L.C.G.), and DA025057 (to L.C.G. and S.W.R.). This work was also supported by a Veterans Affairs Merit award (to L.C.G.).	ABREUVILLACA Y, 2010, BEHAV BRAIN RES; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Alkondon M, 1999, J NEUROSCI, V19, P2693; Alkondon M, 2005, J PHARMACOL EXP THER, V313, P740, DOI 10.1124/jpet.104.081232; Alkondon M, 2006, J PHARMACOL EXP THER, V318, P268, DOI 10.1124/jpet.106.103135; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Brorson JR, 2004, J NEUROSCI, V24, P3461, DOI 10.1523/JNEUROSCI.5023-03.2004; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; BURT AM, 1977, J NEUROCHEM, V28, P961, DOI 10.1111/j.1471-4159.1977.tb10657.x; Campos J, 2003, CURR MED CHEM, V10, P1095, DOI 10.2174/0929867033457539; Carlson NG, 1998, J NEUROBIOL, V35, P29, DOI 10.1002/(SICI)1097-4695(199804)35:1<29::AID-NEU3>3.0.CO;2-D; Cermak JM, 1998, FASEB J, V12, P349, DOI 10.1096/fasebj.12.3.349; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; Corringer PJ, 2006, J PHYSIOL-PARIS, V99, P162, DOI 10.1016/j.jphysparis.2005.12.012; COUTCHER JB, 1992, J PHARMACOL EXP THER, V262, P1128; Detopoulou P, 2008, AM J CLIN NUTR, V87, P424, DOI 10.1093/ajcn/87.2.424; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2005, J NEUROIMMUNOL, V166, P88, DOI 10.1016/j.jneuroim.2005.05.007; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Guseva MV, 2006, PHARMACOL BIOCHEM BE, V84, P26, DOI 10.1016/j.pbb.2006.04.002; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; HAPPE HK, 1993, J NEUROCHEM, V60, P1191, DOI 10.1111/j.1471-4159.1993.tb03277.x; Harkness PC, 2002, J NEUROSCI, V22, P10172; Janardhan S, 2006, CURR MED CHEM, V13, P1169, DOI 10.2174/092986706776360923; Klein J, 2002, J NEUROCHEM, V80, P843, DOI 10.1046/j.0022-3042.2001.00754.x; KLEIN J, 1993, NEUROCHEM INT, V22, P293, DOI 10.1016/0197-0186(93)90058-D; Lockman PR, 2002, DRUG DEV IND PHARM, V28, P749, DOI 10.1081/DDC-120005622; Lopez-Hernandez GY, 2004, J BIOL CHEM, V279, P38007, DOI 10.1074/jbc.M403537200; MANDELZYS A, 1995, J NEUROPHYSIOL, V74, P1212, DOI 10.1152/jn.1995.74.3.1212; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; MARKS MJ, 1985, PHARMACOL BIOCHEM BE, V22, P283, DOI 10.1016/0091-3057(85)90392-2; Matsumoto Mitsuru, 1999, Journal of Medical Investigation, V46, P141; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Melnick M, 2001, ANAT RECORD, V262, P318, DOI 10.1002/1097-0185(20010301)262:3<318::AID-AR1023>3.0.CO;2-3; Michel V, 2006, EXP BIOL MED, V231, P490; Montoya DAC, 2000, DEV BRAIN RES, V123, P25, DOI 10.1016/S0165-3806(00)00075-4; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Ribeiro FM, 2003, J NEUROCHEM, V87, P136, DOI 10.1046/j.1471-4159.2003.01974.x; Rivera CA, 1998, AM J PHYSIOL-GASTR L, V275, pG862, DOI 10.1152/ajpgi.1998.275.4.G862; Rodriguez-Gonzalez Agustin, 2003, Prog Cell Cycle Res, V5, P191; Sallette J, 2004, J BIOL CHEM, V279, P18767, DOI 10.1074/jbc.M308260200; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Sanders Lisa M, 2007, Nutr Today, V42, P181, DOI 10.1097/01.NT.0000286155.55343.fa; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; Slotkin TA, 2005, NEUROPSYCHOPHARMACOL, V30, P129, DOI 10.1038/sj.npp.1300544; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Walsh H, 2008, J BIOL CHEM, V283, P6022, DOI 10.1074/jbc.M703432200; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Xiao YX, 2004, BIOORG MED CHEM LETT, V14, P1845, DOI 10.1016/j.bmcl.2003.09.105; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; ZAHALKA EA, 1993, BRAIN RES, V601, P221, DOI 10.1016/0006-8993(93)91714-4; Zeisel SH, 2000, J AM COLL NUTR, V19, p528S, DOI 10.1080/07315724.2000.10718976	60	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					19793	19801		10.1074/jbc.M110.108803	http://dx.doi.org/10.1074/jbc.M110.108803			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20392695	Green Published, hybrid			2022-12-27	WOS:000279012000012
J	Shridas, P; Bailey, WM; Boyanovsky, BB; Oslund, RC; Gelb, MH; Webb, NR				Shridas, Preetha; Bailey, William M.; Boyanovsky, Boris B.; Oslund, Rob C.; Gelb, Michael H.; Webb, Nancy R.			Group X Secretory Phospholipase A(2) Regulates the Expression of Steroidogenic Acute Regulatory Protein (StAR) in Mouse Adrenal Glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-TYPE RECEPTOR; LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; ARACHIDONIC-ACID; GROUP-V; EICOSANOID PRODUCTION; BIOLOGICAL FUNCTIONS; MAMMALIAN-CELLS; GENE-EXPRESSION; ACTIVATION	We developed C57BL/6 mice with targeted deletion of group X secretory phospholipase A(2) (GX KO). These mice have similar to 80% higher plasma corticosterone concentrations compared with wild-type (WT) mice under both basal and adrenocorticotropic hormone (ACTH)-induced stress conditions. This increased corticosterone level was not associated with increased circulating ACTH or a defect in the hypothalamic-pituitary axis as evidenced by a normal response to dexamethasone challenge. Primary cultures of adrenal cells from GX KO mice exhibited significantly increased corticosteroid secretion compared with WT cells. Conversely, overexpression of GX secretory phospholipase A(2) (sPLA(2)), but not a catalytically inactive mutant form of GX sPLA(2), significantly reduced steroid production 30-40% in Y1 mouse adrenal cell line. This effect was reversed by the sPLA(2) inhibitor, indoxam. Silencing of endogenous M-type receptor expression did not restore steroid production in GX sPLA(2-)overexpressing Y1 cells, ruling out a role for this sPLA(2) receptor in this regulatory process. Expression of steroidogenic acute regulatory protein (StAR), the rate-limiting protein in corticosteroid production, was similar to 2-fold higher in adrenal glands of GX KO mice compared with WT mice, whereas StAR expression was suppressed in Y1 cells overexpressing GX sPLA(2). Results from StAR-promoter luciferase reporter gene assays indicated that GX sPLA(2) antagonizes StAR promoter activity and liver X receptor-mediated StAR promoter activation. In summary, GX sPLA(2) is expressed in mouse adrenal glands and functions to negatively regulate corticosteroid synthesis, most likely by negatively regulating StAR expression.	[Shridas, Preetha; Bailey, William M.; Boyanovsky, Boris B.; Webb, Nancy R.] Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA; [Shridas, Preetha; Bailey, William M.; Boyanovsky, Boris B.; Webb, Nancy R.] Univ Kentucky, Med Ctr, Grad Ctr Nutr Sci, Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Webb, Nancy R.] Dept Vet Affairs Med Ctr, Lexington, KY 40536 USA; [Oslund, Rob C.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Oslund, Rob C.; Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Webb, NR (corresponding author), Univ Kentucky, Med Ctr, Dept Internal Med, 535 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	nrwebb1@uky.edu	Webb, Nancy/AAL-7030-2021; Boyanovsky, Boris/AAQ-5194-2021	gelb, michael/0000-0001-7000-5219	National Institutes of Health [P01 HL080100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080100, R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL080100 (to N.R.W.). This paper is the result of work supported with resources and the use of facilities at the Lexington Veterans Affairs Medical Center.	Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Boilard E, 2006, BIOCHEMISTRY-US, V45, P13203, DOI 10.1021/bi061376d; Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Curfs DMJ, 2008, J BIOL CHEM, V283, P21640, DOI 10.1074/jbc.M710584200; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Granata F, 2005, J IMMUNOL, V174, P464, DOI 10.4049/jimmunol.174.1.464; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hanasaki K, 2002, PROSTAG OTH LIPID M, V68-9, P71, DOI 10.1016/S0090-6980(02)00022-9; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kolko M, 2006, J NEUROSCI RES, V83, P874, DOI 10.1002/jnr.20773; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Masuda S, 2004, BBA-MOL CELL BIOL L, V1686, P61, DOI 10.1016/j.bbalip.2004.08.017; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; Mitsuishi M, 2006, BIOCHEM J, V393, P97, DOI 10.1042/BJ20050781; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; Murakami M, 2003, CURR OPIN LIPIDOL, V14, P431, DOI 10.1097/00041433-200310000-00003; Nakashima S, 2003, BIOCHEM J, V376, P655, DOI 10.1042/BJ20030830; Nilsson M, 2007, MOL ENDOCRINOL, V21, P126, DOI 10.1210/me.2006-0187; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; PARKER KL, 1985, P NATL ACAD SCI USA, V82, P7860, DOI 10.1073/pnas.82.23.7860; Rigotti A, 1996, J BIOL CHEM, V271, P33545, DOI 10.1074/jbc.271.52.33545; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Saiga A, 2005, PROSTAG OTH LIPID M, V75, P79, DOI 10.1016/j.prostaglandins.2004.10.001; Scott GA, 2006, J INVEST DERMATOL, V126, P855, DOI 10.1038/sj.jid.5700180; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Shea-Eaton W, 2002, MOL CELL ENDOCRINOL, V188, P161, DOI 10.1016/S0303-7207(01)00715-8; Steffensen KR, 2004, J MOL ENDOCRINOL, V33, P609, DOI 10.1677/jme.1.01508; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Triggiani M, 2006, BBA-MOL CELL BIOL L, V1761, P1289, DOI 10.1016/j.bbalip.2006.07.003; Wang XJ, 1999, MOL CELL ENDOCRINOL, V158, P7, DOI 10.1016/S0303-7207(99)00130-6; Wang XJ, 2003, ENDOCRINOLOGY, V144, P3368, DOI 10.1210/en.2002-0081; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Yamazaki T, 1996, ENDOCRINOLOGY, V137, P2670, DOI 10.1210/en.137.7.2670; Yokota Y, 2001, FEBS LETT, V509, P250, DOI 10.1016/S0014-5793(01)03173-8; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zvaritch E, 1996, J BIOL CHEM, V271, P250, DOI 10.1074/jbc.271.1.250	45	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	2010	285	26					20031	20039		10.1074/jbc.M109.090423	http://dx.doi.org/10.1074/jbc.M109.090423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	613VS	20421306	hybrid, Green Published			2022-12-27	WOS:000279012000037
J	Hardiville, S; Hoedt, E; Mariller, C; Benaissa, M; Pierce, A				Hardiville, Stephan; Hoedt, Esthelle; Mariller, Christophe; Benaissa, Monique; Pierce, Annick			O-GlcNAcylation/Phosphorylation Cycling at Ser(10) Controls Both Transcriptional Activity and Stability of Delta-Lactoferrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; ESTROGEN-RECEPTOR-BETA; GLCNAC TRANSFERASE; NUCLEOCYTOPLASMIC PROTEINS; MESSENGER-RNA; OKADAIC ACID; GLYCOSYLATION/O-PHOSPHORYLATION; TETRATRICOPEPTIDE REPEATS; CYTOSOLIC PROTEINS; GENE-EXPRESSION	Delta-Lactoferrin (Delta Lf) is a transcription factor that up-regulates DcpS, Skp1, and Bax genes, provoking cell cycle arrest and apoptosis. It is post-translationally modified either by O-GlcNAc or phosphate, but the effects of the O-GlcNAc/phosphorylation interplay on Delta Lf function are not yet understood. Here, using a series of glycosylation mutants, we showed that Ser(10) is O-GlcNAcylated and that this modification is associated with increased Delta Lf stability, achieved by blocking ubiquitin-dependent proteolysis, demonstrating that O-GlcNAcylation protects against polyubiquitination. We highlighted the 391KSQQSSDPDPNCVD404 sequence as a functional PEST motif responsible for Delta Lf degradation and defined Lys379 as the main polyubiquitin acceptor site. We next investigated the control of Delta Lf transcriptional activity by the O-GlcNAc/phosphorylation interplay. Reporter gene analyses using the Skp1 promoter fragment containing a Delta Lf response element showed that O-GlcNAcylation at Ser(10) negatively regulates Delta Lf transcriptional activity, whereas phosphorylation activates it. Using a chromatin immunoprecipitation assay, we showed that O-GlcNAcylation inhibits DNA binding. Deglycosylation leads to DNA binding and transactivation of the Skp1 promoter at a basal level. Basal transactivation was markedly enhanced by 23-fold when phosphorylation was mimicked at Ser(10) by aspartate. Moreover, using double chromatin immunoprecipitation assays, we showed that the Delta Lf transcriptional complex binds to the Delta Lf response element and is phosphorylated and/or ubiquitinated, suggesting that Delta Lf transcriptional activity and degradation are concomitant events. Collectively, our results indicate that reciprocal occupancy of Ser(10) by either O-phosphate or O-GlcNAc coordinately regulates Delta Lf stability and transcriptional activity.	[Hardiville, Stephan; Hoedt, Esthelle; Mariller, Christophe; Benaissa, Monique; Pierce, Annick] Univ Sci & Technol Lille, CNRS, Unite Glycobiol Struct & Fonct, UMR 8576,IFR 147, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Pierce, A (corresponding author), Univ Sci & Technol Lille, CNRS, Unite Glycobiol Struct & Fonct, UMR 8576,IFR 147, F-59655 Villeneuve Dascq, France.	annick.pierce@univ-lille1.fr		Hardiville, Stephan/0000-0002-3554-277X	CNRS UMR 8576 (Unite de Glycobiologie Structurale et Fonctionnelle); Institut Federatif de Recherche 147; Universite des Sciences et Technologies de Lille I; Comite du Nord de la Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer ("Etude du role de la delta-lactoferrine, des gangliosides et des neurotrophines dans le developpement et la progression du cancer du sein")	CNRS UMR 8576 (Unite de Glycobiologie Structurale et Fonctionnelle); Institut Federatif de Recherche 147; Universite des Sciences et Technologies de Lille I; Comite du Nord de la Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer ("Etude du role de la delta-lactoferrine, des gangliosides et des neurotrophines dans le developpement et la progression du cancer du sein")(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by the CNRS UMR 8576 (Unite de Glycobiologie Structurale et Fonctionnelle), the Institut Federatif de Recherche 147, the Universite des Sciences et Technologies de Lille I, the Comite du Nord de la Ligue Nationale contre le Cancer, and the Association pour la Recherche sur le Cancer ("Etude du role de la delta-lactoferrine, des gangliosides et des neurotrophines dans le developpement et la progression du cancer du sein").	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; Baker EN, 2002, BIOCHEM CELL BIOL, V80, P27, DOI 10.1139/o01-153; Benaissa M, 2005, INT J CANCER, V114, P299, DOI 10.1002/ijc.20728; Breton M, 2004, BIOMETALS, V17, P325, DOI 10.1023/B:BIOM.0000027712.81056.13; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Datta R, 2003, BIOCHEMISTRY-US, V42, P5453, DOI 10.1021/bi020699g; Dauphinee SM, 2005, J CELL BIOCHEM, V96, P579, DOI 10.1002/jcb.20508; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; Fu Y, 2007, J CELL BIOCHEM, V102, P704, DOI 10.1002/jcb.21323; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Guinez C, 2004, BIOCHEM BIOPH RES CO, V319, P21, DOI 10.1016/j.bbrc.2004.04.144; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; HARDIVILLE S, 2010, EUR J CELL IN PRESS; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HART GW, 1989, CIBA F SYMP, V145, P102; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Huynh-Dellerme C, 2003, ENVIRON TOXICOL, V18, P383, DOI 10.1002/tox.10140; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Krek W, 1998, CURR OPIN GENET DEV, V8, P36, DOI 10.1016/S0959-437X(98)80059-2; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kuo M, 2008, BIOCHIMIE, V90, P679, DOI 10.1016/j.biochi.2008.03.005; Lefebvre T, 2004, EUR J BIOCHEM, V271, P3843, DOI 10.1111/j.1432-1033.2004.04316.x; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Liu DX, 2003, BIOCHEM BIOPH RES CO, V301, P472, DOI 10.1016/S0006-291X(02)03077-2; Mariller C, 2007, FEBS J, V274, P2038, DOI 10.1111/j.1742-4658.2007.05747.x; Mariller C, 2009, BIOCHIMIE, V91, P109, DOI 10.1016/j.biochi.2008.07.009; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Querfurth HW, 1997, J NEUROCHEM, V69, P1580; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Roos MD, 2000, BIOCHEM BIOPH RES CO, V271, P275, DOI 10.1006/bbrc.2000.2600; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Shaw P, 1996, ONCOGENE, V12, P921; Siebert PD, 1997, P NATL ACAD SCI USA, V94, P2198, DOI 10.1073/pnas.94.6.2198; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Teng C, 2004, BIOMETALS, V17, P317, DOI 10.1023/B:BIOM.0000027711.13818.8a; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Yang Y, 2003, CANCER LETT, V191, P155, DOI 10.1016/S0304-3835(02)00677-8; Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	69	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19205	19218		10.1074/jbc.M109.080572	http://dx.doi.org/10.1074/jbc.M109.080572			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20404350	Green Published, hybrid			2022-12-27	WOS:000278727800030
J	Liu, Q; Moldoveanu, T; Sprules, T; Matta-Camacho, E; Mansur-Azzam, N; Gehring, K				Liu, Qian; Moldoveanu, Tudor; Sprules, Tara; Matta-Camacho, Edna; Mansur-Azzam, Nura; Gehring, Kalle			Apoptotic Regulation by MCL-1 through Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BH3-ONLY PROTEINS; DIPOLAR COUPLINGS; DOWN-REGULATION; BH3 DOMAINS; BCL-2; FAMILY; NMR; INHIBITOR; DEATH	Myeloid cell leukemia 1 (MCL-1), an anti-apoptotic BCL-2 family member active in the preservation of mitochondrial integrity during apoptosis, has fundamental roles in development and hematopoiesis and is dysregulated in human cancers. It bears a unique, intrinsically unstructured, N-terminal sequence, which leads to its instability in cells and hinders protein production and structural characterization. Here, we present collective data from NMR spectroscopy and titration calorimetry to reveal the selectivity of MCL-1 in binding BCL-2 homology 3 (BH3) ligands of interest for mammalian biology. The N-terminal sequence weakens the BH3 interactions but does not affect selectivity. Its removal by calpain-mediated limited proteolysis results in a stable BCL-2-like core domain of MCL-1 (cMCL-1). This core is necessary and sufficient for BH3 ligand binding. Significantly, we also characterized the in vitro protein-protein interaction between cMCL-1 and activated BID by size exclusion chromatography and NMR titrations. This interaction occurs in a very slow manner in solution but is otherwise similar to the interaction between cMCL-1 and BID-BH3 peptides. We also present the solution structure of complex cMCL-1.hBID-BH3, which completes the family portrait of MCL-1 complexes and may facilitate drug discovery against human tumors.	[Liu, Qian; Moldoveanu, Tudor; Sprules, Tara; Matta-Camacho, Edna; Mansur-Azzam, Nura; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Liu, Qian; Sprules, Tara; Matta-Camacho, Edna; Gehring, Kalle] McGill Univ, Grp Rech GRASP, Montreal, PQ H3G 1Y6, Canada; [Sprules, Tara; Gehring, Kalle] McGill Univ, Quebec Eastern Canada High Field NMR Facil, Montreal, PQ H3A 2A7, Canada	McGill University; McGill University; McGill University	Gehring, K (corresponding author), 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	kalle.gehring@mcgill.ca	Moldoveanu, Tudor/N-8173-2018; Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013	Moldoveanu, Tudor/0000-0003-0791-318X; Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research [MOP-81277] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Brunelle JK, 2007, MOL CELL BIOL, V27, P1222, DOI 10.1128/MCB.01535-06; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chauhan D, 2007, ONCOGENE, V26, P2374, DOI 10.1038/sj.onc.1210028; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Germain M, 2007, J BIOL CHEM, V282, P32233, DOI 10.1074/jbc.M706408200; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Meiler J, 2001, J AM CHEM SOC, V123, P6098, DOI 10.1021/ja010002z; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PENG JW, 1994, METHOD ENZYMOL, V239, P563; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; Warr MR, 2005, FEBS LETT, V579, P5603, DOI 10.1016/j.febslet.2005.09.028; Wei MC, 2000, GENE DEV, V14, P2060; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yao Y, 2009, BIOCHEMISTRY-US, V48, P8704, DOI 10.1021/bi901171n; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	49	52	53	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19615	19624		10.1074/jbc.M110.105452	http://dx.doi.org/10.1074/jbc.M110.105452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20392693	Green Published, hybrid			2022-12-27	WOS:000278727800071
J	Lv, XB; Xie, FY; Hu, KS; Wu, YZ; Cao, LL; Han, X; Sang, Y; Zeng, YX; Kang, TB				Lv, Xiao-Bin; Xie, Fangyun; Hu, Kaishun; Wu, Yuanzhong; Cao, Lin-Lin; Han, Xia; Sang, Yi; Zeng, Yi-Xin; Kang, Tiebang			Damaged DNA-binding Protein 1 (DDB1) Interacts with Cdh1 and Modulates the Function of APC/CCdh1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE PROGRESSION; S-PHASE ENTRY; UBIQUITIN LIGASE; GENOMIC STABILITY; COP9 SIGNALOSOME; MITOTIC CYCLINS; PROTEOLYSIS; DEGRADATION; INHIBITOR	APC/C-Cdh1 plays a key role in mitotic exit and has essential targets in the G(1) phase; however, these mechanisms are poorly understood. In this report, we provide evidence that damaged DNA-binding protein 1 (DDB1) is capable of binding the WD40 domains of Cdh1, but not of Cdc20, through its BPA and BPC domains. Moreover, cells lacking DDB1 exhibit markedly elevated levels of the protein substrates of APC/CCdh1. Depletion of DDB1 in mitotic cells significantly delays mitotic exit, which demonstrates that the interaction between DDB1 and Cdh1 plays a critical role in regulating APC/C-Cdh1 activity. However, cells depleted of Cdh1 demonstrated no change in the UV-induced degradation of Cdt1, the main function of DDB1 as an E3 ligase. Strikingly, the APC/CCdh1 substrate levels are normal in cell knockdowns of Cul4A and Cul4B, which, along with DDB1, form an E3 ligase complex. This finding indicates that DDB1 modulates the function of APC/C-Cdh1 in a manner independent on the Cul4-DDB1 complex. Our results suggest that DDB1 may functionally regulate mitotic exit by modulating APC/C-Cdh1 activity. This study reveals that there may be cross-talk among DDB1, Cdh1, and Skp2 in the control of cell cycle division.	[Lv, Xiao-Bin; Hu, Kaishun; Wu, Yuanzhong; Cao, Lin-Lin; Han, Xia; Sang, Yi; Zeng, Yi-Xin; Kang, Tiebang] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Lv, Xiao-Bin; Xie, Fangyun; Hu, Kaishun; Wu, Yuanzhong; Cao, Lin-Lin; Han, Xia; Sang, Yi; Zeng, Yi-Xin; Kang, Tiebang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China; [Xie, Fangyun] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Kang, TB (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, 651 DongFeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	kangtb@mail.sysu.edu.cn	Lv, Xiao-Bin/T-7607-2019	Kang, Tiebang/0000-0001-8805-4174; Sang, Yi/0000-0001-6534-0741; Wu, Yuanzhong/0000-0002-3577-7069	National Natural Science Foundation of China [30840005, 30930045, u0732005]; China's 973 project [2010CB912201]; China's 863 program [2006AA02A404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China's 973 project(National Basic Research Program of China); China's 863 program(National High Technology Research and Development Program of China)	This work was supported by grants from National Natural Science Foundation of China (30840005, 30930045), China's 973 project (2010CB912201) (to T. K.), China's 863 program (2006AA02A404), and the National Natural Science Foundation of China (u0732005) (to Y.-X.Z.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buschhorn BA, 2006, NAT CELL BIOL, V8, P209, DOI 10.1038/ncb0306-209; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Clarke DJ, 2005, CELL CYCLE, V4, P1585, DOI 10.4161/cc.4.11.2143; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Jia XZ, 2009, BIOCHEM PHARMACOL, V77, P770, DOI 10.1016/j.bcp.2008.11.008; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kattan Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002002; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Kohn EA, 2003, CANCER RES, V63, P31; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Liu WJ, 2008, CARCINOGENESIS, V29, P263, DOI 10.1093/carcin/bgm251; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Smith KN, 1999, YEAST, V15, P1255, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1255::AID-YEA451>3.0.CO;2-L; Townsend K, 2009, J BIOL CHEM, V284, P33939, DOI 10.1074/jbc.M109.009191; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381	50	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18234	18240		10.1074/jbc.M109.094144	http://dx.doi.org/10.1074/jbc.M109.094144			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395298	Green Published, hybrid			2022-12-27	WOS:000278453900015
J	Martin, P; Pardo, J; Schill, N; Jockel, L; Berg, M; Froelich, CJ; Wallich, R; Simon, MM				Martin, Praxedis; Pardo, Julian; Schill, Natalie; Joeckel, Lars; Berg, Matthias; Froelich, Christopher J.; Wallich, Reinhard; Simon, Markus M.			Granzyme B-induced and Caspase 3-dependent Cleavage of Gelsolin by Mouse Cytotoxic T Cells Modifies Cytoskeleton Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE-MEDIATED CYTOTOXICITY; SMOOTH-MUSCLE-CELLS; IN-VIVO; ALPHA-TUBULIN; APOPTOSIS; ACTIN; DEATH; SUBSTRATE; PROTEASE; PERFORIN	Granule-associated perforin and granzymes (gzms) are key effector molecules of cytotoxic T lymphocytes (Tc cells) and natural killer cells and play a critical role in the control of intracellular pathogens and cancer. Based on the notion that many gzms, including A, B, C, K, H, and M exhibit cytotoxic activity in vitro, all gzms are believed to serve a similar function in vivo. However, more recent evidence supports the concept that gzms are not unidimensional but, rather, possess non-cytotoxic potential, including stimulation of pro-inflammatory cytokines and anti-viral activities. The present study shows that isolated mouse gzmB cleaves the actin-severing mouse protein, cytoplasmic gelsolin (c-gelsolin) in vitro. However, when delivered to intact target cells by ex vivo immune Tc cells, gzmB mediates c-gelsolin proteolysis via activation of caspases 3/7. The NH2-terminal c-gelsolin fragment generated by either gzmB or caspase 3 in vitro constitutively severs actin filaments without destroying the target cells. The observation that gzmB secreted by Tc cells initiates a caspase cascade that disintegrates the actin cytoskeleton in target cells suggests that this intracellular process may contribute to anti-viral host defense.	[Martin, Praxedis; Pardo, Julian; Schill, Natalie; Joeckel, Lars; Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, D-79108 Freiburg, Germany; [Berg, Matthias] M Scan GmbH, Mass Spectrometry Consultants & Analysts, D-79108 Freiburg, Germany; [Froelich, Christopher J.] Univ Chicago, Sch Med, NorthShore Univ HealthSyst Res Inst, Evanston, IL 60201 USA; [Wallich, Reinhard] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany	Max Planck Society; NorthShore University Health System; University of Chicago; Ruprecht Karls University Heidelberg	Simon, MM (corresponding author), Brombergstr 45, D-79102 Freiburg, Germany.	simon@immunbio.mpg.de	Pardo, Julián/K-6764-2014	Pardo, Julián/0000-0003-0154-0730	National Institutes of Health [R01AI044941]; Ministerio de Ciencia e Innovacion, Spain [SAF2008-02139]; Gobierno de Aragon and Fundacion Aragon I+D (ARAID) [PI076/08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Gobierno de Aragon and Fundacion Aragon I+D (ARAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI044941 (to C.J.F.).; Supported in part by Ministerio de Ciencia e Innovacion, Spain, Grant SAF2008-02139 and Gobierno de Aragon and Fundacion Aragon I+D (ARAID) Grant PI076/08. Present address: ARAID, Dept. of Biochemistry and Molecular and Cellular Biology, Faculty of Science, University of Zaragoza, Zaragoza 50009, Spain.	Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; Bar S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000126; Balkow S, 2001, J VIROL, V75, P8781, DOI 10.1128/JVI.75.18.8781-8791.2001; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; De Corte V, 2002, EMBO J, V21, P6781, DOI 10.1093/emboj/cdf680; DIEFFENBACH CW, 1989, J BIOL CHEM, V264, P13281; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Froelich CJ, 2009, TRENDS IMMUNOL, V30, P117, DOI 10.1016/j.it.2009.01.002; Froelich CJ, 2004, CELL DEATH DIFFER, V11, P369, DOI 10.1038/sj.cdd.4401381; Geng YJ, 1998, EUR J CELL BIOL, V77, P294, DOI 10.1016/S0171-9335(98)80088-5; Goping IS, 2006, J CELL SCI, V119, P858, DOI 10.1242/jcs.02791; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Khaitlina S, 2002, FEBS LETT, V521, P14, DOI 10.1016/S0014-5793(02)02657-1; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kurschus FC, 2008, P NATL ACAD SCI USA, V105, P13799, DOI 10.1073/pnas.0801724105; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Lin KM, 2000, J BIOL CHEM, V275, P27746; LJUNGGREN HG, 1986, J IMMUNOGENET, V13, P141; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Martin P, 2005, BLOOD, V106, P2871, DOI 10.1182/blood-2005-04-1522; Metkar SS, 2003, J CELL BIOL, V160, P875, DOI 10.1083/jcb.200210158; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Pardo J, 2009, MICROBES INFECT, V11, P452, DOI 10.1016/j.micinf.2009.02.004; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Romero V, 2008, TISSUE ANTIGENS, V71, P409, DOI 10.1111/j.1399-0039.2008.01013.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Spinardi L., 2007, V45, P55; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Trapani JA, 2008, IMMUNITY, V29, P665, DOI 10.1016/j.immuni.2008.10.002; Ulanet DB, 2004, ARTHRITIS RHEUM, V50, P233, DOI 10.1002/art.11485; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Waterhouse NJ, 2006, CELL DEATH DIFFER, V13, P1839, DOI 10.1038/sj.cdd.4402023; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278	54	15	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18918	18927		10.1074/jbc.M109.056028	http://dx.doi.org/10.1074/jbc.M109.056028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20395300	Green Published, hybrid			2022-12-27	WOS:000278453900082
J	McIntosh, AL; Huang, HA; Atshaves, BP; Wellberg, E; Kuklev, DV; Smith, WL; Kier, AB; Schroeder, F				McIntosh, Avery L.; Huang, Huan; Atshaves, Barbara P.; Wellberg, Elizabeth; Kuklev, Dmitry V.; Smith, William L.; Kier, Ann B.; Schroeder, Friedhelm			Fluorescent n-3 and n-6 Very Long Chain Polyunsaturated Fatty Acids THREE-PHOTON IMAGING IN LIVING CELLS EXPRESSING LIVER FATTY ACID-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-CELL-FIBROBLASTS; BINDING PROTEIN GENE; CULTURED PRIMARY HEPATOCYTES; ACTIVATED RECEPTOR-ALPHA; L-FABP; ARACHIDONIC-ACID; PARINARIC ACID; LIVING CELLS; MICE LACKING; LIVER	Despite the considerable beneficial effects of n-3 and n-6 very long chain polyunsaturated fatty acids (VLC-PUFAs), very little is known about the factors that regulate their uptake and intracellular distribution in living cells. This issue was addressed in cells expressing liver-type fatty acid-binding protein (L-FABP) by real time multiphoton laser scanning microscopy of novel fluorescent VLC-PUFAs containing a conjugated tetraene fluorophore near the carboxyl group and natural methylene-interrupted n-3 or n-6 grouping. The fluorescent VLC-PUFAs mimicked many properties of their native nonfluorescent counterparts, including uptake, distribution, and metabolism in living cells. The unesterified fluorescent VLC-PUFAs distributed either equally in nuclei versus cytoplasm (22-carbon n-3 VLC-PUFA) or preferentially to cytoplasm (20-carbon n-3 and n-6 VLC-PUFAs). L-FABP bound fluorescent VLC-PUFA with affinity and specificity similar to their nonfluorescent natural counterparts. Regarding n-3 and n-6 VLC-PUFA, L-FABP expression enhanced uptake into the cell and cytoplasm, selectively altered the pattern of fluorescent n-6 and n-3 VLC-PUFA distribution in cytoplasm versus nuclei, and preferentially distributed fluorescent VLC-PUFA into nucleoplasm versus nuclear envelope, especially for the 22-carbon n-3 VLC-PUFA, correlating with its high binding by L-FABP. Multiphoton laser scanning microscopy data showed for the first time VLC-PUFA in nuclei of living cells and suggested a model, whereby L-FABP facilitated VLC-PUFA targeting to nuclei by enhancing VLC-PUFA uptake and distribution into the cytoplasm and nucleoplasm.	[McIntosh, Avery L.; Huang, Huan; Wellberg, Elizabeth; Schroeder, Friedhelm] Texas A&M Univ, Texas Vet Med Ctr, Dept Physiol & Pharmacol, College Stn, TX 77843 USA; [Kier, Ann B.] Texas A&M Univ, Texas Vet Med Ctr, Dept Pathobiol, College Stn, TX 77843 USA; [Atshaves, Barbara P.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Kuklev, Dmitry V.; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Michigan State University; University of Michigan System; University of Michigan	Schroeder, F (corresponding author), Texas A&M Univ, Texas Vet Med Ctr, Dept Physiol & Pharmacol, College Stn, TX 77843 USA.	fschroeder@cvm.tamu.edu	Wellberg, Elizabeth/AFQ-6450-2022		National Institutes of Health, USPHS [DK41402, GM31651, DK70965, DK22042]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041402, R56DK070965, R01DK070965, R37DK022042, R01DK022042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031651] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK41402 (to F. S. and A. B. K.), GM31651 (to F. S. and A. B. K.), DK70965 (to B. P. A.), and DK22042 (to W. L. S.) from USPHS.	Abumrad NA, 2005, J CLIN INVEST, V115, P2965, DOI 10.1172/JCI26955; Anderson BM, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-33; Atshaves BP, 2010, LIPIDS, V45, P97, DOI 10.1007/s11745-009-3379-2; Atshaves BP, 2005, AM J PHYSIOL-CELL PH, V288, pC543, DOI 10.1152/ajpcell.00359.2004; Atshaves BP, 2004, MOL CELL BIOCHEM, V259, P115, DOI 10.1023/B:MCBI.0000021357.97765.f2; Atshaves BP, 2004, J BIOL CHEM, V279, P30954, DOI 10.1074/jbc.M313571200; Atshaves BP, 1999, J LIPID RES, V40, P610; Atshaves BP, 2002, AM J PHYSIOL-CELL PH, V283, pC688, DOI 10.1152/ajpcell.00586.2001; ATSHAVES BP, 2010, J NUTR BIOC IN PRESS; BORDEWICK U, 1989, BIOL CHEM H-S, V370, P229, DOI 10.1515/bchm3.1989.370.1.229; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Bradbury MW, 2004, ADV MOL CEL, V33, P47; Chao H, 2003, J LIPID RES, V44, P72, DOI 10.1194/jlr.M200191-JLR200; Chen CT, 2008, PROSTAG LEUKOTR ESS, V79, P85, DOI 10.1016/j.plefa.2008.09.003; Chuang S, 2009, J MED CHEM, V52, P5344, DOI 10.1021/jm801349e; Davies MN, 2008, J BIOL CHEM, V283, P24029, DOI 10.1074/jbc.M801539200; Ek BA, 1997, BBA-LIPID LIPID MET, V1346, P75, DOI 10.1016/S0005-2760(97)00021-0; Fraser H, 1997, MOL CELL BIOCHEM, V167, P51; Frolov A, 1997, BIOCHEMISTRY-US, V36, P6545, DOI 10.1021/bi970205t; Golovko MY, 2006, J LIPID RES, V47, P1289, DOI 10.1194/jlr.M600029-JLR200; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Heyliger CE, 1996, MOL CELL BIOCHEM, V155, P113; Heyliger CE, 1997, MOL CELL BIOCHEM, V176, P281, DOI 10.1023/A:1006817632484; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; JEFFERSON JR, 1990, J BIOL CHEM, V265, P11062; Jolly CA, 1997, ARCH BIOCHEM BIOPHYS, V341, P112, DOI 10.1006/abbi.1997.9957; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Kuklev DV, 2004, CHEM PHYS LIPIDS, V131, P215, DOI 10.1016/j.chemphyslip.2004.06.001; Kuklev DV, 2004, CHEM PHYS LIPIDS, V130, P145, DOI 10.1016/j.chemphyslip.2004.02.006; Lawrence JW, 2000, J LIPID RES, V41, P1390; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; McArthur MJ, 1999, J LIPID RES, V40, P1371; McGuire SO, 1997, LIPIDS, V32, P219, DOI 10.1007/s11745-997-0028-x; Morris DH, 2007, FLAX HLTH NUTR PRIME, P22; Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG244, DOI 10.1152/ajpgi.1998.275.2.G244; Murphy EJ, 1996, ARCH BIOCHEM BIOPHYS, V335, P267, DOI 10.1006/abbi.1996.0507; Murphy EJ, 1996, BBA-LIPID LIPID MET, V1301, P191, DOI 10.1016/0005-2760(96)00024-0; Murphy EJ, 1999, BBA-MOL CELL BIOL L, V1436, P413, DOI 10.1016/S0005-2760(98)00150-7; NEMECZ G, 1991, ARCH BIOCHEM BIOPHYS, V286, P300, DOI 10.1016/0003-9861(91)90044-J; Norris AW, 2002, J LIPID RES, V43, P646; Paulussen R J, 1990, Subcell Biochem, V16, P175; PROWS DR, 1995, LIPIDS, V30, P907, DOI 10.1007/BF02537481; RAZA H, 1989, BIOCHEM BIOPH RES CO, V161, P448, DOI 10.1016/0006-291X(89)92619-3; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; SAMUEL D, 1976, EUR J BIOCHEM, V64, P583, DOI 10.1111/j.1432-1033.1976.tb10338.x; Schaffer JE, 1995, TRENDS CARDIOVAS MED, V5, P218, DOI 10.1016/1050-1738(95)00102-6; SCHROEDER F, 1993, MOL CELL BIOCHEM, V123, P73, DOI 10.1007/BF01076477; Schroeder F, 2001, MOL CELL BIOCHEM, V219, P127, DOI 10.1023/A:1010851130136; Schroeder F, 1998, CHEM PHYS LIPIDS, V92, P1, DOI 10.1016/S0009-3084(98)00003-6; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Weisiger RA, 1996, COMP BIOCHEM PHYS B, V115, P319, DOI 10.1016/S0305-0491(96)00179-4; Wolfrum C, 2000, BIOCHEMISTRY-US, V39, P1469, DOI 10.1021/bi991638u; Yan J, 2009, J LIPID RES, V50, P2445, DOI 10.1194/jlr.M900177-JLR200	63	26	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18693	18708		10.1074/jbc.M109.079897	http://dx.doi.org/10.1074/jbc.M109.079897			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20382741	hybrid, Green Published			2022-12-27	WOS:000278453900062
J	Sokabe, T; Fukumi-Tominaga, T; Yonemura, S; Mizuno, A; Tominaga, M				Sokabe, Takaaki; Fukumi-Tominaga, Tomoko; Yonemura, Shigenobu; Mizuno, Atsuko; Tominaga, Makoto			The TRPV4 Channel Contributes to Intercellular Junction Formation in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTOR; CELL-CELL ADHESION; CATION CHANNEL; INDUCED DIFFERENTIATION; EPIDERMAL BARRIER; E-CADHERIN; RHO; TEMPERATURE; ACTIVATION; MEMBRANE	Transient receptor potential vanilloid 4 (TRPV4) channel is a physiological sensor for hypo-osmolarity, mechanical deformation, and warm temperature. The channel activation leads to various cellular effects involving Ca2+ dynamics. We found that TRPV4 interacts with beta-catenin, a crucial component linking adherens junctions and the actin cytoskeleton, thereby enhancing cell-cell junction development and formation of the tight barrier between skin keratinocytes. TRPV4-deficient mice displayed impairment of the intercellular junction-dependent barrier function in the skin. In TRPV4-deficient keratinocytes, extracellular Ca2+-induced actin rearrangement and stratification were delayed following significant reduction in cytosolic Ca2+ increase and small GTPase Rho activation. TRPV4 protein located where the cell-cell junctions are formed, and the channel deficiency caused abnormal cell-cell junction structures, resulting in higher intercellular permeability in vitro. Our results suggest a novel role for TRPV4 in the development and maturation of cell-cell junctions in epithelia of the skin.	[Sokabe, Takaaki; Fukumi-Tominaga, Tomoko; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Sokabe, Takaaki; Fukumi-Tominaga, Tomoko; Tominaga, Makoto] Grad Univ Adv Studies Sokendai, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Lab Cellular Morphogenesis, Kobe, Hyogo 6500047, Japan; [Mizuno, Atsuko] Jichi Med Sch, Dept Pharmacol, Minami Kawachi, Tochigi 3290498, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; RIKEN; Jichi Medical University	Sokabe, T (corresponding author), Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	sokabe@nips.ac.jp; tominaga@nips.ac.jp		Sokabe, Takaaki/0000-0003-1280-9424	Ministry of Education, Culture, Sport, Science and Technology in Japan; Nakatomi Foundation	Ministry of Education, Culture, Sport, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatomi Foundation	This work was supported by grants from the Ministry of Education, Culture, Sport, Science and Technology in Japan (to T. S., T. F.-T., and M. T.) and from The Nakatomi Foundation (to M. T.).	Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Bershadsky A, 2004, TRENDS CELL BIOL, V14, P589, DOI 10.1016/j.tcb.2004.09.009; Bikle DD, 2004, J STEROID BIOCHEM, V89-90, P355, DOI 10.1016/j.jsbmb.2004.03.020; Braga VMM, 1999, J CLIN PATHOL-MOL PA, V52, P197, DOI 10.1136/mp.52.4.197; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Cai SW, 2006, PFLUG ARCH EUR J PHY, V452, P43, DOI 10.1007/s00424-005-0001-1; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Denda M, 2007, J INVEST DERMATOL, V127, P654, DOI 10.1038/sj.jid.5700590; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guler AD, 2002, J NEUROSCI, V22, P6408; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; Hakuno M, 2000, BRIT J DERMATOL, V142, P702, DOI 10.1046/j.1365-2133.2000.03415.x; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Komuves L, 2002, J CELL PHYSIOL, V192, P45, DOI 10.1002/jcp.10107; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Lehen'kyi V, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611398200; Liebig T, 2009, MOL BIOL CELL, V20, P452, DOI 10.1091/mbc.E07-11-1197; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Plant T. D., 2007, V179, P189; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Ramadass R, 2007, ARCH BIOCHEM BIOPHYS, V463, P27, DOI 10.1016/j.abb.2007.01.036; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; SHUTTLEWORTH TJ, 1991, J BIOL CHEM, V266, P1410; Smith PL, 2006, J BIOL CHEM, V281, P29897, DOI 10.1074/jbc.M605394200; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Troy TC, 2004, METH MOL B, V289, P121; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Tu CL, 2001, J BIOL CHEM, V276, P41079, DOI 10.1074/jbc.M107122200; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Turksen K, 2003, MECH DEVELOP, V120, P733, DOI 10.1016/S0925-4773(03)00045-5; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245	60	114	123	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 11	2010	285	24					18749	18758		10.1074/jbc.M110.103606	http://dx.doi.org/10.1074/jbc.M110.103606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	606UN	20413591	hybrid, Green Published			2022-12-27	WOS:000278453900066
J	Fulcher, AJ; Dias, MM; Jans, DA				Fulcher, Alex James; Dias, Manisha M.; Jans, David A.			Binding of p110 Retinoblastoma Protein Inhibits Nuclear Import of Simian Virus SV40 Large Tumor Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-T-ANTIGEN; ADENOVIRUS E1A PROTEINS; II SITE FLANKING; LOCALIZATION SEQUENCE; CELL-CYCLE; GENE-PRODUCT; DNA-BINDING; JC VIRUS; NUCLEOCYTOPLASMIC TRANSPORT; QUANTITATIVE-ANALYSIS	Nuclear import of the simian virus 40 large tumor antigen (T-ag) is dependent on its nuclear localization signal (NLS) within amino acids 126-132 that is recognized by the importin alpha/beta 1 heterodimer, as well as a protein kinase CK2 site at serine 112 upstream of the NLS, which enhances the interaction similar to 50-fold. Here we show for the first time that T-ag nuclear import is negatively regulated by N-terminal sequences (amino acids 102-110), which represent the binding site (BS) for the retinoblastoma (Rb) tumor suppressor protein (p110(Rb)). Quantitative confocal laser scanning microscopic analysis of the transport properties of T-ag constructs with or without Rb binding site mutations in living transfected cells or in a reconstituted nuclear transport system indicates that the presence of the RbBS significantly reduces nuclear accumulation of T-ag. A number of approaches, including the analysis of T-ag nuclear import in an isogenic cell pair with and without functional p110(Rb) implicate p110(Rb) binding as being responsible for the reduced nuclear accumulation, with the Ser(106) phosphorylation site within the RbBS appearing to enhance the inhibitory effect. Immunoprecipitation experiments confirmed association of T-ag and p110(Rb) and dependence thereof on negative charge at Ser(106). The involvement of p110(Rb) in modulating T-ag nuclear transport has implications for the regulation of nuclear import of other proteins from viruses of medical significance that interact with p110(Rb), and how this may relate to transformation.	Monash Univ, Dept Biochem & Mol Biol, Nucl Signaling Lab, Clayton, Vic 3800, Australia; [Jans, David A.] ARC Ctr Excellence Biotechnol & Dev, Melbourne, Vic 3000, Australia	Monash University	Jans, DA (corresponding author), Dept Biochem & Mol Biol, Nucl Signaling Lab, Monash Univ Bldg 77, Monash, Vic 3800, Australia.	david.jans@med.monash.edu.au		Jans, David/0000-0001-5115-4745	NHMRC (National Health and Medical Research Council) [ID 143710, 384109]	NHMRC (National Health and Medical Research Council)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported, in whole or in part, by the NHMRC (National Health and Medical Research Council) (ID 143710 and 384109).	Alvisi G, 2006, BIOCHEMISTRY-US, V45, P6866, DOI 10.1021/bi060086u; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; BOLLAG B, 1989, J VIROL, V63, P863, DOI 10.1128/JVI.63.2.863-872.1989; Briggs LJ, 1998, J BIOL CHEM, V273, P22745, DOI 10.1074/jbc.273.35.22745; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHERINGTON V, 1988, MOL CELL BIOL, V8, P1380, DOI 10.1128/MCB.8.3.1380; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; DAVIES R, 1993, J VIROL, V67, P2521, DOI 10.1128/JVI.67.5.2521-2528.1993; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; Ferecatu I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-50; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; FRIEDRICH TD, 1993, ONCOGENE, V8, P1673; FULCHER AJ, 2009, FASEB J IN PRESS; GAGE JR, 1990, J VIROL, V64, P723, DOI 10.1128/JVI.64.2.723-730.1990; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; HAGGERTY S, 1989, J VIROL, V63, P2180, DOI 10.1128/JVI.63.5.2180-2190.1989; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Harris KF, 1996, J VIROL, V70, P2378, DOI 10.1128/JVI.70.4.2378-2386.1996; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; HERRMANN CH, 1991, J VIROL, V65, P5848, DOI 10.1128/JVI.65.11.5848-5859.1991; Hu W, 2005, J CELL BIOCHEM, V95, P782, DOI 10.1002/jcb.20439; Hu W, 1999, J BIOL CHEM, V274, P15820, DOI 10.1074/jbc.274.22.15820; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; Hubner S, 2006, J CELL BIOCHEM, V98, P810, DOI 10.1002/jcb.20791; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; JANS DA, 1995, J BIOL CHEM, V270, P17064, DOI 10.1074/jbc.270.29.17064; JANS DA, 1994, ONCOGENE, V9, P2961; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KALDERON D, 1984, VIROLOGY, V139, P109, DOI 10.1016/0042-6822(84)90334-9; Kuusisto HV, 2008, INT J CANCER, V123, P2965, DOI 10.1002/ijc.23884; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lam MHC, 2001, TRAFFIC, V2, P812, DOI 10.1034/j.1600-0854.2001.21110.x; Mohr S, 2008, J VIROL, V82, P10625, DOI 10.1128/JVI.01187-08; ORDENES GE, 1989, J CELL SCI, V93, P525; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Poon IKH, 2005, J VIROL, V79, P1339, DOI 10.1128/JVI.79.2.1339-1341.2005; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; SCHEIDTMANN KH, 1982, J VIROL, V44, P116, DOI 10.1128/JVI.44.1.116-133.1982; SCHEIDTMANN KH, 1984, J VIROL, V50, P1; SLADEK TL, 1992, J VIROL, V66, P1059, DOI 10.1128/JVI.66.2.1059-1065.1992; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Wagstaff KM, 2005, J FLUORESC, V15, P469, DOI 10.1007/s10895-005-2819-5; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191; Yen A, 1998, EXP CELL RES, V241, P324, DOI 10.1006/excr.1998.4007	59	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17744	17753		10.1074/jbc.M109.055491	http://dx.doi.org/10.1074/jbc.M109.055491			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20356831	hybrid, Green Published			2022-12-27	WOS:000278133400052
J	Haruta, M; Burch, HL; Nelson, RB; Barrett-Wilt, G; Kline, KG; Mohsin, SB; Young, JC; Otegui, MS; Sussman, MR				Haruta, Miyoshi; Burch, Heather L.; Nelson, Rachel B.; Barrett-Wilt, Greg; Kline, Kelli G.; Mohsin, Sheher B.; Young, Jeffery C.; Otegui, Marisa S.; Sussman, Michael R.			Molecular Characterization of Mutant Arabidopsis Plants with Reduced Plasma Membrane Proton Pump Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; NA,K-ATPASE; THALIANA; ISOFORM; GROWTH; PROTEIN; IDENTIFICATION; DEFICIENCY; ACTIVATION; EXPRESSION	Arabidopsis mutants containing gene disruptions in AHA1 and AHA2, the two most highly expressed isoforms of the Arabidopsis plasma membrane H+-ATPase family, have been isolated and characterized. Plants containing homozygous loss-of-function mutations in either gene grew normally under laboratory conditions. Transcriptome and mass spectrometric measurements demonstrate that lack of lethality in the single gene mutations is not associated with compensation by increases in RNA or protein levels. Selected reaction monitoring using synthetic heavy isotope-labeled C-terminal tryptic peptides as spiked standards with a triple quadrupole mass spectrometer revealed increased levels of phosphorylation of a regulatory threonine residue in both isoforms in the mutants. Using an extracellular pH assay as a measure of in vivo ATPase activity in roots, less proton secreting activity was found in the aha2 mutant. Among 100 different growth conditions, those that decrease the membrane potential (high external potassium) or pH gradient (high external pH) caused a reduction in growth of the aha2 mutant compared with wild type. Despite the normal appearance of single mutants under ideal laboratory growth conditions, embryos containing homozygous double mutations are lethal, demonstrating that, as expected, this protein is absolutely essential for plant cell function. In conclusion, our results demonstrate that the two genes together perform an essential function and that the effects of their single mutations are mostly masked by overlapping patterns of expression and redundant function as well as by compensation at the post-translational level.	[Young, Jeffery C.; Sussman, Michael R.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53706 USA; [Nelson, Rachel B.; Sussman, Michael R.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Otegui, Marisa S.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Mohsin, Sheher B.] Agilent Technol, Schaumburg, IL 60173 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Agilent Technologies	Sussman, MR (corresponding author), 425 Henry Mall, Madison, WI 53706 USA.	msussman@wisc.edu		Haruta, Miyoshi/0000-0003-1686-1860; Otegui, Marisa/0000-0003-4699-6950	Department of Energy; National Science Foundation; National Science Foundation [MCB-0619736]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Department of Energy and the National Science Foundation (to M. R. S.) and by National Science Foundation Grant MCB-0619736 (to M. S. O.).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Baxter IR, 2005, P NATL ACAD SCI USA, V102, P2649, DOI 10.1073/pnas.0406377102; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis MW, 1995, J NEUROSCI, V15, P8408; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Ellertsdottir E, 2006, DEV DYNAM, V235, P1794, DOI 10.1002/dvdy.20800; Feng Y, 1997, Genes Funct, V1, P99; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Gevaudant F, 2007, PLANT PHYSIOL, V144, P1763, DOI 10.1104/pp.107.103762; HARPER JF, 1990, J BIOL CHEM, V265, P13601; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Krysan PJ, 1996, P NATL ACAD SCI USA, V93, P8145, DOI 10.1073/pnas.93.15.8145; LARSSON C, 1994, METHOD ENZYMOL, V228, P451; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; Merlot S, 2007, EMBO J, V26, P3216, DOI 10.1038/sj.emboj.7601750; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nelson CJ, 2006, MOL CELL PROTEOMICS, V5, P1382, DOI 10.1074/mcp.M500414-MCP200; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Robertson WR, 2004, GENETICS, V168, P1677, DOI 10.1534/genetics.104.032326; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Shu XD, 2003, DEVELOPMENT, V130, P6165, DOI 10.1242/dev.00844; Vitart V, 2001, PLANT J, V27, P191, DOI 10.1046/j.1365-313x.2001.01081.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019; Zhao RM, 2000, PLANT CELL, V12, P535, DOI 10.1105/tpc.12.4.535	33	118	125	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17918	17929		10.1074/jbc.M110.101733	http://dx.doi.org/10.1074/jbc.M110.101733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20348108	Green Published, hybrid			2022-12-27	WOS:000278133400068
J	Koenig, P; Mirus, O; Haarmann, R; Sommer, MS; Sinning, I; Schleiff, E; Tews, I				Koenig, Patrick; Mirus, Oliver; Haarmann, Raimund; Sommer, Maik S.; Sinning, Irmgard; Schleiff, Enrico; Tews, Ivo			Conserved Properties of Polypeptide Transport-associated (POTRA) Domains Derived from Cyanobacterial Omp85	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; YAET COMPLEX; BIOGENESIS; CHANNEL; FAMILY; SURA; IDENTIFICATION; COMPONENT; ENVELOPE; CLONING	Proteins of the Omp85 family are conserved in all kingdoms of life. They mediate protein transport across or protein insertion into membranes and reside in the outer membranes of Gram-negative bacteria, mitochondria, and chloroplasts. Omp85 proteins contain a C-terminal transmembrane beta-barrel and a soluble N terminus with a varying number of polypeptide-transport-associated or POTRA domains. Here we investigate Omp85 from the cyanobacterium Anabaena sp. PCC 7120. The crystallographic three-dimensional structure of the N-terminal region shows three POTRA domains, here named P1 to P3 from the N terminus. Molecular dynamics simulations revealed a hinge between P1 and P2 but in contrast show that P2 and P3 are fixed in orientation. The P2-P3 arrangement is identical as seen for the POTRA domains from proteobacterial FhaC, suggesting this orientation is a conserved feature. Furthermore, we define interfaces for protein-protein interaction in P1 and P2. P3 possesses an extended loop unique to cyanobacteria and plantae, which influences pore properties as shown by deletion. It now becomes clear how variations in structure of individual POTRA domains, as well as the different number of POTRA domains with both rigid and flexible connections make the N termini of Omp85 proteins versatile adaptors for a plentitude of functions.	[Mirus, Oliver; Haarmann, Raimund; Sommer, Maik S.; Schleiff, Enrico] JWGU Frankfurt Main, Ctr Membrane Prote & Cluster Excellence Macromol, Dept Biosci, D-60439 Frankfurt, Germany; [Tews, Ivo] Heidelberg Univ, Biochem Ctr BZH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Schleiff, E (corresponding author), JWGU Frankfurt Main, Ctr Membrane Prote & Cluster Excellence Macromol, Dept Biosci, Max von Laue Str 9, D-60439 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de; ivo.tews@bzh.uni-heidelberg.de	Schleiff, Enrico/C-5105-2017; Tews, Ivo/A-2750-2010	Schleiff, Enrico/0000-0002-0518-3489; Tews, Ivo/0000-0002-4704-1139	Deutsche Forschungsgemeinschaft (DFG) [SFB 807/P17, TR01/A10, SFB 638]; Cluster of Excellence Frankfurt Macromolecular Complexes; Volkswagenstiftung; Land Baden-Wurttemberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cluster of Excellence Frankfurt Macromolecular Complexes; Volkswagenstiftung(Volkswagen); Land Baden-Wurttemberg	The work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG SFB 807/P17 (to M. S. S., R. H., and E. S.) and SFB TR01/A10 (to O. M. and E. S.)), the Cluster of Excellence Frankfurt Macromolecular Complexes (to P. K. and E. S.), the Volkswagenstiftung (to E. S.), the interdisciplinary Ph.D. program "Molecular Machines: Mechanisms and Functional Interconnections" of the Land Baden-Wurttemberg (to P. K. and I. S.), and a collaborative research grant from the DFG (SFB 638 to I. S.).	Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldwin A, 2005, PLANT PHYSIOL, V138, P715, DOI 10.1104/pp.105.063289; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Bos MP, 2004, CURR OPIN MICROBIOL, V7, P610, DOI 10.1016/j.mib.2004.10.011; Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eckart K, 2002, EMBO REP, V3, P557, DOI 10.1093/embo-reports/kvf110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eppens EF, 1997, EMBO J, V16, P4295, DOI 10.1093/emboj/16.14.4295; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koch O, 2009, PROTEINS, V74, P353, DOI 10.1002/prot.22185; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Manning DS, 1998, MICROB PATHOGENESIS, V25, P11, DOI 10.1006/mpat.1998.0206; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200; Mirus O, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-68; Moslavac S, 2005, FEBS J, V272, P1367, DOI 10.1111/j.1742-4658.2005.04569.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Ruffolo CG, 1996, INFECT IMMUN, V64, P3161, DOI 10.1128/IAI.64.8.3161-3167.1996; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; THOMAS WR, 1986, INFECT IMMUN, V52, P812, DOI 10.1128/IAI.52.3.812-817.1986; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Ward R, 2009, STRUCTURE, V17, P1187, DOI 10.1016/j.str.2009.07.011; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; WUNDER T, 2009, ENDOCYT CELL RES, V19, P20	57	45	45	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					18016	18024		10.1074/jbc.M110.112649	http://dx.doi.org/10.1074/jbc.M110.112649			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20348103	Green Published, hybrid			2022-12-27	WOS:000278133400077
J	Valiron, O; Arnal, I; Caudron, N; Job, D				Valiron, Odile; Arnal, Isabelle; Caudron, Nicolas; Job, Didier			GDP-Tubulin Incorporation into Growing Microtubules Modulates Polymer Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOWLY HYDROLYZABLE ANALOG; DYNAMIC INSTABILITY; GUANOSINE DIPHOSPHATE; GTP HYDROLYSIS; INDIVIDUAL MICROTUBULES; PROTOFILAMENT NUMBERS; STRUCTURAL-CHANGES; ASSEMBLY DYNAMICS; KINETIC-ANALYSIS; ALPHA-TUBULIN	Microtubule growth proceeds through the endwise addition of nucleotide-bound tubulin dimers. The microtubule wall is composed of GDP-tubulin subunits, which are thought to come exclusively from the incorporation of GTP-tubulin complexes at microtubule ends followed by GTP hydrolysis within the polymer. The possibility of a direct GDP-tubulin incorporation into growing polymers is regarded as hardly compatible with recent structural data. Here, we have examined GTP-tubulin and GDP-tubulin incorporation into polymerizing microtubules using a minimal assembly system comprised of nucleotide-bound tubulin dimers, in the absence of free nucleotide. We find that GDP-tubulin complexes can efficiently co-polymerize with GTP-tubulin complexes during microtubule assembly. GDP-tubulin incorporation into microtubules occurs with similar efficiency during bulk microtubule assembly as during microtubule growth from seeds or centrosomes. Microtubules formed from GTP-tubulin/GDP-tubulin mixtures display altered microtubule dynamics, in particular a decreased shrinkage rate, apparently due to intrinsic modifications of the polymer disassembly properties. Thus, although microtubules polymerized from GTP-tubulin/GDP-tubulin mixtures or from homogeneous GTP-tubulin solutions are both composed of GDP-tubulin subunits, they have different dynamic properties, and this may reveal a novel form of microtubule "structural plasticity."	[Valiron, Odile; Arnal, Isabelle; Caudron, Nicolas; Job, Didier] Univ Grenoble 1, Grenoble Inst Neurosci, INSERM, U836, F-38042 Grenoble 9, France; [Arnal, Isabelle] Univ Rennes 1, Inst Federatif Rech 140, CNRS, UMR 6026, F-35042 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Valiron, O (corresponding author), Univ Grenoble 1, Grenoble Inst Neurosci, INSERM, U836, Batiment Edmond J Safra,Site Sante Tronche,BP 170, F-38042 Grenoble 9, France.	odile.valiron@ujf-grenoble.fr	Arnal, Isabelle/X-6559-2019	Arnal, Isabelle/0000-0001-6149-8189	La Ligue Nationale Contre le Cancer; Agence Nationale de la Recherce [ANR-07-PCVI-0012]	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherce(French National Research Agency (ANR))	This work was supported by grants from La Ligue Nationale Contre le Cancer (to O. V. and D. J.) and Agence Nationale de la Recherce Grant ANR-07-PCVI-0012 (to I. A.).	Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; BAYLEY PM, 1986, FEBS LETT, V205, P230, DOI 10.1016/0014-5793(86)80903-6; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; CARLIER MF, 1989, INT REV CYTOL, V115, P139; CARLIER MF, 1978, BIOCHEMISTRY-US, V17, P1908, DOI 10.1021/bi00603a017; Carlier MF, 1997, BIOPHYS J, V73, P418, DOI 10.1016/S0006-3495(97)78081-0; Caudron N, 2000, J MOL BIOL, V297, P211, DOI 10.1006/jmbi.2000.3554; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Fanara P, 1999, EMBO J, V18, P565, DOI 10.1093/emboj/18.3.565; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; HAMEL E, 1986, BIOCHEMISTRY-US, V25, P7054, DOI 10.1021/bi00370a045; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; JAMESON L, 1980, J BIOL CHEM, V255, P2284; JOB D, 1985, J CELL BIOL, V101, P1680, DOI 10.1083/jcb.101.5.1680; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mozziconacci J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003821; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; NICKERSON JA, 1978, BIOCHEM BIOPH RES CO, V85, P820, DOI 10.1016/0006-291X(78)91236-6; OBRIEN ET, 1989, BIOCHEMISTRY-US, V28, P1413, DOI 10.1021/bi00429a070; PATURLE L, 1989, BIOCHEMISTRY-US, V28, P2698, DOI 10.1021/bi00432a050; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; PATURLELAFANECHERE L, 1991, BIOCHEMISTRY-US, V30, P10523, DOI 10.1021/bi00107a022; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Tran PT, 1997, J STRUCT BIOL, V118, P107, DOI 10.1006/jsbi.1997.3844; Valiron O, 2001, CELL MOL LIFE SCI, V58, P2069, DOI 10.1007/PL00000837; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; WADE RH, 1990, J MOL BIOL, V212, P775, DOI 10.1016/0022-2836(90)90236-F; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEHLAND J, 1987, J CELL SCI, V88, P185; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007291; ZACKROFF RV, 1980, J MOL BIOL, V139, P641, DOI 10.1016/0022-2836(80)90053-4	44	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 4	2010	285	23					17507	17513		10.1074/jbc.M109.099515	http://dx.doi.org/10.1074/jbc.M109.099515			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	602IT	20371874	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-27	WOS:000278133400029
J	Czubryt, MP; Lamoureux, L; Ramjiawan, A; Abrenica, B; Jangamreddy, J; Swan, K				Czubryt, Michael P.; Lamoureux, Lise; Ramjiawan, Angela; Abrenica, Bernard; Jangamreddy, Jaganmohan; Swan, Kristin			Regulation of Cardiomyocyte Glut4 Expression by ZAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL DIABETES-MELLITUS; ACTIVATED-RECEPTOR-GAMMA; ZINC-FINGER PROTEIN; MEF2 TRANSCRIPTION FACTOR; II HISTONE DEACETYLASES; TUMOR-SUPPRESSOR GENE; CARDIAC-HYPERTROPHY; MUSCLE DIFFERENTIATION; GLUCOSE-TRANSPORTER; SKELETAL-MUSCLE	The transcription factor ZAC1 is expressed in a variety of tissues including the developing heart, but its physiological role is unclear. We examined the role of ZAC1 in regulating expression of the insulin-responsive glucose transporter GLUT4 and whether ZAC1 expression is altered in cardiomyocyte hypertrophy. We demonstrated expression of Zac1 mRNA and protein in rat cardiomyocytes by PCR and Western blotting, respectively. Using a combination of chromatin immunoprecipitation and luciferase assays, we showed that ZAC1 regulates Glut4 expression via a specific binding site in the Glut4 promoter. Overexpression of ZAC1 increased Glut4 mRNA and protein expression and resulted in increased glucose uptake in cardiomyocytes as determined by a fluorescent analog uptake assay. Induction of hypertrophy by phenylephrine or isoproterenol resulted in increased Zac1 expression. We identified a novel putative promoter in the Zac1 gene and demonstrated increased binding of MEF2 to this promoter in response to hypertrophic stimulation. MEF2 regulated transactivation of the Zac1 promoter and ZAC1 protein expression. This work identifies ZAC1 as a novel and previously unknown regulator of cardiomyocyte Glut4 expression and glucose uptake. Our results also implicate MEF2 as a regulator of ZAC1 expression in response to induction of hypertrophy.	Univ Manitoba, St Boniface Gen Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada; Univ Manitoba, Dept Physiol, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba	Czubryt, MP (corresponding author), 351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	mczubryt@sbrc.ca	Reddy, Jaganmohan/R-9379-2019; Jangamreddy, Jaganmohan Reddy/J-8085-2013	Jangamreddy, Jaganmohan Reddy/0000-0001-6105-1213; Czubryt, Michael/0000-0003-4897-9804	University of Manitoba; Manitoba Medical Services Foundation; Canadian Institutes of Health Research [ROP 83898]	University of Manitoba; Manitoba Medical Services Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the University of Manitoba Research Grants program, the Manitoba Medical Services Foundation, and the Canadian Institutes of Health Research (ROP 83898).	Abdollahi A, 2003, J BIOL CHEM, V278, P6041, DOI 10.1074/jbc.M210361200; ADACHI S, 1994, J MOL CELL CARDIOL, V26, P789, DOI 10.1006/jmcc.1994.1096; Alam S, 2005, DEV DYNAM, V234, P772, DOI 10.1002/dvdy.20577; Armstrong MT, 2000, DEV DYNAM, V219, P226, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1049>3.3.CO;2-S; Arthur EI, 1997, EUR J HUM GENET, V5, P417, DOI 10.1159/000484801; Barz T, 2006, CANCER RES, V66, P11975, DOI 10.1158/0008-5472.CAN-06-1529; Bilanges B, 2001, ONCOGENE, V20, P1246, DOI 10.1038/sj.onc.1204237; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Chen SL, 2000, GENE DEV, V14, P1209; Chiu LL, 2005, HIGH ALT MED BIOL, V6, P256, DOI 10.1089/ham.2005.6.256; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Galuska D, 1998, ADV EXP MED BIOL, V441, P73; Hashimoto T, 2004, J APPL PHYSIOL, V97, P843, DOI 10.1152/japplphysiol.01193.2003; Hoffmann A, 2003, MOL CELL BIOL, V23, P988, DOI 10.1128/MCB.23.3.988-1003.2003; Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004; Huang CY, 2002, CELL BIOL INT, V26, P737, DOI 10.1006/cbir.2002.0919; Huang SM, 2000, MOL CELL BIOL, V20, P1855, DOI 10.1128/MCB.20.5.1855-1867.2000; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Ma D, 2004, J CLIN INVEST, V114, P339, DOI 10.1172/jci200419876; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Minakawa M, 2003, EUR J CARDIO-THORAC, V24, P493, DOI 10.1016/S1010-7940(03)00410-X; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Naya FJ, 1999, DEVELOPMENT, V126, P2045; *NIH, 1996, PUBL NIH, V8523; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Porrello ER, 2008, CLIN EXP PHARMACOL P, V35, P1358, DOI 10.1111/j.1440-1681.2008.05036.x; Rauch C, 2005, AM J PHYSIOL-CELL PH, V288, pC593, DOI 10.1152/ajpcell.00346.2004; Rodriguez-Henche N, 2002, BBA-GENE STRUCT EXPR, V1576, P157, DOI 10.1016/S0167-4781(02)00303-2; Sale MM, 2004, DIABETES, V53, P830, DOI 10.2337/diabetes.53.3.830; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; TURNER JD, 1988, AM J PHYSIOL, V255, pE513, DOI 10.1152/ajpendo.1988.255.4.E513; Valente T, 2005, DEV DYNAM, V233, P667, DOI 10.1002/dvdy.20373; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Varrault A, 2001, J BIOL CHEM, V276, P18653, DOI 10.1074/jbc.C100095200; Varrault A, 1998, P NATL ACAD SCI USA, V95, P8835, DOI 10.1073/pnas.95.15.8835; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Waser M, 1997, J CELL BIOL, V138, P547, DOI 10.1083/jcb.138.3.547; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Xi X, 2001, J BIOL CHEM, V276, P41029, DOI 10.1074/jbc.M102824200; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	49	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 28	2010	285	22					16942	16950		10.1074/jbc.M109.097246	http://dx.doi.org/10.1074/jbc.M109.097246			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	600JS	20363751	Green Published, hybrid			2022-12-27	WOS:000277982600057
J	Goto, A; Yano, T; Terashima, J; Iwashita, S; Oshima, Y; Kurata, S				Goto, Akira; Yano, Tamaki; Terashima, Jun; Iwashita, Shinzo; Oshima, Yoshiteru; Kurata, Shoichiro			Cooperative Regulation of the Induction of the Novel Antibacterial Listericin by Peptidoglycan Recognition Protein LE and the JAK-STAT Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; IMMUNE-RESPONSE; INNATE IMMUNITY; HOST-DEFENSE; BACTERIAL-INFECTION; DROSOPHILA MUTANTS; SIGNALING PATHWAY; JAK/STAT PATHWAY; LISTERIOLYSIN-O; PGRP-LC	Intracellular bacteria cause serious infectious diseases such as tuberculosis, shigellosis, and listeriosis. The Drosophila peptidoglycan recognition protein (PGRP)-LE functions as an important host pattern recognition receptor against intracellular bacteria such as Listeria monocytogenes. One PGRP-LE-mediated intracellular response against L. monocytogenes infection is the induction of autophagy, a conserved intracellular degradation system. Here, to further elucidate PGRP-LE-mediated intracellular innate immune responses, we performed a strategic microarray analysis and identified the Listericin gene, whose expression is induced in response to L. monocytogenes infection in a PGRP-LE-dependent manner. RNA interference and overexpression experiments demonstrated that Listericin gene induction is cooperatively regulated by PGRP-LE and the JAK-STAT (Janus kinase-signal transducers and activators of transcription) pathway. An in vitro cell culture assay showed that Listericin is secreted as processed forms and suppresses the growth of L. monocytogenes and Gram-negative bacteria. A colony formation unit assay clearly demonstrated that induction of the Listericin gene suppresses not only the growth of L. monocytogenes but also the growth of Gram-negative bacteria in vivo. Based on these findings, we propose that the Listericin gene encodes a novel antibacterial peptide-like protein whose induction is cooperatively regulated by PGRP-LE and the JAK-STAT pathway.	[Goto, Akira; Yano, Tamaki; Terashima, Jun; Iwashita, Shinzo; Oshima, Yoshiteru; Kurata, Shoichiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Goto, Akira] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Tohoku University; Tohoku University	Kurata, S (corresponding author), 6-3 Aramaki Aoba Ku, Sendai, Miyagi 9808578, Japan.	kurata@mail.pharm.tohoku.ac.jp	Yano, Tamaki/AHB-5620-2022; GOTO, Akira/V-7847-2017	Yano, Tamaki/0000-0002-5576-1128; GOTO, Akira/0000-0003-3395-484X	National Institutes of Health [AI07495]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Sciences; Japan Science and Technology Agency; Uehara Foundation; Naito Foundation; Tohoku University Ecosystem Adaptability; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007495, R01AI074958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Tohoku University Ecosystem Adaptability; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI07495. This work was also supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Japan Society for the Promotion of Sciences, the Program for the Promotion of Basic Research Activities for Innovative Biosciences, Strategic International Cooperative program from Japan Science and Technology Agency, the Uehara Foundation, the Naito Foundation, and a Global COE Research Grant (Tohoku University Ecosystem Adaptability).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alonso A, 2004, INT MICROBIOL, V7, P181; Asha H, 2003, GENETICS, V163, P203; Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782; BACH EA, 2003, SIGNAL TRANSDUCERS A, P87; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; BINA S, 2008, AJAK STAT PATHWAY DI, P24; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Engstrom Y, 1999, DEV COMP IMMUNOL, V23, P345, DOI 10.1016/S0145-305X(99)00016-6; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; Gordon MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000111; Goto A, 2003, NUCLEIC ACIDS RES, V31, P6619, DOI 10.1093/nar/gkg852; Goto A, 2006, ISJ-INVERT SURVIV J, V3, P103; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; Pizarro-Cerda J, 2006, J PATHOL, V208, P215, DOI 10.1002/path.1888; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482	61	34	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					15731	15738		10.1074/jbc.M109.082115	http://dx.doi.org/10.1074/jbc.M109.082115			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20348097	Green Published, hybrid			2022-12-27	WOS:000277715900008
J	Lymperopoulos, A; Rengo, G; Gao, EH; Ebert, SN; Dorn, GW; Koch, WJ				Lymperopoulos, Anastasios; Rengo, Giuseppe; Gao, Erhe; Ebert, Steven N.; Dorn, Gerald W., II; Koch, Walter J.			Reduction of Sympathetic Activity via Adrenal-targeted GRK2 Gene Deletion Attenuates Heart Failure Progression and Improves Cardiac Function after Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(2)-ADRENOCEPTOR SUBTYPES; CATECHOLAMINE RELEASE; RECEPTOR KINASE; NERVOUS-SYSTEM; POLYMORPHISMS; STIMULATION; PHYSIOLOGY; ABLATION; MICE	Chronic heart failure (HF) is characterized by sympathetic over-activity and enhanced circulating catecholamines (CAs), which significantly increase HF morbidity and mortality. We recently reported that adrenal G protein-coupled receptor kinase 2 (GRK2) is up-regulated in chronic HF, leading to enhanced CA release via desensitization/down-regulation of the chromaffin cell alpha(2)-adrenergic receptors that normally inhibit CA secretion. We also showed that adrenal GRK2 inhibition decreases circulating CAs and improves cardiac inotropic reserve and function. Herein, we hypothesized that adrenal-targeted GRK2 gene deletion before the onset of HF might be beneficial by reducing sympathetic activation. To specifically delete GRK2 in the chromaffin cells of the adrenal gland, we crossed PNMTCre mice, expressing Cre recombinase under the chromaffin cell-specific phenylethanolamine N-methyltransferase (PNMT) gene promoter, with floxedGRK2 mice. After confirming a significant (similar to 50%) reduction of adrenal GRK2 mRNA and protein levels, the PNMT-driven GRK2 knockout (KO) offspring underwent myocardial infarction (MI) to induce HF. At 4 weeks post-MI, plasma levels of both norepinephrine and epinephrine were reduced in PNMT-driven GRK2 KO, compared with control mice, suggesting markedly reduced post-MI sympathetic activation. This translated in PNMT-driven GRK2 KO mice into improved cardiac function and dimensions as well as amelioration of abnormal cardiac beta-adrenergic receptor signaling at 4 weeks post-MI. Thus, adrenal-targeted GRK2 gene KO decreases circulating CAs, leading to improved cardiac function and beta-adrenergic reserve in post-MI HF. GRK2 inhibition in the adrenal gland might represent a novel sympatholytic strategy that can aid in blocking HF progression.	[Lymperopoulos, Anastasios] Nova SE Univ, Dept Pharmaceut Sci, Coll Pharm, Ft Lauderdale, FL 33328 USA; [Lymperopoulos, Anastasios; Rengo, Giuseppe; Gao, Erhe; Koch, Walter J.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Lymperopoulos, Anastasios; Rengo, Giuseppe; Gao, Erhe; Koch, Walter J.] Thomas Jefferson Univ, Dept Med, George Zallie & Family Lab Cardiovasc Gene Therap, Philadelphia, PA 19107 USA; [Ebert, Steven N.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Dorn, Gerald W., II] Washington Univ, Dept Internal Med, Ctr Pharmacogenom, St Louis, MO 63110 USA	Nova Southeastern University; Jefferson University; Jefferson University; State University System of Florida; University of Central Florida; Washington University (WUSTL)	Lymperopoulos, A (corresponding author), Nova SE Univ, Dept Pharmaceut Sci, Coll Pharm, 3200 S Univ Dr,HPD Terry Bldg,Rm 1338, Ft Lauderdale, FL 33328 USA.	al806@nova.edu	Rengo, Giuseppe/AAA-2870-2021; Lymperopoulos, Tasos/AAA-4366-2020; Rengo, Giuseppe/K-4963-2016	Rengo, Giuseppe/0000-0002-9701-0437; Rengo, Giuseppe/0000-0002-9701-0437; Lymperopoulos, Anastasios/0000-0001-9817-6319	National Institutes of Health [HL56205, HL61690, HL085503, HL075443, P01-HL091799]; American Heart Association [09SDG2010138]; Commonwealth of Pennsylvania Dept. of Health [A75301]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075443, R37HL061690, R01HL085503, P01HL091799, R01HL056205, R01HL061690, R01HL087871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Commonwealth of Pennsylvania Dept. of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56205, HL61690, HL085503, and HL075443 (Project 2) and P01-HL091799 (to W. J. K.). This work was also supported by post-doctoral fellowships (to A. L. and G. R.) from the American Heart Association (Great Rivers Affiliate) and by Grant A75301 from the Commonwealth of Pennsylvania Dept. of Health.; Supported by a Scientist Development Grant from the American Heart Association (AHA Grant 09SDG2010138, National Center). To whom correspondence should be addressed: Dept. of Pharmaceutical Sciences, Nova Southeastern University College of Pharmacy, 3200 S. University Dr., HPD ( Terry) Bldg., Rm. 1338, Ft. Lauderdale, FL 33328. Tel.: 954-262-1338; Fax: 954-262-2278; E-mail: al806@nova.edu.	Brede M, 2003, MOL ENDOCRINOL, V17, P1640, DOI 10.1210/me.2003-0035; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Bristow MR, 2004, CIRCULATION, V110, P1437, DOI 10.1161/01.CIR.0000141297.50027.A4; Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Ebert SN, 2004, DEV DYNAM, V231, P849, DOI 10.1002/dvdy.20188; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Floras JS, 2002, CIRCULATION, V105, P1753, DOI 10.1161/01.CIR.0000013788.71817.16; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Lymperopoulos A, 2008, MOL THER, V16, P302, DOI 10.1038/sj.mt.6300371; Lymperopoulos A, 2007, TRENDS MOL MED, V13, P503, DOI 10.1016/j.molmed.2007.10.005; Lymperopoulos A, 2007, NAT MED, V13, P315, DOI 10.1038/nm1553; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Port JD, 2001, J MOL CELL CARDIOL, V33, P887, DOI 10.1006/jmcc.2001.1358; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Rengo G, 2009, CIRCULATION, V119, P89, DOI 10.1161/CIRCULATIONAHA.108.803999; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Small KM, 2003, ANNU REV PHARMACOL, V43, P381, DOI 10.1146/annurev.pharmtox.43.100901.135823; Thomas S, 2007, HEART FAIL CLIN, V3, P381, DOI DOI 10.1016/J.HFC.2007.07.004; Tilley Douglas G, 2006, Expert Rev Cardiovasc Ther, V4, P417, DOI 10.1586/14779072.4.3.417; Wamhoff B R, 2007, Handb Exp Pharmacol, P441; YOUNG JB, 1998, WILLIAMS TXB ENDOCRI; [No title captured]	29	95	97	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 21	2010	285	21					16378	16386		10.1074/jbc.M109.077859	http://dx.doi.org/10.1074/jbc.M109.077859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	596WJ	20351116	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000277715900074
